,drug,count
0,laboratory biomarker analysis,3141
1,placebo,2409
2,cyclophosphamide,1950
3,cisplatin,1705
4,paclitaxel,1551
5,carboplatin,1526
6,radiation therapy,1363
7,docetaxel,1202
8,bevacizumab,1087
9,gemcitabine,990
10,dexamethasone,980
11,pharmacological study,969
12,rituximab,955
13,etoposide,862
14,capecitabine,835
15,quality-of-life assessment,777
16,oxaliplatin,771
17,pembrolizumab,741
18,cytarabine,720
19,filgrastim,698
20,nivolumab,684
21,questionnaire administration,682
22,prednisone,600
23,fluorouracil,572
24,methotrexate,566
25,lenalidomide,563
26,cetuximab,534
27,temozolomide,533
28,bortezomib,498
29,doxorubicin hydrochloride,497
30,melphalan,489
31,fludarabine,471
32,trastuzumab,464
33,peripheral blood stem cell transplantation,459
34,gemcitabine hydrochloride,450
35,conventional surgery,434
36,doxorubicin,430
37,radiotherapy,415
38,pemetrexed,398
39,vincristine sulfate,398
40,ipilimumab,396
41,irinotecan,395
42,leucovorin calcium,355
43,erlotinib,340
44,everolimus,334
45,chemotherapy,319
46,fludarabine phosphate,308
47,sorafenib,303
48,busulfan,296
49,therapeutic conventional surgery,294
50,irinotecan hydrochloride,293
51,adjuvant therapy,282
52,vincristine,279
53,ifosfamide,271
54,letrozole,265
55,questionnaires,264
56,aldesleukin,251
57,surgery,249
58,sargramostim,240
59,dasatinib,237
60,immunohistochemistry staining method,235
61,biopsy,234
62,nab-paclitaxel,232
63,leucovorin,231
64,5-fluorouracil,227
65,gene expression analysis,226
66,azacitidine,222
67,durvalumab,222
68,thalidomide,219
69,atezolizumab,218
70,cyclosporine,214
71,metformin,210
72,questionnaire,207
73,tacrolimus,205
74,vorinostat,202
75,gefitinib,202
76,positron emission tomography,201
77,ibrutinib,201
78,radiation,198
79,mycophenolate mofetil,198
80,decitabine,197
81,sunitinib,194
82,neoadjuvant therapy,194
83,fulvestrant,184
84,imatinib mesylate,184
85,computed tomography,175
86,erlotinib hydrochloride,175
87,temsirolimus,167
88,apatinib,165
89,polymerase chain reaction,163
90,celecoxib,159
91,vinorelbine,158
92,pegfilgrastim,157
93,exemestane,156
94,olaparib,155
95,bendamustine,155
96,idarubicin,152
97,enzalutamide,152
98,intensity-modulated radiation therapy,151
99,allogeneic hematopoietic stem cell transplantation,149
100,avelumab,148
101,carmustine,148
102,magnetic resonance imaging,146
103,educational intervention,145
104,thiotepa,145
105,flow cytometry,144
106,g-csf,143
107,zoledronic acid,142
108,topotecan hydrochloride,141
109,allogeneic bone marrow transplantation,141
110,lapatinib,138
111,pazopanib,137
112,topotecan,137
113,sorafenib tosylate,136
114,anastrozole,136
115,carfilzomib,134
116,sirolimus,131
117,epirubicin,128
118,panitumumab,128
119,clofarabine,124
120,medical chart review,122
121,palbociclib,121
122,brentuximab vedotin,118
123,polymorphism analysis,118
124,microarray analysis,118
125,tamoxifen,118
126,sunitinib malate,118
127,mutation analysis,118
128,stereotactic body radiation therapy,118
129,protein expression analysis,117
130,mitoxantrone hydrochloride,117
131,5-fu,117
132,total-body irradiation,117
133,anti-thymocyte globulin,116
134,venetoclax,116
135,trametinib,116
136,no intervention,115
137,daunorubicin hydrochloride,115
138,psychosocial assessment and care,114
139,mesna,114
140,tremelimumab,113
141,dacarbazine,111
142,mri,111
143,management of therapy complications,109
144,mercaptopurine,108
145,pertuzumab,108
146,recombinant interferon alfa,108
147,bicalutamide,107
148,abiraterone acetate,105
149,brachytherapy,105
150,methylprednisolone,103
151,tamoxifen citrate,103
152,pomalidomide,103
153,obinutuzumab,102
154,degarelix,101
155,ixabepilone,100
156,exercise intervention,100
157,autologous bone marrow transplantation,98
158,usual care,97
159,exercise,97
160,arsenic trioxide,96
161,3-dimensional conformal radiation therapy,95
162,autologous hematopoietic stem cell transplantation,94
163,survey administration,94
164,s-1,93
165,daratumumab,92
166,nilotinib,91
167,alemtuzumab,90
168,vemurafenib,90
169,stereotactic radiosurgery,89
170,prednisolone,88
171,regorafenib,88
172,immunoenzyme technique,88
173,imatinib,87
174,rad001,87
175,blood draw,87
176,reverse transcriptase-polymerase chain reaction,83
177,cytology specimen collection procedure,83
178,sbrt,81
179,veliparib,81
180,radiofrequency ablation,81
181,epirubicin hydrochloride,80
182,lenvatinib,80
183,ruxolitinib,80
184,mitoxantrone,78
185,diagnostic laboratory biomarker analysis,77
186,external beam radiation therapy,77
187,acupuncture,77
188,fludeoxyglucose f 18,76
189,leuprolide acetate,76
190,pemetrexed disodium,75
191,pegylated liposomal doxorubicin hydrochloride,74
192,dna analysis,74
193,tace,73
194,daunorubicin,73
195,asparaginase,73
196,standard of care,73
197,afatinib,72
198,control,71
199,axitinib,71
200,cabozantinib,71
201,pegaspargase,71
202,ofatumumab,71
203,counseling intervention,70
204,ramucirumab,69
205,goserelin acetate,68
206,vinblastine,68
207,vinorelbine tartrate,68
208,interleukin-2,68
209,bleomycin sulfate,67
210,immunologic technique,67
211,gm-csf,66
212,selumetinib,66
213,total body irradiation,66
214,crizotinib,66
215,therapeutic allogeneic lymphocytes,66
216,imiquimod,66
217,assessment of therapy complications,66
218,panobinostat,66
219,bone marrow ablation with stem cell support,66
220,mitomycin c,65
221,goserelin,65
222,dabrafenib,64
223,ixazomib,64
224,tipifarnib,64
225,thioguanine,63
226,observation,63
227,normal saline,63
228,rna analysis,62
229,romidepsin,62
230,epoetin alfa,62
231,lapatinib ditosylate,62
232,bevacizumab [avastin],61
233,blood sampling,60
234,mass spectrometry,60
235,lomustine,60
236,fluorescence in situ hybridization,59
237,imrt,59
238,cabazitaxel,58
239,cobimetinib,58
240,interview,57
241,saline,57
242,aspirin,56
243,plerixafor,56
244,abraxane,56
245,trabectedin,56
246,eribulin mesylate,56
247,folfiri,55
248,velcade,55
249,alvocidib,55
250,isotretinoin,54
251,selinexor,54
252,blood sample,54
253,umbilical cord blood transplantation,53
254,vismodegib,53
255,nimotuzumab,53
256,gemtuzumab ozogamicin,53
257,entinostat,52
258,folinic acid,52
259,amifostine trihydrate,52
260,vandetanib,52
261,study of socioeconomic and demographic variables,52
262,antineoplaston therapy (atengenal + astugenal),51
263,incomplete freund's adjuvant,51
264,herceptin,51
265,taxotere,51
266,icotinib,51
267,"sorafenib (nexavar, bay43-9006)",50
268,ribociclib,50
269,proteomic profiling,50
270,therapeutic hydrocortisone,49
271,bkm120,49
272,cytogenetic analysis,49
273,cognitive assessment,49
274,pharmacogenomic studies,49
275,abemaciclib,49
276,surgical procedure,49
277,vinblastine sulfate,49
278,hydroxyurea,48
279,osimertinib,48
280,flutamide,48
281,western blotting,48
282,cediranib maleate,48
283,therapeutic autologous lymphocytes,48
284,blinatumomab,48
285,survey,47
286,photodynamic therapy,47
287,eribulin,47
288,best supportive care,47
289,biospecimen collection,47
290,low-let photon therapy,47
291,colonoscopy,46
292,darbepoetin alfa,46
293,bleomycin,46
294,etoposide phosphate,46
295,hydroxychloroquine,46
296,vitamin d,46
297,adriamycin,46
298,dna methylation analysis,46
299,paclitaxel albumin-stabilized nanoparticle formulation,45
300,valproic acid,45
301,dynamic contrast-enhanced magnetic resonance imaging,45
302,informational intervention,45
303,non-interventional,44
304,standard care,44
305,biologic sample preservation procedure,44
306,liposomal doxorubicin,44
307,idelalisib,44
308,avastin,44
309,blood samples,43
310,cholecalciferol,43
311,midazolam,43
312,folic acid,43
313,placebo oral tablet,43
314,il-2,43
315,pazopanib hydrochloride,43
316,dexmedetomidine,43
317,stem cell transplant,43
318,alisertib,42
319,cladribine,42
320,ara-c,42
321,medi4736,42
322,denosumab,42
323,ketoconazole,42
324,folfox regimen,42
325,stereotactic body radiotherapy,41
326,leukapheresis,41
327,indocyanine green,41
328,perifosine,41
329,bibw 2992,41
330,epacadostat,41
331,stereotactic body radiation therapy (sbrt),41
332,data collection,41
333,cryotherapy,41
334,curcumin,41
335,laparoscopic surgery,40
336,radical prostatectomy,40
337,sentinel lymph node biopsy,40
338,niraparib,40
339,nonmyeloablative allogeneic hematopoietic stem cell transplantation,40
340,abiraterone,40
341,telephone-based intervention,40
342,pet/ct,40
343,folfox,39
344,pegylated liposomal doxorubicin,39
345,shr-1210,39
346,chlorambucil,39
347,simvastatin,39
348,internet-based intervention,38
349,clinical observation,38
350,itraconazole,38
351,calcitriol,38
352,procarbazine hydrochloride,38
353,gp100 antigen,38
354,hypofractionated radiation therapy,38
355,propofol,38
356,neratinib,38
357,etanercept,38
358,placebos,37
359,anlotinib,37
360,surgical resection,37
361,capecitabine [xeloda],36
362,in vitro-treated peripheral blood stem cell transplantation,36
363,apalutamide,36
364,dactinomycin,36
365,bryostatin 1,36
366,nintedanib,36
367,aprepitant,36
368,high performance liquid chromatography,36
369,physical activity,35
370,elotuzumab,35
371,enzastaurin,35
372,control group,35
373,rucaparib,34
374,oblimersen sodium,34
375,ultrasound,34
376,cryosurgery,34
377,bupivacaine,34
378,palifermin,34
379,bendamustine hydrochloride,34
380,alt-803,34
381,lidocaine,34
382,therapeutic autologous dendritic cells,33
383,trastuzumab emtansine,33
384,tanespimycin,33
385,ascorbic acid,33
386,pdr001,32
387,intensity modulated radiation therapy,32
388,enzyme-linked immunosorbent assay,32
389,dietary intervention,32
390,low-let cobalt-60 gamma ray therapy,32
391,endostar,31
392,metformin hydrochloride,31
393,stem cell infusion,31
394,stem cell transplantation,31
395,cryoablation,31
396,pet scan,31
397,lbh589,31
398,floxuridine,31
399,belinostat,31
400,rapamycin,31
401,external beam radiotherapy,30
402,fenretinide,30
403,ridaforolimus,30
404,study of high risk factors,30
405,motexafin gadolinium,30
406,standard follow-up care,30
407,vindesine,30
408,best practice,30
409,bosutinib,30
410,recombinant interleukin-12,30
411,ondansetron,30
412,thymoglobulin,30
413,talimogene laherparepvec,30
414,acalabrutinib,29
415,atorvastatin,29
416,triapine,29
417,akt inhibitor mk2206,29
418,pentostatin,29
419,blood collection,29
420,microwave ablation,29
421,rfa,29
422,chidamide,29
423,estramustine phosphate sodium,29
424,folfirinox,29
425,ketamine,28
426,acetaminophen,28
427,bibf 1120,28
428,fatigue assessment and management,28
429,byl719,28
430,fentanyl,28
431,pioglitazone,28
432,doxil,28
433,o6-benzylguanine,28
434,tumor biopsy,28
435,yoga,27
436,cixutumumab,27
437,dovitinib,27
438,sipuleucel-t,27
439,stereotactic body radiotherapy (sbrt),27
440,folfiri regimen,27
441,erlotinib [tarceva],27
442,ultrasound imaging,27
443,semaxanib,27
444,mfolfox6,27
445,evaluation of cancer risk factors,27
446,mk-3475,27
447,total body irradiation (tbi),27
448,talazoparib,27
449,ziv-aflibercept,27
450,yttrium y 90 ibritumomab tiuxetan,26
451,xeloda,26
452,allopurinol,26
453,cediranib,26
454,clarithromycin,26
455,morphine,26
456,tretinoin,26
457,physiologic testing,26
458,cilengitide,26
459,clomiphene citrate,26
460,triptorelin,26
461,leuprolide,26
462,esophagectomy,26
463,biological therapy,26
464,paricalcitol,26
465,systemic chemotherapy,25
466,ponatinib,25
467,midostaurin,25
468,glutamine,25
469,"regorafenib (stivarga, bay73-4506)",25
470,doxycycline,25
471,ferumoxytol,25
472,adjuvant chemotherapy,25
473,fludeoxyglucose f-18,25
474,aflibercept,25
475,omeprazole,25
476,hydrocortisone,25
477,behavioral dietary intervention,25
478,propranolol,25
479,nelarabine,25
480,gsk1120212,24
481,chemoradiotherapy,24
482,ct scan,24
483,gabapentin,24
484,vitamin d3,24
485,tocilizumab,24
486,mart-1 antigen,24
487,standard treatment,24
488,neoadjuvant chemotherapy,24
489,pain therapy,24
490,standard chemotherapy,24
491,vitamin e,24
492,magnetic resonance spectroscopic imaging,24
493,vinflunine,24
494,lee011,24
495,su011248,24
496,phone call,23
497,protein analysis,23
498,radionuclide imaging,23
499,azd6244,23
500,dexrazoxane hydrochloride,23
501,alectinib,23
502,autologous tumor cell vaccine,23
503,endocrine therapy,23
504,poly iclc,23
505,hypofractionated radiotherapy,23
506,phone calls,23
507,surveys,23
508,low-let electron therapy,23
509,intervention,22
510,abt-263,22
511,raltitrexed,22
512,ixazomib citrate,22
513,megestrol acetate,22
514,magnetic resonance imaging (mri),22
515,azd1775,22
516,vitamin b12,22
517,brivanib,22
518,sevoflurane,22
519,tomotherapy,22
520,irreversible electroporation (ire),22
521,eltrombopag,22
522,chemoradiation,22
523,autologous stem cell transplantation,22
524,bexarotene,22
525,inotuzumab ozogamicin,22
526,adalimumab,22
527,treosulfan,22
528,5-fluorouracil (5-fu),22
529,azd5363,22
530,tyrosinase peptide,22
531,851b,22
532,abi-007,21
533,comparative genomic hybridization,21
534,chop regimen,21
535,hipec,21
536,nucleic acid sequencing,21
537,mifepristone,21
538,dutasteride,21
539,attention control,21
540,allogeneic stem cell transplantation,21
541,intensity-modulated radiotherapy,21
542,bone marrow aspiration,21
543,blood draws,21
544,ropivacaine,21
545,amg 386,21
546,acetylsalicylic acid,21
547,revlimid,21
548,vinorelbine ditartrate,21
549,proton therapy,21
550,tivantinib,21
551,stereotactic radiotherapy,21
552,ceritinib,21
553,dalteparin,21
554,melatonin,21
555,diffusion-weighted magnetic resonance imaging,21
556,gi-4000,20
557,pevonedistat,20
558,blood test,20
559,zidovudine,20
560,liquid chromatography,20
561,diphenhydramine,20
562,vehicle gel,20
563,inc280,20
564,recombinant interferon alfa-2b,20
565,pralatrexate,20
566,xelox,20
567,porfimer sodium,20
568,tas-102,20
569,ribavirin,20
570,bcg vaccine,19
571,blood sample collection,19
572,ganetespib,19
573,infliximab,19
574,cytoxan,19
575,taxol,19
576,"radium-223 dichloride (xofigo, bay88-8223)",19
577,active surveillance,19
578,lde225,19
579,binimetinib,19
580,gamma-secretase/notch signalling pathway inhibitor ro4929097,19
581,amg 706,19
582,auy922,19
583,deferasirox,19
584,pet-ct,19
585,olaratumab,19
586,copanlisib,19
587,enoxaparin,19
588,sulindac,19
589,octreotide,19
590,transarterial chemoembolization,19
591,best supportive care (bsc),19
592,7-hydroxystaurosporine,19
593,azd2014,19
594,in vitro-treated bone marrow transplantation,19
595,mek162,18
596,azd2171,18
597,amg 479,18
598,mri scan,18
599,nelfinavir,18
600,tarceva,18
601,estramustine,18
602,sham acupuncture,18
603,education,18
604,intensity modulated radiotherapy,18
605,proton beam radiation therapy,18
606,pharmacokinetic study,18
607,open surgery,18
608,interferon alfa-2b,18
609,nk immunotherapy,18
610,etbx-061,18
611,6-mercaptopurine,18
612,colposcopy,18
613,hyperthermia treatment,18
614,oxycodone,18
615,incb050465,18
616,genistein,18
617,internal radiation therapy,18
618,pet/ct scan,18
619,pasireotide,18
620,etbx-011,18
621,octreotide acetate,18
622,cytoreductive surgery,18
623,pharmacogenomic study,18
624,asoprisnil,18
625,imc-a12,18
626,endoscopy,17
627,plx3397,17
628,relatlimab,17
629,exercise training,17
630,cmf regimen,17
631,single photon emission computed tomography,17
632,irofulven,17
633,ciprofloxacin,17
634,etbx-051,17
635,suramin,17
636,saracatinib,17
637,nanoknife,17
638,folfoxiri,17
639,olanzapine,17
640,peg-asparaginase,17
641,cpx-351,17
642,l-asparaginase,17
643,gi-6301,17
644,tivozanib,17
645,zd1839,17
646,denileukin diftitox,17
647,selenium,17
648,autologous stem cell transplant,17
649,radiosurgery,17
650,dexrazoxane,17
651,palonosetron,17
652,pep005,17
653,patient navigation,17
654,gilteritinib,17
655,zd6474,17
656,pf-00299804,17
657,amifostine,17
658,vehicle,17
659,total marrow irradiation,17
660,sodium thiosulfate,17
661,lymphadenectomy,17
662,pimasertib,17
663,minocycline,17
664,th-302,17
665,radical cystectomy,17
666,cabozantinib s-malate,17
667,observational,17
668,irreversible electroporation,16
669,accelerated partial breast irradiation,16
670,pregabalin,16
671,whole breast irradiation,16
672,rituximab [mabthera/rituxan],16
673,bbi608,16
674,therapeutic tumor infiltrating lymphocytes,16
675,liver resection,16
676,smoking cessation intervention,16
677,interviews,16
678,tranexamic acid,16
679,necitumumab,16
680,tki258,16
681,phlebotomy,16
682,methylphenidate,16
683,chop,16
684,allostim,16
685,itacitinib,16
686,nedaplatin,16
687,buparlisib,16
688,quality of life assessment,16
689,rifampin,16
690,rubitecan,16
691,tazemetostat,16
692,bevacizumab (avastin),16
693,screening questionnaire administration,16
694,trastuzumab [herceptin],16
695,cytokine-induced killer cells,16
696,exatecan mesylate,16
697,mln9708,16
698,tirapazamine,16
699,mycophenolate mofetil (mmf),15
700,poly-iclc,15
701,guadecitabine,15
702,mln0128,15
703,intensity modulated radiation therapy (imrt),15
704,azd9291,15
705,sapacitabine,15
706,quality of life questionnaires,15
707,t-dm1,15
708,aminolevulinic acid,15
709,acupuncture therapy,15
710,ketogenic diet,15
711,hepatectomy,15
712,cc-5013,15
713,atra,15
714,armodafinil,15
715,ag-013736,15
716,bez235,15
717,azd6738,15
718,bcnu,15
719,cc-122,15
720,supportive care,15
721,stereotactic ablative radiotherapy,15
722,ngr-htnf,15
723,prostatectomy,15
724,isatuximab sar650984,15
725,hepatic resection,15
726,everolimus (rad001),15
727,epoetin beta,15
728,campath,15
729,prostate biopsy,15
730,e7389,15
731,clinimacs,15
732,stereotactic radiosurgery (srs),15
733,peripheral blood draw,15
734,recombinant interferon gamma,15
735,vilaprisan (bay1002670),15
736,duvelisib,15
737,intraoperative radiotherapy,15
738,bms-986205,15
739,bavituximab,15
740,toremifene,15
741,hpph,15
742,apixaban,14
743,decision aid,14
744,hyperthermia,14
745,"cp-751,871",14
746,omega-3 fatty acid,14
747,comparison of screening methods,14
748,cyberknife,14
749,abt-888,14
750,bronchoscopy,14
751,imc-11f8,14
752,amrubicin,14
753,yttrium y 90 glass microspheres,14
754,calcium carbonate,14
755,induction chemotherapy,14
756,tegafur-gimeracil-oteracil potassium,14
757,monitoring device,14
758,masitinib,14
759,morphine sulfate,14
760,peg-interferon alfa-2b,14
761,fluconazole,14
762,gene rearrangement analysis,14
763,pacritinib,14
764,pf-04449913,14
765,image-guided radiation therapy,14
766,warfarin,14
767,pegylated liposomal doxorubicin (pld),14
768,abt-199,14
769,ipatasertib,14
770,trc105,14
771,ef5,14
772,robot-assisted laparoscopic surgery,14
773,volasertib,14
774,nk cells,14
775,tbi,14
776,ulipristal acetate,14
777,placebo oral capsule,14
778,proton beam therapy,14
779,qs21,14
780,apheresis,14
781,standard colonoscopy,14
782,donor lymphocyte infusion,14
783,lhrh agonist,14
784,modafinil,14
785,aldoxorubicin,14
786,paclitaxel poliglumex,14
787,axitinib (ag-013736),14
788,correlative studies,14
789,antiandrogen therapy,14
790,voriconazole,14
791,ranibizumab,14
792,graft-versus-tumor induction therapy,14
793,valacyclovir,14
794,brigatinib,13
795,pancreaticoduodenectomy,13
796,nicotine patch,13
797,disulfiram,13
798,dinaciclib,13
799,atg,13
800,screening colonoscopy,13
801,sintilimab,13
802,palliative care,13
803,loss of heterozygosity analysis,13
804,ultrasonography,13
805,pentoxifylline,13
806,ganciclovir,13
807,pet/mri,13
808,hank,13
809,eflornithine,13
810,physical activity intervention,13
811,mk-2206,13
812,liver transplantation,13
813,alimta,13
814,lorlatinib,13
815,focus group,13
816,vatalanib,13
817,counseling,13
818,arq 197,13
819,onc201,13
820,rrx-001,13
821,becatecarin,13
822,docetaxel and cisplatin,13
823,focus groups,13
824,patupilone,13
825,cinacalcet,13
826,"cp-675,206",13
827,gi-6207,13
828,bone marrow transplantation,13
829,montanide isa 51 vg,13
830,tgr-1202,13
831,tpi 287,13
832,dalotuzumab,13
833,osi-906,13
834,prehabilitation,13
835,ispinesib,13
836,r-chop,13
837,tegafur-uracil,13
838,behavioral intervention,13
839,optical coherence tomography,13
840,mannitol,13
841,pf-3512676,13
842,pf-03084014,13
843,pd-0332991,13
844,posaconazole,13
845,needle biopsy,13
846,intraoperative radiation therapy,13
847,18f-dcfpyl,13
848,ldk378,13
849,digoxin,13
850,peg-rhg-csf,13
851,ap1903,13
852,androgen deprivation therapy,13
853,aromatase inhibitor,13
854,rovalpituzumab tesirine,13
855,gamma-secretase inhibitor ro4929097,13
856,gardasil,12
857,ingenol mebutate,12
858,herceptin®,12
859,procarbazine,12
860,bl-8040,12
861,enzyme inhibitor therapy,12
862,radiomammography,12
863,rg1507,12
864,ro5185426,12
865,keyhole limpet hemocyanin,12
866,rosuvastatin,12
867,defined green tea catechin extract,12
868,dacomitinib,12
869,valganciclovir,12
870,s1,12
871,sham intervention,12
872,registry,12
873,hyperthermic intraperitoneal chemotherapy,12
874,adi-peg 20,12
875,ublituximab,12
876,all-trans retinoic acid (atra),12
877,etelcalcetide,12
878,lovastatin,12
879,gastrectomy,12
880,placebo comparator,12
881,palonosetron hydrochloride,12
882,bgj398,12
883,laromustine,12
884,donor lymphocyte infusion (dli),12
885,g17dt,12
886,isolated perfusion,12
887,gemcitabine and cisplatin,12
888,mitomycin,12
889,skin biopsy,12
890,proton radiation,12
891,adavosertib,12
892,gvax,12
893,lirilumab,12
894,methadone,12
895,lgx818,12
896,mpdl3280a,12
897,abt-869,12
898,dc vaccine,12
899,molecular breast imaging,12
900,regn2810,12
901,ad5cmv-p53 gene,12
902,gleevec,12
903,bgb-3111,12
904,lonafarnib,12
905,communication intervention,12
906,imiquimod 5% cream,12
907,sgi-110,12
908,5-azacytidine,12
909,gsk2118436,12
910,lycopene,12
911,wbrt,12
912,capecitabine (xeloda),12
913,gadolinium,12
914,mln8237,12
915,5fu,12
916,azd4547,12
917,whole body mri,12
918,m7824,12
919,granulocyte colony-stimulating factor (g-csf),12
920,radiation therapy treatment planning/simulation,12
921,placebo gel,12
922,axillary lymph node dissection,12
923,nelfinavir mesylate,12
924,azd2281,11
925,5 fluorouracil,11
926,caphosol,11
927,video,11
928,rituxan,11
929,standard therapy,11
930,cytosine arabinoside,11
931,ruxolitinib phosphate,11
932,high intensity focused ultrasound,11
933,placebo control,11
934,cabergoline,11
935,endoscopic submucosal dissection,11
936,"6,8-bis(benzylthio)octanoic acid",11
937,eras protocols,11
938,high-intensity focused ultrasound ablation,11
939,computer-assisted intervention,11
940,nilutamide,11
941,lanreotide,11
942,aerobic exercise,11
943,abt-751,11
944,folfox4,11
945,"atezolizumab (mpdl3280a), an engineered anti-pd-l1 antibody",11
946,tak-659,11
947,indocyanine green (icg),11
948,zoledronate,11
949,quizartinib,11
950,"nexavar (sorafenib, bay43-9006)",11
951,cyclophosphamide (cy),11
952,gadopentetate dimeglumine,11
953,utomilumab,11
954,siltuximab,11
955,collagenase clostridium histolyticum,11
956,ontak,11
957,prexasertib,11
958,pci-32765,11
959,paclitaxel and carboplatin,11
960,physical therapy,11
961,dendritic cell vaccine,11
962,oral azacitidine,11
963,mammography,11
964,imc-a12 (cixutumumab),11
965,catumaxomab,11
966,azacytidine,11
967,laser therapy,11
968,positron emission tomography/computed tomography,11
969,pyrotinib,11
970,cisplatinum,11
971,epratuzumab,11
972,remifentanil,11
973,erlotinib (tarceva),11
974,idasanutlin,11
975,hematopoietic cell transplantation,11
976,raloxifene,11
977,campath-1h,11
978,antithymocyte globulin,11
979,laparoscopic gastrectomy,11
980,hematopoietic stem cell transplantation,11
981,zometa,11
982,imaging,11
983,mgcd0103,11
984,zoladex,11
985,rexin-g,11
986,cpt-11,11
987,tmz,11
988,biomarker analysis,11
989,prophylactic cranial irradiation,11
990,aromatase inhibitors,11
991,calcium,11
992,ly3023414,11
993,treatment,11
994,cabazitaxel (xrp6258),11
995,cc-486,11
996,tadalafil,11
997,zalutumumab,10
998,zevalin,10
999,lipiodol,10
1000,magnesium sulfate,10
1001,montanide isa-51,10
1002,navitoclax,10
1003,zd6474 (vandetanib),10
1004,ku-0059436 (azd2281)(parp inhibitor),10
1005,rasburicase,10
1006,dinutuximab,10
1007,bortezomib (velcade),10
1008,esomeprazole,10
1009,radiation therapy (rt),10
1010,lintuzumab,10
1011,cpi-613,10
1012,whole brain radiation therapy,10
1013,at-101,10
1014,conventional radiotherapy,10
1015,interferon-alpha,10
1016,transarterial chemoembolization (tace),10
1017,crenolanib,10
1018,her-2/neu peptide vaccine,10
1019,intensity modulated radiotherapy (imrt),10
1020,oregovomab,10
1021,tositumomab and iodine i 131 tositumomab,10
1022,transcatheter arterial chemoembolization,10
1023,mfolfirinox,10
1024,alpelisib,10
1025,fdg-pet/ct,10
1026,recombinant human endostatin,10
1027,whole brain radiotherapy,10
1028,xl999,10
1029,cervarix,10
1030,pazopanib (gw786034),10
1031,placebo group,10
1032,multivitamin,10
1033,chloroquine,10
1034,pegph20,10
1035,enzastaurin hydrochloride,10
1036,hyperbaric oxygen,10
1037,pet/ct imaging,10
1038,myomectomy,10
1039,filgrastim (g-csf),10
1040,medi-538,10
1041,ipi-504,10
1042,sapanisertib,10
1043,satraplatin,10
1044,cone-beam computed tomography,10
1045,avastin (bevacizumab),10
1046,placebo capsule,10
1047,endoscopic biopsy,10
1048,pet,10
1049,endoscopic mucosal resection,10
1050,histopathologic examination,10
1051,varenicline,10
1052,pd-1 antibody,10
1053,erdafitinib,10
1054,obatoclax mesylate,10
1055,progesterone,10
1056,indomethacin,10
1057,pasireotide lar,10
1058,etbx-021,10
1059,snx-5422,10
1060,ym155,10
1061,screening,10
1062,on 01910.na,10
1063,diet,10
1064,tesetaxel,10
1065,tasquinimod,10
1066,velcade (bortezomib),10
1067,physical exercise,10
1068,entecavir,10
1069,trivalent influenza vaccine,10
1070,ganitumab,10
1071,proton beam radiation,10
1072,pld,10
1073,paravertebral block,10
1074,donor lymphocytes,10
1075,1121b,10
1076,mm-121,10
1077,ombrabulin (ave8062),10
1078,pet imaging,10
1079,p276-00,10
1080,cancer prevention intervention,10
1081,exisulind,10
1082,androgen deprivation therapy (adt),10
1083,resiquimod,10
1084,apatinib mesylate tablets,10
1085,pralatrexate injection,10
1086,radiofrequency ablation (rfa),10
1087,saline solution,10
1088,diffusion tensor imaging,10
1089,orteronel,10
1090,lymphangiography,10
1091,embolization,10
1092,fdg-pet,10
1093,lithium carbonate,10
1094,thoracic radiotherapy,10
1095,open gastrectomy,10
1096,fluorescence activated cell sorting,10
1097,matrix-assisted laser desorption/ionization time of flight mass spectrometry,10
1098,breast biopsy,10
1099,breast imaging study,10
1100,pf-00337210,10
1101,external beam radiation,10
1102,interventional therapy,10
1103,contrast-enhanced magnetic resonance imaging,10
1104,orchiectomy,10
1105,cat-8015 (moxetumomab pasudotox),10
1106,lurbinectedin (pm01183),10
1107,xl184,10
1108,technetium tc 99m sulfur colloid,10
1109,5-azacitidine,10
1110,resistance training,10
1111,nutritional counseling,10
1112,mkc-1,9
1113,sym004,9
1114,palliative radiation therapy,9
1115,massage therapy,9
1116,ibandronate,9
1117,lovaza,9
1118,digital mammography,9
1119,glivec,9
1120,nktr-102,9
1121,5-fluoruracil,9
1122,stereotactic radiation,9
1123,short course radiotherapy,9
1124,paclitaxel + carboplatin,9
1125,fluorescein,9
1126,proton radiotherapy,9
1127,isosulfan blue,9
1128,liposomal cytarabine,9
1129,electrochemotherapy,9
1130,fluorothymidine f-18,9
1131,influenza vaccine,9
1132,5fluorouracil,9
1133,breast surgery,9
1134,conventional laparoscopic surgery,9
1135,antiangiogenesis therapy,9
1136,total lymphoid irradiation,9
1137,patient observation,9
1138,early palliative care,9
1139,ibuprofen,9
1140,omacetaxine mepesuccinate,9
1141,everolimus placebo,9
1142,mt-3724,9
1143,support group therapy,9
1144,romiplostim,9
1145,routine care,9
1146,vp-16,9
1147,peptide vaccine,9
1148,imaging biomarker analysis,9
1149,bay 43-9006,9
1150,rilotumumab,9
1151,dc-cik,9
1152,pulmonary rehabilitation,9
1153,lamivudine,9
1154,azd9150,9
1155,onartuzumab,9
1156,entospletinib,9
1157,whole-brain radiation therapy,9
1158,health education,9
1159,bbi503,9
1160,famitinib,9
1161,savolitinib,9
1162,omacetaxine,9
1163,biological samples,9
1164,tak-228,9
1165,genetic testing,9
1166,nab paclitaxel,9
1167,lifestyle intervention,9
1168,nanoparticle albumin-bound paclitaxel,9
1169,iobenguane i 131,9
1170,cemiplimab,9
1171,ritonavir,9
1172,complementary and alternative therapy,9
1173,imiquimod cream,9
1174,sta-9090,9
1175,stereotactic ablative radiotherapy (sabr),9
1176,lenograstim,9
1177,vp16,9
1178,ono-4538,9
1179,pf-05212384,9
1180,pf-06939999,9
1181,gti-2040,9
1182,placebo cream,9
1183,ner1006,9
1184,resection,9
1185,rimiducid,9
1186,total mesorectal excision,9
1187,bardoxolone methyl,9
1188,ct-011,9
1189,abatacept,9
1190,temozolomide (tmz),9
1191,cpg 7909,9
1192,therasphere,9
1193,norepinephrine,9
1194,androxal,9
1195,pamidronate,9
1196,liposomal bupivacaine,9
1197,glufosfamide,9
1198,hifu,9
1199,soy isoflavones,9
1200,131i-mibg,9
1201,vitamin c,9
1202,nktr-214,9
1203,colposcopic biopsy,9
1204,autologous immunoglobulin idiotype-klh conjugate vaccine,9
1205,contrast-enhanced ultrasound,9
1206,antibody therapy,9
1207,ly2157299,9
1208,wild-type reovirus,9
1209,indocyanine green solution,9
1210,crs-207,9
1211,iodine i 125,9
1212,polatuzumab vedotin,9
1213,kw-0761,9
1214,"sagopilone (bay86-5302, zk 219477)",9
1215,abbv-181,9
1216,preventative dietary intervention,9
1217,fludarabine monophosphate,9
1218,budesonide,9
1219,sutent,9
1220,iressa,9
1221,carvedilol,9
1222,monoclonal antibody 3f8,9
1223,interferon alfa-2a,9
1224,lymphoscintigraphy,9
1225,mastectomy,9
1226,radiochemotherapy,9
1227,sabr,9
1228,bi 2536,9
1229,immunotherapy,9
1230,antineoplaston a10,9
1231,dynamic susceptibility contrast-enhanced magnetic resonance imaging,9
1232,dexamethasone acetate,9
1233,rivaroxaban,9
1234,neulasta,9
1235,"aflibercept (ziv-aflibercept, ave0005, vegf trap, zaltrap®)",9
1236,busulfan (bu),9
1237,hysterectomy,9
1238,functional magnetic resonance imaging,9
1239,desflurane,9
1240,sitagliptin,8
1241,hepatic arterial infusion chemotherapy,8
1242,laparoscopy,8
1243,il13-pe38qqr,8
1244,crlx101,8
1245,imprime pgg,8
1246,levofloxacin,8
1247,hsppc-96,8
1248,mcs110,8
1249,dtic,8
1250,azd1152,8
1251,leuprorelin,8
1252,granisetron,8
1253,v503,8
1254,navelbine,8
1255,casodex,8
1256,mindfulness-based stress reduction,8
1257,spectroscopy,8
1258,polyphenon e,8
1259,folfox6,8
1260,oprozomib,8
1261,carbon ion radiotherapy,8
1262,hepatic artery embolization,8
1263,betalutin,8
1264,poziotinib,8
1265,urelumab,8
1266,interferon,8
1267,fluorine f 18 sodium fluoride,8
1268,antineoplaston as2-1,8
1269,ag-221,8
1270,medi-522,8
1271,depsipeptide,8
1272,proellex,8
1273,pi-88,8
1274,vincristine sulfate liposome,8
1275,mocetinostat,8
1276,molecular genetic technique,8
1277,asa404,8
1278,fluorescent antibody technique,8
1279,mechlorethamine hydrochloride,8
1280,gvhd prophylaxis,8
1281,transvaginal ultrasound,8
1282,oophorectomy,8
1283,quality of life questionnaire,8
1284,pemetrexed/cisplatin,8
1285,intervention group,8
1286,sham,8
1287,sotatercept,8
1288,r-(-)-gossypol acetic acid,8
1289,anti-pd-1 antibody,8
1290,nicotine,8
1291,transoral robotic surgery,8
1292,caffeine,8
1293,probiotic,8
1294,cidofovir,8
1295,liposomal irinotecan,8
1296,echopulse,8
1297,tok-001,8
1298,tecemotide (l-blp25),8
1299,chemoembolization,8
1300,cart-19,8
1301,octreotide lar,8
1302,forodesine hydrochloride,8
1303,immunological diagnostic method,8
1304,immunohistochemistry,8
1305,azd0530,8
1306,graspa,8
1307,radium-223,8
1308,punch biopsy,8
1309,tdt-mediated dutp nick end labeling assay,8
1310,"3,4-diaminopyridine",8
1311,bcg,8
1312,fasting,8
1313,radiography,8
1314,birinapant,8
1315,ag-120,8
1316,complementary or alternative medicine procedure,8
1317,taxane,8
1318,vosaroxin,8
1319,recombinant ephb4-hsa fusion protein,8
1320,acceptance and commitment therapy,8
1321,nk cell infusion,8
1322,urine sample,8
1323,g-202,8
1324,galunisertib,8
1325,ag-013736 (axitinib),8
1326,stereotactic body radiation,8
1327,autologous dendritic cells,8
1328,enmd-2076,8
1329,pyrazoloacridine,8
1330,sch 727965,8
1331,music therapy,8
1332,therapeutic dietary intervention,8
1333,fentanyl citrate,8
1334,fdg,8
1335,rad001 (everolimus),8
1336,eus-fna,8
1337,surgeries,8
1338,apx005m,8
1339,standard,8
1340,humanized anti-pd-1 monoclonal antibody,8
1341,ddp,8
1342,peginterferon alfa-2b,8
1343,allogeneic stem cell transplant,8
1344,copanlisib (bay80-6946),8
1345,exercise program,8
1346,atg fresenius,8
1347,radium-223 dichloride,8
1348,18f-fdg,8
1349,imc-ron8,8
1350,losartan,8
1351,assessments,8
1352,conventional,8
1353,comparator: placebo,8
1354,electroacupuncture,8
1355,abvd,8
1356,palliative radiotherapy,8
1357,whole-brain radiotherapy,8
1358,5 fu,8
1359,radical hysterectomy,8
1360,levetiracetam,8
1361,anakinra,8
1362,platinum,8
1363,valspodar,8
1364,lcl161,8
1365,g-csf plus plerixafor,8
1366,hypofractionation,8
1367,testosterone,8
1368,gamma knife radiosurgery,8
1369,"gemcitabine, cisplatin",8
1370,stent,8
1371,cvx-241,8
1372,atr kinase inhibitor m6620,8
1373,bgb-a317,8
1374,nutrition counseling,8
1375,zd4054,8
1376,leuprorelin acetate,8
1377,ts-1,8
1378,gemox,8
1379,adjuvant radiotherapy,8
1380,ibritumomab tiuxetan,8
1381,recombinant fowlpox-cea(6d)/tricom vaccine,8
1382,gemcitabine + cisplatin,8
1383,proton radiation therapy,8
1384,compliance monitoring,8
1385,fruquintinib,8
1386,parenteral nutrition,8
1387,enhanced usual care,8
1388,soy protein isolate,8
1389,follow-up,8
1390,stellate ganglion block,8
1391,18f-fluoromisonidazole,8
1392,releasing hormone agonist therapy,8
1393,gdc-0980,8
1394,psychosocial support for caregiver,8
1395,all-trans retinoic acid,8
1396,intensity-modulated radiation therapy (imrt),8
1397,concurrent chemotherapy,8
1398,trebananib,8
1399,pyridoxine,8
1400,folfox protocol,8
1401,radiotherapy (rt),8
1402,peripheral blood,8
1403,sugar pill,8
1404,ly2523355,8
1405,azd8931,8
1406,diclofenac,8
1407,"quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine",8
1408,riluzole,8
1409,general anesthesia,8
1410,risedronate,8
1411,alternative product therapy,7
1412,iodine-131 anti-b1 antibody,7
1413,recombinant interleukin-21,7
1414,confocal laser endomicroscopy,7
1415,flow cytometry (fcm),7
1416,dolastatin 10,7
1417,robotic surgery,7
1418,melphalan hydrochloride,7
1419,gc1008 human anti transforming growth factor _beta (tgf?) monoclonal antibody,7
1420,reolysin,7
1421,gtx-758,7
1422,rc48-adc,7
1423,academic detailing,7
1424,differentiation therapy,7
1425,abvd regimen,7
1426,non interventional study,7
1427,177lu-j591,7
1428,sunitinib + folfox,7
1429,gdc-0941,7
1430,gemcitabine plus cisplatin,7
1431,ac220,7
1432,arm a,7
1433,pep005 topical gel,7
1434,ogx-427,7
1435,rt,7
1436,egf816,7
1437,bi 754091,7
1438,egfr-tki,7
1439,pf-02341066,7
1440,iodine i 131 monoclonal antibody bc8,7
1441,platelet transfusion,7
1442,massage,7
1443,total-body irradiation (tbi),7
1444,hormone therapy,7
1445,tew-7197,7
1446,nephrectomy,7
1447,laparoscopic resection,7
1448,n-acetylcysteine,7
1449,positron emission tomography (pet),7
1450,molecular diagnostic method,7
1451,dpx-survivac,7
1452,aeg35156,7
1453,erwinase,7
1454,reolysin®,7
1455,estradiol,7
1456,yoga therapy,7
1457,amg 655,7
1458,opioid,7
1459,taselisib,7
1460,epothilone b,7
1461,sildenafil citrate,7
1462,e7080,7
1463,digital breast tomosynthesis,7
1464,partial breast irradiation,7
1465,irradiation,7
1466,short course treatment,7
1467,ficlatuzumab,7
1468,bgb-290,7
1469,biopsies,7
1470,pqr309,7
1471,cyproterone acetate,7
1472,granisetron hydrochloride,7
1473,epoch,7
1474,cognitive behavior therapy,7
1475,oncolytic measles virus encoding thyroidal sodium iodide symporter,7
1476,peripheral blood stem cell transplant,7
1477,abi-009,7
1478,fluorine f 18 fluorothymidine,7
1479,multi-epitope melanoma peptide vaccine,7
1480,muromonab-cd3,7
1481,e7070,7
1482,iniparib,7
1483,apr-246,7
1484,quality of life,7
1485,proflavine,7
1486,emactuzumab,7
1487,indoximod,7
1488,rhsa/gcsf,7
1489,laparoscopic ovarian drilling,7
1490,huaier granule,7
1491,buserelin,7
1492,carboxyamidotriazole,7
1493,oraxol,7
1494,amg 386 placebo,7
1495,syngeneic bone marrow transplantation,7
1496,mapatumumab,7
1497,preoperative radiotherapy,7
1498,albumin-bound paclitaxel,7
1499,18f-fdg pet/ct,7
1500,placebo pill,7
1501,control arm,7
1502,indium in 111 ibritumomab tiuxetan,7
1503,no treatment,7
1504,matching placebo,7
1505,cb-839,7
1506,entrectinib,7
1507,aromatase inhibition therapy,7
1508,varlitinib,7
1509,microsatellite instability analysis,7
1510,venlafaxine,7
1511,palbociclib 125mg,7
1512,umbralisib,7
1513,concurrent chemoradiation,7
1514,multiparametric magnetic resonance imaging,7
1515,momelotinib,7
1516,incb024360,7
1517,ponatinib hydrochloride,7
1518,regorafenib (bay73-4506),7
1519,strength training,7
1520,capmatinib,7
1521,next generation sequencing,7
1522,rt-pcr,7
1523,loperamide,7
1524,mylotarg,7
1525,perfusion magnetic resonance imaging,7
1526,sample collection,7
1527,neoadjuvant chemoradiotherapy,7
1528,rociletinib,7
1529,monoclonal antibody therapy,7
1530,computed tomography (ct),7
1531,custirsen sodium,7
1532,gemcitabine/cisplatin,7
1533,cnto 328; anti-interleukin-6 monoclonal antibody,7
1534,icg,7
1535,cefazolin,7
1536,neupogen,7
1537,gene mapping,7
1538,pd-0325901,7
1539,fecal occult blood test,7
1540,solumedrol,7
1541,spironolactone,7
1542,cabazitaxel xrp6258,7
1543,biologically based therapies,7
1544,vats,7
1545,txa127,7
1546,axicabtagene ciloleucel,7
1547,estradiol/norethindrone acetate,7
1548,health telemonitoring,7
1549,perillyl alcohol,7
1550,physiotherapy,7
1551,sir-spheres,7
1552,sorafenib (nexavar),7
1553,bupropion hydrochloride,7
1554,bone marrow biopsy,7
1555,adv-tk,7
1556,granulocyte colony-stimulating factor,7
1557,image guided radiation therapy,7
1558,sildenafil,7
1559,basiliximab,7
1560,pulsed dye laser,7
1561,ranitidine,7
1562,motivational interviewing,7
1563,aminolevulinic acid hydrochloride,7
1564,asct,7
1565,picoplatin,7
1566,lumpectomy,7
1567,ct,7
1568,levobupivacaine,7
1569,temoporfin,7
1570,dynamic contrast-enhanced ultrasound imaging,7
1571,autologous transplant,7
1572,telephone counseling,7
1573,lobectomy,7
1574,canakinumab,7
1575,hdr brachytherapy,7
1576,caspofungin acetate,7
1577,leflunomide,7
1578,vigil,7
1579,dfmo,7
1580,vancomycin,7
1581,ras peptide cancer vaccine,7
1582,merestinib,7
1583,polifeprosan 20 with carmustine implant,7
1584,anamorelin hcl,7
1585,chimeric antigen receptor t-cell therapy,7
1586,sugammadex,7
1587,hydrocortisone sodium succinate,7
1588,moxifloxacin,7
1589,xl147 (sar245408),7
1590,rosiglitazone,7
1591,pembrolizumab (mk-3475),7
1592,dexa scan,7
1593,amsacrine,7
1594,fluorescence imaging,7
1595,linifanib,7
1596,laparotomy,7
1597,genetic counseling,7
1598,docetaxel (xrp6976),7
1599,bi 6727,7
1600,encorafenib,7
1601,diffusion weighted imaging,7
1602,autologous-autologous tandem hematopoietic stem cell transplantation,7
1603,ds-8201a,7
1604,ny-eso-1 peptide vaccine,7
1605,tucatinib,7
1606,breast mri,7
1607,educational materials,7
1608,pet-ct scan,7
1609,growth factor antagonist therapy,7
1610,postoperative chemotherapy,7
1611,concurrent chemoradiotherapy,7
1612,pharmacokinetic sampling,6
1613,azd4877,6
1614,cyberknife radiosurgery,6
1615,pharmacokinetic sampling - az5140 and az7550,6
1616,surgical excision,6
1617,qigong,6
1618,radium-223 dichloride (bay88-8223),6
1619,fosaprepitant,6
1620,sar302503,6
1621,scio-469,6
1622,hypnosis,6
1623,fine needle aspiration,6
1624,gimatecan,6
1625,hyperthermic intraperitoneal chemotherapy (hipec),6
1626,ccrt,6
1627,interleukin-2 (il-2),6
1628,hu5f9-g4,6
1629,helicobacter pylori vaccine,6
1630,low level laser therapy,6
1631,2940-nm er:yag afl pretreatment,6
1632,home-based exercise,6
1633,isatuximab,6
1634,calcium gluconate,6
1635,other,6
1636,relugolix,6
1637,3 tesla magnetic resonance imaging,6
1638,paracetamol,6
1639,life information rehabilitation therapy,6
1640,arn-509,6
1641,pirfenidone,6
1642,til infusion,6
1643,apaziquone,6
1644,carboplatin and paclitaxel,6
1645,tetanus toxoid helper peptide,6
1646,gtx-024,6
1647,cp-4055,6
1648,rhgm-csf,6
1649,auranofin,6
1650,echocardiogram,6
1651,indium in 111 monoclonal antibody mn-14,6
1652,autologous dendritic cell vaccine,6
1653,platinum-based chemotherapy,6
1654,comparator: placebo (unspecified),6
1655,sputum cytology,6
1656,bsc,6
1657,larotrectinib,6
1658,immunotoxin therapy,6
1659,chart review,6
1660,methylene blue,6
1661,mitomycin-c,6
1662,natural killer cell therapy,6
1663,mitotane,6
1664,pet/mr,6
1665,clomiphene,6
1666,metformin xr,6
1667,avapritinib,6
1668,image-guided adaptive radiation therapy,6
1669,bms-754807,6
1670,immunoscintigraphy,6
1671,erythromycin,6
1672,genetic analysis,6
1673,18f-dcfpyl injection,6
1674,walk with ease,6
1675,sgn-40,6
1676,ptk787/zk 222584,6
1677,aromatherapy and essential oils,6
1678,etoposide (vp-16),6
1679,interferon alpha-2b,6
1680,oral vinorelbine,6
1681,pentamidine,6
1682,sp-02l (darinaparsin for injection),6
1683,pembrolizumab injection,6
1684,polyacrylamide gel electrophoresis,6
1685,bi 836845,6
1686,v501,6
1687,sd-101,6
1688,sargramostim (gm-csf),6
1689,bevacizumab-irdye800cw,6
1690,cdp6038,6
1691,grape seed extract,6
1692,high-activity natural killer,6
1693,f-627,6
1694,gefitinib (iressa),6
1695,apolizumab,6
1696,mistletoe extract,6
1697,adt,6
1698,cyclosporine a,6
1699,lupron,6
1700,xiapex,6
1701,gemcitabine and oxaliplatin,6
1702,tlk286,6
1703,f-18 16 alpha-fluoroestradiol,6
1704,khk7580,6
1705,liquid biopsy,6
1706,green tea,6
1707,verteporfin,6
1708,liposomal vincristine sulfate,6
1709,blood drawing,6
1710,0.9% saline,6
1711,vgx-3100,6
1712,mr imaging,6
1713,e7050,6
1714,pemigatinib,6
1715,moxetumomab pasudotox,6
1716,6-thioguanine,6
1717,ly2603618,6
1718,graft versus host disease prophylaxis/therapy,6
1719,pharmacokinetic sampling - azd9291,6
1720,breast duct lavage,6
1721,therapeutic surgical procedure,6
1722,database,6
1723,thyroidectomy,6
1724,vehicle cream,6
1725,dec-205/ny-eso-1 fusion protein cdx-1401,6
1726,hdm201,6
1727,talc,6
1728,gedatolisib,6
1729,aromasin,6
1730,matched placebo,6
1731,defactinib,6
1732,gdc-0449,6
1733,pracinostat,6
1734,ro5045337,6
1735,daclizumab,6
1736,tcm,6
1737,mogamulizumab,6
1738,yttrium y 90 monoclonal antibody mn-14,6
1739,adxs11-001,6
1740,epidural,6
1741,liposomal amphotericin b,6
1742,focus group sessions,6
1743,cabiralizumab,6
1744,escitalopram,6
1745,pravastatin,6
1746,som230,6
1747,ebus-tbna,6
1748,isis eif4e rx,6
1749,symptom questionnaire,6
1750,imetelstat,6
1751,functional mri,6
1752,dna stability analysis,6
1753,teniposide,6
1754,abt-348,6
1755,metoclopramide,6
1756,bms-833923,6
1757,selenomethionine,6
1758,alt-801,6
1759,blood and tumor samples,6
1760,3'-deoxy-3'-[18f]fluorothymidine,6
1761,diagnostic test,6
1762,bms-690514,6
1763,tissue collection,6
1764,dw-mri,6
1765,bi 836826,6
1766,symptom questionnaires,6
1767,radioisotope therapy,6
1768,comprehensive geriatric assessment,6
1769,pembrolizumab 200 mg,6
1770,revlimid (lenalidomide),6
1771,ang1005,6
1772,panobinostat (lbh589),6
1773,cardiopulmonary exercise testing,6
1774,extracorporeal photopheresis,6
1775,standard radiation therapy,6
1776,eltrombopag olamine,6
1777,tumor biopsies,6
1778,tomosynthesis,6
1779,alendronate,6
1780,annual screening,6
1781,specimen collection,6
1782,tak-385,6
1783,cs-7017,6
1784,mirtazapine,6
1785,heparin,6
1786,otl38,6
1787,carevive cps,6
1788,non interventional,6
1789,finasteride,6
1790,bms-214662,6
1791,tinzaparin,6
1792,electroporation,6
1793,genetic linkage analysis,6
1794,peripheral blood lymphocyte therapy,6
1795,trastuzumab emtansine [kadcyla],6
1796,blood tests,6
1797,onalespib,6
1798,polyethylene glycol,6
1799,lobaplatin,6
1800,lv5fu2,6
1801,autologous peripheral blood stem cell transplantation,6
1802,sitravatinib,6
1803,dhap,6
1804,lymphokine-activated killer cells,6
1805,nitroglycerin,6
1806,fosaprepitant dimeglumine,6
1807,arq 501,6
1808,pirarubicin,6
1809,mammogram,6
1810,computed tomography perfusion imaging,6
1811,resveratrol,6
1812,radium ra 223 dichloride,6
1813,bronchoscopic and lung imaging studies,6
1814,physician's choice,6
1815,ceevra reveal,6
1816,walking,6
1817,imexon,6
1818,medroxyprogesterone,6
1819,nutritional intervention,6
1820,pd 0332991,6
1821,mdv3100,6
1822,indibulin,6
1823,nutritional support,6
1824,"filgrastim, granulocyte-colony stimulating factor (g-csf); subcutaneous",6
1825,biomarkers,6
1826,surface-enhanced laser desorption/ionization-time of flight mass spectrometry,6
1827,pelvic radiation,6
1828,omega-3 fatty acids,6
1829,beta-glucan,6
1830,4-dimensional computed tomography,6
1831,pd-1 knockout t cells,6
1832,facbc,6
1833,metabolic assessment,6
1834,erbitux,6
1835,mln4924,6
1836,atorvastatin calcium,6
1837,methylphenidate hydrochloride,6
1838,ramucirumab (imc-1121b),6
1839,sox,6
1840,flaxseed,6
1841,pimonidazole,6
1842,bone scan,6
1843,fotemustine,6
1844,ascorbate,6
1845,narrow band imaging,6
1846,tegafur,6
1847,durvalumab (medi4736),6
1848,exablate 2000,6
1849,fish oil,6
1850,anetumab ravtansine,6
1851,propranolol hydrochloride,6
1852,pancreatectomy,6
1853,pegylated interferon alfa,6
1854,water exchange,6
1855,ly573636-sodium,6
1856,surgery alone,6
1857,dendritic cells,6
1858,art therapy,6
1859,erector spinae plane block,6
1860,dual x-ray absorptometry,6
1861,biliary stent,6
1862,cancer ablation,6
1863,placebo tablets,6
1864,veltuzumab,6
1865,air insufflation,6
1866,sodium bicarbonate,6
1867,aldoxorubicin hcl,6
1868,demcizumab,6
1869,anti-cytokine therapy,6
1870,light-scattering spectroscopy,6
1871,recombinant flt3 ligand,6
1872,hank for infusion,6
1873,ado-trastuzumab emtansine,6
1874,"oxaliplatin, capecitabine",6
1875,gemcitabine/carboplatin,6
1876,avx701,6
1877,conventional pathway group,6
1878,gl-onc1,6
1879,toca fc,6
1880,tetrahydrouridine,6
1881,end-of-life treatment/management,6
1882,syb l-0501,6
1883,glembatumumab vedotin,6
1884,lucitanib,6
1885,single low dose cyclophosphamide,6
1886,rosiglitazone maleate,6
1887,linsitinib,6
1888,amd3100,6
1889,852a,6
1890,abt-414,6
1891,follow up,6
1892,shr6390,6
1893,arm b,6
1894,ensartinib,6
1895,rigosertib,6
1896,in situ hybridization,5
1897,low dose cytarabine,5
1898,treatment as usual,5
1899,mm-398,5
1900,rabbit atg,5
1901,american ginseng,5
1902,cervical papanicolaou test,5
1903,pof,5
1904,odm-201,5
1905,pxd101,5
1906,abc294640,5
1907,metronomic cyclophosphamide,5
1908,cmp-001,5
1909,folfox-4,5
1910,vintafolide,5
1911,nc-6004,5
1912,ln-145,5
1913,dextromethorphan hydrobromide,5
1914,iressa (gefitinib),5
1915,healing touch,5
1916,risedronate sodium,5
1917,total nodal irradiation,5
1918,bronchoalveolar lavage,5
1919,donepezil hydrochloride,5
1920,capecitabine and oxaliplatin,5
1921,experimental arm,5
1922,cs-1008,5
1923,hydromorphone,5
1924,endoscopic ultrasound (eus),5
1925,enteral nutrition,5
1926,therapeutic touch,5
1927,efaproxiral,5
1928,fine-needle aspiration,5
1929,paclitaxel liposome,5
1930,"behavioral, psychological or informational intervention",5
1931,nacl,5
1932,optune,5
1933,methoxyamine,5
1934,thoracotomy,5
1935,ethanol,5
1936,l-carnitine,5
1937,low dose ct,5
1938,zinc,5
1939,cinacalcet hcl,5
1940,adaptive radiotherapy,5
1941,reduced intensity conditioning,5
1942,nivolumab injection,5
1943,yf476,5
1944,incb007839,5
1945,1-methyl-d-tryptophan,5
1946,trimethoprim-sulfamethoxazole,5
1947,ketorolac,5
1948,erythropoietin,5
1949,cva21,5
1950,urine collection,5
1951,cognitive behavioral therapy,5
1952,docetaxel/cisplatin,5
1953,panitumumab-irdye800,5
1954,pf-05082566,5
1955,biib021,5
1956,fluciclovine f18,5
1957,platinum-based drug,5
1958,hematopoietic stem cell transplant,5
1959,alvimopan,5
1960,wst11,5
1961,jcar017,5
1962,m6620,5
1963,hki-272,5
1964,aeb071,5
1965,pd0332991,5
1966,testosterone cypionate,5
1967,sonidegib,5
1968,granulocyte-colony stimulating factor,5
1969,therapeutic procedure,5
1970,proton,5
1971,dce-mri,5
1972,lymph node biopsy,5
1973,indwelling pleural catheter,5
1974,selicrelumab,5
1975,rasburicase (sr29142),5
1976,ablation,5
1977,navigation,5
1978,curettage,5
1979,lanreotide (autogel formulation),5
1980,anti-pdl-1 antibody,5
1981,precision cells,5
1982,amg 337,5
1983,as703569,5
1984,cvx-060 + sunitinib,5
1985,sar3419,5
1986,bay1002670,5
1987,impact,5
1988,rogaratinib (bay1163877),5
1989,diagnostic endoscopic procedure,5
1990,granulocyte-colony stimulating factor (g-csf),5
1991,biofeedback,5
1992,dce mri,5
1993,ptvg-hp with rhgm-csf,5
1994,dc-cik immunotherapy,5
1995,stem cell collection,5
1996,medi4736 (durvalumab),5
1997,endobronchial ultrasound,5
1998,shear wave elastography,5
1999,imc-1121b,5
2000,spect/ct,5
2001,ocv-501,5
2002,plitidepsin,5
2003,prostvac-f,5
2004,arzoxifene hydrochloride,5
2005,cik,5
2006,nivolumab + ipilimumab,5
2007,gemcitabine and docetaxel,5
2008,sgt-53,5
2009,first-line chemotherapy,5
2010,peripheral blood stem cell infusion,5
2011,double-unit umbilical cord blood transplantation,5
2012,ro6874281,5
2013,abx-egf,5
2014,streptozocin,5
2015,gallium ga 68-labeled psma-11,5
2016,bms-247550,5
2017,pedometer,5
2018,zolbetuximab,5
2019,peg-filgrastim,5
2020,cc-4047,5
2021,oxaliplatin (sr96669),5
2022,tc 99m ec20,5
2023,phototherapy,5
2024,sar245409,5
2025,gsk2256098,5
2026,examination,5
2027,lenalidomide (revlimid®),5
2028,fdg-pet scan,5
2029,sulfasalazine,5
2030,physical activity counseling,5
2031,chiauranib,5
2032,cord blood transplantation,5
2033,tme,5
2034,pep005 (ingenol mebutate) gel,5
2035,6mhp,5
2036,onivyde,5
2037,decadron,5
2038,incmga00012,5
2039,cardiac mri,5
2040,everolimus and sorafenib,5
2041,allogeneic gm-csf-secreting breast cancer vaccine,5
2042,brivanib alaninate,5
2043,autologous transplantation,5
2044,anticd137,5
2045,standard of care chemotherapy,5
2046,cap,5
2047,ibi308,5
2048,isf35,5
2049,vm26,5
2050,oxycodone hydrochloride,5
2051,biological sample,5
2052,radotinib,5
2053,memantine,5
2054,x-ray,5
2055,clofarabine (iv formulation),5
2056,volitinib,5
2057,metastasectomy,5
2058,elagolix,5
2059,vigil™,5
2060,vehicle topical gel,5
2061,oral placebo,5
2062,gv1001,5
2063,interferon alpha,5
2064,amg 102,5
2065,alecsat,5
2066,written materials,5
2067,ad-rts-hil-12,5
2068,lansoprazole,5
2069,sch 721015,5
2070,alvespimycin hydrochloride,5
2071,mehd7945a,5
2072,imaging with 18f-flt pet,5
2073,nutrition,5
2074,gastrointestinal complications management/prevention,5
2075,gemcitabine + carboplatin,5
2076,"arry-520, ksp(eg5) inhibitor; intravenous",5
2077,hpv vaccine,5
2078,tosedostat,5
2079,therapeutic nutritional supplementation,5
2080,diagnostic procedure,5
2081,durvalumab + tremelimumab,5
2082,ac0010,5
2083,imcgp100,5
2084,ctdna analysis,5
2085,interferon alfa,5
2086,durvalumab and tremelimumab,5
2087,pro95780,5
2088,cpi-444,5
2089,pneumococcal polyvalent vaccine,5
2090,sodium phenylbutyrate,5
2091,astragalus polysaccharides 500 mg,5
2092,ly3300054,5
2093,ro5083945,5
2094,additional biological samples,5
2095,hspe7,5
2096,xl647,5
2097,?? t cell,5
2098,aminolevulinic acid (ala),5
2099,pep005 gel,5
2100,ro6870810,5
2101,modified folfox6,5
2102,icaritin,5
2103,bibw2992,5
2104,am0010,5
2105,dabigatran etexilate,5
2106,thermal ablation therapy,5
2107,nanoliposomal irinotecan,5
2108,acy-1215,5
2109,proflavine hemisulfate,5
2110,vidaza,5
2111,natural killer cells,5
2112,diagnostic colonoscopy,5
2113,cognitive intervention,5
2114,car-t cell immunotherapy,5
2115,niclosamide,5
2116,omegaven,5
2117,azd9291 tablet dosing,5
2118,"elagolix, elagolix sodium",5
2119,fluzoparib,5
2120,cardiopulmonary exercise test,5
2121,tak-117,5
2122,cystoscopy,5
2123,ch14.18/cho,5
2124,resistance exercise,5
2125,copper gluconate,5
2126,opb-111077,5
2127,brostallicin,5
2128,lymphoseek,5
2129,trimetrexate glucuronate,5
2130,cy,5
2131,hsct,5
2132,stretching,5
2133,genexol-pm,5
2134,endurance training,5
2135,erlotinib hcl,5
2136,atrasentan,5
2137,testosterone enanthate,5
2138,hyperfractionated radiation therapy,5
2139,pipac,5
2140,bone marrow aspirate,5
2141,triamcinolone acetonide,5
2142,liposomal annamycin,5
2143,ljm716,5
2144,abdominal surgery,5
2145,cudc-101,5
2146,atiprimod,5
2147,allogeneic tumor cell vaccine,5
2148,sunitinib (sutent),5
2149,ly2940680,5
2150,lum imaging system,5
2151,imgn853,5
2152,endometrial biopsy,5
2153,nicotine replacement therapy,5
2154,immunotherapy allogeneic gm-csf secreting cellular vaccine,5
2155,napabucasin,5
2156,tumor infiltrating lymphocytes (til),5
2157,open pancreaticoduodenectomy,5
2158,telephone interview,5
2159,research blood draw,5
2160,pri-724,5
2161,parecoxib sodium,5
2162,rocuronium,5
2163,ic83/ly2603618,5
2164,maraviroc,5
2165,external beam radiotherapy (ebrt),5
2166,paclitaxel (taxol),5
2167,cns irradiation,5
2168,acyclovir,5
2169,thymalfasin,5
2170,transanal total mesorectal excision,5
2171,selective external radiation therapy,5
2172,water immersion,5
2173,l-leucovorin,5
2174,cord blood infusion,5
2175,liver biopsy,5
2176,oleclumab,5
2177,ct-322,5
2178,blz-100,5
2179,screening method,5
2180,elotuzumab (bms-901608; huluc63),5
2181,pep-cmv,5
2182,"arry-334543, egfr/erbb2 inhibitor; oral",5
2183,lifestyle counseling,5
2184,prednisone/prednisolone,5
2185,pet-mri,5
2186,paclitaxel injection,5
2187,bp-c1,5
2188,at13387,5
2189,surveillance,5
2190,psma adc,5
2191,sativex,5
2192,doxorubicin hydrochloride (liposomal),5
2193,samarium sm 153 lexidronam pentasodium,5
2194,immunostimulating interstitial laser thermotherapy,5
2195,sb1518,5
2196,broccoli sprout extract,5
2197,pegasys,5
2198,apatinib mesylate,5
2199,ypeg-filgrastim,5
2200,sib-imrt,5
2201,arac,5
2202,therapeutic thoracoscopy,5
2203,inositol,5
2204,rifampicin,5
2205,diagnostic,5
2206,haploidentical stem cell transplantation,5
2207,stool sample,5
2208,weight loss intervention,5
2209,ctx,5
2210,diclofenac sodium,5
2211,irx-2,5
2212,core needle biopsy,5
2213,dli,5
2214,natural killer cell infusion,5
2215,tak-700,5
2216,multi-parametric mri,5
2217,ramosetron,5
2218,caelyx,5
2219,young til,5
2220,conatumumab,5
2221,mediterranean diet,5
2222,pexidartinib,5
2223,preoperative chemoradiotherapy,5
2224,rintatolimod,5
2225,hyperbaric oxygen therapy,5
2226,azd8055,5
2227,afx-2,5
2228,bone marrow transplant,5
2229,fractionated stereotactic radiotherapy,5
2230,tetrathiomolybdate,5
2231,kpt-330,5
2232,recombinant human erythropoietin,5
2233,mutation carrier screening,5
2234,ro5503781,5
2235,egfr-tk inhibitor,5
2236,larotaxel (xrp9881),5
2237,ursodeoxycholic acid,5
2238,dkn-01,5
2239,milatuzumab,5
2240,gm-csf (sargramostim),5
2241,probiotics,5
2242,non-specific immune-modulator therapy,5
2243,mfolfox,5
2244,msc1936369b,5
2245,lag525,5
2246,3-tesla magnetic resonance imaging,5
2247,cnto 328,5
2248,afatinib dimaleate,5
2249,naproxen,5
2250,bibf1120,5
2251,reflectance confocal microscopy,5
2252,novottf-200a,5
2253,geriatric assessment,5
2254,quadratus lumborum block,5
2255,edotecarin,5
2256,theophylline,5
2257,gb226,5
2258,autologous stem cell infusion,5
2259,gx-188e,5
2260,pravastatin sodium,5
2261,endoscopic ultrasound,5
2262,bms-936558 (mdx-1106),5
2263,transplant,5
2264,nausea and vomiting therapy,5
2265,actigraph,5
2266,synthetic human secretin,5
2267,m2es,5
2268,liposome-encapsulated daunorubicin-cytarabine,5
2269,celebrex,5
2270,no interventions,5
2271,mk-4827,5
2272,supervised exercise,5
2273,low dose computed tomography,5
2274,iodine i 131 tositumomab,5
2275,docetaxel (taxotere®),5
2276,glucarpidase,5
2277,recombinant fowlpox-tricom vaccine,5
2278,pet/ct scans,5
2279,paclitaxel and cisplatin,5
2280,amn107,5
2281,fluorescence spectroscopy,5
2282,vistusertib,5
2283,anlotinib hydrochloride,5
2284,radical surgery,5
2285,atrasentan hydrochloride,5
2286,indole-3-carbinol,5
2287,cisplatin and docetaxel,5
2288,enalapril,5
2289,gemzar,5
2290,selumetinib sulfate,5
2291,andecaliximab,5
2292,temodar,5
2293,pr104,5
2294,argon plasma coagulation,5
2295,fluorouracil (5-fu),5
2296,photodynamic therapy (pdt),5
2297,xl765 (sar245409),5
2298,cancer stem cell vaccine,5
2299,enfortumab vedotin,5
2300,ferric carboxymaltose,5
2301,water,5
2302,intrathecal methotrexate,5
2303,phosphorus p32,5
2304,enasidenib,5
2305,zileuton,5
2306,dendritic cells dcvac/pca,5
2307,ezn-2208,5
2308,doxercalciferol,5
2309,flt-pet,5
2310,liraglutide,5
2311,gsk2141795,5
2312,motexafin gadolinium injection,5
2313,prostvac-v/tricom,5
2314,pf-03446962,5
2315,red blood cell transfusion,5
2316,chromoendoscopy,5
2317,azd5991,5
2318,pf-04518600,5
2319,local anesthesia,5
2320,px-866,5
2321,ps-341,5
2322,medroxyprogesterone acetate,5
2323,mindfulness,5
2324,recombinant vaccinia-cea(6d)-tricom vaccine,5
2325,tisotumab vedotin,5
2326,a-101,5
2327,tsr-042,5
2328,semi-structured interviews,5
2329,breath test,4
2330,mk-0752,4
2331,mdx-010,4
2332,psc 833,4
2333,tabelecleucel,4
2334,infection prophylaxis and management,4
2335,local excision,4
2336,tivozanib (av-951),4
2337,microwave ablation (mwa),4
2338,boost,4
2339,thoracic radiation therapy,4
2340,rituximab [mabthera],4
2341,as1411,4
2342,abbv-927,4
2343,tpf induction chemotherapy,4
2344,rofecoxib,4
2345,leo 43204,4
2346,proellex 50 mg,4
2347,pemetrexed + cisplatin,4
2348,kn035,4
2349,torisel,4
2350,alvocidib hydrochloride,4
2351,antroquinonol,4
2352,stereotactic radiation therapy,4
2353,zd1839 (iressa),4
2354,trastuzumab (herceptin®),4
2355,hcd122,4
2356,mk2206,4
2357,mirvetuximab soravtansine,4
2358,blood drawn,4
2359,tyrosine kinase inhibitor,4
2360,tarceva (erlotinib hcl),4
2361,caregiver-related intervention or procedure,4
2362,jx-594,4
2363,intravenous dexamethasone,4
2364,comparator: mk0429,4
2365,gnrh antagonist,4
2366,kx2-391,4
2367,lhrha,4
2368,taxotere®,4
2369,standard radiation,4
2370,ly2606368,4
2371,recombinant vaccinia gm-csf; rac vac gm-csf (jx-594),4
2372,"concurrent pemetrexed, cisplatin and radiotherapy",4
2373,telotristat etiprate,4
2374,telephone survey,4
2375,bms-908662,4
2376,avelumab (msb0010718c),4
2377,abbv-399,4
2378,sigmoidoscopy,4
2379,amoxicillin,4
2380,abl001,4
2381,uft,4
2382,open distal gastrectomy,4
2383,talactoferrin,4
2384,weight loss,4
2385,chewing gum,4
2386,msc2156119j,4
2387,triptorelin pamoate,4
2388,xrt,4
2389,modified vaccinia virus ankara vaccine expressing p53,4
2390,ag013,4
2391,ptk787,4
2392,cv301,4
2393,liposomal vincristine,4
2394,strontium chloride sr 89,4
2395,amifampridine phosphate,4
2396,exhalation analysis of breath sample,4
2397,lapatinib plus capecitabine,4
2398,robatumumab,4
2399,her2bi-armed activated t cells,4
2400,next-generation sequencing,4
2401,sarcnu,4
2402,esophagogastroduodenoscopy,4
2403,ibandronate [bondronat],4
2404,tas 102,4
2405,antitumor drug screening assay,4
2406,hbi-8000,4
2407,melflufen,4
2408,patient interview,4
2409,folfiri + cetuximab,4
2410,endostatins,4
2411,tandutinib,4
2412,afuresertib,4
2413,ultrasound scan,4
2414,irradiation with red light-emitting diode lamp,4
2415,ags-003,4
2416,holmium ho 166 dotmp,4
2417,ultrasonic ablation device,4
2418,asparaginase erwinia chrysanthemi,4
2419,patient controlled analgesia,4
2420,sodium glycididazole,4
2421,cpap,4
2422,eras,4
2423,diazoxide,4
2424,tirabrutinib,4
2425,probe-based confocal laser endomicroscopy,4
2426,hmn14 (labetuzumab),4
2427,oral impact,4
2428,electro-acupuncture,4
2429,3dcrt,4
2430,intraoperative radiation therapy (iort),4
2431,magnesium oxide,4
2432,oncos-102,4
2433,gpi-0100,4
2434,systemic treatment,4
2435,gsk2857916,4
2436,"vp16, atg",4
2437,"capecitabine, oxaliplatin",4
2438,ab928,4
2439,detox-b adjuvant,4
2440,tens,4
2441,epinephrine,4
2442,remote ischemic preconditioning,4
2443,androgen deprivation,4
2444,s-8184 paclitaxel injectable emulsion,4
2445,duloxetine,4
2446,trastuzumab deruxtecan (ds-8201a),4
2447,positron emission tomography and computed tomography,4
2448,corticosteroid,4
2449,dexamethasone / prednisolone,4
2450,epirubicine,4
2451,pemetrexed (alimta),4
2452,total lymphoid irradiation (tli),4
2453,fentanyl sublingual spray,4
2454,patritumab,4
2455,electroacupuncture therapy,4
2456,acupressure therapy,4
2457,hydromorphone hydrochloride,4
2458,scb01a,4
2459,ebus,4
2460,haic of folfox,4
2461,intracavitary balloon brachytherapy,4
2462,rehabilitation,4
2463,lgh447,4
2464,nivolumab injection [opdivo],4
2465,laser interstitial thermal therapy,4
2466,levamisole hydrochloride,4
2467,pep02,4
2468,"gadobutrol (gadavist, gadovist, bay86-4875)",4
2469,calcium electroporation,4
2470,aflibercept ave0005,4
2471,pharmacokinetics,4
2472,ocv-103 and ocv-104,4
2473,coenzyme q10,4
2474,saliva samples,4
2475,peg-interferon alfa-2a,4
2476,saline placebo,4
2477,adoptive immunotherapy,4
2478,blood withdrawal,4
2479,dendritic cell vaccine therapy,4
2480,intensity-modulated radiotherapy (imrt),4
2481,trk-950,4
2482,transrectal prostate biopsy,4
2483,ommaya reservoir,4
2484,dovitinib lactate,4
2485,opb-31121,4
2486,68ga-psma,4
2487,hydralazine and magnesium valproate,4
2488,aminocamptothecin,4
2489,gum chewing,4
2490,ec-18,4
2491,pelvic radiotherapy,4
2492,gemcitabine 1000 mg,4
2493,iodine i 131 monoclonal antibody 81c6,4
2494,pm01183,4
2495,dovitinib (tki258),4
2496,plinabulin,4
2497,placebo to match ibrutinib,4
2498,brain mri,4
2499,preparative regimen,4
2500,hematopoietic stem cell transplantation (hsct),4
2501,pantoprazole,4
2502,dc vaccination,4
2503,pi3k inhibitor bkm120,4
2504,whole brain radiation,4
2505,psychoeducation,4
2506,standard supportive care,4
2507,medi4736 + tremelimumab,4
2508,laparoscopic hepatectomy,4
2509,roniciclib (bay 1000394),4
2510,elesclomol sodium,4
2511,ursodiol,4
2512,laparoscopic,4
2513,arq 092,4
2514,endoscopic stenting,4
2515,dasatinib (bms-354825),4
2516,continuous epidural analgesia,4
2517,therapeutic laparoscopic surgery,4
2518,questionnaire and interview,4
2519,carboplatin/paclitaxel,4
2520,her-2/neu intracellular domain protein,4
2521,cytology,4
2522,gemcitabine and carboplatin,4
2523,electroencephalogram (eeg),4
2524,recombinant human thrombopoietin,4
2525,ciclosporin,4
2526,xl820,4
2527,lymph node mapping,4
2528,gx-i7,4
2529,sonovue,4
2530,pharmacodynamic study,4
2531,lidocaine/prilocaine (5%) application,4
2532,aslan001,4
2533,fluorine f 18 fluorodopa,4
2534,allogeneic epstein-barr virus-specific cytotoxic t lymphocytes,4
2535,masitinib (ab1010),4
2536,imc-18f1,4
2537,t cell-depleted hematopoietic stem cell transplantation,4
2538,pcea,4
2539,granulocyte colony stimulating factor,4
2540,bms-982470 (recombinant interleukin-21),4
2541,telephone intervention,4
2542,temsirolimus (cci-779),4
2543,lmb-2 immunotoxin,4
2544,pancreatic surgery,4
2545,metformin er,4
2546,placebo plus docetaxel,4
2547,sufentanil,4
2548,lestaurtinib,4
2549,systemic therapy,4
2550,pg2,4
2551,darinaparsin,4
2552,tisagenlecleucel,4
2553,vigil™ vaccine,4
2554,iort,4
2555,exablate mrgfus,4
2556,isolated limb perfusion,4
2557,vemurafenib and cobimetinib,4
2558,olive oil,4
2559,racotumomab,4
2560,pemetrexed + carboplatin,4
2561,hatha yoga,4
2562,ibandronate sodium,4
2563,cddp,4
2564,rebimastat,4
2565,cyberknife stereotactic radiosurgery,4
2566,gdc-0084,4
2567,prostvac-f/tricom,4
2568,ly2875358,4
2569,acetylcysteine,4
2570,pci-24781,4
2571,transcatheter arterial chemoembolization (tace),4
2572,neostigmine,4
2573,imetelstat sodium (grn163l),4
2574,imm-101,4
2575,neulasta®,4
2576,sgn-liv1a,4
2577,br55,4
2578,medpulser electroporation with bleomycin,4
2579,"docetaxel, cisplatin",4
2580,counseling sessions,4
2581,epoch regimen,4
2582,folfiri protocol,4
2583,mwa,4
2584,fowlpox virus vaccine vector,4
2585,exablate 2100,4
2586,tbi-1401(hf10),4
2587,nesvacumab (regn910/ sar307746),4
2588,inno-206,4
2589,bvd-523,4
2590,methotrexate (mtx),4
2591,lv,4
2592,implanted fiducial-based imaging,4
2593,acy-241,4
2594,ga-68 labeled psma-11 pet,4
2595,tvb-2640,4
2596,pleurectomy/decortication,4
2597,reflexology,4
2598,motivational interview,4
2599,rhtpo,4
2600,crenolanib besylate,4
2601,ngs,4
2602,cep-9722,4
2603,beam,4
2604,interferon gamma-1b,4
2605,bivatuzumab mertansine,4
2606,telapristone acetate,4
2607,"oxaliplatin (oxa), levofolinate calcium (l-lv), 5-fu, panitumumab",4
2608,opb-51602,4
2609,cytoreduction,4
2610,enhanced recovery after surgery,4
2611,foretinib,4
2612,high dose chemo then auto hematopoietic cell transplant,4
2613,flexible sigmoidoscopy,4
2614,recombinant vaccinia-tricom vaccine,4
2615,psilocybin,4
2616,farnesyl protein transferase inhibitor,4
2617,lipotecan,4
2618,communication skills training,4
2619,cs1001,4
2620,surgical treatment,4
2621,metoprolol,4
2622,saliva sample,4
2623,placebo tablet,4
2624,qualitative interviews,4
2625,liposomal daunorubicin citrate,4
2626,radical radiotherapy,4
2627,laser treatment,4
2628,talaporfin sodium,4
2629,gemcitabine + capecitabine,4
2630,radiation therapy (xrt),4
2631,mal application,4
2632,training,4
2633,questionaires,4
2634,veliparib (abt-888),4
2635,copper cu 64-dota-trastuzumab,4
2636,lymph node dissection,4
2637,bioimpedance spectroscopy,4
2638,cudc-907,4
2639,medi-507,4
2640,adrenalectomy,4
2641,definity,4
2642,hypofractionated radiation,4
2643,follow-up care,4
2644,ptc596,4
2645,flt,4
2646,tepotinib,4
2647,transfusion,4
2648,lxh254,4
2649,tapa-pulsed dc vaccine,4
2650,epidural analgesia,4
2651,mr,4
2652,pregnancy test,4
2653,toca 511,4
2654,sjg-136,4
2655,vitamin b6,4
2656,sunitinib malate (su011248),4
2657,piperacillin-tazobactam,4
2658,echocardiography,4
2659,sentinel lymph node biopsy (slnb),4
2660,breast reconstruction,4
2661,transcranial magnetic stimulation,4
2662,white light endoscopy,4
2663,ibritumomab tiuxetan (zevalin),4
2664,molecular imaging,4
2665,sf1126,4
2666,cisplatin/carboplatin,4
2667,pamidronate disodium,4
2668,iodine i 131 monoclonal antibody 3f8,4
2669,mkc1106-mt,4
2670,selumetinib 75mg single dose,4
2671,fosbretabulin disodium,4
2672,volociximab,4
2673,gsk2636771,4
2674,cd19 car t cells,4
2675,cyclophosphamide (ctx),4
2676,copper cu 64 tp3805,4
2677,captopril,4
2678,emd525797,4
2679,recombinant vaccinia prostate-specific antigen vaccine,4
2680,targeted therapy,4
2681,nefopam,4
2682,cd19-targeted car-t cells,4
2683,accelerometer,4
2684,sl-401,4
2685,best available therapy (bat),4
2686,cervarix™,4
2687,emd 521873,4
2688,umbilical cord blood,4
2689,gallium ga 68-edotreotide,4
2690,gemcitabine/nab-paclitaxel,4
2691,jnj-63723283,4
2692,tasigna,4
2693,isavuconazole,4
2694,endocuff vision,4
2695,t cell infusion,4
2696,human papillomavirus vaccine,4
2697,abraxane®,4
2698,romidepsin and chop,4
2699,information,4
2700,xl888,4
2701,monalizumab,4
2702,tumor necrosis factor,4
2703,"irinotecan, capecitabine",4
2704,mira device imaging,4
2705,incyclinide,4
2706,lmb-100,4
2707,surufatinib,4
2708,tumor infiltrating lymphocytes,4
2709,intervention arm,4
2710,stanford v regimen,4
2711,satoreotide trizoxetan,4
2712,autologous hsct,4
2713,valrubicin,4
2714,dacomitinib (pf-00299804),4
2715,realrisks,4
2716,ulipristal,4
2717,glucocorticoid,4
2718,tetracycline hydrochloride,4
2719,yttrium y 90 anti-cd45 monoclonal antibody bc8,4
2720,eus,4
2721,sunscreen,4
2722,estetrol,4
2723,sodium chloride,4
2724,cytarabine (ara-c),4
2725,the imaging biomarkers determined by mr-pet,4
2726,nivolumab and ipilimumab,4
2727,myocet,4
2728,alpps,4
2729,dermatology patients,4
2730,11c-choline,4
2731,tac-101,4
2732,external radiotherapy,4
2733,laser ablation,4
2734,dichloroacetate,4
2735,ebus-gs,4
2736,low fat diet,4
2737,amg 531,4
2738,musculoskeletal complications management/prevention,4
2739,endostatin,4
2740,smoking cessation counseling,4
2741,allostim-8,4
2742,spartalizumab,4
2743,mln1117,4
2744,sb-485232,4
2745,bupropion,4
2746,dribble vaccine,4
2747,tki,4
2748,atamestane,4
2749,paclitaxel/carboplatin,4
2750,boronophenylalanine-fructose complex,4
2751,ertumaxomab,4
2752,sb939,4
2753,daunorubicine,4
2754,sar245408,4
2755,anetumab ravtansine (bay94-9343),4
2756,pixantrone dimaleate,4
2757,regional lymph node dissection,4
2758,vedolizumab,4
2759,fondaparinux,4
2760,peg-l-asparaginase,4
2761,13-cis-retinoic acid,4
2762,5-fu/lv,4
2763,cetuximab (erbitux),4
2764,18f-flt,4
2765,"paclitaxel, carboplatin",4
2766,mk0457,4
2767,pyridoxine hydrochloride,4
2768,usual care (uc),4
2769,sb injection,4
2770,inotuzumab ozogamicin (cmc-544),4
2771,botulinum toxin type a,4
2772,ovarian cystectomy,4
2773,gadobenate dimeglumine,4
2774,omega-3,4
2775,laser,4
2776,eniluracil,4
2777,gene modified t cells,4
2778,p1446a-05,4
2779,ctl019,4
2780,micafungin,4
2781,daunomycin,4
2782,aflibercept (ave0005),4
2783,tobacco cessation counseling,4
2784,rhuph20,4
2785,weekly paclitaxel,4
2786,certolizumab pegol,4
2787,"lenalidomide, bortezomib",4
2788,post-operative radiotherapy,4
2789,ald518,4
2790,postoperative radiotherapy,4
2791,lapatinib (gw572016),4
2792,decitabine (dac),4
2793,ovarian interstitial laser treatment,4
2794,uterine artery embolization,4
2795,ingn 201,4
2796,peg-g-csf,4
2797,protein tyrosine kinase inhibitor therapy,4
2798,whole brain radiotherapy (wbrt),4
2799,cdx-1127,4
2800,osi-774,4
2801,biomarker study,4
2802,nbtxr3,4
2803,medi-565,4
2804,bay86-9766,4
2805,chemoprotection,4
2806,dual x-ray absorptiometry,4
2807,hpv test,4
2808,neck dissection,4
2809,dim red light,4
2810,pioglitazone hydrochloride,4
2811,mvt-5873,4
2812,oxycodone/naloxone,4
2813,tramadol,4
2814,balloon kyphoplasty,4
2815,self-help materials,4
2816,fluorine f 18 l-glutamate derivative bay94-9392,4
2817,hmpl-523,4
2818,vxm01,4
2819,perflutren lipid microspheres,4
2820,maintenance chemotherapy,4
2821,neod001,4
2822,trilaciclib,4
2823,minimally invasive esophagectomy,4
2824,valproate,4
2825,esd,4
2826,cryospray ablation,4
2827,mk-0646,4
2828,chlorogenic acid,4
2829,idh305,4
2830,imatinib mesylate (gleevec),4
2831,exenatide,4
2832,tumor sample,4
2833,keytruda,4
2834,low molecular weight heparin,4
2835,cpi-0610,4
2836,placebo (saline),4
2837,nabiximols,4
2838,lee011 and mek162,4
2839,bright white light,4
2840,hyperpolarized carbon c 13 pyruvate,4
2841,bms-936558,4
2842,regimen b,4
2843,endoscopic surgery,4
2844,golimumab,4
2845,prostvac-v,4
2846,proellex 25 mg,4
2847,ny-eso-1 reactive tcr retroviral vector transduced autologous pbl,4
2848,bmx-001,4
2849,msc2490484a,4
2850,imetelstat sodium,4
2851,veledimex,4
2852,bmn 673,4
2853,obp-301,4
2854,biological collection,4
2855,pf00562271,4
2856,blood draw and questionnaires,4
2857,myo-inositol + folic acid,4
2858,faslodex,4
2859,dendritic cell immunotherapy,4
2860,ak105,4
2861,177lu-dota0-tyr3-octreotate,4
2862,technetium tc-99m sulfur colloid,4
2863,"copanlisib (aliqopa, bay80-6946)",4
2864,anti-thymocyte globulin (rabbit),4
2865,filgrastim-sndz,4
2866,levothyroxine,4
2867,refametinib (bay86-9766),4
2868,erwinia asparaginase,4
2869,olaparib tablet dosing,4
2870,clonidine,4
2871,nab-paclitaxel and gemcitabine,4
2872,fractionated rt,4
2873,traumeel s,4
2874,bosentan,4
2875,colon capsule endoscopy,4
2876,ec20,4
2877,therapeutic education,4
2878,hiltonol,4
2879,ponatinib 30 mg,4
2880,axillary dissection,4
2881,ptc299,4
2882,"atezolizumab (mpdl3280a), an engineered anti-pdl1 antibody",4
2883,campath 1h,4
2884,sentinel lymph node mapping,4
2885,novottf-100l,4
2886,s-1 plus oxaliplatin,4
2887,donafenib,4
2888,ct colonography,4
2889,sns01-t,4
2890,cyclosporin a,4
2891,clinimacs cd34 reagent system,4
2892,oral glucose tolerance test (ogtt),4
2893,bgb324,4
2894,cc-292,4
2895,cyberknife sbrt,4
2896,vismodegib 150 mg,4
2897,ablative allogeneic hematopoietic cell transplantation,4
2898,epidural anesthesia,4
2899,nutrition education,4
2900,mk1775,4
2901,bi 836858,4
2902,exercise programme,4
2903,18f-faza,4
2904,peripheral blood stem cell transplantation (pbsct),4
2905,limberg flap,4
2906,maintenance,4
2907,dha-paclitaxel,4
2908,fludarabine phosphate (fludara),4
2909,endotag-1,4
2910,ortataxel,4
2911,imc-1121b (ramucirumab),4
2912,liposomal paclitaxel,4
2913,povidone-iodine,4
2914,hemopatch,4
2915,karenitecin,4
2916,gene therapy,4
2917,taxoprexin,4
2918,montanide,4
2919,estrace,4
2920,abt-806,4
2921,irinotecan (cpt-11),4
2922,t-cell infusion,4
2923,varlilumab,4
2924,vaccine therapy,4
2925,pv-10 (10% rose bengal disodium),4
2926,intraoperative ultrasound,4
2927,"cp-868,596",4
2928,standard of care colonoscopy,4
2929,acetic acid,4
2930,berberine,4
2931,cart-19 cells,4
2932,peripheral blood stem cells,4
2933,gemzar (gemcitabine),4
2934,mindfulness meditation,4
2935,expressive writing,4
2936,cefixime,4
2937,mdm2 inhibitor amg-232,4
2938,high-dose rate brachytherapy,4
2939,aminocamptothecin colloidal dispersion,4
2940,ethynyluracil,4
2941,igrt,4
2942,endocuff-assisted colonoscopy,4
2943,ga101,4
2944,platelet rich plasma,4
2945,18f-dcfpyl pet/ct,4
2946,intracavitary brachytherapy,4
2947,gemcitabine-releasing intravesical system (gemris)/tar-200,4
2948,glasdegib,4
2949,shr-1316,4
2950,farletuzumab,4
2951,recombinant mage-3.1 antigen,4
2952,optical colonoscopy,4
2953,incb001158,4
2954,thermodox,4
2955,proton pump inhibitor,4
2956,gsk525762,4
2957,cmb305,4
2958,targeted fusion protein therapy,4
2959,autologous hematopoietic cell transplantation,4
2960,ercp,4
2961,genesearch™ breast lymph node (bln) assay,4
2962,megf0444a,4
2963,tositumomab,4
2964,flt pet/ct,4
2965,perioperative chemotherapy,4
2966,fosbretabulin,4
2967,porfiromycin,4
2968,bb2121,4
2969,peptides,4
2970,gw786034,4
2971,transplantation,4
2972,allogeneic transplant,4
2973,dhea,4
2974,cord blood transplant,4
2975,microtransplantation,4
2976,pci-32765 (ibrutinib),4
2977,ultrasound-guided prostate biopsy,4
2978,decitabine (5-aza-2'deoxycytidine),4
2979,iodine i 131,4
2980,mln0264,4
2981,uvb,4
2982,allogeneic hematopoietic cell transplantation,4
2983,wee1 inhibitor azd1775,4
2984,peg-intron,4
2985,chemoprevention,4
2986,bl22 immunotoxin,4
2987,imp321,4
2988,therapeutic lymphadenectomy,4
2989,standard of care (soc),4
2990,gp100:209-217(210m) peptide vaccine,4
2991,sirt,4
2992,ondansetron hydrochloride,4
2993,ly3039478,4
2994,mgcd265,4
2995,osi-7904l,4
2996,"cp-690,550",4
2997,international prostate symptom score,4
2998,air insufflation method.,4
2999,ct perfusion,4
3000,gadobutrol,4
3001,tecogalan sodium,4
3002,conventional rt,4
3003,allogeneic hsct,4
3004,endoscopic procedure,4
3005,stem cells,4
3006,cisplatin or carboplatin,4
3007,"vandetanib, selumetinib",4
3008,high-dose chemotherapy,4
3009,pu-h71,4
3010,standard follow-up,4
3011,pvx-410,4
3012,percutaneous radiofrequency ablation,4
3013,endocrine-modulating drug therapy,4
3014,dendritic cell vaccination,4
3015,5-fluoro-uracil,4
3016,vcn-01,4
3017,ptk787/zk222584,4
3018,opdivo,4
3019,axl1717,4
3020,carboplatine,4
3021,endoscopic resection,4
3022,music,4
3023,antithymocyte globulin (atg),4
3024,etrolizumab,4
3025,topical solution vehicle,4
3026,s-1 plus cisplatin,4
3027,robot-assisted surgery,4
3028,acitretin,4
3029,electrocardiogram,4
3030,single incision laparoscopic surgery,4
3031,i-131-clr1404,4
3032,hydroxychloroquine (hcq),4
3033,tumor resection,4
3034,gemtuzumab ozogamicin (go),4
3035,positron emission mammography,4
3036,5-aminolevulinic acid,4
3037,e7820,4
3038,papanicolaou test,4
3039,botox,4
3040,ly2510924,4
3041,placebo administration,4
3042,sodium selenite,4
3043,sodium stibogluconate,4
3044,reiki,4
3045,pemetrexed/carboplatin,4
3046,cp-461,4
3047,bay86-9596,4
3048,klh,4
3049,hypnotherapy,4
3050,intraoperative complication management/prevention,4
3051,water colonoscopy,4
3052,emd 525797,4
3053,e7974,4
3054,bi 754111,4
3055,naloxegol,4
3056,mv,4
3057,thermal ablation,4
3058,aerobic exercise training,4
3059,autologous stem cell transplant (asct),4
3060,letrozole 2.5mg,4
3061,magnetic resonance guided focused ultrasound,3
3062,hm61713,3
3063,alendronate sodium,3
3064,iloprost,3
3065,epothilone d,3
3066,etoposide/cisplatin,3
3067,mmf,3
3068,open hepatectomy,3
3069,cs1001 placebo,3
3070,procrit (epoetin alfa),3
3071,therapeutic testosterone,3
3072,incb047986,3
3073,bkm120 matching placebo,3
3074,mindfulness intervention,3
3075,acarbose,3
3076,granulocyte-colony stimulating growth factor,3
3077,incagn01949,3
3078,non-interventional study,3
3079,transversus abdominis plane block,3
3080,hycamtin,3
3081,cellular therapy,3
3082,gastric resection,3
3083,18f-fmiso,3
3084,interleukin-2 gene,3
3085,verteporfin pdt,3
3086,oncothermia,3
3087,allogeneic hct,3
3088,pneumococcal 13-valent conjugate vaccine,3
3089,l-lv,3
3090,questionnaires/interviews,3
3091,bind-014,3
3092,exercise counseling,3
3093,tamsulosin,3
3094,concurrent radiotherapy,3
3095,mercaptopurine tablet,3
3096,booklet,3
3097,placebo injection,3
3098,pancreaticojejunostomy,3
3099,endomicroscope,3
3100,ga-68 psma-hbed-cc pet,3
3101,amrubicin hydrochloride,3
3102,near infrared imaging,3
3103,prostate cancer screening,3
3104,standard intervention,3
3105,zio-101 (darinaparsin),3
3106,circulating tumor cell analysis,3
3107,subcutaneous bortezomib,3
3108,strattice,3
3109,elective nodal irradiation (eni),3
3110,novottf-200a device,3
3111,tamibarotene,3
3112,phenoxodiol,3
3113,st. john's wort,3
3114,cis-uca solution,3
3115,talimogene laherparepvec (t-vec),3
3116,arm i (light sedation),3
3117,rhumab 2c4,3
3118,sgn-35,3
3119,cart 19,3
3120,carboplatin auc,3
3121,eflornithine plus sulindac,3
3122,alemtuzumab (campath-1h),3
3123,imrt (intensity-modulated radiation therapy),3
3124,oral rigosertib,3
3125,clostridium novyi-nt spores,3
3126,rigosertib sodium,3
3127,tace (transcatheter arterial chemoembolization),3
3128,phenelzine sulfate,3
3129,gc4419,3
3130,pbsc,3
3131,indisulam,3
3132,darolutamide,3
3133,volume controlled ventilation,3
3134,assessment questionnaires,3
3135,mediastinal irradiation,3
3136,loop electrosurgical excision procedure (leep),3
3137,capecitabine(aibin),3
3138,isis 3521,3
3139,imo-2055,3
3140,karenitecin (bnp1350),3
3141,vaseline,3
3142,naquotinib,3
3143,pixantrone,3
3144,recombinant interferon beta,3
3145,tetrahydrouridine (thu),3
3146,second generation car-t cells,3
3147,pembrolizumab injection [keytruda],3
3148,rituximab (r),3
3149,health coaching,3
3150,vb-111,3
3151,cs1001 monoclonal antibody,3
3152,case management,3
3153,cystectomy,3
3154,office hysteroscopy,3
3155,herceptin (trastuzumab),3
3156,thoracic radiation,3
3157,personalized cellular vaccine,3
3158,levofolinic acid,3
3159,atezolizumab [tecentriq],3
3160,docetaxel and capecitabine,3
3161,virtual reality,3
3162,mgn1703,3
3163,hcg,3
3164,fluorouracile,3
3165,surgical resection of primary tumor,3
3166,involved-field radiation therapy,3
3167,bb-10901,3
3168,folfox 6,3
3169,loratadine,3
3170,monoclonal antibody hu3s193,3
3171,placebo acupuncture,3
3172,nonlinear aerobic training,3
3173,choice,3
3174,docetaxel plus cisplatin,3
3175,lupron depot,3
3176,separable clustered electrodes,3
3177,bpx-501 t cells,3
3178,"nivolumab, ipilimumab",3
3179,percutaneous needle fasciotomy,3
3180,autologous human tumor-derived hsppc-96,3
3181,vinorelbine oral,3
3182,conization,3
3183,trastuzumab-mcc-dm1,3
3184,walking program,3
3185,writing intervention,3
3186,piperacillin/tazobactam,3
3187,ly2090314,3
3188,emr,3
3189,olaparib 300mg tablets,3
3190,recombinant adenovirus-p53 sch-58500,3
3191,vicinium,3
3192,pra-027,3
3193,hc1119,3
3194,cmd-193,3
3195,oral taxane,3
3196,2 cervical takings and 2 sampling of blood,3
3197,observation only,3
3198,chemotherapy (aracytine + daunorubicin),3
3199,methylprednisone,3
3200,floxuridine (fudr),3
3201,krt-232,3
3202,diagnostic bronchoscopy,3
3203,oxaliplatine,3
3204,"atezolizumab (mpdl3280a) [tecentriq], an engineered anti-pdl1 antibody",3
3205,hospital anxiety and depression scale (hads),3
3206,beta alethine,3
3207,adjuvant,3
3208,asa,3
3209,[18f]fluorthanatrace,3
3210,pegylated interferon ?-2b,3
3211,smoking cessation,3
3212,tkm-080301,3
3213,genetically engineered lymphocyte therapy,3
3214,apatinib mesylate tablet,3
3215,adh300004,3
3216,peginesatide,3
3217,cardiopulmonary exercise test (cpet),3
3218,confocal endomicroscopy,3
3219,enbrel,3
3220,68ga-nota-ae105,3
3221,tatme,3
3222,thyrogen,3
3223,telephone coaching,3
3224,vadastuximab talirine,3
3225,normal saline infusion,3
3226,nl201,3
3227,montanide isa 51,3
3228,hematopoietic stem cell infusion,3
3229,confocal laser endomicroscopy (cle),3
3230,sham treatment,3
3231,candida antigen,3
3232,folfoxa,3
3233,tavokinogene telseplasmid (tavo),3
3234,tolbutamide,3
3235,early oral feeding,3
3236,ro4929097,3
3237,venipuncture,3
3238,motexafin lutetium,3
3239,cisplatin-e therapeutic implant,3
3240,sevacizumab,3
3241,sch66336,3
3242,18f-dopa,3
3243,thermochemotherapy,3
3244,bendamustine hcl,3
3245,mental ability tests,3
3246,buthionine sulfoximine,3
3247,intravenous recombinant human mannose-binding lectin (rhmbl),3
3248,quercetin,3
3249,tetanus toxoid,3
3250,lisinopril,3
3251,azacitadine,3
3252,mk-1775,3
3253,retrospective study,3
3254,preoperative short-course radiotherapy,3
3255,syb c-1101,3
3256,motesanib diphosphate,3
3257,pt-523 for injection,3
3258,custirsen,3
3259,calcium citrate,3
3260,kyphoplasty,3
3261,3t mri,3
3262,somatostatin,3
3263,conformal radiotherapy,3
3264,folfiri.3,3
3265,anti-egfr monoclonal antibody,3
3266,radiochemotherapy 2,3
3267,stroboscopic nasopharyngeal laryngoscopy,3
3268,radioiodine,3
3269,lmwh,3
3270,industrialized oral supplementation (ios) and tube feeding regimen (tfr) with nutren,3
3271,letrozole (femara),3
3272,hu14.18-il2,3
3273,cpg 7909 injection,3
3274,tandem colonoscopy,3
3275,thoracic surgery,3
3276,[89zr]df-iab2m,3
3277,shark cartilage extract ae-941,3
3278,zkab001 10mg/kg,3
3279,low dose total body irradiation,3
3280,pf-04856884,3
3281,"docetaxel, epirubicin, cyclophosphamide/navelbine, capecitabine, trastuzumab, bevacizumab",3
3282,interval training,3
3283,prednisone or prednisolone,3
3284,ipi-145,3
3285,ara c,3
3286,fitbit,3
3287,mycophenolate,3
3288,dexlansoprazole,3
3289,ceritinib (ldk378),3
3290,laparoscopic colectomy,3
3291,high-dose cyclophosphamide,3
3292,enadenotucirev,3
3293,ktn3379,3
3294,m200 (volociximab),3
3295,mr-pet,3
3296,consolidation involved-site radiotherapy (isrt),3
3297,mitoxantrone hydrochloride liposome,3
3298,open colectomy,3
3299,til,3
3300,dexanabinol,3
3301,yttrium y 90 monoclonal antibody m170,3
3302,radiochemotherapy 4,3
3303,in vitro sensitivity-directed chemotherapy,3
3304,mabthera,3
3305,afp464,3
3306,melphalan/hds,3
3307,usl311,3
3308,wound care management,3
3309,nicord®,3
3310,recombinant human chorionic gonadotropin,3
3311,hydrocodone/acetaminophen,3
3312,lenvatinib pill,3
3313,nk012,3
3314,treatment with tookad vtp,3
3315,3-dimensional conformal accelerated partial breast irradiation,3
3316,bafetinib,3
3317,vaccination,3
3318,"urlc10, vegfr1 and vegfr2",3
3319,manual lymph drainage,3
3320,recombinant vaccinia-b7.1 vaccine,3
3321,vehicle solution,3
3322,supportive-expressive group therapy,3
3323,vadimezan,3
3324,inhalation anesthesia,3
3325,?? t cells/ a cryosurgery or ire,3
3326,cardiopulmonary exercise testing (cpet),3
3327,pkc412,3
3328,folate,3
3329,depocyt,3
3330,68ga-psma-11,3
3331,calm,3
3332,perfusion ct scan,3
3333,mithramycin,3
3334,99mtc-3prgd2,3
3335,prx302,3
3336,online support group,3
3337,cam exercise therapy,3
3338,multihance,3
3339,histrelin acetate,3
3340,zd6474 (vandetanib) 100mg,3
3341,vtx-2337,3
3342,fluorine f 18 ef5,3
3343,fully covered sems,3
3344,contrast enhanced ultrasound,3
3345,deb-tace,3
3346,telephone questionnaire,3
3347,b,3
3348,nexavar,3
3349,ixazomib (mln9708),3
3350,neoantigen dna vaccine,3
3351,amg 232,3
3352,maxacalcitol,3
3353,mifamurtide,3
3354,tg4010,3
3355,ro6839921,3
3356,rhg-csf,3
3357,fcr,3
3358,eortc qlq c30,3
3359,yervoy,3
3360,bacillus calmette-guerin (bcg),3
3361,methoxsalen,3
3362,next-generation sequencing (ngs),3
3363,mri imaging,3
3364,89zr-bevacizumab,3
3365,5-fluorouracil (5fu),3
3366,dkn-01 600 mg,3
3367,photoacoustic imaging,3
3368,leucovorin (lv),3
3369,medi-551,3
3370,fractionated stereotactic radiosurgery,3
3371,azd6094,3
3372,"zarnestra, tipifarnib, r115777",3
3373,vizablate system,3
3374,ro5429083,3
3375,therapeutic education program,3
3376,go-203-2c,3
3377,biliary stenting,3
3378,cisplatin-docetaxel ± trastuzumab,3
3379,bcd-100,3
3380,sofosbuvir,3
3381,magnetic resonance-guided focused ultrasound,3
3382,cis-platinum,3
3383,audit and feedback,3
3384,bibw 2992 (afatinib),3
3385,glutaminase inhibitor cb-839 hydrochloride,3
3386,a-101 topical solution,3
3387,alloderm,3
3388,stool collection,3
3389,hepatitis a vaccine,3
3390,total thyroidectomy,3
3391,decipher questionnaire,3
3392,cdx-1401,3
3393,ly2228820,3
3394,xpert bladder cancer monitor,3
3395,ccnu,3
3396,immunotherapeutic gsk2132231a,3
3397,laboratory biomarker,3
3398,azd2811,3
3399,azd7762,3
3400,laparoscopic d2 lymphadenectomy,3
3401,gsk2110183,3
3402,medical imaging,3
3403,flt-pet scan,3
3404,talampanel,3
3405,external radiation therapy,3
3406,fertility assessment and management,3
3407,tac + folfox4,3
3408,minnelide,3
3409,doxorubicine,3
3410,bevacizumab injection,3
3411,turbt,3
3412,re-irradiation,3
3413,sevoflurane group,3
3414,ro7082859,3
3415,azd9496,3
3416,docetaxel (taxotere),3
3417,interleukin 7,3
3418,beacopp regimen,3
3419,infrared photocoagulation therapy,3
3420,oral glucose tolerance test,3
3421,vaccine only,3
3422,furosemide,3
3423,ace-011,3
3424,mind-body intervention procedure,3
3425,at7519m,3
3426,molecular profiling,3
3427,educational video,3
3428,enoblituzumab,3
3429,adenosine,3
3430,mk-4280,3
3431,bn83495,3
3432,supervised exercise program,3
3433,egcg,3
3434,gsk2879552,3
3435,paclitaxel plus carboplatin,3
3436,open total gastrectomy,3
3437,physician's choice chemotherapy,3
3438,"paclitaxel, cisplatin",3
3439,tumour markers testing,3
3440,sp,3
3441,figitumumab,3
3442,afm13,3
3443,akt inhibitor gsk2141795,3
3444,geriatric intervention,3
3445,high dose chemotherapy then autologous hematopoietic cell transplant,3
3446,mechanical ventilation,3
3447,zd6474 (vandetanib) 300mg,3
3448,sentinel node mapping,3
3449,high dose il-2,3
3450,cirmtuzumab,3
3451,relaxation therapy,3
3452,crt,3
3453,ag881,3
3454,low tidal volume,3
3455,chemotherapy only,3
3456,experimental,3
3457,contrast-enhanced ct,3
3458,radioimmunotherapy,3
3459,fenofibrate,3
3460,diffusion-weighted mri,3
3461,laparoscopy-assisted distal gastrectomy,3
3462,atengenal,3
3463,trastuzumab iv,3
3464,morab-003,3
3465,far infrared radiation,3
3466,2-deoxy-2-[18f]fluoro-d-glucose (fdg),3
3467,bay1125976,3
3468,hlx01,3
3469,sns-595,3
3470,recombinant fowlpox gm-csf vaccine adjuvant,3
3471,pegintron,3
3472,conditioning chemotherapy,3
3473,standard adjuvant systemic chemotherapy,3
3474,e6201,3
3475,sertraline,3
3476,vitamin d3 (cholecalciferol),3
3477,high-dose chemotherapy and autologous stem cell rescue,3
3478,radiochemotherapy 6,3
3479,interleukin-4 pe38kdel cytotoxin,3
3480,ro6958688,3
3481,pi discretion,3
3482,yttrium y 90 resin microspheres,3
3483,obatoclax mesylate (gx15-070ms),3
3484,tofacitinib,3
3485,bms-936558 (anti-pd-1),3
3486,lmb-2,3
3487,triamcinolone,3
3488,didanosine,3
3489,bone marrow collection,3
3490,additional blood sample,3
3491,electron microscopy,3
3492,video decision aid,3
3493,azd3759,3
3494,tak228,3
3495,bowel preparation,3
3496,pilates,3
3497,blood transfusion,3
3498,alrn-6924,3
3499,magnetic compressive anastomosis,3
3500,cold snare polypectomy,3
3501,incb039110,3
3502,jevtana,3
3503,doxorubicin hydrochloride liposome injection,3
3504,beeam,3
3505,c-car011,3
3506,weekly cisplatin,3
3507,dbt and ffdm,3
3508,claricore system,3
3509,metmab,3
3510,psychological intervention,3
3511,total mesorectal excision (tme),3
3512,ilx651,3
3513,su5416,3
3514,before decision aid,3
3515,dietary high fat,3
3516,18f-dcfbc,3
3517,ly3022855,3
3518,tg02 citrate,3
3519,nab-paclitaxel and s-1,3
3520,oral dexamethasone,3
3521,vaccine,3
3522,pegylated interferon alpha-2b,3
3523,toremifene citrate,3
3524,nivolumab 10 mg/ml,3
3525,standard radiotherapy,3
3526,scv-07,3
3527,percutaneous needle aponeurotomy,3
3528,"autologous, dnp-modified vaccine",3
3529,uv light therapy,3
3530,antiviral therapy,3
3531,tumor tissue,3
3532,ly2584702,3
3533,etoposide and cisplatin,3
3534,gnrh,3
3535,hyperthermic intraoperative peritoneal chemoperfusion,3
3536,imo-2125,3
3537,cognitive behavioral therapy for insomnia,3
3538,pemetrexed and cisplatin,3
3539,semi-structured interview,3
3540,nutrition intervention,3
3541,tislelizumab,3
3542,fecal immunochemical test (fit),3
3543,aezs-108,3
3544,fmiso,3
3545,oncosec medical system (oms),3
3546,denosumab 120 mg/1.7 ml subcutaneous solution [xgeva],3
3547,m3814,3
3548,partial mastectomy,3
3549,lesion count,3
3550,3d-crt,3
3551,floseal,3
3552,doxorubicin hcl liposome injection,3
3553,laparoscopic liver resection,3
3554,waitlist control,3
3555,me-344,3
3556,ttrna-xalt,3
3557,cleveland multiport catheter,3
3558,"cisplatin, docetaxel",3
3559,diagnostic microscopy,3
3560,consolidation involved-field radiotherapy (ifrt),3
3561,sham control,3
3562,uterine artery embolization (uae),3
3563,"doxorubicin, ifosfamide",3
3564,agatolimod sodium,3
3565,palifosfamide-tris,3
3566,modified t cells,3
3567,pyruvate (13c),3
3568,(r-)chop protocol,3
3569,nbi,3
3570,fgfr inhibitor azd4547,3
3571,incb053914,3
3572,autologous dendritic cell-adenovirus p53 vaccine,3
3573,folfox 4,3
3574,placebo sc,3
3575,doxorubicin hcl liposome,3
3576,il2,3
3577,manual lymphatic drainage,3
3578,cancer education,3
3579,medi-575,3
3580,therapeutic immune globulin,3
3581,fdg pet/mr,3
3582,fludarabine and busulfan,3
3583,autologous dendritic cell vaccination,3
3584,magnetic resonance image-guided high intensity focused ultrasound (mr-hifu),3
3585,bi-505,3
3586,irinotecan-eluting beads,3
3587,tibolone,3
3588,alpha-lipoic acid,3
3589,gallium ga 68-labeled grpr antagonist bay86-7548,3
3590,5-fluorouracile,3
3591,ulixertinib,3
3592,trametinib 2 mg,3
3593,ags-1c4d4,3
3594,belotecan,3
3595,dextromethorphan,3
3596,laparoscopic distal pancreatectomy,3
3597,liposomal daunorubicin,3
3598,preoperative chemotherapy,3
3599,bms-936559 (anti-pd-l1),3
3600,interferon-alpha-2b,3
3601,pecs block,3
3602,protontherapy,3
3603,ulocuplumab,3
3604,zinc sulfate,3
3605,"5-fu, oxaliplatin , leucovorin",3
3606,fine needle aspiration biopsy,3
3607,her-2 pulsed dendritic cell vaccine,3
3608,ly293111,3
3609,neoadjuvant radiotherapy,3
3610,peripheral blood collection,3
3611,neo-pv-01,3
3612,liver surgery,3
3613,tbi-1301,3
3614,methadone hydrochloride,3
3615,cellcept,3
3616,medical device,3
3617,cytoreductive surgery and hipec,3
3618,prochlorperazine,3
3619,ffdm,3
3620,mebendazole,3
3621,vats lobectomy,3
3622,enzalutamide (xtandi),3
3623,gdc-0994,3
3624,allovax,3
3625,lipegfilgrastim,3
3626,patent blue v dye,3
3627,ranpirnase,3
3628,nir178,3
3629,"zd6474, vandetanib",3
3630,physical exam,3
3631,hyperpolarized pyruvate (13c) injection,3
3632,diffusion mri,3
3633,corticosteroids,3
3634,magnetic resonance spectroscopy,3
3635,thymosin alpha 1,3
3636,delayed breast reconstruction,3
3637,^1^1c-methionine,3
3638,itf2357,3
3639,tropisetron,3
3640,chess,3
3641,dnib0600a,3
3642,hu3f8,3
3643,talabostat mesylate,3
3644,placebo drug,3
3645,recombinant human papillomavirus nonavalent vaccine,3
3646,living with hope program,3
3647,apo866,3
3648,incb040093,3
3649,meloxicam,3
3650,sct200,3
3651,antiandrogen,3
3652,edoxaban,3
3653,letrozole or anastrozole,3
3654,ofatumumab + bendamustine,3
3655,media intervention,3
3656,radiochemotherapy 1,3
3657,gm-ct-01,3
3658,dm-choc-pen,3
3659,concomitant radiotherapy,3
3660,tumor tissue collection,3
3661,cm082,3
3662,tpf+ccrt,3
3663,dcc-2618,3
3664,stent insertion,3
3665,abraxane ( nab-paclitaxel),3
3666,insulin,3
3667,ro5323441,3
3668,split-course radiotherapy,3
3669,entecavir prophylaxis,3
3670,tecemotide,3
3671,bone marrow aspiration and biopsy,3
3672,transcranial direct current stimulation (tdcs),3
3673,octreotide-lar,3
3674,tasisulam,3
3675,sublobar resection,3
3676,p53 gene therapy,3
3677,bay80-6946,3
3678,anti-bcma car t cells,3
3679,fg-3019,3
3680,conventional laparoscopic hysterectomy,3
3681,standard of care surgery,3
3682,dkn-01 300 mg,3
3683,dtrmwxhs-12,3
3684,hepatitis b vaccine,3
3685,low-level laser therapy,3
3686,morab-003 (farletuzumab),3
3687,aminopterin,3
3688,intrathecal injection,3
3689,amg 073,3
3690,regimen a,3
3691,nutritional assessment,3
3692,famotidine,3
3693,z-endoxifen hydrochloride,3
3694,neoadjuvant chemoradiation,3
3695,yoga intervention,3
3696,egfr antisense dna,3
3697,fate-nk100,3
3698,tlr8 agonist vtx-2337,3
3699,artesunate,3
3700,measurements of the fluorescence intensity,3
3701,ivig,3
3702,stereotactic body radiation (sbrt),3
3703,buprenorphine,3
3704,sr-t100 gel,3
3705,cohort 1,3
3706,no radiation,3
3707,radiotherapy alone,3
3708,rta 744,3
3709,zevalin (ibritumomab tiuxetan),3
3710,vitamin c (ascorbic acid),3
3711,rxdx-105,3
3712,krestin (psk),3
3713,nact,3
3714,electrocautery,3
3715,cinacalcet hydrochloride,3
3716,x4p-001,3
3717,laparoscopic total mesorectal excision,3
3718,momelotinib (mmb),3
3719,oglufanide disodium,3
3720,fdg pet,3
3721,gallium nitrate,3
3722,nab-paclitaxel + gemcitabine,3
3723,side-to-end anastomosis,3
3724,chromosomal translocation analysis,3
3725,lci699,3
3726,harmonic scalpel,3
3727,dacarbazine (dtic),3
3728,lum015,3
3729,kn046,3
3730,bms-663513,3
3731,iv acetaminophen,3
3732,elastography,3
3733,electrochemotherapy with bleomycin,3
3734,r115777,3
3735,gw572016,3
3736,endobronchial ultrasound-guided transbronchial needle aspiration (ebus-tbna),3
3737,recombinant fowlpox-gm-csf,3
3738,netupitant,3
3739,web-based decision aid,3
3740,caspofungin,3
3741,medical questionnaire,3
3742,axillary lymph node biopsy,3
3743,car-t,3
3744,galiximab,3
3745,cervarix tm,3
3746,medi0562,3
3747,chlorhexidine gluconate,3
3748,synchrotope ta2m,3
3749,thoracoscopy,3
3750,indinavir sulfate,3
3751,relaxation techniques,3
3752,self-administered acupressure,3
3753,kw-2246 (fentanyl citrate),3
3754,grapes,3
3755,tivozanib hydrochloride,3
3756,"bicalutamide, cp-675,206 (tremelimumab)",3
3757,pemetrexed plus cisplatin,3
3758,"5-fluorouracil, folic acid, capecitabine; bevacizumab",3
3759,anti-pd-1,3
3760,gnrh agonist,3
3761,iodine-124,3
3762,"docetaxel, doxorubicin, cyclophosphamide",3
3763,abraxane (nab-paclitaxel),3
3764,"[6r] 5,10-methylenetetrahydrofolate",3
3765,broccoli sprout extract - sulforaphane (bse-sfn),3
3766,"eeg, neuropsychological evaluation, psychological questionnaires, medical questionnaire",3
3767,mitomycins,3
3768,natural killer (nk) cells,3
3769,muscle biopsy,3
3770,physical training,3
3771,radiochemotherapy 3,3
3772,tetracycline,3
3773,bi 836880,3
3774,intrathecal triples,3
3775,peginterferon alfa-2a,3
3776,bnc105p,3
3777,alum adjuvant,3
3778,sentinel node biopsy,3
3779,tinzaparin sodium,3
3780,n-803,3
3781,ala,3
3782,psa prostate cancer vaccine,3
3783,tenalisib,3
3784,allogeneic hematopoietic stem cell transplantation (hsct),3
3785,gcsf,3
3786,kinesiotherapy,3
3787,hs-10241,3
3788,gm-k562 cell vaccine,3
3789,hexvix,3
3790,alflutinib,3
3791,stem cell reinfusion,3
3792,lifestyle modification,3
3793,transdermal estradiol,3
3794,ro5126766,3
3795,medical examination,3
3796,"cp-870,893",3
3797,anthracyclines,3
3798,therapeutic endoscopic surgery,3
3799,no further treatment,3
3800,photon therapy,3
3801,percutaneous laser ablation,3
3802,harmonic ace+7,3
3803,cisplatin 2,3
3804,biological response modifier therapy,3
3805,adct-301,3
3806,serum and tissue mesothelin,3
3807,"dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes",3
3808,cavatak,3
3809,routine intravenous drip,3
3810,mycofenolate mofetil,3
3811,18f-fdg-pet,3
3812,open liver resection,3
3813,vidaza®,3
3814,"questionnaires, mri, comet assay and cell senescence",3
3815,midostaurin (pkc412),3
3816,pomegranate juice,3
3817,diffusion tensor imaging (dti),3
3818,allogeneic hematopoietic stem cell transplant,3
3819,placebo for relugolix,3
3820,hyperpolarized 13c-pyruvate,3
3821,medi-573,3
3822,high ligation,3
3823,local radiotherapy,3
3824,tesevatinib,3
3825,anti-cea car-t cells,3
3826,gemcitabine and cisplatin (induction chemotherapy),3
3827,arfi measurement,3
3828,efavirenz,3
3829,investigational drug,3
3830,copper,3
3831,laser surgery,3
3832,recombinant fowlpox-prostate specific antigen vaccine,3
3833,cohort 3,3
3834,best available therapy,3
3835,solu-medrol,3
3836,therapeutic estradiol,3
3837,seliciclib,3
3838,pomalidomide and dexamethasone,3
3839,usual care group,3
3840,sb-743921,3
3841,sulfatinib,3
3842,cdx-301,3
3843,krn5500,3
3844,oral domperidone,3
3845,pvsripo,3
3846,aee788,3
3847,sleep disorder therapy,3
3848,mk-8628,3
3849,car-t cells,3
3850,vaccinia virus (vvdd-cdsr),3
3851,mk-8353,3
3852,"interview, focus group and structured survey",3
3853,dendritic cell-mart-1 peptide vaccine,3
3854,leuprolide acetate ( eligard®) hormonal therapy,3
3855,trifluridine/tipiracil hydrochloride combination agent tas-102,3
3856,pap smear,3
3857,pf-05280014,3
3858,docetaxel and epirubicin,3
3859,brivaracetam,3
3860,gvax pancreas vaccine,3
3861,ex vivo-expanded cord blood progenitor cell infusion,3
3862,simtuzumab,3
3863,"dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes",3
3864,low dose ara-c (ldac),3
3865,hot flashes attenuation,3
3866,whole-body electromyostimulation (wb-ems),3
3867,bis,3
3868,endotag-1 and gemcitabine,3
3869,oral sodium phenylbutyrate,3
3870,fish oil supplement,3
3871,pnt2258,3
3872,"bevacizumab, erlotinib",3
3873,robotic radical prostatectomy,3
3874,neurocognitive testing,3
3875,cisplatin 1,3
3876,bi 894999,3
3877,nanoparticle albumin-bound rapamycin,3
3878,oral contraceptive,3
3879,flexibility training,3
3880,vinorelbine (navelbine),3
3881,nivolumab plus ipilimumab,3
3882,preoperative radiation,3
3883,memory intervention,3
3884,propofol group,3
3885,"gemcitabine, carboplatin",3
3886,diagnosis,3
3887,computer-assisted cognitive training,3
3888,masct-i,3
3889,arq197,3
3890,carotuximab (trc105),3
3891,mick assay,3
3892,arzoxifene,3
3893,bf-200 ala,3
3894,southern blotting,3
3895,mri prostate,3
3896,morab-004,3
3897,iph2101,3
3898,telemedicine,3
3899,pemetrexed 500 mg/m^2,3
3900,biannual ultrasonography,3
3901,samples,3
3902,mbsr,3
3903,tlr9 agonist sd-101,3
3904,sti571,3
3905,dignity therapy,3
3906,chlorhexidine,3
3907,drug cocktail,3
3908,sir-sphere,3
3909,sir-spheres microspheres,3
3910,milciclib maleate,3
3911,abx + ddp,3
3912,goserelin (zoladex),3
3913,cinobufacini injection,3
3914,silymarin,3
3915,marizomib,3
3916,aranesp,3
3917,90y-hpam4,3
3918,vaginal cuff brachytherapy,3
3919,text messaging,3
3920,water exchange colonoscopy,3
3921,sndx-275,3
3922,standard surgery,3
3923,"chemotherapy, intrathecal chemotherapy, steroid therapy",3
3924,diffusion weighted magnetic resonance imaging,3
3925,nimotuzumab and chemotherapy,3
3926,pivanex,3
3927,cabozantinib-s-malate,3
3928,tariquidar,3
3929,pt-112,3
3930,cemiplimab regn2810,3
3931,modradoc006/r,3
3932,intraperitoneal (ip) oxaliplatin (oxa) + systemic folfiri bevacizumab chemotherapy,3
3933,hexaminolevulinate,3
3934,dolasetron mesylate,3
3935,mrs,3
3936,cognitive rehabilitation,3
3937,dietary fasted,3
3938,sgm-101,3
3939,hormonal therapy,3
3940,arm ii (intubated general anesthesia),3
3941,131i-rituximab,3
3942,phy906,3
3943,nal-iri,3
3944,al3810,3
3945,recombinant cd40-ligand,3
3946,docetaxel and gemcitabine,3
3947,blu-u,3
3948,pcia,3
3949,methoxy polyethylene glycol-epoetin beta [mircera],3
3950,"busulfan, melphalan, fludarabine, g-csf",3
3951,endobronchial ultrasound (ebus),3
3952,whole-brain radiation therapy (wbrt),3
3953,incb059872,3
3954,thunderbeat,3
3955,ferumoxtran-10,3
3956,medi9447,3
3957,cochlear implant,3
3958,denileukin diftitox (ontak),3
3959,eicosapentaenoic acid,3
3960,zkab001 15mg/kg,3
3961,rifaximin,3
3962,ghrelin,3
3963,loop electrosurgical excision procedure,3
3964,rebastinib,3
3965,"thalidomide, dexamethasone",3
3966,psychotherapy,3
3967,operation,3
3968,open lobectomy,3
3969,biopsy of breast,3
3970,taurolock,3
3971,atezolizumab placebo,3
3972,intermittent dosing of azd5363,3
3973,spi-2012,3
3974,high dose methotrexate,3
3975,shr3680,3
3976,miltenyi biotec clinimacs,3
3977,fluoropyrimidine,3
3978,hippocampal-sparing wbrt,3
3979,osteodex,3
3980,pelvic ultrasound,3
3981,polyiclc,3
3982,radiation treatment,3
3983,naltrexone,3
3984,lmb-9 immunotoxin,3
3985,nursing intervention,3
3986,neovax,3
3987,leo 43204 gel,3
3988,aromasin (exemestane),3
3989,docetaxel 75 mg/m2,3
3990,vacuum-assisted biopsy,3
3991,nanoknife ledc system,3
3992,docetaxel/carboplatin,3
3993,humax-cd4,3
3994,prinomastat,3
3995,patient decision aid,3
3996,trovax,3
3997,bisacodyl,3
3998,paclitaxel 200 mg/m^2,3
3999,atropine,3
4000,ino-9012,3
4001,quadrivalent hpv vaccine,3
4002,tazarotene,3
4003,ec17,3
4004,d2 lymphadenectomy,3
4005,oncoplastic breast surgery,3
4006,laboratory procedure,3
4007,marginprobe,3
4008,novottf-100a,3
4009,hypofractionated rt,3
4010,nm404,3
4011,mtx,3
4012,autologous hct,3
4013,hsp90,3
4014,immune checkpoint inhibitor,3
4015,adapted physical activity,3
4016,blood specimen,3
4017,hpv testing,3
4018,cohort 2,3
4019,incagn01876,3
4020,dietary counseling,3
4021,bemiparin,3
4022,haloperidol,3
4023,"lenalidomide, dexamethasone",3
4024,bhq880,3
4025,anastrozole (arimidex),3
4026,arq 197 and erlotinib,3
4027,a-101 solution,3
4028,involved-field radiotherapy,3
4029,ct scans,3
4030,sabarubicin,3
4031,bioelectric impedance analysis,3
4032,kinesio taping,3
4033,vertebroplasty,3
4034,fdg pet/ct scan,3
4035,mix vaccine,3
4036,ex vivo-expanded her2-specific t cells,3
4037,cyclophosphamide (cpa),3
4038,gs-5829,3
4039,ga,3
4040,laparoscopic total gastrectomy,3
4041,lletz,3
4042,vitamin e ?-tocotrienol,3
4043,amp-224,3
4044,standard radiation treatment,3
4045,bcg solution,3
4046,sar125844,3
4047,intravenous vitamin c,3
4048,5-fluorouracil/leucovorin,3
4049,recombinant anti-tumor and anti-virus protein for injection,3
4050,nkr-2 cells,3
4051,ultrasound tomography,3
4052,cci-779,3
4053,abexinostat,3
4054,metronidazole hydrochloride,3
4055,cep-18770,3
4056,"imiquimod cream, 3.75%",3
4057,dalantercept,3
4058,drug resistance inhibition treatment,3
4059,incb057643,3
4060,recombinant interleukin-7,3
4061,rivogenlecleucel,3
4062,vanucizumab,3
4063,anti-sema4d monoclonal antibody vx15/2503,3
4064,trovax®,3
4065,glutathione,3
4066,best standard of care,3
4067,whole brain irradiation,3
4068,pr1 leukemia peptide vaccine,3
4069,zkab001 5mg/kg,3
4070,vaginal brachytherapy,3
4071,dexamethasone (or corticosteroid equivalent),3
4072,s-3304,3
4073,triacetyluridine,3
4074,cisplatin chemotherapy,3
4075,allogeneic stem cell infusion,3
4076,gcs-100,3
4077,radiofrequency,3
4078,xofigo,3
4079,ffdm plus dbt,3
4080,docetaxel and prednisone,3
4081,proellex 12 mg,3
4082,standard diet,3
4083,ab122,3
4084,chest x-ray,3
4085,haematology,3
4086,pol6326,3
4087,lurtotecan liposome,3
4088,sh-1028,3
4089,gnrh analogue,3
4090,mm-141,3
4091,yttrium y 90 epratuzumab,3
4092,pancrelipase,3
4093,yttrium y-90 ibritumomab tiuxetan,3
4094,mor00208,3
4095,xelox regimen,3
4096,pf-04691502,3
4097,meropenem,3
4098,car t cells,3
4099,biopsy of prostate,3
4100,etaracizumab,3
4101,123-i-mip-1072,3
4102,ipi-926,3
4103,"docetaxel, cisplatin, fluorouracil",3
4104,pleurodesis,3
4105,ipi-145 (duvelisib),3
4106,levofolinate,3
4107,u3-1287,3
4108,cc-115,3
4109,erlotinib or gefitinib,3
4110,fibrin sealant,3
4111,amg 479 or placebo administered with either exemestane or fulvestrant,3
4112,"aroplatin (liposomal nddp, l-nddp)",3
4113,breast cancer surgery,3
4114,eft508,3
4115,astugenal,3
4116,liothyronine sodium,3
4117,diffuse optical spectroscopy imaging,3
4118,dendritic and cytokine-induced killer cells,3
4119,histamine dihydrochloride,3
4120,cisplatin injection,3
4121,mfolfox6 regimen,3
4122,mtc-dox for injection,3
4123,iph2201,3
4124,automated whole breast ultrasound,3
4125,diagnostic laparoscopy,3
4126,cryosurgery or ire surgery,3
4127,okt3,3
4128,ave1642,3
4129,fludara,3
4130,uprosertib,3
4131,da-epoch-r,3
4132,dnx-2401,3
4133,cisplatin routine-chemotherapy,3
4134,allovectin-7®,3
4135,bendamustine and rituximab,3
4136,capecitabine (xeloda®),3
4137,vcr,3
4138,intrathecal morphine,3
4139,pegylated recombinant human hyaluronidase (pegph20),3
4140,luspatercept,3
4141,rg4733,3
4142,yttrium y 90 dota anti-cea monoclonal antibody m5a,3
4143,ham,3
4144,palliative therapy,3
4145,craniotomy,3
4146,nimorazole,3
4147,aldoxorubicin hydrochloride,3
4148,gem,3
4149,venous blood sample,3
4150,morab-009,3
4151,"ingenol mebutate gel, 0.015%",3
4152,ecc,3
4153,ec145,3
4154,modified barium swallow (mbs),3
4155,intravenous t900607-sodium,3
4156,radium 223,3
4157,soblidotin,3
4158,huachansu,3
4159,dc-based vaccine,3
4160,afimoxifene,3
4161,proton beam radiotherapy,3
4162,pain assessment,3
4163,progenta,3
4164,2-methoxyestradiol,3
4165,exemestane (aromasin),3
4166,talabostat (pt-100) tablets,3
4167,video-assisted surgery,3
4168,pegylated interferon alfa-2b,3
4169,forodesine hydrochloride (bcx-1777),3
4170,hsv-tk,3
4171,image-guided radiotherapy,3
4172,ly2835219,3
4173,saline injection,3
4174,brentuximab vedotin (sgn-35),3
4175,kw2871,3
4176,dsp-7888 dosing emulsion,3
4177,recombinant human stem cell factor,3
4178,meditation therapy,3
4179,interleukin-12,3
4180,choline magnesium trisalicylate,3
4181,acp-196,3
4182,aby-029,3
4183,tissue sample,3
4184,tace drug protocol,3
4185,cytokine therapy,3
4186,tc-3 hydrogel,3
4187,gliolan,3
4188,ex-vivo expanded cord blood progenitor cell infusion,3
4189,mpmri,3
4190,upper endoscopy with biopsies,3
4191,omp-59r5,3
4192,tae,3
4193,bupivicaine,3
4194,umbilical cord blood transplantation as treatment of adult patients with hematologic disorders,3
4195,moviprep,3
4196,cenersen,3
4197,cvac,3
4198,mva-bn-pro,3
4199,doxorubicin-eluting beads,3
4200,taa-specific ctls,3
4201,low carbohydrate diet,3
4202,"chlorambucil, tablets",3
4203,transperineal prostate biopsy,3
4204,sunitinib and ketoconazol,3
4205,memorial anxiety scale for prostate cancer patients,3
4206,anti-thymocyte globulin (atg),3
4207,hifu treatment,3
4208,external beam radiation therapy (ebrt),3
4209,nanopac®,3
4210,glycosylated recombinant human interleukin-7,3
4211,lifeseal™ kit,3
4212,muc1-klh vaccine/qs21,3
4213,aerobic training,3
4214,apricoxib,3
4215,bnav,3
4216,hsp90 inhibitor auy922,3
4217,"cp-547,632",3
4218,standard information,3
4219,kx2-391 ointment 1%,3
4220,cyclophosphamide 50mg,3
4221,pulmonary function tests,3
4222,transoral robotic surgery (tors),3
4223,cfi-400945,3
4224,peripheral blood draws,3
4225,lenalidomide and dexamethasone,3
4226,neo-adjuvant chemotherapy,3
4227,aromatase inhibition,3
4228,fluorophotometry,3
4229,iodinated contrast dye,3
4230,anti-ox40,3
4231,flag,3
4232,autologous ny-eso-1-specific cd8-positive t lymphocytes,3
4233,dichloroacetate (dca),3
4234,lyso-thermosensitive liposomal doxorubicin,3
4235,standard dose,3
4236,photon,3
4237,a,3
4238,srs,3
4239,juven,3
4240,bi 860585,3
4241,total skin electron beam therapy (tsebt),3
4242,liposome-encapsulated doxorubicin citrate,3
4243,fostamatinib,3
4244,dimethyl fumarate,3
4245,dlbs1425,3
4246,robotic-assisted laparoscopic surgery,3
4247,clodronate disodium,3
4248,cart t cells,3
4249,stereotactic ablative body radiation (sabr),3
4250,a-dmdt390-bisfv(ucht1),3
4251,partially covered sems,3
4252,fluorescein sodium injection,3
4253,b12,3
4254,menthol,3
4255,r(+)xk469,3
4256,chimeric antigen receptor t cells,3
4257,roflumilast,3
4258,colectomy,3
4259,telomerase: 540-548 peptide vaccine,3
4260,ezatiostat hydrochloride (telintra®),3
4261,lapatinib oral tablets,3
4262,fish,3
4263,cisplatin chrono-chemotherapy,3
4264,nicotine lozenge,3
4265,radical resection,3
4266,carbon ion boost,3
4267,gdc-0032,3
4268,human papillomavirus 16 e7 peptide,3
4269,rucaparib camsylate,3
4270,mr spectroscopy,3
4271,immunochemotherapy,3
4272,radiochemotherapy 5,3
4273,marimastat,3
4274,nadroparin calcium,3
4275,g-csf (filgrastim),3
4276,inspiratory muscle training,3
4277,silicon phthalocyanine 4,3
4278,oxygen,3
4279,whole brain radiation therapy (wbrt),3
4280,qol questionnaire,3
4281,tai,3
4282,"uft (uracil, tegafur)",3
4283,salsalate,3
4284,pictilisib,3
4285,multiparametric mri,3
4286,onvansertib,3
4287,"docetaxel, oxaliplatin",3
4288,pf-06801591,3
4289,dulanermin,3
4290,cpi-1205,3
4291,mini-mental state exam and blood draw,3
4292,guardant360,3
4293,chemotherapy in combination with trastuzumab,3
4294,diindolylmethane,3
4295,mosunetuzumab,3
4296,mg4101,3
4297,immuncell-lc,3
4298,mv-nis,3
4299,bi 811283,3
4300,meditation,3
4301,water immersion method.,3
4302,lenalidomide 25mg,3
4303,timing of surgery,3
4304,lee011 placebo,3
4305,extended lymphadenectomy,3
4306,tg01,3
4307,saliva test,3
4308,bms-906024,3
4309,anastrazole,3
4310,ar-42,3
4311,ibi188,3
4312,milademetan,3
4313,benadryl,3
4314,experimental group,3
4315,endocuff,3
4316,ffdm alone,3
4317,td,3
4318,photon beam radiation therapy,3
4319,water exchange method.,3
4320,laparoscopic partial nephrectomy,3
4321,clinical examination,3
4322,tdcs,3
4323,mm-151,3
4324,cc-223,3
4325,conjugated estrogens,3
4326,education intervention,3
4327,homoharringtonine,3
4328,stress management therapy,3
4329,digital tomosynthesis mammography,3
4330,cancer macrobead placement in abdominal cavity,3
4331,enb,3
4332,cat-8015 immunotoxin,3
4333,"val-083, dianhydrogalactitol",3
4334,pcd,3
4335,mesenchymal stem cells,3
4336,civasheet,3
4337,tms,3
4338,eortc qlq-c30,3
4339,cintredekin besudotox,3
4340,isis 2503,3
4341,sorafenib and cisplatin,3
4342,fosbretabulin tromethamine,3
4343,mindfulness-based therapy,3
4344,hypofractionated radiosurgery,3
4345,arm 2,3
4346,isovorin,3
4347,"heparin, low-molecular-weight",3
4348,131i-tm601,3
4349,induction,3
4350,pelvic floor muscle training,3
4351,hr,3
4352,immediate surgery,3
4353,retinoic acid,3
4354,gdc-0810,3
4355,mohs surgery,3
4356,adh -1 (exherin™),3
4357,placebo for e2/neta,3
4358,regular diet,3
4359,endurance exercise,3
4360,vx15/2503,3
4361,cyt004-melqbg10,3
4362,neoadjuvant photon radiation,3
4363,ipss questionnaire,3
4364,lamotrigine,3
4365,ramipril,3
4366,nabpaclitaxel,3
4367,misoprostol,3
4368,pembrolizumab (keytruda),3
4369,combined training,3
4370,alemtuzumab (campath),3
4371,cognitive behavioral therapy (cbt),3
4372,panitumumab (abx-egf),3
4373,cisplatin 75 mg/m^2,3
4374,albumin bound paclitaxel,3
4375,amt2003,3
4376,bexxar,3
4377,hu14.18-il2 fusion protein,3
4378,colchicine,3
4379,green tea extract,3
4380,ac regimen,3
4381,cyproheptadine hydrochloride,3
4382,3.75% imiquimod cream,3
4383,emd 640744,3
4384,mutant p53 peptide pulsed dendritic cell vaccine,3
4385,vaccine + cyclophosphamide,3
4386,black cohosh,3
4387,rhtsh,3
4388,pha-739358,3
4389,sgn-40 (anti-hucd40 mab),3
4390,levoleucovorin,3
4391,prophylactic cranial irradiation (pci),3
4392,walk test,3
4393,crcl,3
4394,pegylated g-csf,3
4395,pringle's maneuver,3
4396,first-void urine collection,3
4397,nivolumab/ipilimumab,3
4398,simethicone,3
4399,escalated beacopp,3
4400,placebo (ga-0034),3
4401,placebo iv,3
4402,omp-305b83,3
4403,cabozantinib tablets,3
4404,bismuth,2
4405,care coordination,2
4406,lifileucel,2
4407,facility access,2
4408,11c-acetate,2
4409,deoxycholic acid injection,2
4410,conjugated linoleic acid,2
4411,cntx-4975,2
4412,mitoxantrone hydrochloride liposome injection,2
4413,tetrodotoxin,2
4414,electromagnetic navigation,2
4415,rituximab and bendamustine,2
4416,etomidate,2
4417,placebo to vismodegib,2
4418,denintuzumab mafodotin,2
4419,molecular breast imaging (mbi),2
4420,novottf-100a device,2
4421,standard chemoradiotherapy,2
4422,calcineurin inhibitor,2
4423,secondary cytoreductive surgery,2
4424,antibody tf2,2
4425,laparoscopic and endoscopic cooperative surgery,2
4426,animal assisted therapy,2
4427,autologous dendritic cell-tumor fusion vaccine,2
4428,tenofovir disoproxil,2
4429,gdc-0068,2
4430,aln-vsp02,2
4431,trus probe,2
4432,sgn-cd33a,2
4433,omp-52m51,2
4434,cc-1088,2
4435,5-aminolevuline acid,2
4436,sorafenib (bay-43-9006),2
4437,ascorbic acid (vitamin c),2
4438,tkcell,2
4439,chemotherapy (daunorubicine-cytarabine),2
4440,c-11 acetate pet scan,2
4441,no axillary lymph node dissection,2
4442,motesanib,2
4443,toca 511 vector,2
4444,2 doses of hpv 16/18 bivalent vaccine,2
4445,immunohistochemical staining,2
4446,sb-715992,2
4447,fiber optic,2
4448,mediastinoscopy,2
4449,interferon alfa-n1,2
4450,oshadi d and oshadi r,2
4451,intravenous injection of ebv specific ctls,2
4452,cv9104,2
4453,blood sampling by vena punction.,2
4454,gsk biologicals' hpv vaccine 580299,2
4455,guided relaxation,2
4456,observation arm,2
4457,endocutter,2
4458,patient navigator (pn),2
4459,radiation therapy treatment planning and simulation,2
4460,cliniporator vitae®,2
4461,patients,2
4462,durvalumab + oleclumab,2
4463,high flow oxygen therapy,2
4464,standard transplant care,2
4465,mage-a3,2
4466,diet only,2
4467,pittsburgh sleep quality index (psqi),2
4468,clopidogrel,2
4469,foxy-5,2
4470,linezolid,2
4471,verapamil,2
4472,capecitabine / vinorelbine,2
4473,decitabine (dacogen),2
4474,acp-196 in combination with pembrolizumab,2
4475,lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells,2
4476,rexin-g dose 1,2
4477,blood sample for phenotypic and pharmacogenetic analysis.,2
4478,ckd-581,2
4479,treatment with focal hifu,2
4480,telephone reminder,2
4481,las106521,2
4482,"fludarabine, busulfan, thymoglobulin",2
4483,zd4054 15 mg,2
4484,hmpl-453,2
4485,d-methadone,2
4486,gp100:209-217(210m),2
4487,biopsies taken,2
4488,nasal swab,2
4489,granulocyte colony-stimulating factor plus placebo,2
4490,azd9833,2
4491,gp2013,2
4492,etrolizumab placebo,2
4493,hgs1029,2
4494,palifosfamide,2
4495,taxane-based chemotherapy,2
4496,"epirubicin, cisplatin, capecitabine",2
4497,enucleation,2
4498,comparator: vorinostat,2
4499,orantinib,2
4500,serum,2
4501,ingenol mebutate (perrigo),2
4502,cbi,2
4503,gabapentin prescriptions,2
4504,tomato-soy juice,2
4505,jnj-61186372,2
4506,alpha lipoic acid,2
4507,monoclonal antibody bec2,2
4508,no access to emedonline,2
4509,eltrombopag/revolade,2
4510,ct-scan,2
4511,chart abstraction,2
4512,e6 tcr,2
4513,retinoid 9cuab30,2
4514,terameprocol (em-1421),2
4515,"radium ra 223 dichloride (xofigo, bay88-8223)",2
4516,radio-frequency ablation,2
4517,hexaminolevulinate (hal),2
4518,intramedullary fixation or endoprosthetic reconstruction,2
4519,ski-606 (bosutinib),2
4520,wide local excision = 2cm margin,2
4521,transanal endoscopic microsurgery (tem),2
4522,tiloop bra,2
4523,dendritic cell application,2
4524,cgx1321,2
4525,lenalidomide 15mg,2
4526,systemic chemotherapy (folfox),2
4527,ondansetron 4 mg,2
4528,clinimacs® cd34 reagent system,2
4529,whey protein isolate powder,2
4530,ebr,2
4531,i-124,2
4532,strength training & nutrition,2
4533,rapamune,2
4534,endoscopic ultrasound guided radiofrequency ablation,2
4535,positron emission tomography imaging,2
4536,proctectomy,2
4537,bromodeoxyuridine,2
4538,potassium iodide (ki),2
4539,marqibo,2
4540,leuprolide mesylate,2
4541,avmacol,2
4542,breast ultrasound,2
4543,allovectin-7,2
4544,pentax ec-3870cifk / ec-3870cilk confocal colonoscopes,2
4545,abbv-838,2
4546,full field digital mammography,2
4547,wide local excision = 1cm margin,2
4548,stem cell apheresis,2
4549,targeted biopsy,2
4550,bi 695502,2
4551,zl-2306(nirapairb),2
4552,"doxorubicin, docetaxel",2
4553,nedaplatin and docetaxel,2
4554,bay1905254,2
4555,azd5363 when combined with weekly paclitaxel.,2
4556,mtig7192a,2
4557,recombinant interferon alpha-1b,2
4558,standard practice,2
4559,docetaxel (taxotere®) chemotherapy,2
4560,best support treatment,2
4561,luteinizing-hormone releasing-hormone (lhrh) agonist,2
4562,humax-cd20,2
4563,neulasta® (pegfilgrastim),2
4564,hypofractionated stereotactic body radiation therapy,2
4565,ec90 (klh-fitc),2
4566,i131,2
4567,octav patient,2
4568,cbl0137,2
4569,blood-stage infection of p.vivax,2
4570,mammatyper™,2
4571,yttrium-90 radioembolization,2
4572,vena puncture for blood collection,2
4573,ultratrace iobenguane i 131,2
4574,ferumoxytol non-stoichiometric magnetite,2
4575,citalopram hydrobromide,2
4576,enzalutamide 40 mg,2
4577,magnetic resonance high intensity focused ultrasound,2
4578,fluorescence angiography,2
4579,flow-mrd,2
4580,testicular biopsy,2
4581,concurrent chemotherapy with cisplatin,2
4582,debiri,2
4583,polyethylene glycol (peg),2
4584,tenofovir disoproxil fumarate,2
4585,myo-inositol,2
4586,gefitinib 250 mg,2
4587,magnetic resonance spectroscopy (mrs),2
4588,esophageal stent placement,2
4589,blood donation during radiotherapy,2
4590,cryoballoon ablation system,2
4591,research blood sample,2
4592,diazepam,2
4593,iv vitamin c,2
4594,invitation letter,2
4595,placebo to denosumab,2
4596,intrathecal mafosfamide,2
4597,standard mri,2
4598,lintuzumab ac 225,2
4599,standard exercise,2
4600,investigator's choice,2
4601,mri-based angiogram,2
4602,tai chi chih,2
4603,prostate cryotherapy,2
4604,l-ohp,2
4605,batabulin sodium,2
4606,conventional laparoscopic colectomy,2
4607,non-surgical periodontal treatment,2
4608,nutrifriend cachexia,2
4609,monoclonal antibody m170,2
4610,"pep005 (ingenol mebutate) gel, 0.05%",2
4611,68ga-dotatoc pet/ct,2
4612,invac-1,2
4613,7-hydroxystaurosporine (ucn-01),2
4614,bd hpv assay on viper lt,2
4615,grapefruit juice,2
4616,multistem®,2
4617,5-fu/cisplatin,2
4618,jx-594: recombinant vaccinia virus (tk-deletion plus gm-csf),2
4619,investigator's choice chemotherapy,2
4620,adaptive radiation therapy,2
4621,frailty assessment,2
4622,notch inhibitor,2
4623,prophylactic central lymph node dissection,2
4624,atg fresenius (anti-lymphocyte-globulin),2
4625,treatmentchoice decisional tool,2
4626,percutaneous ethanol injection therapy,2
4627,rituximab plus chop,2
4628,cancervax vaccine (canvaxin),2
4629,progressive resistance training,2
4630,bortezomib (drug),2
4631,irinotecan and cisplatin,2
4632,lavage,2
4633,ra-223 dichloride,2
4634,eribulin mesylate + erlotinib,2
4635,smart,2
4636,fostamatinib disodium,2
4637,sutent (sunitinib),2
4638,grid radiotherapy,2
4639,intravenous anesthesia,2
4640,multimodal intervention,2
4641,multikinase inhibitor at9283,2
4642,respiratory therapy,2
4643,roniciclib (bay1000394),2
4644,bsi-201,2
4645,mr-hifu treatment,2
4646,black tea,2
4647,oral placebo gentamycin,2
4648,dienogest,2
4649,defactinib (vs-6063),2
4650,fluoxetine,2
4651,eus-guided rfa,2
4652,gw572016 oral tablets,2
4653,monopolar electrocautery,2
4654,one injection of 68ga-nodaga-e[c(rgdyk)]2,2
4655,pf-06671008,2
4656,extracorporeal anastomosis,2
4657,observational study.,2
4658,iressa (zd1839),2
4659,"gemcitabine, docetaxel, and capecitabine",2
4660,placebo gefitinib 250 mg,2
4661,placebo to match idelalisib,2
4662,oncoxin,2
4663,placebo arm,2
4664,intraoperative imaging,2
4665,reflectance confocal imaging,2
4666,prehabilitation (prehab),2
4667,platelet aggregation test,2
4668,efatutazone,2
4669,zolendronic acid,2
4670,x-396 (ensartinib),2
4671,dendritic cell-gp100-mart-1 antigen vaccine,2
4672,autologous epstein-barr virus-specific cytotoxic t lymphocytes,2
4673,spect/ct imaging,2
4674,prostatic artery embolization,2
4675,cisplatin (or carboplatin),2
4676,intensity modulated radiation,2
4677,mln2480,2
4678,carboplatin and paclitaxel and pelvic radiation therapy,2
4679,ccx872-b,2
4680,cone beam ct,2
4681,d1/3-mage-3-his fusion protein,2
4682,karydakis flap,2
4683,la-ep2006,2
4684,vincristine liposomal,2
4685,irradiation therapy,2
4686,ctap101 30 ?g capsules,2
4687,dmxaa,2
4688,irreversible electroporation (ire) system,2
4689,piritramid,2
4690,pac-cb,2
4691,"atezolizumab (mpdl3280a), an engineered anti-programmed death-ligand 1 (pd-l1) antibody",2
4692,ga/pcia,2
4693,salvage lymph node dissection,2
4694,bleomycin phc 15 e. (united states pharmacopeia - usp),2
4695,met,2
4696,intuvax (ilixadencel),2
4697,wait list control,2
4698,patient navigation program,2
4699,coagulation study,2
4700,"ec0489, injection",2
4701,zolpidem,2
4702,moxibustion,2
4703,electronic brachytherapy,2
4704,anti-muc1 car-t cells,2
4705,low level laser,2
4706,sms reminder,2
4707,sgx523 capsules,2
4708,mind-body psychotherapy group,2
4709,autologous cd19-targeting car t cells,2
4710,pimasertib capsule (part a),2
4711,rc-1291 hcl,2
4712,abr-217620,2
4713,mycophenylate mofetil,2
4714,trifluridine/tipiracil,2
4715,website,2
4716,"odsh ( 2-o, 3-o desulfated heparin)",2
4717,apc-placebo,2
4718,js001,2
4719,tumor sampling,2
4720,resiniferatoxin,2
4721,cheek swab,2
4722,bacillus calmette-guerin,2
4723,breath collecting unit,2
4724,wire localization,2
4725,nvb,2
4726,salvage chemotherapy,2
4727,human myeloid progenitor cells,2
4728,"ddgp(cisplatin,dexamethasone,gemcitabine,pegaspargase)",2
4729,edp1503,2
4730,moisturizer,2
4731,dc,2
4732,3d laparoscopy,2
4733,clinimacs system,2
4734,letrozole 2.5mg tablet,2
4735,tomivosertib (eft-508),2
4736,qrh-882260 heptapeptide,2
4737,td vaccine,2
4738,campath (alemtuzumab),2
4739,abt-165,2
4740,celiac plexus radiosurgery,2
4741,hf10,2
4742,10% vda-1102,2
4743,liposuction,2
4744,"velcade tm (bortezomib) for injection, or ps-341",2
4745,arterial spin labeling magnetic resonance imaging,2
4746,parietene macro,2
4747,cryo spray ablation,2
4748,pet scan imaging,2
4749,18f-fluorodeoxyglucose (18f-fdg),2
4750,cr011-vcmmae,2
4751,monoclonal antibody,2
4752,bone marrow aspirate/biopsy,2
4753,5% dextrose solution,2
4754,uv1 synthetic peptide vaccine and gm-csf,2
4755,biw-8962,2
4756,treatment as usual (tau),2
4757,protons,2
4758,cellectra™ 2000,2
4759,metaiodobenzylguanidine (mibg),2
4760,ct-2106,2
4761,prednisone 5 mg,2
4762,endorings,2
4763,allele-specific oligonucleotide real-time quantitative polymerase chain reaction,2
4764,abraxane (induction),2
4765,paclitaxel + cisplatin,2
4766,cyclophosphamide and total body irradiation,2
4767,current care,2
4768,smartcare,2
4769,sun-131 1.5% tds,2
4770,physical exercise program,2
4771,cyclosporins,2
4772,oncoe6,2
4773,sequence 2,2
4774,pulmonary function test,2
4775,gemcitabine injection,2
4776,sham injection,2
4777,tl-118,2
4778,enhanced usual care (euc),2
4779,18f-fluciclovine pet ct,2
4780,laying open,2
4781,selenium placebo,2
4782,livopan,2
4783,erythropoetin,2
4784,viagenpumatucel-l,2
4785,p53 peptide vaccine,2
4786,"folfox (5-fluorouracil, leucovorin, oxaliplatin)",2
4787,avn944,2
4788,lorazepam,2
4789,granulocyte-macrophage colony-stimulating factor,2
4790,laparoscopic adrenalectomy,2
4791,gemcitabine hcl,2
4792,chromatography,2
4793,selinexor (kpt-330),2
4794,wt-1-vaccine montanide + gm-csf,2
4795,breast cancer locator (bcl),2
4796,ibi305,2
4797,cisplatin and doxorubicin,2
4798,food frequency questionnaire,2
4799,iodine i 131 metaiodobenzylguanidine,2
4800,b-701,2
4801,imrt + sib + chemotherapy,2
4802,pexastimogene devacirepvec (pexa vec),2
4803,tumor removal,2
4804,conservative treatment,2
4805,active-breathing-controlled deep-inspiratory breathhold,2
4806,seneca valley virus-001,2
4807,perceived stress scale (pss),2
4808,opn-305,2
4809,conventional fractionated radiotherapy,2
4810,meperidine,2
4811,imab362,2
4812,infusional 5-fluorouracil,2
4813,iyengar yoga,2
4814,lum 2.6 imaging device,2
4815,max-pc questionnaire,2
4816,calcium supplement,2
4817,workshop,2
4818,proton radiation and chemotherapy,2
4819,17-n-allylamino-17-demethoxygeldanamycin/bortezomib,2
4820,fecal microbiota transplant (fmt),2
4821,cyc065,2
4822,kte-c19,2
4823,rectal resection,2
4824,docosahexaenoic acid (dha),2
4825,carbohydrate restricted diet,2
4826,flumist,2
4827,alemtuzumab (mabcampath),2
4828,leukocyte therapy,2
4829,research blood draws,2
4830,palonosetron and dexamethasone,2
4831,ppp001,2
4832,pf-06647263,2
4833,high protein diet,2
4834,wx-554,2
4835,tranylcypromine,2
4836,htert mrna dc,2
4837,mfolfox 6,2
4838,portal vein embolization (pve),2
4839,partial nephrectomy,2
4840,iron isomaltoside 1000,2
4841,neulasta (pegfilgrastim),2
4842,octreotide depot,2
4843,bms-986253,2
4844,neuvax vaccine,2
4845,digital imaging,2
4846,investigational treatment,2
4847,suba-itraconazole,2
4848,sequential,2
4849,rhuepo,2
4850,3d printing model,2
4851,laparoscopic d2 distal gastrectomy,2
4852,obe2109 + placebo add-back,2
4853,trivalent baculovirus-expressed influenza ha vaccine,2
4854,anti-cd45,2
4855,short course of radiotherapy,2
4856,pemetrexed/platinum chemotherapy,2
4857,antioxidants,2
4858,trifluridine/tipiracil hydrochloride (s 95005),2
4859,dbt,2
4860,thalomid,2
4861,rabeprazole,2
4862,acetylcholine,2
4863,imtox-25,2
4864,standard leukemia care,2
4865,nutritional supplementation,2
4866,jnj-26481585,2
4867,genetic screening,2
4868,lod,2
4869,ontak (denileukin diftitox),2
4870,non-adjuvanted a(h1n1) influenza vaccine,2
4871,fp-1039,2
4872,epoch-r,2
4873,dnr,2
4874,89zr-girentuximab,2
4875,arx788,2
4876,peripheral blood stem cell,2
4877,plerixafor gz316455,2
4878,r-dhap,2
4879,anti-cxcr4 (bms-936564),2
4880,transperineal ultrasound,2
4881,vinorelbine plus cisplatin,2
4882,cognitive interview,2
4883,walking exercise,2
4884,primovist mri,2
4885,epa,2
4886,paclitaxel liposome injection,2
4887,bexarotene (targretin),2
4888,saliva testing,2
4889,tnp-470,2
4890,placebo plus chemotherapy,2
4891,sunitinib maleate,2
4892,atenolol,2
4893,lidocaine 2%,2
4894,emedonline access,2
4895,img-7289,2
4896,nifurtimox,2
4897,oocyte vitrification,2
4898,ptfe covered comvi [full covered] biliary stent,2
4899,gm2-klh vaccine,2
4900,co-1.01,2
4901,respiration correlated ct scan,2
4902,bms-833923 (xl139),2
4903,plx8394,2
4904,fractionated stereotactic radiotherapy (fsrt),2
4905,carbon c 11 alpha-methyltryptophan,2
4906,guided imagery and progressive muscle relaxation,2
4907,photodynamic therapy with methyl aminolevulinate cream,2
4908,penclomedine,2
4909,magnetic resonance,2
4910,cognitive tests and cerebral irm,2
4911,transcranial direct current stimulation,2
4912,ofatumumab (gsk1841157) infusion,2
4913,pyrotinib plus capecitabine,2
4914,adjuvant radiation,2
4915,"leucovorin, 5-fluorouracil",2
4916,c-car088,2
4917,"questioners, blood specimens, prostate tissue specimens",2
4918,sgn-75,2
4919,carboplatin (induction),2
4920,asp3550,2
4921,autologous cytokine-induced killer cell,2
4922,optical imaging,2
4923,imatinib (sti571),2
4924,dna ploidy analysis,2
4925,g-csf (granulocyte-colony stimulating factor),2
4926,vaginal swab,2
4927,capecitabine monotherapy,2
4928,topotecan liposomes injection (tli),2
4929,hit,2
4930,mafosfamide,2
4931,rdea119,2
4932,vistusertib(azd2014),2
4933,evofosfamide,2
4934,mri diffusion,2
4935,melan-a analog peptide,2
4936,benzoylphenylurea,2
4937,hdarac,2
4938,buccal swab,2
4939,azd4635,2
4940,il-4,2
4941,mek 162,2
4942,concurrent chemoradiotherapy (ccrt),2
4943,ptvg-hp,2
4944,methylthioninium,2
4945,mycobacterium w.,2
4946,sgn-30,2
4947,gemcitabine and abraxane,2
4948,degarelix injection,2
4949,"physio,pain,psychotherapy;social,nutrit.counselling&sports",2
4950,adct-402,2
4951,radiation: diffusing alpha radiation emitters therapy (dart),2
4952,pap testing,2
4953,sunitinib malate (sutent),2
4954,care-as-usual,2
4955,anatomical liver resection,2
4956,relaxation training,2
4957,mmb,2
4958,general health education,2
4959,cardiac assessment,2
4960,placebo + paclitaxel + carboplatin,2
4961,peg interferon alfa-2b,2
4962,zoledronic acid (zometa),2
4963,combination of bendamustine + dasatinib,2
4964,palliative rt,2
4965,dendritic cell immunization,2
4966,"revlimid, melphalan, prednisone, thalidomide",2
4967,supine mri,2
4968,therapeutic angiotensin-(1-7),2
4969,perindopril,2
4970,ocoxin-viusid®,2
4971,therapeutic,2
4972,"arry-614, p38/tie2 inhibitor; oral",2
4973,iodine,2
4974,velcade tm (bortezomib) for injection,2
4975,alfentanil,2
4976,liposomal cytarabine-daunorubicin cpx-351,2
4977,survey web-based or telephone interview,2
4978,local radiation,2
4979,mri-pet,2
4980,malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine,2
4981,continuous positive airway pressure (cpap),2
4982,audiogram,2
4983,dna vaccine,2
4984,astragalus polysaccharides 250 mg,2
4985,inecalcitol,2
4986,endoscopic injection of 99mtc-sulfur colloid,2
4987,rad 001,2
4988,visilizumab,2
4989,irinotecan plus capecitabine,2
4990,bone marrow transplant from a related donor,2
4991,cpi-006 + pembrolizumab,2
4992,dxa scan,2
4993,teas,2
4994,high field strength magnetic resonance imaging,2
4995,odsh,2
4996,high resolution anoscopy,2
4997,plasma/serum sampling,2
4998,mie,2
4999,physiotouch,2
5000,"quality of life instruments, fact-e, symptom assessment scale, brief pain inventory and daily analgesic log",2
5001,tegafur-gimeracil-oteracil potassium (ts-1),2
5002,i-scan 1,2
5003,thunderbeat technology,2
5004,oncalert,2
5005,tnferade biologic,2
5006,prlx 93936,2
5007,"cetuximab, cisplatin",2
5008,oral placebo ornidazole,2
5009,ixazomib + lenalidomide + dexamethasone,2
5010,liothyronine,2
5011,bupivacaine 0.25% with epinephrine,2
5012,copp/abv,2
5013,"s-1, irinotecan, bevacizumab",2
5014,healthy eating control,2
5015,aldesleukin (il-2),2
5016,perfusion computed tomography,2
5017,oral vinorelbine and cisplatin with concomitant radiotherapy 66 gy (total dose),2
5018,dilaudid,2
5019,kos-862,2
5020,crizotinib plus axitinib,2
5021,ekb-569,2
5022,inotuzumab ozogamicin (io),2
5023,placebo for estradiol/norethindrone acetate,2
5024,self-expandable metal stent,2
5025,atovaquone,2
5026,pulmonary function,2
5027,walking test,2
5028,magnetic resonance thermal imaging,2
5029,diagnostic lymphadenectomy,2
5030,aminolaevulinic acid,2
5031,memory anxiety scale for prostate cancer patients,2
5032,v212,2
5033,virtual colonoscopy,2
5034,sns-032 injection,2
5035,nkt cells,2
5036,e7389-lf,2
5037,cloretazine,2
5038,fine needle aspiration cytology,2
5039,cancer treatment,2
5040,givinostat,2
5041,dexmedetomidine supplemented morphine analgesia,2
5042,anti-endoglin chimeric monoclonal antibody trc105,2
5043,visual slit-lamp testing,2
5044,drug,2
5045,anti-pd-1 plus dc-cik,2
5046,omega 3 fatty acids,2
5047,pilocarpine hydrochloride,2
5048,data management and monitoring,2
5049,xl228,2
5050,fpa144,2
5051,immunochemical fecal occult blood test,2
5052,patient-specific dosimetry,2
5053,systematic light exposure,2
5054,local consolidation therapy,2
5055,maltodextrin,2
5056,weight loss only,2
5057,sequencing,2
5058,trx-818 capsules,2
5059,bema fentanyl,2
5060,anterolateral thoracotomy,2
5061,bombesin (68ga) labeled (bay86-7548),2
5062,cryopreservation,2
5063,sodium cridanimod,2
5064,shave excision,2
5065,vitamin k,2
5066,capecitabine and sorafenib,2
5067,radiation alone,2
5068,sgx942,2
5069,orteronel placebo,2
5070,estradiol valerate,2
5071,pf-06650808,2
5072,physical examination,2
5073,video assisted ablation of pilonidal sinus,2
5074,tak-788,2
5075,polyvalent antigen-klh conjugate vaccine,2
5076,nutritional supplements,2
5077,trametinib 0.5 mg,2
5078,liposome entrapped docetaxel (le-dt),2
5079,x,2
5080,treatment plan,2
5081,anlotinib plus docetaxel,2
5082,ixazomib 4 mg capsule b,2
5083,pv-10,2
5084,metree,2
5085,bascom cleft lift,2
5086,part 2,2
5087,m2es 15mg,2
5088,cbt-501,2
5089,vegfr/pdgfr dual kinase inhibitor x-82,2
5090,electro-stimulation of yongquan (k1) acupoint,2
5091,ec17 imaging contrast agent,2
5092,"cp-724,714",2
5093,spinal anesthesia,2
5094,carboxylesterase-expressing allogeneic neural stem cells,2
5095,survivorship care plan,2
5096,et190l1 artemis™ t cells,2
5097,yasmin,2
5098,carcinoembryonic antigen rna-pulsed dc cancer vaccine,2
5099,mitomycin-c 40 mg,2
5100,hematopoietic stem cell transplant (hsct),2
5101,pf-04518600 plus pf-05082566,2
5102,medtronic pump and codman catheter,2
5103,epirubicin+cyclophosphamide,2
5104,trans-urethral resection,2
5105,levo- leucovorin,2
5106,subxiphoid uniportal vats,2
5107,dual specificity cd19 and cd22 car-t cell immunotherapy,2
5108,avb-s6-500,2
5109,sweet esophagectomy,2
5110,fusilev,2
5111,nicotine replacement,2
5112,spy elite,2
5113,sequence 1,2
5114,darbepoetin,2
5115,proteomic profiles,2
5116,needle aponeurotomy,2
5117,oros hydromorphone,2
5118,monoclonal antibody lym-1,2
5119,hematopoietic cell transplant,2
5120,routine care as per site standard.,2
5121,mdv9300,2
5122,[f-18]hx4,2
5123,morphine sulphate,2
5124,f-18-fluoromisonidazole,2
5125,pdt,2
5126,s-1 and oxaliplatin,2
5127,folfoxiri plus bevacizumab,2
5128,ciclofosfamide,2
5129,structured palliative care,2
5130,pedometer intervention,2
5131,exercise regimen,2
5132,low dose ct scan,2
5133,infusion of activated & expanded autologous t cells,2
5134,minocycline hydrochloride,2
5135,standard pancreatoduodenectomy,2
5136,modified radical mastectomy,2
5137,tas-120,2
5138,active control,2
5139,phase 2 - oxi4503 + cytarabine,2
5140,celecoxib 200mg,2
5141,mango juice,2
5142,valsartan,2
5143,complete mesocolic excision,2
5144,avodart,2
5145,autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes,2
5146,side by side,2
5147,autologous gp96 vaccination,2
5148,tgr-1202 + ublituximab,2
5149,cd3/cd28 activated t cells,2
5150,carboplatin auc 6,2
5151,cone beam imaging,2
5152,cognitive behavioral therapy for insomnia (cbti),2
5153,"voluven (hydroxyethyl starch 130/0,4)",2
5154,sta-4783,2
5155,bms-986012,2
5156,halofuginone hydrobromide,2
5157,conbercept,2
5158,single-use injection device,2
5159,anastrozole or letrozole or exemestane,2
5160,bi 6727 (d1 and 15),2
5161,bms-813160,2
5162,octav control group,2
5163,peer support,2
5164,high dose melphalan,2
5165,intra-bone cord blood hematopoietic stem cell transplantation,2
5166,tpi 287 injection,2
5167,68ga-nota-ae105 pet/ct,2
5168,gene expression profiling,2
5169,intraperitoneal docetaxel,2
5170,light emitting diodes (led),2
5171,cisplatin and etoposide,2
5172,folfoxiri + bevacizumab,2
5173,zarnestra,2
5174,monoclonal antibody 11d10 anti-idiotype vaccine,2
5175,incentive spirometry,2
5176,plasma ebv dna,2
5177,surgery or biopsy,2
5178,hematological stem cell transplantation,2
5179,hpv-16/18 vaccine,2
5180,high-dose,2
5181,gilotrif,2
5182,sgn-15 (cbr96-doxorubicin immunoconjugate),2
5183,aa4500,2
5184,galeterone,2
5185,intensity-modulated radiation,2
5186,ocoxin-viusid,2
5187,bronchoscopic thermal vapor ablation,2
5188,neuromuscular electrical stimulation,2
5189,chinese herbs,2
5190,collection of blood and bone marrow,2
5191,fulvestrant 500 mg,2
5192,trastuzumab + nk cells,2
5193,low dose radiotherapy,2
5194,ep2101,2
5195,"s-1, irinotecan, oxaliplatin",2
5196,gemcis,2
5197,ramucirumab dp,2
5198,turmeric,2
5199,thoracic epidural analgesia (tea),2
5200,zstk474,2
5201,reminder letter,2
5202,"sargramostim (gm-csf, leukine)",2
5203,daily log,2
5204,zoledronic acid 20mg tablets,2
5205,multi-epitope folate receptor alpha peptide vaccine,2
5206,rapid on-site evaluation (rose),2
5207,tegafur gimeracil oteracil potassium capsules,2
5208,partial or radical nephrectomy,2
5209,sulfur colloid,2
5210,placebo pills,2
5211,dynamic contrast enhancement mri,2
5212,acelarin,2
5213,umbilical cord blood (ucb),2
5214,pharmacodynamics,2
5215,bortezomib/dexamethasone,2
5216,two-week course of radiation,2
5217,erlotinib (tarceva®),2
5218,tri-modal imaging,2
5219,mri examination,2
5220,hypofractionated stereotactic radiotherapy,2
5221,rilimogene galvacirepvec,2
5222,volumetric modulated arc therapy,2
5223,kalinox,2
5224,biological samples collection,2
5225,gea,2
5226,"cisplatin, capecitabine",2
5227,pegylated interferon alpha 2a and plus ribavirin,2
5228,tc-99m bone scan,2
5229,car-gpc3 t cells,2
5230,pertuzumab [perjeta],2
5231,99mtc-labeled sulfur colloid,2
5232,young tumor infiltrating lymphocytes (til),2
5233,briplatin,2
5234,cervical cancer screening undertaken by hpv testing as a single primary screening test with cytology triage of women who are hpv positive,2
5235,midazolam hydrochloride,2
5236,vitrification,2
5237,sun safe workplaces program,2
5238,monosialotetrahexosylganglioside sodium,2
5239,fractionated radiotherapy,2
5240,peg-bct-100,2
5241,timolol,2
5242,apg-1252,2
5243,involved field radiotherapy,2
5244,mediterranean diet restricted calorie,2
5245,huc242-dm4,2
5246,mm-302,2
5247,shr7390,2
5248,bone scintigraphy,2
5249,qvintip,2
5250,tamoxifen (nolvadex),2
5251,mri (magnetic resonance imaging),2
5252,docetaxel and cisplatin followed by gemcitabine,2
5253,doxorubicin/cyclophosphamide,2
5254,nonmyeloablative allogeneic transplant,2
5255,bendamustine hydrochloride injection,2
5256,stool dna test,2
5257,difluoromethylornithine,2
5258,control condition,2
5259,dose escalation,2
5260,interviews with stakeholders,2
5261,berberine hydrochloride,2
5262,estd,2
5263,magnesium,2
5264,mct,2
5265,vegfr1 and vegfr2,2
5266,radiolabeled (99tc) ec-dg (ethylenedicysteine-deoxyglucose),2
5267,mrna,2
5268,azacitidine (vidaza),2
5269,oral topotecan,2
5270,hmpl-689,2
5271,mindfulness-based cognitive therapy,2
5272,pegylated rhg-csf: 6mg,2
5273,pertuzumab iv,2
5274,hm781-36b,2
5275,ci-1040,2
5276,thoracic epidural block,2
5277,granulocyte-macrophage colony-stimulating factor (gm-csf),2
5278,simo decoction,2
5279,177lu-psma-617,2
5280,nvx-108,2
5281,bind19,2
5282,segmentectomy,2
5283,colli-pee,2
5284,cd19 car t-cells,2
5285,acp-319,2
5286,high dose rate prostate brachytherapy,2
5287,ttfields,2
5288,lenalidomide plus dexamethasone,2
5289,obi-888,2
5290,interactive voice response system,2
5291,hsc835,2
5292,hsp990,2
5293,dcvac/ovca,2
5294,fatigue patient education program (fibs),2
5295,stretching control group,2
5296,continuous docetaxel,2
5297,pazopanib and paclitaxel,2
5298,oral chemotherapy,2
5299,sampling,2
5300,procedure/surgery,2
5301,"folfiri (irinotecan, 5-fluorouracil, and leucovorin)",2
5302,imaging technique,2
5303,naked dna coding for protein amep,2
5304,study questionnaire,2
5305,recombinant asparaginase,2
5306,fresolimumab,2
5307,anlotinib hydrochloride plus docetaxel,2
5308,pulmonary function testing,2
5309,magnetic resonance fingerprinting,2
5310,edo-s101,2
5311,selenomethionine (slm),2
5312,ct-colonography,2
5313,"fluorouracil, oxaliplatin",2
5314,diffusion weighted mri,2
5315,amino acids,2
5316,second-line chemotherapy,2
5317,"gm-csf, pcv, t cell infusion",2
5318,low-dose computed tomography (ldct),2
5319,ginger,2
5320,ionizing radiation,2
5321,sentinel lymph node dissection,2
5322,nab-paclitaxel plus gemcitabine,2
5323,data acquisition and analysis,2
5324,placebo of aprepitant,2
5325,lenalidomide and rituximab,2
5326,mirena®,2
5327,diamorphine,2
5328,ixabepilone + capecitabine,2
5329,flucytosine,2
5330,mcpyv tag-specific polyclonal autologous cd8-positive t cells,2
5331,pt2977,2
5332,canfosfamide hydrochloride,2
5333,fdg-pet-ct,2
5334,tretinoin liposome,2
5335,adjuvant endocrine therapy,2
5336,docetaxel and epirubicin plus endostatin,2
5337,thoracic paravertebral block,2
5338,folfoxiri + panitumumab,2
5339,fg-4592,2
5340,two stage hepatectomy,2
5341,f-18 fdg,2
5342,mri examinations,2
5343,iv paclitaxel,2
5344,krn330,2
5345,zd 1839,2
5346,intraperitoneal oxaliplatin,2
5347,eras perioperative cares,2
5348,vincristine sulfate liposomes injection,2
5349,kidney transplant,2
5350,paraplatin®,2
5351,ingenol mebutate gel 0.05%,2
5352,reduced dose radiotherapy,2
5353,2d mammography,2
5354,sensory tests,2
5355,clofarabine/busulfan x 4,2
5356,hydralazine,2
5357,arginine hydrochloride,2
5358,right thoracotomy,2
5359,patient questionnaires,2
5360,patient-reported outcomes measurement information system (promis)-cancer-fatigue,2
5361,fna,2
5362,mgcd516,2
5363,ep-100,2
5364,histological technique,2
5365,video group,2
5366,multimodality therapy,2
5367,apg101,2
5368,adm,2
5369,lipid microsphere,2
5370,ly900003,2
5371,cytokine-induced killer cell,2
5372,copanlisib (bay 80-6946),2
5373,c-11 choline,2
5374,open esophagectomy,2
5375,kw-2478,2
5376,azd1480,2
5377,patient educational materials,2
5378,triptorelin (decapeptyl®),2
5379,calcium and magnesium,2
5380,"oxaliplatin, capecitabine, trastuzumab",2
5381,concurrent chemo-radiotherapy,2
5382,l-alanosine,2
5383,imrt technique,2
5384,abt-510/thrombospondin-1 mimetic,2
5385,allogeneic hematopoietic stem cell transplantation (allo-hsct),2
5386,stereotactic ablative body radiation,2
5387,non surgical periodontal treatment,2
5388,pai,2
5389,craniospinal radiation,2
5390,yondelis,2
5391,recombinant human erythropoietin (rhuepo),2
5392,autologous stem cell transplantation (asct),2
5393,"cediranib (recentin tm, azd2171)",2
5394,tri-iodothyronine,2
5395,embolization therapy,2
5396,blinatumomab (mt103),2
5397,caf regimen,2
5398,thallium-201 myocardial perfusion study,2
5399,sublingual methadone,2
5400,megestrol acetate concentrated suspension 110 mg/ml,2
5401,delayed surgery,2
5402,sgn-cd19a,2
5403,ono-7475,2
5404,3d-crt (three-dimensional conformal radiation therapy) or imrt (intensity-modulated radiation therapy),2
5405,continuous positive airway pressure,2
5406,trans-arterial chemoembolization (tace),2
5407,epidural catheter,2
5408,ms3tmri / trus guided biopsy,2
5409,bal101553,2
5410,r-cvp,2
5411,lde-225,2
5412,pngvl4a-sig/e7(detox)/hsp70 dna vaccine,2
5413,pain education,2
5414,active lifestyle programme,2
5415,177lu-st2210,2
5416,standard leaflet,2
5417,mindfulness-based stress reduction (mbsr),2
5418,viscum album pini,2
5419,doxorubicina,2
5420,donor natural killer cell infusion,2
5421,drug treatment,2
5422,mk-4827 + pegylated liposomal doxorubicin,2
5423,pregabalin 150mg,2
5424,oxaliplatin(aiheng),2
5425,technetium tc 99m epratuzumab,2
5426,ic9-car19 cells,2
5427,thermal suit,2
5428,velcade®,2
5429,cervical mediastinoscopy,2
5430,algenpantucel-l immunotherapy,2
5431,ih636 grape seed proanthocyanidin extract,2
5432,uncut roux-en-y reconstruction,2
5433,interferon alpha 2b,2
5434,tocosol paclitaxel,2
5435,autologous hematopoietic progenitor cell transplant,2
5436,dual-energy computed tomography,2
5437,conventional esd,2
5438,cvm-1118,2
5439,"tarceva (trademark) (erlotinib hcl, osi-774)",2
5440,magnesium glycinate,2
5441,biomarker sample collection before and after dosing with cytotoxic agent(s),2
5442,l-panp-tme,2
5443,tme surgery,2
5444,methotrexate/hydrocortisone/cytarabine,2
5445,injection of 68ga-nota-ae105,2
5446,90y zevalin,2
5447,image quality and resolution,2
5448,tumor lysate,2
5449,echocardiograms,2
5450,ip chemotherapy,2
5451,epidemiologic study,2
5452,histologic evaluation,2
5453,carbon-ion radiotherapy,2
5454,porcine fibrin sealant (pfs),2
5455,netupitant/palonosetron,2
5456,itraconazole 200 mg,2
5457,inxn-1001,2
5458,gsk1363089 (formerly xl880),2
5459,cd19 car-t cells,2
5460,tg02,2
5461,gx15-070ms,2
5462,r-chop regimen,2
5463,hemihepatic vascular clamping,2
5464,photon radiosurgery system iort,2
5465,observation alone,2
5466,gardasil-9,2
5467,pneumococcal vaccine,2
5468,hlx02,2
5469,iron sucrose injection,2
5470,opc,2
5471,interferon alpha-2a,2
5472,bacillus calmette-guérin (bcg),2
5473,curative proton therapy,2
5474,bay2010112,2
5475,"mk0683, vorinostat, suberoylanilide hydroxamic acid (saha) / duration of treatment 6 months",2
5476,preoperative chemoradiation,2
5477,kanglaite injection,2
5478,placebo tds,2
5479,repeat ct scan,2
5480,ferinject,2
5481,randomized exercise intervention,2
5482,nucleus 24 (discontinued) and abi541 auditory brainstem implants (abi),2
5483,ingestion of a 200 mg dose of amantadine hydrochloride,2
5484,lerafaon,2
5485,single-fraction srs,2
5486,ovarian cryopreservation,2
5487,eortc qlq-30,2
5488,brontictuzumab,2
5489,nov120101 (poziotinib),2
5490,lovaza™,2
5491,me-401,2
5492,ktp laser,2
5493,active comparator,2
5494,emd 121974,2
5495,quinacrine,2
5496,cjm112,2
5497,fluoroscopy,2
5498,placebo to match momelotinib,2
5499,"omeprazole, amoxicillin, clarithromycin",2
5500,interferon-alfa-2b,2
5501,pr-104,2
5502,imatinib mesylate 600 mg,2
5503,therapeutic massage,2
5504,r-idaram plus intrathecal chemotherapy,2
5505,polyethylene glycol 3350 based bowel preparation,2
5506,standard adjuvant chemotherapy,2
5507,proellex®,2
5508,faecal sample acquisition,2
5509,herzuma,2
5510,e7386,2
5511,azd5069,2
5512,pf-06863135,2
5513,gem 231,2
5514,ct053ptsa,2
5515,lde225 0.75%,2
5516,ferinject®,2
5517,ct scan & early cdt lung test,2
5518,early oral nutrition,2
5519,zanubrutinib,2
5520,dpp-4 inhibitors,2
5521,recombinant interferon alpha-2a,2
5522,abi-007 (abraxane),2
5523,webinar,2
5524,alternative/no medication,2
5525,oncoxin-viusid,2
5526,immunochemical fecal occult blood test (i-fobt) kit,2
5527,chemosensitivity assay,2
5528,su014813,2
5529,group 1,2
5530,technetium tc 99m ec20,2
5531,"autologous genetically modified t cells, ny-eso-1?²??t",2
5532,ins316,2
5533,ct-p10,2
5534,18f-fspg,2
5535,[18f]f-arag,2
5536,group a,2
5537,carboplatin + etoposide,2
5538,tumor replication error analysis,2
5539,mutation detection,2
5540,gas chromatography,2
5541,helical tomotherapy imrt,2
5542,gc1008,2
5543,hominex-2,2
5544,zd4054 (zibotentan),2
5545,tumor peptide vaccine,2
5546,gdp chemotherapy,2
5547,kanglaite gelcap,2
5548,breast-conserving surgery,2
5549,mr guided focused ultrasound,2
5550,smartphone,2
5551,idec-114,2
5552,abt-510,2
5553,tissue sampling,2
5554,meaning-making intervention (mmi),2
5555,etbx-061; adenoviral muc1 vaccine,2
5556,"5-fluorouracil, cisplatin",2
5557,cg200745 ppa,2
5558,ltx-315,2
5559,overall survival,2
5560,docetaxel 60 mg/m2,2
5561,multimodal prehabilitation,2
5562,interview.,2
5563,[f-18] hx4,2
5564,m7583,2
5565,idronoxil,2
5566,dna sequencing,2
5567,study drug,2
5568,carac cream,2
5569,conventional radiation,2
5570,erythropoietin beta,2
5571,olaparib tablets,2
5572,green coffee,2
5573,ff-10501-01,2
5574,gc1118,2
5575,177lu-psma,2
5576,"lenalidomide, endoxan, prednisone",2
5577,tarceva (erlotinib),2
5578,standard bipolar electrosurgery,2
5579,yiqiyangyinfang,2
5580,curative resection,2
5581,vegf trap,2
5582,ziconotide,2
5583,workbook,2
5584,azd8835,2
5585,cma microdialysis catheter placement,2
5586,anti-gd2 murine igg3 monoclonal antibody 3f8,2
5587,wbi,2
5588,cfi-402257,2
5589,deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins,2
5590,photoimmunotherapy,2
5591,diet and exercise,2
5592,hai abraxane,2
5593,fluoruracil,2
5594,hysteroscopic morcellator,2
5595,diclofenac sodium gel 3%,2
5596,cbt,2
5597,oral contraceptive pill,2
5598,transrectal ultrasound,2
5599,cytoreductive surgery combined with hipec,2
5600,etbx-051; adenoviral brachyury vaccine,2
5601,donor leukocyte infusion (dli),2
5602,yttrium y 90-edotreotide,2
5603,low dose fractionated radiation therapy (ldfrt),2
5604,magnetic resonance guided high intensity focused ultrasound,2
5605,5-fu and oxaliplatin,2
5606,lab session,2
5607,high dose chemoradiotherapy,2
5608,radiosensitization,2
5609,surgical resection (standard of care),2
5610,recmage-a3 + as15 asci,2
5611,18f-fluoroazomycin arabinoside (18f-faza),2
5612,nintedanib medium dose,2
5613,id-klh,2
5614,^1^8f-fluorodeoxyglucose,2
5615,debulking surgery,2
5616,radiotherapy with carboplatin,2
5617,t-chos,2
5618,recombinant human interleukin-2,2
5619,cervical swab with cervex-brush-combi at t1,2
5620,bp1001 in combination with ldac,2
5621,fluticasone propionate,2
5622,streptozotocin,2
5623,okn-007,2
5624,radioactive iodine 124,2
5625,biotene,2
5626,tc99m tilmanocept,2
5627,exercise for cancer patients,2
5628,allostim-7,2
5629,"folic acid, vit b12",2
5630,pfmt and aes,2
5631,slc-0111,2
5632,mesenchymal stem cell transplantation,2
5633,enalapril maleate,2
5634,epidural block,2
5635,esmolol,2
5636,copanlisib + refametinib (bay86-9766),2
5637,pulmonary complications management/prevention,2
5638,staging surgery or debulking surgery,2
5639,platinum-based systemic chemotherapy postoperatively,2
5640,interleukin-12 gene,2
5641,ags-8m4,2
5642,ribociclib placebo,2
5643,re-resection,2
5644,engineered immune cells,2
5645,aflibercept (ziv-aflibercept),2
5646,"gemcitabine, oxaliplatin",2
5647,peri-operative chemotherapy,2
5648,3d-crt based involved field radiotherapy,2
5649,adverse event,2
5650,aveeno cream,2
5651,moxifloxacin hydrochloride,2
5652,gnkg168,2
5653,biomarker testing,2
5654,breast core biopsy,2
5655,mart-1:27-35 peptide vaccine,2
5656,shr-1701,2
5657,vital signs,2
5658,dvd,2
5659,xl019,2
5660,pembrolizumab or nivolumab,2
5661,reinduction,2
5662,cytochlor,2
5663,et743,2
5664,puncture of head of pancreas,2
5665,vli,2
5666,non-invasive intervention with focused ultrasound (exablate 4000),2
5667,arm 1,2
5668,ineo-vac-p01,2
5669,np2,2
5670,remote ischemic preconditioning (ripc),2
5671,99mtc-mip-1404,2
5672,"ramosetron, aprepitant, dexamethasone",2
5673,autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells,2
5674,jhl1101,2
5675,ipi-549,2
5676,levonorgestrel-releasing intrauterine system,2
5677,deb tace,2
5678,imp321 (eftilagimod alpha),2
5679,patidegib,2
5680,gemcitabine alone,2
5681,selective hepatic vascular exclusion,2
5682,omission of axillary clearance,2
5683,targeted molecular therapy,2
5684,imrt and concurrent cisplatin,2
5685,temozolomide in both arms,2
5686,radical hysterectomy + pelvic lymph node dissection,2
5687,ags-16c3f,2
5688,gmi-1271,2
5689,fentanyl patch,2
5690,rexin-g dose 2,2
5691,moxifloxacin 400 mg,2
5692,bevacizumab and erlotinib,2
5693,hormone replacement therapy,2
5694,prostate sbrt,2
5695,cart-egfrviii t cells,2
5696,fractionated stereotactic radiation therapy,2
5697,cervical swab with cervex-brush-combi at t0,2
5698,sugar pill (placebo),2
5699,lithium,2
5700,dendritic cell therapy,2
5701,clomiphene citrate 50mg,2
5702,dobutamine,2
5703,ef-022 (modified vitamin d binding protein macrophage activator),2
5704,depocyte,2
5705,tempol,2
5706,rhumab vegf (bevacizumab),2
5707,las41005,2
5708,blood and tissue collection,2
5709,lacosamide,2
5710,whole body diffusion mri,2
5711,human cd19 targeted t cells injection,2
5712,emla,2
5713,transarterial chemoembolisation (tace),2
5714,nadolol,2
5715,18-fdg pet/ct,2
5716,rivaroxaban 10 mg,2
5717,jab-3068,2
5718,personalized neoantigen vaccine,2
5719,"dce-mri, dw-mri and mrs",2
5720,imatinib (gleevec),2
5721,mr colonography,2
5722,tocilizumab [roactemra/actemra],2
5723,patient interviews,2
5724,aflibercept + folfiri,2
5725,i-131 mibg,2
5726,68ga-dotatate,2
5727,nutritional supplement,2
5728,alks 4230,2
5729,systematic transrectal ultrasound-guided prostate biopsy,2
5730,tissue procurement,2
5731,crofelemer,2
5732,sv-br-1-gm,2
5733,wedge resection,2
5734,mal-pdt,2
5735,thyroid ultrasonography,2
5736,tumor treating fields,2
5737,diindolylmethane (dim),2
5738,lanreotide autogel 120 mg,2
5739,tumor cell-based vaccine therapy,2
5740,methyl-aminolevulinate application,2
5741,autologous t cells,2
5742,detection of genotype,2
5743,clonality analysis,2
5744,sorafenib or sunitinib,2
5745,amplifeye,2
5746,unpulsed dcs,2
5747,mbg453,2
5748,lung surgery,2
5749,standard broccoli soup,2
5750,capecitabine plus oxaliplatin,2
5751,ibi101,2
5752,proton beam,2
5753,all-trans retinoid acid,2
5754,mb-cart19.1,2
5755,incb054828,2
5756,t-1101 (tosylate),2
5757,adcd40l,2
5758,gs-1101,2
5759,assessment,2
5760,recombinant fowlpox-psa(l155)/tricom vaccine,2
5761,imatinib mesylate 400 mg,2
5762,chest radiation,2
5763,dendritic cell tumor fusion vaccine,2
5764,x-ray imaging,2
5765,administration of lymphodepletion,2
5766,neo-adjuvant erbitux-based chemotherapy,2
5767,self-regulation condition,2
5768,enzyme-inducing anti-epileptic drugs,2
5769,reconstruction after total gastrectomy,2
5770,progressive resistance exercise training,2
5771,5-fu bolus,2
5772,panobinostat - lbh589,2
5773,camprobe,2
5774,kras,2
5775,adjuvant chemoradiotherapy,2
5776,autonomic nervous system monitoring,2
5777,non-myeloablative ex-vivo t-cell depleted pbsc transplant,2
5778,gsk580299 (cervarix),2
5779,intervention systematic light exposure,2
5780,staining method,2
5781,placebo matching ipilimumab,2
5782,cg428,2
5783,artesunate suppositories,2
5784,magnevist,2
5785,perfusion-weighted magnetic resonance imaging,2
5786,jinfukang,2
5787,mk-1496,2
5788,tissue oxygen measurement,2
5789,"docetaxel, doxorubicin or epirubicin, cyclophosphamide",2
5790,amg 208,2
5791,"[90]y-ibritumomab tiuxetan (zevalin, bay86-5128)",2
5792,prophylactic donor leukocyte infusions,2
5793,fluoro-l-thymidine,2
5794,multi-fraction sabr,2
5795,ivosidenib,2
5796,pgl4001 (ulipristal) and iron,2
5797,e. coli cd-expressing genetically modified neural stem cells,2
5798,uni-deb,2
5799,injection of the cell therapy product,2
5800,erlotinib + sirolimus,2
5801,pf-06463922,2
5802,single dose total body irradiation,2
5803,onapristone,2
5804,social cognitive theory,2
5805,abi-1968,2
5806,instiladrin,2
5807,ont-10,2
5808,talazoparib tosylate,2
5809,9-nc in aerosol reservoir,2
5810,cpi-006 + cpi-444,2
5811,nutri-jelly,2
5812,pidilizumab,2
5813,dipyridamole,2
5814,near infrared fluorescence endoscopy platform,2
5815,no medication,2
5816,aranesp®,2
5817,pemetrexed plus carboplatin,2
5818,pf-06263507,2
5819,implanted medical device,2
5820,enema,2
5821,ro5479599,2
5822,resminostat,2
5823,laryngoscopy,2
5824,mk-8776,2
5825,prehabilitation program,2
5826,phenethyl isothiocyanate,2
5827,high end-tidal co2,2
5828,f16il2,2
5829,temsirolimus (torisel),2
5830,illuminating using red light-emitting diode lamps,2
5831,comparator: v505 formulation 2,2
5832,pegamotecan,2
5833,survivorship care plan (scp),2
5834,tri-weekly cisplatin,2
5835,uv counseling,2
5836,ferrous sulphate,2
5837,forecyte breast aspirator,2
5838,candin,2
5839,cold snare,2
5840,iodine i 131 monoclonal antibody cc49-deltach2,2
5841,study diaries,2
5842,cx-3543,2
5843,bis values at return of consciousness in patients + predicted and measured propofol plasma concentrations,2
5844,megestrol,2
5845,99mtc mip 1404,2
5846,nerofe,2
5847,mri-guided laser ablation,2
5848,telephone follow-up,2
5849,carbendazim,2
5850,imrt with an simultaneous integrated boost,2
5851,volume modulated arc therapy,2
5852,pharmaceutical care,2
5853,gemcitabine with escalating ascorbic acid,2
5854,metformin and liraglutide,2
5855,nexavar (sorafenib),2
5856,alloderm rtu,2
5857,dbt plus s-view,2
5858,radspherin,2
5859,"oxaliplatin, capecitabine, radiotherapy",2
5860,oxaliplatin hai,2
5861,hypofractionated radiation treatment,2
5862,donepezil,2
5863,collagenase,2
5864,photopheresis,2
5865,lapatinib and capecitabine,2
5866,gum,2
5867,adenovirus-transfected dc + cik,2
5868,qualitative interview,2
5869,enasidenib mesylate,2
5870,cisplatin (cddp),2
5871,talcum powder,2
5872,rituximab / idec-c2b8,2
5873,bowel obstruction management,2
5874,hydrocortisone/placebo,2
5875,arterial blood pressure,2
5876,tyrosine kinase inhibitor (tki),2
5877,isoquercetin,2
5878,trametinib (gsk1120212),2
5879,tas-102 tablets,2
5880,conservative surgery,2
5881,vitamin b12 injection,2
5882,everolimus (afinitor®),2
5883,activated t lymphocyte,2
5884,laparoscopic rectal resection,2
5885,comparator: adacel™ (concomitant),2
5886,amg 102 at 10 mg/kg,2
5887,laparoscopy assisted distal gastrectomy,2
5888,spleen tyrosine kinase inhibitor tak-659,2
5889,ingenol mebutate (picato®),2
5890,definitive radiochemotherapy,2
5891,simulation training,2
5892,imcnyeso,2
5893,diagnostic imaging,2
5894,peripheral blood stem cell transplantation (pbsc),2
5895,"sorafenib (nexavar, bay 43-9006)",2
5896,ucart19,2
5897,tumor vaccine,2
5898,capsaicin,2
5899,long-term screening,2
5900,microbiome analysis,2
5901,phenylephrine,2
5902,evomela,2
5903,feraheme,2
5904,mfolfiri,2
5905,active living counseling,2
5906,pure-vu system,2
5907,hpv19 mab,2
5908,active breathing coordinator (abc),2
5909,immunosuppressive therapy,2
5910,medi7247,2
5911,ro7198457,2
5912,tookad® soluble,2
5913,granulocyte-colony-stimulating factor,2
5914,pancreatic resection,2
5915,selective treatment,2
5916,cls003,2
5917,"gemcitabine,cisplatin",2
5918,conventional colonoscopy (olympus cf-h180dl),2
5919,tap-144-sr(3m),2
5920,definitive surgery,2
5921,imatinib mesilate,2
5922,falimarev,2
5923,interleukin 2,2
5924,sputum sample,2
5925,68ga-nota-bbn-rgd,2
5926,cefepime hydrochloride,2
5927,mobile app,2
5928,dcp-001,2
5929,bay1862864,2
5930,nms-1116354,2
5931,cognitive testing,2
5932,prostate brachytherapy,2
5933,paclitaxel protein-bound,2
5934,nrx 194204,2
5935,acp-196 (acalabrutinib),2
5936,peg asparaginase,2
5937,reirradiation,2
5938,fpa008,2
5939,tacedinaline,2
5940,diary,2
5941,tk3,2
5942,hexaminolevulinate hcl,2
5943,oxymorphone er,2
5944,carbon nanoparticles,2
5945,plasma exchange,2
5946,esophageal biopsies,2
5947,pf-06804103,2
5948,placebo - concentrate,2
5949,metabolic,2
5950,jvrs-100,2
5951,anti-cd19 car-t,2
5952,clinical alerts,2
5953,e7040,2
5954,clinical management,2
5955,hypofractionated imrt,2
5956,onartuzumab (metmab),2
5957,controlled-release oxycodone,2
5958,empagliflozin,2
5959,single tourniquet,2
5960,vaginal dilator,2
5961,for46,2
5962,axillary lymph node dissection (alnd),2
5963,cabacitaxel,2
5964,ispinesib (sb-715992),2
5965,fsh,2
5966,tetanus toxoid vaccine,2
5967,erectile dysfunction,2
5968,granulocyte macrophage colony-stimulating factor (gm-csf),2
5969,contrast-enhanced intraoperative ultrasound,2
5970,taxotere (docetaxel),2
5971,radioembolization,2
5972,emergency surgery,2
5973,information only,2
5974,bowel cancer screening decision aid,2
5975,"s-1, leucovorin, oxaliplatin",2
5976,me tarp vaccine,2
5977,citrovorum,2
5978,lifestyle modification and telephone counseling,2
5979,"folfox (oxaliplatin, 5fluorouracil, lederfolin)",2
5980,edetate calcium disodium,2
5981,serratus anterior plane block,2
5982,sb3 (proposed trastuzumab biosimilar),2
5983,group phone calls,2
5984,education program,2
5985,sham stimulation,2
5986,er:yag afl-pdt,2
5987,fecal immunochemical testing,2
5988,flow immunophenotyping,2
5989,granulocyte-macrophage colony stimulating factor (gm-csf),2
5990,hlx10,2
5991,dexamethasone tablets,2
5992,clear liquid diet,2
5993,total intravenous anesthesia,2
5994,18f-sodium fluoride (naf),2
5995,cc-8490,2
5996,standard medical therapy,2
5997,calcifediol oral capsule,2
5998,cbct scan,2
5999,whole food intervention,2
6000,cisplatin combine with imrt,2
6001,trental,2
6002,panvac-v,2
6003,neugranin,2
6004,induction therapy,2
6005,hs006+chop,2
6006,hyperpolarized pyruvate,2
6007,neuroblate system,2
6008,tak-901,2
6009,robotic assisted laparoscopic surgery,2
6010,lidocaine-prilocaine 5% cream application,2
6011,group 2,2
6012,monoclonal antibody muj591,2
6013,indium in 111 pentetreotide,2
6014,"mek162, mek inhibitor; oral",2
6015,ly2874455,2
6016,malignant cells,2
6017,ilaprazole,2
6018,irinotecan liposomal injection,2
6019,fluorescein sodium,2
6020,hyperfractionated radiotherapy,2
6021,bevacizumab (avastin®),2
6022,"dexamethasone, steroid; oral",2
6023,vena punction,2
6024,sonohysterography,2
6025,supervised group exercise,2
6026,clinical evaluation,2
6027,blood pressure measurement,2
6028,swe,2
6029,tk006,2
6030,clag,2
6031,yttrium-90 microsphere radioembolization,2
6032,progestin,2
6033,systematic biopsies,2
6034,[18f]fluorthanatrace ([18f]ftt),2
6035,mga271,2
6036,pv701,2
6037,tumor genetic predisposition to develop sarcoma assessment,2
6038,erbitux (cetuximab),2
6039,ivor-lewis esophagectomy,2
6040,gp96,2
6041,sodium picosulphate with magnesium citrate,2
6042,safety testing,2
6043,personalized synthetic long peptide vaccine,2
6044,metronidazole,2
6045,open intersphincteric resection,2
6046,ad5-ycd/muttksr39rep-hil12,2
6047,confocal microscopy,2
6048,plasma samples,2
6049,elective neck dissection,2
6050,shr1210,2
6051,lenalidomide and r-chop,2
6052,total body irradiation 1200 cgy,2
6053,thymoglobulin [anti-thymocyte globulin (rabbit)],2
6054,ifn?2b,2
6055,gastric cancer surgery,2
6056,hypofractionated,2
6057,fenretinide lipid matrix,2
6058,bpx-501,2
6059,cognitive-behavioral group therapy and hypnosis,2
6060,endoscopic spray cryotherapy,2
6061,r-da-epoch-21,2
6062,laparoscopic-assisted rectal resection,2
6063,mva-muc1-il2,2
6064,medi3617,2
6065,nerve sparing radical hysterectomy,2
6066,bowman-birk inhibitor concentrate,2
6067,lymphedema management,2
6068,mct/lct,2
6069,endocervical samples,2
6070,leuvectin,2
6071,dietary restriction,2
6072,fluorine f 18 d-fmau,2
6073,sirna-transfected peripheral blood mononuclear cells apn401,2
6074,feedback,2
6075,90y-dota-3-tyr-octreotide,2
6076,musical training,2
6077,ql1101,2
6078,gvax pancreatic cancer vaccine,2
6079,mitomycin c (mmc),2
6080,laboratory testing,2
6081,trifluridine and tipiracil hydrochloride,2
6082,cs-1008 (humanized anti-dr5 antibody),2
6083,nintedanib (bibf1120),2
6084,d-0502,2
6085,colloidal gold-bound tumor necrosis factor,2
6086,sbg,2
6087,ovarian drilling,2
6088,alvespimycin,2
6089,neuroimaging & neuropsychological evaluation,2
6090,kevetrin,2
6091,dj-927,2
6092,loxo-195,2
6093,gadoterate meglumine,2
6094,ts-1 with cisplatin,2
6095,sentinel node procedure,2
6096,epofolate,2
6097,walnuts,2
6098,adenovirus/psa vaccine,2
6099,afm11,2
6100,non intervention,2
6101,atir101,2
6102,chemoid assay,2
6103,talaporfin sodium (ls11),2
6104,brochure,2
6105,allogeneic cytomegalovirus-specific cytotoxic t lymphocytes,2
6106,heparin sodium,2
6107,5-flourouracil,2
6108,sarilumab,2
6109,hypofractionated imrt using helical tomotherapy.,2
6110,zoledronic acid 4 mg,2
6111,cb-5083,2
6112,bt062,2
6113,magseed marker,2
6114,chemo-radiotherapy,2
6115,atn-224,2
6116,indium in-111 ibritumomab tiuxetan,2
6117,imp4297,2
6118,navigated bronchoscopy,2
6119,vandetanib 300 mg,2
6120,group session,2
6121,ino-5401,2
6122,metatinib tromethamine,2
6123,ec17 (folate-fitc),2
6124,vegf inhibitor ptc299,2
6125,"carfilzomib, cyclophosphamide, dexamethasone",2
6126,isoflurane,2
6127,trx518,2
6128,"autologous, lethally irradiated breast cancer cells",2
6129,rfusin2-aml1 and donor leukocyte infusion,2
6130,placebo for olaparib,2
6131,ibrutinib 420 mg,2
6132,monitoring,2
6133,talc pleurodesis,2
6134,steep pulse device,2
6135,gm102,2
6136,navigator,2
6137,sdm,2
6138,ofatumumab + dhap,2
6139,behavioral techniques,2
6140,desmopressin,2
6141,comparison systematic light exposure,2
6142,elagolix placebo,2
6143,ctdna test,2
6144,home based exercise,2
6145,lungpoint atv system,2
6146,combined epi-ga/pcea,2
6147,lung resection,2
6148,promoting resilience in stress management (prism),2
6149,mva-bn-her2,2
6150,conventional fluid therapy,2
6151,carbon ion,2
6152,anidulafungin,2
6153,omiganan (cls001) topical gel,2
6154,total body radiation,2
6155,abx464 50mg,2
6156,danvatirsen,2
6157,ultrasound elasticity imaging,2
6158,mdx-060,2
6159,reparixin,2
6160,oncosil™,2
6161,intra-operative radiation therapy (iort),2
6162,self-hypnosis + self-care,2
6163,papaverine,2
6164,hyperacute(r)-pancreatic cancer vaccine,2
6165,procrit,2
6166,neuropsychological testing,2
6167,self-administered questionnaire and blood draw,2
6168,endometrial ablation,2
6169,reconval cream,2
6170,zio-201,2
6171,local therapy,2
6172,serum sample,2
6173,open surgery for colorectal cancer,2
6174,proactive psychiatry consultation (ppc),2
6175,collect blood and survey instruments,2
6176,ibrutinib 560 mg,2
6177,mm-111,2
6178,immediate breast reconstruction,2
6179,chemotherapy drugs,2
6180,rabbit anti-thymocyte globulin,2
6181,single-arm feasibility study,2
6182,obe2109 + add-back,2
6183,"pemetrexed, cisplatin",2
6184,ccrt+pf,2
6185,antibody-drug conjugate therapy,2
6186,pretargeted radioimmunotherapy,2
6187,abdominal radical hysterectomy,2
6188,no-touch rfa,2
6189,prostatic biopsies,2
6190,capecitabine/oxaliplatin,2
6191,exemestane 25 mg,2
6192,percutaneous cryoablation,2
6193,cope,2
6194,paclitaxel; cisplatin,2
6195,self-hypnotic relaxation,2
6196,ezatiostat hydrochloride,2
6197,phase ii - preoperative radiation followed by lumpectomy.,2
6198,mdcf,2
6199,observational study,2
6200,aktilite® galderma,2
6201,oxi4503,2
6202,baseline ecg,2
6203,afatinib (bibw 2992),2
6204,premedication,2
6205,fiducial markers,2
6206,transsphenoidal surgery,2
6207,indium in 111 ll2 igg,2
6208,lifestyle,2
6209,h101,2
6210,pnk-007,2
6211,oncaspar,2
6212,questionnaires & online virtual support group,2
6213,oncovin,2
6214,ct-p6,2
6215,cofactor (anx-510),2
6216,kte-x19,2
6217,whole body magnetic resonance imaging (mri),2
6218,xentuzumab,2
6219,triple intrathecal therapy,2
6220,zosuquidar,2
6221,hucart19,2
6222,pf-04136309,2
6223,g-csf and plerixafor,2
6224,virtual reality headset,2
6225,fingolimod,2
6226,mammosite ml,2
6227,bay1075553,2
6228,acetyl-l-carnitine hydrochloride,2
6229,serine proteinase inhibitor wx-671,2
6230,immunotherapy based on dendritic cells,2
6231,gliasite radiation therapy system,2
6232,optimune,2
6233,krestin,2
6234,azd9291 dosing,2
6235,bevacizumab-800cw,2
6236,pelareorep,2
6237,self care,2
6238,hope,2
6239,placebo to match simtuzumab,2
6240,ido1 inhibitor incb024360,2
6241,"lonaprisan (zk 230211, bay86-5044)",2
6242,routine medical care,2
6243,digital rectal exam,2
6244,focal therapy,2
6245,ralpps,2
6246,optional biopsy,2
6247,standard of care treatment,2
6248,regional anesthesia,2
6249,diet group,2
6250,18f-naf,2
6251,immunocryosurgery,2
6252,micronized progesterone,2
6253,lapatinib + capecitabine,2
6254,prostvac-v/f,2
6255,doxorubicin hydrochloride (dox),2
6256,follow-up questionnaire,2
6257,tc 99m sestamibi,2
6258,stapling device,2
6259,azd3514,2
6260,dna banking,2
6261,ertapenem,2
6262,seprafilm,2
6263,abi-011,2
6264,monoclonal antibody huhmfg1,2
6265,rhil-11,2
6266,lactobacillus plantarum strain 299v,2
6267,testosterone gel,2
6268,hypofractionated radiation therapy (hfrt),2
6269,adh-1,2
6270,cetrorelix acetate,2
6271,trimetazidine hydrochloride,2
6272,wound treatment,2
6273,partial brain irradiation,2
6274,epoch-f,2
6275,fluid loading,2
6276,synthetic human papillomavirus 16 e6 peptide,2
6277,tti-237,2
6278,fine needle aspiration (fna),2
6279,nuc-3373,2
6280,iv busulfan,2
6281,assessment for surgical evaluation,2
6282,sugar pill to ctap101 30 ?g capsules,2
6283,comparator: menactra™ (concomitant),2
6284,birinapant (tl32711),2
6285,psychosocial support,2
6286,home-based exercise program,2
6287,screening mammography,2
6288,representational approach,2
6289,palliative care intervention,2
6290,timing of start treatment with pancreatic enzymes,2
6291,pd-1 mab,2
6292,treatment b,2
6293,aprepitant vs. gabapentin,2
6294,placebo for lenvatinib,2
6295,"genasense® (g3139, oblimersen sodium)",2
6296,cesm,2
6297,6-mp,2
6298,adalimumab (humira®),2
6299,problem-solving skills training,2
6300,dimethyl sulfoxide,2
6301,wle,2
6302,gamma probe,2
6303,beacoppesc,2
6304,mobilan (m-vm3),2
6305,carboplatin auc6,2
6306,osi-930,2
6307,promitil,2
6308,intetumumab,2
6309,linear energy transfer-optimized intensity modulated proton therapy,2
6310,aspirin and/or clopidogrel,2
6311,matuzumab,2
6312,low co2 group,2
6313,fdg pet-ct,2
6314,grapiprant and pembrolizumab,2
6315,g17dt immunogen,2
6316,enzyme linked immunosorbent assay (elisa),2
6317,muc-2-globo h-klh conjugate vaccine,2
6318,diffuse optical imaging,2
6319,thoracic hypofractionated radiotherapy,2
6320,"bortezomib, proteasome inhibitor; intravenous or subcutaneous",2
6321,68ga-nodaga-e[c(rgdyk)]2,2
6322,z-360,2
6323,pcar-019 (anti-cd19 car-t cells),2
6324,fasting-mimicking diet,2
6325,imrt simultaneous integrated boost,2
6326,patient registry,2
6327,blood pressure,2
6328,"ckd-810, taxotere inj.",2
6329,bevacizumab/irinotecan,2
6330,trastuzumab or lapatinib,2
6331,registry study,2
6332,dual energy computed tomography,2
6333,high dose methylprednisolone (hdmp),2
6334,"trasylol (aprotinin, baya0128)",2
6335,soy,2
6336,cytomegalovirus pp65-specific cytotoxic t lymphocytes,2
6337,danazol,2
6338,esophagogastrectomy,2
6339,l-lv (dl-lv),2
6340,ranibizumab 0.5 mg,2
6341,imatinib 400mg,2
6342,endo-pat2000 testing,2
6343,myeloid growth factor,2
6344,music listening,2
6345,s-1/cisplatin,2
6346,telephone genetic counseling,2
6347,wallflex™ biliary rx fully covered/uncovered stent system,2
6348,tak-385 40 mg,2
6349,id-klh vaccine,2
6350,egen-001 (phil-12-005/ppc),2
6351,peg- ifn?2b,2
6352,cimetidine,2
6353,bms-986016,2
6354,ebv specific t cells,2
6355,shr3162,2
6356,conventional treatment,2
6357,water infusion colonoscopy,2
6358,32p biosilicon,2
6359,bioluminescence,2
6360,sar245409 (pi3k and mtor inhibitor),2
6361,sorafenib + pravastatin,2
6362,vasopressin,2
6363,standard care (sc),2
6364,recombinant 70-kd heat-shock protein,2
6365,rezum system,2
6366,salivary gland transfer,2
6367,synergo + mmc,2
6368,nadroparin,2
6369,omaveloxolone,2
6370,ji-101,2
6371,tsebt,2
6372,fdg-pet guided dose painting,2
6373,sagopilone (zk 219477),2
6374,g1t38,2
6375,stem cell,2
6376,rehabilitation program,2
6377,stereotactic ablative body radiosurgery (sabr),2
6378,lucanthone,2
6379,carbon dioxide laser,2
6380,cord blood stem cell infusion,2
6381,4x4 minutes high intensity interval training,2
6382,elsiglutide,2
6383,bupivacaine liposome,2
6384,filgrastim sd/01,2
6385,immu-132,2
6386,sutent: observational study,2
6387,aerobic exercise intervention,2
6388,concurrent temozolomide,2
6389,stereotactic ablative radiation therapy,2
6390,uft adjuvant chemotherapy,2
6391,pulsed dye laser (pdl),2
6392,administration of azd6738,2
6393,124-iodine-cg250 (124i-cg250),2
6394,improved atta,2
6395,sham electroacupuncture,2
6396,docetaxel/capecitabine,2
6397,cx-01,2
6398,s-adenosyl methionine,2
6399,cetuximab-irdye800,2
6400,open partial nephrectomy,2
6401,tas-119,2
6402,quality of life.,2
6403,sacituzumab govitecan,2
6404,gray,2
6405,avb-620,2
6406,standard dose bevacizumab,2
6407,lay health worker intervention,2
6408,led-based light infusion device,2
6409,jnj-42756493,2
6410,placebo nasal spray,2
6411,psychoeducational intervention,2
6412,pf,2
6413,s-1+oxaliplatin,2
6414,crizotinib (xalkori),2
6415,image-guided brachytherapy,2
6416,90y-ibritumomab tiuxetan (zevalin),2
6417,pbf-509,2
6418,low dose rate prostate brachytherapy,2
6419,high-resolution microendoscopy,2
6420,cv9103,2
6421,psychological questionnaires,2
6422,ad-p53,2
6423,systemic intravenous lidocaine infusion,2
6424,hepatic arterial infusion,2
6425,tkis,2
6426,high dose ara-c,2
6427,patient-reported outcomes measurement information system (promis)-sleep disturbance,2
6428,adalimumab placebo,2
6429,rna sequencing,2
6430,acridine carboxamide,2
6431,isoflavones,2
6432,"ipilimumab (mdx-010, bms-734016)",2
6433,eortc qlq cr29,2
6434,lt,2
6435,lidocaine 1%,2
6436,pens,2
6437,cytokine induced killer cells,2
6438,odm 203,2
6439,rituximab-chop,2
6440,intensive nutritional counseling,2
6441,carboplatin and etoposide,2
6442,fentanyl nasal spray,2
6443,pelvic imaging,2
6444,ai adjuvant therapy,2
6445,celecoxib (celebrex),2
6446,trus biopsy,2
6447,oxaliplatin s-1,2
6448,5 azacytidine,2
6449,conventional laparoscopic partial nephrectomy,2
6450,psychological counseling,2
6451,trans-thoracic echocardiography,2
6452,sham information,2
6453,paracentesis,2
6454,transarterial chemoembolization(tace),2
6455,spect/ct guided lm/sl,2
6456,recombinant human tnf-?,2
6457,"belinostat, carboplatin, paclitaxel",2
6458,febuxostat,2
6459,intratumoral electroporation,2
6460,chemoprevention of cancer,2
6461,lopinavir,2
6462,eribulin mesilate,2
6463,can008,2
6464,thymoglobulin (atg),2
6465,temozolomide and bevacizumab,2
6466,baseline survey,2
6467,"mec (mitoxantrone, etoposide, cytarabine)",2
6468,extended pelvic lymphadenectomy,2
6469,mesorectal excision,2
6470,asg-5me,2
6471,clinician survey,2
6472,sorafenib (bay 43-9006),2
6473,billroth ii anastomosis,2
6474,sienna+ injection,2
6475,apomine,2
6476,m2es 60mg,2
6477,physical performance testing,2
6478,stem cell transplant (sct),2
6479,g207,2
6480,21g ebus-tbna needle,2
6481,"ct-scan, cea, x-ray of lungs",2
6482,vigabatrin,2
6483,mammaglobin-a dna vaccine,2
6484,personalised treatment,2
6485,en3267,2
6486,pecfent® (fentanyl) nasal spray,2
6487,mri and cognitive evaluation,2
6488,cwp232291,2
6489,thermal imaging,2
6490,palladium pd 103,2
6491,chimio-oncogramme,2
6492,90y-epratuzumab tetraxetan,2
6493,asp3026,2
6494,pharmacodynamic studies,2
6495,standard mammography,2
6496,"survey, questionaire",2
6497,asp8273,2
6498,ivabradine,2
6499,gw572016 (lapatinib),2
6500,ppi,2
6501,ipi-493,2
6502,glucose,2
6503,mozobil,2
6504,prostate cancer screening education,2
6505,"oxaliplatin (oxa), levofolinate calcium (l-lv), 5-fu, bevacizumab",2
6506,anti-pd-1 alone,2
6507,pi3k inhibitor byl719,2
6508,msb0011359c,2
6509,a-101 vehicle,2
6510,deep regional hyperthermia,2
6511,inquiry based stress reduction (ibsr) program,2
6512,no intervention in this retrospective study,2
6513,rad001 (everolimus) in combination with carboplatin,2
6514,resistant starch,2
6515,ketamine hydrochloride,2
6516,tissue biopsy,2
6517,durvalumab + monalizumab,2
6518,apa,2
6519,focal radiotherapy,2
6520,neoadjuvant radiochemotherapy,2
6521,mg1-magea3,2
6522,mal cream,2
6523,68ga-bnota-prgd2,2
6524,"campto, topotesin",2
6525,rehabilitation training,2
6526,sampling of tumor tissue after breast cancer surgery,2
6527,il-12,2
6528,polymorphic microsatellite marker analysis,2
6529,olaparib pill,2
6530,lc n-3 pufa (fish oil) supplement,2
6531,transcriptome analysis,2
6532,pet/mri scan instead of only mri,2
6533,actr t cell product,2
6534,anthracycline,2
6535,moderate exercise group,2
6536,bovine lactoferrin,2
6537,cisplatin and pemetrexed,2
6538,mr linac,2
6539,krn23,2
6540,quisinostat,2
6541,does not apply,2
6542,sox sequential s-1,2
6543,vegan diet,2
6544,managing anxiety from cancer (mac),2
6545,non-contrast mri,2
6546,t-cells,2
6547,laparoscopic pancreaticoduodenectomy,2
6548,hs110 vaccine,2
6549,gm-csf placebo,2
6550,atn-161,2
6551,toripalimab injection(js001 ) combine with chemotherapy,2
6552,sodium borocaptate,2
6553,evidence-based information,2
6554,skin punch biopsy,2
6555,mobile health app,2
6556,cranial irradiation,2
6557,fit screening strategy,2
6558,onartuzumab [metmab],2
6559,opioids,2
6560,jcarh125,2
6561,iron supplementation,2
6562,oxaliplatin 85 mg/m^2,2
6563,alfacalcidol,2
6564,"folfox (oxaliplatin, leucovorin, 5-fluorouracil [5fu])",2
6565,icotinib of high dose,2
6566,placebo to zoledronic acid,2
6567,?? t cells,2
6568,pi3k/mtor inhibitor ly3023414,2
6569,qlq-c30 with hcc module,2
6570,f-18 fluorodeoxyglucose,2
6571,sozo device,2
6572,psma/prame,2
6573,placebo solution,2
6574,gynaecological follow-up,2
6575,docetaxel + cddp,2
6576,imrt combine with cisplatin concurrent chemotherapy,2
6577,sunitinib + mfolfox6,2
6578,omp-21m18,2
6579,rindopepimut (cdx-110) with gm-csf,2
6580,paclitaxel infusion,2
6581,active breathing control,2
6582,sib,2
6583,generic ingenol mebutate,2
6584,hyaluronic acid,2
6585,azd1208,2
6586,mouth rinse,2
6587,blood sample for fshr analysis,2
6588,gnrh agonist/antagonist,2
6589,kd019,2
6590,busulfan and fludarabine,2
6591,ingenol mebutate gel 0.015%,2
6592,flt-pet imaging,2
6593,dlye5953a,2
6594,telephone call,2
6595,soybean oil,2
6596,stereotactic radiation therapy (srt),2
6597,sirolimus (rapamycin),2
6598,nitrous oxide,2
6599,stem cell mobilization,2
6600,standard laparoscopy,2
6601,ci 1033,2
6602,limb salvage,2
6603,nox66,2
6604,bortezomib + rituximab,2
6605,ac0010ma,2
6606,tap-144-sr(6m),2
6607,dc1 vaccine,2
6608,o-panp-tme,2
6609,treatment d,2
6610,high-resolution microendoscopy imaging,2
6611,specialized tumor board recommendation,2
6612,osi-211 (liposomal lurtotecan),2
6613,mrx34,2
6614,bkm 120,2
6615,gls-010,2
6616,tisotumab vedotin (humax-tf-adc),2
6617,anti-cd22-car-transduced t cells,2
6618,exablate transcranial system,2
6619,intensity modulated external beam radiation therapy,2
6620,mnrp1685a,2
6621,therabite,2
6622,"questionaire, blood sample",2
6623,fludarabine and melphalan,2
6624,chemofx,2
6625,bms-188797,2
6626,sandostatin lar depot,2
6627,syb l-1101,2
6628,azd9833 with palbociclib,2
6629,moxr0916,2
6630,detoxpc,2
6631,muc1 peptide-poly-iclc vaccine,2
6632,ivf,2
6633,l19-il2,2
6634,cat-8015 20 mcg/kg,2
6635,chemotherapy and antibodies,2
6636,problem-solving therapy,2
6637,fasting mimicking diet,2
6638,carboplatin paclitaxel bevacizumab,2
6639,"[18f]f-arag pet scan, baseline + post anti-pd-1 therapy.",2
6640,blood,2
6641,antiestrogen therapy,2
6642,oral l-arginine,2
6643,swallowing exercises,2
6644,131i,2
6645,osilodrostat,2
6646,medi2070,2
6647,panvac-f,2
6648,m2es 7.5mg,2
6649,hemay022,2
6650,computer program,2
6651,orantinib (tsu-68),2
6652,gaa/tt-peptide vaccine and poly-iclc,2
6653,breast tissue collection,2
6654,arginine butyrate,2
6655,bpi-9016m,2
6656,conventional therapy,2
6657,cefepime,2
6658,mga012,2
6659,mrgfus,2
6660,yiqifang,2
6661,cediranib placebo,2
6662,edrecolomab,2
6663,carboplatin paclitaxel,2
6664,medi4736+tremelimumab,2
6665,written materials only,2
6666,personalized exercise program,2
6667,ginger extract,2
6668,nasogastric tube,2
6669,sampling of blood,2
6670,premetrexed (alimta),2
6671,intron a,2
6672,isoflavone,2
6673,dstp3086s,2
6674,tocotrienol,2
6675,ly2181308 sodium,2
6676,psychosocial intervention,2
6677,physical activity program,2
6678,zd6474 (zactima),2
6679,molecular fluorescence endoscopy platform,2
6680,port,2
6681,fluzone high dose vaccine,2
6682,smart phone,2
6683,fluorescence visualization device,2
6684,iodixanol,2
6685,questionnaire and review session,2
6686,snx-5422 plus ibrutinib,2
6687,18f-dcfpyl pet/ct scan,2
6688,natalizumab,2
6689,ingenol mebutate 0.015%,2
6690,shr2554,2
6691,capecitabine/cisplatin,2
6692,avastin®,2
6693,induction chrono-chemotherapy,2
6694,physiological saline,2
6695,epo906 (patupilone),2
6696,akynzeo,2
6697,hypo-fractionated radiotherapy,2
6698,sandostatin,2
6699,radiotherapy - patients needing curative neck irradiation,2
6700,177lu-dotatate,2
6701,gadolinium-chelate,2
6702,onco4d biodynamic chemotherapy selection assay,2
6703,ido1 inhibitor bms-986205,2
6704,laparoscopic radical hysterectomy,2
6705,stress management group 2,2
6706,fibrin glue,2
6707,chest radiography,2
6708,treatment a,2
6709,suction and evacuation,2
6710,interferon-gamma,2
6711,recombinant human interleukin-2 and rituximab,2
6712,ttrna-dc vaccines with gm-csf,2
6713,medi4736 monotherapy,2
6714,vitamin d supplement,2
6715,pivka-ii,2
6716,venesection,2
6717,aptima hpv assay,2
6718,monoclonal antibody me1-14 f(ab')2,2
6719,cyclodextrin-based polymer-camptothecin crlx101,2
6720,radiofrequency ablation of fibroids,2
6721,bgt226,2
6722,pf-02341066/pf-00299804,2
6723,g100,2
6724,gnrh analog,2
6725,short term androgen deprivation,2
6726,home-based physical activity program,2
6727,accelerated partial breast irradiation (apbi),2
6728,ttac-0001,2
6729,hbot,2
6730,adv/hsv-tk,2
6731,ultra low dose chest ct,2
6732,xylocaine,2
6733,pck3145,2
6734,extraperitoneal laparoscopic aortic lymphadenectomy,2
6735,dose-intensified tmz,2
6736,standard fluid management,2
6737,arterial embolization,2
6738,rhcg,2
6739,cd19-directed car-t cells,2
6740,"d-chiro-inositol, manganese, folic acid, vit b12",2
6741,alloreactive nk infusion,2
6742,dsc-mri,2
6743,exploratory laparoscopy or laparotomy,2
6744,analgesic ladder,2
6745,wt1 peptide vaccine,2
6746,modified atkins diet,2
6747,"gemcitabine , cisplatin",2
6748,non applicable,2
6749,"mk0869, aprepitant / duration of treatment: 3 days",2
6750,iodine i 131 ethiodized oil,2
6751,tarceva (erlotinib hydrochloride),2
6752,simvastatin 40mg,2
6753,25 mg proellex,2
6754,novartis meningococcal acwy conjugate vaccine,2
6755,ligasure,2
6756,bi 853520,2
6757,placebo for pembrolizumab,2
6758,dendritic cell,2
6759,mp diagnostics htlv blot 2.4,2
6760,cephalexin,2
6761,intervention by caregiver,2
6762,ctc,2
6763,allogeneic natural killer cells,2
6764,beetroot juice,2
6765,ivdd for nk cell activity in whole blood,2
6766,arm 3,2
6767,bbr 3464,2
6768,bendamustine plus rituximab,2
6769,10x1 minute high intensity interval training,2
6770,noni extract,2
6771,baseline questionnaire,2
6772,hypnosedation,2
6773,tenofovir,2
6774,mr-guided laser interstitial thermal therapy system,2
6775,traditional fluid therapy,2
6776,x-82,2
6777,pegylated recombinant human arginase i,2
6778,"melphalan, prednisone and thalidomide",2
6779,fdg pet scan,2
6780,ipad,2
6781,radioisotope,2
6782,0.9% sodium chloride,2
6783,gemcitabine and erlotinib,2
6784,gm1,2
6785,177lu-dota-tate,2
6786,nintedanib high dose,2
6787,"cc-223, oral azacitidine",2
6788,autograft,2
6789,lapatinib (gw572016) oral tablets,2
6790,allogenic transplantation,2
6791,adjuvant radiation therapy,2
6792,saliva collection,2
6793,fluoroestradiol (18f),2
6794,abagovomab,2
6795,laparoscopy-assisted gastrectomy,2
6796,erythromycin breath test (ermbt),2
6797,load703,2
6798,as101,2
6799,immune killer cells (ikc),2
6800,jnj-63723283 480 mg,2
6801,computed tomography (ct scan),2
6802,dsp-7888,2
6803,oral isotretinoin,2
6804,oxaliplatin plus s-1,2
6805,xeliri,2
6806,biib022,2
6807,computer-aided detection/diagnosis,2
6808,the intrathecal morphine injection,2
6809,l-folinic acid,2
6810,buparlisib matching placebo,2
6811,oral ornidazole,2
6812,13-cis retinoic acid,2
6813,mohs micrographic surgery,2
6814,sar405838,2
6815,surgery group,2
6816,radium-223 chloride (bay88-8223),2
6817,retroflexion,2
6818,mini-afterc,2
6819,tqb2303,2
6820,fitness tracker,2
6821,distilled water,2
6822,vaginal renewal program,2
6823,electric field therapy,2
6824,zen003694,2
6825,nbi endoscopy,2
6826,snp analysis,2
6827,bp102,2
6828,therapeutic chemoembolization,2
6829,transanal endoscopic microsurgery,2
6830,rituximab iv,2
6831,doxorubicin hcl,2
6832,em-1421,2
6833,microwave treatment,2
6834,xcellerated t cells,2
6835,obatoclax,2
6836,nipple sparing mastectomy,2
6837,vinorelbine and capecitabine,2
6838,cafusertib hydrochloride,2
6839,radiotherapy/cisplatin,2
6840,health education program,2
6841,gi heptapeptide,2
6842,89zr-pembrolizumab,2
6843,technical measure,2
6844,"cisplatin, 5-fu",2
6845,tai chi,2
6846,kn026,2
6847,paclitaxel+carboplatin,2
6848,evaluation,2
6849,risk-reducing salpingo-oophorectomy,2
6850,tak-580,2
6851,e7107,2
6852,hot snare,2
6853,acetic acid chromoendoscopy,2
6854,cd34+ cells,2
6855,laparoscopic radical prostatectomy,2
6856,4'-iodo-4'-deoxydoxorubicin,2
6857,accelerated radiotherapy fractionation,2
6858,right colectomy,2
6859,egfrbi-armed autologous activated t cells,2
6860,rituximab maintenance,2
6861,indium in 111 monoclonal antibody lym-1,2
6862,anti-ox40 antibody bms 986178,2
6863,bind-014 (docetaxel nanoparticles for injectable suspension),2
6864,cetuximab + irinotecan,2
6865,cholecystectomy,2
6866,t900607,2
6867,trin2755,2
6868,reduced-intensity transplant conditioning procedure,2
6869,quality of life surveys,2
6870,ensure,2
6871,vantictumab,2
6872,eus fna,2
6873,laparoscopic tme,2
6874,placebo patch,2
6875,radiofrequency-guided localization,2
6876,ultra-fluid lipiodol,2
6877,supportive treatment,2
6878,abgn-7,2
6879,pressure dressing,2
6880,cc-90002,2
6881,urine samples,2
6882,no antimicrobial prophylaxis,2
6883,sor007 (uncoated nanoparticulate paclitaxel) ointment,2
6884,"doxorubicin, cyclophosphamide",2
6885,escitalopram oxalate,2
6886,low-molecular-weight heparin,2
6887,zinc gluconate,2
6888,transurethral resection of bladder tumor,2
6889,conventional resection,2
6890,gw003,2
6891,imo-8400,2
6892,venepuncture,2
6893,mycobacterium w,2
6894,prospect,2
6895,triciribine,2
6896,buparlisib (bkm120),2
6897,yoga classes,2
6898,high intensity interval training,2
6899,mouth spray,2
6900,anamorelin hydrochloride,2
6901,rhil-15,2
6902,vbn,2
6903,entinostat (sndx-275),2
6904,cryoballoon ablation,2
6905,cf102,2
6906,dlbs3233,2
6907,endoscopic thyroidectomy,2
6908,no rapid ventricular pacing,2
6909,ict-107,2
6910,letrozole oral tablet,2
6911,c-car-011,2
6912,iodine i 131 monoclonal antibody f19,2
6913,salvage surgery,2
6914,isosulfan blue (patent blue dye v),2
6915,icotinib hydrochloride,2
6916,"lycopene, vitamin d3, selenium, green tea extract, vitamin e",2
6917,seocalcitol,2
6918,iodine i-131,2
6919,aclarubicin,2
6920,chemotherapy ± target therapy,2
6921,vaccinia-tyrosinase vaccine,2
6922,elacestrant,2
6923,"floxuridine, oxaliplatin, cpt-11",2
6924,otsgc-a24,2
6925,herincar-pd1 cells,2
6926,quarfloxin,2
6927,trus-guided biopsy,2
6928,pt-112 injection,2
6929,cohort a,2
6930,lumpectomy without sentinel node biopsy,2
6931,surgical resection of tumor,2
6932,telephone counseling sessions,2
6933,autologous dendritic cell-adenovirus ccl21 vaccine,2
6934,regimen c,2
6935,star™ tumor ablation system,2
6936,acquire eus biopsy device,2
6937,white light endoscopy (wle),2
6938,ncle,2
6939,intraoperative radiotherapy (iort),2
6940,palbociclib 100mg,2
6941,sibutramine,2
6942,mobile community,2
6943,fk228 (romidepsin),2
6944,salpingectomy,2
6945,u3-1402,2
6946,white blood cell transfusion,2
6947,toripalimab,2
6948,"vincristine, carboplatin",2
6949,gp100:209-217 (210m),2
6950,third eye retroscope,2
6951,intensity modulated radiotherapy treatments,2
6952,circulating tumor cells,2
6953,vitamin b complex,2
6954,msc2015103b,2
6955,phenylbutyrate,2
6956,daptomycin,2
6957,peit,2
6958,anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells,2
6959,valproic acid (vpa),2
6960,su011248 (sunitinib),2
6961,sunitinib alone,2
6962,lymphatic mapping,2
6963,hypofractionated helical imrt,2
6964,e. coli asparaginase,2
6965,endoscopic radiofrequency ablation,2
6966,bacillus calmette-guérin,2
6967,octreotide pamoate,2
6968,retrospective analysis of already archived samples,2
6969,clinical assessments,2
6970,cyclosporine a (csa),2
6971,sulforaphane,2
6972,luteinizing hormone-releasing hormone (lhrh) agonist,2
6973,nilotinib (amn107),2
6974,mibg,2
6975,amiodarone,2
6976,18f-fluoromethylcholine,2
6977,bevacizumab 5 mg/kg,2
6978,s-1 and cisplatin,2
6979,esomeprazole magnesium,2
6980,reading materials and discussions,2
6981,cannabis,2
6982,gliadel wafer,2
6983,gpx-150 for injection,2
6984,pimasertib tablet (part a),2
6985,human cmv pp65-lamp mrna-pulsed autologous dcs,2
6986,phosphate-buffered saline (pbs),2
6987,manuka honey,2
6988,enzalutamide capsule,2
6989,pelvic surgery,2
6990,zd6126,2
6991,neurocognitive evaluation,2
6992,drain,2
6993,bms-275183,2
6994,xelox + bevacizumab,2
6995,jcar015,2
6996,pembrolizumab 2 mg/kg,2
6997,salmonella vnp20009,2
6998,coxsackievirus a21,2
6999,self-collection for hpv testing,2
7000,gifox-bortezomib,2
7001,wait list,2
7002,cs7017,2
7003,d5w placebo,2
7004,chr-2797,2
7005,bzl101,2
7006,genetic education and counseling,2
7007,baseline visit blood & urine testing,2
7008,flurbiprofen axetil,2
7009,conventional open surgery,2
7010,lisocabtagene maraleucel,2
7011,iv granisetron,2
7012,mangafodipir,2
7013,high resolution microendoscope,2
7014,pf-06664178,2
7015,support group,2
7016,biaxin (clarithromycin),2
7017,philips shear wave elastography,2
7018,standard palliative care,2
7019,hpv-16 vaccine,2
7020,moderate exercise,2
7021,acupuncture and questionnaires,2
7022,bms-986148,2
7023,dose level 3,2
7024,carbon c 14 oxaliplatin,2
7025,chemotherapy of mfolfox6 or folfiri,2
7026,magnetic resonance elastography,2
7027,sgi-110 (guadecitabine),2
7028,"carboplatin, paclitaxel, and bevacizumab",2
7029,standard colonoscope,2
7030,cannabidiol,2
7031,adalimumab (humira),2
7032,pemetrexed 500 mg/m2,2
7033,near-infrared fluorescence imaging,2
7034,bevacizumab and carboplatin,2
7035,vitamin b-6,2
7036,intrathecal rituximab,2
7037,68ga-rm2 pet/ct,2
7038,cologuard,2
7039,tnferade™,2
7040,temiri,2
7041,dmards,2
7042,open radical cystectomy,2
7043,gelatin sponge articles,2
7044,empathic visitor,2
7045,samalizumab,2
7046,lavage of the cavum uteri and proximal fallopian tubes,2
7047,90y-dota-tyr3-octreotide,2
7048,dehydrated human amnion/chorion membrane,2
7049,cancerlife,2
7050,r-methuscf and filgrastim,2
7051,technetium tc-99m albumin aggregated,2
7052,adriamycin/cytoxan,2
7053,conventional white light colonoscopy,2
7054,archimedes system,2
7055,epz-5676,2
7056,interval debulking surgery,2
7057,laparoscopic-assisted total gastrectomy,2
7058,accelerated radiotherapy,2
7059,radiotherapy - patients needing elective nodal volume (eni),2
7060,magnetic resonance imaging (mri) assessments,2
7061,"paclitaxel + carboplatin + cp-870,893",2
7062,indium in 111 anti-cd45 monoclonal antibody bc8,2
7063,endotracheal tube,2
7064,cisplatin and gemcitabine,2
7065,weight loss plus,2
7066,positron emission tomography and computed tomography scan,2
7067,prosure,2
7068,ipilimumab injection [yervoy],2
7069,blue light,2
7070,cbct,2
7071,dose level 1,2
7072,fec,2
7073,nsaid,2
7074,blood withdrawn,2
7075,levonorgestrel,2
7076,alvac(2)-ny-eso-1 (m)/tricom vaccine,2
7077,pet imaging with ga-68 labeled f(ab') 2- trastuzumab,2
7078,xilonix,2
7079,pet diagnostic imaging,2
7080,follitropin beta,2
7081,ds-3201b,2
7082,adult cancer patients,2
7083,"busulfan, melphalan and fludarabine",2
7084,zio-101-c (darinaparsin),2
7085,femtosecond laser,2
7086,placebo cediranib,2
7087,cdx-011,2
7088,sym022,2
7089,fast-track surgery,2
7090,margetuximab,2
7091,bnp7787,2
7092,vsv-ifn?-nis,2
7093,oxaliplatin; capecitabine,2
7094,ts-1 (s-1),2
7095,karydakis procedure,2
7096,intraoperative lymphatic mapping,2
7097,tetanus peptide melanoma vaccine,2
7098,bms-986213,2
7099,dcvax-direct,2
7100,peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1,2
7101,intracorporeal anastomosis,2
7102,fludarabine (flu),2
7103,amg 102 at 20 mg/kg,2
7104,peptisorb,2
7105,wee-1 kinase inhibitor azd1775,2
7106,cisplatin/docetaxel,2
7107,autologous stem cell rescue,2
7108,hypofractionated imrt boost radiotherapy,2
7109,imrt (intensity modulated radiation therapy),2
7110,pancreatic duct stenting,2
7111,amatuximab,2
7112,monoclonal antibody ch14.18,2
7113,rf ablation,2
7114,vargatef,2
7115,e7050 plus lenvatinib,2
7116,kypho-iort,2
7117,conventional colonoscopy,2
7118,icp-022,2
7119,network analyzer,2
7120,pheresis,2
7121,immu-130,2
7122,bay94-9343,2
7123,omega-3-acid ethyl esters,2
7124,crizotinib plus sunitinib,2
7125,concurrent chemoradiation therapy,2
7126,cryopen,2
7127,human intravital microscopy,2
7128,clinical assessment,2
7129,axillary reverse mapping,2
7130,folfiri + bevacizumab,2
7131,glutaminase inhibitor cb-839,2
7132,msc1936369b (pimasertib),2
7133,imrt combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy,2
7134,standard lymphadenectomy,2
7135,val-083 (dianhydrogalactitol),2
7136,short-term fasting,2
7137,renal biopsy,2
7138,mri guided needles to deliver hdr brachytherapy,2
7139,istodax,2
7140,emibetuzumab,2
7141,lometrexol,2
7142,alitretinoin,2
7143,computed tomography (ct) scan,2
7144,imadetect,2
7145,thermography imaging,2
7146,px-12,2
7147,yttrium y 90 microspheres (therasphere®),2
7148,ingenol mebutate (reference),2
7149,radiation: see intervention description,2
7150,dendritic cells vaccine,2
7151,vitespen,2
7152,optison,2
7153,xiaflex,2
7154,psa dosage,2
7155,dc-pmat,2
7156,iacs-010759,2
7157,no treatment is included in this protocol.,2
7158,ivm,2
7159,vitamins,2
7160,online questionnaire,2
7161,cdc7-inhibitor (bms-863233),2
7162,rapid on-site evaluation,2
7163,plx2853,2
7164,bibf 1120 + pld 30 mg/m2 + cbdca auc5 mg/ml*min,2
7165,dronabinol,2
7166,clinical exam,2
7167,cmvpp65-a*0201 peptide vaccine,2
7168,cyt997,2
7169,capecitabine and cetuximab,2
7170,a-007,2
7171,ropidoxuridine,2
7172,smoking,2
7173,vemurafenib plus cobimetinib,2
7174,pelvic rt,2
7175,gemcitabine (chemotherapy),2
7176,jasper,2
7177,hybrid apc,2
7178,rose,2
7179,control (placebo) group,2
7180,azacitidine injection,2
7181,18f-flt-pet imaging,2
7182,lipo-dox,2
7183,dsm,2
7184,mri-guided biopsy,2
7185,maria scan,2
7186,oblimersen (genasense),2
7187,gsk690693,2
7188,cmd-003,2
7189,influenza vaccination,2
7190,4d ct scans,2
7191,wide local excision,2
7192,tumor cell derivative vaccine,2
7193,prayer,2
7194,trastuzumab sc,2
7195,treatment of physician's choice,2
7196,18f-fluciclatide,2
7197,ly2495655,2
7198,esk981,2
7199,hu14.18k322a,2
7200,tlr4 agonist gla-se,2
7201,isosulfan blue dye,2
7202,bi 695500,2
7203,radiotherapy - patients not needing eni,2
7204,intra-arterial mannitol,2
7205,gastric surgery,2
7206,e75 + gm-csf vaccine,2
7207,debio 1143,2
7208,ilorasertib,2
7209,motivational enhancement therapy,2
7210,flexible 19g ebus-tbna needle,2
7211,rehabilitation education,2
7212,global fibroid ablation (gfa),2
7213,tumor antigen loaded autologous dendritic cells,2
7214,imaging study,2
7215,vs-6063,2
7216,stress management group 1,2
7217,18f-fdg pet scan,2
7218,"mfolfox6 (oxaliplatin, calcium folinate, and 5-fu)",2
7219,printed materials,2
7220,dt2219arl,2
7221,fdg pet/ct,2
7222,cx-4945,2
7223,"hm95573, cobimetinib",2
7224,bez235 + paclitaxel,2
7225,magnetic resonance image,2
7226,3d conformal radiation therapy,2
7227,dce-mri scan,2
7228,av-299,2
7229,netest,2
7230,ridaforolimus + dalotuzumab,2
7231,relatlimab + nivolumab,2
7232,medi6469,2
7233,polyvalent melanoma vaccine,2
7234,al3818,2
7235,ponatinib 15 mg,2
7236,oral gentamycin,2
7237,pet imaging with cuatsm,2
7238,c-rex ring-locking procedure,2
7239,90y ibritumomab tiuxetan,2
7240,restorex,2
7241,?-elemene,2
7242,paclitaxel / gemcitabine,2
7243,taurolidine,2
7244,ginakit cells,2
7245,ds-8273a,2
7246,no drug,2
7247,karyotyping,2
7248,oxaliplatin (eloxatin),2
7249,crs,2
7250,spinal analgesia,2
7251,gp209-2m antigen,2
7252,induction routine-chemotherapy,2
7253,autologous hematopoietic stem cell transplantation (auto-hsct),2
7254,ttac-0001 and pembrolizumab combination,2
7255,medical nutrition therapy,2
7256,rolapitant,2
7257,dyspnea management,2
7258,68ga-dotatate pet/ct,2
7259,isa101b,2
7260,adenovirus-mediated human interleukin-12,2
7261,mindfulness based stress reduction,2
7262,osna breast cancer system,2
7263,selective neck dissection,2
7264,usual practice,2
7265,odanacatib,2
7266,biomarker research,2
7267,laparoscopic intersphincteric resection,2
7268,hc-1119,2
7269,duloxetine hydrochloride,2
7270,oncoxin®,2
7271,paclitaxel/ gemcitabine,2
7272,gentamicin,2
7273,ima950,2
7274,diane-35 pretreatment,2
7275,mouse gp100 plasmid dna vaccine,2
7276,photographs,2
7277,bcr-abl peptide vaccine,2
7278,svn53-67/m57-klh peptide vaccine,2
7279,hdac inhibitor ar-42,2
7280,financial incentive,2
7281,electroporation therapy,2
7282,conventional chemotherapy,2
7283,tp-0903,2
7284,jx-594 recombinant vaccina gm-csf,2
7285,oros hydromorphone hci (slow release),2
7286,docetaxel and carboplatin,2
7287,mgd009,2
7288,enzastaurin hcl,2
7289,hypertonic saline,2
7290,5-fluoro-2-deoxycytidine (fdcyd),2
7291,monoclonal antibody sgn-30,2
7292,tumor specimen collection,2
7293,imaging biomarkers,2
7294,peg-asc,2
7295,synergo® rite + mmc,2
7296,theliatinib,2
7297,rx-3117,2
7298,glumetinib for tablet,2
7299,paclitaxel/doxorubicin/cyclophosphamide,2
7300,surgical wound infiltration,2
7301,soy supplement,2
7302,z-100,2
7303,tocladesine,2
7304,ags67e,2
7305,smartphone or tablet,2
7306,glycopyrrolate,2
7307,vay736,2
7308,blex 404 oral liquid,2
7309,technetium99,2
7310,swedish massage therapy,2
7311,craniospinal irradiation,2
7312,technetium (99mtc) sestamibi,2
7313,18f-fluciclovine,2
7314,mabthera®,2
7315,correlative/special studies,2
7316,apo010,2
7317,stenting,2
7318,mammaprint,2
7319,follow-up phone call,2
7320,comprehensive geriatric assessment (cga),2
7321,"nilotinib, imatinib",2
7322,4-cm margin,2
7323,eortc qlq-c30 questionnaire,2
7324,co-signed letter,2
7325,recombinant interleukin-3,2
7326,cc-90011,2
7327,observational cohort,2
7328,arsenic trioxide (ato),2
7329,pro131921,2
7330,gsk3174998,2
7331,placebo for ipilimumab,2
7332,muc-1 peptide vaccine,2
7333,"paclitaxel, bevacizumab, liposomal doxorubicin, capecitabine",2
7334,ose2101,2
7335,gliadel,2
7336,standard diet (sd),2
7337,autologous cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes,2
7338,linagliptin,2
7339,family history questionnaire,2
7340,fresh tissue biopsy,2
7341,vs-4718,2
7342,dara sc,2
7343,oxaliplatin-based chemotherapy,2
7344,mesalazine,2
7345,bay59-8862 (cytotoxic taxane),2
7346,"carfilzomib, lenalidomide plus dexamethasone",2
7347,ad-magea3,2
7348,sea-bcma,2
7349,educational information,2
7350,ascites collection,2
7351,propranolol and etodolac,2
7352,biological sample collection,2
7353,tp-38,2
7354,ly2127399,2
7355,applanation tonometry,2
7356,virtual chromoendoscopy,2
7357,respiratory gated proton beam radiotherapy,2
7358,auto-hsct,2
7359,ctap101 capsules,2
7360,fac,2
7361,filgrastim-sd/01,2
7362,e7777,2
7363,chloroquinoxaline sulfonamide,2
7364,morphine analgesia,2
7365,sulforadex,2
7366,phone counseling with dietitian,2
7367,oxygen therapy,2
7368,genetic snp profiling,2
7369,9-valent hpv vaccine,2
7370,chemotherapy: r-chop,2
7371,conventional neck dissection,2
7372,peep,2
7373,candesartan,2
7374,cytology specimen,2
7375,open,2
7376,tissue specimen,2
7377,colony-stimulating factor therapy,2
7378,active symptom control,2
7379,177lu-pp-f11n,2
7380,targeted muscle reinnervation,2
7381,tezacitabine,2
7382,laparoscopic ovarian diathermy (lod),2
7383,breast-q questionnaire,2
7384,sancuso,2
7385,metformin plus placebo,2
7386,prophylactic irradiation of the para-aortic lymph nodes and supraclavicular lymph nodes in locally advanced uterine cervical cancer,2
7387,amantadine,2
7388,pcle,2
7389,anti-macrophage migration inhibitory factor (anti-mif) antibody,2
7390,personalized health care service,2
7391,"hpc,a infusion",2
7392,yttrium y 90 monoclonal antibody lym-1,2
7393,placebo + placebo add-back,2
7394,docetaxel-pnp,2
7395,g-eye™ colonoscopy,2
7396,menatetrenone,2
7397,wait-list control,2
7398,"oxaliplatin, 5-fluorouracil",2
7399,montanide adjuvant,2
7400,comparator: gardasil,2
7401,air method,2
7402,sunitinib (su011248),2
7403,pexa-vec,2
7404,belinostat iv,2
7405,oral microencapsulated diindolylmethane,2
7406,progressive stretching,2
7407,primary surgery,2
7408,aiddly (web site),2
7409,cep-701,2
7410,therasphere®,2
7411,cpi-006,2
7412,walking intervention,2
7413,plenaxis,2
7414,mbu/cy and atg,2
7415,immunomagnetic detection,2
7416,"bicalutamide 50 mg film-coated tablets (casodex) (astrazeneca pharmaceutical lp, usa)",2
7417,conventional mammography,2
7418,standard of care therapy,2
7419,tissue analysis,2
7420,rsifn-co,2
7421,plerixafor (mozobil),2
7422,abbv-368,2
7423,video-assisted thoracoscopic surgery,2
7424,cm082 plus js001,2
7425,nurse,2
7426,standard arm,2
7427,cpt-11 (irinotecan),2
7428,icotinib of routine dose,2
7429,"thymalfasin (thymosin alpha 1, ta1)",2
7430,axillary reverse mapping (arm),2
7431,hm95573,2
7432,carmustine in ethanol,2
7433,cellvizio,2
7434,plb1001,2
7435,nbi function,2
7436,magnevist (sh l 451a),2
7437,peer counseling,2
7438,transarterial embolization,2
7439,"l-778,123",2
7440,imatinib discontinuation,2
7441,videos,2
7442,nbm-bmx softgel capsules,2
7443,autologous tcm cells immunotherapy,2
7444,gsk3359609,2
7445,troxatyl™ (cytotoxic chemotherapeutic),2
7446,tarceva (osi-774),2
7447,amolimogene,2
7448,relaxation program,2
7449,pinpoint,2
7450,"cisplatin, gemcitabine",2
7451,cell culture procedure,2
7452,repetitive transcranial magnetic stimulation,2
7453,3d ultrasound,2
7454,campath purged non-myeloablative asct,2
7455,lodac (low dose cytarabine),2
7456,mechanical bowel preparation,2
7457,partner-assisted coping skills training,2
7458,standard tme surgery,2
7459,microdialysis,2
7460,pep503,2
7461,ace-536,2
7462,placebo iv infusion,2
7463,cognitive training,2
7464,flexhd,2
7465,granisetron transdermal system,2
7466,clinicmacs,2
7467,talimogene laherparepvec (tvec),2
7468,nerve stimulation,2
7469,epidoxorubicin,2
7470,eligard,2
7471,ricolinostat,2
7472,personalized peptide vaccine,2
7473,consolidation chemotherapy,2
7474,ots167iv,2
7475,prasterone,2
7476,panzem® ncd,2
7477,iodine i 131 monoclonal antibody tnt-1/b,2
7478,trastuzumab plus pertuzumab,2
7479,dipeptide alanyl-glutamine,2
7480,cs3006,2
7481,5-fluorouracil-based chemotherapy,2
7482,fluorodopa f 18,2
7483,pd-103,2
7484,photodynamic therapy with metvix 160 mg/g cream,2
7485,paclitaxel-loaded polymeric micelle,2
7486,xtandi,2
7487,ibl 20 mw,2
7488,ad5-ycd/muttksr39rep-adp,2
7489,sentinel lymph node procedure,2
7490,niacinamide,2
7491,toripalimab injection(js001 ),2
7492,high dose radiotherapy,2
7493,cdki at7519,2
7494,docetaxel-pm,2
7495,cranial radiotherapy,2
7496,standard oncologic care,2
7497,grn1005,2
7498,lfa102,2
7499,paclitaxel + carboplatine,2
7500,placement of drug delivery system,2
7501,plastic stent,2
7502,mindfulness based meditation program,2
7503,high dose radiation,2
7504,philips mr-guided hifu system,2
7505,nov-002,2
7506,adjuvant rt,2
7507,the intravenous patient-controlled analgesia,2
7508,fluorouracil implants,2
7509,celiac plexus neurolysis,2
7510,radical retropubic prostatectomy,2
7511,dendritic cell/tumor fusion vaccine,2
7512,chitosan,2
7513,concurrent chemoradiation therapy (ccrt),2
7514,health talk and adventure-based training,2
7515,marqibo® (vincristine sulfate liposomes injection),2
7516,cc,2
7517,calorie restriction,2
7518,pixantrone (bbr 2778),2
7519,indocyanine green angiography,2
7520,i-scan 2,2
7521,covidien radial reload stapler with tri-staple technology,2
7522,cobomarsen,2
7523,adenovirus-transfected autologous dc vaccine plus cik cells,2
7524,platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen),2
7525,tyrosine kinase inhibitors,2
7526,vehicle foam,2
7527,health questionnaire,2
7528,normothermia,2
7529,family focused group therapy,2
7530,pcv 13,2
7531,neurocognitive tests,2
7532,levocarnitine,2
7533,bgb-283,2
7534,ground flaxseed,2
7535,inactivated influenza vaccine,2
7536,"zevalin (sh l 749 , bay86-5128)",2
7537,allogeneic hematopoietic stem cell transplant (hsct),2
7538,ephedrine,2
7539,gwp42003-p,2
7540,rice,2
7541,decipher prostate cancer classifier,2
7542,ly2780301,2
7543,total marrow and lymphoid irradiation,2
7544,floseal application,2
7545,olfactory measuring device,2
7546,mcla-128,2
7547,tas-106,2
7548,metronomic temozolomide,2
7549,bay86-4367,2
7550,invitation to screening,2
7551,forodesine,2
7552,gsk2849330,2
7553,mb-6,2
7554,haldol,2
7555,nab-paclitaxel (abraxane),2
7556,optical fluoroscopy,2
7557,hepatic surgery of resection,2
7558,acetylcarnitine,2
7559,granulocyte macrophage colony stimulating factor (gm-csf),2
7560,tavokinogene telseplasmid,2
7561,spi-1620 & docetaxel,2
7562,cisplatin + gemcitabine,2
7563,supervised progressive resistance training,2
7564,kw-2449,2
7565,mirabegron,2
7566,tumor cell vaccine,2
7567,multi-peptide cmv-modified vaccinia ankara vaccine,2
7568,chromogenic in situ hybridization,2
7569,leukovorin,2
7570,aurolase therapy,2
7571,adg106,2
7572,inalimarev,2
7573,propanolol,2
7574,cnf2024,2
7575,ciml nk cell infusion,2
7576,fentanyl transdermal therapeutic system (tts),2
7577,electroencephalography (eeg),2
7578,docetaxel 75 mg/m^2,2
7579,exjade,2
7580,yttrium-90 loaded sir-spheres microspheres,2
7581,multitaa-specific t cells,2
7582,granulocyte colony-stimulating factor plus plerixafor,2
7583,calcium and cholecalciferol,2
7584,e7046,2
7585,spect-ct,2
7586,treatment choice,2
7587,fdg pet/ct imaging,2
7588,"docetaxel, cyclophosphamide",2
7589,beclomethasone dipropionate,2
7590,manual anastomosis,2
7591,placebo for elagolix,2
7592,irinotecan + e7070 combination,2
7593,dirucotide,2
7594,"bicalutamide 50 mg film-coated tablets (sandoz inc., usa)",2
7595,"docetaxel,cisplatin,fluorouracil",2
7596,all trans retinoic acid,2
7597,5-fu infusion,2
7598,mln2704 (dm1 conjugated monoclonal antibody mln591),2
7599,placebo granules,2
7600,pet (positron emission tomography),2
7601,interstitial light emitting diodes,2
7602,cvp,2
7603,androgel,2
7604,biological test,2
7605,colonoscopy with sedation,2
7606,68ga-psma-617 pet/ct,2
7607,autologous pbsc transplant,2
7608,pembrolizumab 25 mg/1 ml intravenous solution [keytruda],2
7609,asn-002,2
7610,androgen suppression,2
7611,radiotherapy followed by chemotherapy,2
7612,gold sodium thiomalate,2
7613,lenalidomide.,2
7614,transnasal endoscopy,2
7615,icg intervention,2
7616,semustine,2
7617,ro6874813,2
7618,tak-931,2
7619,111in-dac,2
7620,"18f-(2s,4r)4-fluoroglutamine",2
7621,mek inhibitor mek162,2
7622,dcr-myc,2
7623,pet/mri imaging,2
7624,methionine-restricted diet,2
7625,passive sitting group,2
7626,krn1493,2
7627,124i-labeled monoclonal antibody mu 11-1f4,2
7628,methylation markers screening,2
7629,radioactive iodine,2
7630,humanized anti-gd2 antibody,2
7631,sar408701,2
7632,resection of oral cancer,2
7633,"bevacizumab, mfolfox, folfiri",2
7634,bioelectrical impedance analysis,2
7635,glide,2
7636,diagnostic intervention: positron emission tomography with 16-alpha-[18-fluoro]-17betaestradiol,2
7637,reconstructive surgery,2
7638,ly573636,2
7639,18f-fhbg,2
7640,gen-1,2
7641,"probiotics (la1, bb536)",2
7642,wb-mri,2
7643,incb052793,2
7644,donafenib tosilate tablets,2
7645,haic,2
7646,guided therapy,2
7647,jnj-56021927,2
7648,yangyinfang,2
7649,sham-ripc,2
7650,photos,2
7651,satoreotide tetraxetan,2
7652,dta-h19,2
7653,none (observational study),2
7654,boost irradiation,2
7655,ipilimumab 1 mg/kg,2
7656,hai,2
7657,neoadjuvant chemotherapy (carboplatin/docetaxel),2
7658,guselkumab,2
7659,research cardiac mri,2
7660,velban,2
7661,xerecept,2
7662,para-toluenesulfonamide,2
7663,autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes,2
7664,eus-guided celiac plexus neurolysis,2
7665,conventional wound closure,2
7666,"tegafur, gimeracil and oteracil potassium capsules?oxaliplatin",2
7667,nurse coaching,2
7668,mr-guided in-bore prostate biopsy,2
7669,bio-specimen collection,2
7670,intravenous immunoglobulin,2
7671,high dose cytarabine,2
7672,sylatron,2
7673,pharmacological studies,2
7674,etarfolatide,2
7675,tct?hpv?colposcopic inspection,2
7676,mk2461,2
7677,scibase iii electrical impedance spectrometer,2
7678,marcaine,2
7679,weight loss program,2
7680,sonovue®,2
7681,estring,2
7682,positron emission tomography (pet) scan,2
7683,saccharomyces boulardii,2
7684,lintuzumab-ac225,2
7685,exercise rehabilitation,2
7686,gemcitabine 1000 mg/m2,2
7687,iohexol,2
7688,t790m+ testing,2
7689,erlotinib hcl (osi-774),2
7690,neuropsychological evaluation,2
7691,phone counseling,2
7692,tnfr:fc,2
7693,azathioprine,2
7694,bpi-7711,2
7695,e2/neta placebo,2
7696,walk with ease program,2
7697,carcinoembryonic antigen-expressing measles virus,2
7698,raltegravir,2
7699,uterine fibroid embolization,2
7700,mst-997,2
7701,thoracic ultrasound,2
7702,"targeted agents indicated in management of advanced/metastatic rcc (sunitinib, sorafenib, bevacizumab, and pazopanib)",2
7703,carboplatin periocular injection,2
7704,av-412,2
7705,x-396 capsule,2
7706,autologous dendritic cell,2
7707,ambulatory surgery,2
7708,amg 176,2
7709,in-person counseling,2
7710,oncoxin-viusid®,2
7711,"fentanyl (nasalfent, fentanyl citrate nasal spray)",2
7712,itmha,2
7713,perjeta,2
7714,4-demethyl-4-cholesteryloxycarbonylpenclomedine,2
7715,pumvc3-higfbp-2 multi-epitope plasmid dna vaccine,2
7716,ym598,2
7717,sar439859,2
7718,l-nmma,2
7719,neulastim,2
7720,ulinastatin,2
7721,ps-341 (bortezomib),2
7722,bli850,2
7723,"kras, nras et braf mutation analysis from circulating plasma dna",2
7724,placebo metformin,2
7725,antithymocyte globulin (rabbit),2
7726,chr-2797 (tosedostat),2
7727,high-dose methotrexate,2
7728,levulan,2
7729,bisphosphonates,2
7730,drug delivery system for administration of ap 12009,2
7731,air colonoscopy,2
7732,proleukin,2
7733,clag-m,2
7734,colon polypectomy,2
7735,umbilical cord blood-derived lymphocyte therapy,2
7736,medi-port,2
7737,laparoscopic surgery(ls),2
7738,skin biopsies,2
7739,continuum™,2
7740,electrosensing antibody probing system (e- ab sensor),2
7741,3 tesla scanning,2
7742,imc-cs4,2
7743,cebranopadol,2
7744,ropivacaine hydrochloride,2
7745,f-18 (bay85-8050),2
7746,alprostadil,2
7747,taladegib,2
7748,pembrolizumab 10 mg/kg,2
7749,antibiotic,2
7750,letrozole 2.5 mg,2
7751,portal vein embolization,2
7752,abx464 100mg,2
7753,light microscopy,2
7754,tumoral specific genetic alterations,2
7755,methylselenocysteine,2
7756,imgn901,2
7757,131 i-metaiodobenzylguanidine (131 i-mibg),2
7758,biomarker,2
7759,argx-110,2
7760,r-da-epoch-21 + auto-sct,2
7761,blood-oxygen-level-dependent functional magnetic resonance imaging,2
7762,comparator: menactra™ (non-concomitant),2
7763,haic of oxa,2
7764,rp6530,2
7765,hm30181ak tablet + irinotecan tablets,2
7766,scio-469 and bortezomib,2
7767,mk-8242,2
7768,guided imagery,2
7769,pet imaging with cu-64 labeled trastuzumab,2
7770,gene-modified tumor cell vaccine therapy,2
7771,carboplatin/paclitaxel/medi-575,2
7772,a multi-omics analysis,2
7773,sym023,2
7774,psychological support,2
7775,huj591,2
7776,calaspargase pegol,2
7777,as703569/gemcitabine,2
7778,involved field irradiation,2
7779,tislelizumab (bgb-a317),2
7780,phenoxybenzamine,2
7781,"9 peptides from her-2/neu, cea, & cta",2
7782,dosage of paclitaxel,2
7783,l-dos47,2
7784,npc-12g gel,2
7785,placebo hcrf,2
7786,doxepin hydrochloride,2
7787,68ga-bbn-irdye800cw,2
7788,carbon monoxide test,2
7789,ucart123,2
7790,standard counseling,2
7791,nktr-118,2
7792,amoxicillin-clavulanate potassium,2
7793,white button mushroom extract,2
7794,distress thermometer,2
7795,histological biopsy procedure,2
7796,oral nutritional supplement,2
7797,acetogenins,2
7798,2b3-101,2
7799,chemosensitization/potentiation therapy,2
7800,patupilone/epo906,2
7801,brivanib placebo,2
7802,mitoguazone,2
7803,som 230 / pasireotide,2
7804,carbogen,2
7805,robot,2
7806,"histone deacetylase inhibitor, ms-275 (bay 86-5274, zk 244894)",2
7807,68ga-psma-hbed-cc,2
7808,iset® - isolation by size of tumor cells,2
7809,beneforte extra broccoli soup,2
7810,sbp-101,2
7811,medical data collection,2
7812,gsk3377794,2
7813,visualase thermal therapy system,2
7814,mpc-6827,2
7815,telepristone acetate 12 mg,2
7816,"busulfan, etoposide, cytarabine, and melphalan",2
7817,aeg35156 antisense iv infusion,2
7818,cbt-i,2
7819,mammography and ultrasound,2
7820,group 3,2
7821,gdc-0919,2
7822,lmp1/2 ctls (group b),2
7823,microablative fractional co2 laser therapy,2
7824,ly2784544,2
7825,erwinia l-asparaginase,2
7826,bay1436032,2
7827,carbon-11 acetate,2
7828,raltitrexed-based chemotherapy,2
7829,doxazosin,2
7830,smart external drain - sed,2
7831,no meditation,2
7832,anti-cd19-car vector-transduced t cells,2
7833,tocopherol,2
7834,wnt974,2
7835,abdominal ultrasound,2
7836,ibl 10 mw,2
7837,8-chloro-adenosine,2
7838,standard endoscopy,2
7839,gsk1795091,2
7840,hypofraction,2
7841,dasatinib (sprycel),2
7842,best supportive care (maintenance),2
7843,video intervention,2
7844,pedsql multidimensional fatigue scale,2
7845,prohance,2
7846,debio 0932,2
7847,compare different self-obtained specimen for hpv identification,2
7848,calciumfolinat,2
7849,silver nitrate,2
7850,t cell-depleted donor lymphocyte infusion,2
7851,intravenous recombinant human mannose binding lectin,2
7852,axillary surgery,2
7853,2-cm margin,2
7854,weight loss counseling,2
7855,endomicroscopy,2
7856,intercostal uniportal vats,2
7857,neomycin,2
7858,18f-fdg pet/ ct,2
7859,definitive radiotherapy,2
7860,squalamine lactate,2
7861,compound ac220,2
7862,amorphous calcium carbonate,2
7863,ctt1057,2
7864,capeox,2
7865,mk - 3475,2
7866,mbu/cy,2
7867,3 doses of hpv 16/18 bivalent vaccine,2
7868,ly2181308,2
7869,tnferade,2
7870,"leo 43204 gel, 0.037%",2
7871,upper endoscopy,2
7872,hormonotherapy,2
7873,hd colon,2
7874,triple tourniquet,2
7875,autologous-allogeneic tandem hematopoietic stem cell transplantation,2
7876,standard adjuvant endocrine therapy,2
7877,ct simulation,2
7878,liposomal t4n5 lotion,2
7879,adi peg20,2
7880,educational program,2
7881,3d,2
7882,decitabine injection,2
7883,proxinium,2
7884,thoracic surgical procedure,2
7885,tbo-filgrastim,2
7886,sativex®,2
7887,sennosides colonic preparation,2
7888,bc-819/pei,2
7889,barium enema injection,2
7890,prostate histoscanning,2
7891,2-cda,2
7892,sgi-1776,2
7893,ifa,2
7894,v930,2
7895,structured exercise training plus mediterranean diet,2
7896,at9283,2
7897,ima_detect,2
7898,intralipid,2
7899,free breathing,2
7900,ds-1205c,2
7901,igrt 45 gy in 5 fractions of 9 gy,2
7902,bsi-201 (iniparib),2
7903,ice-sense3tm,2
7904,bay2287411,2
7905,genome sequencing,2
7906,"imatinib mesylate tablets, 400 mg",2
7907,cik cells,2
7908,opioid growth factor,2
7909,bibh 1,2
7910,photofrin,2
7911,xl844,2
7912,cervarix®,2
7913,tumour tissue collection,2
7914,"lapatinib, vinorelbine",2
7915,cytoreductive surgery (crs),2
7916,vincristina,2
7917,tqb2450,2
7918,jwcar029,2
7919,letrozole / temsirolimus (cci-779),2
7920,chemophase,2
7921,?? t/dc-cik cells,2
7922,cd45ra-depleted peripheral blood mononuclear cells,2
7923,breast tumor blocks,2
7924,68ga-dotatate pet scan,2
7925,uproleselan,2
7926,modulated electro-hyperthermia (meht),2
7927,omalizumab,2
7928,functional assessment of cancer therapy-general (fact-g),2
7929,camp discovery,2
7930,mfgr1877s,2
7931,whole-brain radiotherapy (wbrt),2
7932,procure,2
7933,leep,2
7934,bax69 + panitumumab,2
7935,ro6927005,2
7936,neoadjuvant chemotherapy before surgery,2
7937,pharyngocise,2
7938,99mtc sestamibi,2
7939,5-ala,2
7940,sk-1403,2
7941,indigo carmine,2
7942,recombinant viral vaccine therapy,2
7943,regn2810/chemo/ipi,2
7944,adv/hsv-tk (gene therapy),2
7945,zd4054 10 mg,2
7946,mrz,2
7947,hu3s193,2
7948,tea,2
7949,pill diary,2
7950,oxaliplatin+s-1,2
7951,pbs,2
7952,indium in 111 monoclonal antibody m170,2
7953,active monitoring,2
7954,memantine hydrochloride,2
7955,mindfulness based stress reduction (mbsr),2
7956,simultaneous integrated boost,2
7957,intrathecal cytarabine,2
7958,hdac inhibitor sb939,2
7959,"fludarabine, okt3, treosulfan, thiotepa",2
7960,cy-503,2
7961,cetuximab injection,2
7962,exercise behavior change,2
7963,intravenous chemotherapy,2
7964,electronic chest drainage system,2
7965,bay79-4620,2
7966,folotyn,2
7967,epic sf-12 questionnaire,2
7968,clinical data collection,2
7969,control video,2
7970,sta-5312,2
7971,placebo treatment,2
7972,immunopulse,2
7973,in-vivo imaging,2
7974,patients after esophagectomy,2
7975,pasireotide (som230),2
7976,cognitive behavioural therapy,2
7977,litebook,2
7978,111in-labeled dcs,2
7979,group meetings,2
7980,arm 1- dose escalation,2
7981,cisplatin liposomal,2
7982,intra-arterial cetuximab,2
7983,mindfulness based cognitive therapy,2
7984,dakin's solution,2
7985,voraxaze (glucarpidase),2
7986,cardiac magnetic resonance imaging,2
7987,ps-341 (velcade),2
7988,tc 99m tilmanocept,2
7989,administration of hyperbaric oxygen,2
7990,anlotinib combined docetaxel,2
7991,irosustat,2
7992,eicosapentaenoic acid (epa),2
7993,oral onc201,2
7994,dexmedetomidine group,2
7995,car-bcma t cells,2
7996,perifosine placebo,2
7997,18 f fluorodeoxyglucose,2
7998,completion lymphadenectomy,2
7999,m2es 30mg,2
8000,galiximab in combination with rituximab,2
8001,ku-0059436 (azd2281) (parp inhibitor),2
8002,gemcitabine+cisplatin,2
8003,rituximab sc,2
8004,pf-01367338,2
8005,perflutren protein-type a microspheres,2
8006,"docetaxel, cisplatin and 5-fluorouracil",2
8007,18f-fluoroazomycin arabinoside,2
8008,taxanes,2
8009,trans sodium crocetinate (tsc),2
8010,diagnostic endoscopic surgery,2
8011,im-slnb,2
8012,pbsct,2
8013,blood taking,2
8014,yttrium y 90 anti-cea monoclonal antibody ct84.66,2
8015,allogeneic myeloma vaccine,2
8016,nestle impact advanced recovery,2
8017,capivasertib,2
8018,68ga-nota-rm26,2
8019,shenlingcao oral liquid,2
8020,boron neutron capture therapy,2
8021,chinese herbal medicine,2
8022,fycompa,2
8023,nitroprusside,2
8024,perfosfamide,2
8025,hcrf,2
8026,ec-t,2
8027,conventional perioperative cares,2
8028,surgery followed by adjuvant chemotherapy,2
8029,89zr-trastuzumab,2
8030,endoscopic ultrasonography,2
8031,il-15,2
8032,gsk1363089,2
8033,inositol + folic acid,2
8034,conservative management,2
8035,colistimethate sodium,2
8036,actr087,2
8037,pet/ct dynamic scan,2
8038,alt-803 + pembrolizumab,2
8039,flt-pet/ct,2
8040,activated recombinant human factor vii,2
8041,nv1020,2
8042,lovaza®,2
8043,acetazolamide,2
8044,transperitoneal laparoscopic aortic lymphadenectomy,2
8045,chemotherapy regimen,2
8046,pyrimethamine,2
8047,tumor lysate vaccine,2
8048,melanoma helper peptide vaccine,2
8049,comprehensive health enhancement support system,2
8050,ibandronic acid,2
8051,tumor tissue biopsy,2
8052,high-intensity focused ultrasound,2
8053,extubation,2
8054,cervical cancer screening,2
8055,tas-114,2
8056,abdominal or laparoscopic myomectomy,2
8057,abt-700,2
8058,chrono-chemotherapy pump:melodie,2
8059,eovist,2
8060,amg 162,2
8061,cohort 4,2
8062,ro4987655,2
8063,acupuncture treatment,2
8064,telehealth,2
8065,stiper,2
8066,emd 1201081 + 5-fu + cisplatin + cetuximab,2
8067,orlistat,2
8068,ltt462,2
8069,core biopsy,2
8070,18f-fluorocholine pet/ct,2
8071,preventive intervention,2
8072,mac-321,2
8073,standard rt,2
8074,standard white light cystoscopy,2
8075,workbook/journal on coping with breast cancer,2
8076,pycnogenol,2
8077,liver resection plus thrombectomy,2
8078,sb-as02b adjuvant,2
8079,helicobacter pylori eradication,2
8080,interactive music therapy,2
8081,sodium acetate c11,2
8082,hs-10296,2
8083,elisa,2
8084,wait and watch,2
8085,social support,2
8086,robotic,2
8087,thermocoagulator,2
8088,nox-a12,2
8089,loop ileostomy,2
8090,samples collection,2
8091,ifn,2
8092,hpv self-sampling,2
8093,neurosurgery,2
8094,chemical exchange saturation transfer magnetic resonance imaging,2
8095,met-4,2
8096,gleevec (imatinib mesylate),2
8097,cryotherapy alone to left arm plus cryotherapy + imiquimod to right arm,2
8098,smoking cessation program,2
8099,abt-510 - thrombospondin-1 mimetic,2
8100,aq4n,2
8101,dexamethasone/prednisolone,2
8102,low-fat diet,2
8103,intravenous lidocaine,2
8104,temodar (temozolomide),2
8105,rad001(everolimus),2
8106,ro5045377,2
8107,low-level laser,2
8108,neuropsychological assessments,2
8109,alvac-hb7.1,2
8110,high-dose cytarabine,2
8111,isis 5132,2
8112,"gonal-f, fostimon",2
8113,chest tube,2
8114,injectafer,2
8115,ss1(dsfv)-pe38 immunotoxin,2
8116,thoracoscopic surgery,2
8117,ly3321367,2
8118,lyc-55716,2
8119,azd8835 in combination with fulvestrant,2
8120,etanidazole,2
8121,salvage therapy,2
8122,"vorinostat, bevacizumab, carboplatin, paclitaxel",2
8123,[18f] flt,2
8124,care as usual,2
8125,nicotinamide,2
8126,physician survey,2
8127,treatment c,2
8128,fdg positron emission tomography,2
8129,gd-eob-dtpa,2
8130,3dcrt/imrt,2
8131,mphosph1 and depdc1,2
8132,vilaprisan (bay1002670,2
8133,ft-2102,2
8134,epcam-targeted car-t cells,2
8135,insulin glargine,2
8136,no treatment given,2
8137,one injection of 68ga-nota-ae105,2
8138,"proflavine, high resolution imaging",2
8139,terameprocol,2
8140,"lenalidomide, bendamustine, rituximab",2
8141,ldr,2
8142,"il13r?2-specific, hinge-optimized, 41bb-costimulatory car/truncated cd19-expressing autologous t lymphocytes",2
8143,"sunitinib, pemetrexed",2
8144,teysuno,2
8145,high-dose il-2,2
8146,placebo for abt-869,2
8147,lmp1/2 ctls (group a),2
8148,debio 1347,2
8149,photoacoustic endoscopy,2
8150,sta-9090 (ganetespib),2
8151,tube feeding,2
8152,long term androgen deprivation,2
8153,steroids,2
8154,multispectral digital microscope,2
8155,automated breast ultrasound (abus),2
8156,pg545,2
8157,microscopy,2
8158,chemotherapy (cisplatin),2
8159,imf-001,2
8160,udenafil,2
8161,"folfiri (irinotecan, leucovorin, 5-fluorouracil [5fu])",2
8162,laparotomic radical hysterectomy,2
8163,six-minute walk test,2
8164,pm060184,2
8165,entolimod,2
8166,recombinant human interleukin-21,2
8167,gemcitabine hcl oral formulation,2
8168,smart phone application,2
8169,digital pet/ct scan,2
8170,cto,2
8171,gonadotrophin releasing hormone,2
8172,thoracic radiation therapy (trt),2
8173,mln8054,2
8174,celecoxib 400 mg bid,2
8175,alpha-interferon,2
8176,community garden intervention,2
8177,"ts-1, oxaliplatin",2
8178,atlcar.cd30 cells,2
8179,bemcentinib; pembrolizumab,2
8180,wt1 126-134 peptide,2
8181,thalidomide and megestrol acetate,2
8182,cytosponge,2
8183,bevacizumab and bortezomib,2
8184,sham laser,2
8185,volumetric arc therapy (vmat),2
8186,vitamin e placebo,2
8187,conventional i:e ratio,2
8188,fibrinogen (human) + thrombin (human) (tachosil),2
8189,tsr-022,2
8190,placebo azd9291 80 mg/40 mg,1
8191,"atuveciclib, bay1143572",1
8192,pre-operative radiotherapy followed by surgery then 2 cycles of atezolizumab.,1
8193,hr-c,1
8194,mirabilis system,1
8195,cosmos,1
8196,moxifloxacin hydrochloride 400mg tablet,1
8197,177lu-dotatate 18.5 gbq activity,1
8198,liberal red blood cell transfusion,1
8199,sham electrostimulator device,1
8200,levorphanol,1
8201,rnr inhibitor coh29,1
8202,blood-sample based diagnostic assay,1
8203,holmium-166-dotmp,1
8204,eftr with la,1
8205,kras-variant and microrna binding site mutation testing,1
8206,"institutional standard skin care ""excipial-hydrolotion""",1
8207,kpg-121 dose escalation + enzalutamide,1
8208,bone marrow sampling,1
8209,ensure plus®,1
8210,nivestim®,1
8211,placement of a central venous catheter,1
8212,therapeutic vaccine,1
8213,canakinumab (ain457),1
8214,induction ct+ crt group,1
8215,"paclitaxel, cisplatin, carboplatin",1
8216,folfifinox,1
8217,sequential surgery,1
8218,pembrolizumab at 14 days post,1
8219,fulvestrant 50mg solution for injection,1
8220,individualized dpm,1
8221,hti-1066 dose level 2,1
8222,online mindfulness meditation,1
8223,self-report questionnaires,1
8224,bortezomib plus clofarabine,1
8225,trametinib and dabrafenib,1
8226,research of comorbidities,1
8227,placebo laser acupuncture,1
8228,cm082 combined with everolimus,1
8229,"docetaxel, reolysin and prednisone",1
8230,telelap alf-x,1
8231,decisional regret14,1
8232,placebo text message,1
8233,l19tnf?,1
8234,fluciclatide injection - (ah111585 (f18)),1
8235,physical prophylaxis,1
8236,detect gene mutations of ctdna and ctrna,1
8237,chamomile dose c,1
8238,extracted capsules 13-cra,1
8239,chemotherapy and bevacizumab (ct-bev),1
8240,bosulif,1
8241,fentanyl buccal tablet,1
8242,alpharadin,1
8243,recombinant human follicle stimulating hormone,1
8244,retaspimycin hydrochloride (ipi-504),1
8245,pumvc3-igfbp2-her2-igf1r plasmid dna vaccine,1
8246,speech therapy education and evaluation,1
8247,cold compress,1
8248,biib021 and food,1
8249,raloxifene hydrochloride,1
8250,aquaphor,1
8251,wellness seminar series,1
8252,"idarubicin, etoposide, cytarbine, teniposide",1
8253,clofarabine (oral formulation),1
8254,polypectomy and ngs,1
8255,dietary intervention (red tomato juice),1
8256,ngs techniques,1
8257,radiofrequency ablation of pulmonary malignancies,1
8258,anti-ny eso-1 t-cell receptor pbl,1
8259,ebs group,1
8260,anti-pr1/hla-a2 monoclonal antibody hu8f4,1
8261,1 pomx capsule,1
8262,dendritic cell based p53 vaccine,1
8263,functional mri (dce-mri),1
8264,clinic-based human papillomavirus (hpv) dna screening,1
8265,radiotherapy ablation,1
8266,autosynvax™ vaccine,1
8267,total body weight,1
8268,sunscreen and text message reminders,1
8269,intensive chemotherapy and hematopoietic stem cell rescue,1
8270,etoposide; dexamethasone,1
8271,montanide + cpg-7909 / pf-3512676+melan-a analog peptide + ny-eso-1 analog peptide + mage10 peptide,1
8272,"sirolimus, cyclophosphamide, topotecan",1
8273,placebo matched to atacicept,1
8274,medi-551 maintenance,1
8275,neuvax™ vaccine,1
8276,bone marrow-sparing intensity-modulated radiotherapy,1
8277,local wound infiltration,1
8278,etoposide phosphate 100mg/m2,1
8279,no incentive,1
8280,venous thromboembolism,1
8281,kadcyla 160 mg injection,1
8282,group ad anti-pd + antidepressant,1
8283,scanning a/lci,1
8284,lep-etu,1
8285,r-mt followed by auto-hsct,1
8286,cyberknife boost,1
8287,oral biopsy,1
8288,theratope® vaccine,1
8289,dna analysis of pancreatic cyst fluid / buccal swab,1
8290,diphenylcyclopropenone (dpcp),1
8291,trans sternal approach,1
8292,alternative anti-cancer treatment,1
8293,delayed reconstruction,1
8294,combination therapy (s81694 + paclitaxel) phase i,1
8295,gentamicins,1
8296,cisplatin-navelbine-radiotherapy,1
8297,ablathermy focused ultrasound,1
8298,eprime,1
8299,quality of life sizing nomogram,1
8300,standardized care (intervention i),1
8301,rest / guided imagery,1
8302,sms reminder 1,1
8303,ipatasertib (tablet),1
8304,isolex system,1
8305,dental procedure,1
8306,radiation boost,1
8307,oral morphine,1
8308,dan vinchi robot endoscopy cooperated surgery,1
8309,bimatoprost ophthalmic solution,1
8310,hsct with non-tbi regimen,1
8311,gic-1002 460 mg (equimolar to gic-1001 500 mg),1
8312,no intervention (observational study),1
8313,roll,1
8314,no virtual reality helmet,1
8315,medi4736 in combination with nab-paclitaxel and gemcitabine,1
8316,hs-1000 recording,1
8317,organizational interview,1
8318,"""high touch"" implementation strategy",1
8319,levulan® kerastick®,1
8320,cam therapies,1
8321,fraxinus vbn system,1
8322,inferior mesenteric vein dissection,1
8323,accelarated radiotherapy schedule,1
8324,transverse coloplasty pouch (long limb),1
8325,carboplatin auc=5,1
8326,pn+lcnc,1
8327,dynamic contrast enhanced magnetic resonance imaging (dce-mri),1
8328,micrornas-155,1
8329,outpatient surgery for t1-n0 or t2-n0 cancers of the oral cavity or oropharynx with lymph node search,1
8330,urea cream,1
8331,shared decision making + video,1
8332,polaprezinc,1
8333,paclitaxel (genexol®),1
8334,balloon brachytherapy,1
8335,epidural anaesthesia,1
8336,erector spinae block,1
8337,egfr mutation status in patients,1
8338,gtx-758 125 mg,1
8339,soc tissue biopsy,1
8340,bp-c2,1
8341,zometa (zoledronic acid),1
8342,"docetaxel, carboplatin and trastuzumab",1
8343,grt-r902,1
8344,conventional photodynamic therapy,1
8345,"erlotinib, pemetrexed",1
8346,50% dextrose solution,1
8347,nanoparticle mri,1
8348,epirubicin (post-operative),1
8349,ct tap scan,1
8350,percutaneous ethanol instillation (pei),1
8351,ofatumumab (arzerra),1
8352,ticilimumab,1
8353,yttrium 90 ibritumomab tiuxetan ( zevalin ),1
8354,ritual training program,1
8355,vitamin d 3,1
8356,herpes simplex thymidine kinase,1
8357,dox 2 cycles - surgery - dox 2 cycles,1
8358,neuropsychological examination and quality of life measures,1
8359,functional mri (fmri) of the brain,1
8360,algosteril tm,1
8361,sentinel node detection,1
8362,incentive spirometer,1
8363,social cognition,1
8364,raltitrexed-cisplatin,1
8365,krn321,1
8366,only pulmonary metastasectomy,1
8367,laser speckle flowgraphy,1
8368,na17-a antigen,1
8369,no personalized dose redistribution,1
8370,ly2780301 + paclitaxel,1
8371,laying and management of the drain (strictly randomized arm with drainage),1
8372,fet pet/mri,1
8373,patient-centered discharge instructions: enhanced,1
8374,armodafinil 250 mg,1
8375,4d-ct pre-treatment scan,1
8376,stem cell injection,1
8377,olaparib treatment d,1
8378,sd-101(2),1
8379,endorings device,1
8380,cinacalcet 30 mg tablet,1
8381,physician behavior related to patient preference survey,1
8382,bls-ilb-e710c,1
8383,clinic-level reminder systems,1
8384,pegylated g-csf (pegfilgrastim),1
8385,supervised 1:1 exercise,1
8386,"tagitol v, lo so, readi-cat 2",1
8387,anti-bcma-car-transduced t cells,1
8388,nab-paclitaxel/rituximab-coated nanoparticle ar160,1
8389,metvix,1
8390,vegfr1-a24-1084 (sygvllwei),1
8391,femara,1
8392,pet with fdg,1
8393,"mycograb, docetaxel",1
8394,gw786034 (pazopanib),1
8395,khk7580 high dose,1
8396,induction treatment part 3,1
8397,compression,1
8398,neoadjuvant radiation,1
8399,study of cerebral blood flow,1
8400,18f fluciclovine pet,1
8401,q-122,1
8402,targeted prostate biopsy,1
8403,tser,1
8404,continuous 5 fluouracil infusion plus long-acting octreotide,1
8405,oral paracetamol,1
8406,cicaplast balm b5,1
8407,comfort default ad forms,1
8408,trans-venous embolization (tve),1
8409,epoch-rr,1
8410,thymoglobuline (anti-thymocyte globulin [rabbit]) - genzyme,1
8411,smartbx™ system.,1
8412,preoperative level,1
8413,conventional covered stent,1
8414,kx2-391 ointment,1
8415,automated prompts,1
8416,high dose lx1606 - day 43 (start),1
8417,anti-ctla4 (monoclonal antibody mdx-010),1
8418,minimally invasive group,1
8419,autologous car-t,1
8420,supervised and home based exercise,1
8421,radon and smoking isolated,1
8422,molecular testing for hpv,1
8423,intraoperative celiac plexus neurolysis,1
8424,lrt-tem,1
8425,autologous (auto) peripheral blood stem cell transplantation,1
8426,step up to prevention:belief,1
8427,oxycodone naloxone,1
8428,fecal immunochemical test,1
8429,crolibulin,1
8430,pegph20+nab-paclitaxel+gemcitabine,1
8431,a: mydc vaccination,1
8432,therapeutic exercise-physiotherapy,1
8433,dedicated and coordinated follow-up,1
8434,fluorescence spectroscopy guided surgery,1
8435,tezel method of breast volume measurement,1
8436,allogeneic tumor cell vaccine (k562),1
8437,phase 1: cytarabine,1
8438,vx-984,1
8439,pf-06840003,1
8440,symptom navi© program,1
8441,da vinci sp surgical system - robotic,1
8442,involved-site radiation therapy (isrt),1
8443,information collection,1
8444,placebo + surgery,1
8445,clinical trial fact sheet,1
8446,magnesium-rich mineral water (rozana),1
8447,functional mri imaging and tomotherapy,1
8448,extended release of octreotide,1
8449,consolidative radiotherapy,1
8450,olfactory screening,1
8451,triiodothyronine (t3),1
8452,temsirolimus 25mg and pegylated liposomal doxorubicin 25mg/m2,1
8453,doxazosin 4 mg daily plus celecoxib 200 mg every day (qd),1
8454,icosapent ethyl,1
8455,abiraterone acetate + prednisone + lhrh-therapy,1
8456,stapled anastomosis,1
8457,anti-angiogenesis,1
8458,ly2880070,1
8459,olaparib pill 300 mg,1
8460,bibw 2992 low dose,1
8461,mtp block group,1
8462,lymphocyte harvesting & reinfusion,1
8463,bibw2 component b,1
8464,"bevacizumab, rituximab",1
8465,r-choep 14 with 12x rituximab,1
8466,phase i,1
8467,dose-adjusted sk-1403,1
8468,11c topotecan,1
8469,antibiotics,1
8470,betaquik,1
8471,"vitamin c, e and zinc",1
8472,paclitaxel (chemotherapy),1
8473,fludeoxyglucose (18f)-iba,1
8474,ileostomy closure,1
8475,irradiation-60 gy,1
8476,active provider intervention,1
8477,fasted treatment: axl1717,1
8478,azd3965,1
8479,high frequency ultrasound examination,1
8480,"venous thromboembolic event, arterial thromboembolic event, bleeding events",1
8481,cardiac surgery,1
8482,iop injection,1
8483,brussel sprouts,1
8484,erlotinib /gefitinib,1
8485,radium bromatum pills,1
8486,breast cancer support group,1
8487,jnj-42756493: part 2,1
8488,sgrq,1
8489,multiple tip thermoablation,1
8490,topical dapsone 5% gel,1
8491,your money (financial empowerment),1
8492,mirtazapine 30 mg oral tablets,1
8493,abx464 25mg,1
8494,to clamp or release the catheter for 2 days before removal,1
8495,"achieva, philips medical systems (3t magnet)",1
8496,lymphaticovenous micro-anastomosis,1
8497,"optimal (i. ipth control: zemplar®,mimpara®; phosphorous control: renvela®, phoslo®, osvaren®, foznol®,maalox®; calcium control: calcium and vitamin d",1
8498,cd4 dli,1
8499,vitamin d3 400 unt oral capsule,1
8500,autologous et1402l1-cart cells,1
8501,structolipid,1
8502,multi-virus specific t cells,1
8503,rituximab for patients with b-cell malignancies,1
8504,cetuximab + gemcitabine + oxaliplatin,1
8505,"obatoclax mesylate, carboplatine and etoposide",1
8506,chlorhydrate de ropivacaine,1
8507,pico,1
8508,novaferon,1
8509,clearing agent,1
8510,drug: oxaliplatin,1
8511,anthra,1
8512,tetrahydrouridine (oral),1
8513,resection of liver metastasis,1
8514,spc2996,1
8515,"mri, ct or ultrasound was permitted if mri was contraindicated",1
8516,fdopa pet/ct,1
8517,positive psychology intervention,1
8518,"doxorubicin, 5-fu and cisplatin",1
8519,normal saline and 0.3% ofloxacin,1
8520,dinutuximab. immunotherapy,1
8521,fludarabine and busulfan plus/minus total body irradiation (low dose),1
8522,resistance exercise program,1
8523,bexxar (tositumomab),1
8524,biopsy normal area,1
8525,if mart-1,1
8526,"short video clip including the circumstance of operation theater, and surgeon's interview",1
8527,nanoknife ire system,1
8528,obtaining human tissue,1
8529,ire treatment,1
8530,tpi287,1
8531,tti-621 monotherapy,1
8532,chemotherapy - squamous cell histologies,1
8533,hem(a)+ technology,1
8534,tti-621 + radiation,1
8535,routine reduction of immunosuppressive drugs(cyclosporine),1
8536,taxotere® (100 mg/m2),1
8537,electronic cigarettes,1
8538,association of myosin vi with oestrogen receptor,1
8539,fluorescence-guided surgery,1
8540,carbon-11 labeled acetate,1
8541,nesp - novel erythropoiesis stimulating protein,1
8542,gtc frame,1
8543,temodar and o6-benzylguanine,1
8544,curative resection for colorectal cancer,1
8545,18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography,1
8546,cytarabine dosage,1
8547,"new software sequences, fiesta and vibrant-de and ideal",1
8548,ly3415244,1
8549,sens model,1
8550,telotristat etiprate tablets (250 mg),1
8551,magnetic resonance imaging or endorectal ultrasound,1
8552,clinical treatment,1
8553,imatinib mesylate plus gemcitabine,1
8554,inhalation of salbutamol (5 mg),1
8555,magnetic resonance imaging with positron emission tomography scanning,1
8556,scalp cooling system,1
8557,cyclosporine or tacrolimus,1
8558,dynamic susceptibility-weighted contrast-enhanced perfusion magnetic resonance imaging,1
8559,prostate radiotherapy,1
8560,prostate capsule sparing cystectomy,1
8561,18f fluoroazomycin arabinoside (faza),1
8562,"gefitinib, raltitrexed",1
8563,cisplatin-5fu-afatinib,1
8564,moderated support,1
8565,mmse,1
8566,endoscopic mucosectomy,1
8567,inggenol mebutate 0.015%,1
8568,peritoneal biopsies after complete macroscopic cytoreduction,1
8569,ic9.gd2.car.il-15 t-cells,1
8570,hypofractionated arm (1),1
8571,alvac(2) melanoma multi-antigen therapeutic vaccine,1
8572,phenytoin,1
8573,eto,1
8574,ad-ccl21-dc 3 x 07,1
8575,sb497115,1
8576,intraoperative fluid restriction,1
8577,docetaxel+lapatinib,1
8578,fibroscan,1
8579,mtx based chemotherapy,1
8580,conservative hysterectomy ii,1
8581,behavioral therapy,1
8582,control group (surgery alone),1
8583,pyrotinib combined with capecitabine,1
8584,allogeneic large multivalent immunogen breast cancer vaccine,1
8585,10 minute walk,1
8586,control group - observational,1
8587,"g3139, oblimersen sodium, bcl-2 antisense oligonucleotide",1
8588,uniportal sleeve lobectomy,1
8589,the euroqol5d questionnaires,1
8590,spectro-mri,1
8591,chlorpromazine,1
8592,b: cbdca and radiotherapy,1
8593,allogeneic donor derived lmp specific cytotoxic t-lymphocyte,1
8594,"carboplatin, etoposide & placebo",1
8595,sf-8,1
8596,acadesine,1
8597,delayed apa program,1
8598,tf2 - 68 ga-imp-288:,1
8599,modification in acquisition protocol,1
8600,intravenous arm,1
8601,fmri paradigms,1
8602,abaloparatide,1
8603,trastuzumab subcutaneous (sc),1
8604,gastroduodenostomy,1
8605,ams-800,1
8606,glizigen placebo,1
8607,panhematin,1
8608,sorafenib ramp-up regimen,1
8609,soy and selenium,1
8610,cryoprobe pleural biopsy first,1
8611,laparoscopic assisted resection of colorectal carcinoma,1
8612,sham acupuncture using park sham placebo acupuncture device,1
8613,hepatic arterial infusion(hai),1
8614,high-dose methotrexate (8 gm/m2; hd-mtx),1
8615,docetaxel - cisplatine - 5fu,1
8616,spies+wli assisted turb,1
8617,t2* cardiac and liver mri,1
8618,analysis of microrna expression,1
8619,muc1-peptide-dc-ctl,1
8620,high dose fr? vaccine,1
8621,carboplatin and / or taxol chemotherapy,1
8622,vildagliptin,1
8623,18f-fdg for patients with bladder cancer,1
8624,pelvic radiation capecitabine 5-fluorouracil,1
8625,zhongyaofufang,1
8626,spiral computed tomography,1
8627,22.3 mg/kg ?-tea,1
8628,capecitabine oral product,1
8629,subcutaneous drugs administration,1
8630,pre treatment recurrence score:26-100 letrozole + palbociclib,1
8631,supervised exercise in hospital,1
8632,peripherally located lung tumor,1
8633,tas-118 plus oxaliplatin,1
8634,ad-sig-hmuc-1/ecdcd40l vaccine,1
8635,tc99m sestamibi molecular breast imaging (mbi),1
8636,general health counseling coaching,1
8637,capecitabine - dose a,1
8638,tip,1
8639,osalmid,1
8640,doxorubicin in combination with palifosfamide-tris,1
8641,cd19cart,1
8642,curative therapy,1
8643,bystander-based autologous tumor cell vaccine,1
8644,ue,1
8645,nik-333(peretinoin),1
8646,eva system,1
8647,cx-2009,1
8648,total therapy ii,1
8649,rv-cea(6d)/tricom-rf-cea(6d)/tricom,1
8650,olaparib oral product,1
8651,attention training,1
8652,thoracal paravertebral block,1
8653,semi-controlled nutritional intervention with fish protein diet,1
8654,tc+blue dye,1
8655,sharkcore biopsy system,1
8656,aplidin (plitidepsin),1
8657,[18f] fluorocholine pet/ct,1
8658,a life review program,1
8659,retrocolic reconstruction,1
8660,non-invasive detection of cancer odor,1
8661,port wine stain birthmark,1
8662,dense cranial electroacupuncture stimulation,1
8663,"duration of treatment - during each treatment cycle, treatment is administered twice daily for 14 days, followed by 7 days of rest for a total of 10 cycles",1
8664,vitamin d3 4000 iu,1
8665,afirma gec,1
8666,"toxicity : time to progression, 1 and 2 years survival",1
8667,targeted group,1
8668,docetaxel every 3 weeks + prednisone,1
8669,as1404 (dmxaa),1
8670,durvalumab (medi 4736),1
8671,hpv analysis,1
8672,ocp,1
8673,mhealth intervention,1
8674,topical organogel with nitroglycerin,1
8675,alive,1
8676,survey study,1
8677,simultaneously integrated boost of intensity modulated radiation therapy (sib-imrt) by tomotherapy,1
8678,"1,25 (oh)2 d3",1
8679,"ofatumumab 100 mg, 1000 mg / vial",1
8680,laparoscopic narrow band imaging,1
8681,blue citrus,1
8682,99mtc-hmdp planar bone scintigraphy (bs),1
8683,pbi-shrna stmn1 lp,1
8684,treatment with apg101,1
8685,mouse tyrosinase,1
8686,egfr il12 cart,1
8687,albumin-bound paclitaxel plus nedaplatin,1
8688,empegfilrastim,1
8689,cohort 1 ctap101 capsules- 60µg,1
8690,wholistic turmeric capsules,1
8691,da vinci surgical system,1
8692,restrictive perioperative fluid management,1
8693,low dose selenized-yeast,1
8694,in-depth patient interviews,1
8695,"cisplatin or carboplatin,pemetrexed",1
8696,gene therapy product cyl-02 = plasmid dna pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes,1
8697,ifn-alpha with retinoic acid,1
8698,docetaxel (taxane),1
8699,thyroid hormone withdrawal,1
8700,ftbi,1
8701,aerobic training home-based,1
8702,moderate neuromuscular block using rocuronium and reversal with suggamadex,1
8703,ag013736,1
8704,ds-8273a + nivolumab,1
8705,temsirolimus + sorafenib,1
8706,transoral surgery of primary site,1
8707,lugol chromoendoscopy,1
8708,"phase 1, cohort 3",1
8709,paclitaxel plus trastuzumab,1
8710,caudal nerve block (cnb),1
8711,physical activity intervention (pai),1
8712,comprehensive smoking cessation intervention,1
8713,concurrent chemoradiotherapy with pul (cisplatin/tegafur plus uracil (uft)/leucovorin) every 2 weeks,1
8714,social media feed without indoor tanning,1
8715,leep (device),1
8716,"tab001, recombinant humanized anti-pd-1 monoclonal antibody",1
8717,prpd with proximal roux-en-y gastrojejunal anastomosis,1
8718,"dexamethasone, bortezomib, doxorubicin",1
8719,fludeoxyglucose f18,1
8720,cd19-car-t cells,1
8721,afatinib 40mg,1
8722,side-to-side stapled,1
8723,attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001,1
8724,milk,1
8725,gemcitabine plus nab-paclitaxel,1
8726,dynamic contrast enhanced ct scan,1
8727,carbon black suspension colonic tattoo injection,1
8728,cd40 ligand and il-2-expressing tumor cells vaccine,1
8729,usual care plus nci website,1
8730,nuclear matrix protein 22 urine sample kit,1
8731,traditional electrosurgery with scalpel,1
8732,endocrine therapy 2,1
8733,standard of care mmc mixed with water,1
8734,ultrasonic scissors (ethicon),1
8735,changchun marina,1
8736,2000 mg of jbm-tc4 per day,1
8737,pazopanib treatment,1
8738,stereotactic body radiation therapy (sbrt) (cohort b),1
8739,progress,1
8740,indinavir in association with vinblastina +/- bleomicina,1
8741,mek or pi3k inhibitor,1
8742,trimodal prehabilitation management,1
8743,nilotinib 150mg oral capsule [tasigna],1
8744,millimeter-wave holographic imaging,1
8745,bms-907351 (xl184),1
8746,coppebvcad vs beacopp vs abvd,1
8747,group 3: ustekinumab approximately 6 mg/kg,1
8748,prophylaxis of opportunistic infections and support treatment,1
8749,spect-ct sentinel node mapping,1
8750,bhq990,1
8751,automatic follow-up by genetic counseling staff,1
8752,gammaknifeicon®,1
8753,physiotherapy muscle strengthening,1
8754,combination chemotherapy (pemetrexed + cisplatin),1
8755,"paclitaxel, trastuzumab and mm-111",1
8756,genetic signature,1
8757,nowarta110,1
8758,endoscopic mucosal resection (emr),1
8759,sorafenib standard dose,1
8760,total marrow irradiation (tmi),1
8761,sel-110,1
8762,sabr boost therapy,1
8763,tretinoin and arsenic trioxide,1
8764,biomarker testings,1
8765,videoscopic ilioinguinal dissection,1
8766,"capecitabine, lapatinib",1
8767,online mindful meditation,1
8768,dasatinib and dacarbazine (dtic),1
8769,group 1: peripherally located tumors,1
8770,"ga-68-psma scan, and pet -ct f-18-fdg",1
8771,3 dimensional breast ultrasound,1
8772,therapeutic cytotoxic t lymphocytes,1
8773,md anderson symptom inventory (adolescent version),1
8774,caregiver website,1
8775,di indolylmethane (dim),1
8776,standard upper gi endoscopy,1
8777,vandetanib (sar390530),1
8778,drug-eluting beads (deb) with doxorubicin,1
8779,diagnostic tumor core biopsy,1
8780,chemotherapy and gi-4000,1
8781,cytokine induced killer cell,1
8782,ctap201 injection,1
8783,anti-flt-1 ribozyme,1
8784,methotrexate (arm with bortezomib),1
8785,nivolumab 3 mg/kg,1
8786,"adriamycin (doxorubicin), docetaxel, tamoxifen, cyclophosphamid",1
8787,lateral decubitus,1
8788,tnk (tenecteplase),1
8789,cc-5013 (revlimid™),1
8790,[18f]fes,1
8791,v503 (9-valent human papillomavirus [hpv] l1 virus-like particle [vlp] vaccine),1
8792,evolution® biliary stent - uncovered,1
8793,stopping the standard drug therpy,1
8794,adhibit adhesion prevention gel,1
8795,orectalip,1
8796,data collecting,1
8797,cis,1
8798,electromotive mitomycin,1
8799,expression type,1
8800,spmc 2,1
8801,ct-2103 (poly(l)glutamate-paclitaxel),1
8802,estrogen,1
8803,"platinum-containing salvage chemotherapy (eg, r-ice) followed by high dose therapy (eg, beam) and autologous stem cell transplant in responders.",1
8804,fourier transform infrared spectroscopy,1
8805,tak-701,1
8806,cpd-1061,1
8807,trabectedin + pld,1
8808,niacin,1
8809,irradiation + placebo,1
8810,arc endocuff vision,1
8811,ham + calcium,1
8812,vorinostat velcade dexamethasone,1
8813,ct thorax,1
8814,uncut roux en y gastrojejunostomy,1
8815,conventional care,1
8816,mailed invitation to pick up lab requisition and then kit,1
8817,duet trs,1
8818,quittxt study,1
8819,chest ct scan,1
8820,early salvage radiotherapy,1
8821,cocinar para su salud program,1
8822,biib022 with paclitaxel and carboplatin,1
8823,genuine acupuncture,1
8824,weekly nutritional counseling,1
8825,evaluation of the recurrence rate according to molecular analysis,1
8826,no ppi treatment,1
8827,cisplatin pemetrexed,1
8828,fluorouracil/folinic acid/irinotecan,1
8829,biological: dc activated cik combined with dc,1
8830,walking programme,1
8831,cabazitaxel with abiraterone acetate,1
8832,modified neck dissection,1
8833,oral clomiphene citrate,1
8834,traditional co2 insufflation colonoscopy,1
8835,abiraterone acetate plus degarelix,1
8836,nac sparing mastectomy,1
8837,cd137,1
8838,annexin a3 serum mesurement,1
8839,rituximab + gemcitabine,1
8840,drug (dutasteride) intervention first,1
8841,dermacell®,1
8842,sln biopsy + pln dissection,1
8843,breast cancer surgery decision aid,1
8844,chemotherapy + avelumab followed by avelumab + talazoparib,1
8845,episodic future thinking,1
8846,n acetylcysteine,1
8847,"gemox, cetuximab",1
8848,apvac2 vaccine plus poly-iclc and gm-csf,1
8849,inbrx-105 - pdl1x41bb antibody,1
8850,nab-paclitaxel + gsk1120212,1
8851,ofs + anastrozole,1
8852,phenotype/genotype assessment,1
8853,adaptive dose-painting-by-numbers,1
8854,optical tomography using near infrared diffused light assisted with ultrasound,1
8855,wbi 15 fractions,1
8856,daunorubicin (baml-16-001-s6),1
8857,fentanyl matrix,1
8858,observational cohort with plasma samples,1
8859,avena sativa skincare regimen,1
8860,cd19-specific chimeric antigen receptor,1
8861,technology based cognitive behavioral stress management,1
8862,oleogel-s10 100 mg/g,1
8863,surgery + wbrt,1
8864,hrme examination,1
8865,positioning,1
8866,answering questionnare in differents time of the treatment,1
8867,tumor and blood specimens,1
8868,isotope,1
8869,rif,1
8870,metvix and conventional pdt,1
8871,gw679769,1
8872,"paclitaxel, carboplatin and vorinostat",1
8873,clinimacs fractionation system (arm b),1
8874,pemetrexed - before protocol amendment,1
8875,paricalcitol injection,1
8876,amino acid based medical food/drink,1
8877,t-cell depleted peripheral blood stem cell transplant,1
8878,c-scan system,1
8879,anlotinib + ap/pc,1
8880,nilotinib (tasigna ®) and pegylated interferon alfa 2a (pegasys®),1
8881,pd-1-pik,1
8882,biopsy (optional),1
8883,high psa levels,1
8884,"conbercept, prn",1
8885,mva-muc1-il2 vaccine,1
8886,aspirin 325mg,1
8887,indium in 111-dota-biotin,1
8888,gemcitabine+lobaplatin,1
8889,fractionated radiation,1
8890,patient satisfaction scores,1
8891,water-enema computed tomography,1
8892,ef5 hypoxia,1
8893,interferon-alfa 9mu,1
8894,automatic polyp detection software,1
8895,dacarbazine plus genasense,1
8896,expanded prostate cancer index composite short form 12,1
8897,group control,1
8898,ino-1001,1
8899,bibf 1120 h + docetaxel m,1
8900,chemotherapy-rituximab combination,1
8901,im-tmi (3gy),1
8902,induction cycles,1
8903,panc 10.05 pcdna-1/gm-neo and panc 6.03 pcdna-1 neo vaccine.,1
8904,high resolution mri (hrmri),1
8905,palonosetron - single dose,1
8906,e7389 (eribulin mesylate),1
8907,l9-nc,1
8908,pet/ct and eus,1
8909,group delivered low intensity cognitive behavioural therapy,1
8910,endocrine assessment,1
8911,cohort 3 anti-ox40,1
8912,subventricular zone radiation,1
8913,project onward website + 8 person social network,1
8914,physical tasks,1
8915,erbium-yag laser vaporization,1
8916,fedratinib,1
8917,hygieacare prep,1
8918,cg0070 adenovirus vector,1
8919,anti-influenza vaccine,1
8920,prophylactic postoperative radiation therapy,1
8921,globulina antilinfocitaria,1
8922,hot instant coffee,1
8923,kupperman scale,1
8924,galectin-3 inhibitor: gm-ct-01 peri-tumoral administration,1
8925,prednisone (route of administration),1
8926,antimullerian hormone,1
8927,adriblastin,1
8928,new castle disease virus,1
8929,bnc101 in combination with folfiri,1
8930,pim consult and service provision,1
8931,pbsc graft,1
8932,zemplar (paricalcitol),1
8933,rna sample of total leukocytes before start of treatment,1
8934,pegfilgrastim 6mg,1
8935,"clarithromycin, metronidazole, proton pump inhibitor",1
8936,dna double-strand breaks,1
8937,traditional biomedical educational program,1
8938,trus/fusion biopsy,1
8939,xaliproden,1
8940,hexaminolevulinate hydrochloride (hcl),1
8941,weaving a scarf on a nail frame,1
8942,sandostatin lar® depot,1
8943,blood and biopsy sampling,1
8944,"oxaliplatin, prednisolone",1
8945,vinorelbine and carboplatin,1
8946,collection of blood sample or saliva,1
8947,pti-6d2,1
8948,concurrent use of radium ra 223 dichloride and abiraterone acetate plus prednisone,1
8949,standard prostate cancer information websites,1
8950,"lmp, barf1 & ebna1 specific ctls: a",1
8951,prostate health screening,1
8952,dbt-tobi,1
8953,ct guided radioactive labelling,1
8954,imatinib mesylate 100 mg (glivec),1
8955,"combination radiation, immunotherapy, surgery",1
8956,gemcitabine plus vinorelbine,1
8957,abiraterone acetate or enzalutamide or docetaxel,1
8958,etbx-071; adenoviral psa vaccine,1
8959,beta-glucan mm-10-001,1
8960,intensified treatment including capizzi maintenance,1
8961,pf-06873600,1
8962,percutaneous image-guided gastrostomy,1
8963,personally tailored computer program,1
8964,tumor maker interval shortly,1
8965,nab paclitaxel / gemcitabine,1
8966,sti571 (400 mg/day; or 800 mg/day),1
8967,paclitaxel albumin nanoparticle for injectable suspension,1
8968,erlotinib 100mg tab,1
8969,leucomax,1
8970,compression armsleeves,1
8971,rcomp,1
8972,immunotherapy with allogeneic prostate vaccine,1
8973,mesenchymal stem cells (mscs),1
8974,bevacizumab and cpt-11 and carboplatin,1
8975,administration of daa-based treatment,1
8976,high intensity focused ultrasound (hifu),1
8977,vinflunine and best supportive care,1
8978,hpc(a) stem cell allograft,1
8979,"vinorebine, everolimus",1
8980,aromatase inhibitor(femara or arimidex),1
8981,oral encochleated amphotericin b (camb),1
8982,megadose of cd34 selected progenitor cells,1
8983,fast solid,1
8984,ledipasvir and sofosbuvir,1
8985,omitting axillary surgery in early breast cancer,1
8986,cocoa extract,1
8987,vmd-928 300-mg capsules,1
8988,hd6610 granule placebo,1
8989,gd2bi-aatc,1
8990,peripheral bood stem cell transplantation,1
8991,erlotinb,1
8992,ridaforolimus tablet,1
8993,egfr-tki and chemotherapy,1
8994,500 mg [14c]-lx1606,1
8995,xelox or folfox chemotherapy,1
8996,azacitadine and hematopoietic growth factors,1
8997,percutaneous vertebroplasty,1
8998,modulated tens,1
8999,tykerb® tablets,1
9000,pemetrexed and reolysin (and safety run-in),1
9001,without upper limb elevation,1
9002,sgn-2ff,1
9003,dovitinib and docetaxel,1
9004,beta-tricalcium phosphate (chronos),1
9005,observations,1
9006,dexametasone,1
9007,"pralatraxate, cyclophosphamide, doxorubicin, prednisone, brentuximab vedotin",1
9008,camptothecin-20-o-propionate hydrate (cz48),1
9009,gtx-024 9mg,1
9010,intravoxel incoherent motion mri (ivim),1
9011,matrix-assisted laser desorption ionization mass spectrometry,1
9012,dc vaccine and cyclophosphamide,1
9013,usual surgery,1
9014,doxycycline 50mg tablet,1
9015,dt group,1
9016,face-to-face mbm skills group,1
9017,mobile app/online module,1
9018,distress screening thermometer,1
9019,chidamide + r-chop regimen,1
9020,preoperative enhanced chest ct examination,1
9021,tissue bonding,1
9022,rx108,1
9023,data evaluation,1
9024,iadt + radiotherapy,1
9025,anti-thymocyte globulin as conditioning (atg),1
9026,111in-pertuzumab + spect-ct,1
9027,soft tissue release/debridement/excision,1
9028,cisplatin (dose level 1),1
9029,the neuroblate system,1
9030,couple's cancer education,1
9031,self-sampling kit sent at home,1
9032,jcar017 (lisocabtagene maraleucel) single-dose schedule,1
9033,customized text message invitation ( step 1a),1
9034,fatty acids present in adipose tissue samples,1
9035,analogue machine,1
9036,beck depression inventory (bdi),1
9037,drosophila-peptide pulsed melanoma-reactive autologous cd8+ pbl,1
9038,dfd-07 cream,1
9039,avitene,1
9040,surgery or biopsy of the kidney tumor,1
9041,pump,1
9042,non-drug intervention educational programme,1
9043,"tff3, sfrp4, romo1, nfkb",1
9044,optimal care (psychological and enterostomal therapy clinics),1
9045,brentuximab vedotin and rifampicin,1
9046,endovascular denervation,1
9047,tumor lysate-pulsed dc vaccination+0.2% resiquimod,1
9048,rituximab + bi-weekly chop,1
9049,hipp,1
9050,nivolumab + placebo,1
9051,bpf-ccrt (run-in),1
9052,anti-gpc3 car t,1
9053,ingenol mebutate (picato®) 0.015% gel,1
9054,sequential chemotherapy - 3 courses of ai,1
9055,lung tumor resection,1
9056,clinical and physical assessment,1
9057,ab-101,1
9058,delayed yoga classes,1
9059,repetition of re-staging,1
9060,non-contrast dwi,1
9061,da,1
9062,full bladder,1
9063,apatinib (250 mg/d) + docetaxel (60 mg/m2),1
9064,cep-37440,1
9065,cd3+ teff cells,1
9066,epirubicin + ciclofosfamide + fluorouracil + paclitaxel,1
9067,chidamide combined with cisplatin,1
9068,spinal morphine,1
9069,compression sleeve,1
9070,"nab-paclitaxel 150 mg/m2 + gemcitabine 1000 weeks 1,3/4",1
9071,teaching using hybrid simulation of breast examination,1
9072,aslan003,1
9073,blood sample collection for ctc and mdsc analysis,1
9074,phip,1
9075,ioflupane i123,1
9076,74-80 grays (units of radiation),1
9077,embolization of the inferior mesenteric artery,1
9078,nonavalent hpv vaccine,1
9079,[11c]acetate,1
9080,dw & dce-mri,1
9081,hlx07+mfolfox6,1
9082,"dasatinib, 140 mg + lenalidomide, 25 mg + dexamethasone, 40 mg",1
9083,sknlp,1
9084,atomic force microscopy,1
9085,usual follow up with regular em66 & cga levels assessment,1
9086,131-i-meta-iodobenzylguanidine,1
9087,investigational cancer drug,1
9088,concurrent chemoirradiation (ccrt),1
9089,gamma secretase inhibitor pf-03084014,1
9090,trastuzumab - subcutaneous solution,1
9091,"sunitinib, pemetrexed, cisplatin, carboplatin",1
9092,"folfiri, avastin, irinotecan",1
9093,lik066,1
9094,serial endoscopic surveillance,1
9095,ps 341,1
9096,comparator: ct or mri and fdg-pet,1
9097,vincristine / vindesine,1
9098,doxifluridine,1
9099,pvb,1
9100,tumorectomy,1
9101,therapeutic education strategy,1
9102,biopsy of sentinel lymph nodes,1
9103,cloxacillin and amikacin (once or twice daily dosage),1
9104,ginger root extract (pure encapsulations),1
9105,amulez and sunlight,1
9106,crlx301,1
9107,dietary intake,1
9108,spinal catheter,1
9109,"doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide",1
9110,"rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and qol questionnaire, peg-filgrastim or filgrastim",1
9111,"fludarabine, rituximab, pixantrone",1
9112,lapatinib + capecitabine (phase ii),1
9113,cell infusion,1
9114,seneca valley virus (biological agent),1
9115,histoscanning™ and multiparametric mri,1
9116,with feeding/fluid instruction,1
9117,mindfulness-based day-care clinic group program,1
9118,tace plus autologous tcm immunotherapy,1
9119,enhanced recovery protocol,1
9120,placement of sling,1
9121,sorafenib at a dose of 800 mg / day,1
9122,rice bran arabinoxylan compound (rbac),1
9123,allogeneic sct or autologous sct,1
9124,pazopanib (gw786034) 400 mg,1
9125,iron,1
9126,exodx prostate intelliscore,1
9127,fulvestrant 50 mg/ml prefilled syringe [faslodex],1
9128,"slow-pull, wet suction, standard suction",1
9129,health navigator,1
9130,humanized 3f8 bispecific antibody,1
9131,r-choep chemotherapy,1
9132,liposomal 9-nitrocamptothecin,1
9133,"biopsy track ablator (starmed, goyang, korea)",1
9134,"conventional needle-knife sphincterotome (microknife xl; boston scientific inc, natick, mass)",1
9135,ropivacaine chlorhydrate,1
9136,"missing items, errors in completion, difficulties",1
9137,fiber containing tube feeding formula,1
9138,intervention group - texts,1
9139,6 cycles of standard chemotherapy,1
9140,nivolumab 240 mg,1
9141,hbs antigen and hcv antibody,1
9142,blood sample (dna),1
9143,"cisplatin, ifosfamide, gemcitabine",1
9144,colon- closed as of may 2014,1
9145,levofolinate calcium (l-lv),1
9146,sustained release morphine sulfate,1
9147,heated humidifier,1
9148,interview & questionnaires,1
9149,"one-on-one education, group education, small media",1
9150,immediate surgical resection of melanoma lesion(s),1
9151,olaparib 50 mg,1
9152,ppx (ct2103),1
9153,thl-p,1
9154,hemoglobin a1c,1
9155,9-aminocamptothecin,1
9156,enteric-coated aspirin,1
9157,2d tissue doppler echocardiography,1
9158,silybin-phytosome,1
9159,geriatrician review,1
9160,multi-faceted intervention to improve continuity of care,1
9161,educational strategy,1
9162,conventional rigid thoraoscopy,1
9163,zoledronic acid and aromatase inhibitors,1
9164,biochemistry,1
9165,abiraterone acetate with methylprednisolone,1
9166,compound kushen injection,1
9167,carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly,1
9168,remove drain,1
9169,lmp specific t cells,1
9170,pituitary surgery,1
9171,cediranib 30 - 90 mg,1
9172,pxfk peptide,1
9173,abt-494,1
9174,hipec without flushing afterwards,1
9175,personalized tumor vaccine,1
9176,post-exercise assessment of cardiac function by echocardiography,1
9177,chimeric monoclonal antibody cg250,1
9178,omeprazol,1
9179,atypical type-1,1
9180,g-flip,1
9181,"etoposide, mitoxantrone, clofarabine",1
9182,certolizumab pegol (czp),1
9183,placebo of 'tonifying spleen and kidney sequential regimen,1
9184,gefitinib and metformin,1
9185,temcap,1
9186,endocrine therapies,1
9187,bp1001,1
9188,carboplatin and paclitaxel and radiation therapy,1
9189,"autologous, tumor lysate-loaded, mature dendritic cells (dc)",1
9190,implantation of dermal matrix substitute,1
9191,intra-ophthalmic artery topotecan infusion,1
9192,tailored screening according to breast density,1
9193,training group,1
9194,fluorescence assessment,1
9195,adjuvant nivolumab,1
9196,ch14.18 monoclonal antibody,1
9197,treatment choice (tc),1
9198,autologous tumor cell + cpg vaccine,1
9199,ir-192 high dose rate (hdr),1
9200,thoracic drain tube 24 fr.,1
9201,melcancervac,1
9202,folic acid 350-1000 ?g,1
9203,standard docetaxel and cyclophosphamide,1
9204,daunorubicin (baml-16-001-s1),1
9205,ctgrfa,1
9206,halo,1
9207,satraplatin in combination with paclitaxel,1
9208,apx005m treatment for recurrent or refractory primary malignant cns tumor patients,1
9209,jnj-42756493: part 3,1
9210,peripheral blood for correlative studies,1
9211,catumaxomab (removab),1
9212,suction is set to -10 cmh2o,1
9213,l-blp25,1
9214,observation of cns involvement,1
9215,vandetanib maintenance,1
9216,combination chemotherapy,1
9217,bms-936558 (mdx1106-04),1
9218,usage of fibrin sealant,1
9219,durvalumib,1
9220,eca,1
9221,pemetrexed 500 mg/m^2 plus carboplatin area under the curve (auc) 4-6 mg/ml per minute iv infusion,1
9222,goal setting plus action intentions plus coping intentions,1
9223,radiation prophylactic cranial irradiation,1
9224,targeted therapy based on molecular profiling : lapatinib + trastuzumab,1
9225,carboplatin & paclitaxel & oregovomab,1
9226,tai ji quan training,1
9227,polymva,1
9228,"lortab, fentanyl patch, mouthwash",1
9229,modified bii+braun,1
9230,a-folfoxiri,1
9231,wong-baker faces® pain rating scale,1
9232,bez235 + mek162,1
9233,abr-217620/naptumomab estafenatox,1
9234,ionis-stat3rx,1
9235,avastin and temozolomide,1
9236,gelfoam,1
9237,standard dose prescription,1
9238,fungitell assay in bal,1
9239,123i-iodometomidate,1
9240,intra-thecal baclofen infusion,1
9241,bev,1
9242,90-yttrium ibritumomab tiuxetan,1
9243,tivantinib (arq 197) capsule,1
9244,leo 43204 gel 0.037%,1
9245,simultaneous integrated boost technique,1
9246,mri and ct,1
9247,choline-pet,1
9248,diagnostic cystoscopy,1
9249,focused ultrasound,1
9250,"ct, pet, copy number alteration",1
9251,25-gauge needle,1
9252,thyroseq v.2,1
9253,pm02734,1
9254,mgn-3,1
9255,novottf-100m device,1
9256,whole body magnetic resonance imaging,1
9257,ig-001,1
9258,"subjects undergoing tecr with ecm placement (acell matristem, boston scientific wallflex))",1
9259,"sb-485232 (interleukin 18), pegylated liposomal doxorubicin",1
9260,vt1021,1
9261,acetaminophen 500mg cap,1
9262,metotrexato in consolidation-1,1
9263,bisphosphonate therapy (risedronate),1
9264,??zr-df-iab22m2c,1
9265,ds-2248,1
9266,copper cu-64-dota-alendronate,1
9267,"irinotecan (camptosar, cpt-11)",1
9268,"ovax: autologous, dnp-modified ovarian cancer vaccine",1
9269,anti-angiogenic drugs,1
9270,rem frag,1
9271,vaginal or laparoscopic hysterectomy,1
9272,bone marrow biopsy/aspirate,1
9273,apg-2575,1
9274,selumetinib 25mg,1
9275,vincristine 1.4 mg/m^2,1
9276,peprostat,1
9277,"gemcitabine, erlotinib, osi-906",1
9278,rexin-g dose 3,1
9279,reduced energy diet,1
9280,questionaire about pain,1
9281,hybrid everted esophagogastric anastomosis,1
9282,pet without/with scs,1
9283,placebo (for oral opioids),1
9284,melanoma image analysis algorithm (miaa),1
9285,"vx-006: 0,5mg",1
9286,ro-choep-21 (phase ii),1
9287,solution a (conventional pd solution),1
9288,total therapy approach,1
9289,mri-guided stereotactive body radiation therapy,1
9290,ice chemotherapy,1
9291,olaparib 400 mg,1
9292,tamoxifen citrate (tamoxifen),1
9293,"nab-paclitaxel 125 mg/m2 + gemcitabine 1000 weeks 1,3/4",1
9294,radiotherapy 60 gy(rbe),1
9295,neem mouthrinse,1
9296,4% rebamipide liquid,1
9297,standard of care oral hygiene instructions,1
9298,intensity modulated re-irradiation therapy (immrt),1
9299,dendritic cells dcvac,1
9300,long course concurrent chemoradiation,1
9301,fbntp,1
9302,hpv screening and triage tests,1
9303,montanide + cpg-7909/pf-3512676 + melan-a native and analog peptides + ny-eso-1 long peptide + mage10 peptide + low dose il-2,1
9304,bevacizumab hai plus systemic chemotherapy,1
9305,genome analysis of tissue samples.,1
9306,gi-6301 placebo,1
9307,embolic agents,1
9308,both superficial inferior artery and vein clamped,1
9309,lc bead m1,1
9310,low dose computed tomography scan,1
9311,lenalidomide: open-label,1
9312,ferric saccharose(venofer®),1
9313,pulvis talci,1
9314,amg 211,1
9315,photovoice project,1
9316,oral casopitant (gw679769),1
9317,removal without overtube,1
9318,ct guided celiac plexus neurolysis,1
9319,cognitive behavioral stress management (cbsm),1
9320,boesenbergia rotunda,1
9321,hypofractionated radiation therapy 57 gy in 19 fractions,1
9322,novilase laser ablation,1
9323,not applicable - observational study,1
9324,hepatic artery embolization (hae),1
9325,emg,1
9326,drospirenone ethinyl estradiol myo-inositol,1
9327,placebo to mk-1775,1
9328,empty bladder,1
9329,acit-1,1
9330,mailed printed materials and in-office training,1
9331,self sampling device,1
9332,pet/ct cardiac scan,1
9333,breast conserved surgery,1
9334,blood sampling for il measurement,1
9335,patient discharge on postoperative day 1,1
9336,minocycline-edta,1
9337,medical radiation protectants (forrad®),1
9338,probion clinica,1
9339,nab-paclitaxel and gemcitabine for r-pdac patients,1
9340,sems(self-expandable metallic stent),1
9341,on01910 na,1
9342,adu-s100,1
9343,am4113-n5ut dino-lite,1
9344,gastrointestinal biopsy x 2-4,1
9345,video-thoracoscopy,1
9346,transcatheter arterial pegylated interferon embolization (taie),1
9347,ak-105,1
9348,tailored print intervention,1
9349,usual nutritional care,1
9350,high-selenium brassica juncea,1
9351,diffusion-weighted mr imaging,1
9352,cognitive behavioral stress management (cbsm) group intervention,1
9353,conventional mal-pdt,1
9354,comparator: v505 formulation 3,1
9355,laryngeal mask airway (lma supreme size 3/4,1
9356,zo-nantax,1
9357,avelumab and gemcitabine,1
9358,parathyroid hormone level measurement,1
9359,bifilact®,1
9360,tace+tegafur,1
9361,spanom (identifying msi status from ctdna),1
9362,accelerated partial breast irradiation (apbi) to region of tumour bed using 3d conformal radiation therapy (3d crt),1
9363,pomegranate pill placebo,1
9364,neuradiab in combination with bevacizumab (avastin),1
9365,bibw 2992 ma2 50mg/day,1
9366,doxorubicin hydrochloride (adriamycin),1
9367,vinorelbine+cisplatin,1
9368,the caudal-to-cranial approach,1
9369,niz985,1
9370,speckle-contrast imaging,1
9371,experimental arm: trabectedin + olaparib,1
9372,image-guided imrt,1
9373,gsc-loaded autologous dendritic cells,1
9374,teaching mindfulness-based stress reduction strategies,1
9375,injection of bone marrow mononucleated cells,1
9376,tgf?2 antisense-gmcsf gene modified autologous tumor cell (tag) vaccine,1
9377,pain coping skills brief,1
9378,mammography with community health worker (individual),1
9379,cetomacrogol cream,1
9380,bsg-001,1
9381,tigecycline,1
9382,otl38 for injection,1
9383,modified atkins ketogenic diet,1
9384,margetuximab in combination with pembrolizumab,1
9385,igar-breast teleop,1
9386,radiofrequency ablation of pulmonary neoplasms,1
9387,gleevec and chlorambucil,1
9388,histopathology diagnosis of resected liver specimen,1
9389,whole-body electromyostimulation,1
9390,triple kinase inhibitor bibf1120,1
9391,folinic acid at pharmacological dose is the escalated drug,1
9392,life extension default ad forms,1
9393,toluidine blue assisted oral examination,1
9394,"prostate biopsy, focal brachytherapy , assessment of qol",1
9395,topotecan (chemotherapy),1
9396,print-based education,1
9397,radiation therapy with gemzar,1
9398,metformin group,1
9399,breast reconstruction surgery,1
9400,mobility self-management with guidebook,1
9401,low dose 5'-azacitidine,1
9402,application of activated donor t cells,1
9403,lidocaine per-embolization,1
9404,tandem autologous transplantation,1
9405,radiotherapy before surgery,1
9406,electrocorticography (ecog) with ad-tech grids,1
9407,sc-011,1
9408,tg-1501,1
9409,ceramic implant,1
9410,"carboplatin, gemcitabine , pametrexed",1
9411,procurement of follicular b cell lymphoma cells,1
9412,allogenic gm-csf plasmid-transfected pancreatic tumor cell vaccine,1
9413,parenteral /oral methadone ratio 1:1.2,1
9414,palovarotene 5.0 mg,1
9415,dot1l inhibitor epz-5676,1
9416,"vincristine, doxil (doxorubicin hcl liposomal injection), and dexamethasone (vdd) vs. vincristine, doxorubicin and dexamethasone (vad)",1
9417,positive psychotherapy,1
9418,medical records,1
9419,sta-9090 (ganetespib) with docetaxel,1
9420,f-18-f-dopa,1
9421,physical assessments,1
9422,ldr/hdr,1
9423,cyclophosphamide (injection),1
9424,gleevec/glivec,1
9425,89zr-pembrolizumab pet,1
9426,zoladex ®,1
9427,allo transplantation,1
9428,combination therapy - oxaliplatin,1
9429,anidulafungin 300 mg q72h,1
9430,material incentive,1
9431,ro7009789,1
9432,radical prostatectomy without posterior rhabdosphincter reconstruction,1
9433,tattooing of biopsied node,1
9434,0.4% lugol's solution,1
9435,atr-101,1
9436,personalized synthetic long peptide vaccine (poly iclc),1
9437,"fludarabine, thiotepa, antithymocyte globulin (atg), and total body irradiation (tbi)",1
9438,r-cvp + zevalin therapeutic regimen,1
9439,hyperthermic intraperitoneal perfusion chemotherapy,1
9440,deep shave removal using a blue surgical blade,1
9441,enhance care,1
9442,ivlcm tethered capsule,1
9443,focused ultrasound (fus),1
9444,follow-up surveys,1
9445,sandostatin lar depot versus transsphenoidal surgery,1
9446,mb07133 300mg/m2/day,1
9447,nicorandil,1
9448,brief,1
9449,2 mg/kg gr-md-02,1
9450,rnu,1
9451,hepatectomy and transcatheter arterial chemoembolization,1
9452,dietary assessment,1
9453,cytosine arabinoside + g-csf (filgrastim),1
9454,"patidegib topical gel, 2%",1
9455,kx2-361,1
9456,bpx-501 dose 2,1
9457,spinal sbrt (higher dose),1
9458,lenvatinib + denosumab,1
9459,next-genernation sequence,1
9460,nutritional and functional assessments,1
9461,aldara™,1
9462,interventional endoscopy,1
9463,chemoradiotherapy+ endostar,1
9464,regression of fibrosis,1
9465,azd1480 bid,1
9466,restorative (gentle) yoga practice,1
9467,secretin,1
9468,pathwork® tissue of origin test,1
9469,adjuvant concurrent chemo-radiotherapy,1
9470,placebo-matching telotristat etiprate,1
9471,citrafleet,1
9472,tin ethyl etiopurpurin,1
9473,linear cutter-circular stapler,1
9474,liver transplantation and colo-rectal cancer,1
9475,integrated treatment,1
9476,panobinostat/lbh589b,1
9477,5.0g srt501,1
9478,10% eiso,1
9479,ls11 (talaporfin sodium),1
9480,preoperative mri scan,1
9481,use of app in smartphone,1
9482,tumor biology testing,1
9483,radiotherapy of gastric cancer,1
9484,yourmeds patient education program,1
9485,group (a),1
9486,dexamethasone 4 mg,1
9487,[89zr]-df-trastuzumab,1
9488,levonorgestrel iud,1
9489,cart123 cells; cyclophosphamide; fludarabine,1
9490,wise cortical strip,1
9491,autologous hematopoietic cell transplant (auto-hct),1
9492,metronomic cpa,1
9493,flexible forceps biopsy first,1
9494,pa,1
9495,ingenol mebutate gel,1
9496,"ksp-qrh-e3-irdye800 (peptide 919288g), 0.6 mg",1
9497,12 month exercise and weight loss intervention,1
9498,facilitation of services to improve cancer screening,1
9499,s1+docetaxel,1
9500,combination of bi-1206 with rituximab,1
9501,emotional disclosure condition,1
9502,eagd t-cell infusion (expansion),1
9503,complete blood count,1
9504,blood collect,1
9505,cgc-11047,1
9506,p53-slp vaccine,1
9507,approved anti-pd-1 inhibitor,1
9508,genetic analysis on tumor kept in tumor bank,1
9509,interleukin-2 (proleukin),1
9510,apatinib docetaxel zoledronic,1
9511,lletz on a training model,1
9512,il-15 plus alemtuzumab,1
9513,2-ohoa,1
9514,high dose cytarabine and mitoxantrone,1
9515,bcl201,1
9516,melphalan/prednisone/velcade,1
9517,bortezomib + pegylated liposomal doxorubicin hcl + dexamethasone,1
9518,diagnostic 5-ala and mri for tumor resection,1
9519,reach plus message,1
9520,hpv vaccine (gardasil),1
9521,rp1,1
9522,tdf,1
9523,in-person cp,1
9524,aromatase inhibitor and palbociclib,1
9525,myvax,1
9526,"brivanib 800 mg, qd",1
9527,matching placebos,1
9528,ucart019,1
9529,it-101 (12mg/m2/dose),1
9530,20 gy if-rt,1
9531,calypso beacon implantation,1
9532,bim 23a760,1
9533,massage combined with meditation,1
9534,bikdd nanoparticle,1
9535,child depression inventory,1
9536,icotinib plus wbrt,1
9537,topotecan (tpt),1
9538,pxd101with cisplatin+doxorubicin+cyclophosphamide,1
9539,therapeutic laparoscopic colorectal surgery,1
9540,trovax + docetaxel,1
9541,oncogel (regel/paclitaxel),1
9542,conventional biopsy instrument,1
9543,intravenous morphine patient controlled device,1
9544,panitumumab + folfiri or folfox,1
9545,sham erector spinae plane block,1
9546,modradoc006 10 mg tablet,1
9547,plasma circulating dna analysis,1
9548,6-mercaptopurine (6-mp),1
9549,parp inhibitor bmn-673,1
9550,electrocauterization,1
9551,imaging - dw-mri,1
9552,internal mammary sentinel lymph node biopsy,1
9553,ct guided core biopsy,1
9554,"cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone/prednisolone (chop)",1
9555,inditreat,1
9556,g-csf mobilized cd34+ selected cells for transplantation,1
9557,central nervous system (cns) prophylaxis radiation,1
9558,olaparib pill 100 mg,1
9559,standard chemoradiation,1
9560,dcf,1
9561,chess (comprehensive health enhancement support system) and human cancer mentor,1
9562,cesium-131,1
9563,"tpc -vinorelbine,gemcitabine,docetaxel, and pemetrexed",1
9564,iv placebo for tanezumab,1
9565,mureletecan,1
9566,pd1/pd-l1 exosomal expression,1
9567,vorinostat (mk0683 ),1
9568,non-endoscopic inflatable balloon for the esophagus,1
9569,imx-110,1
9570,hyperpolarized 13cpyruvate,1
9571,progesterone in oil,1
9572,glembatumumab vedotin and cdx-301,1
9573,newsletter about physical activity and breast cancer survivors,1
9574,docetaxel/s-1,1
9575,concentrated citrate,1
9576,factors and perceptions questionnaire,1
9577,omega-3 fatty acids (fish oil),1
9578,7+3 (cytarabine and daunorubicin),1
9579,clipt patch,1
9580,endoscopic full-thickness resection,1
9581,9-aminocamptothecin (9-ac),1
9582,standard cancer pain care,1
9583,"folfiri, target agent",1
9584,r-roscovitine,1
9585,tremelimumab (regimen 2),1
9586,sofosbuvir+velpatasvir,1
9587,angel concentrated platelet rich plasma system,1
9588,pemetrexed + paclitaxel,1
9589,"epirubicin with cyclophosphamide, followed by a taxane",1
9590,dehydrated alcohol,1
9591,brain fitness program (bfp),1
9592,open tpvb,1
9593,gefitinib mono-therapy,1
9594,experimental drug: ondansetron,1
9595,x-suit nir covered biliary stent,1
9596,tube ileostomy,1
9597,lidocaine spray,1
9598,endobarrier treatment in pcos,1
9599,autologous t cells transfected with chimeric anti-mesothelin immunoreceptor ss1,1
9600,visualization relaxation,1
9601,cbt intervention,1
9602,research blood samples,1
9603,transplants from family-mismatched/haploidentical donors,1
9604,ketorolac tromethamine,1
9605,vdc-ie x2,1
9606,re-invitation letter,1
9607,oxaliplatin + folinic acid + fluorouracil,1
9608,laparoscopic staging,1
9609,mfolfox6 or xelox,1
9610,6 mg xanthohumol per day,1
9611,questionnaires & interviews,1
9612,position for the 3.0 tesla in magnetic resonance imaging,1
9613,study treatment,1
9614,topical fluorouracil,1
9615,trimix,1
9616,routine full-field digital mammography,1
9617,anti-ny-eso-1 tcr transduced t cells,1
9618,lenalidomide + rituximab,1
9619,"carboplatin, olaparib",1
9620,postoperative adjuvant chemotherapy,1
9621,resminostat (4sc-201),1
9622,interferon-?-2b,1
9623,cd8 enriched young til,1
9624,fruit and vegetable intake education,1
9625,prohema-cb,1
9626,aerobic exercise and strength training exercises,1
9627,xm02 filgrastim,1
9628,"online, interactive self-help program",1
9629,tarloxotinib bromide,1
9630,contrast enhanced mammography,1
9631,"hypofractionated, image-guided, intensity-modulated external beam radiation",1
9632,eus-fnb with 22 gauge procore needle,1
9633,mindfulness-based cancer survivorship,1
9634,olaparib pill 50 mg,1
9635,3d-conformal external beam,1
9636,rituximab and hyaluronidase human,1
9637,daily food diaries,1
9638,ipilimumab 200 mg in 40 ml injection,1
9639,live video-colposcopy,1
9640,r-bl-m-04 + auto-sct,1
9641,129xe small and large human lung coil,1
9642,total body radiation (tbi),1
9643,yttrium y 90 anti-cd45 monoclonal antibody ahn-12,1
9644,en3835,1
9645,18f-da,1
9646,early palliative care/symptom control,1
9647,trait food craving questionnaire-trait (fcq-t),1
9648,"panitumumab, mytomicin c, 5-fu, radiation",1
9649,tandem autologous stem cell transplant,1
9650,day 8: capsule vinorelbine 50 mg/m2,1
9651,preoperative bowel preparation with sodium phosphate,1
9652,optional 18f-fmiso pet scan (18f-fluoromisonidazole),1
9653,bevacizumab + erlotinib hydrochloride,1
9654,pemetrexed + vinorelbine,1
9655,fosnetupitant/ palonosetron,1
9656,diagnostic (ferumoxytol-enhanced mri),1
9657,germline brca test (blood),1
9658,standard vats lobectomy,1
9659,phase ii - gm.cd40l.ccl21 vaccinations,1
9660,chop + cd4,1
9661,radiofrequency-assisted hepatectomy,1
9662,clinimacs® cd3 and cd19 reagent system,1
9663,cerenkov luminescence imaging.,1
9664,supplemental autologous serum,1
9665,nivolumab 240mg,1
9666,excision of pilonidal sinus with normal dressing,1
9667,arterial puncture,1
9668,68ga-citrate pet/mr,1
9669,current care coordination,1
9670,trabectedin discontinuation,1
9671,mrx-2843,1
9672,jnj-64619178,1
9673,cisplatin?ddp? weekly,1
9674,hypnose sedation,1
9675,ultrasound of hand/wrist,1
9676,storz 3d laparoscopy system,1
9677,"immunodominant peptides from three melanoma antigens, mart-1, gp100 and tyrosinase",1
9678,npc-08,1
9679,axumin pet scan,1
9680,ec regimen,1
9681,serum blood markers,1
9682,ipoi (pre-operative),1
9683,joint stabilisation,1
9684,early ileostomy closure,1
9685,"131 i-iodine (131-i), 124 i-iodine (124-i)",1
9686,oral mucosal deterging and dental prophylaxis,1
9687,laser and rapamycin versus laser alone,1
9688,six minutes stepper test,1
9689,supportive care alone,1
9690,rfa applicator,1
9691,addressing behavior change (abc),1
9692,spine radiosurgery,1
9693,enhanced self-regulation condition,1
9694,spinal and infusion of local anaesthetic,1
9695,hpv screening,1
9696,therapeutic group by teleconference,1
9697,stapling,1
9698,radon only,1
9699,nilotinib + lde225,1
9700,eortc qlq-cipn20,1
9701,cellular immunotherapy,1
9702,postoperative injection (ex vivo),1
9703,"blood draw, skin biopsy or urine collection",1
9704,blood tests.,1
9705,morphological and functional mri (fmri),1
9706,scannographic arm,1
9707,comvi stent,1
9708,tannenbaum fr 10 stent or wallflex stent,1
9709,prophylactic salpingectomy with delayed oophorectomy,1
9710,human alert,1
9711,gonadotropin,1
9712,immediate intervention,1
9713,letter and educational dvd,1
9714,tc 99m filtered sulfur colloid,1
9715,oral topotecan hydrochloride,1
9716,audit,1
9717,omission of radiation,1
9718,tcr - t cell therapy,1
9719,myeloma immunoglobulin idiotype vaccine-klh,1
9720,recombinant human gm-csf,1
9721,recombinant fsh,1
9722,"free doxorubicin plus cyclophosphamide, 4 cycles, followed by docetaxel plus trastuzumab, 4 cycles",1
9723,multi-modal precision ablation,1
9724,part 2 (dose expansion): daratumumab,1
9725,total submuscular coverage,1
9726,fp-1305,1
9727,trastuzumab - emtansine,1
9728,tapentadol prolonged release,1
9729,90-y-ibritumomab tiuxetan,1
9730,mri + pem image,1
9731,adjuvant radiochemotherapy,1
9732,amg 420,1
9733,near infrared fluorescence imaging (nifi),1
9734,ril-21 only,1
9735,baminercept,1
9736,uv4.me2,1
9737,coach training (coach),1
9738,motivational interviewing intervention,1
9739,assess hernia recurrence at 30 days postoperatively,1
9740,questionnaire 2,1
9741,"paced breathing (15 min twice daily, 6 breaths/min)",1
9742,docetaxel 100 mg/m2 iv or paclitaxel 80 mg/m2 iv,1
9743,polihexanide 2%,1
9744,social media message about risk of electronic cigarettes.,1
9745,multipolar radiofrequency ablation,1
9746,"tpf, radiotherapy and cetuximab.",1
9747,lysate of tumor,1
9748,pre operative parathyroid hormone level measurement,1
9749,"cisplatin, paclitaxel",1
9750,high-intensity aerobic interval exercise,1
9751,irinotecan liposomal injection [onivyde],1
9752,lifestyle counseling with emotional freedom techniques (eft),1
9753,630 nm laser irradiation (diomed),1
9754,experimental: 2. experimental,1
9755,wow and bni,1
9756,pembrolizumab with all-trans retinoic acid,1
9757,philips mri-guided hifu system,1
9758,no intervantion,1
9759,"klh, peptides plus montanide",1
9760,"docetaxel, carboplatin",1
9761,pd1,1
9762,"target drug with the score above 0,1",1
9763,advince,1
9764,pleurectomy,1
9765,cxd101,1
9766,rate of remission,1
9767,177lu?j591,1
9768,gpcc (gothenburg person centred care),1
9769,standard treatment protocol with combined chemoradiation,1
9770,self geriatric assessment measure (sgam),1
9771,different surgical approach and techniques being used to treat three subtype of cp,1
9772,allohct for old/mud&fmd,1
9773,anti-bcma car-t cells,1
9774,sbrt and chemotherapy,1
9775,ave0005 (aflibercept),1
9776,endorectal coil magnetic resonance images,1
9777,standardized educational flyer,1
9778,pos + ps2 + velscope,1
9779,surgical evaluation after vaccine #4,1
9780,stress management training,1
9781,high-flow nasal cannula oxygen (hfnco),1
9782,berry powder,1
9783,lemon essential oil,1
9784,kw-2450,1
9785,radiochemotherapy with 77 gy,1
9786,radiotherapy breast cancer,1
9787,cc-486 administration,1
9788,assessment of splicing variants,1
9789,capecitabine plus oxaliplatin after surgery,1
9790,nurse telephone contact,1
9791,endobronchial ultrasound guided transbronchial needle aspiration,1
9792,azd1775 150 mg bd + olaparib 200 mg bd (21-day cycle).,1
9793,gsk525762 besylate tablets,1
9794,melitac 12.1,1
9795,daily stress reduction program,1
9796,radiation therapy-5 fractions,1
9797,radical cystectomy with standardized pelvic lymphadenectomy,1
9798,pulmonary function test (pft),1
9799,onartuzumab placebo,1
9800,alx148,1
9801,bevacizumab + pemetrexed,1
9802,msc-inf?,1
9803,tagrisso® 80mg (osimertinib),1
9804,ifosfamid,1
9805,bone scan: f18-fluoride pet/ct or tc-mdp,1
9806,99mtc-abh2,1
9807,alrn-6924 in combination with cytarabine,1
9808,in-person education,1
9809,education control,1
9810,tumour biopsy,1
9811,[90]y-dotatoc,1
9812,cyanoacrylate,1
9813,secondary brain radiotherapy,1
9814,institutional standard of care,1
9815,gastric cancer pts undergoing surgery,1
9816,"vorinostat, carboplatin, etoposide",1
9817,oblimersen-rituximab-fludarabine,1
9818,"interleukin, nk cells",1
9819,intracavitary applicator placement,1
9820,131i-l19sip radioimmunotherapy (rit) in combination with whole brain radiation therapy (wbrt),1
9821,nivolumab 3 mg/kg iv,1
9822,nk cell adaptive transfer,1
9823,video chat sessions,1
9824,"""air"" contrast cholangiography using carbon dioxide gas",1
9825,5% 5-fu,1
9826,oral,1
9827,online referral nys quitline,1
9828,m3541,1
9829,wide-field fluorescence imaging,1
9830,mbp8298,1
9831,fec-100,1
9832,gynecological surgical procedure,1
9833,urine sample for biomarkers,1
9834,methylphenidate hcl 10mg sr,1
9835,dietary intervention first,1
9836,transcutaneous vagus nerve stimulation,1
9837,philips mr-guided hifu,1
9838,"brachytherapy, external beam radiotherapy",1
9839,mrna-2752,1
9840,nicotinamide expanded haploidentical or mismatched related donor natural killer cells,1
9841,egfrbi armed atc infusions,1
9842,mesh implantation,1
9843,experimental: hla-a2 restricted glioma antigen-peptides with poly-iclc,1
9844,transarterialchemoembolisation (tace),1
9845,external beam whole breast irradiation,1
9846,desipramine,1
9847,genomic and/or molecular testing of blood or tissue,1
9848,cal-1 (lvsh5/c46) drug product,1
9849,laser-based thermotherapy,1
9850,chop/rituximab,1
9851,wearable sensor,1
9852,"endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant",1
9853,dendritic cell fusion vaccine,1
9854,injection of antigen-loaded cultured dendritic cells,1
9855,evaluation of treatment for liver metastasis,1
9856,tf(c)-klh conjugate vaccine,1
9857,airbrush plus,1
9858,itv,1
9859,osteopathic technique,1
9860,exablate,1
9861,online training module,1
9862,xefo,1
9863,erlotinib + gsk1120212,1
9864,memokath 051 ureteral stent,1
9865,artery divestment technique,1
9866,administration of 131 iodine,1
9867,tapentadol in the maintenance phase,1
9868,yttrium y 90 monoclonal antibody bre-3,1
9869,alisertib (mln8237),1
9870,simplified lv5fu2,1
9871,communication of patients lost to follow-up to providers,1
9872,radioactive seed implant to prostate,1
9873,anti-psma car nk cells,1
9874,hmab biwa 4,1
9875,radiotherapy (procedure),1
9876,pasireotide lar + everolimus,1
9877,inyp,1
9878,peripheral/central venous blood draw,1
9879,supportan,1
9880,microwave trans rectal focal treatment,1
9881,infracolic gastrojejunal anastamosis,1
9882,nerve-sparing radical prostatectomy,1
9883,oral administration of stable isotope (deuterium),1
9884,colonoscopy procedure,1
9885,erlotinib w concurrent radiotherapy,1
9886,involved field irradiation (ifi),1
9887,spies assisted turbt,1
9888,sprayshield™,1
9889,npwt for pilonidal surgery,1
9890,egfr mutation test,1
9891,magnetic resonance spectroscopy (3tesla),1
9892,aerobic activity,1
9893,scion (self care improvement through oncology nursing)-pain program,1
9894,imrt to 45 gy; prostate bed proton boost of 21.6 cge,1
9895,managment of oral therapy,1
9896,chamomile dose a,1
9897,gefitinib and capecitabine,1
9898,mvf-her-2(628-647)-crl 1005 vaccine,1
9899,vancomycin oral capsule,1
9900,"arvekap 0.1mg (triptorelin, ipsen, france)",1
9901,mr scans,1
9902,conventional elape,1
9903,"taxol, uft,leucovorin",1
9904,recombinant nematode anticoagulant protein c2 (rnapc2),1
9905,iratumumab,1
9906,therapeutic listening,1
9907,arn509,1
9908,closed stump,1
9909,norethisterone acetate,1
9910,5-flurorouracil,1
9911,"arry-380, her2 inhibitor; oral",1
9912,bay1834942 + pembrolizumab,1
9913,thalidomide(thado),1
9914,locally sourced compression therapy,1
9915,re-transcatheter arterial chemoembolization (re-tace),1
9916,apatinib combined with vinorelbine,1
9917,ddac-cp-olaparib,1
9918,pr104 770 mg/m^2 + sorafenib,1
9919,low intensity amplitude-modulated rf emfs,1
9920,omitting diverting ileostomy,1
9921,conventional pediatric colonoscope,1
9922,dti with titanium coated polypropylene mesh (tilooop® bra),1
9923,intravenous,1
9924,l-selenomethionine placebo,1
9925,irradiated donor-derived lymphoblastoid cell line,1
9926,l-plat,1
9927,classic technique of self-adherent wrap,1
9928,collecting a pad used at the first menstrual period after enrollment,1
9929,bumetanide,1
9930,digital polymerase chain reaction,1
9931,patient preference between mri and ultrasound,1
9932,3 dimensional radiation therapy,1
9933,capeox/xelox,1
9934,group based mind body medicine intervention,1
9935,nov120401,1
9936,topical antiangiogenic,1
9937,seminal vesicle-sparing radical prostatectomy,1
9938,fluorodeoxyglucose f 18,1
9939,pertuzumab 420 mg,1
9940,gic-1002 345 mg tid (equimolar to gic-1001 375 mg tid),1
9941,total parenteral nutrition (tpn),1
9942,dose 4,1
9943,amuvatinib (mp-470),1
9944,tariquidar + vinorelbine,1
9945,radical surgery-peritonectomy,1
9946,sbrt with protons or photons,1
9947,non-humor intervention (distraction),1
9948,ds6051b,1
9949,oxaliplatin and fluorouracil.,1
9950,individual meaning-centered psychotherapy (imcp),1
9951,standard care + conversational hypnosis,1
9952,cetuximab + erlotinib,1
9953,tarp peptide vaccine,1
9954,air placebo,1
9955,observational: stool sample collection,1
9956,lymphopheresis,1
9957,group information,1
9958,et 743,1
9959,flx475,1
9960,kl-a167,1
9961,fludarabine iv- busulfan iv (busilvex®) - anti-thymocyte globulines (thymoglobuline®),1
9962,microsatellite instability,1
9963,individualized interventions,1
9964,renal hypothermia,1
9965,tolipalimab,1
9966,intra-rectal botulinum toxin a injection,1
9967,cervical cancer-specific car-t cells,1
9968,apatinib (500 mg/d) + docetaxel (60 mg/m2),1
9969,gsk461364,1
9970,cblb612,1
9971,walk by faith,1
9972,leucovorin+5-fu,1
9973,"human papillomavirus vaccine l1, type 6,11,16,18",1
9974,montreal cognitive assessment (moca),1
9975,tivo,1
9976,donafenib(300mg),1
9977,lenali,1
9978,the endorotor®,1
9979,autologous stem-cell transplant,1
9980,eus guided fine needle aspiration,1
9981,tinidazole,1
9982,vigam® (human normal immunoglobulin),1
9983,"s-1,docetaxel",1
9984,bone metastases biopsy,1
9985,3d-rt with sequential boost,1
9986,self-paced tobacco quit line,1
9987,radioactive seed localization (rsl),1
9988,definity contrast,1
9989,gemcitabine-oxaliplatin plus rituximab (r-gemox),1
9990,[14c]linifanib,1
9991,"nbtxr3, il or ia injection + sbrt",1
9992,hipec with cisplatin,1
9993,fluorescent peptide,1
9994,limb sparing,1
9995,low volume iso-osmolar non-ionic radio contrast medium,1
9996,biopsy with 19 gauge needle,1
9997,additional blood sampling,1
9998,pet/ct imaging with [18f] 2-deoxy-2-(18f)fluoro-d-glucose (fdg),1
9999,stsg,1
10000,placental biopsy,1
10001,prostate and pelvis imrt,1
10002,glubran 2,1
10003,therapeutic yoga and resistance exercise,1
10004,integrated vs non-integrated risk education,1
10005,mva-bn-cv301,1
10006,bone marrow aspiration /trephine biopsy,1
10007,intravenous morphine patient controlled analgesia device,1
10008,home exercise programme (hep),1
10009,"bortezomib, thalidomide, dexamethasone (vtd) + daratumumab",1
10010,guardix-sg,1
10011,vt-122 low dose,1
10012,intra operative radiation therapy (iort),1
10013,"gliadel wafer, temodar and radiotherapy",1
10014,sig12d loder,1
10015,tranexamic acid (txa),1
10016,chemotherapy plus bevacizumab,1
10017,a-101 40%,1
10018,standard endocrine therapy,1
10019,om pain app,1
10020,mycrcs+prefs,1
10021,antihistamine cetirizine hydrochloride,1
10022,pazopanib and pemetrexed,1
10023,miso pet scan,1
10024,fact-b quality of life,1
10025,fish oil placebo,1
10026,itreg,1
10027,umbilical cord blood unit with c3a fragment,1
10028,oncopheresis,1
10029,altretamine,1
10030,quality of life measurement,1
10031,sham block,1
10032,tyrosine kinase inhibitor gefitinib (iressa),1
10033,radiation : pet-ct with f18-choline examination,1
10034,nx,1
10035,warmed carbon dioxide insufflation,1
10036,scar massage.,1
10037,fulvestrant 500mg,1
10038,anti-ctla-4/pd-1 expressing muc1-car-t,1
10039,paclitaxel/cisplatin,1
10040,myomectomy or adenomyomectomy,1
10041,"[18f] 4-l-fluoroglutamine (2s,4r)",1
10042,dc-cik treatment,1
10043,satisfaction questionnaire - general practitioner or home nurse,1
10044,epic 26,1
10045,infusion of two unexpanded cord blood units.,1
10046,ny-eso-1b peptide plus cpg 7909 and montanide isa-51,1
10047,radiofrequency ablation combined with tace,1
10048,device: transcutaneous acupoint electrical stimulation and seeds for auricular acupressure,1
10049,aurora kinase inhibitor at9283,1
10050,magnetic resonance imaging using an endovaginal receiver coil,1
10051,gastrectomy with d2 or greater lymph node dissection,1
10052,talacotuzumab,1
10053,modified radical mastectomy or breast-conserving surgery,1
10054,tutoring program i,1
10055,regular dietary support,1
10056,16 weeks of vec + cddp,1
10057,sham rtms (same parameters but with coil elevated and angled away from the head) every day for 10 consecutive days (5 days/week).,1
10058,gynoflor,1
10059,mycoach on amazon alexa,1
10060,reduced-intensity conditioning regimen,1
10061,blood test 6hours,1
10062,weight reduction regimen,1
10063,low dose capecitabine,1
10064,concurrent chemoradiation only,1
10065,individually tailored lead weight,1
10066,secondary debulking,1
10067,intake of 60 ml agaricus daily in addition to chemotherapy,1
10068,open rectal resection,1
10069,docetaxel plus capecitabine,1
10070,immunomonitoring,1
10071,to compare the ivf/icsi outcomes of gnrh antagonist cycle versus gnrh agonist cycle,1
10072,making your wishes known,1
10073,cg0070,1
10074,pancreatic resection after preoperative chemotherapy,1
10075,brahms cga ii kryptor,1
10076,resting state functional connectivity mri (rs-fcmri),1
10077,"gemcitabine , cisplatin, oral rehydration solution (ors)",1
10078,300 mg oral azacitidine,1
10079,low-risk lifestyle behaviours,1
10080,melatonin 20 mg oral capsule,1
10081,prophylactic dose antithrombotic,1
10082,18f-fch,1
10083,"stem cell transplant,",1
10084,eras protocol preoperative actions,1
10085,thymosin a1,1
10086,wound infiltration with drug a (active),1
10087,mechanical measures,1
10088,c-met inhibitor amg 337,1
10089,straight coloanal anastomosis,1
10090,"educational materials, plus patient navigation",1
10091,[18f]-fluorothymidine,1
10092,"cyclosporin a,mycophenolate mofetil,methotrexate",1
10093,monoclonal antibody 3h1 anti-idiotype vaccine,1
10094,completion of pro-ctcae items before consultation,1
10095,green tea capsules,1
10096,propofol 4.0 mg/kg + remifentanil 0.5 ug/kg,1
10097,hospitalization for a week,1
10098,flavonoids,1
10099,unlabeled th-302,1
10100,range of motion,1
10101,erythropoietin (epo),1
10102,placebo daily for one year,1
10103,b-cap,1
10104,high voltage electrical stimulation - axillary lymphadenectomy,1
10105,karonudib,1
10106,metabolic rate testing,1
10107,ledipasvir 90mg/sofosbuvir 400 mg,1
10108,daborafenib plus trametinib,1
10109,3d mammogram/breast tomosynthesis scan: selenia® dimensions®,1
10110,tiva-tci,1
10111,pegylated rhg-csf:150 ?g/kg,1
10112,car-t cell,1
10113,oral corticosteroids,1
10114,bipolar versus ultrasonic hemostasis techniques,1
10115,vigorous exercise,1
10116,pre/post test of a lung cancer screening decision aid,1
10117,"molecular testing of dna/rna from skin tumors, scc/bcc",1
10118,mflox,1
10119,lamivudine 100mg once daily; or entecavir 0.5mg once daily.,1
10120,short-term diet and exercise intervention,1
10121,perianal and digital anorectal exam,1
10122,azacitidine plus deferasirox,1
10123,orphenadrine,1
10124,"preoperative hepatic and regional arterial chemotherapy using oxaliplatin, mmc and fudr",1
10125,distal ureterectomy,1
10126,standard fractionation regimen,1
10127,aluminium disk,1
10128,european organization for research and treatment of cancer (eortc) qlq-c30,1
10129,pegylated rhg-csf 100?g/kg,1
10130,cg,1
10131,cab-ror2-adc,1
10132,very accelerated radiotherapy 64.8 gy in 3.5 weeks,1
10133,rapamycin + high dose etoposide and cytarabine,1
10134,isolated roux-en-y type reconstruction,1
10135,intraventricular etoposide,1
10136,surgical electrocautery (eca),1
10137,deep brain stimulation (dbs) of globus pallidus internus (gpi) and best medical treatment (bmt),1
10138,low-dose cytarabine,1
10139,ridaforolimus intravenous (iv) infusion,1
10140,tamoxifen + exemestane,1
10141,protein and creatine,1
10142,routine post-op care,1
10143,rfid and wire localization,1
10144,permanent prostate implant (ppi),1
10145,spect imaging,1
10146,alt-p7 (hm2-mmae),1
10147,asp8273 capsules a,1
10148,eus-b-fna followed by ebus-tbna,1
10149,ravuconazole,1
10150,educational intervention (prevention education),1
10151,pci 32765,1
10152,study diary,1
10153,mailed outreach invitation,1
10154,uc,1
10155,balloon implantation,1
10156,targeted cryoablation therapy,1
10157,hdac chemotherapy,1
10158,mn-166,1
10159,pain scale questionnaire,1
10160,nx group,1
10161,pediatric cancer women survivors,1
10162,unlabelled hmab biwa 4 - high dose,1
10163,"flexible fiber-based co2 laser, quality of life forms",1
10164,patient information leaflet,1
10165,"anastrozole, letrozole, exemestane",1
10166,anticonvulsant,1
10167,benzydamine hydrochloride 0.15% oral rinse,1
10168,hemopoietic stem cell procurement,1
10169,drug: topical rapamycin,1
10170,surgery on demand,1
10171,6600 cgy/33 fractions over 45 days,1
10172,atu027 & gemcitabine in treatment arm 2,1
10173,"sampling on blood, bone marrow and cerebrospinal fluid",1
10174,phase ii- sequence a,1
10175,daily self-monitoring,1
10176,her2 positive lesion detection and safety,1
10177,patients with invasive breast cancer will receive:,1
10178,central lymph node dissection,1
10179,vaccination with mimotope p10s-padre/montanide isa 51 vg,1
10180,intrathecal (it),1
10181,lh-rh agonist,1
10182,physician assessment,1
10183,enalapril and carvedilol,1
10184,topical application cervical spray,1
10185,hypofractionated external beam,1
10186,car-cld18 t cells,1
10187,iodine-124 labeled humanized a33 (antibody),1
10188,arthroscopic synovial tissue biopsy,1
10189,padi,1
10190,non-target drug,1
10191,r-chop / r-had,1
10192,usual care + acupuncture,1
10193,mri scan and fdg-pet scan,1
10194,5fu/leucovorin,1
10195,30 gy in 5 fractions,1
10196,non invasive monitoring device (ani),1
10197,vinorelbine injection,1
10198,continuous intravenous infusion of fluorouracil (civ 5-fu),1
10199,cycle 3 early consolidation,1
10200,mgah22,1
10201,dendritic cells (dc) prostate,1
10202,gemcitabine hydrochloride + cisplatin or carboplatin,1
10203,participant questionnaires,1
10204,cell therapy product,1
10205,fertility treatment,1
10206,docetaxel zoledronic,1
10207,intrabone administration of umbilical cord blood,1
10208,dac,1
10209,azd2014 2 on/5 off & weekly paclitaxel,1
10210,survey assessments,1
10211,a arm (clag-m),1
10212,phenobarbital,1
10213,cabazitaxel 15mg/m2,1
10214,diagnostic imaging aid for one-visit management of cervical lesions,1
10215,peer-pn,1
10216,oral apixaban,1
10217,helical tomotherapy for breast cancer,1
10218,mva-bn-brachyury,1
10219,open-lung approach,1
10220,cap for mucosectomy,1
10221,written information,1
10222,local anaesthetic injection,1
10223,oncology interactive navigator,1
10224,human papillomavirus 16/18 l1 virus-like particle/as04 vaccine,1
10225,patient activation measure (pam) scale,1
10226,lanreotide and metformin,1
10227,placebo 50mg,1
10228,advance care planning (acp) decisions videos decisions aids,1
10229,drug diary filling,1
10230,"gemcitabine, docetaxel and bevacizumab",1
10231,"lzm009,recombinant humanized anti-pd-1 monoclonal antibody for injection",1
10232,cyclophosphamide 750mg/m2 by iv infusion,1
10233,vats (thoracoscopy),1
10234,6 months,1
10235,tace combined with iodine-125 seeds implantation,1
10236,hsp90 inhibitor at13387,1
10237,white light biopsy,1
10238,group c - usual breathing control group,1
10239,prevana dressing,1
10240,sph1188-11,1
10241,diabetes prevention program,1
10242,18f-dcfpyl iv injection,1
10243,asn003 ascending doses,1
10244,rvm(respiratory volume monitor),1
10245,mitozantrone,1
10246,ebc treated participants,1
10247,cobas pcr female swab sample packet,1
10248,trastuzumab and non-pegylated liposomal doxorubicin,1
10249,medical practitioner consultation,1
10250,thyroid surgery,1
10251,sample collection blood,1
10252,short course adjuvent chemotherapy,1
10253,landscape sample method,1
10254,hpph 2-1[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a),1
10255,zfn-603 and zfn-758,1
10256,[15-o] h2o,1
10257,clinimacs cd34+ reagent system,1
10258,pegylated asparaginase,1
10259,purpose project,1
10260,protein-rich nutrition therapy,1
10261,perioperative systemic therapy,1
10262,lc-rt-pcr and ngs,1
10263,sonographic studies,1
10264,3.0 tesla in magnetic resonance imaging,1
10265,active smokers - smoking cessation arm,1
10266,extracorporeal biofeedback device (any kegel),1
10267,axillar sentinel lymph node biopsy,1
10268,ffp+hdmp+rituximab,1
10269,3.0pd,1
10270,implantation of anchored beacon transponder in the lung,1
10271,nk-dli + duk-cpg-001,1
10272,clinical trial matching,1
10273,pertuzumab + trastuzumab + metronomic chemotherapy,1
10274,ofatumumab 1000mg,1
10275,human growth hormone,1
10276,([18f]-ml-10),1
10277,"definity, (lipid microspheres) intravenous suspension",1
10278,"gemcitabine, vinorelbine, filgastrim",1
10279,"dasatinib, 70 mg + lenalidomide, 15 mg + dexamethasone, 40 mg",1
10280,microsurgical removal of vestibular schwannoma,1
10281,colometer,1
10282,faslodex (fulvestrant),1
10283,auto2,1
10284,telephone coaching calls,1
10285,cell sorting,1
10286,"monopolar transurethral resection of the urinary bladder (storz gmbh &co., erbotom, purisole)",1
10287,non-polarized dendritic cells,1
10288,carboplatin and taxol (paclitaxel),1
10289,degarelix 80 mg / degarelix 80 mg,1
10290,morphine s.c.,1
10291,shr1020 plus docetaxel,1
10292,no intervention is being made,1
10293,apatinib and irinotecan,1
10294,"endoxana, leukine, ima910, aldara",1
10295,laparoscopic approach with an extended pelvic lymph,1
10296,placebo 40 mg,1
10297,optical clearing,1
10298,phytoestrogen-rich foods,1
10299,bacteriostatic 0.9% sodium chloride (vehicle),1
10300,evaluation of muscular strength,1
10301,humanized cd19 car-t cells with crs suppression technology,1
10302,khk2823,1
10303,device usability survey,1
10304,pain squad+,1
10305,"pet-scan, mri-scan",1
10306,vitamin e supplement,1
10307,oral anti-diabetic drugs,1
10308,pedsql cancer module,1
10309,pleth variability index (pvi),1
10310,cisplatin plus pemetrexed,1
10311,3 radiofrequency ablation procedures (habib™ eus-rfa),1
10312,endobronchial ultrasound guided transthoracic needle biopsy,1
10313,tesetaxel 10 mg with and then without food,1
10314,find cancer associated antibodies,1
10315,24hour blood pressure,1
10316,redifferentiation with retinoid acid,1
10317,risk factor questionnaire,1
10318,dose distribution data collection,1
10319,patient views nci crc rat,1
10320,conventional eus-fna,1
10321,treatment c (rosuvastatin + 400 mg lx4211 administered concomitantly),1
10322,mr and ct imaging,1
10323,ptk787/zk 222584 (vatalanib),1
10324,mrs spectroscopy,1
10325,pan-301-1,1
10326,lenalidomide 5 mg,1
10327,uniportal pulmonary resection surgery,1
10328,trastuxumab,1
10329,home-based adapted physical activity,1
10330,erc1671,1
10331,without preoperative access to lymphoscintigraphy findings,1
10332,tumor scans,1
10333,duct tape occlusion therapy,1
10334,spinal anesthesia with intrathecal morphine,1
10335,without surgery and without ipch,1
10336,cisplatin/radiation therapy,1
10337,lepirudin,1
10338,"bevacizumab, abt-510",1
10339,bortezomib/dexamethasone/melphalan,1
10340,doxorubicin intravenous,1
10341,lerafaon-etu,1
10342,vcd induction therapy,1
10343,palliative radiotherapy (rt),1
10344,kn035 plus gemcitabine & oxaliplatin,1
10345,endoultrasound guided fnb,1
10346,oesophageal stent followed by external beam radiotherapy,1
10347,"magnetic resonance imaging (mri) 1,5 tesla",1
10348,dopexamine,1
10349,tutoring program ii,1
10350,specialised palliative care (spc),1
10351,alentuzumab,1
10352,prescribed activity,1
10353,lymphoseek and vbd sln dissection,1
10354,renal microdialysis,1
10355,hexaminolevulinate (hexvix),1
10356,placebo (mcg) (aluminum adjuvant)225,1
10357,fluorouracil - infusion,1
10358,megestrol acetate (ma) 400 mg/day,1
10359,placebo acupressure band,1
10360,expectations survey (cancors),1
10361,bile sample analysis,1
10362,bms-986207,1
10363,cg200745,1
10364,decision aid for breast cancer screening,1
10365,oxaliplatin plus capecitabine,1
10366,end of life care coordination,1
10367,radiation with protons,1
10368,palonosetron (aloxi) and dexamethasone,1
10369,irinotecan and docetaxel,1
10370,clinical trial educational materials,1
10371,trail-r1 mab (trm-1; hgs-etr1),1
10372,auto-allo tandem sct and maintenance therapy with thalidomide/ dli,1
10373,electromagnetic acoustic imaging,1
10374,cx-188,1
10375,low-dose azacitidine,1
10376,"ifosphamide, etoposide, methotrexate, vincristine, prednisone",1
10377,catheter,1
10378,uv-detect photos,1
10379,hyperthermic intraperitoneal chemotherapy with carboplatin,1
10380,bortezomib 1.6 mg/m2,1
10381,eszopiclone,1
10382,endoscopy examination with iodine staining,1
10383,tpf group,1
10384,qualitative data collection,1
10385,temsirolimus/pld,1
10386,resistive training,1
10387,placebo (for pregabalin),1
10388,ic9-gd2 t cells,1
10389,lc or oncozene bead with gem-cis or gem-carbo,1
10390,nivolumab 6 mg/kg iv,1
10391,trifluridine/tipiracil hydrochloride (s95005),1
10392,sonatherm 600i ablation system,1
10393,regular early specialist symptom control treatment (ressct),1
10394,vle (volumetric laser endomicroscopy),1
10395,xeliri + bevacizumab,1
10396,anti-cd19 car-t cells and anti-cd20 car-t cells,1
10397,azixa,1
10398,cisplatin + docetaxel,1
10399,wallflex™ biliary partially-covered stent,1
10400,immediate release morphine sulphate,1
10401,ribvd,1
10402,endove,1
10403,sampling of ascites and pleural effusion,1
10404,fit,1
10405,haploidentical hematopoietic stem cell transplantation,1
10406,anti- meso car-t cells,1
10407,chop plus lanzoprazole,1
10408,cradle,1
10409,medi6469 plus durvalumab,1
10410,albis®,1
10411,heat shock protein 70 hsp70,1
10412,telaprevir,1
10413,neurodyn high volt model (ibramed),1
10414,dtgm,1
10415,preoperative rehabilitation program,1
10416,remifentanil-propofol mixture,1
10417,fulvestrant (faslodex),1
10418,carboplatin and paclitaxel followed by surgery,1
10419,rai treatment,1
10420,placebo sar302503,1
10421,"rituximab, bendamustine, mitoxantrone, dexamethasone",1
10422,no test empiric strategy,1
10423,simple seton drain removal,1
10424,intensive chemotherapy,1
10425,pdl192,1
10426,enterade,1
10427,laser system,1
10428,"ixabepilone, 10 mg/d",1
10429,add-on therapy,1
10430,investigator choice therapy,1
10431,stratafix pga suture,1
10432,surgimend® prs,1
10433,hysteroscopic cell sampling of the fallopian tube,1
10434,soy protein,1
10435,digital breast tomosynthesis (dbt),1
10436,emdr psychotherapy,1
10437,red blood cell transfusions,1
10438,pasireotide 0.6mg solution for injection,1
10439,chemotherapy arm b,1
10440,laparoscopic sentinel node biopsy,1
10441,behavioral intervention sessions,1
10442,single positioning,1
10443,pancreato-jejunal anastomosis,1
10444,imc-20d7s (cohort 1a),1
10445,laparoscopic colorectal resection,1
10446,mri with breath-holding,1
10447,anti-ox40 antibody administration,1
10448,dacarbazine + interferon alpha,1
10449,sxl01,1
10450,protocol of physiotherapy exercises,1
10451,sheng-yu-tang,1
10452,"gemcitabina, cisplatino",1
10453,muromonab,1
10454,"erdafitinib, dexamethasone, ixazomib, pomalidomide",1
10455,pf-06647020 q2w,1
10456,rovalpituzumab tesirine (sc16ld6.5),1
10457,electrocautery versus scalpel,1
10458,lozenge - nicotine mini-lozenges,1
10459,focal therapy using high intensity focused ultrasound,1
10460,"camptothecin (cpt) conjugated to a linear, cyclodextrin-based polymer",1
10461,lycopene 30mg,1
10462,endoscopic ultrasound staging,1
10463,aed,1
10464,non-power injectable port (cook vital mini port),1
10465,131 i-mibg,1
10466,intra thecal methotrexate,1
10467,albumin paclitaxel plus carboplatin,1
10468,bone graft,1
10469,myeloablative chemotherapy regimen for non-cord blood unit recipients with myeloid malignancies,1
10470,nanodoce (intravesical instillation) - induction and maintenance instillations,1
10471,adherence,1
10472,asonep,1
10473,h pylori eradication,1
10474,mri with endo-rectal coil,1
10475,c225-ils-dox,1
10476,oxaliplatin (l-ohp),1
10477,primary/bowel-first surgery,1
10478,ancillary study,1
10479,ethanol lock therapy (elt),1
10480,executive functions,1
10481,c-11 methionine pet,1
10482,iheat portable warm compress therapy,1
10483,decision support & navigation,1
10484,high risk with complete early response after 1 abvd and 1 eshap courses. four more chemotherapy courses are delivered alternating eshap and abvd.,1
10485,right internal jugular access.,1
10486,haplo donor stem cell transplantation,1
10487,rrx-001 + wbrt,1
10488,vinblastine + nilotinib,1
10489,spectroscopy device,1
10490,bulking agent injection,1
10491,progesterone vaginal insert,1
10492,alignrt system,1
10493,3l polyethylene glycol,1
10494,tavanic,1
10495,standard-of-care temozolomide,1
10496,"nilotinib,novartis,300 mg twice a day +pegylated interferon 2a,roche, 45 microg weekly starting month 2-month 12 or beyond according to investigator choice.",1
10497,autologous tumor cells plus dendritic cells,1
10498,pegylated liposomal doxorubicin hydrochloride (pld),1
10499,ly2157299 monohydrate,1
10500,ltp flap,1
10501,resmed autoset s9,1
10502,i-scan,1
10503,additional blood drawn,1
10504,adr-529,1
10505,"gemcitabine, nucleoside analogue; intravenous",1
10506,durvalumab (regimen 2),1
10507,normal controls,1
10508,liver perfusion mri,1
10509,ipilimumab (3 mg/kg),1
10510,bibf 1120 high dose,1
10511,imatinib/nilotinib,1
10512,single port robotic colorectal surgery,1
10513,coaching,1
10514,home safety pamphlet,1
10515,flow mediated dilation,1
10516,endotracheal intubation,1
10517,immediate mbsr,1
10518,ck-101,1
10519,cort125281,1
10520,erapid,1
10521,placebo to vorinostat,1
10522,saw palmetto,1
10523,second phase of induction,1
10524,"low dose aspirin, vitamin d placebo",1
10525,measurement of vascular perfusion: contrast enhanced mri,1
10526,show an increase in incidence of cancers in patients with synchronous lymphoma,1
10527,data collection on depo-eligard exposure,1
10528,standard nccn counseling,1
10529,microwave ablation with acculis accu2i pmta applicator,1
10530,"gax - gemcitabine, abraxane and xeloda",1
10531,"cisplatin, gemcitabine, interferon-alpha",1
10532,pre-pectoral tissue expander,1
10533,fudr +oxaliplatin,1
10534,c-choline pet scanning,1
10535,folic acid tablet,1
10536,"rituximab, temsirolimus, dhap, intravenous",1
10537,multispectral imager,1
10538,green tea drink,1
10539,baseline questionnaires,1
10540,routine review of dre results by attending doctors,1
10541,comparison arm,1
10542,rp4010,1
10543,exemestane tablets,1
10544,non intervational,1
10545,shave biopsy,1
10546,ptk787/zk222584 and bevacizumab,1
10547,questionnaire (fagerstrom test),1
10548,gsk biologicals' 719125,1
10549,luteinizing hormone-releasing hormone (lhrh),1
10550,isb dye and standard white light imaging,1
10551,dcs (docetaxel with cisplatin with ts-1),1
10552,tangential radiation,1
10553,bevacizumab + folfiri-3,1
10554,hcq/cq and cab combined treatment,1
10555,intravenous placebo/intravenous placebo,1
10556,doxorubicin 60 mg/m2+cyclophosphamide 600 mg/m2,1
10557,community interlink program,1
10558,"paclitaxel, carboplatin and bevacizumab,erlotinib",1
10559,protective to traditional ventilation,1
10560,placebo: lactose,1
10561,educational counseling intervention,1
10562,series of tests/questionnaires,1
10563,cfg920,1
10564,interferometric synthetic aperture microscopy,1
10565,a-101 solution 40,1
10566,nutropin,1
10567,pf-06821497,1
10568,cryoablation therapy,1
10569,glucosamine,1
10570,metformin/placebo,1
10571,fimepinostat,1
10572,vmat,1
10573,transcranial doppler,1
10574,yallaferon®,1
10575,e39 peptide vaccine,1
10576,pneumoperitoneum pressure 6 mmhg,1
10577,obinutuzumab 25 mg/ml,1
10578,consultation recording,1
10579,js-001,1
10580,2d hdr planning,1
10581,"folinic acid 200 mg/m², 1-2-hour-infusion, day 1",1
10582,atu027,1
10583,autologous dc vaccine,1
10584,astagalus-based formula: qingshu-yiqi-tang,1
10585,dose escalation of durvalumab and trabectedin,1
10586,cognitive decline assessment,1
10587,bilateral arm measurements,1
10588,lbh 589,1
10589,[f 18]hx4,1
10590,"cetuximab, cisplatin, doxorubicin & cyclophosphamide",1
10591,hypofractionated chest radiotherapy,1
10592,partial submuscular coverage,1
10593,131-i mibg and in-111 dotatate,1
10594,doxorubicine + cyclophosphamide sequential,1
10595,ctla-4/pd-1 antibodies expressing mesocar-t,1
10596,3 dimensional tomosynthesis imaging,1
10597,diagnostic laboratory rna and dna biomarker analysis of primary tumors,1
10598,tetanus-cmv fusion peptide vaccine,1
10599,lbc,1
10600,brief behavioral therapy for insomnia (bbt-i),1
10601,vancomycin pretreatment,1
10602,gammapod tumour bed boost,1
10603,fna (fine needle aspiration),1
10604,interferon inoculation,1
10605,oral rinse collection,1
10606,intraoperative intravenous lidocaine infusion,1
10607,clofarabine and cytarabine,1
10608,routine dynastat or flurbiprofen axetil jinjection,1
10609,bcd-135,1
10610,modified atkin's diet,1
10611,haplo-cord transplant,1
10612,supersaturated calcium-phosphate,1
10613,shower patch iv catheter protection,1
10614,tissue tumor biopsy,1
10615,sun safety ink! program,1
10616,virtual bronchoscopy navigation,1
10617,once daily apbi,1
10618,fitbit charge 2,1
10619,contrast-enhanced mr mammography,1
10620,whole brain radiotherapy (wbrt) with concomitant depocyte,1
10621,team-based intervention,1
10622,surgical intervention for cnfa,1
10623,total skeletal irradiation,1
10624,"degarelix acetate, leuprolide acetate",1
10625,tpa low dosage,1
10626,"fmiso-pet, fdg-pet-ct and magnetic resonance imaging (mri)",1
10627,to perform rt-pcr on the tissue obtained during surgery,1
10628,local srt,1
10629,expanded allogeneic cord blood (cb),1
10630,first part of treatment : conformal irradiation,1
10631,18f-fluoro-dihydroxyphenylalanine,1
10632,bortezomib/lenalidomide/ low dose dex,1
10633,dysport (abobotulinumtoxina),1
10634,device(dc bead),1
10635,measurement of intima media thickness of carotid artery,1
10636,manual acupuncture implemented by senior acupuncturists,1
10637,tavocept(bnp7787) in combination with cisplatin and either docetaxel or paclitaxel,1
10638,eras protocol intraoperative actions,1
10639,dexanabinol dose level 4,1
10640,sorafenib 200mg tab,1
10641,hematoporphyrin derivative,1
10642,t lymphocytes icasp9 ?cd19,1
10643,avadomide (cc-122),1
10644,medi2070 high-med dose,1
10645,tanezumab,1
10646,campath-1h /atg,1
10647,breast exam and questionaire,1
10648,comparator: bexarotene,1
10649,acetaminophen/ibuprofen,1
10650,anti thymoglobulin,1
10651,cyberknife® stereotactic body radiotherapy(sbrt)boost,1
10652,acetylsalicylic acid lysinate 100 mg,1
10653,aerosol sargramostim,1
10654,preoperative short-course radiotherapy with local boost,1
10655,usual care - written materials,1
10656,ifosfamide 2000mg/m2,1
10657,hla-a*0201 or hla-a*0206-restricted urlc10 peptides,1
10658,erapa (encapsulated rapamycin),1
10659,[18f]facbc pet and [18f]flt pet imaging,1
10660,0.04 mg/kg cpg 7909,1
10661,patient intervention,1
10662,conventional hospital treatment,1
10663,peri operative cetuximab.,1
10664,abbv-176,1
10665,hl-085,1
10666,mitomycin c; capecitabine; bevacizumab,1
10667,best systemic therapy (bst) + surgery or radiation therapy,1
10668,laboratory investigations,1
10669,4% topical lidocaine gel,1
10670,peptide vaccine for urlc10,1
10671,external drainage tube [polyethylene pancreatic drainage tube],1
10672,ntms data not available for the surgeon,1
10673,self reported quality of life questionnaire,1
10674,lde225+gemcitabine,1
10675,l19il2+l19tnf,1
10676,this is a non-interventional study. patients will be treated with any intervention deemed appropriate by the patient's physician.,1
10677,non-myeloablative conditioning regimen,1
10678,placebo matching dacarbazine,1
10679,association of day hospitalization with hospital-at-home,1
10680,piritrexim,1
10681,video-conference quality of life counseling,1
10682,pd-1 inhibitor + gemcitabine + cisplatin,1
10683,follow up system and multimodality approach,1
10684,anlotinib 10mg + ap/pc,1
10685,phase contrast mammography,1
10686,determination of concentrations of androgens,1
10687,hepatitis a inactivated virus vaccine,1
10688,"pembrolizumab,",1
10689,songyou,1
10690,autologous dexosomes loaded with tumor-specific peptides,1
10691,fentanyl transmucosal,1
10692,"injection with the hypoxia tracer [18f]hx4,",1
10693,fitbit tracker,1
10694,carboplatin and pemetrexed with bevacizumab 15 mg/kg,1
10695,rgx-202-01,1
10696,ifobt,1
10697,ethynyl-estradiol plus cyproterone acetate,1
10698,25 mg/m2 lenalidomide (revlimid®) and 180 mg/m2 vorinostat (zolinza®),1
10699,separable cluster electrode (octopus®),1
10700,endoscopically assisted colostomy with colopexy,1
10701,xpand,1
10702,non-fucosylated regulatory t cells,1
10703,tti-101,1
10704,tnf-alpha inhibitor,1
10705,haploidentical bone marrow/kidney,1
10706,"cetuximab, cisplatin, capecitabine",1
10707,leaf extract of a. indica,1
10708,inguinal lymphadenectomy,1
10709,adding diverting ileostomy,1
10710,cinacalcet capsule,1
10711,slow freeze,1
10712,imrt + oral chemotherapy,1
10713,intermittent pazopanib (arm b),1
10714,therapeutic extended lymphadenectomy,1
10715,control +,1
10716,counselor-initiated tobacco quit line,1
10717,whole body diffusion-weighted mri,1
10718,quadrantectomy and axillary dissection,1
10719,"bevacizumab, irinotecan and temozolomide",1
10720,pegylated interferon-alfa 2b (peg intron),1
10721,in111-pentetréotide,1
10722,phase 1 : regorafenib,1
10723,small bore chest drain + opiate based analgesic regimen,1
10724,reproduce breathing cycle utilizing spirometry,1
10725,cyclophosphamide + mesna,1
10726,premedication for paclitaxel,1
10727,open rectal surgery,1
10728,"mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine",1
10729,nutrient intake,1
10730,radical prosatectomy,1
10731,20 core-biopsy fragments,1
10732,colonic inspection,1
10733,fractionated iced,1
10734,itraconazole capsules,1
10735,trans-arterial chemo-embolization,1
10736,web platform for advance care planning/advance directive,1
10737,teledermatology feedback,1
10738,bibw 2992 high dose,1
10739,hepcortespenlisimut-l,1
10740,desorelle,1
10741,tq-b3525,1
10742,6 tec q 3 weeks,1
10743,ketogenic diet (kd),1
10744,anti-ny eso-1 tcr-transduced t cells,1
10745,technetium-99,1
10746,oral methadone,1
10747,questionnaires on hrqol and sociodemography,1
10748,"gemcitabine, s-1, radiotherapy",1
10749,esomeprazole magnesium (nexium),1
10750,dmot4039a,1
10751,canoeing,1
10752,assessment of health-related quality,1
10753,light therapy intensity 2,1
10754,[18f]fluoromisonidazole,1
10755,avi-4126 injection (resten-ng®),1
10756,estrogens,1
10757,"sie artery clamped, vein unclamped",1
10758,nerve-spring radical hysterectomy,1
10759,ly3295668,1
10760,linear ldr source,1
10761,fluma peptide,1
10762,oral rinse,1
10763,targeted biopsies using magnetic resonance imaging guiding,1
10764,general dietary advices,1
10765,neurotech nt2000 neuromuscular electrical stimulation (nmes),1
10766,clinical course,1
10767,myo-inositol 2000 gr + folic acid 200 mcg,1
10768,chining decoction,1
10769,derma vax (electroporation device),1
10770,stereotactic percutaneous image-guided microwave ablation,1
10771,interactive advance care planning,1
10772,surgical bypass,1
10773,ga-68-dota-toc,1
10774,electrocoagulation,1
10775,bone marrow tests,1
10776,fecal occult blood tests,1
10777,placebo formulation 1,1
10778,metformin hcl 500mg 24hr sa tab,1
10779,neurocognitive remediation,1
10780,balloon implant,1
10781,"idarubicin(10mg/m2), cytosine arabinoside",1
10782,timed get-up and go test (tgug).,1
10783,attention control (reading),1
10784,5 fraction stereotactic body radiation therapy,1
10785,contrasting ct,1
10786,cisplatin 50mg/m2,1
10787,shr-1210+gemox,1
10788,whey protein supplement,1
10789,stereotactic body radiotherapy (sbrt) dosed at the maximum tolerated dose,1
10790,endobronchial ultrasound-guided transbronchial needle aspiration,1
10791,metformide hydrochloride/pioglitazone hydrochloride extended-release tablet,1
10792,lni 15 fractions,1
10793,pre-operative exercise programme (my-pep),1
10794,elbow arthroplasty,1
10795,endoscopic ultrasound-guided fine-needle aspiration (eus-fna),1
10796,rituximab + acvbp regimen plus pegfilgrastim,1
10797,eortc-qlq-c30 questionnaire,1
10798,attention control group,1
10799,conventional treatment protocols of breast cancer,1
10800,high dose chemo and auto hematopoietic cell transplant,1
10801,tocilizumab (roactemra®),1
10802,metformin 1500 mg,1
10803,extubation time and recovery time,1
10804,bio-11006 plus standard of care,1
10805,dacogen,1
10806,tldg or ladg,1
10807,psa and stockholm3,1
10808,continued ablation,1
10809,lni 5 fractions,1
10810,stereotactic radiation arm 1,1
10811,percutaneous hepatic perfusion,1
10812,infra-red coagulation,1
10813,uterine myomectomy with preventive uterine arteries occlusion,1
10814,g-csf mobilized hla-haploidentical donor pbsc,1
10815,jnj-56022473,1
10816,superior hypogastric nerve block,1
10817,electronic + no text message,1
10818,neoviderm cream,1
10819,hippocampal avoidance whole brain radiotherapy,1
10820,carum cravi,1
10821,nurse practitioner consultation,1
10822,traditional laparoscopy-assisted surgery,1
10823,manual acupuncture on p6 point,1
10824,velcade-thalidomide-dexamethasone,1
10825,zavedos®,1
10826,cdmard,1
10827,biomarker screening,1
10828,cd34+ selection with clinimacs device,1
10829,physician does not receive the results,1
10830,"oxaliplatin, irinotecan, bevacizumab, docetaxel",1
10831,ioversol,1
10832,progestin therapy,1
10833,saliva sample collection for genetic analyses,1
10834,molecular nanotechnology,1
10835,twinrix ™ paediatric,1
10836,autofluorescence bronchoscopy,1
10837,pet-tdm for current indication,1
10838,inspiratory muscle program,1
10839,empowerment,1
10840,bsi-201 + temozolomide,1
10841,patient hotline: 24 hour follow-up following call to ask my nurse number,1
10842,2-d laparoscopy,1
10843,"chemotherapy,radiotherapy",1
10844,surgery: left thoraco-abdominal approach,1
10845,medical / surgical treatment,1
10846,siaci of erbitux and bevacizumab,1
10847,intervention invitation materials,1
10848,bedside assessment,1
10849,clindamycin 2% in hydrocortisone 1% lotion,1
10850,mgmt methylation evaluation,1
10851,omega-3 free fatty acids,1
10852,abiraterone acetate 1000 mg,1
10853,health education intervention,1
10854,acetazolamide+ prone positioning,1
10855,doxorubicin hydrochloride injection,1
10856,eryaspase (l-asparaginase encapsulated in red blood cells),1
10857,prone pillow and simple ankle fixation device,1
10858,afatinib plus ruxolitinib combination therapy,1
10859,"sunitinib, pazopanib, bevacizumab, everolimus...",1
10860,aereobic plus resisted exercise,1
10861,mrf scan,1
10862,modern educational program,1
10863,single-fraction radiotherapy with concomitant 5fu and hydrea,1
10864,alflutinib mesylate (ast2818) 80mg//40 mg+ placebo,1
10865,docetaxel+cddp,1
10866,120 mg mmc in 90ml gel,1
10867,ketamine/amitriptyline np-h cream,1
10868,superficial inferior epigastric vessels both unclamped,1
10869,gene therapy product cyl-02,1
10870,low-molecular heparine,1
10871,lymph node,1
10872,high-fat diet,1
10873,reconstruction with a gluteus maximus myocutaneous flap,1
10874,bone marrow sample,1
10875,chestwall xrt,1
10876,nih toolbox cognitive battery,1
10877,anlotinib plus icotinib,1
10878,cc-93269,1
10879,strontium chloride sr,1
10880,seigen alpha ev,1
10881,cinnamon supplementation,1
10882,4d pancreatic protocol ct scan,1
10883,erlotinib chlorhydrate,1
10884,plasma/serum sample for biomarkers,1
10885,ifa (incomplete freund's adjuvant),1
10886,genotyping,1
10887,standard educational material,1
10888,quality of life scale,1
10889,7 days sie plus 4 weeks pre,1
10890,3 weeks dose induction of everolimus,1
10891,dc-tn-muc1: autologous dendritic cells expressing tn-muc1,1
10892,aza-tdcyd,1
10893,screen film mammography,1
10894,different reconstruction methods,1
10895,nintedanib (bibf 1120),1
10896,mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes,1
10897,amoxicillin clavulanate,1
10898,carbon-11 acetate pet scan,1
10899,eguide to colonoscopy and in office ipad education,1
10900,trimix combination (papavarine 30mg/ml phentholamine 1mg/ml prostaglandin e1 10 mcg/mml) and questionnaires,1
10901,ril-21 + sorafenib,1
10902,endothelin receptor b inhibitor bq788,1
10903,etoposide + cisplatin,1
10904,canadvice+® (smart phone app),1
10905,faecal sampling,1
10906,normal saline with salt/soda,1
10907,ultrasound guided systematic biopsy,1
10908,sbrt 47.5 gy,1
10909,dim light,1
10910,afix+ provider communication training,1
10911,citogenex,1
10912,stereotactic radiotherapy 4 x 10 gy,1
10913,nutritional status.,1
10914,mri-guided litt therapy,1
10915,blood sample withdrawal,1
10916,mefloquine,1
10917,kahr-102,1
10918,reconstruction with an acellular porcine collagen implant,1
10919,90y-dota-hll2,1
10920,boswellia serrata extract,1
10921,nucleic acid amplification,1
10922,kos-1584,1
10923,chemotherapy alone following radical resection,1
10924,group (c),1
10925,light sedation,1
10926,carboplatin (area under the concentration curve [auc] 6),1
10927,nci-developed educational materials,1
10928,nutrition /swallowing intervention,1
10929,curcuviva™,1
10930,"epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan",1
10931,swallow therapy in combination with individual dietary counselling,1
10932,carboplatin plus irinotecan vs carboplatin plus etoposide,1
10933,placebo (control procedure),1
10934,capecitabine in combination with cisplatin and irinotecan,1
10935,group b adjuvant chemotherapy,1
10936,phytoestrogen,1
10937,bortezomib iv,1
10938,apbi: 27.5 gy,1
10939,shingrix vaccine,1
10940,cabazitaxel (xrp6258) (rpr116258),1
10941,matrix rf followed by pulse dye laser,1
10942,fecal microbiota transplant with pembrolizumab,1
10943,anti-psma monoclonal antibody mdx1201-a488,1
10944,colposcopic examination,1
10945,arrx,1
10946,nrl0706,1
10947,ro5503781 sdp,1
10948,glembatumumab vedotin and varlilumab,1
10949,lca-p,1
10950,hyperthermia and proton beam,1
10951,bandage skin hydrotac®,1
10952,analysis of methylation for the whole genome (sub-population of 15 samples from group 1),1
10953,oral carnitine supplementation,1
10954,hpv16 e7 peptide-pulsed autologous dcs,1
10955,hai conventional chemotherapy,1
10956,training evaluation,1
10957,medi6383,1
10958,lutetium lu 177-psma-617,1
10959,tt-00420,1
10960,hybrid fractional laser,1
10961,brief motivational enhancement intervention,1
10962,cohort 2-bortezomib (velcade ®),1
10963,focused microwave thermotherapy,1
10964,car-cd19 t cells,1
10965,expiratory muscle strength training,1
10966,web-based tailored information and support system,1
10967,open sleeve lobectomy,1
10968,endoscopic robot-assisted simple enucleation,1
10969,l19tnf plus doxorubicin,1
10970,gemcitabine-cisplatin,1
10971,administation of azd6738 in combination with medi4736,1
10972,device for mechanical excitation by pressure waves,1
10973,apn201,1
10974,injection of tvec into target lesions 2wks after 3rd injection,1
10975,reduced glutathione,1
10976,tailored internet communication with relational agent,1
10977,health education classes,1
10978,baseline and post assessment,1
10979,foretinib (formerly gsk1363089 or xl880),1
10980,four fraction split-course sbrt,1
10981,study-intervention,1
10982,healthy material sample,1
10983,neurocognitive impairment observation,1
10984,gpa-trimar-t,1
10985,tumor biopsy via ultrasound endoscopy,1
10986,ozurdex,1
10987,eapa,1
10988,taxanes plus carboplatin,1
10989,"cisplatin, gemcitabine, panitumumab",1
10990,optical colonoscopy adherence,1
10991,cbm588,1
10992,transanal irrigation,1
10993,literature search and semi-structured interview,1
10994,epirubicin/docetaxel sequential,1
10995,radiotherapy and concurrent chemo-therapy,1
10996,no adt,1
10997,cobicistat,1
10998,allogeneic tumour lysate (melcancervac),1
10999,rectal swab for microbial culture.,1
11000,gene-modified t cells targeted,1
11001,normal lung tissue,1
11002,stapled without mesh reinforcement (per-strips dry),1
11003,continuous preperitoneal analgesia,1
11004,egfrviii-cars,1
11005,68ga-nodaga-ac-cys-zegfr:1907,1
11006,til (t-cells),1
11007,colohybritest or valihybritest,1
11008,curcumin conjugated with plant exosomes,1
11009,outpatient clinic,1
11010,sulfentanyl,1
11011,balanced general anesthesia and postoperative opioids,1
11012,rtl plus 4:1 closure group,1
11013,co-argi-peg,1
11014,mgta 456 infusion,1
11015,gourmet cooking workshop,1
11016,groupe falcon,1
11017,copper iud,1
11018,karolinska sleepiness scale,1
11019,high intensity interval training bout,1
11020,bnp,1
11021,preventive multimedia teaching program,1
11022,fluorine f 18 clofarabine,1
11023,blinded inter-country reading of pelvic mri (magnetic resonance imaging),1
11024,the mucosal microbiome in the biopsy specimen was analysed,1
11025,observational: urine sample collection,1
11026,"3, 4 dap",1
11027,vagifem® (vaginal 17?-estradiol) questionnaire & menopause symptom checklist,1
11028,rituximab injection,1
11029,bms-986249,1
11030,irradiation of cutaneous tumor lesion,1
11031,systematic sampling,1
11032,standard education,1
11033,fear appeal message,1
11034,ingenol disoxate gel 0.037%,1
11035,coaching and habilitation,1
11036,bms-986277,1
11037,mdx-1401,1
11038,ef-2 peptide,1
11039,scc metastasis,1
11040,micopure ultrasound,1
11041,artiss,1
11042,trichloroacetic acid,1
11043,isis 183750,1
11044,capecitabine and concurrent intensity modulated radiotherapy,1
11045,dmsa,1
11046,rt (radiation therapy),1
11047,local excision for early rectal cancer,1
11048,a-101 (32.5) topical solution,1
11049,"determine the incidence , type , and severity of prescribing errors in the oncology department",1
11050,18f-mfbg (meta-fluoro benzylguanidine),1
11051,conventional external beam therapy,1
11052,precise cryoablation system with icerod needles,1
11053,cognitive existential therapy group 1,1
11054,initial evaluation,1
11055,biopsies & blood analyses,1
11056,"ara-c, mitoxantrone, daunorubicin, thioguanin",1
11057,anti-cd19 redirected nk cells,1
11058,active breathing control device (abc),1
11059,paclitaxel protein bound (abraxane),1
11060,pulsecure pulse generator and derm-pulse electrode,1
11061,temozolomide and radiotherapy,1
11062,pathologic large tissue selected table,1
11063,panzem nanocrystal colloidal dispersion,1
11064,polestar n20 intraoperative mri,1
11065,basic physical activity,1
11066,measurable residual disease measured by flow cytometry,1
11067,online social network enrollment plus education and self monitoring,1
11068,placebo wand,1
11069,clofarabine with busulfan,1
11070,magnetic resonance imaging (mri) 7 tesla,1
11071,engineered nasal cartilage graft,1
11072,treg cell infusion,1
11073,anal swabs,1
11074,cavity shaving,1
11075,demeclocycline,1
11076,tailored care,1
11077,bromelain and comosain,1
11078,oral nutritional supplement rich in eicosapentanoic acid,1
11079,transvaginal ultrasounds,1
11080,sunitinib plus paclitaxel,1
11081,imgn289,1
11082,assess surgical site occurrences at 30 days postoperatively,1
11083,men1309,1
11084,mk-7252,1
11085,bacille calmette-guerrin (bcg),1
11086,y-90 ibritumomab tiuxetan,1
11087,measurement of cardiac index,1
11088,metotrexato in induction,1
11089,"dos (docetaxel, oxaliplatin and s-1)",1
11090,investigational 3d mammography system,1
11091,ness-eftr with sentinel lymph node navigation,1
11092,mva vaccine,1
11093,awake,1
11094,adt+docetaxel+enzalutamide,1
11095,laparoscopic assisted total gastrectomy,1
11096,dietary supplementation with fish oil.,1
11097,nivolumab: cohort 1,1
11098,vofatamab,1
11099,machine learning (ml),1
11100,ingenol mebutate gel 0.05 %,1
11101,targeted email,1
11102,mpmri with targeted biopsy,1
11103,azd1775 matching placebo,1
11104,high heme iron diet,1
11105,"in-depth, semi-structured interviews",1
11106,my journey ahead,1
11107,topical phenylephrine solution,1
11108,two injections into the celiac ganglion,1
11109,f-fmiso pet/ct scan,1
11110,ep,1
11111,shape (shp-141) 0.1% bid,1
11112,r-chop/chope or abvd chemotherapy regimen,1
11113,bay1841788 (darolutamide),1
11114,palliative re-irradiation for progressive dipg in children,1
11115,vats with chest tube placement,1
11116,gene mutations analysis and fish,1
11117,loco-regional anaesthesia,1
11118,ly2334737,1
11119,autologous ebv-ctl transduced with vector sfg-cna12,1
11120,adjuvant chemotherapy (gemcitabine and cisplatin),1
11121,assessment of nutritional status,1
11122,til administration,1
11123,integrated staging for early detection of metastases in lung cancer,1
11124,evolution® esophageal stent - fully covered,1
11125,fexofenadine,1
11126,docetaxel (t) + bevacizumab,1
11127,transrectal apt device or transperineal device will be used,1
11128,patient activation and education (pae),1
11129,"holter monitor - medilog ar12 (oxford instruments, oxford, england)",1
11130,eligard 45 mg exposure,1
11131,"her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine",1
11132,inj.cisplatin,1
11133,eoi,1
11134,ehealth for sedentary behavior,1
11135,oat bran and blueberry husks,1
11136,sf6,1
11137,keppra,1
11138,gamma-delta tocotrienol and tocotrienol rich fraction,1
11139,ethyol (drug),1
11140,propofol general anesthesia,1
11141,microscope,1
11142,bmt legal clinic,1
11143,gsk2110183 gelatin capsule,1
11144,habit development intervention,1
11145,focal cryoablation,1
11146,punction of v. subclavia,1
11147,ebv-specific t cells,1
11148,decision-aid,1
11149,"sol(the combination therapy of s-1, leucovorin, and oxaliplatin)",1
11150,fluourouracil,1
11151,"neoadjuvant gemcitabine, capecitabine, and docetaxel",1
11152,erector spinae plane block (group a) and thoracal paravertebral block (group b),1
11153,cbp501,1
11154,rituxan (rituximab),1
11155,anxiety self-management techniques,1
11156,"leukocyte interleukin, injection",1
11157,ccrt+ pf,1
11158,transamin,1
11159,cat-8015 60 mcg/kg,1
11160,"mesothelin, hyaluronan, osteopontin, syndecan-1",1
11161,"ugtia1 genotyping (7,7)",1
11162,som230 s.c.,1
11163,microgynon,1
11164,anticancer medication a01; immune cells ic01,1
11165,"gemcitabine, docetaxel, capecitabine",1
11166,ba duan jin,1
11167,transthoracic ultrasound,1
11168,atezolizumab (anti-pd-l1),1
11169,average score of obesity and weight-loss quality of life questionnaire,1
11170,532 nm q-switched nd:yag laser,1
11171,30-second chair stand,1
11172,sir-sphere radioembolization,1
11173,mal,1
11174,i-125 versus pd-103 radioactive seed insertion,1
11175,elsamitrucin,1
11176,bupicavaine 0.125% epidural solution,1
11177,treatment with vismodegib,1
11178,short-turn radius colonoscope,1
11179,uterine lavage,1
11180,lletz without colposcopy,1
11181,ltm - a porcine-based surgical mesh,1
11182,som230 lar 30 mg,1
11183,chemoradiotherapy arm,1
11184,"irinotecan, cisplatin, gemcitabine, pemetrexed, docetaxel",1
11185,glizigen® + ocoxin-viusid®,1
11186,polyphenon e (veregen) 15% ointment,1
11187,tpf+imrt,1
11188,green tea beverage with defined catechin content,1
11189,extraction genomic dna,1
11190,conventional fractionation (2 gy per day) external beam radiation therapy,1
11191,hepatobiliary iminodiacetic acid (hida) scan,1
11192,combined strength training and functional endurance exercise,1
11193,immu-132 infusion is administered to participants in one arm for the study,1
11194,study assessments,1
11195,pecs ii and parasternal blocks,1
11196,cryotherapy with liquid nitrogen,1
11197,vascana (0.9% nitroglycerin cream),1
11198,neoadjuvant bevacizumab,1
11199,core needle trus needle biopsy (transrectal ultrasound),1
11200,sleep apnea screening with apnealinktm,1
11201,gemcitabine - trastuzumab - erlotinib,1
11202,18f-psma,1
11203,interviews - colorectal cancer participants,1
11204,research brain mri,1
11205,r2*-ute,1
11206,usual care outreach for colon cancer screening,1
11207,device: 20g fnb needle,1
11208,human papilloma virus test from the vaginal vault,1
11209,nov-002 injection in combination with carboplatin vs. paclitaxel and carboplatin,1
11210,incision and curettage,1
11211,pemetrexed - after protocol amendment,1
11212,lwh film,1
11213,inosine pranobex,1
11214,erlotinib with cetuximab,1
11215,imiquimod 5 % cream,1
11216,the first booster vaccine phase:,1
11217,3t mri scanning,1
11218,experimental drug: dexamethasone,1
11219,clinimacs cd25 microbeads and cell sorter,1
11220,klh + gm-csf,1
11221,hd il2,1
11222,tumor markers,1
11223,macrobiotic dietary intervention,1
11224,targeted therapy based on molecular profiling : everolimus,1
11225,liposomal cisplatin,1
11226,positron emission tomography pet/ct,1
11227,biodegradable balloon implant,1
11228,ringer's acetate,1
11229,partial breast irradiation using 40 gy /10 fractions,1
11230,stro-002,1
11231,top concern tailored intervention,1
11232,monoclonal antibody cd19,1
11233,mg7-cart,1
11234,bibf 1120 plus docetaxel,1
11235,sentinel lymph node sampling,1
11236,id-lv305,1
11237,molecular profiling & in vivo drug testing in ppdx and organoid cultures,1
11238,17% salicylate with ethyl pyruvate,1
11239,5-fu 1000 mg/m^2/day,1
11240,cart-19/bcma,1
11241,abb-r-chop,1
11242,radical pleurectomy,1
11243,empegfilrastim 7.5 mg,1
11244,no break,1
11245,social media message about hpv and hpv vaccine,1
11246,there is no intervention - this is an observational study,1
11247,imrt-sib plus sequential ig-rt boost,1
11248,car2 anti-cea car-t cells,1
11249,intra-lesional vaccine administration,1
11250,special diet therapy (usda control),1
11251,"docetaxel,0xaliplatin,capecitabine",1
11252,eabr,1
11253,digital stories intervention,1
11254,cyclical follow up,1
11255,docetaxel - dose b,1
11256,mr-guided high intensity focused ultrasound,1
11257,5-ala-guided surgery,1
11258,novalis shaped beam surgery,1
11259,invitation to educational meeting,1
11260,contact thermographic breast examination device,1
11261,nivolumab 10 mg/ml [opdivo],1
11262,medex,1
11263,25mg cephadol@ (diphenidol),1
11264,fleet,1
11265,eus-fnb with 20-gauge procore® needle,1
11266,tc+spio,1
11267,physical activity program and prevention after cancer,1
11268,tailored message,1
11269,teaching using traditional method,1
11270,personalized dose redistribution,1
11271,abscess de-roofing and curettage,1
11272,oncometabolic reconstruction,1
11273,halflytely,1
11274,cyproterone acetate 5,1
11275,kb004,1
11276,paclitaxel 175mg/m² q21d,1
11277,video assited thoracic surgery,1
11278,decitabine and genistein,1
11279,pn+,1
11280,epidural pca ropivacaine,1
11281,transoral surgery (tos) + neck dissection,1
11282,"ixazomib 4.0 mg, lenalidomide 25 mg, dexamethasone 40 mg",1
11283,toga tools,1
11284,peripheral and bone marrow sampling,1
11285,myeloablative double unit cord blood transplantation,1
11286,integrated care programmes,1
11287,hematopoietic stem cell microtransplantation-short-term,1
11288,psychoeducational,1
11289,fluorouracil (5fu),1
11290,dendritic cell vaccine plus temozolomide chemotherapy,1
11291,sbrt or rfa,1
11292,patient control analgesia (pca) morphine,1
11293,non exposed,1
11294,endurance,1
11295,faza,1
11296,daily dosing,1
11297,mist humidifier,1
11298,"comparator: mk0752, notch inhibitor - 3 days on, 4 off",1
11299,octreotide lar depot,1
11300,recombinant human arginase 1 peg5000,1
11301,steel,1
11302,discussion group,1
11303,consolidation treatment part 1: hd-chemotherapy with asct,1
11304,tmz 200mg/m2,1
11305,phosphate orally,1
11306,treatment with wst09 vascular photodynamic therapy,1
11307,group b - device guided breathing high dose,1
11308,tubal ligation group ii,1
11309,standard external beam radiation therapy,1
11310,biphosphonates,1
11311,co2 use in colonoscopy,1
11312,conformal intensity modulated radiotherapy (imrt),1
11313,sentimag probe,1
11314,partial breast irradiation using 32 gy / 8 fractions,1
11315,aflibercept + mlv5fu2,1
11316,bibf 1120 low dose,1
11317,standard-of-care radiation,1
11318,15 o water,1
11319,proxiscan device,1
11320,ptk787 and pemetrexed with or without cisplatin,1
11321,fermented wheat germ extract (fwge),1
11322,sarcopenia and mobility measurement,1
11323,pegifn-2b,1
11324,radioembolization (sirt),1
11325,"dasatinib, mitoxantrone, cytarabine",1
11326,histology,1
11327,pde-neo ii camera,1
11328,electrodessication & curettage,1
11329,communication aids,1
11330,surgery: gs strategy,1
11331,bkm120-cis,1
11332,reirradiation with concomitant chemotherapy,1
11333,nissen,1
11334,asp8273 capsules,1
11335,bead + dox arm,1
11336,regorafenib/active,1
11337,application of a hemostatic gelatin-thrombin matrix,1
11338,spranc block group,1
11339,virtual chromo-endoscopy using fice fujifilm technology,1
11340,octreotide lar 30mg,1
11341,rmc-4630,1
11342,secretin (human synthetic) - chirhoclin,1
11343,pet imaging with [18f]-flt,1
11344,micrornas,1
11345,biafine cream,1
11346,ultrasound-guided fine needle aspiration biopsy,1
11347,"sevoflurane, rocuronium",1
11348,hspe7 and poly-iclc,1
11349,iodopovidine,1
11350,confocal micro endoscopy,1
11351,nanodoce (direct injection),1
11352,abl001 + nilotinib,1
11353,il-2 plus anti-tnf or thalidomide,1
11354,abp 980,1
11355,adm plus ifo or ifo alone,1
11356,eso,1
11357,chemotherapy (control),1
11358,5-fu based radio-chemotherapy,1
11359,cytotoxic t lymphocytes,1
11360,hemigland cryoablation,1
11361,shenqifuzheng,1
11362,denosumab injection,1
11363,oral decitabine,1
11364,mindfulness-based cognitive therapy (mbct),1
11365,meda,1
11366,azd1775 only,1
11367,"intron a, interferon alpha -2b",1
11368,magnesia,1
11369,health status questionnaire,1
11370,histopathological analysis,1
11371,robotic transperineal biopsy,1
11372,no sympathetic response,1
11373,usual care exercise referral scheme,1
11374,guided injection of triamcinolone,1
11375,mfolfox6 or capecitabine,1
11376,cardiac spect perfusion scan,1
11377,conventional radiotherapy 70 gy in 7 weeks,1
11378,tak-165,1
11379,key hole biopsy ( khb),1
11380,goat milk,1
11381,heat shock protein 70-peptide complexes (hsp70),1
11382,axon flares,1
11383,"""low touch"" implementation strategy",1
11384,neo-urinary conduit,1
11385,nk cell enriched-dli only,1
11386,dna and tissue microarray analysis,1
11387,brief behavioral treatment for insomnia and bright light,1
11388,bms-986310,1
11389,transarterial chemo-embolization using irinotecan drug-eluted beads ((debiri-)tace),1
11390,option of sma and desi or desi only,1
11391,blood test/ additional measurement,1
11392,salicylic acid,1
11393,quantitative sensory tests (qst),1
11394,snx-5422 mesylate hsp90 inhibitor,1
11395,collection of serum and saliva samples,1
11396,stress-management training,1
11397,protocol,1
11398,symptom management group,1
11399,fluphenazine hcl,1
11400,rituximab - cvp,1
11401,integrated molecular analysis,1
11402,kyphoplasty/vertebral augmentation (device-stabilit),1
11403,gdc-0927,1
11404,vaccine + polyiclc,1
11405,"su011248, sutent",1
11406,cognitive behavioral training,1
11407,dendritic cell tumor fusion,1
11408,delphi screener,1
11409,immediate acupuncture group,1
11410,spontaneous ventilation,1
11411,cardiac magnetic resonance scan,1
11412,surgery (wide local excision; limb preservation surgery),1
11413,brilacidin,1
11414,not interventional study,1
11415,project onward website + 16 person social network,1
11416,esophagectomy or gastrectomy,1
11417,velcade subcutaneous melphalan prednisone,1
11418,prostate cancer education,1
11419,ttc-352,1
11420,vnp20009,1
11421,2-deoxy-d-glucose (2dg),1
11422,tandem 3 cycle intensive chemotherapy,1
11423,"lumpectomy, axillary block dissection, breast conserving surgery",1
11424,cervical motor control,1
11425,robotic partial surgery,1
11426,support device for prone radiation therapy (giro-couch),1
11427,cathiporttm,1
11428,luma cervical imaging system,1
11429,extended pap,1
11430,arsenic trioxide tace,1
11431,paced respiration,1
11432,monofer(r),1
11433,"shared video consultation between patient, general practitioner and oncologist",1
11434,i125 radioactive plaques (local treatment),1
11435,225ac?j591,1
11436,vbi-1901,1
11437,wt-1,1
11438,imatinib mesylate (sti571),1
11439,continuous thoracic epidural analgesia,1
11440,"ct, pet and mri",1
11441,amg 596,1
11442,step up to prevention: knowledge,1
11443,su101,1
11444,purine/folic acid analogues,1
11445,epirubicin plus cyclophosphamide,1
11446,young women's intervention (ywi),1
11447,colon cancer screening navigation,1
11448,abl001+dasatinib,1
11449,neuropsychological examination,1
11450,pulse pressure variation guided fluid therapy,1
11451,minimally invasive surgery,1
11452,transversus abdominis-plane block with local anesthetic 20 ml of bupivacaine 0.5% + 10 mg morphine,1
11453,palliative radiation,1
11454,transient elastography,1
11455,2d,1
11456,oratest,1
11457,mocetinostat plus brentuximab vedotin,1
11458,low-dose-bevacizumab/pemetrexed,1
11459,uld il-2,1
11460,monopolar electrocautery loop in transurethral resection of bladder tumors,1
11461,syntocinon,1
11462,mechlorethamine hydrochloride gel,1
11463,bevacizumab and irinotecan and radiotherapy,1
11464,flap transposition procedures,1
11465,norethindrone/ethinyl estradiol,1
11466,lmp2-specific cytotoxic t-lymphocytes,1
11467,dna integrity index,1
11468,tace containing placebo,1
11469,maekmoondong-tang,1
11470,mri with eovist contrast,1
11471,radiation therapy with concurrent paclitaxel,1
11472,conventionnal chemotherapy,1
11473,ro7123520,1
11474,central biobanking,1
11475,four conversations,1
11476,lumen apposing metal stent (lams),1
11477,triptorelin (decapeptyl®) - treatment 8 months (pivotal study) followed by a treatment extension of 8 months (extension study),1
11478,crlm resection group,1
11479,hypofractionated 12x3 gy + integrated boost 12x4 gy,1
11480,"projective methods (thematic apperception test, rorschach)",1
11481,cediranib and olaparib,1
11482,post-operative chemoradiotherapy / accelerated radiotherapy,1
11483,informed consent follow-up visit,1
11484,bibf 1120 es high dose,1
11485,"capecitabine, cisplatin, sorafenib",1
11486,bortezomib (b),1
11487,soybean oil soft gel,1
11488,quality of life questionnaire eortc qlo - h&n35,1
11489,uterine embolization,1
11490,sentimark,1
11491,"target drug with the score equal or below 0,1",1
11492,celecoxib 400 mg,1
11493,torisel dose 15 mg and r-fc,1
11494,"risk-based, escalating levels of monitoring",1
11495,dexamethasone (standard retreatment),1
11496,dss,1
11497,near infra red sentinel node biopsy,1
11498,dim pills,1
11499,miltenyi clinimacs,1
11500,pelvic floor exercise,1
11501,cd+8 t cell depletion,1
11502,granisetron transdermal patch,1
11503,gmcsf,1
11504,characterise the molecular epidemiology of lung adenocarcinoma in multi-ethnic asian phenotypes,1
11505,fluorine f 18-clevudine,1
11506,lite website - lite version of smokefree.gov,1
11507,lci/bli then white endoscopy,1
11508,head and neck,1
11509,regulatory t-cells,1
11510,bep(500),1
11511,paclitaxel+initial radiation+boost,1
11512,mlc tracking,1
11513,2d laparoscopy,1
11514,global fibroid ablation,1
11515,chemotherapy or endocrine therapy or trastuzumab therapy,1
11516,jcar015 (cd19-targeted car t cells),1
11517,dex2,1
11518,abraxane and gemcitabine,1
11519,assess patient pain intensity postoperatively,1
11520,1 tablet composed of antioxidants and minerals,1
11521,orteronel 300mg bid,1
11522,education and general exercise,1
11523,lightpath® imaging system.,1
11524,citarinostat,1
11525,egm,1
11526,naf pet/ct imaging,1
11527,"gemcitabine, docetaxel, 5fu, oxaliplatin",1
11528,post-radiation therapy temozolomide,1
11529,postpartum follow up appointment 2-3 weeks after delivery,1
11530,cbbct,1
11531,percutaneous nerve evaluation,1
11532,lenalidomide oral capsule,1
11533,soludomerin,1
11534,"e0651 pcd with sequential, non-gradient waveform",1
11535,radical proctectomy with total mesorectal excision,1
11536,personal resilience empowerment program including 5 sessions with health coaches,1
11537,ff-10502-01,1
11538,standard wb fractionation+boost,1
11539,ipad activity control group,1
11540,2-dimensional mammogram,1
11541,remove the tube ileostomy,1
11542,immunotherapeutic sb719125 (primary),1
11543,ketamine and bupivacaine injection,1
11544,cortrosyn,1
11545,the fec75 and 95 regimen,1
11546,cnto888 + gemcitabine,1
11547,peripheral nerve stimulation,1
11548,framed hpv vaccination messages,1
11549,second test: transvaginal ultrasound,1
11550,culturally-targeted fear appeal message,1
11551,vioxx,1
11552,"lenalidomide, bendamustine, prednisone",1
11553,ethinylestradiol and cyproterone acetate,1
11554,metronidazole actavis,1
11555,spatially registered endoscopy,1
11556,anti-androgen therapy: bicalutamide,1
11557,"bevacizumab, oxaliplatin, pemetrexed",1
11558,exercise counseling (behavior change techniques),1
11559,nilotinib (400 mg bid),1
11560,oprelvekin,1
11561,fit outreach,1
11562,pet scan after treatment,1
11563,lifestyle questionnaires,1
11564,fulfillment of a preventive programme,1
11565,transarterial chemoembolization using drug-eluting beads,1
11566,naf pet/ct,1
11567,nir imaging system,1
11568,conventional technique,1
11569,standard dose vitamin d3,1
11570,gsk2118436 75mg,1
11571,no preparation bowel,1
11572,eus-guided ethanol ablation,1
11573,enzalutamide tablet,1
11574,almonds,1
11575,sheng bai oral liquid,1
11576,disposable negative wound pressure device (pico),1
11577,"nivolumab 3mg/kg, ipilimumab 1mg/kg",1
11578,durvalumab; medi4736,1
11579,placebo mouthrinse,1
11580,bispecific antibody and di-dtpa-131i,1
11581,mind-body exercises,1
11582,natulan,1
11583,placebo (for enzalutamide),1
11584,"lenalidomide, rituximab, and cyclophosphamide",1
11585,vitablue™,1
11586,chemotherapy+surgery,1
11587,60?g hpv,1
11588,"avastin, docetaxel, carboplatin",1
11589,molecular genetic analysis,1
11590,sodium acetate c11 pet/ct imaging,1
11591,gsk3174998 iv infusion,1
11592,t-rapa cell donor lymphocyte infusion (dli),1
11593,acide zoledronique medac,1
11594,sotatercept 0.3 mg/kg,1
11595,snap® wound care system,1
11596,sor007 (uncoated nanoparticle paclitaxel) ointment,1
11597,bendamustine and subcutaneous rituximab,1
11598,"the arachidonic acid and egfr signaling pathways and their interaction in hnscc tumorigenesis,",1
11599,18f-al-nota-matbbn pet/ct,1
11600,intraductal arm,1
11601,new investigational curved paddle,1
11602,percutaneous placement of device in the liver,1
11603,ckm,1
11604,omega-3 supplementation,1
11605,geriatric assessment and no call from nurse,1
11606,actr707,1
11607,folfox plus bevacizumab and reolysin,1
11608,amg 397,1
11609,oral antibiotics cefdinir or trimethoprim/sulfamethoxazole,1
11610,cgc-11047 and sunitinib,1
11611,"custirsen, paclitaxel and carboplatin",1
11612,postoperative tace,1
11613,blood test 48hours,1
11614,"moxr0916, a humanized agonist anti-ox40 monoclonal antibody",1
11615,cct3833,1
11616,closure of the pelvic peritoneum,1
11617,electrical impedance scanning (eis) of the thyroid gland,1
11618,ultrasound scan of the pancreas,1
11619,imaging study (fdg-pet/ct scan),1
11620,"docetaxel, oxaliplatin, capecitabine",1
11621,adjuvant hipec (open/laparoscopic),1
11622,percutaneous celiac plexus neurolysis,1
11623,oocyte retrieval,1
11624,cohort 2 ctap101 capsules - 30µg,1
11625,methotrexate/hydrocortisone,1
11626,histological examination of surgical specimen,1
11627,patient activation,1
11628,"radical prostatectomy with urethral irrigation but no fascial suturing, qol forms",1
11629,manual imaging fusion of ultrasonography and mri,1
11630,no-transfuse,1
11631,3d roadmap software,1
11632,"asa404, dmxaa, dxaa",1
11633,"mva-fcu1, flucytosine",1
11634,toremifene; anastrozole,1
11635,seldi-tof ms for plasmatic proteic profile,1
11636,vinorelbine oral formulation,1
11637,apatinib 250mg,1
11638,doppler evaluation,1
11639,sn-38 liposome,1
11640,postoperative chemoradiotherapy,1
11641,131i- mibg,1
11642,current initial staging protocols,1
11643,sexual rehabilitation programme,1
11644,onco geriatric evaluation,1
11645,part 3: pt2385 tablets in combination with cabozantinib,1
11646,bevacizumab-pfizer,1
11647,ctnx-4975,1
11648,s-1 (tegafur/gimeracil/oteracil) /cisplatin (investigational arm),1
11649,sub-tenon triamcinolone 40mg,1
11650,pegylated formula interferon-alpha 2b,1
11651,cessation of acid suppressing medications,1
11652,e7016 + tmz,1
11653,stenting with ptfe-coated stent (hilzo),1
11654,"fasting blood draw, measurement of height, weight and waist circumference, and blood pressure",1
11655,endoscopic ultrasound (including fine needle aspiration),1
11656,modified bone marrow stem cell transplantation,1
11657,plm60,1
11658,dre-endoscopy-mri-cea,1
11659,liquid-pap smear,1
11660,risk primer,1
11661,0.04% mechlorethamine gel,1
11662,identifying genes methylated in urine,1
11663,haplo hct ?55 years old,1
11664,peripheral blood stem cell (pbsc) transplantation,1
11665,tc99m-tilmanocept,1
11666,tcr?/?+,1
11667,total intravenous anesthesia (tiva),1
11668,intra-operative radiation,1
11669,antigen-specific igt cells,1
11670,5 - fluorouracil,1
11671,metvix pdt,1
11672,intraoperative radiotherapy (applicator surface dose: 20-40 gy),1
11673,dasatinib (sprycel®),1
11674,lu-177 dota-tate,1
11675,"gastroscopes (pentax, tokyo, japan)",1
11676,language paradigms + rs fmri + one anatomical sequence,1
11677,docetaxel + s-1,1
11678,fentanyl transdermal,1
11679,psychological therapy,1
11680,treatment g,1
11681,nc 6300,1
11682,bone marrow biopsy & aspirate,1
11683,gynecologic surgery - robot assisted coelioscopy,1
11684,astx660,1
11685,treatment of metastatic disease,1
11686,cg 8020 and cg 2505,1
11687,accept reversal operation,1
11688,[14c] th-302 (label 1),1
11689,low dose dfd07 once daily,1
11690,ri8 device imaging,1
11691,mysmartcheck,1
11692,investigational software and coils in pet/mr scan,1
11693,not relevant (there is no intervention in the present study),1
11694,ptc+pertuzumab,1
11695,a low ligation of ima,1
11696,lenalidomide plus low-dose dexamethasone given for 18 four-week cycles,1
11697,active measures of lifestyle modification,1
11698,torisel dose 75 mg and r-fc,1
11699,transvaginal colposcope,1
11700,neoadjuvant short-course photon radiation,1
11701,cetuximab with irinotecan,1
11702,run-in (short pre-surgery course) of endocrine-targeted therapy,1
11703,rh il-2,1
11704,cisplatin plus paclitaxel,1
11705,vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules,1
11706,usual care and health education workshop,1
11707,iv zometa,1
11708,anesthetist-controlled sedation/analgesia,1
11709,pcrt,1
11710,thermal ablation with external beam radiation,1
11711,only withdrawal,1
11712,oxygenesys dissolved oxygen dressing,1
11713,pressure controlled ventilation,1
11714,chemotherapy with eribulin,1
11715,wound catheter,1
11716,oral veledimex,1
11717,zd9393 (zoladex) 10.8 mg,1
11718,provider continuity: specific surgeons responsible for coordinating care with medical/radiation oncology,1
11719,flac with gm-csf,1
11720,group a: closed-face shell,1
11721,nir,1
11722,gsk3377794 (ny-eso-1?²?? t),1
11723,daclatasvir,1
11724,mris with and without intravenous contrast (up to 2),1
11725,induction treatment part 1,1
11726,stereotactic radiotherapy(sbrt),1
11727,temozolomide (for newly diagnosed malignant glioma),1
11728,vb10.16 immunotherapy (dna vaccine),1
11729,arq 501 in combination with gemcitabine,1
11730,docetaxel plus selumetinib,1
11731,gelatine,1
11732,placebo (unspecified),1
11733,"ocz103-os [pentamidine bis(2-hydroxyethanesulfonate)], mfolfox6 or folfiri",1
11734,jnj-63709178,1
11735,computerized cognitive behavior therapy,1
11736,gemcitabine plus carboplatin plus bsi-201,1
11737,pancreatic cancer screening pathway 2,1
11738,methylaminolevulinate hydrochloride,1
11739,panobinostat and bortezomib,1
11740,bcnu 80mg/m2,1
11741,sentinel breastscan ii,1
11742,tg-1701,1
11743,microbiome under chemotherapy,1
11744,hbo,1
11745,standard of care counseling,1
11746,pf-04554878,1
11747,educational intervention to enhance the adherence of patient treated by capecitabine +/- lapatinib,1
11748,blood specimens,1
11749,docetaxel plus doxercalciferol,1
11750,core needle mri/us image fusion guided needle biopsy,1
11751,arm 2 - magnevist,1
11752,bortezomib (velcade ®),1
11753,donor lymphocytes infusion (dli),1
11754,homoeopathic remedies,1
11755,confocal laser endomicroscope,1
11756,cone-beam ct,1
11757,tocotrienol rich fraction (trf),1
11758,plasmapheresis,1
11759,colon imaging study,1
11760,single-port lavh,1
11761,dietary modification,1
11762,bmi-1 antibody,1
11763,birth control plus brevail,1
11764,arm b: folfiri or folfox,1
11765,neupogen injectable product,1
11766,eye001,1
11767,"suberoylanilide hydroxamic acid (saha, vorinostat)",1
11768,pet imaging using 124 ipuh71,1
11769,ipec with cisplatin (75mg/m²),1
11770,family eats,1
11771,quadrant parotidectomy,1
11772,"consultation, evaluation questionnaire",1
11773,35 mcg ethinylestradiol/2 mg cyproterone and selmevit,1
11774,gpi 1485,1
11775,bipolar vessel sealing and cutting device,1
11776,cardiovascular screening,1
11777,tele-cp,1
11778,methotrexate 1500mg/m2,1
11779,combined nursing invention,1
11780,a 24 week center-based structured exercise and education program,1
11781,apatinib+capecitabine,1
11782,respiragene test and risk score,1
11783,gsk3052230,1
11784,dc/aml fusion vaccine,1
11785,bone metastases pain treatment,1
11786,"cryotherapy, further biopsy, leep, surgery as indicated",1
11787,once-weekly breast irradiation,1
11788,vinorelbine cisplatin radiotherapy,1
11789,brivanib + cetuximab,1
11790,kidney transplanted patients,1
11791,pmi-150 (intranasal ketamine),1
11792,"docetaxel,doxorubicin, cyclophosphamide",1
11793,qbx258,1
11794,"pv-10 (rose bengal disodium, 10%)",1
11795,androgen ablation,1
11796,modified method of digestive tract reconstruction,1
11797,rx-0201,1
11798,medi4736 in combination with azd5069,1
11799,fluzoparib capsules,1
11800,hypoxia measurement,1
11801,anti-pd-1 monoclonal antibody,1
11802,fine needle aspiration of the lung,1
11803,5- fluorouracil,1
11804,mood questionnaires,1
11805,genesis and gemini,1
11806,"bevacizumab, docetaxel, cisplatin",1
11807,hyperthermia with concurrent chemo-radiation therapy,1
11808,thermic destruction of tissue by laser using the novilase device,1
11809,sonablate 500 (sb-500),1
11810,rhg-csf regimen,1
11811,gcsf (granulocyte colony stimulating factor),1
11812,vitaltape® bandage,1
11813,annual ct screening,1
11814,diprosone,1
11815,moxtezafin gadolinium,1
11816,standard telephone counseling,1
11817,pd 0360324,1
11818,enlighttm,1
11819,arm ii soy-almond bread,1
11820,"webinar, promotion, and tool access",1
11821,local excision in good responders,1
11822,normal invitation,1
11823,pirarubicin 50mg/m2,1
11824,carboplatin + irinotecan,1
11825,ign523,1
11826,adecatumumab,1
11827,ny-eso-1 iscomatrix® vaccine,1
11828,medi9197,1
11829,bmk120,1
11830,holmium-166-poly (l-lactic acid) microspheres,1
11831,prevnar,1
11832,clip closure,1
11833,augmented autologous stem cell transplant (asct-aug),1
11834,modified fast,1
11835,injection of 99m-tc-nm-01,1
11836,study of the occurrence of carcinoid heart disease,1
11837,clag regimen,1
11838,19.2 mg/kg ?-tea,1
11839,bevacizumab and trabectedin,1
11840,imrt/impt,1
11841,no included anl,1
11842,remicade,1
11843,aminolevulinic acid topical 20% topical solution,1
11844,enterography-mri without enteroclysis,1
11845,moderate-intensity and low-intensity bodywork therapy,1
11846,4scar19 and 4scar38,1
11847,genexol-pm/gemcitabine,1
11848,cis-retinoic acid,1
11849,anesthesia before transurethral resection of the bladder tumor,1
11850,surface imaging,1
11851,dexamethasone 20mg,1
11852,carboplatin/etoposide,1
11853,astx029,1
11854,surgical fixation of fractures,1
11855,4 x 4 lifestyle modification,1
11856,tocilizumab (actemra or roactemra),1
11857,haploidentical stem cell transplantation and nk cell therapy,1
11858,autologous genetically modified mage-a4?¹º³²t cells,1
11859,multi-port,1
11860,dti-015,1
11861,combined surgery and radiation therapy,1
11862,18f-fmiso pet scan,1
11863,gardasil ® (merck & co. inc),1
11864,pegylated l-asparaginase,1
11865,stage 4: glucocorticoid,1
11866,ms-20,1
11867,axitinib + paclitaxel + carboplatin (cohort 3),1
11868,pyrotinib/pyrotinib with docetaxel,1
11869,conventionally fractionated prostate radiotherapy,1
11870,specific risk factors related to hepatocellular carcinoma,1
11871,mastectomy (recommended but not mandatory),1
11872,sc-002,1
11873,endoscopic ultrasound guided biliary drainage,1
11874,pet/ct 20 days after the first cycle of chemotherapy,1
11875,"checklist, mychart, opennotes",1
11876,mode of relapse detection,1
11877,intravesical 2000mg/52.6ml gemcitabine instillation,1
11878,"tailored, interactive intervention for mammography screening",1
11879,13-c-glucose,1
11880,the new model of haplo-hsct for r/r b-all,1
11881,rfsh,1
11882,dimesna,1
11883,cytarabine(actavis italy s.p.a),1
11884,dcf (docetaxel with cisplatin with 5-fu),1
11885,epirubicin - cyclophosphamide / docetaxel + bevacizumab,1
11886,folfox plus bevacizumab,1
11887,imnovid (pomalidomide),1
11888,gp100 human melanoma peptide,1
11889,2.pushing the stylet or injecting air,1
11890,allostim8 or allostim-9,1
11891,caringguidance after breast cancer diagnosis,1
11892,percutaneous fluoro guided celiac plexus neurolysis,1
11893,"hepatocellular cancer (hcc) treatments including oral anti-cancer therapy [nexavar (sorafenib, bay43-9006)]",1
11894,energy healing,1
11895,carbon dioxide fractional laser,1
11896,robotic gastrectomy,1
11897,trebananib 30 mg/kg,1
11898,milled seed mix,1
11899,bn83495 (cohort 2),1
11900,d-0316,1
11901,whyx cancer group,1
11902,use of [18f]fdg - pet/ct for the diagnosis and staging of non-small cell lung carcinoma,1
11903,maintenance therapy,1
11904,"cisplatin, etoposide, ifosfamide (high dose)",1
11905,177lu radiolabeled monoclonal antibody huj591 (177lu -j591),1
11906,peptide vaccine (muc-1),1
11907,"general anesthesia,orbital operation",1
11908,licorice root extract,1
11909,pancreatic stump exposed without omentum binding,1
11910,review of screening tests and molecular test results,1
11911,general anesthesia for ebus/tbna,1
11912,pbr pet,1
11913,vitamin b6 plus folic acid,1
11914,iv ketamine/lidocaine/iv pca apply,1
11915,"rituximab, methotrexate, temozolomide",1
11916,dkn-01 150 mg,1
11917,partial breast radiation after lumpectomy,1
11918,jak2v617f mutation,1
11919,cohort 3-bortezomib (velcade ®),1
11920,fmri scan (optional),1
11921,total abdominal hysterectomy,1
11922,3 month physical activity intervention,1
11923,arm circumference measurement,1
11924,nelarabine injection 650mg/m2,1
11925,"placebo (dmc, são paulo, brazil)",1
11926,neurotization,1
11927,adxs-503,1
11928,mycobacterial cell wall-dna complex,1
11929,sc-peg,1
11930,interleukin-2 (il2),1
11931,"questionaire, blood or saliva sample",1
11932,high dose n-acetylcysteine,1
11933,pancreatic surgical procedure,1
11934,xonrid® gel,1
11935,metformin plus letrozole,1
11936,acenocoumarol,1
11937,rxtimercap,1
11938,ro-choep-21 (phase i),1
11939,placebo cutaneous cream application,1
11940,biological: prohema-cb,1
11941,selective neck dissection including level iib,1
11942,lenalidomide 15 mg,1
11943,collagenase clostridium histolyticum 2.9 mg/ml [xiaflex],1
11944,amonafide dihydrochloride,1
11945,"""investigator's choice"" chemotherapy",1
11946,liposomal-encapsulated doxorubicin,1
11947,"ct-scan, pet-scan",1
11948,digital subtraction angiography,1
11949,art-123 (high frequency),1
11950,dietary recommendations,1
11951,mva 5t4,1
11952,home training,1
11953,"panobinostat, cisplatin, pemetrexed",1
11954,weight measurement,1
11955,caelyx (pegylated liposomal doxorubicin; sch 200746),1
11956,attention control (health education),1
11957,ibrance,1
11958,erlotinib (trade name: tarceva®) or icotinib (trade name: conmana®),1
11959,"vorinostat, lenalinomide and dexamethasone",1
11960,femmed breast health formula,1
11961,tunel assay,1
11962,eus-guided fine needle biopsy sampling (eus-fnb),1
11963,other conventional techniques,1
11964,switch from calcineurin inhibitor to an mtor inhibitor,1
11965,fluorescence and thermal imaging,1
11966,anti-cd19 car t cells,1
11967,123i-meta-iodobenzylguanidine,1
11968,"cardiac, pulmonary, auditory and biological assessment",1
11969,allogeneic lymphocytes,1
11970,s-1; oxaliplatin; 5-fu; leucovorin calcium,1
11971,blood sampling for free mutant dna analysis,1
11972,t cells,1
11973,4sc-202 in combination with pembrolizumab,1
11974,phase ii: placebo,1
11975,"dacarbazine (dtic), trofosfamide, etoricoxib, pioglitazone, temsirolimus",1
11976,standard fractionation (sfx) radiotherapy,1
11977,irx5183,1
11978,"rituximab, cmc544, gemcitabine and oxaliplatine",1
11979,endove endoscopic electroporation,1
11980,p4,1
11981,salirasib,1
11982,renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003,1
11983,swe ultrasound at six months,1
11984,cytoreductive surgery alone,1
11985,zevalin radioimmunotherapy,1
11986,rp2d (pbf-509+pdr001)_immuno naïve,1
11987,experimental arm: tocosol paclitaxel,1
11988,hormonal and biochemical blood tests and ultrasound scanning,1
11989,focal therapies,1
11990,hybridapc,1
11991,aprepitant/ramosetron/dexamethasone,1
11992,survival and late effects,1
11993,dose level 2,1
11994,nk-92 cells,1
11995,emerging from the haze,1
11996,big-bore tube,1
11997,"volasertib, high dose, d1q3w",1
11998,tamoxifen (pharmacodynamic analysis),1
11999,oral contraceptive: ortho-novum® 1/35,1
12000,gossypol,1
12001,organic germanium,1
12002,debio 1562,1
12003,docetaxel 50mg/m2,1
12004,pectoral plane block,1
12005,tobacco and alcohol status follow-up,1
12006,sdx-105,1
12007,yttrium y 90-labeled basiliximab,1
12008,fluorescent in-situ hybridization (fish),1
12009,etoposide (conditioning for auto transplant),1
12010,lactobacillus reuteri oral solution [biogaia],1
12011,treatment based on no genetic mutation,1
12012,anastrozole+fulvestrant,1
12013,education/daily planning,1
12014,herba scutellaria barbata,1
12015,peginterferon,1
12016,sulforaphane-containing broccoli sprout extracts (active agent),1
12017,phosphate buffer saline (pbs),1
12018,standardized medical treatment of hypertension by sahr,1
12019,osteocool™ rf ablation,1
12020,belotecan hydrochloride,1
12021,preservation of denonvilliers fascia during l-panp surgery,1
12022,acyclovir sodium,1
12023,infrared breast scan,1
12024,"vinorelbine, paclitaxel, nab-paclitaxel , docetaxel, capecitabine",1
12025,xeloda tablets:,1
12026,conditioning regimen tbi + fludarabine,1
12027,photoacoustic tomography,1
12028,gefitinib combined with apatinib,1
12029,ccfdna analysis,1
12030,cea and lipase,1
12031,ercp-guided stent insertion,1
12032,propofol dosage,1
12033,prevena™ incision management system,1
12034,genetically modified ctls,1
12035,watch dvd,1
12036,mp-470 + docetaxel,1
12037,acceleration,1
12038,ly2503029,1
12039,abp 798,1
12040,dotap:chol-fus1,1
12041,sipjeondaebo-tang,1
12042,68ga-dotatoc pet positron emission tomography (pet) whole body scan,1
12043,apatinib 750mg,1
12044,placebo (gelatin tablet),1
12045,asciminib add-on,1
12046,lenalidomide and ga101,1
12047,postpartum follow up 6-8wk after delivery,1
12048,cognitive remediation therapy,1
12049,high dose intracavitary brachytherapy,1
12050,3d motion capture system,1
12051,"""capecitabine""",1
12052,intravenous lidocaine (ivl),1
12053,qigong training,1
12054,stroop color-word test,1
12055,long-term follow-up,1
12056,msk-2206,1
12057,antibody ch14.18,1
12058,probiotics (six probiotic cultures),1
12059,sodium chloride 9 mg/ml,1
12060,donafenib 200mg,1
12061,questionniares,1
12062,drugs and anti-cd19 car transduced t cells,1
12063,perioperative fluid treatment,1
12064,iodine i 131 monoclonal antibody lym-1,1
12065,netupitant / palonosetron,1
12066,assessment of pdl1 expression,1
12067,use of a previous blood collection for patients,1
12068,inhalation of essential oils,1
12069,ascites drainage with vascular catheter.,1
12070,amiloride,1
12071,delayed intervention group,1
12072,bec2 vaccine,1
12073,fludarabine/busulfan x 4 days,1
12074,pirarubicin 25mg/m2,1
12075,ercc1 pathways analysis,1
12076,transplant 1 melphalan,1
12077,information gathering,1
12078,quality of life in metastatic bc,1
12079,vapreotide,1
12080,zoladex 3.6mg,1
12081,letrozole - concomitant,1
12082,oxygen saturation,1
12083,treadmill walking (proof-of-concept),1
12084,pace call/fit4life,1
12085,khk2455,1
12086,placebo ast2818 80mg//40 mg,1
12087,cep-701 60mg,1
12088,at13387 and imatinib,1
12089,autologous transplantation using bexxar/beam,1
12090,bexarotene capsules,1
12091,deferasirox (novartis pharma),1
12092,laparoscopic resection for rectal cancer,1
12093,interactive website,1
12094,self-questionnaire,1
12095,referral to a specialist palliative care team.,1
12096,18f-ffnp,1
12097,inrt,1
12098,fotemustine + vemurafenib,1
12099,jnj-212082,1
12100,mid-infrared spectroscopy with atr,1
12101,search of anal citology alterations,1
12102,docetaxel 35mg/m2,1
12103,fluordeoxyglucose f 18,1
12104,tamsulosin and/or dutasteride,1
12105,specimen collection/risk factor assessment -> diet/exercise -> chemotherapy,1
12106,flx925,1
12107,hyperthermic intraoperative intraperitoneal chemotherapy,1
12108,monosialoganglioside(gm1),1
12109,cognitive exams,1
12110,dmrt,1
12111,"leukine® (sargramostim, gm-csf) and water for injection",1
12112,regn1979 multiple dose levels,1
12113,reconstructive surgery following bladder removal.,1
12114,docetaxel with cytoxan,1
12115,tele-dermatology,1
12116,oesophageal stenting with self expandable metal stent,1
12117,control website,1
12118,"educational information, recommendation and instruction",1
12119,klonidin,1
12120,hbi-8000 in combination with nivolumab,1
12121,acupuncture protocol 2,1
12122,nurse-led care,1
12123,docetaxel + ciclofosfamide,1
12124,arm 1: investigational inf,1
12125,tomosynthesis breast scanning,1
12126,"panitumumab, doxycycline/placebo",1
12127,oral tablet dye for detection of polyps during colonoscopy,1
12128,non-contrast ct scans (metallic markers),1
12129,ovarian drilling by fertiloscopy,1
12130,experimental 1: exercise with 2 counseling types,1
12131,peg-l-asparaginase cons,1
12132,video narrative,1
12133,standard therapy + physical activity program,1
12134,"chemotherapy, multiple agents",1
12135,conmed airseal insufflation system (ais) at low pressure,1
12136,fluorescence angiography with indocianyne green,1
12137,m200 (volociximab) in combination with dacarbazine (dtic),1
12138,"chop, cmab304",1
12139,"mammaprint, blueprint, and full-genome testing",1
12140,informed breast cancer surgical treatment,1
12141,perioperative caloric restriction program,1
12142,tegafur and temozolomide,1
12143,sham pemf device,1
12144,"palonosetron, aprepitant, dexamethasone",1
12145,hypofraction radiation,1
12146,spinal anesthesia and continuous postoperative epidural analgesia,1
12147,"prophylactic cranial irradiation, 1.5 gy fx",1
12148,dashboard,1
12149,sodium 2-hydroxylinoleic,1
12150,comparator: dexamethasone,1
12151,total thyroidectomy (mini video assisted thyroidectomy),1
12152,amg386 plus pld,1
12153,bivalent hpv vaccine,1
12154,abh gel,1
12155,camellia oil,1
12156,sample collection for genome-wide sequencing,1
12157,vats lobectomy using modified equipments,1
12158,"nsaids (permitted,not necessary)",1
12159,carboxymethylcellulose eye drops,1
12160,bilateral mastectomy with reconstruction,1
12161,"dexamethasone, ondansetron, aprepitant",1
12162,ff21101,1
12163,concurrent rad001 2.5 mg/day,1
12164,breast magnetic resonance scanning,1
12165,late parenteral nutrition,1
12166,comparison of follow-up,1
12167,inulin and fructo-oligosaccharide,1
12168,standard fractionation radiotherapy,1
12169,la-z-boy massage chair vibration effect on bladder cancer cell concentration,1
12170,gleevec and arsenic trioxide,1
12171,general anesthesia followed by opioid analgesia,1
12172,bendamustine infusions (arm a),1
12173,famitinib l + docetaxel,1
12174,ribomustin,1
12175,radioiodine i-131,1
12176,cryogenic treatment of warts,1
12177,e39 peptide (100mg)/gm-csf vaccine,1
12178,mri scanning,1
12179,"eortc qlq-c30, qlq-sto22, and msk-10",1
12180,soai,1
12181,"docetaxel, oxaliplatin, capecitabin, bevacizumab, trastuzumab",1
12182,diffusion weighted magnetic resonance imaging (dwmr),1
12183,vitamin d with calcium and clomiphene citrate,1
12184,gx-051,1
12185,part a - azd9291 in combination with azd6094,1
12186,decitabine (baml-16-001-s8),1
12187,iset methode,1
12188,hpc-a,1
12189,capacity enhancement,1
12190,physiotherapy guidance,1
12191,biological: tcr-t,1
12192,"gm-csf dna, nsc 683472 gp100: 209-217(210m), nsc 699048 tyrosinase: 368-376(370d)",1
12193,"electronic brachytherapy (6,1 gy)",1
12194,mr elastography,1
12195,lutathera,1
12196,(resiniferatoxin)(rtx),1
12197,sae battery,1
12198,abtl0812,1
12199,pinatuzumab vedotin,1
12200,azd9291 80 mg,1
12201,acupuncture treatment 2,1
12202,spect-ct imaging,1
12203,anti-tumor necrosis factor alpha monoclonal antibody,1
12204,panobinostat nanoparticle formulation mtx110,1
12205,coiled bipolar radiofrequency ablation,1
12206,tozuleristide,1
12207,urea dose c,1
12208,ihc mart-1,1
12209,medi6383 and medi4736,1
12210,threshold inspiratory muscle trainer (imt),1
12211,tezacitabine (fmdc),1
12212,conventional whole breast radiation schedule,1
12213,apr,1
12214,oxygenation with simple breathing mask,1
12215,implant,1
12216,2l peg,1
12217,oral delivery mucosal stain,1
12218,"vinorelbine, cyclophosphamide and interferon alpha 2b",1
12219,"active arm #1, #2, passive arm #1, #2",1
12220,umbilical cord blood unit (cbu),1
12221,lung cancer cohort,1
12222,"liposomal doxorubicin (myocet), docetaxel and trastuzumab",1
12223,measure dcam levels in blood,1
12224,imatinib escalation,1
12225,mendelsohn swallowing exercise,1
12226,spl-108,1
12227,yttrium-ibritumomab (zevalin),1
12228,proton beam rt,1
12229,apd515,1
12230,gemcitabine with therasphere,1
12231,biological: hbv antigen specific tcr redirected t cell,1
12232,maa for diagnostic spect imaging,1
12233,confocal endomicroscope,1
12234,int230-6,1
12235,tavarlin,1
12236,"real rtms(20 hz, 10 trains, inter train interval 30 sc with total pulses 2000, intensity 80% of motor threshold) daily for 10 consecutive days (5 days/week)",1
12237,cik cells without pd-1 blocking,1
12238,somnage,1
12239,"ad.hifn-? (bg00001, idec-201)",1
12240,anti-cd123 car-t treatment,1
12241,ductal lavage microcatheter,1
12242,lb-100 for injection,1
12243,tti-621 plus nivolumab,1
12244,ct-ttnb,1
12245,breath volatile organic compounds under chemotherapy,1
12246,rgx-104,1
12247,mm-302 in combination with trastuzumab and cyclophosphamide,1
12248,"fluciclitite , pet imaging, and bevacizumab",1
12249,dasatinib - 1a,1
12250,com701 with opdivo (nivolumab).,1
12251,dysphagia scores,1
12252,bibf 1120 (high) + pld 30 mg/m2 + cbdca auc5 mg/ml*min,1
12253,oesophageal doppler,1
12254,cb infusion,1
12255,electronic pro in daily clinical practice,1
12256,fluorouracil/irinotecan/levo-folinic acid/bevacizumab,1
12257,care plan during a visit with an additional visit,1
12258,nab-paclitaxel (abraxane)/gemcitabine (gemzar) protocol plus disulfiram/copper gluconate,1
12259,tositumomab and iodine i 131 tositumomab followed by chop,1
12260,samital®,1
12261,spy glass,1
12262,"biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine",1
12263,erector spinae plane block (espb),1
12264,us guided biopsy,1
12265,goal system theory,1
12266,eye amputation,1
12267,bevacizumab treatment,1
12268,cositecan,1
12269,photobiomodulation therapy (pbmt),1
12270,minimal physical activity intervention,1
12271,rt+plnd,1
12272,sinerem (uspio) enhanced mri,1
12273,"docetaxel, placebo",1
12274,standard maintenance,1
12275,shr-1210 plus apatinib,1
12276,denspm ),1
12277,pemetrexed plus gemcitabine,1
12278,androgen blockade + radiation therapy,1
12279,pharmacoeconomic assessment,1
12280,af-guided endobronchial marking,1
12281,prostvac®-vf/tricom™,1
12282,specimen pet/ct scan,1
12283,breast cancer screening and diagnosis,1
12284,set-back suture,1
12285,pembrolizumab mel low dose,1
12286,d3 lymphadenectomy,1
12287,next generation sequencing (ngs) detection,1
12288,placlitaxel,1
12289,decision aid with choice of management,1
12290,standard medical care and cancer resource center,1
12291,"epirubicin, cyclophosphamide, paclitaxel,",1
12292,dexamethasone injection,1
12293,124i-nm404,1
12294,adback nk or t cell,1
12295,eva-online,1
12296,gallium ga 68 psma-r2,1
12297,rapid on-site cytopathologic evaluation (rose),1
12298,donor lymphocyte preparation depleted of functional host alloreactive t-cells (atir),1
12299,pazopanib 5 mg,1
12300,conventional endoscopic mucosal resection,1
12301,ati-0918,1
12302,resection of primary lesion,1
12303,domperidone,1
12304,removal of adrenal tumor,1
12305,tehe only,1
12306,trastuzumab plus docetaxel (for 4 21-day cycles) after four 14-day cycles of doxorubicin plus cyclophosphamide,1
12307,placebo (for bupivacain and fentanyl i epidural catheter),1
12308,neoadjuvant chemotherapy (paclitaxel and carboplatin),1
12309,screening breast magnetic resonance imaging,1
12310,ima950 plus gm-csf,1
12311,mifegyne,1
12312,flocked swab,1
12313,"mouth swab, toe nail clippings, questionnaires",1
12314,port-first,1
12315,etirinotecan pegol (nktr-102),1
12316,platinum-based chemotherapy alone (up to six cycles),1
12317,1% glycated chitosan,1
12318,radiolabeled epratuzumab,1
12319,endoscopic mucosal resection(emr) by mucosectomy kit.,1
12320,standard oncology care,1
12321,clinical follow up,1
12322,long-acting granulocyte colony stimulating factor,1
12323,erectaid,1
12324,kpt-8602,1
12325,conventional weaning,1
12326,nivolumab and entinostat,1
12327,didactic session,1
12328,non-hodgkin's lymphoma (nhl),1
12329,cik cell,1
12330,mor03087,1
12331,radical nephrectomy versus partial nephrectomy (according surgeon judgement),1
12332,trametinib (single tablet),1
12333,anti-tac(fv)-pe38 (lmb-2) immunotoxin,1
12334,pet/ct with iodine-124,1
12335,kinesiotaping bandage,1
12336,crizotinib oral capsule [xalkori],1
12337,"recombinant growth hormone, genotropin (pfizer)",1
12338,lubricant eye drops (refresh endura™),1
12339,f-18 pet bone scan,1
12340,access to unlicensed cord blood units,1
12341,serum prostate antigen test,1
12342,kytril (granisetron),1
12343,"biochemical markers, vegf and mmps, in bile samples",1
12344,585 nm pulsed dye laser,1
12345,upper limb exercises,1
12346,tizanidine,1
12347,bone health care coordinator,1
12348,rgi-2001,1
12349,rabbit antithymocyte globulin,1
12350,umbilical cord blood cell infusion,1
12351,ionizing radiation (ir),1
12352,placebo;etoposide and cisplatin,1
12353,nci booklet,1
12354,"psychosocial care conquer fear support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)",1
12355,para-toluenesulfonamide injection (pts),1
12356,radiofrequency tumor ablation,1
12357,normal saline group,1
12358,transnasal flexible endoscopy with narrowband imaging,1
12359,tnf-alpha antagonists,1
12360,"standardized, manualized group intervention",1
12361,muc_1,1
12362,diagnosis with tomosynthesis,1
12363,ibrutinib-rice,1
12364,pgl4001 10 mg,1
12365,"tbca, tbna",1
12366,cisplatin/gemcitabine,1
12367,vincristrine in consolidation-1,1
12368,chadox1-mva 5t4 vaccine,1
12369,symptoms report,1
12370,neoadjuvant rtx,1
12371,pfp and sf6 human lung coil,1
12372,anthropometic data collection,1
12373,pasireotide 0.6 mg/ml,1
12374,abbv-428,1
12375,active comparator: routine colposcopy,1
12376,pomegranate extract formulation-1,1
12377,adverse events using patient-reported outcomes version of common terminology criteria for adverse events (pro-ctcae) questionaire,1
12378,perifosine + temsirolimus,1
12379,dmuc5754a,1
12380,"[111]in-ibritumomab tiuxetan (zevalin, bay86-5128)",1
12381,azd5363+olaparib+durvalumab,1
12382,protracted course radiotherapy,1
12383,18f-fluorothymidine pet scan,1
12384,d07001-softgel capsules,1
12385,face,1
12386,vonoprazan,1
12387,'r' (electro-kinetically altered beverage),1
12388,no maintenance treatment ( standard of care),1
12389,fact-l,1
12390,drug: s-1 and oxaliplatin,1
12391,neo-201,1
12392,diltiazem,1
12393,bone marrow aspirate or peripheral blood sample collection,1
12394,no octreotide,1
12395,trc102 + pemetrexed,1
12396,ready to care program,1
12397,fecal immunochemical and occult blood test,1
12398,doxorubicin hydrochloride liposome,1
12399,"abt-869, linifanib",1
12400,lapatinib/nab-paclitaxel,1
12401,metformine,1
12402,sorafenib + folfiri,1
12403,sargramostim (leukine),1
12404,sampling of peritoneal washing aspirate,1
12405,prostate fusion biopsy,1
12406,placebo + paclitaxel/carboplatin,1
12407,vibration therapy,1
12408,esomeprazole 40mg before,1
12409,casopitant,1
12410,radiation therapy (rt) 5 days a week +,1
12411,laparoscopic endoscopy combined surgery,1
12412,patients undergo cvats segmentectomy,1
12413,tivantinib (arq 197) tablet,1
12414,zirconium-89-labeled ro5479599,1
12415,18f-rgd-pet-ct and perfusion ct scans on 3 occasions,1
12416,modified cea peptide (1000mcg),1
12417,ct guided spinal biopsy,1
12418,spray,1
12419,haplo-identical hsct,1
12420,preoperative modified folfirinox and postoperative gemcitabine,1
12421,ep & targeted drugs,1
12422,aromatase inhibitors (arimidex),1
12423,water jet group,1
12424,ery974,1
12425,10.0 mg/m2 di-leu16-il2,1
12426,surgical intervention alone without fibrin sealant vh s/d application,1
12427,[14c]-radiolabeled idasanutlin,1
12428,inc280 (capmatinib),1
12429,ipaq,1
12430,temozolomide+placebo,1
12431,sofosbuvir/ledipasvir,1
12432,qualitative information sheet,1
12433,psa flyer,1
12434,microwave thermography rtm-01-res,1
12435,individualized complementary medicine treatment,1
12436,ct-guided percutaneous radiofrequency ablation,1
12437,dsp-0509,1
12438,bst-236,1
12439,cd19-targeting car t cells infusion,1
12440,more frequent surveillance strategy,1
12441,scm-010,1
12442,triple intrathecal therapy (tit),1
12443,patients with negative pet after salvage therapy,1
12444,targeted therapy based on molecular profiling : erlotinib,1
12445,hormonal therapy (lhrh agonist and/or antiandrogens),1
12446,image-guided biopsies,1
12447,30 mg/kg onartuzumab (metmab),1
12448,decapeptyl® sr 11.25mg; prostap® 3 dcs 11.25mg; zoladex® la 10.8mg,1
12449,cyclopleged refraction,1
12450,rq-00000007,1
12451,patient reported outcome (pro),1
12452,nk012 and carboplatin,1
12453,verbal support,1
12454,sputum collection,1
12455,cell search assay,1
12456,s-1 (ts-1) and oxaliplatin (oxalitin),1
12457,anti-cd19-car t cells,1
12458,c. de-intensification rt primary tumor region and contralateral lymph nodes,1
12459,pg13-cea_tcr (anti-cea tcr pbl),1
12460,docetaxel / cyclophosphamide,1
12461,paced respiration as part of peprr,1
12462,oncoquest-l vaccine,1
12463,ucpvax,1
12464,"tamoxifen, letrozole , anastrozole, exemestane",1
12465,endoscopic ultrasound fine needle aspiration,1
12466,viewing of cancer excision defect,1
12467,method of protein detection by immunostaining and flow cytometry,1
12468,music therapy taketina,1
12469,herceptin (trastuzuamb),1
12470,multivitamin supplement,1
12471,controlled oral word association test (cowa),1
12472,adct-601,1
12473,ultrasound sagittal scan,1
12474,trus-guided prostate biopsy,1
12475,combination of mk3475 with metronomic cp and g100,1
12476,gnrh antagonist (cetrorelix),1
12477,mri-targeted prostate biopsy,1
12478,radiochemotherapy or radiotherapy,1
12479,hemo-clipping,1
12480,"cisplatin, capecitabine, trastuzumab and mm-111",1
12481,nerve mobilization,1
12482,cognitive-affective barriers counseling,1
12483,open left-sided hepatectomy,1
12484,oral administration of mifepristone 5 mg daily for three months,1
12485,trufreeze spray cryotherapy,1
12486,experimental 3d breast ultrasound imaging,1
12487,brachytherapy boost with external beam radiotherapy,1
12488,frameless fractionated stereotactic radiation therapy,1
12489,degarelix (lhrh antagonist),1
12490,ultrasound breast scanning,1
12491,cart-meso,1
12492,vemurafenib placebo,1
12493,cardio-vascular mri,1
12494,rituximab - chop,1
12495,neoadjuvant chemotherapy + radical hysterectomy,1
12496,anti-cd20-car-transduced t cells,1
12497,thrombin generation assay,1
12498,doxil/caelyx (doxorubicin) treatment sequence ba,1
12499,reflexology sessions,1
12500,nueva vida intervention,1
12501,smart phone patient education application,1
12502,cytarabine ara-c,1
12503,multicomponent clinic-system strategies,1
12504,intranodal booster immunizations with synthetic melanoma associated epitopes,1
12505,a-vats,1
12506,r-gemox,1
12507,(folpi) picoplatin with 5-fu and leucovorin,1
12508,[13c]-radiolabeled idasanutlin,1
12509,vinca alkaloids,1
12510,rosiglitazone and bexarotene,1
12511,gefitinib tab 250 mg?cttq??from the 8th day of trial.,1
12512,traditional to protective ventilation,1
12513,two-stage tissue expander/implant procedure,1
12514,purified protein derivative,1
12515,radioembolisation (sir-spheres® microspheres),1
12516,home-based upper-body rehabilitation with online support,1
12517,placebo cream application,1
12518,live freeze-dried lactic acid bacteria probiotic,1
12519,lp in a seated position then lp in a lying position,1
12520,restrictive group,1
12521,radiotherapy and drug,1
12522,"autologous genetically modified t cells, magea10????t",1
12523,website and text messages,1
12524,carboplatin/ paclitaxel,1
12525,tumor-homing peptide irgd,1
12526,invance,1
12527,abcdes of melanoma,1
12528,levulan (5-aminolevulinic acid) uptake.,1
12529,"placebo to match zd6474, vandetanib",1
12530,capecitabine and cyclophosphamide,1
12531,fact writing (control),1
12532,celecoxib + exemestane,1
12533,agi-134 + pembrolizumab,1
12534,"velcade, thalidomide, dexamethasone",1
12535,"gemcitabine (gemzar®), oxaliplatin (eloxatin®)",1
12536,routine practice,1
12537,intercessory prayer,1
12538,everolimus (afinitor) tablets,1
12539,lansoprazole (prevacid),1
12540,aerobic plus active exercise,1
12541,capecitabine plus oxaliplatin before and after surgery,1
12542,autologous hematopoietic stem cell transplant (hsct),1
12543,5 azacytidine - valproic acid- retinoic acid,1
12544,distal gastrectomy,1
12545,4scar19 and 4scar30,1
12546,ldepa,1
12547,"docetaxel, capecitabine and oxaliplatin",1
12548,infusion of 13-carbon labeled glutamine,1
12549,central neck dissection first,1
12550,therapeutic mammoplasty,1
12551,three dimensional laparoscopic,1
12552,50 mg/m2 nktr 102,1
12553,mik665,1
12554,histrelin hydrogel implant,1
12555,eortc qlq-lc13,1
12556,amlexanox,1
12557,"doxorubicin, cytoxan",1
12558,survival,1
12559,100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle,1
12560,cmv-alt + saline,1
12561,"wechsler intelligence scale for children, fifth edition (wisc-v)",1
12562,specialty survivor clinic,1
12563,flexibility,1
12564,herceptin+xelox,1
12565,altens,1
12566,sparc1023 ii,1
12567,novottf-100l(p),1
12568,silver nitrate application to the bartholin´s cyst,1
12569,ly2875358 + erlotinib,1
12570,proton/photon radiotherapy,1
12571,"pn-152,243)/pn-196,444",1
12572,delayed mbs intervention,1
12573,diphenydramine,1
12574,energy restriction,1
12575,h+ct,1
12576,sham sphenopalatine ganglion acupuncture,1
12577,brain mapping,1
12578,"bi 836845, high dose, qw",1
12579,bibw 2992 low (20mg) dosage,1
12580,standard of care sentinal node dye,1
12581,afuresertib gc - fasted state,1
12582,standard drain removal,1
12583,fried tallow,1
12584,contract-enhanced mri,1
12585,respiratory rehabilitation,1
12586,byetta 5mcg pen injection,1
12587,shr1459,1
12588,glycar t cells,1
12589,transrectal biopsy,1
12590,pretendinous cord excision,1
12591,ct perfusion imaging,1
12592,pf-06755992,1
12593,optimized esd with snaring,1
12594,chronic lymphocytic leukemia (cll),1
12595,rft5-dga immunotoxin,1
12596,"cisplatin, vinorlebine, cetuximab",1
12597,induction ctx(tpf)+(rt+cetuximab),1
12598,irinotecan & capecitabine,1
12599,ceprate sc,1
12600,self administered stress management,1
12601,laparoscope hepatectomy,1
12602,"daunorubicin, vincristine, prednisone, methotrexate, peg-asparaginase, 6-mercaptopurine, cytoxan, cytosine arabinoside, vm-26 and 6-thioguanine",1
12603,[68ga]-neobomb1,1
12604,respiratory swallow training,1
12605,target tape,1
12606,anti-gd2 antibody,1
12607,kanglaite injection (klt),1
12608,carboplatinum and taxol,1
12609,subtenon carboplatin,1
12610,e7389 in combination with gemcitabine plus cisplatin,1
12611,autologous transplantation (asct),1
12612,communication,1
12613,cell therapy with bispecific antibodies,1
12614,bkm120 combined with vemurafenib (plx4032),1
12615,chemotherapy (docetaxel and prednisone),1
12616,daratumumab 20 mg/ml [darzalex],1
12617,nkp-1339,1
12618,financial incentive to increase ambulation,1
12619,minimal treatment,1
12620,fs118,1
12621,bibw 2992 medium dose,1
12622,endometrin (progesterone 100mg vaginal inserts),1
12623,trans arterial chemoembolization (tace),1
12624,18f-fluoromethylcholine (18f-fch),1
12625,asv™ agen2017 + qs-21 stimulon® adjuvant,1
12626,parathyroid hormone (1-34),1
12627,alks 4230 + pembrolizumab,1
12628,early post-operative enteral feeding,1
12629,maxy-g34,1
12630,radiotherapy as normal based on standard clinical protocols determined by the neuro-oncologist,1
12631,nature video,1
12632,linear analog scale of function,1
12633,131i-8h9,1
12634,progressive group,1
12635,vibrotactile stimulation,1
12636,<sup>18<sup>f-fdg pet/ct dynamic scan,1
12637,dietary advice plus liraglutide pen injector,1
12638,lymphadenectomy in cervical cancer,1
12639,hlx04 100 mg in 4 ml injection,1
12640,rituximab+chop,1
12641,intensive salvage therapy,1
12642,radiotherapy (fractionated stereotactic body radiation),1
12643,tailored counseling,1
12644,telephone education,1
12645,maintenance chemotherapy 2,1
12646,durvalumab +tremelimumab,1
12647,protmune,1
12648,continuous thoracic epidural block,1
12649,cetuximab c225,1
12650,hydromorphone pca,1
12651,upfront surgery,1
12652,"capecitabine, oxaliplatin, cetuximab",1
12653,blood for detection of circulating tumor cells,1
12654,"s-1, docetaxel",1
12655,molibresib,1
12656,filgrastim or pegfilgrastim,1
12657,follow-up visit/call,1
12658,written letter,1
12659,gkr with a single shot of the 8 mm collimator,1
12660,targeted substance according to the avatar model,1
12661,hpv status and typing of tissue,1
12662,percutaneous radiationfrequency ablation,1
12663,cpi-613 + high dose cytarabine and mitoxantrone,1
12664,pembrolizumab (treatment),1
12665,iridium implant,1
12666,rreversible electroporation (ire),1
12667,modified hyper-cvad,1
12668,prf on drg,1
12669,diffusion magnetic resonance imaging,1
12670,rapid test,1
12671,communication skills training package (kew),1
12672,fish oil encapsuled,1
12673,rhil-7,1
12674,ablation of pcl,1
12675,hyperthermal treatment,1
12676,can04,1
12677,medical data,1
12678,4scar19 and 4scar123,1
12679,ym 155,1
12680,methoxypsoralen,1
12681,computed tomography guided radioactive seeds implant,1
12682,cone beam computed tomography (ct) scan,1
12683,offering a choice for colorectal cancer screening,1
12684,"gemcitabine, oxaliplatin, capecitabine,",1
12685,rm28,1
12686,sr,1
12687,placebo/ duration of treatment: 156 weeks,1
12688,blood intake,1
12689,ptk787/ zk 222584,1
12690,recwt1-a10+as01b,1
12691,crs-100,1
12692,cd33-car-t cell infusion,1
12693,head and neck surgery,1
12694,surgery of the tumor,1
12695,ercp plus one biliary stent,1
12696,uncheck symptoms,1
12697,immu-114,1
12698,docetaxel 75 mg/m2 + prednisone 10 mg/d,1
12699,"letter offering a self-sampling kit ""on request""+ sms reminder",1
12700,ethnographic interview,1
12701,avaluation of a medical device: the tomosynthesis,1
12702,berubicin hydrochloride (rta 744),1
12703,narrative medicine,1
12704,user intervention,1
12705,prp injection,1
12706,multivitamin + vitamin b12 + vitamin b6,1
12707,microcoil,1
12708,histological investigation of the sn,1
12709,eortc qlq cx-24,1
12710,pharmacokinetic of nivolumab,1
12711,tb-403 ?175mg/kg,1
12712,breast capsule biopsy,1
12713,allogeneic blood or bone marrow transplantation,1
12714,combination therapy (s81694 + paclitaxel) phase ii,1
12715,no artery first procedure,1
12716,supervised progressive muscle relaxation training (jacobsen method),1
12717,high-risk therapy,1
12718,zn-e4,1
12719,endostar injection,1
12720,d2 distal subtotal gastrectomy,1
12721,pancreatic pseudocyst drainage with a plastic or self-expandable metallic stent (sems),1
12722,bu-cy-e,1
12723,dynamesh ipst,1
12724,doxorubicin hydrochloride (hcl),1
12725,temozolomide followed by high dose busulfan and thiotepa,1
12726,socio-legal counseling,1
12727,bevacizumab and paclitaxel,1
12728,pegylated liposomal doxorubicine,1
12729,capox (oxaliplatin/capecitabine),1
12730,nerve decompression,1
12731,standard of care mammography,1
12732,doppler ultrasound,1
12733,abi-007/carboplatin/trastuzumab,1
12734,lenzilumab,1
12735,inhalation anesthesia group,1
12736,lymphotrack tcr clonality assay,1
12737,laboratory correlative studies,1
12738,placebo lauriad®,1
12739,5 mm vessel clips,1
12740,rt boost,1
12741,stem cell rescue,1
12742,sotrastaurin acetate,1
12743,cvd908ssb-txsvn,1
12744,rehabilitation goals of patients with gynaecological cancer.,1
12745,68ga-psma-11 pet-mri,1
12746,3 months,1
12747,mindfulness-based at therapy,1
12748,preoperative fmri. dti and dsi with tractography,1
12749,pet-fdg brain imaging and npt,1
12750,telephone consultations about psychoeducation program,1
12751,care,1
12752,nivolumab iv,1
12753,imbruvica,1
12754,"ner1006, day before-only dosing",1
12755,cisplatin + doxorubicin,1
12756,rituximab-chop-alemtuzumab,1
12757,hemospray (endoscopic treatment with hemostatic powder),1
12758,patient-controlled epidural analgesia,1
12759,whole breast irradiation (wbi),1
12760,ty21a,1
12761,val401,1
12762,local control at 19.8gy,1
12763,fulvestrant + palbociclib,1
12764,psychological and social consultation,1
12765,transvaginal probe using photoacoustic and ultrasound imaging,1
12766,"imported pca equipment 'infusor sv®, baxter, usa'",1
12767,"urlc10-177, ttk-567, cpg-7909",1
12768,glyceryl tridecanoate,1
12769,apatinib mesylate tablet combined with s-1 capsules,1
12770,indirect calorimetry,1
12771,do not receive iv albumin infusion,1
12772,jejunal feeding,1
12773,ny-eso-1 protein; poly-iclc; montanide,1
12774,alpelisib placebo,1
12775,detection of oral pathology,1
12776,malate given orally,1
12777,dtgm fusion protein,1
12778,mab her 2 (herceptin),1
12779,unlabelled hmab biwa 4 - medium dose,1
12780,regional chemotherapy,1
12781,eating habits questionnaires,1
12782,hla-identical allogenic sct,1
12783,irx-2 regimen,1
12784,chrono-chemotherapy,1
12785,"carboplatin, etoposide & thalidomide",1
12786,inspiratory isometric resistance training,1
12787,laparoscopic surgery data collection,1
12788,arq 092 + paclitaxel (closed),1
12789,non-tailored booklet on exercise and diet,1
12790,"placebo,",1
12791,"oncaspar, doxil, decadron",1
12792,esym app usage,1
12793,placebo+cisplatin or carboplatin + 5-fluorouracil (5-fu),1
12794,early warning system monitoring.,1
12795,infusion a: repo,1
12796,ki-67 protein expression,1
12797,single-hole inflatable mediastinal mirror,1
12798,radiofrequency generator device,1
12799,sc-peg e. coli l-asparaginase,1
12800,abt 510,1
12801,kw-0761 (mogamulizumab),1
12802,cyproterone acetate 15,1
12803,folpi,1
12804,investigator´s choice of chemotherapy,1
12805,apatinib combined with pemetrexed,1
12806,adenovirus-p53 transduced dendritic cell vaccine,1
12807,"docetaxel, trastuzumab and mm-111",1
12808,dietary interview,1
12809,cognitive test passations,1
12810,z-208,1
12811,"mirena(lng-ius), oral mpa",1
12812,extraesophageal saline injection (esi),1
12813,kite-718,1
12814,laser tissue welding device,1
12815,sulindac placebo,1
12816,pd-l1 peptide,1
12817,deep inspiratory breath-holding,1
12818,sevoflurane+placebo,1
12819,part 2: daratumumab,1
12820,expanded prostate cancer index composite questionnaire,1
12821,aequasyal,1
12822,study,1
12823,standard follow-up during the treatment period,1
12824,platinum (cisplatin or carboplatin) + 5-fu,1
12825,fiducial markers placement,1
12826,apd209,1
12827,ga-68 psma ligand,1
12828,mri targeted biopsies,1
12829,systematic pelvic and aortic lymphadenectomy,1
12830,whole breast and nodal irradiation,1
12831,gns spray 0.5mg,1
12832,symptom feedback to health care provider,1
12833,aquagel ag hydrofiber wound dressing,1
12834,blood sample for methylation analysis,1
12835,fetal ovarian cyst aspiration,1
12836,cervical cancer screening and diagnosis,1
12837,autologous dendritic cells co-cultured with cytokine-induced killer cells,1
12838,placebo 12.5mg,1
12839,"octreotide-lar, lanreotide autogel",1
12840,cytokine,1
12841,gemcitabine/oxaliplatin,1
12842,shear-wave ultrasound elastography (swue),1
12843,tdm1,1
12844,chemotherapy plus filgrastim,1
12845,20 mcg ethinylestradiol /3 mg drospirenone,1
12846,whole pelvis radiotherapy,1
12847,l-asparaginase or or pegaspargase containing chemotherapy,1
12848,systematic chemotherapy and antibodies,1
12849,wl and nbi,1
12850,ricover-scheme rituximab,1
12851,atg + csa,1
12852,pemetrexed - phase 2,1
12853,intrarectal lidocaine gel,1
12854,text or email message,1
12855,eci-006,1
12856,famitinib malate,1
12857,placebo plus tamoxifen,1
12858,breathe well,1
12859,web-based interactive tool,1
12860,external- beam radiotherapy,1
12861,cart19 cell and auto-hsct,1
12862,guselkumab 100 mg,1
12863,supportan placebo,1
12864,concurrent chemotherapy with paclitaxel and nedaplatin,1
12865,chemotherapy- scheme,1
12866,transplant 1 dexamethasone,1
12867,dc- beads 300-500µm,1
12868,ar-67 (20s)-7-t-butyldimethylsilyl-10-hydroxycamptothecin),1
12869,transrectal vacuum assisted drainage,1
12870,cart therapy in acute myeloid leukemia(aml),1
12871,oncoquest-cll vaccine,1
12872,safety data collection (following routine vaccination),1
12873,bomet-qol questionnaire,1
12874,tbi-total body irradiation,1
12875,economic evaluation,1
12876,deep brain stimulation,1
12877,indium labeled imp-205xm734,1
12878,intrathecal resiniferatoxin,1
12879,delayed-immediate breast reconstruction,1
12880,thyroidectomy and parathyroid reimplantation in forearm subcutaneous tissue,1
12881,mhealth application,1
12882,steroids switch,1
12883,omeprazole and bortezomib,1
12884,netupitant and palonosetron,1
12885,volumetric incentive spirometry,1
12886,paclitaxel cisplatin,1
12887,low dose bevacizumab,1
12888,picture warning,1
12889,sbrt treatment,1
12890,trail-r1 mab (trm-1;hgs-etr1),1
12891,"ard6562, docetaxel",1
12892,influenza vaccination with influenza vaccine,1
12893,testing of archived cervical cancer tissue samples,1
12894,arm 1 - atezolizumab,1
12895,standard bupivacaine,1
12896,socioeconomic position,1
12897,smoked placebo cannabis low cbd/low thc,1
12898,hm10460a (135 ?g/kg),1
12899,semuloparin sodium,1
12900,normal dose dsa with conventional x-ray technology,1
12901,laparoscopy in gynecologic oncologic indications,1
12902,"gemcitabine, uft",1
12903,"gleevec (imatinib), valproic acid",1
12904,"exercise + fruit & vegetable, low fat + calcium diet",1
12905,99tc-mdp,1
12906,rescue regimen,1
12907,troglitazone,1
12908,conservative,1
12909,endoscopic submucosal dissection (esd) with or without probe-based confocal laser endomicroscopy (pcle),1
12910,imiquimod 5% manufactured by taro,1
12911,balloon dilation,1
12912,mirabilis high-intensity focused ultrasound treatment system,1
12913,hypoperfusion of renal artery,1
12914,endoscopic ultrasound-guided fine-needle aspiration,1
12915,gvax pancreatic cancer,1
12916,lxi-15029+exemestane,1
12917,treatment of physician's choice (tpc),1
12918,biomarker guided weekly taxane treatment in endometrial/ ovarian cancer,1
12919,gamma-interferon-1b (ifn-?),1
12920,mdx-1106,1
12921,medium glycemic load,1
12922,"gemcitabine, docetaxel, cpt-11,cisplatin",1
12923,history and physical exam,1
12924,actinomycin d,1
12925,internet-delivered intervention for sexual re-adjustment,1
12926,shr9549,1
12927,doxorubicin/placebo,1
12928,myocet + cyclophosphamide,1
12929,injection of 37? contrast agent,1
12930,exablate bbbd,1
12931,control sham procedure,1
12932,omaveloxolone lotion 3%,1
12933,chemotherapy + chemoradiotherapy,1
12934,pet/mr (biograph mmr),1
12935,assess bulge at 30 days postoperatively,1
12936,"risk-adapted, mrd-directed therapy",1
12937,low sodium diet,1
12938,androgen-deprivation therapy,1
12939,prevention care management,1
12940,tumor necrosis factor soluble receptor-immunoadhesin complex,1
12941,l-ohp (85 mg/m2),1
12942,capecitabine & oxaliplatin,1
12943,hylacare,1
12944,celecoxib (sc-58635),1
12945,extracorporeal photochemotherapy with transimmunization,1
12946,endobronchial ultrasound (ebus) transbronchial needle aspirate (tbna),1
12947,low literacy intervention for colorectal cancer screening,1
12948,stem cell mobilization and collection,1
12949,pbi-shrna™ ews/fli1 type 1 lpx,1
12950,myofascial massage therapy,1
12951,radiation: short-course preoperative chemoradiotherapy,1
12952,"selenoprecise selenium-enriched yeast tablet, pharma nord denmark a/s",1
12953,no intervention for this study,1
12954,5-fu plus cisplatin,1
12955,tissue samples taken from retinoblastoma,1
12956,fentanyl-tts,1
12957,hanarostent tm covered esophageal stent,1
12958,coq10 & vitamin e,1
12959,artificial pancreas (stg-22),1
12960,no epidural drug administered,1
12961,leukapheresis for research,1
12962,tai combine sbrt,1
12963,lu177-psma-617,1
12964,enteral nutrition emulsion(tpf-t),1
12965,aby-pet,1
12966,mor208,1
12967,headphones,1
12968,torisel dose 50 mg and r-fc,1
12969,microgranular curcumin c3 complex®,1
12970,eber,1
12971,mind programme for cancer patients,1
12972,decitabine plus modified bucy,1
12973,arm b: ga101,1
12974,pd-l1 immunocytochemistry (icc),1
12975,ultrasound evaluation,1
12976,onicolife nail drops,1
12977,neoadjuvant docetaxel + trastuzumab + pertuzumab,1
12978,adjuvant tace,1
12979,"rapamycin, mitoxantrone, etoposide, cytarabine",1
12980,pertuzumab and trastuzumab,1
12981,koning breast ct-guided biopsy,1
12982,dcvac/ovca sequentially chemotherapy,1
12983,bi 6727 + bibw 2992,1
12984,tositumomab 450 mg,1
12985,f-18 fluoro-deoxi-glucose,1
12986,subcutaneous injection saline placebo,1
12987,lapatinib in combination with capecitabine,1
12988,trans oral surgery (tos),1
12989,carboplatin + gemcitabine,1
12990,egfr bats with soc rt and tmz,1
12991,emd 72000 (matuzumab) + ecx,1
12992,brachytherapy + triptorelin 22.5 mg,1
12993,dedicated breast computed tomography imaging,1
12994,car19 t cells carrying cytoplasmic activated pd-1,1
12995,living healthy together,1
12996,complex polypectomy,1
12997,ser-401,1
12998,genexolpm + cisplatin,1
12999,gdc-9545,1
13000,paclitaxel plus gemcitabine,1
13001,irrigation with normal saline,1
13002,"6-mercaptopurine,methotrexate",1
13003,administering three additional mri images,1
13004,"ixabepilone, 32 mg/m^2 + lapatinib, 1000 mg",1
13005,bilateral rectus sheath catheter,1
13006,collection of a tumor sample taken before the participation of the patient in study,1
13007,panitumumab 20 mg/ml intravenous solution [vectibix],1
13008,seal-g mist system,1
13009,rectal spacer,1
13010,zen003365,1
13011,modified barium swallow impairment profile (mbsimp),1
13012,cevimeline,1
13013,"0.25 % bupivacaine (2.5 mg/ml) w/ 1:100,000 epinephrine & 4 mg dexamethasone",1
13014,absolute voice rest,1
13015,wbi 5 fractions,1
13016,r-choep14x6+hd-arac+hd-mtx,1
13017,coffee with milk,1
13018,loco-regional rt,1
13019,conformal brain radiation therapy,1
13020,[18f]- parpi,1
13021,"questionnaire, blood draw and urine sample",1
13022,xr9576,1
13023,bilateral scalp nerve blocks,1
13024,cart-egfr,1
13025,intensity modulated radiotherapy treatment,1
13026,"digital foot candle datalogging light meter (extech instrument, model sdl400)",1
13027,low-dose cytarabine alone,1
13028,green tea and milk thistle supplements,1
13029,functional compressive bandaging,1
13030,20 mg/kg tru-016 + rituximab,1
13031,tps / domestic accelerator,1
13032,long-acting g-csf,1
13033,lapatinib in tandem with capecitabine,1
13034,embolisation,1
13035,adjuvant hipec,1
13036,imgn779,1
13037,histology of resected pancreas cyst,1
13038,invance sling,1
13039,general anesthesia with opioid analgesia,1
13040,low dose computed tomography (ct),1
13041,early lung cancer detection,1
13042,hf-niv-mr,1
13043,iop by tonometer,1
13044,artemis™ software system,1
13045,pevonedistat 25 mg/m^2,1
13046,"standard treatment (lidocaine viscous solution, morphine, paracetamol, nsaid, gabapentin)",1
13047,arm 1: sentinel node biopsy,1
13048,laser en bloc resection,1
13049,bortezomib (standard retreatment),1
13050,lllt :low level laser therapy,1
13051,blood or bone marrow samples,1
13052,f-miso pet,1
13053,combined condition,1
13054,xelox/sox,1
13055,infusion of inkt cells and cd8+t cells,1
13056,mailing completed kits in for processing,1
13057,thymus transplantation,1
13058,photochemotherapy,1
13059,5-fluorouracile (5-fu),1
13060,her-2 pulsed dc1,1
13061,lucron depot,1
13062,assessment of expression of mcm5 in the urine (adx bladder),1
13063,ski-g-801,1
13064,"transperineal template guided mapping biopsy, multiparametric mri, hemiablative focal brachytherapy",1
13065,75 approved agents,1
13066,injection of lidocaine into foot,1
13067,15 mg/kg onartuzumab (metmab),1
13068,preoperative treatment of chemotherapy and radiation,1
13069,"pbsc-m87o, gene (m87o)-modified, cd34+ peripheral blood progenitor cells (pbsc)",1
13070,fixed prosthodontics,1
13071,ca102n,1
13072,ofs + exemestane,1
13073,international physical activity prevalence study environmental module,1
13074,tenpa (targeting-enhancing nanoparticles of paclitaxel),1
13075,ic green,1
13076,docetaxel and cisplatin + radiotherapy followed by docetaxel and cisplatin,1
13077,placebo mld,1
13078,total knee arthroplasty,1
13079,dynamic muscular endurance,1
13080,five wishes form,1
13081,3d laparoscopic total gastrectomy,1
13082,conventional or hypofractionated,1
13083,lidocaine hydrochloride 0.8% in dextrose 5% solution,1
13084,percutaneous ablation,1
13085,mindfulness training,1
13086,tumor biobank realization,1
13087,fdg-pet/mr,1
13088,samscore questionnaire,1
13089,90-y-imp-288,1
13090,daratumumab 16 mg/kg (part 1),1
13091,euroqol eq-5d 7-item questionnaire,1
13092,hif-2alpha inhibitor pt2385,1
13093,standard intravenous blood sampling,1
13094,e7820 plus cetuximab,1
13095,brain games stimulation,1
13096,"the isotope 68ga, netspot and 18f-fdg-pet/ct",1
13097,haic using oxaliplatin plus fluorouracil/leucovorin,1
13098,paricalcitol oral capsule,1
13099,oxaliplatin and capecitabine (capeox) or oxaliplatin and leucovorin and 5-fu (mfolfox6),1
13100,dc aml vaccine,1
13101,kytril 1mg (iv injection),1
13102,5-fu (fluorouracil),1
13103,nivolimumab+carboplatin/paclitaxel+radiation,1
13104,18f flt,1
13105,upper gastrointestinal endoscopy with biopsy and collection of refluxate,1
13106,autonomic nervous system activity records,1
13107,bladder tumor biopsy,1
13108,injection of sandostatine,1
13109,a steroid-free immunosuppression protocol,1
13110,placebo erlotinib 150/100mg,1
13111,doxycycline (tetracycline),1
13112,standard ultrasound guided prostate biopsy,1
13113,dynamic contrast-enhanced computed tomography,1
13114,reference1210,1
13115,best supportive care (bsc) +/- imatinib or sunitinib,1
13116,pca pump,1
13117,yiqi-yangyin-jiedu decoction,1
13118,survivin sur1m2 peptide vaccine,1
13119,ex vivo module,1
13120,self-report written questionnaire,1
13121,trilostane,1
13122,biosyn,1
13123,novel nano-scintillator fiber-optic dosimeter (nanofod),1
13124,haploidentical transplantation with donor nk cells,1
13125,cytology staining,1
13126,endocytoscope,1
13127,ch14.18,1
13128,"cyclophosphamide, docetaxel, dendritic cells, ok-432",1
13129,intraoperative mri,1
13130,"ketoconazole, dexamethasone",1
13131,naquotinib mesilate,1
13132,"pertuzumab, trastuzumab-emtansine",1
13133,oral narcotic,1
13134,perampanel,1
13135,global relaxation massage,1
13136,vigorous yoga practice,1
13137,stepped palliative care,1
13138,qadratus lumborum block,1
13139,caloric management protocol,1
13140,"bicalutamide (casodex), goserelin (zoladex)",1
13141,docetaxel - dose a,1
13142,anti-muc1 car-pnk cells,1
13143,traditional rehabilitation (tr),1
13144,lapr-tilt,1
13145,yq1,1
13146,game intervention,1
13147,paclical®,1
13148,metabolomic analysis,1
13149,fasteem4 system,1
13150,sorafenib 400 mg (expansion),1
13151,erlotinib + rosuvastatin,1
13152,folfiri+bevacizumab,1
13153,endoscopic stenting followed by elective laparoscopic resection,1
13154,proton radiation for neurofibromas,1
13155,"comparator: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant (qhpv) vaccine from current manufacturing facility (cmf)",1
13156,cisplatin docetaxel gefitinib pemetrexed vinorelbine gemcitabine,1
13157,ultrasonic dissector,1
13158,afm 13,1
13159,egfr,1
13160,tri-staple reloads,1
13161,recombinant ny-eso-1 protein,1
13162,metabolic treatment,1
13163,usual care fit screening strategy,1
13164,pd-1 antibody expressing mesothelin specific car-t cells,1
13165,allovectin-7/dacarbazine,1
13166,oxycodone hcl cr,1
13167,support,1
13168,"oxaliplatin, lv, 5-fu",1
13169,trq15-01,1
13170,daily radiation therapy,1
13171,adhaqp1,1
13172,nutri-peitc jelly,1
13173,bavituximab plus paclitaxel and carboplatin,1
13174,social norms a reminder,1
13175,unfractionated heparin,1
13176,18f-fluorestradiol pet/ct scan,1
13177,mindfulness-based therapy group for couples,1
13178,nivolumab+gemcitabine,1
13179,attending for cervical cytology,1
13180,pazopanib plus capecitabine,1
13181,ac480,1
13182,adjuvant systemic therapy,1
13183,pac-1 compound,1
13184,diffusion-weighted [dw] mri,1
13185,a protein level,1
13186,telephone coaching/phone calls,1
13187,car-t combining pd-1 knockout,1
13188,harmonic scalpel dissection,1
13189,ultrasound image manual review,1
13190,diosmectite + loperamide,1
13191,standard of care (no intervention),1
13192,alternate bolus,1
13193,stent dysfunction,1
13194,patient navigation enhanced with legal support,1
13195,gdc-0575,1
13196,bsi-201 + carboplatin/paclitaxel,1
13197,sequential bibf 1120 + bibw 2992,1
13198,audio program,1
13199,connaught,1
13200,intrauterine ultrasound-guided radiofreq. ablation system,1
13201,"oxaliplatin,5fu, leucovorin",1
13202,"h. pylori eradication (amoxaxillin, lanston, clarithromycin)",1
13203,ihealth wireless blood pressure monitor,1
13204,postoperative dwell with paclitaxel and 5-fu,1
13205,bevacizumab + doxorubin hydrochloride liposme,1
13206,godin leisure-time exercise questionnaire (glteq),1
13207,upfront breast surgery,1
13208,microwave pre-coagulation,1
13209,tamoxifen 40mg qd,1
13210,radiomics,1
13211,pazopanib plus gemcitabine,1
13212,"irinotecan, leucovorin, 5-fluorouracil, docetaxel, cisplatin",1
13213,"total laparoscopic surgery with no incision (natural orifice transluminal endoscopic surgery, noses)",1
13214,avs performed with no intraprocedural rapid cortisol assay,1
13215,maximal cytoreductive surgery,1
13216,(clinimacs) t-cell depleted pbsc transplant,1
13217,letrozole; avastin,1
13218,expect 19 g flex needle,1
13219,68ga-dotanoc pet/ct and 18f-fdg pet/ct in nec,1
13220,teleconsultation,1
13221,esd using master slave robotic system,1
13222,triamcinolone acetonide/5-fluorouracil mixture,1
13223,rnf43-721,1
13224,jnj-64041757,1
13225,combined n-acetyl cysteine -cc,1
13226,"heparin, low-molecular-weight, or direct oral anticoagulants",1
13227,education information system,1
13228,nomogram-based selection for acute normovolemic hemodilution,1
13229,chk1 inhibitor sch 900776,1
13230,"bortezomib with mitoxantrone, etoposide and cytarabine",1
13231,information leaflet,1
13232,somatostatin analog,1
13233,mucolox,1
13234,skin self examination information and abcde rule,1
13235,colorecatal cancer screening activation,1
13236,probiotic group,1
13237,aspirin 81 mg,1
13238,cd 40,1
13239,mei,1
13240,bms-817378,1
13241,standardized care pathways,1
13242,in-vivo skin tumor imaging via optical coherence tomography,1
13243,systemic trus guided biopsy,1
13244,"venetoclax, dexamethasone, ixazomib, pomalidomide",1
13245,non-bcaa protein supplement,1
13246,lactose,1
13247,exercise on stationary recumbent exercise cycle,1
13248,exemestane and gnrh analogue,1
13249,"t-cell depleted hsct from a related, haploidentical donor",1
13250,collection and infusions of donor pbsc,1
13251,chemoembolization using lifepearl,1
13252,memorial anxiety scale for prostate cancer,1
13253,individualized exercise program,1
13254,ancillary treatment,1
13255,generic 0.5% 5-fluorouracil cream,1
13256,fibroblast growth factor 5 (fgf-5):172-176/217-220,1
13257,experimental group: bushen culuan decoction and clomiphene citrate tablets placebo,1
13258,digital photography,1
13259,rocket® ipc- short external length,1
13260,sotatercept 0.1 mg/kg,1
13261,wic fresh start program,1
13262,"height, weight, bmi measure",1
13263,endoesophageal brachytherapy,1
13264,atlcar.cd30.ccr4 cells,1
13265,3d-ex,1
13266,preoperative flexible sigmoidoscopy,1
13267,"intrabeam (carl zeiss, oberkochen, germany)",1
13268,implantation of neurostimulators and their auxiliary components,1
13269,measurement level of myeloid derived suppressor cells in cml patients treated with nilotinib 600 mg/day,1
13270,arm 1: with twice-daily thoracic radiotherapy/ arm 2: with once-daily thoracic radiotherapy,1
13271,cytapheresis + transfusion of autologous peripheral blood stem cells,1
13272,dalotuzumab 15/7.5 mg/kg,1
13273,single-fraction stereotactic body radiation therapy (sbrt),1
13274,cyt004-melqbg10 + imiquimod,1
13275,rabbit anti-thymocyte globulin and cyclosporine or tacrolimus,1
13276,peripheral blood stem cell (pbsc) collection,1
13277,docetaxel/oxaliplatin,1
13278,arm f: folfiri or folfox plus bevacizumab and cetuximab,1
13279,gallium-68 dota tate pet scan,1
13280,sr-t100 gel with 2.3% of sm,1
13281,"mitoxantrone, cytarabine",1
13282,lar octreotide,1
13283,counselor call,1
13284,"everolimus, bevacizumab",1
13285,mammographic breast density at diagnosis,1
13286,juliet feminine laser,1
13287,high-dose hypofractionated srs,1
13288,fine needle aspiration using conventional fna for cytology,1
13289,tp regimen,1
13290,sar650984,1
13291,ponv prophylaxis with ondansetron + dexamethasone,1
13292,"metformin, pioglitazone",1
13293,nutrison,1
13294,tmz(temozolomide),1
13295,robotic assisted distal gastrectomy,1
13296,placebo transdermal patch,1
13297,tnf-alpha and hbv genotype,1
13298,inductionconsolidation cyclophosphamide,1
13299,normal hospital environment,1
13300,surgery and radiation therapy,1
13301,quality of life questionnaire for gastrointestinal tract,1
13302,"cc-223, erlotinib",1
13303,imrt 75 gy,1
13304,belotecan/cisplatin,1
13305,probiotic formula capsule,1
13306,radiological imaging studies,1
13307,choep + g-csf followed by beam,1
13308,gic-1001 500 mg tid,1
13309,antiangiogenic paptide vaccine,1
13310,mitoxsnteone,1
13311,colonoscopist only,1
13312,non-investigational platinum-based doublet chemotherapy,1
13313,traceit tissue marker,1
13314,transarterial chemotherapy plus embolization,1
13315,clomiphen citrate,1
13316,modified folfirinox,1
13317,"doxorubicin, cotrimoxazole, carboplatin, ifosfamide, dexamethasone, prednisone, vincristine, cytarabine, methotrexate, etoposide, cyclophosphamide, vinblastine",1
13318,olympus colonoscope cfhq190al,1
13319,deuterated phenanthrene tetraol,1
13320,transperineal prostate mapping biopsy,1
13321,locoregional anesthesia,1
13322,antibiotic prophylaxis,1
13323,4 fec 100 followed by 4 taxol,1
13324,adjuvant radio(-chemo)therapy,1
13325,"ga -exendin pet/ct, in- exendin spect/ct, mri",1
13326,raloxifene 30 mg oral tablet,1
13327,busulphan plus cyclophosphamide,1
13328,spirus,1
13329,cognitive training program,1
13330,peas,1
13331,oxycodone(single compound),1
13332,test yliver,1
13333,trajectories of body fatness and diet,1
13334,avelumab 10mg/kg with carboplatin/gemcitabine,1
13335,fluorouracil 400 mg/m^2,1
13336,videothoracoscopy,1
13337,folfox4 + cetuximab,1
13338,decision tool,1
13339,"0,9% nacl",1
13340,online support decision tool,1
13341,flox (5-fluorouracil/folinic acid/oxaliplatin) and cetuximab,1
13342,study introduction visit,1
13343,morab-028,1
13344,pranayama (yoga breathing) techniques,1
13345,small bore chest drain + nsaid based analgesic regimen,1
13346,ccadss,1
13347,protocols for treatment,1
13348,ipec with cisplatin (100mg/m²),1
13349,bipolar radiofrequency focal ablation,1
13350,[14c]abt-199 (gdc-0199),1
13351,access,1
13352,quality of life evaluation,1
13353,maintenance with lower doses of lenalidomide and dexamethasone,1
13354,nlg802,1
13355,nuvigil®,1
13356,vs-5584,1
13357,18f-tfb-pet,1
13358,transrectal shear wave elastography of the prostate,1
13359,efi,1
13360,focus group - pediatric patient,1
13361,"ner1006,1-day morning split-dosing",1
13362,cc0 - cisplatin (ip) - epirubicin (iv),1
13363,chimeric antigen receptor t cell,1
13364,navigation guided bronchoscopy,1
13365,"conventional tace in combination with sorafenib, administered on a continuous schedule",1
13366,imatinib and vinorelbine,1
13367,60 gy radiotherapy,1
13368,5fluorouracil (5-fu),1
13369,fentanyl 1-day transdermal patch (double blind phase),1
13370,aop2014 / pegylated-proline-interferon alpha-2b,1
13371,kbp-5209,1
13372,wli assisted turb,1
13373,navigator intervention,1
13374,3d hi and shi of uca,1
13375,dexamethasone+tropisetron,1
13376,omp-131r10,1
13377,voriconazole (dosing according to the spc),1
13378,s 055746,1
13379,pp mesh,1
13380,acy-1215 in combination with pomalidomide and dexamethasone,1
13381,abiraterone acetate in combination with prednisone,1
13382,gc33(ro5137382),1
13383,[18f]-ski-249380,1
13384,mes with apatinib,1
13385,water (placebo),1
13386,jnj-26854165,1
13387,humidification,1
13388,hartmann´s procedure,1
13389,trans bronchial biopsy guided by echo-endoscopic miniprobes,1
13390,"bortezomib, cytarabine, dexamethasone, pegteograstim",1
13391,endostar and chopt,1
13392,sham-acupuncture group,1
13393,atra-iv,1
13394,ferumoxtran-10 (uspio),1
13395,limited surgical evaluation,1
13396,radiologic exams,1
13397,cmv-dcs with gm-csf,1
13398,"cpt-11, 5-fu and l-lv",1
13399,acupressure intervention,1
13400,punch biopsy of the primary tumor,1
13401,family centered advance care planning for teens with cancer,1
13402,v504,1
13403,time,1
13404,[18f]fp-r01-mg-f2,1
13405,diagnostic imaging: 18f-fes pet/ct - baseline,1
13406,ablative treatment,1
13407,pedometer + hospital based intervention,1
13408,srt501,1
13409,surgery combined with rad-p53 gene therapy,1
13410,online spaced education,1
13411,ace,1
13412,intact parathyroid hormone level,1
13413,trixiera,1
13414,salmonella typhimurium,1
13415,6 mercaptopurine (6mp),1
13416,social contact intervention,1
13417,placebo to bf-200 ala gel,1
13418,polysiloxane gd-chelates based nanoparticles (aguix),1
13419,intravenous normal saline,1
13420,no shave margins,1
13421,apto-253,1
13422,amg 162 180 mg (sc) q 12 weeks,1
13423,liberal perioperative fluid management,1
13424,abi-007 (abraxane) and carboplatin,1
13425,radiotherapy+apatinib,1
13426,questionnaire t2 to fill,1
13427,discontinuation of therapy,1
13428,paclitaxel (taxane),1
13429,cold knife conization without stitches,1
13430,eluting-bead,1
13431,timed get up and go test,1
13432,asp1948,1
13433,urinary cotinine assesment,1
13434,axillary treatment,1
13435,relaxation response and virtual reality (vr) session,1
13436,cytosine arabinoside (ara-c),1
13437,traditional perioperative program,1
13438,"chemotherapy, gemcitabine",1
13439,xerostomia questionnaire,1
13440,research interviews,1
13441,secondary wound healing,1
13442,therapeutic melatonin,1
13443,folfirinox regimen plus disulfiram/copper gluconate,1
13444,apbi 27gy in 5 fractions,1
13445,double-track anastomosis,1
13446,folfox4 chemotherapy regimen,1
13447,myelo001,1
13448,pemetrexed & gemcitabine,1
13449,"enoxaparin, heparin",1
13450,sterile water,1
13451,high-risk message,1
13452,"penile exam, peyronie's plaque and erectile function assessment",1
13453,2-deoxyglucose,1
13454,"heparin, fondaparinux, vitamin-k antagonists, aspirin",1
13455,1.1 ml of ino-3112 (vgx-3100 + ino-9012) delivered im via ep with cellectra-5p device,1
13456,group education,1
13457,carboplatin and liposomal doxorubicin,1
13458,specialist palliative care,1
13459,cll1-cd33 ccar t cells,1
13460,raltitrexed combined with apatinib,1
13461,patupilone + midalzolam,1
13462,glucose load,1
13463,radical therapy (prostatectomy or radiotherapy),1
13464,verum acupuncture and medicine,1
13465,standard surgical resection,1
13466,smoked plum,1
13467,cisplatin (dose level 4),1
13468,pimasertib once daily,1
13469,renovocath™ r120 catheter,1
13470,tmtp1,1
13471,oxycodone/acetaminophen,1
13472,hd201,1
13473,"gemcitabine, capecitabine",1
13474,theravac,1
13475,glyburide,1
13476,sympathetic response,1
13477,not preserving the left colic artery,1
13478,bio-absorbable felt(neoveil®),1
13479,hyperimmune colostrum,1
13480,puva (8-mop + uva),1
13481,anlotinib hydrochloride with irinotecan,1
13482,drug: selumetinib,1
13483,platinum-doublet chemotherapy,1
13484,semi-structured face to face interviews.,1
13485,revised invitation signed by the attending physician,1
13486,fbp,1
13487,olokizumab q4w,1
13488,vitamin b,1
13489,multiple-fraction stereotactic body radiation therapy (sbrt),1
13490,18f-fes pet,1
13491,vein ligation first,1
13492,rigid bronchoscopy with ultraviolet transmission,1
13493,gc,1
13494,pa newsletter,1
13495,"imaging guided biopsy, surgical biopsy or surgical excision",1
13496,gefitinib plus etoposide,1
13497,endoscopy ultrasound,1
13498,bi 905677,1
13499,tobacco dependence/smoking cessation counseling,1
13500,psv,1
13501,"taxotere, cisplatin, gemcitabine",1
13502,"none, screening only",1
13503,calcium levofolinate,1
13504,art-therapy,1
13505,fatigue counseling,1
13506,pre-operative radiation,1
13507,eus guided ercp,1
13508,docetaxel-carboplatin,1
13509,conformal radiation therapy,1
13510,image guided stereotatic ablative radiotherapy,1
13511,prm-151,1
13512,biometric feedback,1
13513,pentosan polysulfate na 100mg cap,1
13514,platinum microcoil,1
13515,hypofractionated re-irradiation,1
13516,tutoring classes,1
13517,assess surgical site occurrences at 1 year postoperatively,1
13518,durvalumab + tremelimumab + chemotherapy treatment,1
13519,arm 1 600 cgy x 5 fractions,1
13520,cpop-r,1
13521,placebo or control group,1
13522,irinotecan + carboplatin + erbitux,1
13523,metvix®,1
13524,comp02,1
13525,d2 resection,1
13526,r-hcvad and r-mc,1
13527,stem cell transplant x 1 or x 2,1
13528,autologous pbmcs in gm-csf (mc),1
13529,beauty care,1
13530,multiple injection paravertebral blocks,1
13531,patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy,1
13532,refrigerator magnet,1
13533,pet-scan,1
13534,interoperative radiation,1
13535,cardiac 3d mri,1
13536,etoposide capsule,1
13537,rehabilitation planning consult (rpc),1
13538,ablation probe,1
13539,emesis diary,1
13540,iseganan hcl oral solution,1
13541,cd22 car-t,1
13542,plasma blood collection,1
13543,no hipec,1
13544,four dimensional computed tomographic imaging (4dct),1
13545,exercises,1
13546,"aspirin placebo, vitamin d",1
13547,in vitro kinase inhibitor assay,1
13548,byl719 as film-coated (fc) whole tablets,1
13549,endoscopic ultrasound guided needle based confocal endomicroscopy,1
13550,observation group,1
13551,"fludarabine, cyclophosphamide, rituximab, lenalidomide",1
13552,electromagnetic measurement,1
13553,"""prophylactic"" delayed activated donor lymphocyte infusion",1
13554,depfff,1
13555,curietherapy and radiotherapy,1
13556,arm b durvalumab/tremelimumab/chemotherapy association,1
13557,abgn-107,1
13558,intraoperative colon lavage with primary anastomosis,1
13559,interdisciplinary lifestyle intervention,1
13560,radiographic evaluation,1
13561,breath holding,1
13562,chlorhexidine irrigation,1
13563,no pharmaceutical consultations,1
13564,robi forceps-karl storz,1
13565,barrier resection/1cm resection,1
13566,uracil,1
13567,gemcitabine(g) carboplatin(c),1
13568,behavioral activation therapy,1
13569,methotrexate and temozolomide,1
13570,cisplatin/platinol,1
13571,3d cone-beam imaging,1
13572,monoclonal antibody a1g4 anti-idiotype vaccine,1
13573,pemetrexed (alimta) in combination with gemcitabine (gemzar),1
13574,human neural stem cells,1
13575,leac-102 500mg capsule and folfox + bevacizumab/cetuximab,1
13576,low risk with complete early response after two cycles of abvd chemotherapy schedule. only one more abvd course is delivered.,1
13577,synthetic mammography + digital breast tomosynthesis,1
13578,macrogol 4000,1
13579,3t magnetic resonance spectroscopic imaging,1
13580,standard fluid therapy,1
13581,esp block,1
13582,cetuximab plus folfiri/folfox,1
13583,ao+mist,1
13584,reduced fluid volume,1
13585,csc-dc,1
13586,azacitidine subcutaneous injection or intravenous infusion,1
13587,pfp,1
13588,letrozolo+cyclophosphamide,1
13589,nesiritide (natrecor),1
13590,gm-ct-01 plus 5-fluorouracil,1
13591,web-based screening and tailored support,1
13592,radiofrequency ablation (rfa) or surgery,1
13593,htert,1
13594,radiosurgery (srs),1
13595,epirubicin - cyclophosphamide / docetaxel + trastuzumab,1
13596,octreotide long acting release,1
13597,thoracic epidural analgesia,1
13598,sm-edtmp (low dose),1
13599,g-pbsc infusion,1
13600,oncoimmunome,1
13601,collection of data concerning their sexuality,1
13602,oral cinnamon extract,1
13603,18f-p3bza,1
13604,pomalidomide 2 mg oral capsule [pomalyst],1
13605,docetaxel + oxaliplatin,1
13606,5 day thiarabine,1
13607,nasal continuous positive airway pressure (cpap),1
13608,cc5013,1
13609,robotic-assisted resection.,1
13610,curcumin (+ gemcitabine),1
13611,4 txt q 2 weeks followed by 4 ec q 2 weeks,1
13612,myofascial induction,1
13613,"chp-her2, chp-ny-eso-1",1
13614,topical 85% trichloroacetic acid (tca),1
13615,webcore telephone survey system,1
13616,qpl-ct,1
13617,unmilled mln0128 api,1
13618,s-1 chemotherapy,1
13619,"bevacizumab, everolimus, panitumumab",1
13620,assuremdx,1
13621,early stage,1
13622,granisetron 2mg tablet,1
13623,placebo/folfox,1
13624,intraoperative acquisition (robotic c-arm) of images,1
13625,waterjet-assisted esd,1
13626,oral cep-701,1
13627,part a: dose escalation of cantrixil,1
13628,cold water bath,1
13629,mrgfus treatment,1
13630,bkm120 days 1 - 21 plus paclitaxel + carboplatin,1
13631,loteprednol etabonate/tobramycin opthalmic suspension,1
13632,mk-3475 (neoadjuvant),1
13633,cr1447,1
13634,r-mabhdi and abvd,1
13635,hexal,1
13636,abdominal surgery under general anesthesia,1
13637,focus resilience enhancement program,1
13638,touch 2 screen,1
13639,"cisplatine, etoposide, cetuximab",1
13640,gastric pull up,1
13641,transplant 1 and 2 bortezomib,1
13642,cell proliferation assay,1
13643,5-fraction stereotactic body radiation therapy,1
13644,ap611074 matching placebo,1
13645,cystoscopy and pathology,1
13646,phase 2,1
13647,asp9521,1
13648,nkm injection,1
13649,sr-a + epratuzumab,1
13650,no surgery,1
13651,verbal and written instruction,1
13652,proton craniospinal irradiation (csi),1
13653,lazanda,1
13654,depomedrol,1
13655,ketorolac rinse,1
13656,technologist-controlled (tc) breast compression,1
13657,internet-delivered mindfulness-based cognitive therapy,1
13658,chidamide with egfr-tki,1
13659,blood sampels from vena rectalis superior and vena cubiti,1
13660,late spa treatment,1
13661,ict supported hap,1
13662,flag induction,1
13663,combined anterior and posterior lumbosacral rhizotomy,1
13664,"sid530, taxotere",1
13665,on 01910 na,1
13666,classification,1
13667,sbrt (stereotactic body radiotherapy),1
13668,uft/ leucovorin + cetuximab + radiotherapy,1
13669,pylorus-preserving pancreaticoduodenectomy,1
13670,bpx-501 dose 4,1
13671,fluorouracil - bolus,1
13672,serum sodium,1
13673,pod,1
13674,individualized exercise,1
13675,irradiated haploidentical allogeneic lymphocytes,1
13676,gefitinib group,1
13677,nk cells infusion,1
13678,reference ultrasound,1
13679,creatinine clearance,1
13680,"negative pressure wound therapy (activvac, kci)",1
13681,r-chop + placebo,1
13682,biopsies using urostation® (image fusion),1
13683,mixed cd19/cd20 car-t transfer,1
13684,fam-sotc-pl,1
13685,mgcd265+docetaxel,1
13686,depo-eligard®,1
13687,rt (70 gy in 35 fractions),1
13688,ca 125 and ct scan,1
13689,gefitinib 250mg po qd or tarceva 150mg po qd or icotinib 125mg po tid other name: gefitinib/tarceva/icotinib,1
13690,tacrolimus 90,1
13691,side effect prevention training (sept),1
13692,"bioptics, faxitron, and full field digital mammography (ffdm) selenia",1
13693,adjuvant palbociclib (if palbociclib given neoadjuvant),1
13694,tumor purged/cd25 depleted lymphocytes,1
13695,normal group,1
13696,ipdr,1
13697,early and active nutritional support.,1
13698,pek fusion protein vaccine,1
13699,"in ""cold"" group 13 patients were treated by scalpel.",1
13700,fast release brb confection,1
13701,go-lytely,1
13702,combination chemotherapy plus intrathecal topotecan,1
13703,tanshinone placebo,1
13704,ev1000(flotrac system 4.0),1
13705,home-based human papillomavirus (hpv) dna screening,1
13706,zolbetuximab 800/600 mg/m2,1
13707,pamiparib 60 mg po bid,1
13708,osi-774 (tarceva),1
13709,best clinical practices plus standard print materials,1
13710,imipenem,1
13711,low anterior resection,1
13712,transoral surgery,1
13713,placebo (for pazopanib),1
13714,medgyn mgc 200,1
13715,vinflunine plus gemcitabine,1
13716,wst11 mediated vascular targeted phototherapy (vtp),1
13717,cdgp/5-fu combined with radiation,1
13718,ckd-516 inj,1
13719,strength training group,1
13720,milkshake,1
13721,regimen d,1
13722,bilateral superficial cervical plexus block,1
13723,nkae cells infusion,1
13724,vx-006: 1mg,1
13725,adapt-c intervention,1
13726,women attending reproductive health clinics,1
13727,hyperthermic peritoneal perfusion (hipec),1
13728,best supportive care (standard care),1
13729,ttp607,1
13730,olaparib treatment a,1
13731,group medical consult,1
13732,"temsirolimus, pazopanib",1
13733,temporally feathered radiation therapy (tfrt),1
13734,rare sirloin steak,1
13735,right hemicolectomy with d2 lymph node dissection,1
13736,euclidian robot,1
13737,"stress management, in two steps",1
13738,"bort, dex, and dox with alcar",1
13739,"sorafenib (nexavar), dacarbazine (dtic)",1
13740,paclitaxel & cisplatin,1
13741,"cusa (cavitron ultrasonic aspirator; valleylab, boulder, co)",1
13742,imp-288-lutetium,1
13743,"consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (vcd) regimen",1
13744,neoadjuvant hormonal therapy,1
13745,livestrong,1
13746,2b3-101 60 mg/m2 every 4 weeks,1
13747,hybrid breast fdg pet/mri,1
13748,iv placebo,1
13749,"apatinib,paclitaxel,cisplatin,rt",1
13750,oral bacterial study,1
13751,education by pamphlets,1
13752,follow-up for death and recurrence of patients,1
13753,sf-36 (short form health survey),1
13754,pembrolizumab/ exemestane/ leuprolide,1
13755,exercise stress test,1
13756,facbc pet-ct,1
13757,gemcitabine combined with cisplatin,1
13758,scopp-cw,1
13759,hla-a2 peptides,1
13760,torisel dose 50 mg and r-dha,1
13761,diagnostic mri,1
13762,"cisplatin,p-hdfl",1
13763,a placebo in combination with weekly paclitaxel.,1
13764,epoetin/atra,1
13765,deletion tumor tissue by snare,1
13766,placebo capsule of dlbs3233,1
13767,from cancer to health (c2h-d),1
13768,microsurgery,1
13769,low iron diet,1
13770,medroxyprogesterone acetate tablets or megestrol acetate,1
13771,abi-008,1
13772,da - quantitative,1
13773,mogamulizumab + nivolumab,1
13774,vaginal dna collection,1
13775,medication event monitoring system,1
13776,sargramostim gz402664,1
13777,methotrexate (intravenous administration),1
13778,subarachnoid block,1
13779,xelox postoperative chemotherapy,1
13780,placebo capsules,1
13781,haploidentical bone marrow transplant,1
13782,surgery of liver and lung,1
13783,"sorafenib, vorinostat and bortezomib",1
13784,plasmid amep,1
13785,teddi,1
13786,vicriviroc,1
13787,"taxol, cisplatin, 5-fluorouracil, g-csf",1
13788,"ideal-e observation (investigators choice of imatinib, nilotinib, dasatinib, radotinib)",1
13789,standard fb with fluoroscopy,1
13790,docetaxel (post-operative),1
13791,irinotecan hydrochloride hydrate (cpt-11),1
13792,bupivacaine hydrochloride,1
13793,capecitabine+irinotecan (1st line),1
13794,irinotecan (drug),1
13795,sodium chloride solution,1
13796,laparoscopic colorectal cancer resection,1
13797,radiotherapy 72 gy(rbe),1
13798,fsfi questionnaire,1
13799,non surgical management,1
13800,foscan,1
13801,cyt004-melqbg10 intra nodal injection,1
13802,quilting suture without drainage,1
13803,"pld, cyclophosphamide, trastuzumab, paclitaxel",1
13804,enteral nutrition alone for patients after esophagectomy,1
13805,"questionnaire, blood specimens",1
13806,external radiation therapy (xrt),1
13807,"entinostat days 3, 10",1
13808,vinorelbine & plerixafor on day when cd34 count is at least 15'000 cd34+ cells/ml of peripheral blood,1
13809,"gemcitabine plus pemetrexed, paclitaxel plus gemcitabine",1
13810,compound 121564,1
13811,dexamethasone 8 mg,1
13812,palbociclib oral capsule,1
13813,p6 stimulation with intravenous infusion of ramosetron,1
13814,salagen,1
13815,cd3/cd19 depletion on clinimacs,1
13816,emd 525797 750 mg,1
13817,radiofrequency ablation under eus,1
13818,idec-152,1
13819,computed tomography x-ray system,1
13820,bold mri test,1
13821,opioid-free group,1
13822,telotristat ethyl,1
13823,communication with oncology team,1
13824,mailed reminders with fecal immunochemical testing kits,1
13825,maintenance therapy post-hsct,1
13826,depot lupron followed by progesterone plus placebo.,1
13827,anti-b1 antibody and iodine-131 anti-b1 antibody (tositumomab and iodine i 131 tositumomab),1
13828,thermocoagulation (device),1
13829,cisplatin + etoposide,1
13830,anti-kras g12v mtcr,1
13831,belotecan and ifosfamide,1
13832,"the functional assessment of chronic illness therapy-fatigue subscale, version 4",1
13833,the second booster vaccine phase:,1
13834,"genexol-pm 260mg/?, carboplatin 5auc",1
13835,anastrazole (arimidex®),1
13836,tyroserleutide for injection,1
13837,set-diet plus clomiphene,1
13838,abiraterone - group 2,1
13839,hyperacute - breast cancer vaccine,1
13840,self-management group,1
13841,light source (interstitial light emitting diodes),1
13842,hlx07,1
13843,hec or mec,1
13844,erroneous off-midline closures,1
13845,autologous hematopoietic and immune cell rescue (transplantation),1
13846,endoclot,1
13847,pre-implant transrectal ultrasound images and planning,1
13848,pd l 506,1
13849,gonadotropins; folic acid,1
13850,sonazoid,1
13851,hyperpolarized xenon-129 mri,1
13852,online mindfulness training,1
13853,bal101553 at mtd,1
13854,fibrin structure,1
13855,252-cf neutron intracavitary brachytherapy,1
13856,"beta-blocker (esmolol, metropolol)",1
13857,mass closure technique,1
13858,cd34+ selection,1
13859,sorafenib & capecitabine,1
13860,expanded prostate cancer index composite-sf12,1
13861,open label lam-003,1
13862,comparator: blinded placebo,1
13863,berberine chloride,1
13864,ast-vac2,1
13865,placebo osimertinib 80mg/40mg,1
13866,dexamethasone and rituximab,1
13867,letrozole for 34 months,1
13868,eflornithine placebo & sulindac,1
13869,hydrochloroquine,1
13870,lf-pb,1
13871,hpv gsk 580299 vaccine,1
13872,pegylated interfon alpha 2b,1
13873,gsk21110183,1
13874,qol survey booklet,1
13875,imagio oa/us,1
13876,exemestane + dasatinib,1
13877,patient controlled analgesia (pca),1
13878,onx-0801,1
13879,montreal cognitive assessment,1
13880,dna intercalators,1
13881,placebo (for varlitinib),1
13882,reduced port laparoscopic distal gastrectomy,1
13883,hu-cart meso cells,1
13884,women's stories,1
13885,apr-246 + azacitidine,1
13886,docetaxel plus lonafarnib,1
13887,dc-ova,1
13888,ro7121661,1
13889,peg asparaginase at two weeks interval,1
13890,smear and biopsy testing for hpv-types and viral load,1
13891,farydak,1
13892,alpha-glucosidase inhibitors,1
13893,11c or 18f-choline pet/ct,1
13894,therapeutic target tailored chemotherapy,1
13895,dosage of d-2hg in the urine,1
13896,harvard health professionals survey,1
13897,busulfan (conditioning for allo transplant),1
13898,adapted walking platform,1
13899,fops,1
13900,chemotherapy: paclitaxel/carboplatin,1
13901,calcium folinate (cf),1
13902,motivational and behavioral counseling,1
13903,bicalutamide and calcium/ vitamin d supplementation,1
13904,fdg = fluorodeoxyglucose,1
13905,stage 1 group 2: abiraterone acetate,1
13906,axitinib + capecitabine (cohort 7),1
13907,caffe,1
13908,irradiation prophyllactique cérébrale,1
13909,ngc-triple regimen,1
13910,letrozole - sequential,1
13911,apx005m treatment for newly diagnosed dipg patients,1
13912,interview and wait list,1
13913,asct conditioning,1
13914,bli (blue laser imaging),1
13915,rituximab+chlorambucil,1
13916,intravenous placebo,1
13917,expressive writing (arm will not be include in the randomization),1
13918,cart22 cells,1
13919,donafenib(200mg),1
13920,self-collected hpv vaginal swab,1
13921,blood collection and micronuclei assay on binucleate lymphocytes in culture,1
13922,zyban,1
13923,perioperative rehabilitation program,1
13924,prophylactic irradiation of tracts (pit),1
13925,colonoscopy only,1
13926,fluid loading of volulyte 300 ml,1
13927,esophagogastrostomy,1
13928,olaptesed pegol - monotherapy,1
13929,the fecal incontinence quality of life scale (fiqol) questionnaires,1
13930,validated questionnaires,1
13931,standard-dose epirubicin combined with cvp ± rituximab,1
13932,proton or photon radiation therapy,1
13933,absorbent pads,1
13934,18-f-fdg pet/mr scan,1
13935,sema4c low value follow-up group,1
13936,amgen 386,1
13937,intravitreal melphalan (local treatment),1
13938,enhanced recovery program,1
13939,questionnaire for former bleeding events,1
13940,androderm® 5.0mg,1
13941,p946,1
13942,sun safe workplaces -in person,1
13943,"""apatinib"" and ""capecitabine""",1
13944,tomox,1
13945,puva (8mop + uva) + ifn,1
13946,"lactobacillus, bifidobacterium and enterococcus",1
13947,lower neck ct,1
13948,soft tissue sarcomas in adults,1
13949,rfa+highly-purified ctl,1
13950,zoledronic acid i.v. 5 years,1
13951,resection pulmonaire,1
13952,robot-assisted total mesorectal excision,1
13953,h2rb,1
13954,laparascopic or percutaneous cryoablation,1
13955,mk-2206 combined with carboplatin + paclitaxel,1
13956,vancomycin powder,1
13957,otsa101-dtpa-90y level 2,1
13958,breast cancer surgery only - arm iii,1
13959,hai chronomodulated chemotherapy,1
13960,late leukostim,1
13961,bcg tokyo-172 strain solution,1
13962,rituximab s.c.,1
13963,low-dose temozolomide plus sorafenib,1
13964,back-loaded needle (device),1
13965,difinsa53,1
13966,elotuzumab in combination with lenalidomide and dexamethasone,1
13967,diet and exercise intervention,1
13968,in-vitro maturation oocytes,1
13969,weekly telephone follow up,1
13970,decitabine and pegylated interferon-alfa 2b,1
13971,myeloablative chemotherapy regimen for lymphoid malignancies or cord blood unit recipients,1
13972,endoscopic nir imaging and gamma probe,1
13973,ropivacaine for serratus plane block (spb),1
13974,ys110,1
13975,photodynamic therapy blue light,1
13976,detection and resection of sentinel lymph node,1
13977,fludeoxyglucose (18f),1
13978,descartes-08,1
13979,mechanical temporal summation assessment,1
13980,2nd generation adt (abiraterone or enzalutamide),1
13981,medi4736 (durvalumab) + tremelimumab,1
13982,"california verbal learning test, children's version",1
13983,mabp1,1
13984,metformin-oral contraceptive(oc),1
13985,long course chemoradiotherapy (lcrt),1
13986,4scar-psma,1
13987,endoscopy using narrow band imaging,1
13988,avelumab 800 mg in combination with gemcitabine / cisplatin.,1
13989,unmatched standard of care,1
13990,pre-treatment tumour oxygen measurements,1
13991,virtual reality helmet,1
13992,68ga-psma-11 pet,1
13993,flt3l,1
13994,risk map dss tool,1
13995,myeloablative allogeneic hct with a non-tbi conditioning regimen,1
13996,pancreaticoduodenectomy with standard lymphadenectomy,1
13997,asn001: escalating dose part a,1
13998,follow-up strategy for breast cancer,1
13999,cutting scalp hair,1
14000,thyroid resection,1
14001,evonail® solution,1
14002,sham low-frequency rotating magnetic therapy system,1
14003,usual psychosocial support,1
14004,erlotinib + sorafenib,1
14005,twice daily radiotherapy,1
14006,"sgx201 (delayed release beclomethasone 17,21-dipropionate)",1
14007,methyl aminolevulinate (mal) and hexaminolevulinate (hal),1
14008,liquid-based cytology (lbc) sampling,1
14009,advanced mri imaging,1
14010,cancer information mentor,1
14011,"rad001, sunitinib",1
14012,3d-rt or imrt,1
14013,cytovene (ganciclovir sodium),1
14014,pre-dli salvage chemotherapy,1
14015,donor lymphocyte infusions,1
14016,aerobic cardiovascular exercise program,1
14017,trametinib 1 mg,1
14018,atezolizumab (mpdl3280a),1
14019,recombinant vaccinia-cea(6d)/tricom vaccine,1
14020,bax69 + infusional 5-fu/lv,1
14021,allomem™,1
14022,platinum + gemcitabine,1
14023,promis-10 questionnaire,1
14024,"lenalidomide, bortezomib and dexamethasone",1
14025,best systemic therapy,1
14026,computed tomographic colonography,1
14027,human breath samples,1
14028,dc/aml fusion cells,1
14029,30% eiso,1
14030,"fragmin, 5-fluorouracil, folinic acid, irinotecan, bevacizumab",1
14031,pmkt questionnaire,1
14032,protective therapy,1
14033,gvax prostate cancer vaccine,1
14034,clinimacs® tcr??/cd19 combined depletion system,1
14035,pediatric cancer young adult survivors,1
14036,stem cell product infusion,1
14037,kapa hyper prep kit + agilent sureselectqxt,1
14038,cold-steel surgery (forceps),1
14039,fact-gp,1
14040,technetium tc 99m maa,1
14041,curative surgery for resectable pancreatic duct adenocarcinoma,1
14042,in-person support group,1
14043,vsl#3 (probiotic),1
14044,cbd,1
14045,testicular tissue cryopreservation,1
14046,cd4+cd25+ regulatory t cells,1
14047,oxaliplatin 85 mg/m2 iv,1
14048,daily visits from pain team whilst in hospital,1
14049,paclitaxel polyglumex (xyotax),1
14050,neutral text message reminder,1
14051,bay1082439,1
14052,practice facilitation,1
14053,non-awake anesthesia protocol,1
14054,pet therapy,1
14055,"quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (hpv 6, 11, 16, 18, 31, 33, 45, 52, 58)",1
14056,multi-targeted next generation sequencing,1
14057,grifola frondosa,1
14058,sh t00268c,1
14059,standardized exercise intervention program,1
14060,standard of care: docetaxel,1
14061,seca mbca,1
14062,pulmonary lobectomy,1
14063,treatment actinomycin-d,1
14064,dose-intensified image-guided sbrt using simultaneous integrated boost,1
14065,operation - marcy,1
14066,breast brachytherapy with mammosite rts,1
14067,gns561,1
14068,68ga-dotatoc pet-ct imaging,1
14069,boost stereotactic body radiation therapy,1
14070,"nab-paclitaxel 100 mg/m2 + gemcitabine 1000 weeks 1,2,3/4",1
14071,without apa program,1
14072,ploidy and tumour:stromal ratio measurements,1
14073,integrative medicine treatment program,1
14074,non- head and neck self reporting,1
14075,pemetrexed 500 mg,1
14076,early rehabilitation,1
14077,peripheral blood for cmv dna pcr,1
14078,food safety guidelines,1
14079,combination of cyberknife with s-1,1
14080,"listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see intervention description)",1
14081,"touch, caring and cancer dvd program",1
14082,nktr-262,1
14083,intra-operative lowtemperature at 34.7 ±0.6 degree centigrade,1
14084,iron sucrose injection usp,1
14085,venous blood draw,1
14086,cooling helmet,1
14087,prolonged continuous infusion gemcitabine,1
14088,"paclitaxelpaclitaxel (albumin bound),bleomycin combined with cisplatin or carboplatin",1
14089,trichostatin a,1
14090,boronophenylalanine-based bnct,1
14091,g8 screening,1
14092,later entry group,1
14093,blue light photodynamic therapy illuminator (blu-u),1
14094,culdocentesis,1
14095,tnf alpha blockers,1
14096,caltrate,1
14097,endocrine,1
14098,vesnarinone,1
14099,cyclophosphamide epirubicin etoposide prednisolone,1
14100,optimal sbrt,1
14101,lobar or segmental lipiodol transarterial chemoembolization,1
14102,exemestane followed by combination therapy,1
14103,reducing ctv,1
14104,[18f]fdg-pet-voxel intensity-based imrt,1
14105,usual post operative care,1
14106,vincristine sulfate injection (vsi),1
14107,neoadjuvant chemotherapy(ts-1+cddp) followed by gastrectomy,1
14108,p53 with chemotherapy,1
14109,111in-cp04,1
14110,gemcitabine/docetaxel combination,1
14111,flt3 ligand,1
14112,d2 lymphadenectomy excluding no. 10,1
14113,clarity ultrasound,1
14114,web intervention,1
14115,otl0038,1
14116,5 fluorouracil (systemic),1
14117,ivf/icsi,1
14118,nk cell infusion:,1
14119,recombinant interferon-?,1
14120,induction paclitaxel,1
14121,dibh vmat,1
14122,ls tumor screening,1
14123,treated by endostar combined with docetaxel and cisplatin,1
14124,a structured interview with every patient,1
14125,lymph node dissection using the peritoneal iliac flap approach to seal lymphatic vessels,1
14126,molecular profiling analyses,1
14127,medical nutrition therapy + metformin,1
14128,investigator choice of chemotherapy,1
14129,mfolfox6 with radiation,1
14130,body mind training (bmt),1
14131,zinc oxide,1
14132,depakote,1
14133,complementary medicine consultation and treatment,1
14134,dental panorama,1
14135,lymphatic massage (decongestive lymphatic therapy) (arm 1),1
14136,photodynamic therapy daylight,1
14137,utilisation of daily igrt (set-up according to bony structures),1
14138,antiperistaltic billroth ii + braun anastomosis,1
14139,interventions,1
14140,primary retroperitoneal lymph-node dissection (prplnd),1
14141,xingzaoruanjian,1
14142,relaxing music (rm) therapy,1
14143,polidocanol injection,1
14144,technetium tc 99m methylene diphosphonate,1
14145,"5-fu, leucovorin, docetaxel, oxaliplatin (flot), trastuzumab",1
14146,hypofractionated radiation therapy 60 gy in 20 fractions,1
14147,bupropion extended release (wellbutrin xl),1
14148,administration of a lhrh agonist and bicalutamide,1
14149,breast-q© questionnaire,1
14150,zoledronic acid; letrozole,1
14151,wearable technology - fitbit alta,1
14152,one time radiation,1
14153,iodine 125 standard loose brachytherapy seeds,1
14154,"taxotere, cisplatin, and 5-fu",1
14155,irinotecan 240 mg/m2,1
14156,74 gy rt,1
14157,epidoxorubicin and cisplatin and lipiodol,1
14158,lumenr retractor,1
14159,chemotherapy by investigator's choice,1
14160,pde-5 inhibitors group,1
14161,radio guided occult lesion localisation,1
14162,hycamptin,1
14163,emotional skills,1
14164,denovoskin,1
14165,nuc-3373 + oxaliplatin + panitumumab,1
14166,adefovir,1
14167,enk cell infusion,1
14168,12 week resistance training program,1
14169,suranix,1
14170,irinotecan 165 mg/m2 iv,1
14171,surgery?ucnd?unilateral central lymph node dissection?,1
14172,university of washington quality of life,1
14173,abtl0812 in combination with paclitaxel and carboplatin,1
14174,questionnary,1
14175,carboplatin & paclitaxel,1
14176,lung radiofrequency ablation,1
14177,pembrolizumab plus chemotherapy,1
14178,zsp1603 12.5 mg,1
14179,"radical external beam radiotherapy, 50gy in 25 fractions",1
14180,pain threshold assessment,1
14181,yangzhengxiaoji capsule combined with chop regimen,1
14182,high-resolution microendoscopy (hrme) imaging,1
14183,cra-24781,1
14184,simple gauze dressings,1
14185,acceptance and commitment therapy for erectile dysfunction (act-ed),1
14186,ct-2103,1
14187,ellagic acid + annona muricata,1
14188,clinical trial kiosk,1
14189,panitumumab+irinotecan,1
14190,"usual, standard-of-care informed consent for chemotherapy",1
14191,leep or cold knife,1
14192,bay1841788 / darolutamide (odm-201),1
14193,0.25% timolol maleate gel forming solution,1
14194,mrcp001,1
14195,pragmatic standard care.,1
14196,vmat_fb,1
14197,bone marrow aspiration from the iliac crest,1
14198,umbilical cord blood transplant,1
14199,gallium-68 thp-psma,1
14200,proton therapy (radiation therapy),1
14201,wt1 126-134 peptide vaccine,1
14202,whipples surgery,1
14203,blocking with medunasal®-heparinblock,1
14204,rad001; cisplatin; 5-fu; leucovorin,1
14205,diagnostic pet/ct scans,1
14206,polysialic acid,1
14207,paclitaxel 200mg/m2,1
14208,azd9496 variant d,1
14209,sonovue (sulphur hexafluoride microbubbles),1
14210,sirolimus and methotrexate,1
14211,enbd group,1
14212,tamoxifen (nolvadex) placebo,1
14213,"regimen 2, course, 1, cycle c1",1
14214,fr901228,1
14215,sbrt 50.0 gy,1
14216,prospective study on digestive affections in an homogeneous cohort of hematological patients,1
14217,tcr??+/cd19+ depleted haploidentical hsct,1
14218,[18f] cfa,1
14219,the left colonic artery is not preserved,1
14220,genetic analysis for the detection of prostasomes,1
14221,bms-986242,1
14222,saponin-based immunoadjuvant obi-821,1
14223,holmium-166 polylactic microspheres,1
14224,diagnosis methods,1
14225,archival tumor tissue collection and blood draws,1
14226,ivf antagonist protocol,1
14227,fentanyl sublingual spray (fss),1
14228,facbc pet-ct imaging,1
14229,epirubicin - cyclophosphamide / docetaxel,1
14230,implantable pump with continuous flow,1
14231,90y-ahn-12,1
14232,continuous pd-1 inhibitor therapy,1
14233,sbrt+tki,1
14234,erlotinib 150mg,1
14235,perfluorinated gas/oxygen mixture,1
14236,adjuvant chemotheapy,1
14237,apitolisib,1
14238,eras group,1
14239,mapleson circuit and nasal trumpet,1
14240,transvaginal ultrasound scanning,1
14241,hal 5% with illumination,1
14242,bead block microspheres,1
14243,18f- fluorocholine,1
14244,"ingenol mebutate picato® day 2, 3, 4",1
14245,mag-tn3 + as15,1
14246,"oxaliplatin, paclitaxel",1
14247,standard dose cetuximab,1
14248,doxorubicin and cisplatin,1
14249,biological/genetically modified t cells,1
14250,parvovirus h-1 (h-1pv),1
14251,vlx1570 and dexamethasone,1
14252,working memory training,1
14253,qol,1
14254,"immucin, hgm-csf",1
14255,standard dose dense doxorubucin and cyclophosphamide,1
14256,sequential pebus - enb,1
14257,high level vitamin d,1
14258,"paclitaxel, carboplatin, temozolomide",1
14259,tissue banking,1
14260,health literacy appropriate education and demonstration,1
14261,early allocation to palliative care,1
14262,standard chemotherapy (pcde or pe),1
14263,app supported colonoscopy preparation,1
14264,blood-sampled,1
14265,tegafur-uracil (uft),1
14266,vp -16,1
14267,anakinra plus standard of care,1
14268,sorafenib and radiotherapy for hepatocellular carcinoma,1
14269,concomitant bevacizumab,1
14270,echelon flex™ 45 and 60 powered endopath® stapler articulating endoscopic linear cutter,1
14271,imaging devices,1
14272,ven (venetoclax),1
14273,cart22 cells transduced with a lentiviral vector to express anti-cd22 scfv tcrz:41bb,1
14274,peg low volume with bisacodyl,1
14275,0.5g/kg of 20% mannitol,1
14276,standard diagnostic evaluation,1
14277,coxsackievirus a21 (cva21),1
14278,68ga-neb,1
14279,intermittent pd-1 inhibitor therapy,1
14280,capoten®,1
14281,arm a directed exercise program,1
14282,template-guided localization,1
14283,ny-eso-1?²??t cells,1
14284,anastrozole plus tegafur-uracil,1
14285,pembrort,1
14286,sip feed,1
14287,transrectal ultrasound scan of prostate,1
14288,liposomal sn-38,1
14289,"compression sleeve, daytime wear",1
14290,foliri,1
14291,standard per daily radiation therapy,1
14292,docetaxel/pemetrexed,1
14293,biopsy/lumpectomy/mastectomy,1
14294,30gy (gray) planning target volume (ptv),1
14295,ordinary endosonography(eus),1
14296,sativex high dose,1
14297,participants asked questions about recent experiences of anal intercourse in the last six months.,1
14298,two-field lymphadenectomy,1
14299,"capecitabine, dacarbazine",1
14300,air-mrsi,1
14301,intermittent compression devices (icd),1
14302,64cu-atsm,1
14303,amixea,1
14304,reading tutoring intervention,1
14305,panolosetron,1
14306,pd-l1 expression,1
14307,surgery after 12 weeks from chemoradiation treatment,1
14308,subcutaneous rituximab,1
14309,intra-operative magnetic resonance imaging (mri),1
14310,(eortc qlq-c30) questionnaire,1
14311,online educational group,1
14312,radiotherapy of neo-adjuvant therapy,1
14313,cesium cs 137,1
14314,selumetinib (azd6244 hyd sulfate) 50mg/dose,1
14315,resting vitals,1
14316,beneforte broccoli soup,1
14317,amg 330,1
14318,lovastatin ™,1
14319,health education for lymphedema prevention,1
14320,manual therapy,1
14321,buccal swabs and obtaining peripheral blood,1
14322,fpprgd2,1
14323,near-infrared (nir) dye indocyanin green (icg),1
14324,resistance and aerobic training,1
14325,nimotuzumab and tp regimen,1
14326,cultural cbt,1
14327,"gefitinib, radiotherapy",1
14328,normal dressing,1
14329,standard chemotherapy medicine,1
14330,trimodal prehab & erp,1
14331,itd consolidation and ixazomib maintenance vs. no further therapy,1
14332,autologous hematopoietic stem cells (hsc),1
14333,cisplatin and 5-fluorouracil,1
14334,lung function imaging,1
14335,soap,1
14336,prophylactic percutaneous gastrostomy,1
14337,hll1,1
14338,spectra-scope,1
14339,post-operative adjuvant therapy,1
14340,oncologist recommendation,1
14341,dose escalation of ad-hcmv-tk and ad-hcmv-flt3l,1
14342,imrt using individualized ctv,1
14343,asn002 rd,1
14344,placebo formulation 2,1
14345,ivct,1
14346,131- i metaiodobenzylguanidine,1
14347,preoperative warm-up on simulator,1
14348,adaptive skin sutures.,1
14349,vincristine (vcr),1
14350,limited lymphadenectomy,1
14351,cb-103,1
14352,radiotracer [18f]iso-1,1
14353,summary of psychosocial risk factors,1
14354,tissue glu,1
14355,everted suture technique,1
14356,bone marrow transplant from same donor,1
14357,consolidative surgery,1
14358,chemoradiotherapy regimen between pc and pe,1
14359,furosemide topical gel,1
14360,activated dcs,1
14361,bone marrow for correlative studies,1
14362,routine ct,1
14363,device: fitbit flex wrist band,1
14364,maltodextrin and amioca starch,1
14365,satraplatin in combo with vinorelbine,1
14366,octylcyanoacrylate (dermabond),1
14367,fast track diagnosis,1
14368,mdc vaccination,1
14369,observation about the presence of metabolic syndrome,1
14370,primary wound closure in allgower technique vs. secondary open wound healing of pin-sides after removal of the fixated-externe,1
14371,afirma gsc,1
14372,nasopharyngeal airway without jet ventilator,1
14373,nerve capping device,1
14374,bcc surgery,1
14375,tace with surefire,1
14376,quality of life assessment and clinical evaluation,1
14377,day 1: vinorelbine 30 mg/m2,1
14378,limited palmar fasciectomy,1
14379,"topotecan, temozolomide",1
14380,"tissue, blood, research imaging (tbri)",1
14381,anemia,1
14382,"panitumumab, oxaliplatin, folinic acid, 5fluoruracil",1
14383,"quality of life questionaires & interview: eortc qlq c-30, eortc qlq h&n-35, health behaviors, subjective significance questionnaire, qualitative assessment",1
14384,carbohydrate restricted dietary intervention,1
14385,mgc018,1
14386,active comparator: olaparib tablets,1
14387,trametinib tablet,1
14388,multi-collect swab,1
14389,biopsy (standard of care),1
14390,right heart catheterization,1
14391,"part 2, cohort 1",1
14392,ramelteon,1
14393,boston scientific large capacity with needle biopsy,1
14394,exercise based on active video gaming,1
14395,postremission consolidation based on mrd status,1
14396,phase ib - nivolumab,1
14397,systemic chemotherapy (folfiri),1
14398,cyclophosphamide (ac),1
14399,splenic irradiation,1
14400,individual phone intervention and questionnaires,1
14401,once daily for two consecutive days (picato),1
14402,topical abi-1968 cream,1
14403,a positive psychology workshop,1
14404,ac (adm 40mg/m2+cpa 500mg/m2) q21 days x 6 cycles,1
14405,cardio-pulmonary exercise testing (cpex),1
14406,endoscopic imaging,1
14407,self-expandable metallic biliary stent,1
14408,mucipliq,1
14409,contrast enhanced cone beam breast ct scan,1
14410,ko-947,1
14411,sbrt with proton beam radiation,1
14412,ank (nk-92),1
14413,nolatrexed dihydrochloride,1
14414,las41007 o.d.,1
14415,topical saline,1
14416,30 milliliters of 0.375% ropivacaine,1
14417,trx518 with gemcitabine,1
14418,mri of the resection specimen,1
14419,eortc qlq oes-18,1
14420,ultrasound contrast agent (contrast-enhanced ultrasound),1
14421,rpfna,1
14422,lhrh analogs + aromatase inhibitors,1
14423,zd1839 (iressa™),1
14424,"carboplatin,",1
14425,drainage diary,1
14426,bkm120 + paclitaxel + trastuzumab,1
14427,post-operative cht,1
14428,tti-622 + pd-1/pd-l1 inhibitor,1
14429,investigational informed consent for chemotherapy,1
14430,anti-cd33 car-nk cells,1
14431,"gemcitabine, oxaliplatin, 5-fluorouracil, leucovorin (gofl)",1
14432,phone questionnaires,1
14433,mri guided biopsy,1
14434,superficial parotidectomy,1
14435,oncolar® (registered trademark),1
14436,a multilevel cbpr intervention,1
14437,serum-derived bovine immunoglobulin protein isolate,1
14438,lae001,1
14439,spiritual support,1
14440,bortezomib 1.3mg/m^2,1
14441,therapeutic management of the prostate cancer as usual,1
14442,"oxaliplatin, gemcitabine, bevacizumab",1
14443,placebo infusion,1
14444,sulfonylureas,1
14445,oral hydromorphone,1
14446,p53 gene with surgery,1
14447,multi-spectral digital colposcopy (mdc),1
14448,extensive intraperitoneal lavage,1
14449,nebulized dexmedetomidine,1
14450,dyadic communication reinforcement intervention,1
14451,amount of pneumoperitoneum pressure applied during rarp,1
14452,zevalin regimen,1
14453,psma-pet/ct scan,1
14454,brentuximab vedotin (recombinant),1
14455,spyglass pancreatoscopy,1
14456,follow-up for death and recurrence,1
14457,chess/cope,1
14458,hypofractionated partial breast irradiation,1
14459,liposomal arac,1
14460,venae sectio,1
14461,0.25% ropivacaine epidural block,1
14462,bgb a317,1
14463,dre-endoscopy,1
14464,intensive group,1
14465,nx-1207 15 mg,1
14466,pelvic and lower extremity exercise,1
14467,report of peripheral neuropathy after cisplatin therapy,1
14468,colesevelam pill,1
14469,training in hypnoanalgesia,1
14470,needle angle measurement,1
14471,only identification of sentinel nodes (without pelvic lymph-node dissection),1
14472,targeted focal hdr brachytherapy,1
14473,"lisinopril, ace-inhibitor",1
14474,therapeutic education programm,1
14475,traditional exercise,1
14476,on the road to quitting - self help,1
14477,propacetamol alone,1
14478,resting state functional magnetic resonance imaging (rfmri),1
14479,stopping treatment with tki,1
14480,sl-401/ pomalidomide/ dexamethasone,1
14481,tace transarterial chemoembolization,1
14482,anti-psma designer t cells,1
14483,doctaxel,1
14484,pasireotide long acting release (lar),1
14485,low-dose cinefluorography,1
14486,"lomustine, intermediate dose cytarabine",1
14487,herceptin™ (her) + chemo,1
14488,weight loss counseling- in-person,1
14489,moderate-intensity exercise,1
14490,chemotherapy: paclitaxel/cisplatin,1
14491,general reminder message,1
14492,medical and/or radiation oncology appointment session,1
14493,aspiration sclerotherapy,1
14494,liposome bupivacaine + bupivacaine,1
14495,stereotactic radiation therapy (sbrt),1
14496,loop ileostomi,1
14497,jamshidi needle,1
14498,muscle tissue biopsy sample,1
14499,prostatectomy/surgery,1
14500,emotion regulation therapy,1
14501,extrapleural pneumonectomy (epp),1
14502,crlx101 (cerulean),1
14503,post therapy surgery,1
14504,esophageal cooling/warming device,1
14505,potassium iodide solution,1
14506,5-azacytidine (5-aza) group 2,1
14507,narrow band imaging guided biopsy,1
14508,peripheral blood stem cell harvest,1
14509,"neoadjuvant chemotherapy folfirinox, 4 cycles",1
14510,h&e,1
14511,hsct with tbi regimen,1
14512,contact intervention,1
14513,human albumin,1
14514,testim 1%,1
14515,becaplermin nonusers,1
14516,functional mri before start of treatment.,1
14517,rifampicin capsules,1
14518,ctc and cfdna analysis,1
14519,ado-trastuzumab emtansine (t-dm1),1
14520,cylindrical abdominoperineal resection,1
14521,dacarbazine plus endostar (experimental group),1
14522,glp-1 receptor agonists,1
14523,pelitrexol,1
14524,transplant 1 adriamycin,1
14525,anthropometric measurement,1
14526,cta,1
14527,assess pain interference at last office visit preoperatively,1
14528,educational intervention via dvd,1
14529,staple line reinforcement,1
14530,selective suture ligation,1
14531,"irinotecan, docetaxel",1
14532,muscadine plus grape skin extract,1
14533,neurotic disorders,1
14534,azd6244 + erlotinib,1
14535,b-lymphocyte stimulator (blys),1
14536,sonazoid-enhanced ultrasonography,1
14537,sleep intervention,1
14538,physiotherapy in patients with stem cell transplantation,1
14539,haematology/blood chemistry,1
14540,prerandomization chemotherapy (pcde or pe),1
14541,mri ultrasound fusion guided biopsy,1
14542,printed material,1
14543,medical therapy,1
14544,lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells,1
14545,eovist-enhanced mri,1
14546,dropping completed kits at lab for processing,1
14547,neoadjuvant folfoxiri,1
14548,nerve stimulator (stimuplex hns12),1
14549,anidulafungin 200 mg q48h,1
14550,cryo-assisted core needle biopsy,1
14551,pembrolizumab injectable product - chemotherapy - bev,1
14552,question prompt list (qpl),1
14553,ctl019 t-cells,1
14554,imaging investigations (not radiation),1
14555,purified isoflavones,1
14556,induction carboplatin,1
14557,dual x-ray absorptimetry,1
14558,shared decision-making program,1
14559,undergo surgery,1
14560,ibi308\cisplatinum\pemetrexed,1
14561,diethylstilbestrol,1
14562,accelerometry,1
14563,paclitaxel and sorafenib,1
14564,fujinon ec-450bi5 double-balloon colonoscope,1
14565,cm-cs1 t-cell infusion,1
14566,shr1020,1
14567,whole brain imrt,1
14568,secm probe,1
14569,pth (1-34) and pthrp (1-36),1
14570,preventive care management for depression,1
14571,diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed,1
14572,linaclotide,1
14573,valchlor,1
14574,psychoeducative,1
14575,nasal swabs,1
14576,hyper insulinemic euglycemic clamp,1
14577,ipratropium,1
14578,s-1 de-escalation,1
14579,"ganirelix 0.25mg (orgalutran, organon, the netherlands)",1
14580,clampless robotic partial nephrectomy,1
14581,mg005,1
14582,gadolinium-dpta,1
14583,cosmetic assessment,1
14584,white-light examination,1
14585,it knife,1
14586,tislelizumab carboplatin nab-paxlitaxel,1
14587,higher per daily radiation therapy,1
14588,peep challenge,1
14589,renovocath,1
14590,"nivolumab, ramucirumab",1
14591,envision the rhythms of life program/distance,1
14592,xelox (oxalipaltin+capecitabine),1
14593,unmanipulated bone marrow graft with cyclophosphamide,1
14594,"vp16, carboplatin, vincristin",1
14595,a1: amg 386 10 mg/kg + liposomal doxorubicin,1
14596,"aczone (dapsone) gel, 5%",1
14597,radical hysterectomy and bilateral pelvic lymphadenectomy,1
14598,curcumin c3 complex®,1
14599,surgical resection of the tumor,1
14600,clinical videography,1
14601,melphalan hcl for injection (propylene glycol-free)/alkeran for injection,1
14602,imagio gray scale ultrasound,1
14603,biomarker (er/pr) guided lymphadenectomy,1
14604,osi-930 and erlotinib,1
14605,drug-eluting beads loaded with doxorubicin hydrochloride,1
14606,"mercaptopurine, imatinib",1
14607,tumor tissue sample collection,1
14608,bls_ils_e710c 500mg,1
14609,prostate mri and biopsy,1
14610,nk cells + chemotherapy starting,1
14611,1 healthy eating,1
14612,docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy,1
14613,fed treatment: axl1717,1
14614,control - no result,1
14615,"fludarabine, cyclophosphamide, atg",1
14616,arm 3: both arm 1 and 2 + rt,1
14617,pro onc assay and treatment,1
14618,dual energy x-ray absorptiometry (dxa),1
14619,vepeside-ifosfamide-cisplatin,1
14620,tracking & feedback,1
14621,autologous hemopoietic stem cell transplant 1,1
14622,stage 1 arm 2: low dose cyclophosphamide (ctx),1
14623,volumetric mr imaging,1
14624,eus guided neurolysis,1
14625,fosaprepitant (emend),1
14626,early reversal of temporary ileostomy,1
14627,bortezomib retreatment due to relapse,1
14628,r-chop-50,1
14629,4-1bb selected tumor infiltrating lymphocytes (til),1
14630,nutrition education intervention,1
14631,arm 1 probes,1
14632,medical management,1
14633,mrs imaging,1
14634,biguanides,1
14635,cetuximab-zr. 89,1
14636,high flow nasal cannula or low flow nasal cannula,1
14637,cocoa extract placebo,1
14638,chemotherapy agents,1
14639,iodine i 131 monoclonal antibody 8h9,1
14640,5 ml peripheral blood,1
14641,calm app meditation,1
14642,adoptive cell therapy with til,1
14643,provider education,1
14644,darbepoetin alfa and epoetin alfa,1
14645,cascade genetic screening,1
14646,irinotecan (weekly schedule),1
14647,36.25 gy imrt,1
14648,exablate mrgfus for prostate cancer,1
14649,t-spot tb test,1
14650,no snare tip soft coagulation,1
14651,standard self-regulation,1
14652,high voltage radiation therapy (linear accelerator),1
14653,routine surgery,1
14654,simultaneous resection of liver metastasis and the colorectal primary tumor,1
14655,alimta®,1
14656,fit plus incentive,1
14657,direct laryngoscopy,1
14658,coriolus versicolor extract,1
14659,oral docetaxel (modradoc/r),1
14660,"leuprolide acetate 22.5 mg depot, gp-pharm sa",1
14661,sexual and menopausal health resources,1
14662,ywi,1
14663,hkt288,1
14664,exointelliscore prostate,1
14665,risk of malignancy index,1
14666,pbi,1
14667,autologous dendritic cells loaded with autologous tumor rna,1
14668,bw and height,1
14669,chinese herbal formulation phy906,1
14670,lymphoma-biopsy,1
14671,blackberries,1
14672,"vegfr1, vegfr2",1
14673,intervention 1,1
14674,carbo/cyclo,1
14675,sulijia,1
14676,cessation counseling,1
14677,dexrazoxane (dzr),1
14678,alogliptin,1
14679,behavioral disorders,1
14680,dfrf4539a,1
14681,loxo-305,1
14682,bgg492,1
14683,68ga-dotatoc,1
14684,stepped collaborative care intervention,1
14685,cisplatin plus etoposide,1
14686,"hipec,chemotherapy and surgery",1
14687,npi-2358 + docetaxel,1
14688,bi-chop (dose intensified chop),1
14689,eryaspase,1
14690,"pembrolizumab, gemcitabine and cisplatin",1
14691,platinum acetylacetonate (1% wt) supported by sol-gel technology functionalized titania,1
14692,folfox4 or xelox,1
14693,modified wet-suction technique,1
14694,lymphocyte depletion,1
14695,"cmf(cyclophosphamide, methotrexate, fluorouracil) and tamoxifen",1
14696,hematopoietic stem cell microtransplantation-long-term,1
14697,"leuprolide acetate depot susp. 11.25 mg (poland), 3.75 mg (ukraine)",1
14698,sequential boost (15 x 2.67 gy wbi + 4 x 2.5 gy boost),1
14699,hidra/vpa,1
14700,carmustin,1
14701,endoscopic ultrasound-guided celiax plexus neurolysis,1
14702,fluciclovine,1
14703,da vinci firefly imaging system,1
14704,modified smile ?mtx?dex?ifo?l-asp?etoposide?mesna?,1
14705,gsk1120212b,1
14706,coban 2 lite,1
14707,apatinib mesylate +shr-1210,1
14708,62cu-ethylglyoxal bis,1
14709,al2846,1
14710,vrp-her2,1
14711,radiological exploration by ct scan or mri,1
14712,en3285,1
14713,btz,1
14714,anti-gp 100:154 tcr pbl,1
14715,thermodox (thermally sensitive liposomal doxorubicin),1
14716,bema™ fentanyl,1
14717,tasisulam-sodium,1
14718,focal salvage therapy,1
14719,"qol, neurocognitive and psycholpathological assessment",1
14720,glucose tolerance assessment,1
14721,lenalidomide-low dose dexamethasone plus rituximab,1
14722,enhanced mri scan,1
14723,feasibility study,1
14724,"epirubicin, oxaliplatin, capecitabine (eox)",1
14725,afp,1
14726,atra plus 6-mp and mtx,1
14727,oropharyngeal swab,1
14728,image-guided remove port wine stain,1
14729,platelet-pheresis,1
14730,folic acid tablets,1
14731,physician-to-physician engagement,1
14732,hyperthermic intra-peritoneal chemotherapy (hipec),1
14733,mpmri/verdict,1
14734,pit-picking technique,1
14735,0.25% eiso mouth rinse,1
14736,cisplatin: 40 mg/m2 weekly during radiation,1
14737,acupuncture (huatuo),1
14738,lactated ringer's with 0.03% ofloxacin,1
14739,gd2-cart01,1
14740,lc bead loaded with doxorubicin,1
14741,recombinant modified vaccinia ankara-5t4 vaccine,1
14742,theater testing workshop,1
14743,active comparator: progressive resistance training (prt) and a healthy diet,1
14744,"rituximab, gemcitabine, oxaliplatin, dexametasone",1
14745,focused attention sessions,1
14746,radiofrequency ablation (rfa) using the halo ablation system,1
14747,surgical cyst-gastrostomy,1
14748,upper limb elevation to 30º,1
14749,morphine prolonged release,1
14750,"multi method questionary (developped by de rosa, in 1995 and 2014)",1
14751,"aslan001 + mfolfox6 (5-fu, leucovorin)",1
14752,imagery,1
14753,peg-interferon alpha2b,1
14754,immediate-delayed ibbr+tiloop®bra,1
14755,"systemic chemotherapy alone (oxaliplatin, 5-fluorouracil, isovorin)",1
14756,placing the resorbable mesh,1
14757,stereo navigator accessory to pem flex pet scanner,1
14758,ct scan and education,1
14759,liquid oral feeding,1
14760,intrinsic subgroups of breast cancer,1
14761,colectomy or hepatectomy,1
14762,concomitant temozolomide (tmz),1
14763,act-774312,1
14764,interviews with a psychologist,1
14765,intra-tumoral t4 immunotherapy,1
14766,polyamine-free diet,1
14767,tace-deb,1
14768,autologous car.cd30 ebv specific-ctls,1
14769,125i brachytherapy plus gemcitabine,1
14770,knee extension strength,1
14771,124icg250,1
14772,t-rex tri00a,1
14773,bendamustine at a dose of 100 mg/m2,1
14774,vorinostat (saha),1
14775,consolidation treatment part 2: radiotherapy,1
14776,bronchoscopic ablation catheter,1
14777,vmat with kv-ray,1
14778,high resolution microendoscopy (hrme),1
14779,computerized working memory training program (intervention),1
14780,ingenol metabute,1
14781,pm01183 + paclitaxel +/- bevacizumab,1
14782,68-ga-dotanoc,1
14783,ultrasound biopsy needle echo tip procore,1
14784,cryopreservation of hscs using 10% dmso concentration,1
14785,store-and-forward teledermatology evaluation,1
14786,percutaneous endoscopic gastrostomy,1
14787,bay1000394 (2.5mg),1
14788,hybridknife,1
14789,eribulin mesylate (eribulin; e7389),1
14790,injection of 18f-asis,1
14791,imrt with or without radiosensitive therapy,1
14792,rqnestin,1
14793,theophyllin,1
14794,stage 1 arm 1: low dose cyclophosphamide (ctx),1
14795,cyclosporine + campath-1h,1
14796,dalantercept and axitinib,1
14797,phase ii- sequence b,1
14798,kilovoltage intrafraction monitoring,1
14799,transoral robotic-assisted surgery with da vinci xi,1
14800,reduced intensity conditioning stem cell transplantation,1
14801,psma pet/ct scan,1
14802,lap+lus,1
14803,nefopam-propacetamol combination,1
14804,fmri navigation avm resection,1
14805,pharmaceutical care and adherence aids,1
14806,"fludarabine, methotrexate, mercaptopurine",1
14807,metformin and fluorouracil,1
14808,ndc vaccination,1
14809,filling a questionnaire and interviewdescription,1
14810,bupivacaine / epinephrine,1
14811,pk guided arm,1
14812,platinum-based chemotherapy followed by maintenance therapy with gefitinib,1
14813,adjuvant epirubicin+ cyclophosphamide,1
14814,volumetric intensity-modulated arc therapy,1
14815,simple hysterectomy + pelvic lymph node dissection,1
14816,high intensity counseling + varenicline,1
14817,sentinel node,1
14818,lung cancer screening decision tool,1
14819,cirrhosis without hcc,1
14820,chemotherapy and blood stem cell transplantation,1
14821,alb 109564(a) (12´-methylthiovinblastine dihydrochloride),1
14822,tqb2450+cisplatin or carboplatin + 5-fluorouracil (5-fu),1
14823,hypo-fractionated srs,1
14824,mailed invitations for a colonoscopy,1
14825,licartin and cik,1
14826,monoclonal antibody cal,1
14827,culture on sabouraud's dextrose agar (sda),1
14828,sham apa control,1
14829,gsk biologicals' recombinant wt1 antigen-specific cancer immunotherapeutic (asci),1
14830,tlk286 in combination with docetaxel,1
14831,zemy software,1
14832,somatropin,1
14833,anchorseed iodine 125 brachytherapy prostate implant,1
14834,digoxin topical gel,1
14835,testosterone gel applied to skin,1
14836,corticosteroid injection,1
14837,traditional chinese medicine,1
14838,laser speckle imaging,1
14839,focus groups and individual interviews,1
14840,single needle celiac neurolysis (sncn),1
14841,6-[18f]fluorodopamine,1
14842,handsewn anastomosis,1
14843,in-111 dtpa (in-111 pentetate),1
14844,yttrium-90 radiolabeled anti-tac antibody,1
14845,loncastuximab tesirine,1
14846,epa supplementation,1
14847,fludeoxyglucose f 18 (fdg-pet),1
14848,peg-interféron at 90 microg/week,1
14849,telepristone acetate 24 mg,1
14850,predefined titration steps,1
14851,real acupuncture,1
14852,imatinib and ptk/zk222584,1
14853,"ifo, vp-16, ddp, dxm",1
14854,single dose of ctl019,1
14855,gemcitabine + erlotinib,1
14856,neoadjuvant treatment - mfolfox6 & pembrolizumab,1
14857,acoustic coupling fluid,1
14858,ingenol disoxate gel 0.018%,1
14859,ampligen,1
14860,mindful movement and breathing program,1
14861,intermittent propofol sedation,1
14862,asparaginase (e. coli),1
14863,ov-watch,1
14864,sedentary behavior,1
14865,thalidomide and ufur,1
14866,biopsy sample from port wine stain birthmark,1
14867,"everolimus , temozolomide",1
14868,hepatic trans-arterial embolization (tae),1
14869,intraarterial chemoembolization,1
14870,hexaminoavolunate,1
14871,low intensity amplitude-moduled electromagnetic fields,1
14872,dppos boost lifestyle,1
14873,patupilone + omeprazole,1
14874,non-steroidal anti-androgen,1
14875,premarin,1
14876,technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2,1
14877,standard of care questionnaire,1
14878,eribulin + g-csf (granulocyte-colony stimulating factor),1
14879,recombinant fowlpox-psa (l155)-tricom (prostvac-f/tricom),1
14880,coping with breast cancer web-based workbook,1
14881,dexamethasone or equivalent steroid,1
14882,biopsies from routine clinical surveillance endoscopies,1
14883,biomarker draws,1
14884,"doxorubicin, l-asparaginase, peg-l-asparaginase, erwinia asparaginase",1
14885,neoadjuvant cyclophosphamide (after 10 weeks of olaparib alone),1
14886,circumferential submucosal incision resection,1
14887,temozolomide and o6-benzylguanine,1
14888,involved site radiation therapy,1
14889,css-cg,1
14890,faecal incontinence score,1
14891,hematologic malignancy,1
14892,ultrasound image review with cadx,1
14893,tremelimumab+medi4736,1
14894,arm a durvalumab/chemotherapy association,1
14895,coti2,1
14896,imiquimod used as an adjunct to cryotherapy,1
14897,ql block,1
14898,study part 1: krp203,1
14899,2d laparoscope,1
14900,na17.a2 peptide vaccine,1
14901,total body irradiation (tbi) (plan 1),1
14902,ondansetron placebo,1
14903,"complete endoscopic resection at day 1 and months 2, 4, 6 8 and month 10.",1
14904,hpph 6 mg/m2,1
14905,1l treatment,1
14906,lde 225,1
14907,ai presentation,1
14908,urinary volatile organic compound analysis,1
14909,tumors are confirmed by surgery and pathology,1
14910,fecal microbiome transplantation,1
14911,tai-chi,1
14912,vinorelbine followed by cisplatin,1
14913,recombinant human interleukin-15 (rhil-15),1
14914,high dose chemotherapy with autologous transplantation,1
14915,paclitaxel apatinib s-1,1
14916,customized vacuum immobilization device (cvid),1
14917,improvisational comedy,1
14918,"paracetamol 1,5 g",1
14919,cetuximab wkly,1
14920,radiation of 45 grays on 5 weeks,1
14921,"evaluate treatment of lymphedema, with in the quality of life and depression",1
14922,haematology / blood chemistry sampling,1
14923,bcg tokyo-172 strain vaccine,1
14924,everolimus dose escalation,1
14925,3d surfacic scan,1
14926,standard decision board,1
14927,4 cycles cisplatin-5-fluorouracil,1
14928,computer with internet,1
14929,mis416,1
14930,baseline study measures,1
14931,sar302503 (tg101348),1
14932,non-invasive positive pressure ventilation (nippv),1
14933,valstar - maintenance therapy,1
14934,diphtheria/tetanus vaccine,1
14935,talabostat mesylate tablets,1
14936,external--?beam irradiation 50.4 gy,1
14937,arts-based programming,1
14938,tas266,1
14939,pilates exercise,1
14940,web-based counseling,1
14941,only radiation therapy,1
14942,pet/ct scan for rt planning,1
14943,amg 954/panitumumab,1
14944,decad decision aid,1
14945,treatment with tinostamustine,1
14946,tsh-suppressive therapy,1
14947,recentin (cediranib),1
14948,nsai: letrozole or anastrazole,1
14949,mocetinostat maintenance phase + ipilimumab + nivolumab,1
14950,lb-100,1
14951,"lapatinib, trastuzumab, paclitaxel, and mm-111",1
14952,gefitinib and pemetrexed/cisplatin,1
14953,proton stereotactic body radiation therapy (sbrt) (3-5 fractions; various dose and fractionation regimens depending on treatment site).,1
14954,radical retropubic prostatectomy surgery,1
14955,sitagliptin and metformin,1
14956,no curettage,1
14957,4fx x 5gy,1
14958,transfusion graft,1
14959,hdr brachytherapy as monotherapy,1
14960,"aldara (imiquimod) cream, 5%",1
14961,ringer lactate solution,1
14962,amphotericin b,1
14963,glycoprotein 100 (gp100): 209-217 (210m),1
14964,comthyroid,1
14965,ethanol and paclitaxel injection,1
14966,virtual support group,1
14967,three dimensional conformal radiotherapy,1
14968,colonoscopy with enhanced dye,1
14969,therapeutic interventions,1
14970,intense pulsed light + paring versus paring alone,1
14971,acetaminophen (paracetamol) or equivalent,1
14972,clinical follow-up 3,1
14973,chemofx assay,1
14974,mr imaging with endorectal coil,1
14975,educational internet site on prostate cancer screening,1
14976,phase ii - nivolumab,1
14977,immunohistochemistry/tissue microarrays,1
14978,dynamic susceptibility contrast mri,1
14979,hmrs,1
14980,whole body non-contrast mri,1
14981,ivosidenib (ag-120),1
14982,size 3 i-gel supraglottic airway device,1
14983,mycophenolate mofetil 250mg,1
14984,"rituximab, bortezomib,y90 ibritumomab tiuxetan",1
14985,surgicel,1
14986,tmx-101,1
14987,biopsy collection,1
14988,rgct,1
14989,observe postoperative complications,1
14990,avastin in combination with roferon-a,1
14991,iv cisplatin and iv bolus etoposide,1
14992,radiotherapy to tumour bed and/or residual tumour,1
14993,hand and wrist arthroplasty,1
14994,?? t,1
14995,standard (kabiven),1
14996,chemotherapy±target therapy,1
14997,asa 100 mg,1
14998,standard colonoscopy with insufflation of air,1
14999,double umbilical cord blood transplant,1
15000,scaledown,1
15001,idh1 peptide vaccine,1
15002,folfiri plus bevacizumab,1
15003,blood sampling for pre-existing immunity,1
15004,wonders & worries psychosocial intervention,1
15005,multifocal tissue banking,1
15006,simple reminder,1
15007,pacetin® (cefoxitin),1
15008,paclitaxel - cohort 4,1
15009,8 cycles beacoppesc plus oral contraceptive,1
15010,runkeeper app,1
15011,methyl-5-aminolevulinate hydrochloride cream,1
15012,scannographic evaluation of the tumor response performed with mrecist criteria after 3 months of treatment with sorafenib,1
15013,parallel stent,1
15014,placebo (corresponding to metformin),1
15015,iv abraxane,1
15016,vip/abvd,1
15017,brief behavioral treatment for insomnia,1
15018,comparator: [18f]-fdg pet/ct and volumetric ct,1
15019,blood test and self-administrated questionnaires,1
15020,thioguanine (oral),1
15021,punch incision of epidermal cyst,1
15022,pancreaticogastrostomy,1
15023,ngs test,1
15024,ll37,1
15025,late rehabilitation,1
15026,you decide,1
15027,"follicular lymphoma, patient-specific, soluble protein idiotype vaccine",1
15028,tomato rich diet,1
15029,the information + appearance video,1
15030,sterile humidification device,1
15031,everolimus 10 mg,1
15032,aldara,1
15033,plasmalytea with 1% human serum albumin,1
15034,[18f] fmiso,1
15035,traditional genetic counseling,1
15036,csf collection by lumbar puncture (optional),1
15037,eus-guided laser ablation,1
15038,fludarabin,1
15039,transplant 1 and 2 thalidomide,1
15040,cycle 7 consolidation,1
15041,interferon-beta,1
15042,high frequence ultrasound doppler (hfud) utilisation,1
15043,brief focus program,1
15044,18f-al-nota-prgd2 pet/ct,1
15045,liquid based cytology,1
15046,pac-1,1
15047,no systematic pelvic lymphadenectomy,1
15048,collecting breath samples,1
15049,radical antegrade modular pancreatectomy without splenectomy,1
15050,methotrexate (intrathecal administration),1
15051,rehabilitation consult (rc),1
15052,physician chart reminder,1
15053,fluid restricted group,1
15054,(cpr) video and questionnaires,1
15055,sirsphere trans-arterial radioembolization,1
15056,intraperitoneal administration,1
15057,double dose morphine,1
15058,30 mcg ethinylestradiol/3 mg drospirenone,1
15059,cci; cancer care coordination instrument,1
15060,bp31510 monotherapy,1
15061,hematopoietic stem cells transplantation,1
15062,99mtc-ec20 (folic acid-technetium 99m conjugate),1
15063,"samples of blood, saliva and urine",1
15064,doxorubicin and bortezomib,1
15065,canaliculo- dacryocystorhinostomy,1
15066,niraparib + nivolumab,1
15067,shave margins,1
15068,sp-2577,1
15069,0.5% lignocaine 60mm,1
15070,magnesium group,1
15071,capecitabine and oxaliplatin + cetuximab,1
15072,cb-839 plus everolimus,1
15073,lv5fu or folfiri,1
15074,healthwise educational program,1
15075,thalidomine,1
15076,"cytarabine, all-trans retinoic acid, valproic acid",1
15077,smartcare/ps (automated weaning),1
15078,psc-833,1
15079,hd6610 granule,1
15080,cripec docetaxel,1
15081,amh level difference between patient with pcos and multicystic ovaries.,1
15082,survival time of therapy,1
15083,infusion of nk cells,1
15084,minimum dose computed tomography (mndct) scan,1
15085,topical sodermix dismutase in the form of sodermix (sod),1
15086,natural killer,1
15087,"pyrotinib, trastuzumab, docetaxel",1
15088,standardized care + woman-pro ii program (intervention ii),1
15089,"""get behind your health""",1
15090,gnrh analogue (zoladex),1
15091,hsv1716,1
15092,concurrent,1
15093,ramsay sedation scale,1
15094,preservation (endopelvic fascia),1
15095,cd19.car t cells,1
15096,"placebo control, 1.0ml",1
15097,reduced intensification,1
15098,education brochure of groupe français des myélodysplasies,1
15099,decompression surgery,1
15100,whey protein and dietary supplements,1
15101,blood & fecal collection,1
15102,organizational survey,1
15103,"pomalidomide, cyclophosphamide, prednisone",1
15104,endoscopic retrograde cholangiopancreatography,1
15105,xelac rt,1
15106,proton therapy system,1
15107,mk0966; rofecoxib / duration of treatment: 156 weeks,1
15108,gross total resection and gliadel(r) wafers implanted,1
15109,hdr prostate brachytherapy,1
15110,pet without scs,1
15111,robot-assisted radical hysterectomy,1
15112,hefi-1 monoclonal antibody,1
15113,act-based group therapy,1
15114,broccoli,1
15115,pro-ctcae,1
15116,vattikuti urology institute radical prostatectomy,1
15117,weekly dp chemotherapy concurrent with thoracic radiotherapy,1
15118,cavilon (tm) durable barrier cream,1
15119,k562/gm-csf cell vaccine,1
15120,diuretics,1
15121,coordinated pcp visit,1
15122,dc vaccine + ifn,1
15123,durvalumab with tremelimumab,1
15124,structured rehabilitation program,1
15125,retrospective chart review,1
15126,prototype intraoperative handheld gamma camera (pihgc),1
15127,25mg sunitinib alternating with cisplatin and gemcitabine,1
15128,tucotuzumab celmoleukin (emd 273066),1
15129,sg2000,1
15130,"nanoknife ""irreversible electroporation (ire)""",1
15131,positon emission tomography using 18f-fmiso,1
15132,fluid management,1
15133,mage-a3 asci injections with poly ic:lc,1
15134,pemetrexate,1
15135,phase 2: cytarabine,1
15136,traditional chinese medicine herbals,1
15137,eus-cgn,1
15138,advtmm2/dc vaccination,1
15139,radation therapy,1
15140,siemens pet/mr scanner,1
15141,portal vein embolization or ligation,1
15142,"capecitabine, imatinib mesylate",1
15143,no drugs are involved,1
15144,promensil,1
15145,"placebo, vehicle control",1
15146,fluorine-18 fluorodeoxyglucose positron emission tomography (18f-fdg-pet),1
15147,bces 6 week program,1
15148,first questionnaire,1
15149,posterolateral thoracotomy,1
15150,direct fluorescent oral visualization examination,1
15151,orthonovum 1/35,1
15152,mri with diffusion tensor imaging (dti),1
15153,"dpx-0907 consists of 7 tumor-specific hla-a2-restricted peptides, a universal t helper peptide, a polynucleotide adjuvant, a liposome and montanide isa51 vg",1
15154,monoclonal antibody 4b5 anti-idiotype vaccine,1
15155,methylprednisolone sodium succinate,1
15156,phase 1: trabectedin,1
15157,subplatysmal flap,1
15158,abiraterone acetate with prednisone,1
15159,this group of patients will be exposed to multimedia,1
15160,fluorouracil infusion,1
15161,nipple aspirator,1
15162,eplerenone,1
15163,glp-1 analogs,1
15164,lee-011,1
15165,scib1,1
15166,bacillus of calmette-guerin (bcg),1
15167,accl. radiotherapy + nimorazole,1
15168,"capsule endoscopy, double balloon enteroscopy sequential use",1
15169,trastuzumab in combination with ts-one and cisplatin,1
15170,pegvisomant,1
15171,docetaxel and cisplatin (induction chemotherapy),1
15172,ogtt by indication,1
15173,fit(eiken oc-sensor) two-year interval,1
15174,low dose methotrexate,1
15175,high-dose vitamin d 3,1
15176,"ixabepilone, 32 mg/m^2",1
15177,ptc-pz,1
15178,easyx,1
15179,mri-trus fusion prostate biopsy,1
15180,antibody drug conjugate chemotherapeutic,1
15181,folfox neoadjuvant chemotherapy,1
15182,3dv+tps?varian tps?fonicsplan,1
15183,long term pac placement,1
15184,pet mr,1
15185,supportive,1
15186,trus-ralrp,1
15187,prolonged 6-hr infusion of gemcitabine,1
15188,bright,1
15189,buccal mucosa samples for extraction of bacterial dna,1
15190,bms-986226,1
15191,cilengitide (2-times weekly),1
15192,fk506,1
15193,r2: lenalidomide + ixazomib maintenance,1
15194,lapr,1
15195,prophylactic mastectomy with immediate breast reconstruction,1
15196,size 4 i-gel supraglottic airway device,1
15197,"tislelizumab,cisplatin or carboplatin ,pemetrexed",1
15198,apf530,1
15199,electrical transurethral resection of bladder tumor,1
15200,home visits,1
15201,aezs-108 at mtd,1
15202,alkati by customized nanostring assay,1
15203,multiplexed heptapeptides,1
15204,12.5 mg proellex,1
15205,gallium-67 citrate (ga-67),1
15206,goals-of-care (goc) video,1
15207,trastuzumab in combination with subq gm-csf,1
15208,12.5mg sunitinib with cisplatin and gemcitabine,1
15209,gl-0817,1
15210,silver leaf dressing,1
15211,interactive voice response telephone system,1
15212,99mtc - labelled hmab biwa 4,1
15213,routine cystoscopy,1
15214,sorafenib 400mg twice daily + intravenous infusion ofvit k1,1
15215,tsr-022 and tsr-042,1
15216,xmt-1107,1
15217,"bi 836845, middle dose, qw",1
15218,extralevator apr,1
15219,penumbra ruby coil system,1
15220,sestamibi (tc-mbi) scan of the breast,1
15221,macitentan in combination with rt and tmz,1
15222,pervenio™ lung rs assay,1
15223,clinimacs® cd56 reagent system,1
15224,transfemoral tae - bland embolization with 40-100 microparticles,1
15225,day 1: vinorelbine 25 mg/m2,1
15226,construction of a prognostic score (non-drug intervention types),1
15227,advance care planning video,1
15228,ranolazine,1
15229,21 gy radiation,1
15230,lii,1
15231,sexual medicine rehabilitation program + nurse practitioner information phone calls,1
15232,uronav guided biopsy,1
15233,pembrolizumab plus bevacizumab,1
15234,gefitinib and fulvestrant,1
15235,needle free injection device (tropis®),1
15236,bx2,1
15237,1 retrograde radical prostatectomy rrp,1
15238,loco-regional radiotherapy,1
15239,minimally invasive pilonidal excision,1
15240,vevo 3100 lazr-x,1
15241,leuprolide acetate for injectable suspension,1
15242,tmz plus cddp,1
15243,99mtc-ec-dg,1
15244,alternating chemotherapy,1
15245,adriamycin+cyclophosphamide>docetaxel,1
15246,sentinel node technique,1
15247,gp-2250,1
15248,anticipatory care planning letter,1
15249,psychological support (interactive/cognitive strategies),1
15250,"rituximab, methotrexate, vincristine, procarbazine, pbpcs collection, busulfan, thiotepa, and cyclophosphamide",1
15251,tailored education,1
15252,spi-1005 middle dose,1
15253,co2re fractional laser therapy,1
15254,photdynamic therapy (pdt),1
15255,4d computed tomography (ct),1
15256,mm-398 (irinotecan sucrosofate liposome injection) plus cyclophosphamide,1
15257,jnj-63723283 240 mg,1
15258,fnb alone,1
15259,dna methylation,1
15260,brca1 brca2 pten palb2 mutation,1
15261,ng-350a,1
15262,drug: hyperacute lung cancer cell vaccine,1
15263,specialized symptom management and supportive care,1
15264,cyproterone acetate (androcur),1
15265,adjuvant chemotherapy only,1
15266,adenoviral vector encoding rat her-2/neu,1
15267,routine template-based lymphadenectomy,1
15268,tc99-maa,1
15269,open left lateral hepatic sectionectomy,1
15270,ferrous sulfate,1
15271,tqb2450 injection combined with anlotinib hydrochloride capsule,1
15272,robot-assisted thyroidectomy,1
15273,relaxation and visualization therapy,1
15274,intra-arterial cerebral infusion of trastuzumab,1
15275,qualitative interviews with patients,1
15276,csk ai system,1
15277,clinic-based physical therapy program.,1
15278,imaging and angiogenic profiles,1
15279,anatomical right posterior sectionectomy of the liver by ious-guided finger compression.,1
15280,observation alone after pericardial drainage,1
15281,paclitaxel 45 mg/m^2,1
15282,intensified chemotherapy,1
15283,interferon beta 1a 30 ug im once weekly,1
15284,nitrate supplementation,1
15285,prophylactic donor lymphocyte infusion (dli),1
15286,clomiphene citrate with plasebo,1
15287,sym004 (12 mg/kg),1
15288,treatment with exit-target volume,1
15289,long course 5-fu bases radiochemotherapy,1
15290,fit-dre,1
15291,vincristine (cellcristin®),1
15292,hilzo esophageal stent,1
15293,serum carotenoids,1
15294,dls insertion,1
15295,cd11b and cd56 markers,1
15296,"erlotinib, docetaxel",1
15297,vivomixx,1
15298,cytoscopy,1
15299,ingenol mebutate 0.015 percent or 0.05 percent gel,1
15300,traditional incision,1
15301,"romidepsin, gemcitabine",1
15302,auto-auto tandem stem cell transplantation and maintenance therapy with thalidomide,1
15303,tocopherol acetate,1
15304,study part 1 - dose daunorubicin,1
15305,"hectorol (doxercalciferol capsules), 0.5mcg",1
15306,all patients,1
15307,tamoxifen citrate 20mg tab,1
15308,111in-girentuximab dota spect,1
15309,docetaxel + sorafenib,1
15310,endocuff vision (ecv) second generation,1
15311,arcon,1
15312,pazopanib in combination with capecitabine and oxaliplatin,1
15313,vaccination with gardasil,1
15314,5fu/lv,1
15315,proton radiation for mpnst,1
15316,r-chop+gm-csf,1
15317,tip / impact plus care coordination,1
15318,cjlp243,1
15319,"post-therapy 18f-thymidine (flt) pet/ct to assess for pemetrexed induced tumor flt ""flare""",1
15320,impact intervention,1
15321,docetaxel + plinabulin (dp),1
15322,radio-immunotherapy,1
15323,no small renal mass biopsy,1
15324,nicotine patches,1
15325,[f-18] dcfpyl,1
15326,peripheral blood stem cell transplantation--cd34 hsct,1
15327,tmt212,1
15328,sanchi powder,1
15329,hydrocodone-acetaminophen tab 5-325 mg,1
15330,resting state fmri (rsfmri),1
15331,space cpsxl bone cement and space 360 delivery system,1
15332,chamomile dose b,1
15333,placebo and rhg-csf 5ug/kg/d,1
15334,pbcar0191,1
15335,exemestane and tamoxifen,1
15336,assess physical functioning at last office visit preoperatively,1
15337,som 230 lar,1
15338,i.v. antibiotics,1
15339,celecoxib and chemotherapy,1
15340,monitoring by web-application,1
15341,it system,1
15342,lyso-thermosensitive liposomal (ltsl) doxorubicin,1
15343,radp53 plus cisplatin,1
15344,mitoxantrone hcl liposome injection,1
15345,"str(tm) (skeletal targeted radiotherapy, holmium-166-dotmp)",1
15346,lidocaine post-embolization,1
15347,mk-1454,1
15348,apbi,1
15349,bortezomib sc,1
15350,androderm® 7.5mg,1
15351,18-f fdg,1
15352,molecular imaging with 89zr-ro5323441,1
15353,skin scrape,1
15354,khk7580 middle dose,1
15355,health care process with nurse navigator,1
15356,neoadjuvant chemotherapy program,1
15357,"5-fluorouracil, leucovorin, oxaliplatin",1
15358,superior mesenteric artery first (sma),1
15359,ep-2101,1
15360,radiolabeled [68ga]aby-025,1
15361,virtual reality (vr) and reminiscence intervention,1
15362,av2,1
15363,7 + 3 induction,1
15364,supraclavicular area radiotherapy,1
15365,intrathecal (injected into the spinal fluid) depocyt,1
15366,oral atenolol,1
15367,rehabilitation by effort,1
15368,dendritic cell vaccination (active specific immunotherapy),1
15369,dotarem®,1
15370,injection of alcohol into foot,1
15371,pediquest response,1
15372,cyberknife radiation and gemcitabine,1
15373,precision multiple antigen t cell,1
15374,pamphlets,1
15375,no foley urinary catheter,1
15376,educational intervention via brochure,1
15377,genomic profile by foundationone,1
15378,chop and alemtuzumab,1
15379,jnj-30979754 15 mg/m2,1
15380,sar245408 (xl147),1
15381,ibrutinib + ofatumumab,1
15382,imc-11f8 i.v.,1
15383,pre-radiotherapy commencement of anastrozole,1
15384,dalteparin (fragmin®),1
15385,erwinase®,1
15386,capecitabine in hcc,1
15387,daily rt (65gy in 25 fractions) to the chest,1
15388,"induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (ctd) regimen",1
15389,cabazitaxel + androgen deprivation therapy,1
15390,revised psa tool,1
15391,ipd1 cd19 ecar t cells,1
15392,moderate hypofractionated radiotherapy,1
15393,intervantions for anastomotic leakage after esophagectomy,1
15394,tumor samples from patients treated with ttfields at tumor recurrence.,1
15395,iv analgesia,1
15396,combination of docetaxel (dtx) and epirubicin (epi),1
15397,preoperative fractionated radiation therapy and chemotherapy,1
15398,standard karydakis technique.,1
15399,low-risk biopsy,1
15400,ivit melphalan,1
15401,"exercising at home, unsupervised",1
15402,cervical lymph node fine needle aspiration,1
15403,inspection of covered areas,1
15404,interferon ?-2b,1
15405,dose level -1,1
15406,axios stent with electrocautery enhanced delivery system,1
15407,observation using i-scan system,1
15408,colonoscopy outreach + mailed fit follow-up,1
15409,neoadjuvant chemotherapy with oxaliplatin and capecitabine,1
15410,v3-myoma,1
15411,"fludarabine, mitoxantrone, dexamethasone, vorinostat",1
15412,"pgl4001, progestin",1
15413,herpes zoster vaccine,1
15414,p276-00 along with gemcitabine and carboplatin,1
15415,physical activity goal setting,1
15416,venlafaxine hydrochloride extended release,1
15417,mesh or suture stoma site closure,1
15418,pgl4001 matching placebo and iron,1
15419,pembrolizumab (pd-1 blocking antibody),1
15420,systematic ascites evacuation,1
15421,robot assisted partial nephrectomy with renal artery clamping,1
15422,measurement of heart rate variability and baroreflex sensitivity,1
15423,arm 2 weekly boost of radiation therapy,1
15424,fufa,1
15425,"intervention, camp plus reunions",1
15426,folfoxiri and bevacizumab,1
15427,flot regimen,1
15428,"mk0457, vx-680 (aurora kinase inhibitor)",1
15429,optimal support treatment,1
15430,start cediranib after 28 days best supportive care,1
15431,clioquinol,1
15432,neurolytic celiac plexus block (ncpb),1
15433,rv-b7.1,1
15434,anetumab ravtansine (bay 94-9343),1
15435,mesh repair,1
15436,high-dose endorectal brachytherapy,1
15437,"allogeneic, donor-derived nk cells",1
15438,all trans retinoic acid (vesanoid),1
15439,sensorimotor training,1
15440,bexarotene 1% gel,1
15441,fulvestrant with enzalutamide,1
15442,durvalumab+olaratumab+doxorubicin cobination,1
15443,single port laparoscopic colectomy,1
15444,ultrasound contrast,1
15445,high-dose ngr-htnf,1
15446,radical resection of hbv-related hcc,1
15447,velcade (bortezomib) plus eloxatin (oxaliplatin),1
15448,surgery combined with imrt-igrt,1
15449,"30% animal, 70% plant proteins in diet",1
15450,ductoscopic papillomectomy,1
15451,ovage assessment,1
15452,tbx-3400,1
15453,td (tetanus toxoid),1
15454,late mri and pet/ct 6 weeks post chemo/rt,1
15455,"durvalumab,tremelimumab,fulvestrant",1
15456,å6 subcutaneous injection,1
15457,periprostatic block,1
15458,"gemcitabine, oxaliplatin, capecitabine",1
15459,cd123 car-t cells,1
15460,exablate mrffus,1
15461,"daunorubicin, adriamycin",1
15462,2d us grayscale plus quantitative vceus,1
15463,indium-111-dota-labetuzumab-irdye800cw injection,1
15464,rats lobectomy,1
15465,cis - telephone cessation quitline counseling,1
15466,capmatinib (inc280),1
15467,ad5-hgcc-padre vaccine,1
15468,cbt-101,1
15469,treatment chosen per investigator´s judge,1
15470,pp65-shlamp dc with gm-csf,1
15471,eu-licensed herceptin,1
15472,eicosapentanoic acid (epa),1
15473,iv cyclophosphamide 500-700mg/m2,1
15474,serum estradiol (e2) on day 12,1
15475,group 1: epoetin alfa,1
15476,diagnostic imaging: c11 choline pet; c11 acetate pet; and mri spectroscopy,1
15477,crcs patient decision aid (ptda) video,1
15478,dietary protein,1
15479,participation,1
15480,prone treatment,1
15481,5-fu chemoradiation,1
15482,pegylated irinotecan,1
15483,adjustment of mechanical ventilator inspiratory to expiratory time ratio (1:2 to 1:1),1
15484,cost/future condition,1
15485,prednisolone 10 mg,1
15486,conventional gnrh agonist (triptorelin),1
15487,pre-coagulation of the liver parenchyma with hifu,1
15488,gravity,1
15489,partial breast irradiation (pbi),1
15490,low dose fdg pet/ct 5 x.,1
15491,bcg+alt-803,1
15492,exercise logs,1
15493,hplc-uv,1
15494,group,1
15495,perflutren lipid microsphere intravenous suspension,1
15496,ingenol mebutate gel 0.015 %,1
15497,"o-ice (ofatumumab, ifosfamide, carboplatin, etoposide)",1
15498,10-day concomitant therapy,1
15499,bms-936559 (anti pd-l1),1
15500,meid5083 with durvalumab,1
15501,sequencing of mirna/lncrna,1
15502,standard of care chemotherapy regimen,1
15503,experimental: imaging arm,1
15504,radiosurgery + wbrt,1
15505,cinacalcet (amg 073),1
15506,1h spectroscopy at 1.5t and 3t,1
15507,discharge planning: assessment of barriers to discharge,1
15508,prednisone 60mg/m2,1
15509,ct and mri scans,1
15510,gns spray 2.0mg,1
15511,personalized mature dendritic cell vaccine,1
15512,no visual support,1
15513,[11c]acetate brain imaging,1
15514,sun protection program,1
15515,ctpve,1
15516,"etoposide, ifosfamide, methotrexate",1
15517,questionnaires/scales,1
15518,chromogranin a,1
15519,"placebo, omeprazole or rabeprazole, clarithromycin",1
15520,baseline demographics,1
15521,afuresertib ect - fasted state,1
15522,diet a,1
15523,mr colonography with dynamic contrast uptake,1
15524,amg 562,1
15525,agi-101h vaccine,1
15526,unmanipulated bone marrow,1
15527,doxil/caelyx,1
15528,high dose dexmedethomidine,1
15529,htert/survivin multi-peptide vaccine,1
15530,sf-12 quality of life survey,1
15531,allogeneic human mesenchymal stem cells,1
15532,high-dose trivalent inactivated influenza vaccine,1
15533,breast cancer genetics referral screening tool 3.0,1
15534,active ric,1
15535,low intensity counseling + bupropion + prn nrt,1
15536,iyengar yoga therapy,1
15537,chidamide combined with r-gdp,1
15538,gs results for primary indications only,1
15539,non-diluted spacer,1
15540,rating and ranking task,1
15541,"egfr-tkis(erlotinib, gefitinib and icotinib)",1
15542,cisplatin+til,1
15543,standard trivalent influenza vaccine,1
15544,no academic detailing,1
15545,one-on-one intervention,1
15546,iobenguane i 123 injection,1
15547,urelumab + nivolumab,1
15548,sart,1
15549,other bowel resection,1
15550,o-(2-[f-18]fluorethyl)-l-tyrosin (fet) - pet,1
15551,intrathecal triple,1
15552,other intravenous chemotherapy drugs,1
15553,fluorouracil/cisplatin (control arm),1
15554,carboplatin/paclitaxel (cp),1
15555,apalutamide placebo,1
15556,unsigned note to provider about cessation medication prescription,1
15557,oshadi d & oshadi r,1
15558,21.6gy/12fx to the tumor bed and 36gy/20fx to the tumor,1
15559,the impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts:,1
15560,myo-inositol 1500 gr,1
15561,piritramide,1
15562,topical testosterone,1
15563,bb4 antibody-iodine 131,1
15564,"normal saline , cisplatin , 5-fu",1
15565,olaparib 300 mg,1
15566,tositumomab 35 mg,1
15567,perioperative care and wetness management,1
15568,asp7991,1
15569,sonazoid (perflubutane),1
15570,conventional syringe - bd ref 309604,1
15571,vibramycin,1
15572,tki258 (dovitinib),1
15573,phase1 and phase 2: decitabine,1
15574,icg localization with spy thoracoscope localization,1
15575,decitabine and cytarabine,1
15576,"vincristine, adriamycin and cytoxan, alternating with ifosfamide vp-16",1
15577,sir-spheres agent administration,1
15578,eribulin mesylate administration as a 2 to 5 min iv infusion on day 1 and day 8,1
15579,autosuture premium plus ceea/ethicon proximate ils,1
15580,sedated endoscopy,1
15581,external beam radiation (standard),1
15582,combined spinal-epidural anesthesia,1
15583,online mindfulness based cancer recovery (mbcr),1
15584,standard-pressure pneumoperitoneum,1
15585,articulation therapy,1
15586,endotoxin,1
15587,d3,1
15588,ezn-4176,1
15589,tesetaxel 10 mg without and then with food,1
15590,aprepitant+tropisetron,1
15591,american ginseng root,1
15592,muc-1 cart cell immunotherapy,1
15593,conventional 3d-crt or imrt,1
15594,oncogel (paclitaxel gel),1
15595,exclusive external beam radiotherapy,1
15596,incagn02390,1
15597,escalating dose of casodex from 50mg daily to 150 mg daily,1
15598,local consolidative treatment,1
15599,lavender aromatherapy,1
15600,trastuzumab subcutaneous device administration,1
15601,control intervention,1
15602,cdx-3379 and cetuximab,1
15603,th-4000,1
15604,covered self-expanding metal biliary stents (c-sems),1
15605,hlx07+paclitaxel+carboplatin,1
15606,colorectal cancer screening intervention,1
15607,acupressure for children in treatment for a childhood cancer,1
15608,ultrapulse carbon dioxide laser,1
15609,denenicokin,1
15610,text + lottery,1
15611,sib 15 fractions if needed,1
15612,"carfilzomib, proteasome inhibitor; intravenous",1
15613,3.0-t mri,1
15614,saline solution (placebo),1
15615,tgfbdnrii-transduced autologous tumor infiltrating lymphocytes,1
15616,at least unilateral systematic pelvic lymph node dissection,1
15617,gain-framed text messages,1
15618,local treatment by surgery,1
15619,standard of care: planned surgery,1
15620,klh conjugates with gd2l and gd3l,1
15621,commercial weight loss program (cwlp),1
15622,lotion vehicle/placebo,1
15623,cancer: thriving and surviving online workshop,1
15624,'intra-luminal radiofrequency ablation (habib endohpb),1
15625,d-cycloserine,1
15626,cediranib (azd2171),1
15627,conventional pap smear,1
15628,endoscopic retrograde cholangio-pancreatography,1
15629,pelvic floor electrical stimulation,1
15630,t138067 intravenous,1
15631,cc 5013,1
15632,pd-l1 peptide vaccine,1
15633,placebo tablets and questionaires,1
15634,webcan,1
15635,primary tumor resection + chemotherapy,1
15636,ny-eso-1 protein vaccine,1
15637,mssm/biir hdc vax-001 (host dendritic cells),1
15638,serum and pleural effusion ca-125 level,1
15639,rna marker analysis of lymph node and primary tumors,1
15640,"innovative colonoscopy (olympus cf-hq190f, nbi + dual focus)",1
15641,suprapubic catheterization,1
15642,spectral diagnosis probe,1
15643,"determine the levels of the ""hem"" substance in seminal plasma",1
15644,12-item short form health survey,1
15645,immunohistochemistry (ihc) analysis,1
15646,laboratory blood samples,1
15647,lenalidomide (cc-5013),1
15648,exclusive single-fraction irradiation,1
15649,r2*-gre,1
15650,pilot study: 150 men examined every 6 months for 4 years.,1
15651,receive an adult-onset result,1
15652,concurrent chemo-radiotherapy arm,1
15653,bevacizumab 5 mg/kg intravenously every 2 weeks,1
15654,[225ac]-fpi-1434 injection,1
15655,no additional educational intervention,1
15656,"thalidomide, interferon, octreotide",1
15657,docetaxel/capecitabine followed by xec,1
15658,r-cdop/cdope or dbvd chemotherapy regimen,1
15659,dose-escalated selinexor treatment,1
15660,tandem high-dose therapy (hdt) followed by autologous peripheral blood stem cell (pbsc),1
15661,herceptin ?post-operative),1
15662,family-based family cancer literacy intervention,1
15663,rhil-7-hyfc,1
15664,3-d breast imaging,1
15665,"ipi-504, docetaxel",1
15666,no premedication,1
15667,caelyx (pegylated lyposomal doxorubicin),1
15668,hypertherm intraperitoneal chemotherapy with cisplatin (75mg/m²),1
15669,1:1 training,1
15670,cal,1
15671,28 gbq 177lu-dotatate,1
15672,sar260301,1
15673,non-myeloablative allogeneic (allo) transplant,1
15674,smancs,1
15675,2 sample insure,1
15676,active fbt with ppp001 placebo,1
15677,orienx010,1
15678,cyberknife accelerated hemilarynx stereotactic radiotherapy,1
15679,game-based intervention,1
15680,human umbilical cord-derived mscs,1
15681,autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine,1
15682,cep-701 40mg,1
15683,internet da,1
15684,opb 31121,1
15685,breast cancer patients,1
15686,prfa or pmct,1
15687,non-resorbable synthetic mesh.,1
15688,alvac(2)-ny-eso-1(m)/tricom vaccine,1
15689,recombinant interleukin-6,1
15690,careseng 1370,1
15691,arm i soy bread,1
15692,anticoagulants,1
15693,palliative care assessment,1
15694,two day food records,1
15695,c-arm ct + dsa as needed,1
15696,breast cancer treatment decision aid for women 70+,1
15697,interoperative optical imaging and spectroscopy,1
15698,robot assisted partial nephrectomy super-selective clamping,1
15699,"vinorelbine, cyclofosfamide",1
15700,anti-protein 53 or tumor protein 53 (p53) t-cell receptor transduced peripheral blood lymphocytes,1
15701,morphine in the titration phase,1
15702,tasquinimod 0.25 mg; 0.5 mg,1
15703,treatment of diffuse ocular surface squamous neoplasia,1
15704,gynecological consultation,1
15705,"uft 250mg/m2, daily for 1 year",1
15706,lapatinib vinorelbine,1
15707,caringguidance™ after breast cancer diagnosis,1
15708,synergo-intravesical chemotherapy instillation combined with hyperthermia,1
15709,irinotecan eluting beads,1
15710,anti-ley-car-transduced t cells,1
15711,etoposide capsule + methotrexate tablet + topotecan capsule,1
15712,tumor-draining lymph node lymphocyte therapy,1
15713,thyroid decision aid,1
15714,contrast-enhanced ultrasound guided biopsy,1
15715,lmhf mechanical stimulation active device,1
15716,large loop excision of the transformation zone,1
15717,functional status and symptom questionnaire,1
15718,cone beam ct localization and placement of microcoil,1
15719,hyperthermic intraperitoneal,1
15720,non-invasive magnetic resonance imaging (mri),1
15721,rectal radiotherapy,1
15722,mittens and booties,1
15723,computed tomography-guided optical sensor-guided radiofrequency ablation,1
15724,topical vitamin d (calcipotriol) application,1
15725,pld-q,1
15726,myobloc,1
15727,placebo of tecemotide (l-blp25) and hormonal treatment,1
15728,billroth-ii-type reconstruction,1
15729,antihistamine,1
15730,rp101,1
15731,hyperthermia system,1
15732,psychological and sociological evaluation,1
15733,lmp 400,1
15734,(18f)fes,1
15735,assessment of the pelvic floor function,1
15736,endocare cryocare cryosurgical and galil medical cryo-hit systems (cryotherapy),1
15737,electron beam therapy,1
15738,autologous cik dose level 2,1
15739,2.5 gy/fraction,1
15740,technetium 99m ethylenedicysteine-deoxyglucose,1
15741,"gx-188e, gx-i7",1
15742,radiofrequency ablation of barrett's esophagus,1
15743,adjuvant chemoradiation,1
15744,forodesine hcl,1
15745,mil60,1
15746,montanide isa51,1
15747,f-18 fluorodopa,1
15748,tandem high-dose chemotherapy (melphalan),1
15749,thyrotropin alpha,1
15750,ldv/sof,1
15751,ds-1001b,1
15752,111-indium-ch806,1
15753,vaccaria seed,1
15754,conventional diagnosis,1
15755,usual care tobacco treatment services,1
15756,"anti-thymocyte globulin, rabbit",1
15757,symptom assessment scale,1
15758,magnetic resonance + hemodynamic + infusion of gadolinium,1
15759,toxicity and outcome measures of imrt,1
15760,tuberculin,1
15761,cetuximab-irdye 800cw,1
15762,mycostatin oral suspension,1
15763,sunitinib malate schedule 4/2,1
15764,md anderson dysphagia inventory,1
15765,insulin glargine recombinant,1
15766,albumin-bound paclitaxel plus cisplatin,1
15767,winged perimeter biliary stent insertion (viaduct),1
15768,stereotactic conformal radiotherapy,1
15769,ceftolozane-tazobactam,1
15770,sor007 ointment vehicle,1
15771,emd 525797 500 mg,1
15772,t-cell replete haplo-transplant,1
15773,prevention of sleep disorders in icu,1
15774,information control intervention,1
15775,"audio recordings , questionnaires",1
15776,l-thyroxin,1
15777,anti-gd2-car engineered t cells,1
15778,timolol 0.5% gel forming solution (gfs),1
15779,stereotactic body radiation therapy(sbrt),1
15780,placebo to match olaparib 300mg,1
15781,sterotactic body radiation therapy (sbrt),1
15782,no mobile community,1
15783,cdx-301 and plerixafor,1
15784,abbv-744,1
15785,mckeown esophagectomy,1
15786,abacavir/3tc/zidovudine,1
15787,"neoadjuvant capecitabine, panitumumab and radiation",1
15788,concurrent platinum-based chemotherapy,1
15789,comparison of data from mri with data from ct compared with intraoperative data from endoscopic pituitary adenoma surgery,1
15790,patient interviewing to obtain menstrual history,1
15791,molecular diagnostic testing,1
15792,solifenacin succinate,1
15793,met analysis on tissue and blood,1
15794,integra plus stsg,1
15795,accelerated recovery plan,1
15796,medical telephone contact,1
15797,active comparator: lifestyle counseling arm 1,1
15798,deep biopsy via esd technique,1
15799,tamoxifen stim in late follicular phase,1
15800,ultrasound for localizing intercostal perforating vessels,1
15801,biricodar dicitrate,1
15802,[18f]fhbg,1
15803,cohort of bc of each subtypes,1
15804,flexible versus rigid cystoscopes,1
15805,infrared thermography,1
15806,opioid reduction intervention,1
15807,sleep study and blood sample,1
15808,changing your habits brochure,1
15809,bms-777607,1
15810,clinimacs® (t cell depletion),1
15811,prdr,1
15812,a: de-intensification rt primary tumor region,1
15813,estimation of prognosis questionnaire,1
15814,oral oxycodone,1
15815,"endomicroscope (pentax, tokyo, japan)",1
15816,psychological prehabilitation,1
15817,bovine colostrum,1
15818,group phone counseling,1
15819,managing cancer care: a caregiver's guide,1
15820,cd3-/cd19-,1
15821,sterostatic body radiation therapy (sbrt),1
15822,creative writing workshop,1
15823,l-carnosine,1
15824,acei,1
15825,dcb-bo1202,1
15826,fixed dose temozolomide (75 mg/m2),1
15827,"endoscopic management, surgery and follow up",1
15828,genetic risk assessment,1
15829,dtpace,1
15830,cipatinib,1
15831,chimeric antigen receptor modified t cells targeting cd19,1
15832,hev vaccine,1
15833,piperacillin/tazobactam (tazocin),1
15834,intravenous or oral bone antiresorptive treatments,1
15835,mge,1
15836,chop-daclizumab,1
15837,(partial) oncological home-hospitalization,1
15838,storytelling intervention for patient participants,1
15839,atra + ida,1
15840,torisel dose 50 mg and r-chop,1
15841,infusion of 4h11-28z/fil-12/egfrt+ genetically-modified t cells,1
15842,electronic monitor + text messages,1
15843,cohort b,1
15844,het,1
15845,recombinant dna- pvax/l523s,1
15846,part b - azd9291 in combination with medi4736,1
15847,staged resection of liver metastasis and the colorectal primary tumor,1
15848,"anlotinib combined with paclitaxel and carboplatin, phase ii",1
15849,nivolumab induction,1
15850,polio vaccine,1
15851,lenalidomide/rituximab,1
15852,breast surgery + lymph node removal,1
15853,the lung cancer app - lucapp,1
15854,tegafur gimeracil oteracil potassium capsule,1
15855,double isolated limb perfusion with melphalan alone,1
15856,biopsies with histopathology,1
15857,double matched sibling transplantation,1
15858,external beam partial-breast irradiation,1
15859,oncoplastic free rom,1
15860,carboplatin + laser day 1 (chemothermotherapy),1
15861,fitbit flex2 tm,1
15862,harmonic ace23p scalpel,1
15863,regorafenib and irinotecan,1
15864,"therapy with rituximab, gemcitabine and oxaliplatin",1
15865,single fraction sabr,1
15866,high-resolution contrast-enhanced mri scan,1
15867,levosimendan,1
15868,claricore optical biopsy system,1
15869,patient navigator,1
15870,90y-dota-toc,1
15871,tox,1
15872,conventional colon surgery,1
15873,cd19 targeted chimeric antigen receptor t cells,1
15874,no intervention will be given to patients.,1
15875,temozolomide oral product,1
15876,community health activities model program for seniors (champs),1
15877,radiotherapy delivery in deep-inspiration,1
15878,isotoxic hypofractionated group,1
15879,diffusion weighted mri scan,1
15880,intranasal fentanyl spray,1
15881,experimental: nutritional supplementation with epa,1
15882,penetration/aspiration scale,1
15883,behavioral: team-based intervention,1
15884,bgb-a333,1
15885,stepping on education program,1
15886,allogeneic hematopoietic stem cell transplantation (unmanipulated t cell replete bm),1
15887,bcg instillation therapy,1
15888,ifrt,1
15889,standard bolus,1
15890,eribulin in combination w/ cyclophosphamide,1
15891,"telemedicine pain management intervention (waitlist group, intervention administered following 4-week waitlist period)",1
15892,topical resiquimod 0.03%,1
15893,mychoice,1
15894,desogestrel,1
15895,cohort 2 neo-adjuvant,1
15896,exercise oe workbook,1
15897,psychosocial variables,1
15898,intelligent electric bicycle (velis) sessions,1
15899,ethiodized oil; doxorubicin;gelfoam;,1
15900,polyphenol,1
15901,pediatric multitaa t cells stage,1
15902,lactobacillus plantarum strain 299,1
15903,"beery developmental test of visual motor integration, 6th edition",1
15904,ril-2,1
15905,irradiation + carboplatin,1
15906,"lansoprazole, amoxicillin, clarithromycin, metronidazole",1
15907,isolex 300i stem cell selection,1
15908,low saturated fat diet,1
15909,nivolumab infusion [opdivo],1
15910,mems intervention,1
15911,the cms (child memory scale),1
15912,inotuzumab ozogamicin [cmc-544],1
15913,treatment for epitheloid sarcoma,1
15914,mk-4621/jetpei™,1
15915,virtual meetings,1
15916,3rp-aya,1
15917,combination immunotherapy with ipilimumab and nivolumab,1
15918,"cohort 3, ceplene® and proleukin®",1
15919,diffuse optical spectroscopy,1
15920,hqis implementation,1
15921,optical endomicroscopy system,1
15922,induction of ovulation using clomiphene citrate-pioglitazone-metformin,1
15923,microscope integrated optical coherence tomography,1
15924,mindfulness-based stress reduction - cancer-related fatigue,1
15925,at the discretion of the investigator,1
15926,bio 300 oral suspension,1
15927,3f8 monoclonal antibody combined with interleukin-2,1
15928,curcumin; coenzyme q10,1
15929,imagio oa/us (us and oa/us),1
15930,sym021,1
15931,gemcitabine (gemox),1
15932,specimen bank,1
15933,19f cell sense-labeled pbmc,1
15934,urlc10,1
15935,day 8: capsule vinorelbine 60 mg/m2,1
15936,150-water,1
15937,99mtc-rhannexin v-128,1
15938,expect eus aspiration needle,1
15939,comparator: blinded ridaforolimus,1
15940,hpv self-sampling kit,1
15941,two stage esophagectomy,1
15942,velcade and sorafenib,1
15943,personalised care plan,1
15944,v935,1
15945,fractional co2 laser assisted pdt,1
15946,5-aminolevulinic acid (5-ala),1
15947,photon therapy versus proton therapy,1
15948,1 day low residue diet prior to the colonoscopy,1
15949,anesthesia maintenance,1
15950,oral lapatinib tablets or placebo tablets,1
15951,golimumab 50 mg,1
15952,5-fu continuous infusion,1
15953,54 gy radiotherapy,1
15954,tissue samples,1
15955,ic9/car.19/il15-transduced cb-nk cells,1
15956,digital health physical activity intervention group,1
15957,daily supplements,1
15958,intraoperative intracavitary lung ultrasonography,1
15959,vx-970,1
15960,provide a saliva sample for genetic testing,1
15961,new functional magnetic resonance imaging (mri) protocols,1
15962,150 mg/m2 lenalidomide (revlimid®) and 180 mg/m2 vorinostat (zolinza®),1
15963,cyberknife radiation therapy,1
15964,normal saline lavage,1
15965,purell vf481,1
15966,scapular exercises,1
15967,placebo (for aspirin 300),1
15968,envision the rhythms of life program,1
15969,iv casopitant (active),1
15970,medical history and physical examination,1
15971,patient reported outcome,1
15972,alvac gp100 vaccine,1
15973,allohct for young/msd,1
15974,reconstruction breast-q,1
15975,"mri, ct, or bone scan",1
15976,electronic reminder,1
15977,ps341 (bortezomib),1
15978,multi-beam intensity-modulated radiation therapy,1
15979,salvia sample,1
15980,verbal instructions,1
15981,apremilast,1
15982,wait-list control group.,1
15983,autonomy supportive counselling,1
15984,ice-sense,1
15985,adjuvant nivolumab and ipilimumab,1
15986,pegcrisantaspase,1
15987,igf1r antibody mk0646,1
15988,neoadjuvant erlotinib therapy,1
15989,erbium yag laser,1
15990,intensive/low-risk follow up (ia g1; ia g2),1
15991,oral diet enriched with arginine (cubitan),1
15992,erlotinib (tarceva™),1
15993,recombinant anti-tumor and anti-virus protein for injection (novaferon),1
15994,imaging procedures (nbi),1
15995,paclitaxel 80 mg/m2,1
15996,nhs-il-12,1
15997,needle core biopsies of metastatic lesion,1
15998,"standard chemotherapy (7+3 scheme): daunorubicin, cytarabine",1
15999,diagnosed as cml,1
16000,tas-102 with a light tracer dose of [14c] tpi,1
16001,colonoscopy system (peerscope b system™),1
16002,"cyclophosphamide, vindelsine, cytarabine, doxorubincin, prednisone",1
16003,fosbretabulin + paclitaxel + carboplatin,1
16004,"injectable rectal spacer (spaceoar, duraseal or equivalent)",1
16005,gastric tube,1
16006,ballon technique,1
16007,treated with folfiri±cetuximab,1
16008,igf-1r/as odn,1
16009,"folfox7 (folinic acid, 5-fluorouracil, and oxaliplatin)",1
16010,oncologist recommendation + dvd,1
16011,hemospray®,1
16012,egfr cart,1
16013,post-stem cell infusion mesna,1
16014,parenteral nutrition.,1
16015,semi-tailored newsletter,1
16016,mtx + 5-fu sequential therapy,1
16017,positron emission tomography scans,1
16018,placebo erlotinib,1
16019,ltx-315 consecutive lesions,1
16020,telavancin,1
16021,cell-assisted lipotransfer,1
16022,docetaxel/ oxaliplatin,1
16023,13-cis retino acid,1
16024,convection-enhanced delivery (ced),1
16025,megestrol acetate 20mg/day,1
16026,mri-trus fusion guided single frac hdr,1
16027,choice screening strategy,1
16028,"folfox {5-fluorouracil (5-fu), leucovorin, and oxaliplatin}",1
16029,idelalisib and rituximab,1
16030,low-dose radiotherapy (rt),1
16031,fentanyl 3-day transdermal patch (double blind phase),1
16032,contralateral esophageal sparing technique (cest),1
16033,177lu-edotreotide prrt,1
16034,natriumfolinate,1
16035,ramosetron 0.45mg,1
16036,no preoperative nutrition support,1
16037,arq 751,1
16038,clara,1
16039,taest16001,1
16040,"pembrolizumab 200 mg iv twice interval 21d,surgery after 10d",1
16041,"certolizumab pegol (cdp870, czp)",1
16042,termino-terminal colorectal anastomosis,1
16043,exercise behaviour maintenance,1
16044,monoclonal antibody to tgf-beta,1
16045,flavopiridol,1
16046,first-line chemotherapy after recurrence,1
16047,liposome-encapsulated irinotecan hydrochloride pep02,1
16048,protein restrictive diet,1
16049,hsct from msd,1
16050,mr pet guided brachytherapy,1
16051,mk-0457,1
16052,low dose gtn 0.0285 mg/hr,1
16053,electronic patient-reported outcomes,1
16054,stenting only,1
16055,plitidepsin and sorafenib,1
16056,r-acvbp14 induction regimen,1
16057,cisplatin 100 mg/m^2,1
16058,evaluation of cerebrospinal fluid of all,1
16059,bgb324+dabrafenib and trametinib,1
16060,pancreaticojejuno anastomosis,1
16061,intraoperative electron radiotherapy,1
16062,erismodegib,1
16063,wx-0593 tablets,1
16064,"car-t cells targeting her2, mesothelin, psca, muc1, lewis-y, or cd80/86",1
16065,yttrium-90 resin microspheres,1
16066,egfrviii car t cells,1
16067,prednisone 2.5 mg twice daily,1
16068,yogic breathing,1
16069,isosulfan blue (isb),1
16070,meditation video,1
16071,1.11gbq of 177lu-eb-psma-617,1
16072,cc-486 (oral azacitidine),1
16073,check symptoms,1
16074,standardized lifestyle management,1
16075,nuc-3373 + irinotecan + cetuximab,1
16076,hd pet/ct,1
16077,gsk2857916 in combination with pomalidomide and dex,1
16078,esd and lrld,1
16079,docetaxel+capecitabine,1
16080,referral to ahec/quitline,1
16081,iv administration of fluorine-18 fluorocholine followed by pet/ct imaging,1
16082,fine needle biopsy using procore needle for histology.,1
16083,"dasatinib, 100 mg + lenalidomide, 25 mg + dexamethasone, 40 mg",1
16084,ensartinib with fed or fasting,1
16085,endoscopic full thickness resection (eftr),1
16086,preventive care management for cancer screening,1
16087,postoperative rehabilitation,1
16088,100mg berberine hydrochloride,1
16089,cohort 1 matching sugar capsule,1
16090,rx-0201 plus gemcitabine,1
16091,levetiracetam extended release,1
16092,videoscopic procedure,1
16093,glucarpidase (50 units/kg),1
16094,her2-status,1
16095,celiac plexus resection,1
16096,"comparator: mk0752, notch inhibitor - 450 mg",1
16097,"clomiphene citrate, metformin, metformin plus clomiphene citrate, gonadotropins",1
16098,robotic assisted rectal resection,1
16099,pbsc mobilization and leukapheresis,1
16100,bupropion and intensive behavioral therapy,1
16101,without dexmedetomidine,1
16102,diode laser (980 nm) tumor destruction,1
16103,"nab-paclitaxel,s-1",1
16104,random fine need aspiration (rfna),1
16105,30 grays,1
16106,telephone delivered education only,1
16107,tice bacillus calmette-guerin (bcg),1
16108,"etoposide 150 mg/m2/day (days 1, 2, 3) and ifosfamide 3g/m2/day (days 1, 2, 3)",1
16109,dbd,1
16110,chromocolonoscopy,1
16111,neoadjuvant chemo + igrt,1
16112,sr-1 ucb,1
16113,computer tailored information,1
16114,standard advance care planning,1
16115,dwi mri,1
16116,hank™,1
16117,"cyclophosphamide, prednisone, lenalidomide",1
16118,dabrafenib + trametinib,1
16119,px-478,1
16120,surgery and hyperthermic intraperitoneal chemotherapy with mmc,1
16121,colofit+ intervention,1
16122,esophagus biopsies (healthy zones),1
16123,"arm b pemetrexed, cisplatin and mk-0646",1
16124,multi-pronged ethanol ablation,1
16125,a book and videos about pain control,1
16126,"open, traditional approach",1
16127,all -trans retinoic acid (atra),1
16128,philips intelivue mp70 monitor,1
16129,gbr 1342,1
16130,[f-18] fmiso,1
16131,lupartumab amadotin (bay1129980),1
16132,positive online psychotherapy,1
16133,30?g hpv,1
16134,proactive management,1
16135,cord blood,1
16136,head and neck reconstruction,1
16137,adi-peg 20 (arginine deiminase formulated with polyethylene glycol),1
16138,tapentadol in the titration phase,1
16139,clinic staff,1
16140,adher-2/neu transduced dendritic cells,1
16141,antangiogenesis,1
16142,diluted spacer,1
16143,radiopharmaceutical administration [18f]-fdg,1
16144,transanal tube placement,1
16145,medi4736 (anti pd-l1),1
16146,micro-ultrasound targeted biopsy,1
16147,"doxorubicinhydrochloride, lapatinib",1
16148,mr-compatible scinti-mammography (mri-smm) system,1
16149,skin biopsy (optional),1
16150,liraglutide pen injector [saxenda],1
16151,photofrin (porfimer sodium) & photodynamic therapy.,1
16152,monotherapy (gemcitabine or vinorelbine),1
16153,abiraterone/prednisone,1
16154,providing tailored message on disclosing terminal illness,1
16155,"dynamic contrast-enhanced mri, diffusion-weighted mri & chemical exchange saturation transfer mri",1
16156,dacarbazine and bortezomib,1
16157,vaginal placebo+ oral placebo,1
16158,standard dli,1
16159,"metenkephalin, ogf-opioid growth factor",1
16160,in vitro expanded cytokine induced killer (cik) cells,1
16161,talotrexin ammonium,1
16162,large bore chest drain + opiate based analgesic regimen,1
16163,tachosil group,1
16164,tocotrienol 300 mg x 3 daily,1
16165,tumor treating fields (ttf) therapy,1
16166,pemetrexed pluscisplatin,1
16167,folfox6 cycles 4 onwards,1
16168,diagnostic imaging technique,1
16169,self-help,1
16170,cisplatin & pemetrexed,1
16171,endostar(recombinant human endostatin injection),1
16172,endomaxx,1
16173,colorectal cancer screening pamphlet,1
16174,echocardiogram (echo),1
16175,contingency management (cm),1
16176,intensity modulated proton therapy (impt),1
16177,lv5fu2-cddp,1
16178,bilateral mammography with tomosynthesis,1
16179,protocolled,1
16180,megestrol acetate concentrated suspension 60 mg/ml,1
16181,minor or major liver resection,1
16182,karl storz d-light c pdd flexible videoscope system,1
16183,radical gastrectomy plus d2 lymphadenectomy,1
16184,polysaccharide-k,1
16185,hyperpolarized [13c]pyruvate,1
16186,deep transcranial magnetic stimulation (dtms),1
16187,"paclitaxel, epirubicin",1
16188,cmet rna car t cells,1
16189,needle core biopsies,1
16190,remicade (anti tumor necrosis factor inhibitor),1
16191,th2 cells,1
16192,wt_vdibh,1
16193,muc-2-klh vaccine,1
16194,"rituximab, ifosfamide, carboplatin, etoposide, bortezomib",1
16195,combination tissue plasminogen activator (tpa) and dornase alfa (dnase),1
16196,t-cell depleted or t-cell replete strategies,1
16197,nuevo amancer-ii stress management program,1
16198,emb-01,1
16199,supraclavicular lymph node ultrasound,1
16200,bp31510 in combination with chemotherapy,1
16201,velcade™ (bortezomib) for injection (formerly ps-341),1
16202,questionnaire on sun exposure,1
16203,laparoscopic intersphincteric resection (lisr group),1
16204,community health worker,1
16205,allogeneic mpbc transplantation from matched related donor,1
16206,serratus anterior plane catheter block,1
16207,cryospray ablation system,1
16208,epirubicin: observational study,1
16209,"pet/mri system (siemens ag, munich, germany; distributed in france by siemens s.a.s, saint-denis, france)",1
16210,standard abdominal approach for rectal excision,1
16211,cat-8015 40 mcg/kg,1
16212,home care,1
16213,radical antegrade modular pancreatectomy with splenectomy,1
16214,c arm fluoroscopic device,1
16215,louis-3d imaging procedure,1
16216,transpapillary brush cytology,1
16217,chemopreventive application (acitretin),1
16218,d2 and #14v lymphadenectomy,1
16219,intermed release brb confection,1
16220,direct liver transplant,1
16221,bimiralisib,1
16222,tmz maintenance,1
16223,mersina,1
16224,intraoperative testing of colorectal anastomoses,1
16225,3 cycles chemotherapy,1
16226,valanced salt colloid,1
16227,[18f]-fluorodeoxyglucose,1
16228,zalcitabine,1
16229,peritoneal fluid and blood sample,1
16230,grnvac1,1
16231,bevacizumab and radiation (imrt),1
16232,blood and urine samples,1
16233,dermal autograft,1
16234,tegafur uracil - folinic acid,1
16235,isolated soy protein,1
16236,fluorescence-aided confocal endomicroscopy guided biopsy.,1
16237,biib015,1
16238,177lu-psma-r2,1
16239,amg 160,1
16240,tq-b3234,1
16241,robotic single port surgery and notes,1
16242,anti-egfrviii car transduced pbl,1
16243,sham auricular acupoints acupressure,1
16244,interdisciplinary team-based approach,1
16245,therapeutic + lower body exercise,1
16246,leuporelin acetate,1
16247,tailored feedback messages,1
16248,anlotinib plus gemcitabine/cisplatin,1
16249,freebreathing in body fix mold,1
16250,radiation with photons,1
16251,abdominal total hysterectomy,1
16252,standard preparation,1
16253,pemetrexed /carboplatin,1
16254,pillcam® colon capsule,1
16255,ofdi capsule,1
16256,home exercise program,1
16257,gemcitabine and nab-paclitaxel,1
16258,nintedanib low dose,1
16259,gvax and ipilimumab,1
16260,centella cream,1
16261,hypofractionated ablative imrt (hfa-imrt),1
16262,telephone interview or self report survey.,1
16263,cyp2d6 inhibiting drugs,1
16264,stratification,1
16265,image guided biopsies,1
16266,[131i]icf01012 (therapeutic dose level 2),1
16267,discharge the ng tube during the surgery,1
16268,sodium sulfate/potassium sulfate/magnesium sulfate solution,1
16269,prototype system,1
16270,tumor associated antigen lymphocytes (taa-t),1
16271,"ksp-qrh-e3-irdye800 (peptide 919288g), 1.8 mg",1
16272,liver volumetry of the graft on ct,1
16273,"autologous, dnp-modified melanoma vaccine",1
16274,"cyclophosphamide (cyclo, cy)",1
16275,dydrogesterone,1
16276,residential program,1
16277,"""cryoprobes""",1
16278,thoracic ct,1
16279,text message reminder,1
16280,atezolizumab - cohort 2,1
16281,stereotactic spine radiosurgery (ssrs),1
16282,usual care by cancer center care team,1
16283,dre (digital rectal examination ),1
16284,nanodoce (intravesical instillation) - visit 2 instillation,1
16285,dexchlorpheniramine or diphenhydramine,1
16286,mp0250,1
16287,collection of biospecimens and quality of life (qol) assessment,1
16288,c: combined mydc/pdc vaccination,1
16289,al 3818,1
16290,tapentadol,1
16291,blood draw and baseline questionnaire,1
16292,computerized tomography,1
16293,endobronchial hamartomas treatment,1
16294,fluoroscopic technique,1
16295,veteran patient navigator and social work intervention,1
16296,mobile health application and fitbit + standard of care,1
16297,gmci,1
16298,molecular microscope diagnostic system,1
16299,quality of communication (qoc),1
16300,tumor vaccine: cd40 ligand and il-2 gene modified autologous skin fibroblasts and tumor cells,1
16301,transmid,1
16302,800 iu vitamin d supplement,1
16303,self-directed learning group,1
16304,blood samples will be collected at different time points:,1
16305,"gemcitabine, capecitabine and sorafenib (6 cycles)",1
16306,stage 2: low dose cyclophosphamide (ctx),1
16307,icovir-5,1
16308,ih anesthesia,1
16309,"neoadjuvant cisplatin, nab-paclitaxel",1
16310,radio-frequency ablation (rfa),1
16311,palliative pelvic soft-tissue radiation (external beam),1
16312,wt1 peptide-pulsed dendritic cells,1
16313,metformin (arm b),1
16314,factual writing,1
16315,normal subject,1
16316,regn4659,1
16317,gemcitabine-based chemotherapy,1
16318,levulan (5-aminolevulinic acid) photodynamic therapy.,1
16319,semi-structured interview conducted by a psychiatrist specialized in psycho-oncology,1
16320,opioid group,1
16321,ad-rts-hil-12 and veledimex,1
16322,fentanyl-based analgesia,1
16323,resection of the esophagus and the gastroesophageal junction,1
16324,contrast enhanced digital mammography,1
16325,dexamethasone intermittent,1
16326,ny-eso-1 protein/cpg,1
16327,stereotactic biopsy,1
16328,oxymorphone hydrochloride,1
16329,standard subtotal nodal irradiation,1
16330,peritumoral glial cell infiltration,1
16331,amphinex and gemcitabine,1
16332,"rnf43, tomm34, vegfr1 and vegfr2",1
16333,active ppp001 with fbt placebo,1
16334,18f-faza (f18-fluoroazomycin arabinoside),1
16335,24-hour ambulatory blood pressure monitoring,1
16336,"vincristine, carboplatin, etoposide",1
16337,ogx-011,1
16338,hepatic intra arterial chemotherapy,1
16339,blu-u blue light phototherapy illuminator,1
16340,orteronel+prednisone,1
16341,hypoxia-activated prodrug th-302,1
16342,sentinel lymph node biopsy(slnb),1
16343,behavioral intervention.,1
16344,accelerated conformational radiotherapy,1
16345,70% isopropyl alcohol embedded caps,1
16346,atezolizumab1200 mg iv,1
16347,the spy® intraoperative imaging system,1
16348,therakos cellex photopheresis system,1
16349,pharmacodynamic analysis,1
16350,patients starting a treatment with doxorubicin and ifosfamide,1
16351,clopidogrel (plavix),1
16352,high-dose radiotherapy,1
16353,89zr-bevacizumab pet imaging,1
16354,band together,1
16355,chemoradiotherapy (crt),1
16356,68ga psma pet-ct,1
16357,staging laparoscopy,1
16358,total body irradiation (8gy),1
16359,encapsulated olive oil,1
16360,20 mcg ethinylestradiol/3 mg drospirenone and selmevit,1
16361,elective mucosal irradiaton,1
16362,diathermy,1
16363,laparoscopic ovarian cystectomy using suture,1
16364,3- cervical pap smears,1
16365,gen0101,1
16366,bladder neck level on cystography,1
16367,interferon gamma 1b in combination,1
16368,depression intervention,1
16369,bcl-2 inhibitor gdc-0199,1
16370,accure navigator,1
16371,aerobic exercise and relaxation,1
16372,nanopac® 300 mg/m2,1
16373,dual energy contrast enhanced digital mammography (de cedm),1
16374,galil medical patented 17g cryoablation needles,1
16375,luteolin,1
16376,ip,1
16377,avastin + mfolfox6,1
16378,mccorkle model intervention,1
16379,vo2max measurements,1
16380,ringer's lactate,1
16381,nadroparin: short-term,1
16382,crizotinib (pf-02341066),1
16383,sodium heparin,1
16384,cetuximab induction,1
16385,histology (gold standard),1
16386,ultrasound-guided core needle biopsy,1
16387,heat treatment,1
16388,cart-138 cells,1
16389,carboplatin hyperthermic intraperitoneal chemotherapy (hipec),1
16390,preoperative concurrent chemoradiation,1
16391,now i'm telling you,1
16392,usg stellate ganglion block,1
16393,oxaliplatin + folinic acid + fluorouracil + bevacizumab,1
16394,standard behavioral weight change intervention,1
16395,conventional pca mode,1
16396,surgical removal of primary and/or of all oligometastases,1
16397,intravenous methylprednisolone,1
16398,zd1839 (gefitinib),1
16399,ligasure precise instrument,1
16400,chemovax,1
16401,"nivolumab (opdivotm, 40 mg/4ml solution)",1
16402,rhenium sulfure,1
16403,unmanipulated ucb,1
16404,pancreatosplenectomy,1
16405,allogeneic b7.1/hla-a1,1
16406,high dose aspirin & vitamin d,1
16407,pelvic physiotherapy,1
16408,electrical stimulation pain therapy,1
16409,lct,1
16410,neoadjuvant gemcitabine plus nab-paclitaxel with sbrt,1
16411,oxymorphone ir,1
16412,physician-collected sampling,1
16413,rad001 and mitomycinc,1
16414,"radium-223 chloride (xofigo®, bay88-8223) injection",1
16415,doxepin cream 5%,1
16416,low-dose ngr-htnf,1
16417,gastric partitioning plus gastro-entero anastomosis,1
16418,panitumumab + paclitaxel,1
16419,gp100:280-288(288v) peptide vaccine,1
16420,adaptation of imcp for chinese immigrant cancer patients,1
16421,gsk3368715,1
16422,trec-onco,1
16423,pedicare,1
16424,eus-guided fine needle,1
16425,mri perfusion imaging,1
16426,continuous oral cyclophosphamide and methotrexate,1
16427,decision aid invitation,1
16428,preladenant,1
16429,placebo to adalimumab,1
16430,autologous dendritic cells transfected with amplified tumor rna,1
16431,additive homeopathic treatment,1
16432,split-dose peg based lavage (2l + 2l) with standard dietary instructions,1
16433,gelatin capsule,1
16434,mindfulness based cancer recovery,1
16435,tray,1
16436,diabetes,1
16437,lidocaine bolus infusion,1
16438,volumetric measurements of liver metastases,1
16439,polarity therapy,1
16440,hma,1
16441,tlpldc,1
16442,mag-epa,1
16443,menopausal status at diagnosis,1
16444,bibw 2992 medium (40mg) dosage,1
16445,radical laparoscopy prostatectomy,1
16446,lidocaine hydrochloride,1
16447,"docetaxel, oxaliplatin, 5-fu, leucovorin",1
16448,"5fu, leucovorin, oxaliplatin",1
16449,standard advance directive,1
16450,protracted oral etoposide,1
16451,crystalloid,1
16452,lansoprazole (proton pump inhibitor),1
16453,cd19.car-cd28z t cells - dose escalation 2,1
16454,metformin cloridrate,1
16455,fractionated 5-aminolevulinic acid hydrochloride 20% gel pdt,1
16456,control diet group,1
16457,local standard of care,1
16458,eus-guided ethanol-lipiodol mixture ablation,1
16459,wbrt with hippocampus-sparing and sib,1
16460,allograft arthrodesis of ankle,1
16461,"paclitaxel, cisplatin, 5-fluorouracil",1
16462,watchman active surveillance,1
16463,omni-biotic 10,1
16464,interferon-2a,1
16465,actinium-225-labeled humanized anti-cd33 monoclonal antibody hum195,1
16466,"velcade (ps-341, bortezomib)",1
16467,hdr brachytherapy of 7 gy in 3 fractions,1
16468,conventional white-light colonoscopy,1
16469,"amg 386 30 mg/kg, paclitaxel and trastuzumab",1
16470,laryngeal carcinoma,1
16471,6-minute withdrawal time,1
16472,sleep education program,1
16473,pemetrexed at progression,1
16474,polysporin,1
16475,"magnetic resonance imaging; spectroscopic imaging, contrast enhanced imaging",1
16476,oxcarbazepine,1
16477,crs+hipec,1
16478,inferior mesenteric artery dissection,1
16479,buddy,1
16480,leuprolide acetate and bicalutamide,1
16481,interferon-alpha-2a,1
16482,niraparib treatment,1
16483,[18f]psma-11,1
16484,standard hysteroscopic resection,1
16485,"vincristin , adriamycin, dexamethasone = vad",1
16486,aspirin (asa) + metformin (met),1
16487,yttrium-90 ibritumomab tiuxetan,1
16488,dignity therapy - chaplain led,1
16489,"vcr, ctx, adm; ifo, vp-16",1
16490,incagn02385,1
16491,arrest-study,1
16492,"either wait and see, or supportive treatment, or active treatment at physician discretion",1
16493,eloxatin injectable product,1
16494,radiotherapy imrt,1
16495,4-hydroxytamoxifen,1
16496,dexamethasone (tablets),1
16497,palliative rt for bone cancer pain,1
16498,intracorporeal roux-en-y esophagojejunostomy,1
16499,klh-id vaccine,1
16500,ponatinib 45 mg,1
16501,sparc1210,1
16502,phos istos pdt,1
16503,mfolfox6 chemotherapy,1
16504,standard dose cytarabine for induction,1
16505,18f-fluorothymidine,1
16506,tumor specific antigen-loaded dendritic cells,1
16507,mk-1308,1
16508,s 64315 (also referred as mik665) and venetoclax,1
16509,pilimumab,1
16510,6b11-ocik injection,1
16511,augmented reality,1
16512,motorized spiral enteroscopy,1
16513,facilitator-based intervention,1
16514,interleukin-2 (1 million iu),1
16515,tmz-pet,1
16516,wobe-mugos e,1
16517,metoclopramide hydrochloride,1
16518,pld and ifo,1
16519,nitrogen mustard,1
16520,telemedicine pain management intervention (immediate group),1
16521,tg-0054 (2.24 mg/kg),1
16522,subtotal parathyroidectomy,1
16523,adenosine triphosphate,1
16524,ambulatory blood pressure measurement,1
16525,pf-05280586,1
16526,a166,1
16527,4-peptide melanoma vaccine plus ontak,1
16528,autologous lymphocyte infusion (ali),1
16529,nitroglycerin-citrate-ethanol (nice),1
16530,chemotherapy with pdd regimen,1
16531,the gamma pod,1
16532,cancer stem cells sensitivity assay,1
16533,ibrutinib ou idelalisib,1
16534,dietary advice,1
16535,"pzp115891, pci-24781",1
16536,20 gy in 5 fractions,1
16537,docetaxel or pemetrexed,1
16538,karl storz d-light c photodynamic diagnostic (pdd) system,1
16539,300mg berberine hydrochloride,1
16540,intracavitary vaginal brachytherapy,1
16541,combination cinacalcet with vitamin d analogue,1
16542,cervical tissue biopsy analysis: comet assay,1
16543,"placebo/celecoxib 400 mg and cholecalciferol 400 iu/cholecalciferol 2,000 iu",1
16544,fluorouracil/folinic acid/oxaliplatin,1
16545,niti-s stent (d type),1
16546,asp-1929,1
16547,conventional-dose vitamin d 3,1
16548,chemoradiotherapy plus bevacizumab,1
16549,standard resistance training,1
16550,standard of care non-distressed,1
16551,pancreatic resection (pd),1
16552,neurophysiological and psychophysical evaluations,1
16553,curettage (intralesional surgery),1
16554,tace plus rad-p53 artery injection,1
16555,abvd chemotherapy,1
16556,gastrojejunostomy,1
16557,500 mg of depot hydroxy-progesterone,1
16558,dasatinib 100 mg,1
16559,pv-10 (rose bengal disodium 10%),1
16560,cat 8015 (moxetumomab pasudotox),1
16561,"tenalisib,",1
16562,mogamulizumab (kw-0761),1
16563,isis 104838,1
16564,pulmonary radiofrequency ablation,1
16565,erlotinib/placebo,1
16566,tomato product,1
16567,0.9% nacl,1
16568,methotrexate(necessary),1
16569,enhanced usual care packets,1
16570,youth tobacco and nicotine product primary care survey,1
16571,h3b-6545,1
16572,avitinib maleate,1
16573,vaginal brachytherapy 2,1
16574,yttrium-90 (y-90),1
16575,kibur microdevice,1
16576,conventional pci,1
16577,heat therapy,1
16578,rad-p53,1
16579,meg and mri,1
16580,"consolidation, i ham cycle",1
16581,fsp peptides,1
16582,autologous fat transplantation,1
16583,ec1169,1
16584,5-fluorouracil (infusional),1
16585,stereotactic body radiation sbrt,1
16586,inactivated influenza vaccine and the 23- valent pneumococcal vaccine,1
16587,intramuscularly (im injection),1
16588,lumascan image guided surgery,1
16589,experimental intervention,1
16590,radical surgery or limited surgery,1
16591,sanguisorba officinalis l.,1
16592,amphinex,1
16593,interferon-alpha2a,1
16594,acellular dermal matrix implantation,1
16595,docetaxel + trastuzumab + lapatinib,1
16596,abbreviated pb mri,1
16597,leukine,1
16598,endo cdx brush biopsy,1
16599,"selenium, selenomethionine",1
16600,idarubicin(8mg/m2) and cytosine arabinoside,1
16601,mitoxantrone (novantrone),1
16602,induction therapy - capecitabine,1
16603,corticosteroid: hydrocortisone,1
16604,connected to care,1
16605,patient self-reporting of symptoms,1
16606,inhaled delta-8-thc,1
16607,"expanded , activated nk cells",1
16608,lomustine and procarbazine,1
16609,c-scan procedure,1
16610,trametinib 1.5 mg,1
16611,14c-labeled vemurafenib,1
16612,"idarubicin, cytarabine",1
16613,frailty model,1
16614,physical performance,1
16615,tai-chi/qi-gong,1
16616,"3t mri (magnetom verio 3t, erlangen, germany)",1
16617,cls006 (furosemide) topical gel,1
16618,traditional ivm system,1
16619,topical menthol,1
16620,auroshell particle infusion,1
16621,active intervention control,1
16622,1 week rt,1
16623,educational videos,1
16624,eq-5d,1
16625,behavioral weight loss,1
16626,macroscopic deciduosis,1
16627,whole body pet/ct scan,1
16628,18f-fdg pet/ct balanced-time imaging,1
16629,conventional colposcopy (wallach zoomscope),1
16630,carcinoembryonic antigen peptide 1-6d,1
16631,low glycemic index mediterranean diet,1
16632,gefitinib only,1
16633,miseq sequencer,1
16634,docetaxel and capecitabine and oxaliplatin,1
16635,exercise and adjustable compression wrap,1
16636,primary tumor resection (ptr),1
16637,mesoglycan oral tablet,1
16638,"vorinostat, capecitabine, and cisplatin",1
16639,diet advice,1
16640,nis observational stud,1
16641,weekly docetaxel alone,1
16642,intravesical bcg and emda/mmc,1
16643,gmcsf (granulocyte macrophage colony stimulating factor),1
16644,higher dose (50.4gy/28f) of neoadjuvant chemoradiation,1
16645,autologous wt1 tcr transduced t cells,1
16646,x-ray computed tomography (ct),1
16647,biphasic bone graft material (bgm) in combination with autologous platelet-rich fibrin (prf),1
16648,group crc,1
16649,vivascope 2500 ex-vivo fluorescent confocal microscope,1
16650,zd-1839,1
16651,cc-90003,1
16652,combination carboplatin and paclitaxel,1
16653,novottf200a (optune),1
16654,non navigated latinas,1
16655,total body irradiation (8gy/4fr),1
16656,68ga-dotatoc-pet,1
16657,uterovaginal brachytherapy,1
16658,everolmus,1
16659,isotonic solution,1
16660,tace+ systemic bevacizumab,1
16661,doxorubicin and cyclophosphamide,1
16662,subcutaneous drainage,1
16663,gc022,1
16664,"tissue sampling (""g.i.u.m."" catheter)",1
16665,adjusted dynastat or flurbiprofen axetil jinjection,1
16666,plaque radiotherapy,1
16667,imatinib mesylate 400mg capsule,1
16668,multilingual aphasia examination,1
16669,allogeneic matched related or unrelated donor transplant.,1
16670,daunorubicin + cytarabine,1
16671,docetaxel + cyclophosphamide + pegfilgrastim,1
16672,lapatinib and everolimus,1
16673,baseline geriatric screening/assessment,1
16674,autologous cd19-cd8-cd28-cd3zeta-car-mbil15-her1t t cells,1
16675,permanent breast seed implant (pbsi),1
16676,pre-treatment phase group,1
16677,"beam (carmustine (bcnu), etoposide, cytarabine, melphalan)",1
16678,guided imagery and music,1
16679,gemcitabine+placebo,1
16680,dexamethasone for control of symptoms,1
16681,livact,1
16682,methylene blue 20 mg/ml,1
16683,hbv screening tests,1
16684,ldr brachytherapy,1
16685,imrt + ct + mr scan,1
16686,donor lymphocyte preparation depleted of host functional alloreactive t-cells,1
16687,b7-dc cross-linking antibody rhigm12b7,1
16688,"paced breathing (10 min once daily, 14 breaths/min)",1
16689,pegylated arginine deiminase,1
16690,lung tumor associated antigen,1
16691,chg regimen,1
16692,surgical performance,1
16693,consolidation radiotherapy,1
16694,micro needle array-doxorubicin (mna-d),1
16695,tykerb,1
16696,ibrutinib oral capsule [imbruvica],1
16697,indoximod freebase,1
16698,chemotherapy and surgery,1
16699,antiemetics,1
16700,susceptibility weighted imaging,1
16701,glad press 'n seal,1
16702,ebna1 c-terminal/lmp2 chimeric protein-expressing recombinant modified vaccinia ankara vaccine,1
16703,sham art therapy,1
16704,re-active,1
16705,"personalized, motivational messages",1
16706,oxaliplatin and raltitrexed,1
16707,sebutape,1
16708,resting energy expenditure,1
16709,non-insertion of misoprostol pfizer brand,1
16710,oral nutrition support,1
16711,medical chart reviews,1
16712,green tea placebo capsules,1
16713,mdx-ctla4 antibody; tyrosinase/gp100/mart-1 peptides melanoma vaccine,1
16714,ekg,1
16715,talimogene laherparep 100 mil pfu/ml 1ml,1
16716,bevacizumab and second-line chemotherapy,1
16717,therapy for targeted therapy-related fatigue (ttf),1
16718,vmat with cbct,1
16719,dermasil lotion,1
16720,observation of surface patterns of polyps,1
16721,msb0010445 (0.3 milligram per kilogram [mg/kg]),1
16722,targeted,1
16723,hydroxyzine 25mg,1
16724,second line chemoregime for advanced gastric cancer,1
16725,lr-chop21,1
16726,placebo plus corticosteroid,1
16727,egd with eus,1
16728,standard folfirinox chemotherapy prior to surgery,1
16729,hucart19 cells,1
16730,"alignrt system (visionrt ltd, uk)",1
16731,androgen receptor antagonists,1
16732,metformin and bicalutamide,1
16733,bpi-15086,1
16734,fat emulsion,1
16735,standard arm (mail/telephone),1
16736,auto3,1
16737,"r1: ixazomib, lenalidomide, dexamethasone (ird) induction therapy - reactive arm",1
16738,gallium-68-dotatate pet/ct (index test),1
16739,letrozole as adjuvant therapy,1
16740,behavior,1
16741,panitumumab with capecitabine and oxaliplatin (capox) followed by,1
16742,cerebral irmf,1
16743,polarized reflectance spectroscopy system,1
16744,no additional treatment,1
16745,coriolus versicolor,1
16746,normal protein diet,1
16747,cdp791 10mg/kg,1
16748,thermal therapy,1
16749,realgar-indigo naturalis formula,1
16750,carbon monoxide (co) test,1
16751,bi-con-02,1
16752,getting back on track,1
16753,lucas decision aid,1
16754,photoaging mirroring intervention,1
16755,luteinising hormone releasing hormone analog agonist (lhrha),1
16756,combretastatin a4 phosphate (ca4p),1
16757,sulindac plus placebo,1
16758,4.0 mg/m2 di-leu16-il2,1
16759,hippocampal-sparing prophylactic cranial irradiation,1
16760,immune thrombocytopenics,1
16761,vb-111 + paclitaxel,1
16762,proflavine solution,1
16763,stress,1
16764,"prednisone,vincristine, cyclophosphamide",1
16765,carboplatin (palaplatin),1
16766,endo-cuff,1
16767,"administration of bicalutamide, dutasteride and tamoxifen",1
16768,self sample from the oral cavity,1
16769,medi5083 monotherapy,1
16770,b-ultrasonography,1
16771,ultrasound therapy,1
16772,outdoor sun behavior,1
16773,lenograstim 10 microgram/kg/day,1
16774,rna anti-cd19 car t cells,1
16775,lu-177-dota-girentuximab,1
16776,esd/emr,1
16777,"cyclophosphamide, anti-thymocyte globulin",1
16778,crlm ablation group,1
16779,unconventional lymph node dissection,1
16780,adv-tk/gcv,1
16781,x-396,1
16782,control group (no bcaas provided),1
16783,yunzhi extract,1
16784,group a adjuvant chemotherapy,1
16785,cmv-mva triplex vaccine,1
16786,monoclonal antibody mik-beta-1,1
16787,"high-dose methotrexate, leucovorin",1
16788,pu-ad,1
16789,pulsed dye laser 595 nm,1
16790,apt mr imaging,1
16791,eagd t-cell infusion (phase i),1
16792,low intra abdominal pressure hipec,1
16793,chimeric fibril-reactive monoclonal anti-body 11-1f4,1
16794,azacitidine for injection,1
16795,icasp9m28z t cell infusions,1
16796,writing b (experimental noninformative writing),1
16797,prior exercise behavior questions - harvard health professionals exercise questionnaire,1
16798,satraplatin plus radiation therapy,1
16799,low bacterial diet,1
16800,up-front neck dissection,1
16801,control rinse,1
16802,culture medium metabolomic analysis,1
16803,allogeneic hematopoietic stem cell transplantation (naive t cell-depleted pbsc),1
16804,docetaxel and diethylstilbestrol (des),1
16805,"clofarabine, ara-c",1
16806,general anesthesia and patient controlled intravenous analgesia,1
16807,"subtotal gastrectomy with roux-en-y gastrojejunostomy,",1
16808,combination group,1
16809,second look dls,1
16810,comprehensive intervention,1
16811,pivmecillinam/augmentin,1
16812,layered closure technique,1
16813,conformal thoracic radiotherapy (ctrt),1
16814,"photodynamic therapy (pdt) (ala-pdt, ameluz®-pdt)",1
16815,vandetanib induction,1
16816,rituximab maintenance therapy,1
16817,taking charge: managing cancer online,1
16818,cbt and relaxation,1
16819,laparoscopic spleen-preserving no. 10 lymph node dissection,1
16820,giotrif 20mg,1
16821,amg 404,1
16822,e-pamphlet,1
16823,eortc qlq-ov28 questionnaire,1
16824,stage 3: abiraterone acetate,1
16825,poly-iclc as immune adjuvant,1
16826,pet scan with ga68-dotanoc,1
16827,re-irradiation (rt),1
16828,fast-track peri-operative program,1
16829,hbs antibody and hbc antibody,1
16830,extracellular matrix,1
16831,su5416 and carboplatin,1
16832,norepinephrine intra-arteriel/hepatic,1
16833,thoracentesis,1
16834,chemotherapy followed by radiotherapy,1
16835,a 2 intervention arm flex sig + ifobt,1
16836,otx008,1
16837,p16_37-63 peptide combined with montanide® isa-51 vg,1
16838,mils,1
16839,noninvasive positive-pressure ventilation (nppv),1
16840,oncolytic hsv-1716,1
16841,3dv+tps/varian,1
16842,chemotherapy ± targeted therapy,1
16843,hyperbaric oxygen given at 2.4 ata for 30 minutes immediately prior to srs - hbot for 30 minutes - srs without prior hbo,1
16844,interview performed by mhp student,1
16845,kim-chi,1
16846,amrubicin (japan),1
16847,"bevacizumab, nab-paclitaxel, carboplatin, doxorubicin hydrochloride, cyclophosphamide, peg-filgrastim",1
16848,calcium phosphate (caphosol) ca2+/po43- mouth rinse,1
16849,3f8/gm-csf immunotherapy plus 13-cis-retinoic acid,1
16850,ultratrace iobenguane i131,1
16851,c134,1
16852,val201,1
16853,olaparib (for levels 1 and 5),1
16854,structured smoking cessation counselling based on motivational interviewing (mi) and adapted for the cancer setting eventually combined with provision of smoking cessation medication,1
16855,uniportal video-assisted thoracoscopic surgery in total thymectomy,1
16856,uv fluorescent ink,1
16857,mtx followed by fludarabine,1
16858,expiratory muscle strength training (emst),1
16859,allo hsct with reduced-intensity conditioning,1
16860,"mabcampath,",1
16861,external beam radiation (hyperfractionated),1
16862,pad induction,1
16863,imatinib mesylate 600mg/day,1
16864,hypofractionated 3d-crt or imrt,1
16865,hpv self collection,1
16866,post-operative adjuvant radiotherapy,1
16867,first oe,1
16868,conventional axillary dissection,1
16869,clinical biological database collection,1
16870,tissue from core biopsy,1
16871,"temozolomide, cisplatinum",1
16872,pf-ccrt (randomized),1
16873,pre-hct mesna on days -5 and -4,1
16874,gefitinib or docetaxel,1
16875,cb-03-10,1
16876,she project,1
16877,blue light source,1
16878,cerebral radiotherapy,1
16879,high quality volume ct scan; mri scan,1
16880,infrared camera,1
16881,oxaliplatin + docetaxel,1
16882,sln mapping/biopsy,1
16883,ip catheter insertion,1
16884,sgx301 (synthetic hypericin),1
16885,whole brain radiotherapy (wbrt) and a simultaneous integrated boost (sib) using volumetric modulated arc therapy,1
16886,treated by docetaxel and cisplatin,1
16887,fragmin (dalteparin sodium ),1
16888,evaluation to determine if patient is a candidate to proceeed with surgical resection or not,1
16889,treatment with arq 197 in combination with sorafenib,1
16890,s1 generic,1
16891,to study the characteristics of patients with dia / dig,1
16892,visit based care,1
16893,flt-pet/ct: (3'deoxy-3'-[(18)f] fluorothymidine) pet/ct,1
16894,methylaminolaevulinate cream,1
16895,octavalent hpv with 15 mcg imx / aahs,1
16896,probe based confocal laser endomicroscopy,1
16897,adriacin,1
16898,r-mabhd,1
16899,cyclophosphamide or bendamustine,1
16900,vitamin k antagonists,1
16901,talen,1
16902,intrathecal chemotherapy without radiation,1
16903,fpa144 + mfolfox6,1
16904,facebook group,1
16905,liver mri with gdfos,1
16906,intraprostatic maximal simultaneous boost,1
16907,class 1 compression garment,1
16908,bi 811283 (d1),1
16909,vindesine sulfate,1
16910,endoscopic injection of mitomycin c,1
16911,definity suspension for injection,1
16912,paclitaxel.,1
16913,high-dose cisplatin,1
16914,iv pca only apply,1
16915,elective lymph node dissection,1
16916,stereotactic mri-guided on-table adaptive radiation therapy,1
16917,"mitomycin, doxifluridine and cisplatin",1
16918,particle therapy,1
16919,peptide placebo,1
16920,capecitabine plus cisplatin(xp) versus capecitabine plus paclitaxel(xt),1
16921,protein expression by immunohistochemistry and immunofluorescence,1
16922,5-fluoro-uracil/oxaliplatin/leucovorin (folfox),1
16923,hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine,1
16924,"markers in tissue samples: (tigar , trim59, p53, akt, gsh)",1
16925,ocaratuzumab,1
16926,mri scan of soft tissue tumor,1
16927,blood test: ca-125 biomarker,1
16928,cs-1000 labeled svf cells,1
16929,zoledronic acid in combination with therapy,1
16930,behavioral medicine strategies,1
16931,maintenance vitamin d3,1
16932,stereotactic body radiotherapy/sbrt,1
16933,velcade prednisone,1
16934,shr-1603,1
16935,resting assessment of cardiac function by echocardiography,1
16936,recombinant human interleukin-15,1
16937,ew02,1
16938,comparison of evidential versus non-evidential education on women's breast cancer prevention behaviors,1
16939,total laryngectomy,1
16940,incobotulinumtoxina,1
16941,nab-paclitaxel iv,1
16942,leisure activity (film showing),1
16943,azithromycin immediate release (zithromax),1
16944,imaging drug fluorthanatrace (ftt),1
16945,tailored nutrition intervention,1
16946,sulfur hexafluoride lipid microspheres,1
16947,cinobufacini tablets,1
16948,immune complex predictive index,1
16949,tailoring the flap according to clinical assessment,1
16950,"am001 cream, 7.5%",1
16951,gynecologist collection,1
16952,therapeutic intervention,1
16953,"cisplatin, vindesine, dacarbazine (drugs)",1
16954,treatment a - azd1775 administered under fasted conditions,1
16955,myeloablative conditioning,1
16956,deb-tace using anthracyclin loaded lifepearl™,1
16957,ofatumumab plus dexamethasone,1
16958,recombinant anti-egfr monoclonal antibody,1
16959,febuxostat 80/120mg/day,1
16960,anatomic pulmonary resection,1
16961,b-dim,1
16962,azacitidine (aza) days 1 - 5,1
16963,mb07133 1200 mg/m2/day,1
16964,prednisone/prednisolone or dexamethasone,1
16965,topical abi-1968,1
16966,fts,1
16967,biopsies using image fusion,1
16968,bavituximab and sorafenib,1
16969,mitolactol,1
16970,2nd generation designer t cells,1
16971,experimental: 3. experimental,1
16972,pembrolizumab post-resection,1
16973,fcm,1
16974,tc chemotherapy,1
16975,locoregional treatments,1
16976,standard-of-care treatment with panitumumab,1
16977,biop colposcopy system,1
16978,primary surgical resection with sequential adjuvant therapy,1
16979,icus,1
16980,surgery for eoc with trial (pj) device (plasmajet),1
16981,ict-121 dc vaccine,1
16982,high frequency group,1
16983,melan-a,1
16984,continuous pazopanib (arm a),1
16985,imiquimod topical cream 3.75%,1
16986,com701,1
16987,diagnostic thoracoscopy,1
16988,gv 1001 telomerase peptide,1
16989,probiotic agent,1
16990,paclitaxel and carboplatin (tc arm),1
16991,folfox6 and avastin,1
16992,local excision or wait-and-see,1
16993,autologous dendritic cells pulsed with tumor lysate antigen vaccine,1
16994,sonocloud,1
16995,2 gy targeted radiotherapy,1
16996,buspirone hydrochloride,1
16997,lungpoint virtual bronchoscopic navigation (computer-assisted image-guided bronchoscopic navigation),1
16998,cialis,1
16999,delirium screen,1
17000,velcade administered by subcutaneous injection,1
17001,elsamitrusin,1
17002,modradoc001 10mg capsules,1
17003,lnd only for lymph nodes enlargement found in preoperative image or during surgery,1
17004,hemoclip,1
17005,dhes0815a,1
17006,inductive chemotherapy + concurrent cisplatin and imrt,1
17007,height and weight,1
17008,solu medrol,1
17009,kl-140,1
17010,regimen based on expertise anaesthesist,1
17011,"vinflunine, carboplatin",1
17012,drmi,1
17013,interactive empowerment tool,1
17014,isha kriya (ik) meditation,1
17015,metformin and roflumilast,1
17016,donor-derived cik cells,1
17017,surgery first,1
17018,simeprevir,1
17019,plasma levels of elemental arsenic,1
17020,automated reminders,1
17021,antecolic reconstruction,1
17022,becaplermin users,1
17023,ribociclib and aromatase inhibitor,1
17024,ipl quantum product manufactured by luminis ltd.,1
17025,peg solution in a single dose of 3 liters,1
17026,ima901 and leukine,1
17027,participation on the acor listserv,1
17028,optional research biopsy,1
17029,"metronidazole, clarithromycin, ciprofloxacin and lansoprazole",1
17030,"consolidation, iii hidarac cycle",1
17031,synthetic tumor-associated peptide vaccine therapy,1
17032,tax-iri,1
17033,paclitaxel + carboplatin + aslan001,1
17034,nsaa,1
17035,multispectral imaging,1
17036,monitor intervention,1
17037,cobimetinib - cohort 1,1
17038,oxaliplatin + 5-fluorouracil/leucovorin,1
17039,standard care control,1
17040,gnrh antagonist-cetrorelix,1
17041,laparoscopic primary cytoreduction,1
17042,auto graft,1
17043,biopsies (upper endoscopy),1
17044,irreversible electroporation ablation,1
17045,placebo sachets,1
17046,bay 2315497 injection,1
17047,pelitinib,1
17048,onco-repair/ placebo,1
17049,rtm,1
17050,bevacizumab 7.5 and tac,1
17051,ima201 product,1
17052,vsli,1
17053,zolderonic acid (zometa),1
17054,yttrium-90 conjugated chimeric g250 (^90y-dota-cg250),1
17055,apatinib + s-1,1
17056,"gemcitabine, paclitaxel",1
17057,anti-cd133-car vector-transduced t cells,1
17058,vacuum erection device,1
17059,igf/mtx,1
17060,vb-111 + bevacizumab,1
17061,high resolution anoscopy (hra),1
17062,nutren® optimum,1
17063,methotrxate vinblastine doxorubicine cisplatine g-csf,1
17064,total body irradiation 200 cgy,1
17065,oncoplastic limited rom,1
17066,bismuth quadruple therapy,1
17067,cirrhosis with hcc,1
17068,plasma collection,1
17069,ritalin,1
17070,monthly phone calls,1
17071,68ga-dota tate,1
17072,adenovirus-p53 transduced dendritic cell (dc) vaccine,1
17073,gemcis + panitumumab,1
17074,video with non-moving images,1
17075,gemcitabine / cisplatin / sorafenib,1
17076,demethylated drug decitabine,1
17077,standard of care diagnostic mibg scan for neuroendocrine tumor diagnosis.,1
17078,yttrium 90 (therasphere),1
17079,cd45 expression,1
17080,m,1
17081,cyst fluid,1
17082,dabrafenib 150 mg,1
17083,fdg pet/ct scan with iv contrast,1
17084,fecal immunochemical test (fit) kit,1
17085,health education and handouts,1
17086,mailed educational reminder,1
17087,working with the caregiving family (wcf) training,1
17088,beta-carotene,1
17089,platinum based chemotherapy,1
17090,vincristine + carboplatin + etoposide,1
17091,lycopene and docetaxel,1
17092,ethyl alcohol,1
17093,audio-taped interview,1
17094,alm201,1
17095,oral eflornithine placebo,1
17096,trametinib pediatric formulation,1
17097,mgh ofdi marking,1
17098,mychemocare ipad application,1
17099,er:yag laser,1
17100,16s rrna gene sequencing assay,1
17101,intervention 2,1
17102,andes-1537 for injection,1
17103,zsp1603 7.5 mg,1
17104,elastic band strengthening exercise,1
17105,60gy (7.5gy x 8fr.),1
17106,pts operated for pancreatic cancer,1
17107,intron-a,1
17108,placebo to match ruxolitinib,1
17109,pre-surgery ultrasound,1
17110,blex 404,1
17111,phase i dose level 3,1
17112,cd25 depletion,1
17113,computerized cytomorphometry,1
17114,progress reporting,1
17115,debdox,1
17116,no nicotine electronic cigarette,1
17117,holistic needs assessment,1
17118,cga and geriatric follow-up,1
17119,no drains,1
17120,tip-c plus handbook,1
17121,multi-language online patient education module in addition to standard patient teaching,1
17122,"induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (crda) regimen",1
17123,"cisplatin, gemcitabine, interferon-a",1
17124,inductive chemotherapy + imrt,1
17125,thulium laser en bloc resection of bladder tumor,1
17126,asyms-can,1
17127,tegafox sequential s-1.,1
17128,mgd007,1
17129,bevacizumab-containing regimen,1
17130,comparator: adacel™ (non-concomitant),1
17131,capecitabine during all radiotherapy period,1
17132,bibw 2992 high (50mg) dosage,1
17133,endoscopic ultrasound guided needle tissue acquisition.,1
17134,scoring acute toxicity,1
17135,xeloxa-a,1
17136,standard messaging,1
17137,light glasses (comparison),1
17138,post procedure mammogram,1
17139,analysis,1
17140,- use of resorbable membrane seprafilm,1
17141,best practice algorithm for postoperative care,1
17142,pancreaticogastrostomy group,1
17143,"epirubicin, ctx, paclitaxel",1
17144,usual diagnostic workup,1
17145,cyclophosphamide 750mg/m2,1
17146,surface-controlled water soluble curcumin mtd,1
17147,nivolumab or pembrolizumab,1
17148,mr/mrcp,1
17149,standard lesion biopsies,1
17150,"pirarubicin,mitomycin and lobaplatin",1
17151,docetaxel + standard dose vitamin d2,1
17152,"dietary fish (canned salmon, albacore)",1
17153,prevenar 13,1
17154,bis sensor attachment,1
17155,sorafenib 100 mg (50-mg tablet),1
17156,3-d trus navigation software during t-ralp,1
17157,sensory test,1
17158,gold seeds insertion to detect movements at pelvis,1
17159,anesthesia,1
17160,photodynamic therapy with bf-rhodoled,1
17161,radiation therapy (rad),1
17162,bevacizumab plus ipilimumab cohort 1,1
17163,preoperative short-course radiotherapy without local boost,1
17164,iodine i 131 monoclonal antibody muj591,1
17165,imaging with s-flare imaging system,1
17166,cinnamon extract,1
17167,tedd,1
17168,busulphan,1
17169,radiation arm b,1
17170,physician information,1
17171,survivorship chess,1
17172,liver irradiation,1
17173,r-epoch and cart,1
17174,hydralazine and valproic acid: cohort 0,1
17175,ultrasound with intravenous microbubble contrast injection,1
17176,everolimus and exemestane,1
17177,inhalation of hyperpolarized xenon gas,1
17178,hla-matched related donor bone marrow,1
17179,amblyomin-x,1
17180,dasatinib + pegifn,1
17181,"""endostar""",1
17182,urtica comp. gel,1
17183,standard platinum-based chemoradiotherapy,1
17184,gbm patients,1
17185,skin sealant,1
17186,"comparator: mk0752, notch inhibitor - 1 day on, 6 off",1
17187,video-strobe procedure,1
17188,ec1456,1
17189,cetuximab 5mg/ml,1
17190,viusid placebo,1
17191,oxycodone (oxynorm®) injection,1
17192,conformational radiotherapy,1
17193,"maintenance chemotherapy (vincristin, cisplatin and ccnu)",1
17194,6 cycles chemotherapy,1
17195,tumor interstitial fluid pressure (ifp) assessments,1
17196,pembrolizumab 200 mg iv single dose,1
17197,oligometastatic patients with abdominal-pelvic lymph nodes,1
17198,godin leisure time exercise questionnaire (glteq),1
17199,addiction support,1
17200,group b: carfilzomib & imid containing regimen.,1
17201,n-acetyl cysteine,1
17202,adjuvant chemotherapy with paclitaxel and nedaplatin,1
17203,biosamples from airway and blood,1
17204,carboplatin and gemcitabine,1
17205,dd-mvac,1
17206,laparoscopic sigmoid resection,1
17207,intraoperative cholangio-ultrasound,1
17208,bms-582664,1
17209,epirubicin and lipiodol,1
17210,cx5461,1
17211,activated cik and cd3-muc1 bispecific antibody in treating liver cancer,1
17212,oral nutritional supplement (ons),1
17213,"treatment strategy: induction, consolidation, hsct, maintenance",1
17214,era-923,1
17215,placebo gefitinib tablets,1
17216,40ml of 0.25% bupivacaine,1
17217,1:1 ratio,1
17218,azd6738 160 mg od + olaparib continuous 300 mg bd (28-day cycle).,1
17219,radiation: 60-66 gy in 2 gy daily fractions,1
17220,fulvestrant or tamoxifen or aromatase inhibitor,1
17221,step-up hp u fsh,1
17222,40 mg mmc in 40 ml tc-3.,1
17223,sleep hygiene video,1
17224,group a (povidone-iodine wash the surgical incision),1
17225,health promotion,1
17226,tf 002,1
17227,hypofractionated stereotactic irradiation (hfsrt),1
17228,photosensitizer(photofrin),1
17229,urea-based cream,1
17230,metal patch tests,1
17231,physician feedback form,1
17232,preventive administration of rapaflo,1
17233,metvix and natural daylight pdt,1
17234,gi-4000 vaccine,1
17235,physiotherapist intervention,1
17236,placebo (0.9% nacl),1
17237,"""truebeam"" stereotactic body radiosurgery",1
17238,placebo for enzalutamide,1
17239,audit-and-feedback,1
17240,daunoxome,1
17241,personal patient profile - prostate (p3p),1
17242,usual care disease monitoring,1
17243,wheatgrass juice,1
17244,ptv reduction,1
17245,opportunistic breast cancer screening,1
17246,lenalidomide; chlorambucil,1
17247,optimized mmc,1
17248,laparoscopic left lateral hepatic sectionectomy,1
17249,transpupillary thermotherapy,1
17250,mechanical stimulation (lpg system; cellu m6 integral i),1
17251,learning session 3,1
17252,bupropion immediate release (ir),1
17253,placebo photodynamic therapy (pdt) (vehicle to bf-200 ala containing no active ingredient),1
17254,seprafilm™,1
17255,everolimus plus exemestane,1
17256,placebo + lenalidomide + dexamethasone,1
17257,"sorafenib, ts-1",1
17258,partially hla-matched unrelated donor cells,1
17259,iv casopitant (placebo),1
17260,high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin,1
17261,inc280 in combination with erlotinib,1
17262,xenogeneic tyrosinase dna vaccine,1
17263,carfilzomib/dexamethasone maintenance,1
17264,medi3726 post-chemo,1
17265,stepped collaborative care,1
17266,stereotactic or conventional radiotherapy and chemotherapy in curative intent,1
17267,phase 1 - oxi4503 + cytarabine,1
17268,fulguration,1
17269,ga-68 psma pet,1
17270,dexa scans,1
17271,amino acid solution,1
17272,sh003,1
17273,autologus elutriated monocyte placebo vaccine,1
17274,breast-conserving therapy,1
17275,acide folinique,1
17276,proton beam radiotherapy (pbrt),1
17277,apatinib?tab. 500mg/d? combined with egfr-tki?as previously?,1
17278,arfi,1
17279,"vemurafenib + cobimetinib, decitabine",1
17280,carrageenan-containing gel,1
17281,anti-egfr car t,1
17282,nanoparticle albumin bound paclitaxel followed by fec,1
17283,bioactive glass (sp53p4),1
17284,bx4-suspended,1
17285,lon002,1
17286,radioactive iodine therapy,1
17287,hpv vaccinations,1
17288,erlotinib in combination with capecitabine,1
17289,pr610,1
17290,harmonic,1
17291,dexamethasone (iv),1
17292,il2-pet scan,1
17293,fmri evaluation,1
17294,couplelinks.ca website,1
17295,activated cik and cd3-muc1 bispecific antibody in treating kidney cancer,1
17296,electronically activated recorder (ear),1
17297,cell therapy,1
17298,elagolix dose 2 plus cyclical progesterone,1
17299,plerixafor 0.12 mg/kg,1
17300,radical nephroureterectomy,1
17301,ct + placebo,1
17302,choline pet/ct and dual time point fdg pet/ct,1
17303,gdc-0917,1
17304,volumetric laser endomicroscopy,1
17305,ketalar,1
17306,pathwork too test,1
17307,panobinostat capsules,1
17308,r-da-epoch,1
17309,pk-pd analysis,1
17310,fluvastatine,1
17311,data collection from medical record,1
17312,"taxotere (docetaxel), cisplatin, 5fu",1
17313,s-1 oxaliplatin,1
17314,high-dose chemotherapy: ara-c /melphalan,1
17315,"cp 675,206",1
17316,mvct,1
17317,mln-518 (tandutinib),1
17318,albuterol,1
17319,docetaxel plus placebo,1
17320,mov-gamma chimeric receptor gene,1
17321,cisplatin (associated to radiotherapy),1
17322,genomic testing,1
17323,dppos group lifestyle,1
17324,gene expression profiling (analysis) of tumor samples,1
17325,mecobalamin,1
17326,dexmedetomidine 1.5µg.kg-1,1
17327,tecemotide (l-blp25) and hormonal treatment,1
17328,no intervention - observational study,1
17329,near focus with narrow band imaging,1
17330,propofol-fentanyl,1
17331,acidophilus,1
17332,bez235 + paclitaxel + trastuzumab,1
17333,cyproterone acetate + estradiol,1
17334,telephone counselling,1
17335,precise treatment,1
17336,hyperacute-pancreatic cancer vaccine,1
17337,50-60 gy and 70 gy,1
17338,autologous peripheral blood stem cell transplant,1
17339,apollo micro catheter device,1
17340,"ttk, ly6k, and imp-3 peptides",1
17341,"bevacizumab, carboplatin and paclitaxel",1
17342,walking+simulated-altitude,1
17343,a: radiotherapy alone,1
17344,"v501, gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / duration of treatment: 4 years",1
17345,uv photo,1
17346,placebo (saline solution),1
17347,proscavax,1
17348,"anthracycline, cyclophosphamide, docetaxel, capecitabine",1
17349,patient records,1
17350,177lu-dota-eb-tate 2,1
17351,behavioral placebo treatment,1
17352,gs-9191,1
17353,low risk: oupatient management,1
17354,fecal microbiota transplantation,1
17355,loestrin 1/20,1
17356,nuclear medicine cardiac scan,1
17357,oxaliplatin + cisplatin + 5-fluorouracil (5-fu),1
17358,3'-deoxy-3'-[18f]flt,1
17359,ercp (endoscopic retrograde cholangiopancreatography),1
17360,placebo (petroleum jelly),1
17361,personalized risk assessment,1
17362,ss-lar,1
17363,venapunction,1
17364,vagus nerve-preserving robot-assisted gastrectomy,1
17365,part 4a tpst-1120 + nivolumab,1
17366,medela thopaz thoracic drainage system,1
17367,stereotactic body radiotherapy-proton,1
17368,adaptive-planning organ localisation (a-polo) (planning ct scan),1
17369,khk2898,1
17370,mnsod,1
17371,fenretinide/lxs oral powder,1
17372,treatment level 2,1
17373,nigella sativa,1
17374,phone interview/questionnaire,1
17375,granulocyte colony-stimulating factor(g-csf),1
17376,high intensity counseling + varenicline + prn nrt,1
17377,kls martin mandibular reconstruction implant,1
17378,instanyl (intranasal fentanyl),1
17379,radiation plus erlotinib,1
17380,"rituximab, ifosfamide, carboplatin, vp-16, mesna, g-csf, stem cell transplant",1
17381,pet/ct and bh pet/ct,1
17382,tositumomab and iodine i-131 tositumomab,1
17383,systemic treatment + stereotactic body radio-therapy (sbrt),1
17384,perindopril or bisoprolol or placebo,1
17385,ceop/imvp-dexa chemotherapy,1
17386,cgc-11047 and bevacizumab,1
17387,"pemetrexed, cisplatin, bevacizumab",1
17388,multi-modality imaging,1
17389,prospective study,1
17390,standard dose acclerated fraction radiotherapy,1
17391,"docetaxel, cisplatin, fluorouracil, neulasta, or neupogen",1
17392,"oxaliplatin, capecitabine, gemcitabine, cetuximab",1
17393,"poly-iclc (hiltonol),",1
17394,zen meditation,1
17395,10 mg/kg tru-016 + rituximab,1
17396,anti-cd30-car t cells,1
17397,recombine endostatin,1
17398,chemort,1
17399,omega nutrition cold-milled flaxseeds,1
17400,ultrasonographic dermal thickness measurements,1
17401,autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine,1
17402,intra-peritoneal antibiotic lavage,1
17403,gc1008 human anti transforming growth factor _beta (tgf? ) monoclonal antibody,1
17404,clinician-directed prophylactic swallowing exercises,1
17405,lenvatinib + letrozole,1
17406,capecitabine oxaliplatin,1
17407,sentoclone®,1
17408,thoracoscopic pulmonary lobectomy,1
17409,clarithromycin and lenalidomide,1
17410,whole neck irradiation,1
17411,third generation car-t cells,1
17412,intermittent midazolam/propofol injection controlled by endoscopist,1
17413,neurocognitive and behavioral evaluation,1
17414,sabr treatment of lesions,1
17415,peritumoral adipose tissue sample,1
17416,follow-up healthcare provider assessment,1
17417,surgery to remove tumor for growth of til,1
17418,composite gel containing black raspberry,1
17419,enzalutamide 160mg daily (oral),1
17420,everolimus-placebo,1
17421,quality-of-life,1
17422,modified radical hysterectomy,1
17423,oral complex c3 curcumin + chemotherapy,1
17424,bf-200 ala 3%,1
17425,dmuc4064a,1
17426,velbe-bleomycin-cisplatin,1
17427,breath test- sampling using enose,1
17428,"docetaxel, carboplatin, bortezomib",1
17429,combined group,1
17430,standard surgical excision,1
17431,[18f]faza,1
17432,pankomab-gex™,1
17433,cx22,1
17434,3dcrt treatment (sequential boost),1
17435,photodynamic therapy using photosan and lumacare™ lamp model lc-122m,1
17436,abt-767,1
17437,preoperative ct angiography,1
17438,methylaminolevulinate cream,1
17439,degarelix 240 mg / 80 mg,1
17440,palbociclib isethionate,1
17441,double placebo,1
17442,ds-3032b,1
17443,cd19 car t,1
17444,integrative supportive care,1
17445,bms-986183,1
17446,adenosine stress test mri,1
17447,aldeslaukin,1
17448,cd19-specific t cell infusion,1
17449,two anti-angiogenesis drugs?endostar and thalidomide?,1
17450,whole abdomen irradiation using imrt,1
17451,"erbitux,merck serono",1
17452,tibetan yoga,1
17453,elacytarabine,1
17454,cryoballoon focal ablation system - 10 seconds,1
17455,robotic bronchoscopy platform,1
17456,seaweed,1
17457,c2 cryoballoon focal ablation system,1
17458,eus-guided fna performed without on-site cytopathologist,1
17459,skin flakes collection,1
17460,otme,1
17461,background hormonal therapy,1
17462,incb018424,1
17463,ibritumomab tiuxetan (zevalin®),1
17464,group 2: tk216,1
17465,22 gauge fine needle aspiration,1
17466,lipoderm cream base,1
17467,ny-eso-1 t cells,1
17468,phone counseling sessions,1
17469,afatinib 40mg once daily (od),1
17470,dose level 5 onc201 125mg,1
17471,pf03512676,1
17472,pain coping skills training,1
17473,stereotactic body radiation treatments,1
17474,codox-m,1
17475,fasciectomy,1
17476,stabilit® vertebral augmentation system,1
17477,"5-fluorouracil, levamisol, interferon",1
17478,prn1371,1
17479,placebo esbl eradication,1
17480,fluorodeoxyuridine,1
17481,alloreactive ctl,1
17482,give blood sample,1
17483,azacitidine combined to lenalidomide,1
17484,dedicated ultrasonographic probe during bronchoscopy,1
17485,3dv + tps / domestic accelerator,1
17486,dexamethasone (optimized retreatment),1
17487,oral contraceptive pill combination of ethyl estradiol and cyproterone acetate,1
17488,lead-in ridaforolimus,1
17489,111in-j591,1
17490,whole brain radiotherapy with volumetric arc therapy,1
17491,general anesthesia and local anesthesia,1
17492,calcium leucovorin,1
17493,5-azacitadine,1
17494,phenylephrine infusion,1
17495,over-the-scope clips,1
17496,lightpathtm imaging system,1
17497,docetaxel every 3 week in combination with capecitabine,1
17498,"""straight"" laparoscopic proctectomy",1
17499,single dose morphine,1
17500,5-days prophylactic cefazolin* antibiotic regimen,1
17501,physician counseling,1
17502,vvz-149 injections,1
17503,endoscopic ultrasound-fine needle biopsy,1
17504,dose-deescalated treatment,1
17505,qualms-1 questionnaire,1
17506,bi 907828,1
17507,tlk286 (telcyta) hcl for injection,1
17508,blood test for ctc evaluation,1
17509,dexamethason,1
17510,sb-as15 adjuvant,1
17511,rituximab plus temozolomide,1
17512,ultrasound-guided hepatectomy,1
17513,breast conserving surgery or mastectomy + snb/axillary dissection,1
17514,computed tomography of the chest,1
17515,eg scan ii (transnasal endoscopy),1
17516,som230 lar,1
17517,denosumab 60 mg,1
17518,"cyclophosphamide, vincristine, prednisone, dacarbazine",1
17519,"hpv 16/18 vaccine, 1.0ml",1
17520,tmz 150mg/m2 six 8-week cycles,1
17521,"epidoxorubicine, docetaxel, cyclophosphamide",1
17522,holistic education,1
17523,msb0011359c (m7824),1
17524,pamiparib,1
17525,myeloablative conditioning regimen,1
17526,feraheme®,1
17527,gp+ccrt,1
17528,pegylated interferon alpha-2b (pgi),1
17529,mr-guided single dose preoperative pbi,1
17530,evaluation of nutritional status,1
17531,3d mr fingerprinting scan,1
17532,nutrition/diet evaluation,1
17533,"epirubicin, cyclophosphamide, paclitaxel, carboplatin, g-csf",1
17534,morphine sulphate controlled release,1
17535,family history questionnaire (fhq),1
17536,indocyanine green (icg) image-guided surgery,1
17537,tem surgery,1
17538,durvalumab plus sbrt,1
17539,late stage,1
17540,targeted therapy based on molecular profiling : vemurafenib,1
17541,daily stereotactic body radiotherapy,1
17542,sham group,1
17543,injection of tvec into target lesions - week 1-2,1
17544,lumretuzumab,1
17545,111indium-cg250,1
17546,brimonidine tartrate 0.2%,1
17547,"thalidomide, alpha interferon",1
17548,hypertonic saline 3% bolus administration,1
17549,"v501, gardasil, quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine / duration of treatment : 4 years",1
17550,physical therapy and dynasplint,1
17551,leukemia profiling,1
17552,facial exercises,1
17553,velcade and rituximab,1
17554,cb transplantation,1
17555,"blood and tumor tissue analysis, clinical response.",1
17556,"doxorubicin, ifosfamide, cisplatin",1
17557,axillary radiotherapy,1
17558,stellate ganglion block with ropivacaine 0.2% 5 ml,1
17559,bb-mpi-03,1
17560,one cycle tpf induction chemotherapy for npc,1
17561,multiple pet/mri with gallium-68 labeled psma-hbed-cc,1
17562,[18-f]- fdg - pet,1
17563,experimental: mentored gardening intervention,1
17564,prevnar-13,1
17565,phase i: glembatumumab vedotin,1
17566,short term psychotherapy,1
17567,voreloxin injection and cytarabine,1
17568,cognitive behavioral mult-symptom management(cbt),1
17569,wound infiltration with drug p (placebo),1
17570,conventional fractionated intensity modulated radiotherapy,1
17571,"ontak (denileukin diftitox, dab389 il-2)",1
17572,super-selective intraarterial intracranial infusion of temozolomide,1
17573,digital rectal examination,1
17574,amoxicillin/clavulanic acid suspension,1
17575,apc-100,1
17576,roux-en-y reconstruction,1
17577,urinary and blood sample for cystaine dosage,1
17578,vehicle of las41007,1
17579,sleep-related disturbances (exposure),1
17580,gemcitabine/fluorouracil with external beam radiation,1
17581,"ibandronate, capecitabine",1
17582,clown theatrical performance,1
17583,bluetooth-enabled activity monitor,1
17584,anti-gd2 cart,1
17585,minimal stimulation ivf,1
17586,altcar.cd30 cells,1
17587,chemotherapy without cisplatine,1
17588,headspace analysis for biological material,1
17589,internet peer-support group,1
17590,combination of nktr-214 + nivolumab + ipilimumab,1
17591,autonomic function tests,1
17592,abraxane + tigatuzumab,1
17593,treatment vincristin,1
17594,3f8 monoclonal antibody and 13-cis-retinoic acid,1
17595,chemotherapy: dexa-beam,1
17596,icg+methylene blue,1
17597,arm a: folfiri or folfox + bevacizumab,1
17598,eye removal,1
17599,fixed-dose combination of capecitabine and cyclophosphamide sar439281,1
17600,health measurements,1
17601,hdr,1
17602,methyprednisolone,1
17603,leukapheresis #2,1
17604,vitamin b12 and folic acid,1
17605,oncovir poly ic:lc,1
17606,"tbi, thiotepa, cyclophosphamide, atg",1
17607,stationary carbon nanotube x-ray digital breast tomosynthesis scanner,1
17608,progel pleural air leak sealant,1
17609,messenger text message reminder,1
17610,"fec (fluorouracil, epirubicin, cyclophosphamide) + filgrastim + paclitaxel",1
17611,16-week exercise training program,1
17612,sorbolene,1
17613,ag-221 (baml-16-001-s3),1
17614,"propranolol, etodolac",1
17615,intrathecal t-cells,1
17616,langer mindfulness scale (lms),1
17617,immunization schedule patients <7 years.,1
17618,nitrogen,1
17619,bls_ilb_710c 1000mg,1
17620,mlf 541,1
17621,transplant 1 and 2 pegfilgrastim,1
17622,mind-body intervention,1
17623,bay1841788 (odm-201),1
17624,telmisartan,1
17625,pet-ct scans supplemented with 11c-choline tracer,1
17626,antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant),1
17627,"endoxana, leukine, ima910",1
17628,"l-asparaginase, erwinia asparaginase",1
17629,visits with a supportive care clinician,1
17630,bsi-201 + gemcitabine,1
17631,pet/ct scan and eus,1
17632,endostar -continued pumping into+gp,1
17633,biopsy (metastatic),1
17634,post radiotherapy commencement of anastrozole,1
17635,cyclosporine (csp),1
17636,physician feedback letter,1
17637,tegafur/gimeracil/oteracil potassium (s-1),1
17638,gadovist®/gadavist®,1
17639,no intervention. applying gene profiling on needle aspirates,1
17640,non-invasive transcranial direct current stimulation (tdcs),1
17641,zileuton (zyflo®) dasatinib (sprycel®),1
17642,anti-lymphocyte globulin,1
17643,3d shear wave elastography (swe),1
17644,"lenalidomide, dexamethasone, pbsct",1
17645,nutrition plus exercise,1
17646,radium-223 and enzalutamide,1
17647,sphenopalatine block with local anesthetic,1
17648,recombinant vesicular stomatitis virus-expressing interferon-beta and tyrosinase related protein 1,1
17649,transplant preparative regimen (flu/cy/mes),1
17650,litebook edge (experimental),1
17651,breast reconstruction- implant + dermal sling/ld flap,1
17652,stereotactic body radiotherapy (sbrt) 30 gy 3 fractions (#),1
17653,gwdp,1
17654,abt-751 and carboplatin,1
17655,"gadoxetic acid disodium (eovist, bay86-4873)",1
17656,oncoplastic approach excisional breast biopsy,1
17657,sparc-08-038,1
17658,cyclophosphamide 1g/m^2,1
17659,ofatumumab/hdmp,1
17660,excision,1
17661,sirolimus and hydroxychloroquine,1
17662,technology-based physical activity promotion,1
17663,"stem cell transplantation, hematopoietic",1
17664,breathing test,1
17665,placebo matching zd6474,1
17666,spanish-language self-administered training plus usual care (sl-sat),1
17667,sirolimus (sir),1
17668,3 week rt,1
17669,anti-lag-3 antibody,1
17670,thymoquinone 200mg,1
17671,culture specific,1
17672,zirconium zr-89 panitumumab,1
17673,external-beam radiotherapy,1
17674,3-4 diaminopyridine,1
17675,herceptin iv [trastuzumab],1
17676,mantle irradiation,1
17677,web-based questionnaire,1
17678,single-port laparoscopic myomectomy,1
17679,flac chemotherapy with gm-csf,1
17680,thoracolaparoscopic esophagectomy,1
17681,radiation therapy and temozolomide,1
17682,quadrivalent human papillomavirus vaccine delayed administration,1
17683,lung sound transmission measurement,1
17684,prv111 (cisplatin transmucosal system),1
17685,liocyx,1
17686,nutritional intervention with the ketogenic diet,1
17687,active pain management,1
17688,"aspirin (acetylsalicylic acid, baye4465)",1
17689,flucytosine (5-fc),1
17690,real-time contrast-enhanced ultrasound sonography,1
17691,egfrbi-armed autologous t cells,1
17692,"psychometric tests, questionnaires and neurocognitive assessments",1
17693,"cp-609,754",1
17694,cyclophosphamide + fludarabine lymphodepletive conditioning,1
17695,conventionally fractionated imrt,1
17696,fimaporfin (photosensitizer),1
17697,"taxane, avastin, xeloda",1
17698,accelerated partial breast irradiation - imrt planning,1
17699,lenalidomide (revlimid) and romidepsin (istodax),1
17700,"bone graft substitute, autograft or allograft",1
17701,facing forward booklet,1
17702,pet/ct(3hours],1
17703,radiofrequency generator,1
17704,"volasertib, low dose, d1q3w",1
17705,oto-104,1
17706,ketorolac tromethamine and remote ischemic preconditioning,1
17707,mobile health quality of life assessements,1
17708,xl418,1
17709,adult differentiated autologous t-cells,1
17710,pet/ct with gallium-68 labeled psma-hbed-cc,1
17711,qt ultrasound,1
17712,ablative,1
17713,bevacizumab and temozolomide and radiotherapy,1
17714,smartpill,1
17715,anti pd1/pdl1 treatment,1
17716,mab-425,1
17717,first questionnaire application,1
17718,"questionnaires every 6 weeks (t0, t1, t2, t3 and t4)",1
17719,intake anthocyanin-rich corn extract,1
17720,alpha-gal glycosphingolipid,1
17721,"home delivered, medically tailored meals (hdtm)",1
17722,selumetinib+docetaxel,1
17723,magnetic tracking system (mts) and radio-opaque markers,1
17724,combination of arixtra with chemotherapy,1
17725,"questionnaires, telephone interview, optional blood drawn",1
17726,prednisone (or equivalent),1
17727,mesenchymal stromal cells,1
17728,dc/apo-nec,1
17729,vpa,1
17730,kit for self-collected vaginal sample,1
17731,diclofenac na gel,1
17732,induction/consolidation etoposide,1
17733,filgrastim prefilled syringe [zarzio®],1
17734,cognitive-behavioral stress management,1
17735,gsk3359609 (icos agonist),1
17736,power-remote,1
17737,brief behavioral therapy,1
17738,ipi 504 plus docetaxel,1
17739,stem cell re-infusion,1
17740,intracostal suture technique,1
17741,monoclonal antibody mono-dga-rfb4,1
17742,lifestyle modification in routine care of patients,1
17743,omega-3 pufa,1
17744,f18-ffnp,1
17745,cisplatin/capecitabine,1
17746,cdx-3379 (erbb3 antibody),1
17747,injections subcutaneously talazoparib,1
17748,yttrium-90 radioactive resin microspheres,1
17749,nanosomal docetaxel lipid suspension,1
17750,tgfbeta resistant lmp-specific ctls,1
17751,collection of biological samples,1
17752,excision/division/release of palmar fascia,1
17753,briciclib,1
17754,ptx-9908 injection,1
17755,peptide-nucleic acid solution avr118,1
17756,romidepsin + chop,1
17757,pd-1 and dc-nk cells,1
17758,"imiquimod cream, 5%",1
17759,return of results conversation,1
17760,nurse-led consultation,1
17761,interviews and clinic visit,1
17762,azacitidine (aza),1
17763,gemigliptin,1
17764,aerobic training - flexible schedule,1
17765,"nab-paclitaxel, 100mg/m^2",1
17766,therapeutic assessment -radio-surgical guidance.,1
17767,"biopsies, blood and urine samples",1
17768,combination therapy,1
17769,permanent section control,1
17770,split bolus dual energy ct,1
17771,doxorubicin followed by paclitaxel,1
17772,saliva or blood sample collection,1
17773,iknife i.e. rapid evaporative ionisation mass spectrometry,1
17774,zactima,1
17775,isoperistaltic billroth ii + braun anastomosis,1
17776,0.25% bupivacaine,1
17777,"ipilimumab, nivolumab or pembrolizumab",1
17778,standard prostate cancer education presentation,1
17779,radiotherapy planning using both ct and mri scans,1
17780,nir imaging with flare and mini-flare imaging system,1
17781,carotid intima-media thickening ultrasound,1
17782,"oxaliplatin, folinic acid, fluorouracil",1
17783,usual and customary group (u&c),1
17784,"gemcitabine, cisplatin, capecitabine",1
17785,nab-paclitaxel (paclitaxel-albumin) + carboplatin,1
17786,"hormonal treatment (tamoxifen, exemestane, anastrozole or letrozole)",1
17787,everolimus and intravesical gemcitabine,1
17788,ethinyl estradiol/levonorgestrel,1
17789,75mg selumetinib,1
17790,"radiotherapy 70 gy, 35 fractions",1
17791,anti-ctla-4/pd-1 expressing egfr-car-t,1
17792,compact discs (cd's) + printed materials,1
17793,nursing educational intervention,1
17794,research scan for gradient-echo spectroscopic imaging (gsi),1
17795,stereotactic radiotherapy (srs),1
17796,cyberknife boost 18 gy,1
17797,indoximod 600mg,1
17798,limited malignancy screening,1
17799,home environs-based lifestyle counseling,1
17800,classic v high-frequency electrocoagulation,1
17801,mk6592,1
17802,axitinib: observational study,1
17803,anp therapy,1
17804,virus specific t-cell (vst) infusion,1
17805,til-ad-infg,1
17806,cancer-directed therapy or best supportive care,1
17807,omega-3 polyunsaturated fatty acids,1
17808,ibi301 plus chop,1
17809,cd8-depleted pbsc after nonmyeloablative conditioning,1
17810,electromagnetic guided bronchoscopic radioactive labelling,1
17811,anti-cd19-car transduced t cells,1
17812,anti-cd33-car-transduced t cells,1
17813,j pouch,1
17814,patient derived cd171 specific car t cells expressing egfrt (3rd generation t cells),1
17815,forticare,1
17816,oleum neutralicum,1
17817,tobramycin once a day,1
17818,multicycle ss1p,1
17819,3dimensional mammography,1
17820,cefazolin sodium,1
17821,hypofractionated dose escalated vmat,1
17822,biliary drainage,1
17823,stretching program,1
17824,a classic stratified tool,1
17825,coronary ct assessment,1
17826,magnesium sulfate (mgso),1
17827,additional rmis,1
17828,lung ct,1
17829,preoperative treatment with carbohydrates,1
17830,"bevacizumab, cisplatin, cetuximab, radiation therapy",1
17831,combined treatment,1
17832,pelvic sabr with intra-prostatic sabr,1
17833,sbrt 42.5 gy,1
17834,ly3076226,1
17835,academic detailing (medical practices)+decision aids (patients),1
17836,standard anaesthesia (bupivacaine),1
17837,palonosetron (palo),1
17838,compound 2055269,1
17839,pasireotide lon acting release formulation,1
17840,krdd only,1
17841,concurrent chemoradiotherapy with 5-fu/cf,1
17842,percutaneous aponeurotomy,1
17843,esmart-mh,1
17844,education about sun protection,1
17845,ibrutinib 840 mg,1
17846,s-1 & oxaliplatin,1
17847,pet scan in addition to conventional ct imaging,1
17848,interpheron alpha,1
17849,diet and antismoking advice,1
17850,tositumomab and iodine i 131 tositumomab (anti-b1 antibody),1
17851,lateral decubitus positioning,1
17852,age of patient,1
17853,hydrocodone/acetaminophen 5 mg-325 mg oral tablet,1
17854,afatinib 40mg tab,1
17855,eus with fiducial,1
17856,standard surgical treatment,1
17857,ious - siemens anteras,1
17858,gefitinib and placebo,1
17859,azd1775 placebo,1
17860,5-azacytidin,1
17861,filanesib,1
17862,cease,1
17863,bevacizumab + capecitabine + radiotherapy,1
17864,fat grafting,1
17865,gdp,1
17866,folforinox,1
17867,90y-dota-epratuzumab igg/epratuzumab igg,1
17868,"sunitinib, chemotherapy",1
17869,intralipid 20%,1
17870,blood sample draw,1
17871,smoking cessation treatment plus health education,1
17872,pancreatoduodenectomy,1
17873,radiotherapy weekly verification standard safety margins,1
17874,visicoil gold marker 0.7 x 20 mm,1
17875,anti-egfr-il-dox,1
17876,braf v600e mutation by pyrosequencing technique,1
17877,bgb-3111 and obinutuzumab,1
17878,dedicated and coordinated e-follow-up.,1
17879,computed tomography angiography (cta),1
17880,invitation for breast screening,1
17881,ro5458640,1
17882,dual inspection colonoscopy,1
17883,photon therapy (radiation therapy),1
17884,placebo for nivolumab,1
17885,radium bromatum/apis mellifica/belladonna placebo pills,1
17886,oral propranolol,1
17887,dose dense abvd,1
17888,r-mnhl-bfm-90 + auto-sct,1
17889,on 01910.na and oxaliplatin,1
17890,mindfulness body scan,1
17891,targeted radiotherapy,1
17892,nuc-1031 750mg,1
17893,semi-controlled intervention with other animal proteins,1
17894,bushen-jianpi dedoction,1
17895,"hycamtin, oral capsules",1
17896,provider unrelieved symptom alert,1
17897,placement of double bare stent,1
17898,nov 002,1
17899,50 µg doxorubicin-containing mna,1
17900,myeloma immunoglobulin idiotype vaccine,1
17901,xmt-1522,1
17902,anti-cd19-car,1
17903,pimasertib capsule (part b and trial extension phase),1
17904,fucosylated regulatory t cells,1
17905,tgfa-pe38 immunotoxin,1
17906,hydroxyurea capsules,1
17907,early recovery,1
17908,gemcitabine nab-paclitaxel,1
17909,gsk3359609 iv infusion,1
17910,pulsed electromagnetic field therapy,1
17911,sm-aet,1
17912,tti-622 + rituximab,1
17913,durvalumab plus olaparib,1
17914,"nerofe is a first in class derivative of a human hormon-peptide(tcapf), with cancer suppressive properties.",1
17915,"melphalan, endoxan, dexamethasone (mcdex)",1
17916,high dose therapy and autologous stem cell transplantation,1
17917,procedure - adoptive cell transfer,1
17918,recombinant nonpathogenic polio-rhinovirus chimera (pvsripo),1
17919,cxbladder,1
17920,lonafarnib (sarasar),1
17921,depatuxizumab mafodotin,1
17922,home-based self-assisted exercise program,1
17923,part 1: daratumumab,1
17924,microdermabrasion,1
17925,"paclitaxel poliglumex, pemetrexed",1
17926,tetmyb vaccine,1
17927,bevacizumab and temozolomide,1
17928,durvalumab + olaparib combination therapy,1
17929,fentanyl in epidural catheter,1
17930,contigen,1
17931,liver preparation before major hepatectomy,1
17932,bolus,1
17933,flot + herceptin/pertuzumab,1
17934,45 gy/25 fractions,1
17935,clofarabine for remission induction,1
17936,2l peg+simethicone,1
17937,re-irradiation with sbrt,1
17938,cisplatin administered intraoperatively as hyperthermic intraperitoneal chemoperfusion,1
17939,intratumoral dendritic cell immunotherapy,1
17940,nanoliposomal cpt-11,1
17941,"pemetrexed, carboplatin, sorafenib",1
17942,ren-1654,1
17943,surgery complications,1
17944,swallowing exercise group,1
17945,pk button vaporization electrode in transurethral resection of bladder tumors,1
17946,autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine,1
17947,pre-stem cell infusion mesna,1
17948,"daratumumab, dexamethasone, ixazomib, pomalidomide",1
17949,"urlc10, ttk and koc1",1
17950,"fluorouracil, epirubicin, cyclophosphamide, docetaxel",1
17951,homeopathic treatment,1
17952,ex-vivo umbilical cord blood expansion,1
17953,gsk3145095,1
17954,abnoba viscum f 20mg,1
17955,fluoro-d-glucose,1
17956,pazopanib monotherapy,1
17957,video-assisted thoracic surgery (vats) wedge resection,1
17958,mobility tracker,1
17959,arm1: statin,1
17960,gemcitabine and lapatinib,1
17961,"talimogene laherparepvec 1 million pfu/ml inj,susp,1ml,vil",1
17962,elemene,1
17963,ly3009120 capsule,1
17964,dietary soy,1
17965,rapamycin dosage,1
17966,gemcitabine neoadjuvant,1
17967,tadalafil placebo,1
17968,"vorinostat, gefitinib",1
17969,metastatic breast cancer,1
17970,cryoablation / cryotherapy,1
17971,hydrocortisone in induction,1
17972,autologous cik dose level 3,1
17973,part a - avelumab,1
17974,experimental: moderate to high-intensity exercise,1
17975,il-2 (interleukin-2),1
17976,bladder epicheck,1
17977,minimally-invasive gastrectomy,1
17978,needle based confocal laser endomicroscopy (ncle),1
17979,darbepoetin alpha,1
17980,tissue sample (procedure/screening),1
17981,nivolumab 3 mg/kg iv q2 weeks,1
17982,prospective intervention,1
17983,liraglutide for 26 weeks,1
17984,trovax in combination with il-2,1
17985,jojoba aromatherapy,1
17986,"aromatase inhibitors (letrozole, anastrozole)",1
17987,hemospan (mp4ox),1
17988,preoperative preparation 2010,1
17989,innohep,1
17990,hypo fractionated irradiation,1
17991,pleural elastance,1
17992,plasti-med oxygen therapy mask,1
17993,tegafur and temozolomide combined with thalidomide,1
17994,will look for immune infiltration,1
17995,azd0156,1
17996,totally laparoscopic distal gastrectomy,1
17997,pretend reiki,1
17998,ct scan guide percutaneous biopsy of lytic bone metastases of lung cancer,1
17999,laser interstitial thermotherapy (litt),1
18000,tri-incision,1
18001,part 2: decitabine 10mg/m2,1
18002,imc-20d7s (cohort 3a ),1
18003,preservation of denonvilliers fascia,1
18004,msc-plga,1
18005,imatinib mesilate (glivec),1
18006,expander prosthesis,1
18007,tvi-brain-1,1
18008,bipolar transurethral standard resection,1
18009,live education and exercise instruction,1
18010,"bevacizumab, oxaliplatin and raltitrexed combination",1
18011,yoga questionnaire,1
18012,lobradimil,1
18013,ms-533,1
18014,genetic study of dna copies,1
18015,etoposide injection plus methotrexate injection,1
18016,"chemotherapy, radiation therapy & surgery",1
18017,lxs196,1
18018,"total body irradiation (tbi) 200cgy twice a day on days -3, -2, -1",1
18019,yttrium y 90 daclizumab,1
18020,ca-170,1
18021,black raspberry (brb) slurry,1
18022,placebo administration.,1
18023,salvage radiotherapy srt,1
18024,ca and nivolumab,1
18025,pro-self plus pain management program,1
18026,positron emission tomography computed tomography (pet/ct),1
18027,alclometasone cream,1
18028,sham recruitment maneuver,1
18029,handheld device (smart phone),1
18030,ropinirole,1
18031,loft therapy,1
18032,lactofos,1
18033,corynebacterium granulosum p40,1
18034,robot assisted distal gastrectomy (davinci),1
18035,"tarceva (erlotinib hcl, osi-774)",1
18036,5- fluorouracil (5-fu),1
18037,oxaliplatin and gemcitabine,1
18038,reciva breath sampler,1
18039,peri-operative cht + post-operative cht-rtx,1
18040,core biopsy/cryoablation,1
18041,forodesine 200 mg,1
18042,conventional excisional breast biopsy,1
18043,antimitotic agent,1
18044,we will screen potential agencies using our call script and our agency screener,1
18045,gnrha + gonadotropins,1
18046,bibf 1120 l + pemetrexed,1
18047,crixotinib 250 mg and sunitinib cohort 2,1
18048,fact/gog-ntx questionnaire,1
18049,ae37 + gm-csf vaccine,1
18050,conventional hand-stitching colostomy,1
18051,confocal microscopy in vivo,1
18052,miltenvi clinimacs cd34 reagent system,1
18053,genomic markers,1
18054,tarceva 100mg tablet,1
18055,remote ischaemic preconditioning,1
18056,sbpt (stereotactic body proton therapy),1
18057,3g mtx,1
18058,usability of an electronic symptom management application,1
18059,duk-cpg-001,1
18060,ious-guided intrahepatic vessel compression,1
18061,cell search® ctc epithelial kit,1
18062,treated recommended,1
18063,comparator: octavalent hpv vaccine - dose formulation 3,1
18064,epoetin alfa 450 iu/kg once a week (qw),1
18065,remission consultation,1
18066,ciclosporine,1
18067,vinorelbine tartrate / g-csf,1
18068,ulnt 1 and emg recording,1
18069,plx51107,1
18070,interferon-alfa,1
18071,jak2 inhibitor wp1066,1
18072,gist registry,1
18073,etc-1907206,1
18074,rx-5902,1
18075,organic disorders,1
18076,and diet,1
18077,haploidentical transplantation of hematopoietic progenitors,1
18078,alpha folate receptor expression test,1
18079,bethanechol,1
18080,"full intensity, double umbilical cord, stem cell transplant",1
18081,blumgart anastomosis,1
18082,green tea polyphenon e,1
18083,188re-sss lipiodol,1
18084,rabeprazole sodium,1
18085,induction chemotherapy using pf (5-fluorouracil),1
18086,shared decision-making for psa screening tool,1
18087,radio(chemo)therapy,1
18088,mr perfusion scan,1
18089,blu-u blue light photodynamic therapy illuminator,1
18090,wellness contact control,1
18091,daunorubicin in induction,1
18092,acz885,1
18093,"durvalumab, tremelilumab, medi 9447, medi 0562",1
18094,patient derived cd171 specific car t cells expressing egfrt (long spacer 2nd generation t cells),1
18095,dp,1
18096,tyrosinase-related protein-1,1
18097,data record,1
18098,citric acid,1
18099,ps,1
18100,delta-shaped anastomosis,1
18101,no intervention : measure of score,1
18102,arimidex (anastrozole),1
18103,ro5217790,1
18104,dynamic susceptibility contrast magnetic resonance imaging,1
18105,eras protocol postoperative actions,1
18106,colonoscopy with indigo-carmine chromoendoscopy,1
18107,advanced magnetic resonance imaging scan,1
18108,skin-oriented spa care,1
18109,unenhanced magnetic resonance imaging.,1
18110,trifluridine and tipiracil tas-102,1
18111,pepsinogen and gastrin,1
18112,double cord blood transplantation,1
18113,synchronous resection of primary pancreatic cancer and liver oligometastasis,1
18114,delay procedure of siea flap.,1
18115,combi tep : pet / enhanced ct scan,1
18116,soc-directed biopsies using the spyglass system,1
18117,capecitabine/cisplatin + sorafenib,1
18118,18f mel050,1
18119,"realisation of blood sample, urinary sample and tumor biopsy",1
18120,serum progesterone on day 21,1
18121,gr-md-02,1
18122,uridine 5'-triphosphate (utp) solution for inhalation,1
18123,blood samples (biomarkers),1
18124,autologous csr t,1
18125,car-t combined with pd-1 knockout t cells,1
18126,vincristin,1
18127,"intensified cyclophophamide, carboplatin and thiotepa",1
18128,intravenous pca only,1
18129,mva-ebna1/lmp2 vaccine,1
18130,radiation by brachytherapy,1
18131,self-management intervention,1
18132,standard chemo- or endocrine therapy,1
18133,b: pdc vaccination,1
18134,biopsy and resection,1
18135,varenicline plus motivational interviewing counseling,1
18136,"escalation cohort: regorafenib (stivarga, bay73-4506) 140 mg",1
18137,"gemcitabine, folinic acid, 5-fu",1
18138,eras pathway for total mastectomy,1
18139,hyalo-gyn,1
18140,undefined (standard care),1
18141,paclitaxel 200 mg/m^2 plus carboplatin auc 4-6 mg/ml per minute iv infusion,1
18142,exercise and body composition test,1
18143,"gw786034, iv",1
18144,temozolomide (for relapsed malignant glioma),1
18145,postoperative radiotherapy program,1
18146,homeodent®,1
18147,interferon-alpha (ifn-alpha),1
18148,sugar-free chewing gum,1
18149,lymphoid radiation,1
18150,lovastatin 60 mg,1
18151,standard adjuvant local radiation therapy or cranial radiation therapy,1
18152,laparoscopic ovarian transposition,1
18153,fentanyl- ketorolac,1
18154,"cabazitaxel, docetaxel, mitoxantrone or satraplatin",1
18155,amg 224,1
18156,immu 130,1
18157,radiation (3 days),1
18158,withdrawal of antiandrogen therapy,1
18159,blood drawn for pharmacokinetic measures,1
18160,fec-doc adjuvant chemotherapy,1
18161,pladd,1
18162,qigong mind-body exercise,1
18163,temozolomide and su11248,1
18164,nilotinib+ad induction,1
18165,erivedge,1
18166,osteocalcin,1
18167,oral nutrition with dextrose and pressurized whey protein,1
18168,immediate diet and exercise intervention,1
18169,lasofoxifene,1
18170,ferro sanol,1
18171,lenalidomide or pomalidomide,1
18172,beep regimen,1
18173,oophrectomy,1
18174,lhrh agonists (goserelin acetate),1
18175,paclitaxel loaded polymeric micelle,1
18176,codox-m/ivac,1
18177,tranversus abdominis plane block,1
18178,"no intervention, this is an observational study",1
18179,polatuzumab vedotin (lyophilized),1
18180,idiotype vaccine,1
18181,gclq lymphedema symptom assessment questionnaire,1
18182,stapler,1
18183,x-ray placement,1
18184,axillary magseed,1
18185,vintafolide iv infusion,1
18186,discovering novel risk factors.,1
18187,facing forward,1
18188,cti/siemens biograph 40 pet/ct scanner,1
18189,pembrolizumab 3 mg/kg,1
18190,aesthetic care,1
18191,prostatic boost in brachytherapy with high dose rate (hdr),1
18192,rfa vertebroplasty,1
18193,e7449 alone,1
18194,nanoxel (paclitaxel nanoparticle formulation ),1
18195,blac,1
18196,therasphere® yttrium-90 (y-90) microspheres,1
18197,high dose melphalan therapy and autologous stem cell transplant (intensive pathway only),1
18198,gemcitabine / cisplatin,1
18199,ultrasound guided injection,1
18200,act-d,1
18201,"neuropsychological assessment, mri",1
18202,abt-888 20 mg x 21 days,1
18203,lapatinib and capecitabine and vinorelbine,1
18204,robotic distal gastrectomy with d2 nodal dissection,1
18205,therapeutic conventional therapy,1
18206,"bendamustine, velcade and dexamethasone",1
18207,"combined use of azacitidine, valproic acid, hydroxurea and eventually donor leukocyte infusions.",1
18208,jinfukang koufuye,1
18209,131i-tenatumomab,1
18210,hr-mri,1
18211,hydroxychloroquine (hc),1
18212,ct or mri,1
18213,multispectral ct of the liver,1
18214,maintenance with metronomic oral vinorelbine,1
18215,exodx prostate (intelliscore),1
18216,placebo: saline,1
18217,mri machine,1
18218,"quadrivalent hpv (types 6,11,16,18) l1 vlp vaccine 40/40/40/40",1
18219,3d conformational radiation,1
18220,blood or stool samples will be collected,1
18221,asp9853,1
18222,zero ischemia robot-assisted laparoscopic rfa assisted te,1
18223,reflexology procedure,1
18224,chw and self-sampling for cervical cancer,1
18225,nvn1000 24%,1
18226,acp conversation,1
18227,microneedle roller,1
18228,goal setting plus coping intentions,1
18229,cd-rom-based prostate ca treatment education+decision tools,1
18230,pedometer walking program,1
18231,rrx-001 + eloop device,1
18232,"apatinib, etoposide",1
18233,cgc-11047 and erlotinib,1
18234,"rituximab, bendamustine, cytarabine",1
18235,myeloma patient outcome scale (mypos),1
18236,nivolumab 360mg,1
18237,donor il-15 stimulated nk cells infusion,1
18238,"pembrolizumab, bevacizumab, and binimetinib",1
18239,rifampin 600 mg od,1
18240,st1968,1
18241,parenteral chemotherapy,1
18242,car™ 27,1
18243,v503 vaccine,1
18244,balm arm,1
18245,autologous tumor infiltrating lymphocytes mda-til,1
18246,interstitial brachytherapy,1
18247,pencil beam scanning radiation,1
18248,interactive computer intervention,1
18249,early physical therapy plus educational strategy,1
18250,ultrasonic elastography,1
18251,reduced-exertion high-intensity interval training,1
18252,carboplatin (auc 5),1
18253,prehabilitation + eras,1
18254,intervionnal,1
18255,-oxaliplatin 85 mg/m2 iv on day 1,1
18256,morab-202,1
18257,pwo,1
18258,stereotactic ablative body radiotherapy,1
18259,pd-0332991 (palbociclib),1
18260,omaveloxolone capsules (2.5 mg/capsule),1
18261,other: not applicable - observational study,1
18262,vesanoid,1
18263,health newsletter,1
18264,chemotherapy with or without radiotherapy,1
18265,"metformin, exenatide or combined (metformin & exenatide )",1
18266,recombinant human apo-2 ligand for injection,1
18267,technetium tc 99m demobesin-4,1
18268,clinical trial educational video,1
18269,sti571 (glivec®),1
18270,tbi-1201,1
18271,fluorine-18-labeled fluoro-misonidazole positron emission,1
18272,rrx-001 dose escalation with tmz + rt,1
18273,arimidex dummy,1
18274,rh il-15,1
18275,physical exercise and dyspnoea counseling,1
18276,observer nodule detection,1
18277,docetaxel + prednisone* + zoledronic acid,1
18278,induction chemotherapy with gemcitabine or folfirinox,1
18279,fine needle biopsy,1
18280,acessa procedure,1
18281,gemcitabine and pazopanib,1
18282,imaging investigations (with radiation),1
18283,genetic expression,1
18284,reactive skin treatment,1
18285,xmt-1001,1
18286,curate.ai-guided dosage modulation,1
18287,bupivacaine block,1
18288,nice classification,1
18289,biomega sda®,1
18290,radiographic surveillance,1
18291,qutenza,1
18292,collection of human samples,1
18293,adcucd40l,1
18294,complete embolization,1
18295,lci699 matching placebo,1
18296,regional anesthesia and analgesia,1
18297,video-c,1
18298,trc253,1
18299,peak airway pressure,1
18300,bms-986179,1
18301,10 gy low-kv iort,1
18302,device: ipad,1
18303,incb062079,1
18304,sevi-d (seviteronel in combination with dexamthasone),1
18305,transarterial radioembolization (tare),1
18306,nucleoside analog (suggest to use entecavir),1
18307,itv depocyt + temozolomide,1
18308,indium in-111 pentetreotide,1
18309,classical lymphadenectomy,1
18310,docetaxel + sunitinib,1
18311,gastroduodenal stent placement,1
18312,emd 1204831,1
18313,neoadjuvant oxaliplatin,1
18314,5-alpha reductase inhibitors,1
18315,edmonton symptom assessment scale,1
18316,penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site,1
18317,methyl testosterone,1
18318,mk-2206 combined with erlotinib,1
18319,curettage and cautery,1
18320,radiotherapy to the pelvis,1
18321,chop administration,1
18322,expanded prostate cancer index composite sf-12,1
18323,nimesulide,1
18324,"questionnaires, oncotype dx assay",1
18325,alpelisib (byl719),1
18326,cal-101,1
18327,sunitinib 37.5 mg [sutent],1
18328,targeted therapy based on molecular profiling : sorafenib,1
18329,sar439459,1
18330,transplant 1 cyclophosphamide,1
18331,standard transrectal ultrasound (trus) guided biopsy,1
18332,mfolfoxiri,1
18333,anti-meso-car vector transduced t cells,1
18334,peer-led,1
18335,fermented soy,1
18336,r-chop or r-bendamustine,1
18337,umbilical cord blood-derived natural killer cells,1
18338,lifestyle physical activity,1
18339,eus enhanced with contrast to evaluate pancreas,1
18340,care coordination tool,1
18341,anthracycline/dexamethasone-based induction chemotherapy,1
18342,faslodex 500mg,1
18343,part-trial,1
18344,fostamatinib and paclitaxel,1
18345,direct surgery for acromegaly,1
18346,"ifosfamide, carboplatin, and etoposide (ice) regimen",1
18347,"ifosfamide, gemcitabine, vinorelbine",1
18348,cabazitaxel chemotherapy,1
18349,standardized 400kcal semi-liquid meal,1
18350,ultrasound-guided tpvb,1
18351,couple-based cbt intervention,1
18352,nurse practitioner,1
18353,chest wall motion analysis,1
18354,no headphones,1
18355,jin fu kang,1
18356,"liquidbiopsy®, nk vuetm",1
18357,transgenic lymphocyte immunization vaccine (tli),1
18358,laparoscopic d1 lymphadenectomy,1
18359,cisplatin-based neoadjuvant chemotherapy,1
18360,selatinib ditosilate tablets,1
18361,the p1 check-cap capsule,1
18362,acupressure,1
18363,"ixabepilone, 40 mg/m^2 + bevacizumab, 15 mg/kg",1
18364,unilateral metal stent insertion,1
18365,(nab)-paclitaxel,1
18366,controlled ovarian hyperstimulation for ivf with a long agonist protocol,1
18367,pectoral nerve block,1
18368,vitamin d and calcium citrate,1
18369,digestive tract reconstruction,1
18370,transcutaneous electrical nerve stimulation (tens),1
18371,ethacrynic acid,1
18372,automated reminder plus script,1
18373,arm a: adapted physical activity + enhanced geriatric follow-up,1
18374,diagnostic tomosynthesis,1
18375,"fmri scan, pre- and post language evaluation",1
18376,amg 102 and erlotinib,1
18377,optical coherence tomography (oct) with skintell,1
18378,cord blood-derived expanded allogeneic natural killer cells,1
18379,her-2 vaccine,1
18380,allogeneic umbilical cord mesenchymal stem cells,1
18381,combig-dc (ilixadencel),1
18382,sentinel node procedure under general anaesthesia,1
18383,antiandrogen+docetaxel,1
18384,pcv chemotherapy alone,1
18385,biopsy: measurement of histone gamma h2ax phosphorylation,1
18386,letrozole + gonadotropins,1
18387,pleural biopsy,1
18388,fenofibric acid,1
18389,algrx 4975,1
18390,prudent diet (pd),1
18391,conventional feeding,1
18392,trientine mtd,1
18393,postoperative chemotherapy with mfolfox6 or capox regimens,1
18394,4 mg oral pom + 40 mg oral dex,1
18395,placebo + cetuximab + folfiri,1
18396,stereotactic radiotherapy 5 x 8 gy,1
18397,exrecise intervention,1
18398,pegfilgrastim (drug),1
18399,panobinostat (capsules),1
18400,non-prophylactic,1
18401,ag-120 (baml-16-001-s16),1
18402,non-surgical treatment,1
18403,ei or m-api regimen depending on patient age,1
18404,egfr806-specific chimeric antigen receptor (car) t cell,1
18405,restored kidney transplant between third parties,1
18406,laparoscopic surgery for rectal carcinoma,1
18407,avr118,1
18408,hypofractionated radiation therapy followed by surgery,1
18409,acupuncture protocol 1,1
18410,intrahepatic arterial infusion,1
18411,ivor lewis esophagogastrectomy,1
18412,distal pancreatectomy,1
18413,questionnaire-data collection,1
18414,m1 scheme,1
18415,clinimacs cd25 reagent device,1
18416,chep,1
18417,broad area ala 3-hour incubation,1
18418,therapeutic white cell transfusion,1
18419,fabricated food,1
18420,mayo clinic conduit report card questionnaires,1
18421,rice bran meals and snacks,1
18422,single arm dose dense mvac,1
18423,lymfactin® (1x10e11 vp),1
18424,nd-420,1
18425,tds-im electrode array system,1
18426,pentoxifylline plus chemotherapy,1
18427,probiotic yogurt d: placebo -- no added micronutrients,1
18428,18f-choline pet-ct,1
18429,aspiration with percutaneous capsulotomy for digital mucous cysts,1
18430,nuc-3373 + oxaliplatin + bevacizumab,1
18431,isoperistaltic,1
18432,rhtsh stimulation,1
18433,lenalidomide standard of care,1
18434,combined photodynamic & pulsed dye laser treatment,1
18435,egir tape,1
18436,isoperistaltic side-to-side ileocecal anastomosis,1
18437,misoprostol pfizer brand,1
18438,plerixafor + g-csf,1
18439,physical decline assessment,1
18440,consecutive radical cystectomies,1
18441,1.0 mg/m2 di-leu16-il2,1
18442,car-bcma t cell,1
18443,steroids concentrations determination,1
18444,"oxaliplatin, capecitabine, bevacizumab",1
18445,thalidomide plus dexamethasone,1
18446,impact oral,1
18447,men1611,1
18448,sym004 (9/6 mg/kg),1
18449,specimen samples,1
18450,obtaining information from survivors' medical file,1
18451,capecitabine 1200 mg/m^2/day,1
18452,mycophenolate (standard gvhd prophylaxis),1
18453,radiation therapy (imrt or 3d-crt),1
18454,triple antibiotic irrigation,1
18455,paxman orbis scalp cooler,1
18456,custom-made compression sleeve and -gauntlet,1
18457,healthpatch,1
18458,values inventory (vi),1
18459,open laparotomy and rectal resection,1
18460,metallic stent deployment in hilar obstruction,1
18461,tap flap reconstruction,1
18462,pet imagery,1
18463,mfhp,1
18464,arm 2 post operative chemoradiation,1
18465,targeted therapy based on molecular profiling : dasatinib,1
18466,talabostat,1
18467,nutritional intervention with dietician plus usual nutritional care,1
18468,placebo lanreotide,1
18469,postoperative radiotherapy breast/chest wall + regional lymph nodes,1
18470,deb,1
18471,trus-biopsy,1
18472,tipifarnib;zarnestra; r115777,1
18473,tumor tissue samples will be requested,1
18474,standard of care robotic-assisted radical prostatectomy,1
18475,brivanab,1
18476,chemotherapy with endostar,1
18477,azd9496 variant c,1
18478,50% caloric restriction,1
18479,scai (spiritual care assessment and intervention),1
18480,magnetic resonance imaging (dce-mri),1
18481,petroleum jelly,1
18482,tru-016 10-20 mg/kg + ibrutinib,1
18483,conventional gastrectomy or radical lymph node dissection,1
18484,rt (radiotherapy),1
18485,carboplatin (standard of care),1
18486,tremelimumab (treme),1
18487,biomarker assay (ca125 and he4),1
18488,ctla-4 antibody,1
18489,max-40279,1
18490,5-fu cream,1
18491,automated mailing plus assisted,1
18492,"dasatinib, 70 mg + lenalidomide, 20 mg + dexamethasone, 40 mg",1
18493,p-y reconstruction after total gastrectomy,1
18494,change antithrombotic drug,1
18495,lenalidomide and azacitidine combination,1
18496,resection as clinical care,1
18497,resection for primary lesion and cervical lymph node dissection,1
18498,cetuximab (erbitux®) and gemcitabine,1
18499,fractionated cisplatin,1
18500,desi for viewing at shared medical appointment,1
18501,seribantumab,1
18502,primary closure for tongue cancer defect,1
18503,tumor irradiation,1
18504,oral mixed natural carotenoids with vitamin a,1
18505,brain tumor excision,1
18506,9-minute withdrawal,1
18507,diffusing alpha radiation emitters therapy (dart),1
18508,neoadjuvant chemotherapy or adjuvant chemotherapy,1
18509,simultaneous radiotherapy,1
18510,"beacoppescalated (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone)",1
18511,oros hydromorphone hcl ; morphine sulfate,1
18512,neoveil (polyglycolic acid mesh),1
18513,kinesio tape lymphatic drainage technique application,1
18514,cisplatin + radiotherapy,1
18515,cng chemotherapy,1
18516,oral moisturizing jelly,1
18517,fecal microbiota transplantation (fmt),1
18518,erlotinib placebo,1
18519,oral alimentation started 12 hours after colorectal surgery,1
18520,geriatric assessment (ga),1
18521,isu104,1
18522,mammography according to an auto-compression procedure,1
18523,water immersion/co2,1
18524,oral salt and soda mouthwash,1
18525,"prednisone, vincristine, daunorubicin , cyclophosphamide , l.-asparaginase, cytosine-arabinoside, methotrexate, etoposide",1
18526,flexible sigmoidoscopy screening arm,1
18527,second reminder,1
18528,classic closure,1
18529,axillary dissection for breast carcinomas,1
18530,cd40 gene transfer,1
18531,mdasi-cml questionnaire,1
18532,ex vivo cd3/cd28 costimulated umbilical cord blood t cells,1
18533,radiotherapy plus metronidazole,1
18534,explorer liver image guided system,1
18535,double pigtail plastic stent (dpps),1
18536,ofatumumab plus dacarbazine,1
18537,apatinib;etoposide and cisplatin,1
18538,prophylactic endoscopic ultrasound,1
18539,esophagectomy program:,1
18540,outreach with patient education and patient navigation services,1
18541,sham auricular acupuncture,1
18542,european organization for research and treatment of cancer quality of life questionnaire c30,1
18543,integrated imaging high intensity focused ultrasound,1
18544,"0.25mg, fludiazine",1
18545,impact advanced recovery,1
18546,exemestane (aromasin®),1
18547,water infusion,1
18548,busulfan (conditioning for auto transplant),1
18549,subcutaneous injection,1
18550,cohesive gel breast implant,1
18551,omega-3 fatty acid ethyl esters (2 gram),1
18552,genome wide association studies,1
18553,gpc3 targeting car-t cells,1
18554,betamethason-17-valerate and fusidic acid,1
18555,surgery and hipec with lobaplatin,1
18556,fractionated total body irradiation (ftbi),1
18557,l9nc: liposomal 9-nitro-20 (s)-camptothecin,1
18558,post surgery - group b,1
18559,standard websites,1
18560,"duodenoscopy, pancreatoscopy, cholangioscopy, confocal microscopy",1
18561,physical and nutrition program,1
18562,polyphenon e and placebo,1
18563,pirarubicin and cyclophosphamide,1
18564,mri/fusion biopsies,1
18565,activated cik and cd3-muc1 bispecific antibody in treating lung cancer,1
18566,irinotecan liposome,1
18567,serratus plane block with saline,1
18568,acupuncture with seirin® needles,1
18569,lenalidomide & dexamethasone,1
18570,ixazomib placebo,1
18571,bronchoscopy with bronchoalveolar lavage,1
18572,interventionally implanted hepatic arterial port catheter,1
18573,"gemicitabine 1000mg/m2, day1 and day 8, every 3 week, 6",1
18574,observe the patient's condition and then change the regimen,1
18575,fluoromethyl hexafluoroisopropyl ether,1
18576,implementation of a care pathway,1
18577,magnetic resonance spectroscopy [mrs],1
18578,hospice video educational tool,1
18579,positron emission tomography and mri,1
18580,laparoscopic radical hysterectomy (type iii/c2).,1
18581,g17dt-irinotecan,1
18582,fuse® colonoscopy,1
18583,low dose fractionated radiotherapy,1
18584,placebo azd9291 80 mg/ 40 mg,1
18585,oral etoposide,1
18586,circulating tumor cell,1
18587,cancer distress coach mobile app,1
18588,ceop/ive/gdp chemotherapy regimen,1
18589,lymph node template,1
18590,saline solution 0.9%,1
18591,eshap-imatinib,1
18592,hepatoma requiring radiotherapy,1
18593,"autologous dendritic cells generated using gm-csf, interferon alpha and lps",1
18594,tailored telephone counseling,1
18595,sdx-101 (r-etodolac),1
18596,less frequent surveillance strategy,1
18597,clomifene citrate,1
18598,elotuzumab 400 mg,1
18599,ima202 product,1
18600,"leflunomide (permitted, not necessary)",1
18601,68ga-nota-exendin-4,1
18602,"folic acid, vitamin b6 and b12 or placebo",1
18603,survey for long-term follow-up of the disease,1
18604,ny-eso-1 olp4 + montanide,1
18605,breathlessness intervention service,1
18606,phase 1 dose escalation,1
18607,perfusion ct imaging,1
18608,bibf 1120 rd + pemetrexed,1
18609,ned,1
18610,non intervention / observationnal,1
18611,icg-nanocoll (indocyanine green coupled to the human albumin colloidal particle nanocoll),1
18612,hypofractionated radiotherapy (hyport),1
18613,positron emission mammography (pem) and magnetic resonance imaging (mri),1
18614,weekly taxotere with weekly carboplatin,1
18615,r-fm,1
18616,placebo in combination with bendamustine and rituximab,1
18617,glossectomy,1
18618,aer-o-scope colonoscopy,1
18619,68ga-sgc8,1
18620,recombinant human mannose-binding lectin,1
18621,interwalk,1
18622,l19il2 monoclonal antibody-cytokine fusion protein in combination with gemcitabine,1
18623,septin9,1
18624,high-let heavy ion therapy,1
18625,"paclitaxel protein-bound, and carboplatin",1
18626,home based training using the xbox kinect system,1
18627,cpi 613,1
18628,placebo to match zd6474 (vandetanib at the dose of 100 mg),1
18629,bevacizumab + octreotide lar + capecitabine,1
18630,68ga-dota-jr11,1
18631,integrated psychological care,1
18632,colesevelam,1
18633,free-breathing,1
18634,carbon-14-labeled carboplatin,1
18635,valdecoxib,1
18636,psychoeducation group,1
18637,baf312,1
18638,3d conformal or intensity modulated radiation therapy (imrt),1
18639,laparoscopic left colonic resection,1
18640,"5-fu, imiquimod or treatment with cryotherapy",1
18641,nimodipine,1
18642,group deep: rocuronium 0.6 mg/kg followed by rocuronium infusion with target level ptc 0-1 combined with bolus saline (placebo) mimicking standard treatment.,1
18643,cardiopulmonary exercise testing and post-cpet cardiac function,1
18644,ad5-cmv-nis,1
18645,ip chemotherapy plus simvastatin,1
18646,velcade/thalidomide/dexamethasone,1
18647,decitabine (baml-16-001-s5),1
18648,stress management,1
18649,ilnd - inguinal lymph node dissection,1
18650,lipiodol ethanol mixture,1
18651,montanide isa-51/survivin peptide vaccine,1
18652,peg-p-inf alpha-2b (p1101),1
18653,s ckd602,1
18654,head down tilt,1
18655,imrt/tomo,1
18656,transanal total mesorectal excision (tatme),1
18657,abbv-151,1
18658,none - standard of care,1
18659,theya recovery range,1
18660,18f-fet,1
18661,mucosal impedance (mi),1
18662,rh-1,1
18663,blu-u blue light photodynamic therapy,1
18664,"eribulin, gemcitabine",1
18665,high-dose anthracycline,1
18666,alsertib,1
18667,resistance and endurance exercise,1
18668,sm-153,1
18669,standardized meals for diet stabilization,1
18670,efavirenz/emtricitabine/tenofovir disoproxil fumarate,1
18671,dalfampridine,1
18672,normal diet,1
18673,standard imrt,1
18674,magensium sulphate,1
18675,tvgv-1,1
18676,phytochemical,1
18677,conventional processing,1
18678,peppermint oil,1
18679,blueberry powder,1
18680,community resource,1
18681,inbrx-109 - multivalent dr5 agonist antibody,1
18682,chronic pain identification questionnaires,1
18683,dermamatrix,1
18684,combination,1
18685,silk suture,1
18686,as03-adjuvanted h1n1 pandemic influenza vaccine,1
18687,"rad001, docetaxel, bevacizumab",1
18688,high-flow oxygen,1
18689,mini thoracotomy,1
18690,medi2070 low-med dose,1
18691,ace-041,1
18692,tr?freeze™ spray cryotherapy,1
18693,o-(2[18f]fluoroethyl)-l-tyrosine,1
18694,bupivacaine (transversus abdominis plane block),1
18695,telepristone acetate 3 mg,1
18696,tep scanner with choline,1
18697,"standard of care, enzalutamide",1
18698,rv-ny-eso-1 vaccine,1
18699,blood for angiome profiling,1
18700,chemosensitization/potentiation,1
18701,fluorothymidine f 18,1
18702,aeonosetm,1
18703,pinpoint ir ir9000 flourescence imaging system (fis),1
18704,infiltration with ropivacaine solution,1
18705,"fluorouracil, leucovorin, oxaliplatin, docetaxel",1
18706,vizishot 22g needle (standard),1
18707,"concurrent chemotherapy (gemcitabine, capecitabine)",1
18708,tegavivint,1
18709,"oxaliplatin, capecitabine, panitumumab",1
18710,follow up by phone,1
18711,zyclara® (imiquimod) topical cream 3.75%,1
18712,high intra abdominal pressure hipec,1
18713,radiofrequency ablation of dysplastic mucosa (halo),1
18714,hdac inhibitor (mk-0683),1
18715,"bendamustine, rituximab",1
18716,90y-ibritumomab tiuxetan,1
18717,azd4017 and prednisolone,1
18718,cc-5013 plus dexamethasone,1
18719,idarubicin in induction-2,1
18720,gemcitabine + cisplatin + regional hyperthermia,1
18721,sunitinib and capecitabine,1
18722,mirvetuximab soravtansine (imgn853),1
18723,"pixantrone, cyclophosphamide, vincristine, rituximab, prednisone",1
18724,hand grip strength test,1
18725,large loop electrosurgical excision,1
18726,cortrium c3 device,1
18727,estriol,1
18728,3d conformal ebrt,1
18729,sd-101 + pembrolizumab,1
18730,erlotinib (tarceva) and bexarotene (targretin),1
18731,"bortezomib, melphalan, prednisone, thalidomide",1
18732,cau+ (enhanced care as usual),1
18733,hrme+cvc,1
18734,fchv home visit,1
18735,3d mri-guided brachytherapy,1
18736,no other,1
18737,taxus + platinum,1
18738,survivor survey (1): pre-visit baseline,1
18739,azacitidine (baml-16-001-s6),1
18740,dermatologic complications management/prevention,1
18741,arteriography,1
18742,"paclitaxel 60mg/m2, oxaliplatin 50mg/m2, leucovorin 20mg/m2, and 5-fu 425mg/m2 iv weekly",1
18743,nasofibroscopy,1
18744,bactrim,1
18745,aqueous cream,1
18746,standard childhood uk all protocol,1
18747,sorafenib and temozolomide,1
18748,avelumab (expansion cohort),1
18749,degarelix or gnrh agonist,1
18750,darolutamide (bay1841788),1
18751,azd9496 variant a,1
18752,"111in-cs-1008, cs-1008",1
18753,etirinotecan pegol,1
18754,etoposide and cisplatin after chemoradiotherapy,1
18755,losartan potassium,1
18756,"oxaliplatin, irinotecan, folinic acid, fluorouracil",1
18757,melaxin (autologous dendritoma vaccine) and bcg,1
18758,1-year treatment with icotinib,1
18759,shr-a1403,1
18760,peg split-dose and simethicone,1
18761,"capecitabine, bevacizumab",1
18762,ceramide nanoliposome,1
18763,peg-asp,1
18764,131-i mibg and 111-in pentetreotide,1
18765,visual analogue scales (evas),1
18766,cdx-014,1
18767,5-fluorouracil and cisplatin,1
18768,audio storybooks,1
18769,image guided biopsy,1
18770,contrast enhanced-transrectal ultrasound,1
18771,icg-tmtp1,1
18772,dexamethasone-nalbuphine,1
18773,standard staging,1
18774,high intensity focused ultrasound (hifu) in combination with thermodox,1
18775,pre-hct mesna on days -2 and -1,1
18776,novel wound healing protocol,1
18777,"doxil, methotrexate, l-asparaginase, prednisone",1
18778,ct colonoscopy(normal dose),1
18779,18f dcfpyl- radiopharmaceutical,1
18780,trans-perineal mri targeted biopsy,1
18781,pegylated gcsf (peg-gcsf),1
18782,mr-hifu induced hyperthermia,1
18783,webchoice ihca,1
18784,22 gauge needle,1
18785,im156,1
18786,"busulfan, melphalan, fludarabine, anti-thymocyte globulin, palifermin, stem cell transplant",1
18787,the wisc-iv,1
18788,open-label placebo intervention,1
18789,laparoscopic-assisted gastrectomy with d2 lymphadenectomy,1
18790,vaccine treatment,1
18791,short course radiotherapy (scrt),1
18792,evidenced-based symptom management and coping intervention,1
18793,adjuvant chemotherapy with 5-fu isolated,1
18794,radiotherapy 50gy,1
18795,control no treatment,1
18796,endoscopic ultrasonography-guided double ethanol lavage,1
18797,ntms data available for the surgeon,1
18798,tace-haic,1
18799,systemic chemotherapy lv5fu2,1
18800,"proton therapy, photon therapy, srs, brachytherapy",1
18801,ogx-427 1000 mg,1
18802,no drugs,1
18803,analyze the role of glucocorticoid in at distribution.,1
18804,tumor exome analysis,1
18805,main renal artery clamping,1
18806,abi-009; nab-rapamycin; albumin-bound rapamycin,1
18807,intake of red and processed meat and fibres,1
18808,toronto extremity salvage score,1
18809,self care + hypnosis group,1
18810,gliolan®,1
18811,non 3d printing model,1
18812,5% dextrose (placebo),1
18813,pimonidazole hydrochloride (hypoxyprobe™-1),1
18814,lymfactin® [1 x 10e11 vp],1
18815,olive oil capsules,1
18816,dabigatran,1
18817,indirect laryngoscopy,1
18818,pf-06688992,1
18819,carrageenan-based gel,1
18820,parathyroidectomy,1
18821,ibrutinib until progression/relapse,1
18822,standard: homogene dose plan,1
18823,part c - azd6094 monotherapy (japan only),1
18824,pf-03758309,1
18825,high-dose cisplatin chemotherapy,1
18826,mpcl,1
18827,axitinib + docetaxel (cohort 5),1
18828,conventional radiotherapy 70 gy,1
18829,sunitinib monotherapy,1
18830,apc8015f,1
18831,support: a theatre nurse + an anaesthetic nurse,1
18832,tubal sterilization with bipolar energy,1
18833,healthy eating education learning (heal),1
18834,radiation of the pelvis,1
18835,hydrophor (group a),1
18836,aromatase inhibition therapy - observational only,1
18837,nimustine,1
18838,bioseal fibrin sealant,1
18839,growth factor support,1
18840,anti-lag-3 monoclonal antibody bms 986016,1
18841,fsf with cad\cam customized cutting guide,1
18842,rocuronium 0.3mg/kg/hr,1
18843,total thyroidectomy with bilateral prophylactic central compartment (level vi) neck dissection,1
18844,neuron-specific enolase to albumin ratio,1
18845,btrc4017a,1
18846,nivolumab (phase 2),1
18847,vincristine sulfate liposomes injection (vsli),1
18848,surgical excision of the tumor,1
18849,non invasive ventilation (niv),1
18850,recombinant human regf-p64k/montanide vaccine,1
18851,nk012 and 5-fu,1
18852,epa-enriched supplement,1
18853,placebo + vinorelbine,1
18854,trelstar,1
18855,bevacizumab plus ipilimumab cohort 2,1
18856,sodium ferric gluconate complex in sucrose,1
18857,flu-bu-cy,1
18858,chop combined with cmab304,1
18859,cbr96-doxorubicin immunoconjugate,1
18860,observation of clinician-patient interactions and interviews,1
18861,combination treatment - cohort 1,1
18862,intravenous oxaliplatin with intraperitoneal docetaxel,1
18863,margin-based radiotherapy planning,1
18864,dose to prostate bed with integrated boost,1
18865,lung ultrasound,1
18866,experimental: rp2d (pbf-509+pdr001)_immuno treated,1
18867,nitinol,1
18868,"vats, talc-pleurodesis, tunneled pleural drainage",1
18869,nutritional counselling,1
18870,standard-of-care treatments for lv impairment,1
18871,demerol on demand,1
18872,heterogeneously hypofractionated radiotherapy,1
18873,"nilotinib, pegylated interferon alpha-2b, imatinib",1
18874,cdc brochure only condition,1
18875,hvegf26-104/rfase,1
18876,patient-controlled sedation/analgesia,1
18877,en3348,1
18878,ebd and pancreatoduodenectomy,1
18879,cd20 car-t cells,1
18880,combretastatin a-4 phosphate + paclitaxel + carboplatin,1
18881,busulfan and cyclophosphamide,1
18882,placebo (for ruxolitinib),1
18883,arteries interruption before vein interruption,1
18884,hypothermia,1
18885,secretary phone call (step 2),1
18886,resil intervention,1
18887,th-302 and dexamethasone,1
18888,"clofarabine, cyclophosphamide",1
18889,131i-mip-1095,1
18890,aerobic/ resistance exercise intervention,1
18891,fec chemotherapy,1
18892,3t mr spectroscopy,1
18893,cart-bcma,1
18894,non pegylated liposomal doxorubicin and docetaxel,1
18895,preoperative intensity modulated radiation therapy,1
18896,oral mucosa deterging and periodontal debridement (omdp),1
18897,ladg arm,1
18898,cobas hpv dna test,1
18899,silibin-phytosome,1
18900,la,1
18901,"bi 2536, intravenous",1
18902,induction/consolidation dexamethasone,1
18903,"simvastatin,zoledronic acid,bortezomib,bendamustine,methylprednisolone.",1
18904,dendritic cell vaccine (dc1),1
18905,onabotulinum toxin type-a,1
18906,iodine i 124 iododeoxyuridine,1
18907,38.5°c temperature limit defining fever,1
18908,autologous dendritic cell-tumor cell immunotherapy (dc-tc),1
18909,5-azacytidine (5-aza),1
18910,transanal inspection and management of low colorectal anastomosis,1
18911,mitochondria-targeted system therapy combined with radiofrequency ablation,1
18912,with ipss,1
18913,assess pain interference postoperatively,1
18914,conventional fractionation radiotherapy,1
18915,gip-a,1
18916,postoperative mobilization program,1
18917,actiq (oral transmucosal fentanyl citrate [otfc]),1
18918,gkr with a single shot of the 4 mm collimator,1
18919,local consolidative therapy (lct),1
18920,telephone coaching sessions,1
18921,pep-pal,1
18922,"fully coated, removable , self-expanding oesophageal stent",1
18923,smoking cessation program tfc and activity tracker,1
18924,monoclonal antibody j591,1
18925,mk-2206 combined with docetaxel,1
18926,1,1
18927,oltipraz,1
18928,antiperspirant cream f511,1
18929,chromium,1
18930,body-mind-spirit group therapy,1
18931,inxn-2001,1
18932,questionary,1
18933,extraperitoneal laparoscopic lymphadenectomy,1
18934,modulated imaging,1
18935,smart intervention,1
18936,telephone booster,1
18937,laparoscopic right hemicolectomy for cancer,1
18938,blood samplings,1
18939,"gemcitabine, sorafenib",1
18940,4scar19 and 4scar20,1
18941,eus-fnb,1
18942,pc-pep - prostate cancer patient education program,1
18943,givinostat (itf2357) 50 mg o.d. + mtd hydroxyurea,1
18944,lavender,1
18945,pro sub-study,1
18946,online health management program,1
18947,pretreatment with co2 laser before photodynamic therapy,1
18948,5 vs 6 weekly fraction of rt,1
18949,"hpv vaccine,270?g/1.0ml",1
18950,paclitaxel/ irinotecan,1
18951,ak001 high dose,1
18952,drug: ad.p53-dc vaccines,1
18953,thyrogen (thyrotropin alfa for injection),1
18954,docetaxel + prednisone,1
18955,uv4.me,1
18956,sphincterometry,1
18957,airbrush,1
18958,n-acetyl-cysteine,1
18959,hiob,1
18960,radiotherapy of bone metastasis,1
18961,biological/vaccine: imc-20d7s (cohort 3b ),1
18962,clamp crushing technique,1
18963,accelerated fractionation by concomitant boost,1
18964,educational small group session,1
18965,diagnostic mammography,1
18966,soy isoflavone nutritional supplements,1
18967,the first pass is made with modified wet suction technique,1
18968,intravenous injection docetaxel,1
18969,hydroxyurea (hu),1
18970,zanolimumab,1
18971,pillcam colon capsule endoscopy (given® diagnostic system),1
18972,reduction of overall treatment time,1
18973,high dose boost,1
18974,"gemcitabine,pegaspargase,cisplatin,dexamethasone",1
18975,endoscopic surgery (standard of care),1
18976,bowel cleansing,1
18977,bio feedback,1
18978,natural orifice specimen extraction,1
18979,palliative care support,1
18980,0.5 mg estradiol / 0.1 mg norethindrone acetate,1
18981,"comparator: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant",1
18982,cold espresso,1
18983,vls ablation/portal ligation/hepatectomy,1
18984,3d-histology,1
18985,"gtx (gemcitabine, docetaxel and capecitabine)",1
18986,distress barometer,1
18987,treatment suggestion,1
18988,"realtime-elastography, linear ultrasound probe, hitachi eub-900, japan",1
18989,levocetirizine,1
18990,sorafenib standard dosing regimen,1
18991,reference147609,1
18992,dual energy ct,1
18993,usual care educational website,1
18994,doxorubicin liposomal,1
18995,thalidomide combined with r-chop,1
18996,hm781-36b(poziotinib),1
18997,folfirinox neoadjuvant chemotherapy,1
18998,gaba 30mg/kg group,1
18999,metastatic lesion biopsy,1
19000,donor natural killer (nk) cells,1
19001,occlusin 500 microspheres,1
19002,cycle 1 induction,1
19003,mpath-crc,1
19004,luckyvec 400mg film coated tablet,1
19005,corn starch pill,1
19006,cyclophosphamide (tablet),1
19007,therapy for head and neck cancer,1
19008,pd-1 antibody + cox inhibitor,1
19009,il-7/il-15 pre-treated cd19 cells,1
19010,taiwan ace beads with doxorubicin,1
19011,"carfilzomib, thalidomide and dexamethasone",1
19012,overcoming psychological distress through hymns intervention,1
19013,educational materials/mail,1
19014,adefovir dipivoxil and lamivudine,1
19015,phone call follow up,1
19016,ct scan of the chest under deep inspiration breath hold,1
19017,htert i540/r572y/d988y multipeptide vaccine,1
19018,sapylin,1
19019,post-hct mesna,1
19020,mr/pet,1
19021,cd40 ligand,1
19022,jugular venous bulb catheterization,1
19023,histopathology see-fim,1
19024,aloe exosomes,1
19025,methylprednisolone + prednisone,1
19026,doxorubicin or epirubicin,1
19027,percutaneous placement of device in liver metastases,1
19028,7 days sie plus 3 weeks pre,1
19029,erlotinib®,1
19030,"comparator: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant (qhpv) vaccine from future manufacturing facility (fmf)",1
19031,hand assisted laparoscopic nephrectomy,1
19032,rxdx-106,1
19033,4 - 7 days a week self-monitoring,1
19034,bay73-4506,1
19035,myo-inositol plus folic acid,1
19036,stro-001,1
19037,"pet-based, dose-painted, accelerated chemoradiotherapy",1
19038,osi-906 and pemetrexed,1
19039,ovarian function suppression/ablation,1
19040,sampling peritoneal tissue,1
19041,niagen,1
19042,lhrh agent,1
19043,water load (wl) post-operative day 1,1
19044,intrathecal morphine+la,1
19045,calcium carbonate 1500 mg with vitamin d,1
19046,arq 736,1
19047,cetuximab in combination with carboplatin/gemcitabine,1
19048,68ga?psma?hbed?cc,1
19049,bupivacaine hcl inj 0.25%,1
19050,thalidomide/prednisone/velcade,1
19051,sorafenib and vinorelbine,1
19052,chemotherapy +/- disulfiram,1
19053,mrx0518,1
19054,"oxaliplatin, 5 fu",1
19055,lapatinib and capecitabine or vinorelbine,1
19056,device: 22g fna needle,1
19057,"bevacizumab with chemotherapy, pleur-xtm catheter placement",1
19058,s-1/gemcitabine,1
19059,thermalcore hyperthermia system,1
19060,roux-en-y gastrojejunostomy after subtotal gastrectomy,1
19061,"prolanta, a human prolactin receptor antagonist",1
19062,pd p 506 a,1
19063,ig-impt,1
19064,dune device,1
19065,state-trait anxiety inventory (stai),1
19066,oral tki,1
19067,video declarations (videc),1
19068,xrp6976 (docetaxel/taxotere),1
19069,robot assisted endoscopic head and neck surgery using the davinci robotic surgical system,1
19070,white carrots,1
19071,"ropivacain 5 mg/ml, 35 ml",1
19072,automated mailing,1
19073,tki discontinuation,1
19074,mk-7162,1
19075,icaspase9-transduced t cells,1
19076,ts-1 and eloxatin,1
19077,oral contraceptive plus metformin,1
19078,induction with car-cy-dex and conditioning with carfilzomib and highdose melphalan,1
19079,hunger training,1
19080,mdasi-gist questionnaire,1
19081,vaccination program,1
19082,radiation treatment (rt),1
19083,adxs31-142 + pembrolizumab (mk-3475),1
19084,group 1: tk216,1
19085,new norwegian food based dietary guidelines,1
19086,oravescent fentanyl (ovf),1
19087,treatment as usual (medical),1
19088,clomiphene citrate and human chorionic gonadotropin (hcg),1
19089,limited field radiation,1
19090,ultratrace® iobenguane i131,1
19091,standard-omega 3 fatty acid,1
19092,intracorporeal morcellation,1
19093,3d-conformal radiotherapy (3d-crt),1
19094,folfox and folfiri,1
19095,ad.hil-12,1
19096,objective measurement of physical activity and fitness,1
19097,ct colonography and optical colonoscopy,1
19098,intervention b: etoposide; carboplatin; neulasta,1
19099,biopsy of abnormal & suspicious areas of the bronchial tree,1
19100,bn83495 (cohort 1),1
19101,celon pro surge,1
19102,transcranial exablate,1
19103,sorafenib with temsirolimus,1
19104,internet arm,1
19105,dbt+s2d,1
19106,pbcar3-phosphopeptide,1
19107,hpv oncogenes,1
19108,tissue repository,1
19109,3d-printed patient-specific titanium plates,1
19110,megestrol acetate and metformin,1
19111,anti-mage-a3 hlaa* 01-restricted tcr,1
19112,ct scan radiation,1
19113,cd11301 0.06%,1
19114,"doxorubicin, paclitaxel poliglumex, capecitabine, cyclophosphamide, methotrexate",1
19115,low glycemic index diet,1
19116,non-drug intervention type,1
19117,70.2 gy 3d-crt/imrt,1
19118,"visual analog scale and 10 point-scales to measure fatigue, general well-being, subjective sleep and pain",1
19119,cancer-related body image scale,1
19120,pf04518600,1
19121,gastrostomy,1
19122,crs/hipec,1
19123,hras detection assay,1
19124,autologous monocytes + actimmune + sylatron,1
19125,mac,1
19126,radical prostatectomy for prostate cancer,1
19127,dhap rescue and autologous stem cell transplantation,1
19128,low dose fr? vaccine,1
19129,low ligation,1
19130,sar428926,1
19131,oncological pulmonary resection,1
19132,laser diode,1
19133,msb0010445 (1.8 mg/kg),1
19134,cosyntropin,1
19135,0.5% levobupivacaine,1
19136,strength-training,1
19137,oc-ctls,1
19138,icp-105,1
19139,standardized materials group,1
19140,hai plus systemic chemotherapy,1
19141,src kinase inhibitor kx2-391,1
19142,brca1 and brca2,1
19143,stage 2: abiraterone acetate,1
19144,consolidation paclitaxel,1
19145,nim-eclipse,1
19146,"lmp, barf1 & ebna1 specific ctls : b",1
19147,no acupuncture treatment,1
19148,hyperacute-prostate cancer vaccine,1
19149,cyp2d6,1
19150,sodium bicarbonate buffered lidocaine,1
19151,temsirolimus and capecitabine,1
19152,liquid 13-cis retinoic acid,1
19153,l19il2 at rd - ph ii,1
19154,european organization for research and treatment of cancer-quality of life questionnaire,1
19155,therapeutic lymphadenectomy (temla) and stereotactic body radiation therapy (sbrt),1
19156,psycho-physiological intervention,1
19157,valchuff,1
19158,daylight and maquet power 500 led surgery light,1
19159,epothilone d (kos-862),1
19160,liposome encapsulated mitoxantrone (lem),1
19161,5-fu with leucovorin,1
19162,tesetaxel once weekly,1
19163,lower gi endoscopy,1
19164,bspan,1
19165,unsupervised apa program,1
19166,yoga practice plan,1
19167,ten item personality inventory,1
19168,cm082 plus paclitaxel,1
19169,heat pain sensory testing,1
19170,teicoplanin,1
19171,fluoro-ethyl-coline-pet/ct,1
19172,hypofractionated index site radiation,1
19173,vmat (volumetric modulated arc therapy),1
19174,total body magnetic resonance imaging,1
19175,tumor-pulsed dendritic cells,1
19176,grn-1201 + pembrolizumab,1
19177,patient navigated latinas,1
19178,cyclophoshamide,1
19179,standard external beam irradiation,1
19180,pdm08,1
19181,mart-1,1
19182,jnj-26866138 1.3 mg/m2,1
19183,sr-t100 gel with 2.3% of sm in solanum undatum plant extract,1
19184,pulmonary perfusion/reserve with tc-99m-maa spect/ low dose ct,1
19185,cci-779 (temsirolimus),1
19186,breast q,1
19187,monopolar diathermy,1
19188,idarubicin?ida?,1
19189,cytokines,1
19190,print media,1
19191,"capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)",1
19192,allogenic nk cells infusion,1
19193,0.06% resiquimod gel - c,1
19194,autologous hematopoietic stem cell,1
19195,this study has no intervention,1
19196,uvb irradiation,1
19197,bortezomib + ganciclovir,1
19198,preoperative 3d-ct reconstruction,1
19199,"use of sunitinib, bevacizumab, or sorafenib",1
19200,estrogen receptor (er) status,1
19201,bi 1361849,1
19202,"mri, neuropsychological evaluation, blood sampling",1
19203,18f-fluoroacetate,1
19204,rose bengal disodium,1
19205,health education session,1
19206,dv281,1
19207,busulfan/cyclophosphamide,1
19208,sienna+ peri,1
19209,conformal radiation,1
19210,som230b,1
19211,ev3d assay,1
19212,oral rehydration solution,1
19213,hlx07+gemcitabine+cisplatin,1
19214,haploidentical allogeneic transplantation,1
19215,"ifosfamide, gemcitabine",1
19216,arq 761 weekly administration,1
19217,naphazoline,1
19218,unactivated nometex device,1
19219,laser interstitial thermotherapy,1
19220,89zr-trastuzumab human dosimetry and safety,1
19221,zhen qishen capsule and oral supplement of yuyikang,1
19222,mct/lct and fish oil,1
19223,"""oncotool"" control (health +ht education)",1
19224,nivolumab 360 mg,1
19225,tpa standard dosage,1
19226,web-based patient centered toolkit (pctk),1
19227,diet b,1
19228,clinically assisted hydration arm,1
19229,erlotinib in combination with dasatinib,1
19230,local consolidation therapy (lct),1
19231,adjuvant chemotherapy with gemcitabine,1
19232,platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and hsct,1
19233,musical intervention,1
19234,multitaa specific t cells,1
19235,60 gy rt,1
19236,glucocorticoids,1
19237,forodesine hydrochloride capsules (100 mg),1
19238,"hpc, cord blood",1
19239,"none, standard chemotherapy only",1
19240,eof5,1
19241,chemo-irradiation,1
19242,home-based exercise intervention,1
19243,pufa,1
19244,fluorouracil implant,1
19245,therapeutic platelet transfusion,1
19246,shade ultraviolet sensor,1
19247,novosyn® quick,1
19248,placebo plus pld,1
19249,bilateral gluteal advancement flap,1
19250,ltx-315 + ipilimumab,1
19251,collection of stool and serum samples,1
19252,ceep regimen,1
19253,radiation therapy (radiotherapy),1
19254,daltéparine,1
19255,"taxotere , epirubicin",1
19256,siemens somatom definition edge,1
19257,"standard suction, wet suction, slow-pull",1
19258,"cetuximab, irinotecan",1
19259,vadimezan™,1
19260,vats lobectomy using less staples,1
19261,tazorac,1
19262,interstitial implant brachytherapy,1
19263,doxorubicin hcl inhalation solution,1
19264,implantation of morphine sulfate delivering programmable pump,1
19265,amg 119,1
19266,cisplatin (dose level 2),1
19267,quality of life (qol) assessment,1
19268,gelatin,1
19269,deceased donor liver transplantation,1
19270,protexa,1
19271,polyglutamate camptothecin,1
19272,[18f]fluorodeoxyglucose,1
19273,"taxane, avastin",1
19274,internet-based sun protection education,1
19275,posterior septectomy,1
19276,aggressive drainage instructions,1
19277,ky leads survivorship care,1
19278,abscess wide local excision,1
19279,progastrin,1
19280,mosapride,1
19281,bortezomib following nonmyeloablative allogeneic transplant,1
19282,one - three cycles of cell therapy during 4-6 weeks (3-5x10^7 cells/kg will be given through iv systemically,1
19283,ss1(dsfv)-pe38,1
19284,study sample collection,1
19285,physical activity tests,1
19286,arteriography and preoperative embolization,1
19287,sleep hygiene and relaxation education,1
19288,no name,1
19289,carboplatinum,1
19290,prednisolone 50 mg,1
19291,di,1
19292,high intensity radiation therapy,1
19293,"irinotecan, cisplatin, celecoxib",1
19294,ivm (in vitro maturation) treatment,1
19295,standard consolidation therapy,1
19296,picc or subcutaneous venous port,1
19297,"cp-751,871 (figitumumab)",1
19298,hypofractionated volumetric radiotherapy in 20 fractions,1
19299,macrogol 3350 na sulphate nacl kcl ascorbic acid na ascorbate,1
19300,"zw25, her2 inhibitor",1
19301,mindfulness based pulmonary rehabilitation,1
19302,intravenous topotecan,1
19303,surgery: classic strategy,1
19304,av-203,1
19305,screening for anal squamous intraepithelial lesions,1
19306,immunoscintigraphy with radiolabeled cimzia®.,1
19307,b7-1,1
19308,an integrated experiential training program with coaching,1
19309,high fiber diet,1
19310,afp464 + faslodex,1
19311,3-dimensional photograph with simulation,1
19312,sorafenib with capecitabine and oxaliplatin,1
19313,pain squad+ with nurse support,1
19314,locally directed therapy,1
19315,infrared imaging device- alias,1
19316,auricular acupressure,1
19317,1540 nanometer erbium glass laser,1
19318,transcutaneous acupoint electrical stimulation,1
19319,"slow-pull, standard suction, wet suction",1
19320,arm ii,1
19321,paclitaxel+carboplatin/concurrent radiation,1
19322,information services (irx),1
19323,suberoylanilide hydroxamic acid,1
19324,stereotactic body radition (sbrt),1
19325,lumiliximab with fcr,1
19326,bevacizumab (aka avastin or rhu mab vegf),1
19327,afp-l3 and pivka-ii in hcc,1
19328,deciatbine(dac),1
19329,transurethral resection,1
19330,codetron altens,1
19331,standard ct imaging,1
19332,radiation therapy + temozolomide,1
19333,factsheet,1
19334,mp-470 + paclitaxel/carboplatin,1
19335,dtec?dtt,1
19336,secretin synthetic human (rg1068),1
19337,flir thermacam p-65,1
19338,orcagraft,1
19339,gliadel wafers in combination with o6-benzylguanine,1
19340,rocuronium 1.5mg/kg/hr,1
19341,nanofat-seeded biological scaffold on surgical defect,1
19342,extending withdrawal time in the proximal colon,1
19343,folfir + aflibercept,1
19344,relocatable fixation system,1
19345,hepasphere combined with cryosurgery,1
19346,egf-pti,1
19347,partial breast irradiation utilizing permanent breast seed implant,1
19348,betel nut cessation booklet,1
19349,[18f]-azafol,1
19350,yn968d1,1
19351,human recombinant anti-tumor necrosis factor alpha monoclonal antibody injection,1
19352,carfilzomib for inj 60 milligram (mg),1
19353,jnj-42756493 (erdafitinib),1
19354,any platinum-based doublet chemotherapy,1
19355,paclitaxel 80mg/m2 weekly x 12 weeks,1
19356,predictive no-show overbooking,1
19357,visica 2 treatment system,1
19358,mri-tulsa,1
19359,capecitabine tablets,1
19360,sterile becaplermin gel vs. sterile placebo gel treatment 1,1
19361,neoadjuvant atezolizumab,1
19362,ck boost pelvis,1
19363,anticipated regret,1
19364,tg4050,1
19365,human papillomavirus genotyping,1
19366,cccr-nk92 cells,1
19367,the use of i-scan in the detection of polyps in hnpcc,1
19368,sham transcranial direct current stimulation,1
19369,eus-fnb with procore needle,1
19370,paclitaxel loaded polymeric micelle (genexol-pm®),1
19371,shared decision making (sdm),1
19372,infrared endoscopy,1
19373,horse anti-thymocyte globulin (hatg),1
19374,novel 22-gauge core biopsy needle + standard biopsy needle,1
19375,bcr-abl tyrosine kinase inhibitor (tki),1
19376,"qol assessment, neuropsychological",1
19377,tc-99m-tetrofosmin spect,1
19378,sorafenib 400 mg (200-mg tablet),1
19379,yttrium y 90 monoclonal antibody hu3s193,1
19380,neoadjuvant treatment - hormonal therapy,1
19381,evaluation of the oral conditionand proper care,1
19382,etoposide plus lobaplatin,1
19383,modified cea peptide (100mcg),1
19384,uterine fibroid embolization beadblock™,1
19385,transarterial chemoembolization using a drug-eluting bead,1
19386,rituxumab,1
19387,tissue sample storage,1
19388,"stereotactic, ultra-fractionated radiotherapy",1
19389,tace-sorafenib group,1
19390,conventional hepatectomy,1
19391,combination of varlilumab and nivolumab,1
19392,mdx-1379 (gp100) melanoma peptide vaccine,1
19393,neurological exam,1
19394,double-balloon enteroscopy forceps biopsy,1
19395,cisplatin and radiation,1
19396,chi lob 7/4 (a chimeric monoclonal antibody),1
19397,geomail fit screening strategy,1
19398,single-port or two-port surgery,1
19399,11c acetate imaging,1
19400,"bay2757556 (larotrectinib, vitrakvi)",1
19401,endosonography,1
19402,eras perioperative management,1
19403,s-1 plus lv (the combination therapy of s-1 and leucovorin),1
19404,conventional ventilation,1
19405,placebo - anastrozole,1
19406,not experienced,1
19407,brentuximab vedotin - induction,1
19408,sns-314,1
19409,bf+support,1
19410,ovarian irradiation,1
19411,"imaging, adrenal acans",1
19412,"•referral to genetic counselor, if indicated",1
19413,topotecan (japan/europe),1
19414,tilsotolimod,1
19415,nutrawell powder,1
19416,bladder tumor resection using diathermia,1
19417,soc (tyrosine kinase inhibitor),1
19418,subcutaneous enoxaparin,1
19419,early palliative care integration,1
19420,amphotericin b deoxycholate,1
19421,uft (tegafur/uracil),1
19422,ezetimibe 10mg-simvastatin 40mg,1
19423,invitation for breast screening and random allocation,1
19424,zosuquidar trihydrochloride,1
19425,large plastic biliary stent,1
19426,biofeedback; functional electrical stimulation; pelvic floor muscle training exercises,1
19427,oxybutynin chloride,1
19428,phenomenological interviews,1
19429,bacillus calmette guerin and interferon alpha,1
19430,oxaliplatin/gemcitabine,1
19431,cyclophosphamide (cy) (plan 1),1
19432,thymoglobulin (ratg),1
19433,actisight™ needle guidance system,1
19434,89zr-daratumumab,1
19435,topical podophyllin,1
19436,dynamic contrast enhanced magnetic resonance imaging,1
19437,transvaginal ultrasonography,1
19438,"bronchoscopy, ct-guided biopsy, pet scan, mediastinoscopy",1
19439,lapatinib and vinorelbine,1
19440,fiducial marker (kv imaging),1
19441,olympus,1
19442,nanoknife low energy direct current (ledc) system ablation,1
19443,cs1003 monoclonal antibody,1
19444,neoadjuvant (f)ec-paclitaxel chemotherapy,1
19445,tit,1
19446,minimal intervention,1
19447,hepatic venous pressure gradient (hvpg) measurement,1
19448,capecitabine+cisplatin,1
19449,mp-470 + carboplatin/etoposide,1
19450,micronized trans-resveratrol,1
19451,hypofractionation with simultaneous integrated boost,1
19452,epirubicin (e),1
19453,hs-pci,1
19454,fluourine-18 fluoromethylcholine pet/ct imaging,1
19455,open kidney cancer surgery,1
19456,a (thalidomide + dexamethasone),1
19457,mage - a3/a6 screening test,1
19458,communication feedback form for patients with serious illness,1
19459,ugi endoscopy,1
19460,azacitidine (baml-16-001-s3),1
19461,"lde225, etoposide and cisplatin",1
19462,sb--?485232 (human recombinant interleukin--?18),1
19463,lavage/irrigation,1
19464,paclitaxel-eluting metal stent,1
19465,conventional whole blood,1
19466,white noise,1
19467,usual care: telephone counseling (3 sessions) with nicotine replacement,1
19468,preservative free artificial tear gel.,1
19469,internal drainage tube [polyethylene pancreatic drainage tube],1
19470,carboplatin and vinorelbine,1
19471,spirometer,1
19472,pegylated filgrastim,1
19473,palliative homecare nursing,1
19474,"relacorilant, 100mg qd",1
19475,gonadotropin releasing hormone agonist therapy,1
19476,sodium chloride 0.9 %,1
19477,0.12% chlorhexidine solution,1
19478,white light perfusion assessment,1
19479,abraxane alone,1
19480,dendritic cell-idiotype-keyhole limpet hemocyanin vaccine,1
19481,nilotinib + paclitaxel,1
19482,azd4573,1
19483,131i-omburtamab,1
19484,bi-parametric mri,1
19485,radioactive labelling of pulmonary nodules,1
19486,sbrt by linear accelerator,1
19487,"experimental: prt and a healthy diet, plus weight loss",1
19488,sonopet ultrasonic aspirator,1
19489,sems only,1
19490,cognitively-based compassion training control (cbct),1
19491,bright narrow band imaging,1
19492,hdr interstitial brachytherapy,1
19493,c-met/pd-l1 car-t cell injection,1
19494,docetaxel and placebo,1
19495,physician's choice (pc),1
19496,"evaluation of adherence to 3 oral anticancer treatment using a "" medication event monitoring system """,1
19497,ranibizumab 0.5mg,1
19498,las41007 b.i.d.,1
19499,ibrutinib 560mg po daily (imbruvica),1
19500,anti-tnf-alpha,1
19501,vehicle topical cream,1
19502,bkm120 + mek162,1
19503,herceptin sc,1
19504,hpph 3 mg/m2,1
19505,sretp,1
19506,bevacizumab placebo (saline solution),1
19507,"durvalumab, pazopanib",1
19508,whole body electromyostimulation exercise,1
19509,behavioral activity counseling,1
19510,beam conditioning,1
19511,cardiac output maximization,1
19512,mri-trus fusion guided real time hdr,1
19513,mobile device training,1
19514,vorinostst/bevacizumab/temozolomide,1
19515,induction chemotherapy and concurrent radiation,1
19516,fenretinide (4-hpr),1
19517,iph2102 at 1 mg/kg,1
19518,rq-pcr rna analysis,1
19519,sparc147709,1
19520,granulocyte colony-stimulating factor (kirinkunpeng),1
19521,etoposide-carboplatin,1
19522,cyclophosphamide fluorouracil epirubicin docetaxel,1
19523,usg pecs2 with drug a (active),1
19524,genistein supplement,1
19525,2-0 absorbable vicryl suture,1
19526,doxorubicin-hpma conjugate,1
19527,vk-2019,1
19528,intratumoral ipilimumab,1
19529,oral topotecan (sk&f-104864); lapatinib (gw572016),1
19530,personalized supervised physical activity,1
19531,adjuvant tamoxifen + goserelin (premenopausal women),1
19532,docetaxel 75 mg/m2 + prednisone 10 mg/d + abiraterone 1000 mg/d,1
19533,diamel,1
19534,"mage-3/melan-a/gp100/na pbmc, rhil-12 (drug)",1
19535,oral drug and oral placebo,1
19536,68ga-psma-r2,1
19537,ad5-delta24rgd,1
19538,mgd013,1
19539,autologous blood stem transplantation,1
19540,"dexamethasone, cytarabine, etoposide, pegylated-asparaginase",1
19541,dasatinib and lenalidomide,1
19542,tgfbeta resistant her2/ebv-ctls,1
19543,betalutin with lilotomab dose 1,1
19544,photon therapy versus c-ion therapy,1
19545,"hla-a*2402restricted urlc10, cdca1, vegfr1 and vegfr2",1
19546,rf-psa,1
19547,no uterine manipulator,1
19548,part 1: bo-112,1
19549,abt-888/bortezomib,1
19550,symptoms surveys,1
19551,autologous platelets gel,1
19552,"bevacizumab, cyclophosphamide, capecitabine",1
19553,fact-vci,1
19554,tachosil,1
19555,16-week exercise rehabilitation program for breast cancer survivors,1
19556,low dose fractionated whole abdominal radiation therapy,1
19557,patupilone and omeprazole,1
19558,endocrine therapy alone without radiotherapy,1
19559,placebo + cyclophosphamide - epirubicin 6,1
19560,imrt extended field external beam radiation therapy,1
19561,gemcitabine; cisplatin or carboplatin; erlotinib,1
19562,"cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.",1
19563,radioguided seed localization for nonpalpable breast cancers,1
19564,dcvac-l,1
19565,electropalatography biofeedback training,1
19566,group based exercise,1
19567,personalized titanium plate,1
19568,lanreotide-autogel 120 mg,1
19569,90?g hpv,1
19570,high-dose chemotherapy with tandem pbsc rescue.,1
19571,9vhpv vaccine,1
19572,kd018,1
19573,lymphocyte infusions,1
19574,tak-573,1
19575,optical biopsy imaging,1
19576,"clodronate (bonefos, bay94-8393)",1
19577,adaptive reserve and change process capability questionnaire,1
19578,ade protocol,1
19579,providing testimonies from survivors of transplants to patients,1
19580,hematopoietic umbilical cord blood stem cell transplantation,1
19581,nacl solution,1
19582,car2 anti-cd38 a2 car-t cells,1
19583,"erypo®, janssen-cilag, solution for injection (s.c.)",1
19584,standard anesthesia,1
19585,resection for primary lesion,1
19586,pancreo-kit breath test,1
19587,pt2385 tablets,1
19588,paclitaxel (standard of care),1
19589,"g.e. healthcare 1.5t mr, systems revision 12.0 m5",1
19590,folic acid calcium vitamin d3,1
19591,injection of il-2-secreting cd40l-expressing autologous b-cll cells,1
19592,spectrum image analysis using a linear array ultrasound bronchoscope,1
19593,palliative therapy + idiographic,1
19594,ropivacaine + opioid epidurally,1
19595,autologous or syngeneic pbtls and ebv-ctls,1
19596,platinum (cisplatin or oxaliplatin) + paclitaxel,1
19597,acupuncture + electrical stimulation,1
19598,evonail,1
19599,mammosite radiation therapy system,1
19600,bortezomib (optimized retreatment),1
19601,bowel preparation: senna & gastrofin versus picolax (standard),1
19602,cognitive behavioral therapy: questionnaires,1
19603,simvastatin and micronized trans-resveratrol,1
19604,writing a (experimental informative writing),1
19605,no preparation,1
19606,"topotecan, filgrastim (g-csf), pegfilgrastim",1
19607,high-dose density therapy,1
19608,folfox and erlotinib,1
19609,entinostat(placebo),1
19610,mhealth case management system,1
19611,isotretinoin (13-cis-retinoic acid),1
19612,fresh embryo transfer,1
19613,conners,1
19614,imaging in trimodality,1
19615,ganglion sphenopalatine block with local anesthetic,1
19616,entecavir therapy,1
19617,restaging review after radiation,1
19618,il-2/ifn-?,1
19619,pentoxifylline with tocopherol,1
19620,motorized spiral colonoscopy,1
19621,resection of nerve fibers around ima,1
19622,virtual chromoendoscopy-tb,1
19623,hyperinsulinemic euglycemic clamp and 2h20,1
19624,tenckhoff catheter placement,1
19625,clomiphene citrate +highly purified ufsh,1
19626,abt-806i,1
19627,bf-200 ala cream,1
19628,self-completion questionnaire,1
19629,ad5 cea vaccine,1
19630,glizigen + viusid,1
19631,influenza vaccine trivalent inactivated (tiv),1
19632,reference carboplatin,1
19633,omentum preserving,1
19634,cognitive restructuring,1
19635,part 1 (dose escalation): daratumumab,1
19636,phenprocoumon,1
19637,docetaxel-irinotecan,1
19638,irinotecan bead,1
19639,"pulsed radiofrequency of 2nd , 3rd and 4th thoracic dorsal root ganglia.",1
19640,mindfulness based cancer recovery (mbcr),1
19641,acolbifene hydrochloride,1
19642,outreach strategy,1
19643,improved intervention,1
19644,"ebus-tbna, eus-na",1
19645,surgery utilizing v-loc suture,1
19646,respiratory symptoms questionnaire,1
19647,trabectedin 1.3 mg/m2,1
19648,dietary supplementation with vegetable oil,1
19649,pharmacogenomics,1
19650,c7r-gd2.cart cells,1
19651,endoxan (cyclophosphamide),1
19652,pharmaceutical consultations,1
19653,mrd and clonal evolution,1
19654,spaceoar™ implantation,1
19655,anti-cd123/cd3 monoclonal antibody mgd006,1
19656,spaceoar system,1
19657,app-based mindfulness training,1
19658,self-completed implementation intention,1
19659,epitinib succinate,1
19660,2h-afl-pdt,1
19661,ektotherix,1
19662,allogeneic hsc transplantation,1
19663,placebo oral tablet to match venetoclax,1
19664,matching on the basis of molecular analysis,1
19665,crush the crave application,1
19666,rchop,1
19667,wait-list,1
19668,123i-mip-1072,1
19669,pazopanib + paclitaxel,1
19670,archival tumor tissue collection,1
19671,hr pem scan,1
19672,inspection and palpation of the appendix,1
19673,inotuzumab ozogamicin-dose level 2,1
19674,signa excite 3.0 t mri scan,1
19675,"colectomy, ga and mv",1
19676,4 mg/kg onartuzumab (metmab),1
19677,stereotactic ablative radiation,1
19678,tiva (total intravenous anesthesia with propofol and remifentanil),1
19679,custirsen (ogx-011)/docetaxel,1
19680,placebo (normal saline) continuous infusion,1
19681,ceop regimen,1
19682,transoral robotic assisted surgery,1
19683,integrated robotic surgery,1
19684,pegylated interferon,1
19685,111-in capromab pendetide,1
19686,iv pegylated liposomal doxorubicin (pld),1
19687,lhwo about crc,1
19688,"cetuximab (erbitux, c225)",1
19689,fact-hep questionnaire,1
19690,tailored navigation,1
19691,caudal levobupivacaine,1
19692,ara-c in induction-2,1
19693,pixantrone + rituximab,1
19694,mri scanner,1
19695,"bcg, interferon",1
19696,soc (chemotherapy and platinum agent),1
19697,"larotaxel (rpr109881, xrp9881)",1
19698,evri (bms-690514),1
19699,habib™ endohbp,1
19700,entecavir 1mg oral tablet,1
19701,lgk974,1
19702,nccn guidelines: distress management,1
19703,pemf device,1
19704,meaning-centered group psychotherapy,1
19705,meeting a therapist - attention control,1
19706,conventional routine ct examination,1
19707,puncture with fine needle aspiration under endoscopic ultrasonographic control,1
19708,ho/02/02 20µg,1
19709,calcium-rich diet,1
19710,folinic acid + 5 fu,1
19711,screening data,1
19712,reproductive health survivorship care plan (scpr),1
19713,azacitidine (baml-16-001-s4),1
19714,osteopathy sessions,1
19715,serratus anterior muscle plane block (sam block),1
19716,regorafenib 160mg or 120mg,1
19717,"clomiphene citrate, metformin, highly purified urinary fsh",1
19718,lung biopsy,1
19719,endostartm injection,1
19720,hrme imaging,1
19721,gimeracil and oteracil potassium capsule,1
19722,smof kabiven,1
19723,conventional controlled ovarian stimulation proctol,1
19724,robotic rehabilitation,1
19725,embolic agent,1
19726,standard intensity-modulated radiotherapy (imrt),1
19727,1% chlorhexidine gluconate gel,1
19728,civo device,1
19729,"velcade, melphalan, and dexamethasone",1
19730,placebo (normal saline solution),1
19731,thoracic rt,1
19732,captain's log computer program,1
19733,angel-6000d multiparameter anesthesia monitor (ioc),1
19734,taxteral,1
19735,muc1-gene-dc-ctl,1
19736,risk assessment (ccrat),1
19737,hyperacute vaccine,1
19738,lat,1
19739,support and attention (usual care),1
19740,moderate anxiety/depression: low intensity stepped care,1
19741,definity contrast agent,1
19742,decitabine induction chemotherapy,1
19743,interactive voice response symptom management,1
19744,only chemotherapy treatment for study cohort,1
19745,artery ligation first,1
19746,immunochemical faecal occult blood test (ifobt),1
19747,irinotecan/cetuximab,1
19748,"nintedanib or placebo; carboplatin, paclitaxel",1
19749,pegfilgrastim?peg-rhg-csf?,1
19750,tisagenlecleucel after optional bridging and lymphodepleting chemotherapy,1
19751,dial,1
19752,blank placebo,1
19753,strataxrt,1
19754,weight management classes,1
19755,sodium bicarbonate (nahco3),1
19756,flo-trac monitoring system,1
19757,electro-hyperthermia,1
19758,allogeneic cd123car-cd28-cd3zeta-egfrt-expressing t-lymphocytes,1
19759,hypovolemic phlebotomy,1
19760,standard of care second line therapy,1
19761,sta 9090,1
19762,exacto™,1
19763,pegylated recombinant human hyaluronidase ph20,1
19764,"ixabepilone, 16 mg/m^2 + bevacizumab, 10 mg/kg",1
19765,arm d: folfiri or folfox plus cetuximab,1
19766,opt-in outreach,1
19767,"bt062 , intravenous administration",1
19768,falls efficacy scale-international (fes-1),1
19769,0.5% ropivacaine,1
19770,"early postoperative enteral nutrition, based on standard elementary diet (peptisorb)",1
19771,"induction chemotherapy (fludarabine, cytarabine, idarubicin)",1
19772,erlotinib and dasatinib,1
19773,low dose fractionated radiation therapy,1
19774,"interferon (ifn?, roferon-a)",1
19775,benjamin rose institute (bri) care consultation™ program,1
19776,placebo - capsule,1
19777,donor-derived wt1-ctl and p-ctl,1
19778,"trastuzumab biosimilars(herzuma), gedatolisib",1
19779,conservative fluid therapy,1
19780,additional doses of rituximab,1
19781,peri-transfusion qol assessment,1
19782,facebook-based self-help comparison,1
19783,"bevacizumab, trabectedin and carboplatin",1
19784,transdermal nicotine,1
19785,lvef 3 month,1
19786,spatially fractioned radiation therapy,1
19787,"mastectomy, preservation of the skin envelope,followed by immediate reconstruction with autologous latissimus dorsi flap.",1
19788,split-dose peg based lavage (2l + 2l) with low-fibre lunch dietary instructions,1
19789,sequential cord blood transplantation,1
19790,norzyme,1
19791,bsi-201 plus temozolomide,1
19792,mri of liver,1
19793,dalotuzumab 10 mg/kg,1
19794,imaging phantoms,1
19795,gemcitabine in long infusion,1
19796,24 mg xanthohumol per day,1
19797,cirmtuzumab plus ibrutinib,1
19798,[68ga]aby-025,1
19799,standard of care proton therapy,1
19800,pegteograstim,1
19801,endoscopic mucosal resection of large colon polyps (greater than or equal to 20 mm in size),1
19802,conventional neuronavigation,1
19803,no nursing visit,1
19804,68ga-rm2 (rm2),1
19805,hp 3he,1
19806,water exchange (we) method,1
19807,thymus honey mouthwash,1
19808,ono-7436,1
19809,inreach strategy,1
19810,ubidecarenone injectable nanosuspension,1
19811,reconstituted grape powder,1
19812,hlx04,1
19813,standard transabdominal laparoscopic proctectomy,1
19814,blood draw/saliva sample,1
19815,endoscopic ultrasound-guided fna,1
19816,bi 836909,1
19817,vinblastine and sirolimus,1
19818,image quantify,1
19819,l-carnitine l-tartrate,1
19820,pantoprazole sodium for injection,1
19821,pem breast biopsy,1
19822,exendin 9-39,1
19823,als-357,1
19824,training with feedback,1
19825,pain coping skills training full,1
19826,caloric restriction diet,1
19827,dimethylfumarate,1
19828,combig-dc (allogeneic dendritic cells) cancer vaccine,1
19829,topotecan and vp16,1
19830,near-infrared icg fluorescence imaging,1
19831,oligomeric procyanidin complex,1
19832,mepitel® film,1
19833,tumor rna transfected dendritic cells,1
19834,gnrha,1
19835,trastuzumab+tp,1
19836,increased dietary intake of salmon or cod,1
19837,rehabilitation programme,1
19838,haemoglobin measure,1
19839,serial collection of plasma and serum and urine samples,1
19840,161533 trike phase ii,1
19841,placebo (for 33a),1
19842,"super selective transarterial chemoembolization of chc, with doxorubicin reconstituted in 5cc iso-osmolar ionic iodinated contrast media",1
19843,dietary and life style modification and probiotic sanprobi super formula,1
19844,pre-op cta with iv contrast,1
19845,fluorescent crgdy-peg-cy5.5-c dots,1
19846,drug-based intervention,1
19847,exablate 4000 - type 2,1
19848,"cp 751,871 (figitumumab)",1
19849,balloon capsule device,1
19850,multimodal and exercise-based intervention,1
19851,ct or mri based radiomics,1
19852,3 month ultrasound(us)+3 month ct/mri+3 month us+3 month ct/mri,1
19853,carboplatin/gemcitabine alone,1
19854,mobile health,1
19855,placebo changtai keli,1
19856,cirt arm (3gye per fraction),1
19857,standard care text messages,1
19858,oral brush biopsy,1
19859,temozolomide/hycamtin (topotecan),1
19860,posaconazole oral suspension,1
19861,laparoscopic dermoid cystectomy,1
19862,current practice procedure,1
19863,fludarabine in induction-2,1
19864,"the electric vibrating massager,sampo®",1
19865,mainly exercise induced weight loss,1
19866,high dose interleukin-2 (il-2),1
19867,"evaluation of mri, us for pelvic and uterine conditions",1
19868,additive classical homeopathy,1
19869,intrabone injection,1
19870,lidocaine 1% with epinephrine 1/400000,1
19871,"deferasirox dfx, dt",1
19872,ire,1
19873,skeletal muscle force,1
19874,anti-cdl9-chimeric- antigen-receptor- transduced t cells,1
19875,s64315,1
19876,feces samples,1
19877,bone pain education dvd,1
19878,placebo vaccine for female participants only,1
19879,autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine,1
19880,initial surgery,1
19881,compression anastomosis device,1
19882,approved gnrh agonist,1
19883,p28,1
19884,epal mobile application,1
19885,clearread ct insight,1
19886,mistletoe extract (iscador qu),1
19887,pancreatic cancer vaccine,1
19888,skylight nuclear camera,1
19889,cd19.car-multivst for group a,1
19890,intensive counseling (ic),1
19891,vipdomet,1
19892,surgery to remove ovaries or high dose chemotherapy,1
19893,collection of blood samples,1
19894,recombinant thyrotropin alfa,1
19895,microbiomes,1
19896,bracketing,1
19897,low dose doxorubicin,1
19898,dexamethasone tapering dose,1
19899,chemotherapy and concomitant radiotherapy,1
19900,ra,1
19901,"essex® cream (schering-plough), aqueous cream without parabens",1
19902,imrt versus conventional radiotherapy,1
19903,video presentation,1
19904,ec-17,1
19905,fuse image mri guided prostate cryotherapy,1
19906,group a - device guided breathing low dose,1
19907,microneedle lesion preparation,1
19908,activated nk,1
19909,hla-mismatched micro-transplantation after induction chemotherapy,1
19910,tst-tristaple(3lines stapler)technology,1
19911,chemotherapy (gemcitabine + nab-paclitaxel),1
19912,photonblade vs bovie for lumpectomy shaved surgical margins,1
19913,robotic-assisted thoracic surgery,1
19914,lungcare,1
19915,interferon alpha 2a,1
19916,diet modification and physical activity increase,1
19917,"fludarabine monophosphate, melphalan, bortezomib",1
19918,repevax™ (non-concomitant),1
19919,fibrin sealant vh s/d,1
19920,pazopanib (gw786034)(gw786034),1
19921,conventional surgical treatment,1
19922,in2005e,1
19923,c-11 choline pet imaging,1
19924,loc-paclitaxel,1
19925,pneumovax® 23,1
19926,vaccination with rna-transfected mature autologous dc,1
19927,chemoradiation + hdrbt boost,1
19928,trisulfate solution,1
19929,classical hepatectomy,1
19930,billroth-i,1
19931,amonafide and cytarabine,1
19932,supportive care/therapy,1
19933,gallium-68 citrate pet,1
19934,"radium-223 dichloride (xofigo, bay 88-8223)",1
19935,seviteronel,1
19936,donor pain management,1
19937,ct scan with deep inspiration breath hold (dibh) technique,1
19938,gatipotuzumab and tomuzotuximab,1
19939,"combined chemotherapy (abvd, bacopp-d)",1
19940,meditative practices,1
19941,trastuzumab emtansine [kadcyla] 3.6 mg/kg,1
19942,false injection,1
19943,mv mix vaccine,1
19944,cognitive flexibility scale (cfs),1
19945,psychological education program for nurses,1
19946,iota,1
19947,geriatrician co-management,1
19948,determination of risk of malignancy of these thyroid lesions,1
19949,neuropsychological testing and mri assessments,1
19950,us-guided laser ablation for refractory neoplasms,1
19951,stereotactic body rt and irga,1
19952,robot assisted partial nephrectomy,1
19953,sham-intervention,1
19954,total omentectomy,1
19955,zsp1602,1
19956,vinflunine + ixabepilone,1
19957,spy-phi ir9000 flourescence imaging system (fis),1
19958,paclitaxel hcl,1
19959,high taurine and saturated fat diet,1
19960,177lu-dota-eb-tate,1
19961,cetuximab and radiation therapy,1
19962,hysteroscopic resection with bipolar energy,1
19963,ct liver perfusion,1
19964,medroxyprogesterone (provera),1
19965,"regimen 2, course 1",1
19966,"busulfan, fludarabine, cytoxan",1
19967,"nab-paclitaxel, 80mg/m^2",1
19968,calcipotriol 0.005% ointment,1
19969,mrz 0.5 mg/m^2,1
19970,neoadjuvant stereotactic body radiation (sbrt),1
19971,assess patient quality of life at last office visit preoperatively,1
19972,8.5mg ino-5150 plus 1mg ino-9012 and electroporation device cellectra®-5p,1
19973,comparator: modified process hepatitis b vaccine,1
19974,intervention-specific carevive questionnaire,1
19975,v932,1
19976,tcm+ goserelin acetate+ bicalutamide,1
19977,radiotherapy stent,1
19978,"mtd of velcade, nipent and rituxan established in part 1",1
19979,abiraterone acetate and prednisone,1
19980,full bilateral laparoscopic lymphadenectomy and hysterectomy,1
19981,tenofovir alafenamide,1
19982,> 15% risk of + ln,1
19983,ct virtual proctoscopy (ctvp),1
19984,eus and/or ercp with ethanol injections of pancreatic cyst,1
19985,th-302 dose escalation and dexamethasone in combination with bortezomib,1
19986,plevitrexed,1
19987,intellectual disorders,1
19988,initially dissection of inferior mesenteric artery,1
19989,standard therapy or clinical trial,1
19990,mvst,1
19991,dexpantenol [bepantol],1
19992,cordotomy,1
19993,rfa therapy simulator,1
19994,gr1405 injection,1
19995,paclitaxel albumin nanoparticle for injectable suspension (abraxane),1
19996,fatigue intervention,1
19997,location of the suspected lesions,1
19998,amg 114,1
19999,voruciclib,1
20000,contura catheter,1
20001,chinese acupuncture,1
20002,fluorine f 18 dasa-23,1
20003,development of the most specific physiologically relevant experimental patient models,1
20004,pevonedistat 10 mg/m^2,1
20005,"elastography, contrast enhancement",1
20006,ebrt,1
20007,umbilical cord stem cells,1
20008,liposome-encapsulated cytarabine (depocyte),1
20009,torisel dose 15 mg and r-dha,1
20010,biparametric mri before biopsy,1
20011,autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine,1
20012,d2 radical resection,1
20013,ascorbic acid + sorafenib,1
20014,bortezomib (btz),1
20015,idarubicin(ida),1
20016,[18f] fluciclatide,1
20017,control group: clomiphene citrate tablets and bushen culuan decoction placebo,1
20018,wt1-sensitized allogeneic t-lymphocytes,1
20019,education materials,1
20020,standard of care surgical excision,1
20021,transsphenoidal surgery treatment,1
20022,observation of transponder stability,1
20023,calmangafodipir (5 µmol/kg),1
20024,erlotinib plus sulindac,1
20025,quell,1
20026,liberal group,1
20027,estrogen transdermal patch,1
20028,endoscopic band ligation without resection,1
20029,folfox (chemotherapy),1
20030,sensory and fine-motor tests,1
20031,"y-strut® (hyprevention, pessac, france)",1
20032,blood samples collection before radiotherapy,1
20033,adoptive cellular immunotherapy,1
20034,cdx-1140,1
20035,cpx-1 (irinotecan hcl:floxuridine) liposome injection,1
20036,7 tesla scanning,1
20037,ad-e6e7,1
20038,"xeloda,",1
20039,oxycodone-naloxone,1
20040,standard enhanced care,1
20041,oral nvb weekly,1
20042,"cyclophosphamide, methotrexate, and fluorouracil",1
20043,"gx-188e, imiquimod",1
20044,weekly telephone symptom assessment,1
20045,alt-803 + atezolizumab,1
20046,hti-1066 dose level 1,1
20047,tc-94m sestamibi,1
20048,mnk-010,1
20049,aerobic capacity,1
20050,corn oil pearls,1
20051,rfa + sorafenib,1
20052,docetaxel (d),1
20053,bmdex,1
20054,gemcitabine (mg/m²),1
20055,endomina,1
20056,"etoposide, doxorubicin, vincristine, cyclophosphamide, rituximab",1
20057,mf-wlp,1
20058,interstitial illumination photodynamic therapy,1
20059,capecitabine +/- oxaliplatin,1
20060,modified lateral positioning.,1
20061,miltenyi magnetic cell sorter for cd3,1
20062,underwater resection,1
20063,amg386,1
20064,mouthwash-standard pharmacy preparation,1
20065,3-5% acetic acid,1
20066,epothilone,1
20067,non-specific text-based reminder (general health tip),1
20068,disulfiram/copper,1
20069,prospective midazolam,1
20070,simvastatine,1
20071,fine needle aspiration and core biopsy of lymph node,1
20072,gcsf (growth colony stimulating factor),1
20073,final breath volatile organic compounds,1
20074,"sorafenib (nexavar, bay43-9006) + interferon",1
20075,indocyanine green tracer,1
20076,concurrent capecitabine or 5-fu,1
20077,histamine dihydrochloride and il-2,1
20078,biologic: pegylated recombinant human hyaluronidase,1
20079,cd19.car-ankt cells,1
20080,modified-folfirinox,1
20081,"cryopreservation of hscs using 7,5% dmso concentration",1
20082,lntme,1
20083,pcr/pcr/ldr strategy,1
20084,"smartphone equipped with application ""bouge"" = coach group",1
20085,"healing elements,methuselah medical technology",1
20086,carmustine (bcnu),1
20087,ct scan with spirometry,1
20088,intralesional cryotherapy,1
20089,abbv-085,1
20090,4-aminopyridine,1
20091,von frey hairs,1
20092,agen2034,1
20093,cd3+ t cell product infusion,1
20094,alpha-lipoic acids,1
20095,continuous glucose monitor,1
20096,azd1152 part a,1
20097,arry-382,1
20098,azd4901 (oral),1
20099,mitoxantrone hydrochloride (dhad),1
20100,delivery of questionnaires,1
20101,targeted therapy based on molecular profiling,1
20102,mastectomy with bovie,1
20103,"genexol-pm 300mg/?, carboplatin 5auc",1
20104,gsk1120212 plus everolimus,1
20105,tripterygium wilfordii,1
20106,low risk with partial remisssion after 4 cycles of abvd chemotherapy schedule. two eshap courses are delivered.,1
20107,excision of the levator muscle,1
20108,lubiprostone,1
20109,cross-over to azd9291,1
20110,zd1839 iressa,1
20111,testing of brca status regarding germline and somatic mutation,1
20112,psychosexual intervention,1
20113,automated breast ultrasound,1
20114,"3,4 diaminopyridine",1
20115,"epirubicin, cyclophosphamide, paclitaxel, dabepoetin alfa",1
20116,combination of treatment modalities,1
20117,vinorelbine and gemcitabine,1
20118,olaparib+cediranib combination therapy,1
20119,physical activities adapted to children,1
20120,montanide + cpg-7909/pf-3512676 + melan-a native and analog peptides + ny-eso-1 long peptide + mage10 peptide,1
20121,splanchnicectomy,1
20122,tds-im system,1
20123,vcl-im01 (encoding il-2) with electroporation,1
20124,usual care plus lef-scp,1
20125,"imatinib mesylate, cyclophosphamide (dosing level 2)",1
20126,"tegafur/gimeracil/oteracil potassium (s-1), krestin (psk)",1
20127,navigation services,1
20128,mek162 + raf265,1
20129,eligible patients' paper-based reminder,1
20130,pfk-158,1
20131,"cisplatin, fluorouracil and concurrent radiation therapy",1
20132,re-mission,1
20133,positron emission tomography and ct,1
20134,18f-fdg-tep,1
20135,escalated dose,1
20136,duraseal,1
20137,solvent with specific gravity less than lipiodol,1
20138,tru-016 20 mg/kg + obinutuzumab,1
20139,lanthanum carbonate,1
20140,dacogen (decitabine) only,1
20141,cognitive evaluation by mms (mini-mental state examination) and moca (montreal cognitive assessment) tests,1
20142,planning prompt,1
20143,trastuzumab+capecitabine+oxaliplatin,1
20144,sir-spheres® yttrium 90,1
20145,muscular strength,1
20146,inferior alveolar nerve block,1
20147,docetaxel oxaliplatin,1
20148,endo-laparoscopic approach,1
20149,western-style diet (wd),1
20150,writing d (control noninformative writing),1
20151,sdregn2810/ipi,1
20152,"observational study, no intervention",1
20153,rapamycin-generated autologous th1/tc1 cells (modified primary human t cells),1
20154,hexvix pdt with karl storz t-light,1
20155,fluorouracil injectable product,1
20156,hospital counseling + nicotine replacement therapy. questionaires,1
20157,medi3726 & enzalutamide combo,1
20158,"nexavar (sorafenib, bay43-9006) + carboplatin + paclitaxel",1
20159,contrast enhanced intraoperative ultrasound,1
20160,ablative or excisional therapy,1
20161,gelport,1
20162,low dose of aspirin,1
20163,ligasure vessel sealing system,1
20164,gynecologic surgery - standard coelioscopy,1
20165,ocpm immunotherapeutic vaccine,1
20166,ifx-hu2.0,1
20167,ckd-516 inj.,1
20168,complete larynx radiotherapy,1
20169,cat-8015 30 mcg/kg,1
20170,arm 2- dose expansion,1
20171,placebo intake,1
20172,one-time questionnaire + recorded qualitative interview,1
20173,serratus plane block with local anesthetic,1
20174,stereotactic ablative body radiotherapy as monotherapy,1
20175,arginine in powder form,1
20176,placebo to pembrolizumab,1
20177,th2 rapa cells,1
20178,dexamethasone plus radium-223,1
20179,re-irradiation therapy (rrt) to brain,1
20180,picture option grid,1
20181,paclitaxel and carboplatin combination,1
20182,strattice™ acellular dermal matrix,1
20183,ala-rich diet,1
20184,prostate cancer screening decision aid,1
20185,embosphere®,1
20186,apg-115,1
20187,supracolic gastrojejunal anastamosis,1
20188,no intervention; this is an observational study,1
20189,18f-fluordeoxyglucose positron emission tomography/ computed tomography,1
20190,high risk lymphedema education and device intervention,1
20191,azacitidine and oral vorinostat,1
20192,distal gastrectomy with d2 lnd,1
20193,pem scan with clearpemsonic,1
20194,laparoscopic dg,1
20195,auto car t cell therapy,1
20196,comparator: quadrivalent human papillomavirus (hpv) vaccine,1
20197,dydrogesterone m ( case 2 ),1
20198,mindfulness training program,1
20199,aer-o-scope (colonoscopy),1
20200,tsh stimulation,1
20201,immune-checkpoint inhibitors therapies,1
20202,test result sent by letter,1
20203,protein vaccination,1
20204,irinotecan-capecitabine-oxaliplatin,1
20205,retzius sparing radical prostatectomy,1
20206,interactive preventive health record,1
20207,activity and exercise intervention,1
20208,chest radiotherapy,1
20209,"rescue therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).",1
20210,prosense™,1
20211,positron emission tomography/computed tomography (pet/ct),1
20212,occlusive wound closure,1
20213,patient assistance,1
20214,"nivolumab, surgery, chemoradiotherapy",1
20215,normal saline sinus rinse,1
20216,transcatheter arterial embolization,1
20217,gewf solution,1
20218,tumor associated antigen lymphocytes (taa-ctl),1
20219,ia carbo+ radiation,1
20220,reconstruction,1
20221,pre-operative counseling and education,1
20222,follow-up assessments (6 and 12 months),1
20223,bms-986258,1
20224,5fu+l-leucovorin,1
20225,durvalumab plus tremelimumab,1
20226,hydralazine and valproic acid: cohort 4,1
20227,"radiotherapy, 28 x 1.8 gy",1
20228,dignity psychotherapy,1
20229,zhen qishen capsule placebo and oral supplement of yuyikang placebo,1
20230,"nivolumab, iv, 240 mg",1
20231,opb-111001,1
20232,tace+rfa,1
20233,3'-deoxy-3'-[18f]fluorothymidine (flt),1
20234,rad.cd40l,1
20235,reconval k1 cream,1
20236,temozolomide 200 mg/m^2,1
20237,group 2: peripherally located chest wall adjacent tumors,1
20238,u3-1287 (unlabeled),1
20239,zd6474 (vandetanib at the dose of 100 mg),1
20240,genomic test,1
20241,infusion of mixture of anticancer agent and lipiodol,1
20242,rindopepimut,1
20243,infrared coagulator,1
20244,continuous aerobic exercise training,1
20245,mobile application,1
20246,radiotherapy (curative) for head and neck cancer,1
20247,active care team alert,1
20248,cd19- specific car engineered autologous t-cells (sjcar19 product),1
20249,arachides oleum raffinatum,1
20250,epirubicin and paclitaxel,1
20251,polyp removal upon withdrawal only,1
20252,antiinfectives,1
20253,tace after rfa,1
20254,patients: questions to ask your doctor: a workbook for patient-doctor teams,1
20255,gs-9191 ointment,1
20256,tas-114/capecitabine,1
20257,renca macrobeads,1
20258,proctoscopy,1
20259,endoscopic scissors,1
20260,phase ib: m3814,1
20261,dcvac/pca,1
20262,msc-1,1
20263,the local anesthetic injection,1
20264,extended timing,1
20265,b-cll vaccine,1
20266,20 gy ifrt (involved field radiotherapy),1
20267,semi-allogeneic human fibroblasts (mrc-5) transfected with dna,1
20268,dtpa,1
20269,vinorelbine weekly,1
20270,adjuvant oxaliplatin/s-1?sox?,1
20271,placebo dlbs3233,1
20272,"quantitative t-, b-, and nk cell subsets",1
20273,intensive chemo with concurrent growth factor,1
20274,"vats, talc-pleurodesis",1
20275,metronimic chemotherapy,1
20276,telerounding versus bedside rounding,1
20277,focused rigidity bi-valve long arm cast,1
20278,dose level 2/mtd,1
20279,ofatumumab and bortezomib,1
20280,laparoscopic microwave ablation-assisted enucleation,1
20281,adding human papillomavirus testing to organised cervical screening,1
20282,virtual peer-to-peer support mentoring,1
20283,"sms offering a self-sampling kit ""on request""+ sms reminder",1
20284,percutaneous trans-hepatic biliary drainage,1
20285,paclitaxel-carboplatin,1
20286,azacitidine (baml-16-001-s16),1
20287,"folfox4 (oxaliplatin), cetuximab",1
20288,experimental: arm 2 (resist. exercise),1
20289,d-cik and anti-pd-1 antibody,1
20290,"18-fdg pet/ct, dwi, dce-mri",1
20291,breast cancer exercise intervention,1
20292,adrenal venous sampling,1
20293,"paclitaxel , carboplatin, endostatin",1
20294,personalized risk model+website+coaching intervention,1
20295,pedicle screw system,1
20296,there will be no intervention.,1
20297,mab-3f8,1
20298,enhanced recovery after surgery protocol,1
20299,shen-mai san,1
20300,text message application,1
20301,comparator,1
20302,printed education material,1
20303,goals-of-care (goc) video and narrative question,1
20304,total abdominal hysterectomy and methotrexate,1
20305,black currant juice,1
20306,"basic cachexia management (prokinetics, physical activity counselling, nutritional counselling)",1
20307,fdopa-pet/mri imaging,1
20308,standard post-lobectomy wound care plus use of prp and pppc prepared by gps and plasmax respectively,1
20309,"docetaxel, oxaliplatin, capecitabin, bevacizumab",1
20310,experimental: protection routine 2,1
20311,phone nursing follow-up,1
20312,phrmi,1
20313,ginsenoside h dripping pills+placebo,1
20314,da vinci robotic surgery,1
20315,pecblock under echoguidance,1
20316,tap block,1
20317,aijp (arnebia indigo jade pearl),1
20318,chess system,1
20319,oral topical vitamin e,1
20320,anti-icos monoclonal antibody medi-570,1
20321,urea cream based,1
20322,medical outcomes study social support survey,1
20323,mri with dwi vs ct,1
20324,lower-load resistance training (ll),1
20325,c11-amt pet scan,1
20326,ablc,1
20327,anlotinib plus chemotherapy,1
20328,ga-68 psma11,1
20329,surgery for placement,1
20330,receives iv albumin infusion,1
20331,ha-irinotecan,1
20332,electronic brachytherapy (7 gy),1
20333,lonsurf,1
20334,intrabeam®,1
20335,smart phone monitoring device,1
20336,real time registry and data feedback only,1
20337,quality of life questionnaire c30 version 3,1
20338,prednimustine,1
20339,carbohydrate group,1
20340,standard dose capecitabine,1
20341,68ga-dota-bombesin,1
20342,"dacomitinib, pemetrexed",1
20343,concurrent boost rt,1
20344,dcc-2036,1
20345,vbp-926,1
20346,"7 tesla mri, no contrast agent",1
20347,"5-fluorouracil, leucovorin, oxaliplatin, avastin",1
20348,"patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and 8, repeated every 21 days over four cycles.",1
20349,shorter pict,1
20350,potato starch,1
20351,education group,1
20352,radiation by sbrt,1
20353,active vitamin d,1
20354,alpha interferon,1
20355,debio 1143 (at-406),1
20356,monoclonal antibody gd2 anti-idiotype vaccine,1
20357,177lu-cyt-500,1
20358,electroporation using cellectra®-5p,1
20359,autotransfusion,1
20360,d2 lymphadenectomy including no. 10,1
20361,"low calorie, low nitrogen parenteral nutrition for patient with nrs score 3",1
20362,ovarian autotransplantation,1
20363,vats approach,1
20364,new colorectal cancer screening patient education document,1
20365,patients receive slnb,1
20366,therapeutic egf vaccine (cyclophosphamide and the recombinant human regf-p64k/montanide isa 51 vaccine),1
20367,auscultation,1
20368,based on sensitivity analysis,1
20369,oral rucaparib,1
20370,[111in]-fpi-1547 injection,1
20371,zinecard,1
20372,rta 402 dose1,1
20373,fludarabine mono,1
20374,all-transretinoic acid,1
20375,alogenic mini trasplantation,1
20376,gastric cancer,1
20377,gsk1120212 (trametinib),1
20378,systemic anti-tumor therapy,1
20379,111in-bu-12,1
20380,bevacizumab and etoposide,1
20381,high-dose-rate prostate brachytherapy,1
20382,autologous anti-cd19 car t cells,1
20383,palifermin 2 x 180 ?g/kg/day,1
20384,physician's counseling,1
20385,cryo biopsy,1
20386,autologous anti-gp 100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes,1
20387,"phyxoltm, cisplatin",1
20388,placebo to match azd4901,1
20389,family conference,1
20390,flax seed oil,1
20391,collect samples,1
20392,mometasone furoate 0.1%,1
20393,0.08 mg/kg cpg 7909,1
20394,azd9291 40 mg,1
20395,"2-d high definition vision systems, transanal endoscopic operation (teo)",1
20396,3d-conformal radiotherapy,1
20397,dara iv,1
20398,fuse-tm colonoscope,1
20399,infusion of non-t-cell depleted bone marrow on day 0,1
20400,calcifediol oral product,1
20401,the kidney cancer questionnaire,1
20402,obi kv imaging,1
20403,ebus-tbna followed by eus-b-fna,1
20404,endocuff vision assisted colonoscopy,1
20405,dynamic mri acquisition,1
20406,combined chemotherapy with trabectedin followed by irinotecan,1
20407,maintenance erlotinib,1
20408,"chemotherapy: ts-1, leucovorin and gemcitabine",1
20409,bms-690514 / folfiri,1
20410,circulating tumor cells test,1
20411,gentle exercise,1
20412,intra-arterial chemotherapy,1
20413,4 cycles of vamp chemotherapy,1
20414,interstitial laser therapy,1
20415,neo-adjuvant treatment,1
20416,sorafenib-vorinostat,1
20417,dim red light therapy device,1
20418,"induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (crd) regimen",1
20419,radical non-small cell lung cancer (nsclc) surgery,1
20420,lightpath,1
20421,sbg (soluble beta-glucan),1
20422,betalutin with lilotomab dose 2,1
20423,superselective intraarterial cerebral infusion of cetuximab,1
20424,proxiscan,1
20425,cooked parsnips with parsley,1
20426,hsv1716 intra-pleural delivery,1
20427,pegifn alfa-2b,1
20428,arm a : iv iron + epoietin zeta,1
20429,intravesical baobab oil,1
20430,flu-fobt program,1
20431,aglatimagene besadenovec,1
20432,no passive bending function,1
20433,fluphenazine hydrochloride,1
20434,k0706,1
20435,swift home intervention,1
20436,"intercalation therapy using pemetrexed, cisplatin and erlotinib",1
20437,hypo fractionated whole breast radiotherapy,1
20438,0.5% timolol maleate gel forming solution,1
20439,skeletal muscle index,1
20440,mechlorethamine,1
20441,pi3k-delta inhibitor tgr-1202,1
20442,68ga-nota-nfb,1
20443,placebo and paclitaxel-carboplatin,1
20444,blood simple,1
20445,68ga dotatate,1
20446,neurofeedback training (randomized),1
20447,fluvoxamine,1
20448,roux-en-y anastomosis,1
20449,exercise based multimodal intervention,1
20450,klh day 29,1
20451,"rhegf + povidone iodine, chlorhexidine, & nystatin",1
20452,illumination with ceramoptec laser,1
20453,anaerobic exercise,1
20454,standard of care nutritional support,1
20455,supportive therapy group 2,1
20456,ventilation image-guided radiotherapy,1
20457,"anti-ley- scfv-cd28-? vector,.",1
20458,paclitaxel plus 5-fluorouracil,1
20459,part 1: sym004 6 mg/kg + cisplatin/gemcitabine,1
20460,metformin hydrochloride extended release 750mg,1
20461,mobile phone app + patient navigation,1
20462,low dose fractionated radiation - 80cgy with chemotherapy,1
20463,uv1 vaccine,1
20464,llnd,1
20465,"aspirin placebo, vitamin d placebo",1
20466,autologous natural killer cell-like ctls,1
20467,autologous hematopoietic cell transplantation (hct),1
20468,bedside talc slurry pleurodesis,1
20469,rocking chair intervention,1
20470,hdwle,1
20471,synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine,1
20472,pdr brachytherapy,1
20473,il15-dc vaccine,1
20474,dexlansoprazole placebo,1
20475,rituximab plus chop immunochemotherapy,1
20476,placebo oral tablet and prednisolone,1
20477,flexible drill biopsy instrument,1
20478,20 mg/kg tru-016 and bendamustine,1
20479,replens and coconut oil,1
20480,sphingosine kinase-2 inhibitor abc294640,1
20481,irradiation plus stereotactic radiosurgery,1
20482,paclitaxel 80 mg/m^2,1
20483,hamsa-1™ tl-118,1
20484,"concurrent sorafenib and imrt, followed sorafenib maintenance",1
20485,pegylated rhg-csf regimen,1
20486,autologous peripheral blood stem cell transplantation.,1
20487,international prostate symptom score (ipss),1
20488,diffusion/perfusion-weighted magnetic resonance imaging,1
20489,indocyanine green infusion,1
20490,18f-miso,1
20491,"m200 (volociximab), carboplatin, paclitaxel",1
20492,blood/urine sample collection,1
20493,skinercity plus sirolimus/rapamycin,1
20494,folfox6m,1
20495,patients in long response during halaven® treatment,1
20496,mammography-histopathological examination of breast mass specimens- polymerase chain reaction,1
20497,"gemcitabine, nedaplatin, iv",1
20498,cart-123 cells,1
20499,skin cream,1
20500,autologous ikdc-like cells,1
20501,infusion of cd3/cd28 stimulated t cells,1
20502,medicinal plant,1
20503,amonafide l-malate,1
20504,interoperative radiation by intrabeam using low energy x-ray,1
20505,cinobufotalin injection,1
20506,metotrexato in consolidation-3,1
20507,yasmin;,1
20508,trastuzumab plus letrozole,1
20509,natural killer and natural killer t cell,1
20510,surgeon team alone management,1
20511,phase i - gm.cd40l.ccl21 vaccinations,1
20512,water exchange/ai,1
20513,sagopilone (zk 219477) + carboplatin,1
20514,25 gy,1
20515,maltodextrins,1
20516,4scar-fra,1
20517,imatinib mesylate 400 mg + cytarabine,1
20518,methyl aminolevulinate,1
20519,brief cognitive behavioral therapy,1
20520,emd 273066,1
20521,thromboreductin,1
20522,c-choline,1
20523,pharmorubicin,1
20524,transanal hybrid-laparoscopic total mesentery excision,1
20525,clofarabine incorporated into a 5-drug regimen,1
20526,panher,1
20527,lmp 776,1
20528,nc318,1
20529,1 pet/ct with f-18-fch + 1 pet/ct with ga-68-nodaga-mj9,1
20530,low dose radioactive seed followed by surgery and mammogram,1
20531,anti-ctla4 monoclonal antibody and hdi,1
20532,anti-cd19/22-car vector-transduced t cells,1
20533,transplant with pbscs,1
20534,functional jejunal interposition,1
20535,three dimensional laparoscopic pancreaticoduodenectomy,1
20536,pregabalin/placebo,1
20537,conventional postoperative care,1
20538,diffuse optical spectroscopy imaging (dosi),1
20539,alimta or taxotere,1
20540,"docetaxel, cisplatin and 5-fu treatment followed by concomitant cisplatin, 5-fu and radiotherapy",1
20541,facial morphing intervention,1
20542,"not applicable, observational study",1
20543,adenovirus vector,1
20544,adjuvant nab-paclitaxel/gemcitabine,1
20545,recombinant human interferon a-2b gel,1
20546,muc-2-klh,1
20547,hdi,1
20548,open resection for pcca,1
20549,smart phone based smoking cessation,1
20550,catumaxomab 140µg,1
20551,pd,1
20552,ar inhibitor with cdk4/6 inhibitor,1
20553,breast radiation plus regional radiation,1
20554,cyclophosphamide (c),1
20555,2d laparoscopic surgery,1
20556,lee011 (ribociclib),1
20557,pegzilarginase,1
20558,intake of 60 ml placebo daily in addition to chemotherapy,1
20559,sequenced group,1
20560,sbrt 60.0 gy,1
20561,az2281 + carboplatin,1
20562,thyroseq v.3,1
20563,analysis of spectroscopic biomarkers of proliferation for six-month survival,1
20564,eus-fnb with ez shot 2 19g first,1
20565,hypofractionated therapy,1
20566,cidan capsule,1
20567,surgical treatment for renal mass,1
20568,class ii hysterectomy,1
20569,peginterferon alpha-2a and ribavirin,1
20570,optimox plus bevacizumab,1
20571,adaptive dose-escalated multi-modality image-guided radiotherapy,1
20572,ilio-inguinal lymphadenectomy,1
20573,stem cell transplant (stc),1
20574,"capecitabine, irinotecan, 5-fluorouracil+calciumfolinat",1
20575,respirology counseling,1
20576,drug: cisplatin and 5-fluorouracil,1
20577,pha-793887,1
20578,parenteral over night nutrition,1
20579,pf-06459988,1
20580,tds-im system (inchor medical systems),1
20581,radioactive iodine seed,1
20582,tnferade™ biologic,1
20583,serum-derived bovine immunoglobulin/protein isolate (sbi),1
20584,mature dendritic cell (dc) vaccine,1
20585,picc with high pressure tolerance,1
20586,leucovorin(iv),1
20587,paclitaxel-based chemotherapeutic regimens,1
20588,recombinant prame protein combined with the as15 adjuvant system gsk2302032a,1
20589,tesmilifene (ymb1002),1
20590,wt1:126-134,1
20591,standard of care adt + (hmb + arginine + glutamine),1
20592,adagloxad simolenin/obi-821,1
20593,writing,1
20594,vocal hygiene,1
20595,"pegylated interferon (pegrifn-?, pegasys)",1
20596,fludarabine-cladribine-busulfan conditioning regimen,1
20597,any mmy treatment,1
20598,picato gel,1
20599,hipec-gemcitabine,1
20600,arm 4: dc vaccine,1
20601,electronic newsletters,1
20602,internet-based stepped care,1
20603,minicare h-2000,1
20604,"cryosurgery , ire surgery ,surgery",1
20605,combination diet,1
20606,targretin® (bexarotene),1
20607,vmat-sib,1
20608,phase i dose level 1,1
20609,ligasure device,1
20610,health education control,1
20611,"lavage of the cavum uteri and proximal fallopian tubes, performed in the luteal phase of the female cycle",1
20612,anti-seizure prophylaxis,1
20613,2d/3d tomosynthesis,1
20614,external 3-dimensional conformal radiotherapy (3d-crt),1
20615,treatment with arq 197 in combination with gemcitabine,1
20616,epidiferphane,1
20617,flotrac sensor,1
20618,postoperative ccrt,1
20619,"hormonal analysis, pelvic us",1
20620,neoantigen vaccines,1
20621,large loop excision of transformation zone (cone biopsy),1
20622,bladder catheterization,1
20623,tila-tace,1
20624,magnetic resonance imaging with contrast,1
20625,dydrogesterone m ( case 1 ),1
20626,calorimetry,1
20627,l-arginine (10 min infusion),1
20628,zyclara®,1
20629,external beam radiation (dose level 1),1
20630,ct or pet scans,1
20631,recombinant tissue plasminogen activator,1
20632,radioiodine therapy after rhtsh,1
20633,preference based decision aid,1
20634,corticosteroid with lidocaine,1
20635,endoscopic screening,1
20636,99technetium-sulfur colloid radiolabel,1
20637,elemental calcium,1
20638,tasquinimod 0.25 mg; 0.5 mg; 1.0 mg,1
20639,rituximab+mvpdl,1
20640,bibf 1120 (low) + pld 30 mg/m2 + cbdca auc5 mg/ml*min,1
20641,relaxation audio recording,1
20642,5-fu / cisplatin,1
20643,nst using mud for metastatic renal cell carcinoma,1
20644,"dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 iv",1
20645,cachexia acupuncture-a (peace classic needles® ),1
20646,intracavitary ultrasound,1
20647,3-d laparoscopy,1
20648,bibw 2992 in combination with vinorelbine,1
20649,azacitidine and venetoclax,1
20650,conventional resistance training,1
20651,"uncovered stent (bona stent, pyloric/duodenal) insertion",1
20652,follow up/phone call,1
20653,interview regarding experiences and opinions as to condition and treatment,1
20654,brief supportive psychotherapy,1
20655,[14c]azd9291,1
20656,cohort 1: carfilzomib 15 mg/m2,1
20657,avm-related ich,1
20658,cognitive-existential intervention,1
20659,a book and videos about acp,1
20660,"vorinostat, lenalidomide, carfilzomib, dexamethasone",1
20661,sinus pilonidal excision and standard cares,1
20662,cancer-focused relationship enhancement,1
20663,intravascular ultrasound of the liver,1
20664,intracavitary accelerated partial breast irradiation,1
20665,abbv-221,1
20666,gbm6-ad and poly-iclc after surgery only,1
20667,cyberknife robotic radiosurgery system,1
20668,urine samples (biomarkers),1
20669,adh -1 and capecitabine,1
20670,bcl-xl_42-caf09b vaccine,1
20671,i can pic,1
20672,myostrain®,1
20673,isavuconazonium sulfate - intravenous,1
20674,ulipristal acetate (upa) 10 mg,1
20675,bay94-9343 (expansion),1
20676,tcelna,1
20677,faz053,1
20678,informational videos,1
20679,docetaxel + oxaliplatin + capecitabine,1
20680,radical total gastrectomy with d2 (d2 - #10) lymph node dissection by open conventional approach,1
20681,"zevalin ([90]y-ibritumomab tiuxetan, bay86-5128)",1
20682,bms-986205 placebo,1
20683,fast track protocol,1
20684,aktilite cl128,1
20685,leflunomide 10 milligram (mg),1
20686,placebo plus best investigator's choice (bic),1
20687,lanreotide acetate,1
20688,six months home-based exercise training,1
20689,amg 595,1
20690,fentanyl 1-day transdermal patch (titration phase),1
20691,erythropoietin: observational study,1
20692,olympus elite,1
20693,folfoxiri with bevacizumab,1
20694,docetaxel + estramustine + hydrocortisone,1
20695,routine dose icotinib,1
20696,clinical germline analysis,1
20697,standard endopath,1
20698,psa assay,1
20699,r-y reconstruction after total gastrectomy,1
20700,social norms b reminder,1
20701,punch skin biopsy,1
20702,lbh581,1
20703,folfiri-cetuximab,1
20704,vizablate intrauterine ultrasound-guided rf ablation,1
20705,ce-lus,1
20706,silver-releasing dressings,1
20707,no interventions will be taken in this observational study,1
20708,hpv self-testing,1
20709,breast conserving surgery,1
20710,ptcd and pancreatoduodenectomy,1
20711,kareniticin and cyclophosphamide,1
20712,image guided video-assisted thoracic surgery (vats) resection,1
20713,111indium chx-a,1
20714,b0 group: bolus 0.6mcg/kg without background infusion,1
20715,"6-mercaptopurine, methotrexate",1
20716,rad 001 in combination with caelyx,1
20717,colonic reservoir,1
20718,non-juven supplement,1
20719,"no intervention, observation only",1
20720,dexaméthasone,1
20721,detection of circulating tumor cells in blood samples,1
20722,ec to docetaxel or paclitaxel,1
20723,patient derived cd19 specific car t cells also expressing an egfrt,1
20724,bpi-16350,1
20725,apatinib/capecitatine,1
20726,ebv specific ctls,1
20727,cisplatinium and fluorouracil - standard treatment,1
20728,y-stent (bonastent m-hilar),1
20729,nurse education and care program,1
20730,imc-3c5,1
20731,pco plus,1
20732,cisplatin; etoposide; radiation therapy; docetaxel; neulasta,1
20733,gp100:209-217,1
20734,brushing of the olfactory cleft,1
20735,nutrition - small group educational session,1
20736,short-form 12 of health related quality of life questionnaire,1
20737,goal-directed therapy,1
20738,autologous monocyte-derived dendritic cells (dc) transfected with dna,1
20739,axitinib + paclitaxel + carboplatin (cohort 1),1
20740,decision aid (da),1
20741,^111 in ibritumomab tiuxetan,1
20742,dapagliflozin (dapa),1
20743,research of constitutional genetic alterations,1
20744,non-myeloablative stem cell transplantation,1
20745,hipec with cisplatin (100mg/m²),1
20746,pembrolizumab at 7 days prior,1
20747,chemoradiotherapy (ctrt),1
20748,zio-101,1
20749,vandetanib and dasatinib,1
20750,avastin injectable product,1
20751,autologous hematopoietic cell transplant,1
20752,54gy 18gy/fr. x 3 fractions,1
20753,pemetrexed and cisplatin or carboplatin,1
20754,usual care (wait-list control),1
20755,pathologic large tissue embedded table,1
20756,pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery,1
20757,car.cd30 t cells,1
20758,anticachectic therapy,1
20759,response to therapy,1
20760,wokvac vaccine,1
20761,ct guided percutaneous ablation,1
20762,lcv,1
20763,pazopanib 400 mg qd - gemcitabine and docetaxel in combination,1
20764,post-gastrectomy peritoneal washing cytology,1
20765,eppendorf hypoximeter,1
20766,methodological pens,1
20767,oir imaging,1
20768,"tbi, systemic chemotherapy and antibodies as follows:",1
20769,hope enhancement workshop,1
20770,chemotherapeutic combinations,1
20771,chemotherapy drugs+iodized oil,1
20772,"hospital counseling + nicotine replacement + presurgical scheduled reduced smoking, questionaires",1
20773,laparoscopic d2 lymphadenectomy plus cme,1
20774,ultrasonography and elastography,1
20775,early physical therapy and educational strategy,1
20776,chest xray,1
20777,tapestry,1
20778,endoscopic cystogastrostomy,1
20779,js001 120mg+gp,1
20780,standard platinum-based chemotherapy,1
20781,navigated endoscopy,1
20782,av-mel-1,1
20783,placebo (vitamin d),1
20784,cd19 cart,1
20785,intravenous contrast administration,1
20786,questionnaire t5 to fill,1
20787,gevokizumab,1
20788,portal vein occlusion,1
20789,vats without chest tube placement,1
20790,idiotype-pulsed autologous dendritic cell vaccine apc8020,1
20791,2mg ino-5150 plus 1mg ino-9012 and electroporation device cellectra®-5p,1
20792,da vinci® si™,1
20793,nivolumab & ipilimumab,1
20794,gleevec®,1
20795,self-administered form of cognitive-behavioral therapy,1
20796,des (volatile anesthetic-desflurane),1
20797,hign dose daunorubicin,1
20798,supportive care program,1
20799,enzalutamide placebo to match (ptm),1
20800,omron walking style pro. 20,1
20801,tamoxifen stim in early follicular phase,1
20802,tai-meso-cart,1
20803,induction or consolidation ip chemotherapy,1
20804,somatic yoga and meditation (sym),1
20805,feed-back,1
20806,six and three time schedule,1
20807,apatinib 500mg,1
20808,group intervention and questionnaires,1
20809,serum microrna-25 detection,1
20810,ct-707,1
20811,ky1044,1
20812,axillary sampling,1
20813,pre-surgical chemotherapy,1
20814,entonox,1
20815,hextend,1
20816,patients with positive pet after salvage therapy,1
20817,rectectomy,1
20818,xenmatrix,1
20819,2mg ino-5150 and electroporation device cellectra®-5p,1
20820,sir-spheres yttrium-90 microspheres,1
20821,da vinci robotic transoral robotic surgical system,1
20822,standard of information,1
20823,salpingo-oophorectomy only by laparoscopy,1
20824,pdt treatment,1
20825,veran system,1
20826,megestrol acetate 160mg tablet,1
20827,0.06% resiquimod gel - b,1
20828,vincristine and topotecan,1
20829,dignity therapy - nurse led,1
20830,panitumumab+folfox-4,1
20831,initial breath volatile organic compounds,1
20832,fluvastatin sodium,1
20833,cognitive-behavioral intervention,1
20834,empowered primary care model,1
20835,"gemcitabine, paclitaxel and oxaliplatin (gempox).",1
20836,auricular point acupressure,1
20837,docetaxel + oxaliplatin + 5-fu,1
20838,wearable device (fitbit charge hr® or fitbit alta ®),1
20839,low frequency group,1
20840,kidrolase,1
20841,allogeneic cell transplantation,1
20842,automated reminder,1
20843,methyl-aminolevulinate,1
20844,ny-eso-1 olp4 vaccine with poly-iclc and montanide,1
20845,preoperative sbrt,1
20846,computed tomography perfusion,1
20847,ec,1
20848,stereotactic hypofractionated radioablation,1
20849,alc and placebo,1
20850,"statin, such as simvastatin, atorvastatin, rosuvastatin, pravastatin)",1
20851,[3'-deoxy-3'-[f-18] fluorothymidine,1
20852,ca plus vit d,1
20853,celebrex (celecoxib),1
20854,expectancy,1
20855,best practices in pancreatic cancer care,1
20856,avastin/folfiri,1
20857,irinotecan plus lobaplatin,1
20858,antireflux surgery,1
20859,iodine i 131 chimeric monoclonal antibody g-250,1
20860,vinorelbine per os 80 mg/m²,1
20861,tositumomab and iodine i 131 tositumomab (anti-b1 antibody and iodine-131 anti-b1 antibody),1
20862,"dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy",1
20863,pik3ca,1
20864,instrumental activities of daily living,1
20865,mode of detection: cancer detected at screening,1
20866,sodium nitrate,1
20867,1.5% nacl,1
20868,sema4c high value follow-up group,1
20869,pegcyte,1
20870,doxil/caelyx reference product (treatment a),1
20871,maintenance lenalidomide,1
20872,ibuprofen 400 mg,1
20873,hrqol questionnaire,1
20874,social incentive (way to health),1
20875,"chemotherapy, celecoxib, and radiation",1
20876,block with lidocaine for sam and pec i block,1
20877,euroqol eq-5d-3l,1
20878,australian government bowel cancer screening booklet,1
20879,cest mri,1
20880,laparoscopic ovarian cyst enucleation,1
20881,kx2-391 and paclitaxel,1
20882,vitamin supplements,1
20883,mm-310,1
20884,ultrasound exam with doppler,1
20885,ovidrel 250 mcg per 0.5 ml prefilled syringe,1
20886,"imatinib mesylate, cyclophosphamide (dosing level 1 )",1
20887,aerobic training - fixed schedule,1
20888,nab paclitaxel.,1
20889,stereotactic body radiotherapy ( sbrt),1
20890,hads score,1
20891,i-131 tositumomab therapeutic regimen,1
20892,vtx-2337 plus radiotherapy,1
20893,pre-test video education,1
20894,"cpi 613, mfolfirinox",1
20895,neobladder posterior wall suspended with round ligament of uterus,1
20896,25 µg doxorubicin-containing mna,1
20897,cmv-alt + cmv-dcs,1
20898,octreotide (immediate release),1
20899,aerobic resistance exercise,1
20900,immunological and tumour characterization,1
20901,epo906 epothilone b,1
20902,circulating tumor cells evaluation,1
20903,tc99m-sulfur colloid,1
20904,pertuzumab (rhumab 2c4),1
20905,gdc-0077,1
20906,laxative treatment,1
20907,serum tumor marker directed disease monitoring,1
20908,ptbd group,1
20909,comparator: odanacatib,1
20910,brachytherapy or sbrt (stereotactic body radiation therapy),1
20911,doxorubicin/cyclophosphamide (ac) or docetaxel/cyclophosphamide (tc),1
20912,lung and coronary ct assessment,1
20913,y90 ibritumomab tiuxetan rit,1
20914,"placebo, velcade and dexamethasone",1
20915,tab premarin (ethinyl estradiol),1
20916,subchondroplasty procedure with accufill,1
20917,mixed powder of a. digitata and m. sylvestris,1
20918,low-flow air,1
20919,"imatinib mesylate, cyclophosphamide (dosing level 3)",1
20920,r-ebus with ultrathin bronchoscope,1
20921,epoetin alfa and darbepoetin alfa,1
20922,azacitidine plus r-gdp,1
20923,biodex system 3 dynamometer,1
20924,80 mg mmc in 40 ml tc-3.,1
20925,therasphere-yttrium 90 microsphere,1
20926,bay1000394 (5mg),1
20927,copper cu 64-dota b-fab,1
20928,placebo (for fish oil),1
20929,gemcitabine + trabectedin,1
20930,caregiver psychoeducational consultation program (cpcp),1
20931,pcr,1
20932,wst 11 -mediated -vtp,1
20933,nx-1207 2.5 mg,1
20934,radium bromatum/apis mellifica/belladonna pills,1
20935,transrectal ultrasound-guided biopsy,1
20936,atezolizumab (mpdl3280a) [tecentriq],1
20937,eu-approved avastin®,1
20938,changes in preoperative care,1
20939,ct-fdg/pet scan of the head-and-neck region,1
20940,clr 131,1
20941,gefitinib tablets,1
20942,"vinorelbine, g-csf, & plerixafor",1
20943,standard fractionated radiation therapy,1
20944,ps q18,1
20945,follow up with mobile device,1
20946,standard dose pelvic radiation therapy,1
20947,"paclitaxel,cisplatin,5-fu,folic acid",1
20948,estradiol plus mpa,1
20949,radiotherapy (radiation),1
20950,neoadjuvant docetaxel + cyclophosphamide,1
20951,apdc + chemotherapy,1
20952,induction and gap chemotherapy (capecitabine combine with oxaliplatin),1
20953,wait-list control condition (wlc),1
20954,surgical debulking and intrathoracic hyperthermic chemotherapy,1
20955,leucovorin 200 mg/m^2,1
20956,multiparametric mri. multi-parametric ultrasound,1
20957,shared care,1
20958,hespecta,1
20959,blueprint,1
20960,sexual counseling sessions,1
20961,light physical activity,1
20962,supplemental survey,1
20963,3'-deoxy-3'-18f fluorothymidine (flt),1
20964,switching level of suction,1
20965,connected device,1
20966,virtue,1
20967,ex vivo expanded cord blood cells,1
20968,quinacrine dihydrochloride - escalation dose,1
20969,sib 5 fractions if needed,1
20970,infinia hawkeye spect/ct gamma camera,1
20971,stage 1 low dose methylenedioxymethamphetamine,1
20972,wireless pulse oximeter (wipox),1
20973,external beam radiotherapy (xrt),1
20974,"ipilimumab, nivolumab, pembrolizumab or atezolizumab",1
20975,"ypeg-rhg-csf, 20?g/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle",1
20976,nivolumab 240 mg iv,1
20977,laparoscopically-assisted esophagectomy,1
20978,thermal destruction with radiofrequency or laser,1
20979,smart app wearable,1
20980,23-32 mmhg compression sleeve with gauntlet,1
20981,coping class,1
20982,whey protein supplementation,1
20983,ebrt target concept related to the primary tumor (ctv-t) and internal motion; concepts for oar contouring,1
20984,self-management support,1
20985,enteral feeding,1
20986,ptbd,1
20987,laparoscopic ovarian cystectomy using ultrasonic scalpel,1
20988,opt-821,1
20989,"5fu/lv, oxaliplatin, bevacizumab, irinotecan",1
20990,capsules placebo,1
20991,oral vioxx (rofecoxib),1
20992,"calendula weleda cream (weleda ag, sweden) contains extracts of marigold plant (calendula officinalis 10%), wool fat and sesame oil",1
20993,indocynanine green,1
20994,64-mdct scanning,1
20995,exemestane and pazopanib,1
20996,endoscopic ultrasound-guided protal venous blood sampling,1
20997,al101,1
20998,mfolfox-6 + cetuximab until disease progression or early withdrawal.,1
20999,12 week exercise intervention,1
21000,lamivudine or entecavir,1
21001,pegylated recombinant l-asparaginase erwinia chrysanthemi,1
21002,neurocognitive exams,1
21003,gcp - genistein combined polysaccharide,1
21004,fs102,1
21005,cdphl algorithm,1
21006,89zr?dfo?regn3504,1
21007,electrical stimulation,1
21008,carbop-paclit,1
21009,asn007: ascending doses,1
21010,laser hyperthermia,1
21011,starch,1
21012,functional imaging before treatment.,1
21013,tissue and blood collection,1
21014,annual fit and colonoscopy in case of a positive test,1
21015,esophageal sparing imrt,1
21016,bi 811283 (d 1 and 15),1
21017,neoadjuvant and adjuvant durvalumab,1
21018,tasting of flavours,1
21019,patient health questionnaire 9-item version,1
21020,fresh tumor tissue biopsy,1
21021,autologous neuroblastoma vaccine,1
21022,liposomal nddp,1
21023,hd204,1
21024,light therapy intensity 1,1
21025,hydromorphone 10 mcg/ml epidural solution,1
21026,follow up for death and recurrence,1
21027,masticators sparing techniques,1
21028,epoetin beta [neorecormon],1
21029,pva microporous hydrospheres/doxorubicin hydrochloride,1
21030,web-based decision aid alone,1
21031,leo 43204 formulation 2 dose xx,1
21032,tranexamic acid injection,1
21033,mailed self sampler,1
21034,xenetix-ct perfusion imaging,1
21035,fentanyl pectin nasal spray (fpns),1
21036,hpv-16/18 l1 vlp as04 (cervarix tm),1
21037,"survey, interview",1
21038,paclitaxel+reparixin,1
21039,quality of life measurements,1
21040,tlpldc vaccine,1
21041,ligasure tissue sealing device,1
21042,batracylin,1
21043,gp100:154-162 peptide,1
21044,straight wire excision of transformation zone,1
21045,peginterferon-alpha 2b (pegifna2b);,1
21046,prompts to report adherence and symptoms via study app,1
21047,urine 6-sulphatoxymelatonin (amt6s),1
21048,fast excitation-emission matrix system,1
21049,ny-eso-1 iscomatrix®,1
21050,p7170,1
21051,endorectal brachytherapy,1
21052,gastropexy,1
21053,pelvic dcfpyl pet-mri fusion or pet/mri,1
21054,mr colonography with fecal tagging,1
21055,roux-en-y anastomosis of the pancreatic stump,1
21056,adi-peg-20,1
21057,parp inhibitor bgb-290,1
21058,online questionnaire of max-pc,1
21059,collagen/aloe vera/vitamin e/lidocaine topical hydrogel,1
21060,gemcitabine adjuvant,1
21061,"epirubicin, cyclophosphamide, docetaxel",1
21062,trement,1
21063,lenalidomide + ancestim,1
21064,post-radiation temozolomide,1
21065,lumaflex light delivery catheter,1
21066,received concomitant vaccines first,1
21067,tumor resection surgery,1
21068,natural killer cell,1
21069,d2 radical operation,1
21070,midazolam 3 mg syrup,1
21071,pet/ct scan to assess treatment efficacy,1
21072,"0.25% bupivacaine, 0.5ml/kg",1
21073,supine radiotherapy,1
21074,mri/us fusion-guided prostate biopsy,1
21075,clinolipid,1
21076,colon screening strategy,1
21077,trans-perineal template-guided mapping biopsy,1
21078,fractionated stereotactic radiation therapy (fsrt),1
21079,comparator: erlotinib + dalotuzumab,1
21080,iodopovidone solution,1
21081,psopc pathway approach,1
21082,web-based decision aid system,1
21083,oral examination with oralid,1
21084,intraoperative complication management and prevention,1
21085,therapeutic exercises,1
21086,1.5g/kg of 20% mannitol,1
21087,questionnaires to evaluate anxiety related to genetic testing,1
21088,yoga intervention (yocas),1
21089,"cyclophosphamide, oncovin, myocet, prednisone & rituximab (r-comp)",1
21090,chemotherapy followed dendritic cells,1
21091,lifestyle management program,1
21092,visualase® thermal therapy system,1
21093,radiation in supine position,1
21094,inhaled budesonide 800 µg twice daily,1
21095,eus-guided drainage,1
21096,cmv specific cytotoxic t lymphocytes (ctl),1
21097,duda device,1
21098,tru-016,1
21099,emd 525797 250 mg,1
21100,decipher,1
21101,us-guided rfa,1
21102,absence of radiotherapy,1
21103,oral 5-azacitidine in combination with romidepsin,1
21104,pomalidomide 0.5 mg,1
21105,two staged turnbull-cutait procedure,1
21106,part c2: abiraterone acetate combination with azd8186,1
21107,pbi with chemotherapy,1
21108,5-fluorouracil and leucovorin calcium,1
21109,usual chemotherapy education (ce),1
21110,nocturnal oximetry,1
21111,"carboplatin, pemetrexed and bevacizumab",1
21112,geriatric assessment adapted therapy,1
21113,monopolar enucleation of the prostate,1
21114,ebus guided fna with and without suction,1
21115,breast conservative surgery,1
21116,gemox chemotherapy,1
21117,"epirubicin, cisplatin, lv?leucovorin?? 5-fu?5-fluorouracil?",1
21118,chinese herb medicine,1
21119,radiation in combination with systemic therapy,1
21120,gemcitabine 1800 mg/m2 (day 1) and dacarbazine 500 mg/m2 (day 1),1
21121,pemetrexed with bevacizumab,1
21122,creatine monohydrate,1
21123,any treatment for unresectable hcc as chosen by the physician,1
21124,fper,1
21125,"idarubicin, methotrexate, filgrastim, intrathecal ara-c",1
21126,tomo,1
21127,gdc -0941,1
21128,estrogen replacement therapy,1
21129,omega-3 fish oil emulsion (omegaven ),1
21130,io102,1
21131,ctc biomarker expression prevalence,1
21132,both insertion and withdrawal,1
21133,"capecitabine (xeloda), oxaliplatin, irinotecan, bevacizumab",1
21134,non-transplant treatment approach for consolidation,1
21135,irinotecan (irinotecan cell pharm®),1
21136,bay86-9766 mek inhibitor + sorafenib,1
21137,weekly telephone coaching,1
21138,mm-302 monotherapy,1
21139,placebo (olive oil) supplement,1
21140,tumor collection,1
21141,colon cancer surgery,1
21142,azd9496 (reference),1
21143,cvx-060,1
21144,decitabine at 15 mg/m2,1
21145,apatinib/docetaxel/pemetrexed,1
21146,"s-1, leucovorin",1
21147,magnetic resonance-guided high-intensity focused ultrasound (mrgfus),1
21148,mucoadhesive oral wound rinse,1
21149,single agent arsenic trioxide,1
21150,150 weekly minutes walking,1
21151,.5% bupivacaine,1
21152,cetuximab and lapatinib,1
21153,"dendritic cells - transfected with htert-, survivin- and tumor cell derived mrna + ex vivo t cell expansion and reinfusion",1
21154,autologous tumor cells plus gm-csf-in adjuvant,1
21155,thymosin-?1,1
21156,endometrial currettage,1
21157,nelipepimut-s plus gm-csf vaccine,1
21158,ssr97225,1
21159,eus-guided biliary drainage with a hybrid metallic stent,1
21160,pemetrexed - phase 1,1
21161,continuous bolus,1
21162,quality of life assessments,1
21163,anti-cd19 anti-cd20 bispecific car-t,1
21164,emr tailoring,1
21165,hemoporfin,1
21166,smarttarget - biopsy,1
21167,regular diet as the first postoperative meal,1
21168,high dose aldesleukin,1
21169,haloperidol decanoate,1
21170,high-dose sequential chemotherapy and autologous transplant,1
21171,patient preference results,1
21172,bortezomib + temozolomide+ radiation therapy,1
21173,tgr-1202 + brentuximab vedotin,1
21174,treatment with immune checkpoint inhibitors.,1
21175,guided activities,1
21176,bone health educational materials,1
21177,radiotherapy 60 gray/day,1
21178,"lenalidomide, ibrutinib, rituximab",1
21179,mra,1
21180,tm-601,1
21181,pulsed radiofrequency,1
21182,everolimus (10 mg qd),1
21183,jnj-64007957,1
21184,doxorubicin / cyclophosphamide / paclitaxel / carboplatin,1
21185,[14c]pf00299804,1
21186,imab027,1
21187,erlotinib mono-therapy,1
21188,valchlor 0.016 % topical gel,1
21189,placebo cutaneous solution,1
21190,offer of vaginal self collection,1
21191,sample of cancerous epithelium from the tongue,1
21192,"mage-a1, mage-a3, and ny-eso-1 vaccine",1
21193,doxercalciferol (gz427397),1
21194,gleevec (imatinib),1
21195,0.25% ropivacaine hydrochloride,1
21196,erlotinib with chemotherapy,1
21197,intermediate risk with partial remission after two cycles of abvd chemotherapy schedule. four more chemotherapy courses are delivered alternating eshap and abvd.,1
21198,nutrition and exercise group,1
21199,latero-terminal colorectal anastomosis,1
21200,"fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft",1
21201,acupoint electric stimulation,1
21202,the clinimacs device,1
21203,20% mannitol bolus administration,1
21204,placebo oral tablets,1
21205,senna then peg,1
21206,hm10460a (270 ?g/kg),1
21207,wdvax,1
21208,radio-labeled osi-906,1
21209,luvena,1
21210,ocl 503 (uterine artery embolization),1
21211,conventional turb,1
21212,i124-nm404,1
21213,existing online health education,1
21214,intuitive vessel sealer,1
21215,navigation surgery,1
21216,vsl#3,1
21217,dose escalation using stereotactic boost,1
21218,induction/consolidation adriamycin,1
21219,covered or uncovered stents,1
21220,budesonide 0.5 mg/ml,1
21221,scan,1
21222,silybin,1
21223,oxaliplatin (eloxatin) + fluorouracil + folinic acid,1
21224,cd11301 0.03%,1
21225,70 gy in 20 fractions over 4 weeks,1
21226,sensor-based interactive exercise (game-based exercise),1
21227,surgery after 12 weeks of delay after chemoradiotherapy.,1
21228,pam 50 test,1
21229,gemcitabine and nanoparticle albumin bound paclitaxel,1
21230,intraoperative dual-modality imaging,1
21231,"standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 chromic gut)",1
21232,amg 820,1
21233,"rad001, everolimus",1
21234,"gemcitabine, local delivery",1
21235,proton beam radiation using pencil beam scanning,1
21236,saliva and/or urine sample,1
21237,qax576,1
21238,cc-5013 (lenalidomide),1
21239,conformal high dose intensity modulated radiation therapy,1
21240,ctt1403,1
21241,immunological factors,1
21242,intravesical electromotive mitomycin,1
21243,carboplatin/taxol,1
21244,interferon maintenance,1
21245,suntent,1
21246,standard fall care,1
21247,ai,1
21248,methylaminolevulinate - photodynamic therapy,1
21249,radiolucent cushion,1
21250,preoperative hyperbaric oxygen,1
21251,sensory neuropathy scale instrument,1
21252,[f18]fluorothymidine,1
21253,thoracic paravertebral block (tpvb),1
21254,standard oncological care,1
21255,bemcentinib,1
21256,mbb afo,1
21257,c11-choline pet/ct,1
21258,billroth-i reconstruction,1
21259,erbitux®,1
21260,capecitabine 500 mg,1
21261,mako 7,1
21262,intravenous injection bgb-a317,1
21263,evaluation of anxiety with psychosocial scales,1
21264,apbi utilizing 3d-crt radiation,1
21265,saha,1
21266,mal pdt day 5,1
21267,neoadjuvant chemotherapy with folfoxiri + bevacizumab,1
21268,rituximab-hds,1
21269,asyms intervention group,1
21270,cardiac examination,1
21271,total operative time,1
21272,ipc placement,1
21273,recombinant anti-egfr antibody,1
21274,philips brilliance big bore ct/simulator,1
21275,radio frequency ablation probe,1
21276,pd-l2 peptide,1
21277,cosyntropin stimulation test,1
21278,1rg-cart/m^2 (dose level 4),1
21279,classification of oral microbiome using taxonomic approach,1
21280,laparoscopic assisted distal gastrectomy,1
21281,prevastein hc®,1
21282,non-myeloablative allogeneic stem cell transplant with prophylactic activated dli,1
21283,rituximab prednisone,1
21284,monoclonal antibody rav12,1
21285,mri/mrs scan,1
21286,18f-vm4-037,1
21287,hent1,1
21288,yttrium-90 plaque applicator,1
21289,blind gastric tube placement,1
21290,xilonix plus onivyde and 5fu,1
21291,tailored cancer communication,1
21292,injection of [18f]hx4,1
21293,galunisertib 150mg by mouth twice a day,1
21294,vt-122 (propranolol plus etodolac),1
21295,3t mr imaging,1
21296,:yoga therapy,1
21297,sor-c13,1
21298,secretrol,1
21299,smart after-care (mobile health),1
21300,hipec: cddp 75 mg/m2 @t0,1
21301,azadirachta indica,1
21302,autologous fat graft,1
21303,real-time monitoring and instruction of cancer pain,1
21304,gemcitabine & oxaliplatin,1
21305,375 mg/m2 rrituximab,1
21306,home-based lymphedema care program,1
21307,reach plus phone,1
21308,mvt-2163,1
21309,"vinflunine, gemcitabine",1
21310,p53 gene,1
21311,biopsy of non-target tissue,1
21312,three dimensional ultrasound probe,1
21313,partner-assisted tailored intervention,1
21314,chinese traditional medicine xh1,1
21315,tdcyd,1
21316,99mtc-mebrofenin hepatobiliary scintigraphy (hbs),1
21317,ablation system plus anti-secretory medication,1
21318,patient-centered oncology care,1
21319,"tp-hdfl,tp-ccrt, esophagectomy",1
21320,surgical resection for patients with both intra- and extra-hepatic metastases,1
21321,tcr alfa beta t cell depletion,1
21322,"""my guide"" (psychoeducation & self-management program)",1
21323,bone marrow aspirates and biopsy,1
21324,525 mg leronlimab,1
21325,gvax lung cancer vaccine,1
21326,pharmacokinetic sampling - rosuvastatin,1
21327,devaluing energy-dense foods for cancer-control,1
21328,contrast-enhanced ultrasound (ceus),1
21329,human recombinant interleukin-2 (rhil-2),1
21330,pixelshine,1
21331,d,1
21332,genetic and biomarkers,1
21333,tsr042,1
21334,cognitive behavioral intervention for breathlessness,1
21335,placebo oral zinc capsule,1
21336,operation - pirs,1
21337,ec chemotherapy,1
21338,chw outreach and hpv self-sampling,1
21339,ofatumumab 500mg,1
21340,collection of blood,1
21341,1 day low residue diet,1
21342,device for pet,1
21343,telephone-based exercise intervention,1
21344,bkm120 (days 1-21) + paclitaxel (day 1) + carboplatin (day 1),1
21345,basic drugs therapy of hcc,1
21346,j65 vaccine then e39 vaccine,1
21347,"irinotecan, gemcitabine",1
21348,rapamycin treatment of port wine stain,1
21349,cumulative bed ? 100,1
21350,carboplatin + gsk1120212,1
21351,"iloprost injection, for intravenous use",1
21352,boost radiotherapy (xrt),1
21353,lhrh agonists (goserelin acetate) and calcium/ vitamin d supplementation,1
21354,abacavir /3tc plus ritonavir boosted lopinavir,1
21355,sexual health inventory for men (shim) questionnaire administration,1
21356,sentimag device,1
21357,th-302 in combination with doxorubicin,1
21358,dti with acellular dermal matrix (cellis® breast),1
21359,transarterial chemoembolisation with doxorubicin,1
21360,self expanding metal stent,1
21361,smartbx,1
21362,tube drain insertion,1
21363,megestrol acetate (ma),1
21364,oxaliplatin intra-arteriel,1
21365,lovaza 4gm oral,1
21366,tissue dielectric constant measurement,1
21367,her.car cmv-specific ctls,1
21368,gemcitabine®,1
21369,"docetaxel 40mg<7m2 d1,8, 21, 28+ gemcitabine 1200mg/m2 d1,8, 21, 28 + concomitant docetaxel 20mg/m2/w+carboplatin auc 2/w+ concomitant rdt 2gy/d",1
21370,medel test electrode placer,1
21371,smoking status questions,1
21372,carnoy solution,1
21373,5-azacytidine (5-aza) group 1,1
21374,whole precutting,1
21375,haic regimen,1
21376,mr lymphangiography,1
21377,18-fdg,1
21378,intravenous docetaxel,1
21379,comparator: ondansetron / duration of treatment: 3 days,1
21380,"adriamycin (doxorubicin), docetaxel, tamoxifen",1
21381,chemoradiotherapy with cisplatin,1
21382,salvage treatment,1
21383,mri uronav fusion biopsy,1
21384,group-based mind body medicine intervention + family focus,1
21385,observation of treatment management,1
21386,astx727,1
21387,doxil/caelyx test product (treatment b),1
21388,bony toxicity,1
21389,sham quell,1
21390,breath sample,1
21391,18f-fdg pet combined with ct without injection,1
21392,chemotherapy - bev,1
21393,inod system,1
21394,maltodextrine,1
21395,tiweb+csc,1
21396,fdx104 (4% doxycycline),1
21397,transarterial infusion,1
21398,"bkm120, paclitaxel + carboplatin",1
21399,azacitidine and cisplatin,1
21400,hypofractionated arm (2),1
21401,cook magnetic anastomosis device (mad) with stent,1
21402,mr-guided cryoablation,1
21403,dasatinib and rituximab,1
21404,cuff-manometer,1
21405,the lcp-i program,1
21406,laparoscopic high anterior resection without splenic flexure mobilization,1
21407,self-collection,1
21408,standard internal radiation therapy,1
21409,"filanesib, pomalidomide and dexamethasone",1
21410,dexamethasone 40 mg,1
21411,"decitabine, arsenic trioxide and ascorbic acid",1
21412,medication taken to manage the symptom burden of cipn,1
21413,contrast enhanced liver ct,1
21414,discontinuation of anti-tnf treatment,1
21415,telephone support,1
21416,chemoradiation therapy,1
21417,daratumumab sc: daratumumab + rhuph20,1
21418,part 1: pt2385 tablets,1
21419,imiquimod vehicle,1
21420,simple adhesive dressing,1
21421,evaluate serum level he4 in endometrial cancer,1
21422,liquid nitrogen spray cryotherapy with the trufreeze device,1
21423,pegylated interferon and imatinib,1
21424,receptivity to participating in diet interventions,1
21425,(c-11 acetate),1
21426,general anaesthetic,1
21427,facebook,1
21428,cisplatin/ etoposide,1
21429,transvaginal sonography,1
21430,cetuximab plus p-hdfl,1
21431,zibotentan,1
21432,18f- fluorodeoxyglucose,1
21433,ct colonoscopy (low dose),1
21434,participation in the internet forum,1
21435,scp care,1
21436,serologic testing,1
21437,diagnostic and therapeutic management,1
21438,desi for home viewing,1
21439,placebo dc,1
21440,thermochemoradiotherapy (ctrtht),1
21441,prevadh film,1
21442,selective traditional tace,1
21443,sunitinib and bortezomib,1
21444,s-warfarin,1
21445,detection of driver mutation,1
21446,olaparib pill 250 mg,1
21447,docetaxel/carboplatin/bevacizumab/erlotinib,1
21448,dsc,1
21449,t-pouch orthotopic urinary diversion,1
21450,epirubicin with a taxane,1
21451,conventional vincristine,1
21452,prophylactic vancomycin,1
21453,third eye panoramic device,1
21454,mage-a3 asci injections without poly ic:lc,1
21455,methylnaltrexone bromide,1
21456,"cni, mmf, steroids, aza etc. (mtor inhibitor free)",1
21457,fluid collection,1
21458,il-2 s.c.,1
21459,scar technique,1
21460,resiquimod 0.03%,1
21461,i-131 iodocholesterol,1
21462,radioactive tc99m,1
21463,home exercises,1
21464,prolaris testing,1
21465,autologous cik dose level 1,1
21466,2-chlorodeoxyadenosine (cda) daily,1
21467,brentuximab vedotin (genetical recombination),1
21468,phase ii: glembatumumab vedotin,1
21469,nanoxel,1
21470,placebo for ag-120,1
21471,whole genomic,1
21472,irx4204,1
21473,jobelyn + cyclophosphamide-epirubicin6,1
21474,videothoracoscopic talc poudrage (vt).,1
21475,treat regimen,1
21476,left axilar vein access.,1
21477,conventional surgery (abdominal radical surgery),1
21478,chemotherapy with gemcitabine or folfirinox according to induction chemotherapy,1
21479,mabthera/rituxan,1
21480,induction phase,1
21481,dexanabinol dose level 3,1
21482,bvac-b,1
21483,zd4054 zibotentan,1
21484,placebo +g-csf,1
21485,placebo ?1,1
21486,hr-a,1
21487,metformin/simvastatin/fulvestrant,1
21488,stride,1
21489,manuka honey in lozenge form,1
21490,drospirenone/ethinyl estradiol,1
21491,erlotinib 150/100 mg,1
21492,dedn6526a,1
21493,fluroscopic guided block,1
21494,weekly cisplatin with rt,1
21495,"tissue, blood and clinical data collection",1
21496,text messages without pictures,1
21497,"chest x-ray with or without cad, lose dose ct scan",1
21498,"intelligent breast exam, ibe",1
21499,sib (15 x 2.67 gy wbi and sib 15 x 2.67-3.12 gy),1
21500,pet scan ou tep-tdm,1
21501,base and apex local anesthesia,1
21502,"cyclophosphamide, thiotepa, carboplatin (ctc) or stamp v (ctc)",1
21503,cysview,1
21504,ags-16m18,1
21505,ptx-200,1
21506,alpha-cyclodextrin,1
21507,boswellia,1
21508,intracellular fluorescence polarization analysis,1
21509,cyclophosphamide 50 mg/kg iv days 3 and 4 post transplant,1
21510,bat,1
21511,"regimen 2, course 2",1
21512,ag-120 (ivosidenib) with azacitidine,1
21513,inno-406,1
21514,nursing telephone intervention,1
21515,medi3726 pre-chemo,1
21516,tamoxifen (post-operative),1
21517,ca-4948,1
21518,multimodal exercise intervention,1
21519,rectus sheath catheters,1
21520,adh -1 and docetaxel,1
21521,measure of biomarkers in serum and endometrial tissue,1
21522,"volasertib, middle dose, d1q3w",1
21523,informational material,1
21524,e.coli l-asparaginase,1
21525,eflornithine placebo,1
21526,im-tmi (6gy),1
21527,stretching exercise,1
21528,"capecitabine (xelodaâ), xrt & cetuximab (erbitux®)",1
21529,imp-288-indium,1
21530,milled mln0128 api,1
21531,visually enhanced prostate cancer educational presentation,1
21532,arm placebos,1
21533,laser alone,1
21534,induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy,1
21535,ly2624587,1
21536,fcn-411,1
21537,trastuzumab (9 weeks) + docetaxel,1
21538,bevacizumab and sunitinib,1
21539,vaginal dhea,1
21540,oximeter,1
21541,positron emission mammography (pem) when available,1
21542,motor speed test,1
21543,trametinib and / or supportive care,1
21544,standard individual supportive psychotherapy (isp),1
21545,implanted markers,1
21546,whipples pancreatico-duodenectomy,1
21547,"ixabepilone, 15 mg/d",1
21548,perform dynamic contrast enhanced (dce) mri,1
21549,tace with drug eluting beads procedure,1
21550,mammography and tomosynthesis imaging,1
21551,blood collections,1
21552,folfiri 1-bevacizumab,1
21553,preoperative concurrent chemoradiotherapy,1
21554,patient controlled epidural analgesia,1
21555,itp,1
21556,systemic application of simultaneous chemotherapy,1
21557,capecitabine and bevacizumab,1
21558,double modality (ultrasound and fluroscopic) guided block,1
21559,auditory attention and executive functions test,1
21560,surface-controlled water soluble curcumin,1
21561,corticosteroid: betamethasone,1
21562,low levels of amplitude-modulated electromagnetic fields,1
21563,gamma knife radiosurgery (15 gy to 50% isodose),1
21564,ct-1530,1
21565,lletz under local anaesthesia,1
21566,m-tor inhibitor free,1
21567,contrast-enhanced computed tomography,1
21568,translation of district sun safe policies to schools,1
21569,conventional (gas distended colon) resection,1
21570,2 cycles cisplatin-5-fluorouracil,1
21571,bisphosphates,1
21572,metformin 500 mg tablet,1
21573,early allogeneic pbsct within induction therapy,1
21574,medoc advanced medical systems pathway model ats,1
21575,text-based reminder for recommended hpv vaccine or wcc,1
21576,second line chemotherapy,1
21577,3-dimensional ultrasound-guided radiation therapy,1
21578,7 t mri,1
21579,treosulfane,1
21580,anxiety questionnaire administration,1
21581,peripheral blood progenitor cell transplant,1
21582,"alloderm, questionnaires",1
21583,uracil-tegafur,1
21584,extracorporeal roux-en-y esophagojejunostomy,1
21585,home exercise,1
21586,planar imaging,1
21587,vrx-3996,1
21588,"quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (v501)",1
21589,pf-06936308,1
21590,extraperitoneal laparoscopic lymphadenectomy (eplnd),1
21591,imc-tr1,1
21592,ccrt with ip chemotherapy (irinotecan + cisplatin),1
21593,azd6918,1
21594,spironolactone (+/- furosemide),1
21595,orcein staining,1
21596,basic public reporting,1
21597,enitinostat,1
21598,"oxaliplatin , capecitabine",1
21599,no lung plug,1
21600,flt3 ligand therapy (cdx-301),1
21601,conventionally fractionated whole breast irradiation,1
21602,proton beam therapy rt,1
21603,cns radiation treatment for all with prior cns disease patients,1
21604,"mfolfox, nivolumab, ipilimumab",1
21605,cme,1
21606,140 mg mmc in 60ml gel,1
21607,vortx rx treatment,1
21608,weight bearing for lower extremities only,1
21609,high dose bolus interleukin-2 (hd il2),1
21610,transartery chemoembolization,1
21611,standard postpartum tubal ligation,1
21612,molecular analysis of exon 9 and 20 of pi3k,1
21613,pr-1 vaccine,1
21614,gleevec™,1
21615,professional audit and feedback,1
21616,peripheral parenteral nutrition,1
21617,receptor specific activation method,1
21618,doxorubicin pegylated,1
21619,focal salvage hdr prostate brachytherapy,1
21620,conservative hysterectomy i,1
21621,high-risk subtype detection panels,1
21622,endostar and chop,1
21623,iscomatrix® adjuvant,1
21624,"any treatment, watch and wait policy included",1
21625,care management+community health worker,1
21626,mbsr(bc) 6 week program,1
21627,predicare,1
21628,areola sparing mastectomy,1
21629,ctfea,1
21630,radiadyne immobilizer,1
21631,intrabone transplantation,1
21632,nortriptyline hydrochloride,1
21633,"combination of gemcitabine, capecitabine, and bevacizumab",1
21634,fluorine-18-prostate specific membrane antigen-1007- positron emission tomography/computer tomography,1
21635,allogeneic hematopoietic stem cell transplant (allo-hsct),1
21636,family-based attachment-focused intervention,1
21637,near infrared (nir) fluorescence imaging,1
21638,rituximab in combination with placebo,1
21639,chop + tbi and autotransplant,1
21640,educational handouts,1
21641,cyt004-melqbg10 + montanide + imiquimod,1
21642,phase i dose level 2,1
21643,ingenol once daily for two consecutive days,1
21644,abi-007(abraxane),1
21645,serum vitamin d level measured by elisa kit,1
21646,reference1507,1
21647,allogeneic stem cell transplant versus second autologous transplantation,1
21648,antitumor b kac-?,1
21649,ensure powder,1
21650,goserelin plus bicalutamide,1
21651,digital pleural manometry,1
21652,chemoradiotherapy cisplatin,1
21653,prophylactic growth factors; subcutaneous,1
21654,chinese herbal concoction twice a day for 6 months,1
21655,weekly docetaxel + cisplatin combination,1
21656,posterior retroperitoneoscopic adrenalectomy,1
21657,zoledronate therapy,1
21658,"durvalumab, tremelimumab and ,folfox",1
21659,impt,1
21660,other alk inhibitors,1
21661,bright light therapy,1
21662,resection of adenocarcinoma of the head of the pancreas,1
21663,dextropropoxyphene hydrochloride,1
21664,bt1718,1
21665,pericardial instillation of bleomycin after drainage,1
21666,traditional staple,1
21667,low dose dsa (75% reduction compared to normal dose) with novel x-ray imaging technology.,1
21668,pf-05212384 (also known as pki-587),1
21669,tissue sample for genetic testing,1
21670,non-buffered lidocaine,1
21671,humira®,1
21672,ento,1
21673,z-endoxifen,1
21674,mbvd (myocet+bvd),1
21675,standard educational materials on breast cancer,1
21676,"gefitinib (iressa™, zd1839)",1
21677,flexible fiberoptic laryngoscopy,1
21678,98% ethanol & paclitaxel injection,1
21679,epitinib,1
21680,abiraterone acetate + prednisone/ prednisolone + exemestane,1
21681,colon j pouch,1
21682,donor leukocyte infusions (dli),1
21683,docetaxel plus prednisone,1
21684,cycle 8 reinduction,1
21685,close focus hd nbi colonoscopy system,1
21686,the functional assessment of cancer therapy- colorectal,1
21687,acthrel,1
21688,hormonal analysis,1
21689,trastuzumab-eu,1
21690,statin and metformin use,1
21691,l19il2 - ph i,1
21692,g-csf (granulocyte colony-stimulating factor),1
21693,intratumoral g100,1
21694,all study participants,1
21695,informal interview,1
21696,mfolfox6-bevacizumab,1
21697,survivorlink,1
21698,handbook,1
21699,accelerated fractionation (afx) radiotherapy,1
21700,oral nsaid,1
21701,lapatinib capecitabine,1
21702,the relaxation response resiliency program (3rp) via skype,1
21703,oncogeriatric evaluation,1
21704,gp100-fowlpox vaccine,1
21705,eloxatin,1
21706,melectis g,1
21707,abraxane + carboplatin,1
21708,cmc-544,1
21709,fitbit and text messages,1
21710,ck boost radiation,1
21711,sorafenib 400 mg (50-mg tablet),1
21712,eischens yoga,1
21713,sensipar®,1
21714,fluorine-18-labeled fluoro-misonidazole (18f-fmiso),1
21715,"ct colonography with computer assisted diagnosis (cad),cadcolon -im3d spa., torino italy",1
21716,cervical collar therapy indicator (coti),1
21717,arm b: atezolizumab,1
21718,traditional mld,1
21719,cryocontact therapy,1
21720,matrix rf,1
21721,standard dialysis on a high flux ployflux dialyser,1
21722,epispot detection of the number of circulating cells,1
21723,standard treatment of scchn patients,1
21724,peripheral blood progenitor cell,1
21725,"docetaxel, psk®",1
21726,ds-8895a 3 mg/kg,1
21727,medical clowning for children,1
21728,dn-101,1
21729,radical prostatectomy without implantation of allograft,1
21730,paclitaxel; cisplatin; 5-fluorouracil,1
21731,arm c : single epoietin zeta,1
21732,eus-cpn,1
21733,pulse-based diet,1
21734,structured lifestyle education,1
21735,long-term follow-up of patients who received car-20/19-t cells,1
21736,multivitamin placebo,1
21737,pembrolizumab + epacadostat,1
21738,avoiding hypothermia,1
21739,tipifarnib plus bortezomib,1
21740,psilocybin (drug),1
21741,conventional closure with drainage,1
21742,control group-blood sampling,1
21743,nm-il-12 and tsebt,1
21744,online tutorial,1
21745,sham exercise,1
21746,mobilization,1
21747,surgical debulking with peritonectomy,1
21748,3-minute withdrawal time,1
21749,cbct verification,1
21750,chir-258 (tki258),1
21751,abiraterone acetate + prednisone,1
21752,bevacizumab maintenance therapy,1
21753,intervention without game-based exercise,1
21754,arm 2: l19il2 + dacarbazine,1
21755,interferon-alpha2b - 2 years,1
21756,"influenza a (h1n1) 2009 monovalent vaccine, inactivated",1
21757,virtual bronchoscopy guided transbronchial needle aspiration,1
21758,aminophylline,1
21759,dermatological examination,1
21760,"g207, an oncolytic virus",1
21761,rt with concurrent chemotherapy,1
21762,medi5752,1
21763,comparator: mk-8033,1
21764,photoacoustic endoprobe,1
21765,pembrolizumab mel high dose,1
21766,intravenous salin water,1
21767,89zr-pertuzumab,1
21768,rituxan and epoch,1
21769,2-hour empathic communication skills training,1
21770,"vinblastine, vincristine, prednisone, daunorubicin",1
21771,sr-b + epratuzumab,1
21772,single port surgery,1
21773,"carmustine, etoposide, cytarabine, melphalan",1
21774,pegylated liposomal doxorubicin (doxil) and rituximab,1
21775,part 3 tpst-1120,1
21776,high-selenium baker's yeast,1
21777,desvenlafaxine succinate 50mg,1
21778,intranasal oxytocin,1
21779,rotational technique,1
21780,guanabenz acetate,1
21781,interferon gamma,1
21782,cd62l- tem,1
21783,"amg 479, everolimus, panitumumab",1
21784,thermal rf lesioning is done using bailys rf generator,1
21785,cone-beam ct-guided,1
21786,nilotinib followed by treatment-free,1
21787,online lifestyle intervention,1
21788,gan fu le tablets,1
21789,noscapine,1
21790,euthyroid group,1
21791,krn951,1
21792,gvax pancreas,1
21793,firinox,1
21794,pre-procedural preparation,1
21795,cs-131 brachytherapy seeds,1
21796,pectoralis type 2 block and catheter insertion without lidocaine dissection,1
21797,[18 f]-6-l-fluorodihydroxyphenylalanine (18f-fdopa),1
21798,mk-1697,1
21799,hysteroscopic repeat curettage,1
21800,"pva, lipiodol, doxorubicin",1
21801,16 x 3.125 gy,1
21802,ruxolitinib tablets,1
21803,ptp-01,1
21804,chlorhexidine acetate gargle,1
21805,gefitinib 500mg/gefitinib 250mg,1
21806,relaxation acupressure,1
21807,lenalidomide: double-blind maintenance,1
21808,saxagliptin,1
21809,capecitabine in aduvant setting,1
21810,credo standard of care,1
21811,s-1 therapy,1
21812,"enasidenib, dexamethasone, ixazomib, pomalidomide",1
21813,toce plus rfa,1
21814,non-myeloablative conditioning chemotherapy,1
21815,standard patient-physician counseling interaction,1
21816,"docetaxel, cyclophosphamide, capecitabine",1
21817,combination of local steroid injection?triamcinolone ?with oral steroid administration?prednisone?,1
21818,hyperpolarized pyruvate (13c),1
21819,conventional laparoscopic instruments,1
21820,activity-oriented proprioceptive antiedema therapy (tapa),1
21821,cone beam ct acquisition,1
21822,18f ml-10,1
21823,4scar19 and 4scar70,1
21824,biopsy or surgical resection of tumor and blood sampling,1
21825,implantation of the interstimtm,1
21826,spy intra-operative angiography,1
21827,maintenance chemotherapy 1,1
21828,preoperative ct scan-guided localization,1
21829,10 week behavioral intervention program,1
21830,fluciclovine pet/mri,1
21831,harmonic ace®+ shears (hs),1
21832,paclitaxel + s-1 + oxaliplatin,1
21833,homeopathic placebo globules,1
21834,vitamin d3 prior to second visit,1
21835,cadi-05,1
21836,nyeso-1c259 t cells,1
21837,paricalcitol capsules,1
21838,panagen,1
21839,"mitomycin c, vindesine, cisplatin and radiotherapy",1
21840,colonoscopy direct mail coupled with a financial incentive,1
21841,shuti,1
21842,hla 10/10 mud stem cell transplantation,1
21843,angiogenesis inhibitor gsao,1
21844,conventional d-type stent,1
21845,tissue infiltration : placebo,1
21846,shape-up following cancer treatment,1
21847,nilotinib + cetuximab,1
21848,artesunate ointment 40%,1
21849,follow-up phone calls,1
21850,zoladex goserelin implant,1
21851,pelvic ct or mri + mdp bone scan + or - 18f-naf pet/ct(soc),1
21852,cooling spray during laser treatment,1
21853,ileal,1
21854,fluciclatide injection,1
21855,"cyclophosphamide 14.5 mg/kg/day iv on days -6, -5",1
21856,automated plus live prompts,1
21857,quarterly monitoring of iep,1
21858,rabbit atg (ratg),1
21859,placebo and then 100 mg pyc,1
21860,go lytely,1
21861,emend,1
21862,gsk1120212b (lower dmso content),1
21863,photographies,1
21864,couples control condition,1
21865,"reduced intensity conditioning, busulfan and fludarabine",1
21866,6-hydroxymethylacylfulvene,1
21867,local anesthetic solution,1
21868,b-lite® light weight breast implant,1
21869,ipad application,1
21870,ro7070179,1
21871,conventional adjuvant folfox,1
21872,sienna+ peri 4-6,1
21873,maintainance therapy of intravesical chemotherapy-epirubicin-,1
21874,"low- dose, local radiotherapy",1
21875,"clarithromycin, oral, high dose",1
21876,y90 radioembolization,1
21877,bacillus calmette-guérin (bcg) vaccine,1
21878,90y-hll2,1
21879,lenalidomide plus melphalan during autologous stem cell transplantation,1
21880,no study intervention,1
21881,group r rasagiline,1
21882,novottf-100l(o),1
21883,sunitinib-malate,1
21884,multivitamins,1
21885,160 mg mmc in 60ml gel,1
21886,oxaliplatin;capecitabine;bevacizumab,1
21887,experimental drug: olanzapine,1
21888,xelox regimen according to standard procedures,1
21889,iv/oral n-acetylcysteine,1
21890,home jejunostomy feeding,1
21891,oct mapped,1
21892,insertion of pressure equalization (pe) tubes,1
21893,stool collection kit,1
21894,painconsultn,1
21895,minimal diet intervention,1
21896,recombinant interferon alfa (inf alpha),1
21897,ultrasonic surgical aspiration of the cervix,1
21898,"gleevec, taxotere",1
21899,dexamethasone 0.5 mg once daily,1
21900,bay 56-3722,1
21901,pro self pain control programme,1
21902,total body irradiation 400 centigray (200 cgy x 2),1
21903,interferon beta-1b,1
21904,low dose human chorionic gonadotropin,1
21905,thyroid function test,1
21906,"part 2, stage 2",1
21907,duravalumab,1
21908,vehicle rinse,1
21909,oppc service,1
21910,percutaneous microwave ablation,1
21911,honey,1
21912,ssp treatment,1
21913,education program on healthy habits,1
21914,reduced intensity haplodentical stem cell transplant,1
21915,arm a vinorelbine (navelbine oral) capecitabine (xeloda),1
21916,vinflunine plus capecitabine,1
21917,cpgj602,1
21918,stz-5fu,1
21919,post-operative cht + post-operative cht-rtx,1
21920,abdominoperineal extra-elevators rectal resection for low lying rectal cancer,1
21921,covered self-expandable metal stent,1
21922,denovoderm,1
21923,bupivacaine-fentanyl,1
21924,m7824 - patients with stage ii or iii her2+ breast cancer,1
21925,wx-037,1
21926,cd133+ infusion,1
21927,"insulatard, flexpen",1
21928,dosing with zileuton/dasatinib in cml,1
21929,fruquintinib (hmpl-013),1
21930,futuximab,1
21931,research of disease-related factors,1
21932,placebo for study drug,1
21933,opioid anesthetics,1
21934,breast cancer group,1
21935,electroporation/ nano knife treatment,1
21936,eadm,1
21937,deep neuromuscular block using rocuronium and reversal with suggamadex,1
21938,individual consult,1
21939,trecam,1
21940,randomized cohort,1
21941,tb-403 100mg/kg,1
21942,drug: everolimus,1
21943,autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes,1
21944,suprep oral sulfate solution,1
21945,lenalidomide and dexametasone,1
21946,cytarabine plus daunorubicin [arm ii (ad regimen)],1
21947,auto3 (cd19/22 car t cells,1
21948,biopsy or surgical sampling,1
21949,systemic therapy/standard of care,1
21950,myoinositol 1500 mg,1
21951,22 gauge eus fna bnx,1
21952,deb-tace with surefire precision infusion system,1
21953,fluid management guided by the ev1000,1
21954,structured medical follow-up after operation,1
21955,endoscopic retrograde cholangiopancreatography - no intervention have been used other than standard of care,1
21956,hand grip strength,1
21957,stoma closure at different times,1
21958,rejuvenair™ radial spray cryotherapy,1
21959,kcp-330,1
21960,tapentadol er,1
21961,sclerotherapy arm,1
21962,ponatinib (iclusig®),1
21963,ibrutinib (maintenance),1
21964,need for children's palliative care,1
21965,guided injection of mepivacaine,1
21966,faslodex dummy,1
21967,polycystic ovary syndrome,1
21968,focal treatment,1
21969,sorafenib plus tegafur-uracil,1
21970,self-test arm,1
21971,sutures,1
21972,tec,1
21973,whoqol questionnaire,1
21974,immunicell®,1
21975,ara-c in consolidation-2,1
21976,potlako intervention,1
21977,89zr-mmot0530a,1
21978,polygenic risk score,1
21979,herceptin sc [trastuzumab],1
21980,megavoltage photon beam,1
21981,"imatinib, fluorouracil, oxaliplatin, leucovorin and bevacizumab",1
21982,magnifying endoscopy with narrow band imaging (me-nbi),1
21983,t + trastuzumab followed by cef + trastuzumab,1
21984,mr saline peritoneography,1
21985,autologous islet transplantation,1
21986,troxatyl™ (troxacitabine),1
21987,neoadjuvant chemo-radiotherapy (ncrt),1
21988,receive a pediatric-onset result,1
21989,open radical cystectomy with open urinary diversion,1
21990,isolated roux pj group,1
21991,nutritional support resource 2.5,1
21992,qigong/tai chi easy,1
21993,adxs31-142,1
21994,metformin up to 2500mg/d,1
21995,functional assessment of cancer therapy - melanoma (fact-m)11,1
21996,precise measure of movement testing,1
21997,"pd-0332991 will be administrated orally, formulated as gelatin capsules of 100 mg and 25 mg respectively.",1
21998,autologous genetically modified anti-bcma car transduced t cells (kite-585),1
21999,"capecitabine, 5-fluorouracil prodrug; oral",1
22000,gns spray 1.0mg,1
22001,exercising block,1
22002,aflibercept-folfiri,1
22003,low dose gc4419: 30mg/day,1
22004,gemcitabine (1000 mg/m2),1
22005,som230c,1
22006,teriparatide,1
22007,multiple dose azd2014,1
22008,active video game-based intervention,1
22009,cytoreduction and heated intraperitoneal surgery,1
22010,"ixabepilone, 25 mg, with food",1
22011,conventional consolidation chemotherapy,1
22012,rectal cancer radiotherapy,1
22013,map set at 60-65 mmhg for 5 min,1
22014,doxorubicine pegylated,1
22015,tachosil® patches,1
22016,codeine phosphate,1
22017,placebo sirolimus,1
22018,trans-arterial chemoembolization,1
22019,placebo drink,1
22020,ly2801653,1
22021,cat,1
22022,"embolizations ,uterine fibroid",1
22023,intrathecal drug administration,1
22024,intravenous tramadol hcl,1
22025,biopsy to obtain a chemogram,1
22026,quill knotless tissue-closure device,1
22027,rspsma protein plus alhydrogel® vaccine,1
22028,sleep testing,1
22029,continuous infusion of 5-fluorouracil,1
22030,inotuzumab ozogamicin (ino),1
22031,leep procedure,1
22032,convection-enhanced delivery,1
22033,paraplatin (carboplatin injection),1
22034,monocryl subcuticular sutures.,1
22035,stool sampling,1
22036,s95005,1
22037,dual polarisation interferometry,1
22038,late paravertebral block.,1
22039,bipolar electrosurgical generator and instruments,1
22040,flotrac,1
22041,evaluation of cpg methylation,1
22042,super-selective intraarterial intracranial infusion of bevacizumab,1
22043,immunotherapeutic agent,1
22044,xiap antisense,1
22045,matrix radiofrequency,1
22046,culturally tailored reading materials,1
22047,homologated placebo.,1
22048,nirapaib,1
22049,spect-based treatment plan,1
22050,rhomboid excision with the limberg flap,1
22051,organ preservation,1
22052,transplants from 8/8-matched unrelated donors,1
22053,"cyclophosphamide, fludarabine, clofarabine, etoposide, interleukin-2",1
22054,rt and hyperthermia after tace,1
22055,intra-operative tumor tissue biopsy,1
22056,endoscopic retrograde cholangio-pancreatography (ercp),1
22057,mobile mood tracking (mood 24/7),1
22058,spy elite imaging,1
22059,bip biopsy system,1
22060,intensified dietary intervention,1
22061,adher2/neu dc vaccine,1
22062,jnj-42160443,1
22063,visiocyt® diagnostic test,1
22064,postoperative radiotherapy and panitumumab,1
22065,a-101 solution 45,1
22066,mailed in-home high-risk hpv testing kit,1
22067,"trastuzumab, docetaxel, bevacizumab",1
22068,personalized cessation care,1
22069,ruxolitinib-placebo,1
22070,tak-385 placebo,1
22071,ny-eso-1 plasmid dna cancer vaccine,1
22072,excisional surgery of epidermal cyst,1
22073,arm a: standard anti-emetic regimen,1
22074,mri with eovist,1
22075,vortioxetine,1
22076,"patients receives letter, phone call, office visit, educational materials",1
22077,ar-67 (formerly db-67),1
22078,wellness intervention,1
22079,follow up dw mri,1
22080,lc bead,1
22081,biofeedback-mediated stress management (bfsm),1
22082,endoscopic injection of icg,1
22083,peptide specific ctl,1
22084,use of the femto-st institute medical device,1
22085,ch806,1
22086,atracurium besylate,1
22087,preparation with spirulina,1
22088,retroflexion in the total colon,1
22089,bone marrow specimen banking,1
22090,tc:paclitaxel + carboplatin,1
22091,beacopp,1
22092,ablative radiation therapy,1
22093,apatinib (also known as rivoceranib),1
22094,oral administration of mifepristone 2.5 mg daily for three months,1
22095,da viewing,1
22096,adc-1013,1
22097,cc-401,1
22098,cmc-544 (inotuzumab ozogamycin),1
22099,standard: dexamethasone,1
22100,cleanc system,1
22101,ropivacaine nebulization,1
22102,stemgen,1
22103,unrelated donor transplant,1
22104,"bortezomib, tositumomab",1
22105,continued irinotecan hydrochloride (hci) treatment,1
22106,multispectral digital colposcope with probe,1
22107,anti-cd19/20-car vector-transduced t cells,1
22108,standard polypectomy,1
22109,ppi (proton pump inhibitor),1
22110,tr(ace) assay testing,1
22111,"carboplatin, thiotepa, and cyclophosphamide",1
22112,cypam2 (experimental),1
22113,metacognitive therapy,1
22114,bazedoxifene,1
22115,c-lma,1
22116,nac-gemabr,1
22117,enhanced supportive care - referrals,1
22118,anti-cd137 (4-1bb) (bms-663513),1
22119,cpi 613 in combination with gemcitabine and nab-paclitaxel,1
22120,pre-treatment,1
22121,pet/nirf,1
22122,il-12 gene,1
22123,nuc-3373 + leucovorin,1
22124,protocol ii-ida,1
22125,performance of immunohistochemical analysis,1
22126,primary anastomosis,1
22127,multimodal analgesia,1
22128,fluorouracil/adrucil,1
22129,combined bipolar radiofrequency&pulsed dye laser,1
22130,hyperbaric chamber,1
22131,brentuximab vedotin (bv),1
22132,experimental: protection routine 1,1
22133,early mobilization program,1
22134,hdr-brachytherapy,1
22135,vienna nomogram prostate biopsy protocol,1
22136,mri scan with the specified sequences below:,1
22137,preoperative radiochemotherapy,1
22138,parent brief questionnaire,1
22139,pressurized intraperitoneal air-flow chemotherapy (pipac) increasing single dose,1
22140,ucla geriatrics attitudes scale,1
22141,fast-track protocol,1
22142,intravenous busulfan,1
22143,tomotherapy based igrt,1
22144,reduced out of pocket expense,1
22145,etoposide (dose level 2),1
22146,cbct imaging,1
22147,no bolus,1
22148,measurement of microcirculation,1
22149,b arm (dac),1
22150,spirulina,1
22151,diagnostic tests for suspected deep vein thrombosis,1
22152,canakinumab matching placebo,1
22153,educational website,1
22154,irinotecan+carboplatin/concurrent radiation,1
22155,sintilimab combined with docetaxel,1
22156,doppler-guided uterine artery occlusion device (duao),1
22157,prospective wound complication protocol,1
22158,tace+stereotactic body radiotherapy,1
22159,imc-11f8 (necitumumab),1
22160,atezolizumab-bevacizumab,1
22161,botox® solution,1
22162,chop14 chemotherapy (see specification under arm b) plus g-csf,1
22163,brentuximab vedotin - maintenance,1
22164,gvhd prophylaxis (tacrolimus and sirolimus),1
22165,radical treatment,1
22166,low-risk therapy,1
22167,radiotherapy with boost,1
22168,day 1: carboplatin auc=5,1
22169,treosulfan iv,1
22170,combined hyperthermia and radiation therapy,1
22171,early intervention,1
22172,intrathecal triple therapy given it,1
22173,eus-fnb(endoscopic ultrasonography guided fine needle biopsy),1
22174,cereport,1
22175,"psa, sthlm3 and mpmri for pc detection",1
22176,monopolar suction diathermy,1
22177,investigational drug ingn 241,1
22178,spectroscopic magnetic resonance imaging,1
22179,platelets-rich-plasma,1
22180,carcinological surgery,1
22181,ttt + icg-based pdt,1
22182,primovist mri (3 tesla),1
22183,colon kcc heptapeptide,1
22184,midazolam 0.02mg/kg,1
22185,trc105 and pazopanib,1
22186,surveillance program after completion of primary treatment,1
22187,discussion & scoring of health states related to the treatment of cervical cancer,1
22188,obturator nerve block,1
22189,low intensity counseling + varenicline + prn nrt,1
22190,fec/te iodine,1
22191,"5-fluorouracil, leucovorin",1
22192,preoperative budesonide inhalation,1
22193,gardasil™,1
22194,51.6 gy imrt,1
22195,laser treatment of port wine stain birthmarks,1
22196,match placebo,1
22197,bpx-101,1
22198,propofol alone,1
22199,medi0680 (amp-514),1
22200,grn 1005,1
22201,muc1 - poly iclc,1
22202,bemarituzumab (fpa144),1
22203,prometrium® 400 mg,1
22204,web based multimedia intervention,1
22205,mr scan,1
22206,photodynamic diagnostic and therapy,1
22207,docetaxel and azd6244,1
22208,cimicifuga racemosa,1
22209,standard of care pelvic mri,1
22210,urinary nnn assesement,1
22211,rte-guided eus-fna,1
22212,standard inspection colonoscopy,1
22213,ness-eftr,1
22214,cruciferous and dark leafy green intervention,1
22215,ac,1
22216,melphalan hcl (propylene glycol-free),1
22217,sonovue-enhanced ultrasound,1
22218,superficial hyperthermia,1
22219,liver resection surgery,1
22220,prostate cancer education and resources for couples (perc),1
22221,cohesive bandage,1
22222,artificial intelligence dermatology assistant (aida™),1
22223,doppler-guided uterine artery occlusion device,1
22224,eortc qlq-c30 (version 3.0).,1
22225,psychiatric evaluation,1
22226,magnesium: magnésium upsa action continue®,1
22227,carbon ions therapy,1
22228,placebo for moxifloxacin,1
22229,qst,1
22230,2b3-101 50 mg/m2 every 3 weeks,1
22231,manualized group intervention,1
22232,eribulin plus ketoconazole,1
22233,relaxation therapy 1,1
22234,rose bengal,1
22235,meopa group,1
22236,pdt-deuteporfin?6 hour),1
22237,microsurgical resection of brain avms,1
22238,"carbo, 5fu, cetuximab",1
22239,ap23573,1
22240,bi 836858 (baml-16-001-s2),1
22241,interferon alfa?fluorouracil,1
22242,tru-016 and bendamustine,1
22243,"day 3: follicle stimulating hormone (fsh), luteinizing hormone (lh), thyroid stimulating hormone (tsh), total testosterone",1
22244,2-year treatment with icotinib,1
22245,bone marrow examination,1
22246,zephyr biopatch device,1
22247,oral capsules talazoparib,1
22248,bevacizumab placebo (ie saline solution),1
22249,image-guided surgery,1
22250,no enoxaparin,1
22251,"phase 1, cohort 4",1
22252,"methotrexate,calcium folinate",1
22253,"131i-mibg , etoposide, melphalan, carboplatin, autologous peripheral stem cell transplantation",1
22254,cladribine and pegylated interpheron alpha-2a,1
22255,[14c]azd2014,1
22256,weekly cabazitaxel,1
22257,abbv-621,1
22258,solifenacin,1
22259,mdasi-hf questionnaire,1
22260,fluorescent lectin application,1
22261,conventional colon resections,1
22262,robot assited thoracic surgery,1
22263,pulmonary rehabilitation program,1
22264,genetically modified dendritic cells + cytokine-induced killer,1
22265,mr guided high intensity focused ultrasound,1
22266,fudr-dex,1
22267,licochalcone a,1
22268,chemoresistance signature,1
22269,s-1 plus cisplatin concurrent radiotherapy,1
22270,dinitrophenyl,1
22271,ct (computed tomography),1
22272,gallium citrate,1
22273,good responder group adjuvant chemotherapy,1
22274,focal brachytherapy,1
22275,combined intravenous-inhalational anesthesia,1
22276,plasma em66 & cga levels assessment,1
22277,gard treatment,1
22278,emotional freedom techniques,1
22279,tinostamustine (edo-s101),1
22280,biophotonic platform for voc detection,1
22281,[68]ga-ha-dotatate,1
22282,gilteritinib (baml-16-001-s8),1
22283,10-day sequential treatment,1
22284,technetium tc-99m dtpa,1
22285,cryopreservation of hscs using 5% dmso concentration,1
22286,s-1 plus cisplatin hipec,1
22287,bcnu wafer,1
22288,"part 1, dose level 1 and dose level 2a: ipatasertib",1
22289,alpha-tocopherol,1
22290,"sorafenib, administered orally",1
22291,renorrhaphy,1
22292,supervised training,1
22293,eradication treatment of helicobacter pylori infection,1
22294,afix only,1
22295,static care plan,1
22296,intravenous paricalcitol,1
22297,topotecan and taxotere,1
22298,garlic oil,1
22299,gsk2820151,1
22300,urelumab (bms-663513),1
22301,biclamp group,1
22302,gadolinium-dtpa,1
22303,my own resources,1
22304,topical diclofenac daily,1
22305,verum acupuncture,1
22306,midazolam premedication,1
22307,halo ablation system,1
22308,tea capsule,1
22309,"dietaty education, physical training, physiotherapy and spa cares",1
22310,patient specific instrument,1
22311,leuprolide or goserelin acetate,1
22312,dose fraction forms,1
22313,mm-302 in combination with trastuzumab,1
22314,fine needle aspiration (fna) and core biopsy (fnb),1
22315,"educational program and fobt kits, and technical assistance",1
22316,immunomodulating nutrition (reconvan),1
22317,cd34-tk75 transduced donor lymphocytes,1
22318,nedaplatin and gemcitabine,1
22319,usual care (routine chemotherapy cycles and imaging studies),1
22320,"rituximab, etoposide, cyclophosphamide, doxorubicin, vincristine,prednisone, filgrastim",1
22321,capecitabine + radiotherapy,1
22322,molecular biology analysis of pancreatic intra-cyst fluid,1
22323,pharmacokinetic sampling - rifampicin,1
22324,donepezil and questionaires,1
22325,vioxx (rofecoxib),1
22326,"risedronate, calcium/vit d, strength weight training",1
22327,ct or mri + blood test,1
22328,pre test counseling,1
22329,22 gauge needle liver biopsy,1
22330,nivolumab and epoch,1
22331,imaging on experimental tomo device,1
22332,zytiga® (abiraterone acetate),1
22333,not suitable for tad,1
22334,crt + panitumumab,1
22335,postoperative adjuvant rt,1
22336,changtai keli,1
22337,education and feedback,1
22338,enb-guided endobronchial marking,1
22339,individual patient-directed program,1
22340,high dose selenized-yeast,1
22341,"gemcitabine, oxaliplatin , fluorouracil, and leucovorin",1
22342,human whole exome,1
22343,nci healthyyoutxt--get active (hyt--ga),1
22344,cyberknife based stereotactic radiotherapy,1
22345,biospecimens collection,1
22346,real-time ceus,1
22347,reference gemcitabine,1
22348,"radium-223-dichloride (xofigo, bay88-8223)",1
22349,mild-dose imrt,1
22350,gastro-entero anastomosis only,1
22351,cd5789 0.01% cream,1
22352,folfiri.,1
22353,questionnaire bundle,1
22354,monosialotetrahexosylganglioside,1
22355,mdc3/8-kras vaccine,1
22356,aspiration in thyroid node for molecular cytogenetic analysis.,1
22357,dietary counselling,1
22358,combi,1
22359,autologous breast reconstruction,1
22360,bilateral epididymal-sparing orchidectomy,1
22361,retroperitoneal lymph node dissection,1
22362,saffron stepped care,1
22363,cd19-ucart,1
22364,adu-1604,1
22365,psychosocial treatment,1
22366,functional imaging of treatment effects,1
22367,no adjuvant chemotherapy,1
22368,cpg-odn,1
22369,"(capecitabine, oxaliplatin, 5-fluorouracil)",1
22370,surgery after 7 weeks of delay after chemoradiotherapy,1
22371,taking of urines,1
22372,18fdg-pet/tc,1
22373,temla,1
22374,apatinib (750 mg/d) + docetaxel (60 mg/m2),1
22375,no additional therapy after surgery,1
22376,hipec: cddp+ doxorubicin 50 mg/m2 @t0 15 mg/m2 @t0,1
22377,epirubicin + cisplatin + capecitabine polychemotherapy,1
22378,palivizumab,1
22379,anal pap smear and hpv dna testing,1
22380,ibrutinib + venetoclax 15 cycles,1
22381,"pemetrexed, cisplatin and cbp501",1
22382,nove-hidac,1
22383,hypoxia marker,1
22384,"chemotherapy ( folfiri regimen, folfox regimen or lv5fu2 regimen) + bevacizumab",1
22385,ulipristal acetate - open label,1
22386,toce plus peit,1
22387,icg fluorescence imaging,1
22388,middle dose et019002- t cells,1
22389,intra-operative mri,1
22390,electrocautery resection and quality of life forms,1
22391,hqp1351,1
22392,s1 combined with cisplatin,1
22393,sentinel node procedure under local anaesthesia,1
22394,podofilox gel 0.5%,1
22395,acetylsalicylic acid (asa)/aspirin 100 mg daily,1
22396,hybridknife esd,1
22397,rituximab + standard chop,1
22398,dach polymer platinate ap5346,1
22399,"""yale coaching""",1
22400,coxen,1
22401,radical surgery only,1
22402,colonoscopy and histology,1
22403,zinc sulfate 220 mg,1
22404,approach for cancer resection,1
22405,"doxorubicin, methotrexate, cyclophosphamide, l-asparaginase",1
22406,at-406 in combination with daunorubicin and cytarabine,1
22407,placebo ointment without illumination,1
22408,pharmacology studies,1
22409,adagloxad simolenin combined with obi-821,1
22410,surgery: splenectomy,1
22411,clinic-directed intervention program,1
22412,bereavement risk screening tool,1
22413,oesophagectomy,1
22414,y zevalin,1
22415,cart-meso-19 t cells,1
22416,curettage and resection,1
22417,mk-1775 20 mg,1
22418,car-t re-treatment,1
22419,simultaneous surgery,1
22420,hu-placebo,1
22421,redcap,1
22422,biliary stent placement,1
22423,sbrt for vertebral/paraspinal metastases,1
22424,nutritional status,1
22425,parapl,1
22426,"acd19z cells, il2, pre conditioning cyclophosphamide & fludarabine",1
22427,haplo-identical cells (donor),1
22428,allogeneic stem cell transplantation.,1
22429,phase 1: cyclophosphamide,1
22430,lipotransplantation,1
22431,one-time implementation intention,1
22432,2 fit kit,1
22433,intensity-modulated whole-abdominal radiotherapy,1
22434,omp-18r5,1
22435,insomnia severity index (isi),1
22436,myo-inositol plus folic acid plus alpha-lactalbumin,1
22437,medi-551 2 mg/kg,1
22438,best medical therapy,1
22439,valproic aicd,1
22440,"ultrasonic knife (ultracision®, ethicon endo surgery)",1
22441,fluorouracil [5-fu],1
22442,cerebrospinal fluid sampling,1
22443,ck-301,1
22444,saline tissue expansion,1
22445,supportive psychotherapy,1
22446,kl-a167 injection,1
22447,photoplethysmography,1
22448,liver mri with ecgd,1
22449,strength and balance tests,1
22450,mak683,1
22451,comparison of capsule endoscopy pillcam ii™ versus colonoscopy,1
22452,"isotonic, 0.9% sodium chloride",1
22453,botox injection,1
22454,"therasphere, yttrium-90 glass microspheres",1
22455,ank for infusion,1
22456,cgc-11047 and docetaxel,1
22457,diagnostic prostate biopsy,1
22458,lay navigation,1
22459,srt-100,1
22460,analgesia nociception index,1
22461,hs-410,1
22462,electroporation (ep),1
22463,f-18 fes,1
22464,blood sample for genetic test,1
22465,claudiximab,1
22466,hrqol questionnaires.,1
22467,endurance exercise training,1
22468,diagnostic thyroid surgery,1
22469,standard dose trivalent inactivated influenza vaccine,1
22470,"biopsy, fine needle aspiration (fna)",1
22471,experimental (fludarabine),1
22472,pelitrexol/ag-2037,1
22473,peg-rasnase,1
22474,gemcitabine and cisplatin plus sorafenib,1
22475,acupuncture stimulation,1
22476,insulin aspart,1
22477,apatinib combined with docetaxel,1
22478,indwelling catheter,1
22479,colorectal cancer screening decision aid,1
22480,weekly internet based pro questionnaires,1
22481,0.8% lugol's solution,1
22482,imiquimod cream + surgery,1
22483,colonoscopy cap,1
22484,ethicon powered vascular stapler,1
22485,raltegravir and cisplatin,1
22486,neoadjuvant intravesical mitomycin-c 40mg/20ml instillation,1
22487,gm-csf + naxitamab,1
22488,living related donor partial liver transplantation,1
22489,sildenafil and questionnaire,1
22490,anti-cd20-car vector-transduced autologous t cells,1
22491,"selenium (l-selenomethionine),",1
22492,liposome entrapped paclitaxel easy to use,1
22493,vinblastin,1
22494,placebo cetaphil cream,1
22495,restriction of radiotherapy to fdg-pet positive areas only,1
22496,part 2b tpst-1120 + docetaxel,1
22497,apply cipka mode,1
22498,"crs-hipec, experimental arm",1
22499,mr-hifu uterine fibroid treatment,1
22500,omega 3 group,1
22501,photon radiotherapy,1
22502,diet intake messages,1
22503,ace inhibitor,1
22504,boost radiation,1
22505,direct antiviral agents for hepatitis c,1
22506,ultrasound-guided axillary lymph nodes fnac and\or cnb.,1
22507,conventional nsaa,1
22508,spinal sbrt (standard dose),1
22509,sr57746a,1
22510,power injectable port (angiodynamics smart port ct mini),1
22511,selective intra-arterial floxuridine and systemic gemcitabine and cisplatin,1
22512,tissue sample collection,1
22513,intravesical bcg instillation,1
22514,liposomal doxorubicin combined with ifosfamide,1
22515,to infuse water into colon to open the lumen for water infusion colonoscopy,1
22516,three-field lymphadenectomy,1
22517,adgmcaix-transduced autologous dendritic cells,1
22518,"the placebo ,chemotherapy(mitomycin, and fluorouracil )",1
22519,ds-8895a 1 mg/kg,1
22520,dn24-02,1
22521,uroxatrol (drug),1
22522,arry-380 twice daily dosage,1
22523,nirfli with icg,1
22524,intravenous morphine,1
22525,surgery and quilting sutures,1
22526,timolol maleate 0.5% gel,1
22527,fanning,1
22528,dynamic contract-enhanced magnetic resonance imaging,1
22529,"thalidomide, melphalan, prednisone",1
22530,uncovered sems,1
22531,bgb-a425,1
22532,caring canine program,1
22533,hand-held dynamometer,1
22534,far infrared radiation (5?m to 20?m wavelength),1
22535,gazyvaro,1
22536,ig imrt,1
22537,external fractionated radiotherapy,1
22538,combined t3 and methimazole treatment,1
22539,red yeast rice,1
22540,implementation of routine videorecording,1
22541,iri/epi,1
22542,"doxorubicin, superabsorbent polymer microspheres, embolotherapy",1
22543,cefoxitin,1
22544,fludarabine as part of lymphodepletion,1
22545,cb-aza,1
22546,"busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.",1
22547,hypozalix spray (artificial saliva),1
22548,docetaxel®,1
22549,imatinib mesylate and zoledronic acid,1
22550,second-line chemotherapy agents,1
22551,ifosfamide chemotherapy (ai),1
22552,quality of life questionairre and education,1
22553,mgmtp140k-encoding retroviral vector,1
22554,metastasis biopsy,1
22555,alemtuzumab plus fludarabine,1
22556,folfox-6 (m),1
22557,"androgen suppression, radiotherapy, iodine 125 brachytherapy",1
22558,"hpv brochure, recall, reminders",1
22559,ft-1101,1
22560,background treatment,1
22561,mal-pdt re-treatment,1
22562,total body irradiation (tbi) 200cgy on day -1,1
22563,sponge,1
22564,text messages with pictures,1
22565,balloon catheter,1
22566,pae plus physician activation (pae + md),1
22567,tazemetostat and [14c] tazemetostat,1
22568,hpv self-sampling kit mailed directly,1
22569,bay 1841788(odm-201),1
22570,pittsburgh sleep quality index,1
22571,"""oncotool"" intervention (mbsr + ht education)",1
22572,sct400 plus chop,1
22573,stereotactic hypofractionated rt 5x7gy,1
22574,thinstrand,1
22575,follow-up for spontaneous regression of the lesion,1
22576,5-ala (gliolan),1
22577,"at-101, prednisone and docetaxel",1
22578,with and without sdb,1
22579,donor hematopoietic stem cell harvest,1
22580,total gastrectomy or proximal gastrectomy,1
22581,recombinant epstein-barr virus (ebv) vaccine,1
22582,part 2c tpst-1120 + cetuximab,1
22583,fluorodeoxyglucose-18-pet/ct,1
22584,chinese medical treatment-lch1,1
22585,d-tect,1
22586,patient-reported outcomes measurement information system (promis)-depression,1
22587,dendritic cells (dc) malignant melanoma,1
22588,medi9090,1
22589,18f-fdg pet/ct and comet assay guide imrt,1
22590,f16il2 in combination with doxorubicin,1
22591,extended pancreatoduodenectomy,1
22592,total aa vs eaa+leu,1
22593,pre-test assessment,1
22594,fluorescéine sodique faure,1
22595,carcinoembryonic antigen peptide 1,1
22596,raloxifene followed by combination therapy,1
22597,"idh mutation test performed at diagnosis or relapse until january 31st, 2019.",1
22598,"indomethacin, celecoxib, esomeprazole",1
22599,trastuzumab deruxtecan,1
22600,night-time compression custom-made garment,1
22601,tamoxifen 20 mg,1
22602,lymphoscintigraphy with 99-technetium (99tc) sulfur colloid (tsc),1
22603,dexamfetamine sulphate,1
22604,combined aerobic and strength exercise training,1
22605,bevacizumab plus erlotinib,1
22606,fec-d,1
22607,ocean nutrition 2050,1
22608,hcc under treatment with radioablation,1
22609,3d power doppler vaginal ultrasound,1
22610,olanzapine placebo,1
22611,posterior reconstruction,1
22612,no local definitive radiotherapy,1
22613,abcdes of melanoma skin cancer,1
22614,cp-4126,1
22615,1rg-cart/m^2 (dose level 5),1
22616,ketamine-ketorolac,1
22617,microsoft band 2,1
22618,gk567,1
22619,saliva sampling,1
22620,cryoapplication (local treatment),1
22621,chloroquine standard dose (500mg/week),1
22622,no dli,1
22623,ltx-315 (oncopore™),1
22624,real-time position management system,1
22625,xtampza er,1
22626,conformal wbrt,1
22627,endoscopic linear cutter stapler and reloads (frankenman),1
22628,jnj-38877605,1
22629,clinical hypnosis,1
22630,[f-18] flt,1
22631,abitren,1
22632,89zr-nanocoll and indocyanine green,1
22633,fatty tissue transfer,1
22634,"cladribine, cyclophosphamide, cytarabine, daunorubicin, dexamethasone",1
22635,clinical chemistry,1
22636,haploidentical stem cells,1
22637,interim pet,1
22638,compression garment,1
22639,accelerated external beam 3-d conformal radiotherapy,1
22640,cnto 888,1
22641,cognitive-behavioral meetings,1
22642,clinimacs cell processing system for tcr?? + t cell and cd45ra depleted peripheral stem cell addback,1
22643,aspirin (asa),1
22644,apricoxib + lapatinib + capecitabine,1
22645,momelan technologies epidermal graft harvesting system,1
22646,d2 gastric and imaging metastases resection,1
22647,fotonovelas,1
22648,coloscopy,1
22649,tom-ox,1
22650,lomustine chemotherapy,1
22651,montanide isa 51 vegetable grade (vg),1
22652,placebo (nacl 0.9%),1
22653,intravenous antibiotic,1
22654,tch,1
22655,"tpf, radiotherapy and cetuximab",1
22656,psa-activated psa-pah1,1
22657,endoscopic ultrasound (standard of care),1
22658,tumor biopsy study,1
22659,enteral immunonutrition,1
22660,gene modified t cells and interleukin 2,1
22661,bobath neurodevelopmental treatment approach,1
22662,"durvalumab, tremelimumab, paclitaxel",1
22663,casein proteins,1
22664,allogeneic large multivalent immunogen vaccine,1
22665,"thiotepa, carboplatin, etoposide",1
22666,apatinib plus xelox,1
22667,er plus apc,1
22668,gleevec and taxotere,1
22669,combined reminder-recall and audit-and-feedback,1
22670,vicryl sutures,1
22671,nuc-1031,1
22672,"romidepsin (depsipeptide, fk228)",1
22673,three-dimensional reconstruction,1
22674,mln8237 (alisertib),1
22675,cyclosporine and methotrexate,1
22676,auc 5 carboplatin,1
22677,diet counseling,1
22678,"pre-operative assessment, counseling and education",1
22679,anti-cd123-car-transduced t cells,1
22680,weight loss specialist,1
22681,information campaign,1
22682,adjuvant treatment - mfolfox & pembrolizumab,1
22683,diclofenac suppository plus lidocaine gel,1
22684,oxaliplatin and irinotecan,1
22685,[18f] fluciclovine,1
22686,msc_apceth_101,1
22687,"[f-18]fluoro-dopa pet, a diagnostic radiopharmaceutical",1
22688,intrathecal,1
22689,hypofractionated wbi,1
22690,ecteinascidin 743,1
22691,fludarabine and total body irradiation,1
22692,gemcitabine and cisplatin (dd gc),1
22693,"fibrin sealant (beriplast p, tisseel vh)",1
22694,(extended) pleurectomy decortication,1
22695,confocal endo-microscopy,1
22696,oral ?-glucan,1
22697,ultrasonographic screening,1
22698,amifostine/azacitidine,1
22699,explorer liver passive tracking,1
22700,allergen one-port tissue expander placement,1
22701,concert-cl® station,1
22702,prevnar- pneumococcal conjugate vaccine (pcv),1
22703,narrow tube reconstruction after subtotal gastrectomy,1
22704,xer2020,1
22705,1 blood sample,1
22706,cancer cell lines establishment,1
22707,cervical sampling,1
22708,sonablate hifu device,1
22709,nipple-sparing mastectomy,1
22710,gemcitabine + cisplatine,1
22711,promotora,1
22712,conture multi-lumen balloon,1
22713,stable disease (sd) group,1
22714,ham + tocopherol,1
22715,triple endoscopy and biopsy,1
22716,four and two time schedule,1
22717,energy restricted ketogenic diet (erkd) (metabolic nutritional therapy),1
22718,nab-paclitaxel in combination with gemcitabine + cisplatin,1
22719,lymph node yield (lny) and lymph node ratio (lnr),1
22720,dcc-2701 tablet,1
22721,paravertebral blocks (pvb),1
22722,ad26.hpv16,1
22723,complete resection - surgery for tumor removal,1
22724,analyze the pharmacokinetics of busulfan for transplantation,1
22725,web-based health planner on diet and exercise,1
22726,iph2102 at 0.1 mg/kg,1
22727,chest computed tomography scan,1
22728,high throughput screening,1
22729,cold ischemia procedure,1
22730,qualitative fecal immunochemical test,1
22731,brain x-ray,1
22732,my living story,1
22733,cdd,1
22734,visual inspection with acetic acid (via),1
22735,non-steroidal aromatase inhibitor,1
22736,pesco-vegetarian diet,1
22737,hypothalamic deep brain stimulation,1
22738,"lenalidomide, decitabine",1
22739,chemotherapy plus endocrine therapy (administered either concomitantly or sequentially),1
22740,sildenafil therapy plus sham post-nsrrp hbo2t,1
22741,modified measles virus,1
22742,cisplatin + 5-fluorouracil (or+ leucovorin),1
22743,"clofarabine, methotrexate, mercaptopurine, dexamethasone, etoposide, dasatinib",1
22744,0.12 mg/kg cpg 7909,1
22745,meditative slow breathing (msb),1
22746,radiotherapy (extrernal beam radiotherapy + brachytherapy),1
22747,"placebo + povidone iodine, chlorhexidine, & nystatin",1
22748,ceftriaxone sodium,1
22749,isolated inferior limb perfusion,1
22750,linac-based radiosurgery with edge,1
22751,treatment with electronic brachytherapy,1
22752,brachytherapy boost,1
22753,melanoma vaccine modified to express hla a2/4-1bb ligand,1
22754,blood and marrow transplant (bmt),1
22755,baseline surveillance endoscopy,1
22756,obinutuzumab (g),1
22757,thoracic 3-d conformal radiotherapy,1
22758,the pleurapump system,1
22759,second autologous transplantation,1
22760,ginsenoside rg3 plus first-line chemotherapy,1
22761,imn1207,1
22762,arb,1
22763,radiofrequency ablation(rfa) by halo device.,1
22764,1 mg estradiol / 0.5 mg norethindrone acetate,1
22765,pyrotinib+trastuzumab+docetaxel+carboplatin,1
22766,spio alone,1
22767,ebv-lmp-2,1
22768,ly01005,1
22769,intravenous cisplatin & etoposide along with oral cyclophosphamide,1
22770,dim red light using light visor cap,1
22771,dc1-ctl,1
22772,anthracycline and taxane based chemotherapy,1
22773,sagopilone,1
22774,stress reduction intervention,1
22775,at,1
22776,bpi-short form,1
22777,normale saline solution,1
22778,"docetaxel, capecitabine, cisplatin",1
22779,multi-herbal agent acapha,1
22780,endoscopic ultrasound elastography (eg-eus),1
22781,ccb use,1
22782,iv thiotepa,1
22783,indoximod hcl,1
22784,m-vtd-pace,1
22785,total body dual-energy x-ray absorptiometry,1
22786,capecitabine pill,1
22787,dexamethasone (intrathecal),1
22788,labeled line,1
22789,diagnostiskt centrum,1
22790,neupogen 5µg/kg/day,1
22791,abvd and radiotherapy,1
22792,"setting up a specific care path ""allotc"" for management of tve in patients with cancer",1
22793,dn-101 (calcitriol) - drug,1
22794,intraoperative near-infrared (nir),1
22795,pentetic acid calcium,1
22796,partial precutting,1
22797,mvac protocol,1
22798,web + streamlined telephone genetic counseling,1
22799,nilotinib-adriamycin,1
22800,anatomo-pathologic procedure,1
22801,"escalation cohort: regorafenib (stivarga, bay73-4506) 40 mg",1
22802,prosigna,1
22803,pancreatic adenocarcinoma diagnosis,1
22804,early palliative care visit,1
22805,incb007839 300mg bid,1
22806,pregabalin/celecoxib,1
22807,radiation: sirt + chemotherapy (cisplatin-gemcitabine),1
22808,true acupuncture,1
22809,written advice,1
22810,full field digital mammogram (planmed sophie nuance),1
22811,tumor genomic analysis,1
22812,hypofractionated stereotactic irradiation,1
22813,high-dose single-fraction image-guided radiotherapy for men undergoing radical prostatectomy,1
22814,no nasal packing.,1
22815,aerobic exercise only,1
22816,wr-22 model microwave sensor,1
22817,automatic speech processing tool,1
22818,occupational and physical therapy,1
22819,dasatinib in combination with imatinib,1
22820,alectnib,1
22821,oxaliplatin 100 mg,1
22822,vibration response imaging,1
22823,part 2: pt2385 tablets in combination with nivolumab,1
22824,gemcitabine cisplatine,1
22825,3l peg,1
22826,trimm,1
22827,immunonutrition with arginine,1
22828,carboplatin with vincristine,1
22829,anti-egfrviii car t cells,1
22830,irradiation: ha-pci,1
22831,polyethylene glycol morning,1
22832,cnb,1
22833,behavioral and pharmacologic tobacco use intervention,1
22834,chemokine modulatory regimen,1
22835,cetuximab + platinum (cisplatin or carboplatin) + 5fluorouracil (5-fu),1
22836,fiberoptic nasal laringoscopy,1
22837,high-dose sequential chemotherapy followed by asct,1
22838,"subtotal esophagectomy at the azygos vein, total gastrectomy",1
22839,esophagogastroduodenoscopy with high definition-white light end endoscopy (hd-wle) and narrow band imaging (nbi),1
22840,physical prehabilitation,1
22841,wellness landscape intervention,1
22842,tq-b3233,1
22843,"oxaliplatin, irinotecan, capecitabine",1
22844,"gemcitabine 1000 weeks 1,2,3/4",1
22845,roux-en-y gastric bypass surgery,1
22846,akt levels,1
22847,2l treatment,1
22848,1018 iss immunostimulatory oligonucleotide,1
22849,b3: amg 386 15mg/kg + topotecan,1
22850,tethered capsule endoscopy,1
22851,methylprednisoloneacetate,1
22852,ipilumumab,1
22853,"concomitant radiochemotherapy - radiotherapy 66 gy, cisplatin, and docetaxel",1
22854,photon treatment plans,1
22855,verify radiation dose to heart and lung,1
22856,animal-assisted interactions,1
22857,uv1/gm-csf,1
22858,l-phenylalanine mustard,1
22859,imrt radiation,1
22860,ldwart (low dose whole abdominal radiation therapy),1
22861,gen3013 (duobody®-cd3xcd20),1
22862,"pdr001, imatinib",1
22863,neoadjuvant short course imrt,1
22864,visco-ease,1
22865,physician-directed regimens without cyclophosphamide,1
22866,supervised home based training,1
22867,efficacy evaluation,1
22868,atu027 & gemcitabine in treatment arm 1,1
22869,hcbe-11,1
22870,cart-19/22,1
22871,group 2 perform self sample at home or pap smear,1
22872,pure chemotherapy?xelox?,1
22873,prasterone (dhea),1
22874,cohort 2 adjuvant,1
22875,pharmacokinetic 5-fu dose adjustment using ondose® assay,1
22876,ibi301,1
22877,lung cancer symptom scale for mesothelioma questionnaire,1
22878,survey questions,1
22879,177lu-3bp-227 (also called 177lu-ipn01087),1
22880,chimiopal,1
22881,norethindrone acetate,1
22882,hd-mtx-ara-c regimen,1
22883,omega 3 fatty acids (epa (eicosapentaenoic acid) and dha (docosahexaenoic acid)),1
22884,linear accelerator,1
22885,r-mant,1
22886,1000 mg iron isomaltoside 1000,1
22887,bevacizumab and eribulin,1
22888,stealth liposomal doxorubicin,1
22889,68ga-nota-3p-tate-rgd,1
22890,flot alone,1
22891,azacitidine associated with valproic acid,1
22892,pet mri,1
22893,tmz (temozolomide),1
22894,theratope stn-klh vaccine,1
22895,18f-flt-pet/ct imaging,1
22896,evaluation of emotional status,1
22897,psa,1
22898,jnj-68284528,1
22899,recombinant vaccinia-psa(l155)/tricom (prostvac-v/tricom),1
22900,haplo/cord transplant,1
22901,herbal therapy,1
22902,metabolic imaging,1
22903,web app intervention group,1
22904,microtubule-targeted agent bal101553,1
22905,geniusvac-mel4,1
22906,ebna with rose,1
22907,4- [f-18] fluoropaclitaxel,1
22908,bay1163877,1
22909,ak002,1
22910,nurse support and selfmanagement intervention,1
22911,molecular alteration,1
22912,cga,1
22913,conventional t cells (tcon) and regulatory t cells (treg),1
22914,website session,1
22915,tcm herbal decoction (shi pi),1
22916,iht,1
22917,"chloroquine, a-cq 100",1
22918,anergized cell infusion,1
22919,metabolome study,1
22920,discontinuation of azathioprin,1
22921,eonconote,1
22922,eg12014,1
22923,physician choice,1
22924,rachel,1
22925,healthlinks,1
22926,whole bladder laser light treatment as an alternative to radical cystectomy,1
22927,"part 1, dose level 2a and dose level 3: rucaparib",1
22928,stage 2 active methylenedioxymethamphetamine,1
22929,"there is no intervention, only observation",1
22930,iv lbh589,1
22931,stereotactic radiation arm 3,1
22932,sensipar,1
22933,dose escalation cetuximab,1
22934,intra-operative frozen section,1
22935,group metacognitive therapy,1
22936,90y-ibritumomab,1
22937,161533 trike phase i,1
22938,minimal access surgery,1
22939,levonorgestrel ius,1
22940,epacadostat (phase 1),1
22941,ct/us fusion,1
22942,cellectra®5p device (cellectra 2000),1
22943,topotecan/docetaxel combination,1
22944,tomivosertib (eft508),1
22945,holmium laser enucleation of prostate (holep),1
22946,fiducials,1
22947,absorbable gelatin sponge particles,1
22948,fet-pet,1
22949,fatigue and depressive symptom assessment and management,1
22950,intrathecally treatment,1
22951,laparoscopic ovarian drilling (lod),1
22952,oxaliplatin; capecitabine; concurrent radiotherapy,1
22953,intravenous injection of 177lu-octreotate,1
22954,thermovision a20m infrared camera,1
22955,habibtm endohpb catheter,1
22956,surveillance cystoscopy and urinary cytology,1
22957,etoposide - usual,1
22958,enhanced print da,1
22959,vacc. w/ poly-iclc & peptide-pulsed dendritic cells,1
22960,multidisciplinary bladder-preservation therapy,1
22961,preoperative exercise program,1
22962,whole lung radiation,1
22963,sorafenib escalated dose,1
22964,anti-protozoal agents,1
22965,salvia for germline dna,1
22966,act with til infusion,1
22967,fact-h&n,1
22968,deep neuromuscular blockade (nmb),1
22969,avidinox,1
22970,cetuximab/erbitux,1
22971,transverse coloplasty,1
22972,semi-structured interview conducted by a clinical psychologist,1
22973,leo 43204 formulation 1,1
22974,prospace,1
22975,1 fit kit,1
22976,screening tomosynthesis,1
22977,regular bupropion use,1
22978,crest toothpaste,1
22979,calcumin (curcumin),1
22980,reversed tracking method,1
22981,"standard docetaxel, carboplatin, and herceptin",1
22982,tak-733 and alisertib,1
22983,high flow nasal cannula oxygen therapy,1
22984,js001 480mg+gp,1
22985,oral information and interviews,1
22986,astx727 dose escalation,1
22987,cs7017 tablets,1
22988,apx001 with standard of care anti-fungal agent,1
22989,"part 1, cohort 3",1
22990,ceritinib 750mg,1
22991,22g needle,1
22992,accelerated hypofractionated radiotherapy (ahf-rt),1
22993,"health questionnaire, blood draw and skin exam",1
22994,amg 386 + paclitaxel,1
22995,clearsight™ system,1
22996,q-icg,1
22997,89zr-df-iab2m,1
22998,esomeprazole (nexium) 40 mg/day,1
22999,gadofosveset enhanced mrl of axillary lymph nodes,1
23000,oxycodone hcl 5mg,1
23001,concurrent rad001 10 mg/day,1
23002,fluciclovine pet/ct,1
23003,treg infusion,1
23004,amulez and red light treatment,1
23005,aguix®,1
23006,degree of constipation,1
23007,0.5 mg ranibizumab,1
23008,control arm (seq):,1
23009,miltenyi biotec clinimacs device,1
23010,ifabond (tm),1
23011,odm-201 tablet b,1
23012,e7449,1
23013,nurse amie,1
23014,sir-spheres®,1
23015,high glycemic load diet,1
23016,gammaknife(r) stereotactic radiosurgery,1
23017,add,1
23018,sln detection +/- complementary axillary lymphadenectomy,1
23019,cbct intervention,1
23020,calcium alumina-silicate (casad),1
23021,pdc or mydc,1
23022,pain questionnaires,1
23023,biological image-guided radiotherapy with conventional dose.,1
23024,hypo-fractionated postoperative imrt-sib,1
23025,ovarian cancer screening,1
23026,"lbh589, paclitaxel, carboplatin, bevacizumab",1
23027,dietary control,1
23028,provox vega voice prosthesis (20 fr),1
23029,mdx-010 (anti-ctla4) monoclonal antibody,1
23030,endo-gia,1
23031,hepatitis a,1
23032,"chemotherapy (capecitabine, oxaliplatin, 5-fu, leucovorin)",1
23033,read unfavorable article prior to answering questions,1
23034,surgery for acromegaly,1
23035,hipec cytoreductive surgery,1
23036,taking photographs of suspicious lesions with his smartphone and sending them to the dermatologist,1
23037,immediate apa program,1
23038,antiemetic,1
23039,cetuximab plus platinum-based doublet chemotherapy,1
23040,disulfiram (dsf),1
23041,pancreas-sparing duodenectomy,1
23042,regular use of any other antidepressant,1
23043,wide excision and sentinel lymph node (sln) biopsy,1
23044,laparoscopic ppg,1
23045,10-core prostate biopsy protocol,1
23046,integrative medicine care,1
23047,carbon monoxide (co) level test,1
23048,ramucirumab dp (imc-1121b),1
23049,standard c02 cryotherapy,1
23050,injection of mouse tyrp2 dna,1
23051,18f-fes pet ct scan,1
23052,nimotuzumab ( h-r3),1
23053,modulated electro-hyperthermia,1
23054,fpv-cv301,1
23055,cisplatin + docetaxel + enoxaparin,1
23056,broccoli sprout extract (bse),1
23057,secretin-enhanced magnetic resonance cholangiopancreatography,1
23058,imaging with high resolution microendoscope,1
23059,mp0250 plus bor+dex,1
23060,fractionated whole brain radiation therapy (wbrt),1
23061,patient-reported outcome measures,1
23062,lutetium lu 177 monoclonal antibody j591,1
23063,whole-pelvic radiotherapy (wprt),1
23064,four-port laparoscopic surgical staging,1
23065,radioiodine therapy,1
23066,methotrexate / hydrocortisone / cytarabine,1
23067,dimac02,1
23068,ono-7579,1
23069,intrathecal drug delivery system,1
23070,pertuzumab + trastuzumab,1
23071,propofol - remifentanil group,1
23072,interferon-alpha2b - 1 year,1
23073,normal analgesia pump administration,1
23074,avelumab phase 1b,1
23075,5-fu 1200 mg/m^2 x 2 d,1
23076,qbkpn ssi,1
23077,fl/tax,1
23078,124i-humanized 3f8,1
23079,emotional supportive mindfulness-based program,1
23080,quantitative sensory testing,1
23081,metal wire,1
23082,counseling session,1
23083,bortezomib; pegylated liposomal doxorubicin,1
23084,non-anatomical liver resection,1
23085,low dose cyclophosphamide (oral),1
23086,guaraná,1
23087,"scaling and root planing , myo-inositol",1
23088,multicolour inking specimens,1
23089,di-leu16-il2 immunocytokine,1
23090,radical prostatectomy with posterior rhabdosphincter reconstruction,1
23091,3 tesla mri scan,1
23092,pagetex pdt,1
23093,baclofen/amitriptyline/ketamine gel,1
23094,vaginal auto-takings and urinary test,1
23095,ldct brochure,1
23096,131i-f16sip radioimmunotherapy (rit),1
23097,hybrid argon plasma ablation (hapc),1
23098,megestrol acetate 40 mg,1
23099,napt,1
23100,blood samples for serum stability,1
23101,standard printed dietary guidelines,1
23102,autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014,1
23103,bibw 2992 ma2 40mg/day,1
23104,thoracic epidural block (tea),1
23105,cohort 1 anti-ox40,1
23106,multimodal treatment,1
23107,dox 4 cycles - surgery,1
23108,cranial radiation (once daily fractionation),1
23109,"comparator: quadrivalent hpv vaccine (qhpv), (gardasil™)",1
23110,it cytarabine,1
23111,mri with ivim dw-mri,1
23112,lr-eshap (lenalidomide 5 mg),1
23113,pld and carboplatin,1
23114,dsa only,1
23115,"quadrivalent hpv for types 6, 11, 16 and 18",1
23116,adriamycine,1
23117,bibx 1382,1
23118,drug withdrawn,1
23119,incisionless laparoscopic colectomy,1
23120,laparoscopic esophagectomy,1
23121,standard first line anti-tb drugs,1
23122,proteasome sirna and tumor antigen rna-transfected dendritic cells,1
23123,ovarian tissue biopsy,1
23124,poly-iclc (cohort b),1
23125,positron emission tomography-computed tomography,1
23126,new indwelling pleural catheter,1
23127,fleet enema,1
23128,polyvinylpyrrolidone-sodium hyaluronate gel,1
23129,ciclopirox,1
23130,high-dose trt,1
23131,18f-fmiso pet-scanning,1
23132,oral 9-nitrocamptothecin,1
23133,intraoperative imaging device,1
23134,breast reconstructive surgery,1
23135,gallium ga68-labeled psma-11,1
23136,gemcitabine-nab paclitaxel,1
23137,best medical treatment,1
23138,transthoracic needle biopsy,1
23139,apatinib plus s-1,1
23140,peg ifn alfa-2b,1
23141,transversus abdominal plane block with placebo,1
23142,monoclonal antibody 11d10 anti-idiotype,1
23143,cetuximab (erbitux®),1
23144,model care,1
23145,a cervico-vaginal cervical smear,1
23146,samarium-153,1
23147,radiopharmaceutical: [18f]-flt,1
23148,cd19car/virus specific t cells,1
23149,transverse uterine incision,1
23150,sample without dna,1
23151,intravenous etoposide/cisplatin,1
23152,exablate mrgfus (magnetic resonance guided focused ultrasound surgery),1
23153,complications of therapy,1
23154,relative copy number of mitochondrial dna,1
23155,meiqx,1
23156,"humanised monoclonal antibody, veltuzumab",1
23157,cardio-green,1
23158,edap,1
23159,transurethral catheterization using foley catheter,1
23160,expanded prostate cancer index composite (epic),1
23161,testosterone undecanoate and sunitinib or pazopanib,1
23162,treatment with poziotinib,1
23163,"abiraterone acetate, prednisolone",1
23164,eus guided rfa of cystic tumours of the pancreas,1
23165,zinc acetate,1
23166,radium 223 dichloride (xofigo®),1
23167,lapatinib in combination with weekly paclitaxel,1
23168,self-sampling,1
23169,concurrent durvalumab,1
23170,tlh,1
23171,the marketed product 2-5 mbq/kg 18f-fluorodeoxyglucose,1
23172,the current season's trivalent killed influenza vaccine,1
23173,standard endurance training,1
23174,additional radiation boost to the primary tumor volume,1
23175,blood sample for identifying the polymorphism,1
23176,pomalidomide 4 mg oral capsule,1
23177,traditional bowel anastomosis,1
23178,aroma therapy,1
23179,niris 1300e,1
23180,cm082 tablet,1
23181,diet and absorption of colopeg,1
23182,radiotherapy by prone and decubitus,1
23183,fludarabine plus cyclophosphamide,1
23184,siemens inspiration digital breast tomosynthesis (dbt) system,1
23185,short-acting g-csf,1
23186,imp-288 labeled with in111 and lu177,1
23187,tp-3654,1
23188,immunohistochemical detection of lymphocytes t cd8+/foxp3 ratio,1
23189,docetaxel/ddp,1
23190,audio cd,1
23191,brain radiotherapy,1
23192,gt0918,1
23193,brushing of bile duct strictures for cytology,1
23194,folic acid 400 mg,1
23195,c14 azd1152,1
23196,lidocaine hydrochloride 2% with epinephrine,1
23197,tcs,1
23198,darbepoetin alfa - 2.25 mcg/kg,1
23199,zd6474 (vandetanib) 200mg,1
23200,external radiotherapy + curietherapy,1
23201,btct4465a (mosunetuzumab) sc,1
23202,storytelling intervention for nurse participants,1
23203,tl32711,1
23204,medi6469 plus tremelimumab,1
23205,neurosensory testing,1
23206,re-biopsy,1
23207,standard of care based on target(s) identified via gws.,1
23208,urea cream 20%,1
23209,fmri,1
23210,patient diary proms,1
23211,app for stress management,1
23212,gallium ga 68-dotatate,1
23213,post-therapy 18f-thymidine (flt) pet/ct to assess for pemetrexed induced changes in tumor proliferation,1
23214,maintenance intervention,1
23215,dalteparin injection,1
23216,tablet computer-based education,1
23217,ibrutinib (arm 1 - closed with amendment g),1
23218,bravo ph monitoring,1
23219,mesenchymal stromal cells-derived exosomes with kras g12d sirna,1
23220,olmutinib,1
23221,progressive walking and resistance exercise treatment,1
23222,oxaliplatin (via hai),1
23223,einsteinvision 3d visualization system,1
23224,metformin hydrochloride 500mg tablet,1
23225,nei-vfq-25 questionnaire,1
23226,"mage-3/melan-a/gp100/na17 peptide-pulsed autologous pbmc, rhil-12 with il-2",1
23227,"drug: taxol,cisplatin and capecitabine",1
23228,tissue biopsies,1
23229,gene-modified (gm) t cell therapy,1
23230,haplotype pbsct,1
23231,cervarix data collection,1
23232,toxicity,1
23233,tissue-of-origin (origin-panca?r) profiling,1
23234,prolarix (tretazicar co-administered with caricotamide),1
23235,nabilone,1
23236,enhanced internet + phone,1
23237,rituximab i.v.,1
23238,perihepatic phlebotomy,1
23239,amg 714,1
23240,urodynamics test,1
23241,4 week assessment,1
23242,donor nk cell infusion,1
23243,pl225b,1
23244,"risk-based, escalating levels of co-management",1
23245,disease screening,1
23246,dpx-e7 vaccine,1
23247,"docetaxel plus capecitabine for 6 cycles, followed by capecitabine",1
23248,"echo, exercise echo, and if indicated, right heart catheter",1
23249,electrotherapy,1
23250,placebo for veliparib,1
23251,fludarabine (fludara),1
23252,22 gauge vizishot needles,1
23253,artificial urinary sphincter,1
23254,neoadjuvant cisplatin and gemcitabine,1
23255,electromagnetic navigation bronchoscopy,1
23256,validated health-related quality of life questionnaires,1
23257,one-staged hybrid operation,1
23258,cik-cells,1
23259,therapy,1
23260,surgical exploration,1
23261,5-fluouracil,1
23262,fruit and vegetable extracts,1
23263,behavioral: psychosexual intervention,1
23264,fn-1501,1
23265,lay health advisor interactions,1
23266,gas,1
23267,integrated fitness assessment,1
23268,d2c7-it,1
23269,muscle relaxation,1
23270,help prevent cancer intervention,1
23271,no loco-regional treatment,1
23272,gamma-camera imaging,1
23273,one-on-one interview,1
23274,anterior electronic portal images (epi),1
23275,conventional open retropubic radical prostectomy,1
23276,hand cycling,1
23277,anti-cd30 car t cells,1
23278,guide sheath,1
23279,aldara (imiquimod 5% cream),1
23280,he3235,1
23281,placebo matching lapatinib,1
23282,vaccine (autologous dendritic cells),1
23283,recurrence rate of cca after surgery,1
23284,coxen analysis for chemotherapy prediction,1
23285,recombinant human interleukin 21 and rituximab,1
23286,vp-102-cantharidin topical film forming solution,1
23287,swallowable sponge cell sampling device,1
23288,blind injection of mepivacaine,1
23289,aromatase inhibitor plus gnrh analog,1
23290,sugical resection,1
23291,tremelimumab + durvalumab,1
23292,anti-pd-1 antibody shr-1210,1
23293,"radical prostatectomy with fascial suturing but no urethral irrigation, qol forms",1
23294,systematic nutritional consultation at home,1
23295,definitive chemoradiation,1
23296,intrathecal chemotherapy,1
23297,autologous peripheral bld stem cell transplantation with in vivo purging as an alternate stem cell transplantation,1
23298,ly353381,1
23299,empirical vancomycin,1
23300,vitamin capsules,1
23301,dose level 2 onc201 500mg,1
23302,cytosponge™,1
23303,oxaliplatin: bsa-based hipec,1
23304,thyroid lobectomy,1
23305,bl22,1
23306,c-14 labeled rucaparib,1
23307,"capecitabine, temozolomide",1
23308,different timing of taking polyethylene glycol(peg),1
23309,"docetaxel, nedaplatin, and capecitabine",1
23310,combination of irinotecan and cisplatin,1
23311,self-sampling kit sent at home + sms reminder,1
23312,bms-986012 (anti-fucosyl-gm1),1
23313,placebo plus metformin,1
23314,benigh gallbladder diseases,1
23315,nirogacestat oral tablet,1
23316,shape (shp-141) 1.0% bid,1
23317,fluoromisonidazole-pet/ct,1
23318,wt 1 testing,1
23319,renal ultrasound,1
23320,cd7.car/28zeta car t cells,1
23321,12 week walking program,1
23322,values survey (serious illness care program),1
23323,combination iv gemcitabine and iv carboplatin (auc2),1
23324,maintenance with pemetrexed,1
23325,"questionnaires, interviews and or tissue donation",1
23326,balance sheet task,1
23327,daratumumab/lenalidomide/dexamethasone until progression,1
23328,electroencephalogram,1
23329,sphenopalatine ganglion (spg) block,1
23330,leukemic or stroma cells,1
23331,betel nut cessation social support,1
23332,18f-facbc radiotracer,1
23333,community health advisor education,1
23334,"farletuzumab, carboplatin, and pld",1
23335,"supportan(r) (disease-specific enteral tube feed, food for special medical purposes)",1
23336,vb6-845,1
23337,hpph 4 mg/m2,1
23338,adherence-encouraging interventions - group meeting,1
23339,training session,1
23340,3rp-lymphoma,1
23341,[131]i-mibg,1
23342,garlic,1
23343,cyclophosphamide and jx-594 dose escalation,1
23344,"ccrt, pelvic lymphadenoectomy.",1
23345,hepatic artery embolizations,1
23346,zolinza (vorinostat),1
23347,cbp/beta-catenin antagonist pri-724,1
23348,emri/mrsi,1
23349,decipher genomics resource information database (grid),1
23350,definitive treatment,1
23351,radioactive tracers,1
23352,right hepatectomy with classic approach,1
23353,placebo a,1
23354,dna extraction,1
23355,appear procedure,1
23356,quality of life and quality of sexual life questionnaires,1
23357,melphalan iv,1
23358,gi-6207 [recombinant saccharomyces cerevisia,1
23359,astx727 + day 2 food,1
23360,initial blood draw,1
23361,colonoscopic biopsies,1
23362,onm-100,1
23363,tumor grade,1
23364,"trastuzumab, lapatinib",1
23365,liposo,1
23366,pneumococcal polysaccharide vaccine (ppv),1
23367,water enema,1
23368,titanium marker,1
23369,preserving the left colic artery,1
23370,50 gy,1
23371,da- vinci robot and conventional laparoscopic instruments,1
23372,part 1: interview + questionnaires,1
23373,bcd-145,1
23374,arm 1 daily boost of radiation therapy,1
23375,nonspecific pleuritis after vats thoracoscopy,1
23376,if cocktail,1
23377,operative hysteroscopy,1
23378,arm a chemotherapy,1
23379,speckle tracking echocardiography,1
23380,cytarabine (baml-16-001-s6),1
23381,s-1 maintenance,1
23382,thalidomide (thado),1
23383,pelvic exercise,1
23384,anti-gitr,1
23385,n-13 ammonia or f-18 fluorodeoxyglucose,1
23386,bpt,1
23387,core biopsy procedure,1
23388,surgiflo injection,1
23389,perioperational nutrition surpport,1
23390,idarubicin and lipiodol,1
23391,lomustine (ccnu),1
23392,fmiso pet,1
23393,breast implant,1
23394,"oxaliplatin, cetuximab, bevacizumab, panitumumab, irinotecan, leucovorin, 5fluorouracil",1
23395,hpv e7 (human papilloma virus e7) peptides,1
23396,nasal packing,1
23397,methyl 5-aminolevulinate,1
23398,biologic: pegylated recombinant human hyaluronidase (pegph20),1
23399,"methotrexate , procarbazine ,vincristine ,cytarabine",1
23400,stm 434,1
23401,docetaxel(xrp6976),1
23402,usual clinical and radiological criteria,1
23403,closed suction drainage,1
23404,flare,1
23405,proton (prostate bed) to 70.2 cge,1
23406,donor lymphocyte harvest,1
23407,cost discussion,1
23408,tongue depressors,1
23409,anti-muc1 car t cells,1
23410,elotuzumab (bms-901608),1
23411,detection of single nucleotide polymorphisms (snp),1
23412,auricular points sticking,1
23413,etoricoxib 120 mg,1
23414,reduction of vaginal source loading,1
23415,bp intraperitoneal mesh,1
23416,infusion of inkt cells,1
23417,savi scout surgical guidance system,1
23418,taking blood samples,1
23419,erlotinib (aka tarceva or osi-774),1
23420,transport on foot,1
23421,roux-en-y pouch reconstruction or conventional roux-en-y reconstruction,1
23422,biopsies of rectal and colon mucosa,1
23423,raltitrexed plus docetaxel,1
23424,sinus excision,1
23425,aromatase inhibitor + palbociclib,1
23426,letrozole-metformin,1
23427,spect-ct scan,1
23428,25g whitacre needle,1
23429,"ivac mutanome, rbl001/rbl002",1
23430,questionnaires set 1,1
23431,oneome rightmed®,1
23432,bortezomib + dexamethasone,1
23433,preoperative docetaxel monotherapy,1
23434,sct,1
23435,laparoscopic adjustable gastric banding,1
23436,"pertuzumab 840 mg iv saturation, then 420 mg iv (selected her2 positive patients only)",1
23437,local anesthetic,1
23438,mitomycin and doxifluridine,1
23439,whole brain xrt 30gy/10 fractions with,1
23440,leteprinim potassium (neotrofin),1
23441,medial group retropharyngeal node?mrln? sparing,1
23442,cisplatinum and everolimus,1
23443,hybrid pet-ct imaging system,1
23444,litt,1
23445,whole brain radiotherapy with simultaneous boost,1
23446,laparoscopy assisted total gastrectomy,1
23447,psychoeducative training,1
23448,axon reflexes,1
23449,pembrolizumab and high dose interferon alfa-2b (hdi),1
23450,dexketoprofen,1
23451,intensified chemotherapy (folfoxiri/bevacizumab),1
23452,placebo to v503,1
23453,study part 2: krp203 higher dose,1
23454,diet and nutrition coaching,1
23455,alkeran for injection/melphalan hcl for injection (propylene glycol-free),1
23456,"ner1006, 2-day split-dosing",1
23457,"cellsearch detection of the number of circulating, functional, prostate cells",1
23458,perioperative chemotherapy with mfolfox6 or capox regimens,1
23459,high intensity interval training with body weight,1
23460,transrectal mpmri-us fusion prostate biopsy,1
23461,docetaxel + cef,1
23462,melitac 12.1 + montanide isa-51 + lipopolysaccharide (lps),1
23463,enhanced internet da,1
23464,off-site pathologist,1
23465,controllable infrared bioeffect system,1
23466,enoxaparin sodium,1
23467,"vinorelbine plus capecitabine for 6 cycles, followed by capecitabine",1
23468,mopp regimen,1
23469,cordycepin,1
23470,roux-en y reconstruction,1
23471,msi-1436c,1
23472,assessment of oral hpv infection,1
23473,uncovered wallstent,1
23474,sc-003 in combination with abbv-181,1
23475,ly3164530,1
23476,chemotherapy plus p53,1
23477,eco-4601,1
23478,risetx,1
23479,cognitive surveys,1
23480,mirna,1
23481,double placebo control,1
23482,placebo therapeutic touch,1
23483,pec i/ii blocks by surgeon - intra-operative,1
23484,tegafur?gimeracil and oteracil potassium,1
23485,viewray mri,1
23486,cdp791 20mg/kg,1
23487,tumor tissue collection (optional),1
23488,nivolumab (cohort a and b),1
23489,pemetrexed 1000 mg/m2,1
23490,intermittent aspiration,1
23491,"vp-16, cisplatin, ifosfamide, dexamethosone, mesna, if-rt",1
23492,r-choep,1
23493,probe drugs,1
23494,mpact,1
23495,"methotrexate, teniposide, peg-asparaginase",1
23496,asymmetric primary closure and additional skin excision technique,1
23497,intercept,1
23498,inconclusive results da,1
23499,esomeprazole (nexium),1
23500,3 day thiarabine,1
23501,lymph node sorting for pathological examination,1
23502,amoxicillin hydrate,1
23503,intensity modulated proton therapy (impt) +/- chemotherapy,1
23504,performance status,1
23505,tailored physician recommendation letter,1
23506,h2ra and surgicel,1
23507,eviderma smart phone teledermatology application (eviderma),1
23508,chamomilla recutita gel,1
23509,deoxycoformycin,1
23510,low intensity laser for oral mucositis,1
23511,pad followed by asct,1
23512,ca125 assay on abbott architect i1000sr platform,1
23513,egfr or her2 inhibitor,1
23514,atra+chemo,1
23515,nipple reconstruction,1
23516,higher peep ventilation,1
23517,ilx-295501,1
23518,"questionnaire, focus group participation",1
23519,pyruvate kinase isoform m2,1
23520,tbl 12,1
23521,neoadjuvant stereotactic radiosurgery,1
23522,chemoradiation (radiation therapy),1
23523,endostar for two cycles,1
23524,"arry-382, cfms inhibitor; oral",1
23525,"clofar, cyclophos, alemtuzumab",1
23526,probiotic formula,1
23527,telephone follow-up nursing device,1
23528,rm-1929,1
23529,echo/stress echo,1
23530,samples with 2 treatments,1
23531,paclitaxel+oxaliplatin+fluorouracil,1
23532,counselling,1
23533,therapeutic progesterone,1
23534,mri abdomen,1
23535,tnx-650,1
23536,real time pcr,1
23537,eflornithine & sulindac placebo,1
23538,concomitant medication review,1
23539,calcium folinate 200 mg/m2 iv,1
23540,everolimus (rad 001),1
23541,"gemcitabine, bosutinib",1
23542,oxaliplatin (in folfox),1
23543,bright blue-green light,1
23544,treatment questionnaire,1
23545,autologous t cells-based immunotherapy,1
23546,opsite(tm) disk,1
23547,ido1 inhibitor,1
23548,reduced intensity stem cell transplantation,1
23549,procase decision-aid,1
23550,liposomal-doxorubicin+cyclophosphamide,1
23551,oral contraceptive: ovcon® 35,1
23552,rexin-g dose 4,1
23553,gsk2857916 lyophilized,1
23554,no preoperative imaging,1
23555,karnofsky performance status score,1
23556,eus-fna for rpln in npc patients,1
23557,lymph node staining for h&e and pancytokeratin ihc,1
23558,permanent iodine-125 (brachytherapy),1
23559,patient outreach,1
23560,compass course,1
23561,vulnerability and therapeutic changes in older patients with multiple myeloma.,1
23562,amifostine everyday regimen,1
23563,stenting by ercp (endoscopic retrograde cholangiopancreatography),1
23564,intrabeam,1
23565,left colic artery,1
23566,postural sensory therapy program,1
23567,pegfilgrastim (neulasta),1
23568,near infrared camera imaging system,1
23569,chemotherapy?gemcitabine,1
23570,radio-guided sentinel node biopsy,1
23571,recombinant human choriogonadotropin (r-hcg),1
23572,irinotecan + carboplatin,1
23573,liposomal doxorubicin+gemcitabine,1
23574,pre-radiotherapy commencement of arimidex,1
23575,pledox (10 µmol/kg),1
23576,recombinant hgm-csf herpes simplex virus injection,1
23577,bone marrow analysis to identify disseminated tumour cells,1
23578,cd22-car,1
23579,pro pn,1
23580,"gemcitabine,",1
23581,"mfolfox6 (folinic acid, 5-fluorouracil, and oxaliplatin )",1
23582,simvastatin and zoledronic acid,1
23583,epidural fentanyl,1
23584,botulinum toxins,1
23585,"clofarabine, cytarabine, idarubicin",1
23586,speak up,1
23587,transitional care programme,1
23588,p53 gene therapy with radioactive iodine,1
23589,lci+white light,1
23590,low risk proton radiation,1
23591,allo-mscs,1
23592,comparator: recombivax hb™,1
23593,tbccn-developed educational materials,1
23594,planning for the care you want,1
23595,local anesthetic wound infiltration-based anlagesia,1
23596,genetically informed therapy,1
23597,tempo colo,1
23598,abiraterone acetate mtd,1
23599,btk inhibitor pci-32765,1
23600,cetuximab + rt,1
23601,"lenalidomide, bortezomib, rituximab, dexamethasone",1
23602,patients and caregivers are taught problem solving skills,1
23603,asonep (sonepcizumab/lt1009),1
23604,hormonal therapy with anastrozole and fulvestrant,1
23605,ab154,1
23606,peg then senna,1
23607,blood collection for research,1
23608,tldg arm,1
23609,cd4car,1
23610,"capecitabine (xeloda), oxaliplatin and bevacizumab (avastin)",1
23611,individual peptide vaccination with adjuvant gm-csf and imiquimod,1
23612,"cd34+ enriched, t cell depleted donor stem cell product",1
23613,saucerization biopsy,1
23614,folfox + panitumumab,1
23615,chocolate cake,1
23616,[14c]-pevonedistat,1
23617,(anti-kir),1
23618,the dexmedetomidine group,1
23619,map set at 80-85 mmhg for 5 min,1
23620,ketaconazole,1
23621,"gemcitabine, irinotecan, panitumumab",1
23622,home-based training program,1
23623,epoetin zeta,1
23624,mgn1601,1
23625,mage-a10 peptide,1
23626,sipuleucel-t without booster,1
23627,igg-rfb4-smpt-dga,1
23628,fentanyl (iv),1
23629,tremelimumab plus medi4736,1
23630,health and diet questionnaire,1
23631,graft versus host disease prevention (gvhd prophylaxis),1
23632,care coordination strategies,1
23633,surgery of breast cancer,1
23634,usual care control,1
23635,nelfinavir (viracept®) 1250 mg,1
23636,virtual visit,1
23637,read favorable article prior to answering questions,1
23638,"genetic variants of trpv1, trpm2, trpa1 and orai",1
23639,blood samples of 10 ml,1
23640,methyl cellulose blend,1
23641,chest drain insertion and talc pleurodesis,1
23642,2.4 mg/kg ?-tea,1
23643,vandetanib 300mg,1
23644,smv-orientated right hemicoloectomy,1
23645,immediate axillary plasty,1
23646,neoantigen-based melanoma-poly-iclc vaccine,1
23647,albumin-bound paclitaxel /nab-paclitaxel,1
23648,pa intervention,1
23649,bupivacaine hcl,1
23650,combination azd1775 with arac,1
23651,darbepoetin alfa sc,1
23652,stranded palladium seed interstitial implant,1
23653,video-based terminal feedback,1
23654,mpus multiparametric ultrasound,1
23655,molecular profiling & in vivo drug testing in pdx,1
23656,breast cancer risk report,1
23657,gvp,1
23658,an anticancer medication (a01) and immune cells (ic01),1
23659,pl-doxorubicin and epirubicin,1
23660,abbv-155,1
23661,spm 927,1
23662,mk-8628 dose a,1
23663,endoscopic snare papillectomy,1
23664,negative pressure wound therapy/ wound vac,1
23665,tumor biopsy (optional),1
23666,skin swab,1
23667,npc-1c,1
23668,regular care,1
23669,2x cc,1
23670,imatinib tablets,1
23671,unsupervised activity,1
23672,participant interview,1
23673,limbal autograft,1
23674,arq 751 + paclitaxel,1
23675,orthoptic balance,1
23676,intra-arterial cisplatin (plat),1
23677,"rituximab, mitoxantrone, bendamustine",1
23678,physician's choice soc,1
23679,stereotactic radiosurgery (cyberknife),1
23680,plx038,1
23681,arm a mylotarg plus da versus cpx-351,1
23682,eortc qlq-c30 and eortc bls-24 questionnaire,1
23683,support: a nurse from the ward + an anaesthetic nurse,1
23684,venous puncture,1
23685,no specific interventions,1
23686,high intensity aerobic and resistance training,1
23687,22 gbq 177lu-dotatate,1
23688,myo-inositol + folic acid + melatonin,1
23689,pre-consultation educational group intervention,1
23690,ibrutinib and bortezomib + r-chop,1
23691,insertion of suction drain(s) following mastectomy,1
23692,usual care with attention,1
23693,platinum chemotherapy (cisplatin or carboplatin),1
23694,membrane-bound interleukin-21-expanded haploidentical natural killer cells,1
23695,mri-us fusion guided biopsy,1
23696,surgery alone group,1
23697,standard of care schedule variation: sabr,1
23698,miniature spectral imaging system,1
23699,imipramine,1
23700,modified bucy,1
23701,combination of ribociclib + capecitabine,1
23702,doxorubicin hydrochloride (doxil/caelyx),1
23703,nurse-led telephonic case management,1
23704,ombitasvir/paritaprevir/ritonavir and dasabuvir,1
23705,r-y reconstruction,1
23706,double needle celiac neurolysis (dncn),1
23707,viveve®,1
23708,pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin,1
23709,caregiver questionnaires,1
23710,pemetrexed+carboplatin,1
23711,npc-1c/neo-102,1
23712,donor apheresis,1
23713,complete health improvement program (chip),1
23714,anti-ny eso-1 t cell receptor (tcr) cluster of differentiation 62l (cd62l)+ cells,1
23715,outlook attention control,1
23716,tam,1
23717,question prompt list,1
23718,heat-killed whole cell m.obuense (imm-101) 0.5 mg,1
23719,recombinant anti-egfr monoclonal antibody?sct200?,1
23720,endoscopy tissue collection,1
23721,early parenteral nutrition,1
23722,vinflunine + ketaconazole,1
23723,celsite chemoport implantation,1
23724,06benzylguanine,1
23725,intensive screening,1
23726,cox-2 inhibitor 6-8 weeks prior to surgery,1
23727,education presented by trained caregiver,1
23728,cac-score,1
23729,plerixafor and g-csf,1
23730,avastin + campto / radiotherapy + temodal + avastin (4 cures),1
23731,extrafascial hysterectomy,1
23732,dendritic cell vaccine in combination with imiquimod cream,1
23733,lcp,1
23734,gemcitabine+erlotinib,1
23735,folfoxiri+cetuximab+surgery+bevacizumab,1
23736,1st line chemotherapy,1
23737,ofloxacin,1
23738,neck flexion,1
23739,xrt(x-ray radiation treatment),1
23740,bovine lactoferrin supplement,1
23741,same day discharge,1
23742,blood and urine sampling,1
23743,palovarotene 2.5 mg,1
23744,rapid immunosuppressive taper,1
23745,nuclear breast imaging using mbi gamma camera,1
23746,morphine sulfate placebo,1
23747,hand-held laser scanner,1
23748,oestrogen patches,1
23749,standardized minimental testing,1
23750,ags-006,1
23751,sr48692,1
23752,mdg1011,1
23753,presurgical mri,1
23754,ct-2103/carboplatin,1
23755,smofkabiven® e,1
23756,foreskin from healthy adults for organotypic culture,1
23757,paclitaxel and epirubicin,1
23758,watch dvd and small group discussion,1
23759,iv iron dextran,1
23760,arm c da v flag-ida v dac,1
23761,2:1 group,1
23762,scanning fiber endoscope,1
23763,esd/emr plus cell sheet,1
23764,bicalutamide placebo,1
23765,on-body injector,1
23766,"sorafenib (nexavar®), thalidomide (thado®)",1
23767,psa tool,1
23768,corticotropin-releasing hormone,1
23769,apatinib plus radiotherapy,1
23770,mfolfirnox,1
23771,autologous fat transfer,1
23772,diagnostic breast cancer scan,1
23773,low-intensity exercise therapy,1
23774,ferric hydroxide saccharate,1
23775,low dose radiation,1
23776,gdc-0941 matching placebo,1
23777,low intensity radiation therapy,1
23778,patient-controlled analgesia with morphine,1
23779,gonadotropin-releasing hormone analog,1
23780,giotrif 30mg,1
23781,timolol maleate 0.5% oph soln,1
23782,extrapleural pneumonectomy,1
23783,"nab-paclitaxel 150 mg/m2 days 1, 8 and 15",1
23784,communicating about sexual concerns and dysfunction effectively,1
23785,s1 or gemcitabine,1
23786,bio-tech and omega-3 plus,1
23787,gene-activated matrix (ocp + plasmid dna with vegf gene),1
23788,3% nacl,1
23789,pemetrexel,1
23790,control population,1
23791,"ps-341, doxorubicin",1
23792,break-through scan,1
23793,blue light therapy,1
23794,robot assisted laparoscopic prostatectomy,1
23795,early postoperative diet,1
23796,azacitidine 75 mg/m^2,1
23797,fitbit zip,1
23798,xy0206,1
23799,novartis access,1
23800,group therapy intervention,1
23801,"paclitaxel, 90 mg/m^2 + bevacizumab, 10 mg/kg",1
23802,follow-up after neoadjuvant chemotherapy,1
23803,resistance training - flexible schedule,1
23804,"contrast swallow radiography, endoscopy",1
23805,tremelimumab (anti-ctla4),1
23806,lead rt,1
23807,imc-a12 (cixutumumab) - 20 mg/kg,1
23808,ibrutinib + ld-arac,1
23809,standard-care simulation,1
23810,cep-701 80mg,1
23811,combined intervention (chemoembolization/ablation),1
23812,radiofrequency ablation with stenting,1
23813,home finger-prick capillary blood count monitoring,1
23814,exposure_having children with cancer,1
23815,measurement of triceps skinfold thickness,1
23816,rabbit anti-thymocyte globulin (atg),1
23817,r-tme,1
23818,asn007 rd,1
23819,inofolic (r),1
23820,tumor debulking surgery (surgery in recurrent ovarian disease),1
23821,disaccharide tripeptide glycerol dipalmitoyl,1
23822,"busulfan, cyclophosphamide and fludarabine",1
23823,picc,1
23824,"dendritic cells, ok-432",1
23825,0.5% timolol maleate eye drop,1
23826,bpx-501 dose 1,1
23827,folfox regimen (oxaliplatin/leucovorin/5fu),1
23828,standard radiation dose therapy,1
23829,3m cavilon no sting barrier film,1
23830,laser-assisted fluorescence angiography,1
23831,tru-016 6-20 mg/kg + idelalisib + rituximab,1
23832,leo43204 gel,1
23833,uscom scan,1
23834,radiation therapy plus dc-cik cellular therapy,1
23835,bicalutamide 150 mg,1
23836,automated breast ultrasound (abus) as an adjunct to digital screening mammography,1
23837,galinpepimut-s,1
23838,"docetaxel, cisplatin, 5-fluorouracil (5-fu), radiotherapy",1
23839,emr and rfa effect on stem cell marker expression in be/eac,1
23840,icg and spy system for wound complications,1
23841,behavioral study in women,1
23842,"pertuzumab, trastuzumab",1
23843,azd5312,1
23844,biopsies of bile duct stricture with pediatric biopsy forceps,1
23845,rad001 + bez235,1
23846,kanglaite,1
23847,buccal cavity examination,1
23848,blood sample and questionnaire,1
23849,essential amino acid (eaa) supplement,1
23850,practical counseling,1
23851,educational intervention (one-on one education),1
23852,dose reduction of preoperative radiotherapy in mls,1
23853,extraperitoneal laparoscopic extended retroperitoneal lymph node dissection,1
23854,additional biopsy,1
23855,153 sm-edtmp,1
23856,ldex measurement of arms,1
23857,endoscopic variceal ligation,1
23858,rh il-15 (5 days),1
23859,booster program,1
23860,nla101,1
23861,physical activity education,1
23862,"collection of blood, urine, tumor and ascite samples",1
23863,pembrolizumab - additional treatment,1
23864,high intensity interval training (hiit),1
23865,aurora b/c kinase inhibitor gsk1070916a,1
23866,app-based behavioral intervention,1
23867,measurement of gitr,1
23868,bendamustine-eam,1
23869,"diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias)",1
23870,liver abalation,1
23871,pancreatectomy or hepatectomy,1
23872,cusa induced dissection,1
23873,localization group,1
23874,colonoscopy scheduling assistance,1
23875,placebo for thalidomide,1
23876,high-dose interleukin-2,1
23877,5ht3 receptor antagonist,1
23878,direct exhaust,1
23879,survey: regret,1
23880,dirt,1
23881,offering an alternative colorectal cancer screening method,1
23882,bay80-6964 fixed dose,1
23883,radiotherapy (rt) in combination with temozolomide and bevacizumab,1
23884,inspiratory muscle training (imt),1
23885,neoantigen reactive t cells(nrts),1
23886,the control group,1
23887,anti-pd1,1
23888,18f-dcfpyl pet,1
23889,cls006 vehicle,1
23890,chemotherapy group,1
23891,targomirs,1
23892,sta-4783/paclitaxel,1
23893,guideline concordant care,1
23894,eo9 (apaziquone),1
23895,non steroidal anti androgens and lhrh-a,1
23896,standard of care aromatase inhibitors,1
23897,sms before invitation,1
23898,"bevacizumab, etoposide, cisplatin",1
23899,afatinib - 1a,1
23900,rigosertib oral capsules / rigosertib oral liquid solution / rigosertib intravenous,1
23901,ablative endocrine surgery,1
23902,standard antibacterial prophylaxis,1
23903,acai juice product,1
23904,"decitabine, lbh589, tamoxifen",1
23905,estrogen antagonists,1
23906,ivr+pcc,1
23907,cold emr,1
23908,cla,1
23909,concurrent thoracic radiation therapy,1
23910,docetaxel;oxaliplatin;s1,1
23911,standard mobilization,1
23912,tumor biopsy and blood draw,1
23913,erlotinib and capecitabine,1
23914,single needle,1
23915,familial risk assessment and personalized prevention messages,1
23916,anti-csf1 monoclonal antibody pd-0360324,1
23917,final histopathological diagnosis,1
23918,group b. sugammadex sodium-ionm,1
23919,endostar for one cycle,1
23920,dendritic cell vaccine with mrna from tumor stem cells,1
23921,tailored exercise,1
23922,counseling alone,1
23923,msg drink,1
23924,self expanding metallic stent (sems),1
23925,improving the delivery of effective care to minorities,1
23926,"irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator",1
23927,weekly procrit dosing,1
23928,pelvic mri and f miso tep,1
23929,ultrasound and fna,1
23930,holter ecg monitor,1
23931,"ixabepilone, 30 mg/d",1
23932,nurse-provided guidance,1
23933,incb054329 monotherapy,1
23934,papillectomy without injection,1
23935,vx-001,1
23936,colonoscopy force monitor,1
23937,iron status follow up,1
23938,genasense® (oblimersen),1
23939,ledipasvir+sofosbuvir,1
23940,pancreatic duct stent placement,1
23941,fine needle aspiration biopsy (fnab),1
23942,isolated pelvis perfusion,1
23943,aerobic walking,1
23944,scion-hsct program,1
23945,5-fluorouracil (bolus),1
23946,smartphone triggered control intervention,1
23947,educational print booklet,1
23948,"carboplatin/gemcitabine, carboplatin/taxol",1
23949,fes pet,1
23950,neoadjuvant nivolumab,1
23951,go girls! fitness support group,1
23952,saline bolus infusion,1
23953,e7389 + carboplatin auc 5,1
23954,questionnaires assessments,1
23955,uva1 irradiation,1
23956,geriatric care and longitudinal follow up,1
23957,placebo (for sunitinib),1
23958,treosulfan + cytarabine,1
23959,measurement of carbon monoxide levels expired,1
23960,colonoscopic evaluation only,1
23961,conventional surgical technique,1
23962,isolex 300i plus moabs,1
23963,bn80927,1
23964,one paraffin blocks,1
23965,[68ga]dotatoc,1
23966,pace with cabazitaxel (20 mg/m2),1
23967,supplementation,1
23968,ip paclitaxel,1
23969,best clinical practices alone,1
23970,referral to social worker,1
23971,pyrosequencing,1
23972,colonic stenting with elective surgery,1
23973,gadolinium dtpa,1
23974,interactive voice response (ivr) reminders,1
23975,trinity multipotent stem cells,1
23976,personalized treatment recommendations,1
23977,vincristine in induction,1
23978,indocyanine green drug,1
23979,functional living index-emesis questionnaire,1
23980,electronic activity monitoring (eam),1
23981,ct pulmonary angiogram and d-dimer draw,1
23982,recorded relaxation intervention,1
23983,niraparib plus tsr-042,1
23984,dietary standard,1
23985,pembrolizumab & bemcentinib,1
23986,american diabetes association diet,1
23987,the cognitive log,1
23988,autologous fat grafting of the breast,1
23989,continuous propofol infusion with opioid administration,1
23990,sisom,1
23991,loxo-292,1
23992,palliative care team,1
23993,bp selfstanding felt,1
23994,transplant with haploidentical donor,1
23995,cd25/71 allodepleted donor t-cells,1
23996,specimen protocol,1
23997,dnx2401 and temozolomide,1
23998,standard lumpectomy without nonlinear microscopy imaging,1
23999,fk506 (tacrolimus) or cyclosporine,1
24000,doxorubicin hydrochloride liposome injection and cyclophosphamide,1
24001,garlic treatment,1
24002,neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab,1
24003,"pulsed dye laser (candela), intense pulsed light (palomar)",1
24004,view presentation regarding current chance of having an advanced adenoma,1
24005,surveys assessing taste disturbances,1
24006,aspirin intake,1
24007,postoperative nutritional supplement,1
24008,brush cytology,1
24009,lutetium-177 octreotate,1
24010,bioprotect biodegradable balloon implant,1
24011,polydextrose,1
24012,oral contraceptive plus spironolactone,1
24013,hand gauge,1
24014,vincristine sulfate (oncovin),1
24015,expansion of umbilical cord stem cells,1
24016,cytokine assessment,1
24017,l19-il2 - ph i,1
24018,cervarixtm (gsk580299),1
24019,contour profile tissue expander,1
24020,"sra737, gemcitabine, cisplatin",1
24021,quadrivalent human papillomavirus vaccine on-time administration,1
24022,oral iron,1
24023,mr-guided transurethral us ablation of prostate tissue,1
24024,dexamethasone sodium sulfate,1
24025,began to take solid diet after anal exhaust,1
24026,nivolumab maintenance,1
24027,neoadjuvant chemotherapy with docetaxel,1
24028,intra-operative sentinel node procedure,1
24029,dasatinib discontinuation,1
24030,fluorine-18-l-dihydroxyphenylalanine,1
24031,radiation & immunotherapy,1
24032,gembrax,1
24033,recurrence laryngeal cancer,1
24034,dietary management adapted to the nutritional status,1
24035,cereal or grain consumption,1
24036,fine needle aspiration of the thyroid,1
24037,mesorectal excision without lateral lymph node excision,1
24038,phase 1 - oxi4503,1
24039,flavopiridol (alvocidib),1
24040,"docetaxel, cisplatin, 5-fu and cetuximab",1
24041,genetic study mt-rn1,1
24042,ap 12009,1
24043,short-term granulocyte colony stimulating factor,1
24044,open lung approach,1
24045,mdt (multidisciplinary team) meeting observation,1
24046,oral bowel preparations,1
24047,routine imaging mri with a vr model,1
24048,amg 386 10mg/kg,1
24049,placebo for abt-414,1
24050,provox voice prosthesis,1
24051,capecitabine and imrt (if randomized to this arm),1
24052,"ion ampliseq brca 1/2 panel (life technologies, carlsbad, ca, usa) ,ion pgm platform",1
24053,research bone marrow (optional),1
24054,non-prayer,1
24055,ropeginterferon,1
24056,he4 assay on architect i1000sr platform,1
24057,topcare: use of provider knowledge vs. automated system,1
24058,intervention/procedure,1
24059,hsp90 inhibitor auy 922,1
24060,11c-methionine pet-mri,1
24061,self administered surveys,1
24062,pegylated-proline-interferon alpha-2b,1
24063,antibiotic lavage,1
24064,irinotecan and cisplatin after chemoradiotherapy,1
24065,follow up endoscopy 1,1
24066,radiotherapy 66 gray/day,1
24067,"escalation cohort: regorafenib (stivarga, bay73-4506) 120 mg",1
24068,quality of life counseling,1
24069,circular stapler,1
24070,laparoscopic alpps,1
24071,web+txt+tts,1
24072,phase 1 : avelumab,1
24073,"rituximab, etoposide, methylprednisolone, cytarabine, cisplatin",1
24074,placebo for rovalpituzumab tesirine,1
24075,bf-200 ala 10%,1
24076,fpa150,1
24077,cd8+ t cells,1
24078,124i-iodo-azomycin galacto-pyranoside,1
24079,"6-minute walk test) every 6 weeks (t0, t1, t2, t3 and t4)",1
24080,epoetin biosimilar,1
24081,routine mri,1
24082,memory structuring intervention + vagal breathing,1
24083,"oxaliplatin(oxa), 5-fluorouracil (5-fu)",1
24084,group debriefing,1
24085,magnetic resonance image based brachytherapy,1
24086,midline incision or off-midline incision,1
24087,"capecitabine, cisplatin",1
24088,blood drawl,1
24089,perioperative geriatrics intervention,1
24090,standardized fluid therapy,1
24091,tilmanocept,1
24092,sorafenib + docetaxel/carboplatin,1
24093,stereotactic ablative radiotherapy (sar),1
24094,av-299 + erlotinib,1
24095,anlotinib combined with pemetrexed and carboplatin,1
24096,abiraterone acetate 1000 mg po daily,1
24097,"lenalidomide, liposomal doxorubicin, bevacizumab",1
24098,stomatherapy consultation,1
24099,'survivorship care plan builder',1
24100,whole blood draw,1
24101,cypep-1,1
24102,tongue assessment,1
24103,vt-464: given orally once daily in 28 day cycles,1
24104,atu027 & gemcitabine in lead in safety period,1
24105,"gc chemotherapy plus cik cells (gemcitabine, cisplatin, autologous cik cells)",1
24106,jnj-26866138 0.7 mg/m2,1
24107,intraoperative direct subcortical electrical stimulation,1
24108,intraoperative near-infrared imaging system,1
24109,cremophor,1
24110,environmental assessments,1
24111,protective ventilation,1
24112,gemcitabine -oxaliplatine combination,1
24113,barco digital dermatoscope device images,1
24114,fusidic acid [verutex],1
24115,diclofenac + calcitriol,1
24116,oral lbh589,1
24117,project onward website + social network,1
24118,enzalutamide with sorafenib,1
24119,cls2702c/cls2702d,1
24120,peptide,1
24121,lenvatinib mesylate,1
24122,sequential treatment,1
24123,"ct7, mage-a3, and wt1 mrna-electroporated langerhans cells ( lcs)",1
24124,sivelestat sodium hydrate,1
24125,flot-a,1
24126,denileukin diftitox/sc pegylated ifn?-2a,1
24127,20% eiso,1
24128,normal saline+heparin,1
24129,restore rehabilitation program,1
24130,cervical swabs,1
24131,c-myb as odn,1
24132,wo2085 moisturising cream,1
24133,dose escalation radiotherapy,1
24134,third eye retroscope auxiliary imaging system,1
24135,tumor treating fields therapy,1
24136,tisseel®,1
24137,eus-fnb with ez shot 3plus first,1
24138,ocrelizumab,1
24139,t-cell and b-cell depletion,1
24140,dynamic contrast-enhanced mri (dce),1
24141,stable erythropoietin therapy,1
24142,combinatory eus and ercp,1
24143,enclomiphene citrate,1
24144,feedback for professionals,1
24145,intensification phase,1
24146,maintenance pemetrexed,1
24147,concomitant cisplatin chemotherapy,1
24148,peg-gastropexy,1
24149,anti-third party cytolytic t-lymphocytes (ctl),1
24150,manipulator consultation radiotherapy added to standard care,1
24151,epirubicin 90 mg/m2 iv,1
24152,prophylactic radiation to the contralateral breast,1
24153,surgical preparation program,1
24154,ado trastuzumab emtansine,1
24155,whole breast radiotherapy,1
24156,three-port laparoscopic surgery,1
24157,ac and docetaxel 60mg/m2 alternately q21 days for 6 cycles,1
24158,"temozolomide or dacarbazine-based chemotherapy, endostatin",1
24159,"cohort a: varlilumab & ipilimumab; cohort b: varlilumab, ipilimumab, cdx-1401 & poly-iclc",1
24160,3d ultrasound-guided biopsy,1
24161,cyclophosphamide and jx-594,1
24162,lucanix® (belagenpumatucel-l),1
24163,body training (bt):,1
24164,short-course radiotherapy with neoadjuvant chemotherapy,1
24165,ds-8895a 10 mg/kg,1
24166,patient questionnaire,1
24167,seviteronel: given orally once daily in 28 day cycles,1
24168,haplo hct <55 years old,1
24169,"chemotherapy (mitoxantrone, cytarabine)",1
24170,surgery to excise rectal cancer,1
24171,cool water immersion colonoscopy,1
24172,oral swabs for hpv-typing and high-risk hpv-determination,1
24173,3d mandibular plate,1
24174,culturally tailored genetic counseling,1
24175,rocket® ipc- long external length,1
24176,tremelimumab 300 mg,1
24177,activated cik,1
24178,2.5% imiquimod cream,1
24179,diazepam and lidocaine 1%,1
24180,botox injection multiguide,1
24181,individualized stereotactic body radiation therapy (sbrt),1
24182,mk-2206 with or without trastuzumab,1
24183,cogmed working memory training program,1
24184,ic,1
24185,radiomics: analysis of textural features of imaging (mri and ultrasound),1
24186,99mtc-sestamibi imaging,1
24187,seaweed and soy protein,1
24188,recombinant human endostatin adenovirus,1
24189,thermal ablation of bone metastasis with mr-hifu device philips sonalleve coupled with philips ingenia 3.0t,1
24190,peritoneal closure,1
24191,combination treatment - cohort 3,1
24192,"temozolomide (induction),",1
24193,intraoperative imaging using 1.5t mri,1
24194,bay1143269 tablet,1
24195,activated cik and cd3-muc1 bispecific antibody in treating breast cancer,1
24196,temozolomide (temodar),1
24197,symptom management education and nurse coaching,1
24198,neoadjuvant gemcitabine plus nab-paclitaxel,1
24199,avastin+chemotherapy of mfolfox6 or folfiri,1
24200,mk-2206 + azd6244,1
24201,ctdna detection,1
24202,program participants,1
24203,cohort 2: carfilzomib 20 mg/m2,1
24204,79.2 gy 3d-crt/imrt,1
24205,nolvadex placebo,1
24206,vt-464: given orally twice daily in 28-day cycles,1
24207,carboplatin.,1
24208,standard adt (androgen deprivation therapy),1
24209,simple goal setting,1
24210,aminobiphosphonate,1
24211,resistance training (rt),1
24212,"fludarabine, clofarabine, busulfan, atg, tbi (myeloablative)",1
24213,anastrozol,1
24214,motolimod,1
24215,120 mg/m2 nktr 102,1
24216,standard enditracheal tube,1
24217,pembrolizumab plus amurubicin,1
24218,sequential dose-escalated radiotherapy level 2,1
24219,squid non-adhesive liquid embolic agent,1
24220,capecitabine + ganetespib,1
24221,htimrt,1
24222,standard lung cancer treament,1
24223,reims iknife,1
24224,bms-986156,1
24225,v502,1
24226,definitive resection,1
24227,allogeneic blood stem cell transplant,1
24228,"everolimus (rad001) , afinitor®",1
24229,tests of microsatellite instability,1
24230,temozolomide(tmz) 75mg,1
24231,hu-mik-beta-1,1
24232,12 cycles of oxaliplatine based adjuvant chemotherapy,1
24233,lonquek,1
24234,chemotherapy(c-att),1
24235,mri with multihance,1
24236,vitamin d3 prior to first visit,1
24237,"metformin hcl (cidophage®; cid,cairo, egypt), cc (clomid®; global napi pharmaceuticals,cairo, egypt),cairo, egypt)",1
24238,allogeneic hematopoietic cell transplant (allo-hct),1
24239,standard home lymphedema care,1
24240,c,1
24241,sterile saline,1
24242,anhydrovinblastine,1
24243,dendritic cells pulsed with tumor lysate,1
24244,biopsie liver,1
24245,diffuse optical tomography (dot) system,1
24246,subject diary,1
24247,"group 2: radiation, paclitaxel, carbo, dasatinib days 1-38",1
24248,niraparib + ipilimumab,1
24249,prophylactic dli,1
24250,advanced practice nurse consultation,1
24251,adjuvant ct,1
24252,intraoperative intravenous lidocaine placebo infusion,1
24253,gdc-0623,1
24254,pre-operative concurrent chemoradiation therapy,1
24255,"doxorubicin, docetaxel, cisplatin",1
24256,adjuvant chemotherapy (paclitaxel and cisplatin),1
24257,auricular needling,1
24258,xelox rt,1
24259,diffusion-weighted magnetic resonance imaging + pet ct,1
24260,normofractionated,1
24261,multi-angle compound shear wave elasticity imaging,1
24262,accessory joint mobilization,1
24263,high-dose intensity-modulated radiotherapy,1
24264,follow -up visits,1
24265,i2,1
24266,lmb c,1
24267,txa127 300 mcg/kg/day,1
24268,gentle yoga therapy,1
24269,as1402,1
24270,standard of care follow-up,1
24271,intervention b - priority,1
24272,cbt mobile application,1
24273,jnj-2641585 / velcade / dexamethasone,1
24274,"flucytosine (5-fc, ancotil)",1
24275,standardized method of pathological evaluation,1
24276,haploidentical donor derived natural killer cell infusion,1
24277,radiofrequency ablation; interferon-alpha,1
24278,lp in a lying position then lp in a seated position,1
24279,blood sample for flcn mutation analyses,1
24280,"paced breathing (15 min once daily, 6 breaths/min)",1
24281,pasireotide + total body irradiation,1
24282,clipping of uterine arteries during laparoscopic myomectomy,1
24283,intra spinal microdialysis monitoring,1
24284,clinical criteria of lynch syndromes,1
24285,flox (5-fluorouracil and folinic acid and oxaliplatin) intermittently and maintenance cetuximab,1
24286,endoscopic resection at month 2 and month 4,1
24287,adipose tissue biopsy,1
24288,therapeutic drug monitoring of 5fu,1
24289,intercalated combination of chemotherapy and erlotinib,1
24290,reduced glycemic load diet,1
24291,health education programme,1
24292,human papillomavirus,1
24293,life,1
24294,placebo + paclitaxel,1
24295,cycle 6 consolidation,1
24296,pomegranate liquid extract,1
24297,tocotrienol 300 mg x 3 daily until progression,1
24298,receiving an educational booklet,1
24299,"using 20g fnb, the first pass is mwst",1
24300,durvalumab + chemotherapy treatment,1
24301,"hpv self collection, followed by visual assessment of the cervix for treatment (vat) and treatment",1
24302,relaxation response resiliency program (3rp),1
24303,cost analysis,1
24304,interferon-gamma and nivolumab,1
24305,imiquimod cream 3.75%,1
24306,interferon alpha-2b (ifn-?) 3 million units (mu) subcutaneous daily,1
24307,mindfulness program,1
24308,early removal group,1
24309,dc + ctx,1
24310,general-epidural anesthesia,1
24311,inno-105,1
24312,givinostat (itf2357) 50 mg b.i.d. + mtd hydroxyurea,1
24313,whole brain radiation(wbi),1
24314,velcade and vorinostat,1
24315,co2 laser,1
24316,ebrt dose prescription and reporting,1
24317,conventionally fractionated versus hypofractionated boost,1
24318,transdermal oestradiol,1
24319,comparator: 18-f-fdg pet/ct and volumetric ct,1
24320,e2/neta,1
24321,nbf-006,1
24322,pf-299804 (dacomitinib),1
24323,randomization to no panitumumab,1
24324,radiopaque marker,1
24325,video assisted thoracoscopic surgery (vats),1
24326,gemtuzumab ozogamicin (mylotarg),1
24327,boost plus,1
24328,balloon catheter for transurethral bladder-drainage,1
24329,endoscopic tattooing,1
24330,ikc (immune killer cells),1
24331,period of quiet time,1
24332,sunitinib 5 mg,1
24333,drug-azd8931,1
24334,cfi-400945 fumarate,1
24335,arestm,1
24336,general acupuncture-b (peace classic needles®),1
24337,mk-3475(pembrolizumab),1
24338,post-operative srs,1
24339,oral smear and feces specimen,1
24340,ny-eso-1 redirected autologous t cells with crispr edited endogenous tcr and pd-1,1
24341,dual-energy x-ray absorptiometry (dxa) scan,1
24342,blood urea and serum creatinine every month,1
24343,jnj-64457107,1
24344,novel nano-scintillatorfiber-optic dosimeter ( nanofod),1
24345,telomerase activity on a blood sample,1
24346,endoscopic retrograde cholangiopancreatogram,1
24347,injection cnp before nat,1
24348,"doxorubicin, cyclophosphamide, paclitaxel, trastuzumab",1
24349,external beam radiation therapy (ebrt) + brachytherapy,1
24350,organisational intervention,1
24351,follow-up calls & webinars,1
24352,blood collection during standard of care treatment,1
24353,3t mri scanner,1
24354,10-meter walk test,1
24355,satraplatin and capecitabine,1
24356,"thalidomide,pirarubicin,dexamethasone",1
24357,urocool,1
24358,ropivicaine 0.4% continuous infusion,1
24359,tumor samples from patients treated with ttfields at initial diagnosis.,1
24360,abdominal compression,1
24361,bevacizumab cycles 3 onwards,1
24362,budget impact,1
24363,imgn632,1
24364,led lamp,1
24365,icl670/deferasirox,1
24366,amg 386 placebo iv,1
24367,smoking prevention program,1
24368,lightpath® imaging system and 68ga-rm2,1
24369,hypericum perforatum,1
24370,multipeptide vaccine s-588210,1
24371,"sodium ferric gluconate, ferrous sulfate, standard of care",1
24372,intensified preoperative chemotherapy,1
24373,"quadrivalent hpv (types 6,11,16,18) l1 vlp vaccine 80/80/40/80",1
24374,benzodiazepines,1
24375,focal cryoballoon ablation system - 8 seconds,1
24376,poligraphy,1
24377,"high dose aspirin, vitamin d placebo",1
24378,cytokine gene adjuvant,1
24379,images,1
24380,mmprofiler sky92 gene signature,1
24381,amg 780,1
24382,artesunate 200mg,1
24383,porcine intestinal submucosal xenograft,1
24384,skin specimen,1
24385,duavee,1
24386,f18-fdg pet/ct,1
24387,women under 40 years old with histological diagnosis of breast cancer,1
24388,cyclophosphamide for remission induction,1
24389,sexual medicine rehabilitation program + acceptance and commitment therapy for erectile dysfunction,1
24390,shr3680; shr3162,1
24391,infusion of donor dendritic cells,1
24392,fkb238 (bevacizumab),1
24393,interdisciplinary rehabilitation,1
24394,abi-010,1
24395,capsules probiotic powder and corn starch,1
24396,arm b chemotherapy,1
24397,lumosity,1
24398,radiological imaging,1
24399,vesicare,1
24400,"oblimerson sodium, g3139",1
24401,cisplatin and either fluorouracil (5-fu) or capecitabine,1
24402,"gm-csf, sargramostim",1
24403,newcastle virus,1
24404,montanide + melan-a analog peptide + ny-eso-1 analog peptide + mage10 peptide,1
24405,vx-853,1
24406,geriatric assessment targeted recommendations,1
24407,dxa (dual-energy x-ray absorptiometry) scan,1
24408,intrathecal morphine+la+ mg sulp. 50,1
24409,concurrent chemo + igrt,1
24410,patient reported outcome measure (prom): breast-q,1
24411,"omegaven, dipeptiven",1
24412,alkagin paste,1
24413,nact (paclitaxel + cisplatin or carboplatin),1
24414,transanal endoscopic surgery,1
24415,hla mismatched stem cell,1
24416,aspirin 300mg,1
24417,puncture set and flexible protector,1
24418,enhanced tailored,1
24419,intralesional rituximab,1
24420,hdr brachytherapy of 9 gy in 2 fractions,1
24421,erwinaze® (asparaginase erwinia chrysanthemi)/erwinase® (crisantaspase),1
24422,daunorubicin and cytarabine,1
24423,lugol upper gastrointestinal endoscopy,1
24424,dexmeditomedine,1
24425,photofrin 2.0 mg/kg,1
24426,brachial artery catheter,1
24427,iac regimen,1
24428,iron dextran complex,1
24429,positron emission tomography-magnetic resonance imaging,1
24430,airway and/or pulmonary vessels transplantation,1
24431,darleukin,1
24432,pembrolizumab (keytruda®),1
24433,proton radiation hypofractionation,1
24434,intensified protocol,1
24435,mpdl3280a dose level 1,1
24436,gpx-100,1
24437,advanced external radiotherapy by xrays or protons,1
24438,sorafenib tosylate tablets,1
24439,daily dosing of zileuton/dasatinib,1
24440,mpt0e028,1
24441,"paclitaxel, platinum-based drug",1
24442,18f-fdg injection,1
24443,sct-i10a,1
24444,"cp-675,206 and leuprolide acetate and bicalutamide",1
24445,gene-modified hiv-protected hematopoietic stem cells,1
24446,lxi-15029,1
24447,apg115 + carboplatin,1
24448,bcma car-t,1
24449,brca-gist,1
24450,"combination of dexamethasone, ofatumumab and bendamustine",1
24451,gc33,1
24452,erlotinib 150 mg,1
24453,donor derived g-csf mobilized pbc,1
24454,"""melanoma survivor"" plaque",1
24455,lean book/videos,1
24456,cat-8015 5 mcg/kg,1
24457,daratumumab 8 mg/kg (part 1),1
24458,g1t48,1
24459,stereotactive ablative body radiotherapy,1
24460,antibiotic and antifungal drugs,1
24461,dose-dense doxorubicin or dose-dense epirubicin,1
24462,hpv test with partial genotyping and via triage,1
24463,focal lesional radiation,1
24464,temozolomide and accelerated hypofractionation rt,1
24465,survey instrument,1
24466,autologous tumor cells,1
24467,virtual technology - highly tailored,1
24468,droplet digital pcr,1
24469,short message service based re-education,1
24470,nelfinavir and temsirolimus,1
24471,nanoknife procedure,1
24472,no-touch surgery,1
24473,ct-guided transthoracic needle aspiration,1
24474,usual primary care counselling,1
24475,bisoprolol (5mg daily for 3 weeks),1
24476,bucy vs buflu,1
24477,degarelix 240/80 mg,1
24478,bay 1251152,1
24479,iron saccharate (venofer),1
24480,"2 vaccine injections in different limbs, the vaccine does not contain the mhc class ii peptide mage-a3-dp4",1
24481,pd-l1,1
24482,bay1895344,1
24483,fch positron emission tomography,1
24484,transcranial direct current stimulation tdcs,1
24485,til + il-2 + nivolumab,1
24486,3d printed bolus,1
24487,cognitive-behavioral therapy,1
24488,ecg-guided insertion of picc,1
24489,surgical total parathyroidectomy with forearm autografting,1
24490,lapcac laparoscopic compression anastomosis clip,1
24491,paclitaxel/anthracycline,1
24492,lymphocyte dpd dosage,1
24493,lactobacillus rhamnosus supplementation,1
24494,standard gastroscopy,1
24495,postoperative intensity modulated radiation therapy,1
24496,18f-faza pet imaging,1
24497,rectal thermistor 400 series,1
24498,modified bolus 5-fu/lv with irinotecan,1
24499,tetradecanoylphorbol acetate,1
24500,anti-gitr monoclonal antibody mk-4166,1
24501,bms-936564 (anti-cxcr4),1
24502,azacitidine (baml-16-001-s9),1
24503,intra-operative sn mapping with patent v blue dye,1
24504,folfox4 plus recombinant human endostatin (endostar),1
24505,selective internal radiation therapy of the liver with yttrium-90 glass microspheres (therasphere),1
24506,ald-451,1
24507,fully covered metal stents,1
24508,screening advice based on a basic risk assessment,1
24509,d961h capsule 10mg,1
24510,neoadjuvant chemotherapy with gemcitabine/oxaliplatin,1
24511,biophilic nature scene and sound,1
24512,trastuzumab and pertuzumab (combination treatment),1
24513,5-fluorouracil ( in folfox),1
24514,cystoscopy with biopsy,1
24515,low dose nk cells ×4 times,1
24516,ebv-specific ctls and cd45 mab,1
24517,fractionation,1
24518,early palliative care integrated with usual oncologic care,1
24519,automated cbc,1
24520,intellicare + phone coaching,1
24521,p-bcma-101 car-t cells,1
24522,blood sugar testing,1
24523,tumor specific mesorectal excision,1
24524,lipofundin mct,1
24525,intravitreal triamcinolone injection of avastin (1.25 mg),1
24526,pre-chemotherapy visit summary video,1
24527,neuroregen scaffold transplantation,1
24528,medication,1
24529,extensive intraoperative peritoneal lavage,1
24530,fc infusion,1
24531,percutaneous ablation of hepatocellular carcinoma,1
24532,local anaesthetic wound infusion catheter,1
24533,accelerated radiation therapy,1
24534,multiple-trauma patients,1
24535,supportive /palliative care intervention,1
24536,phone referral,1
24537,vincristine sulfate liposome injection,1
24538,dsa arteriogram- hepatic arteries,1
24539,without copadm3,1
24540,radiolabeled (99mtc) gp (glycopeptide),1
24541,surgical resection of brain metastases,1
24542,multichannel auditory brain stem implant,1
24543,s1/anlotinib,1
24544,"letrozole, pd 0332991",1
24545,lmis 50 mg,1
24546,blood sample-dna testing / tumour-genetic markers,1
24547,epstein-barr virus specific immunotherapy,1
24548,sjnb-jf-il2 and sjnb-jf-lptn,1
24549,dermoscopy,1
24550,10% neutral buffered formaldehyde,1
24551,autologous hematopoietic stem cell harvesting and transplantation,1
24552,activated and expanded natural killer cells (nkaes),1
24553,essiac,1
24554,lhrh analogues,1
24555,alcohol injection,1
24556,choline pet/mr,1
24557,standard wound closure,1
24558,cancer pain educational program,1
24559,nursing visit,1
24560,"nutrition education, dietary counseling, and cooking",1
24561,luminal type-1,1
24562,imc-12,1
24563,epidural patient controlled analgesia,1
24564,[18f]fluoroglucose(fdg),1
24565,amg 386 3mg/kg,1
24566,c11 methionine positron emission tomography,1
24567,unplugged pulsed shortwave therapy,1
24568,contura mlb breast brachytherapy catheter,1
24569,caregiver satisfaction questionnaire,1
24570,functional imaging previous the surgery,1
24571,otx015/mk-8628,1
24572,cyproterone acetate 25,1
24573,pleur-x,1
24574,polarized dendritic cells,1
24575,bendamustine and lenalidomide,1
24576,clinic-focused intervention,1
24577,sample testing,1
24578,preference-tailored information,1
24579,proton apbi,1
24580,genetic risk score: number + pictograph,1
24581,chadox1.5t4,1
24582,stem cells autograft,1
24583,pre-study questionnaire,1
24584,pen-paper,1
24585,high dose of methotrexate,1
24586,ier+med group,1
24587,laryngoscopy and bronchoscopy,1
24588,esomeprazole 40mg concomitantly,1
24589,endoscopic exams,1
24590,docetaxel plus bavituximab or placebo,1
24591,da vinci robot xi,1
24592,benadryl®,1
24593,early paravertebral block,1
24594,topical morphine,1
24595,no walking exercise,1
24596,conventional chemotherapy(forfirinox) combined with target agents,1
24597,experimental: immediate colposcopy,1
24598,"capecitabine, oxaliplatin, irinotecan and bevacizumab",1
24599,decitabine in combination with genistein,1
24600,correlative laboratory samples,1
24601,endoscopy exam,1
24602,xmab®22841,1
24603,rad001 (everolimus) + cisplatin,1
24604,program of geriatric and social intervention associated techniques of domotic and remote assistance,1
24605,air insufflation use in colonoscopy,1
24606,bio-field energy therapy,1
24607,cisplatinum (50mg/m2) iv (in the vein) on day 1 and day 8 of a 28-day cycle for 2 cycles,1
24608,drug (including placebo),1
24609,calypso® 4d localization system,1
24610,18f-fluoroethylcholine pet,1
24611,surgery of the primary tumour,1
24612,cisplatin-fluorouracil chemotherapy,1
24613,tac chemotherapy,1
24614,"bevacizumab, oxaliplatin and 5fu combination",1
24615,pr104 550 mg/m^2 + sorafenib,1
24616,pbf-509_640 mg,1
24617,physician's best choice,1
24618,radiation combined with weekly carboplatin,1
24619,part 2 (dose expansion): duvortuxizumab,1
24620,endoxan,1
24621,"rfa, bevacizumab and second-line chemotherapy",1
24622,alloplastic free rom,1
24623,gain-framed messaging,1
24624,blood draw and ultrasound,1
24625,sm-edtmp,1
24626,d2 lymphadenectomy including no. 14v,1
24627,vinorelbine i.v. 25 mg/m²,1
24628,"etoposide, cytarabine, gemtuzumab, l-asparaginase, mercaptopurine, methotrexate, mitoxantrone, prednisone, vincristine",1
24629,tractography,1
24630,qol assessment,1
24631,alexis - a wound protector,1
24632,ptv50.4,1
24633,ultrasound guided imaging,1
24634,human stem cell transplantation,1
24635,carfilzomib and panobinostat,1
24636,self-regulation,1
24637,laser spectroscopy,1
24638,cetuximab + folfiri,1
24639,radiation therapy*,1
24640,meaning centered group psychotherapy,1
24641,"tlk286, cisplatin",1
24642,cutaneous cream application,1
24643,ngs molecular screening,1
24644,car-cd19 t cell,1
24645,"panitumumab, oxaliplatin, 5-fu",1
24646,orange juice,1
24647,light touch intervention,1
24648,color genomics genetic education,1
24649,"bevacizumab (drug), herceptin (drug)",1
24650,abvd induction,1
24651,oral bicalutamide placebo,1
24652,whole brain radiation (wbrt),1
24653,prostate radiation + tumor boost irradiation,1
24654,levonorgestrel intrauterine system,1
24655,non-manualized supportive intervention.,1
24656,minimally invasive esophagectomy (mie),1
24657,personally-tailored educational software program,1
24658,osdi questionnaire,1
24659,three in-person sessions,1
24660,astx727 + day 4 food,1
24661,odm-207,1
24662,comparator: mk-8033 +/- omeprazole,1
24663,octavalent hpv with 120 mcg imx / aahs,1
24664,epi/docetaxel,1
24665,autologous dendritic cells electroporated with mrna,1
24666,total mediastinal lymph node dissection and pulmonary metastasectomy,1
24667,endocrine therapy 1,1
24668,cyclophosphamide doxorubicin vincristine lamivudine,1
24669,manual lymph drainage (mld),1
24670,pentax eb-1990i hd-bronchoscope guided biopsy,1
24671,sharpness sensory testing,1
24672,"surgery for pilonidal disease, midline excision",1
24673,distress screening,1
24674,autologous dendritic cells loaded with autologous tumour homogenate,1
24675,collagenase injection,1
24676,cisplatin phase 2,1
24677,pbi-05204,1
24678,1.0 ?g/day alfacalcidol,1
24679,nasal brushings,1
24680,ro5490258,1
24681,theo,1
24682,tbna,1
24683,pazopanib+sorafenib,1
24684,"capecitabine, cetuximab, oxaliplatin",1
24685,12-week aerobic exercise and cognitive-behavioral therapy,1
24686,enhanced iccs with kpnw web resources and the comprehensive health enhancement support system (chess.),1
24687,hsct from hrd,1
24688,lapatinib and bortezomib,1
24689,combination of gen0101 and pembrolizmub,1
24690,pneupac vr1,1
24691,abnobaviscum fraxini,1
24692,bio-specimen retention,1
24693,neo-adjuvant tmz followed by accelerated hypofractionated ebrt,1
24694,vcap-amp-vecp with g-csf and intrathecal prophylaxis,1
24695,clomiphene citrate treatment,1
24696,discovery st multislice pet/ct scanner,1
24697,part d - azd9291 in combination with azd6094,1
24698,comprehensive srs replacement,1
24699,chemotherapy & wbh,1
24700,s 55746,1
24701,breast reconstruction- autologous tissue,1
24702,2 cycles of atezolizumab followed by surgery then post-operative radiotherapy,1
24703,thomsen-friedenreich antigen,1
24704,rectosigmoïdal biopsies,1
24705,first exercise session - compression,1
24706,comparative genomic analysis,1
24707,"""cholecalciferol"" and ""placebo""",1
24708,professionally administered cognitive-behavioral therapy,1
24709,cobimetinib - cohort 2,1
24710,thalidomide®,1
24711,bc-819,1
24712,dose dense adriamycine and cyclophosphamide,1
24713,rituximab-dexamethasone-lenalidomide,1
24714,western medicine,1
24715,survivorship education,1
24716,micro-tech endoscopic gauge,1
24717,stereotactic radiotherapy delivered by cyberknife,1
24718,motivational interviewing (mi),1
24719,vcl-cb01,1
24720,arm b: helical tomotherapy intensity modulated radiotherapy,1
24721,vax014,1
24722,increasing hat use,1
24723,regular tampax used in 3 hours,1
24724,intravenous urography (ivu),1
24725,neuromuscular taping,1
24726,biosensor point of care device,1
24727,intermediate dose antithrombotic,1
24728,valproic acid & fludarabine,1
24729,"mini cyve, without 3 maintenance courses",1
24730,"collecting pre-operative, per-operative data, neuro-radiological data and post-operative neuro-surgery complications",1
24731,mibg label with i123 or i124,1
24732,gilupi cellcollector®,1
24733,neuroregen scaffold/huc-mscs transplantation,1
24734,sinecatechins 15% ointment,1
24735,tamoxifen 20mg tablet,1
24736,mqx-503,1
24737,conventional fractionated rt,1
24738,"smartphone application ""placebo""",1
24739,intravenous cisplatin & etoposide,1
24740,clinical biological data collection on melanoma,1
24741,expanded nk cell infusion,1
24742,thoracoscopic ultrasound,1
24743,svv-based gdft,1
24744,"crs-207, live-attenuated listeria monocytogenes expressing human mesothelin",1
24745,"autologous dendritic cells loaded with mage-a3, melana and survivin",1
24746,imrt to 45 gy; proton boost to prostate bed to 25.2 cge,1
24747,human tyrosinase,1
24748,"immunotherapeutic gsk2302025a, different formulations",1
24749,odm-201 tablet a,1
24750,follicular lymphoma,1
24751,wait&see or tem with intensive follow-up,1
24752,wbrt with avoidance of hippocampus,1
24753,5-hydroxy-tryptamine,1
24754,rta 402,1
24755,conisation,1
24756,igf-methotrexate conjugate,1
24757,genetic counseling intervention,1
24758,continuing medical education,1
24759,pet-scan before treatment start,1
24760,evaluation of the tomosynthesis,1
24761,"chop14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus g-csf, combined with alemtuzumab",1
24762,intraoperative contact ultrasonography,1
24763,xoft axxent electronic brachytherapy system,1
24764,fna and core biopsy,1
24765,laparoscopic nerve-sparing radical hysterectomy-type iii/c1,1
24766,laparoscopic proximal gastrectomy,1
24767,european organization for research and treatment of cancer (eortc) qlq-30,1
24768,"bipolar transurethral resection of the urinary bladder (plasmakinetic, gyrus, fresenius)",1
24769,bupivacaine-epinephrine,1
24770,"group 1: radiation, paclitaxel,carbo, dasatinib days 1-47",1
24771,ima203 product,1
24772,hals,1
24773,carboplatin + paclitaxel,1
24774,y-90 ibritumomab,1
24775,patient-reported pain scores,1
24776,abiraterone + prednisone,1
24777,iobenguane i-131,1
24778,cabazitaxel 10mg/m2,1
24779,t regulatory cells,1
24780,autologous t cells modified to recognize merkel cell polyomavirus (fh-mcva2tcr),1
24781,co2 laser or microsurgery,1
24782,conventional facial closure,1
24783,ka2507,1
24784,abiraterone acetate escalated dose,1
24785,blood sample tear drop sample,1
24786,pre-op rt +/- chemotherapy,1
24787,jojoba,1
24788,tas-102 oral solution,1
24789,aa normal dose-fasting conditions (c),1
24790,peptide-tet,1
24791,solaraze® (diclofenac sodium) gel 3%,1
24792,nab-paclitaxel and gemcitabine for br-pdac patients,1
24793,topical anti-infective product,1
24794,mri biopsy,1
24795,selective axillary lymph node dissection (sad),1
24796,3d laparoscopic surgery,1
24797,placebo (injection),1
24798,enlarge irradiation volume,1
24799,football,1
24800,muc1-klh conjugate vaccine,1
24801,optical frequency domain imaging (ofdi) system,1
24802,"r-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + peptides from hpv-16 e6 and e7",1
24803,moderate physical activity,1
24804,vaselitulle,1
24805,prostate cancer treatment desi,1
24806,microneedle,1
24807,ac-can,1
24808,recombinant vesicular stomatitis virus-expressing interferon-beta,1
24809,89zr-mpdl-3280a-pet scans,1
24810,prophylactic quadrivalent hpv vaccine merck (gardasil®),1
24811,frozen-thawed embryo transfer,1
24812,solumatrix™ (abiraterone acetate),1
24813,fis-00 fluorescence imaging system (fis),1
24814,topical 0.5% timolol maleate,1
24815,gdc-0349,1
24816,cgc-11047 and cisplatin,1
24817,jnj-64041757 (cohort 1a and 1b),1
24818,surgery and catheter placement (2 procedures),1
24819,"endoscopic submucosal dissection (esd) using device, master",1
24820,"tarceva (erlotinib hcl, osi-774 )",1
24821,incb040093 monotherapy,1
24822,everolimus and letrozole,1
24823,cd19-car-t2 cells,1
24824,gefitinib and bkm120,1
24825,irradiation-66 gy,1
24826,random four-quadrant biopsies.,1
24827,decision support workshop,1
24828,ofatumumab (this arm is closed),1
24829,placebo (folic acid ),1
24830,fluciclatide,1
24831,"gadobutrol (gadovist, bay86-4875)",1
24832,serological examination and gastroscope,1
24833,tpf experimental,1
24834,microcoil insertion and excision,1
24835,dietary education and counseling,1
24836,eicosapentaenoic acid free fatty acid (epa-ffa),1
24837,antiviral treatment (lamivudine or entecavir),1
24838,stem cell radiotherapy (scrt) and temozolomide,1
24839,blinatumomab injection,1
24840,zolbetuximab 1000 mg/m2,1
24841,postoperative routine treatment,1
24842,glioblastoma multiforme multipeptide vaccine ima950,1
24843,nis793,1
24844,laparoscopic myomectomy and supracervical hysterectomy with gynecare morcellex,1
24845,interleukin-1,1
24846,high dose vitamin d,1
24847,autologous cd8+ slc45a2-specific t lymphocytes,1
24848,folate and b12,1
24849,fdg-pet/ct guided bone marrow sampling,1
24850,0.125% bupivicaine with 2 mcg/ml fentanyl.,1
24851,no carrier added metaiodobenzylguanidine,1
24852,positron emission tomography (pet) imaging,1
24853,laparotomy+ hipec +/- crs,1
24854,tmem-mri,1
24855,arq 171,1
24856,guided therapy- pediatric gene analysis platform,1
24857,xrp9881,1
24858,ky1044 and atezolizumab,1
24859,iv anti-thymocyte globuline,1
24860,ldac,1
24861,ad-ccl21-dc exd,1
24862,canvas system,1
24863,administration of questionaires to patients receiving an upper endoscopy with cryotherapy in addition to chemotherapy for esophageal cancer palliation.,1
24864,bispecific antibody 4g7xh22,1
24865,sodium bicarbonate solution,1
24866,fischer cone biopsy excisor,1
24867,cabrilizumab,1
24868,moluodan simulation,1
24869,gm-k562 vaccine,1
24870,optimal turb,1
24871,treated by synchrotron radiation,1
24872,non-invasive multimodal imaging,1
24873,laromustine (vnp40101m) and ara-c,1
24874,polyp removal upon insertion and withdrawal,1
24875,hyperspectral imaging,1
24876,paclitaxel/carboplatin/lapatinib,1
24877,miw815,1
24878,waiting list control,1
24879,newly developed questionnaire,1
24880,therapeutic exercise,1
24881,medi4736 (durvalumab)+tremelimumab,1
24882,"arm b, tumor markers assessment",1
24883,lenvatinib matching placebo,1
24884,photodynamic therapy using polyhematoporphyrin,1
24885,multimodal spectroscopy (mms),1
24886,recombinant gm-csf,1
24887,gw-2000-02,1
24888,zr89-trastuzumab,1
24889,radical rectal cancer resection,1
24890,independent writing - control group,1
24891,online psychoeducation,1
24892,apvac1 vaccine plus poly-iclc and gm-csf,1
24893,prostate sbrt with concurrent boost to intraprostatic lesion(s),1
24894,tegafur- gimeracil-oteracil potassium,1
24895,percutaneous rfa,1
24896,ferumoxtran-10 enhanced mri; mri contrast agent,1
24897,normal dose nk cells ×8 times,1
24898,cd40l,1
24899,anti-hiv agents,1
24900,"da-epoch-r for dlbcl, ptld, and pmbcl",1
24901,gemcitabine-cisplatin chemotherapy,1
24902,human epididymis protein 4,1
24903,"prednisone, dexamethasone, vincristine, daunorubicin, peg-l-asparaginase",1
24904,your move (physical activity),1
24905,pemetrexed plus carboplatin combined with gefitinib,1
24906,ons from the start of radiotherapy,1
24907,nuc-3373 + irinotecan,1
24908,zafirlukast,1
24909,hr hc2® hpv dna,1
24910,urine marker,1
24911,online counseling sessions,1
24912,pg13-mage-a3 tcr9w11 (anti-mage-a3/12 tcr) transduced autologous peripheral blood lymphocytes,1
24913,intravenous narcotics,1
24914,standard post-lobectomy wound care,1
24915,standard combination chemotherapy,1
24916,hepatitis b antigen peptide,1
24917,uncovered self-expanding metal biliary stents (u-sems),1
24918,follow up visit,1
24919,placebo feedback,1
24920,68ga-nota-aca-bbn,1
24921,pf-00477736,1
24922,both doses late,1
24923,capnothorax,1
24924,"sirolimus combined with cp, mt and za",1
24925,"bevacizumab, cetuximab",1
24926,degarelix 160 mg / degarelix 160 mg,1
24927,patients treated with immune checkpoint blockade,1
24928,observational approach,1
24929,bright narrow band imaging.,1
24930,azacytidine and multitaa t cells stage,1
24931,41 ca,1
24932,"l-vax: autologous, dnp-modified nsclc vaccine",1
24933,roux-en-y,1
24934,cetuximab and folfox,1
24935,expanded prostate cancer index composite-short form 12,1
24936,doxorubicin 60 mg/m2 +cyclophosphamide 600 mg/m2,1
24937,"bortezomib, rituximab, ifosphamide, etoposide, carboplatin",1
24938,pet/mr-ultrasound guided fusion biopsy,1
24939,low intensity laser for oral mucositis switch off,1
24940,diffuse optical spectroscopy and near infrared spectroscopy,1
24941,tf2,1
24942,19 gauge eus fna bnx,1
24943,consolidation: radiation therapy to metastatic sites,1
24944,cytarabine and mitoxantrone,1
24945,icvt topical gel,1
24946,comprehensive chemical gustometry,1
24947,il-2 secreting and hcl4ol-expressing autologous b-cll cells,1
24948,no intervention no transcatheter arterial chemoembolization,1
24949,prism care program,1
24950,triciribine phosphate,1
24951,ct abdomen and pelvis scan,1
24952,"5-fluorouracil, leukovorin, bevacizumab",1
24953,bone cements,1
24954,s-1 (452500ach),1
24955,fentanyl d-trans,1
24956,cg1940/cg8711,1
24957,quality of life questionnaires completion,1
24958,ct- simulation scan,1
24959,zoely,1
24960,control pill,1
24961,healthy nutrition,1
24962,second look endoscopy,1
24963,ptns,1
24964,gemcitabine/bevacizumab,1
24965,mln7243,1
24966,total gastrectomy,1
24967,craniotomy under general anesthesia,1
24968,iron isomaltoside,1
24969,mov18 ige,1
24970,chest x ray,1
24971,detecting lymph node metastasis by staining,1
24972,propylene glycol-free melphalan hydrochloride,1
24973,panitumumab irdye 800,1
24974,personalized web intervention arm,1
24975,three-dimensional conformal radiation therapy,1
24976,radiofrequency (rf star electrode electrode_fixed),1
24977,"sequential chemotherapy ?paclitaxel 80mg/m2 d1,d8) and radiotherapy",1
24978,bbb disruption with chemotherapy arm,1
24979,irinotecan + capecitabine,1
24980,ginger exosomes,1
24981,peer training,1
24982,gemcitabine/s-1,1
24983,rituximab + bendamustine,1
24984,none intervention,1
24985,[11c] lapatinib,1
24986,activated/costimulated autologous t-cell,1
24987,mini chep,1
24988,vicryl® rapid,1
24989,app+,1
24990,cytotoxic t-lymphocytes,1
24991,taxol (paclitaxel),1
24992,spot,1
24993,"capecitabine, cisplatin, radiotherapy (+/-)",1
24994,intensive cardiovascular monitoring,1
24995,pet/ct with fdg,1
24996,"abemaciclib, dexamethasone, ixazomib, pomalidomide",1
24997,"phase 1b: cwp232291, lenalidomide, dexamethasone",1
24998,axitinib + gemcitabine + cisplatin (cohort 8),1
24999,zsp1241,1
25000,pet scan with [18f]fluoro-2-deoxyglucose (fdg),1
25001,standard vitamin d3 supplementation,1
25002,concurrent chemoradiation (cisplatin),1
25003,hfsh-hp,1
25004,lgh447 + midostaurin,1
25005,cystectomy and lymphadenectomy,1
25006,intermediate-dose cytarabine (idac),1
25007,vipd?cisplatin?etoposide?ifosfamide? dexamethasone?mesna?,1
25008,¹?f-fluoromisonidazole,1
25009,omega 3 ffa,1
25010,primary chemoradiation therapy,1
25011,administration of ipilimumab10mg/kg,1
25012,mylotarg purging before autologous pbsc transplantation,1
25013,ga 101,1
25014,urokinase-derived peptide a6,1
25015,lasw1510,1
25016,lymphoscintigraphy with intraoperative gamma probes (gp),1
25017,sentinel node biopsy and mastectomy,1
25018,simrt,1
25019,ex-vivo drug response assay,1
25020,mediastinal irradiation (if residual tu),1
25021,zactima (vandetanib) (zd6474),1
25022,solex 300i stem cell selection,1
25023,doxorubicin (adriamycin),1
25024,xenografts and cell cultures,1
25025,transthorathic echocardiogram,1
25026,starch tablet,1
25027,external-beam radiation therapy,1
25028,msb0010445 (2.4 mg/kg),1
25029,torisel dose 25 mg and r-dha,1
25030,tseb therapy,1
25031,sra737,1
25032,cibisatamab,1
25033,"using 22g fnb, the first pass is mwst",1
25034,tj004309,1
25035,proflavine hemisulphate salt,1
25036,6mpindividualized,1
25037,5-azacytidine (5-aza) group 3,1
25038,pvb group,1
25039,stretching/flexibility exercise,1
25040,ctdna methylation analysis by ngs,1
25041,standard taxane therapy,1
25042,prednisone tablets,1
25043,18f-ethylcholine positron emission tomography (fec-pet),1
25044,"mogamulizumab: kw-0761, nivolumab: (ono-4538/bms-936558)",1
25045,blood samples collection after radiotherapy,1
25046,esophageal stump washout,1
25047,sienna+ retro 4-6,1
25048,"breast tissue, lymph node tissue or blood",1
25049,haploidentical stem cell transplant,1
25050,lipo-merit,1
25051,monitor size,1
25052,blind biopsy with a pipette,1
25053,sildenafil therapy plus post-nsrrp hbo2t,1
25054,re-activated t cells,1
25055,varenicline without counseling,1
25056,ly3007113,1
25057,l19il2 + l19tnf,1
25058,varian truebeam radiotherapy system,1
25059,insertion of tissue expander with fluid reservoir,1
25060,igimrt 27 gy in 3 fractions,1
25061,panitumumab+folfiri,1
25062,cabazitaxel plus bavituximab,1
25063,rhil-2,1
25064,border zone stereotactic radiosurgery (bz-srs),1
25065,asp3350,1
25066,js001 alone,1
25067,mri ultrasound biopsy,1
25068,contrast enhanced spectral mammogram,1
25069,liaison services,1
25070,"irinotecan, zd1839, vincristine, cefixime, cefpodoxime.",1
25071,metabolic activity measured by fdg-pet,1
25072,eras protocol,1
25073,focus group & questionaire,1
25074,non-aerobic stretching,1
25075,health communication intervention,1
25076,"deferasirox dfx, fct",1
25077,iact-bc,1
25078,software for acquiring ultrasound and endoscopic images,1
25079,injection tramadol,1
25080,visits conducted via telemedicine,1
25081,whole body contrast enhanced computer tomography,1
25082,physical activity motivation,1
25083,mycophenolate or cyclosporine and methotrexate,1
25084,static version of cansort tool,1
25085,"5-fluorouracil, irinotecan and leucovorin",1
25086,folfox regimen according to standard procedures,1
25087,tti-621 + pegylated interferon-?2a,1
25088,runkeeper app + physiotherapy coaching,1
25089,open-label azd2014,1
25090,nurse-led supportive care,1
25091,low-dose methotrexate,1
25092,azd2461,1
25093,pbsc transplant,1
25094,epi procolon,1
25095,co2 insufflation colonoscopy,1
25096,telemedicine weight management plus wi-fi scale (arm a),1
25097,epacadostat (incb024360),1
25098,a matched peripheral donor stem cells,1
25099,zostavax,1
25100,evaluation of the hepatic fibrosis,1
25101,genetic video,1
25102,conventional transarterial chemoembolization (ctace),1
25103,dynamic contrast enhanced mri (dce-mri),1
25104,usual clinical practice,1
25105,megestrol acetate 160 mg,1
25106,plasma-tissue testing,1
25107,nurse navigation,1
25108,gardasil vaccine,1
25109,ls11,1
25110,meaning-centered psychotherapy for cancer caregivers / mcp-c,1
25111,cart therapy in relapsed/refractory multiple myeloma,1
25112,subclinical cardiotoxicity surveillance and treatment,1
25113,sym015,1
25114,special diet therapy (low-carb),1
25115,peptide vaccine + poly-iclc,1
25116,device: smartphone,1
25117,reduced-intensity allogeneic hematopoietic stem cell transplantation,1
25118,escalating doses,1
25119,european organization for research and treatment of cancer quality of life questionnaire lc-13,1
25120,cannulation of ampulla of vater,1
25121,low-pressure pneumoperitoneum,1
25122,epat© educational package,1
25123,sensitizing dpcp ointment,1
25124,citrated whole blood collection bag,1
25125,b-all protocol,1
25126,arm a : standard neoadjuvant chemoradiotherapy group,1
25127,bright light therapy device,1
25128,torisel dose 15 mg and r-chop,1
25129,ublituximab + tgr-1202,1
25130,study follow-up,1
25131,auricular acupuncture,1
25132,phlebotomies,1
25133,cycolphosphamide,1
25134,hti-1066 dose level 3,1
25135,preserve the left colonic artery,1
25136,standard white-light laparoscopy,1
25137,1: fdg pet,1
25138,sequencing of ctdna in plasma,1
25139,bloodsampling,1
25140,regional interventional chemotherapy group,1
25141,"chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)",1
25142,sdx-7320,1
25143,"nilotinib (tasigna ®), capsules of 150 mg",1
25144,aerobic and muscle resistance training,1
25145,laparoscopic ovarian diathermy,1
25146,lenalidomide and melphalan,1
25147,isolation of tumor dna,1
25148,cyp1a2 (caffeine),1
25149,allogeneic bone marrow,1
25150,concurrent chemotherapy with cisplatin during radiotherapy,1
25151,111indium-bevacizumab,1
25152,underwater endoscopic mucosal resection,1
25153,folarell,1
25154,conventional colon resection,1
25155,accelerated hypofractionation radiotherapy,1
25156,mep monitoring with continuous infusion of vecuronium during general anesthesia,1
25157,"cyclophosphamide, vincristine, prednisone/prednisolone (cvp)",1
25158,face-to-face,1
25159,tq-b3139,1
25160,idronoxil (nox66) suppository,1
25161,g-csf mobilized peripheral blood cells,1
25162,safety data collection (following routine vaccination) by a continuous surveillance method.,1
25163,scalp nerve blocks with saline,1
25164,lag-3,1
25165,tt3-lite regimen (l-tt3),1
25166,tuly,1
25167,neuradiab + radiotherapy + temozolomide,1
25168,"capecitabine, 5-fluorouracil",1
25169,concept elicitation,1
25170,psycho-oncological intervention,1
25171,pdc vaccination,1
25172,opd surgery,1
25173,incidence of cancers,1
25174,prospare,1
25175,nv-vpac1 pca urine diagnostic test,1
25176,i-040302,1
25177,arq-761,1
25178,"liquorice (2 weeks, glycyrrhizin 290-370 mg daily)",1
25179,khk2375,1
25180,doxil (pegylated liposomal doxorubicin),1
25181,standard reminder postcard,1
25182,evaluation of the reading assistance technique,1
25183,life completion and preparation,1
25184,adjuvanted a(h1n1) influenza vaccine,1
25185,aezs-108 / zoptarelin doxorubicin,1
25186,metronomic therapy,1
25187,liver resection for primary and secondary disease,1
25188,double tract anatomosis,1
25189,papanicolau test,1
25190,help with physician office and patient management,1
25191,40 mg mmc gel,1
25192,"oxaliplatin, irinotecan, 5-fu & leucovorin",1
25193,everolimus 10mg daily,1
25194,chemotherapy (carboplatin and docetaxel),1
25195,core breast tumor biopsy,1
25196,post-operative adaptive radiation therapy,1
25197,"bortezomib, dexamethasone, rituximab",1
25198,bms-844203 (ct-322),1
25199,lovaza-omega 3 fatty acid capsules,1
25200,atorvastatin 80mg,1
25201,bplnd,1
25202,hysteroscopic resection of endometrial polyps. (tcrp),1
25203,blood tests for blood urea nitrogen and creatinine,1
25204,transoral endoscopic thyroidectomy vestibular approach,1
25205,kymriah,1
25206,5% albumin infusion 30 min,1
25207,sorcin gene expression,1
25208,endoscopic ultrasound (eus) for fiducial placement,1
25209,surgical resection and adjuvant therapy,1
25210,ebr plus hdrib,1
25211,mycrcs+prefs+barriers,1
25212,ny-eso-1 protein; montanide isa®-51 vg; resiquimod/placebo,1
25213,curcumin-based gel,1
25214,cold biopsy forceps,1
25215,lmb b,1
25216,patient coach,1
25217,lipiodol® ultra fluid with surgical glues,1
25218,activated cik and bispecific antibody,1
25219,standard of care imrt (photon),1
25220,ganirelix acetate,1
25221,vinorelbine tartrate oral,1
25222,amphinex induced pci of bleomycin,1
25223,nutritional consults,1
25224,mobile health (mhealth),1
25225,pomegranate extract,1
25226,ap611074 5% gel,1
25227,perihepatic lymphadenectomy,1
25228,non chemotherapy,1
25229,psma-based 18f-dcfpyl pet tracer,1
25230,infrascanner,1
25231,tg6002,1
25232,i-131,1
25233,nvn1000 16%,1
25234,surgery: spleen-preservation,1
25235,mammography appointment reminders; telephone counseling,1
25236,kirtan kriya meditation,1
25237,conventional decision algorithm,1
25238,ok432,1
25239,ofatumumab and bendamustine,1
25240,iron supplements,1
25241,bcnu 150mg/m2,1
25242,placebo (for omega 3 fatty acid supplement),1
25243,combination drug therapy,1
25244,"cetuximab, capecitabine",1
25245,maintenance:bevacizumab,1
25246,csl362,1
25247,lanreotide lp 90,1
25248,neoadjuvant followed by operation,1
25249,40ml of 0.9% normal saline,1
25250,s-1 monotherapy,1
25251,prostate health cocktail,1
25252,xmab13676,1
25253,tace+ rtc,1
25254,no prophylaxis,1
25255,regimen,1
25256,paclitaxel and tak-228,1
25257,decongestive physiotherapy plus taping,1
25258,b (placebo + dexamethasone),1
25259,frequently sampled intravenous glucose tolerance test (fsivgtt),1
25260,closure of the ileostomy,1
25261,minnelide™ 001,1
25262,drug: pegylated rhg-csf: 100µg/kg,1
25263,"metformin, ethinylestradiol 30µg-drospirenone",1
25264,flu-mel,1
25265,left-sided colonic resection,1
25266,ralimetinib,1
25267,carnoy's solution,1
25268,rh-endostatin,1
25269,metformin / placebo treatment for 4 months,1
25270,evaluations,1
25271,"abvd (adriamycin, bleomycin, vinblastine, dacarbazine)",1
25272,technetium tc 99m-labeled tilmanocept,1
25273,"sorafenib (nexavar, bay43-9006) sorafenib (nexavar, bay43-9006) + nerison fatty ointment sorafenib (nexavar, bay43-9006)+neribas fatty ointment",1
25274,placebo vaginal lubricant,1
25275,surgery and drain(s),1
25276,automated telephone outreach with speech recognition,1
25277,computerised tomography (ct) scan,1
25278,the m.d. anderson symptom inventory (mdasi),1
25279,131iodine-anti-b1 radioimmunotherapy,1
25280,measurement of salivary flow,1
25281,ps-341 (velcade-drug),1
25282,alcohol-free dexamethasone mouth rinse,1
25283,surefire precision infusion system,1
25284,methodological compensation,1
25285,motor imagery,1
25286,probe based laser endomicroscopy (pcle),1
25287,treatment b - azd1775 administered under fed conditions.,1
25288,comparator: ridaforolimus + dalotuzumab,1
25289,folate plus metformin,1
25290,ruthenium ru 106,1
25291,stem cells collections,1
25292,peip (weekly) and tciv,1
25293,anti-pd(l)-1,1
25294,cep-11981 (kinase inhibitor),1
25295,"docetaxel, doxorubicin, and cyclophosphamide (tac)",1
25296,"licensed quadrivalent hpv vaccine, gardasil",1
25297,hal proctectomy,1
25298,holmium 166 microspheres,1
25299,manual lymphatic drainage (mld) + intermittent pneumatic compression,1
25300,post surgery therapy (trastuzumab),1
25301,thermo-coagulation,1
25302,pledox (2 µmol/kg),1
25303,diclofenac epolamine patch,1
25304,arzerra,1
25305,"xofigo (radium-223 dichloride, bay88-8223",1
25306,standard induction therapy,1
25307,collecting urine samples,1
25308,individualized dose escalation,1
25309,embedded supportive care,1
25310,oct,1
25311,personalized intervention,1
25312,pembroliziumab,1
25313,immune assessment,1
25314,ethanol injection into a cyst,1
25315,plasma azd9291 testing,1
25316,cd-rom intervention,1
25317,cytarabine (phase 1 only),1
25318,oxaliplatin+capecitabine+bevacizumab,1
25319,plasma/buffy coat,1
25320,carboplatin/cisplatin,1
25321,platinol,1
25322,amylase test,1
25323,protocol m,1
25324,leucovorin(oral ),1
25325,anti-cd19- car,1
25326,impact® advanced recovery,1
25327,sublobar dissection,1
25328,prostvac,1
25329,hi-maize 260 and polydextrose,1
25330,feedback of patient-reported outcomes,1
25331,quality of life survey,1
25332,conventional glucocorticoid therapy,1
25333,ca 125 analysis,1
25334,dc-tc+gm-csf,1
25335,healthy living (chip + pre-train),1
25336,18f-peg6-ipqa,1
25337,transverse abdominal plan (tap),1
25338,arm 2 probes,1
25339,blood cell transplantation,1
25340,haplo-identical cord transplantation,1
25341,physical performance testing and patient-generated health data,1
25342,cisplatin (or alternative),1
25343,sirolimus 0.4%,1
25344,omental transposition,1
25345,panzem nanocrystal colloidal dispersion (ncd),1
25346,89zr dfo-mstp2109a,1
25347,wxeliri regimen,1
25348,uterine manipulator,1
25349,thoracic irradiation + pemetrexed,1
25350,icotinib+chemotherapy,1
25351,"stereotaxic unit, navigation",1
25352,photothermal laser,1
25353,radiation arm a,1
25354,blood draw for teg analysis,1
25355,treatment with in vitro expanded haploidentical nk cells,1
25356,cp4071,1
25357,sativex low dose,1
25358,"polysomnography (easy ambulatory 2 cadwell, kennewick, wa)",1
25359,higher dose,1
25360,standard ventilation group,1
25361,radiotherapy 70 gray/day,1
25362,smart matrix scaffold,1
25363,cognitive interviewing,1
25364,her-2 testing,1
25365,pedss - support for the caregiver,1
25366,"immunochemotherapy, in vivo purging and autrotransplant",1
25367,mifepristone tablets,1
25368,portal irradiation stent placement,1
25369,"without alloderm, questionnaires",1
25370,adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist,1
25371,peritumoural carboplatin administration.,1
25372,re-stimulated tumor-infiltrating lymphocytes (tils),1
25373,endoscopy with biopsy,1
25374,busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf,1
25375,nir/us neoadjuvant chemotherapy group,1
25376,ibuprofen tab 400 mg,1
25377,bevacizumab placebo,1
25378,xelox or xeliri bevacizumab,1
25379,dietary intervention (tangerine tomato juice),1
25380,shareclinic,1
25381,"docetaxel, leucovorin, fluorouracil, cisplatin",1
25382,sunitinib added to folfiri,1
25383,ganoderma lucidum spore,1
25384,thoracic surgery pleurectomy / extended decortication,1
25385,no intervention provided,1
25386,hr-b,1
25387,concurrent brain radiotherapy,1
25388,questionnaires or telephone interview,1
25389,melphalan (intra-arterial infusion),1
25390,tunneling epidural catheter,1
25391,cmv-tcr transduced donor-derived t cells,1
25392,cnf2024 (biib021),1
25393,sox postoperative chemotherapy,1
25394,"doxorubicin, capecitabine",1
25395,decitabine 20 mg/m^2,1
25396,pearl triology imaging system,1
25397,oral defense toothpaste,1
25398,rta 402 dose2,1
25399,trastuzumab (9 weeks) + docetaxel + cef + trastuzumab (up to 51 weeks),1
25400,dalotuzumab (mk0646),1
25401,salicylic acid (6%),1
25402,bay86-9766+gemcitabine,1
25403,mwv,1
25404,proton beam therapy (pbt),1
25405,bms-901608 (elotuzumab) 20 mg,1
25406,multiparameter magnetic resonance imaging,1
25407,barium swallow,1
25408,denosumab (standard dosing),1
25409,cyclosporin (csa),1
25410,cellvizio dual band,1
25411,carboplatin pemetrexed,1
25412,treatment group 1,1
25413,web-based module group,1
25414,metronidazole 0.8%,1
25415,90y ibritumomabtiuxetan,1
25416,laparoscopic procedures,1
25417,home based self paced walking program,1
25418,staple line without reinforcement,1
25419,healthy bones pamphlet,1
25420,standard protocol,1
25421,tegafur/uracil (ufur®),1
25422,limonene containing massage oil,1
25423,oncozene-deb-tace,1
25424,"5 peptide vaccines of koc1, ttk, co16, depdc1, mphosph1",1
25425,leuprolide acetate depot (lad) 11.25 mg 3 month,1
25426,all types of surgery procedures,1
25427,"hbig, epivir, hepsera",1
25428,dexamethasone supression test,1
25429,baseline strength test,1
25430,gemcitabine lapatinib,1
25431,montanide vaccine,1
25432,yttrium y 90 monoclonal antibody b3,1
25433,cll vaccine using dna plasmid vector,1
25434,syb c-0501,1
25435,cyclosporin-a,1
25436,120 mg mmc in 60ml gel,1
25437,donor right hepatic lobectomy,1
25438,jnj-61610588,1
25439,dwj1319,1
25440,bisphosphonate,1
25441,spectra optia apheresis system,1
25442,conventional management (repeat pap smear at 6 months),1
25443,sodium chloride (nacl),1
25444,written instructions,1
25445,standard chop,1
25446,insurance intervention,1
25447,sotatercept 0.5 mg/kg,1
25448,ureteral stent,1
25449,combination of nktr-214 + nivolumab,1
25450,co2 insufflations,1
25451,maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance,1
25452,spot ala 2 hour incubation,1
25453,physician's choice of salvage therapy - carboplatin,1
25454,shear wave elasticity imaging,1
25455,surepath,1
25456,mammoalert screening test,1
25457,"hla-a*2402restricted urlc10, ttk, vegfr1 and vegfr2",1
25458,transverse versus vertical closure,1
25459,production of genetically-modified t cells,1
25460,d4064a,1
25461,oral ketamine,1
25462,gemcitabine intravenous,1
25463,"temozolomide, decitabine, panobinostat",1
25464,clindamycin,1
25465,maps,1
25466,combined systemic and intrathecal chemotherapy followed by hd-asct,1
25467,engineered autologous t cells,1
25468,association chemotherapy and radiochemotherapy,1
25469,xmab18087,1
25470,suicide plus immunogene therapy,1
25471,first session,1
25472,"folfox4 chemotherapy,preoperative",1
25473,oral cc - 486,1
25474,tegafur and uracil,1
25475,tg4001,1
25476,pet-mri scan,1
25477,x-396(ensartinib) capsule,1
25478,bononophenylalanine (bpa)-based bnct,1
25479,40 gy in 10 fractions,1
25480,crizotinib plus vegf inhibitor combinations,1
25481,dos3w,1
25482,verbal teaching,1
25483,mp-470 + erlotinib,1
25484,"cyclophosphamide, methotrexate, fluorouracil, peg-filgrastim",1
25485,everolimus 10 mg/day,1
25486,eucalyptus essential oil,1
25487,"gadopentetate dimeglumine (magnevist, bay86-4882)",1
25488,"bevacizumab, pemetrexed, cisplatin",1
25489,strorz (commercial),1
25490,prevnar®13,1
25491,swallowing therapy & resistance training,1
25492,exploratory investigation,1
25493,ceus and targeted biopsies,1
25494,f-18-iso,1
25495,first-line chemotherapy agents,1
25496,sequential boost (15 x 2.67 gy wbi + 6 x 2.48 gy boost),1
25497,tomo assessment,1
25498,arixtra (fondaparinux sodium),1
25499,usual customary care group,1
25500,tas-109,1
25501,"clevudine, adefovir",1
25502,intensive lifestyle group session,1
25503,respiratory-swallow phase training,1
25504,intravenous ferric carboxymaltose,1
25505,transcatheter aortic valve implantation (tavi),1
25506,supervised physical activity plus behavioral counseling,1
25507,iort with ct-guided hdr brachytherapy,1
25508,p10s-padre with montanide™ isa 51 vg,1
25509,gemcitabine plus ts-1,1
25510,theraspheres,1
25511,srt to the resection cavity,1
25512,geriatric assessment of health status scale administration,1
25513,common surgical techniques,1
25514,wb-dw-mr scan,1
25515,patient diary,1
25516,prednisone placebo,1
25517,positron emission tomography/ computed tomography,1
25518,gla-se,1
25519,olokizumab 240 mg,1
25520,syn004,1
25521,high intensity postoperative oncologic surveillance,1
25522,"leptin level with a blood test every 12 weeks (t0, t2 and t4)",1
25523,molecular target,1
25524,green tea extract of camellia sinensis followed by placebo,1
25525,"group b-naviaid™ g-eye procedure, then standard colonoscopy",1
25526,no-scar transanal total mesorectal excision(tme),1
25527,renin measurement,1
25528,nonoperative management,1
25529,123i-mibg (meta-iodobenzylguanidine),1
25530,screening interview,1
25531,optonuclear probe,1
25532,placebo to match zd6474 (vandetanib at the dose of 300 mg),1
25533,water o-15,1
25534,sar245409 placebo,1
25535,transplant 2 dexamethasone,1
25536,aop2014,1
25537,im21 cart,1
25538,adi-peg 20 (arginine deiminase pegylated),1
25539,plastic stent (7-10fr),1
25540,sorafenib with everolimus,1
25541,lhc165,1
25542,compression therapy,1
25543,mavrilimumab 100 mg,1
25544,primovist,1
25545,indinavir,1
25546,afamelanotide (cuv1647),1
25547,pevonedistat 44 mg/m^2,1
25548,alt-803 subcutaneous,1
25549,conformal radiotherapy +/- boost,1
25550,palbociclib 75mg,1
25551,early salvage neck dissection in case of less than ccr (arm a only),1
25552,recipients,1
25553,donor t cells,1
25554,bibf 1120 l + docetaxel m,1
25555,ctl,1
25556,"regimen 1, course 2",1
25557,barrx™ anorectal wand,1
25558,vemurafenib (all groups),1
25559,egfrt/bcma-41bbz car t cell,1
25560,long-acting triptorelin,1
25561,conventional rectal surgery,1
25562,this is a non-interventional trial,1
25563,inhaled budesonide,1
25564,0.9% sodium chloride irrigation solution,1
25565,68ga-nodaga-exendin 4 pet/ct,1
25566,idarubicin hydrochloride,1
25567,first line systemic treatment,1
25568,sbrt 45.0 gy,1
25569,pimonidazol,1
25570,yy-20394,1
25571,intra-arterial administration of dc beadsr,1
25572,gingival crevicular fluid,1
25573,c11-sodium acetate,1
25574,combined resection of the splenic vein,1
25575,comprehensive computed tomography of the abdomen/pelvis,1
25576,2.0 mg/m2 di-leu16-il2,1
25577,oncotype dx,1
25578,8 hla-a2 restricted peptides and montanide isa-51,1
25579,vt-122 high dose,1
25580,89zr-abt806 pet,1
25581,4d pet scan,1
25582,eus-guided fine needle biopsy,1
25583,hybrid knife,1
25584,autologous multi-lineage potential cells (ampc),1
25585,related or unrelated bone marrow cells,1
25586,18f-fdg pet/ct and comet assay guide rapidarc,1
25587,autologous anti-gp 100:154-162 t-cell receptor gene-engineered tumor infiltrating lymphocytes,1
25588,traditional microsurgical operation,1
25589,subcutaneous progesterone,1
25590,special diet,1
25591,cryo-biopsy via radial ebus navigation,1
25592,mri/ultrasound transperineal fusion-guided prostate biopsy,1
25593,cellvizio mini laser probe,1
25594,imiquimod (topical use),1
25595,soc agent,1
25596,cgc-11047 and 5-flurouracil / leucovorin,1
25597,forcep,1
25598,placebo plus pem cis,1
25599,intratumoral injections of l19il2,1
25600,bipolar energy sealing system (ligasure precise),1
25601,pyruvate,1
25602,monsel´s paste,1
25603,tbi+cy+vp-16,1
25604,cellu m6,1
25605,conventional surgery +rte,1
25606,diammonium glycyrrhizinate,1
25607,low position space group,1
25608,"drug will be recommended based on ihc/fish, cgh and pan-xenobank",1
25609,"high-dose ifosfamide 14 g/m2, given in in 14 days",1
25610,ror1r-car-t cell infusion,1
25611,hm10460a (45 ?g/kg),1
25612,olokizumab q2w,1
25613,xpert hpv,1
25614,hgs1036 + cisplatin + etoposide,1
25615,tumour markers detection,1
25616,18f- dcfpyl pet/ct,1
25617,dietary intervention in addition to standard recommendations,1
25618,assess quality of life postoperatively,1
25619,n-acetylcystein,1
25620,cbt-1®,1
25621,50 gm civi/24 hours x 5 days every 4 week,1
25622,tace combined with local regional therapies without hepatectomy,1
25623,vemurafenib + hd il-2,1
25624,yttrium y 90 monoclonal antibody m195,1
25625,permanent prostate implant,1
25626,st571 + byl719,1
25627,dovitinib + paclitaxel,1
25628,bladder training,1
25629,can be any registered nonpegylated form of g-csf,1
25630,lu-prrt,1
25631,individualized usual care,1
25632,lifestyle factors independently or combined,1
25633,laparoscopic reinforcement suture,1
25634,survivor survey (4): 6 month post-visit,1
25635,surgery for standard axillary node dissection,1
25636,high dose proton pump inhibitor,1
25637,anti-b-raf,1
25638,eribulin (reproline),1
25639,sl-701; poly-iclc (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose),1
25640,taped music,1
25641,smoked marijuana,1
25642,tgr-1202 + obinutuzumab + chlorambucil,1
25643,online symptom management,1
25644,sy-1425 (tamibarotene),1
25645,vinorelbine and plerixafor,1
25646,wire-guided localization (wgl),1
25647,hyperpolarised mri,1
25648,prolene,1
25649,bevacizumab and capecitabine,1
25650,grt-c901,1
25651,gem registry,1
25652,adaptative radiotherapy,1
25653,multiple low dose cyclophosphamide,1
25654,everolimus(afinitor),1
25655,"lapatinib + 1,76 mg eribulin",1
25656,3d-proton/conventional plan or 3d-proton only,1
25657,focal laser ablation of the prostate,1
25658,starvation,1
25659,pen-221,1
25660,anti-mesothelin car transduced pbl,1
25661,no routine videorecording,1
25662,tumor purged/cd25 depleted lymphocytes with tumor lysate/klh pulsed dendritic cell vaccine,1
25663,"isotopically labeled lycopene, phytoene or phytofluene",1
25664,no interventions will take place (observational),1
25665,cancer vision goggles,1
25666,risas,1
25667,clinical follow-up 2,1
25668,pulsed low dose rate radiation therapy,1
25669,cycle 5 consolidation,1
25670,da vinci® robotic system,1
25671,mri- us fusion prostate biopsy (fpb),1
25672,belinostat (pdx101),1
25673,vti probe,1
25674,mfolfox7,1
25675,cabazitaxel 25 mg/m2 iv,1
25676,lptme,1
25677,treatment for clinical practise,1
25678,vintafolide iv bolus,1
25679,omp-54f28 with sorafenib,1
25680,pembrolizumab 1 mg/kg,1
25681,cbt-1(registered trademark),1
25682,quadrivalent influenza vaccine,1
25683,fine needle aspiration assessing tumour tnfa levels,1
25684,milataxel,1
25685,concurrent capecitabine-based long-term radiotherapy followed by 4 cycles xelox and a delayed tme,1
25686,22g procore biopsy needle,1
25687,"rituximab, methylprednisolone",1
25688,possible reinitiation treatment: ibrutinib + venetoclax 12 cycles,1
25689,surgical removal of acf,1
25690,aeonose,1
25691,low-risk bcc excisional margins,1
25692,imetx intervention,1
25693,levofloxacin 500mg oral tablet,1
25694,vinflunine 320 mg/m² as a 20-minute infusion on day 1 of each cycle repeated every 3 weeks gemcitabine 1000 mg/m² iv on day 1 and 8 repeated every 3 weeks,1
25695,low dose n-acetylcysteine,1
25696,apl-1202,1
25697,urethral catheter loaded with beacon transponders,1
25698,sbrt 57.5 gy,1
25699,lucanix™,1
25700,carboplatin (dose level 1),1
25701,casopitant/docetaxel,1
25702,surgical staging,1
25703,cd19 car and pd-1 knock out engineered t-cells,1
25704,"doxorubicin , ifosfamide",1
25705,scale of subjective total taste acuity,1
25706,leukemia cell harvest,1
25707,p2x7 assay,1
25708,mole mapping diagram,1
25709,paravertebral nerve block: 4 ml ropivacaine 0.5% at each of six levels,1
25710,diverting loop ileostomy without rod,1
25711,hand-held fan,1
25712,klh-pulsed autologous dendritic cell vaccine,1
25713,early drainage removal,1
25714,standard dry gauze dressing,1
25715,goldlock,1
25716,ultrasonic coagulating shears,1
25717,activated cik and cd3-muc1 bispecific antibody in treating gastric cancer,1
25718,ts-1 with radiation,1
25719,thermotest,1
25720,chemotherapy + valproate,1
25721,"ability to swallow, speak and quality of life",1
25722,troxacitabine,1
25723,folfiri+aflibercept,1
25724,precise segmental renal arterial clamping,1
25725,inframammary fold incision or lateral radial incision,1
25726,prostate cancer vaccine ony-p1,1
25727,tidal volume challenge test,1
25728,18f-l-dopa pet,1
25729,endostar -injecting into +gp,1
25730,intravenous docetaxel with intraperitoneal oxaliplatin,1
25731,radical total gastrectomy with d2 (d2 - #10) lymph node dissection by laparoscopic approach,1
25732,stabilized sulphur hexafluoride microbubble-based contrast agent,1
25733,fresh tissue from ovary,1
25734,near infrared (nir) emissive nanotechnology,1
25735,tb-403 50mg/kg,1
25736,neoadjuvant endocrine therapy,1
25737,routine digestive tract reconstruction,1
25738,ingenol mebutate 500 ucg,1
25739,megavoltage ct scan,1
25740,t-cell replete pbpc allograft,1
25741,ruxolitinib (incb018424),1
25742,sit and reach test,1
25743,[68ga]cbp8,1
25744,blood collection for hormonal status analysis,1
25745,"urlc10, ttk, koc1, vegfr1, vegfr2, cisplatin, fluorouracil",1
25746,bismuth tablets,1
25747,brief supportive-expressive group therapy,1
25748,mailed invitations for fit test kits,1
25749,paclitaxel-albumin,1
25750,etaf,1
25751,conservation surgery,1
25752,normal fluid volume,1
25753,almac her-seq assay kit,1
25754,ncrt,1
25755,xmab14045,1
25756,ts-1/cisplatin,1
25757,pdl treatment,1
25758,pth followed by dose dense ac of fec,1
25759,romidepsin (fr901228),1
25760,lymphatic drainage,1
25761,bibw 2992 qd,1
25762,"cisplatin, liposomal",1
25763,"cisplatin, gemzar, docetaxel, alimta",1
25764,ima950/poly-iclc and pembrolizumab,1
25765,iopromide,1
25766,bilateral stent-in-stent insertion,1
25767,pain evaluation,1
25768,laboratory evaluation,1
25769,bcd-115,1
25770,detection of kir receptor by rt pcr,1
25771,gp followed by js001,1
25772,azacitidine (monotherapy),1
25773,cohort: 3000 men examined every 6 months for 4 years.,1
25774,dietary education,1
25775,b-d quincke type point,1
25776,capsule colonoscopy;,1
25777,apply methyl-ala cream,1
25778,lobar or segmental hepatic chemoembolization with debdox (100-300 or 300-500 micron beads loaded with doxorubicin per manufacturer ifu,1
25779,survivors treated with crt,1
25780,simmitecan hydrochloride for injection,1
25781,fried soybean oil,1
25782,azd5153,1
25783,placebo ?2,1
25784,memory test,1
25785,one time blood draw,1
25786,radio- chemotherapy,1
25787,"hysteroscopic resection of fibroids, polyps and endometrium.",1
25788,re-turbt,1
25789,recombinant interleukin-11,1
25790,direct electrical stimulation mapping,1
25791,hipec orientation,1
25792,adjuvant androgen-deprivation therapy,1
25793,novo-ttf,1
25794,13c-glucose,1
25795,mab nimotuzumab,1
25796,intracavitary cisplatin-fibrin,1
25797,"azd9150, durvalumab",1
25798,intra-arterial infusion of chemotherapy,1
25799,myosure tissue removal system,1
25800,urinary pca3 test using progensa® pca3 assay kit (gen-probe),1
25801,arfolitixorin,1
25802,untreated arm (control),1
25803,measurement level of myeloid derived suppressor cells in cml patients treated with imatinibe 400 mg/day,1
25804,alkeran®,1
25805,padding,1
25806,total thyroidectomy with ccnd,1
25807,panitumumab (part 1a only),1
25808,sebastian clinical decision support system (cdss),1
25809,hepatocellular carcinoma,1
25810,68ga- psma-hbed-cc,1
25811,mesocancervac,1
25812,bioelectric field imaging,1
25813,painless indwelling catheter,1
25814,microscopic resection,1
25815,using cone beam ct in patients with bladder cancer,1
25816,photoacoustic imaging scans for breast cancer screening,1
25817,ngfds selected treatment,1
25818,"tpf, radiotherapy and cisplatin.",1
25819,aferbio,1
25820,gnrh (agonist),1
25821,elasto-gel™,1
25822,decongestive physiotherapy,1
25823,cisplatin (arm b),1
25824,fludarabine and cytarabine followed by iv busulfan and cyclophosphamide,1
25825,continuing medical education and electronic decision support,1
25826,warm ischemia procedure,1
25827,ct and mr fusion,1
25828,tetracaine 0.5%,1
25829,pre-operative prehabilitation,1
25830,dcik,1
25831,i:e = 1:1 ratio,1
25832,xianlinggubao,1
25833,endoscopic placement of expandable stent,1
25834,dher2 + as15 asci,1
25835,placebo (water),1
25836,"panitumumab, oxaliplatin, folinic acid, 5fluoruracil, irinotecan",1
25837,"sorafenib (nexavar,bay43-9006)",1
25838,"erlotinib, standard dose",1
25839,minimally invasive inguinal lymph node dissection,1
25840,spa laparoscopic hysterectomy,1
25841,bevacizumab-eu,1
25842,doxorubicin/genexol-pm,1
25843,ugt1a1 genotyping (ta6/ta7),1
25844,cardiac imaging modalities,1
25845,"afatinib, ribavirin, and weekly carboplatin/paclitaxel",1
25846,clinic intervention,1
25847,paclitaxel dosing according to smpc,1
25848,visual analogue scale,1
25849,wt1 analog peptide vaccine,1
25850,cypath,1
25851,laryngoscope with nbi system,1
25852,successful survivorship health education and support group,1
25853,individualized food-based intervention,1
25854,standard communication training,1
25855,molecular analysis.,1
25856,the cancer home life intervention,1
25857,brief negotiated mobile application,1
25858,isolation of circulating tumor cells (ctc) from veinous blood,1
25859,mdna55,1
25860,selectmdx,1
25861,neoadjuvant chemotherapy + interval debulking surgery,1
25862,sonowand,1
25863,lapatinib and paclitaxel,1
25864,transplant 2 melphalan,1
25865,polyphenon e (egcg),1
25866,tailored health partnership program,1
25867,supportive expressive group therapy using videoconferencing,1
25868,topical lidocaine,1
25869,robotic assisted radical prostatectomy,1
25870,placebo (for bavituximab),1
25871,sfx-01,1
25872,dasatinib maximum tolerated dose,1
25873,"fludarabine, thiotepa, melphalan, thymoglobuline (atg)",1
25874,conventional open rectal resection,1
25875,prestage,1
25876,mitomycin (mmc),1
25877,"docetaxel, epirubicin and cyclophosphamide",1
25878,reduced rt,1
25879,hematopoietic stem cell mobilization,1
25880,dmri scan,1
25881,celyvir,1
25882,cd4+ t cells,1
25883,ping-hher3fl,1
25884,intraperitoneal (ip) cisplatin,1
25885,rapamycin (liquid),1
25886,calcium and vitamin d3 combined,1
25887,atg-008,1
25888,provider determined,1
25889,emotional supportive program,1
25890,"small media intervention using video, flip chart, and pamphlets and a tailored interactive multimedia intervention",1
25891,35 mcg ethinylestradiol/2 mg cyproterone,1
25892,pegylated filgrastim and ?lgrastim,1
25893,delayed-immediate reconstruction,1
25894,nurse-led counselling,1
25895,"arg1-18,19,20",1
25896,patients with renal cell carcinoma,1
25897,screening digital breast tomosynthesis,1
25898,dna and rna analysis,1
25899,30gy in-rt (involved-node radiotherapy),1
25900,derma vax™ intradermal dna delivery system,1
25901,concurrent chemoirradiation,1
25902,oxaliplatin (205803bij),1
25903,prompts to report symptoms via study app,1
25904,docetaxel & prednisone,1
25905,online patient decision aid,1
25906,voyager,1
25907,pirs2-phosphopeptide,1
25908,pemetrexed and gemcitabine,1
25909,oprm1,1
25910,flexitheralight pdt,1
25911,randomized midazolam,1
25912,biological statement,1
25913,¹³c-octanoate breath test,1
25914,comparator: adacel™,1
25915,fpv-brachyury,1
25916,sapacitabine and seliciclib,1
25917,psycho-educational support group therapy,1
25918,pedsql,1
25919,laparoscopic supracervical hysterectomy,1
25920,social support intervention,1
25921,aggressive thoracic radiotherapy,1
25922,ixabepilone + cetuximab,1
25923,collection of urine and bladder tumor specimens,1
25924,gsk biologicals' recombinant wt1 antigen-specific cancer immunotherapeutic (asci) gsk2130579a,1
25925,bcma-specific car-expressing t lymphocytes,1
25926,power morcellation,1
25927,exercise instruction,1
25928,dabrafenib plus trametinib placebo,1
25929,recombinant interferon alfa (ifn-a),1
25930,nk-dli,1
25931,sleep environment intervention,1
25932,waitlist control i,1
25933,real acupressure band,1
25934,blood-stage infection of p. vivax,1
25935,touch screen intervention,1
25936,native aortic valve,1
25937,"gemcitabine, docetaxel, doxorubicin",1
25938,powerplay,1
25939,bemobile,1
25940,ufur and iressa,1
25941,sacuitril,1
25942,experienced,1
25943,allogeneic hla-identical sibling transplantation,1
25944,curcumin powder,1
25945,gemcitabine and cisplatin or gemcitabine and carboplatin,1
25946,cblb502,1
25947,carboplatin auc3,1
25948,mart-1: 26-35(27l) peptide,1
25949,pulsed low dose radiation,1
25950,4d pet-ct,1
25951,dc/klh,1
25952,sensipar (cinacalcet hcl),1
25953,educational information session for patients and caregivers,1
25954,informational intervention with coaching,1
25955,jns002,1
25956,part 1; cohort 1,1
25957,"concomitant chemoradiotherapy - radiotherapy 66 gy, cisplatin, and docetaxel",1
25958,arm egf ointment 20 ppm,1
25959,controlled ovarian hyperstimulation (coh),1
25960,respiratory training,1
25961,temodar and irinotecan,1
25962,docetaxel x 3 followed by fac x 3,1
25963,ao-176,1
25964,ff-10832 gemcitabine liposome injection,1
25965,ipilimumab and dabrafenib,1
25966,narrow resection margin <1cm,1
25967,cmab009,1
25968,anti-cea 2nd generation designer t cells,1
25969,rpve,1
25970,in vitro treated peripheral blood stem cell transplantation,1
25971,²¹²pb-tcmc-trastuzumab,1
25972,levobupivacaine + dexmedetomidine,1
25973,compression bandaging,1
25974,hp 129xe,1
25975,internet communication application,1
25976,ileostoma closure,1
25977,acupuncture and patient education,1
25978,200 µg doxorubicin-containing mna,1
25979,fvd regimen,1
25980,mocetinostat induction phase + ipilimumab + nivolumab,1
25981,3m™ cavilon™ advanced skin protectant,1
25982,research blood draw and tissue biopsy,1
25983,first-line bevacizumab and chemotherapy,1
25984,18 f fdg followed by pet/ct imaging,1
25985,intercostal approach extended thymectomy by vats,1
25986,speed of processing training,1
25987,"part 1, cohort 1",1
25988,self-help program,1
25989,colposcopy/biopsy,1
25990,"mitozantrone, etoposide, cytarabine (combination chemotherapy)",1
25991,timed up and go walking test,1
25992,chloroquine diphosphate,1
25993,ga101/hdmp,1
25994,follow-up telephone call,1
25995,"propofol, bupivacaine",1
25996,standard forward-viewing colonoscopy,1
25997,"rituximab, gemcitabine, oxaliplatin",1
25998,hd cytarabine,1
25999,cap - transparent retractable extension device.,1
26000,eus fna with 4 passes,1
26001,geriatric intervention plan (gip),1
26002,s-1 for 1 year,1
26003,• arm a: best standard of care only [a structured programme of rehabilitation exercises] for 6 months,1
26004,"oxaliplatin, capecitabine, gemcitabine cetuximab",1
26005,stereoscopic digital mammography,1
26006,telephone coaching session,1
26007,imatinib treatment,1
26008,cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic stem cell transplantation,1
26009,services from a nurse navigator,1
26010,g250 peptide,1
26011,questionnaires completion,1
26012,standard anti-viral therapy,1
26013,usel/leucovorin,1
26014,lidocaine topical,1
26015,define macrophages migration mode,1
26016,(18)f-fluoroazomycin arabinoside,1
26017,preoperative irradiation,1
26018,pf03446962,1
26019,experimental beta probe,1
26020,supervised physical activity plus exercise counseling,1
26021,gsk1059615,1
26022,systematic pelvic lymphadenectomy,1
26023,partial brain re-irradiation.,1
26024,patient receives written information on how to find genetic services in their area,1
26025,direct rigid endoscopy,1
26026,prospective tdm arm,1
26027,ex vivo expansion,1
26028,alefacept,1
26029,hifu (sonablate® 500),1
26030,laparoscopic aon-anatomical hepatectomy,1
26031,evax-01-caf09b,1
26032,1capecitabine + oxaliplatin + bevacizumab + cetuximab,1
26033,"- lyc-o-mato (dietary supplement, 30 mg lycopene/day)",1
26034,tagged axillary metastatic node,1
26035,hpv dna plasmids therapeutic vaccine vgx-3100,1
26036,sorafenib in combination with tace,1
26037,azd4785,1
26038,home monitoring teleconsult visits,1
26039,liposome doxorubicin,1
26040,vsv-ifn?-nis and avelumab,1
26041,bbi intervention,1
26042,hyperfractionated rt,1
26043,assessment of sarcopenia by ct-scan,1
26044,danggui buxue tang,1
26045,gd2 t cells,1
26046,sunitinib: observational study,1
26047,music video,1
26048,cbp501 and cisplatin,1
26049,naloxone,1
26050,canarypox-hil-12 melanoma vaccine,1
26051,l19il2,1
26052,arginine/omega-3 fatty acids/nucleotides oral supplement,1
26053,biib0121 and antacid,1
26054,biopsies for gastric microbiota,1
26055,autologous cmv-specific ctl,1
26056,gm-csf s.c.,1
26057,arm b: a combination of pentoxifylline and tocopherol acetate in addition to best standard care [a structured programme of rehabilitation exercises] for 6 months,1
26058,topotecan (<=8cc),1
26059,mri targeted focal thermal therapy of prostate cancer,1
26060,cetuximab +/- dexamethasone,1
26061,h-1pv,1
26062,gene mutations analysis,1
26063,interstitial laser photocoagulation,1
26064,one-stage dermal matrix/implant procedure,1
26065,docetaxel+cisplatin+5-fu+ radiotherapy+cetuximab,1
26066,"single source dual energy compted tomography (ct750hd, general electric, usa) with krypton as a gaseous contrast media",1
26067,oxaliplatin+s1,1
26068,trametinib daily until pd,1
26069,assess physical functioning postoperatively,1
26070,wave-caipi,1
26071,aav2haqp1,1
26072,"diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg",1
26073,compound vitamin b12,1
26074,double-layer hand sutures,1
26075,tq-b3395,1
26076,radiation therapist planning,1
26077,fentanyl citrate nasal spray (fcns),1
26078,sc-005,1
26079,cytoxan-containing chemotherapy regimens,1
26080,inpatient management,1
26081,standard postoperative radiotherapy for breast cancer,1
26082,aya steps,1
26083,maximization of cardiac stroke volume with fluid infusion,1
26084,de-cedm,1
26085,transdermal nitroglycerin,1
26086,perfusion imaging,1
26087,endoscopic vacuum assisted closure,1
26088,act individual treatment,1
26089,"gemcitabine, capecitabine, docetaxel followed by radiotherapy",1
26090,18fdg pet,1
26091,"combination of bortezomib, fludarabine and cyclophosphamide",1
26092,sinecatechins 10%,1
26093,denosumab q4w,1
26094,chlorambucil (drug),1
26095,"carboplatin, paclitaxel",1
26096,mp0274,1
26097,g1tksvna.53 producer cell line,1
26098,radon & smoking synergistic,1
26099,carboplatin + paclitaxel + bevacizumab + pf-3512676,1
26100,aromatase inhibitors (femara),1
26101,venographic occlusion of spermatic veins,1
26102,oc-l/montanide isa 51 vg,1
26103,ipilimumab and radiation therapy,1
26104,tors,1
26105,mtx 1,1
26106,sink,1
26107,injected ct-scan,1
26108,blood drawings,1
26109,dosimetry-guided peptide receptor radiotherapy,1
26110,plasma analysis of circulating cell free dna,1
26111,anastrozole and goserelin,1
26112,azd2014 3 on/4 off & weekly paclitaxel,1
26113,qol via fact-br,1
26114,"temozolomide, surgery, radiotherapy",1
26115,standard axillary surgery (slnb or alnd),1
26116,survivorship intervention,1
26117,pallov-cc,1
26118,administration of radium-223,1
26119,a3: amg 386 15mg/kg + liposomal doxorubicin,1
26120,placebo (0.9 % saline),1
26121,topotecan/cisplatin,1
26122,cryoballoon™ full ablation system,1
26123,polypectomy,1
26124,lay health advisor visits and newsletter,1
26125,weekly telephone consultations concerning exercise and diet.,1
26126,cisplatin + gemcitabine with subatm-itraconazole,1
26127,cs1002,1
26128,questionnaires for the evaluation of quality of life,1
26129,maintenance venetoclax,1
26130,head neck self reporting,1
26131,kytril 1mg (tablet),1
26132,cancerscan™,1
26133,mri and pet-ct,1
26134,analysis of lymph nodes,1
26135,laboratory test,1
26136,prostatak®(adv-tk) + valacyclovir,1
26137,cell injection,1
26138,haplo hct ?55 and < 65 years old,1
26139,3-dimensional surface image,1
26140,cardiovascular polypill,1
26141,carbon ions,1
26142,functional oral intake scale,1
26143,hypofractionated photon radiotherapy,1
26144,apalutamide 240 mg,1
26145,concurrent nimotuzumab during radiotherapy,1
26146,fluvastatin,1
26147,inositol powder,1
26148,exergame,1
26149,"next generation sequencing (ngs): exome, rna seq",1
26150,th-302 monotherapy,1
26151,"capecitabine, oxaliplatin and irinotecan (capoxiri)",1
26152,fentanyl (matrifen),1
26153,"docetaxel, 75 mg/m^2 + capecitabine, 1000 mg/m^2",1
26154,oral impact®,1
26155,anti-mart-1 f5 tcr pbl,1
26156,supervised exercise sessions,1
26157,jj stent,1
26158,hospira docetaxel injection,1
26159,loop excision procedure,1
26160,18f dcfpyl- radiopharmaceutica,1
26161,mri targeted focal laser thermal therapy,1
26162,chec-up,1
26163,rsrclm,1
26164,doxorubicin/cyclophosphamide(ac) treatment,1
26165,mri targeted biopsy,1
26166,omaveloxolone lotion 0.5%,1
26167,aspira catheter,1
26168,quantitative interviews,1
26169,nzv930,1
26170,conventional tace,1
26171,anesthetic methods,1
26172,ruxolitinib pre- hematopoietic cell transplantation (hct),1
26173,arm 2: cisplatin + paclitaxel,1
26174,"isoflurane, propofol, dexmedetomidine",1
26175,maintenance weekly x4,1
26176,paravertebral block/local anaesthetic infiltration,1
26177,myeloproliferative neoplasms,1
26178,polestar n20,1
26179,umbilical cord derived mesenchymal stromal cells (uc-msc),1
26180,intensive nutrition intervention,1
26181,no partial breast irradiation,1
26182,"hpv vaccine,135?g/0.5ml",1
26183,nystatin,1
26184,"mitoxantrone/cyclophosphamide, fludarabine, rituximab and gm-csf",1
26185,dc-006 vaccine,1
26186,online participant reported questionnaire,1
26187,legume diet group,1
26188,controlled oral word association test,1
26189,th,1
26190,autologous dendritic cell adenovirus ccl21 vaccine,1
26191,caspofungin as preemptive antifungal therapy,1
26192,typhoid vaccine,1
26193,vigileo monitor,1
26194,concurrent chemo-proton therapy,1
26195,post-transcriptional regulation of cd9,1
26196,evaluation of the long-term complete remission rate (> 12 months),1
26197,total mesorectal excision before 56 days (4-8 weeks),1
26198,serious illness care program (sicp),1
26199,amorphous calcium carbonate (acc) - amor,1
26200,hybrid optical-gamma imaging,1
26201,bevacizumab:,1
26202,fibroscan test,1
26203,"transperineal, mri-guided, prostate biopsy",1
26204,spinal,1
26205,fulvestrant + anastrozol,1
26206,3d conformal radiation therapy and radiosurgery,1
26207,bone marrow analyses,1
26208,health professional intervention,1
26209,drug: gemcitabine and cisplatin,1
26210,infusion of autologous cik cells,1
26211,mln518,1
26212,ugt1a1 genotyping (ta6/ta6),1
26213,weight loss and exercise,1
26214,retrospective populations,1
26215,peripheral blood stem cell transplantation--ahsct,1
26216,allogeneic related stem cell transplant,1
26217,neoadjuvant chemoradiation plus pd-1 antibody(shr-1210),1
26218,placebo matching lenvatinib,1
26219,trisenox,1
26220,three dimensional power doppler,1
26221,urethral length measure,1
26222,tourniquet ischemia,1
26223,"quadrivalent hpv (types 6,11,16,18) l1 vlp vaccine 20/40/40/20",1
26224,immunohistochemistry staining,1
26225,mk-3475 and bcg,1
26226,verification set,1
26227,herpes zoster vaccine (gsk 1437173a),1
26228,standard gastrectomy with d2 lymphadenectomy,1
26229,hemithoracic radiation therapy,1
26230,sch 900105,1
26231,transplantation of cd3/cd19 depleted stem cells,1
26232,weight maintenance program,1
26233,decitabine at 20 mg/m2,1
26234,guided lesion biopsies,1
26235,comp03,1
26236,gic-1001,1
26237,topotecan hydrochloride liposomes,1
26238,etanercept (half dose),1
26239,oxaliplatin and on 01910.na,1
26240,starting the conversation video,1
26241,pemetrexed/cisplatin (carboplatin),1
26242,8.0 mg/kg ?-tea,1
26243,jumpstart intervention,1
26244,dcvax-l and t cells,1
26245,non myeloablative allogeneic stem cell transplantation,1
26246,talazoparib phase 2,1
26247,ambulatory physical exercise program,1
26248,dexanabinol dose level 5,1
26249,balloon catheter for suprapubic bladder-drainage,1
26250,"consolidation chemotherapy, i.e. high-dose cytarabine (hidac)",1
26251,exspiron respiratory variation monitor,1
26252,3d ultrasound scan,1
26253,3 dus,1
26254,'pap smear' arm,1
26255,"bevacizumab, ca4p",1
26256,during the surgical procedure of laparoscopic low anterior resection with total mesorectal excision .,1
26257,qapzola,1
26258,tacrolimus and mmf,1
26259,adjuvant surgery + folfox + cetuximab,1
26260,otsa101-dtpa-90y level 1,1
26261,attention control group (acg),1
26262,rhg-csf 5 ?g/kg/day,1
26263,trans-arterial tirapazamine embolization,1
26264,cmf,1
26265,neurocognitive assessment,1
26266,reduced dose of radiotherapy,1
26267,pre-stem cell infusion cyclophosphamide,1
26268,leica tp1020,1
26269,fesoterodine,1
26270,bibf 1120 (medium) + pld 30 mg/m2 + cbdca auc5 mg/ml*min,1
26271,cytogenetic and molecular studies,1
26272,tak-285 recommended phase 2 dosing cohort,1
26273,saliva or blood samples,1
26274,"irinotecan, oxaliplatin, leucovorin, 5-fu",1
26275,sham injections,1
26276,fluorine f 18 ara-g,1
26277,anti-ccr2 monoclonal antibody mln1202,1
26278,bcma-ucart,1
26279,neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel,1
26280,laser (local treatment),1
26281,tacrolimus 120,1
26282,tumor-infiltrating lymphocytes (tils),1
26283,collecting saliva sample,1
26284,multi-professional breathlessness service (mbs),1
26285,eusra rfa needle,1
26286,tre vs. nbi,1
26287,app software,1
26288,bismuth bi213 monoclonal antibody m195,1
26289,viewing of a 2-dimensional photographic library,1
26290,mri-guided sbrt,1
26291,3f8/gm-csf immunotherapy plus 13-cis-retinoic,1
26292,iv cetuximab,1
26293,i.v. iron sucrose,1
26294,young tumor infiltrating lymphocytes (young til),1
26295,monitoring devices,1
26296,odm-204,1
26297,placebo to dabigatran etexilate,1
26298,4sc-203,1
26299,adenoviral-mediated interferon-beta,1
26300,protectiscop cs,1
26301,proton plus carbon-ion radiotherapy,1
26302,in-person pc,1
26303,phase 2 : regorafenib,1
26304,synthetic tumor-specific breakpoint peptide vaccine,1
26305,mouth wash with morphine,1
26306,stage 1,1
26307,lpaparoscopic hepatectomy,1
26308,haploidentical transplantation of t-cell depleted graft,1
26309,hypofractionation radiotherapy,1
26310,experimental dosing method arm: cisplatin (chemotherapy) dosing based on individual lean body mass,1
26311,p16 methylation and lung cancer education,1
26312,conventional fraction,1
26313,pet/mri scan,1
26314,retroperitoneal drainage,1
26315,ulipristal acetate 10 mg,1
26316,trans-tympanic injection of a sodium thiosulfate gel,1
26317,intensity-modulated radiation therapy (imrt) external beam radiation,1
26318,goserelin 3.6 mg,1
26319,medlight pdt balloon,1
26320,ipgdp regimen chemotherapy,1
26321,intrathecal pump placement,1
26322,lesion excision/surgery,1
26323,targeted messaging,1
26324,24 hour ph study and upper endoscopy (egd),1
26325,genomic and proteomic profiling,1
26326,anagrelide retard,1
26327,adaptive androgen deprivation therapy (adt),1
26328,delayed cbt,1
26329,j-pouch coloanal anastomosis,1
26330,amxt 1501,1
26331,nanoknife angiodynamics us ltd,1
26332,mediastinal irradiation (if residual tumor),1
26333,20 mci dose for a 50 kg individual of [f-18]hx4,1
26334,post-radiation rad001 10 mg/day,1
26335,integration of pet/mri in radiotherapy,1
26336,aspiration of breast,1
26337,pyrotinib with capecitabine,1
26338,high resolution anoscopy biannually,1
26339,delayed intervention,1
26340,balance test,1
26341,resection of rectum,1
26342,hydralazine and magnesium valproate administration,1
26343,"ixazomib, thalidomide, & dexamethasone (itd) re-induction",1
26344,chemotherapy with temodar.,1
26345,assessment of pain,1
26346,pelvic floor rehabilitation program with neuromodulation,1
26347,nonmyeloablative stem cell transplant,1
26348,bevacizumab 15 mg/kg iv,1
26349,capsule sponge,1
26350,group counseling,1
26351,mor00208 (formerly xmab 5574),1
26352,apx3330,1
26353,vats hyperthermic chemoperfusion,1
26354,bay1161909,1
26355,quizartinib dihydrochloride,1
26356,oral pentamidine,1
26357,stent and iodine-125 seed strand implantation,1
26358,developmental disorders,1
26359,physical activity referral scheme,1
26360,post radiotherapy commencement of arimidex,1
26361,homeopathy remedy,1
26362,nab-paclitaxel - cohort 4,1
26363,three-port pulmonary resection surgery,1
26364,technetium tc 99m human serum albumin colloid,1
26365,contact control,1
26366,robotic radiosurgery,1
26367,cd19 or cd20 car t cells briging hsct,1
26368,rabbit anti-human t-lymphocyte globulin,1
26369,metformin tablets,1
26370,experimental: arm 1 (aerobic exercise),1
26371,capecitabine + erlotinib,1
26372,prospective cohort,1
26373,autologous anti-mart-1 f5 t-cell receptor gene-engineered tumor infiltrating lymphocytes,1
26374,pre-anesthetic medication with diazepam,1
26375,sg-wlp,1
26376,chromopertubation,1
26377,counseling group,1
26378,appointment before discharge: additional measure to ensure awareness of next clinic visit,1
26379,standardized cognitive rehabilitation,1
26380,semi-structured interview using a questionnaire,1
26381,sleep hygiene,1
26382,fa+tbi+cy+vp-16,1
26383,f-18 fluoroestradiol,1
26384,carboplatin-based chemotherapy,1
26385,stomach-small intestine reconstruction,1
26386,aprepitant 80 mg,1
26387,abnobaviscum 900,1
26388,pleurodesis with either talc or iodopovidone,1
26389,ivr only,1
26390,s-1-ccrt,1
26391,aerobic and resistance exercise training,1
26392,neo-adjuvant treatment with bevacizumab,1
26393,gadoxetate disodium,1
26394,bortezomib-melphalan,1
26395,physician intervention,1
26396,nd:yag laser,1
26397,y90 ibritumomab tiuxetan,1
26398,ceus guided biopsy,1
26399,docetaxel+imrt,1
26400,umfollowup,1
26401,single umbilical cord blood unit transplant,1
26402,vehicle pdt (veh),1
26403,"midostaurin,",1
26404,oral ulcer gargle (forrad®),1
26405,sublingual sufentanil nanotabs™ and placebo nanotabs™,1
26406,progressive disease (pd) group,1
26407,higher intensity physical activity intervention,1
26408,"carboplatin, 5fu, taxol and radiation",1
26409,standard treatment (as per protocol isg ssg iii),1
26410,chop-r,1
26411,physical activity intervention group,1
26412,b: de-intensification rt contralateral lymph nodes,1
26413,carboplatin + su011248 (sunitinib) + paclitaxel,1
26414,"3,4 dap",1
26415,chess website for lung cancer patient + internet access if needed,1
26416,"vinorelbine, oxalplatin, ifosfasmide, etoposide, mitoxatrone, gemcitabine or rituximab",1
26417,impact of cd9 expression level on motility assays,1
26418,intrahepatic glisson's approach,1
26419,standard selection for anh based on a planned resection of 3 or more segments,1
26420,photodynamic therapy with 100j/cm2 light dose using a broad-band red light source,1
26421,teamwork app,1
26422,bifidobacterium lactis probiotic supplement,1
26423,standard maintenance for squamous nsclc,1
26424,radiation - no radiation see intervention description,1
26425,ointment,1
26426,jnj-30979754 20 mg/m2,1
26427,"tissue infiltration : ropivacaine 2mg/ml (0,3ml/kg)",1
26428,printed educational materials (pem),1
26429,"regorafenib (stivarga, bay 73-4506)",1
26430,attenuated measles vaccine,1
26431,mri guided procedure software evaluation,1
26432,cep-37250/khk2804,1
26433,a-101 32.5%,1
26434,intensive lifestyle intervention,1
26435,"doxorubicin, paclitaxel, cisplatin",1
26436,liver metastasectomy,1
26437,endocrine therapy combined with trastuzumab,1
26438,msi screening test,1
26439,classic e.r.a.s.,1
26440,jaw dynasplint system,1
26441,lymphedema survey,1
26442,standard-glutamine-omega 3,1
26443,interventions are self controlled by the patient via a mp3 player and noise reduction headphones.,1
26444,0.15% benzydamine hcl,1
26445,"cis platinum, etoposide, s1",1
26446,docetaxel xrp6976,1
26447,"bicalutamide and cp-675,206 (tremelimumab)",1
26448,trans-rectal mri targeted biopsy,1
26449,conventional tumor puncture rfa,1
26450,clag-m regimen,1
26451,carcik-cd19,1
26452,"gemcitabine?nedaplatin, bai",1
26453,lenalidomide maintenance,1
26454,monitoring with nodal ultrasound,1
26455,research bone marrow aspirate,1
26456,advanced pelvic floor muscle exercise (apfx),1
26457,"reduced-exertion, high-intensity interval training (rehit)",1
26458,durvalumab / tremelimumab combination therapy,1
26459,education for professionals,1
26460,epic with fudr and leucovorin,1
26461,arm1,1
26462,usual dietary care,1
26463,goc intervention,1
26464,tace plus cyber knife,1
26465,sample of blood or saliva,1
26466,high dose et019002- t cells,1
26467,surgery after 8 weeks from chemoradiation treatment,1
26468,s1?oxaliplatin?radiation,1
26469,comparison of two anesthetics protocol,1
26470,anti-pd-l1 antibody atezolizumab,1
26471,allogeneic hematopoietic cell transplant,1
26472,ofdi,1
26473,bizelesin,1
26474,"cp-868,596 + docetaxel",1
26475,thin convex probe endobronchial ultrasound (tcp-ebus),1
26476,iv ibuprofen placebo,1
26477,alvimopan 1 mg/day,1
26478,sorafenib and osi-906,1
26479,hypofractionated whole breast radiation schedule,1
26480,framed loss text reminder,1
26481,fact-67 validated survey,1
26482,pressurized intraperitoneal air-flow chemotherapy (pipac) fixed repeated dose,1
26483,igcdg,1
26484,alt-803 + avelumab,1
26485,lbh589 (i.v. panobinostat),1
26486,fdr-pet,1
26487,skincerity,1
26488,intravenous patient-controlled analgesia (pca) morphine,1
26489,iodine i 131 monoclonal antibody a33,1
26490,accupuncture,1
26491,epigenetically modified autologous tumor,1
26492,bgj398 (infigratinib),1
26493,trilogy,1
26494,semi-directive interview,1
26495,car-20/19-t,1
26496,exercise and nutrition during radiotherapy,1
26497,the family talk intervention,1
26498,collection of biospecimen,1
26499,mm-121 (sar256212),1
26500,"floxuridine (fudr),dexamethasone (dxm), heparin in combination with oxaliplatin and capecitabine (capeox) or in combination with oxaliplatin and leucovorin and 5-fu (mfolfox6)",1
26501,docetaxel and cyclophosphamide (tc),1
26502,oncogramme®,1
26503,"multiple drug microinjection: rituximab, vincristine, doxorubicin, bendamustine, prednisolone or a combination of them",1
26504,hydrocortisone sodium succinate mixed with aluminium phosphate gel (route of administration),1
26505,axios stent & delivery system,1
26506,conventional insufflation system (cis),1
26507,hyperinsulinemic euglycemic isoaminoacid clamp,1
26508,tace using drug eluting beads loaded with doxorubicin,1
26509,tri-virus specific cytotoxic t-cells,1
26510,s-1 radiotherapy,1
26511,"health literacy, health message",1
26512,single-fraction radiotherapy,1
26513,centrum,1
26514,placebo control gummy,1
26515,3d-crt (photon) apbi,1
26516,communication tool,1
26517,questionnaires and training workshop,1
26518,fm+r,1
26519,pcur - 101,1
26520,s-1 single,1
26521,arterial access,1
26522,robotic esophagectomy,1
26523,mailed fecal immunochemical tests,1
26524,leuprorelin (gc),1
26525,preoperative risk stratification,1
26526,intracutaneous sutures,1
26527,muc1 antigen/sb as-2,1
26528,msc2363318a plus tamoxifen,1
26529,european organization for research and treatment of cancer-quality of life questionnaire (eortc qlq-c30),1
26530,non-restricted diet,1
26531,roux-en-y+pouch anastomosis,1
26532,sorafenib (200 or 400mg bid) and taxotere iv,1
26533,cng radiation,1
26534,epacadostat 100 mg,1
26535,active smokers - control arm,1
26536,e0652 pcd with peristaltic pulse waveform,1
26537,cetuximab + concomitant boost radiotherapy,1
26538,exercise dvd,1
26539,"adriamycin, taxol and cytoxan",1
26540,marker cd74 and vascular endothelial growth factor vegf,1
26541,etoposide (50mg/m2) iv (in the vein) on day 1 to day 5 of a 28-day cycle for 2 cycles,1
26542,analgesics,1
26543,prophylactic 4scar19 cells,1
26544,proton or photon sbrt (3-5 fractions; various dose and fractionation regimens depending on treatment site).,1
26545,comprehension assessment,1
26546,screen for life brochure,1
26547,goserelin + aromatase inhibitor + palbociclib,1
26548,genexol pm,1
26549,colon biopsies,1
26550,irinotecan and cetuximab subsequently,1
26551,hyperacute-lung cancer vaccine,1
26552,lifescience technologies application,1
26553,ligasure™,1
26554,collection of a blood sample and breast and ovarian tissue,1
26555,urine collection and blood draw,1
26556,dermacell adm without basement membrane,1
26557,patients will receive a standard preparative regimen (i.e. one that does not contain thymoglobulin),1
26558,bay94-9343 (1.8 mg/kg),1
26559,l-bupivacaine ; morphine,1
26560,melafind(r),1
26561,evolution® biliary stent-fully covered,1
26562,prothesis voice,1
26563,cesamet™ (nabilone),1
26564,isavuconazonium sulfate - oral,1
26565,visionrt,1
26566,durvalumab (imfinzi),1
26567,alpha-beta depleted t-cell infusion after post-transplant cyclophosphamide.,1
26568,abl001+imatinib,1
26569,post-procedural quality of life (qol),1
26570,ivac_w_bre1_uid/ivac_m_uid,1
26571,high-definition,1
26572,metformin alone (arm a),1
26573,cmv specific lymphocyte infusion,1
26574,sodium bicarbonate (g/kg/day),1
26575,chemotherapy (chop),1
26576,medroxyprogesterone with cyclophosphamide + methotrexate,1
26577,donafenib 300mg,1
26578,a 6 microrna stratified tool,1
26579,taxotere-cisplatin-5fu,1
26580,control group c,1
26581,matched targeted drug treatment,1
26582,hyperinsulinemic euglycemic hyperaminoacid clamp,1
26583,c-myb antisense oligonucleotide g4460,1
26584,cryoimmunotherapy,1
26585,"aq-flex 19 probe (mauna kea technologies, paris)",1
26586,transverse coloplasty pouch (short limb),1
26587,letrozole plus leuprolide,1
26588,placebo plus s1,1
26589,informed consent counseling,1
26590,soy isoflavone,1
26591,ak 3012,1
26592,non-operative management,1
26593,nano-luteolin,1
26594,tumor biopsy specimens and blood samples,1
26595,"hla-a*2402restricted urlc10, cdca1, and kif20a peptides",1
26596,ac-lintuzumab,1
26597,radical nephrectomy,1
26598,tumoral biopsy,1
26599,"lifestyle, screening",1
26600,basic drugs therapy of hcc by tace,1
26601,exercise education and walking program,1
26602,s-488410,1
26603,bibf 1120+ pld 30 mg/m2 + cbdca auc5 mg/ml*min,1
26604,monoclonal antibody f19,1
26605,high-intensity aerobic interval training (hiit),1
26606,red reflex testing,1
26607,placebo auricular acupressure,1
26608,sunlight omnisense quantitative ultrasound,1
26609,standard care after 24 weeks,1
26610,patients with primary colon cancer,1
26611,laparoscopic distal gastrectomy with d2 nodal dissection,1
26612,confirmmdx,1
26613,zeushield cytotoxic t lymphocytes,1
26614,flowcytometry,1
26615,total androgen suppression (tas) with goserelin acetate,1
26616,18f]-fmiso pet-ct,1
26617,remifemin,1
26618,dli sensitized against antigens expressed by the host.,1
26619,9-valent hpv recombinant vaccine,1
26620,azd6244 and sorafenib,1
26621,venous occlusion plethysmography,1
26622,(vic-)trastuzumab duocarmazine,1
26623,cyclophosphamide and docetaxel,1
26624,acetylcysteine inhalation,1
26625,"polysomnograph - embla a10 (medcare, reykjavik, iceland)",1
26626,educational intervention via internet,1
26627,hand sewn,1
26628,expiratory muscle strength training (emst) device,1
26629,cellectra™-5psp,1
26630,elr+cxcl cytokines levels are of sunitinib response,1
26631,oraquick fingerstick,1
26632,biliodigestive anastomosis,1
26633,machine learning planning,1
26634,hydrea,1
26635,saquinavir mesylate,1
26636,ductal lavage,1
26637,blood and urine collection,1
26638,patient utility scores (i.e. patient preference weights),1
26639,rapamycin-calcitriol combination,1
26640,capecitabine plus temozolomide vs capecitabine,1
26641,questionnaires administration,1
26642,"etoposide, cytarabine, mercaptopurine",1
26643,g-csf or peg-gcsf,1
26644,"mp0250 darpin® drug candidate, osimertinib",1
26645,type of anastomosis after pancreaticoduodenectomy,1
26646,concurrent capecitabine-based long-term radiotherapy followed by a regular tme and 6 cycles xelox,1
26647,tmtp1-icg,1
26648,triptorelin pamoate 11.25mg,1
26649,ml10,1
26650,right colon retroflexion,1
26651,quantitative information sheet,1
26652,e39 vaccine then j65 vaccine,1
26653,phone interview,1
26654,quality of life (qol) surveys: fact-o,1
26655,thoracoscopic lobectomy and mediastinal lymph node dissection,1
26656,nrx 195183 soft gelatin capsule,1
26657,valeriana officinalis extract,1
26658,ebv specific ctl infusion,1
26659,diode laser,1
26660,women with arthralgia,1
26661,surgical management,1
26662,sham-treatment,1
26663,pinaverium bromide,1
26664,genistein combined polysaccharide (gcp),1
26665,bevacizumab plus ipilimumab cohort 3,1
26666,"vilaprisan, bay1002670",1
26667,"methotrexate, ifosfamide, dexamethasone, etoposide, pegasparagase,",1
26668,gefitinib tablets (yi ruisha??first medication,1
26669,high protein/high dairy,1
26670,partially supervised exercise intervention,1
26671,arn-509 (phase 2),1
26672,robotic prostatectomy (rarp),1
26673,detection of sentinel node,1
26674,gs-9820,1
26675,full mailed booklet - nci's detailed 36-page quit guide,1
26676,virtual coach,1
26677,"cp-868,596 + ag-013736 + docetaxel",1
26678,"epidural infusion of saline, ropivecaine, or ropivacaine and sufentanil",1
26679,mva-brachyury- tricom,1
26680,pre-operative sn mapping with radionucleide,1
26681,injection of allogeneic neuroblastoma cells,1
26682,dendritic cell based cryoimmunotherapy,1
26683,eortc og-25,1
26684,spect/ct scan,1
26685,paricalcitol (zemplar),1
26686,self-administered white noise hypnosis,1
26687,state food craving questionnaire-state (fcq-s),1
26688,anti-cd19-car ??t,1
26689,"tcm allogeneic humane central memory t cells, cryopreserved",1
26690,hydrocortisone 1% cream,1
26691,pemetrexed plus cisplatin or carboplatin,1
26692,repositioning,1
26693,8-methoxypsoralen,1
26694,non-tailored control computer program,1
26695,gemcitabine with placebo,1
26696,ixempra (ixabepilone (bms-247550) ),1
26697,doxorubicine + cyclophosphamide combined,1
26698,standard transurethral resection,1
26699,"gemcitabine, nab-paclitaxel, and hydroxychloroquine",1
26700,cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy procedure,1
26701,"hla vaginal gel (hyalogyn®),",1
26702,ethyol (amifostine),1
26703,sequential boost radiotherapy,1
26704,the the family assessment of treatment at the end of life (fate ) survey,1
26705,individually tailored lifestyle feedback,1
26706,aromatase inhibitors (ais),1
26707,broad area ala 1-hour incubation,1
26708,both interventions together,1
26709,specialized pathology review (germany only),1
26710,whole blood/ plasma / serum sampling,1
26711,endostatin gene,1
26712,gefitinib standard dose,1
26713,domino game,1
26714,pembrolizumab plus denosumab,1
26715,curcuminoids,1
26716,platinum (cisplatin or carboplatin),1
26717,melphalan hcl for injection (propylene glycol free),1
26718,emerging from the haze class,1
26719,instant radiotherapy according to guidelines,1
26720,lubricating gel,1
26721,"induction therapy (regimen 1, course 1, cycle a1",1
26722,117lu-j591,1
26723,cyanocobalamin,1
26724,ksp/qrh dimer,1
26725,protective ileostomy,1
26726,allogeneic dcs and autologous rcc tumor derived cells,1
26727,bb-401,1
26728,"drug: gemcitabine, s-1",1
26729,ci-994,1
26730,"irinotecan, oxaliplatin",1
26731,adjuvant systemic chemotherapy,1
26732,educational materials/participant choice,1
26733,single balloon,1
26734,afp + gm-csf plasmid prime and afp adenoviral vector boost,1
26735,fully covered irradiation stent,1
26736,"palonosetron, dexamethasone, carboplatin, paclitaxel, olanzapine",1
26737,total thyroidectomy - clnd,1
26738,mometasone furoate cream,1
26739,supra-early temodal® chemotherapy,1
26740,non-absorbable nylon sutures,1
26741,thermodox in combination with microwave hyperthermia (heat),1
26742,diagnostic dna methylation signature,1
26743,eating assessment tool-10,1
26744,craniotomy scheduled,1
26745,bendamustin,1
26746,exisulind therapy,1
26747,haplo hct ?65 and ?75 years old,1
26748,chw navigation,1
26749,argx-110 with aza,1
26750,radical pbs,1
26751,hpv-6/11/16/18 vaccine,1
26752,"tissue biopsy, blood sample",1
26753,combined epi-ga,1
26754,colorectal cancer resection,1
26755,0.1% fluocinonide cream,1
26756,"dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab",1
26757,axillary thoracotomy,1
26758,abt-869 .25 mg/kg,1
26759,pd-l2 and pd-l1 peptide,1
26760,ttrna-dcs,1
26761,30 milliliters of 0.9% nacl,1
26762,tace+sorafenib,1
26763,"doxil, melphalan, bortezomib",1
26764,vgx-100,1
26765,reduced intensity conditionings,1
26766,pf-06647020 q3w,1
26767,medi0639,1
26768,gene modified neuroblastoma cells,1
26769,macy catheter,1
26770,stem cell collection and infusion,1
26771,dendritic cell vaccine plus denileukin difitox,1
26772,"paclitaxel, cisplatin ip",1
26773,cd19car-28-zeta t cells,1
26774,6 gy/ fraction,1
26775,elective neck irradiation,1
26776,ilf,1
26777,il-13-pe,1
26778,stent in stent,1
26779,lovaza 4gm & raloxifene 30mg,1
26780,nprofiler i stomach cancer assay kit,1
26781,interviews with coach,1
26782,smoking cessation training,1
26783,exercise program low intensity,1
26784,20-30 mmhg compression sleeve and gauntlet,1
26785,ai-human interaction,1
26786,egcg ( green tea extract),1
26787,feedback report,1
26788,"conventional tace in combination with sorafenib, administered on a sequential schedule",1
26789,"docetaxel, erlotinib",1
26790,low dose chest ct,1
26791,insulin protocol,1
26792,rfid localization,1
26793,spot photoscreener,1
26794,pico™,1
26795,nuc-3373 + oxaliplatin,1
26796,melanoma scale questionnair,1
26797,sm 153 lexidronam,1
26798,dli will be administered from month 6 (+/- 20 days) after stem cell transplant according to institutional practice,1
26799,vehicle control,1
26800,sg will be screened every time when they visit the clinics.,1
26801,"floxuridine, 5-fluorouracil, leucovorin",1
26802,adjuvant breast radiotherapy,1
26803,lmwh: dalteparin,1
26804,enhanced exercise,1
26805,irradiation (in specific conditions),1
26806,cbp501 + cisplatin + pemetrexed,1
26807,paxman cooling machine,1
26808,deep neuromuscular blockade,1
26809,shade sail,1
26810,trientine,1
26811,"oxaliplatin, irinotecan",1
26812,laniquidar,1
26813,art-therapie,1
26814,azd5363when combined with weekly paclitaxel.,1
26815,vaccination with pneumococcal conjugate vaccine (pcv13),1
26816,arsenic trioxide (tricenox),1
26817,cerubidine,1
26818,paclitaxel+hm30181,1
26819,topical timolol maleate,1
26820,ucb-nk cells,1
26821,1% lignocaine,1
26822,standard educational information,1
26823,cooked navy bean powder meals and snacks,1
26824,amg 706 placebo,1
26825,"mediterranean diet, restricted calorie",1
26826,nutridrink compact protein,1
26827,polycap,1
26828,"letrozole, lapatinib",1
26829,allogeneic bone marrow transplant,1
26830,pembrolizumab (200mg iv for 30 minutes,1
26831,learning workshops,1
26832,"adjuvant cisplatin,nab-paclitaxel",1
26833,triple therapy,1
26834,(pdt) photodynamic therapy,1
26835,"endoxana, ima901, leukine",1
26836,honey mouthwash,1
26837,"general anesthesia with sufentanil, propofol and rocuronium and sevoflurane",1
26838,pharmacogenomic testing,1
26839,lifting of the gastric tube to the neck for gastro-esophageal anastomosis through trans-substernal or trans-esophageal bed path.,1
26840,exercise and relaxation,1
26841,pelvic mri,1
26842,cross-linked hyaluronan gel,1
26843,universal dual specificity cd19 and cd20 or cd22 car-t cells,1
26844,60gy (12 x 5 fr.s),1
26845,"docetaxel, capecitabine, cisplatin, bevacizumab",1
26846,medroxyprogesterone progesterone acetate (mpa),1
26847,niraparib plus cabozantinib,1
26848,ly01008,1
26849,hydrotherapy according to kneipp rules,1
26850,akn-028,1
26851,feasible study using hyperpolarized 13c-pyruvate injection,1
26852,doxorubicine + docetaxel sequential,1
26853,immediate instillation of intravesical chemotherapy-epirubicin-,1
26854,zalypsis (pm00104),1
26855,dc ova with cyclophosphamide,1
26856,analysis of methylation profiles of numerous gsi and te,1
26857,standard-glutamine,1
26858,"cisplatin, etoposide, ifosfamide (standard)",1
26859,tak-593,1
26860,"avastin, alimta",1
26861,"erlotinib, escalating dose",1
26862,hand-assisted laparoscopic proctectomy,1
26863,sbrt delivers high dose selective irradiation with millimeter precision to a small volume. the cyberknife® is a robotic sbrt dedicated device that can deliver 100 to 200 photobeams to the target,1
26864,2d radiotherapy,1
26865,elemental 028 extra liquid,1
26866,protamin,1
26867,collecting stool samples,1
26868,placebo tablets (resembling revatio),1
26869,nodal status,1
26870,segmental stiffening wire,1
26871,unnamed consumer-based app meditation,1
26872,chemotherapy as needed by the patient´s tumor and stage,1
26873,act,1
26874,sustained released 5-fu,1
26875,standard pamphlet,1
26876,trastuzumab + letrozole,1
26877,intravenous iron,1
26878,prolonged overnight fasting,1
26879,nurse practitioner clinic,1
26880,questionnaire given to the two groups,1
26881,laboratory biomarker identification and analysis,1
26882,blend,1
26883,patients with a living donor,1
26884,u3-1565,1
26885,standard pneumoperitoneum,1
26886,valganciclovir (may substitute with ganciclovir),1
26887,perjeta injectable product,1
26888,intravenous morphine sulphate,1
26889,infusion of treg,1
26890,maintenance icotinib,1
26891,"aldesleukin,",1
26892,total thyroidectomy + clnd,1
26893,leo 27847,1
26894,catumaxomab 100µg,1
26895,high dose dexamethasone,1
26896,leuprolide acetate (eligard®),1
26897,18f dcfbc,1
26898,fish oil + epo,1
26899,standard online support group,1
26900,cta018 injection,1
26901,mesorectal excision with lateral lymph node dissection,1
26902,educational outreach,1
26903,generic fluorouracil cream,1
26904,cognitive rehabilitation program,1
26905,99mtc-sc,1
26906,fibered confocal microscope,1
26907,low in taurine and saturated fat diet,1
26908,"facbc, methionine",1
26909,research skin biopsy,1
26910,ino-1400,1
26911,radiotherapy after rfa,1
26912,"gemcitabine , paclitaxel",1
26913,npi-0052,1
26914,"5-fluorouracil, epirubicin, cyclophosphamide, docetaxel",1
26915,anti-muc1 vaccine,1
26916,tme with lar,1
26917,radioembolization with y-90,1
26918,radium ra 223 dichloride with enzalutamide,1
26919,recombinant thyroid-stimulating hormone,1
26920,"vitamin, polyvitamins tablets",1
26921,dvd-r,1
26922,without intervention,1
26923,pik-pd-1 cells,1
26924,standard radiochemotherapy (hart),1
26925,plastic stents,1
26926,physical activity program after a balneotherapy,1
26927,docetaxel-cisplatin,1
26928,questionnaire of the history of the hair loss,1
26929,gammanorm,1
26930,avelumab 1200 mg in combination with gemcitabine/cisplatin,1
26931,5-fluorouracil 5% cream,1
26932,collection and storage of tissue samples for research,1
26933,low residue diet,1
26934,cryopreserved third-party donor cells,1
26935,ceritinib (ldk378) 750 mg,1
26936,the number of circulating tumor cells,1
26937,conditioning for non-cr group,1
26938,rapid ventricular pacing (rvp),1
26939,peg-asp in consolidation-2,1
26940,branch iv,1
26941,docetaxel (t),1
26942,imrt-sib,1
26943,obp-801,1
26944,snx-1012 (meclocycline sulfosalicylate),1
26945,"veliparib, capsule",1
26946,2-dimensional distal pancreatectomy,1
26947,stage 3: glucocorticoid,1
26948,prostascinct,1
26949,demographics questionnaire,1
26950,iron isomaltoside(monofer®),1
26951,"68ga-psma-11 and/or 18f-fdg pet/mr, pet/ct",1
26952,blood samples collection during radiotherapy,1
26953,fnhlid1,1
26954,the third space robotic and endoscopic cooperative surgery,1
26955,2-fluoropropionyl-labeled pegylated dimeric rgd peptide,1
26956,ptk7-adc,1
26957,desipramine hcl,1
26958,"etoposide, thioguanine, cyclophosphamide, busulfan, melphalan",1
26959,normocaloric diet,1
26960,the bilateral axillo-breast approach,1
26961,intra-arterial cisplatin,1
26962,virulizin®,1
26963,ultrasound hyperthermia,1
26964,computed tomography scan and magnetic resonance imaging,1
26965,conventional hospital clothes,1
26966,placebo (corresponding to atorvastatin),1
26967,xermelo,1
26968,injection of ytttrium-90 microspheres into the hepatic artery,1
26969,sulindac (drug),1
26970,mood disorders,1
26971,actisight needle guidance system,1
26972,skin spect dermoscope,1
26973,sn2310 injectable emulsion,1
26974,nintedanib and aml induction,1
26975,assessment of already preacquired i-124 pet/us,1
26976,irosustat (bn83495),1
26977,infusions of panitumumab,1
26978,avs performed plus intraprocedural rapid cortisol assay,1
26979,6mv-x ray,1
26980,ima970a plus cv8102 and cyclophosphamide,1
26981,xmab20717,1
26982,radiotherapy + nivolumab,1
26983,cefepime with or without vancomycin,1
26984,arm ii (a-folfox/a-folfiri),1
26985,"crenolanib besylate (cp-868,596-26), dose: 140mg bid",1
26986,total mesometrial resection,1
26987,fat reduction without increased fiber,1
26988,injectable control (sodium chloride injection united states pharmacopeia (usp) (0.9%)),1
26989,platinum based chemotherapies,1
26990,multiple fractions,1
26991,"2,6-diisopropylphenol",1
26992,ramosetron 0.6mg,1
26993,bevacizumb,1
26994,etoposide - study,1
26995,methylene blue (1%),1
26996,8 mg/kg gr-md-02,1
26997,polyethylene glycol afternoon,1
26998,irinotecan associated to fluorouracil and leucovorin,1
26999,personality disorders,1
27000,device assisted colonoscopy,1
27001,black raspberry (brb) suppositories,1
27002,moving on abc plus,1
27003,wait list control (wlc),1
27004,ocz103-os,1
27005,not applicable for study,1
27006,tumor lysate/klh pulsed dendritic cell vaccine,1
27007,combination of trabectedin with durvalumab,1
27008,ic9-car19 t cells,1
27009,invisionfirst® molecular panel,1
27010,fluorescence bronchoscopy/narrow band bronchoscopy,1
27011,palifermin before only,1
27012,(s)-4-(3-[18f]fluoropropyl)-l-glutamic acid (18f-fspg),1
27013,pbi radiotherapy 6 gy,1
27014,wide resection margin >1cm,1
27015,quality of life questionaire,1
27016,three cycles tpf induction chemotherapy for npc,1
27017,exhaled breath sampling,1
27018,bleomycin based electrochemotherapy,1
27019,imaging (dynamic pet-ct scan),1
27020,[18f]florbetaben,1
27021,pilocarpine,1
27022,administration of hypertonic solution 7.5% vs mannitol 20%,1
27023,16 french foley catheter,1
27024,eribulin mesylate administration as a 2 to 5 min iv infusion at on day 1,1
27025,zarnestra (r115777),1
27026,cancer prevention wizard (cpw),1
27027,support provided by social worker,1
27028,participants receive slnb as well as non slns resection,1
27029,vinorelbine plus oxaliplatin,1
27030,curretage,1
27031,i-gel,1
27032,esd - endoscopic submucosal dissection,1
27033,statin therapy,1
27034,bgb-a317 and gemcitabine plus cisplatin (or carboplatin),1
27035,anxiety scores,1
27036,socks containing copper-oxide fibers,1
27037,imrt 60-66gy,1
27038,cd8+ t-cell depleted donor lymphocyte infusion,1
27039,"docetaxel, cisplatin, and fluorouracil",1
27040,identification and provision of lacking information,1
27041,cb-cabo,1
27042,choosing to write advance directives,1
27043,dasatinib - 1b,1
27044,standard dose radiotherapy,1
27045,sacral neuromodulation,1
27046,"chart reminder, educational mat'ls, fit",1
27047,intra spinal pressure monitoring,1
27048,oncocare,1
27049,standard chemotherapy treatment,1
27050,gp100 peptide,1
27051,temodal® or dacarbazine medac®,1
27052,weight gain prevention program,1
27053,transcutaneous electrical stimulation (es),1
27054,topotecan hcl,1
27055,5g mtx,1
27056,cancer-related discussion program,1
27057,standard radio(chemotherapy),1
27058,"neuroblastoma vaccine (unmodified sknlp, with gene-modified sjnb-jf-il2 and sjnb-jf-ltn neuroblastoma cells)",1
27059,mk-1775 (azd1775),1
27060,placebo (for ssr411298),1
27061,usual post-operative care,1
27062,lopinavir/ritonavir plus emtricitabine/tenofovir versus efavirenz plus emtricitabine/tenofovir,1
27063,oral ferrous fumarate,1
27064,uspio-enhanced mri,1
27065,mk-1248,1
27066,patient-led follow-up,1
27067,medi0680 10 mg/kg,1
27068,qbi-139,1
27069,sham qigong,1
27070,tas-117,1
27071,ivor lewis,1
27072,met/vegfr2 inhibitor foretinib,1
27073,high-resolution microendoscopy (hrme),1
27074,nutrition /swallowing counseling,1
27075,sequential packaging (set),1
27076,hizentra,1
27077,"tandutinib, bevacizumab, and temozolomide",1
27078,bortezomib and tipifarnib,1
27079,arm b: iv iron + epoietin zeta sequence,1
27080,johnson&johnson medical suzhou made spine fusion system,1
27081,cabozantinib (xl184),1
27082,immunologic evaluation,1
27083,amino levulinic acid,1
27084,sharkcore (tm) fnb exchange system,1
27085,rt+cetuximab,1
27086,caffeine anhydrous 5% added to lipoderm cream base.,1
27087,ag-120 matched placebo,1
27088,ablation therapy,1
27089,endoscopic ultrasound-guided drainage,1
27090,sofenacin,1
27091,spiritual counseling,1
27092,intensity-modulated x-ray therapy (imrt),1
27093,hysteroscopic polypectomy,1
27094,bf-200 ala gel,1
27095,chronic myeloid leukemia + nk cell,1
27096,cure tape™ covering t 7 and t 8 dermatomes,1
27097,[68ga]p16-093,1
27098,tumor resection and neck dissection,1
27099,agi-134,1
27100,repca a,1
27101,i-131-clr1404 injection,1
27102,health professional face-to-face appointment (step 3),1
27103,photon radiosurgery system (intrabeam),1
27104,"5fu, paraplatin",1
27105,vaginal laser treatment,1
27106,three fraction accelerated partial breast irradiation,1
27107,aquapheresis,1
27108,return of results follow-up visits,1
27109,flexible sigmoidoscopy or colonoscopy,1
27110,high-flow air,1
27111,humanized anti-her2 antibody,1
27112,pain intensity measured in vas scale,1
27113,mri group,1
27114,trc105 chimeric anti-cd105 antibody,1
27115,growing resiliency and courage with cancer™ (grace),1
27116,tamoxifen + aminoglutethimide,1
27117,asp5878,1
27118,mid-level recruitment strategy consent form,1
27119,intensity modulated radiation therapy boost,1
27120,cytomegalovirus ie-1-specific cytotoxic t lymphocytes,1
27121,tak-981,1
27122,gsk2118436 150mg,1
27123,exercise home program,1
27124,message sidedness,1
27125,msx-122,1
27126,hight-fat breakfast,1
27127,ceftazidim,1
27128,zoledronic acid i.v. 2 years,1
27129,bilateral thoracoscopic splanchnicectomy,1
27130,tabalumab,1
27131,nant-008,1
27132,combination of ganetespib and docetaxel,1
27133,chronic pain evaluation,1
27134,gemcitabine-oxaliplatin regimen,1
27135,analgesic/antipyretic and antihistamine drugs,1
27136,dietary supplementation with capsules containing rosemary and alkylglycerol,1
27137,processed human nerve tissue scaffold,1
27138,hb002.1t,1
27139,autologous ebv specific cytotoxic t lymphocytes,1
27140,bupivacaine liposome suspension,1
27141,neoadjuvant ct,1
27142,observance of oral drug treatment,1
27143,8.5mg ino-5150 and electroporation device cellectra®-5p,1
27144,vehicle topical,1
27145,tbi-1501,1
27146,sparc147609,1
27147,177lu-octreotate,1
27148,practice logs,1
27149,complete decongestive therapy (cdt),1
27150,ccc website,1
27151,"skin, mouth, and/or ocular swab",1
27152,gm-csf and montanide isa-51,1
27153,speech mapping,1
27154,cytarabine.,1
27155,eus-fna with corkscrew technique,1
27156,patient-centered approach (pca) + app,1
27157,no intervention study,1
27158,supervised aerobic exercise training,1
27159,cetuximab + docetaxel + cisplatin,1
27160,icar19 car-t cells,1
27161,giant completed patient,1
27162,health education counseling,1
27163,mfolfox6+placebo,1
27164,lumason,1
27165,modified pectoral block,1
27166,blinatumomab expanded t-cells (bet),1
27167,emotional induction,1
27168,sunitinib-sorafenib,1
27169,tunneled intraperitoneal drain (ipd),1
27170,rivoceranib,1
27171,telepristone acetate 6 mg,1
27172,sems insertion,1
27173,standard formula supplement,1
27174,cc-5103 (lenalidomide),1
27175,asn002 dose escalation,1
27176,topical amphimatrix,1
27177,get up and go test,1
27178,mgcd0103 and azacitidine,1
27179,cytosin-arabinosid,1
27180,luitpold azacitidine,1
27181,highly-purified ctl,1
27182,hepasphere with 50-75mg doxorubicin,1
27183,asg-22ce,1
27184,erlotinib po and vidaza iv,1
27185,"evaluation of social, cultural and behavioral factors",1
27186,ultrasound guided celiac plexus neurolysis (cpn),1
27187,broccoli sprout powder,1
27188,personalized mrna tumor vaccine,1
27189,best clinical practices plus culturally targeted print materials,1
27190,cyt004-melqbg10 + montanide,1
27191,mor03087 phase 1 dose escalation,1
27192,bridging followed by transplant,1
27193,"cg53135-05, velafermin",1
27194,abx-egf (panitumumab),1
27195,web-only,1
27196,staff multi-component implementation strategy,1
27197,no specific intervention,1
27198,peg asparaginase at six weeks interval,1
27199,testosterone (androgel®) with the 5?-reductase inhibitor dutasteride,1
27200,"other academic ""sham"" tutoring",1
27201,saline (sodium chloride),1
27202,89zr-dfo-huj591,1
27203,standard closure of the surgical incision,1
27204,key informant,1
27205,arq 751 + fulvestrant,1
27206,chop plus famotidine,1
27207,appearance-focused website intervention,1
27208,unenhanced ultrasound,1
27209,docetaxel oxaliplatin 5-fu cf,1
27210,sorafenib + lbh589,1
27211,recommendations,1
27212,isotoxic hypofractionation,1
27213,ctdna analysis for the detection of genetic mutations,1
27214,monoclonal antibody 3h1 alu gel,1
27215,cto alone,1
27216,investigational medical product (imp) administered in parent study,1
27217,biopsy sponge pad,1
27218,methyl aminolaevulinate 16% cream,1
27219,computer-based cognitive training,1
27220,syb c-1101 and azacytidine,1
27221,gsk2857916 frozen,1
27222,post intervention,1
27223,kappa cd28 t cells,1
27224,np137,1
27225,mage-3.a1 peptide and cpg 7909,1
27226,stepped crcs interventions,1
27227,regn4018,1
27228,wide-field white light imaging,1
27229,vorinostat plus erlotinib,1
27230,induction tp chemotherapy,1
27231,satraplatin and docetaxel,1
27232,brief mailed booklet - smaller version of nci's booklet,1
27233,electronic consult system,1
27234,trovax® (immunological vaccine therapy),1
27235,infusion of one mpc expanded cord unit and one unexpanded cord unit,1
27236,"trastuzumab, docetaxel and carboplatin in dose dense regimen",1
27237,fisiogel,1
27238,anti-cd7 car-pnk cells,1
27239,technology-based information and coaching/support program,1
27240,abt199,1
27241,zd1694 (tomudex),1
27242,vibrossense meter®,1
27243,bkm120 + lapatinib,1
27244,sta 4783,1
27245,fdg pet ct,1
27246,ski-606,1
27247,deep local anesthesia alone,1
27248,eus-rfa using habib tm as a probe,1
27249,ercp guided brushing and biopsy,1
27250,g-flip-dm,1
27251,lifestyle changes with the support of health technology,1
27252,whole pelvic radiotherapy,1
27253,bupivacaine 0.75% in dextrose inj 8.25%,1
27254,pancreaticoduodenectomy with retroperitoneal lymphadenectomy,1
27255,recombinant human adenovirus type 5 injection,1
27256,gcsf mobilized allogeneic pbsc cultured w/cytokines; transduced w/rv,1
27257,5-aminolévulinique acid (5-ala),1
27258,allostim®,1
27259,coenzyme q10 placebo,1
27260,cevimeline hydrochloride,1
27261,angiography and embolotherapy,1
27262,coloshield,1
27263,flow cytometric analysis,1
27264,intermediate-risk therapy,1
27265,gemcitabine +carboplatin,1
27266,varilrix,1
27267,optical spectroscopy,1
27268,imatinib + lbh589,1
27269,nanoparticle albumin-bound paclitaxel/carboplatin,1
27270,iv caldolor (iv ibuprofen),1
27271,wst 11-mediated vtp therapy,1
27272,transgastric endoscopic peritoneoscopy.,1
27273,70g of fully digestible starch amylopectin corn starch,1
27274,sami,1
27275,chest tomosynthesis and x-ray,1
27276,confocal laser endomicroscopy (pcle),1
27277,management of therapy and complications,1
27278,interstitial radiation therapy,1
27279,hot emr,1
27280,"methylaminolevulinate (metvix, metvixia)",1
27281,topotecan + cisplatin,1
27282,early detection,1
27283,maltodextrin/dextrose,1
27284,1.2% lugol's solution,1
27285,gatorade g2,1
27286,sirt yttrium-90,1
27287,endoscope,1
27288,obi-3424,1
27289,"pre, during and pos-treatment swallowing exercises",1
27290,calfactant,1
27291,zio-201-t and doxorubicin,1
27292,indocyanine green (ic-green),1
27293,intraoperative ct imaging,1
27294,arm a-bavituximab 3mg/kg iv over 90 minutes weekly x 3 followed by bavituximab 3mg/kg iv over 90 minutes weekly x 12 plus ipilimumab 3mg/kg iv,1
27295,aqualief,1
27296,genetic interaction analysis,1
27297,morphine patient controlled analgesia,1
27298,nutritional management,1
27299,replens,1
27300,solar simulator,1
27301,"surveys, evaluative tests for leg function",1
27302,bupivacaine in epidural catheter,1
27303,scintigraphy 99mtc-mdp-spect/ct.,1
27304,helical tomotherapy (ht),1
27305,imaging 18f-fdg-pet/ct,1
27306,text message smoking cessation support,1
27307,re-examination,1
27308,arm a: rituximab,1
27309,fitness testing,1
27310,whole breast irradiation plus simultaneous tumor bed boost,1
27311,use of navigated 3d ultrasound during surgery,1
27312,computerized risk stratification tool,1
27313,reducing sitting time group,1
27314,home-based sleep intervention,1
27315,sm-lhw,1
27316,pf-04449913 (glasdegib),1
27317,stellate ganglion block injection with bupivicaine,1
27318,250ml glucose 5%,1
27319,"their will be no intervention in any of the groups, the study is retrospective",1
27320,robot based transtympanic drain placement,1
27321,shoulder conventional exercises,1
27322,tandem microsphere loaded with epirubicin,1
27323,azacitidine and eltrombopag,1
27324,midostaurin placebo,1
27325,folfox + cetuximab,1
27326,intensive decongestive treatment,1
27327,loco regional therapies for hcc,1
27328,anastrozole 1mg tablet,1
27329,anagrelide,1
27330,supr,1
27331,blood sample for genetic analysis (identification of germ line genetic factors that influence the risk of metastatic breast cancer),1
27332,pdr001+mcs110,1
27333,magnetic resonance image scanner,1
27334,colestipol,1
27335,lidocaine (xylocaine),1
27336,iterative picc placement,1
27337,flare imaging system,1
27338,meditation and discussion sessions,1
27339,dual internally cooled-wet electrodes,1
27340,nanthealth gps cancer test,1
27341,htp treatment,1
27342,bexarotene (targretin®),1
27343,adjusted dezocine injection,1
27344,mri±biopsy,1
27345,"lapatinib + 1,23 mg eribulin",1
27346,5-ht3 inhibitor,1
27347,f-18-fdg,1
27348,regorafenib 160 mg,1
27349,anti-pd-1 monoclonal antibody regn2810,1
27350,veltuzumab and milatuzumab,1
27351,"resovist (bay86-4884, sh u 555 a)",1
27352,f18-fgd pet/ct,1
27353,dexanabinol dose level 1,1
27354,sodium alginate mixed with calcium lactate,1
27355,tivozanib (av-951) plus folfox6,1
27356,women without arthralgia,1
27357,"abr-215050, tasquinimod",1
27358,lifepearl microspheres loaded with irinotecan,1
27359,alpha-tocopherol and beta-carotene,1
27360,intrathecal morphine+la+ mg sulp. 100,1
27361,90yttrium ibritumomab tiuxetan (zevalin),1
27362,mgh ofdi imaging,1
27363,pembrolizumab 200 mg q3w,1
27364,velcade cyclophosphamide prednisone,1
27365,exercise and self-management,1
27366,immunotherapeutic agents,1
27367,eus-fnb with sharkcore needle,1
27368,distortion product otoacoustic emission measurement (dpoae),1
27369,transurethral resection of prostate,1
27370,dose dense ac-p,1
27371,levonorgestrel-releasing intrauterine system(lng-ius),1
27372,avelumab (once weekly),1
27373,arimidex 1mg,1
27374,paclitaxel +/- bevacizumab,1
27375,water infusion in lieu of air insufflation,1
27376,intensive intervention,1
27377,neck dissection impairment index,1
27378,self-expandable biliary nitinol alloys stent,1
27379,nk-cell infusion,1
27380,progestins,1
27381,oravescent fentanyl citrate,1
27382,sorafenib (bay43-9006),1
27383,omega-3 fish oil,1
27384,"questionnaire, educational material",1
27385,investigators choice single agent,1
27386,adecatumumab and folfox,1
27387,green indocianine,1
27388,open pancreatoduodenectomy,1
27389,co2 aortogram,1
27390,routine leg edema and groin dissection,1
27391,0.1% uracil ointment,1
27392,mt-sdna screening test,1
27393,traditional surgery type,1
27394,e. coli nissle suspension,1
27395,hypofractionated palliative re-irradiation,1
27396,vicryl plus and monocryl plus,1
27397,photodynamic therapy (aktilite),1
27398,stressmanagement,1
27399,combined real-time use of 'multi-leaf collimator adaptation' and 'kv intrafraction monitoring',1
27400,neuromuscular blockade,1
27401,nanopulse system,1
27402,gi-6301 vaccine (yeast- brachyury),1
27403,hsv-tk +valacyclovir in combination with brachytherapy,1
27404,chemotherapy - nsclc other than squamous cell,1
27405,one-time blood draw,1
27406,vac wound dressing,1
27407,resiquimod 0.01%,1
27408,tumor specimens,1
27409,imu-131,1
27410,?amphotericin b,1
27411,restoration of port-a-cath® with alteplase,1
27412,mk-3475 (phase i),1
27413,annual intervention group,1
27414,arm a: 3d-conformal radiation,1
27415,pd-1 antibody expressing mesocar-t cells,1
27416,monoclonal antibody hefi-1,1
27417,normal fractionated irradiation,1
27418,cetuximab + platinum + gemcitabine,1
27419,bipolar coagulation,1
27420,clopidogrel bisulfate,1
27421,extension her-2 vaccine trial at obd,1
27422,preoperative and intraoperative sln mapping,1
27423,mrghifu system,1
27424,magnetic resonance-guided high-intensity focused ultrasound,1
27425,"bcd chemotherapy (bendamustine, carboplatin, dexamethasone)",1
27426,combo pbf-509 (160 mg) + pdr001,1
27427,dna ploidy,1
27428,contrast-enhanced renal ultrasonography (ceus),1
27429,pamiparib capsule,1
27430,neoadjuvant mfolfirinox,1
27431,adriamycin and cyclophosphamide,1
27432,magnesium l-threonate,1
27433,surveys and cognitive tests,1
27434,dovitinib plus imatinib,1
27435,assessment of the performances of qcad/lyon in characterizing gleason ?7 cancers among contoured lesions,1
27436,trientine dihydrochloride,1
27437,fdc of pertuzumab and trastuzumab sc,1
27438,guided imagery and music therapy,1
27439,analysis with molecular biology,1
27440,nimotuzumab (theracim h-r3),1
27441,stress and symptom management program 1,1
27442,perioperative pregabalin,1
27443,cortisol tests,1
27444,smoking prevention usual care,1
27445,radioembolization with sir-spheres® (yttrium microspheres),1
27446,beneca system,1
27447,tailored print plus tailored phone intervention,1
27448,"""cholecalciferol"" and ""c. xanthorrhiza""",1
27449,no cytoreductive vs cytoreductive drugs,1
27450,t-pat,1
27451,furazolidone,1
27452,17b-estradiol,1
27453,immunoglobulin g (igg),1
27454,a novel mobile phone-based intervention for automated electronic pro collection,1
27455,velcade/dexamethasone/cyclophosphamide,1
27456,cirrhotic albumin,1
27457,"everolimus, lupron, bicalutamide, and radiation",1
27458,"ipilimumab, 3 mg",1
27459,dietary advice plus myo-inositol and folic acid,1
27460,higher-load resistance training (hl),1
27461,diagnostic imaging: 18f-fes pet/ct - 3 month follow-up,1
27462,anti-ngf ab,1
27463,"etoposide, cytarabine, vincristine, dexamethasone",1
27464,combined laproscopic and minilaparotomy ovarian cystectomy,1
27465,omt,1
27466,arms,1
27467,hpv 4,1
27468,oe,1
27469,"mage-a3, hiltonol® (poly-iclc)",1
27470,pad combination,1
27471,blood samples analysis,1
27472,standard doxorubucin and cyclophosphamide,1
27473,yttrium y 90-dota-biotin,1
27474,adi peg 20,1
27475,frozen tumor specimens,1
27476,tau,1
27477,hypocaloric hyperproteic diet,1
27478,"oxaliplatin, irinotecan, s-1(ois)",1
27479,hydrogel hydrosorb®,1
27480,gemcitabine and cisplatin (induction and adjuvant chemotherapy),1
27481,sustained released 5-fu and sustained released cisplatin,1
27482,environ cosmetic roller,1
27483,blz945,1
27484,calmangafodipir (2 µmol/kg),1
27485,lifemel honey intake every day,1
27486,prednisolone synthetic cortisone and isoproterenol together,1
27487,planar scintigraphy imaging,1
27488,ultrasound/mammogram,1
27489,"optical imaging agents (emi-137, nap)",1
27490,endoscopic ultrasound guided fine needle biopsy,1
27491,cell saver,1
27492,bevacizumab + blood samples,1
27493,palbociclib 200mg,1
27494,tumor rda biopsy,1
27495,ms3tmri,1
27496,low-dose interleukin,1
27497,haploidentical bone marrow transplantation,1
27498,ranibizumab 2 mg,1
27499,screening for cervical cancer,1
27500,zd6474 (zactima) 300mg,1
27501,18f-fch pet scan,1
27502,embospheres microspheres,1
27503,prosigna pam-50 assay,1
27504,"hematopoietic stem cell transplantation,",1
27505,adxs-neo,1
27506,smokeless tobacco awareness program,1
27507,poly-myomectomy,1
27508,drotrecogin alfa (activated),1
27509,nk vue: nk cell activity in stimulated whole blood,1
27510,whole breast rt on prone position,1
27511,supportive-expressive group therapy plus education,1
27512,wgt3x-bt,1
27513,green tea (epigallocathechin gallate),1
27514,"6-[f-18]-fluoro-l-3,4,-dihydroxyphenylalanine",1
27515,cognitive function tests,1
27516,c.e.r.a.,1
27517,xrp6976,1
27518,patient to receive standard care without acupuncture or sham acupuncture.,1
27519,dynamic hormone study and magnetic resonance imaging,1
27520,sod1 inhibitor atn-224,1
27521,lipitor,1
27522,small-gauge pars plana vitrectomy,1
27523,esset-cinv,1
27524,neovasculgen,1
27525,bpx-601,1
27526,lletz under general anaesthesia,1
27527,g-scf,1
27528,fna biopsy,1
27529,web-based decision aid plus personalized risk assessment,1
27530,docetaxel + gemcitabine + carboplatin + radiotherapy,1
27531,lyn00101,1
27532,11carbon-acetate-pet,1
27533,ethiodized oil,1
27534,single fraction stereotactic radiosurgery (srs),1
27535,tarceva and rapamycin,1
27536,serum proteomics,1
27537,"trastuzumab, ts one, cisplatin",1
27538,mr mammography,1
27539,part 2: multiple questionnaires,1
27540,bismuth subcitrate,1
27541,"period 1 gx-30, period 2 thyrogen®",1
27542,ipilimumab infusion,1
27543,uft/lv,1
27544,low intensity counseling + varenicline,1
27545,radiofrequency ablation catheter (habib endohbp),1
27546,cd19 car-t,1
27547,proteosome inhibition assessment,1
27548,cardiorespiratory assessment,1
27549,2-(5-fluoro-pentyl)-2-methyl-malonic-acid ([18f]-ml-10),1
27550,gm-csf gene transduced allogeneic vaccine gvax,1
27551,high tie of ima,1
27552,[124i]meta-iodobenzylguanidine,1
27553,dexamethasone (oral),1
27554,"intraoperative mr (polestar n-20, medtronics)",1
27555,standard care of parenteral nutrition,1
27556,radiotherapy 62-64 gy in 5 w (31-32 f. of 2 gy bid),1
27557,salicylate ointment,1
27558,decreased trendelenburg,1
27559,examination of the scalp,1
27560,coping skills intervention training,1
27561,radio-guided surgery,1
27562,nonintubated thoracoscopic lobectomy,1
27563,biopsy with 25 gauge needle,1
27564,questionnaire of clinicals signs,1
27565,granulocyte colony stimulating factor: filgrastim or pegfilgastrim,1
27566,digital glove procedure,1
27567,"rituximab, bendamustine, cytarabine.",1
27568,portal vein embolization + major liver resection,1
27569,ganglioside-monosialic acid,1
27570,therapeutic conventional colorectal surgery,1
27571,sonazoid; perflubutane for injection,1
27572,tti-621 plus rituximab,1
27573,hyperbaric oxygen stimulation,1
27574,liebowitz social anxiety scale and the social phobia and anxiety inventory,1
27575,iv bag protectant for moxetumomab pasudotox,1
27576,monalizumab (iph2201,1
27577,visi mobile,1
27578,short message service,1
27579,extra early mobilization,1
27580,empathic attention,1
27581,autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine,1
27582,emergency endoscopic colonic stenting,1
27583,bym338 active drug,1
27584,radiation therapy of the pelvis,1
27585,placebo oral tablet with calcium and clomiphene citrate,1
27586,sonablate 500(sb-500),1
27587,tumor cell lysate vaccine therapy,1
27588,lymphadenectomy radio-isotope method,1
27589,kir genotype,1
27590,r-ceop90 + auto-hsct,1
27591,recombinant interleukin-2,1
27592,navarixin,1
27593,cd19.car-cd28z t cells - dose escalation 1,1
27594,metastasized intestinal net,1
27595,oxazolidine,1
27596,digital stories,1
27597,no hyperbaric oxygen therapy,1
27598,caffeine (200 mg),1
27599,transgastric diagnostic endoscopic peritoneoscopy,1
27600,radiation treatment and surgery,1
27601,mor00208 (formerly xmab5574),1
27602,thymalfasin (thymosin alpha-1),1
27603,"ixabepilone, 40 mg/m^2 + lapatinib, 1250 mg",1
27604,ppi-2458,1
27605,e-assist: colon health,1
27606,pamphlet,1
27607,prospective surveillance group,1
27608,irinotecan/docetaxel,1
27609,irinotecan + cisplatin,1
27610,"vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-c",1
27611,tti-621,1
27612,standard random esophageal biopsies,1
27613,temodar and sch 66336,1
27614,gm102 antibody,1
27615,car19 t-cells,1
27616,ca 19-9 assay,1
27617,catheter locking systems,1
27618,transcranial doppler microemboli detection study,1
27619,epidermal growth factor receptor tyrosine kinase inhibitor,1
27620,hydralazine and valproic acid: cohort 2,1
27621,melphalan kinetic study,1
27622,ipilimumab 1 mg/kg iv,1
27623,ortho-novum® tablet 1/35,1
27624,clinician communication skills training,1
27625,"endosonography guided fine needle aspiration cytology ( cook medical, boston scientific)",1
27626,transdermal therapeutic system (tts)-fentanyl,1
27627,maitake mushroom extract compound,1
27628,therapeutic videothoracoscopy,1
27629,bismuth subsalicylate,1
27630,prostate cancer decision aid,1
27631,demethylation drug,1
27632,"folfiri (the combination regimen of irinotecan, l-leucovorin and 5-fluorouracil)",1
27633,pet scan use in radiotherapy planning,1
27634,ganglion impar block,1
27635,expanded prostate cancer index composite-sf-12,1
27636,trimethoprim/sulfamethoxazole,1
27637,89zr-bevacizumab pet scan,1
27638,intra-abdominal lidocaine,1
27639,internet weight loss intervention,1
27640,chop+rituximab,1
27641,pegylated interferon-alfa-2b,1
27642,"cp 870,893",1
27643,asparaginase (erwina),1
27644,alt-836 in combination with gemcitabine,1
27645,folinic acid (fa),1
27646,cliniporator,1
27647,nebuliser solution,1
27648,e7389 21 day cycle,1
27649,lyrica 300 mg,1
27650,oxaliplatin+capecitabine+pembrolizumab,1
27651,controlled diet without brassica vegetables,1
27652,welgenaleucel,1
27653,oxaliplatin (eloxatin®),1
27654,rapamycin (sirolimus),1
27655,rontine central venous catheter,1
27656,1 or 2 cycle(s) hdm (high dose melphalan),1
27657,cpg oligodeoxynucleotide,1
27658,laparoscopic right colectomy with intracorporeal ileocolic anastomosis (iia),1
27659,platinum/pemetrexed,1
27660,1018 iss,1
27661,adjuvant temozolomide,1
27662,assessment of serum corticosteroid intermediates and acth,1
27663,a-dmdt390-bisfv(ucht1) (resimmune®),1
27664,implant of bilaminar chitosan scaffold,1
27665,acalabrutinib in combination with bendamustine and rituximab,1
27666,f901318 with fluconazole low dose,1
27667,anti-cd45 monoclonal antibody ahn-12,1
27668,traditional neurocognitive assessments,1
27669,"ixabepilone, 32 mg/m^2 + carboplatin, 5 mg/min/ml",1
27670,standard handout,1
27671,6 mercaptopurine,1
27672,sham infrared laser moxibustion,1
27673,high intensity exercise,1
27674,focal-fusion bx,1
27675,drains,1
27676,"no intervention, only observation",1
27677,ce,1
27678,robotic-assisted radical prostatectomy,1
27679,sativex medium dose,1
27680,"survey of client health, personal habits, family history",1
27681,clr 131 multiple dose,1
27682,veru-944,1
27683,immunonutrition,1
27684,"bonefos (clodronate, bay94-8393)",1
27685,temozolomide (temodal),1
27686,monosyn,1
27687,aca 125,1
27688,syngeneic lymphocytes (cd4+) cultured with okt3 (ortho) and interleukin-2 (chiro,1
27689,autologous nk cells infusions,1
27690,loncastuximab tesirine and durvalumab,1
27691,no radiotherapy if cr at the end of chemotherapy.,1
27692,lorvotuzumab mertansine (imgn901),1
27693,eus-endodrill biopsy,1
27694,pembrolizumab 100 mg in 4 ml injection,1
27695,sr31747a,1
27696,non-nurse coach,1
27697,nipent,1
27698,"cetuximab, oxaliplatin, leucovorin, 5fu, irinotecan",1
27699,rituximab 375 mg/m^2,1
27700,albuterol inhaler,1
27701,monoclonal antibody ca2,1
27702,placebo plus folic acid,1
27703,smartphone app evaluations,1
27704,blood draw and mri,1
27705,decision aid exposure,1
27706,cold water test,1
27707,trail making test (parts a & b),1
27708,placebo?for probiotic?,1
27709,combination therapy - radiation,1
27710,testosterone undecanoate,1
27711,endoscopic surveillance,1
27712,afatinib treatment,1
27713,nifedipine gtis,1
27714,tucatinib (ont-380),1
27715,25 mg androxal,1
27716,"prophylactic cranial irradiation, 2.0 gy fx",1
27717,epacadostat + pembrolizumab,1
27718,ultrasound-guided transbronchial needle-delivered interstitial photodynamic therapy,1
27719,radiotherapy 23 x 1.8 gy,1
27720,cd3-/cd19- natural killer cells,1
27721,cisplatin+vindesine+mmc/ concurrent radiation,1
27722,prevalence-based model,1
27723,darbepoetin alfa iv,1
27724,sorafenib + erlotinib,1
27725,indium in 111 monoclonal antibody hu3s193,1
27726,muscles exercises program,1
27727,pre-treatment swallowing exercises,1
27728,cv9201,1
27729,art therapy group,1
27730,lu-dota-tate,1
27731,pdt + low level laser,1
27732,ato,1
27733,an ultrasound-based technique to identify prostate cancer,1
27734,sir-spheres microspheres (yttrium-90 microspheres),1
27735,lipidem- fish oil emulsion bbraun uk,1
27736,15 gy low-kv iort,1
27737,sr-t100 ® gel,1
27738,s-adenosyl-l-methionine disulfate p-toluene-sulfonate,1
27739,autologous ade1- latent membrane protein ctls,1
27740,fludarabine(flu),1
27741,cervical smear,1
27742,rituximab combined with eshap,1
27743,c-x-c chemokine receptor 4,1
27744,the vdr genotype,1
27745,nivolumab with chemoradiation,1
27746,evaluation of the success rate of implants,1
27747,unconjugated idec-159,1
27748,third look dls,1
27749,thinprep cytology test (tct) and hpv infection types were tested by gynecologist,1
27750,high dose mtx,1
27751,the axillary bilateral-breast approach,1
27752,cromoglicate,1
27753,ta-cin,1
27754,stereotactic radiation arm 2,1
27755,chemotherapy following concurrent chemoradiotherapy,1
27756,b43-genistein immunoconjugate,1
27757,interview with a sociologist,1
27758,gemcitabine/gemzar,1
27759,vpm1002bc,1
27760,"dox: docetaxel, oxaliplatin, capecitabine",1
27761,paclitaxel & carboplatin,1
27762,68ga-hbed-cc-psma pet/ct,1
27763,lactate-containing vaginal lubricant,1
27764,ethiodized oil + doxorubicin,1
27765,"fecal immunochemical test, guaiac fecal occult-blood test, and helicobacter pylori stool antigen test",1
27766,weekly radiation therapy,1
27767,fluoroscopy-guided mld,1
27768,contrast-enhanced diffusion-weighted mri,1
27769,hematopoietic cell transplant (hct),1
27770,telemedicine transmission of biological results,1
27771,msc2363318a,1
27772,in vitro matuartion of oocytes,1
27773,at13148,1
27774,placebo (for atorvastatin),1
27775,cho-h01,1
27776,nsaids (ketorolac and ibuprofen),1
27777,cansort online tool,1
27778,catheterization of internal jugular vein,1
27779,tandem hdct/auto-sct,1
27780,ab prep,1
27781,individualised follow-up,1
27782,dtic-dome (dacarbazine),1
27783,conventional fractionation,1
27784,"gemcitabine, intravenous and oral ascorbic acid (vitamin c)",1
27785,adjuvant chemotherapy (taxol and carboplatin),1
27786,"stop, breathe & think™",1
27787,gemcitabine + rapamycin,1
27788,urea dose b,1
27789,rituximab (rtx),1
27790,calcio levofolinate,1
27791,immune cell,1
27792,gcsf administration on days 8 and 12 after chemotherapy,1
27793,denosumab (reduced dosing),1
27794,cd19 rna redirected autologous t-cells (rna cart19 cells),1
27795,tivozanib (av-951) and capecitabine (xeloda®),1
27796,rsi,1
27797,3d tomosynthesis and ultrasound imaging,1
27798,propofol-dexmedetomidine group,1
27799,injection of normal saline,1
27800,reduced target delineation,1
27801,solaraze 3% topical gel,1
27802,same-day preoperative consultation,1
27803,paclitaxel - induction cohort,1
27804,needle acupuncture,1
27805,ebus_tbna,1
27806,24 gy,1
27807,smartgoggle,1
27808,physical therapy intervention,1
27809,ds-1062a,1
27810,flame boost,1
27811,cytarabine vs. cytarabine+amsacrine+mitoxantrone,1
27812,18f-faza-pet/ct,1
27813,gastrectomy and/or metastasectomy,1
27814,diphenhydramine hydrochloride (hcl),1
27815,casper,1
27816,cts-bc-ch,1
27817,tailored adjuvant therapy,1
27818,sulfamethoxazole/trimethoprim,1
27819,6-minute withdrawal,1
27820,"dexamethasone, rituximab, cyclophosphamide, bortezomib",1
27821,tivozanib (av-951) + paclitaxel,1
27822,dexamethasone and ondansetron during ce-treatment,1
27823,fertility-sparing survey,1
27824,acellular dermal matrix,1
27825,nanoknife system,1
27826,sns-062,1
27827,six months supervised resistance training,1
27828,nivolumab - arm a,1
27829,partial breast irradiation with cyberknife,1
27830,r0 d2 gastrectomy,1
27831,ramucirumab 10 mg/ml intravenous solution [cyramza],1
27832,low-dose helical computed tomography,1
27833,preoperative biliary drainage,1
27834,allopurinol 100 up to 600mg/day,1
27835,satisfaction questionnaire - patient,1
27836,d961h capsule 20 mg,1
27837,navigational bronchoscopy,1
27838,retroflexion with the pediatric colonoscope.,1
27839,topotecan hydrochloride for injection,1
27840,cisplatin + vinorelbine,1
27841,nov1501 (abl001),1
27842,"imatinib mesylate tablet 400 mg, 1 tablet",1
27843,two cycles of neoadjuvant chemotherapy,1
27844,pasireotide + chemo,1
27845,dece mammography,1
27846,px-866 (scchn),1
27847,analyze systematically morphological and molecular changes associated with glioblastoma progression and therapy-resistance,1
27848,"asp7487, velcade, dexamethasone",1
27849,"cop, copadm8, cyve",1
27850,panobinostat (lbh589) and 5-azacytidine,1
27851,concurrent decrescendo biochemotherapy regimen,1
27852,fast track perioperative treatment,1
27853,multifaceted educational intervention,1
27854,denileukin diftitox (e7777),1
27855,cellutome epidermal harvesting system,1
27856,lenalidomide (control),1
27857,probiotic yogurt b: with various micronutrients,1
27858,0.9% sodium chloride injection,1
27859,"evaluation after 1,3,6,9,12 months",1
27860,placebo + gemcitabine + erlotinib,1
27861,abdominal high resolution ct,1
27862,"combination of everolimus, letrozole and leuprolide",1
27863,nms-1286937,1
27864,yttrium 90 -labeled ibritumomab tiuxetan (zevalin),1
27865,soy milk,1
27866,ro70097890,1
27867,avotermin,1
27868,acalabrutinib in combination with vr,1
27869,methylene blue mmx®,1
27870,histologic examination,1
27871,r-ceop90,1
27872,weekly carboplatin & taxol w/concurrent rt,1
27873,kava,1
27874,s-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + cdhp (gemeracil) + oxo (oteracil),1
27875,tln-232,1
27876,focal irradiation,1
27877,irradiated allogeneic cells,1
27878,dedicated axillary hybrid pet-mri,1
27879,suture removal time 7 days,1
27880,phlebotomy - blood sampling for gp88 at mm,1
27881,high dose methotrxate,1
27882,hm781-36b tablets,1
27883,combined radiation and chemotherapy,1
27884,surgical removal of sinonasal papiloma,1
27885,incb018424/cc-4047,1
27886,fluorouracil cream 0.5%,1
27887,action group,1
27888,stupp protocol,1
27889,adt (androgen deprivation therapy) (i.e. leuprolide) plus an androgen receptor inhibitor (i.e. bicalutamide),1
27890,uterine arterial embolization,1
27891,crizotinib plus sorafenib,1
27892,amg 162- 180 mg q 4 weeks,1
27893,"cytophosphan, celecoxib, methotrexate",1
27894,meso biomatrix device,1
27895,combination of varlilumab and atezolizumab,1
27896,software,1
27897,confocal laser microscopy,1
27898,tesmilifene (ymb 1002),1
27899,astatine at 211 monoclonal antibody 81c6,1
27900,amg 228,1
27901,loperamide hydrochloride,1
27902,"gadofosveset trisodium 244 mg in 1 ml intravenous injection, solution [ablavar]",1
27903,traction assisted endoscopic mucosa resection,1
27904,placebo in combination with cisplatin and docetaxel or paclitaxel,1
27905,hank™ for infusion,1
27906,galectin-3 inhibitor: gm-ct-01 systemic injections,1
27907,"lapatinib, docetaxel, trastuzumab",1
27908,manual mini system,1
27909,colonoscopy with endocuff™,1
27910,18f-flt and 18f-miso-pet,1
27911,clamping group,1
27912,octavalent hpv with 60 mcg imx / aahs,1
27913,tnf alpha,1
27914,hysteroscopy/curettage in case of suspicious aspect will be done a rapid section,1
27915,hiv-gag mrna-pulsed autologous dcs,1
27916,high dose cytarabine for consolidation,1
27917,parenteral /oral methadone ratio 1:2,1
27918,ro6895882,1
27919,melitac 12.1 + montanide isa-51 + polyiclc,1
27920,mtm,1
27921,air insufflation group,1
27922,"s-1 (tegafur, gimeracil and oteracil porassium capsules)",1
27923,qol and developed questionnaires for healthcare research,1
27924,serum and urinary ca9 level,1
27925,"oral impact, nestlé health science",1
27926,substance p-saporin,1
27927,studer pouch orthotopic urinary diversion,1
27928,supervised-occupational therapy program,1
27929,aroplatin (liposomal nddp) in combination with capecitabine,1
27930,stop oral angiogenesis inhibitor,1
27931,induction treatment part 2 with pbpc collection,1
27932,perfusion-ct,1
27933,stereotactic radiotherapy 4 x 12 gy,1
27934,obinutuzumab (ga101),1
27935,xelox regimes,1
27936,"tsh, t3, t4 and thyroid gland dvh",1
27937,arixtra + filter,1
27938,low dose et019002- t cells,1
27939,complications,1
27940,positron-emission tomography (pet) 18f-flt,1
27941,the integrated cancer care access network (iccan),1
27942,morning bright light therapy,1
27943,18f-flt-pet/ct and dwi-mri,1
27944,crs extended with dual-modality imaging,1
27945,nivolumab and ablation,1
27946,"fludarabine, busulfan and atg",1
27947,"carbplatin, cyclophophamide, atezolizumab",1
27948,neural progenitor cell sparing radiation,1
27949,rf-cea(6d)/tricom,1
27950,standard care plus contingency management,1
27951,"sorafenib tosylate, hace : doxorubicin hydrochloride and mitomycin c",1
27952,nelarabine injection 1000mg/m2,1
27953,pdt with 5-ala radiosensitization,1
27954,daily xray volume imaging for planning radiotherapy,1
27955,dacarbazine plus placebo,1
27956,imrt with concomitant boost,1
27957,in vivo confocal microscopy probe,1
27958,cd5.car/28zeta car t cells,1
27959,transdermal testosterone,1
27960,cea pulsed dendritic cells,1
27961,neurocognitive assessments,1
27962,eus fna with 2 passes,1
27963,tumor fluorescence,1
27964,"aspirin, 1,25-dihydroxycholecalciferol, calcium",1
27965,vip - västerbotten intervention programme,1
27966,2x ec,1
27967,screening anal pap smear - no high-resolution anoscopy,1
27968,bkm120 + temozolomide,1
27969,"tarceva, erlotinib, osi-774",1
27970,dms 612,1
27971,depression self-care,1
27972,amg 673,1
27973,rose essential oil,1
27974,"5-fu, epirubicin, cyclophosphamide, docetaxel",1
27975,15 mg/kg tru-016 and bendamustine,1
27976,e7130,1
27977,velcade/dexamethasone,1
27978,dissection of the superior mesenteric vein lymph node,1
27979,transoral radiofrequency resection in oropharyngeal tumor surgery,1
27980,"filgrastim, tbo-filgrastim or pegfilgrastim",1
27981,[131i]icf01012 (therapeutic dose level 1),1
27982,salpingectomy with delayed oophorectomy,1
27983,cholecalciferol 100 000 ui,1
27984,survey tailoring,1
27985,"thalidomide, melphalan, endoxan, dexamethasone (mcdex-thal)",1
27986,n/a (non-interventional study),1
27987,mobymax,1
27988,heat killed whole cell m. obuense (imm-101) 0.1 mg,1
27989,rad001 + amg479,1
27990,cea peptide 1-6d,1
27991,i-124-clr1404,1
27992,laparoscopic sentinel node navigation surgery,1
27993,advanced imaging for radiotherapy planning and guidance,1
27994,rabbit anti?human thymocyte globulin (atg),1
27995,s-1 plus leucovorin,1
27996,act-hla,1
27997,bladder epicheck urine test,1
27998,in vitro diagnostic,1
27999,single-nucleotide polymorphisms's genotyping,1
28000,three mr examination,1
28001,the iot,1
28002,stereotactic apbi,1
28003,rectal biopsy during colonoscopy,1
28004,endoscopic ultrasound-guided fine needle aspiration,1
28005,naf pet/mri,1
28006,folfiri and cetuximab,1
28007,dc-cholesterol liposome,1
28008,dnr.npc-specific t cells + cyclophosphamide + fludarabine,1
28009,anti-gp100:154-162 tcell receptor (tcr) peripheral blood lymphocyte (pbl),1
28010,mistletoe,1
28011,vax-dc/mm,1
28012,sspa,1
28013,tace with irinotecan loaded lifepearl,1
28014,regadenoson,1
28015,erlotinib with neoadjuvant chemotherapy,1
28016,t-reg depleted dli,1
28017,safety and efficacy of escalating doses,1
28018,cap-232,1
28019,social support and counseling,1
28020,bendamustine infusion (arm b),1
28021,chamomila recutita gel,1
28022,paclitaxel(intravenous) + carboplatin(intraperitoneal),1
28023,post-operative stereotactic radiosurgery (srs),1
28024,patients with sunitinib or pazopanib,1
28025,cost condition,1
28026,wt1 vaccine,1
28027,everolimus 10 mg daily,1
28028,postoperative complications,1
28029,conditioning for allogeneic hsct,1
28030,rabbit atg?sanofi/genzyme?,1
28031,denosumab 70 mg/ml,1
28032,mitoxantrone packaged edv (engeneic delivery vehicle),1
28033,explorer air camera,1
28034,"hx575, solution for injection (s.c.)",1
28035,high-dose mpx,1
28036,desatinib or sunitinib or erlotinib or everolimus or lapatinib or sorafenib,1
28037,enzastaurin (ly317615),1
28038,injection of 68ga-nodaga-e(c[rgdyk])2,1
28039,ostheopathic treatment,1
28040,regular tca (tricyclic antidepressants) use,1
28041,eftr,1
28042,eflornithine and placebo,1
28043,transanal total mesorectal excision of rectal cancer,1
28044,learning session 1,1
28045,computer symptom capture tool,1
28046,2d echocardiogram,1
28047,docetaxel and cisplatin and nimotuzumab,1
28048,non-surgical lat,1
28049,acai group (coloanal anastomosis immediate),1
28050,limb volume measurements and gclq lymphedema symptom assessment questionnaire,1
28051,89zr-bevacizumab pet,1
28052,pembrolizumab nsclc high dose,1
28053,oxaliplatin+leucovorin+5-fu,1
28054,osteopathic treatment,1
28055,chemoradiotherapy for nasopharyngeal carcinoma,1
28056,standard and respiratory-gated pet acquisitions,1
28057,quantative gustatory testing using taste strips,1
28058,health management surveys,1
28059,hypofractionated radiation/chemotherapy,1
28060,nab-rapamycin,1
28061,zoladex 10.8 mg,1
28062,pre surgical chemotherapy,1
28063,indium in 111-labeled autologous peripheral blood mononuclear cells,1
28064,5-azacytidine (5-aza) maintenance therapy after transplant,1
28065,multiple sampling,1
28066,pbn,1
28067,gemcitabine and nab paclitaxel,1
28068,hold,1
28069,stereotactic body radiation then surgery,1
28070,biafine,1
28071,covered stent (bona stent pyloric/duodenal covered) insertion,1
28072,redon drain,1
28073,one-lung ventilation,1
28074,dissection of sentinel lymph node(s),1
28075,repetitive transcranial magnetic stimulation (rtms),1
28076,delayed orchiectomy or depot lhrh,1
28077,robot-assisted lobectomy,1
28078,no bladder training,1
28079,kpt-9274,1
28080,unique medical visit of the study,1
28081,adv-tk (aglatimagene besadenovec) + valacyclovir,1
28082,ultrasound examination and colonoscopy examination,1
28083,"nivolumab, surgery, radiotherapy",1
28084,bortezomib 1.8 mg/m2,1
28085,impedance measure,1
28086,consultation,1
28087,89zr-dfo-trastuzumab,1
28088,polyethylene glycol hydrogel,1
28089,plastic surgery,1
28090,prolifespan 20 with carmustine implant (gliadel® wafer),1
28091,"""sirolimus"" and ""hydroxychloroquine"" 400 mg",1
28092,nis (non interventional study) observational study,1
28093,oncodoc logiciel,1
28094,adult physical activity questionnaire (apaq),1
28095,rp2d of gsk2857916,1
28096,gemcitabine or interferon (only),1
28097,ly3405105,1
28098,pams i,1
28099,tai chi/qigong (tcq) for cancer patients,1
28100,vaccine consisting of a peptide derived from the protein ido,1
28101,blood samples (plasma preparation and ctc),1
28102,eortc qlq-my20 questionnaire,1
28103,amphinex (tpcs2a),1
28104,abbv-321,1
28105,dnazyme targeting ebv-lmp1 (dz1),1
28106,tg-0054 (3.14 mg/kg),1
28107,renal sympathetic denervation,1
28108,sob,1
28109,oc-eies,1
28110,standard two dimension digital mammogram,1
28111,non-daily stereotactic body radiotherapy,1
28112,stereotactic body radiation therapy plus surgery,1
28113,wheat flour,1
28114,c1,1
28115,placebos (matched to 4 mg and 10 mg lenvatinib capsules).,1
28116,"sorafenib (nexavar, bay43-9006) + dacarbazine (dtic)",1
28117,vdcld regimen,1
28118,surgical excision of the metastatic process,1
28119,formal study using hyperpolarized 13c-pyruvate injection,1
28120,complete mesocolon excision,1
28121,biopsy excisional,1
28122,in zevalin,1
28123,intrabone cord blood infusion,1
28124,daclatasvir+ asunaprevir,1
28125,cap-fitted colonoscopy,1
28126,in vitro maturation of immature oocytes,1
28127,xenon,1
28128,volociximab (anti-?5?1 integrin monoclonal antibody),1
28129,intra-operative mammography,1
28130,trabectedin continuation,1
28131,amoxicillin/omeprazole,1
28132,tri-weekly cisplatin with rt,1
28133,spi-1620,1
28134,sc-007,1
28135,conventional photon radiotherapy,1
28136,mammography according to a standard procedure,1
28137,sta9090 with dutasteride,1
28138,ibandronate (bondronat),1
28139,ultrasonic microbubbles,1
28140,home-based rehabilitation,1
28141,trebananib 10 mg/kg,1
28142,"ifosfamide, etoposide, cytarabine, and methotrexate (ivam) chemotherapy",1
28143,open thyroidectomy,1
28144,autologous cik dose level 4,1
28145,targeted radiation therapy,1
28146,palifosfamide tris and doxorubicin,1
28147,mesna (iv),1
28148,mylotarg (gemtuzumab ozogamicin) injection,1
28149,fluoroscopy guided spinal biopsy,1
28150,hyperacute-melanoma vaccine,1
28151,srt with vertebral augmentation procedure,1
28152,endosphenoidal coil,1
28153,lymph node sampling,1
28154,miltenyi reagent system,1
28155,bone marrow analyses and cbc with differential,1
28156,(18f)dcfpyl,1
28157,brush,1
28158,eflornithine plus placebo,1
28159,pcle guided evaluation,1
28160,coloassist,1
28161,nci website,1
28162,"echocardiography, right heart catheterisation",1
28163,ama (assistance for ambulatory patients),1
28164,nucleus abi541 auditory brainstem implant,1
28165,infusion with ipilimumab 3 mg/kg q3wks,1
28166,hlx06,1
28167,evaluation for response and surgery,1
28168,spliceosome,1
28169,conventional care regimen,1
28170,tlc178,1
28171,home safety guide,1
28172,pvo surgery,1
28173,no media,1
28174,"image-guided, volumetric intensity-modulated arc radiotherapy (igrt-vmat)",1
28175,medication check,1
28176,epirubicin + cisplatin + fluorouracil,1
28177,laparoscopic or robotic partial nephrectomy,1
28178,initial swe ultrasound,1
28179,ct-2584,1
28180,photodynamic therapy-photofrin,1
28181,moclobemide,1
28182,liver elasticity,1
28183,no mhealth,1
28184,levonorgestrel-releasing iud,1
28185,topical no,1
28186,respiratory distress symptom intervention,1
28187,vesanoid (atra),1
28188,eci301,1
28189,f-18 fluorothymidine,1
28190,angelica sinensis,1
28191,ancillary-correlative,1
28192,epigallocatechin gallate,1
28193,drug resistance inhibition,1
28194,sm04755,1
28195,long-term chemoradiotherapy,1
28196,letrozole plus low-dose metronomic capecitabine,1
28197,radiofrequency ablation protocol,1
28198,taxotere (drug),1
28199,garmin vivofit device,1
28200,intermediate risk proton radiation,1
28201,first icotinib and then pemetrexed plus cisplatin,1
28202,anlotinib hydrochloride; etoposide and cisplatin,1
28203,decitabine and hiltonol,1
28204,conventional iv catheter protection,1
28205,cd3-cd56+ natural killer cells,1
28206,"paclitaxel, mitotic inhibitor; intravenous",1
28207,mhealth,1
28208,klh; peptides; dendritic cells,1
28209,vincristine 1.4mg/m2,1
28210,measurement of stress-related hormones,1
28211,ame-133v (ly2469298),1
28212,xl147,1
28213,multi-vitamins,1
28214,e7080 capsule,1
28215,preptin and amylin level,1
28216,continuous thoracic paravertebral block,1
28217,tme (total mesorectal excision),1
28218,triptorelin 3.75 mg,1
28219,sequential clomiphene citrate and gonadotropin,1
28220,radiation therapy positioning intervention,1
28221,cd34+ cell selection,1
28222,imc-a12 (cixutumumab) - 10 milligrams/kilogram (mg/kg),1
28223,contrast enhanced digital mammography (cedm),1
28224,percutaneous endoscopic gastrostomy tube placement,1
28225,pylorus-resecting pancreaticoduodenectomy,1
28226,impact advance recovery (r),1
28227,"cp-751, 871",1
28228,glucose infusion,1
28229,pembrolizumab pre-resection,1
28230,"serum specimens obtained will be utilized for proteomic profiling comprising maldi-tof ms, and serum biomarker assays.",1
28231,lanreotide 60mg solution for injection,1
28232,psychiatric consult,1
28233,no vaccination,1
28234,mobile oct m3 scope,1
28235,"no intervention, purely observational.",1
28236,allohct for young/mud&fmd,1
28237,corticosteroid: dexamethasone,1
28238,axitinib plus everolimus,1
28239,self-efficacy training for caregivers,1
28240,2-hydroxyoleic acid (2-ohoa/2ohoa),1
28241,dendritic cells pulsed with muc-1/wt-1 peptides,1
28242,pretraining,1
28243,ce-bmri,1
28244,chpp with cisplatin,1
28245,infracyanine,1
28246,ny-eso-1 olp4 vaccine with poly-iclc,1
28247,5-fu?intravenous bolus?+epirubicin+cyclophosphamide,1
28248,aml-related healthcare resources,1
28249,radiofrequency ablation/microwave ablation,1
28250,fludarabine and pegylated liposomal doxorubicin,1
28251,entospletinib (baml-16-001-s5),1
28252,craniectomy,1
28253,skin or nipple-sparing mastectomy,1
28254,"velcade (bortezomib), rituximab, ifosfamide, carboplatin, etoposide",1
28255,computerized working memory training program (control),1
28256,fk50,1
28257,blood draw (venipuncture),1
28258,docetaxel and gm-csf,1
28259,c-pdt,1
28260,nano-pulse stimulation (nps),1
28261,r2: lenalidomide plus placebo maintenance,1
28262,androgen suppression therapy,1
28263,dignicap system,1
28264,imatinib mesylate & hydroxyurea,1
28265,immunization schedule patients > or = to 11 years of age,1
28266,common-sense model (csm) be well,1
28267,nivolumab+ipilimumab in combination with anti tnf-? infliximab,1
28268,intrinsic subtyping of primary breast cancer,1
28269,lmp1/2 ctls (group c),1
28270,(41.4 gy/23 fractions),1
28271,sulforaphane administration,1
28272,hot filter coffee,1
28273,bms-690514 / folfox,1
28274,"50% animal, 50% plant proteins in diet",1
28275,arm 3: dacarbazine,1
28276,ethinyl estradiol,1
28277,160 mg mmc in 90ml gel,1
28278,methionine c 11,1
28279,"""bevacizumab"" in combination with ""modified folfox6"".",1
28280,diabetes prevention program (dpp),1
28281,"ketoconazole, hydrocortisone",1
28282,use of mono- and bipolar electrocautery and surgical clips,1
28283,water method group,1
28284,ceramide,1
28285,humax-cd4 (zanolimumab),1
28286,8 week assessment,1
28287,pectoralis nerve block,1
28288,sar103168,1
28289,contact by clinical center,1
28290,medi-551 12 mg/kg,1
28291,neurocognitive exam,1
28292,18f-fludarabine,1
28293,mk2206 every other day,1
28294,radiotherapy +/- ct,1
28295,low-dose fractionated radiation therapy/paclitaxel,1
28296,active comparator (no fludarabine),1
28297,hsp90 inhibitor sta-9090,1
28298,zometa™,1
28299,"gemcitabine, epirubicin, paclitaxel",1
28300,peri-neuronal catheter,1
28301,rad001 (everolimus) and pasireotide (som230) lar,1
28302,4scar19/22 t cells,1
28303,co2 laser surgery,1
28304,external beam boost,1
28305,allogeneic pbsct or bmt,1
28306,concomitant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist,1
28307,supine and standing catecholamines,1
28308,fluconazole 200mg tab,1
28309,gemcitabine(g) carboplatin(c) endostar,1
28310,tableted vaccine (v3-ova) containing ovarian cancer antigens,1
28311,lateral transperitoneal la,1
28312,resection of tumor,1
28313,rh il-12,1
28314,incshr01210 injection,1
28315,pre-operative chemotherapy,1
28316,california verbal learning test (cvlt-c),1
28317,open label rad001 (only used for post-extension phase),1
28318,"gemcitabine, ifosfamide",1
28319,nccn chemotherapy,1
28320,memokath 028sw urethral stent,1
28321,sc-43 oral solution,1
28322,ab-16b5,1
28323,radiotherapy with protons,1
28324,folinic acid/5-fu/oxaliplatin (mfolfox-6),1
28325,"docetaxel, carboplatin, trastuzumab and lapatinib",1
28326,cord blood units,1
28327,pik-her2,1
28328,gemcitabine ts-1,1
28329,1h-magnetic resonance spectroscopy,1
28330,99mtc-medronate whole body bone scan with spect,1
28331,pemebit,1
28332,paleolithic diet,1
28333,vinblastine sulphate,1
28334,dfd05 cream,1
28335,durvalumab placebo,1
28336,dinitrophenyl(dnp),1
28337,megestrol acetate placebo 40 mg/day,1
28338,offered hpv vaccine only,1
28339,high-dose chemo with autologous bmt,1
28340,"crenolanib (cp-868,596)",1
28341,walking tests,1
28342,cisplatin combined with s-1,1
28343,penicillamine,1
28344,mesenchymal-marker based ferrofluid (c-met),1
28345,myeloablative haploidentical stem cell transplant,1
28346,thoracic reirradiation registry,1
28347,nivolumab plus radiotherapy,1
28348,inkt,1
28349,isocaloric placebo,1
28350,"ptx 175mg/m2, doc 75mg/m2",1
28351,"sis.net, routine follow-up",1
28352,folfox/ folfiri with bevacizumab,1
28353,photon/proton imrt,1
28354,trc 102,1
28355,wuling san,1
28356,ribociclib (lee011),1
28357,neoadjuvant tamoxifen + goserelin (premenopausal women),1
28358,boost of radiotherapy + high dose il-2 treatment,1
28359,administration of cimzia®,1
28360,dapsone,1
28361,observed dietary pattern,1
28362,"melphalan, prednisone, lenalidomide",1
28363,tk99un,1
28364,adi-peg 20 plus modified folfox6,1
28365,eus guided radiofrequency ablation,1
28366,blu-u iilluminator,1
28367,ankle range of motion,1
28368,anti-cd30-car-transduced t cells,1
28369,care manager outreach,1
28370,iv anesthesia,1
28371,ionizing radiation (ir) therapy,1
28372,fit invitation only,1
28373,transarterial chemoembolization versus the standard treatment with sorafinib,1
28374,collection of stool sample,1
28375,immune checkpoint inhibitor targeting pd1,1
28376,oxycodone cr,1
28377,humanised monoclonal antibody epratuzumab,1
28378,breast-conserving surgery (bcs),1
28379,near infrared camera,1
28380,177-lu-dota-cg250,1
28381,sm-88,1
28382,polarization enhanced reflectance and fluorescence system,1
28383,placebo (for ciprofloxacin),1
28384,leucovorin 400 mg/m^2,1
28385,placebo (for semuloparin),1
28386,intrathecal interleukin-2,1
28387,adjuvant folfox,1
28388,patient activated controlled expansion device,1
28389,visualase®,1
28390,external beam radiation treatment,1
28391,simple cue for patient to talk to doctor,1
28392,68ga- psma,1
28393,tissular,1
28394,pepidh1m vaccine,1
28395,video with animated images,1
28396,"gastroflex uhd, cellvizio; mauna kea technologies, paris, france",1
28397,the second donor's stem cell,1
28398,geriatric assessment and telephone call from nurse,1
28399,patient-controlled cognitive-behavioral intervention,1
28400,peds-ql,1
28401,sodium bicarbonate 8.4% solution for injection,1
28402,pz01 car-t cells,1
28403,iodine-125 seed,1
28404,identification of appropriate therapies according to risks factors,1
28405,reduced dose radiation,1
28406,standard atg,1
28407,"sorafenib 400 mg po bid, continuously",1
28408,gadodiamide,1
28409,high chlorophyll diet - control 1st,1
28410,"calcitriol, ketoconazole, hydrocortisone",1
28411,oros hydromorphone hci cr,1
28412,api 31510 topical cream,1
28413,busulfan iv,1
28414,sklb1028,1
28415,las41007,1
28416,os (oxalipaltin+s-1),1
28417,ovarian preservation surgery,1
28418,cap treatment,1
28419,dexanabinol dose level 2,1
28420,whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy,1
28421,hidrocortisone,1
28422,64cu-dotatate,1
28423,tas0728,1
28424,rad140,1
28425,tracheal intubation,1
28426,collegenase injection,1
28427,busulphan plus fludarabine,1
28428,hgs1036 + docetaxel,1
28429,first autologous transplantation,1
28430,e7090,1
28431,preoperative chest physiotherapy,1
28432,[89zr]panitumumab pet-mri,1
28433,high dose rate vs low dose rate brachytherapy,1
28434,preoperative 18f-fdg pet/ct scan,1
28435,er plus rfa,1
28436,cisplatin phase 1,1
28437,vaginal self-sampling brush,1
28438,temozolomide 100 mg/m^2,1
28439,genasense followed by dtic; then dtic alone,1
28440,nurse education,1
28441,dna microarray and maldi-tof mass spectrometry,1
28442,"bevacizumab, novottf100a, temozolomide",1
28443,dexamethasone group,1
28444,fudr,1
28445,ecp with 5-aminolevulinic acid,1
28446,chemotherapy (gemcitabine + carboplatin or eribulin),1
28447,dot imaging,1
28448,patient-reported outcomes measurement information system (promis)-physical function,1
28449,"none, n/a",1
28450,smac mimetic tl32711,1
28451,100 mg pyc and then placebo,1
28452,flow cytometry and western blot analysis,1
28453,90y-idec-159,1
28454,denosumab (cohort a),1
28455,azd8330,1
28456,arm b delayed intervention group,1
28457,excision of tumor/mastectomy,1
28458,sy-1365,1
28459,mcs110/pdr001 combination,1
28460,surgery as needed by the patient´s tumor and stage,1
28461,stenting with immediate surgery,1
28462,"dexamethasone, rituximab, cyclophosphamide",1
28463,writing c (control informative writing),1
28464,parasitological examination,1
28465,treatment for ovarian cancer,1
28466,medi-573 (1 of 3 doses),1
28467,ultrasound guidance,1
28468,dna mass,1
28469,m2es 45mg,1
28470,zegerid (proton pump inhibitor),1
28471,"nab-paclitaxel 100 mg/m2 days 1, 8 and 15",1
28472,homeopathy medicine,1
28473,more good days video&brief questionnaire,1
28474,r2-mant,1
28475,carboplatin monotherapy every 3 weeks,1
28476,azd4205,1
28477,2d pc,1
28478,"interferon, retinoic acid and radiation",1
28479,imatinib mesylate followed by a combination of imatinib mesylate & panitumumab,1
28480,educational booklet,1
28481,agreement between oral and cervical hpv infection,1
28482,delcath hepatic delivery system,1
28483,mln4924 and azacitidine,1
28484,amitriptyline,1
28485,"docetaxel, cisplatin and sti571",1
28486,e7389 + carboplatin auc 6,1
28487,psma -pet/ct simulation,1
28488,upper vaginectomy,1
28489,ipilimumab 3 mg/kg iv,1
28490,cz48,1
28491,pegylated interferon-alpha-2a,1
28492,narrative information sheet,1
28493,combination of veliparib + lapatinib,1
28494,improving cognition with group intervention,1
28495,randomisation course 1 mitoxantrone versus daunoxome,1
28496,donor-derived cd19/22 bispecific car-t cells or cd19-directed car-t cells; donor-derived-hsct,1
28497,amrubicin hydrocloride,1
28498,nerve function tests,1
28499,open dialogue about complementary alternative medicine,1
28500,drug selected in the study,1
28501,pre treatment recurrence score:18-25 letrozole + palbociclib,1
28502,nutritional screening tools,1
28503,genetic counselor,1
28504,enable,1
28505,spectrila®,1
28506,dect,1
28507,23-valent polysaccharide pneumococcal vaccine (pneumovax tm),1
28508,waterjet induced dissection,1
28509,gemcitabine-pazopanib,1
28510,daunorubicin (dnr),1
28511,vemurafenib - cohort 1,1
28512,emd 1201081,1
28513,bms-936558 (nivolumab),1
28514,to assess risk of osa,1
28515,mild hypothermia,1
28516,ccrt arm without consolidation chemotherapy,1
28517,ba,1
28518,high-dose acupuncture with intravenous infusion of ramosetron,1
28519,iv fludarabine,1
28520,methylphenidate via transdermal patch compared to placebo,1
28521,cantharidin,1
28522,mart-1a peptide,1
28523,normal removal group,1
28524,sln procedure (carolires camera),1
28525,cone beam ct scan,1
28526,imatinib 400mg qd,1
28527,niv,1
28528,hf10 plus ipilimumab,1
28529,"combination metyrosine-derivative, low-dose sirolimus, phenytoin and methoxsalen",1
28530,on 013105,1
28531,antipain,1
28532,dedicated sexual health clinic appointment,1
28533,lvef 4 month,1
28534,palliative thoracic radiotherapy,1
28535,arm2: placebo,1
28536,eicosapentanoic acid and docosahexanoic acid,1
28537,increased use of ic/is technique in bt,1
28538,"standard suction, slow-pull, wet suction",1
28539,cilengitide 2000 mg twice weekly,1
28540,myeloablative hematopoietic stem cell transplantation,1
28541,drug-placebo,1
28542,low glycemic load,1
28543,preadmission counselling,1
28544,white endoscopy and then lci/bli,1
28545,chronic pain,1
28546,epidural analgesia with naropin + sufentanil,1
28547,oral contraceptive pill pretreatment (marvelon),1
28548,aloe vera jel,1
28549,gene rearrangement,1
28550,standard practice education,1
28551,open left colonic resection,1
28552,pd-1 knockout engineered t cells,1
28553,regorafenib/folfox,1
28554,pre-operative breast magnetic resonance imaging,1
28555,gore seamguard® bioabsorbable staple line reinforcement,1
28556,central/peripheral,1
28557,panitumumab (within re-induction phase),1
28558,hepatectomy alone,1
28559,intervention a - behavioural regulation,1
28560,600mg/day of imatinib,1
28561,"crs-hipec, control arm",1
28562,"50,000 iu vitamin d3",1
28563,standard of care brain biopsy and tumor removal,1
28564,leucovorin (calcium folinate),1
28565,intraoperative ultrasonography,1
28566,tcg,1
28567,pca morphine,1
28568,sham self-acupressure,1
28569,vemurafenib (zelboraf®),1
28570,low venous pressure general anesthesia,1
28571,intercoat administration,1
28572,immuncell-lc intravenous infusion using a cik cell agent,1
28573,nimotuzumab plus s1,1
28574,transanal minimally invasive total mesorectal excision,1
28575,"cddp, 5 fu",1
28576,consolidation phase (on day +50),1
28577,stenting procedure,1
28578,germline genotyping analyses for tser,1
28579,ivr plus triage,1
28580,dopamine agonist treatment,1
28581,individualized manualized ayurvedic intervention,1
28582,early cdt lung blood test,1
28583,ro5503781 mbp,1
28584,hypofractionation proton beam therapy with concurrent treatment of the prostate and pelvic nodes,1
28585,ldr brachytherapy and external beam radiation therapy,1
28586,"low fat, high fiber, high fruit and vegetable eating plan",1
28587,nipple delay surgery,1
28588,chidamide plus dice regimen,1
28589,[^14c]-alisertib,1
28590,bibf 1120 es,1
28591,"durvalumab,tremelimumab",1
28592,physical therapya,1
28593,fudr via hai pump,1
28594,laparoscopic interval debulking surgery,1
28595,treatment with ny-eso-1c259-modified t cells,1
28596,18-f-miso,1
28597,pazopanib in combination with weekly topotecan,1
28598,sparc1507,1
28599,vertical mattress suture,1
28600,irinotecan hydrochloride trihydrate,1
28601,capecitabine plus bevacizumab,1
28602,novel erythropoiesis stimulating protein (nesp) (darbepoetin alfa),1
28603,decadron®,1
28604,hpn424,1
28605,idea-070,1
28606,"radium-223 dichloride, (xofigo, bay88-8223)",1
28607,pioglitazone + tki,1
28608,clostridium novyi-nt,1
28609,"busulfan, melphalan",1
28610,panitumumab with capecitabine and radiation,1
28611,quick diagnosis program,1
28612,pom,1
28613,5-fluorouracil 3200 mg/m2,1
28614,pulmozyme,1
28615,90y-hpam4 + gemcitabine,1
28616,duodenoscopy and enteroscopy,1
28617,combined tas-102 and tas-ox,1
28618,cyclophosphamide?fludarabine?cart-138/bcma cells,1
28619,rectal biopsy at randomization,1
28620,nci information booklets (ib),1
28621,daratumumab/lenalidomide/dexamethasone for 24 months,1
28622,ovarian cancer surgery,1
28623,circulating osteocalcin-positive (coc) cells,1
28624,brown rice pills,1
28625,s-1 + cisplatin (arm a),1
28626,lymph nodes debulking surgery.,1
28627,wide tube reconstruction after subtotal gastrectomy,1
28628,drug eluting bead transarterial chemoembolization,1
28629,carboplatin - phase 1,1
28630,89zr-amg211,1
28631,autologous or allogeneic tumor cells,1
28632,group 2 ustekinumab 130 mg,1
28633,rituximab + chop chemotherapy,1
28634,18f-fch pet/mri imaging,1
28635,ixazomib and daratumumab,1
28636,combined immune adjuvants and radiation,1
28637,goserelin with bicalutamide and dutasteride,1
28638,cap assisted colonoscopy,1
28639,vgx 3100,1
28640,icotinib®,1
28641,laparoscopic or open colorectal surgery,1
28642,tolcapone,1
28643,ophthalmic eua,1
28644,stat 3 decoy,1
28645,gimeracil and oteracil porassium capsules,1
28646,[11c]-methionine pet/mri,1
28647,"no intervention, only complete a survey",1
28648,cetuximab if,1
28649,intraperitoneal and systemic chemotherapy plus maximum cytoreduction plus hipec,1
28650,?? t cells/ surgery,1
28651,15 mm pyloric balloon dilatation,1
28652,fatigue inventory,1
28653,hc2 collection kit with a swab or brush,1
28654,40um embozene tandem microspheres,1
28655,sphenopalatine block with saline,1
28656,methazolamide,1
28657,[18f]-ml-10 in conjunction with pet imaging,1
28658,no daily chest xray,1
28659,astx727 dose confirmation,1
28660,"docetaxel, cisplatin, capecitabine, bevacizumab",1
28661,omp-313m32,1
28662,entospletinib (baml-16-001-s4),1
28663,"selective decontamination of the digestive tract (sdd) (colistin sulfate, tobramycin, amphotericin b)",1
28664,zidovudine (azt),1
28665,daily cone beam ct,1
28666,alternate dosing,1
28667,5-fluorouracil [5-fu],1
28668,"anlotinib combined with pemetrexed and carboplatin, phase i",1
28669,"risk-based, escalating levels of care",1
28670,the domestic pca equipment 'accufuser omnibus®',1
28671,irradiated donor lymphocyte infusion,1
28672,[68ga]mln6907,1
28673,"radical abdominal hysterectomy (class iii), bplnd & lower para aortic lymph node sampling",1
28674,stent strategy,1
28675,cisplatin/irinotecan,1
28676,ipci (cddp+5fu),1
28677,thermoplastic hand splint,1
28678,ex-vivo expanded effector cells,1
28679,azd1775 and carboplatin (cbpt),1
28680,individual diet & physical activity counselor and website through healthways at hopkins,1
28681,oocyte retrieval for ivm,1
28682,rivs vascular access,1
28683,sterile compound c31510 for injection,1
28684,epl diluent,1
28685,celecoxib plus calcitriol,1
28686,"mk0663, etoricoxib / duration of treatment: 4 weeks",1
28687,"medical diode laser emitting light at a wavelength of 652 nm. (ceralas pdt 652, ceramoptec gmbh)",1
28688,ny-eso-1(c259)t cells,1
28689,device? ngs sequencing cfdna,1
28690,hrbmp4,1
28691,lattice extreme ablative dose (lead) radiation therapy,1
28692,s-1 and paclitaxel,1
28693,cryotherapy (device),1
28694,local hyperthermia at 44?,1
28695,azd 2014,1
28696,matched targeted therapy,1
28697,prs-343 in combination with atezolizumab,1
28698,ad 923,1
28699,endoscopic drainage,1
28700,cnf2024 + trastuzumab,1
28701,cardiac output normalization,1
28702,bispecific antibody mdx447,1
28703,facit-fatigue,1
28704,ivor lewis oesophagectomy,1
28705,post-treatment follow up,1
28706,"egfr-tkis (erlotinib, gefitinib and osimertinib)",1
28707,adhere,1
28708,rfta,1
28709,seldinger technique,1
28710,non-clinically assisted hydration arm,1
28711,ra223,1
28712,methotrexate oral product,1
28713,brachytherapy with iodine-125 seeds,1
28714,ezn-3042,1
28715,brimonidine tartrate,1
28716,"mk0683, vorinostat, suberoylanilide hydroxamic acid (saha)",1
28717,educational materials only,1
28718,fentanyl buccal tablet (fbt),1
28719,alimta plus oxaliplatin versus oxaliplatin plus 5-fluorouracil and leucovorin (folfox 4 regimen),1
28720,induction dcs chemotherapy,1
28721,penetrating auditory brainstem implant,1
28722,positron emission tomography/x-ray computed tomography,1
28723,"""bard""powerport sip implantable port",1
28724,measuring estradiol and progesterone levels in saliva,1
28725,capecitabine + bevacizumab,1
28726,survey/interview,1
28727,cd19.car-multivst for group b,1
28728,testing for mutation status,1
28729,wx-671,1
28730,dcdt2980s,1
28731,eus-bd,1
28732,surgery: d2+paraaortic dissection,1
28733,lu-177-dotatate,1
28734,pathological revision,1
28735,mk-347,1
28736,"myo-inositol,alpha-lipoic acid and folic acid",1
28737,high-dose chemotherapy with autologous stem cell rescue,1
28738,sonogram,1
28739,5-fluorouracil/salicylic acid,1
28740,cetuximab plus radiotherapy,1
28741,patient discharge in the day of surgery,1
28742,90y-re,1
28743,"naloxone hydrochloride lotion, 0.5%",1
28744,octreotide acetate and cabergoline/octrotide and somavert,1
28745,sorafenib 200 mg (50-mg tablet),1
28746,"melphalan, prednisone, thalidomide",1
28747,group a:cytokine-induced killer cell +gefitinib,1
28748,ucb and hpdsc,1
28749,patients starting a treatment by ici,1
28750,l-selenomethionine,1
28751,cd19-tricar-t,1
28752,exablate treatment uf v2,1
28753,"fludarabine, busulfan, and atg",1
28754,veliparib + vx-970 + cisplatin,1
28755,liver resection and placement of hepatic artery infusion pump,1
28756,rad-p53 gene,1
28757,direct transthoracic cardiac tumor radio frequency ablation therapy,1
28758,hiltonol (poly-iclc),1
28759,iph5401 and durvalumab,1
28760,interventional arm,1
28761,cish inactivated til,1
28762,'open window' project,1
28763,mek-162,1
28764,ublituximab + tgr-1202 + bendamustine,1
28765,standard biopsy,1
28766,"cisplatin, thiosulfate",1
28767,telephone counseling & navigation (tcn),1
28768,regular ssri (selective serotonin reuptake inhibitors) use,1
28769,treatment a (rosuvastatin),1
28770,phenylacetate,1
28771,cefmetazole,1
28772,radiation therapy followed by prostatectomy,1
28773,yttrium-90 (90y),1
28774,5-fluoro-2-deoxycytidine,1
28775,northern blotting,1
28776,hyaluronic acid-carboxymethylcellulose,1
28777,nextseq500 sequencer,1
28778,cd45 antibodies,1
28779,-irinotecan 180 mg/m2 iv on day 1,1
28780,epi-506,1
28781,physical therapyb,1
28782,geriatric fragility test gerico,1
28783,traditional laparoscopic radical gastrectomy,1
28784,tt vaccine booster,1
28785,gm-csf (granulocyte-macrophage colony-stimulating factor),1
28786,mr-only imaging on biograph mmr scanner,1
28787,electronic self-report assessment - cancer (esra-c),1
28788,mis,1
28789,caring hand massage,1
28790,"gene-activated matrix ""nucleostim""",1
28791,gefitinib single agent,1
28792,olympus spectrum,1
28793,cybercycling,1
28794,sequential maintenance therapy,1
28795,higher dose combination chemotherapy plus intrathecal topotecan and orbital radiotherapy,1
28796,arimidex,1
28797,denosumab placebo,1
28798,stereotatic body radiotherapy (sbrt),1
28799,capécitabine,1
28800,play intervention,1
28801,cto and temodar®,1
28802,surefire infusion system,1
28803,daunorubicin liposomal injection [daunoxome],1
28804,trip patient navigation intervention,1
28805,wide field fluorescence system,1
28806,drug: paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide,1
28807,patient-assisted (pa) breast compression,1
28808,brief psychosocial intervention,1
28809,infusion of donor lymphocytes,1
28810,pcr and serum markers for breast cancer,1
28811,directview cr mammography,1
28812,testing of pre-positioning frame,1
28813,retroflexion in the right colon,1
28814,"gemcitabine, cisplatin and bevacizumab",1
28815,calcium/vitamin d,1
28816,"ipolysite ® mini série 3108 or polysite ® standard, série 4108.",1
28817,axitinib oral tablet [inlyta],1
28818,anlotinib plus irinotecan,1
28819,prostatic artery embolization (pae),1
28820,epoetin alfa 450 iu/kg once a week,1
28821,tacrolimus (arm with mmf and cyclophosphamide),1
28822,jnj-42756493: part 1,1
28823,standard neoadjuvant cht,1
28824,leridistim,1
28825,cesium 131,1
28826,naf-pet-ct,1
28827,ferinject (ferric carboxymaltose),1
28828,docetaxel / capecitabine,1
28829,acetaminophen/hydrocodone,1
28830,[18f]fluorofuranylnorprogesterone (ffnp) pet/mr imaging,1
28831,mfolfox-6,1
28832,pexastimogene devacirepvec (pexa-vec),1
28833,rad001 in combination with sorafenib,1
28834,breast biopsy or surgery,1
28835,gamma 1b potential expansion,1
28836,ad5f35-lmp1/lmp2-transduced autologous dendritic cells,1
28837,mibi-tc99m/iodine-123,1
28838,flexible support groups,1
28839,circulating tumour dna testing,1
28840,bone marrow cell,1
28841,radiochemotherapy 7,1
28842,"zoster vaccinerecombinant, adjuvanted",1
28843,"propofol, remifentanil, sevoflurane",1
28844,biological: humanized anti-pd-l1 monoclonal antibody,1
28845,il-2 pre-treated cd19 cells,1
28846,colloid,1
28847,extended hypofractionation radiotherapy,1
28848,pre- and post-operative consultation,1
28849,docetaxel cyclophosphamide,1
28850,esophagoscopy and chromoendoscopy,1
28851,talc slurry through a chest tube (dt).,1
28852,caregiver wellness videos,1
28853,hydromorphone hcl,1
28854,human activity profile,1
28855,angiocal® (prs-050-peg40),1
28856,"ypeg-rhg-csf, 30?g/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle",1
28857,promis survey,1
28858,ril-21,1
28859,percutaneous transhepatic cholangiography vs. endoscopic biliary drainage,1
28860,placebo for ag-221,1
28861,cryotherapy and veregen,1
28862,breast health education,1
28863,part 2: bo-112,1
28864,superior mesenteric artery approach for pancreatoduodenectomy,1
28865,cg 428 cutaneous solution,1
28866,d1extra-resection,1
28867,hippocampus avoidance,1
28868,allogeneic hematopoietic cell transplantation (hct),1
28869,"gene directed enzyme prodrug therapy, fp253/fludarabine",1
28870,cripec® docetaxel,1
28871,autologous cik transfusion plus chemotherapy,1
28872,matching placebo in the maintenance phase after tapentadol in the titration phase,1
28873,carboplatin auc2,1
28874,adjuvant image-guided radiotherapy,1
28875,modified radical mastectomy or breast conserving surgery with axillary lymph node dissection,1
28876,nk-92/5.28.z (her2.tank),1
28877,polyamine analogue pg11047,1
28878,goal directed intravenous restrictive fluid therapy,1
28879,cyclophosphamide 600 mg/m2 iv,1
28880,bbi608(napabucasin),1
28881,ec145 + docetaxel,1
28882,methylene blue dye injection of sentinel lymph node,1
28883,chop21-r,1
28884,"irinotecan (camptosar), gefitinib (iressa)",1
28885,sipt treatment,1
28886,mastocytosis diagnosis,1
28887,moderately hypofractionated conformal radiation combined with cisplatin,1
28888,standard white light colonoscopy-equivalent to placebo,1
28889,cyclophosphamide administration,1
28890,screening platform,1
28891,patient therapeutic education (pte) programme,1
28892,"exercise, elevation, and compression garment",1
28893,sc-004,1
28894,laboratory assay,1
28895,"rituximab, idelalisib, and venetoclax",1
28896,cbt and physical activity,1
28897,90y-smt487,1
28898,99mtc-hmdp single photon emission computer tomography/computer tomography,1
28899,yttrium y 90 basiliximab,1
28900,amg 427,1
28901,surgisis male sling,1
28902,phase ii - gm.cd40l cells vaccinations,1
28903,american taxotere®,1
28904,dance,1
28905,topical vaseline,1
28906,arterial spin labeling blood flow magnetic resonance imaging,1
28907,olympus um 2000,1
28908,car138 t cells,1
28909,gelad,1
28910,tb-403 20mg/kg,1
28911,biological image-guided sbrt with dose-escalation.,1
28912,geneinsight clinic (gic),1
28913,prednisone 5 mg po bid,1
28914,aromatase inhibitor (litrezole) plus ufsh arm,1
28915,[68ga]psma-11,1
28916,doxorubicin (dox),1
28917,control invitation materials,1
28918,drug: carboplatin,1
28919,l-carnitine (lc),1
28920,full-spectrum colonoscopy,1
28921,sorafenib plasma concentration 4 weeks after treatment initiation,1
28922,"oral nutritional supplement, food for special medical purposes",1
28923,abiraterone - group 1,1
28924,0.9% nacl solution,1
28925,liposomal pegylated doxorubicine,1
28926,single dose ablative radiotherapy,1
28927,not interventional,1
28928,vitamin d3 placebo,1
28929,111in-daclizumab,1
28930,ipilimumab+ budesonide,1
28931,low-dose protocol computed tomography,1
28932,avidinox/st2210,1
28933,psa:154-163(155l) peptide vaccine,1
28934,morphine plus dexmedetomidine,1
28935,arq 092 + carboplatin + paclitaxel (closed),1
28936,implanted port for chemo administration (x-port isp),1
28937,"genasense® (, oblimersen sodium g3139)",1
28938,body composition and vital signs,1
28939,stereotactic ablative radiation therapy (sabr),1
28940,opii normata treatment,1
28941,hx 008 injection,1
28942,prone to supine mri,1
28943,oral contraceptive pills (yasmin),1
28944,oct-afi,1
28945,apatinibmesylatetablets,1
28946,cyclophophamide,1
28947,potentially curative surgery,1
28948,ct abdomen,1
28949,mri guided prostate biopsy and trus guided biopsy,1
28950,otovent®,1
28951,proton stereotactic body radiation therapy (sbrt) (5 fractions; 3500-4500 cgy),1
28952,exemestane + placebo,1
28953,sterile water placement,1
28954,permanent iodine-125 seed implant,1
28955,leo 43204 vehicle,1
28956,methionine,1
28957,14c-labeled poziotinib,1
28958,frontal view,1
28959,acts intervention,1
28960,demographics questionnaires and the fact hn questionnaire,1
28961,hdr brachytherapy monotherapy,1
28962,cpap machine,1
28963,investigational pet scanner coils and software,1
28964,impt + sib + chemotherapy,1
28965,solution b (balance pd solution),1
28966,denosumab (xgeva),1
28967,physician involvement,1
28968,"dose escalation, medi2228, adc (antibody drug conjugate)",1
28969,autologous idiotype-protein pulsed dendritic cells,1
28970,cold caps,1
28971,18fmiso pet/ct scan,1
28972,supervised apa program,1
28973,groin ultrasound +/- fine needle aspiration,1
28974,short course vaginal cuff brachytherapy,1
28975,harmonic generation microscopy,1
28976,"epirubicin / cyclophosphamide in combination with paclitaxel/trastuzumab, followed by postoperative trastuzumab",1
28977,icg fluorescence technique,1
28978,co-1.01 formulation a (aqueous suspension containing 15 mg/ml of drug solubilized in purified phospholipids),1
28979,superficial cervical plexus block,1
28980,carboplatin paclitaxel plus concurrent radiotherapy,1
28981,high dose dfd07 twice daily,1
28982,matching placebo after tapentadol in the titration phase.,1
28983,ds,1
28984,perioperative nab-paclitaxel/gemcitabine,1
28985,"paclitaxel, gemcitabine, and oxaliplatin",1
28986,pegylated endostatin and paclitaxel-carboplatin,1
28987,imc-20d7s (cohort 2a ),1
28988,placebo drug: docetaxel drug: carboplatin,1
28989,cetuximab and savolitinib,1
28990,r0 resection,1
28991,goal directed therapy,1
28992,pegylated liposomal doxorubicin (caelyx),1
28993,graded resistance training,1
28994,electromagnetic navigation bronchoscopy (enb),1
28995,target volume delineation after nact,1
28996,reduced_intensity conditioning,1
28997,blood collection for laboratory studies,1
28998,"chop (cyclophosphamide (c), adriamycin (h), vincristine (o), and prednisone (p)) chemotherapy",1
28999,mcrc intervention,1
29000,1.85gbq of 177lu-eb-psma-617,1
29001,pamphlet intervention,1
29002,alginates,1
29003,atezolizumab + avastin + platinum-based chemotherapy,1
29004,litebook® advantage,1
29005,hpph 3.5 mg/m2,1
29006,fexofenadine tablet dosing,1
29007,[18f] fluciclovine pet/mri,1
29008,h,1
29009,fluoscope,1
29010,nevus doctor clinical decision support,1
29011,compressed sleeve treatment,1
29012,retarded ids (interval debulking surgery),1
29013,in-depth interviews,1
29014,"gsk580299, gsk biological's hpv vaccine",1
29015,sm08502,1
29016,vin,1
29017,cancer and aging research group geriatric assessment,1
29018,gsk 2132231a,1
29019,pliates method treatment,1
29020,melanoma vaccine,1
29021,daily vacuum therapy,1
29022,onco-peptide loaded autologous dendritic cells,1
29023,dexmedetomidine 1,1
29024,platinum-based two medicine (carboplatin / cisplatin) .,1
29025,high frequency percussive ventilation (hfpv),1
29026,glycerol,1
29027,ultrasonic scalpel,1
29028,energy instruments,1
29029,iodine i 131 tositumomab therapeutic regimen,1
29030,ipsilateral radiation,1
29031,standard radiochemotherapy to 68 gy,1
29032,1% xylocaine,1
29033,education counseling session for psa screening,1
29034,"pembrolizumab, cetuximab",1
29035,physician and patient intervention,1
29036,uae inhibitor tak-243,1
29037,diffuse weighted mri,1
29038,pgl4001,1
29039,2.15 gray and 1.8 gray. max. 6 weeks.,1
29040,talazoparib with enzalutamide,1
29041,colonoscopy done with:peermedical system and olympus/pentax/fuji colonoscopy system,1
29042,screening by head and neck clinical examination with a fiberoptic nasolaryngoscopy and an oesopharyngeal brush biopsy annually during 3 years,1
29043,total thyroidectomy (classic thyroidectomy),1
29044,"ketoconazole, hydrocortisone and dutasteride",1
29045,recombinant follicle stimulating hormone,1
29046,aminoflavone prodrug,1
29047,endoscopic bipolar radiofrequency probe (endohpb),1
29048,diagnosis of breast cancer by x-ray diffraction of hair,1
29049,"arsenic trioxide, ascorbic acid and bortezomib",1
29050,detecting of biological borders of gliomas,1
29051,transvaginal ultrasound educational dvd,1
29052,tme operation,1
29053,breast cancer database,1
29054,capecitabine and pseudomonas aeruginosa combination,1
29055,radiotherapy or concurrent chemoradiation therapy (ccrt),1
29056,lac triple therapy,1
29057,dpc,1
29058,cisplatin 80mg/m² concurrent chemotherapy,1
29059,lmp744,1
29060,leukapheresis or collection of pbmcs,1
29061,spect ct,1
29062,laparoscopic surgical removal of the adrenal tumor,1
29063,pet/ct (fdg pet/ct),1
29064,fragmin,1
29065,placebo (for aflibercept),1
29066,family and network consultations,1
29067,diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation,1
29068,tetanus-diphtheria booster,1
29069,hommed telemonitor,1
29070,transpedicular instrumentation,1
29071,bioseal,1
29072,irinotecan combination chemotherapy,1
29073,cart30,1
29074,amv564 intermittent dosing,1
29075,oe mode was used for colonoscopy withdrawal,1
29076,"ois (oxaliplatin, irinotecan, s-1)",1
29077,anti-cd33 car t cells,1
29078,recombinant human endostatin plus gemcitabine and cisplatin,1
29079,5fu/folinic acid,1
29080,epacadostat (incb024360) in combination with pembrolizumab (mk-3475) and azacitidine (vidaza),1
29081,single port laparoscopic right hemicolectomy,1
29082,lumbar puncture,1
29083,terlipressinum,1
29084,undergo hrv and wear accelerometer to assess therapy complications,1
29085,mk-2118,1
29086,no treatment before definitive ccrt,1
29087,pneumoperitoneum,1
29088,dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine medi0457,1
29089,conventional arm (3),1
29090,morphine p.o.,1
29091,lapatinib and temozolomide,1
29092,n/a- this is an observational study,1
29093,foundationone dx genomic profile (archival tumour specimen),1
29094,fdopa pet,1
29095,docetaxel & gemcitabine,1
29096,shoulder arthroplasty,1
29097,chinese medicine formula,1
29098,biliary cannulation with straight guidewire,1
29099,standard postoperative care,1
29100,resting state fmri,1
29101,full ablative co2 laser,1
29102,ketorolac 30 mg iv,1
29103,actinomycin-d,1
29104,combination nivolumab and ipilimumab,1
29105,tesetaxel-capecitabine-cisplatin,1
29106,cetuximab and folfiri,1
29107,billroth-ii (b-ii),1
29108,native l asparaginase,1
29109,ambulight (ambicare health),1
29110,mini-thoracoscopy,1
29111,darbepoetin and filgrastim,1
29112,"cognitive, functional and subjective assessments",1
29113,dotap:chol-tusc2,1
29114,abraxane® (paclitaxel protein-bound particles for injectable suspension),1
29115,carboplatin i.d. days 1 & 15,1
29116,laser ablation of thyroid nodule,1
29117,aranesp (darbepoetin alfa),1
29118,laparotomy plus hipec,1
29119,standard chemotherapy (pemetrexed and cisplatin) + bevacizumab,1
29120,75 weekly minutes walking,1
29121,colorectal cancer resection+ adjuvant chemotherapy (mfolfox6),1
29122,twi 5 fractions,1
29123,rsfcmri,1
29124,aurixim,1
29125,"chemotherapy (carboplatin, etoposide, thiotepa)",1
29126,option grid,1
29127,voluntary deep-inspiratory breath hold,1
29128,bnc 105,1
29129,intrathecal (it) methotrexate,1
29130,remote ischemia precondition,1
29131,skin microcirculatory blood flow,1
29132,700 mg leronlimab,1
29133,4dct-ventilation,1
29134,thioureidobutyronitrile,1
29135,conventional cold snare polypectomy,1
29136,revm10/polas gene,1
29137,recorded hypnosis intervention,1
29138,low dose irradiation + nivolumab + ipilimumab + aspirin,1
29139,non-estrogenic pollen extract pcc-100,1
29140,dendritic cell vaccination plus chemotherapy,1
29141,amg 510,1
29142,photoacoustic imaging (pai),1
29143,laser acupuncture,1
29144,fpac,1
29145,dexamethasone in consolidation-3,1
29146,infusion of myocet,1
29147,psa rna-pulsed dendritic cell vaccine,1
29148,surepathtm,1
29149,jnj-64041757 (cohort 2a and 2b),1
29150,interleukin,1
29151,yogurt,1
29152,concurrent rad001 5 mg/day,1
29153,fentanyl buccal soluble film (fbsf),1
29154,ibrutinib 140 mg oral capsule [imbruvica],1
29155,muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells,1
29156,genetic testing and gain report,1
29157,steriotactic radiation therapy,1
29158,partial mastectomy plus additional shave margin,1
29159,fluorine f 18 feqa + positron emission tomography,1
29160,non- interventional,1
29161,patients with ca or suspected risk of ca or a family hx,1
29162,transfusion of allogeneic red blood cell concentrate,1
29163,frameless stereotactic radiosurgery with radiation mask,1
29164,placebo of succinate of solifenacin,1
29165,"folfiri (5-fluorouracil, folinic acid, irinotecan)",1
29166,"uft, calcium folinate",1
29167,high instensity focused ultrasound,1
29168,enlight,1
29169,hepatectomy (conventional method),1
29170,cytarabine or supportive care,1
29171,"gemcitabine, nab-paclitaxel, hydroxychloroquine and avelumab",1
29172,hydralazine and valproic acid: cohort 3,1
29173,imprime pgg injection,1
29174,combined exercise training,1
29175,non-invasive measurement of intracranial pressure,1
29176,translational research,1
29177,"etoposide, carboplatin, ifosfamide",1
29178,medi4736 (durvaluman) in combination with tremelimumab (anti-ctla4),1
29179,bipolar transurethral en bloc resection,1
29180,supervised exercise training,1
29181,chemotherapies protocols,1
29182,interviews - caregivers of colorectal cancer participants,1
29183,gastrectomy+ chemotherapy,1
29184,folic acid tablet simulation,1
29185,methylene blue mmx tablets,1
29186,imatinib oral tablet,1
29187,intron a (interferon alfa-2b; sch 30500),1
29188,cytokine levels,1
29189,goal directed fluid management based on continuous monitoring of stroke volume,1
29190,pyrotinib plus trastuzumab and docetaxel,1
29191,fecal microbial transplantation,1
29192,raltitrexed and s-1,1
29193,remeron (mirtazapine),1
29194,sterotactic radiosurgery,1
29195,search for polymorphisms of rasa1 gene,1
29196,3 tesla (3t) siemens total imaging matrix (tim) trio whole-body system,1
29197,ercp with sems alone (standard of care),1
29198,radiotherapy consolidation,1
29199,standard of care single agent chemotherapy,1
29200,"s-1, bevacizumab",1
29201,irradiation of the chest-wall and supraclavicular fossa,1
29202,standard treatment plus nitroglycerin,1
29203,carbo/cyclo + atezolizumab,1
29204,traction neurectomy,1
29205,lateral lymph node dissection(lldd),1
29206,yisaipu,1
29207,melatonin oral gel 3%,1
29208,tak-960,1
29209,sysmex's 5-blade lymph node cutter,1
29210,study of the pleural cavity with a confocal laser endomicroscope.,1
29211,endoscopic cyst-gastrostomy,1
29212,sv40 vectors carrying sirna,1
29213,tenovus cancer choir,1
29214,paclitaxel + carboplatin + bevacizumab,1
29215,large bore chest drain + nsaid based analgesic regimen,1
29216,iph4102,1
29217,registry of patients with tako-tsubo cardiomyopathy,1
29218,dynamic contrast-enhanced (dce) mri,1
29219,cd19/cd22 car t-cells,1
29220,robotic-assisted radical cystectomy,1
29221,3.70gbq of 177lu-eb-psma-617,1
29222,effentora®,1
29223,data correlation,1
29224,ca,1
29225,cisplatin & gemcitabine,1
29226,chemotherapy for hematologic malignancy,1
29227,daily hyperfractionated radiation therapy,1
29228,ulipristal acetate (upa) 5 mg,1
29229,ny-eso-1 olp4,1
29230,litebook edge (comparator),1
29231,placebo q2w,1
29232,bone marow samples,1
29233,srf231,1
29234,fentanyl transdermal matrix patch zr-02-01,1
29235,laparoscopic technique and thoracic epidural anesthesia,1
29236,computer-assisted histological prediction of colon polyps,1
29237,ge-148 (18f),1
29238,cisplatin (3 weekly),1
29239,ho:yag laser enucleation of the prostate,1
29240,cyproterone compound + spironolactone,1
29241,with comprehensive geriatric assessment,1
29242,visit with a volunteer,1
29243,pembrolizumab 200 mg every 3 weeks,1
29244,gsk923295,1
29245,dtic (dacarbazine),1
29246,pillbox,1
29247,zero ischemia laparoscopic rfa/mva assisted tumor enucleation (te),1
29248,placebo 1.7 ml subcutaneous solution,1
29249,iv casopitant (gw679769),1
29250,lasix,1
29251,white light withdrawal,1
29252,folfirinox + regorrafenib,1
29253,adoptive cell transfer,1
29254,physical training in group,1
29255,pronase,1
29256,sln mapping,1
29257,slnb versus completion alnd,1
29258,ipad counseling,1
29259,nurse case management,1
29260,intrabone allogeneic transplant,1
29261,"standard radiotherapy, 60 gy in 30 fractions.",1
29262,treatment doxorubicin,1
29263,carboplatin - phase 2,1
29264,remote psychosocial intervention,1
29265,urea/lactic acid-based topical cream,1
29266,reverse trendelenburg position - 30 degree,1
29267,cardiovascular autonomic function studies,1
29268,5hmc profile in plasma cell-free dna after liver resection,1
29269,definitive surgical resection,1
29270,ferumoxtran-10 enhanced mri (mrl),1
29271,incb028060,1
29272,bez235 (stage 1),1
29273,albumin-bound paclitaxel (abi-007),1
29274,liquid nitrogen and cantharidin,1
29275,imc-001,1
29276,intra-operative c-arm ct imaging,1
29277,"videos of polyps, resection of polyps",1
29278,arq 531,1
29279,humax-il8,1
29280,pocket coach for aya with cancer,1
29281,epac,1
29282,colorectal surgery,1
29283,igrt 24 gy single dose,1
29284,bystander vaccine,1
29285,standard chemo- or endocrine therapy + lapatinib,1
29286,klh and tumor lysate pulsed dc vaccine,1
29287,salvage radiation therapy,1
29288,ferrous sulfate tablets,1
29289,focal brachytherapy with psma pet imaging,1
29290,high dose interleukin-2,1
29291,functional assessment of cancer therapy - brain,1
29292,folotyn and leucovorin,1
29293,me-143,1
29294,discussions of cost app (disco app),1
29295,placebo to bevacizumab,1
29296,interventions of the cancéropôle nord-ouest,1
29297,"ondansetron, dexamethasone, placebo",1
29298,gelonin,1
29299,dermatologic examination,1
29300,cohort observation,1
29301,carboplatin and paclitaxel and or without trastuzumab,1
29302,web-based advance care planning,1
29303,progressive muscle relaxation,1
29304,measure of resting energetic expenditure,1
29305,best medical care,1
29306,blood tests and muscular biopsies,1
29307,consultation with pct doctor,1
29308,pvaxrcpsav53l (dna encoding rhesus psa),1
29309,early order of palliative care consultation,1
29310,preemptive dexmedetomidine epidural bolus injection(1.5 mcg/kg),1
29311,prophylactic enoxaparin,1
29312,3d conform radiotherapy,1
29313,svv,1
29314,"irinotecan, oxaliplatin, ts-1",1
29315,conditioning regimen,1
29316,chimeric anti-cd20 monoclonal antibody,1
29317,in-zevalin,1
29318,ptvg-hp plasmid dna vaccine,1
29319,mri-hifu,1
29320,etoposide for remission induction,1
29321,apg-1387 for injection,1
29322,talimogene laherparepvec in combination with pembrolizumab,1
29323,0.16 mg/kg cpg 7909,1
29324,hla-a*2402-restricted cdca1 and kif20a peptides,1
29325,i-dac (intermediate dose cytarabine),1
29326,"autologous peripheral blood stem cell transplantation, ex vivo amplified",1
29327,laparoscopic bilateral occlusion of uterine artery,1
29328,di-leu16-il2,1
29329,oxygen and air administration,1
29330,co2 standard cryotherapy,1
29331,localization of breast lesion,1
29332,single photon emission computed tomography (spect),1
29333,tumor biopsy (fine-needle aspiration),1
29334,sentinella intraoperative imaging protocol,1
29335,vital port®minititanium,1
29336,89zr-bevacizumab pet-scan,1
29337,transplant conditioning,1
29338,scalp nerve blocks with ropivacaine,1
29339,segmental withdrawal,1
29340,local distribution points association,1
29341,no weight loss group,1
29342,bcnu 200mg/m2,1
29343,bz (bortezomib),1
29344,axitinib + paclitaxel (cohort 4),1
29345,standard of care procedure as described in arm,1
29346,do leave a chest tube in the pleural cavity.,1
29347,educational program and fobt kits,1
29348,diane-35;metformin;clomiphene citrate; human menopausal gonadotropin,1
29349,mri and pet imaging,1
29350,radiotherapy to the prostate,1
29351,biweekly follow up,1
29352,placebo injections,1
29353,anti-cd19/cd22 car nk cells,1
29354,tsr-011,1
29355,"gemcitabine,carboplatin,endostar",1
29356,nss-2 bridge,1
29357,trpv6 calcium channel inhibitor sor-c13,1
29358,smoking cessation program and activity tracker,1
29359,ono/gs-4059,1
29360,aad spotme? skin cancer screening,1
29361,doxorubicin hcl liposomal injection,1
29362,idarubicine,1
29363,precision cell immunotherapy,1
29364,low-power microwave breast imaging system,1
29365,bispectral index monitoring,1
29366,short pap,1
29367,superficial shave biopsy,1
29368,sonoporation,1
29369,"tamoxifen, letrozole, anastrozole or exemestane",1
29370,placebo alone,1
29371,bioxmark liquid fiducial markers,1
29372,contact with palliative care unit.,1
29373,alloplastic limited rom,1
29374,indocyanine-green(icg),1
29375,zd6474 (zactima) 100mg,1
29376,palbociclib + letrozole or fulvestrant,1
29377,18f-fet pet,1
29378,fmiso-pet/ct,1
29379,cytology and cytometry specimen collection procedure,1
29380,pain app,1
29381,ogtt by randomization,1
29382,"""cross"" closure",1
29383,cyclophosphamide 300mg/m^2,1
29384,tet-p,1
29385,decision aids,1
29386,biological: ace-011,1
29387,stromal vascular fraction,1
29388,technetium tc-99m sodium pertechnetate,1
29389,balance training,1
29390,dc-ctl,1
29391,cox2 inhibitor (celecoxib),1
29392,fdht-pet scan,1
29393,cc>0 - carboplatin (iv)- paclitaxel (iv),1
29394,gemcitabine + cetuximab,1
29395,methylene blue intradermal injection,1
29396,complex physical therapy,1
29397,dacogen™ (decitabine),1
29398,"tretinoin 0,05% cream",1
29399,standard of care: cyclophosphamide,1
29400,azurin-derived cell-penetrating peptide p28,1
29401,pelvic examination,1
29402,resting night splint,1
29403,isereadom service package,1
29404,dual-agent therapy or docetaxel alone or best supportive care,1
29405,"anlotinib combined with paclitaxel and carboplatin, phase i",1
29406,incb7839,1
29407,positron emission tomography with fludeoxyglucose f 18,1
29408,"arry-142886, mek inhibitor; oral",1
29409,bumel,1
29410,64cu-llp2a,1
29411,tp-1287,1
29412,verbal numeric pain scale,1
29413,expanded haploidentical natural killer cells (nkaes),1
29414,capecitabine 1000 mg/m^2,1
29415,radical colorectal resection,1
29416,debdox tace,1
29417,placebo (inactive),1
29418,indium 111 ibritumomab tiuxetan,1
29419,cap assisted colonoscopy (cac),1
29420,silver nitrat stick,1
29421,cognitive-behavior groups,1
29422,screening patient navigation,1
29423,melan-a plus dacarbazine,1
29424,regular insulin,1
29425,ai plus dimethyldiguanide,1
29426,minimally invasive hemodynamic monitoring,1
29427,netupitant/palonosetron hydrochloride,1
29428,"5-aminolevulinic acid (5-ala), is a non fluorescent prodrug.",1
29429,5-fu/epirubicin/ctx following docetaxel,1
29430,total skin electron beam radiation therapy,1
29431,cyanoacrylate tissue glue versus fast absorbing gut,1
29432,radiation with concurrent chemotherapy,1
29433,multitargeted receptor tyrosine kinase inhibitor mp470,1
29434,"filgrastim (granulokine, amgen)",1
29435,2nd dose on time and 3rd dose late,1
29436,"rad001, sorafenib",1
29437,sg001,1
29438,sleep healthy using the internet (shuti),1
29439,ox,1
29440,compound 451238,1
29441,carboplatin i.d. day 1; normal saline i.d. day 15,1
29442,sodium fluorescein,1
29443,18f-fluorodeoxyglucose positron emission tomography,1
29444,post-test questionnaire,1
29445,stemex,1
29446,adjuvant hypofractionated radiation,1
29447,relacorilant,1
29448,left lateral,1
29449,unrelated allogeneic stem cell transplantation,1
29450,photon stimulation,1
29451,recombinant vaccinia-psa (l155)-tricom (prostvac-v/tricom),1
29452,maximum tolerated dose of anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody,1
29453,bicalutamide + triptorelin,1
29454,genetic risk score: number format,1
29455,positive activities,1
29456,medical history of cardiovascular risk factors and cardiovascular diseases,1
29457,estradiol plus progesterone,1
29458,nutrinidrink/fortini mf unflavoured (1.5kcal/ml),1
29459,idarubicina,1
29460,patient navigator matched with subject,1
29461,tapentadol extended release,1
29462,bibw 2992 medium dose 6 day,1
29463,fluoroglutamine [18f]f-gln,1
29464,"ipilimumab (yervoytm, 50 mg/10 ml solution)",1
29465,8 cycles of oxaliplatine based adjuvant chemotherapy,1
29466,methylaminolevulinate photodynamic therapy,1
29467,curcuphyt,1
29468,placebo & vitamin e,1
29469,dt388il3,1
29470,apatinib + etoposide capsule,1
29471,crs and hipec,1
29472,hypoglossal acupuncture,1
29473,picibanil,1
29474,ifosfamide + mesna,1
29475,autologous tumor cell-based vaccine,1
29476,hope app,1
29477,re biopsy,1
29478,"toxicity, pharmacokinetics",1
29479,the observer mobility scale,1
29480,letter and informational sheet,1
29481,poly-gamma glutamic acid,1
29482,tamsulosin 0.4mg,1
29483,"no interventions, this is an observational study",1
29484,18f faza,1
29485,viba collection brush,1
29486,"multi-tracer pet exams of 18f-fdg, 18f-flt, 11c-ace, and 15o-h2o",1
29487,pet/mri with gallium-68 labeled psma-hbed-cc,1
29488,real-time position transponder beacons,1
29489,mgmt p140k,1
29490,other approved anti-cancer agent,1
29491,single-dose infusion of cart bcma or cart bcma + hucart19,1
29492,cognitive-behavioral therapy and hypnosis group,1
29493,care management by oncology nurses,1
29494,traditional delivery,1
29495,controlled ovarian hyperstimulation for ivf with an antagonist protocol,1
29496,sinistrin clearance dynamic measurement,1
29497,targeted biopsy using hysteroscopy,1
29498,functional assessment of cancer therapy-bone marrow transplant (fact-bmt),1
29499,behavior assessment system for children/parent report,1
29500,0.9%sodium chloride,1
29501,pet/ ct,1
29502,cetuximab and lenalidomide,1
29503,crotoxin,1
29504,constant weekly message reminding patient to exercise,1
29505,newbreez,1
29506,bibf 1120 h + pemetrexed,1
29507,stem cell harvest,1
29508,confocal endomicroscopy with the cellvizio® system (mauna kea technology),1
29509,genetic: mutation profile,1
29510,non-invasive mechanically-assisted ventilation,1
29511,traditional hand-sewn anastomosis,1
29512,havrix™-based investigational formulation,1
29513,baseline visit survey,1
29514,ssm,1
29515,nccn recommendations for solid tumor post treatment,1
29516,chemotherapy(folfirinox) + sbrt prior to surgery if applicable,1
29517,pet scan with injection of 5-8 mci of 18fes,1
29518,w0101 - cohort a1,1
29519,hydroxydaunorubicin,1
29520,177lutetium,1
29521,bf200-ala/5-aminolevulinic acid,1
29522,integrated palliative care intervention,1
29523,mometasone nasal spray,1
29524,fresubin(r),1
29525,ensure plus (r),1
29526,comparator: placebo / duration of treatment: 24 weeks,1
29527,pi3k-beta inhibitor gsk2636771,1
29528,"taxotere, fluorouracil, leucovorin",1
29529,ibi303,1
29530,lenalidomide: double-blind induction,1
29531,cerebral magnetic resonance imagery,1
29532,lenvatinib 24 mg,1
29533,tumor lysate-loaded autologous dendritic cells,1
29534,other radical treatments,1
29535,serum albumin,1
29536,care supports,1
29537,esra-c,1
29538,"5-fluoruracil, cisplatinum",1
29539,magnemarker,1
29540,ly3200882,1
29541,fractionated stereotactic body radiation therapy,1
29542,subcutaneous hydromorphone delivered by pain pen,1
29543,18f-alfatide ? pet/ct,1
29544,nativis voyager,1
29545,diagnostic analysis,1
29546,endoscopic retrograde cholangiopancreatoscopy(ercp),1
29547,individualized manualized health education intervention,1
29548,"intraoperative nerve monitoring,",1
29549,pazopanib/paclitaxel,1
29550,football fitness,1
29551,escalation of dose (radiotherapy treatment),1
29552,occupational therapy,1
29553,simultaneous integrated boost intensity-modulated arctherapy,1
29554,photobiomodulation,1
29555,lapatinib (tyverb™),1
29556,pazopanib + interferon alpha 2a,1
29557,pre operativetrastuzumab,1
29558,impact of device 18f-fdopa pet on treatment decisions,1
29559,cryopop,1
29560,quality of recovery-15 questionaire,1
29561,chemoembolization with irinotecan bead,1
29562,clr457,1
29563,5fluorouracil bolus,1
29564,pre-emptive skin treatment,1
29565,nab-paclitaxel+carboplatin,1
29566,dbt mammography,1
29567,vermurafenib,1
29568,hct symptoms and steps,1
29569,25 g soy protein supplement,1
29570,ly2275796,1
29571,psma-based 18f-dcfpyl pet tracer for pet/ct exams,1
29572,"part b, cohort 1- vs-4718, nab-paclitaxel, gemcitabine",1
29573,gm,1
29574,black raspberry (brb) placebo slurry,1
29575,videoconsultation,1
29576,deep local anesthesia + virtual reality,1
29577,epirubicin/cyclophosphamide,1
29578,"melphalan, velcade, thalidomide, dexamethasone",1
29579,fresubin energy drink,1
29580,dose 1,1
29581,"bevacizumab, bicalutamide and goserelin",1
29582,rapidarc,1
29583,gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin,1
29584,tct-t cells,1
29585,part 2; stage 1,1
29586,conventional tumor puncture rfa arm,1
29587,retrospective survival analysis,1
29588,"igf-1r/as odn; surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with igf-1r/as odn within 24 hours of craniotomy, implanted for 48 hours.",1
29589,intracorporeal robot assisted radical cystectomy,1
29590,hybrid capture 2,1
29591,baseline biopsy,1
29592,physician's choice of salvage therapy - lomustine,1
29593,life completion,1
29594,ultrasound transverse scan,1
29595,bcr-abl multipeptide vaccine,1
29596,4scar-gd2,1
29597,first exercise session + compression,1
29598,zsp1603 25 mg,1
29599,probio-fix inum®,1
29600,hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine,1
29601,ultrasound gray-scale ratio,1
29602,"s-1,oxaliplatin",1
29603,autoflow-volume controlled ventilation,1
29604,immediate cediranib,1
29605,pf-06439535,1
29606,internet intervention,1
29607,tumor cell-derivative vaccine therapy,1
29608,cyp2c19 (omeprazole),1
29609,sham comparator: fast shallow breathing,1
29610,investigator's choice drug therapy,1
29611,swus elastography,1
29612,neoadjuvant treatment with capecitabine and oxaliplatin,1
29613,"an iso-caloric, iso-nitrogenous control feed",1
29614,"single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate",1
29615,2g-1 tcr retroviral vector-transduced lyn,1
29616,campth-1h,1
29617,2hg spectroscopy scan,1
29618,treadmill walking phase 1b: dose-expansion,1
29619,pet scan after course 1 and surgery after 8 courses,1
29620,jnj-54767414 (daratumumab),1
29621,high-dose cytarabine (hidac),1
29622,clinical assessments and blood samples; no 12mo follow-up,1
29623,fenretinide (4-hpr) plus intravenous safingol,1
29624,cu-64 rituximab,1
29625,efg816,1
29626,expanded prostate cancer index composite,1
29627,inframammary fold incision,1
29628,endoscopic sub-mucosal dissection,1
29629,korean red ginseng,1
29630,intervention - eswt storz duolith high energy,1
29631,targeted biopsies guided by a fusion of mri and ultrasound- images,1
29632,ak-104,1
29633,lentiviral-based cart meso therapy,1
29634,recombinant vaccinia-muc1 vaccine,1
29635,lgg,1
29636,mc1r testing website,1
29637,intensity modulated radiotherapy (imrt) - standard,1
29638,no intervention but patients are undergoing an upper gi endoscopy and biopsies for clinical purposes,1
29639,cryotherapy (ptc),1
29640,no cell saver,1
29641,ft,1
29642,curcumin c3 tablet,1
29643,no intervation,1
29644,radical prostatectomy (rp),1
29645,high-resolution micro-ultrasound guided prostate biopsy,1
29646,radioiodine (rai),1
29647,r-megachop,1
29648,retrospective medical records analyze,1
29649,patients without antifungal prophylaxis,1
29650,home study support materials,1
29651,levobupivacaine and tramadol,1
29652,non-renorrhaphy,1
29653,recombinant interferon alfa 2a,1
29654,[18f]-fluorodeoxythymidine,1
29655,oxaliplatin + capecitabine (xelox chemotherapy),1
29656,research of druggable molecular alterations on tumor biopsy,1
29657,3-d ultrasound,1
29658,alpha1h,1
29659,virtue sling,1
29660,"ixabepilone, 32 mg/m^2 + carboplatin, 6 mg/min/ml",1
29661,vats three-portal lobectomy and lymphoadenectomy,1
29662,igp-elvis-v4 macroscopic specimen imager,1
29663,"non pegylated liposomal doxorubicin, trastuzumab, docetaxel",1
29664,dcvac add on to soc,1
29665,epirubicin - cyclophosphamide / docetaxel + lapatinib,1
29666,ldac and/or mitoxantrone,1
29667,placebo (for ramucirumab),1
29668,standardized ginger extract,1
29669,swallow fuction and swallow training,1
29670,ags-22m6e,1
29671,psychosocial component,1
29672,icodextrin,1
29673,c-kit inhibitor,1
29674,cpc634 (cripec® docetaxel),1
29675,dietician counseling,1
29676,chinese herbs formula: shu yu wan,1
29677,"surgery (pore excision, curettage, and injection of cymetra)",1
29678,cdb-2914,1
29679,pdt prior to mohs surgery,1
29680,"50 gy, 2 gy/session; 25 fractions",1
29681,tc99m sestamibi,1
29682,bcma car-t cells,1
29683,guadecitabine (sgi-110),1
29684,b-cure laser pro and needles,1
29685,"gemcitabine, erlotinib",1
29686,infuse bone graft (bmp-2),1
29687,distress thermometer and problems list,1
29688,online stress management program,1
29689,type-5 phosphodiesterase inhibitor (sildenafil),1
29690,"cyclophosphamide, capecitabine, methotrexate, celecoxib, pamidronate (or zoledronate)",1
29691,clinical instrumental examinations,1
29692,hippocampal sparing whole brain radiotherapy,1
29693,zevalin plus beam,1
29694,"nutritional and goal-setting education, yoga",1
29695,adhesive compression bandage,1
29696,cetuximab radioimmunotherapy,1
29697,protective analgesia,1
29698,"belinostat, warfarin",1
29699,tethered capsule endomicroscopy (tce),1
29700,pdt-deuteporfin?9 hour),1
29701,vir007,1
29702,hexylaminolevulinate cream,1
29703,current practice,1
29704,tech support only,1
29705,observation: nonintervention,1
29706,device for intrapleural visudyne-mediated low-dose photodynamic therapy with integrated in situ light dosimetry,1
29707,zelboraf,1
29708,unlabelled hmab biwa 4 - low dose,1
29709,"induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (ccrd) regimen",1
29710,bb21217,1
29711,star website,1
29712,surveys and questionnaires,1
29713,tolfenamic acid + gemcitabine + radiation,1
29714,dietary supplementation with control capsules,1
29715,nk infusion,1
29716,annual invitation to mammography,1
29717,som230c lar,1
29718,visualase thermal therapy,1
29719,osteopathic manipulative treatment,1
29720,ono-4578,1
29721,atr kinase inhibitor azd6738,1
29722,laparoscopic ramps,1
29723,montelukast,1
29724,androgen hormonal suppression and radiation,1
29725,pdc-1421 capsule,1
29726,irinotecan and bortezomib,1
29727,experimental: newsletters and peer counseling,1
29728,immediate post operative acupuncture treatment,1
29729,naso-gastric/jejunal tube,1
29730,contrast-enhanced torso ct,1
29731,clinical and psychosocial phone calls,1
29732,isotonic nacl,1
29733,8h9,1
29734,proton to 66.6 cge,1
29735,3d mammography (tomosynthesis),1
29736,two-step remission induction and risk-oriented consolidation,1
29737,transplantation of unrelated cord blood unit(s),1
29738,dtrm-555,1
29739,sedoanalgesia,1
29740,allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy,1
29741,standard endoscopic evaluation,1
29742,live music,1
29743,5-azacytidine until progress,1
29744,axitinib + pemetrexed + cisplatin (cohort 9),1
29745,triportal pulmonary resection surgery,1
29746,mammosite brachytherapy radiation,1
29747,phenergan,1
29748,non-active moisturizing cream,1
29749,gemcitabine platinum combined with erlotinib,1
29750,"retrospective, cross-sectional descriptive analysis",1
29751,systematic consideration of the advice of the ent surgeon in the determination of the radiotherapy target volumes in head and neck cancers.,1
29752,recombinant human hyaluronidase [rhuph20]) sc administration,1
29753,asimadoline,1
29754,l-ascorbic acid,1
29755,tc (docetaxel/carboplatin) versus ec followed by t (epirubicin/cyclophosphamide followed by docetaxe),1
29756,arry-380 once daily,1
29757,hpv-16/18 l1 vlp as04,1
29758,vascular ultrasound,1
29759,nasopharngeal brush,1
29760,mk0731,1
29761,trying activity for kidney cancer survivors (tracks) trial,1
29762,"daratumumab, thalidomide and dexamethasone",1
29763,peri-operative cht,1
29764,inspection and palpation of the gallbladder,1
29765,crispr/cas9,1
29766,subglottic stenosis,1
29767,"rituximab (mabthera) , ffp (fresh frozen plasma)",1
29768,adxs11-001 (adxs-hpv),1
29769,educational programme for smoking and alcohol cessation,1
29770,pembrolizumab - 8 cycle,1
29771,cm-24 (mk-6018),1
29772,bms-911543,1
29773,ibrutinib (arms 2 and 3),1
29774,combo pbf-509 (320 mg) + pdr001,1
29775,enhanced usual care / euc,1
29776,coping and communication support (ccs) intervention,1
29777,visual oral screening examination,1
29778,chidamide qd,1
29779,lung cavitation,1
29780,modradoc003 10mg tablets and modradoc004 10/50 mg,1
29781,text message management prompts,1
29782,cervical samples,1
29783,first line chemotherapy,1
29784,perioperative care pathway guided by cpx results,1
29785,bivalent or quadrivalent hpv vaccines,1
29786,hg146,1
29787,bortezomide,1
29788,respite care,1
29789,bez235 + trastuzumab phase l/phase ll),1
29790,health information,1
29791,eve medical self-collection system©,1
29792,percutaneous radiologic gastrostomy,1
29793,"diffusion weighted mri (dw- mri)- philips achieva 3.0t x, netherlands, 2011",1
29794,comparator: docetaxel,1
29795,anti-tnf drug,1
29796,2nd phase - onabotulinum toxin type-a,1
29797,wooden spatula,1
29798,untreated cb,1
29799,omega-3 fatty acid supplement,1
29800,adjuvant ebrt,1
29801,self-help book,1
29802,"temodar, o6-bg, and irinotecan",1
29803,ic2000 and spy-phi,1
29804,ferumoxtran-10 (combidex),1
29805,pegylated liposomal doxorubicin plus bortezomib,1
29806,egen-001-301,1
29807,standard of care wbrt or srs,1
29808,oc-l,1
29809,adjuvant chemotherapy with cisplatin and docetaxel,1
29810,capecitabine - dose b,1
29811,tissue from diagnostic laparoscopy,1
29812,ibi308\cisplatin\gemcitabine,1
29813,intraperitoneal 5fu,1
29814,"rivaroxaban (xarelto, bay 59-7939)",1
29815,surgical cohort,1
29816,snare tip soft coagulation,1
29817,ct-011 (anti-pd1 antibody),1
29818,auto4,1
29819,"combination of tg6002 and 5-flucytosine (5-fc, ancotil®)",1
29820,enteroscopy,1
29821,medical ultrasound device (shearwave system),1
29822,post-surgical radiation,1
29823,colonic resection with d2 lymph node dissection,1
29824,erlotinib + docetaxel,1
29825,functional electrical stimulation,1
29826,"radiotherapy, dose fractionation",1
29827,inofolic: myo-inositol and folic acid,1
29828,lay navigator intervention,1
29829,formal hypnosis,1
29830,[i-124]-cpd-1028 injection,1
29831,online platform webcore,1
29832,amifostine administered subcutaneously,1
29833,professionally-administered cognitive-behavioral therapy for insomnia (cbt-i),1
29834,brivanib (active),1
29835,vardenafil,1
29836,tibial nerve stimulation,1
29837,panitumumab + chemotherapy,1
29838,salivary equivalent,1
29839,yttrium y 90 anti-cd19 monoclonal antibody bu12,1
29840,blood and salivary sampling of amifostine,1
29841,laparoscopic bursectomy and d2 lymphadenectomy,1
29842,irofulven + capecitabine,1
29843,blind injection of morton neuroma,1
29844,"amg 386 30 mg/kg, capecitabine and lapatinib",1
29845,[f-18]flt,1
29846,"ibi188, rituximab",1
29847,plyometric training program,1
29848,wafarin,1
29849,rocking chair motion,1
29850,daily clinical practice,1
29851,"part a- vs-4718, nab-paclitaxel, gemcitabine",1
29852,t cells modified with rna anti -cmet car,1
29853,chemrad assay,1
29854,hdr vaginal brachytherapy,1
29855,topical ointment,1
29856,treatment by surgical resection,1
29857,interleukin-2 (aldesleukin),1
29858,endorings ii distal attachment,1
29859,cohort 1-bortezomib (velcade ®),1
29860,benazepril hydrochloride,1
29861,"patidegib topical gel, vehicle",1
29862,oxaliplatin sr96669,1
29863,lymph node removal procedure,1
29864,ultralow-dose-ct,1
29865,sorafenib+pazopanib,1
29866,doctor experience,1
29867,cognitive tests,1
29868,installation or registration of smartphone application,1
29869,sunitinib and rapamycin (drug will be held),1
29870,paclitaxel dose escalation,1
29871,mcla-117 bispecific antibody,1
29872,su011248/trastuzumab,1
29873,telephone interactive system,1
29874,"clinical, venous blood samples, pancreatic tissue",1
29875,providing general information about crc sreening,1
29876,standard dose radiation,1
29877,medications for acromegaly,1
29878,g-pert,1
29879,genetically engineered ny-eso-1-specific t lymphocytes,1
29880,"surgery for pilonidal disease, karydakis operation",1
29881,pillcam® colon 2 procedure-control,1
29882,clomiphene citrate with ethinyl esteradiol,1
29883,subjects received 3 doses of gsk biologicals' hpv vaccine (580299) (cervarix™),1
29884,genetic counselling only,1
29885,atacicept,1
29886,written educational brochure,1
29887,cbt-1,1
29888,18f-alf-nota-neurotensin,1
29889,muc1 peptide-poly-iclc adjuvant vaccine,1
29890,stereotactic radiosurgical boost,1
29891,multiple drug microinjection,1
29892,totally laparoscopic total gastrectomy,1
29893,7800 cgy/39 fractions in 8 weeks,1
29894,epacadostat 25 mg,1
29895,transarterial chemoembolization using tandem and idarubicin,1
29896,hot compress plus tobramycin drops and ointment,1
29897,self-reported signs & symptoms of cipn,1
29898,contrast-enhanced whole brain mri,1
29899,"cyclophosphamide, dexamethasone",1
29900,erlotinib and bortezomib,1
29901,nutritional support before operation,1
29902,bl-nhl,1
29903,remifentanyl,1
29904,inoperable thoracic nodes metastases,1
29905,th-302 combination with pemetrexed,1
29906,robotic-assisted gastrectomy(rag),1
29907,vincristine in consolidation-3,1
29908,combined administration of irinotecan and rapamycin,1
29909,noninvasive method of icp measurements (elios),1
29910,18f-fdg pet combined with ct with iodinated contrast injection,1
29911,eox,1
29912,50mg/m2 rituximab,1
29913,needle based cle,1
29914,neurological examination/questionnaires,1
29915,dose escalated radiochemotherapy up to 84 gy,1
29916,tch chemotherapy,1
29917,"il-1, tnf-alpha, il-10",1
29918,in-person active surveillance,1
29919,manufacturer (vpap st),1
29920,cognitive behavioral stress management,1
29921,liver-pilp kit,1
29922,interferon-alpha (inf-a),1
29923,"docetaxel, cisplatin, and capecitabine",1
29924,recombinant human gcsf (shantha biotechnics limited),1
29925,bariatric surgery,1
29926,pet / ct,1
29927,1rg-cart/m^2 (dose level 1),1
29928,paclitaxel + atezolizumab,1
29929,lumpectomy/mastectomy,1
29930,one-stage ultrasound guided hepatectomy,1
29931,tumor biopsies / tumor surgery,1
29932,gliadel wafers,1
29933,smartmatrix dermal replacement scaffold,1
29934,vats uni-portal lobectomy and lymphoadenectomy,1
29935,progenipoietin,1
29936,myelogram,1
29937,imrt followed by mpmri guided sbrt boost with sib to intraprostatic lesions,1
29938,mass spectrometer analysis of tissue sample,1
29939,ketoprofen,1
29940,traditional pre-test genetic counseling,1
29941,hdr partial prostate brachytherapy,1
29942,gallium-68 dotatoc,1
29943,neurofeedback,1
29944,scalp block,1
29945,irintoecan,1
29946,ativan®,1
29947,experimental smoking cessation smartphone app,1
29948,supportive programming,1
29949,sodium (na) magnetic resonance imaging (mri),1
29950,firmagon given by prescription according to spc,1
29951,carboplatin/paraplatin,1
29952,rta 744 injection,1
29953,injectable clostridial collagenase,1
29954,foliri plus e7820,1
29955,d-cik,1
29956,single dose sbrt and vmat technique,1
29957,"propofol+ rocuronium+ fentanyl 2 mcg/kg+ inhalational agent, bupivacaine 0.125% + fentanyl 5 mcg/ml",1
29958,"mylotarg associated with conventional chemotherapy (arac + daunorubicin),",1
29959,ganoderma spore lipids,1
29960,30 gy if-rt,1
29961,daratumumab subcutaneous (sc) administration,1
29962,dendritic cell-precision t cell for neo-antigen combined with gemcitabine treatment,1
29963,merck 3475 pembrolizumab,1
29964,myamino,1
29965,cyclophosphamide and fludarabine,1
29966,cetuximab; mfolfox6,1
29967,[18f]-ml-10,1
29968,pet/ct (low-dose),1
29969,nintedanib-placebo,1
29970,bleomycin sulfate (blm),1
29971,health chat including indoor tanning,1
29972,hdr brachytherapy boost,1
29973,curcumin-mtd,1
29974,cm-bc2,1
29975,intraarterial cetxuimab (erbitux),1
29976,ks24.22 cells,1
29977,surgical neuronavigation with 18f-dopa pet imaging,1
29978,siennaxp,1
29979,anti-vegfr2 car cd8 plus pbl,1
29980,68ga rm2,1
29981,lomustine/vincristine/procarbazine,1
29982,cetugex™,1
29983,earlytect colon cancer,1
29984,placebo tens,1
29985,yttrium-90 microspheres (therasphere mds nordion),1
29986,offering an online risk assessment questionnaire,1
29987,biosample and imaging collection,1
29988,metotrexate,1
29989,fsfi,1
29990,the first donor's stem cell,1
29991,standard health educational booklet,1
29992,gastroesophageal cancer surgery,1
29993,3d mrsi,1
29994,oxaliplatin intravenous,1
29995,biopsy(ies) during high resolution anoscopy,1
29996,conect,1
29997,positron emission tomography (pet/ct).,1
29998,"epidural 250ml of 0.2% ropivacaine and 2 ?g/ml of fentanyl, 5 ml/hr continuous infusion and 0.5 ml bolus dose",1
29999,standard two field lymphadenectomy,1
30000,"urc10, ttk, koc1",1
30001,montanide adjuvant + gm-csf (this arm is closed),1
30002,20 gy low-kv iort,1
30003,semi directive interview,1
30004,the ginsenoside rg3,1
30005,cetuximab (crc),1
30006,"folfox4 chemotherapy,post-operative",1
30007,infliximab + prednisone,1
30008,light physical activity 2,1
30009,[f-18] vm4-037,1
30010,"""my health"" (health education program)",1
30011,sorafenib dose escalation,1
30012,salpingo-oophorectomy,1
30013,"cyclophosphamide 50mg/kg/day iv on days -2,-1",1
30014,geriatric assessment and quality of life,1
30015,tg-0054,1
30016,continuous epidural infusion,1
30017,allograft (frozen femoral head),1
30018,pre liver transplantation laparoscopic hand assisted staging,1
30019,calrlong36 peptide,1
30020,supersonic imagine aixplorer swe ultrasound imaging,1
30021,stimulating acupressure,1
30022,awake craniotomy,1
30023,gen 1b,1
30024,sms/mms text messaging,1
30025,gallium dotatate,1
30026,data collection about eligible patients presented to our department from 2015 to 2018. then follow up for 2 years till 2020.,1
30027,sglt-2 inhibitors,1
30028,mri mapping to guide pathological sampling of extranodal tumour deposits,1
30029,myl-1401h,1
30030,part 2: tk216,1
30031,quality of life questionnaire (qlq),1
30032,allogenic stem cell transplant (asct),1
30033,sham massage,1
30034,"indirect calorimetry, accelerometer and seven-day dietary recall",1
30035,pet scanning,1
30036,culturally-adapted decision support navigation intervention,1
30037,correlation between molecular anomalies of the primary tumor and circulating tumor dna,1
30038,breathe anew survivorship program,1
30039,klh vaccine,1
30040,zinc-containing multivitamin,1
30041,"5-fluorouracil, hydroxyurea-[fhx], bevacizumab",1
30042,"ngs, ihc",1
30043,docosahexaenoic acid,1
30044,votrient,1
30045,autologous tumor lysate-pulsed dc vaccination,1
30046,extended information,1
30047,microarray profiling of primary tumors,1
30048,best standard of care (bsoc),1
30049,standard of care distressed in study arm distressed,1
30050,prophylactic gpbpci,1
30051,wgt3x-bt actigraph,1
30052,oral microbiota assessment,1
30053,nestis® jet injector system with a bi-functional catheter,1
30054,xaluprine,1
30055,vacuum assisted closure,1
30056,self-monitored exercise,1
30057,palatal augmentation prosthesis (pap),1
30058,tace for hcc with portal vein invasion,1
30059,d3 resection,1
30060,mesalamine 2400 mg (5-asa),1
30061,acupuncture treatment 1,1
30062,99mtc-mip-1404 injection,1
30063,proteomic analysis,1
30064,zometa + neoadjuvant therapy,1
30065,3 pomx capsules,1
30066,breath sampling,1
30067,experimental 1: ketogenic diet (kd).,1
30068,ad17137 topical treatment,1
30069,"surgical og radiological intervention, antibiotics",1
30070,bortezomib and g-csf,1
30071,"molecular profiling, patient derived cells",1
30072,aida,1
30073,provider reporting,1
30074,middle accelerated radiotherapy 70 gy in 6 weeks,1
30075,mailed invitation,1
30076,waitlist,1
30077,elagolix dose 1 plus estradiol/norethindrone acetate,1
30078,modufolin,1
30079,enhanced usual care group (arm c),1
30080,adjuvant external beam radiation therapy,1
30081,mifepristone vaginal tablets,1
30082,bms-641988 (ar#2),1
30083,no further alnd arm,1
30084,therasphere hud,1
30085,vuelock™ anterior cervical plate,1
30086,velcade administered by intravenous infusion,1
30087,salvage therapy cytosar and mitoxantrone,1
30088,acute postoperative pain,1
30089,ngr-htnf plus best investigator's choice (bic),1
30090,cysectomy,1
30091,serial liquid biopsy,1
30092,68ga-dotanoc pet/ct and 18f-fdg pet/ct in net,1
30093,european taxotere®,1
30094,mdasi questionnaire,1
30095,usual mal-pdt,1
30096,"mr-based image-guided, intensity-modulated radiotherapy",1
30097,bendamustine and rituximab induction followed by rituximab and lenalidomide maintenance,1
30098,bevacizumab and hipec (oxaliplatin 360 mg/m2).,1
30099,stool sample collection kit,1
30100,observation (no treatment),1
30101,magnesium oxide supplement,1
30102,"cohort 1, ceplene® and proleukin®",1
30103,conventional analgesic treatments,1
30104,sr-t100 gel with 1.0% of sm,1
30105,endostatins (endostar),1
30106,lumiliximab + fcr,1
30107,cetuximab plus irinotecan synchronously,1
30108,abdomen ct,1
30109,cytological imprints,1
30110,thermotron rf-8,1
30111,passive ankle pump motions on the day of surgery,1
30112,deferoxamine and conventional tace,1
30113,breast reconstruction decision aid,1
30114,hdr 2 fraction,1
30115,navigo,1
30116,tg-0054 combined with g-csf,1
30117,non-steroidal anti-inflammatory drugs,1
30118,1.0g/kg of 20% mannitol,1
30119,conjugated estrogens/bazedoxifene,1
30120,enzastaurin (ly317615) monohydronchloride,1
30121,cardiac magnetic resonance imaging (cmr),1
30122,neukoplast™ (nk-92),1
30123,89zr-gc1008,1
30124,medtronic intrathecal pump,1
30125,nivolumab (240 mg),1
30126,vemurafenib + cobimetinib,1
30127,yf476 placebo,1
30128,y-zevalin,1
30129,neurocap®,1
30130,plx7486 tsoh,1
30131,dosi,1
30132,loperamid treatment,1
30133,contrast-enhanced ultrasonography (ceus),1
30134,rranibizumab 0.5 mg,1
30135,smarttarget therapy,1
30136,modified folfiri,1
30137,rhendostatin,1
30138,capecitabine orally days 1 -21,1
30139,pacox,1
30140,complete mesocolic excision (cme),1
30141,two-dimensional shear-wave elastography (swe),1
30142,145 mg/m2 nktr 102,1
30143,fenugreek seeds extract 500 mg,1
30144,daily cone beam ct for imaging guidance for radiotherapy,1
30145,suramin drug:docetaxel drug: carboplatin,1
30146,lv5fu2 + irinotecan,1
30147,dabrafenib 150 mg twice a day (bid),1
30148,mailed outreach invitation and patient navigation,1
30149,ct and mri with contrast,1
30150,"""perpdt""",1
30151,"epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile",1
30152,bhr-200 (0.36% transdermal 17?-estradiol gel),1
30153,autologous anti-mart-1 f5 t-cell receptor,1
30154,talacotuzumab 9 mg/kg,1
30155,poly ic-lc,1
30156,tannenbaum 10 fr biliary stent,1
30157,mtx 2,1
30158,trivalent inactivated influenza vaccine,1
30159,novottf-100l(p) device,1
30160,tobacco treatment program,1
30161,painreportit,1
30162,phase 2: cyclophosphamide,1
30163,physical function tests,1
30164,hydromorphone hcl oros,1
30165,doxorubicin and cyclophosphamide (ac) + bevacizumab,1
30166,ultralow anterior rectal resection with total mesorectal excision,1
30167,oshadi d & oshadi r;,1
30168,anti-cd33 cart,1
30169,apatinib single agent,1
30170,high dose rate brachytherapy,1
30171,aml induction (placebo),1
30172,mkd,1
30173,dhap rescue and f+c,1
30174,simvastatin and metformin,1
30175,gemcitabine and fractionated cisplatin (combination treatment),1
30176,lam-002a,1
30177,no early bladder training and no bethanechol chloride,1
30178,"write, draw and interview",1
30179,day hospitalization exclusively,1
30180,mri contrast agent combidex (ferumoxtran-10),1
30181,vec + hd-mtx,1
30182,laser and mld combined,1
30183,sdregn2810,1
30184,potassium titanyl phosphate (ktp),1
30185,physical activity education pamphlet,1
30186,stereotactic radiation arm 4,1
30187,depocyte®,1
30188,placebo to asa,1
30189,socio-aesthetic care,1
30190,gastropanel test,1
30191,ndl-pdt,1
30192,endowrist,1
30193,electrodessication,1
30194,collection of salivary cytokines,1
30195,abdominal ultra sound,1
30196,sham radiotherapy,1
30197,sci hard,1
30198,intra-arterial injection of melphalan,1
30199,nccn radiation,1
30200,curcumin (turmeric),1
30201,corticosteroid: methylprednisolone,1
30202,siltuximab11 mg/kg,1
30203,saliva collection prior to clinically driven oral biopsy,1
30204,"paclitaxel, cisplatin, pegfilgrastim",1
30205,eob-mri,1
30206,health related quality of life using the functional assessment of cancer therapy - gynecologic oncology group neurotoxicity scale (fact gog/ntx),1
30207,tln-4601,1
30208,"blood draw, bone marrow procedure, or tissue biopsy",1
30209,symptom education,1
30210,extended release of placebo,1
30211,gefitinib combined with chemotherapy,1
30212,fludarabine 25 mg/m² d 1-3 + rituximab 375 mg/m² d 1 q4w,1
30213,whole breast radiation,1
30214,blr-nhl,1
30215,indoor exercise,1
30216,(cisplatin 80 mg/?+5fu 800mg/?×5days)×2?surgery,1
30217,cart-meso cells,1
30218,minos protocol,1
30219,alvac ny eso-1 vaccine,1
30220,r-ceop-90,1
30221,capecitabine/cisplatin(xp),1
30222,medi6469 monotherapy,1
30223,normal colorectal tissues,1
30224,lobectomy followed by concomitant mediastinal chemoradiotherapy,1
30225,custom pack,1
30226,"steroid therapy, hematopoietic stem cell transplantation",1
30227,everolimus 2.5 mg/day,1
30228,autologous human anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes,1
30229,early-drain removal,1
30230,mk-8808,1
30231,ultrasonography after removal of the drains,1
30232,sub study - 18 fhbg pet/ct scans,1
30233,double-labeled water,1
30234,iodine i 123 anti-cea recombinant diabody t84.66,1
30235,mesh enforced cruciate incision,1
30236,"docetaxel, cisplatin, fluorouracil, bevacizumab, leucovorin",1
30237,ga + paravertebral block,1
30238,placebo lapatinib,1
30239,mri/ct scan,1
30240,pai/ultrasound diagnostic group,1
30241,he stain,1
30242,"dexamethasone, vindesine, methotrexate, ifosfamide, daunorubicin, pegylated-asparaginase",1
30243,[f-18] fluorinated dihydrotestosterone (fdht),1
30244,ldac (low dose cytosine arabinoside),1
30245,gemcitabine oxaliplatin 5fu and leucovorin,1
30246,js001?an engineered anti-pd-1 antibody,1
30247,ct/pet scans,1
30248,4 ec q 2 weeks followed by 4 txt q 2 weeks,1
30249,velcade™,1
30250,tevagastrim,1
30251,dalantercept plus sorafenib,1
30252,family history: number format,1
30253,chemo with concomitant capecitabine and kd018,1
30254,apatinib s-1 radiotherapy,1
30255,eus-b-fna followed by eus-fna for lag analysis,1
30256,csa system (cryospray ablationtm system),1
30257,eus guided fna and fine needle punction,1
30258,odm-201 capsule formulation,1
30259,peg-interferon alpha-2b,1
30260,cd34+ cells selected with the miltenyi clinimacs machine,1
30261,dc/aat-flu,1
30262,ozarelix,1
30263,low/medium intensity exercise,1
30264,allogeneic hematopoietic sct,1
30265,tivozanib + capecitabine,1
30266,tiva+lidocaine,1
30267,surgery (standard of care),1
30268,patient-collected cervical pap smear,1
30269,depot leuprolide plus estrogen/progestin replacement,1
30270,narrowband-ultraviolet light b,1
30271,aixplorer® shearwave elastography (swe™),1
30272,"compression vest, thuasne",1
30273,default,1
30274,peripheral blood stem cell donation,1
30275,endorings-2,1
30276,be resilient to breast cancer,1
30277,whole brain radiation therapy arm,1
30278,telephone arm,1
30279,2% morphine solution,1
30280,msc2363318a plus trastuzumab,1
30281,patient with ovarian epithelial cancer,1
30282,pdt with placebo cream,1
30283,omp-54f28,1
30284,"avastin® (bevacizumab, reference product)",1
30285,surgical removal of tumor tissue for t cell production,1
30286,sorafenib:,1
30287,gdc-0853,1
30288,adjuvant transarterial chemoinfusion (tai),1
30289,sm-edtmp (higher dose),1
30290,rituximab +bendamustine,1
30291,nutritional education.,1
30292,complete salpingectomy,1
30293,hypofractionation with sib,1
30294,mri assisted trus guided biopsy,1
30295,health communication student review - text messages,1
30296,roux en y,1
30297,apbsct,1
30298,automated visual field,1
30299,gynecological cancer,1
30300,cm4307,1
30301,rectus sheath block (rsb),1
30302,fulvestrant injectable product,1
30303,facit-fatigue 52-point questionnaire,1
30304,octreotide lar (long-acting release),1
30305,bonfils fiberscope intubation,1
30306,legumes,1
30307,3% diclofenac in 2.5% hyaluronic acid gel,1
30308,dnr.npc-specific t cells,1
30309,assess pain intensity at last office visit preoperatively,1
30310,mf-ssrs,1
30311,gentuximab injection,1
30312,c46/ccr5/p140k lentiviral vector-transduced autologous hspcs,1
30313,smartphone-triggered bodily interventions,1
30314,rimo-301,1
30315,all-trans-retinoid acid,1
30316,hepatic vein-sparing hepatectomy,1
30317,fluorouracil (5-fu) 1000 mg/m^2 plus carboplatin or cisplatin,1
30318,hyperfractionated radiochemotherapy,1
30319,integrative care,1
30320,ly3114062 sc,1
30321,administration of high dose simplified folfiri,1
30322,regorafenib + panitumumab,1
30323,myofascial release,1
30324,hepatic arterial catheter implantation,1
30325,sham laser sessions,1
30326,incresync,1
30327,group-based intervention,1
30328,"hdct 1(ttc), hdct2(mec)",1
30329,vls-101,1
30330,peer pn,1
30331,gadofosveset contrast agent enhanced mri axilla,1
30332,omega-3 enriched fruit juice,1
30333,iodine-131 anti-b1 antibody versus anti-b1 antibody in chemotherapy-relapsed/refractory low-grade or transformed low-grade non-hodgkin's lymphoma (nhl),1
30334,postop imrt for head/neck cancer,1
30335,y-90,1
30336,annual noncontrast mri,1
30337,lipiflow system,1
30338,parathyroid cytology,1
30339,biomarkers testing,1
30340,culturally targeted photo novella booklet,1
30341,adjuvant chemotherapy by fotemustin,1
30342,durvalumab with carboplatin/paclitaxel,1
30343,autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine,1
30344,prompts to report symptoms via the web-enabled app,1
30345,chamomile oral cryotherapy,1
30346,tumor rna disruption assay™ (rda),1
30347,tislelizumab carboplatin paxlitaxel,1
30348,robotic thoracic surgery,1
30349,"70% animal, 30% plant proteins in diet",1
30350,trigrid delivery system,1
30351,5-day tmz,1
30352,sbrt + durvalumab,1
30353,ablacare kit,1
30354,pap test,1
30355,contrast-enhanced spectral mammography (cesm),1
30356,biopsy samples,1
30357,fat reduction with increased fiber,1
30358,superparamagnetic iron oxide magnetic resonance imaging,1
30359,steroid therapy,1
30360,ima 950,1
30361,5-ala plus blu-light,1
30362,gm.cd40l vaccine,1
30363,fitbit versa,1
30364,cpt-11 and ts-1,1
30365,small milk casein-derived polypeptides (12 weeks daily),1
30366,[18f]ge-226,1
30367,concurrent chemo radiotherapy,1
30368,ixabepilone (ixempra),1
30369,rapidstrand seeds for use with 18g needle,1
30370,"bendamustine, rituximab, lenalidomide",1
30371,counselling based on yoga,1
30372,daromun,1
30373,sodium fluoride (naf) positron emission tomography/computed tomography (pet/ct) imaging,1
30374,neoadjuvant therapy with cisplatin plus docetaxel,1
30375,scheduled radiologic evaluations,1
30376,standard nccn counseling and oncotype dx results,1
30377,"gemcitabine, ts-1",1
30378,"mesna, cisplatin, etoposide, rituximab",1
30379,proactive cell phone smoking cessation counseling,1
30380,baxter isolex 3001 stem cell selection system,1
30381,oc-dc vaccine,1
30382,investigator choice (ic) chemotherapy,1
30383,mri guided intensity modulated radiotherapy (imrt) planning,1
30384,image-guided radiation therapy using 3d ultrasound guided-therapy,1
30385,voc detection in breath and in skin headspace,1
30386,ipilimumab 1mg/kg,1
30387,transvaginal extraction,1
30388,episil®,1
30389,tumour infiltrating lymphocytes,1
30390,advance/advancexp,1
30391,oral antibiotics,1
30392,"docetaxel 50 mg/m2, 1-hour-infusion, day 1",1
30393,magseed® localization,1
30394,routine central neck dissection,1
30395,mercaptopurine 50mg tablet,1
30396,2% rebamipide liquid,1
30397,chidamide with ice regimen,1
30398,herceptin (her2-neu positive patients only),1
30399,uncut roux-en-y gastrojejunostomy,1
30400,cisplatin & nab paclitaxel,1
30401,beta carotene and retinol,1
30402,combination of two marketed drugs (irinotecan and cisplatin),1
30403,aromatase inhibitors (aromasin),1
30404,goserelin with dutasteride,1
30405,treatment for est,1
30406,fluglucoscan injection (18f-fdb) pet scan,1
30407,w0101 - cohort a2,1
30408,ebv-specific cytotoxic t lymphocytes,1
30409,granisetron iv,1
30410,thoracoscopy/vats,1
30411,lar,1
30412,patient education: one-on-one visit,1
30413,s-1 concurrent radiotherapy,1
30414,19 gauge,1
30415,"gemcitabine, oxaliplatin, photodynamic therapy (photosan®)",1
30416,on 01910.na concentrate,1
30417,"atezolizumab (mpdl3280a), an engineered anti-programmed death-ligand 1 (anti-pd-l1) antibody",1
30418,prednisone in induction,1
30419,abiraterone acetate (zytiga): prostate cancer registry,1
30420,olaparib treatment c,1
30421,4-peptide melanoma vaccine,1
30422,general health counselling and risk information,1
30423,standard neck dissection,1
30424,anti-cd22 car nk cells,1
30425,total laparoscopic hysterectomy,1
30426,multimodal spectroscopy,1
30427,randomization between two established chemotherapies,1
30428,"fiducial markers, pet and mri",1
30429,early antibiotic discontinuation,1
30430,carmustine bcnu,1
30431,adjuvant capecitabine,1
30432,urea hand-foot cream,1
30433,cipralex,1
30434,"vincristine, carboplatin and etoposide",1
30435,labs,1
30436,change intervention,1
30437,anti-egfr immunoliposomes loaded with doxorubicin,1
30438,amg 386 with or without trastuzumab,1
30439,15% as101 gel,1
30440,resting,1
30441,cohort 1 adjuvant,1
30442,ultrasound biopsy needle sharkcore,1
30443,yoga skills training,1
30444,prl3-zumab,1
30445,navy beans (canned),1
30446,comparator drug,1
30447,4scar19 and 4scar22,1
30448,ldr-brachytherapy with i125 seeds,1
30449,fursultiamine,1
30450,ag 6013736,1
30451,laparoscopic right-hemicolectomy,1
30452,"diagnostic cervical cancer screening tests (pap smear, hpv and/or p16)",1
30453,"tyroserleutide for injection ,chemotherapy(mitomycin, and fluorouracil )",1
30454,single infusion of 124i-labeled anti-amyloid mab 11-1f4: 2 mci (1 mg),1
30455,recent physical activity questionnaire,1
30456,c-cpt,1
30457,22-gauge needle,1
30458,hybrid dyna-ct guided localization,1
30459,reading of automated breast ultrasound in conjunction with screening mammography,1
30460,"bevacizumab, pemetrexed, carboplatin",1
30461,external beam radiation therapy (rt),1
30462,vte treatment in cancer patient description,1
30463,"bs, spect/ct, pet/ct, mri",1
30464,eusra rf electrode,1
30465,cisplatin iv,1
30466,vyxeos,1
30467,shear wave elastography (swe),1
30468,near infrared fluorescence (nirf),1
30469,"cyclophosphamide, vincristine, cytarabine, doxorubincin, prednisone",1
30470,lymph node clearing technique with carnoy solution,1
30471,lapatinib (1500 mg qd),1
30472,s-1 + irinotecan,1
30473,es414,1
30474,endoscopic injection of spot,1
30475,solvent with specific gravity equivalent to lipiodol,1
30476,pet-adaptive rt,1
30477,fda-approved drug or combination of drugs,1
30478,vemurafenib (post surgery) - group a + c,1
30479,small media,1
30480,ohr/avr118,1
30481,lletz cone,1
30482,eribulin mesylate 1.4 mg/m^2 intravenous,1
30483,the navigator tool intervention,1
30484,tp,1
30485,genetically modified t cells # 1138,1
30486,evaluation of functional status,1
30487,melatonin 3 mg,1
30488,axitinib 1 mg,1
30489,standard polypectomy snare,1
30490,docetaxel + trastuzumab,1
30491,music-based meditation,1
30492,arm a: pemetrexed cisplatin,1
30493,"treatment of choice ( topotecan, pegylated liposomal doxorubicin, or paclitaxel)",1
30494,stereotactic body radiotherapy (sbrt) 54 gy 3 fractions (#),1
30495,ny-eso-1 combined with mpla vaccine,1
30496,surgical resection of a brain tumor,1
30497,carboplatin auc 2/paclitaxel,1
30498,homeopathic remedies,1
30499,without tdt,1
30500,fenretinide lym-x-sorb oral powder,1
30501,pre-treatment and progression tumor biopsies,1
30502,transcranial doppler (tcd),1
30503,"s-1, gemcitabine, cisplatin",1
30504,fluorometholone eye drops (fml forte®),1
30505,m4344,1
30506,blood analysis by epispot and cellsearch,1
30507,160 mg trimethoprim and 800 mg sulfamethoxazole,1
30508,second examination,1
30509,docetaxel weekly+ prednisone,1
30510,fludarabine and cyclophosphamide,1
30511,vincristine sulfate liposome injection plus rituximab,1
30512,omegaven 10%,1
30513,radiosurgery with gamma knife perfexion,1
30514,vemurafenib (vem),1
30515,inbody 720,1
30516,radiotherapy 62-64 gy in 22-23 d (31-32 f of 2 gy bid),1
30517,biopsy or cytopuncture,1
30518,glycolic acid,1
30519,myfortic,1
30520,dasatinib + placebo,1
30521,simultaneous-integrated boost intensity-modulated radiation therapy,1
30522,dose-escalation stage,1
30523,tae plus p53 gene,1
30524,panobinostat/lbh589,1
30525,anti-cd19 car-t cells injection,1
30526,chemoradiotherapy (cxrt),1
30527,standard ids (interval debulking surgery),1
30528,wbrt without avoidance of hippocampus,1
30529,reinforcement with light polypropylene mesh,1
30530,traditional closure,1
30531,ct scan (standard),1
30532,bpx-501 dose 3,1
30533,wt2725,1
30534,microrna,1
30535,choice decision aid,1
30536,oratecan and capecitabine,1
30537,weekly paclitaxel and carboplatin,1
30538,imgn529,1
30539,best supportive/best standard of care,1
30540,multimedia psychoeducational intervention,1
30541,support calls,1
30542,abbv-075,1
30543,everolimus followed by pasireotide lar + everolimus,1
30544,sparc1613,1
30545,hysteroscopic resection with monopolar energy,1
30546,jx-594 followed by sorafenib,1
30547,poly-iclc combination treatment with apd-1 (nivolumab or pembrolizumab) or apd-l1 (atezolizumab or durvalumab) over 6 months,1
30548,toremifene 20 mg,1
30549,lifetime total physical activity questionnaire,1
30550,segmental artery clamping,1
30551,cdop plus rituximab,1
30552,allogeneic hemopoietic stem cell transplant,1
30553,experimental drug,1
30554,peaches,1
30555,anti-cd19-car pbl,1
30556,tablet pyridoxine hydrochlorid,1
30557,h3b-8800,1
30558,diagnostic surgical procedure,1
30559,physical activity training,1
30560,post-lavage peritoneal washing cytology,1
30561,ophthalmology examination,1
30562,recombinant humanized anti-pd-1 monoclonal antibody injection,1
30563,home-based palliative care,1
30564,roux-en y gastrojejunostomy,1
30565,pledox (5 µmol/kg),1
30566,arm c,1
30567,ifosfamide and doxorubicin vs gemcitabine and docetaxel,1
30568,patient-reported outcomes questionnaire,1
30569,sonoelastography,1
30570,avelumab 800 mg in combination with pemetrexed / carboplatin,1
30571,contour se™ microspheres,1
30572,low dose lx1606 - day 1 (start),1
30573,received hpv vaccine first,1
30574,oc-igt cells,1
30575,dce-mri and quantitative doppler ultrasound,1
30576,vt-122,1
30577,mucosal impedance,1
30578,conditionally replicative adenovirus 3/5-delta,1
30579,letter,1
30580,docetaxel and reolysin,1
30581,peci/spb block with active anesthetic + placebo multilevel intercostal nerve block followed by latissimus dorsi flap breast reconstruction,1
30582,orange,1
30583,functional photoacoustic microscopy,1
30584,ic+ccrt,1
30585,volitinib(hmpl-504),1
30586,paper decision board,1
30587,btg-002814 (vandetanib-eluting radiopaque beads),1
30588,umbilicus preserving surgery,1
30589,conventional oxygen treatment,1
30590,iniparib (sar2405550 -bsi-201),1
30591,belotaxel,1
30592,lipotecan® (tlc388),1
30593,multi-fields radiotherapy,1
30594,"stilling the waters of uncertainty: a yoga program for women with gynecologic, gastrointestinal (gi), or thoracic cancer",1
30595,isotonic saline (perfusate),1
30596,chemotherapy and/or radiation therapy,1
30597,sct510,1
30598,ibrutinib combined with as2o3,1
30599,arm b : adjuvant folfox group,1
30600,armodafinil 150 mg,1
30601,delayed weight loss program group,1
30602,conventional roux-en-y gastrojejunostomy,1
30603,distant healing,1
30604,placebo for shape (shp-141),1
30605,darbepoetin alfa (aranesp®),1
30606,associating liver partition and portal vein ligation for staged hepatectomy,1
30607,neuro-cognitive testing (cogstate),1
30608,autologous melanoma lysate-pulsed autologous dendritic cell vaccine,1
30609,[131i]-sgmib anti-her2 vhh1,1
30610,jnj-64041809 (cohort 2a and 2b),1
30611,mose,1
30612,no music therapy,1
30613,dc/rcc fusion vaccine,1
30614,eltrombopag and vorinostat,1
30615,conventional photon radiation plan,1
30616,short-course radiotherapy,1
30617,sequential ivm system,1
30618,maitake,1
30619,hbv screening - small group educational session,1
30620,magnetic nanoparticle injection,1
30621,calcitriol + gemcitabine,1
30622,leo 43204 formulation 1 dose y,1
30623,liver radiation therapy,1
30624,brief test of attention,1
30625,abiraterone acetate standard dose,1
30626,apatorsen (ogx-427),1
30627,sevoflurane-remifentanil,1
30628,branch iii,1
30629,cisplatin 100mg/m² concurrent chemotherapy,1
30630,sodium chloride 0.9%,1
30631,evaluation of port-a-cath®,1
30632,endorotor mucosal resection system,1
30633,recombinant fowlpox-tyrosinase vaccine,1
30634,tetanus-diphtheria toxoid (td),1
30635,metformin plus folic acid,1
30636,bx3,1
30637,cervical brush,1
30638,halt procedure,1
30639,part a - azd9291 in combination with medi4736,1
30640,hydrocodone,1
30641,centrally located lung tumor,1
30642,surveys & mailed materials,1
30643,manuka honey in liquid form,1
30644,lung tumor biopsy,1
30645,"docetaxel , cisplatin , capecitabine",1
30646,radiosurgery dose escalation,1
30647,thc alone,1
30648,initial fasting,1
30649,cetuximab/imrt plus ipilimumab,1
30650,valproic acid and 2-chlorodeoxyadenosine,1
30651,dose level 4 onc201 250mg,1
30652,captivator cassette,1
30653,print materials,1
30654,pf-3512676 + erlotinib,1
30655,permanent breast seeds implant,1
30656,pilonidal sinus excision,1
30657,melphalan and bortezomib,1
30658,le-dt,1
30659,test result conveyed by general practitioners,1
30660,secondary debulking with intraperitoneal chemotherapy,1
30661,decision aids (tamoxifen-related educational materials in brochure or mobile app),1
30662,clonidine lauriad® 100µg,1
30663,dexamethasone iv,1
30664,consultation with survivorship navigator,1
30665,tqb2450 injection and anlotinib hydrochioride capsules,1
30666,genetic test,1
30667,telephone-based coping skills training (cst),1
30668,mesna (mercaptoethane sulfonate),1
30669,targeted therapy based on molecular profiling : abiraterone,1
30670,full cdt,1
30671,garment sleeve,1
30672,subcutaneous heparin,1
30673,111in-exendin-4 imaging,1
30674,prophylaxis cranial radiotherapy,1
30675,stoppage of antibiotics,1
30676,all concerns tailored intervention,1
30677,lcl-161,1
30678,albuterol nebulizer,1
30679,brightmatter™ products,1
30680,fgf401,1
30681,asp,1
30682,paclitaxel plus cisplatin with radiotherapy,1
30683,motor control therapy,1
30684,selective internal radiation therapy with quiremspheres®,1
30685,b1: amg 386 10 mg/kg + topotecan,1
30686,clr 131 single dose,1
30687,usual care group - outcome measures,1
30688,any non-gemcitabine chemotherapies or best supportive care,1
30689,mitomycin + gemcitabine,1
30690,light-activated au-011,1
30691,npi-0052 (marizomib) + vorinostat,1
30692,exercise group,1
30693,malnutrition screening and perioperative nutritional support,1
30694,endobronchial or endoscopic ultrasound,1
30695,testosterone enanthate 100 mg/ml,1
30696,a) cbc . b) rbg. c)kft. d) lft.,1
30697,telephone interpersonal counseling (tip-c),1
30698,hcg hormone,1
30699,nir fluorescence endoscopy,1
30700,breast cancer treatment,1
30701,monoclonal antibody 3a1,1
30702,4 mg/kg gr-md-02,1
30703,endoresection,1
30704,monoclonal antibody 95-6-22,1
30705,pathological evaluation,1
30706,cis/carboplatin and etoposide,1
30707,blue light photodynamic therapy,1
30708,"standard white-light endoscopy (pentax, 90i)",1
30709,tti-622 + proteasome-inhibitor regimen,1
30710,p03277,1
30711,wearable exercise tracker watch,1
30712,capthpv method,1
30713,eribulina,1
30714,blood draw at six months,1
30715,sorafenib monotherapy,1
30716,3000 mg of peg-400 per day,1
30717,ublituximab + tgr-1202 + ibrutinib,1
30718,non-tailored crc screening brochure,1
30719,no- bis sensor attachment,1
30720,18f-fdg-pet scan,1
30721,blood test sample,1
30722,peritoneal-venous shunts (pvs),1
30723,her2(eq)bb?/cd19t+ tcm,1
30724,il-12p dna,1
30725,laparoscopic anatomical hepatectomy,1
30726,direct transthoracic cardiac tumor laser ablation therapy,1
30727,hyfrecator,1
30728,"hipec: mmc + cddp 30mg @ t0, 10mg @ t45min 50 mg/m2 @t0",1
30729,intranasal fentanyl spray (infs),1
30730,sms,1
30731,nonmyeloablative allogeneic hematopoietic cell transplant,1
30732,human blood sample,1
30733,elrr by tem,1
30734,invitation for oral cavity cancer screening,1
30735,ciclophosphamide,1
30736,anti-gd2 3f8 monoclonal antibody,1
30737,crixotinib 200 mg and sunitinib cohort 1,1
30738,dacarbazine + interferon alpha + thymosin-alpha-1 6.4 mg,1
30739,conventional t-cells,1
30740,gemcitabine mono and nab-paclitaxel and gemcitabine,1
30741,mrna-2416,1
30742,pembrolizumab and ipilimumab combination,1
30743,"bevacizumab (avastin), taxotere (docetaxel), vinorelbine tartrate (navelbine)",1
30744,"entinostat days 10,17",1
30745,excess human biological tissue,1
30746,dp001 softgel capsules,1
30747,imaging with 89zr-trastuzumab pet,1
30748,ce-us (sonazoid™),1
30749,transurethral catheterization,1
30750,pulsed electromagnetic field (pemf) device,1
30751,fluorescent angiography with indocyanine-green (not to exceed 5mg/kg),1
30752,mri of the liver before start of treatment,1
30753,fdg?pet guided gradient dose prescription,1
30754,reference group (group 3),1
30755,ny-eso-1?tcr affinity enhancing specific t cell therapy?,1
30756,omnimmune®,1
30757,gardasil 9,1
30758,"rehabilitation programme ""getting better together""",1
30759,dextrins,1
30760,flamsa,1
30761,ashwagandha,1
30762,body scan,1
30763,anlotinib plus pemetrexed,1
30764,omega-3 ffa,1
30765,warfarine - low molecular heparin,1
30766,concurrent chemotherapy of neo-adjuvant therapy,1
30767,1.1 ml of ino-3112 (combination) delivered via im ep,1
30768,alimta (pemetrexed),1
30769,high volume,1
30770,osi-027,1
30771,mesenchymal-marker based ferrofluid (n-cadherin or o-cadherin based),1
30772,cik cells with pd-1 blocking,1
30773,"hpv testing of evalyn®brush, floqswab and colli-pee specimens",1
30774,temsirolimus and sorafenib,1
30775,consolidation with 4 cycles of carcydex,1
30776,asn003 mtd,1
30777,id cytarabine,1
30778,condylox topical gel 0.5%,1
30779,screening digital mammography,1
30780,coreg cr®,1
30781,80 mg mmc gel,1
30782,srs/sbrt,1
30783,raloxifene 60 mg oral tablet,1
30784,combination panitumumab and vemurafenib,1
30785,mr imaging on the siemens vida 3t mr scanner,1
30786,levothyroxin treatment,1
30787,antiretroviral combinations,1
30788,high frequency ultrasound imaging,1
30789,t,1
30790,cest-mri,1
30791,carlo erba ink injection,1
30792,"nanoparticle albumin-bound paclitaxel, s-1",1
30793,the first pass is made with 5ml suction technique,1
30794,effortful swallowing exercise,1
30795,methadone plus acetaminophen or placebo,1
30796,semi-structured exploratory interviews and focus group with mdt health professional attendees,1
30797,arm cisplatin + gemcitabine (arm b),1
30798,cancer patients,1
30799,cranial radiation (twice-daily fractionation),1
30800,99m tc - hynic -toc edda and 111in - dtpa-octreotide,1
30801,ultrasound or ct or mri to locate implant,1
30802,ltx-315 and tils,1
30803,fccam,1
30804,measurement of prostate health index (phi),1
30805,erlotinib and bevacizumab,1
30806,vzv vaccine,1
30807,mobile application (app),1
30808,10-day bismuth-based quadruple therapy,1
30809,nanoknife irreversible electroporation,1
30810,hatg,1
30811,canpatroltm to detect ctcs,1
30812,"docetaxel, trastuzumab",1
30813,oxaliplatin and docetaxel,1
30814,mln 9708,1
30815,cruciate incision,1
30816,cardiac coherence,1
30817,elastic compression,1
30818,contrast enhanced ultrasound guided liver biopsy,1
30819,diet intervention,1
30820,tailored newsletters,1
30821,traceit®,1
30822,computed tomography-guided biopsy,1
30823,the hyfrecator ® 2000 electrosurgical system,1
30824,indium-111-octreoscan (standard test),1
30825,lifestyle alteration,1
30826,mapped tumor salvage rt (mtsrt),1
30827,magnesium aluminum hydroxide,1
30828,cognitive support program,1
30829,collecting nevi,1
30830,nobelactive,1
30831,ct + rt,1
30832,radiotherapy 50 gy,1
30833,"gemcitabine, cisplatin, erlotinib (tarceva)",1
30834,tailored patient family decision making,1
30835,extensive peritoneal lavage,1
30836,white light imaging,1
30837,"induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (ctda) regimen",1
30838,adderall-xr®,1
30839,sel24/men1703,1
30840,ipilimumab and fotemustine,1
30841,oxalate-rich test meal,1
30842,interleukin-11 (il-11 or neumega),1
30843,quality of life pathway,1
30844,"cpt-11, raltegravir (isentress®), midazolam",1
30845,hpv genotype test,1
30846,chloroquine low dose (250mg/week),1
30847,influvac tetra,1
30848,rg7388,1
30849,bronchoalveolar lavage (bal),1
30850,hyperthermic intraperitoneal chemotherapy (hipec) with oxaliplatin,1
30851,ultrasound by general gynaecologist,1
30852,folfoxiri+cetuximab regimen,1
30853,ixo regimen + bevacizumab,1
30854,adjuvant chemotherapy for active comparator group,1
30855,placebo twice daily,1
30856,choline pet/ct and meaib pet/ct,1
30857,romiplostim (formerly amg 531),1
30858,auditory consonant trigrams test,1
30859,cellvizio needle-based confocal laser endomicroscopy (ncle) system,1
30860,single cycle ss1p,1
30861,sodium chloride injection 0.9%,1
30862,radio-labeled naquotinib,1
30863,cilengitide 2000 mg once weekly,1
30864,mammography (mx) + ultrasonography (us),1
30865,hpv dna testing,1
30866,transplant 2 etoposide,1
30867,guardix,1
30868,colorectal web,1
30869,9-cis-retinoic acid,1
30870,nuc-7738,1
30871,yoga evaluation,1
30872,question prompt sheet (qps),1
30873,epi procolon test,1
30874,"ebus-tbna, integrated pet/ct",1
30875,"e0652 pcd with sequential, gradient waveform",1
30876,cough reflex,1
30877,pedylated recombinant human endostatin,1
30878,desvenlafaxine succinate 100mg,1
30879,pet with 18f-fdopa,1
30880,arm exercises.,1
30881,thoracic radiotherapy(trt),1
30882,hypoxia gene expression profile.,1
30883,"melphalan, prednisone",1
30884,the dermal powdermed® devices,1
30885,low intensity exercise training 1,1
30886,the cost,1
30887,email outreach,1
30888,endocystoscopy during colonoscopy,1
30889,epc2407 (crinobulin),1
30890,ima950/poly-iclc,1
30891,odyssey clx imaging system,1
30892,ultrasound- virtual touch tissue imaging quantification,1
30893,mfolfox6 (within re-induction phase),1
30894,sodium fluoride pet,1
30895,paravertebral group,1
30896,high dose gc4419: 90mg/day,1
30897,"high intensity focused ultrasound, hifu",1
30898,adenovirus interferon gamma,1
30899,magic mouthwash,1
30900,apg-115+pembrolizumab,1
30901,dynamic mri and bone marrow sampling,1
30902,hpv-16/18 placebo,1
30903,total lymphoid irradiation and anti-thymocyte globulin,1
30904,collecting sputum,1
30905,imprime pgg® injection,1
30906,bax69 + 5-fu/lv,1
30907,cabometyx,1
30908,cns prophylaxis,1
30909,recombinant tumor necrosis factor family protein,1
30910,3l treatment,1
30911,mc-5a,1
30912,89zr-gsk2849330,1
30913,assess overall complications at 30 days postoperatively,1
30914,measuring liver function by pet/ct,1
30915,6 weeks of radiotherapy,1
30916,intensive induction-bmt,1
30917,radical fimbriectomy,1
30918,colonoscopy biopsy,1
30919,standardized bcs+cm assessment.,1
30920,ctc/dtc count,1
30921,lpat device,1
30922,lindi skin care products,1
30923,0.5% ropivacaine paravertebral block,1
30924,tergenpumatucel-l,1
30925,?dc1 vaccine,1
30926,standard ptcy,1
30927,mr contrast media and medications,1
30928,pet/computed tomography (ct),1
30929,distal pancreatectomy sealing using ltw,1
30930,flot regimen chemotherapy,1
30931,diffusion of direct electric stimulation,1
30932,dtic alone; then genasense followed by dtic,1
30933,pd-l1 group,1
30934,evalyn brush,1
30935,lc bead-tace,1
30936,vintafolide 2.5 mg,1
30937,hypomethylating agent (hma),1
30938,leuprolide 7.5 mg,1
30939,abiraterone acetate placebo,1
30940,medi9447 (oleclumab),1
30941,pembrolizumab nsclc 200 mg,1
30942,treatment determined by physician,1
30943,rad001 (in addition to standard radiation and chemotherapy),1
30944,immu-107 (hpam4),1
30945,peg-p-ifn-alpha-2b (aop2014),1
30946,patient-directed wellness account,1
30947,"""interim gallium or pet/ct""",1
30948,medrol-dose pack (steroid),1
30949,hydralazine and valproic acid: cohort 1,1
30950,pre-operative fasting at least 8h,1
30951,mammaprint 70-gene expression profile,1
30952,aerobic program,1
30953,mri of head and neck,1
30954,"phase 1, cohort 2",1
30955,"saliva sample, questionaire",1
30956,mesa chemotherapy,1
30957,adct-502,1
30958,acupression's bracelet,1
30959,aslan002( bms 777607),1
30960,"epirubicin, carboplatin, docetaxel",1
30961,follow-up surgical visit session,1
30962,surgery?bcnd?bilateral central lymph node dissection?,1
30963,emitter of low levels of amplitude-modulated electromagnetic fields,1
30964,algorithmic risk stratification tool,1
30965,tnf-blockers suspension in patients with rheumatoid arthritis,1
30966,"individual patient interview, focus group and structured survey",1
30967,chvp + interferon,1
30968,prophylactic use of coagulation therapy,1
30969,psycho-educational,1
30970,temsirolimus (non-interventional study),1
30971,fms inhibitor jnj-40346527,1
30972,modified trans-esophageal prosthesis,1
30973,baseline surveys,1
30974,8.0 mg/m2 di-leu16-il2,1
30975,contralateral submental flap for tongue cancer defect,1
30976,oral 5-azacitidine,1
30977,abt-348 and azacitidine,1
30978,test product (bendamustine),1
30979,aquamin®,1
30980,5-fu and cisplatin,1
30981,medi-547,1
30982,pet scan with 124i-crgdy-peg-dots,1
30983,tegafur/uracil,1
30984,standard surgical procedure for endometrial cancer,1
30985,vegf-receptor tyrosine kinase (kdr),1
30986,"biomarker analyses head & neck cancer tissue, blood specimen",1
30987,low molecular weight heparin (lmwh),1
30988,selective serotonin uptake inhibitor (ssri),1
30989,intraoperative mobile gamma camera imaging,1
30990,biobank constitution,1
30991,placebo oral,1
30992,fact-g7,1
30993,acoustic angiography,1
30994,miralax-gatorade prep,1
30995,high-dose epirubicin combined with cvp ± rituximab,1
30996,mesenchymal stem cell infusion,1
30997,"chemotherapy drugs, cancer",1
30998,lhrh therapy,1
30999,durvalumab + tremelimumab + metronomic vinorelbine,1
31000,sln biopsy only,1
31001,"dose escalated, accelerated, hypofractionated radiotherapy",1
31002,convention,1
31003,messages generated by learning algorithm,1
31004,rituximab + mg4101,1
31005,ad5-sge-reic/dkk3,1
31006,prealbumin goal-based ons,1
31007,cd19+,1
31008,45 gy in 30 fractions,1
31009,gelox,1
31010,multiport surgery,1
31011,stereotactic ablative radiosurgery (sart),1
31012,boost to the tumour bed,1
31013,rtxm83,1
31014,300mg vandetanib,1
31015,cart-her-2,1
31016,history data,1
31017,biopsy or prostatectomy,1
31018,conventional laparoscopic access,1
31019,local chemotherapy,1
31020,kv x-ray images,1
31021,morab-009 (amatuximab),1
31022,clt-008,1
31023,standard ot,1
31024,ss1(dsfv)pe38 - lot 073i0809,1
31025,pillcam colon 2,1
31026,"paclitaxel, trastuzumab and carboplatin",1
31027,second-line ibrutinib,1
31028,bay 1000394,1
31029,ec1456 and ec20,1
31030,2 anterograde radical prostatectomy rrp2a,1
31031,modified bfm-90 protocol,1
31032,pancreatic mri,1
31033,paricalcitol placebo,1
31034,irinotecan.,1
31035,environmental music therapy,1
31036,benadryl and tylenol,1
31037,bipap vision,1
31038,aprepitant / fosaprepitant,1
31039,audio recorded questionnaires,1
31040,comparator: octavalent hpv vaccine - dose formulation 1,1
31041,cerenkov emissions from the pet tracer 18f-fdg and the radiotherapeutic 131i,1
31042,behavioral activation/problem-solving (ba/ps),1
31043,myeloablative chemotherapy,1
31044,routine follow-up,1
31045,energy goal-based ons,1
31046,asidna,1
31047,vlx600,1
31048,bortezomib and tositumomab i-131,1
31049,stopping their tki,1
31050,hypofractionated intensity-modulated radiation therapy,1
31051,non-intervention,1
31052,mini locus of control test (mls),1
31053,early tumor response evaluation by mri volumetry,1
31054,fecal calprotectin test,1
31055,fact-an questionnaire,1
31056,neck dissection with harmonic scalpel,1
31057,axillary radiation therapy,1
31058,pgx-odsh-2013-aml-1,1
31059,"sunitinib, docetaxel, cisplatin",1
31060,cd133+ selected autologous stem cell infusion,1
31061,avastin 100 mg in 4 ml injection,1
31062,functional assessment of chronic illness therapy - treatment satisfaction - general (facit-ts-g)13,1
31063,buccal epithelium collection,1
31064,laparoscopic colonic surgery,1
31065,collection of peripheral blood and apheresis samples,1
31066,"cemip , ca19-9 ,cea",1
31067,mint,1
31068,radiofrequency ablation plus sorafenib,1
31069,simultaneous resection,1
31070,follow up endoscopy 2,1
31071,byl719 and olaparib,1
31072,"sequential chemotherapy (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and radiotherapy",1
31073,"surgery, radiotherapy and chemotherapy",1
31074,pet/mr scanner,1
31075,18f-deoxyglucose (fdg),1
31076,induction/consolidation cisplatin,1
31077,cda-2 (cell differentiation agent 2),1
31078,social media feed with indoor tanning,1
31079,diet + exercise,1
31080,ts-1 with oxaliplatin,1
31081,"trabectedin (ecteinascidin-743, et-743, yondelis [r])",1
31082,opt-out outreach,1
31083,monoclonal antibody 95-5-49,1
31084,"trofosfamide, idarubicin, etoposide",1
31085,fear of cancer recurrence intervention,1
31086,gleevec/paclitaxel,1
31087,ifn-?2b,1
31088,healthy lifestyles,1
31089,oral therapeutic vaccine v3-x to treat cholangiocarcinoma,1
31090,external-beam radiation,1
31091,folfiri-hd,1
31092,sorafenib 400 mg twice daily + intravenousinfusion of placebo,1
31093,standard dietary intervention,1
31094,dasatinib 100 mg [sprycel],1
31095,7f-imrt,1
31096,tru-016 10-20 mg/kg + bendamustine,1
31097,prostate cancer foundation booklet,1
31098,"no interventions, only data collection",1
31099,gem-cis or gem-carbo,1
31100,cotinine level testing,1
31101,a t cell depleted stem cell transplant,1
31102,tissue samples from abdominal subcutaneous adipose,1
31103,metrocx,1
31104,preoperative boost (rt),1
31105,pathology,1
31106,chemotherapy combined with trastuzumab,1
31107,enteroct with enteroclysis,1
31108,medical acupuncture,1
31109,hypofractionated image guided radaition therapy,1
31110,smac mimetic lcl161,1
31111,mr-guided laser ablation,1
31112,chemotherapy + blinatumomab,1
31113,bgb-a333 and bgb-a317,1
31114,leuprolide(lorelin depot),1
31115,pelvic external radiotherapy,1
31116,adxs31-164,1
31117,mind-body bridging program,1
31118,mri screening,1
31119,standard white light,1
31120,epidermis fascia taping,1
31121,finasteride 5mg oral daily,1
31122,"oxaliplatin, capecitabine or irinotecan",1
31123,"-5-fu (fluorouracil) 2,400 mg/m2 iv over 46-48 hours",1
31124,discrete choice task,1
31125,"sgn-15, docetaxel",1
31126,"busulfan, fludarabine, rabbit atg",1
31127,[f-18]-fch,1
31128,iodine i-124 girentuximab,1
31129,post treatment surgery,1
31130,irmf bold,1
31131,anti-endosialin/tem1 monoclonal antibody morab-004,1
31132,pemetrexed therapy,1
31133,single nucleotide polymorphism (snp),1
31134,research biopsies,1
31135,"etoposide, carboplatin, melphalan, cisplatin, thiotepa",1
31136,sgn-cd19b,1
31137,za,1
31138,3 mg drospirenone and 30 µg ethinyl-estradiol,1
31139,(rs)2-(3-benzoylphenyl)-propionic acid,1
31140,amniofix®,1
31141,zero ischemia laparoscopic rfa assisted te,1
31142,mycobacterium obuense,1
31143,allogeneic blood stem cell transplantation,1
31144,decision aid tool,1
31145,amg386 and bevacizumab,1
31146,synthroid,1
31147,cordycepin plus pentostatin,1
31148,duvortuxizumab,1
31149,community vital signs,1
31150,c2 cryoballoon swipe ablation system,1
31151,fentanyl taifun,1
31152,routine digital breast tomosynthesis,1
31153,open or robotic radical cystectomy,1
31154,measuring emptying rate from the gastric tube,1
31155,chemotherapy plus monoclonal antibody,1
31156,chidamide biw,1
31157,a-101 vehicle solution,1
31158,boost breeze,1
31159,stereotatic radiotherapy,1
31160,rad1901,1
31161,bleomycin etoposide and cisplatin,1
31162,in depth genomic sequencing,1
31163,control arm: quadruple choice,1
31164,online mbm skills group,1
31165,melanoma and peritumoral skin excision,1
31166,"xl147 (sar245408),",1
31167,intravenous topotecan/cisplatin,1
31168,salivary kit,1
31169,vactosertib/imatinib combination,1
31170,radp53,1
31171,valproate plus doxorubicin,1
31172,lingzhi capsule,1
31173,daylight photodynamic therapy using methylaminolevulinate (mal),1
31174,vs-5584 and vs-6063,1
31175,bibf 1120 m + docetaxel m,1
31176,treatment h,1
31177,minnelide™capsules,1
31178,geriatric follow up,1
31179,1 mri scan,1
31180,bg00002 (natalizumab),1
31181,oesophageal doppler monitor,1
31182,samsung gearvr,1
31183,with tdt,1
31184,sl fentanyl,1
31185,neuromonitoring,1
31186,no intervention/exposures,1
31187,exemestane+bicalutamide,1
31188,dexmedetomidine (precedex),1
31189,reference147709,1
31190,"enzalutamide, 160mg, 40 mg soft capsules, once daily",1
31191,ic-green kit,1
31192,lenalidomide (revlimid),1
31193,placebo (laser low level energy nonfunctional),1
31194,staphylococcal enterotoxin b,1
31195,"ixabepilone, 40 mg/m^2 + capecitabine, 1000 mg/m^2",1
31196,gel-beads embolic material,1
31197,bortezomilb,1
31198,ro5323441 + bevacizumab [avastin],1
31199,"autologous, lethally irradiated melanoma cells",1
31200,implementation aids,1
31201,fluorouracil/epirubicin/cyclophosphamide,1
31202,ec0652,1
31203,message delivered via virtual technology,1
31204,cilengitide (5-times weekly),1
31205,armodafinil 150 mg/day,1
31206,conventional open colectomy,1
31207,ginkgo biloba,1
31208,mesylate imatinib capsule,1
31209,colonoscopy with colic videocapsule,1
31210,zalypsis ( pm00104),1
31211,peritoneal mesometrial resection,1
31212,gsk biologicals hpv 16/18 vaccine 580299 (cervarixtm),1
31213,"cisplatin, irinotecan, capecitabine",1
31214,everolimus + letrozole,1
31215,"flp,dose escalation,mtd",1
31216,"revlimid, doxil, avastin",1
31217,pcia analgesia,1
31218,adi peg,1
31219,melanoma antigen recognized by t-cells (mart)-1: 26-35(27l),1
31220,pulmicort,1
31221,tlc 388,1
31222,placebo - everolimus,1
31223,early supplemental parenteral nutrition,1
31224,icotinib combined dihydroaremisinin,1
31225,veltuzumab and 90y-epratuzumab tetraxetan,1
31226,modified cystoscopy,1
31227,conventional whole brain radiotherapy,1
31228,single tip thermoablation,1
31229,lubricant gel,1
31230,nelarabine injection 1500mg/m2,1
31231,pet/ct imaging sessions,1
31232,alt803,1
31233,l-leucyl-l-leucine methyl ester (llme),1
31234,preben,1
31235,lunicalcipol 270,1
31236,hematology/blood chemistry,1
31237,heavy water (2h2o),1
31238,"experimental 2: ""low glycämic and insulinemic"" diet (logi)",1
31239,stereotactic radiosurgery using the novalis tx,1
31240,combined oral contraceptive pill,1
31241,"smoking cessation training, support, and telephone follow-up",1
31242,serum regucalcin antibody,1
31243,heart rate variability biofeedback,1
31244,genetical analyses,1
31245,access to an oppc service,1
31246,tak-733,1
31247,etoposide-cisplatin combined chemotherapy,1
31248,open label selinexor,1
31249,eus guided echobrush sampling,1
31250,dota-toc treatment,1
31251,vinorelbine per os 60 mg/m²,1
31252,physical activity plus education,1
31253,cx-2029,1
31254,proton treatment plans,1
31255,novottf-100l device,1
31256,hepatitis c testing,1
31257,ultrasound-based cancer-specific images,1
31258,enhanced colorectal geriatric care,1
31259,delayed start enteral support @ pod5,1
31260,"relacorilant, 150mg qd",1
31261,advanced mri sequences,1
31262,"biological/vaccine: vaccine comprised of klh conjugates of gd2l, gd3l, globo h, fucosyl gm1, and n-propionylated polysialic acid plus opt-821 adjuvant",1
31263,pace with cabazitaxel (15 mg/m2),1
31264,computerized tasks,1
31265,ufox + cetuximab,1
31266,nacl 0.9 %,1
31267,mr-guided laser focal therapy,1
31268,octreotate,1
31269,body & soul nutritional intervention,1
31270,oncolytic adenovirus expressing gmcsf,1
31271,biological and pathological markers of ischemia,1
31272,modified ileal conduit,1
31273,cetuximab + nk cells,1
31274,vapotherm,1
31275,whipple at the splenic artery (watsa),1
31276,3d printed applicator,1
31277,fabrication of thermoplastic face (the orfit thermoplastic face mask system is routinely used for the treatment of brain and head),1
31278,silicone trachea-bronchial stent dumon (novatech),1
31279,blood sampling for antibody determination,1
31280,leuprolide (lucrin/lucrin-tri-depot),1
31281,gemdox,1
31282,f-choline-pet,1
31283,pentoxifylline+tocopherol + hyperbaric oxygen therapy,1
31284,watercress juice,1
31285,pcphc,1
31286,alimta plus epirubicin,1
31287,arsenic trioxide intravenous infusion,1
31288,gene panel sequencing of tumor specimens,1
31289,doxorubicine + docetaxel combined,1
31290,amatuximab (morab-009),1
31291,bibf 1120 es low dose,1
31292,t-cell antigen presenting cells expressing truncated cd19 (t-apc),1
31293,lattice extreme ablative dose radiation therapy,1
31294,sipuleucel-t (provenge),1
31295,epithelial cell adhesion molecule (epcam) ferrofluid,1
31296,topical as101,1
31297,toriplimab,1
31298,telephone interpersonal counseling,1
31299,dabrafenib 75 mg capsule,1
31300,"polyamines depleted diet, associating polydol® cans and predefined menus low in polyamines",1
31301,standard subcutaneous medication,1
31302,bard goldmarker larger size,1
31303,cyclophosphamide 400mg,1
31304,standard transrectal 12 core biopsy,1
31305,irinotecan + 5 fu + folinic acid,1
31306,via + cryosurgery,1
31307,ap 12009 10 µm,1
31308,ngf group,1
31309,androgen suppression plus radiation therapy,1
31310,visualization balloon,1
31311,black coffee,1
31312,atg/ptcy,1
31313,calcium aluminosilicate anti-diarrheal,1
31314,whole-body fdg pet-ct alone,1
31315,interruption of glivec®,1
31316,good clinical practice,1
31317,gsk3745417,1
31318,sinotecean,1
31319,radiotherapy 60gy,1
31320,age at diagnosis,1
31321,support education activity,1
31322,nlscp,1
31323,20 mg melatonin,1
31324,screening population,1
31325,peg intron,1
31326,nitrocamptothecin,1
31327,mt110,1
31328,"quadruple mixture, composed of dexamethasone, gentamicin, vitamin b12, and procaine",1
31329,patients affected by prostate cancer,1
31330,esophagogastroduodenoscopy (egd),1
31331,brain radiotherapy/stereotactic radiosurgery,1
31332,"balanced crystalloid solution (components: sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride)",1
31333,survivor survey (2): post-visit,1
31334,pemetrexe,1
31335,calcium glucarate,1
31336,5-fu based doublet chemotherapy,1
31337,chromoendoscopy with indigo carmine,1
31338,pemetrexed and gemcitabine plus bevacizumab,1
31339,grooved pegboard test,1
31340,mle4901 40mg,1
31341,sentinel node resection followed by node examination,1
31342,"polyphenon e ointment 10%, polyphenon e ointment 15%",1
31343,dexmethylphenidate(d-mph),1
31344,echoing of the lower limbs and measuring the systolic pressure index,1
31345,gemcitabine - 21 day cycle,1
31346,nivolumab 360 mg+ paclitaxel 80 mg/m2,1
31347,primary surgical treatment,1
31348,robotic-assisted total gastrectomy,1
31349,hla-a02 restricted hig2,1
31350,som230 lar 10 mg,1
31351,biopsy material,1
31352,ra-223 in combination with enzalutamide,1
31353,clonidine lauriad® 50µg,1
31354,orthogonal polarization spectral (ops) imaging,1
31355,sunflower oil high oleic,1
31356,elderly cancer patients,1
31357,cytoreductive surgery + gastrecomy,1
31358,magprobe (tm),1
31359,sc group,1
31360,high intensity counseling + bupropion,1
31361,chemotherapy (5-fu+ddp),1
31362,18fml10,1
31363,lycopene placebo capsules,1
31364,flamazine cream,1
31365,oradoxel,1
31366,gcb,1
31367,5fluorouracile and mitomycin-c,1
31368,efficast®,1
31369,treatment group,1
31370,stereotactic ablative body radiotherapy as a boost,1
31371,dmf5 melanoma reactive til,1
31372,laparoscopic hepatectomy (surgery),1
31373,cmpe optical sensor device,1
31374,klh day 1,1
31375,cipn assessment and management algorithm,1
31376,fake biofield therapy,1
31377,tea+dex,1
31378,"er,cr:ysgg laser",1
31379,post?operative recovery registry,1
31380,placebo combined with oxaliplatin and capecitabine or placebo combined with cisplatin and 5-fu,1
31381,imiquimod 5%: manufactured by apotex,1
31382,wait and see,1
31383,laparoscopic-assisted gastrectomy(lag),1
31384,ixabepilone + lapatinib + capecitabine,1
31385,autologous hematopoietic stem cell transplantation (asct),1
31386,pembrolizumab (200 mg),1
31387,imatinib treatment discontinuing,1
31388,kgel vaccine,1
31389,ptk 787 (vatalanib),1
31390,gsk1572932a antigen-specific cancer immunotherapeutic,1
31391,protons and carbon ions,1
31392,"sagopilone (bay86-5302 , zk219477)",1
31393,pimecrolimus,1
31394,mycobacterial cell-wall dna complex,1
31395,cinnamon cap 500 mg,1
31396,moderate intensity exercise,1
31397,"bortezomib, melphalan, prednisone",1
31398,respiratory muscle performance,1
31399,breath analysis,1
31400,activities of daily living,1
31401,web-based cognitive-behavioral therapy for insomnia (cbt-i),1
31402,radiotherapy (for patients with newly diagnosed malignant glioma),1
31403,abbott realtime high risk hpv,1
31404,high radiation dose therapy,1
31405,bax69 double-route arm,1
31406,stress reduction with health education,1
31407,intensive/high-risk follow up (? ia g3),1
31408,open nsm,1
31409,radical d2 total gastrectomy,1
31410,selective internal radiation therapy to the liver using yttrium-90 glass microspheres (therasphere),1
31411,superselective ctace doxorubicin,1
31412,ks structured clinical care training,1
31413,msb0010445 (1.0 mg/kg),1
31414,sta9090,1
31415,proton or photon,1
31416,embosphere® microspheres,1
31417,3 mg/kg anti-pd-1 mab js001 q2w,1
31418,"physician's choice regimen (vinorelbine, erlotinib, gemcitabine, paclitaxel, docetaxel, pemetrexed)",1
31419,64cu-dota-u3-1287,1
31420,mk-1966,1
31421,true biofield therapy,1
31422,electronic decision aid tool,1
31423,peri-areolar incision,1
31424,post-stem cell infusion cyclophosphamide,1
31425,risk model of tumor relapse,1
31426,skin staples;,1
31427,sentinel basin dissection,1
31428,paclitaxel or docetaxel and carboplatin or cisplatin,1
31429,cheek cell sample or blood sample (4ml),1
31430,mk-3475 (phase ii),1
31431,telcyta,1
31432,aminolevulinic acid %20 topical solution,1
31433,transarterial chemoembolisation,1
31434,gsk biologicals' 2241658a antigen-specific cancer immunotherapeutic (asci),1
31435,navifus system,1
31436,conventional monopolar electrocautery,1
31437,nci arm,1
31438,"escalation cohort: regorafenib (stivarga, bay73-4506) 20 mg",1
31439,individual elape,1
31440,intra-operative radiation to tumor bed,1
31441,anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes,1
31442,complier device,1
31443,patient ambassador support,1
31444,daratumumab (part 2),1
31445,placebo buccal tablet,1
31446,hemi-thyroidectomy - clnd,1
31447,molecular profiling of tumors,1
31448,68ganota-anti-her2 vhh1,1
31449,second transplantation,1
31450,the medial-to-lateral approach,1
31451,enantone,1
31452,t-allo10,1
31453,placebo for aspirin,1
31454,radiotherapy for cnfa,1
31455,nivolumab: cohort 2,1
31456,[f-18]rgd-k5,1
31457,injections of om-174,1
31458,cd45ra-depleted hpc transplant,1
31459,pixantrone iv infusion,1
31460,patient questionaires,1
31461,genomic imprinting testing,1
31462,zero ischemia robot-assisted laparoscopic partial nephrectomy,1
31463,western diet,1
31464,open right hemicolectomy plus eras,1
31465,bilateral metal stent insertion,1
31466,alemtuzumab (campath 1h) associated to g-csf,1
31467,nutritional consultation and exercise program,1
31468,oxaliplatin or irinotecan,1
31469,placebo (melatonin),1
31470,broccoli sprout extract beverage,1
31471,very low carbohydrate diet,1
31472,intratympanic application of gentamicin,1
31473,validate assays and shipping methods,1
31474,ensure surgical,1
31475,consultations,1
31476,ablative fractional carbon dioxide (co2) laser,1
31477,enzalutamide and dutasteride,1
31478,intensity modulated radiotherapy (imrt) for breast cancer,1
31479,conventional perioperative treatment,1
31480,mammography with community health worker (group),1
31481,hand-sewn coloanal anastomosis,1
31482,tace and apatinib,1
31483,platinum (cisplatin or oxaliplatin) + fluorouracil (5-fu),1
31484,isocapnic hyperventilation,1
31485,braf,1
31486,shrna,1
31487,plasti-med triflo,1
31488,perflutren lipid,1
31489,bms-986158,1
31490,the transdermal therapeutic system-fentanyl (tts-f),1
31491,clomiphen citrate plus hmg,1
31492,placebo of modafinil,1
31493,ir methylphenidate,1
31494,innohep®,1
31495,local anesthesia of trnasperineal prostate biopsy,1
31496,pre-operative conformal radiotherapy,1
31497,nivolumab + plinabulin,1
31498,validate system,1
31499,zk 219477,1
31500,aflibercept injection,1
31501,131i-3f8,1
31502,lycopene supplement,1
31503,3000 mg of jbm-tc4 per day,1
31504,patient-centered communication of life expectancy,1
31505,transoral robot-assisted tumor resection using the da vinci robot,1
31506,gelatin capsule containing cellulose and magnesium stearate,1
31507,gemcitabine - nabpaclitaxel,1
31508,cdc health pamphlets,1
31509,peptide loaded dendritic cell vaccine,1
31510,arm b vinorelbine (navelbine oral) capecitabine (xeloda),1
31511,iodine i -01 tositumomab (bexxar),1
31512,ballon implantation,1
31513,educational intervention mailed,1
31514,topotecan and pegylated doxorubicin,1
31515,unenhanced monitoring,1
31516,the rectal anastomosis will be reinforced with hemopatch.,1
31517,tru-016 (anti-cd37 protein therapeutic),1
31518,cetuximab-containing chemotherapy,1
31519,mri and mrsi,1
31520,radiaplexrx gel,1
31521,periodontal pocket samples,1
31522,"irinotecan, 5fu, leucovorin",1
31523,"floseal, surgicel, surgiflo, arista",1
31524,at home screening procedure every 3 months,1
31525,ct three-dimensional reconstruction,1
31526,focus program,1
31527,sait301,1
31528,dietary supplements,1
31529,regorafenib (bay73- 4506),1
31530,"moviprep, 2-day split-dosing",1
31531,higher dose icotinib,1
31532,dietary/physical activity intervention,1
31533,liquid nitrogen cryotherapy,1
31534,aminosyn ii,1
31535,tace therapy,1
31536,lsz102,1
31537,fludarabine and rituximab,1
31538,placebo for bevacizumab 5 mg/kg,1
31539,ask120067,1
31540,tmvp1-icg,1
31541,camrelizumab,1
31542,ro5212054,1
31543,fast-track recovery strategy,1
31544,mbp-426/leucovorin/5-fu,1
31545,daunorubicin liposomal or daunorubicin or idarubicin,1
31546,epidemiological study according to clinical practice,1
31547,problem solving,1
31548,"test for circulating tumor cells, dna alterations",1
31549,pegylated liposomal doxorubicin (pld/doxil®/caelyx®),1
31550,cirt arm,1
31551,placebo pf00299804,1
31552,placebo (for selinexor),1
31553,"cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)",1
31554,pancreatic cyst fluid glucose analysis using a bedside glucometer,1
31555,standard technique eus-fna,1
31556,megestrol acetate 40 mg/day,1
31557,ofdi capsule marking,1
31558,p03277 half dose,1
31559,tetanus day 1,1
31560,small volume radiation,1
31561,cord blood infusions,1
31562,magnesiun,1
31563,lmp400,1
31564,erlotinib plus bevacizumab,1
31565,ipi-926 plus gemcitabine,1
31566,mri perfusion and pet/ct scans,1
31567,22-g procore needle,1
31568,placebo b,1
31569,nbi/bli +/- chromoendoscopy (nbibli +/- ce),1
31570,18f-choline pet/ct,1
31571,electrodesiccation,1
31572,allogeneic peripheral blood stem cells (allo-pbsc) transplantation,1
31573,olaparib treatment b,1
31574,elad (extracorporeal liver assist system),1
31575,thalidomide/dexamethasone vs melphalan/prednisone,1
31576,cohort 1 neo-adjuvant,1
31577,rapid ventricular pacing,1
31578,"irinotecan,5fu, leucovorin",1
31579,chemoembolization and response-dependent resection,1
31580,obinutuzumab (ro5072759),1
31581,r-etodolac + chlorambucil,1
31582,optimised magnetic resonance image-guided intra-uterine brachytherapy,1
31583,dexmedetomidine injection [precedex],1
31584,holmium-166 (poly l lactic acid) microspheres,1
31585,em tracking,1
31586,"intraoperative ultrasound (sonowand, mison)",1
31587,cucumber cream,1
31588,mirasol platelets (mir plts),1
31589,docetaxel/gemcitabine,1
31590,standard post op pain control,1
31591,arm a cyclophosphamide,1
31592,ixazomib 2.5 mg,1
31593,bascom cleft lift procedure,1
31594,biwa 4,1
31595,endoscopic biopsies,1
31596,chamomila recutita infuse,1
31597,etoposide capsule plus methotrexate tablet,1
31598,sutent®/sunitinib,1
31599,luminal type-2,1
31600,nilotinib 400 mg bid,1
31601,homeopathic medicine,1
31602,the placebo,1
31603,ertafolide,1
31604,eus with fine-needle aspiration of pancreatic cyst,1
31605,"gefitinib, hydroxychloroquine",1
31606,navigational template,1
31607,panc 10.05 pcdna-1/gm-neo and panc 6.03 pcdna-1/gm-neo vaccine,1
31608,dasatinib and blinatumomab,1
31609,"quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil™)",1
31610,personalized neoantigen dna vaccine,1
31611,chemotherapy or radiation therapy,1
31612,stereotactic linear accelerator,1
31613,inspiratory muscle training-rehabilitation,1
31614,contrast enhanced breast mri,1
31615,delayed gardening intervention,1
31616,5ht3,1
31617,low frequency sound waves,1
31618,50.4 gy,1
31619,person-centred communication,1
31620,"cycolophosphamide, vacristine, and pednisone (cvp) x6 cycles followed by tositumomab and iodine i 131 tositumomab.",1
31621,plasmablade 3.0s,1
31622,obturator block,1
31623,ags-003-lng,1
31624,segmental examination twice of the proximal colon,1
31625,leuprolide acetate fluidcrystal® injection depot,1
31626,cofactor,1
31627,erythropoietin alpha,1
31628,trastuzumab+docetaxel+npld+bevacizumab,1
31629,head and neck patients,1
31630,mb07133 2400 mg/m2/day,1
31631,dfp-10917,1
31632,faecal tagging,1
31633,sbrt + adt,1
31634,lidocaine gel only,1
31635,endomaxx endoluminal valve technology (evt),1
31636,written educational material,1
31637,nutrition physical activity text message,1
31638,torisel dose 75 mg and r-chop,1
31639,alexandrite laser,1
31640,hifu hemi-ablation combined with adt.,1
31641,laser-assisted icg dye angiography (spy system),1
31642,horne-ostberg morningness-eveningness questionnaire,1
31643,pyroxamide,1
31644,placebo liraglutide pen injector,1
31645,healthy controls,1
31646,placebo plus gemcitabine,1
31647,biosimilar infliximab,1
31648,tariquidar + paclitaxel/carboplatin,1
31649,ct/mri,1
31650,"gemcitabine, and s-1",1
31651,n-methyl-pyrrolidone,1
31652,combined decongestive therapy,1
31653,tailored group intervention (prepare),1
31654,transversus abdominal plane block with ropivacaine,1
31655,pemetrexed/oxaliplatin,1
31656,concomitant cisplatin,1
31657,vistusertib (azd2014),1
31658,nexrutine,1
31659,anlotinib 12mg + ap/pc,1
31660,folfirinox or gemcitabine based chemotherapy,1
31661,caprelsa (vandetanib),1
31662,toremifine,1
31663,urine pregnancy test,1
31664,"lhrh agonist (leuprorelinacetat, goserelinacetat, buserelinacetat, triptorelinacetat)",1
31665,audio recorded focus group,1
31666,placebo and axitinib,1
31667,hemi gland focal ldr brachytherapy,1
31668,pembrolizumab + placebo,1
31669,laparoscopic radical cystectomy with open urinary diversion,1
31670,sgn-cd123a,1
31671,gardasil® hpv vaccine,1
31672,"methotrexate, 6-mercaptopurine",1
31673,dftrd,1
31674,avx 470,1
31675,colonic resection,1
31676,fda-approved hpv dna test,1
31677,r-chop14 induction regimen,1
31678,[18f]-flt-pet/ct scans,1
31679,part 1; cohort 2,1
31680,blood draw for research purposes,1
31681,"usual care american society of plastic surgeons booklet ""breast reconstruction""",1
31682,zsp1603 50 mg,1
31683,120 mg ly2784544,1
31684,jtx-2011,1
31685,orlistat/meal replacement/lifestyle modification,1
31686,intensity modulated radiotherapy (imrt) - deintensified,1
31687,serum and plasma samples,1
31688,matched placebo in combination with pemetrexed,1
31689,olimel peri 2.5% ®,1
31690,rft5-smpt-dga,1
31691,egfr tyrosine kinase inhibitor,1
31692,cdx1307,1
31693,epo,1
31694,osteopathy + conventional analgesic treatments,1
31695,mobile app for follow-up care,1
31696,polyethylene glycols,1
31697,proleukin and dacarbazine,1
31698,meltenyi clinimacs,1
31699,parp-1,1
31700,hsp-130,1
31701,amg 531 (romiplostim),1
31702,nov140101 (idx1197hcl),1
31703,nonlinear microscopy imaging of excised surgical margins,1
31704,long limb roux-en y reconstruction,1
31705,lyophilized black raspberry lozenge,1
31706,iodine-125 seed strand implantation,1
31707,hepatic artery catheter,1
31708,core stability,1
31709,e7016,1
31710,mpeg-r-crisantaspase,1
31711,intensity modulated radiation therapy in both arms,1
31712,mirena (lng-ius),1
31713,paravertebral block (pvb),1
31714,semen collection and analysis,1
31715,darinaparson,1
31716,quality initiative in rectal cancer (qirc) strategy,1
31717,tivantinib (arq 197),1
31718,anastomotic reinforcing sutures,1
31719,implementation intentions-based telephone counseling,1
31720,new course of treatment,1
31721,cancer screening and health education,1
31722,"bicalutamide, cp-675,206",1
31723,t2* imaging,1
31724,subtotal surgical removal plus ablative radiation dose,1
31725,intubated thoracoscopic lobectomy,1
31726,dose de escalation,1
31727,pegylated lipoxomal doxorubicin (pld),1
31728,tirapazamine (sr259075),1
31729,bay1187982,1
31730,working to optimize wellness in tees with pcos (wow),1
31731,oral tpx-0005,1
31732,"epirubicin, capecitabine, cisplatin",1
31733,pet-mr imaging on biograph mmr scanner,1
31734,cpi-444 + atezolizumab,1
31735,gm-csf vaccine,1
31736,tivozanib + temsirolimus,1
31737,individualized chemotherapy,1
31738,brca testing and questionnaire assessments,1
31739,trans-quadrant channel surgery,1
31740,biorepository,1
31741,glibenclamide,1
31742,tumor growth factor concentration,1
31743,"cd 74, vegf detection",1
31744,fecal immunological test (fit),1
31745,tatme with cs-compact (gelpoint pathway),1
31746,"sagopilone 16 mg/m^2 i.v. and placebo 1000 mg tid, hrpc only: prednisone or prednisolone 5 mg bid",1
31747,eye exam,1
31748,tumor specific peptides: mage-3.a1 and / or na17.a2,1
31749,peptide vaccine (pr1 peptide),1
31750,probenecid,1
31751,research blood for germline dna,1
31752,chr-2845,1
31753,brain mri study and a brief neuropsychological evaluation,1
31754,"oxaliplatin, gemcitabine, cisplatin, lipiodol",1
31755,hgs1036 + paclitaxel + carboplatin,1
31756,"using device for scoring pain scale, named ""anapa®""",1
31757,submandibular gland transfer,1
31758,bel-x-hg,1
31759,promets probiotics powder,1
31760,mr-hifu,1
31761,sildenafil citrate (viagra),1
31762,bgb-a317 and paclitaxel plus cisplatin (or carboplatin),1
31763,pf-03732010,1
31764,staff training and patient reminders,1
31765,three dimensional conformal radiation therapy (3d-crt),1
31766,lerisetron,1
31767,pazopanib (gw786034) 800 mg,1
31768,upright mri,1
31769,sphygmocor,1
31770,tissue registry study,1
31771,liquid (blood) biopsies and tumor biopsy (optional),1
31772,cinobufacin injection,1
31773,intramuscular vaccination,1
31774,dahuang gantsao tang,1
31775,f-miso,1
31776,patients with metastatic melanoma,1
31777,episodic recent thinking,1
31778,part 2a tpst-1120 + nivolumab,1
31779,acupuncture(hwato®),1
31780,lc-ctls,1
31781,imatinib ending,1
31782,tx-plore,1
31783,m032 (nsc 733972),1
31784,erlotinib & celecoxib,1
31785,surgical resection of melanoma metastases,1
31786,placebo treatment (0.9% nacl),1
31787,engagement in physical activity,1
31788,capox,1
31789,avova-1,1
31790,vitamin d2 (ergocalciferol),1
31791,laugh yoga,1
31792,propofol 2.0 mg/kg + remifentanil 1.5 ug/kg,1
31793,thiazolidinediones,1
31794,pazopanib plus paclitaxel,1
31795,bnct(boron neutron capture therapy),1
31796,pafa,1
31797,citsav survey,1
31798,genetic sequencing,1
31799,prompt-sheet,1
31800,moderate hypo-fractionation,1
31801,proton arm 1: standard proton therapy,1
31802,alk analysis on ctcs detected by iset,1
31803,intrathecal ketamine,1
31804,tretinoin 0.1% cream or placebo,1
31805,cryoballoon focal ablation,1
31806,advice to use condoms,1
31807,atezolizumab - cohort 4,1
31808,ibritumomab tiuxetan + maintenance,1
31809,4d conformal image-guided partial breast rt,1
31810,1rg-cart/m^2 (dose level 3),1
31811,education and exercise intervention,1
31812,myoinositol,1
31813,gem-tax,1
31814,irinotecan 125mg,1
31815,isovue-m 200,1
31816,placebo + lapatinib + capecitabine,1
31817,hand grip test,1
31818,haematopoietic stem cell infusion,1
31819,halo90 ablation catheter,1
31820,stereotactic radiation (srs),1
31821,"3, 4-diaminopyridine",1
31822,sln mapping and removal of pet-positive lymph nodes,1
31823,atezolizumab & bevacizumab,1
31824,yoga and stretching group,1
31825,co2 insufflation first,1
31826,selumetinib (oral),1
31827,ovarian cancer peptide vaccine,1
31828,ema-approved ati based targeted therapy,1
31829,behavioral: resiliency intervention,1
31830,single-agent gemcitabine (gemzar) regimen plus disulfiram/copper gluconate,1
31831,blood concentration check,1
31832,gs-9219,1
31833,paclitaxel plus ptk787,1
31834,star™ tumor ablation system and stabilit® vertebral augmentation system,1
31835,electronic questionnaires,1
31836,rna extraction and amplification from biopsy specimens,1
31837,retcam,1
31838,188re-pti-6d2,1
31839,melitac 12.1 peptide vaccine,1
31840,pf-114,1
31841,diverting loop ileostomy with rod,1
31842,tti-622 monotherapy,1
31843,enhanced treatment-as-usual (tau),1
31844,"single-arm, non-randomized biodynamic imaging (bdi)",1
31845,demographic and background questions,1
31846,demographic form and semi-structured interview guide,1
31847,exercise sessions,1
31848,side-to-end coloanal anastomosis,1
31849,fluobeam,1
31850,laparoscopic ovarian cystectomy using bipolar,1
31851,complete axillary dissection (alnd),1
31852,lapatinib in combination with an anti-cancer agent,1
31853,folfoxiri+cetuximab+surgery+cetuximab,1
31854,web-based information and support,1
31855,conventional radiograph based brachytherapy,1
31856,rad-ifn,1
31857,"docetaxel, doxorubicin",1
31858,scto2,1
31859,team based care,1
31860,xenograft developed drug therapy,1
31861,neoadjuvant docetaxel/cisplatin/fluorouracil,1
31862,provider referral,1
31863,sequential icotinib plus chemotherapy,1
31864,hll1-dox (the doxorubicin conjugate of milatuzumab),1
31865,ultrasound guided surgery.,1
31866,standard care control condition,1
31867,everolimis,1
31868,"cp-675,206 and gemcitabine",1
31869,placebo and erlotinib,1
31870,intravenous artesunate,1
31871,colonic resection with d3 lymph node dissection,1
31872,multiwavelength and coherence confocal reflectance microscopy (vivascope 1500m multiwavelength),1
31873,problem solving skills training,1
31874,nalbuphine,1
31875,a single 2 ml heparinised peripheral blood sample,1
31876,the-optimal-lymph-flow,1
31877,cat scan,1
31878,zopiclone,1
31879,hormone and radiation therapy,1
31880,eus of pancreatic cyst lesion,1
31881,non targeted quadrantic biopsies,1
31882,immunogenic profile,1
31883,trident specimen radiography system,1
31884,etoolbox,1
31885,whole body pet-ct,1
31886,elacytarabine plus idarubicin,1
31887,reveal linq,1
31888,mep monitoring with continuous infusion of cisatracurium during general anesthesia,1
31889,m4n,1
31890,aerobic exercises,1
31891,hydralazine and valproic acid: cohort 5,1
31892,ck2 and atm inhibitors serine/ threonin kinase combination,1
31893,saline mixture,1
31894,gx-188e administered by electroporation,1
31895,multimodal liver function assessment,1
31896,perioperative folfiri-bevacizumab,1
31897,single-arch laparoscopic and endoscopic cooperative surgery,1
31898,there is no study-specific intervention,1
31899,"complete blood picture ,serum urea and creatinine,liver function test,t3,t4,thyroid stimulating hormone,thyroglobuline and thyroglobuline anti body specific test real time polymerase chain reaction",1
31900,reversal of defunctioning stoma,1
31901,the chemotherapeutic drug chosen by the investigator.,1
31902,engerix-b™,1
31903,arm 1: cytokine-induced killer cell + cisplatin + paclitaxel,1
31904,gwn323,1
31905,ec followed by cc,1
31906,"doxorubicin, cisplatin",1
31907,laparoscopic myomectomy. following analysis and proliferation of cells isolated from removed human leiomyoma.,1
31908,"bevacizumab, capecitabine",1
31909,tamoxifen stim in luteal phase,1
31910,infusion of opioid growth factor,1
31911,right hepatic vein embolization,1
31912,cellectra™ 5psp,1
31913,dcfpyl-pet/mri or -pt/ct,1
31914,ac5 topical hemostatic device,1
31915,simulation teaching session,1
31916,injection of pet tracer 68ga-nota-ae105,1
31917,fluorescence bronchoscopy with airway biopsy,1
31918,perflutren protein-type a microspheres injectable suspension,1
31919,5% bupivacaine,1
31920,dermatologic complications management,1
31921,glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine,1
31922,"manual therapy, kinesiotherapy",1
31923,"fludarabine, cyclophosphamide",1
31924,multilevel training intervention (control group with crossover),1
31925,video-assisted thoracoscopic lobectomy with powered vascular stapler,1
31926,exercise + diet counseling + psycho-emotional support,1
31927,cobas® pcr female swab self-sampling,1
31928,partner-assisted emotional disclosure,1
31929,caiman® device,1
31930,questionnaire and semi-structured interviews,1
31931,"vincristine, actinomycin-d, ifosfamide",1
31932,ridaforolimus (mk8669),1
31933,gemcitabine/oxaliplatin with erlotinib (tarceva),1
31934,s-1 plus gefitinib,1
31935,confocal group,1
31936,framed gain text reminder,1
31937,hyperthermic isolated limb perfusion,1
31938,cancer pain management,1
31939,hypofractionated whole breast irradiation with simultaneously integrated boost,1
31940,ef-1 peptide,1
31941,tsr-033,1
31942,exenatide once weekly (eqw ),1
31943,cisplatin+capecitabine,1
31944,colonoscopy (conventional colonoscope),1
31945,mep,1
31946,prednisone (or prednisolone),1
31947,tiotropium,1
31948,triptorelin embonate 22.5 mg,1
31949,annual abbreviated liver mri,1
31950,akti-treated til,1
31951,reference platelets (ref plts),1
31952,mindfulness for health,1
31953,5-ala photodynamic therapy,1
31954,zd6474 (vandetanib at the dose of 300 mg),1
31955,ct-simulation and 4d pet-ct,1
31956,tace plus rt,1
31957,external beam radiotherapy (78 gy in 39 fractions or 46 gy in 23 fractions plus brachytherapy boost),1
31958,video-assisted thoracic surgery,1
31959,purple grape juice,1
31960,evaluation maximal respiratory pressures,1
31961,"docetaxel, s-1",1
31962,"campt, topotesin",1
31963,"bkm120 (days 1 - 28, ) plus paclitaxel + carboplatin",1
31964,pre-treatment acupuncture,1
31965,bupivacaine + saline,1
31966,automated breast ultrasound examination (abus),1
31967,adriamycin and cytoxan (ac),1
31968,medi4736 evaluate medi4736 in mds,1
31969,sgn-30 (monoclonal antibody),1
31970,urine infrared analysis,1
31971,s-1 + paclitaxel chemotherapy,1
31972,rutin,1
31973,sx-682,1
31974,hypofractionated linear accelerator radiotherapy,1
31975,multilevel training intervention (intervention group),1
31976,bvz+xelox,1
31977,entospletinib sdd,1
31978,e7337,1
31979,"gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine",1
31980,polypepi1018 crc vaccine,1
31981,learning session 4,1
31982,web-based family outreach registry,1
31983,r mini chop,1
31984,beacopp escalated q3 weeks,1
31985,(68ga)psma-hbed-cc,1
31986,autologous effector lymphocytes expanded ex-vivo,1
31987,sunitinib malate continuous daily dosing,1
31988,cab-axl-adc,1
31989,graft cell infusion,1
31990,"aslan001+ capox (oxaliplatin, capecitabine)",1
31991,0.6% lugol's solution,1
31992,hot compresses,1
31993,laproscopy,1
31994,uab30,1
31995,sleep-diary,1
31996,tafetinib,1
31997,different alternatives to improve the coverage of the populational screening programmes of cervical cancer,1
31998,standard end-hole catheter,1
31999,pcv13,1
32000,fiducial marker placement,1
32001,home based health promotion,1
32002,lipidem fish oil infusion + gemcitabine chemotherapy,1
32003,epratuzumab (hll2- anti-cd22 humanized antibody),1
32004,sbrt by cyberknife,1
32005,nivolumab+ipilimumab in combination with anti tnf-? certolizumab,1
32006,designed music narratives,1
32007,compound 506u78,1
32008,anti-her2 car-t,1
32009,lca-np,1
32010,mabel ctls,1
32011,eus-fna (echotip ultra),1
32012,confocal microscopy and endocytoscopy,1
32013,biology study and tissue banking,1
32014,e7050 plus lenvatinib or lenvatinib alone plus e7050 add-on therapy,1
32015,rotterdam symptom checklist,1
32016,iontophoresis application,1
32017,5250 cgy/20 fractions over 28 days,1
32018,pazopanib (800 mg qd),1
32019,gemcitabine+simvastatin,1
32020,"doxil, paclitaxel, cyclophosphamide, avastin",1
32021,anakinra (kineret),1
32022,nemo: new model of follow-up,1
32023,haplo-cord stem cell transplantation,1
32024,paraplatin,1
32025,concurrent chemoradiation therapy without panitumumab,1
32026,sr-t100 gel with 2.3% sm,1
32027,"paclitaxel, cisplatin,surgery, ccrt",1
32028,study subjects,1
32029,intraperitoneal gemcitabine,1
32030,intrathecal triple chemotherapy,1
32031,questionnaires & study visit,1
32032,preoperative liver stiffness measurement,1
32033,conventional sbrt: 24 gy in 2 fractions,1
32034,reposmbz,1
32035,recombinant fowlpox-b7.1 vaccine,1
32036,azd9291 80mg oral each day,1
32037,"gavi , merck® (automated vitrification instrument)",1
32038,indoximod 1200mg,1
32039,"this study is non-interventional study, so this section is not applicable.",1
32040,chemotherapy with pad regimen,1
32041,hll1-dox (immu-115),1
32042,prednisone 5 mg twice daily,1
32043,pegylated-proline-interferon alpha-2b in a pre-filled pen,1
32044,paclitaxel liposome injection plus cisplatin,1
32045,aldara - imiquimod 5%,1
32046,mri and hida scan,1
32047,bayer specialist,1
32048,increasing the controlled-release oxycodone dose frequency,1
32049,co2 laser ablation,1
32050,intrathecal triple therapy,1
32051,hartmann solution,1
32052,adoptive cell therapy (act),1
32053,image guidance with general anesthesia and suspended ventilation during treatment delivery,1
32054,breath collection apparatus,1
32055,idarubincin and amufostine (ethyol),1
32056,biospy,1
32057,"in ""hot"" group 16 patients were treated by diathermy in ""cold""",1
32058,blood and respiratory fluids sampling,1
32059,hbv risk assessment survey,1
32060,cobas® 4800 hpv test,1
32061,"doxorubicin 50 mg dissolved in 10 ml dilute contrast and emulsified with 10-20 cc iodized oil, followed by 50-500 ?m microspheres.",1
32062,conventional biopsy technique,1
32063,gammaknife®,1
32064,"r-chop-14r-hidac,followed by rit/hdt/ascr.",1
32065,124 pet/ct imaging,1
32066,image guided dynamic dosimetry,1
32067,"ceplene®, il-2, azacitidine",1
32068,modified seldinger technique,1
32069,fitbit only,1
32070,"individualized, tailored follow-up program",1
32071,intraoperative peritoneal hyperthermic chemotherapy with cisplatin and mitomycin,1
32072,76 gy/ 56 fx/ 10/w with cisplatin 40 mg/m2/w and nimorazole,1
32073,endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or cdk4/6 inhibitor plus endocrine therapy,1
32074,ly2452473,1
32075,survey: standard,1
32076,2% lignocaine,1
32077,tositumomab (anti-b1 antibody) and iodine-131 tositumomab,1
32078,freeze-dried black raspberry powder,1
32079,usual care arm,1
32080,"magnetic resonance imaging, siemens",1
32081,peripheral nerve block,1
32082,ixo regimen,1
32083,antiseptic occlusive dressing group,1
32084,comparison conditions for caregivers,1
32085,ad5.sstr/tk.rgd,1
32086,valganciclovir (valcyte),1
32087,idarubincin,1
32088,vehicle pdt,1
32089,proapoptotic peptide cigb 300,1
32090,temozolomide + chloroquine,1
32091,medium intensity (group 2),1
32092,hypofractionated simultaneous integrated boost radiotherapy,1
32093,cholecalciferol 12 000 ui,1
32094,irinotecan 70 mg/m2,1
32095,pthrp (1-36),1
32096,procalcitonin test,1
32097,lr-eshap (lenalidomide 15 mg),1
32098,azd4547 / anastrozole or letrozole,1
32099,manualized calm intervention,1
32100,oral paclitaxel,1
32101,bulletin board or telephone depth interview (tdi),1
32102,single fraction,1
32103,activated t lymphocyte(immuncell-lc),1
32104,referral to a multidisciplinary expert panel at the uppsala university hospital after tumor detection,1
32105,oral tablet: cabozantinib,1
32106,barco nv digital dermatoscope device images,1
32107,di-b4,1
32108,infrared laser moxibustion,1
32109,bay 59-8862,1
32110,metvix (methyl aminolevulinate),1
32111,papillectomy with injection,1
32112,isotonic saline,1
32113,blood test (psa),1
32114,multilayer bandage,1
32115,acttrust condor instrument watch,1
32116,hll2 (epratuzumab),1
32117,second generation 4-1bb? egfr806-egfrt and a second generation 4 1bb? cd19-her2tg,1
32118,dual or multiple paraffin blocks,1
32119,2 vaccine injections in 1 limb,1
32120,eq5d questionnaire and a demographic questionnaire,1
32121,home food-delivery service,1
32122,group 4,1
32123,trigrid delivery system for intramuscular electroporation,1
32124,"bi 2536 bs, intravenous",1
32125,anti-epcam x anti-cd3 (removab),1
32126,rhenium re 188-p2045,1
32127,hyper-cvad,1
32128,r-ceop-70,1
32129,rituximab/hyaluronidase human,1
32130,"docetaxel, nedaplatin, and fluorouracil",1
32131,bibw 2992 low dose 6 day,1
32132,isa 101,1
32133,decision self-efficacy scale,1
32134,virtual reality videos,1
32135,burixafor hydrobromide,1
32136,sodium folinate,1
32137,local resection,1
32138,heart rate variability biofeedback training,1
32139,sham tibial nerve stimulation,1
32140,questionnaires set 2,1
32141,aminoleban en,1
32142,dce-mri and dwi,1
32143,chemotherapie tip,1
32144,niraparib iv (labeled),1
32145,melphalan+prednisolone,1
32146,im862,1
32147,facbc pet/mri in a subset of participants,1
32148,autologous fl vaccine,1
32149,"sorafenib (nexavar, bay43-9006) + mfolfox6 (5-fu, levo-leucovorin, oxaliplatin)",1
32150,to test the frequency of braf and nras mutations among nevi,1
32151,"abraxane,cyclophosphamide,carboplatin",1
32152,healthy wife control group,1
32153,screening for barrett's esophagus,1
32154,ct scan of the thorax,1
32155,hypnosis intervention,1
32156,pa prescription plan,1
32157,regranex (becaplermin) comparators,1
32158,range of motion therapy program,1
32159,co2 or room air insufflation during esd for gastric tumor,1
32160,digital contrast mri scan,1
32161,sodium selenite (introselen),1
32162,jcar017 (lisocabtagene maraleucel) + ibrutinib,1
32163,ratiotherapy,1
32164,ffdm mammography,1
32165,interpersonal psychotherapy,1
32166,macrogol 3350-based oral osmotic laxative,1
32167,radiation combined with iniparib (bsi-201),1
32168,bl group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr,1
32169,deep breathing exercises,1
32170,clinical follow-up control,1
32171,vorinostat in combination with bortezomib,1
32172,ch14.18-utc,1
32173,prophylactic intrathecal chemotherapy,1
32174,"doxorubicin, rituxan, cyclophosphamide, vincristine and prednisone",1
32175,panitumumab and bortezomib,1
32176,inotuzumab ozogamicin-dose level 1,1
32177,circulating tumor dna assay,1
32178,pwt-143,1
32179,autophagy inhibition therapy,1
32180,"docetaxel, anthracycline (doxorubicin or epirubicin), cyclophosphamide",1
32181,standard conservative breast surgery,1
32182,"period 1 thyrogen®, period 2 gx-30",1
32183,group b:gefitinib,1
32184,ferrous fumarate,1
32185,afl-assisted cisplatin+5-fu,1
32186,ultrasound-guided percutaneous biopsy,1
32187,"thyroxin, triiodothyronine",1
32188,epoetin beta (neorecormon),1
32189,thunbergia cream,1
32190,vaccine vehicle only,1
32191,bay1179470,1
32192,"high flow nasal cannula, hfnc",1
32193,"docetaxel, cisplatin, 5-fluorouracil",1
32194,laparoscopic or robotic surgery,1
32195,low anterior resection for rectum cancer,1
32196,genexol®-pm 260mg/m2 plus carboplatin 5 auc,1
32197,promoting participation in cervical cancer screening,1
32198,bf-200 ala 1%,1
32199,pedometer-based walking program,1
32200,cu 64 anti-cea monoclonal antibody m5a iv,1
32201,gleevec + sorafenib,1
32202,cat-8015 50 mcg/kg,1
32203,meclizine oral tablet,1
32204,electronic nose device,1
32205,neoadjuvant docetaxel/cisplatin,1
32206,autologous peripheral blood stem cell transplant (asct),1
32207,watercress,1
32208,polymorphism of il-1 beta and tnf-alpha,1
32209,pancreas biopsy,1
32210,radiotherapy (sabr),1
32211,serum ferritin,1
32212,busulfan (busilvex ®),1
32213,peep level of 5 cmh2o,1
32214,6-mp (6-mercaptopurine),1
32215,nanoparticulate paclitaxel,1
32216,cyclo thal dex daratumumab,1
32217,injection of tracer ( icg) and detection of sentinel lymph nodes,1
32218,glivec®/gleevec®,1
32219,gut microbiota samples,1
32220,everyday experiences writing,1
32221,placebo tea,1
32222,lederfolin,1
32223,"vinorelbine, cisplatin",1
32224,beacoppesc - abvd - pet2,1
32225,111-in-dota-cg250,1
32226,tracheostomy,1
32227,drospirenone ethinyl estradiol,1
32228,mwa system,1
32229,biological samples collection and analysis,1
32230,training set,1
32231,anlotinib and 14c-labeled anlotinib,1
32232,physiatry assessment,1
32233,open distal pancreatectomy,1
32234,carboplatin auc 5+paclitaxel 175 mg/mq q 21 for 6-8 cycles,1
32235,placebo to optional asa as comedication,1
32236,adct-602,1
32237,18f-fch pet,1
32238,liposomal interleukin-2,1
32239,end-of-study healthcare provider assessment,1
32240,cognitively-based compassion training,1
32241,treatment for ampullary adenocarcinoma,1
32242,immunohistochemistry and/or fish,1
32243,nivolumab placebo,1
32244,menadione topical lotion,1
32245,prevnar 13,1
32246,placebo matching bms-936558 (nivolumab),1
32247,wound dressing,1
32248,natural killer (nk) cell transplant,1
32249,fit bit device,1
32250,wait list intervention,1
32251,decision support intervention (dsi),1
32252,srp and fotosan 630,1
32253,sexual activity questionnary,1
32254,"l-asp, dxm, ifo, vp-16, ddp",1
32255,sq109,1
32256,actigraphy device,1
32257,"rad001 (everolimus, afinitor®)",1
32258,donors,1
32259,sitravatinib tislelizumab,1
32260,bromocriptine,1
32261,pn usual,1
32262,dendritic vaccine pulsed with multiple peptides,1
32263,internet mobile technology,1
32264,robotic assisted laparoscopic hysterectomy,1
32265,vandetanib and etoposide,1
32266,standard radiochemotherapy or dose-escalated radiochemotherapy,1
32267,haploidentical transplant,1
32268,external beam radiation (dose level 2),1
32269,caris mi profiling,1
32270,"serratus plane bloc : ropivacaine 2mg/ml (0,3ml/kg)",1
32271,skin and blood vessel procedures,1
32272,neuropsychological test battery,1
32273,"laterally extended endopelvic resection, total mesometrial resection",1
32274,celecoxib 200mg oral capsule,1
32275,radiosensitive therapy,1
32276,"pembrolizumab, paclitaxel",1
32277,non-icu specialty ward,1
32278,text message intervention,1
32279,lidocaine in vaseline ointment,1
32280,gvd chemotherapy,1
32281,f-dcfpyl injection,1
32282,project cornerstone,1
32283,flu-fit program,1
32284,open radical prostatectomy,1
32285,standard fractionated radiotherapy,1
32286,hla-a2 restricted synthetic tumor antigen,1
32287,3d prostate ultrasound,1
32288,robotic assisted laparoscopic radical prostatectomy (rarp),1
32289,samarium (153sm),1
32290,dtp348,1
32291,peptide natriurétique de type b,1
32292,ga-driven intervention,1
32293,amg 424,1
32294,"blood sample, thoracocentesis",1
32295,monoclonal antibody anti-anb3 integrin,1
32296,etc-1922159,1
32297,letrozole (aromatase inhibitors),1
32298,cisplatin and gemcitabine combination with bevacizumab,1
32299,whole body vibration,1
32300,treatment b (lx4211),1
32301,cranial radiation,1
32302,"panobinostat (lbh589), carboplatin and paclitaxel",1
32303,hyperglycemic clamp,1
32304,gastroscopy,1
32305,tolvaptan,1
32306,transanal minimally invasive total mesorectal excision (tamis group),1
32307,afatinib (30 or 40mg) + nimotuzumab (100 or 200mg),1
32308,hepasphere/quadrasphere microspheres,1
32309,cisplatin/paclitaxel,1
32310,intracorporeal esophagojejunostomy,1
32311,c-reactive protein levels,1
32312,2d ffdm,1
32313,cone-beam computed tomography (ct),1
32314,ultrasound-guided biopsy,1
32315,pct,1
32316,nerve block,1
32317,"aclacinomycin, cytarabine",1
32318,nanopac® 100 mg/m2,1
32319,burosumab,1
32320,apt mri,1
32321,endoscopy screening with narrow band imaging,1
32322,audio recording of initial consultation and debriefing interviews.,1
32323,propofol-remifentanil,1
32324,"comparator: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine",1
32325,blood draw - dendritic cells,1
32326,oxaliplatin (oxal),1
32327,relaxation therapy 2,1
32328,tak-164,1
32329,day 1 to day 14,1
32330,elective colon resection,1
32331,cpg dna,1
32332,18f-fdg pet-mri-imaging,1
32333,intervention. exercise,1
32334,g-tube/swallowing intervention,1
32335,pf (cisplatin and 5-fluorouracil) group,1
32336,iv glutamine,1
32337,secondary citoreduction,1
32338,117-126:fibroblast growth factor 5 (fgf-5),1
32339,[124i] psca-minibody pet/ct imaging of the whole body,1
32340,ny-eso-1,1
32341,enhanced recovery pathway,1
32342,robotic gastric gastrointestinal stromal tumors resection,1
32343,cannula ileostomy,1
32344,a (pembrolizumab+rt),1
32345,measuring liver function by 18-fdgal pet/ct,1
32346,cudc-427,1
32347,extension of ltfu as per protocolamendment7 7jun18,1
32348,avelumab 1200 mg in combination with pemetrexed/carboplatin,1
32349,in-situ split,1
32350,fluorouracil + folinic acid,1
32351,cisplatin plus epirubicin,1
32352,hyperfractionation,1
32353,rxdx-107,1
32354,acellular cadaveric dermal matrix,1
32355,diffusion-weighted nuclear magnetic resonance imaging (mri),1
32356,2-deoxyglucose (2dg),1
32357,dietary intervention (resistant starch),1
32358,iadt,1
32359,64cu-dota-eclii,1
32360,conventional polypectomy,1
32361,miller air tip,1
32362,conventional clothing,1
32363,"su-011,248",1
32364,simple informational booklet,1
32365,infusion with nivolumab 1 mg/kg q3wks,1
32366,ice chemotherapy regimen,1
32367,immediate gardening intervention,1
32368,dna extraction determination of mc1r genotypes,1
32369,se-methyl-seleno-l-cysteine,1
32370,oral masitinib,1
32371,q.d. rt,1
32372,incidental genomic sequencing results,1
32373,radiotherapy / ep combined with recombinant human endostatin,1
32374,laparoscopic ultrasound,1
32375,primovist-enhanced mri,1
32376,miltenyi system,1
32377,shared decision making for colorectal cancer screening,1
32378,dvd decision aid,1
32379,radiotherapy dose,1
32380,calcium gluconate and magnesium sulfate,1
32381,whole-body scintigraphy,1
32382,"vaccine comprised of klh conjugates of gd2l, gd3l, globo h, fucosyl gm1, and n-propionylated polysialic acid plus opt-821 adjuvant",1
32383,standard beacopp,1
32384,description of the cirrhosis management,1
32385,"thyrogen, thyroid hormone withdrawal, iode 131",1
32386,desipramine hydrochloride,1
32387,cpx-pom,1
32388,breast cancer screening decision aid,1
32389,staphylococcus aureus carriage,1
32390,the chimeric antigen receptor t cell immunotherapy (car-t),1
32391,goserelin+tam+ai,1
32392,heat shock protein peptide complex-96 (hsppc-96),1
32393,dedicated and coordinated e-follow-up during the treatment period,1
32394,alprostadil (e1),1
32395,lapatinib/temozolomide/radiation,1
32396,palcociclib,1
32397,vert system,1
32398,biliary cannulation with loop guidewire,1
32399,oxycodone fentanyl,1
32400,miha-loaded pd-l-silenced dc vaccination,1
32401,"super selective transarterial chemoembolization of chc, with doxorubicin reconstituted in 5cc normal saline",1
32402,flt pet,1
32403,doxycline,1
32404,ymb 1002,1
32405,docetaxel+lobaplatin,1
32406,"single arm, open-label",1
32407,nab-paclitaxel - induction cohort,1
32408,no active treatment - completed prior radiation,1
32409,im-tmi (9gy),1
32410,2-point dixon magnetic resonance imaging,1
32411,fixed dose plerixafor,1
32412,vismodegib (gdc-0449),1
32413,endocuff attachment,1
32414,curative resection without pringle,1
32415,program of support of the sexual health,1
32416,cc&s,1
32417,grid&direct short pulse laser photocoagulation,1
32418,laparotomy or laparoscopy,1
32419,combination of magic mouthwash plus sucralfate,1
32420,non-contrast computed tomography (ct) scans (metallic markers),1
32421,cisplatin (ddp),1
32422,mpc-2130,1
32423,medtec s-frame immobilization masks,1
32424,l-folinic,1
32425,high risk: inpatient management,1
32426,standard pebus with guide sheath,1
32427,intensity modulated radiation treatment (imrt),1
32428,standard oral hygiene,1
32429,ugn-102,1
32430,r11577,1
32431,dual-energy contrast-enhanced digital spectral mammography,1
32432,"capecitabine, gemcitabine, docetaxel",1
32433,sgn-15,1
32434,standard anti-emetics in conjunction with r-chop,1
32435,epoetin alfa 150 iu/kg 3 times a week,1
32436,exercise prescription,1
32437,orientation group,1
32438,epoetin alfa + packed rbc transfusion,1
32439,gsk biological's hpv vaccine gsk580299 (cervarix™),1
32440,chemotherapy (phase 1),1
32441,preop®,1
32442,neoadjuvant treatment - cabazitaxel,1
32443,"cetuximab, imrt, albumin-bound paclitaxel (abraxane®)",1
32444,home yoga practice,1
32445,conventional port,1
32446,l-arginine hydrochloride solution,1
32447,placebo mr guided focused ultrasound,1
32448,allogeneic hematopoietic stem-cell-transplantation,1
32449,non-navigated,1
32450,whole grain rye,1
32451,iv bisphosphonate q 4 weeks,1
32452,screening anal pap smear - with high resolution anoscopy,1
32453,perflutren lipid microsphere,1
32454,hepatectomy (rapid ligating),1
32455,h1299 lysate vaccine,1
32456,radioimmuniguided intenstiy modulated radiotherapy,1
32457,zevalin-bucye,1
32458,hemi-thyroidectomy + clnd,1
32459,nac,1
32460,cd34+ selection.,1
32461,artichoke wpc,1
32462,boost plus®,1
32463,gasless single-port laparoscopic surgery,1
32464,300mg netupitant/0.5mg palonosetron hydrochloride,1
32465,picato 0.05% topical gel,1
32466,cisplatin combined with topotecan,1
32467,type of breast cancer surgery,1
32468,interactive voice response (ivr),1
32469,local hyperthermia at 37?,1
32470,atomoxetine,1
32471,neuristim,1
32472,study diary plus actigraph,1
32473,agen1884 in combination with pembrolizumab,1
32474,plasma hpv,1
32475,ugt1a1 non-genotyping,1
32476,technetium 1,1
32477,tigr®,1
32478,anthracycline based chemotherapy,1
32479,menstrual blood analysis (menstrual blood analysis),1
32480,busulfan plasma level measurements,1
32481,palliative care training,1
32482,regorafenib (bay73-4506) + rifampin,1
32483,interviews with 2 oncologists and 10 patients,1
32484,cilengitide emd 121974,1
32485,brain mri scan,1
32486,ed coil / electro-detach generator v4,1
32487,letter to gp,1
32488,mid-low dose lx1606 - day 15 (start),1
32489,pre operative radiotherapy,1
32490,bipolar electrosurgical instruments (medtronic) (sls- clips),1
32491,24-hour prophylactic cefazolin* antibiotic regimen,1
32492,mastectomy or lumpectomy,1
32493,dietary supplement,1
32494,folfox4 regimen,1
32495,azd9291 tablets,1
32496,cyberknife stereotactic accelerated partial breast irradiation (ck-sapbi),1
32497,fludarabine and busulfan + low dose total body irradiation (ld tbi),1
32498,multimedia education,1
32499,adjuvant chemotherapy using pf (5-fluorouracil ),1
32500,m-trap,1
32501,tsd,1
32502,cart bcma or cart bcma + hucart19,1
32503,laparoscopic total gastrectomy with d2 lymphadenectomy,1
32504,tumor derived microparticles,1
32505,inspection with narrow-band imaging(nbi),1
32506,rucaparib (co-338; formally ag-014699 or pf-01367338),1
32507,folded technique of self-adherent wrap,1
32508,oral examination with incandescent light,1
32509,md-3511356,1
32510,vertebral augmentation with balloon kyphoplasty,1
32511,interleukin-2 & ipilimumab (p-ii),1
32512,automatic imaging fusion of ultrasonography and mri,1
32513,rituximab or iodine i 131 tositumomab therapy,1
32514,hsct from mud,1
32515,imatinib (gleevec/ glivec),1
32516,tas4464,1
32517,hwh340 tablet,1
32518,pazopanib and th-302,1
32519,dynamic contrast- enhanced (dce) mri,1
32520,brentuximab vedotin 1.8 mg/kg,1
32521,high intensity counseling + long acting nrt + prn nrt,1
32522,intravenous (iv) and oral vitamin c,1
32523,device: fitbit aria weight scale,1
32524,nail polish,1
32525,[68ga]dotatate-pet/mri,1
32526,dcvac/ovca in parallel with chemotherapy,1
32527,bay1143572,1
32528,azacitidine and idarubicin,1
32529,health coordinator (or patient navigator),1
32530,optical spectroscopy bench-top system,1
32531,taking blood samples from healthy people,1
32532,male circumcision,1
32533,cldn15/vim test,1
32534,integral attention program (pai),1
32535,radiotherapy (primary or postoperative),1
32536,novel drug combination,1
32537,group of patients,1
32538,regranex (becaplermin),1
32539,guardant health ct-dna lunar assay,1
32540,virtual reality distraction,1
32541,patient discharge on postoperative day 2,1
32542,taa-t cells,1
32543,branch ii,1
32544,ly2875358 at part a highest dose + trametinib,1
32545,folfox and bevacizumab,1
32546,gallium-68 dotatoc pet,1
32547,"vaccine--?primed, cd3/cd28--?costimulated autologous peripheral blood t--?cells",1
32548,circumferential measurements in different upper limb positions.,1
32549,eus-guided fine-needle injection of dcs vaccinations,1
32550,percutaneous radiation therapy,1
32551,electrosensing antibody probing system (e- ab sensing),1
32552,topical retinoid and blue-light therapy with photosensitizing agent,1
32553,bacille calmette-guerin,1
32554,ifosfamide-based chemotherapy (ai),1
32555,early bladder training and bethanechol chloride,1
32556,"amg 386, paclitaxel and carboplatin",1
32557,donor lymphapheresis,1
32558,physical intervention,1
32559,mk-3475 (adjuvant),1
32560,stereotactic boost,1
32561,irinotecan-based chemo + bevacizumab,1
32562,cola,1
32563,topical resiquimod 0.06%,1
32564,fluorine f 18 dcfpyl,1
32565,allovax™,1
32566,"""ablatherm foc/dyn"" or ""focal one"" hifu treatment",1
32567,pediacel®,1
32568,selective tace via microsphere loaded with doxorubicin,1
32569,sunscreen spf 50+,1
32570,famitinib h + docetaxel,1
32571,citicoline,1
32572,oligo fucoidan,1
32573,baseline participant assessment,1
32574,virtual technology - tailored minimally,1
32575,iset system,1
32576,njh395,1
32577,health risk and behavioral skills coaching sessions,1
32578,sig12d-loder,1
32579,unaided visual inspection,1
32580,afatinib 30mg tab,1
32581,pegylated liposomal doxorubicin and docetaxel,1
32582,bnc101 solution for infusion,1
32583,preoperative normal saline inhalation,1
32584,hdregn2810,1
32585,"vorinostat, lenalidomide",1
32586,macrogen pan cancer panel (tier 2),1
32587,cdx-0158 (formerly known as ktn-0158),1
32588,shorter wb fractionation,1
32589,conversion rate to open surgery,1
32590,mitoxantrone + etoposide + gemtuzumab ozogamicin,1
32591,"radiochemotherapy,combination cetuximab-folfox",1
32592,right hemicolectomy with d3 lymph node dissection,1
32593,"immunohistochemical, methylation, gene transfection",1
32594,standard imaging,1
32595,targeted biopsies of the prostate,1
32596,high dose gtn 0.057 mg/hr,1
32597,ct/cbct thermometry method,1
32598,fsrt stereotactic radiation therapy,1
32599,telephone implementation intention,1
32600,combretastatin a1 diphosphate (oxi4503),1
32601,ganglion sphenopalatine block with placebo,1
32602,physical activity coaching,1
32603,proton radiation plan,1
32604,b arm (flag-ida),1
32605,tp-0903 and ibrutinib combination therapy,1
32606,temozolomide with radiation therapy,1
32607,modified folfirinox regimen,1
32608,rise,1
32609,panvac,1
32610,hydralazine/magnesium,1
32611,evaluation of response by recist,1
32612,"pep005 (ingenol mebutate) gel, 0.015%",1
32613,ms201408-0005b,1
32614,bey1107,1
32615,vtp195183,1
32616,"cyclophosphamide, methotrexate, 5 fu",1
32617,biospeciman collection,1
32618,"peritoneal microdialysis, ct-scan, leakage scoring",1
32619,ibrutinib + ga101 +gdc-0199,1
32620,radioiodide (131i-),1
32621,standard siemens software,1
32622,comparator: placebo (concomitant-vaccine matched) / duration of treatment : 4 years,1
32623,whole body dynamic contrast enhanced mri (wb-dce-mri),1
32624,vitamin d (calcitriol),1
32625,high-dose beam plus autologous sct,1
32626,ad-ccl21-dc .05 x 07,1
32627,de-ct's and se-ct,1
32628,d-via,1
32629,hormones,1
32630,general anesthetic,1
32631,"perioperative parenteral immunonutrition (dipeptiven, omegaven)",1
32632,as usual,1
32633,ii consolidation hidarac,1
32634,information booklet,1
32635,peg,1
32636,azacitidine for injectable suspension,1
32637,repetitive epipac-ox,1
32638,lu 177,1
32639,exploration of abdominal cavity and liver using a nir/icg camera,1
32640,bibw 2992 high dose 6 day,1
32641,additional tme surgery,1
32642,"busulfan, and melphalan, and alemtuzumab",1
32643,liposomeal curcumin,1
32644,salkera emollient foam,1
32645,tumor size,1
32646,fec3-d3,1
32647,docetaxel + carboplatin + radiotherapy + docetaxel + gemcitabine,1
32648,myeloid progenitor cell transplantation,1
32649,blood testing,1
32650,bi-weekly administration of arq 761,1
32651,vm206ad,1
32652,extremely low dose ct,1
32653,docetaxel+s-1,1
32654,get connected,1
32655,injection of isotope,1
32656,chest irradiation,1
32657,optune system,1
32658,darbepoetin alfa - 500mcg,1
32659,ahcc 3 grams once a day,1
32660,ny-eso-1 protein,1
32661,pasireotide sub-cutaneous,1
32662,cervico-vaginal smears analysis,1
32663,neoadjuvant cisplatin chemotherapy,1
32664,epilepsy early diagnosis protocol,1
32665,ss1(dsfv)-pe38 (ss1p) anti-mesothelin immunotoxin,1
32666,fit(eiken oc-sensor) one-day sampling,1
32667,iron tracer,1
32668,anti-kir (1-7f9),1
32669,tomotherapy hd,1
32670,"cis platinum/carboplatin, pemetrexed disodium",1
32671,pomegranate-extract pill,1
32672,symptom inventory,1
32673,vaccine 1650-g,1
32674,none: questionnaire study,1
32675,pre-surgical treatment with bevacizumab plus chemotherapy,1
32676,goserelin with bicalutamide and dutasteride and ketoconazole,1
32677,at-101 and docetaxel,1
32678,ag-270,1
32679,letrozole plus metformin,1
32680,biopsy of adipose and muscular tissue,1
32681,cryotherapy or photodynamic therapy with methyl aminolevulinate cream,1
32682,bipolar rfa,1
32683,3t multiparametric mri,1
32684,rad001(afinitor),1
32685,cone beam computed tomography,1
32686,immunotherapeutic gsk1572932a,1
32687,"bortezomib, dexamethasone, thalidomide, and cyclophosphamide",1
32688,tesetaxel once every 3 weeks,1
32689,panax ginseng,1
32690,ruxolitinib oral tablet [jakafi],1
32691,videoendoscopic resection of pilonidal sinus,1
32692,wire-guided lesion localization,1
32693,magnesium sulphate,1
32694,preperitoneal catheter,1
32695,"20-gauge procore® first, then 22-gauge acquire®",1
32696,brochure of secondary cancer screening,1
32697,biological: pegylated recombinant human hyaluronidase (pegph20),1
32698,mpc-6827 + temozolomide,1
32699,allocation of treatment with metformin or rosiglitazone,1
32700,educational dvd,1
32701,"siltuximab, velcade and dexamethasone",1
32702,peg solution (fortrans®) and mentholyptus drops (halls®),1
32703,iv administration of gadolinium-containing contrast agent,1
32704,single agent chemotherapy,1
32705,standard symptom management,1
32706,alvocidib plus decitabine,1
32707,dna vaccination,1
32708,medihoney (group b),1
32709,dta/dba c-arm fluoroscopy system with dyna ct,1
32710,tobacco cessation counseling and coordination of cessation medications,1
32711,injection of radioactive tracer combined with patent blue,1
32712,short breast mri (sbmri),1
32713,patients will be divided in two groups- those having right colectomy by standard laparoscopy and those having single incision laparoscopic surgery (sils),1
32714,grapiprant,1
32715,therabionic device,1
32716,apatinib and xelox combined treatment group,1
32717,huluc63,1
32718,a combination of gemcitabine and cisplatin,1
32719,day 1: cisplatin 75 mg/m2,1
32720,robotic-assisted lobectomy using da vinci surgical system,1
32721,ar-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin),1
32722,dhp107,1
32723,trabedersen,1
32724,bethanechol chloride,1
32725,endoscopic examination,1
32726,cabazitaxel 10 mg/m2,1
32727,eligard (tm),1
32728,relaxation therapy 3,1
32729,tumor surgical excision,1
32730,"adriamycin, cyclophosphamide, vindesine, valproic acid",1
32731,placebo for antibiotic,1
32732,suitable for tad,1
32733,fludarabina,1
32734,vasoconstrictor eye drop,1
32735,pancreatico gastro anastomosis,1
32736,shark mouth modified pancreaticojejunostomy,1
32737,methylnaltrexone,1
32738,consult visit,1
32739,nivolumab & tumor infiltrating lymphocytes with/without interferon-alpha,1
32740,nrx194204,1
32741,r/t gating kv intrafraction monitoring,1
32742,pasireotide s.c.,1
32743,dc/myeloma fusions/gm-csf,1
32744,18-f-faza,1
32745,cenersen sodium,1
32746,radioactive stent,1
32747,positron emission tomography and ultrasonogram,1
32748,standard cessation (sc),1
32749,german pro-self(c) plus pain control program (pcp),1
32750,germline genetic testing of brca1 and brca2,1
32751,urinary excretion of flc immunoglobulin,1
32752,delayed coloanal anastomosis (acad),1
32753,"topotecan, dexamethasone, vincristine",1
32754,continuous infusion of local anaesthetic,1
32755,apricoxib/erlotinib,1
32756,"chromoendoscopy, high definition white light and narrow band imaging",1
32757,webchoice,1
32758,imo-8400 0.6 mg/kg/wk or 1.2 mg/kg twice weekly,1
32759,thermal comfort questionnaire,1
32760,tli,1
32761,coil testing,1
32762,conventional endoscopy,1
32763,isosulfan blue based lymphatic mapping,1
32764,cirt with systemic therapy arm,1
32765,fluorescent laparoscopic radical gastrectomy,1
32766,dose escalated five fraction stereotactic radiosurgery,1
32767,rv001v,1
32768,transcervical oropharyngeal ultrasound,1
32769,pi3kbeta inhibitor azd8186,1
32770,dcds0780a,1
32771,navelbine (oraly),1
32772,"phase 1, cohort 1",1
32773,dynamic susceptibility contrast-mri (dsc-mri),1
32774,education about hpv by school nurse,1
32775,extensive ga,1
32776,gadofosveset trisodium (ablavar™ ),1
32777,mek162+capecitabine,1
32778,follitropin alpha,1
32779,tlk286 hcl for injection,1
32780,gic-1001 375 mg tid,1
32781,casodex and zoladex (or lupron),1
32782,flu matrix peptide p58-66,1
32783,dose dense ac or fec100 followed by paclitaxel or docetaxel chemotherapy,1
32784,26.8 mg/kg ?-tea,1
32785,inquiry based stress reduction (ibsr),1
32786,post-operative treatment trastuzumab mono therapy,1
32787,tmz 150mg/m2 six 6-week cycles,1
32788,quinacrine dihydrochloride - extension dose,1
32789,standard adt,1
32790,recombinant humanized bispecific monoclonal antibody mbs301,1
32791,ga and integrated care plan,1
32792,octavalent hpv with 30 mcg imx / aahs,1
32793,[11c]martinostat,1
32794,blue light tur-bt,1
32795,perioperative symptom measurement,1
32796,f5 tcr transgenic cells and mart-1 peptide pulsed dendritic cells,1
32797,cyclophosphamide based chemotherapy regimens,1
32798,anti-tumor necrosis factor alpha agents,1
32799,catheterization of subclavian vein,1
32800,androgen deprivation therapy - gnrh antagonist,1
32801,cc-11006,1
32802,5-azacytidine and lenalidomide,1
32803,antiepileptic drug (1 to 3 only),1
32804,galactose,1
32805,hljdt,1
32806,onyx-015,1
32807,latest generation chemotherapies for t-lbl + transplant,1
32808,irreversible electroporation (ire ),1
32809,pasireotide with or without cabergoline,1
32810,"fludarabine, busulfan, thymoglobuline",1
32811,pet-mri and ebus-tbna,1
32812,pembrolizumab 200 mg iv infusion,1
32813,sienna+ retro,1
32814,ginseng,1
32815,pralatrexate with vitamin b12 and folic acid,1
32816,conformal three-dimensional radiotherapy,1
32817,endorectal balloon insertion,1
32818,pembrolizumab nsclc,1
32819,diagnostic (18f-flt pet/ct),1
32820,prism (promoting resilience in stress management),1
32821,bispectral index will be targeted at 50,1
32822,meditation intervention,1
32823,azd9291 80 mg/40 mg + placebo,1
32824,amlodipine,1
32825,sems plus radiofrequency ablation,1
32826,spi-1005 high dose,1
32827,3d-models,1
32828,hdr brachytherapy + hypofractionated ebrt,1
32829,topical spray on the cervix,1
32830,optical molecular imaging,1
32831,taiwan ace beads,1
32832,"ipilimumab, 10 mg",1
32833,mri-targeted biopsy,1
32834,"bcs, modified radical mastectomy",1
32835,self-report assessments,1
32836,surgery for primary breast tumor.,1
32837,bendamustine iv,1
32838,microsurgical resection,1
32839,date fruit - ajwa variety,1
32840,modified radical neck dissection,1
32841,biopsies during colonoscopy,1
32842,standard dosing method arm: cisplatin (chemotherapy) dosing based on body surface area,1
32843,"concurrent radiotherapy (rt)/cisplatin, vipd",1
32844,"rapamycin, sirolimus",1
32845,real time position management system,1
32846,pd-616,1
32847,iomab-b,1
32848,retrospective comparison,1
32849,5 cm colon-j-pouch,1
32850,focal high intensity focused ultrasound (hifu) treatment,1
32851,polio/rhinovirus recombinant (pvsripo),1
32852,talazoparib phase 1b,1
32853,hyperthermic intravesical chemotherapy,1
32854,vivofit watch,1
32855,drug&radiation,1
32856,patients receiving conventional supportive care,1
32857,everolimus and rituximab,1
32858,tg-1801,1
32859,aerosolized aldesleukin,1
32860,beetroot,1
32861,"mk0683, vorinostat",1
32862,eus-guided fna performed with on-site cytopathologist,1
32863,thymoquinone 100mg,1
32864,gemcitabine plus abraxane,1
32865,group (b),1
32866,xpede™ bone cement,1
32867,conventional induction chemotherapy,1
32868,"sagopilone (bay 86-5302, zk 219477)",1
32869,aim materials and assessments,1
32870,cytosine arabinoside with g-csf (filgrastim),1
32871,administration of a propranolol (hemangiol®) and oral metronomic vinorelbine (navelbine®) combination,1
32872,topical anaesthesia,1
32873,elemene injection/elemene oral emulusion,1
32874,capecitabine and mitomycin,1
32875,"vincristin, daunorubicine, asparaginase, methotrexate",1
32876,couples-based behavioral weight and symptom management,1
32877,bevacizumab standard of care,1
32878,low dose ketamine,1
32879,immersive assessment,1
32880,seviteronel: given orally once daily in 28-day cycles,1
32881,alecsat cell based immunotherapy,1
32882,"""prophylactic"" delayed adli",1
32883,computer decision board,1
32884,multi-disciplinary treatment,1
32885,22g standard fna needle,1
32886,consumer assessment of health care providers and systems program (cahps),1
32887,"two complex naturopathic add-on therapies, leaflet 5-a-day",1
32888,ppx with cisplatin and radiation,1
32889,piecemeal resection,1
32890,unmanipulated pbsc after nonmyeloablative conditioning,1
32891,eoc317 tablet,1
32892,auriculotherapy for analgesic use,1
32893,pd-1 antibody (shr-1210),1
32894,matching placebo (normal saline),1
32895,pravastatin pill,1
32896,conventional chemotherapy(forfirinox),1
32897,10 mg melatonin,1
32898,ad/pnp,1
32899,flysyn,1
32900,intravenous anesthetics,1
32901,coping-focused counseling telephone calls,1
32902,cotinine education,1
32903,whole genome sequencing,1
32904,different volume aspiration,1
32905,f18-choline pet examination,1
32906,"therapeutic cellular vaccine, gm-csf producing",1
32907,pre-treatment tumour oxygen measurements (under anesthesia),1
32908,nir/us diagnostic group,1
32909,3 cycles of standard chemotherapy,1
32910,anti-mesothelin car t cells,1
32911,low intensity counseling + long acting nrt,1
32912,lef measures,1
32913,no live video-colposcopy,1
32914,ag-d-cik,1
32915,iv fluorescein administration,1
32916,tumor marker detection in lymph nodes,1
32917,ga-68-dotatate,1
32918,solumatrix™ abiraterone acetate,1
32919,cryotherapy alone,1
32920,low dose rate brachytherapy,1
32921,initial fecal volatile organic compounds,1
32922,ctt1057 or 68ga-psma-11,1
32923,laparoscopic d2 radical total gastrectomy with bursectomy using a left outside bursa omentalis approach,1
32924,placebo testosterone,1
32925,preoperative proton therapy,1
32926,psychoeducational my surgical success video,1
32927,dose expansion of durvalumab and trabectedin,1
32928,fes pet/ct,1
32929,endostar routine intravenous infusion,1
32930,standard gauze dressing,1
32931,psychologic distress,1
32932,zk219477,1
32933,placebo with azacitidine,1
32934,sham nss-2 bridge,1
32935,carfilzomib/lenalidomide/dexamethasone,1
32936,ganciclovir (gcv),1
32937,standard oral information,1
32938,rhsa-gcsf 2.4mg,1
32939,cc-100004,1
32940,brain pet/ct step,1
32941,living donor liver transplantation with two-staged hepatectomy.,1
32942,ex vivo cd3/cd28-costimulated vaccine-primed peripheral blood autologous t cells,1
32943,transplantation of cord blood expanded with um171,1
32944,deep inspiration breath hold and free-breathing,1
32945,conventional cytogenetics studies,1
32946,adriamycin (doxorubicin),1
32947,standard of care/placebo,1
32948,sequentially,1
32949,folfox6 cycles 1-3,1
32950,tps / varian,1
32951,cesium-131 brachytherapy seed,1
32952,anti-pd-1/pd-l1 antibodies,1
32953,anticoagulation treatment.,1
32954,part b) advanced solid tumor,1
32955,accelerated hypofractionated rt,1
32956,sorafenib and gemcitabine,1
32957,cholin-pet-ct,1
32958,cg - social skills activities,1
32959,3 days sie plus 4 weeks pre,1
32960,mtl-cebpa,1
32961,syndros,1
32962,radiological embolization (ufe),1
32963,"rituximab, ifosfamide, etoposide, carboplatin, stem cell collection, mitoxantrone, cyclophosphamide and etoposide, carmustine",1
32964,topical infliximab,1
32965,optimox-bevacizumab,1
32966,gte (green tea extract),1
32967,pevonedistat 20 mg/m^2,1
32968,cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine,1
32969,oral cell dna adducts,1
32970,acidolphilus,1
32971,mammalian omega 3 fatty acids,1
32972,capecitabine oral tablet [xeloda],1
32973,prostate mri,1
32974,eurofarma's pegfilgrastim,1
32975,val-083,1
32976,f-18 florbetapir/c-11 acetate pet,1
32977,fibrin sealant (tisseel) used in the experimental arm.,1
32978,"velcade, thalidomide, and dexamethasone",1
32979,usual medical care,1
32980,chemotherapy drug,1
32981,tamoxifen oral product,1
32982,temozolomide 100mg,1
32983,positive pressure ventilation,1
32984,contrast-enhanced dynamic ct perfusion study,1
32985,physical activity recall,1
32986,"1 tachosil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.",1
32987,montanide adjuvant + gm-csf,1
32988,escitalopram oral tablet,1
32989,lanreotide atg 120mg,1
32990,gemcitabine with r115777,1
32991,dose dense ac followed by t + trastuzumab + pertuzumab,1
32992,dt pace + rituxan,1
32993,"iort with 50 kv x-rays, 20 gy",1
32994,double-brewed green tea,1
32995,"docetaxel, oxaliplatin and 5-fu",1
32996,cyclophosphomide,1
32997,breast reconstruction with artificial implant,1
32998,answatch,1
32999,arm nai-iri + 5-fu + leucovorin (arm a),1
33000,"""epi procolon 2.0 ce"" test from epigenomics, inc (berlin, germany)",1
33001,improved,1
33002,the patient-satisfactive® model,1
33003,10% fluorescein,1
33004,methylsulfonic apatinib,1
33005,conventionally fractionated radiotherapy,1
33006,antineoplastic and immunomodulating agents,1
33007,single ft1050 treated ucb unit,1
33008,pg,1
33009,cyc,1
33010,mrtx849,1
33011,american heart association step 1 diet,1
33012,vitamin d3 analogue ilx23-7553,1
33013,capecitabine+irinotecan+bevacizumab,1
33014,lymph nod detection,1
33015,gemcitabine 500 mg,1
33016,no intervention: observational study,1
33017,submaximal exercise,1
33018,"prosm guidelines for preoperative, anesthesia and postoperative care for lung resections",1
33019,cordin,1
33020,spine x-ray,1
33021,99mtc mip 1405,1
33022,[18f]-fdg pet/mr,1
33023,cyclophosphamide + busilvex,1
33024,light infusion therapy™,1
33025,fluoropyrimidine (5-fu/lv or capecitabine),1
33026,urine flow and residual,1
33027,immediate spa treatment,1
33028,g-eye(tm) colonoscopy,1
33029,"hipec: mmc 30mg @ t0, 10mg @ t45min",1
33030,umbilical cord blood after reduced-intensity conditioning,1
33031,"pae physician activation, plus teledermoscopy (pae +md +td)",1
33032,pegylated interferon-alpha 2b,1
33033,l-ohp (130mg/m2),1
33034,definity®,1
33035,epirubicin cyclophosphamide paclitaxel,1
33036,deferiprone,1
33037,car-t cells to treat advanced lung cancer,1
33038,co-educational workshops,1
33039,glivec 100mg film coated tablet,1
33040,"dexamethasone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, doxorubicin, 6-mercaptopurine",1
33041,dosage of free circulating plasmatic dna,1
33042,bi-1206 single agent expansion phase,1
33043,integrated addiction treatment program,1
33044,perioperative capox-bevacizumab,1
33045,"busulfan, melphalan, rabbit atg",1
33046,decitabine plus fludarabine and busulfan,1
33047,broccomax®,1
33048,mind-body medicine group program,1
33049,potassium iodide,1
33050,pemetrexed+cisplatin,1
33051,"biopsy: immunohistochemistry: ca9, glut1, hif-1 alpha",1
33052,ponatinib 15 mg qd,1
33053,pegfilgrastim 12 mg,1
33054,complete lymph node dissection,1
33055,pasireotide lar 60 mg,1
33056,levo-folinic acid,1
33057,b001,1
33058,pharmacokinetic,1
33059,surgical re-exploration,1
33060,hsppc-96 or oncophage,1
33061,abraxane every three weeks and daily vandetanib,1
33062,samples and follow up,1
33063,fna biopsy for thyroid nodule(s),1
33064,propranolol gel,1
33065,18f-flt-tep,1
33066,fulvestrant + zactima,1
33067,crc surgery,1
33068,craniospinal irradiation with boost to the primary tumor site,1
33069,5ala,1
33070,pedometer-based activity monitoring after asct,1
33071,a-101 25%,1
33072,ultrasound examination,1
33073,prostvac-f/ tricom,1
33074,"part b, cohort 2- vs4718, nab-paclitaxel, gemcitabine",1
33075,comp04,1
33076,khk2866,1
33077,dnx-2440 injection,1
33078,home-based pulmonary rehabilitation program,1
33079,lymfactin® [1 x 10e10 vp],1
33080,sch 66336,1
33081,casein,1
33082,r-bl-m-04,1
33083,folfiri-bevacizumab,1
33084,arq 087,1
33085,docetaxel + trastuzumab sc + pertuzumab,1
33086,webcasts,1
33087,r-mnhl-bfm-90,1
33088,immunological peptides and immunological adjuvants,1
33089,exatherm-tbh system,1
33090,sham acupuncture therapy,1
33091,mri guided focal laser interstitial thermal ablation,1
33092,bfcr4350a,1
33093,bendamustine + rituximab + pixantrone,1
33094,contrast-enhanced endoscopic ultrasound (ce-eus),1
33095,rituximab and chop regimen + pbsct,1
33096,sbrt 40.0 gy,1
33097,native and dynamic contrast-enhanced ct,1
33098,postural rehabilitation program,1
33099,zometa(drug),1
33100,oral nutrition supplement,1
33101,laparoscopic myomectomy with unidirectional barbed suture,1
33102,bupivacaine + fentanyl,1
33103,cisplatin/vinorelbine,1
33104,prolaris,1
33105,megaprosthetic implants the next generation (ming),1
33106,pegylated recombinant human arginase,1
33107,discontinuation of imipenem-cilastatin or meropenem,1
33108,"intensity modulated radiation therapy, radical cystectomy",1
33109,capecitabine/oxaliplatin/bevacizumab/rad001 (xelox-a-ev),1
33110,pqr 309,1
33111,family physician reminder letter,1
33112,5-fluorouracil or capecitabine,1
33113,"matching placebo + mfolfox6 (5-fu, levo-leucovorin, oxaliplatin)",1
33114,miracle mouthwash plus hydrocortisone,1
33115,awareness campaign,1
33116,"biochemical, hormonal and metabolic phenotyping",1
33117,oral care programme,1
33118,js001 240mg q2w,1
33119,clobetasol propionate,1
33120,limes,1
33121,dexamethasone plus placebo,1
33122,cb-erl,1
33123,ice,1
33124,5-aza-cytidine and thalidomide,1
33125,paclitaxel weekly in combination with capecitabine,1
33126,anakinra (il-1ra),1
33127,br-dim,1
33128,mri-guided transurethral ultrasound ablation,1
33129,bladder biopsy,1
33130,amg 655 placebo,1
33131,"gw786034, radiolabeled oral",1
33132,radiosurgery gammaknife,1
33133,wire-localized abnormal node,1
33134,b infusion repo combined with vitamins pills,1
33135,phone interview and blood test,1
33136,donor leukocytes,1
33137,7-t-butyldimethylsilyl-10-hydroxycamptothecin,1
33138,ny-eso-1 protein; montanide isa®-51 vg; resiquimod,1
33139,su11248,1
33140,informational brochure,1
33141,lymph node clearing technique with gewf solution,1
33142,carboplatin auc 5 mg/ml/min,1
33143,temo + avastin,1
33144,conventional radiotherapy schedule,1
33145,part d2 azd2014 combination with azd8186,1
33146,vinorelbine plus epirubicin,1
33147,lappaconitine adhesive patch,1
33148,second autologous transplant,1
33149,genetic testing results,1
33150,print brochure,1
33151,conditioning therapy,1
33152,"pvic, tace",1
33153,ercp with 10 french biliary plastic stent placement,1
33154,sandostatin lar,1
33155,aroplatin,1
33156,petmr study,1
33157,mpt test,1
33158,avid100 iv,1
33159,educational brochure,1
33160,weight loss dietary pattern,1
33161,uncovered metal duodenal prosthesis,1
33162,sir spheres intra-arterial hepatic,1
33163,nvn1000 8% gel,1
33164,in vitro maturation,1
33165,sma-orientated right hemicoloectomy,1
33166,mab-425 radiolabeled with i-125,1
33167,dvd and pamphlet,1
33168,rectal cancer resection,1
33169,"docetaxel, doxorubicin, cyclophosphamide (tac) + bevacizumab",1
33170,neuroblate® system therapy,1
33171,environmental intervention,1
33172,punctures,1
33173,her2-specific t cells,1
33174,autologous ebv specific ctls,1
33175,avx901,1
33176,famitinib m + docetaxel,1
33177,ccrt+midle chemotherapy,1
33178,placebo matching nivolumab,1
33179,afuresertib hpmc capsule - fed state,1
33180,postoperative glycaemic control,1
33181,thymopentin,1
33182,89zirconium-labeled ipilimumab,1
33183,natural killer cell activity assay,1
33184,"mitomycin c,epirubicin,cisplatin,5-fluorouracil,leucovorin",1
33185,gnrha with tamoxifen,1
33186,olympus ultrathin bronchofibervideoscope (xp260f),1
33187,necuparanib,1
33188,electrofusion dc vaccine,1
33189,fluid administration,1
33190,cognitive behavioral therapy cbt) for weight loss,1
33191,curettage with puncture (c & p),1
33192,assess hernia recurrence at 1 year postoperatively,1
33193,npmw-peptide vaccine,1
33194,imatinib maintenance,1
33195,"blood/saliva samples, historic breast imaging",1
33196,realbuild,1
33197,botulinum toxin type a 12.5 iu,1
33198,ex vivo expansion of cord blood,1
33199,icg-cp,1
33200,pet/mri for evaluation,1
33201,incb040093 + itacitinib,1
33202,radiofrequency ablation only,1
33203,"walk, eat, & breathe",1
33204,life orientation test (lot),1
33205,drugs and anti-cd19-car transduced t cells,1
33206,ro7172508,1
33207,bortezomib injection,1
33208,endometrial cancer radical surgery,1
33209,flexitouch system,1
33210,neuropsychologic evaluation,1
33211,hpv genotyping,1
33212,inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone,1
33213,co-1.01 formulation b (aqueous suspension containing 30 mg/ml of drug solubilized in purified phospholipids),1
33214,bright blue-green light using light visor cap,1
33215,"loperamide (""seldiar"")",1
33216,6.0 mg/m2 di-leu16-il2,1
33217,group b (normal saline wash the surgical incision),1
33218,col-3,1
33219,"ct, mri and pet scans",1
33220,cancer type id test,1
33221,various biological sampling,1
33222,circulating tumor cell blood draw,1
33223,torisel dose 25 mg and r-chop,1
33224,ultrasound plus clinical breast examination,1
33225,visceral adipose tissue specimen,1
33226,pancreaticoduodenectomy microdialysis catheter analyses,1
33227,her-2/neu pulsed dc1 vaccine,1
33228,alcohol intervention counseling,1
33229,shape (shp-141) 0.5% bid,1
33230,"arq761, olaparib",1
33231,"combination therapy of irinotecan with 5-fu, leucovorin plus bevacizumab in the neoadjuvant setting.",1
33232,pemetrexed®,1
33233,transrectal ultrasound 3-d (trus),1
33234,recombinant human follicle stimulating hormone (r-hfsh),1
33235,endostar continuous intravenous infusion,1
33236,molecular response by pcr,1
33237,miles surgery,1
33238,standard vertebroplasty,1
33239,simple non-exposure eftr,1
33240,"epirubicin, cisplatin, capecitabine, panitumumab",1
33241,endometrial cancer screening and diagnosis,1
33242,adrenocorticotropin,1
33243,duodenal biopsy,1
33244,intrapleural docetaxel administration,1
33245,daily dosing with zileuton/dasatinib for cml,1
33246,cybernetic microradiosurgery,1
33247,"erbitux, paclitaxel & carboplatin",1
33248,the carevive cps,1
33249,urescan,1
33250,"bortezomib, rifampicin",1
33251,head and neck educational handbook,1
33252,logiq e9 scanner (contrast-enhanced ultrasound),1
33253,ebvint cell,1
33254,suspected pancreatic tumor,1
33255,conected objects,1
33256,cancer immunotherapy,1
33257,iv cp-4126,1
33258,ro7051790,1
33259,quality of life questionaires,1
33260,adherence-encouraging interventions - individual meetings,1
33261,total laparoscopic or robotic radical hysterectomy,1
33262,fact complex-targeting curaxin cbl0137,1
33263,patritumab and trastuzumab,1
33264,breast ct scanning,1
33265,mvx-onco-1,1
33266,multidisciplinary team intervention,1
33267,"lbh589, gemcitabine",1
33268,"nadroparin, long term",1
33269,cyp2d6*10 gene test,1
33270,opening (endopelvic fascia),1
33271,luteinizing hormone-releasing hormone (lhrh) short acting or long acting,1
33272,molecular profile,1
33273,lcar-b38m car-t cell injection,1
33274,no intervention was required,1
33275,volumetric arc radiotherapy,1
33276,0.5 mg/m2 di-leu16-il2,1
33277,gefitinib®,1
33278,patients receiving cancer pain treatment,1
33279,collection of volatile organic compounds during exhalation,1
33280,n/a - observational,1
33281,proton arm,1
33282,peri-operative chemotherapy of ecx,1
33283,hypofractionated dose escalation radiotherapy,1
33284,imatinib and nilotinib,1
33285,arm b-ipilimumab 3mg/kg iv over 90 minutes day 1 followed three weeks later by ipilimumab every 3 weeks x 3.,1
33286,brain glioma registry,1
33287,allogeneic donor derived b-lymphocytes,1
33288,tace-rfa,1
33289,oncomine comprehensive assay,1
33290,the ctdna dynamic monitoring,1
33291,hyperthermic perfusion,1
33292,wearable activity monitor,1
33293,stellate block,1
33294,continental breakfast,1
33295,arm 2: standardized muscle stretching and strength,1
33296,behavioral group counseling,1
33297,temodar® (temozolomide),1
33298,idelalisib 100 mg,1
33299,deileostomy,1
33300,alt-803 + nivolumab,1
33301,dc vaccination with cisplatinum,1
33302,hot snare polypectomy,1
33303,"sonovue, bracco",1
33304,performance status scale for head and neck cancer patients,1
33305,chemotherapy with lmwh - enoxaparin,1
33306,hepaticojejunostomy and gastroenterostomy,1
33307,lop628,1
33308,standard sunscreen,1
33309,medi0680 2.5 mg/kg,1
33310,bile sampling for bacterial examination,1
33311,oxaliplatin+capecitabine,1
33312,whatsapp message,1
33313,ak104,1
33314,stent; idoine-125,1
33315,"bortezomib (velcade, ps-341)",1
33316,salvage neck dissection,1
33317,aps001f,1
33318,melanoma antigens-specific cd8+ t lymphocytes,1
33319,staging operation,1
33320,chemotherapy?pemetrexed+cisplatin?,1
33321,educational presentations,1
33322,group b,1
33323,68ga-dotatoc pet/c,1
33324,bacitracin ointment,1
33325,placebo and then 50 mg pyc,1
33326,oxycodone acetaminophen,1
33327,placebo and soy protein,1
33328,ic9-gd2 t cells - frozen,1
33329,microsoft band 2 + uv messaging,1
33330,inodiftagene vixteplasmid,1
33331,gastro-retentive (gr) formulation,1
33332,bbt-i,1
33333,autologous dendritic cell vaccine (dc/pc3),1
33334,standard follow-up or treatment.,1
33335,stamm approach,1
33336,silgard,1
33337,aza,1
33338,5ac,1
33339,continuous hyperthermic peritoneal perfusion (chpp) with cisplatin,1
33340,radiation + cisplatin + gemcitabine,1
33341,gemcitabine cisplatin followed by docetaxel,1
33342,"ixabepilone, 25 mg/d",1
33343,fentanyl pectin nasal spray,1
33344,without nasogastric tube,1
33345,su011248; gemcitabine,1
33346,transthoracic esophagectomy 2-field extended lymphadenectomy,1
33347,"mitomycin-c, cisplatin",1
33348,facbc pet-ct scan,1
33349,colorectal resections,1
33350,palliative regimen consisting of litt,1
33351,anti-transforming growth factor-beta (gc 1008),1
33352,first sense medical®,1
33353,collection of cervical cancer tissue samples,1
33354,18f-fluorodeoxyglucose,1
33355,eylea,1
33356,tea polyphenols,1
33357,csl360,1
33358,celecoxib/placebo,1
33359,"cb-839, pomalidomide, and low dose dexamethasone",1
33360,combination of temsirolimus and sunitinib,1
33361,rpm,1
33362,f901318 with fluconazole high dose,1
33363,short course radiation,1
33364,ct for radiation treatment planning,1
33365,digital colposcope,1
33366,surgery: d2 dissection,1
33367,sar566658,1
33368,dynamic cultures of in vitro hematopoietic stem cells,1
33369,supportive group psychotherapy,1
33370,stereotactic surgery (srs),1
33371,aurora a kinase inhibitor mln8237,1
33372,treatment j,1
33373,passation of neuropsychological test,1
33374,supervised progressive muscle relaxation training (jacobson method),1
33375,"oxaliplatin,capecitabine",1
33376,game application,1
33377,blood stem cell transplantation,1
33378,chemotherapy + bevacizumab followed by bevacizumab,1
33379,contrast enhanced dual energy (cedem),1
33380,131-i-tm-601,1
33381,schizophrenia disorders,1
33382,3d hdr planning,1
33383,in-person dermatology evaluation,1
33384,cox-2 inhibitor for 6 months prior to follow-up eus or ercp,1
33385,arm b (tepadina®-carmubris®-busilvex®),1
33386,3m™ tegaderm™ chg iv and 3m™ tegaderm™ advanced iv,1
33387,mepore self-adhesive absorbent dressing,1
33388,adjuvanted influenza a(h1n1) vaccines,1
33389,group 1: placebo,1
33390,omega-3 acid ethyl esters,1
33391,botulinum toxin-a,1
33392,25g needle,1
33393,combination of mk3475 with metronomic cp,1
33394,azacitidine mtd,1
33395,weight-based plerixafor,1
33396,rabeprazole 40 mg once daily (od),1
33397,oratecan,1
33398,ps-ot,1
33399,stage 2,1
33400,radiation therapy and egfr-tki target therapy,1
33401,nilotinib 150 mg [tasigna],1
33402,observational study so no intervention,1
33403,mental training,1
33404,comprehensive vaccine promotion package,1
33405,1.eus-fna with or without suction,1
33406,da-epoch-r followed by nivolumab,1
33407,hu14.18-interleukin-2 fusion protein,1
33408,selumetinib placebo,1
33409,fluorine f18 ef5,1
33410,sta 9090 (ganetespib),1
33411,trastuzumab + paclitaxel,1
33412,arq 092 + anastrozole,1
33413,docetaxel plus gemcitabine,1
33414,ecography,1
33415,prone positioning,1
33416,peripheral ebv-dna load,1
33417,laparoscopic surgery for colorectal cancer,1
33418,temozolomide + valproic acid,1
33419,[18f] - fludarabine pet/ct,1
33420,comp01,1
33421,cold snare polypectomy with suction,1
33422,"casodex, zoladex , lupron",1
33423,nurse observation during colonoscope withdrawal,1
33424,sunitiinb and ketoconazol,1
33425,hpv-ctls,1
33426,standard quadrantectomy,1
33427,apatinib tablet,1
33428,yh25448,1
33429,wide excision,1
33430,"(pn-152,243)/ pn-196,444",1
33431,"placebo, sugar pill",1
33432,"uft, leucovorin",1
33433,abt-348 and carboplatin,1
33434,"placebo, prednisone and docetaxel",1
33435,nurse phone call,1
33436,cetuximab( erbitux®),1
33437,mdx-1342,1
33438,standard of care (investigator choice),1
33439,asp8374,1
33440,laparoscopic complete mesocolic excision,1
33441,api 31510,1
33442,"irinotecan, leucovorin, and 5-fluorouracil (5-fu) (folfiri)",1
33443,morphine in the maintenance phase,1
33444,"peg-rhg-csf, 100?g/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle",1
33445,flc removal hd (gambro hco 1100),1
33446,gemcitabine?capecitabine,1
33447,dna microarray analysis,1
33448,magnetic resonance spectroscopy imaging with rectal probe,1
33449,nutrition consult,1
33450,'fatigue facts & fixes',1
33451,intrabuccally-administered amplitude-modulated rfem,1
33452,ff-10101-01,1
33453,modified folfox,1
33454,anakinra and peg stnf-r1,1
33455,lung cancer risk test,1
33456,inkt cells,1
33457,if first one negative: samples under fluoroscopic control,1
33458,ultrasound device,1
33459,pancreatic cyst aspiration,1
33460,tx05 (trastuzumab),1
33461,true beam,1
33462,leucovorin (in folfox),1
33463,follow-up assessments: questionnaires,1
33464,hu3f8 with gm-csf,1
33465,co-1.01 and cisplatin,1
33466,comparator: v505 formulation 1,1
33467,gemcitabine+erlotinib+capecitabine,1
33468,blood samples obtained,1
33469,[18f]flt,1
33470,polatuzumab vedotin placebo,1
33471,"reassortant vaccine virus nymc x-179a (new york medical college, new york) derived form the a/california/7/2009 (h1n1) virus",1
33472,"irinotecan liposomal injection [onivyde]; oxaliplatin, 5-fu; levofolinic acid",1
33473,cd133kdel (dcd133kdel),1
33474,transarterial embolization (tae),1
33475,helical tomotherapy treatment,1
33476,short-course radiation,1
33477,pn only,1
33478,oncolytic adenovirus (serotype 5) - cg0070,1
33479,scp-hospice alert,1
33480,excision of denonvilliers fascia,1
33481,symphony mri guided high intensity focused ultrasound (hifu),1
33482,ebv ctl's,1
33483,body mass index (bmi) calculation,1
33484,recombinant albumin fusion protein sephb4-hsa,1
33485,molecular fingerprint,1
33486,part b: azd8186 monotherapy,1
33487,dkk1,1
33488,standard intervention (si) educational materials,1
33489,flumatinib 600mg qd,1
33490,local treatment by radiotherapy,1
33491,care-management-phone-calls,1
33492,radiotherapy with concurrent chemotherapy,1
33493,pd-0332991 and t-dm1,1
33494,deferoxamine,1
33495,stemex®,1
33496,tazobactam sodium,1
33497,placebo(megestrol acetate),1
33498,control with standard colonoscope olympus cf-h180,1
33499,cure tape™ away from dermatomes t 7 and t 8,1
33500,pgg beta-glucan,1
33501,local definitive radiotherapy,1
33502,viusid®,1
33503,fluorescence-guided sentinel lymph node detection,1
33504,thioplex®,1
33505,blood test for serum psa,1
33506,multi-parametic mri,1
33507,gen-009 adjuvanted vaccine,1
33508,tlk199 hcl liposomes for injection,1
33509,persumac,1
33510,inpatient stays,1
33511,treatment recommendation,1
33512,renal cell carcinoma,1
33513,gallium-68 psma-11 prepared using psma-11 sterile cold kit,1
33514,perform sensory tests,1
33515,complex physical therapy plus pressotherapy,1
33516,human synthetic secretin,1
33517,peripheral stem cell collection,1
33518,shear-wave elastography,1
33519,samalizumab (baml-16-001-s1),1
33520,lapatanib,1
33521,hematopoietic stem cell transplantation.,1
33522,eus guided biliary drainage,1
33523,conventional prpd,1
33524,margin assessment,1
33525,"gemcitabine, capecitabine and bevacizumab",1
33526,the survivor stories tablet,1
33527,macrodyne livmd plate,1
33528,cyclophosphamide 300 mg/m2/d for 3 days,1
33529,percutaneous radiofrequency thermal ablation,1
33530,infusion #1,1
33531,18-f-fdg pet scan,1
33532,api 31510 3% topical cream,1
33533,magnetic affinity cell sorting,1
33534,dcvax-l,1
33535,s-phase%,1
33536,xmab®23104,1
33537,glasdegib (pf-04449913),1
33538,gemcitabine + rituximab,1
33539,center for epidemiological studies - depression,1
33540,capecitabine and mitomycin c,1
33541,exposure: adjuvant hormonal therapy treatment,1
33542,oral cytobrushing,1
33543,rituximab + hd- methotrexate (mtx),1
33544,etrarp,1
33545,mesopher,1
33546,smoking relapse prevention for cancer patients (srp-cap),1
33547,tqb3456,1
33548,active ctc assessment,1
33549,radiation segmentectomy,1
33550,other subcutaneous immunoglobulins,1
33551,bronchoalveolar lavage (bal) for cytokine analysis,1
33552,prostatic urethral lift (pul),1
33553,140 mg mmc in 90ml gel,1
33554,folfiri (m),1
33555,asp1951,1
33556,tagrisso,1
33557,cc-eies,1
33558,detection of the tumor lesion,1
33559,igf-1r inhibitor osi-906,1
33560,ldh serum level,1
33561,gsk 249553 vaccine,1
33562,"metformin hcl (cidophage®; cid,cairo, egypt)",1
33563,indwelling pleural catheter insertion and talc pleurodesis,1
33564,gsk2126458 and gsk1120212,1
33565,placebo comparator: standard physiotherapy,1
33566,methotrexate injectable solution,1
33567,r-eshap,1
33568,trametinib 2.0 mg,1
33569,mart-1:26-35(27l),1
33570,breast-q -reconstruction module (preoperative) version 2.0 satisfaction with breasts questionnaire,1
33571,sapacitabine and decitabine,1
33572,paclitaxel and gemcitabine,1
33573,arm a: atezolizumab and radiotherapy,1
33574,pet/ct post 2 cycles of chemotherapy,1
33575,niti-s spaxus stent,1
33576,placebo (for syntocinon),1
33577,imetelstat (7.5 mg/kg),1
33578,pet/ct breath hold,1
33579,"thalidomide, cyclophosphamide, dexamethasone, bortezomib",1
33580,oxygen delivery devices,1
33581,balanced solutions,1
33582,combined computer and nutritionist,1
33583,bsma,1
33584,time to remove drainage and duration of hospital staying,1
33585,preparative regimen for allogenic stem cell transplantation,1
33586,extracorporeal morcellation,1
33587,tall-104 cells,1
33588,ptvg-ar,1
33589,metformin hydrochloride 850 mg,1
33590,casodex (bicalutamide),1
33591,novilase interstitial laser therapy,1
33592,"thalidomide, celebrex",1
33593,imgn388,1
33594,fractionated proton radiation,1
33595,"palbociclib / chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen)",1
33596,pharmacist-intervention,1
33597,carboplatin area under the curve (auc)5,1
33598,ags15e,1
33599,dcll9718s,1
33600,autologous ebv-ctl transduced with control vector sfg-cna8,1
33601,lymphodepletion with cyclophosphamide,1
33602,hla-a2 restricted glioma antigen peptides vaccine,1
33603,tadalafil and vaccination,1
33604,scrambler therapy device,1
33605,zemplar (paricalcitol injection),1
33606,use of the light-ct scanner,1
33607,conditioning for cr group,1
33608,external beam whole pelvis radiation therapy,1
33609,evaluation of gender differences on the psychosocial and economic impact.,1
33610,10% fbr containing bioadhesive gel,1
33611,cohort 3b: carfilzomib 27 mg/m2,1
33612,sti571 and peg intron,1
33613,[14c] th-302 (label 2),1
33614,sham software,1
33615,induction therapy - oxaliplatin,1
33616,clofarabine plus low dose ara-c,1
33617,l-lysine,1
33618,cd19.car-t cells,1
33619,early palliative care consultation,1
33620,pegylated rhg-csf: 100µg/kg,1
33621,nktr-102 + cetuximab,1
33622,geriatric oncology collaborative care,1
33623,taxotere/cisplatin,1
33624,customized treatment,1
33625,i-124 pgn650 for pet/ct,1
33626,a-101 (40) topical solution,1
33627,"part 2, cohort 2",1
33628,ifo,1
33629,idh mutation test performed at diagnosis,1
33630,fbta05,1
33631,a new surgical technique,1
33632,"mk0752, (notch inhibitor)",1
33633,4:1 closure group,1
33634,obinutuzumab and pixantrone,1
33635,transcutaneous sutures,1
33636,hypoigrt,1
33637,cisplatinum or carboplatin and e.g.etoposide+enoxaparin,1
33638,vle imaging for staging eac,1
33639,2nd dose late and 3rd dose on time,1
33640,reducing your risks in the crash,1
33641,transarterial radioembolization,1
33642,non standard of care blood samples collection,1
33643,chemo-radiotherapy with imrt technique,1
33644,oros hydromorphone hci,1
33645,proellex 24 mg,1
33646,local anesthetic infiltration,1
33647,azacitidine associated with lenalidomide,1
33648,vascular testing,1
33649,senna tablets,1
33650,oral cryotherapy (ice chips),1
33651,ultrasound image-guided ablation device,1
33652,enoxaparin + rosuvastatin,1
33653,caffeine (100 mg),1
33654,acute lymphobastic leukemia (all) treatment options,1
33655,cytosar,1
33656,high dose rate (hdr) brachytherapy using iridium 192 radioactive seeds,1
33657,bevacizumab+carboplatin,1
33658,stenting with neoadjuvant chemotherapy,1
33659,anti-mage-a3-dp4 tcr pbl,1
33660,monogin,1
33661,cyclophosphamide-based chemotherapy,1
33662,chinese herbal medicine decoction,1
33663,chemotherapy with temozolomide or no chemotherapy,1
33664,lanreotide (microparticle formulation),1
33665,"hpv vaccine, gardasil 9",1
33666,hla-a*02:01-restricted vegfr1-derived peptide vaccination,1
33667,hematopoietic stem cell allograft,1
33668,dasatinib 50 mg,1
33669,esbl eradication regimen,1
33670,qbm076,1
33671,oncologic breast surgery,1
33672,other drugs,1
33673,lanreotide autogel 90 mg and 120 mg,1
33674,preop booster (food for special medical purposes),1
33675,carbon ion therapy,1
33676,bollywood dance,1
33677,humor intervention,1
33678,5-fluoro-3-pyridinecarboxylic acid,1
33679,injection of 18f-fdg,1
33680,iv sea-cd40 monotherapy regimen,1
33681,xl092,1
33682,ref-08-038,1
33683,arq 197 as monotherapy or in combination with other drug(s),1
33684,niraparib oral capsules (labeled),1
33685,standard-dose,1
33686,a bipolar percutaneous intramuscular electromyography electrode,1
33687,spatially fractionated radiation therapy,1
33688,folfirinox + crt,1
33689,concurrent chemotherapy with radiation,1
33690,"ac-p,tec,ac,tc,tch,cef,tac,caf",1
33691,fructooligosaccharide,1
33692,zr-dfo-pertuzumab pet/ct,1
33693,intraoperative fluorescence imaging system,1
33694,lumbar sympathetic ganglion block,1
33695,ds-3078a,1
33696,no treatment control,1
33697,mcy-m11,1
33698,amuvatinib,1
33699,temozolomide 75 mg x 21 days,1
33700,cartmeso cart19,1
33701,bench-top optical spectrometer,1
33702,digital cervicography,1
33703,sorafenib and zoledronic acid,1
33704,psychosocial rehabilitation course,1
33705,su011248 capsule,1
33706,traceit tissue marker injection,1
33707,wt1/prame vaccination,1
33708,pemcarbo,1
33709,circular incision,1
33710,multimodal physiotherapy,1
33711,fluorouracil and platinum,1
33712,isocaloric diet with 6 meals,1
33713,lenalidomide-dexamethasone-dli,1
33714,tumor genetic sequencing,1
33715,ps341,1
33716,endopat2000,1
33717,peer support program,1
33718,clinimacs cell separation system,1
33719,computerized cognitive treatment,1
33720,intrapleural catheter (ipc) drained,1
33721,medi2070 high dose,1
33722,parenteral supplement with enteral nutrition for patients after esophagectomy,1
33723,focal radiation therapy,1
33724,ny-eso-1-specific t cells,1
33725,18f-alf-nota-octreotide,1
33726,providing non-tailored message on pain control,1
33727,gadoxetate,1
33728,mln0128 (rp2d),1
33729,injection of melphalan into the ophthalmic artery,1
33730,anti-cea-car t,1
33731,changes in intraoperative care,1
33732,gsk biologicals' recombinant wt1 antigen-specific cancer immunotherapeutic (asci) gsk2302024a,1
33733,pimasertib twice daily,1
33734,single cell photoacoustic microscopy,1
33735,blood specimen collection,1
33736,calorie-restricted ketogenic diet and transient fasting,1
33737,pure encapsulations branched chain amino acid powder,1
33738,surgery after 11 weeks of delay after chemoradiotherapy.,1
33739,pathologic evaluation of excised tissue,1
33740,liposomal doxorubicin/melphalan/bortezomib,1
33741,polyethylenglycol,1
33742,byl719 drink suspension,1
33743,additional imaging or surgery,1
33744,azd1152 part b,1
33745,gas chromatography-mass spectrometry,1
33746,placebo caplet of metformin xr,1
33747,prone and supine simulation,1
33748,sequential gefitinib with pemetrexed/platinum,1
33749,pathway,1
33750,mri t1 t2 sequences,1
33751,"gemcitabine, intravenous",1
33752,progressive muscle relaxation (via mobile app),1
33753,subtotal esophagectomy and gastric pull up,1
33754,qyhj granules,1
33755,personalized dc vaccine,1
33756,anthracycline (doxorubicin),1
33757,mdm2/mdmx inhibitor alrn-6924,1
33758,bcg (bacillus calmette-guerin),1
33759,"bevacizumab,trastuzumab,paclitaxel,cyclophosphamide,myocet",1
33760,phenformin,1
33761,"web-based learning, didactic lecture and role-play",1
33762,??zr-df-iab22m2c infusion,1
33763,"trivirus specific ctls for ebv, cmv and adenovirus infection",1
33764,robotic placement device,1
33765,pm01183 + olaparib,1
33766,plerixafor granulocyte-colony stimulating factor,1
33767,epirubicin + ifosfamide + etoposide,1
33768,chw outreach,1
33769,the radical mastectomy of breast cancer,1
33770,fluzoparib combined with apatinib,1
33771,sch 721015 with sch 209702,1
33772,mri after treatment,1
33773,2d laparoscopic total gastrectomy,1
33774,placebo lotion,1
33775,e-coli l-asparaginase,1
33776,radiation method b,1
33777,sunitinib + capecitabine,1
33778,collect retrospectively the follow-up data,1
33779,rituximab and dexabeam,1
33780,ultrasound and contrast agent,1
33781,billroth ii reconstruction,1
33782,2 fes-pet imaging will be performed:,1
33783,laparoscopic assisted transanal total mesorectal excision,1
33784,conventionally fractionated radiotherapy (conrt),1
33785,patient reported outcomes (pro),1
33786,sr-89,1
33787,mk-1775 65 mg,1
33788,screening colonoscopy according to resect-and-discard strategy,1
33789,group r+ad rasagiline + antidepressant,1
33790,icon-1,1
33791,fibroscan (transient elastography measurement),1
33792,watchful waiting,1
33793,il-12 transduced til,1
33794,laparoscopic assisted gastrectomy,1
33795,depot octreotide,1
33796,"atra plus g-csf (filgrastim, neupogen (r)) combination",1
33797,lv5fu2 or capecitabine,1
33798,auto transplant followed by allo transplant,1
33799,topical steroid ointment,1
33800,generic print intervention,1
33801,inferior mesenteric artery ligation,1
33802,derazantinib,1
33803,adipose svf cell,1
33804,cb-839 and low dose dexamethasone,1
33805,surgery +(cisplatin 80 mg/?+5fu 800mg/?×5days)×2,1
33806,surgery combinate with endocrine therapy,1
33807,retapamulin 1%,1
33808,applicability assessment,1
33809,mcla-158,1
33810,recombinant interleukin-4,1
33811,mcs®,1
33812,neuroendocrine type-2,1
33813,intubated anesthesia with single-lung mechanical ventilation,1
33814,preemptive local ablative therapy,1
33815,functional magnetic resonance imaging (fmri),1
33816,eu-sourced avastin®,1
33817,tanezumab 10 mg iv,1
33818,obi-833/obi-821,1
33819,non-pegylated liposomal doxorubicin,1
33820,sd-101(1),1
33821,nivolumab 1 mg/kg iv,1
33822,igrt for prone partial breast irradiation (pbi),1
33823,tadalafil oral tablet,1
33824,consilium,1
33825,carboplatin-nab-paclitaxel,1
33826,isr,1
33827,positron emission tomography (pet/ct) imaging,1
33828,artemether,1
33829,bkm120-carbo,1
33830,volatile agent,1
33831,prophylactic central neck lymph node dissection(pcnd),1
33832,humanised monoclonal antibodies veltuzumab and epratuzumab,1
33833,"gemcitabine, s-1",1
33834,temozolomide plus cisplatin,1
33835,za matching placebo,1
33836,tak-079,1
33837,cyclophosphamid,1
33838,3d digital camera,1
33839,thiotepa melphalan,1
33840,gliadel/avastin/cpt-11,1
33841,tc-325,1
33842,asica digital app,1
33843,rf-ny-eso-1 vaccine,1
33844,leap,1
33845,"anesthetics, local",1
33846,medical records abstraction,1
33847,carotid color flow duplex testing,1
33848,tallow,1
33849,mobile application intervention,1
33850,suction curettage,1
33851,medi1873,1
33852,pancreatic pseudocystgastrostomy,1
33853,"endodrill 1a (bibbinstruments, lund, sweden)",1
33854,carevive software,1
33855,stereotactic biopsy of brain tumor,1
33856,ab-110,1
33857,follicular growth,1
33858,individualized precision therapy programs,1
33859,virtual reality scene viewing,1
33860,minimally invasive pancreatoduodenectomy,1
33861,sym013,1
33862,lcz696,1
33863,cirmtuzumab + paclitaxel,1
33864,"e-hdfl,ep,te,n-hdfl,np,t-hdfl,tp",1
33865,self-expandable metal stent insertion,1
33866,humanized cd19 car-t cells,1
33867,medical consultation for a standardized geriatric evaluation,1
33868,nal-irinotecan,1
33869,co-argi-peg modified human arginase i,1
33870,division/manipulation of the cord,1
33871,hypofractionated proton therapy,1
33872,89zr-atezolizumab pet scans,1
33873,pecfent and epistatus,1
33874,patient care by a psychologically trained physician,1
33875,ampicillin/sulbactam,1
33876,oxaliplatin: concentration-based hipec,1
33877,surgiguard,1
33878,intra-lesional injection of nivolumab,1
33879,cisplatin combined with paclitaxel,1
33880,g-tube,1
33881,pr1-primed lymphocyte (pr1-ctl) infusion,1
33882,l-asparaginase encapsulated in rbc,1
33883,"dasatinib, paclitaxel, and carboplatin",1
33884,75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle,1
33885,whole abdomen radiotherapy,1
33886,tace plus sorafenib,1
33887,robot-assisted distal pancreatectomy,1
33888,therasphere treatment,1
33889,t900607-sodium intravenous,1
33890,chemotherapy: temozolomide,1
33891,"acetylsalicylic acid(baye4465, aspirin )",1
33892,levonorgestrel intrauterine device (iud),1
33893,mint1526a,1
33894,conebeam ct,1
33895,vitamin d supplementation,1
33896,glycosaminoglycan plasma score,1
33897,sbrt for benign extradural spine tumors,1
33898,norgestrel,1
33899,• tf2 and 68 ga-imp-288,1
33900,transdermal nicotine patch,1
33901,mayo interactive breath hold monitor,1
33902,behavioural and pharmacotherapy for tobacco cessation,1
33903,lapatinib and rad-001,1
33904,"interview, questionnaire, updated biochemical tests",1
33905,interactive sessions,1
33906,blood culture ( aerobic and anaerobic),1
33907,beta-blockers,1
33908,megstrol acetate,1
33909,test of motor proficiency,1
33910,150 mg/m2 lenalidomide (revlimid®) and 230 mg/m2 vorinostat (zolinza®),1
33911,biopsy during colonoscopy,1
33912,histone deacetylase inhibitor (itf2357),1
33913,dasatinib and imatinib,1
33914,uterine fibroid embolization embosphere®,1
33915,sham inspiratory isometric resistance training,1
33916,"soluble beta-1,3/1,6-glucan",1
33917,lapatinib and ixempra,1
33918,"cilengitide, radiochemotherapy",1
33919,standard of care adt,1
33920,mart-1 reactive cd8+ pbl,1
33921,part b - azd9291 in combination with selumetinib,1
33922,tamoxifen and gnrh analogue,1
33923,c-11 choline pet tracer,1
33924,segmentectomy or wedge resection,1
33925,dpx-survivac(aqueous),1
33926,genz-644282 (28-day dosing schedule),1
33927,audiology,1
33928,[18f]hx4 diagnostic pet/ct scan,1
33929,humanport chemoport implantation,1
33930,bacille calmette-guérin,1
33931,lbc plus hpv dna testing,1
33932,prednisone 5mg,1
33933,mindfulness questionnaire (ffmq),1
33934,metformin hydrochloride 500 mg,1
33935,vorinostat oral capsule,1
33936,multimodal treatment: compression bandaging and manual lymph drainage.,1
33937,palcebo,1
33938,ipilumimab,1
33939,spark,1
33940,doxorubicin 50mg/m2,1
33941,risedronate (including placebo),1
33942,fact sheet,1
33943,"tyrosinase, mage-3, gntv",1
33944,trofosfamide,1
33945,taxel plus raltitrexed,1
33946,red blood cell transfusions (rbct),1
33947,acalabrutinib (acp-196),1
33948,true auricular acupressure,1
33949,clin b (chop- campath) chemo-immunotherapy,1
33950,decapeptyl® sr 22.5mg,1
33951,neurorrhaphy,1
33952,"docetaxel, carboplatin, trastuzumab (tch) + bevacizumab",1
33953,sandostatin long acting release (lar) depot (somatostatin analogue),1
33954,surgical marker for tissue marking,1
33955,mr images,1
33956,ab0024,1
33957,emd 525797 1000 mg,1
33958,standard pbs,1
33959,ethinyl estradiol and cyproterone acetate,1
33960,everolimus + gsk1120212,1
33961,p946/tet-p,1
33962,nelarabine injection 400mg/m2,1
33963,spark intervention,1
33964,methotrexate (arm with maraviroc),1
33965,zydena tab.75mg(udenafil 75mg),1
33966,a2/4-1bbl melanoma vaccine,1
33967,ono-7746,1
33968,journaling,1
33969,dummy infusion,1
33970,adv-tk (adenovirus-thymidine kinase enzyme) gene therapy,1
33971,tak-700 and lhrh agonist,1
33972,3-dimensional distal pancreatectomy,1
33973,consultation of the patient's medical files at the hospital,1
33974,neoadjuvant chemotherapy (taxol and carboplatin),1
33975,it-pil12-ep,1
33976,ep2006,1
33977,symptom management program for chemotherapy patients,1
33978,castalie water spray,1
33979,leica fluorescence microscope,1
33980,education and electronic support,1
33981,scoring quality of life (qol),1
33982,"blood sampling, the sf-36 questionnaire",1
33983,extra treatment planning ct-scan,1
33984,mpmri guided prostate examination using pi-rads v2,1
33985,non-vaccine clinically matched control group,1
33986,scalp block with 0.9% normal saline,1
33987,thulium-fiber laser enucleation of the prostate,1
33988,biopsy salivary gland,1
33989,standard of care oral hygiene,1
33990,enzalutamide liquid,1
33991,tech-supported hbpc,1
33992,sacral canal cyst microscopic tamponade,1
33993,dose fractionation,1
33994,13 week pilot intervention study.,1
33995,xmab5574,1
33996,parecoxib,1
33997,r115777 (farnesyl transferase inhibitor),1
33998,post-chlorambucil therapy follow-up,1
33999,mathematical model-adapted radiation fractionation schedule,1
34000,tace with sorafenib,1
34001,personalized medication log,1
34002,radiology/mri scan,1
34003,mk3475,1
34004,experimental arm (con):,1
34005,gemcitabine plus carboplatin,1
34006,promoting resilience in stress management,1
34007,external beam radiation or proton beam radiation,1
34008,recombinant human erythropoietin placebo,1
34009,cisplatin & etoposide,1
34010,human papillomavirus (hpv) 16 monovalent,1
34011,hdil-2,1
34012,abp 215,1
34013,"paclitaxel, carboplatin and bevacizumab",1
34014,ag-013736 + docetaxel,1
34015,surveillance and rescue surgery in cases of resectable loco-regional recurrence,1
34016,hai with folfox,1
34017,clino-san vaginal lubricant,1
34018,2d mammogram,1
34019,light dosimetry,1
34020,torisel dose 25 mg and r-fc,1
34021,liver nk cell inoculation,1
34022,eulexin,1
34023,"escalation cohort: regorafenib (stivarga, bay73-4506) 100 mg",1
34024,gj-tube,1
34025,bl-8040 plus pembrolizumab,1
34026,"oxaliplatin, s-1, radiotherapy",1
34027,bcg (immucist®),1
34028,placebo2,1
34029,131 i-lipiodol,1
34030,docetaxel only,1
34031,megadose t-cell depleted hla-nonidentical blood progenitor cell transplantation,1
34032,busulfan pharmacokinetics,1
34033,aminolevulinic acid pdt (ala),1
34034,luz11,1
34035,acetylsalicylic acid (asa)/aspirin 200 mg daily,1
34036,adjuvant treatment beliefs scale10,1
34037,dermatologist skin exam,1
34038,pertuzumab in combination with trastuzumab and paclitaxel,1
34039,cap-assisted chromoendoscopy,1
34040,lenvatinib plus e7050,1
34041,plavix,1
34042,enteral feeding and total parental support,1
34043,laparoscopic liver surgery,1
34044,bronchoalveolar lavage (bal) fluid,1
34045,sentinel lymph node detection,1
34046,tacrolimus and thymoglobulin,1
34047,sharkcore needle,1
34048,multimodal hypoxia imaging,1
34049,osilodrostat placebo,1
34050,dose dense ac followed by t + trastuzumab,1
34051,"voriconazole, micafungin",1
34052,epworth sleepiness scale,1
34053,wbrt or srs,1
34054,39.6 gy radiation,1
34055,gum arabic,1
34056,adblock,1
34057,screening invitation-reminder,1
34058,fluorocholine pet/ct,1
34059,pet/mr imaging,1
34060,quadravalent human papillomavirus vaccine,1
34061,pegylated liposomal doxorubicin (pld) + carboplatin (cd),1
34062,other: control group - minimal intervention,1
34063,hormonal function measurement,1
34064,tramadol hci/acetaminophen,1
34065,gastrectomy with more than d2 dissection,1
34066,exercise (ex),1
34067,cervarix™ (hpv-16/18 l1 vlp as04),1
34068,il-1 receptor antagonist anakinra,1
34069,p-i reconstruction after total gastrectomy,1
34070,amonafide l-malate (drug),1
34071,cpk dosage,1
34072,"combined, intensified and modulated adjuvant radiotherapy",1
34073,mgd007 + mga012,1
34074,mva.5t4,1
34075,clostridial collagenase injectable,1
34076,order of treatment,1
34077,"non-thermal, atmospheric plasma",1
34078,an educational intervention,1
34079,tongue conservation surgery,1
34080,combination therapy - capecitabine,1
34081,functional resistance training,1
34082,"rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone, liposomal cytarabine, methotrexate",1
34083,cyclophosphamide and methotrexate and aspirin,1
34084,cognitive training intervention group,1
34085,tace (transarterial chemoembolization),1
34086,i131 1.1 gbq,1
34087,"csf470 vaccine, bcg, molgramostim",1
34088,nanopac® 200 mg/m2,1
34089,nbtxr3 activated by imrt only,1
34090,pegfiligrastim,1
34091,single suture ligation,1
34092,177lu-psma617,1
34093,veregen,1
34094,handgrip evaluation,1
34095,lutrate,1
34096,immunotherapy plus chemotherapy,1
34097,rituximab (rituxan),1
34098,adh -1 and carboplatin,1
34099,aminolevulinic acid hcl,1
34100,a combination of intratumoral ifn-gamma plus systemic vaccination with melitac 12.1,1
34101,cpap (continuous airway pressure),1
34102,multiparametric mr imaging (mpmri),1
34103,pembrolizumab dose c,1
34104,"thymoglobulin®, rabbit anti-thymocyte globulin (ratg)",1
34105,pet/ct of liver,1
34106,concomitant cyclin-dependent kinase 4/6 (cdk4/6) inhibitor plus endocrine therapy,1
34107,"docetaxel, epirubicin and cyclophosphamide plus endostar",1
34108,"flag (granulocyte colony-stimulating factor (g-csf), fludarabine, cytarabine)",1
34109,external peep,1
34110,prone and supine position,1
34111,mri/mrcp,1
34112,hexablate,1
34113,irinotecan standard doses,1
34114,conventional radiotherapy with 'high' dose cisplatin,1
34115,allodepleted t cells,1
34116,cik and ?? t,1
34117,radical external beam radiotherapy,1
34118,autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes,1
34119,bilateral leg compression stockings,1
34120,arm 1- dose expansion,1
34121,upper limb function,1
34122,standard cyclophosphamide,1
34123,afatinib and paclitaxel,1
34124,androgen ablation therapy,1
34125,hypnosis sedation,1
34126,auto plus,1
34127,mgd,1
34128,tetanus day 29,1
34129,fit(eiken oc-sensor) one-year interval,1
34130,taichi,1
34131,3d surface imaging,1
34132,placebo ointment,1
34133,axitinib + capecitabine (cohort 6),1
34134,mri 3t scanner,1
34135,hpv self-sampling test,1
34136,liquid nitrogen and topical placebo,1
34137,"gemcitabine, vinorelbine",1
34138,patient mailing,1
34139,gemcitabine/eloxatin (gemox),1
34140,apatinib plus chemoradiation,1
34141,sbrt to symptomatic bony metastatic bony site(s),1
34142,indium-111-ibritumomab tiuxetan,1
34143,red bull™ sugar-free drink,1
34144,phenylephrine solution,1
34145,cd3/cd28,1
34146,miv-818,1
34147,papaverine hydrochloride,1
34148,olokizumab 120 mg,1
34149,dietary intervention (regular starch),1
34150,laparoscopic hysterectomy,1
34151,afatinib oral tablet,1
34152,colorectal surgery (resection),1
34153,fr? peptide plus adjuvant (gm-csf),1
34154,mr therapy,1
34155,ag-024322,1
34156,pet/tdm,1
34157,eaca,1
34158,acetaminophen plus codeine,1
34159,zk-epo,1
34160,quantitative fecal immunochemical test,1
34161,standard dose ara-c,1
34162,medicaid expansion,1
34163,standard fractionation rt,1
34164,molecular genetic analyses,1
34165,sparc1023 i,1
34166,leuprolide acetate - formulation b,1
34167,anastrozole plus goserelin,1
34168,measurement of body awareness,1
34169,cb-10-01 (transgenic lymphocyte immunization),1
34170,(r)-cvp regimen,1
34171,cognitive behavioral mutli-symptom management(cbt),1
34172,20 minute walk,1
34173,zevalin therapeutic regimen,1
34174,bkm120 + paclitaxel,1
34175,pazopanib 2 week,1
34176,-csf,1
34177,exablate 4000 system,1
34178,r+cvp+ifn,1
34179,vizishot flex 19g needle,1
34180,pulsed 1064nm nd:yag,1
34181,hla matched stem cell,1
34182,flutamide (eulexin) and lupron or zoladex,1
34183,hart-cn,1
34184,mupirocin 2% ointment,1
34185,11c-sarcosine,1
34186,ipas,1
34187,hectorol (doxercalciferol capsules),1
34188,message framing,1
34189,immune-attractant,1
34190,urine collection and ultrasonography,1
34191,"ixabepilone, 32 mg/m^2 + lapatinib, 1250 mg",1
34192,in vitro-treated peripheral blood stem cell transplantation (pbsct),1
34193,rfa assisted hepatectomy,1
34194,yh25448 240mg,1
34195,surgical residents' comprehension of the hepatic anatomy,1
34196,acupuncture - group 1,1
34197,oleic acid,1
34198,cs-7017 and bexarotene,1
34199,tube feeding nutrition supplement,1
34200,cct301-59,1
34201,phase 1a: cwp232291,1
34202,mb02 (bevacizumab biosimilar drug),1
34203,xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410,1
34204,131i-sibrotuzumab,1
34205,g9a protein,1
34206,activity bands,1
34207,standard of care (sc),1
34208,dna/rna sequencing and expression levels,1
34209,111-in-aby-025,1
34210,zalypsis,1
34211,ag-013726,1
34212,quality of life and brief pain inventory,1
34213,fibrinogen/thrombin-coated collagen patch,1
34214,phase ii: m3814,1
34215,part 1 (dose escalation): duvortuxizumab,1
34216,blood for cfdna,1
34217,bendamustine+rituximab,1
34218,preliminary validation of the cobqol questionnaire,1
34219,activated ptcy-mils,1
34220,robotic assisted no.10 lymph node dissections,1
34221,vegan,1
34222,clasp retained obturator,1
34223,in vivo practice-base learning phase,1
34224,xonrid,1
34225,monocolour inking specimens,1
34226,"bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone",1
34227,venous blood samples,1
34228,eribulin alone,1
34229,vascular endothelial growth factor receptor [vegfr] and platelet-derived growth factor receptor [pdgfr] inhibitor,1
34230,sonata system,1
34231,spirometry with co test,1
34232,floxuridine fudr,1
34233,bio impedance analysis measurement,1
34234,mesothelin-targeted t cells,1
34235,pemetrexed + gsk1120212,1
34236,tumor debulking surgery by laparoscopy,1
34237,isotretinoin (accutane),1
34238,tas-116,1
34239,photon beam radiation,1
34240,68ga-dotanoc pet/ct; diffusion weighted mri,1
34241,azacitidine (baml-16-001-s2),1
34242,ipi-926 and cetuximab,1
34243,unilateral adjuvant radiation therapy,1
34244,comprehensive preoperative testing for risk factors of persistent postoperative pain,1
34245,branch v,1
34246,yttrium y 90 monoclonal antibody cc49,1
34247,"questionnaires, telephone interview and optional blood drawn",1
34248,immediate mammary reconstruction,1
34249,sirolimus and cyclophosphamide,1
34250,"paclitaxel, carboplatin, epoetin alpha",1
34251,laproscopic prostatectomy,1
34252,health coaching and tech support,1
34253,arm b : mfolfirinox,1
34254,integrated pet/mri,1
34255,tcm+goserelin acetate+abiraterone acetate,1
34256,"cellcollectortm (gilupi, germany) needle",1
34257,cryoballoon™ swipe ablation system,1
34258,standard silicone-based breast implant,1
34259,transcatheter arterial infusion,1
34260,dose level 3 onc201 375mg,1
34261,tailored knowledge translation,1
34262,stereotactic radiotherapy 4 x 8 gy,1
34263,mln4924 + gemcitabine (arm 3),1
34264,"panitumumab, epirubicin, oxaliplatin, xeloda",1
34265,bnct + ig-imrt,1
34266,"pgl4001, progestin, drug free period",1
34267,"lipovenoes® 10% and omegaven®,",1
34268,herceptin™ (her),1
34269,zd4054 22.5 mg,1
34270,evening primrose oil,1
34271,letrozole -berberine,1
34272,trametinib (multiple tablet),1
34273,interleukin-2 & ipilimumab (p-ib),1
34274,optical coherence tomography (oct) with vivosight,1
34275,histologic types,1
34276,first wli,1
34277,5-fluorouracil plus leucovorin,1
34278,nicardipine,1
34279,neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone),1
34280,nimotuzumab combined with paclitaxel and cisplatin,1
34281,dexmedetomidine - remifentanil group,1
34282,topical keratin,1
34283,ny-eso-1 157-165 (165v),1
34284,comparator: lenalidomide,1
34285,post therapy pet/ct imaging,1
34286,allohct,1
34287,abdominal sonogram,1
34288,evaluate the improvement in response from the end of anti-pd-1 monotherapy,1
34289,veno-veno-arterial ecmo,1
34290,"evaluation of cognitive function (fact-cog, v. 3.0)",1
34291,dc bead™,1
34292,methoxy polyethylene glycol epoetin beta,1
34293,lapatinib/herceptin,1
34294,"gc chemotherapy (gemcitabine, cisplatin)",1
34295,uterine fibroid embolization (ufe),1
34296,selumetinib 50mg,1
34297,oral topotecan and temodar,1
34298,hands-on-healing,1
34299,men1112,1
34300,oxymorphone extended release,1
34301,immune cell and ctc detection procedures,1
34302,adt (standard of care),1
34303,metastases resection,1
34304,daily survey administration,1
34305,oral immunonutrition,1
34306,tk216,1
34307,immunohistochemistry using pancytokeratin staining,1
34308,avr,1
34309,nk105,1
34310,cnto888 + paclitaxel and carboplatin,1
34311,131-i-mip-1145,1
34312,enzalutamide (cohort a = closed to accrual),1
34313,chemotherapy with doxorubicin and cisplatin,1
34314,cc placebo,1
34315,triptorelin pamoate (pamorelin® la 11.25 mg),1
34316,suprapubic catheterization using central venous catheter(cvc-2 7f),1
34317,responsive respiratory rehabilitation,1
34318,hartmann's solution,1
34319,corifollitropin alfa,1
34320,fractional ablative co2 laser,1
34321,trastuzumab and chemotherapy,1
34322,eftilagimod alpha,1
34323,functional lung avoidance thoracic radiotherapy,1
34324,ktp laser photoablation (standard of care),1
34325,70 gy/cge,1
34326,neuropsychological testing and quality of life assessments,1
34327,"ct scan of the chest, abdomen and pelvis",1
34328,imatinib (glivec),1
34329,acvbp,1
34330,wear novottf-200a,1
34331,anthropometric and physical examination,1
34332,hot biopsy forceps,1
34333,continuation of anti-tnf treatment,1
34334,89zr- dfo-mstp2109a,1
34335,g-csf (pegfilgrastim) 3.6 mg,1
34336,emails - brief smoking prevention messages,1
34337,plastic scintillation detectors,1
34338,pf-06747775,1
34339,mri oxygen saturation map,1
34340,modified brief fatigue inventory,1
34341,tas-102 with a light tracer dose of [14c]ftd,1
34342,de-escalation radio(chemo)therapy - level 2,1
34343,"catumaxomab, fluorouracil, leucovorin, oxaliplatin, docetaxel",1
34344,hologic selenia dimensions digital breast tomosynthesis system,1
34345,"hypofractionated rt 5 x 7,25 gy",1
34346,ontak dc,1
34347,post-operative brachytherapy,1
34348,active choice,1
34349,dt-lm,1
34350,linked color imaging,1
34351,[18f]hx4,1
34352,radiotherapy of the metastatic spine process,1
34353,hiltonol and autologous dendritic cells,1
34354,intraoperative chest tube removal,1
34355,whole breast screening ultrasound (wbus),1
34356,digoxin combination,1
34357,conventional vats,1
34358,supraclavicular lymph node dissection,1
34359,ultrasonically activated shears,1
34360,cyclophosphamide and topotecan,1
34361,prevention of gvhd,1
34362,lunacalcipol 180,1
34363,nerve sparing cystectomy,1
34364,part 1: sym004 6 mg/kg + cisplatin/pemetrexed,1
34365,"gemcitabine, cisplatin, sunitinib",1
34366,transanual tube placement,1
34367,jnj-42756493: part 4,1
34368,vandetanib (zd6474),1
34369,vinorelbine 25 mg/m2 weekly,1
34370,cintec plus,1
34371,bpx-701,1
34372,procarbacine,1
34373,12 week stanford v chemotherapy,1
34374,vorinostat (suberoylanilide hydroxamic acid [saha]) in combination with pemetrexed and cisplatin,1
34375,intravenous recombinant human il-15 (rhil-15),1
34376,nutritional supplement (protein),1
34377,type of decision aid,1
34378,prednisone 5 mg once daily,1
34379,active intervention,1
34380,perioperative pregabalin placebo,1
34381,mimig system,1
34382,egfr tyrosine kinase inhibitor with chemotherapy,1
34383,endothelial function testing,1
34384,vorinostat (hdac inhibitor),1
34385,eus-guided laser ablation for refractory neoplasms,1
34386,reminder and outreach intervention,1
34387,molecular assays on biopsied tissue,1
34388,nerve-sparing radical hysterectomy,1
34389,2-hydroxyflutamide (2-hof) [liproca depot],1
34390,standard laparoscopic surgery,1
34391,"docetaxel, capecitabine",1
34392,18f- fdg pet scans,1
34393,cytology (fnab) or surgery,1
34394,biochemo + bevacizumab then ipilimumab,1
34395,qualitative interviews concerning the implementation of aac,1
34396,her2 bats,1
34397,"gvax leukemia vaccine (therapeutic cellular vaccine, gm-csf producing)",1
34398,iodine (124i) girentuximab,1
34399,pbsc reinfusion,1
34400,cancer patients admitted to the icu,1
34401,pleural intensity modulated radiation therapy,1
34402,"placebo control, 0.5ml",1
34403,"bortezomib (velcade), thalidomide, and dexamethasone (vtd)",1
34404,paclitaxel + everolimus (rad001),1
34405,dcd+p,1
34406,"capillary ""slow pull"" technique",1
34407,computerized tomography (ct) scan of the chest,1
34408,chromoendoscopy with magnification,1
34409,maintenance (intensive & non-intensive pathways) - lenalidomide maintenance,1
34410,online cognitive battery (cogsuite),1
34411,ar-12: (2-amino-n-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl] phenyl]-acetamide),1
34412,"irinotecan, 5-fluorouracil, leucovorin",1
34413,conventional or high dose radiotherapy,1
34414,act01,1
34415,hal 1% with illumination,1
34416,pngvl3-hicd vaccine,1
34417,other exploratory blood biomarkers,1
34418,high-level recruitment strategy consent form,1
34419,caregiver-assisted training,1
34420,breathing and journaling exercise,1
34421,rest,1
34422,pembrolizumab (k),1
34423,argatroban,1
34424,levulan kerastick,1
34425,"blood test, urine test, and bone density x-ray.",1
34426,[131i]icf01012 (therapeutic dose level 4),1
34427,"cetuximab,paclitaxel, carboplatin",1
34428,platinum-based agent,1
34429,pdl,1
34430,caprosyn subcuticular sutures.,1
34431,full conditioning,1
34432,sterotactic body radiotherapy/sbrt,1
34433,lintuzumab (sgn-33),1
34434,polyps resection with bipolar electrode,1
34435,comparison light,1
34436,ts-1 with irinotecan,1
34437,patient provider orientation scale,1
34438,prophylactic swallowing home exercise program,1
34439,dp001,1
34440,"ascorbic acid, vitamin e, beta carotene, selenium, zinc",1
34441,conventional thyroidectomy,1
34442,modified gemcitabine plus nab-paclitaxel combination chemotherapy,1
34443,indoor tanning behavior,1
34444,ob318 capsule,1
34445,lymphodepleting chemotherapy,1
34446,a 1 intervention arm flex sig,1
34447,blue light treatment,1
34448,"gemcitabine, cisplatin, s-1",1
34449,rivaroxaban 20 mg,1
34450,recombinant human angiostatin protein,1
34451,"ifosfamide, oncovin, actinomycine d, epirubicine, carboplatinum, etoposide",1
34452,chondroitin,1
34453,reach plus,1
34454,anastozole (arimidex),1
34455,instruction in self-referral,1
34456,soluble beta-glucan (sbg),1
34457,mit,1
34458,fasting blood sample.,1
34459,blood samples (5 ml) will be taken,1
34460,modifiedfolfox6 + cetuximab,1
34461,irinotecan injection,1
34462,"s-1, cisplatin",1
34463,no interventions - retrospective data collection,1
34464,low intensity counseling + long acting nrt + prn nrt,1
34465,therapeutic education and psychological support,1
34466,intravenous colloid bolus with voluven,1
34467,lateral sentinel lymph node biopsy,1
34468,sulforaphane glucosinolate capsules,1
34469,no oral supplementation,1
34470,electrocorticography with electrostimulation,1
34471,gerdx(tm),1
34472,project connect online,1
34473,e0650 pcd with non-sequential waveform,1
34474,cancer clinical trials education program,1
34475,186 re - labelled hmab biwa 4,1
34476,5-fu plus cddp,1
34477,hipec with flushing afterwards,1
34478,"lv5fu2 simplified, folfox 4 simplified, folfiri modified",1
34479,measurement of platelet count at diagnosis,1
34480,related donor transplant,1
34481,s-lmwh,1
34482,khk7580 low dose,1
34483,nivolumab (phase 1),1
34484,oliclinomel n4 per bag 1.5 l,1
34485,"ixabepilone, 20 mg/d",1
34486,fti,1
34487,"acetylsalicylic acid (aspirin, baye4465)",1
34488,placebo (5 percent dextrose - d5w),1
34489,fibroblast growth factor receptor inhibitor clinical trial assay (fgfri cta),1
34490,ati neurostimulation system,1
34491,isolated milk protein,1
34492,act pet/ct,1
34493,ultrasound scan of the liver,1
34494,lf-pb and placebo,1
34495,mirna quantification,1
34496,celecoxib oral product,1
34497,light induced fluorescence intraoral camera,1
34498,"prednisone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, daunorubicin, 6-mercaptopurine",1
34499,dose to prostate bed,1
34500,activity monitor,1
34501,"methotrexate, hydrocortisone and cytarabine with leucovorin",1
34502,escalated: inhomogene dose plan,1
34503,av-gbm-1,1
34504,the decídetext program,1
34505,hepasphere tace (transarterial chemoembolization),1
34506,"regorafenib (stivarga,bay73-4506)",1
34507,transrectal ultrasound (bk medical pro focus ultraview 2202 system),1
34508,mitogel™ instillations,1
34509,higher dose combination chemotherapy plus intrathecal topotecan,1
34510,r-epoch,1
34511,individualized stereotactic ablative radiotherapy (isabr),1
34512,radiofrequency ablation (barrx™),1
34513,bortezomib or observation,1
34514,obtaining biospecimen,1
34515,chemoradiation plus cetuximab,1
34516,mk2206 once weekly,1
34517,caregiver support group,1
34518,morphine sustain release (sr),1
34519,ximingting tablet,1
34520,131i-chtnt-1/b mab (cotara),1
34521,conventional ultrasound group,1
34522,genetically modified dcs plus cik cells,1
34523,pet-imaging with cuatsm,1
34524,individual dietary counseling.,1
34525,panitumumab + folfiri,1
34526,"reduced intensity, related donor stem cell transplant",1
34527,tubeless uniportal video-assisted thoracoscopic surgery in total thymectomy,1
34528,radium 223 55mbq/kg every 4 weeks intravenously,1
34529,relaxation,1
34530,oral approved anticancer drug,1
34531,cpt-11 and platinum analogues,1
34532,p501-as15 vaccine,1
34533,rituximab and lenalidomide,1
34534,cytokine-induced killer cells (cik),1
34535,pdt with metvix 160 mg/g cream,1
34536,dexamethasone continuous,1
34537,gefitinib-surgery-gefitinib,1
34538,transbronchial biopsy,1
34539,cirt with concurrent chemo arm,1
34540,azole antifungal,1
34541,laparoscopic myomectomy without pbs,1
34542,cyclosporine eye drops (restasis),1
34543,auto-questionnaires,1
34544,[177]lu-dota-tate,1
34545,peripheral blood tests,1
34546,chemotherapy: folfox 4,1
34547,philips sonalleve® mr-hifu breast therapy system,1
34548,leo 43204 gel 0.018%,1
34549,medi9447 and medi4736,1
34550,bisegmentectomy,1
34551,paclitaxel+cisplatin+5fluorouracil,1
34552,esophagus biopsies (pathologic and healthy zones),1
34553,tw1025,1
34554,meal composition,1
34555,ld muscle flap harvest procedure,1
34556,ofatumumab with gsk2110183,1
34557,plitidepsin plus cytarabine,1
34558,acalabrutinib in combination with br,1
34559,coach directed behavioral weight loss,1
34560,symptoms questionnaire,1
34561,conventional surgery for select patients,1
34562,huachansu pian,1
34563,icotinib combined with pemetrexed plus cisplatin,1
34564,egb761,1
34565,feedback messages,1
34566,regn1979,1
34567,tookad vtp,1
34568,ceep-rituximab,1
34569,mode of detection: interval cancer,1
34570,busulfan (zhejiang otsuka pharmaceutical co. ltd),1
34571,discharge instructions reminders,1
34572,multitargeted tyrosine kinase inhibitor plx3397,1
34573,gingival crevicular fluid collection,1
34574,carboplatin (dose level 2),1
34575,21-day tmz,1
34576,canfosfamide hcl for injection,1
34577,break,1
34578,amg 386 and trastuzumab,1
34579,degarelix acetate,1
34580,hfsrs,1
34581,laparoscopic-lar,1
34582,5 weeks of radiotherapy,1
34583,grn163l,1
34584,gene methylation analysis,1
34585,erlotinib (drug),1
34586,drug exposition data,1
34587,5% albumin infusion 3 hours,1
34588,autologous hsp-70 protein-peptide complex (ag-858) plus gleevec™.,1
34589,wx-uk1 in combination with capecitabine,1
34590,sorafenib with low-dose fp,1
34591,spleen radiation,1
34592,rituximab 375 mg/m2,1
34593,mifl + bevacizumab,1
34594,ida,1
34595,imaging beta probe (ibp),1
34596,patient activation booklet and nursing support for patients with lars,1
34597,"diet, fat-restricted",1
34598,genexol-pm®,1
34599,mek162 and mfolfiri,1
34600,"contrast dye, iodinated",1
34601,pancreatic tumor vaccine,1
34602,reapprasial condition,1
34603,placebo (d5w),1
34604,dca (dichloroacetate),1
34605,diagnostic screening for occult malignancy,1
34606,benralizumab 30 mg sc + mometasone furoate,1
34607,paclitaxel for injection (taxol),1
34608,epoetin alfa 150 iu/kg 3 times a week (tiw),1
34609,parent reminders,1
34610,cisplatin/carboplatin plus etoposide,1
34611,roux en y gastrojejunostomy (ry-gj),1
34612,fludeoxyglucose f 18 dynomic contrast,1
34613,hpvid,1
34614,folfirinox drugs,1
34615,tak-931 pic,1
34616,health-literacy focused education session,1
34617,cetuximab and stereotactic radiosurgery,1
34618,breast mri interpretation,1
34619,palliative performance scale version 2 (ppsv2),1
34620,endocrine therapy (non imp),1
34621,oral soy protein/isoflavones powder,1
34622,enhanced recovery after surgery (eras),1
34623,"ksp-910638g, 1.2 mg",1
34624,tumoral sample,1
34625,spectracure p18 system,1
34626,physician receives qol results,1
34627,cisplatin (or alternative) - deintensified,1
34628,gz17-6.02,1
34629,default initiation,1
34630,holmium-166 poly lactic acid microspheres,1
34631,transperitoneal laparoscopic adrenalectomy,1
34632,doxorubicin.,1
34633,focal phothtermal ablation,1
34634,pneumoperitoneum pressure 15 mmhg,1
34635,glycopeptide,1
34636,lc bead lumi,1
34637,rogaratinib,1
34638,dose dense ac,1
34639,"control arm, standard care",1
34640,"cisplatin,etoposide,ifosfamide,dexamethasone,mesna",1
34641,regn2810 (maintenance),1
34642,lymphadenectomy (lne),1
34643,bkm120 and erlotinib,1
34644,erc,1
34645,radiation therapy as needed by the patient´s tumor and stage,1
34646,timely follow-up: barriers to clinic follow-up visits will be discussed,1
34647,diffusion-weighted nuclear magnetic resonance imaging,1
34648,h&n surgery,1
34649,diagnostic performance 3d t1,1
34650,standard temozolomide,1
34651,biomarker testing and ultrasonography,1
34652,biomedical component,1
34653,methotrexate plus folinic acid alone,1
34654,"oxaliplatin, cytosine arabinoside, dexamethasone with rituxan (road)",1
34655,diabetes coping skills training (dcst),1
34656,dyadic progressive walking and resistance exercise,1
34657,collection of sample and data,1
34658,"gemcitabine , docetaxel",1
34659,1 or 2-level acdf utilizing bio4 with bio avs cervical allograft (with graft window).,1
34660,faq sheet,1
34661,matrix-asst laser desorption/ionization time flight mass spectrometry,1
34662,imatinib 400 mg,1
34663,comparator: repevax™ (concomitant),1
34664,biodegradable stenting anastomoses,1
34665,pain questionnaire,1
34666,psa blood test,1
34667,gastric tube anastomosis,1
34668,thiotepa in conditioning before transplantation,1
34669,cpet procedures,1
34670,dha,1
34671,"brivanib 400 mg, bid",1
34672,omnivorous diet,1
34673,full liquid diet,1
34674,letter only,1
34675,postoperative bleeding,1
34676,cabozantinib capsules,1
34677,pul-042,1
34678,evaluation of physical performance,1
34679,"placebo 7.5 and docetaxel, doxorubicin, and cyclophosphamide (tac)",1
34680,c225 (cetuximab),1
34681,immediate orchiectomy or depot lhrh,1
34682,89zr-kn035,1
34683,metformin and fshr,1
34684,ag-636,1
34685,the drop program of pharmaceutical interventions,1
34686,aptima® hpv assay,1
34687,topical 0.5% timolol,1
34688,expansion phase decitabine,1
34689,'self-collected vaginal swab for hpv testing + pap smear triage' arm,1
34690,standard second-line chemotherapy,1
34691,interferon alfa 2a [roferon],1
34692,astatine at 211 anti-cd45 monoclonal antibody bc8-b10,1
34693,"s1,",1
34694,mri-guided laser induced thermal therapy,1
34695,cisplatin-gemzar,1
34696,neoadjuvant docetaxel and cyclophosphamide,1
34697,gp75 dna vaccine,1
34698,pem only,1
34699,sperm and blood collected for analysis,1
34700,calcipotriol,1
34701,14c-labeled gilteritinib,1
34702,anti-grp78 monoclonal igm antibody pat-sm6,1
34703,dp & targeted drugs,1
34704,thermotron rf-8ex,1
34705,dexmedetomidine and dexamethasone,1
34706,acupressure wristbands,1
34707,functional imaging previous the second course,1
34708,1.4% sodium bicarbonate solution,1
34709,remifentanil 50 mikrog/ml,1
34710,r-fcm,1
34711,activated lymphocytes,1
34712,low-dose computed tomography annual scan x3,1
34713,preoperative radiation therapy,1
34714,rituximab (iv),1
34715,intraoperative identification method,1
34716,normal level vitamin d,1
34717,ny-eso-1?²??t in combination with pembrolizumab,1
34718,text-only,1
34719,18f-fdg pet/ct initial-time imaging,1
34720,standard-dose protocol computed tomography,1
34721,sgn-cd70a,1
34722,cd24fc,1
34723,geriatric screening test g8,1
34724,conventionally fractionated full dose re-irradiation,1
34725,fdcyd + thu,1
34726,evaluation of erectile dysfunction,1
34727,biweekly-chop with g-csf and intrathecal prophylaxis,1
34728,azd1390,1
34729,p.dom-wt1-37 dna vaccine and p.dom-wt1-126 dna vaccine,1
34730,traditional rfa,1
34731,cev chemotherapy,1
34732,nerve section,1
34733,tumor cell collection,1
34734,lymphodepletion with fludarabine,1
34735,hypo-flame study,1
34736,dexamethasone in consolidation-1,1
34737,conventional breast surgery,1
34738,nivolumab + ipilimumab - arm b,1
34739,open and laparoscopic surgery,1
34740,usual care observational control,1
34741,physiological measurements,1
34742,hpph 5 mg/m2,1
34743,only support from an anaesthetic nurse on the surgery ward,1
34744,liquefied petroleum gas (lpg) cookstove,1
34745,pep-3 vaccine,1
34746,oil massages,1
34747,cytokine-treated veto cells,1
34748,clinic visit and interview,1
34749,nab-paclitaxel 125 mg/m2,1
34750,standard snare for polypectomy,1
34751,hla-mismatched microtransplantation,1
34752,aa reduced dose-normal diet (a),1
34753,"radium-223 (xofigo, bay88-8223)",1
34754,intubation with a cuffed et tube,1
34755,gbm6-ad and poly-iclc before and after surgery,1
34756,hippocampal avoidance wbrt,1
34757,131 i-metaiodobenzylguanidine,1
34758,general condition,1
34759,one-time qualitative assessment,1
34760,polypectomy using a cold snare,1
34761,diet and exercise guidance and modifications,1
34762,communication lecture,1
34763,v3-cervix,1
34764,collected at pre-treatment tumor biopsy,1
34765,acetaminophen plus ibuprofen,1
34766,anti?human thymoglobulin,1
34767,docetaxel: increase of the dose,1
34768,active music engagement,1
34769,sct400,1
34770,pegylated liposomal doxorubicin (caelyx) & carboplatin,1
34771,oncoplastic breast surgery.,1
34772,contralateral healthy tissue biopsy,1
34773,lenalidomide plus rituximab,1
34774,citrulline,1
34775,oral cyclophosphamide,1
34776,ppb,1
34777,4-field radiation planning,1
34778,epoch-f/r,1
34779,normal brain tissue,1
34780,"bevacizumab, capecitabine, oxaliplatin",1
34781,oral contraceptive: microgestin fe® 1/20,1
34782,hpv dna testing + cryosurgery,1
34783,erlotinib plus digoxin,1
34784,iapa-dc/ctl adoptive cellular immunotherapy,1
34785,177lu?psma?617,1
34786,lapatinib-placebo,1
34787,ultrasonograph,1
34788,mobility self-management with mentor,1
34789,cobimetinib + vemurafenib combination treatment,1
34790,arq 197 plus erlotinib,1
34791,self-monitor arm volume,1
34792,internet-based protocol and physician referral,1
34793,spinal anesthesia with bupivacaine hyperbar 0.5 %,1
34794,esophageal resection,1
34795,ammonium tetrathiomolybdate,1
34796,cyclophosphamide 750 mg/m^2,1
34797,vigorous aerobic training,1
34798,ruxolitinib 20 mg,1
34799,"epirubicin, paclitaxel",1
34800,virtual non-calcium dual-energy computed tomography,1
34801,robotic assisted surgery,1
34802,topical liquid lidocaine,1
34803,inxn-3001,1
34804,optical frequency domain imaging (ofdi),1
34805,gen1029 (hexabody®-dr5/dr5),1
34806,sorafenib (400 mg bid),1
34807,high-dose methotrexate infusion duration,1
34808,tumor delineation,1
34809,melanoma antigen recognized by t-cells (mart)-1: 27-35,1
34810,cpert,1
34811,cytoreductive surgery and intraperitoneal chemotherapy,1
34812,reduced calorie diet (rcd),1
34813,adjuvant letrozole (postmenopausal women),1
34814,paclitaxel/ddp,1
34815,radical trachelectomy,1
34816,blood sample for hormonal measurement,1
34817,mesenchymal stem cell,1
34818,chemotherapy then hormonotherapy,1
34819,hpv 16 e7:12-20 peptide vaccine,1
34820,pill cam,1
34821,cryotherapy (ice chips),1
34822,emotional expression,1
34823,psycho-social support,1
34824,bilateral simple orchidectomy (bso),1
34825,"measuring satisfaction, knowledge and bias",1
34826,möllers omega-3 ekstra sterk,1
34827,standard high-definition white light,1
34828,axp107-11,1
34829,tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell vaccine,1
34830,olympus pcf-y0014-l,1
34831,s-588410,1
34832,observation using nbi system,1
34833,generic = plerixafor,1
34834,urinary analysis,1
34835,30 mcg ethinylestradiol/3 mg drospirenone and selmevit,1
34836,riop-intrabeam® system,1
34837,rad,1
34838,hypofractionated stereotactic radiation therapy,1
34839,charlson score and community social deprivation,1
34840,dentoxol,1
34841,elasto-gel cap,1
34842,3d mri scans,1
34843,"docetaxel 60 mg/m2, epirubicin 60 mg/m2, q3wks",1
34844,iph2101 combined to lenalidomide,1
34845,compound 31543 calcitriol,1
34846,scalpel for tissue scoring,1
34847,functional decline assessment,1
34848,peptide specific dendritic cell,1
34849,azacitidine + lenalidomide,1
34850,alkaline water,1
34851,tacrolimus (tac),1
34852,multi-port laparoscopic myomectomy,1
34853,osmotic release oral system (oros) hydromorphone,1
34854,double umbilical cord blood transplantation,1
34855,mindfulness meditation program (administered via mobile app),1
34856,unroofing biopsy,1
34857,foflox4,1
34858,red rice bran,1
34859,pepcan+candin,1
34860,fiberoptic bronchoscopy and bronchoalveolar lavage,1
34861,eus-guided celiac ganglion neurolysis,1
34862,individualized pharmacokinetically driven paclitaxel dosing,1
34863,solid ankle foot orthotic,1
34864,vbmcp/vbad/velcade,1
34865,mrna-2752 + tremelimumab,1
34866,patient-reported-outcomes,1
34867,targeted chemotherapy after surgery,1
34868,bilateral salpingectomy,1
34869,tti-621 + t-vec,1
34870,spa,1
34871,salvage radiotherapy,1
34872,novel pelvic mri scan assessment,1
34873,irinotecan cisplatin,1
34874,ethyol,1
34875,"etoposide, cyclophosphamide, carboplatin",1
34876,regular occupation therapy,1
34877,blood for pbmcs,1
34878,autologous hematopoietic stem cells (hscs),1
34879,transanal tube drainage,1
34880,administration of zinkgluconaat or placebo,1
34881,"carboplatin, bevacizumab and pemetrexed",1
34882,"irinotecan,oxaliplatin, and s1",1
34883,pregabalin 150 mg,1
34884,isophosphamide,1
34885,alkylating agent of physician choice registered in cancer,1
34886,intensity modulated radiotherapy with chemotherapy,1
34887,gene detection,1
34888,samarium sm-153 lexidronam + docetaxel,1
34889,gemcitabine 700 mg,1
34890,ataxia score,1
34891,6-mercaptopurine.,1
34892,non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere,1
34893,mindful movement program,1
34894,tab08,1
34895,gel-based artificial saliva,1
34896,18f-ef5,1
34897,"tivantinib (arq 197) capsule d, oral",1
34898,elesclomol (sta-4783),1
34899,confirmed left-sided breast cancer,1
34900,gene mutation analyses and fish,1
34901,synergo,1
34902,cct301-38,1
34903,anti [18f]facbc,1
34904,guiding equipments,1
34905,erlotinib + placebo,1
34906,high-dose ia regimen,1
34907,tlc quarterly,1
34908,final fecal volatile organic compounds,1
34909,peripheral intravenous cannula (ivc),1
34910,whole-gland hdr brachytherapy,1
34911,liposomal amphotericin b (ambisome®),1
34912,tailored program of pa and nutritional counseling,1
34913,diaphragmatic breathing and relaxation,1
34914,andrographolides,1
34915,stat rt planning and delivery workflow,1
34916,phone,1
34917,biopsies of bile duct stricture with cholangioscopy-directed biopsies,1
34918,submucosal injection needle ; eus,1
34919,pevonedistat infusion,1
34920,"filanesib, ksp(eg5) inhibitor; intravenous",1
34921,fdg-/flt-pet,1
34922,ms201408-0005c,1
34923,needle without sideport (na-220h-8022),1
34924,screening anal pap smear - high-resolution anoscopy,1
34925,non-cancer medical illness,1
34926,gp+imrt,1
34927,gefitinib 250mg qd,1
34928,leskell gamma unit,1
34929,3d printing,1
34930,epclin genomic test,1
34931,audio-based mindfulness,1
34932,unsupervised exercise (unsup),1
34933,iv ondansetron hydrochloride,1
34934,moving forward together 2,1
34935,two field vs three field lymphadenectomy,1
34936,treatment level 1,1
34937,interleukin-2 (3 million iu),1
34938,tak700,1
34939,radiochemotherapy cap 50,1
34940,"standard of care scissors, ligatures, clips, and sutures",1
34941,pazopanib or chemotherapy,1
34942,nebuliser suspension,1
34943,suprapubic tube ex 2 day,1
34944,lipovaxin-mm,1
34945,zgn-440 sterile diluent,1
34946,depot medroxyprogesterone acetate,1
34947,targeted sampling,1
34948,laparoscopic high anterior resection splenic flexure mobilization,1
34949,pf804,1
34950,phyxol(paclitaxel),1
34951,androgen blockade,1
34952,hypofractionated concurrent chemoradiotherapy,1
34953,follow up endoscopy 3,1
34954,optune ttf device,1
34955,bevacizumab 7.5 mg/kg,1
34956,2'-f-ara-deoxyuridine,1
34957,spi-1005,1
34958,amg 479 placebo,1
34959,sthlm3,1
34960,fec/te placebo,1
34961,radiotherapy combined with ep,1
34962,vignette,1
34963,prednisone + everolimus,1
34964,eqw plus dapa,1
34965,sibrt,1
34966,cyclosporin,1
34967,whatsapp reminder,1
34968,tailored education and referral,1
34969,sexual and urological intervention,1
34970,cd137l-dc-ebv-vax,1
34971,active ankle pump motions and abdominal breathing training on the 1-3 day after the surgery,1
34972,[18f]-fluoro-2-deoxy-d-glucose and -[18f] dihydro-testosterone,1
34973,axitinib + paclitaxel + carboplatin (cohort 2),1
34974,18f-naf pet/ct,1
34975,erythromycin [eritex],1
34976,intensity modulated proton therapy,1
34977,hydromprphone hydrochloride (hcl) oros,1
34978,e-motivate group,1
34979,"conbercept, fixed",1
34980,life bronchoscopy,1
34981,conventional intravenous fluid therapy,1
34982,orbital irradiation,1
34983,colonring™,1
34984,pneumatic pyloric dilatation,1
34985,standard fractionation radiation therapy,1
34986,perioperative simplified folfox-4 chemotherapy,1
34987,"lv5fu2 simplified,folfox 4 simplified, folfiri modified, bevacizumab 5 mg/kg/ 2 weeks",1
34988,"irinotecan, oxaliplatin, and cetuximab",1
34989,nivolumab + cabiralizumab,1
34990,quantitative brain imaging,1
34991,curative surgery,1
34992,drivers 65 plus,1
34993,part 2: decitabine 20 mg/m2,1
34994,iri regimen,1
34995,standard: ondansetron,1
34996,r-chop/r-dhap,1
34997,routine care + nutritional product,1
34998,timolol + lcp,1
34999,r-blocks,1
35000,imiquimod vehicle manufactured by taro,1
35001,laparoscopic radical prostatectomy (without a simulator),1
35002,nursing education related to gastrostomy tube care,1
35003,fruquintinib+paclitaxel,1
35004,busulfex®,1
35005,fluorine f 18 fluorthanatrace,1
35006,ror1 car-specific autologous t-lymphocytes,1
35007,induction venetoclax,1
35008,stepped-care intervention,1
35009,atope-i,1
35010,imatinib mesylate (glivec),1
35011,delayed diet and exercise intervention,1
35012,salicylates,1
35013,acute tryptophan depletion,1
35014,pericostal suture technique,1
35015,ids,1
35016,hololens,1
35017,standard of care tissue expander breast reconstruction surgery after mastectomy,1
35018,pf-05212384 (gedatolisib),1
35019,blood draw at three months,1
35020,grn163l in combination with trastuzumab,1
35021,matching placebo sc + mometasone furoate,1
35022,taxane chemotherapy,1
35023,single-port laparoscopic surgical staging,1
35024,quality of life (eortc-qlq-30),1
35025,3d conformal external beam irradiation,1
35026,"standardized regimen of exercises, including a warm-up period, rom arm exercises, and strength training exercises.",1
35027,ligasure-covidien,1
35028,structured clinical interview for the diagnostic and statistical manual-iv scid,1
35029,low glycemic load diet,1
35030,primary debulking surgery + adjuvant chemotherapy,1
35031,embolizations,1
35032,dexmedetomidine 3,1
35033,fenestration,1
35034,observational only - transcutaneous oxygen measurement,1
35035,tailored education intervention,1
35036,adjuvant trastuzumab,1
35037,epoetin alfa group,1
35038,educational card,1
35039,pneumatic compression pump,1
35040,adjuvant chemotherapy with 5-fu associated with oxaliplatin,1
35041,experimental drug: aprepitant,1
35042,"trastuzumab 8 mg/kg iv saturation, then 6 mg/kg iv (her2 positive patients only)",1
35043,app,1
35044,recombinant fowlpox-psa(l155)/tricom (prostvac-f/tricom),1
35045,rbl001/rbl002,1
35046,translational research and multimodal treatment,1
35047,bls_ils_e710c 1500mg,1
35048,capiri-sutent,1
35049,bi 891065,1
35050,goal directed fluid therapy with the edwards ev1000 system,1
35051,xelox (capecitabine and oxaliplatin),1
35052,interferon-gamma (ifn-?),1
35053,sigmoid,1
35054,bcd-057,1
35055,single fraction of 7 gy,1
35056,boost® high protein,1
35057,mr-spectroscopy,1
35058,standard wide local excision.,1
35059,magnetic resonance imaging (mri) scan,1
35060,gemcitabine 900 mg/m2 (days 1 and 8) and docetaxel 75 mg/m2 (day 8),1
35061,etoposide (dose level 1),1
35062,rc-1291,1
35063,thermoplastic facemask,1
35064,acy-1215 (ricolinostat) in combination with pomalidomide and dexamethasone,1
35065,chemoradiation with temozolomide,1
35066,"pep005 (ingenol mebutat gel, 0.05 %)",1
35067,liposome-encapsulated sn38,1
35068,active comparator: niraparib,1
35069,sorbstar®,1
35070,enbd and pancreatoduodenectomy,1
35071,two consecutive weeks administration of arq 761 with one week of rest,1
35072,surgimend,1
35073,"temozolomide, thiotepa",1
35074,reduced port robotic distal gastrectomy,1
35075,complete a health questionnaire,1
35076,axitinib + docetaxel + carboplatin (cohort 4a),1
35077,ckd-516 tablet,1
35078,opc-18,1
35079,touchscreen computer program,1
35080,tumor specimen for methylation analysis,1
35081,postoperative hypofractionated stereotactic radiotherapy,1
35082,"vorinostat, suberoylanilide hydroxamic acid (saha)",1
35083,oac triple therapy,1
35084,multiphoton microscopy,1
35085,tpf neoadjuvant chemotherapy,1
35086,pre-operative bilateral breast mri,1
35087,magnetic resonance - guided radiation therapy (mrgrt),1
35088,tucatinib in combination with palbociclib and letrozole,1
35089,89-zramg211 pet,1
35090,"gemcitabine, docetaxel",1
35091,d3-laparoscopic colectomy,1
35092,ed-tbi,1
35093,90yttrium colloid,1
35094,"dexamethasone, steroid; oral or intravenous",1
35095,sirolimus based immunosuppression,1
35096,18f-flt pet scan,1
35097,food record,1
35098,part b: debio 1143,1
35099,abt-888 40 mg x 21 days,1
35100,fruquintinib placebo + paclitaxel,1
35101,social-health care intervention,1
35102,standard postoperative dressing,1
35103,mail-based,1
35104,endoscopic retrograde cholangiopancreatography (ercp),1
35105,single operator cholangioscopy,1
35106,aeroform tissue expander,1
35107,bkm120 +temozolomide with/without radiotherapy,1
35108,"ebus-tbna, eus-b-fna (eus-fna with bronchoscope)",1
35109,"rituximab (mabthera®, roche pty ltd, basel, switzerland)",1
35110,strontium-89,1
35111,gallium ga 68-labeled psma ligand glu-urea-lys(ahx),1
35112,brief preoperative smoking intervention,1
35113,prostate immobilization device,1
35114,dose level 1 onc201 625mg,1
35115,ny-eso-1 expression testing,1
35116,nimotuzumab + shr-1210,1
35117,interventional radiological or surgical management,1
35118,bci assay results,1
35119,131i-chtnt-1/b,1
35120,afp gene hepatocellular carcinoma vaccine,1
35121,bevacizumab (bmab),1
35122,concurrent chemoradiotherapy plus dc-cik immunotherapy,1
35123,folfiri infusion,1
35124,side-to-side stapled esophagogastric anastomosis,1
35125,novel pet tracer facbc,1
35126,contrast-enhanced ultrasound group,1
35127,telisotuzumab vedotin,1
35128,palliative radiotherapy and chemotherapy,1
35129,aeroform breast tissue expander,1
35130,routine diet,1
35131,inotuzumab,1
35132,ham + pomegranate extract,1
35133,human telomerase reverse transcriptase,1
35134,dasatinib + ketoconazole,1
35135,pn-lhw,1
35136,bevacizumab combined with dose dense chemotherapy,1
35137,standard-dose aza,1
35138,metfomin plus simvastatin,1
35139,neoadjuvant s-1 plus nab-paclitaxel with sbrt,1
35140,gmx1777,1
35141,gardasil9,1
35142,standard breast irradiation,1
35143,"mitomycin, fluorouracil",1
35144,eus-guided fistulization axios,1
35145,high risk hpv dna testing,1
35146,docetaxel + hormonal treatment (lh-rh agonist),1
35147,sodium salicylate,1
35148,pimodivir,1
35149,xenograft,1
35150,exposure: human development index of country,1
35151,89zr bevacizumab pet scan,1
35152,intensity modulated radiation plan,1
35153,tds-im electroporation device,1
35154,a circular anal dilator (cad),1
35155,radial tae - bland embolization with 40-100 microparticles,1
35156,folfiri/folfox/capeox,1
35157,salpingectomy group i,1
35158,lxs196 and hdm201,1
35159,linguistically and culturally tailored information,1
35160,laparoscopic cystogastrostomy,1
35161,visual inspection with acetic acid,1
35162,- certagen (multivitamins with minerals),1
35163,intravenous cisplatin,1
35164,msj-0011,1
35165,imc-3g3,1
35166,decision aid for colon cancer screening,1
35167,tendrils,1
35168,[f-18]-5-fluoro-2'-deoxycytidine,1
35169,chemokine modulation therapy,1
35170,brentuximab,1
35171,multi-parametric mri(mp-mri),1
35172,elastic abdominal binder,1
35173,gc007f,1
35174,magnetom avanto (mri device),1
35175,intravenous bortezomib,1
35176,cytarabine in induction,1
35177,xiaflex / xiapex,1
35178,pilonidal sinus,1
35179,"bendamustine, bortezomib, prednisone",1
35180,paclitaxel / carboplatin,1
35181,pirarubicin(thp),1
35182,iscar quercus,1
35183,human anti-human antibodies,1
35184,agent vm110 and laproscopic infra-red probe,1
35185,mk-8628 dose b,1
35186,"type wallflex or evolution biliary, stent system",1
35187,surgicel® absorbable haemostat,1
35188,tracerinjection,1
35189,eculizumab,1
35190,body measurements,1
35191,sildenafil 20 mg tablets,1
35192,bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine,1
35193,cs1003,1
35194,nanoplatin (nc-6004) and gemcitabine,1
35195,granix,1
35196,hysteroscopic morcellator (truclear),1
35197,standard salvage radiation treatment (ssrt),1
35198,darbepoetin alpha (aranesp),1
35199,endorectal balloon,1
35200,xl281,1
35201,patients undergo cvats lobectomy,1
35202,"glivec film-coated tablet 100 mg, 4 tablets",1
35203,ct-16,1
35204,i123,1
35205,nevus doctor program,1
35206,ac480iv,1
35207,amg 319,1
35208,percutaneous tumor cryoablation,1
35209,systemic chemotherapy except s-1,1
35210,alemtuzumab s.c.,1
35211,unid 3d vbr,1
35212,bxq-350,1
35213,"administration of mucolytic solution before upper endoscopy (espumisan, acc long)",1
35214,wt1 and pr1 peptide vaccine,1
35215,rg3,1
35216,breast lesion localization needles (interv),1
35217,xiaoai jiedu decoction,1
35218,engerix™,1
35219,urea dose a,1
35220,atypical type-2,1
35221,pf-04605412,1
35222,ct and histopathological classification,1
35223,adaptation of ebrt nodal elective ctv according to risk of nodal and systemic recurrence,1
35224,group a 2.5 mg letrozole oral tablets,1
35225,usual pathways,1
35226,intuitive plan,1
35227,kml-001,1
35228,radioactive iodine-labeled monoclonal antibody 8h9,1
35229,geriatric assessment and management,1
35230,"arcoxia, 120 mg",1
35231,thoracotomy lobectomy,1
35232,scintigraphy in 123i-ibzm,1
35233,ttm tailored,1
35234,"neoadjuvant chemotherapy (cisplatin, 5-fluorouracil)",1
35235,yoga exercise,1
35236,low dose cyclophosphamide,1
35237,busulfan-cyclophosphamide as conditioning regimen before allogeneic hematopoietic stem cell transplantation,1
35238,placebo 300mg,1
35239,[18f] dihydro-testosterone,1
35240,cisplatin + pemetrexed,1
35241,assess the level of expression of ip3r3 in cancerous tissues and healthy tissues,1
35242,"conventional chemotherapy (arac + daunorubicin),",1
35243,radiation hippocampal avoidance pci,1
35244,bay1000394,1
35245,web education control,1
35246,nm-3,1
35247,mindfulness-based-stress-reduction,1
35248,photo acoustic microscopy and optical coherence tomography,1
35249,standard of care comparator,1
35250,delta-24-rgd adenovirus,1
35251,paclitaxel protein-bound particles for injectable suspension (albumin-bound),1
35252,investigator's choice of anti-cancer treatment (except immunotherapy),1
35253,covered biliary stents,1
35254,guided imagery with audio media,1
35255,nuc-1031 500 mg,1
35256,quality of life forms,1
35257,msc,1
35258,tj202 and dexamethasone,1
35259,step up to prevention,1
35260,efudex (5-fluorouracil),1
35261,relaxation only,1
35262,progesterone vaginal gel 8%,1
35263,respecting choices first steps,1
35264,nab-paclitaxel+ gemcitabine,1
35265,breast magnetic resonance imaging (mri),1
35266,umbilical cord blood transplantation (ucbt),1
35267,bilateral mastectomy,1
35268,timing of anastrozole in respect to radiotherapy,1
35269,mutation and signal pathway activation status analysis drug: forfirinox,1
35270,informed assent,1
35271,docetaxel- carboplatin,1
35272,intravenous sedation,1
35273,integrin + dacarbazine,1
35274,sample of polyp,1
35275,ponatinib 30 mg qd,1
35276,carboplatin auc 6 mg/ml/min,1
35277,standard mammography and tomosynthesis,1
35278,mailed fecal occult blood tests,1
35279,chemotherapy education intervention (cei),1
35280,mr-hifu treatment for pain palliation of bone metastases,1
35281,cytoreductive surgery (crs) plus hyperthermic intraoperative peritoneal chemotherapy with cisplatin (hipc),1
35282,comparator: carboplatin,1
35283,sponge capsule,1
35284,fl/doc,1
35285,vdc-ie,1
35286,scheduled worry practice,1
35287,psychoeducation.,1
35288,methylcellulose placebo,1
35289,use of a picc line for chemo administration (powerpicc solo²),1
35290,acupuncture and touch/relaxation,1
35291,pemetrexed/cisplatin intercalating gefitinib,1
35292,imexon in combination with gemcitabine,1
35293,"folinic acid, interferon-alpha",1
35294,ac [adriamycin (a) (also known as doxorubicin) and cyclophosphamide (c)] followed by paclitaxel (p),1
35295,parathyroid hormone (teriparatide),1
35296,wechat based re-education,1
35297,high dose dfd07 once daily,1
35298,pegylated liposomal doxorubicin and carboplatin,1
35299,all eligible subjects will provide blood for sept9 biomarker testing,1
35300,usual rectal cancer surgery,1
35301,pactn,1
35302,pbi 05204,1
35303,inverse ie,1
35304,cancer episode payment model (cem),1
35305,dth skin test,1
35306,specimen and questionnaires only,1
35307,nd yag laser,1
35308,pharmorubicin or pirarubicin,1
35309,da - verbal,1
35310,(epirubicin cisplatin 5-fluorouracil / xeloda) or 5-fluorouracil leucovorin oxaliplatin docetaxel,1
35311,pro-active eat,1
35312,oral anticancer medications,1
35313,dcc,1
35314,bibf 1120 and bibw 2992,1
35315,combination treatment - cohort 4,1
35316,lighter intensity physical activity intervention,1
35317,koning breast ct,1
35318,22 gauge,1
35319,fluoxymesterone 10 mg,1
35320,placebo - cap,1
35321,hcq,1
35322,monoclonal antibodies,1
35323,lymphodepleting,1
35324,tak-285 dose escalation cohorts,1
35325,mk0966; rofecoxib / duration of treatment: 24 weeks,1
35326,positive cytology with hipec,1
35327,elotuzumab (huluc63),1
35328,abt-869 0.10 mg/kg,1
35329,folfoxiri + cetuximab,1
35330,nolvadex (tamoxifen),1
35331,vosaroxin + cytarabine,1
35332,methyl-prednisolone,1
35333,micronutrient-fortified probiotic yogurt,1
35334,phase i dose level -1,1
35335,other: 4. usual care,1
35336,acebutolol,1
35337,"prednisone, vincristine, daunorubicin, peg-l-asparaginase, erwinia l-asparaginase, doxorubicin, cyclophosphamide, cytarabine, thioguanine",1
35338,carboplatin-taxol-radiotherapy,1
35339,high-dose chemotherapy: cyclophosphamide,1
35340,oxaliplatin-based chemotherapy (eshaox),1
35341,cetuximab + cisplatin + vinorelbine,1
35342,axillary lymph node sampling clip,1
35343,dli of the 20 fraction of the ucbt,1
35344,cd19-targeted cart cells,1
35345,collaboration,1
35346,multi-beam imrt,1
35347,sonocloud-9,1
35348,idarubicin versus daunorubicin,1
35349,onyx,1
35350,3 day low residue diet,1
35351,iptld and nutrition therapy,1
35352,"ts-one, cisplatin, rad001",1
35353,epson v600,1
35354,margin probe,1
35355,sonography assisted breast surgery,1
35356,velcade-dexamethasone,1
35357,tc-3 gel,1
35358,alkeran,1
35359,urinalysis,1
35360,neurotherapy,1
35361,ttf-ngr,1
35362,diffusion tensor imaging (dti) in breast mri,1
35363,multi-tracer pet exams of [18f]flt and [18f]fluciclovine,1
35364,131-i-chtnt-1/b mab,1
35365,auto mailing plus lottery,1
35366,goggle-based device with light-emitting diodes (led),1
35367,watch and wait strategy,1
35368,preoperative chemo-radiation with ig-imrt dose escalation,1
35369,midazolam(placebo),1
35370,odour sampling,1
35371,health counselling by nurse navigator,1
35372,no lct,1
35373,enhanced feedback,1
35374,ga-hbed-ipsma pet,1
35375,acide zoledronic,1
35376,fulvestrant plus goserelin,1
35377,trf on drg,1
35378,amg102,1
35379,single application multi-fraction brachytherapy,1
35380,choose two tumor tissue paraffin blocks,1
35381,gemtuzumab,1
35382,peprr,1
35383,imaging with 18f-fspg pet/ct scans,1
35384,standardized geriatric intervention,1
35385,metformin plus clomiphene citrate,1
35386,"prevpac (prevacid, amoxicillin, clarithromycin)",1
35387,telephone interviews,1
35388,consolidation volume rt (cvrt),1
35389,chemotherapy: r-fc,1
35390,thawed embryo transfer (tet),1
35391,tacrolimus (standard gvhd prophylaxis),1
35392,everolimus or placebo,1
35393,cyclin b1 peptide,1
35394,dn-101 (calcitriol),1
35395,111-indium-cmd-193,1
35396,lactated ringer´s solution,1
35397,anti-kras g12d mtcr pbl,1
35398,dacarbazine or dtic,1
35399,bibw2992 + paclitaxel,1
35400,eflornithine placebo & sulindac placebo,1
35401,leukopheresis,1
35402,encorafenib + binimetinib,1
35403,ipatasertib (capsule),1
35404,subcutaneous decitabine,1
35405,perioperative/folfox + cetuximab,1
35406,ltx-315 + pembrolizumab,1
35407,atac therapy,1
35408,aml cell vaccine,1
35409,administration of ipilimumab 3mg/kg + hdi,1
35410,hrqol survey packet,1
35411,clomiphine citrate plus low dose ufsh,1
35412,endoscopic ultrasonography guided biliary drainage,1
35413,cardiac imaging and circulating biomarkers,1
35414,"celecoxib, gefitinib",1
35415,melanoma detection system -mds,1
35416,sector irradiation,1
35417,placebo comparator: lifestyle counseling dinner diet arm 2,1
35418,focal cryotherapy,1
35419,bone marrow cells,1
35420,registration,1
35421,68ga-psma (hbed-cc) pet,1
35422,iv pca fentanyl+nefopam+ramosetron,1
35423,hormonal antineoplastics,1
35424,gonzalez regimen,1
35425,neo-adjuvant chemoradiotherapy followed by mckeown mie,1
35426,e-chec-up,1
35427,imprime pgg + cetuximab,1
35428,cerdulatinib (prt062070),1
35429,patient recruitment,1
35430,asp1235,1
35431,dce-mri scans,1
35432,"prophylactic cranial irradiation, 2.5 gy fx",1
35433,predetermined distance,1
35434,dvc ligation,1
35435,preventive services,1
35436,biomarker assessment,1
35437,peptide application,1
35438,tritube,1
35439,64cu-atsm pet,1
35440,cturbt,1
35441,gap t cells,1
35442,dexamethasone based mouthwash,1
35443,gpx-100 (13-deoxydoxorubicin),1
35444,pre-filled syringe,1
35445,ai+chemotherapy adjuvant therapy,1
35446,f-18 fdg-pet/ct,1
35447,psoralen,1
35448,dendritic cell (dc) injections,1
35449,"avastin (bevacizumab, rhumab vegf)",1
35450,100 mg enteric-coated aspirin,1
35451,sialyl lewisª-keyhole limpet hemocyanin conjugate vaccine,1
35452,fludarabin (post-allograft immunosuppressive therapy modulation and dli mononuclear cells from allogenic blood),1
35453,byl719 as dispersible tablets (dt),1
35454,standard care plus exercise,1
35455,stamp app,1
35456,3'-deoxy-3'-(18) f-fluorothymidine,1
35457,evaluation of the tumor for dna mutations,1
35458,cidofovir gel,1
35459,radiation (standard of care),1
35460,neoadjuvant olaparib,1
35461,carboplatin+ paclitaxel,1
35462,pre-surgical diagnosis of uterine malignant tumors,1
35463,doxycycline monohydrate,1
35464,anlotinib 8mg + ap/pc,1
35465,advanced image guidance,1
35466,in vitro ngs-panel,1
35467,airseal® system-interventional,1
35468,laboratory tumor marker analysis,1
35469,medication monitoring control,1
35470,infusional 5-fu/lv with irinotecan,1
35471,tumor-lysate pulsed dc vaccination +adjuvant polyiclc,1
35472,gene gun vaccine,1
35473,"no intervention, observational study.",1
35474,standard fractionation,1
35475,duct-to-mucosa,1
35476,minimalist/high-risk follow up (? ia g3),1
35477,trc 105,1
35478,systematic evaluation by an intensivist,1
35479,contrast enhanced ultrasonography,1
35480,new radiological staging classification system for patients with advanced and recurrent colorectal cancer undergoing pelvic exenterative surgery,1
35481,bay 1217389,1
35482,tlh _adnexal preservation,1
35483,gold standard biopsy,1
35484,bnct,1
35485,informed consent trough a portable video media,1
35486,peg-asc with simethicone,1
35487,blue laser imaging,1
35488,external radiation therapy with gemcitabine,1
35489,high cut-off hemodialysis,1
35490,polysomnography (psg),1
35491,psychosocial counseling,1
35492,"t-cell replete hsct from a related, haploidentical donor",1
35493,ecg,1
35494,zd1839 in combination with docetaxel,1
35495,mometasone furoate,1
35496,recurrence risk evaluation,1
35497,tlpd surgery,1
35498,esophagectomy (procedure),1
35499,surgery followed by folfox4 chemotherapy,1
35500,self administrated questionnaire,1
35501,traditional open surgery,1
35502,ascent,1
35503,laparoscopic sentinel lymph node biopsy,1
35504,partial chest wall radiation therapy,1
35505,semen analysis,1
35506,tumor core biopsy for rna isolation,1
35507,mechlorethamine-mch (nitrogen mustard),1
35508,folfox and celecoxib,1
35509,tissue harvest,1
35510,erlotinib 100 mg orally days 1-28,1
35511,administrative data,1
35512,direct acting antivirals against hepatitis c virus infection,1
35513,"ont-10, varlilumab combination",1
35514,pci-27483,1
35515,mab 216,1
35516,randomisation course 2 adxe versus fladx,1
35517,bibf 1120 h + docetaxel h,1
35518,3-d conformal radiation therapy,1
35519,blood test 24hours,1
35520,imatinib stop,1
35521,pancreatic cancer screening pathway 1,1
35522,reduced sedentary time intervention (rsti),1
35523,alkylating-based chemotherapy,1
35524,"pemetrexed, carboplatin, placebo",1
35525,"trivax, temozolomide, surgery, radiotherapy",1
35526,bms-184476,1
35527,stereotactic radio-surgery (srs) therapy,1
35528,"biopsy of esophageal/stomach tissue, lymph nodes, tumor",1
35529,"capecitabine, nab-paclitaxel",1
35530,mgh secm imaging capsule,1
35531,accelerated intensity modulated radiation therapy (aimrt),1
35532,"verum, broccoli sprout grain",1
35533,gefitinib and nimotuzumab,1
35534,fbt,1
35535,marinated rare sirloin steak,1
35536,recombinant human interleukin-11,1
35537,cetuximab paclitaxel,1
35538,issue of information booklet,1
35539,quality improvement strategies,1
35540,standard nutrition,1
35541,collecting data,1
35542,conversion surgery,1
35543,anti-cd19 icar nk cells,1
35544,resistance exercise training,1
35545,text messages,1
35546,medivators endocuff,1
35547,standard dissemination,1
35548,beeam regimen,1
35549,oral daily administration of bal101553,1
35550,apixaban 5 mg,1
35551,complete cardiac magnetic resonance imaging (mri),1
35552,il-2 i.v.,1
35553,transrectal random biopsy of the prostate,1
35554,fentanyl ncs,1
35555,refametinib,1
35556,ddac-mini ctc,1
35557,f-18 flt,1
35558,standard-of-care intensity modulated radiotherapy (imrt) planning,1
35559,4sc-205,1
35560,cabazitaxel-xrp6258 (5-week cycle),1
35561,stress management sessions,1
35562,abt-348 and docetaxel,1
35563,lsg,1
35564,cisplatin (weekly),1
35565,pro-stat 101,1
35566,2014-alc-919-us,1
35567,calcium folinate,1
35568,orthostatic hypotension,1
35569,diffusion weighted (dw) mri,1
35570,cyclophosphamide (cy) (plan 2),1
35571,js001+chemotherapy,1
35572,multidisciplinary education programme,1
35573,gimeracil and oteracil potassium ?tegafur?,1
35574,transrectal specimen extraction,1
35575,acute normovolemic hemodilution,1
35576,"cisplatin,fluorouracil",1
35577,manual acupuncture implemented by acupuncturist 2,1
35578,a high ligation of ima,1
35579,eligibility questionnaire,1
35580,folfirinox or gemcitabine/abraxane,1
35581,genomic driven chemotherapy,1
35582,ssr411298,1
35583,bioactive glass and/or autogenous bone,1
35584,vagifem,1
35585,hpv self testing,1
35586,bryostatin-1,1
35587,vemurafenib and trientine,1
35588,blood samples and bone marrow aspirates will be collected,1
35589,whole blood sample,1
35590,bubble gum,1
35591,"peripheral blood sampling and performing: elisa test of sfas, sfasl, il - 17 and bursttest",1
35592,gemcitabine + nab-paclitaxel,1
35593,cep-701 (lestaurtinib),1
35594,hormonal levels,1
35595,tamis,1
35596,"merck's human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine (gardasil)",1
35597,m40403,1
35598,visica 2™ treatment system,1
35599,"5-fluorouracil,leucovorin,panitumumab",1
35600,auricular acupoints acupressure,1
35601,lung resection surgery,1
35602,mypatientpal smartphone app,1
35603,contrast-enhanced computed tomography (ct),1
35604,daily questionnaire,1
35605,abi-007 (abraxane®),1
35606,the tranbergcls,1
35607,e-communication,1
35608,no link to etoolbox,1
35609,pillars4life,1
35610,hs-196,1
35611,plasmid dna vaccine therapy,1
35612,flox,1
35613,avi-014 versus filgrastim,1
35614,shape,1
35615,indium in 111 monoclonal antibody bre-3,1
35616,the nvision vle imaging system,1
35617,anti-egfr (panitumumab or cetuximab),1
35618,ebus-tbna-rte,1
35619,anti-fungal agents,1
35620,gatipotuzumab,1
35621,ginsenoside h dripping pills,1
35622,tobacco cessation intervention,1
35623,cart-19 autologous t-cells,1
35624,manual acupuncture implemented by acupuncturist 1,1
35625,focal hifu treatment using focal one (edap tms),1
35626,5-fluorouracil (tpf) (only until feb 2009),1
35627,cnf1010 (17-aag),1
35628,evaluation of the feasibility and acceptability of delivery of early detections services,1
35629,endoscopic strategy,1
35630,"bortezomib,pirarubicin,dexamethasone",1
35631,fluorine 18-fludeoxyglucose positron emission tomography,1
35632,app notifications,1
35633,endoscopic injections of spot,1
35634,heckel infrared radiant heat device,1
35635,ucart19 follow-up,1
35636,mirtazapine plus gemcitabine,1
35637,calcifidiol,1
35638,gastrectomy with d2 dissection,1
35639,pf-04691502 in combination with letrozole,1
35640,aspirin 75 mg,1
35641,use of iv contrast during head and neck ct,1
35642,second questionnaire,1
35643,mind-body program for fear of recurrence,1
35644,pet cuatsm,1
35645,egf vaccine,1
35646,"conditioning treatment ""thiotepa-treosulfan-fludarabine""",1
35647,bioperine,1
35648,radical gastrectomy plus d4 lymphadenectomy,1
35649,ercp plus two biliary stents,1
35650,xmt-1536,1
35651,framed information sheet,1
35652,paclitaxel concurrent with radiation therapy,1
35653,biopsies (sigmoidoscopy),1
35654,"s-1, irinotecan",1
35655,anti-ny eso-1 mtcr pbl,1
35656,adjuvant pelvic proton radiation,1
35657,omega-3 fatty acid-based parenteral nutrition,1
35658,questionnaire regarding behavior/lifestyle changes since diagnosis,1
35659,matched sibling allogeneic transplantation,1
35660,fosamax,1
35661,3t mri scan,1
35662,donor tcr ?/?-depleted cells,1
35663,adv-tk + valacyclovir,1
35664,jianpi huatan dispensing granule,1
35665,transarterial chemoinfusion (tai) combine toripalimab,1
35666,imaging procedure of ct colonography,1
35667,group-based walking,1
35668,clinical outcomes,1
35669,cryospray ablation system (510(k) no: k070893),1
35670,paramedic telephone consultation,1
35671,"docetaxel, cisplatin and fluorouracil",1
35672,en-bloc resection,1
35673,"temozolomide, bevacizumab and bortezomib",1
35674,stem cells infusion,1
35675,blood draws for pharmacokinetic testing,1
35676,mt-102,1
35677,endoscopy with polyscope (polydiagnost tm) coupled with multi-spectral imaging light-source,1
35678,olympus scopeguide,1
35679,bried and intensive therapy,1
35680,baduanjin qigong,1
35681,'cutler-beard modified with graft',1
35682,medihoney®,1
35683,f-18 rgd-k5,1
35684,immune checkpoint inhibitors or docetaxel,1
35685,metformin-glp-1 receptor agonist,1
35686,flexitouch,1
35687,docetaxel and celecoxib,1
35688,group e,1
35689,oral hycamtin (topotecan) capsules + iv avastin (bevacizumab),1
35690,chemotherapy (induction period),1
35691,low dose dexmedethomidine,1
35692,idarubcin,1
35693,technology based health promotion group-based attention matched control condition,1
35694,weekly assessment of patient's weight,1
35695,cryospray ablation (tm) system,1
35696,pol-103a without api,1
35697,online social-networking intervention,1
35698,exercise and diet,1
35699,act workshop,1
35700,"prednisone, dexamethasone, vincristine, daunorubicin",1
35701,educational supplement,1
35702,high-resolution magic-angle spinning nuclear magnetic resonance spectroscopy,1
35703,mm-151 + irinotecan,1
35704,hypnotic relaxation therapy,1
35705,dvt prophylaxis,1
35706,high dose melphalan (hdr),1
35707,narrow band imaging colonoscope,1
35708,"chop (cyclophosphamide, hydroxydaunorubicin [doxorubicin], oncovin [vincristine], prednisone)",1
35709,sham electro-acupuncture,1
35710,zl-2306 (niraparib),1
35711,fdht pet,1
35712,aplidin®,1
35713,anti-cd20 b9e9 scfv-streptavidin fusion protein,1
35714,carboplatin (auc 6),1
35715,manual lymphatic drainage therapy,1
35716,regional analgesia and propofol,1
35717,temozolomide plus thalidomide,1
35718,pembrolizumab nsclc low dose,1
35719,mesalamine 1200 mg,1
35720,placebo 25mg,1
35721,"irinotecan, cefpodoxime",1
35722,luteinizing hormone releasing hormone [lhrh] agonist,1
35723,cord blood unit,1
35724,biological sampling,1
35725,adjuvant temozolomide (tmz),1
35726,nivolumab monotherapy,1
35727,pd-103 with 20 vs 44 gy supplemental beam xrt,1
35728,deuterated phenanthrene,1
35729,pemetrexed/ carboplatin,1
35730,oral clofarabine,1
35731,weight training,1
35732,ginseng compound,1
35733,gm-k562/leukemia cell vaccine,1
35734,xp,1
35735,conventional insufflator and trocar,1
35736,radiotherapy with simultaneous modulated accelerated boost,1
35737,low-dose il-2,1
35738,matched unrelated donor transplant,1
35739,side-effect questionnaires,1
35740,matching on the basis of physician's choice,1
35741,tailored chemotherapy,1
35742,nonmoving touch therapy,1
35743,laser ablation (la),1
35744,everolimus plus octreotide lar plus metformin,1
35745,placebo to tocilizumab,1
35746,mri post-tace,1
35747,therapeutic bronchoscopy,1
35748,hf-niv-pet,1
35749,low dose chest ctscan,1
35750,salvage radiation,1
35751,dcb-bo1301,1
35752,physical activity resource kit,1
35753,carboplatin (carboplatin kabi),1
35754,thoracoscopy and pleurx,1
35755,pre-treatment volume margin resection,1
35756,radical radiotherapy (conventional rt and sabr),1
35757,land-based exercise group,1
35758,radiation therapy (imrt or impt),1
35759,"docetaxel, bevacizumab",1
35760,radiation: pelvic lymph nodes with boost to prostate,1
35761,recombinant adenovirus-hifn-beta,1
35762,pegylated recombinant human g-csf,1
35763,placebo powder,1
35764,rectoscopy,1
35765,"""we want to know"" campaign, patient survey at 2 time points",1
35766,"50,000 iu vitamin d supplement",1
35767,immunotherapy + radiotherapy arm,1
35768,gpc3-cart cells,1
35769,hum-195/rgel,1
35770,rad001: everolimus,1
35771,surveys and semi-structured interviews,1
35772,statin communication tool,1
35773,latissimus dorsi flap reconstruction,1
35774,intermediate-dose ia regimen,1
35775,limit heart dose,1
35776,atracurium injectable product,1
35777,ventricular irradiation,1
35778,prometra programmable intrathecal infusion pump,1
35779,narrow band imaging transurethral resection,1
35780,hyperfractionated imrt,1
35781,radiosurgery/sbrt,1
35782,total two field lymphadenectomy,1
35783,pve,1
35784,epid verification,1
35785,revlimid (cc-5013),1
35786,131i-hua33 (131-iodine on humanised monoclonal antibody a33),1
35787,"cisplatin, 5-fluorouracil (5-fu), radiotherapy",1
35788,neuroendocrine type-1,1
35789,pohim-rt,1
35790,standard screening tests,1
35791,"filanesib, ksp (eg5) inhibitor; intravenous",1
35792,s-1 only,1
35793,tanshinone,1
35794,inspection during withdrawal,1
35795,mdx-1203,1
35796,intoplicine,1
35797,white blood cells/granulocytes,1
35798,golytely 4 liters,1
35799,mb07133 1800 mg/m2/day,1
35800,grip sensor procedure,1
35801,11c-erlotinib pet/ct,1
35802,novantrone,1
35803,distraction condition,1
35804,24 gy in 3 fractions,1
35805,musculoskeletal tumor society score,1
35806,color-coded materials,1
35807,paclitaxel bound albumine,1
35808,one stage esophagectomy,1
35809,tak-228 & tak-117,1
35810,18f-fch pet/mri scan,1
35811,"forodesine hydrochloride sterile solution, 5 mg/ml",1
35812,treatment e,1
35813,111in zevalin,1
35814,posterior ra,1
35815,ga101_dhap,1
35816,cdk 4/6 inhibitor,1
35817,questionnary of quality of life,1
35818,ultrasound measurement of variations in the diameter of the sheath of the optic nerve,1
35819,cyberknife stereotactic radiotherapy,1
35820,"vincristine, irinotecan, temozolomide",1
35821,symptom management toolkit,1
35822,low ligation with apical lymph node dissection,1
35823,adenosine 5'-triphosphate,1
35824,brim3 educational intervention,1
35825,pwcb,1
35826,tissue autograft of pedicled temporoparietal fascial (tpf) or pericranial flap to bypass the blood brain barrier (bbb),1
35827,iv injection of icg,1
35828,"pegylated liposomal doxorubicin (pld), doxil",1
35829,gabapentin 300mg,1
35830,18f-?v?6-bp,1
35831,bipap,1
35832,ercp with sems plus radiofrequency ablation,1
35833,srt,1
35834,monoclonal antibody cd20,1
35835,multiparametric mri diagnostics,1
35836,nitric oxide-releasing acetylsalicylic acid derivative,1
35837,slne with preoperative hybrid spect/ct,1
35838,tch (docetaxel/carboplatin/trastuzumab) versus ec-th(epirubicin/cyclophosphamide followed by docetaxe plus trastuzumab),1
35839,mri guided high intensity focused ultrasound,1
35840,small-bore tube,1
35841,casad,1
35842,adara 5% cream canada,1
35843,cisplatin and doxorubicin and cyclophosphamide,1
35844,gefitinib tab ?cttq??first medication?gefitinib tab ?cttq??from the 8th day of trial,1
35845,partner and cdc brochure condition,1
35846,cobiprostone,1
35847,chest ct,1
35848,sentinel node resection,1
35849,late drainage removal,1
35850,"capecitabine, irinotecan",1
35851,"immunohistochemical staining, transfection, invasion assay",1
35852,"iv busulfan, cyclophosphamide and etoposide (bucye regimen)",1
35853,anti-cd20 (rituximab),1
35854,hank®,1
35855,xinmailong injection,1
35856,ihl-305 (irinotecan liposome injection),1
35857,pca3 assay,1
35858,eflornithine hcl ointment,1
35859,mirtoselect® + meriva®,1
35860,genetic counseling and testing youtube video,1
35861,under- or overdiagnosed cancer,1
35862,torisel (temsirolimus),1
35863,final microbiome,1
35864,gefitnib,1
35865,health promotion intervention,1
35866,tc-3 gel mixed with mitomycin c (mmc),1
35867,nimotuzumab injection,1
35868,sib (15 x 2.67 gy wbi and sib 15 x 2.67-3.33 gy),1
35869,physician's-choice,1
35870,krdd followed by auto-hct,1
35871,portal triad clamping,1
35872,methyl prednisolonate,1
35873,surgery followed with chemoradiation,1
35874,extensive intraperitoneal lavage (eipl),1
35875,immunotoxin dose,1
35876,care group cervical cancer screening education curriculum,1
35877,dynamic susceptibility contrast (dsc) mri,1
35878,total thyroidectomy + prophylactic central neck dissection,1
35879,utidelone injection,1
35880,treatment with bsct,1
35881,experienced endoscopy nurse participation,1
35882,drug intervention,1
35883,standardized patient assessments,1
35884,hla-mismatched stem-cell microtransplantation,1
35885,dacarbazine + interferon alpha + thymosin-alpha-1 1.6 mg,1
35886,needle core biopsies of liver metastasis,1
35887,"lenalidomide, pioglitazone, dexamethasone, treosulfan",1
35888,radiotherapy combined with sorafenib,1
35889,cxcr4 antagonist,1
35890,autologous peripheral blood cell transplantation,1
35891,bax2398 + 5-fu/calcium levofolinate,1
35892,educational intervention to increase informed decision making for prostate cancer screening,1
35893,nm-il-12,1
35894,"eviendep (cm&d pharma limited, uk)",1
35895,cellaegis' autoric™ device,1
35896,fatigue severity score questionnaire,1
35897,actigraphy assessment,1
35898,cart22-65s cells,1
35899,oral nutrition supplements,1
35900,d1+ distal subtotal gastrectomy,1
35901,"hpv 16/18 vaccine, 0,5ml",1
35902,eortc qlq-bn20,1
35903,prrt every 8-10 weeks,1
35904,adaptive planning radiotherapy,1
35905,phosphoethanolamine,1
35906,general adolescent vaccine brochure,1
35907,preservation of nerve fibers around ima,1
35908,standard wb fractionation,1
35909,education and empowerment,1
35910,other multikinase inhibitors,1
35911,non drains will be placed during operation,1
35912,"pegfilgrastim (neulasta, amgen)",1
35913,dmxaa in combination with carboplatin and paclitaxel,1
35914,isquemic compression,1
35915,cisplatin + 5-fluorouracil (5fu),1
35916,radiation (post induction),1
35917,multi disciplinary palliative care monthly consultations,1
35918,computed tomography scan - 70% dose reduction,1
35919,"cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan",1
35920,peginterferon ?2b,1
35921,general electric logiq e9 ultrasound system,1
35922,pringle,1
35923,mfolfox6 + bibf 1120,1
35924,peripheral blood samples,1
35925,d2 gastrectomy,1
35926,extensive focus program,1
35927,tc-nk infusion,1
35928,"arc endocuff (aec 110, 120, 130, 140)",1
35929,kol,1
35930,nutrition education + crc brochure,1
35931,"ybritumomab tiuxetan (zevalin); rituximab; beam (bcnu, arac, vp16 and melphalan)",1
35932,cabazitaxel with peg-filgrastim,1
35933,cdc-501,1
35934,crystallised phenol,1
35935,"oxaliplatin, fluorouracil, leucovorin, capecitabine",1
35936,transcranial magnetic stimulation clinical research system,1
35937,malformations resection,1
35938,segmentecomy,1
35939,"docetaxel, mitotic inhibitor; intravenous",1
35940,ts-1 + cisplatin,1
35941,ceus (contrast-enhanced ultrasound),1
35942,cd-rom-based prostate cancer treatment education,1
35943,single pre-operative radiation therapy,1
35944,multidisciplinary palliative care team met with patient,1
35945,wound care,1
35946,chemotherapy and radioimmunotherapy,1
35947,neo vax,1
35948,oral palonosetron,1
35949,mendec spine bone cement,1
35950,pre operative parathyroid cytology,1
35951,endoscopy with staining of the mucosa,1
35952,greater omentum binding,1
35953,caregiver reported outcomes instruments,1
35954,nitric oxide breath test,1
35955,a painbuster® catheter,1
35956,hygiene and dietetic advices,1
35957,system support mapping,1
35958,irreversible electroporation (nanoknife),1
35959,dexmedetomidine 2µg.kg-1,1
35960,surgery: oophorectomy,1
35961,nbtxr3 activated by brachytherapy & imrt,1
35962,group art therapy,1
35963,community-based testing with standard linkage to care,1
35964,"gemcitabine 1000 mg/m2 iv days 1, 8, 15 of a 28 day cycle",1
35965,completion axillary treatment,1
35966,suprep oral sulfate solution with gastrografin,1
35967,informed assent discussion,1
35968,cisplatin/flavopiridol,1
35969,hydrpxychloroquine (hcq),1
35970,clinimacs cd34 selection system,1
35971,immunotherapy treatment for solid tumors,1
35972,ny-eso-1 protein with cpg 7909 and montanide,1
35973,oxy111a,1
35974,sham comparator,1
35975,partial breast irradiation using 36 gy / 9 fractions,1
35976,calcium and calcitriol,1
35977,physiological support,1
35978,co-transplantation of mesenchymal stem cells,1
35979,acupressure wrist bands (sea-bands),1
35980,"generic haart triomune : d4t, 3tc, nvp",1
35981,"radical prostatectomy with both urethral irrigation and fascial suturing, qol forms",1
35982,vx-006: 10mg,1
35983,ablation with the nanoknife low energy direct current (ledc) system,1
35984,shearwave elastography,1
35985,decision aid group,1
35986,ala-induced fluorescence,1
35987,capsule endoscopy,1
35988,5% vda-1102,1
35989,evaluation of patients resistance to immunotherapies in multiple myeloma,1
35990,pelvic ebrt and brachytherapy,1
35991,car-cld18 t cell,1
35992,cv8102 + anti-pd-1 therapy,1
35993,gastroscope fuse™,1
35994,naproxen-n-butyl nitrate,1
35995,5 flourouracil/ capecitabine,1
35996,ethinylestradiol,1
35997,donor mobilized pbsc infusion,1
35998,gemcitabine and ufte chemotherapy,1
35999,diagnosed as all,1
36000,cogmed,1
36001,omp-336b11,1
36002,tailored internet communications,1
36003,educational control,1
36004,biopsy before and after three weeks of study treatment,1
36005,psma-pet-ct,1
36006,organ motion,1
36007,gadobenate dimeglumine (multihance),1
36008,toce,1
36009,three field lymphadenectomy,1
36010,"endostar, cisplatin, capecitabine",1
36011,radiotherapy 68 gy(rbe),1
36012,radiofrequency ablation; sunitinib maleate,1
36013,a psycho-educational control,1
36014,kanamycin/metronidazole,1
36015,discovery nm/ct 670 czt imaging scan,1
36016,multisession radiosurgery,1
36017,questionnaire administration followed by cognitive interviews,1
36018,cryoablation and external beam radiation,1
36019,onerna,1
36020,18f-fluorodeoxyglucose-pet (fdg-pet),1
36021,pre- and postoperative mri,1
36022,trx518 monotherapy,1
36023,"ixabepilone, 32 mg/m^2 + capecitabine, 1000 mg/m^2",1
36024,alteplase injectable solution,1
36025,"pdl-585, scleroplus laser",1
36026,cbt-101 oral capsules,1
36027,ultrasound guided biopsy,1
36028,pharmacodynamic purposes of 89zr-labelled cetuximab and kinase activity profiles,1
36029,inject of autologous adipose-derived stem cells,1
36030,clonidine 75 µg/ml in sacrococcygeal block,1
36031,22g sharkcore™ needle,1
36032,hqk-1004,1
36033,conventional medical management,1
36034,hpv e6-specific tcr-t cells,1
36035,immu-107,1
36036,part d1: azd2014 combination with azd8186,1
36037,cnto888+doxil®/ caelyx® doxorubicin hcl liposome injection,1
36038,dash group,1
36039,endo gia™ stapler with tri-staple™ technology,1
36040,jacobsons pmrt group,1
36041,fec?t,1
36042,cv9202,1
36043,anti-androgen,1
36044,shr9146+shr-1210,1
36045,ly3381916,1
36046,research tumor biopsy,1
36047,part b - azd9291 in combination with azd6094,1
36048,hpv 16/18,1
36049,blood and bile,1
36050,mk-5108,1
36051,voreloxin injection,1
36052,"epirubicin, paclitaxel, cyclophosphamide, methotrexate, 5 fu, darbepoetin alfa",1
36053,reminder letter only,1
36054,double compression bandage,1
36055,iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2,1
36056,irrigation with clindamycin solution,1
36057,green tea extract supplement,1
36058,paclitaxel and irinotecan,1
36059,autologous dendritic cell vaccine with adjuvant,1
36060,gp2 peptide + gm-csf vaccine plus trastuzumab,1
36061,isoflurane group,1
36062,slow release morphine,1
36063,"ly6k, vegfr1, vegfr2",1
36064,lumosity (waitlist control),1
36065,partial or total mastectomy,1
36066,neurologic evaluation,1
36067,allogeneic cart-19,1
36068,autologous pbmcs,1
36069,dim-avail 100mg,1
36070,ct scan and bone scan,1
36071,solu-medrol 125 mg,1
36072,veregen only,1
36073,"intrathecal triple therapy (intrathecal cytarabine, hydrocortisone, and methotrexate)",1
36074,one unmanipulated and one expanded cord blood unit,1
36075,regorafenib (bay73-4506) - sequential / cisplatin / pemetrexed,1
36076,glpg0187,1
36077,chemotherapy and radiotherapy,1
36078,physical activity materials,1
36079,esophageal-sparing intensity-modulated radiotherapy,1
36080,cyberknife partial breast irradiation,1
36081,high-dose ifn-a2b,1
36082,vistao2,1
36083,youth perceptions of tobacco - questionnaires,1
36084,computed tomography scan - 50% dose reduction,1
36085,pf-06747143,1
36086,group c,1
36087,"gemcitabine, ifosfamide, cisplatin, g-csf",1
36088,olaptesed pegol + pembrolizumab - combination therapy,1
36089,cg8123,1
36090,supratotal resection,1
36091,manual manoeuver + stretching,1
36092,ap 12009 80 µm,1
36093,adnexmr scoring system,1
36094,fluorescence spectroscopy and diffuse spectroscopy,1
36095,endostar and icotinib,1
36096,blood tests & cardiac imaging,1
36097,otx015,1
36098,rtvp-1 gene,1
36099,taa-t,1
36100,ancillary/correlative,1
36101,go-203-2c + decitabine,1
36102,oxycodone pr tablets,1
36103,dose escalation of cetuximab,1
36104,ts-1 combined with cisplatin,1
36105,biopsy of a metastatic lesion.,1
36106,"dose expansion, medi2228, adc (antibody drug conjugate)",1
36107,irofulven (mgi-114),1
36108,the low anterior resection score (lars) questionnaires,1
36109,panitumumab + folfox (no-dp),1
36110,azd0424,1
36111,pouch reconstruction after total gastrectomy,1
36112,blue laser imaging colonoscopy,1
36113,temozolomide and sch66336,1
36114,epacadostat (phase 2),1
36115,control: additional inspection,1
36116,rv-df3/muc1,1
36117,medi4736 (anti-pd-l1),1
36118,graft manipulation (cd34+ selection),1
36119,(np-59),1
36120,arm a early intervention group,1
36121,definity infusion,1
36122,lapatinib +/- trastuzumab and mm-111,1
36123,esophagectomy with three-field lymphnode dissection,1
36124,oral quercetin capsules,1
36125,adcc & tace,1
36126,growth hormone,1
36127,left thoracotomy,1
36128,89zr-j591,1
36129,allo-depleted lymphocyte infusion,1
36130,cryoballoon,1
36131,kanglaite injection plus gemcitabine,1
36132,only chemotherapy,1
36133,wechsler intelligence scale for children - 5th edition (wisc-v),1
36134,irinotecan based chemotherapy,1
36135,myl- 1401o,1
36136,pre-operative videos,1
36137,isoproterenol,1
36138,a tailored physical activity program during chemotherapy,1
36139,oral nvb metronomic,1
36140,erlotinib and bexarotene,1
36141,"""nitinella"" ; sx-ella stent biliary (biliary metal stent)",1
36142,f16il2 in combination with paclitaxel,1
36143,permacol,1
36144,bone marrow puncture and venous blood samples,1
36145,controlled exposure to environmental contaminant,1
36146,dose escalated imrt,1
36147,patient-centered materials,1
36148,mb-cart20.1,1
36149,nsaids and sulfasalazine,1
36150,abdominal subcutaneous adipose tissue biopsy,1
36151,questionnaire on quality of life,1
36152,fnac (fine needle aspiration cytology),1
36153,epa-dha arm,1
36154,self-efficacy assessment,1
36155,adalimumab (d2e7),1
36156,tnf inhibitor/tcz,1
36157,zolpidem tartrate,1
36158,wt1-sensitized t cells,1
36159,"l-asparaginase, methotrexate, idarubicin, etoposide, cyclophosphamide, cytarabine, mercaptopurine",1
36160,resistance bands,1
36161,hpv oncotect™,1
36162,radiofrequency ablation of the thyroid nodule,1
36163,"stivarga (regorafenib, bay73-4506)",1
36164,removal of urinary catheter after radical surgery,1
36165,clermont-ferrand uterine manipulator,1
36166,irinotecan drug-eluting-bead trans arterial chemoembolisation,1
36167,ro5509554,1
36168,standard bronchoscopy,1
36169,tailored axillary surgery,1
36170,exposure to glioma resection surgery,1
36171,il-2 and human cd40 ligand plasmid gene modified autologous tumor cells,1
36172,dnt cells,1
36173,melafind,1
36174,early tpa and dnase,1
36175,low-dose total skin electron beam therapy (4 gy),1
36176,d0316,1
36177,tailored lifestyle intervention (tli),1
36178,fiducials placement,1
36179,intermediate embolization,1
36180,imiquimod 5% cream with prior curettage,1
36181,"gl-onc1 alone, or in combination with chemotherapy with or without bevacizumab",1
36182,aprotinin,1
36183,hydrocortisone supplementation,1
36184,magnetic resonance spectroscopy imaging,1
36185,cago questionnaire outcome,1
36186,standard chemotherapy + imatinib,1
36187,consultation by an untrained physician,1
36188,liposome paclitaxel,1
36189,guidance of magnetic endoscopic imaging (mei) system,1
36190,pegpem,1
36191,pm01183 1 mg powder for concentrate for solution for infusion and pm01183 4 mg powder for concentrate for solution for infusion,1
36192,other anti-vegfs,1
36193,inactivated influenza vaccine and the ppv23 vaccine (pneumovax),1
36194,liposomal doxorubicin or mitoxantrone,1
36195,written informed consent,1
36196,"pgl4001, placebo",1
36197,short intervention protocol,1
36198,prosocial online support group,1
36199,acs usual messages,1
36200,self-administered hypnosis,1
36201,injection of [18f]-ods2004436 radiotracer,1
36202,intravesical passive diffusion mitomycin,1
36203,total neoadjuvant treatment,1
36204,cold knife conization with stitches,1
36205,amplifeye device,1
36206,edaravone,1
36207,palliative surgery,1
36208,"triple intrathecal therapy (mtx, cytarabine, hydrocortisone)",1
36209,tb-403,1
36210,gemcitabine and capecitabine and avastin,1
36211,"environmental, occupational and lifestyle-related exposures",1
36212,"mk-0752, docetaxel, pegfilgrastim",1
36213,etopside,1
36214,ptbd drainage,1
36215,intra-operative radiation therapy - iort,1
36216,pan fgfr kinase inhibitor bgj398,1
36217,intelligent pain management system,1
36218,dietary counseling via nutritionist,1
36219,breast cancer clinical trials education program,1
36220,ethanol ablation,1
36221,[f18]cp-18 injection,1
36222,standard cbt,1
36223,neuroimaging,1
36224,ihp,1
36225,taxane (docetaxel or paclitaxel),1
36226,dose escalation (radiotherapy treatment schedule),1
36227,not provided,1
36228,a biopsy sample,1
36229,jnj 56021927,1
36230,active cycling,1
36231,visual milieu enhancement (fine art photograph),1
36232,intervention/treatment,1
36233,combined optical and mr imaging,1
36234,salvia hispanica seed,1
36235,ttk peptide mixed with montanide isa 51,1
36236,< 15% risk of + ln,1
36237,vocal function exercises,1
36238,cognitive affective preparation,1
36239,rituximab /dexamethasone/cyclophosphamide,1
36240,all the indicators,1
36241,fiau-pet-ct-2,1
36242,recombinant human hsp110-gp100 chaperone complex vaccine,1
36243,belotecan(ckd-602),1
36244,"sofosbuvir 400 mg, daclatasvir, ribavirin",1
36245,crs alone,1
36246,lenalidomide + plerixafor (+ rituximab),1
36247,"no intervention required, purely observational",1
36248,glargine insulin,1
36249,vinorelbine-docetaxel,1
36250,brief psychological intervention,1
36251,adenovirus rsv-tk,1
36252,recmage-a3 + as15,1
36253,"nipent, cytoxan, rituxan",1
36254,mg1-e6e7,1
36255,chemotherapy: r-dhap,1
36256,hyperthermia treatment with an mri compatible radiofrequency extremity hyperthermia applicator,1
36257,marinol (dronabinol),1
36258,12-o-tetradecanoylphorbol-13-acetate,1
36259,oxaliplatin;s1,1
36260,stepped pc,1
36261,access needle,1
36262,ranitidine or equivalent,1
36263,alpha-type-1 polarized dendritic cells,1
36264,carboplatin+paclitaxel,1
36265,gadoteridol,1
36266,patient-derived cd19- and cd22 specific car,1
36267,off in experimental arm,1
36268,bard goldmarker smallest size,1
36269,zgn-440 for injectable suspension,1
36270,recombinant human hyaluronidase,1
36271,eus-fnb with 22-gauge acquire® needle,1
36272,interviews with 15 patients,1
36273,medi2070 low dose,1
36274,stealth station,1
36275,visual tasking state fmri,1
36276,braf inhibitor dabrafenib and mek inhibitor trametinib,1
36277,(will be assigned based on molecular profile and rpma),1
36278,th2 cells in allo hsctt,1
36279,probiotic yogurt c: with basic micronutrients,1
36280,bgb-a317and pemetrexed plus cisplatin (or carboplatin),1
36281,imb intervention group,1
36282,"3d-crt, imrt, bt, bt combined 3d-crt or imrt",1
36283,activity actigraph,1
36284,arm exercises,1
36285,cocculine®,1
36286,panitumumab plus gemox chemotherapy,1
36287,131 i-metaiodobenzylguanidine (131i-mibg),1
36288,bioxmark,1
36289,124i-mibg (no-carrier added),1
36290,kw-2450 in combination with lapatinib and letrozole,1
36291,multidimensional body self relations questionnaire - appearance subscales,1
36292,"neomycin,metronidazole",1
36293,background questionnaire,1
36294,dolcanatide,1
36295,"oxaliplatin 85 mg/m², 2-hour-infusion, day 1",1
36296,"web portal: "" mon réseau cancer du sein "" (""my breast cancer network"")",1
36297,regional nodal xrt,1
36298,pursestring wound closure,1
36299,fulvestrant and erlotinib,1
36300,hand therapy pipj affected,1
36301,a polymerase chain reaction -based hypoxia classifier,1
36302,antiperistaltic,1
36303,hypofractionated 10x3 gy,1
36304,azithromycin sr,1
36305,acute paracentesis.,1
36306,cisplatin + capecitabine,1
36307,injection with [18f] hx4 and pet imaging,1
36308,dual-time pet/ct (low-dose),1
36309,tioguanin,1
36310,tucotuzumab celmoleukin,1
36311,ldk378(ceritinib),1
36312,water infusion first,1
36313,gnrh antagonist depot degarelix,1
36314,telerehabilitation ecuidate system,1
36315,carboplatin-paclitaxel,1
36316,"68ga-neobomb1, 2-vial kit",1
36317,dmb-3111,1
36318,constiutional dna sampling,1
36319,olympus disposable distal attachment cap,1
36320,afo device,1
36321,audio record,1
36322,methylprednisolone 0.5mg•kg-1,1
36323,no intervention conventional strategy,1
36324,evoskin,1
36325,co-created pem,1
36326,xihuang capsules,1
36327,vats-associated best practices,1
36328,campto (irinotecan),1
36329,biopsy specimen radiography,1
36330,3he human lung coil,1
36331,dalteparin (fragmin),1
36332,smoking relapse prevention booklets,1
36333,delayed metformin,1
36334,adhesive barrier,1
36335,pinpoint endoscopic fluorescence imaging system,1
36336,mdx-010 / mdx-010 + docetaxel,1
36337,pf-06755990,1
36338,"localization, simulation and immobilization",1
36339,primary closure,1
36340,cea-loaded dendritic cell vaccine,1
36341,physicians: educational module,1
36342,f901318 with posaconazole,1
36343,peripheral blood progenitor cells carrying mdr1,1
36344,nilotinib with imatinib,1
36345,pazopanib 800 mg,1
36346,blind injection of triamcinolone,1
36347,immu-132 plus carboplatin infusion,1
36348,"zactima, gleevec, hydroxyurea",1
36349,bevacizumab / irinotecan,1
36350,endotag®-1,1
36351,endoscopic radiofrequency ablation (erfa),1
36352,therapeutic neck dissection,1
36353,gynegals support group,1
36354,dynamic contrast-enhanced magnetic resonance imaging (dce-mr),1
36355,auto stem cell transplant,1
36356,"hypocaloric diet, restricted calorie",1
36357,"online, adaptive mr-guided sbrt",1
36358,website access,1
36359,radiotherapy+pcv chemotherapy,1
36360,study drug diary,1
36361,usual care during neoadjuvant chemotherapy/exercise after surgery,1
36362,placebo ganglion block,1
36363,mid-point measures,1
36364,surgery of resectable lesions,1
36365,wxfl10030390,1
36366,morphine mouthwash,1
36367,asp1650,1
36368,surgeon's 'standard of care' stapler,1
36369,"thermal radio frequency, selective (unilateral s3, bilateral s4 and s5) saddle rhizotomy",1
36370,"part 1, dose level 2b and dose level 3: ipatasertib",1
36371,parenteral nutrition. smofkabiven infusion in central vene. fresenius kabi,1
36372,cytological screening in a1 and a3,1
36373,apheresis product,1
36374,conventional autologous stem cell transplant (asct-con),1
36375,instructed to read patient education pamphlets,1
36376,rimiducid may be administered as indicated,1
36377,ranibizumab injection and ttt - icg based,1
36378,irx 2,1
36379,enhanced scope training,1
36380,classification of oral microbiome using 16s rrna gene sequence-based approach,1
36381,atg (rabbit),1
36382,bone marrow punction,1
36383,home exercise program.,1
36384,saliva sample and questionaire,1
36385,n-acetylcysteine 1000 mg,1
36386,quitline,1
36387,epi,1
36388,carboplatin and caelyx or doxorubicin,1
36389,oral intake,1
36390,laparotomic radical trachelectomy,1
36391,day 1 to day 5,1
36392,tumour biopsies and blood sampling,1
36393,videoconferencing support group,1
36394,afatinib once daily (od),1
36395,home parenteral nutrition,1
36396,bendamustine plus bortezomib plus dexamethasone,1
36397,"investigator's choice treatment (darcabazine, pazopanib, gemcitabine + docetaxel, doxorubicin, ifosfamide)",1
36398,mechanical testing,1
36399,myoma removal,1
36400,3 alternating cycles of vamp/cop chemotherapy,1
36401,surveys completed by subject,1
36402,nitroglycerin patch,1
36403,genomic profile by other methods,1
36404,amg 172,1
36405,plenadren,1
36406,trc105 and axitinib,1
36407,office visit,1
36408,radiotherapy 70 gy,1
36409,tad,1
36410,image guided external beam radiotherapy with or without brachytherapy boost,1
36411,rav12 plus gemcitabine,1
36412,pd-1 inhibitor,1
36413,coronal calcium score measurement,1
36414,sorafenib and dacarbazine,1
36415,humanized 3f8 monoclonal antibody (hu3f8),1
36416,arixtra alone,1
36417,hd- methotrexate (mtx),1
36418,tailored email,1
36419,combined stress management and exercise training,1
36420,tributyrin,1
36421,intravenous busulfan and melphalan,1
36422,"regimen 1, course 1, cycle a2 (days 22 - 42)",1
36423,amg820 and pembrolizumab,1
36424,standard microsurgery,1
36425,strenght training,1
36426,"oshadi d, oshadi r",1
36427,"irinotecan&temsirolimus:arm 2, level 1",1
36428,"cisplatin, etoposide, apatinib",1
36429,immunoablative hematopoietic pbsc transplant,1
36430,obatoclax mesylate 250 ml,1
36431,hpv assay,1
36432,ciprofloxacin administration,1
36433,cytokine-induced killer cells+ folfox4,1
36434,pemetrexed phase 1,1
36435,gemcitabine+nab-paclitaxel,1
36436,p53: 264-272 peptide,1
36437,patient-controlled analgesia pump,1
36438,squid™,1
36439,cortiva 1mm allograft dermis,1
36440,functional assessment of cancer therapy-brain (fact-br),1
36441,high hb target,1
36442,delivery device cathetar and miniaturised imaging fibre,1
36443,sonatherm 600i ultrasonic lesion generating system,1
36444,lfb-r603,1
36445,scheduled interval tace - rt,1
36446,radiotherapy+ialuril®+ialuril soft gels®,1
36447,gemcitabine 2 g,1
36448,gene-eden-vir/novirin,1
36449,cross-linked hyaluronan hydrogel,1
36450,digital foot candle datalogging light meter,1
36451,suction is set to -2 cmh2o,1
36452,4-peptide and 12-peptide melanoma vaccines,1
36453,broad area ala 2 hour incubation,1
36454,egfr bats after standard of care chemo,1
36455,hartmann's operation,1
36456,hucart-meso cells,1
36457,lidocaine and ketamine,1
36458,oral zinc,1
36459,oncovax and surgery,1
36460,anti-thyroglobulin mtcr pbl,1
36461,cfz,1
36462,cohort 2 anti-ox40,1
36463,plant-based high non-heme iron diet,1
36464,difluoromethylornithine (dfmo),1
36465,"gemcitabine, carboplatin, bevacizumab",1
36466,tak-441,1
36467,hyper thermic chemo + surgery,1
36468,mailing of fit kit directly to patient,1
36469,l-glutamine,1
36470,[18f]iso-1,1
36471,ft-lars questionnaire,1
36472,immersive virtual reality (vr),1
36473,fcr + lumiliximab,1
36474,screening anal pap smear - no high resolution anoscopy,1
36475,least acupuncture stimulation,1
36476,liquid nitrogen,1
36477,ds-1123,1
36478,self-examination of the skin,1
36479,surgical wound closure,1
36480,measles-mumps-rubella vaccine,1
36481,oral control (sucrose pill),1
36482,gsk1363089 (foretinib),1
36483,irinotecan monotherapy,1
36484,tanibirumab,1
36485,alignrt,1
36486,low-dose mpx,1
36487,afuresertib ect - fed state,1
36488,"melan-a vlp vaccine, imp321 adjuvant",1
36489,pretreatment pet/ct-scan (performed two times),1
36490,siroquine,1
36491,dimerizer drug ap1903,1
36492,"in-person, facilitated advance care planning",1
36493,assess bulge at 1 year postoperatively,1
36494,less intensive,1
36495,r-ice,1
36496,mfolfiri+nimotuzumab,1
36497,investigational imaging device,1
36498,trametinib tablets,1
36499,sodium chloride 9mg/ml,1
36500,"egfr tkis (gefitinib, erlotinib, afatinib, et al)",1
36501,standard surgical approach,1
36502,tem - transanal endoscopic microsurgery,1
36503,systems-level intervention to promote colon cancer screening,1
36504,nih toolbox cognition battery,1
36505,imatinib/acetaminophen,1
36506,cergutuzumab amunaleukin,1
36507,corticosteroid: triamcinolone,1
36508,colonic biopsies,1
36509,sjdbt,1
36510,"i-scan ce, se, te mode",1
36511,holter monitor,1
36512,allogeneic nk cells,1
36513,"without ""dog ear"" group",1
36514,prophylactic platelet transfusion,1
36515,no voriconazole (vfend),1
36516,tomotherapy treatment planning,1
36517,penrose drain placement,1
36518,transperineal mpmri-us fusion prostate biopsy,1
36519,endocuff colonoscopy,1
36520,sr methylphenidate,1
36521,yangzhengxiaoji capsule,1
36522,group b: open-face shell,1
36523,tumor cell-derived vaccine therapy,1
36524,polarized endurance training,1
36525,tnf-alpha and hbv genotypes,1
36526,semi automated core needle biopsy of orbital tumors,1
36527,"cyproterone acetate (androcur, bay94-8367)",1
36528,ferric(iii)carboxymaltose,1
36529,sorbact tm,1
36530,[177lu] dota-tate,1
36531,psma pet/ct,1
36532,somatuline depot,1
36533,regn421(sar153192),1
36534,cdx-1307,1
36535,gaze stabilization exercises,1
36536,6mpfixed,1
36537,distance supervised physical activity,1
36538,search010/rv254,1
36539,amv564 14-day civ,1
36540,fluorocholine (18f-fch) injection,1
36541,conventionally fractionated concurrent chemoradiotherapy,1
36542,it-141,1
36543,therapy dog visit,1
36544,nkr-2 car-t cells,1
36545,vitoss morsels,1
36546,peg-l-asparaginase ind,1
36547,pgx-guided post-operative pain management,1
36548,potassium titanyl phosphate (ktp) laser,1
36549,s1/paclitaxel chemotherapy plus apatinib,1
36550,avelumab administration at 10mg/kg,1
36551,blood sample (mremvi positive patient),1
36552,biological mesh assisted perineal closure,1
36553,sensewear armband (swa) monitoring,1
36554,preference elicitation,1
36555,changing body position in bed,1
36556,lenvatinib matched placebo,1
36557,surgical removal of osteoid osteoma,1
36558,targeting the teachable moment,1
36559,2 dimensional digital imaging,1
36560,ibandronat,1
36561,standard long course chemoradiotherapy,1
36562,dtrm-505,1
36563,cd19-car t cell,1
36564,pegylated ifn-alpha 2b,1
36565,combined adenovirus vectored p53 tranfected dedritic cell vaccine and ex vivo expanded t-lymphocytes,1
36566,concurrent crt group,1
36567,"cr,ed mat'ls, fit, phone call",1
36568,injections,1
36569,eligard 22.5mg,1
36570,isocaloric diet with 3 meals,1
36571,cardiac magnetic resonance (cardiac mri),1
36572,electrocorticography (ecog) with pmt grids,1
36573,active breathing coordinator,1
36574,aqueduct,1
36575,education brochure,1
36576,leuprolide 7.5 mg / degarelix 80 mg,1
36577,to study the polymorphism of the gene encoding vegf (rs699947) as a predictive marker,1
36578,nk cells +clinimacs cd3 and cd56 systems,1
36579,focus group questionnaires,1
36580,registry of patients (exposure is cutaneous lymphoma),1
36581,charged particle radiation therapy,1
36582,rats,1
36583,chemotherapy and target therapy,1
36584,fluorocholine pet,1
36585,odm-208,1
36586,mm-302 in combination with trastuzumab q3w,1
36587,xaliproden (sr57746a),1
36588,hypnosis recordings,1
36589,planning 4d-ct,1
36590,breast reconstruction - implant and an adm (surgimend),1
36591,amniotic membrane placement,1
36592,cc0 - carboplatin (iv) - paclitaxel (iv),1
36593,nsclc expansion cohort: regorafenib 100 mg,1
36594,vcap/amp/vecp(mlsg15),1
36595,laparoscopic-assisted colectomy,1
36596,"with ""dog ear"" group",1
36597,ca coli follow-up by gp,1
36598,ds (docetaxel+s-1),1
36599,biopsy of the major carinal area,1
36600,intravenous infusion of ramosetron,1
36601,ethanol lavage,1
36602,oxaliplatin based chemotherapy,1
36603,voriconazole (vfend),1
36604,plasma msept9 level,1
36605,cslo imaging,1
36606,nolbaxol,1
36607,mage-a3 asci,1
36608,ly2787106,1
36609,perox quench,1
36610,ds-8895a,1
36611,warm vs cool water,1
36612,"ict of gemcitabine,oxapliplatin, leucovorin, and fluorouracil + ccrt",1
36613,compression and drainage therapy,1
36614,peginterferon-?-2a,1
36615,mln4924 and docetaxel,1
36616,vitamin e compound,1
36617,5-fluorouracil and irinotecan,1
36618,data review,1
36619,cervarix.,1
36620,small bowel video capsule endoscopy (vce) given/covidien ltd,1
36621,sequencing for mismatch repair genes,1
36622,contrast agent,1
36623,normal education material,1
36624,radiotherapy with adjuvant androgen deprivation therapy,1
36625,cyclophosphamide as part of lymphodepletion,1
36626,enhanced mindfulness intervention,1
36627,a high-intensity interval exercise group,1
36628,imrt and accelerated hypofractionation technique,1
36629,"adriamycin, vinblastine, and dacarbazine",1
36630,performance measure modification,1
36631,volumetric modulated arc therapy (vmat) and high-dose rate (hdr) radiotherapy,1
36632,report symptoms via web or phone-based system,1
36633,six week physical activity intervention,1
36634,letrozole and atorvastatin,1
36635,conmana,1
36636,wt1 tcr-transduced t cells,1
36637,"functional lung avoidance radiotherapy, 60 gy in 30 fractions",1
36638,5 - fu,1
36639,catheter resistance monitoring,1
36640,fludeoxyglucose (18f) (fdg),1
36641,"low level laser therapy- (dmc, são paulo, brazil)",1
36642,myocet / paclitaxel,1
36643,elos,1
36644,serum levels of immunologic profiles,1
36645,conditioning regimen ii (tli 8 gy + atg [thymoglobulin]),1
36646,vascularized lymph node transfer,1
36647,spiritual interview,1
36648,ino-3112 vaccine,1
36649,radioprotection,1
36650,patient management,1
36651,dose-dense doxorubicin/cyclophosphamide,1
36652,tace + folfox 4,1
36653,self directed weight loss,1
36654,questionnaires set,1
36655,"mk0683, vorinostat, suberoylanilide hydroxamic acid (saha) / duration of treatment - up to 8 cycles or 6 months",1
36656,tiva+placebo,1
36657,mri scanner with sequence,1
36658,onc1-0013b,1
36659,healthy lifestyles video,1
36660,health awareness control intervention,1
36661,radiation in squamous head and neck cancer,1
36662,vehicle (placebo),1
36663,bevacizumab and oxaliplatin,1
36664,call center,1
36665,standard perioperative care,1
36666,couples prostate cancer support group,1
36667,pegliposomal doxorubicin,1
36668,103-palladium,1
36669,autologous dendritic cells (dc),1
36670,drug-eluting beads,1
36671,"panzem (2-methoxyestradiol) ncd, avastin (bevacizumab)",1
36672,qualitative interview and focus group discussions,1
36673,hepatic biomagnetic susceptibility measurement,1
36674,clinimacs fractionation system (arm a),1
36675,radio-frequency ablation (rfa) encage™,1
36676,"ino-3106, ino-9012",1
36677,polyic,1
36678,pneumatic tourniquet,1
36679,drainage alone.,1
36680,elisa testing,1
36681,metastases resection ( multiple steep surgery possible),1
36682,sagopilone (zk 219477) + prednisone,1
36683,18f-fdg (fluorodeoxyglucose) pet,1
36684,body composition measurement,1
36685,"amg 386 10 mgkg, paclitaxel and trastuzumab",1
36686,post-treatment volume margin resection,1
36687,"epirubicine, oxaliplatin, capecitabine, panitumumab",1
36688,bortezomib and temozolomide phase ii,1
36689,p-akt immunohistochemical staining,1
36690,hifu (echopulse),1
36691,gemcitabine and plitidepsin,1
36692,pasireotide lar followed by pasireotide lar + everolimus,1
36693,tcr transduced t-cells,1
36694,algorithm-based triage tool,1
36695,e7070 + irinotecan combination,1
36696,endostar(rh recombinant endostatin) plus docetaxel,1
36697,"folfirinox (oxaliplatin, leucovorin, irinotecan)",1
36698,functional mobile game,1
36699,89zr-dfo-crgdy-peg-cy5-c' dots pet imaging,1
36700,safety laboratories,1
36701,methoxsalen+ecp,1
36702,adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine,1
36703,ultrasonography or mri,1
36704,high intensity counseling + bupropion + prn nrt,1
36705,[18f]f-ara-g,1
36706,genetically engineered t cell receptors,1
36707,scalp block with 0.5% plain marcaine,1
36708,normal saline solution,1
36709,89zr-avelumab pet,1
36710,plb1003,1
36711,hti-1090,1
36712,autologous cytokines,1
36713,"sorafenib (nexavar, bay43-9006) plus doxorubicin",1
36714,peg-3350 and gatorade,1
36715,ebxrt,1
36716,focused ultrasound (fus) bbb disruption,1
36717,neoadjuvant chemotherapy followed by surgery,1
36718,enhanced intervention,1
36719,cancer control navigator,1
36720,test - standard closure with tissuglu surgical adhesive,1
36721,vincristine placebo,1
36722,group 2: placebo,1
36723,ny-eso-1/lage-1 hla class i/ii peptide vaccine,1
36724,dose escalation to prostate focal lesion,1
36725,cdc7-inhibitor,1
36726,salvage iressa,1
36727,bendamustine + rituximab,1
36728,thalidomide celgene™,1
36729,talking about cancer (tac),1
36730,laparoscopy assisted gastrectomy,1
36731,stereotactic body radiotherapy (sabr),1
36732,fdg-pet-based dose escalation using intensity modulated radiation therapy (imrt).,1
36733,endoscopic endonasal surgery with upsit,1
36734,reflexology treatment.,1
36735,pk testing,1
36736,performance of pet/ct and whole-body mri,1
36737,patient-participation aid,1
36738,hypo-proliferative thrombocytopenics,1
36739,core-needle biopsy of the breast,1
36740,part 1: sym004 6 mg/kg + carboplatin/paclitaxel,1
36741,culture ex vivo with exposure to different therapeutic agents alone or in combination.,1
36742,caelyx (pegylated liposomal doxorubicin),1
36743,blossom,1
36744,mr1-1,1
36745,j-plasma,1
36746,peg solution,1
36747,nicotinamide riboside,1
36748,diagnostic imaging: 18f-fdg pet/ct scan - baseline,1
36749,genetic variation analysis,1
36750,transurethral catheter ex 5 day,1
36751,2.15 gray and 1.8 gray. max. 5 weeks.,1
36752,[68ga]pentixafor,1
36753,wt1 peptides,1
36754,hidac (high dose cytarabine),1
36755,docetaxel and cisplatin plus hypofractionated radiotherapy,1
36756,tear collection,1
36757,biobeat sensor,1
36758,sonographically assisted breast surgery,1
36759,girentuximab,1
36760,carboplatin/gemcitabine,1
36761,duloxetine 60mg,1
36762,aq4n (chemotherapy),1
36763,spi feedback,1
36764,lacto-ovo-vegetarian diet,1
36765,vindesin,1
36766,dietary energy restriction,1
36767,"methotrexate, cyclophosphamide, cytarabine, etoposide",1
36768,targeted therapy based on molecular profiling : tamoxifen (or letrozole if contra-indication),1
36769,levonorgestrel intrauterine device (liud),1
36770,irinotecan and on 01910.na,1
36771,polysomnography,1
36772,biib028,1
36773,proton-decoupled 31p mrs at 1.5t,1
36774,breast cancer screening compliance,1
36775,stress cardiac mri,1
36776,patient concerns inventory,1
36777,ankl(ex vivo-expanded nk cell enriched lymphocytes),1
36778,2-chlorodeoxyadenosine weekly,1
36779,intervention (promotora),1
36780,an mri-based technique to identify prostate cancer,1
36781,surgery: abdominal and transhiatal approach,1
36782,er+/her2-bc:dc vaccine+preop chemo,1
36783,sildenafil 100mg,1
36784,humax-axl-adc,1
36785,5-fluorouracil injection,1
36786,bth1704,1
36787,rapid pleurodesis protocol,1
36788,hplc,1
36789,the carer support needs assessment tool (csnat) intervention,1
36790,fna with rose,1
36791,111indium-zevalin and 90yttrium-zevalin,1
36792,blis with apatinib,1
36793,50 mg/m2 lenalidomide (revlimid®) and 180 mg/m2 vorinostat (zolinza®),1
36794,g-pb transplant,1
36795,endurance-strength training,1
36796,leg function and balance tests,1
36797,hydrogen peroxide,1
36798,captivator™ emr,1
36799,fluocinonide cream,1
36800,68ga-dota-toc,1
36801,"determination of ca 125 and he4, computed tomography",1
36802,glowcap device,1
36803,177lu-dota-jr11,1
36804,quantitative bcrabl recording every month for first 6 months,1
36805,acetylsalicylic acid lysinate 300 mg,1
36806,definity perflutren injectable suspension,1
36807,hormonal treatment (neoadjuvant androgen deprivation),1
36808,slim bronchoscope without a guide sheath,1
36809,cyclophosphamide and rituximab,1
36810,gm-csf secreting leukemia vaccine,1
36811,"vinorelbine, ifosfamide, mesna",1
36812,immunization schedule patients > or = to 7 years and <11 years of age,1
36813,folfox (oxaliplatin/leucovorin/5-fluorouracil),1
36814,"paclitaxel, nanoparticle albumin-bound",1
36815,dysis,1
36816,spinal group,1
36817,tumor tissue aspiration,1
36818,oleclumab (medi9447),1
36819,capox (or folfox) including flouropyrimidine and oxaliplatin combination chemotherapy,1
36820,frozen glove,1
36821,3-dimensional conformal radiation therapy (3d-crt),1
36822,5-fu (mfolfox6),1
36823,anti-meso car-t cells,1
36824,anti-bacterial agents,1
36825,educational/counseling intervention,1
36826,bendamustine (ben),1
36827,triptorelin embonate (inn),1
36828,flow cytometry analysis of neutrophil myeloperoxidase expression,1
36829,i125 brachytherapy,1
36830,e7449 plus carboplatin and paclitaxel,1
36831,phone call/email,1
36832,interview and physical activity,1
36833,enhanced internet,1
36834,"lenalidomide, dexamethasone, and medi-551",1
36835,vandetanib/metformin,1
36836,"anlotinib combined with pemetrexed and carboplatin, phase ii",1
36837,injection of 64cu-dota-ae105,1
36838,apatinib oral tablet,1
36839,"temsirolimus, rituximab, bendamustin",1
36840,print educational intervention,1
36841,no pelvic drainage,1
36842,enoxaparin sodium 40 mg/0.2 ml subcutaneous injectable,1
36843,pet images with 18f-fluoromethylcholine,1
36844,tyrosine kinase inhibitor erlotinib (tarceva),1
36845,biological/vaccine: therapeutic autologous dendritic cells.,1
36846,paracervical block,1
36847,lidoderm patch,1
36848,1.5pd,1
36849,hepatectomy combined with lymphadenectomy,1
36850,prednisolone (corticosteroid),1
36851,immune profiling and dc vaccine,1
36852,bkm120 and olaparib,1
36853,serum golgi protein 73,1
36854,quercetin supplement,1
36855,reciva,1
36856,iso-fludelone,1
36857,commercially-available tomato food product,1
36858,wt1 derived peptides,1
36859,monocyte derived dcs loaded with krn7000,1
36860,neurofeedback training,1
36861,tmz plus concurrent re-irradiation,1
36862,body mass index (bmi),1
36863,intercept (dose escalation),1
36864,pepc,1
36865,no formal exercise plus phone calls,1
36866,chess (comprehensive health enhancement support system),1
36867,reminder/recall notices for vaccines,1
36868,skin cancer screening training,1
36869,radiation?imrt?,1
36870,bkm120 in combination with lh-rh agonists (suprefact) and bicalutamide,1
36871,pet/ct 4d imaging in a synchronized mode centered on the thorax.,1
36872,cryotherapy + medical analgesics,1
36873,"confocal laser endomicroscopy (pentax, eg3870k)",1
36874,peripheral blood sampling,1
36875,tumor ablation,1
36876,"tac,tc,ta,caf,cef",1
36877,placebo vaccine,1
36878,cystoprostatectomy,1
36879,language paradigms + rs fmri,1
36880,local biopsy in the tumor,1
36881,"nilotinib, interferon-alfa",1
36882,hm43239,1
36883,s1 plus cisplatin with radiotherapy,1
36884,enobosarm,1
36885,ct and dexa scans,1
36886,niraparib oral capsules (unlabeled),1
36887,not balanced,1
36888,microbiological analysis,1
36889,haploidentical nk cell,1
36890,loncastuximab tesirine and ibrutinib,1
36891,cngrc peptide-tnf alpha conjugate,1
36892,primary perineal closure,1
36893,"in vitro tumor reactive, chimeric t cell receptor (car ) gene-transduced pbl plus iv aldesleukin",1
36894,abarelix,1
36895,panobinostat with rituximab,1
36896,cancer early detection,1
36897,supraclavicular irradiation,1
36898,combined general/epidural anesthesia,1
36899,supine decubitus,1
36900,gem-ox,1
36901,placebo (mcg) (aluminum adjuvant) 450,1
36902,hpv vaccine (gsk580299) cervarix tm,1
36903,metformin pre-surgery,1
36904,copad,1
36905,organoid in vitro culture,1
36906,surgery and wafer placement (1 procedure),1
36907,"near-infrared fluorescence (nir) imaging (pinpoint, novadaq, waterloo)",1
36908,liposomal cytarabine/daunorubicin,1
36909,"abvd (adriamycin, bleomycin, vincristine, dacarbazine)",1
36910,zd 1839 500mg,1
36911,cerament™ ,1
36912,"gm-csf, ifn alpha and il-2",1
36913,ginger aromatherapy,1
36914,ixazomib/pomalidomide/dexamethasone,1
36915,necitumumab-gemcitabine-cisplatin,1
36916,peptide vaccine (lpv7) + tetanus peptide,1
36917,18 gy radiation,1
36918,no bevacizumab,1
36919,stereotactic radiosurgery using the cyberknife system.,1
36920,genomic signature,1
36921,mri-dce,1
36922,conventional mode,1
36923,personalized support program,1
36924,dci,1
36925,disposable stapling instruments,1
36926,follow-up participant assessment,1
36927,propofol+ rocuronium+ fentanyl + inhalational,1
36928,no touch (nt),1
36929,connect,1
36930,ic9-gd2 t cells - fresh,1
36931,propranolol oral tablet,1
36932,haplo-mismatched cell therapy (hmct),1
36933,carbohydrate,1
36934,testicular tissue biopsy,1
36935,osmt group to uc group,1
36936,chemoradiation + ebrt boost,1
36937,ara-c:,1
36938,d2 radical gastrectomy,1
36939,hemay020,1
36940,quantitative,1
36941,biospecimen banking,1
36942,hyperfractionated,1
36943,vidaza and valproic acid,1
36944,preoperative chemo- and chemoradiotherapy,1
36945,imri,1
36946,self-help (shi),1
36947,iniparib (sar240550-bsi-201),1
36948,standard triple therapy,1
36949,125-iodine,1
36950,br,1
36951,community-based hpv testing with enhanced linkage to care,1
36952,low dose dexamethasone,1
36953,ultrasound imaging with contrast,1
36954,iodine i 124 chimeric monoclonal antibody g250,1
36955,conventional postoperative surgery,1
36956,amg 701,1
36957,thinprep,1
36958,oncotypedx test,1
36959,nitrous oxide anesthesia,1
36960,mccorkle symptom distress scale (sds),1
36961,optimised rituximab-schedule,1
36962,temozolomide and lomustine,1
36963,lugol's solution (1.5%),1
36964,combinations treatment,1
36965,keratinocyte growth factor,1
36966,ercp and photodynamic therapy,1
36967,dose-escalated radiotherapy level 1,1
36968,second generation sequencing,1
36969,e7389+carboplatin auc 6,1
36970,fk-506,1
36971,inj. progesterone,1
36972,[18f]-dcfpyl pet/ ct scan (psma pet),1
36973,hpph 2.5 mg/m2,1
36974,"tetravalent recombinant human papilloma virus vaccine (6,11,16,18 type) (hansenula polymorpha)",1
36975,optical spectral reflectance and autofluorescence imaging,1
36976,mindfulness meditation-based stress reduction,1
36977,mixed meal tolerance test,1
36978,optimized localization technique,1
36979,msb0010718c,1
36980,hfjv,1
36981,nt-i7,1
36982,minimally invasive ablative therapy (miat),1
36983,"imrt 50 gy + folfox4 simplified (oxaliplatin, leucovorin, 5-fu)",1
36984,leo 43204 formulation 2 dose yy,1
36985,pembrolizumab injectable product,1
36986,t27,1
36987,ultra-slim upper endoscope,1
36988,standard: aprepitant,1
36989,dynamic contrast-enhanced mri,1
36990,placebo( for misoprostol),1
36991,biometric devices,1
36992,pressure-controlled ventilation,1
36993,air anesthesia,1
36994,vigorous exercise intervention - cybercycling,1
36995,conventional eus fna needle,1
36996,flav-ein capsules,1
36997,trh (thyrotropin releasing hormone),1
36998,th2/tc2 cells,1
36999,atezolizumab - cohort 3,1
37000,immediate weight loss program group,1
37001,"fludarabine , cytarabine",1
37002,dual axis endoscopic microscope,1
37003,rvv-740cta,1
37004,obinutuzumab injection [gazyva],1
37005,project heal 2.0,1
37006,fentanile,1
37007,helixor® m,1
37008,"ypeg-rhg-csf, 45?g/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle",1
37009,"breast reconstruction, direct to implant with strattice",1
37010,art-123 (low frequency),1
37011,flt pet/mr,1
37012,pet and mri exams,1
37013,optimizing b.i (new) pca mode,1
37014,adjuvant chemoradiation therapy,1
37015,vorolanib,1
37016,manual manipulation,1
37017,eflornithine hcl,1
37018,post test administration,1
37019,spiritual therapy,1
37020,cabazitaxel + cisplatin chemotherapy,1
37021,nutritional support with standard diet,1
37022,pwt33597 mesylate,1
37023,lower dose (41.4gy/23f) of neoadjuvant chemoradiation,1
37024,scs,1
37025,19-28z t cells,1
37026,4sc-201,1
37027,metformin plus spironolactone,1
37028,da vinci xi,1
37029,"chemotherapy ( folfiri regimen, folfox regimen or lv5fu2 regimen)",1
37030,standard post surgery care,1
37031,hcc antigens-specific cd8+ t lymphocytes,1
37032,rg1068 (synthetic human secretin),1
37033,enoblituzumab plus ipilimumab,1
37034,ct-guided percutaneous irreversible electroporation,1
37035,tyrosinase/gp100/mart-1 peptides,1
37036,water exchange/co2,1
37037,zoladex+ai,1
37038,mailed targeted print (tp),1
37039,"vincristine, irinotecan",1
37040,3 x fec 3 x doc / gemcitabine,1
37041,nonmyeloablative stem cell conditioning regimen,1
37042,"immunotherapeutic gsk2302032a, different formulations",1
37043,comprehensive health enhancement support system (chess.),1
37044,positron emission tomography/ computed tomography (pet/ct),1
37045,zr-89 labelled durvalumab pet/ct,1
37046,radiotherapy (imrt or 3-d crt),1
37047,breast imrt,1
37048,on 01910.na and irinotecan,1
37049,oral glutamine,1
37050,immunotherapy (standard of care),1
37051,blueprint 80 gene expression profile,1
37052,non-myeloablative hematopoietic cell transplantation,1
37053,bisantrene,1
37054,petcect,1
37055,cyrcadia cbr™ device placement for abnormality screening,1
37056,basic internet,1
37057,continous epidural analgesia,1
37058,opioid growth factor (ogf),1
37059,multiplex respiratory viral pcr,1
37060,"cyclophosphamide, pentostatin, rituximab",1
37061,e10a,1
37062,mpmri targeted biopsy,1
37063,68ga-(hbed-cc)-psma,1
37064,dabrafenib and trametinib,1
37065,androgen deprivation therapy - gnrh agonist,1
37066,demeclocycline hydrochloride,1
37067,telerehabilitation program,1
37068,assessment of dietary intake,1
37069,brachytherapy apbi,1
37070,morab-004 (monoclonal antibody to tem1),1
37071,cisplatin or nedaplatin,1
37072,"questionnaires and standardized, digital voice recording",1
37073,general anesthesia with preoperative session of hypnosis,1
37074,general anesthesia and opioids,1
37075,daily sms text messaging,1
37076,"gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or folfirinox, or folfox, or folfiri.",1
37077,vitamin b12 1000 ?g,1
37078,complete questionnaire,1
37079,epalrestat,1
37080,pulse dye laser followed by matrix rf,1
37081,natural killer cell (nk) therapy,1
37082,chemoembolization with doxorubicin/collagen,1
37083,"doxorubicin, docetaxel, tamoxifen",1
37084,personalized information,1
37085,biopsy sample performed after the sonovue® injection,1
37086,flexitouch head and neck lymphedema treatment system,1
37087,ibrutinib and immunochemotherapies,1
37088,sgn-00101,1
37089,n-13 ammonia pet,1
37090,tpiv200,1
37091,carbon dioxide laser ablation,1
37092,rapamycin + mec,1
37093,complete responders and non-complete responders,1
37094,g-csf in induction-2,1
37095,nicotine replacement therapy (nrt),1
37096,ido peptide vaccination,1
37097,100 µg doxorubicin-containing mna,1
37098,xelox chemotherapy,1
37099,nimotuzumab (anti egfr humanized monoclonal antibody),1
37100,6 weeks bcg instillation,1
37101,teysuno (s1) in combination with epirubicin and oxaliplatin,1
37102,human prostate-specific membrane antigen plasmid dna vaccine,1
37103,annual noncontrast liver mri,1
37104,meclofenamate,1
37105,exercise only,1
37106,tbna + transbronchial lung biopsy + bronchial washing,1
37107,atd group,1
37108,radiotherapy daily verification reduced safety margins,1
37109,npc-06,1
37110,modified genetic counseling,1
37111,cypath®,1
37112,compliance guided an optimal positive end-expiratory pressure,1
37113,good surgical technique alone,1
37114,amifostine every-other-day regimen,1
37115,oxyhydrogen generator (byt-ch-h01),1
37116,azd6738 and olaparib,1
37117,spartalizumab (pdr001),1
37118,dc-cik cells,1
37119,self measurement of limb volume +water displacement,1
37120,preparation and life completion,1
37121,dual specificity cd38 and bcma car-t cells,1
37122,combination of tlc d-99 and ifosfamide,1
37123,oxaliplatin + 5-fluorouracil (5fu) + leucovorin (calcium folinate/folinic acid),1
37124,graceful lifestyle changes,1
37125,molecular profiling and drug testing,1
37126,"ingenol mebutate picato® and mal pdt day 1, day 5",1
37127,contralateral central lymph node dissection,1
37128,preoperative short course radiation,1
37129,thoracoscopic esophagectomy,1
37130,mdi,1
37131,disney movie,1
37132,saline placebo for pembrolizumab,1
37133,piperacillin sodium,1
37134,nac-sparing mastectomy,1
37135,narrow band imaging (nbi),1
37136,focal irreversible electroporation of the prostate cancer,1
37137,nodal radiation therapy,1
37138,skin or nipple sparing mastectomy,1
37139,bms-986218,1
37140,swetz,1
37141,2d photography,1
37142,management of therapy,1
37143,symptom-limited cardiopulmonary exercise test (cpet),1
37144,docetaxel and samarium,1
37145,vacuum assisted closure in experimental arm,1
37146,laboratory evaluations of immune responses,1
37147,lactobacillus brevis cd2 lozenge,1
37148,surgery (based on preoperative multimodal mri) followed by the standard radio-chemotherapy stupp protocol,1
37149,trivirus-specific ctls,1
37150,zn-c5,1
37151,haploidentical/cord transplant,1
37152,ia session,1
37153,combined bone marrow and kidney transplant,1
37154,placebo (for bl-8040),1
37155,5-aminolevulinic acid (ala),1
37156,cannabics capsules,1
37157,c-pert,1
37158,l19tnf,1
37159,radiolabeled monoclonal antibody anti-b1 for the treatment of b-cell lymphomas (tositumomab and iodine i 131 tositumomab),1
37160,mr urography; ct urography,1
37161,syd985 (trastuzumab vc-seco-duba),1
37162,"radical prostatectomy with neither urethral irrigation nor fascial suturing, qol forms",1
37163,18-fdg-pet-ct,1
37164,docetaxel & capecitabine,1
37165,biomarker lpa and he4,1
37166,dynamic contrast-enhanced magnetic resonance imaging (dce-mri),1
37167,'osna stadification during surgery',1
37168,prevacid solutabs,1
37169,suture removal time14 days,1
37170,in-person education sessions,1
37171,tailored exercise prescription,1
37172,n-telopeptide of type 1 collagen,1
37173,surface expression of functional biomarkers of the nk cell,1
37174,gold seed implantation,1
37175,durvalumab + bevacizumab,1
37176,"depsipeptide, fr901228, fk228",1
37177,using neuromonitoring to find ebsln,1
37178,co2 fractional ablative laser,1
37179,alternative anticancer treatment,1
37180,part 1: jnj-42756493,1
37181,calcium folinate (lv),1
37182,sample of blood,1
37183,streptococcus pneumoniae,1
37184,pf00299804,1
37185,gut microbiota,1
37186,visicoil larger size,1
37187,quantification of braf and nras mutation,1
37188,lyophilized black raspberry confection,1
37189,cisplatin plus 5-fluorouracil,1
37190,hemicolectomy,1
37191,clinacanthus nutans,1
37192,diffusion weighted mri (dw- mri),1
37193,roux-en-y gastric bypass,1
37194,additional pvb (ropivacaine) and elastomeric disposable infusion pump,1
37195,conventional tace (transarterial chemoembolization) with doxorubicin/mitomycin-c,1
37196,arm 1: l19il2 + dacarbazine,1
37197,hydromorphone hci oros,1
37198,t-cell therapy + rituximab + il-2,1
37199,serum biomarkers,1
37200,total thyroidectomy alone without neck dissection,1
37201,zofran,1
37202,clofarabine in conditioning before transplantation,1
37203,autologous genetically modified mage a10????t cells,1
37204,zl-2306 (nirapairb),1
37205,"wrist-actigraph - octagonal basic motionlogger, ambulatory monitoring inc, new york, usa",1
37206,x-act,1
37207,gp-100 peptide vaccine,1
37208,smoked cannabis high cbd/low thc,1
37209,intraoperative sealing test,1
37210,peep group,1
37211,conventional laparoscopic total mesentery excision,1
37212,observational: blood sample collection,1
37213,2 yearly endoscopy,1
37214,short-course antibiotic therapy,1
37215,glucophage tablets and victoza,1
37216,tak-202,1
37217,intensive telephone counseling (8 sessions) with nicotine replacement,1
37218,p16 metabolic way,1
37219,smartphone application,1
37220,22 gauge procore needle biopsy,1
37221,pd-l1 immunohistochemistry (ihc),1
37222,cabazitaxel 20mg/m2,1
37223,atra and or chemo as maintenance,1
37224,platinum (cisplatin or oxaliplatin) + capecitabine,1
37225,skin barrier moisturier,1
37226,rh il-15 (10 days),1
37227,moc31pe immunotoxin,1
37228,eramip,1
37229,rectal cancer surgery,1
37230,vx-006: 5mg,1
37231,viberect device,1
37232,symbiotic group,1
37233,off,1
37234,photon beam therapy,1
37235,belimumab,1
37236,androderm® 2.5mg,1
37237,short-course radiation therapy(5gy*5),1
37238,17 allylamino-17-demethoxygeldanamycin,1
37239,early ccrt,1
37240,thc and cbd mixture,1
37241,papillon +tm,1
37242,recombinant interferon alpha-2b,1
37243,transducer-catheter spc-320 + amplifier,1
37244,comprehensive geriatric assessments,1
37245,e-talkcare,1
37246,there is no intervention,1
37247,healing touch therapy,1
37248,comparison of screening scales,1
37249,brequinar,1
37250,arm 2: dc vaccine + ifn-alfa,1
37251,positron emission tomography (pet) whole body scan,1
37252,liposomal paclitaxel plus capecitabine,1
37253,goserelin acetate (zoladex),1
37254,omegarich fish oil supplement,1
37255,icbn preservation surgery,1
37256,neoadjuvant chemotherapy plus concurrent chemoradiotherapy,1
37257,oral ascorbic acid,1
37258,"cc (clomid®; global napi pharmaceuticals, cairo, egypt)",1
37259,indium-111 ibritumomab tiuxetan,1
37260,hads,1
37261,"rs183489969,rs185670819",1
37262,"procrit 40,000 iu qw",1
37263,urine test,1
37264,tf2 antibody/68ga-imp-288,1
37265,aminolevulinic acid based photodynamic therapy,1
37266,cx-4945 oral formulation,1
37267,general anesthésia,1
37268,vm206dna,1
37269,prostvac v/f,1
37270,cervical biopsy,1
37271,mitogel,1
37272,invivo microscopy group,1
37273,one radiation treatment,1
37274,tgr-1202 + ublituximab + bendamustine,1
37275,corticosteroid: prednisone,1
37276,cetuximab:,1
37277,brivudine phosphoramidate,1
37278,nuc-1031 and carboplatin,1
37279,conmed airseal insufflation system (ais) at higher pressure,1
37280,astx727 ld,1
37281,en-bloc turb,1
37282,c11-erlotinib pet/ct,1
37283,guarana extract,1
37284,active comparator (erlotinib),1
37285,point-of care biomarkers,1
37286,iv adminstration of emi-137,1
37287,excised tissues,1
37288,yoga program,1
37289,brinjal peel extract containing cream,1
37290,bupivacaine hcl 0.25% inj,1
37291,chest drain and talc pleurodesis,1
37292,docetaxel-based chemoradiotherapy,1
37293,surgeon-palliative care team co management,1
37294,diagnostic biopsy and surgical procedure,1
37295,therapeutic insulin,1
37296,serum calcium testing,1
37297,m-vac protocol,1
37298,baricitinib,1
37299,intra-operative 5-fu chemotherapy,1
37300,tld1433 infusion and photodynamic therapy (pdt) treatment,1
37301,olaparib oral product in combination with durvalumab,1
37302,iv pca,1
37303,nanoparticle albumin bound paclitaxel,1
37304,trimodality protocol,1
37305,metformin plus chemo-radiotherapy,1
37306,azacitidine and lde255,1
37307,prostate cancer foundation diet,1
37308,erlotinib plus dasatinib,1
37309,miltenyi cd34 reagent system,1
37310,primary wound closure using a limberg flap,1
37311,tea with lem,1
37312,"cisplatin, vinblastine, temozolomide",1
37313,intraoperative radiotherapy by intrabeam?zeiss meditech?jena?germany?,1
37314,erwinia chrysanthemi asparaginase,1
37315,n-plate / romiplostim,1
37316,gemtuzumab ozogamycin,1
37317,treatment duration of cisplatin based chemotherapy,1
37318,verbal-based support,1
37319,rbbx-01,1
37320,lr-eshap (lenalidomide 10 mg),1
37321,treatment f,1
37322,trastuzumab subcutaneous inyection vial,1
37323,neoadjuvant intensity-modulated radiation therapy (imrt),1
37324,gsk3326595.,1
37325,diet and physical exercise,1
37326,complications to whipples procedure,1
37327,injection of orthopaedic cement into vertebral bodies,1
37328,smart-brain,1
37329,pca062,1
37330,tg02-treatment,1
37331,upfront staging laparoscopy + peritoneal biopsy,1
37332,"vincristine, cyclophosphamide, and doxorubicin",1
37333,gi-4000 vaccine + activated t cells,1
37334,intranodal immunization with a recombinant vaccinia virus expressing 5 transgenes,1
37335,pelvic floor muscle physical therapy,1
37336,oil fish,1
37337,hycamtin (topotecan),1
37338,verbal and written plus simulation,1
37339,stem cell and mutational assay,1
37340,plitidepsin + dexamethasone,1
37341,attention usual care,1
37342,anlotinib and docetaxel,1
37343,cea rna-pulsed dc cancer vaccine,1
37344,intensive chemo - ric preparation,1
37345,aim regimen / gt regimen,1
37346,pembrolizumab and nanoparticle albumin-bound paclitaxel,1
37347,retrieval and cryopreservation,1
37348,paclitaxel 80 mg/m2 weekly,1
37349,benign breast tumor group,1
37350,educational handout about prostate cancer screening,1
37351,self-collected hpv test,1
37352,full website - standard smokefree.gov website content,1
37353,yondelis®-caelyx®,1
37354,ridaforolimus 100 mg,1
37355,bibf 1120 m + docetaxel h,1
37356,microdebrider,1
37357,dynamic contrast enhancement mri (mr-dce),1
37358,milnacipran,1
37359,allohct for old/msd,1
37360,e7449 plus tmz,1
37361,"mtx, mvd, via",1
37362,"capecitabine, interferon, interleukin",1
37363,parp inhibitor,1
37364,ipilimumab (bms-734016),1
37365,physician choice-usual care (pc-uc),1
37366,arms and ddpcr,1
37367,simethicone solution,1
37368,etrozulimab,1
37369,"docetaxel, cisplatin, 5-fu",1
37370,prs-343,1
37371,biological: humanized anti-pd-1 monoclonal antibody,1
37372,h2 antagonist,1
37373,cognitive behavioral therapy for insomnia (cbt-i),1
37374,gonadotropin-releasing hormone agonist,1
37375,boron phenylalanine,1
37376,10 mm nitinol zilver stent,1
37377,avid200,1
37378,epidermal growth factor receptor status,1
37379,"systemic therapy (chemotherapy, hormon therapy, target therapy etc)",1
37380,90y-daclizumab,1
37381,individualized integrative medicine intervention,1
37382,recombinant human keratinocyte growth factor,1
37383,targeted therapy tailored treatment,1
37384,tonifying spleen and kidney sequential regimen,1
37385,blood samples for metabolite analysis,1
37386,mighty men intervention,1
37387,4d-elf,1
37388,peripherally inserted central catheter (picc),1
37389,cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr,1
37390,tumor tissue analysis of circulating cell free dna,1
37391,telecare,1
37392,swallowing therapy,1
37393,e7 peptide,1
37394,nhs-il12,1
37395,faircare system,1
37396,global proteomic profiling,1
37397,decision aid website,1
37398,dose-escalated radiation therapy,1
37399,computertomography-guided marking of colorectal liver metastases,1
37400,mechnicov probiotics,1
37401,arn-509 (phase 1),1
37402,"cyclophosphamide, epirubicin, paclitaxel",1
37403,immunological adjuvant opt-821,1
37404,cetuximab nanoparticles,1
37405,"melphalan, carboplatin",1
37406,jnj-26866138 1.0 mg/m2,1
37407,tumor removal surgery under general anesthesia,1
37408,donepezil 5 mg,1
37409,tc-h x paclitaxel (p) + trastuzumab(t),1
37410,pec i/ii blocks by anesthesiologist - pre-operative,1
37411,arm 1 pre-operative chemoradiation,1
37412,endobronchial ultrasound miniprobe,1
37413,"scales, questionnaires and inventory",1
37414,control sham-eswt storz duolith [0.01mj/mm2],1
37415,comprehensive bone health assessment,1
37416,practices evaluation,1
37417,radiation therapy (external beam photons),1
37418,regn3767,1
37419,skincerity plus sirolimus/rapamycin,1
37420,atezolizumab - cohort 1,1
37421,"npi-0052 on days 1, 8, 15 every 28 days",1
37422,high-dose recombinant interferon a-2b,1
37423,local rectal excision,1
37424,sodium hypochlorite (dakin's solution),1
37425,supportive oncology care at home,1
37426,induction chemotherapy followed by ccrt,1
37427,pancreatic cancer,1
37428,patient navigator satisfaction survey,1
37429,20% betulinic acid ointment,1
37430,cytomegalovirus (cmv)-specific cytotoxic t cells (ctls),1
37431,interpretation of the abstract,1
37432,rectal biopsy prior to colonoscopy,1
37433,walk with ease arm a,1
37434,motion ct scans,1
37435,laryngeal mask,1
37436,breast irradiation,1
37437,retrieve massive allograft,1
37438,handgrip strength test,1
37439,couples mbsr,1
37440,long course adjuvant chemotherapy,1
37441,rft5pdga,1
37442,dc vaccine + standard of care chemotherapy,1
37443,outreach and reminder intervention,1
37444,cycles n5 and n6,1
37445,a tailored physical activity program after chemotherapy,1
37446,pen-866,1
37447,"psa measurement, uroflowmetry, ipss, transrectal ultrasonography",1
37448,robot-assisted prostate biopsy,1
37449,chemotherapy + apatinib,1
37450,treatment with chemotherapy,1
37451,cytokine-induced killer cell immunotherapy,1
37452,follow-up ct scans during week 3 and week 5 of treatment,1
37453,anterior chamber depth measurement by ultrasound,1
37454,afa group (successive patients),1
37455,vaporizing humidifier,1
37456,peg-ifn-?,1
37457,stem cell source,1
37458,trx518 with pembrolizumab,1
37459,"(pn-152,243)/pn-196,444",1
37460,proxiscan (scintigraphic rectal probe),1
37461,couples skill-training (cst),1
37462,high-dose melphalan hcl for injection (propylene glycol-free),1
37463,white light,1
37464,arginmax,1
37465,meglitinides,1
37466,neck dissection with conventional hand-tie ligation,1
37467,s1+docetaxel followed by s1,1
37468,cancer risk communication skills training,1
37469,"metoclopramide, granisetron, or ondansetron",1
37470,npc-07 for oral administration,1
37471,with data,1
37472,lmhf mechanical stimulation placebo device,1
37473,standard endoscopy (egd),1
37474,"cttc scan, cardiac mri, ecg, 6 minute walking test, echocardiogram",1
37475,alpha cyclodextrin,1
37476,aminolaevulinic acid photodynamic therapy,1
37477,osimertinib; azd9291,1
37478,oral triamcinalone,1
37479,hyperthermic intraperitoneal chemotherapy (hipec) with raltitrexed,1
37480,placebo (iv),1
37481,lymphedema risk reduction,1
37482,program of adapted physical activity,1
37483,18f-fluoro-2-deoxy-d-lucose,1
37484,intravenous ketorolac tromethamine,1
37485,intraoperative radiotherapy using intrabeam®,1
37486,mri with gadofosveset and mr elastography,1
37487,mrna-2752 + durvalumab,1
37488,proton beam irradiation,1
37489,radiotherapy - arm a,1
37490,peptide-pulsed dendritic cells,1
37491,prevention coordinator,1
37492,b.i.d.rt,1
37493,robotic hysterectomy,1
37494,"bcg and cp-675,206",1
37495,"rhenium (re 188 p2045, bay86-5284)",1
37496,blood test 28days,1
37497,cisplatinum combined with infusional fluorouracil (5 fu),1
37498,baduanjin exercise,1
37499,imexon + docetaxel,1
37500,autologous genetically modified afp?³³²t cells,1
37501,isa101/isa101b,1
37502,thai version of the edmontom symptom assessment system (esas),1
37503,cisplatin and paclitaxel,1
37504,curriculum group,1
37505,water immersion/ai,1
37506,aclacinomycin,1
37507,high intensity counseling + long acting nrt,1
37508,placebo saline infusion,1
37509,lapatinib and sorafenib,1
37510,"zbeam (zevalin, bcnu, etoposide, aracytine, melphalan)",1
37511,resectoscope,1
37512,123-i-mip-1095,1
37513,cine mri,1
37514,microsphere-mediated lymphocele prevention,1
37515,retrograde venous infusion of gemcitabine/lipiodol,1
37516,goal setting plus action intentions,1
37517,mri/acetate-pet imaging,1
37518,stable isotope amino acid infusion,1
37519,sunitinib malate dose escalation,1
37520,corticosteroid: fludrocortisone,1
37521,off-clamp partial nephrectomy,1
37522,nb1011,1
37523,2% viscous lidocaine,1
37524,act-lcs therapy,1
37525,medi0457,1
37526,pad-vcd,1
37527,akrq questionnaire,1
37528,pegylated liposomal doxorubicin (sch 200746),1
37529,ophthalmologic evaluation,1
37530,common intervention components for lifestyle,1
37531,minocycline with chemoradiation (temozolomide and radiation therapy),1
37532,questionnaire/survey administration,1
37533,high voltage electrical stimulation,1
37534,autologous renal cell vaccine based on dnp modified cells,1
37535,ultrafractionated brain irradiation,1
37536,platelet concentrate transfusion,1
37537,csi-sh- cancer survivorship intervention,1
37538,pazopanib as add-on to vinflunine,1
37539,"part 1, cohort 2",1
37540,nanoxel®m,1
37541,anti-cd19-car-t cells,1
37542,[131]i-iaza,1
37543,cytarabine consolidation,1
37544,mov19-bbz car t cells,1
37545,pei experimental light,1
37546,intravenous patient controlled analgesia (pca) morphine,1
37547,phytomed™,1
37548,limited pelvic lymphadenectomy,1
37549,"epirubicin, paclitaxel, filgrastim",1
37550,folfox induction regimen,1
37551,olaparib oral capsule,1
37552,mugard,1
37553,immunosuppression,1
37554,okt-3,1
37555,interval debulking,1
37556,collaborative care,1
37557,rociletinib mono-therapy,1
37558,bicarbonate sodium mouthwash,1
37559,tocotrienol-rich fraction (trf),1
37560,efudex®,1
37561,iron-tracer guided axillary ultrasound and biopsy,1
37562,gallium ga 68-psma,1
37563,waitlist control condition,1
37564,generic message,1
37565,second part : hypofractionated stereotactic boost,1
37566,maxitrol®,1
37567,message x onsite/offsite vaccination,1
37568,concurrent chemotherapy with docetaxel,1
37569,imrt using traditional ctv,1
37570,blood samples and skin biopsies,1
37571,bl22 (cat-3888),1
37572,questioners,1
37573,mbsr 6 weeks program,1
37574,synbiotics,1
37575,"osi-774: erlotinib, tarcevatm",1
37576,chemotherapy alone,1
37577,fludeoxyglucose f 18 positron-emission tomography (pet) scan,1
37578,pap smear test and hpv test,1
37579,"placebo acupuncture, questionnaires",1
37580,"gardasil (vlp, hpv quadrivalent prophylactic vaccine)",1
37581,step completion assessment,1
37582,mart-1:26-35(27l) peptide vaccine,1
37583,ibrutinib+azacitidine,1
37584,observation without carfilzomib/dexamethasone maintenance,1
37585,nab-paclitaxel (paclitaxel-albumin) + gemcitabine,1
37586,magnesium isoglycyrrhizinate injection,1
37587,ds-7423,1
37588,doxorubicin+cisplatin+ifosfamide,1
37589,parathyroid hormone testing,1
37590,"cyclophosphamide, topotecan, and bevacizumab",1
37591,household food inventory (hfi),1
37592,tki (gefitinib or tarceva ),1
37593,ligasure maryland,1
37594,transferrin-crm107,1
37595,epro survey,1
37596,blood oxygen level dependent [bold] mri,1
37597,111in ibritumomab,1
37598,bf-rhodoled,1
37599,dexmedetomidine 1µg.kg-1,1
37600,"paclitaxel, carboplatinum, doxorubicin, endoxan, capecitabine",1
37601,port-last,1
37602,thymoglobulines,1
37603,"cag regimen (aclacinomycin, cytarabine, with/w/o g-csf)",1
37604,histopathological examination,1
37605,zinc sulfate oral product,1
37606,technetium tc99m sulfur colloid,1
37607,acetaminophen 650 mg,1
37608,continuous intravenous analgesia,1
37609,"cohort 2, ceplene® and proleukin®",1
37610,trastuzumab+docetaxel+npld,1
37611,norwood scale,1
37612,sham teas,1
37613,transoral robotic surgery (tors) with the davinci robotic surgical system device,1
37614,verbal group,1
37615,ad-sig-hmuc-1/ecdcd40l vector vaccine,1
37616,"paclitaxel, or docetaxel, or irinotecan",1
37617,not applicable - blood tests/tissue specimen tests will be undertaken,1
37618,early postoperative intraperitoneal chemothgerapy,1
37619,extracoporal photopheresis (ecp),1
37620,virtual radial task in 3d,1
37621,mifamurtide (l-mtp-pe),1
37622,m-folfox,1
37623,administered therapeutic regimens,1
37624,high-dose interferon alfa-2b,1
37625,biomarker (not used as an intervention),1
37626,hyperfractionated accelerated radiotherapy,1
37627,iressa day 21 given with arimidex and faslodex,1
37628,semi-allogenic human fibroblast (mrc-5) transfected with dna,1
37629,electrode sleep recorder,1
37630,standard nutrition (peptisorb),1
37631,[123]i-mibg,1
37632,placebo plus everolimus,1
37633,abdominoperineal resection,1
37634,kw-2871,1
37635,no amil,1
37636,response-driven adaptive radiation therapy,1
37637,cyclophosphamide and interleukin 2,1
37638,pembrolizumab - 4 cycle,1
37639,taxotere/docetaxel,1
37640,bendamustine at a dose of 120 mg/m2,1
37641,mb07133 600 mg/m2/day,1
37642,20% vda-1102,1
37643,part a - azd9291 in combination with continuous selumetinib (asian subjects),1
37644,endoscopic sinus surgery,1
37645,self-control weight loss,1
37646,mri tracker,1
37647,group exercise,1
37648,ch14.18 -nci,1
37649,focal cryoballoon ablation system - 6 seconds,1
37650,dignicap™,1
37651,a drug withdrawal during the long protocol,1
37652,positron emission mammography (pem),1
37653,telbivudine,1
37654,mrg-106,1
37655,screening evaluation,1
37656,mobile phone,1
37657,13c sodium octanoate,1
37658,linaclotide acetate,1
37659,kepivance (palifermin),1
37660,short course of palliative radiotherapy,1
37661,clinimacs device,1
37662,ara-c (cytarabine),1
37663,general information sheet (gis),1
37664,adjuvant opt-821 in a vaccine containing two antigens (gd2l and gd3l) covalently linked to klh,1
37665,zactima (vandetanib),1
37666,standard thoracic radiotherapy,1
37667,abt-199 and ibrutinib combination,1
37668,whole liver lobe ctace doxorubicin,1
37669,osi 7904l,1
37670,denosumab-nivolumab combination,1
37671,pd1 antibody,1
37672,hcrf [xerecept (corticorelin acetate injection)],1
37673,systematic utilisation of imrt,1
37674,next generation genome sequencing,1
37675,light therapy,1
37676,blood drawn for genotyping,1
37677,bcx-1777,1
37678,erlotinib hydrochloride (tarceva),1
37679,manometry,1
37680,sevoflurane + remifentanil,1
37681,testosterone transdermal gel,1
37682,yyb101,1
37683,improve awareness of checking moles,1
37684,blood samples for psa and immune assays,1
37685,drug: carfilzomib,1
37686,exablate treatment,1
37687,aa reduced dose-fat diet (b),1
37688,breast pet,1
37689,standard post-operative chest tube,1
37690,ly3114062 iv,1
37691,aprepitant placebo,1
37692,visual analogue scale (vas),1
37693,survey instruments using web-based data collection system (wbdc) survey content,1
37694,cumulative bed ? 130 gy2,1
37695,"immediate menveo vaccine, delayed gardasil 9",1
37696,de-escalation radio(chemo)therapy - level 1,1
37697,saline 2 ml i.v.,1
37698,btp-114,1
37699,erlotinib/gefitinib combined with bevacizumab,1
37700,alimta/gemcitabine,1
37701,radiotherapy group,1
37702,preloaded needle (device),1
37703,18f fluorothymidine pet ct,1
37704,tivantinib (arq197),1
37705,avelumab combined with chemoradiation,1
37706,laparoscopic right hemicolectomy plus eras,1
37707,22g bnx eus-fna needle,1
37708,sham procedure,1
37709,"vegfr1-1084, vegfr2-169",1
37710,nimotuzumab+chemoradiotherapy,1
37711,gtx-758 250 mg,1
37712,latanoprost 0.005%,1
37713,dexeryl,1
37714,laparoscopic myomectomy and supracervical hysterectomy with rotocut g1,1
37715,surgimend® acellular dermal matrix,1
37716,nitroprusside and phenylephrine,1
37717,glse compound,1
37718,hdr (19gy) or sbrt (35-40gy),1
37719,compression anastomosis ring (car),1
37720,circular stapler-assisted colostomy,1
37721,chs 828,1
37722,tissue-oxygen-level-dependent functional magnetic resonance imaging,1
37723,d1 or d2 lymphadenectomy for gastric cancer patients,1
37724,epr oximetry measurement,1
37725,anti-ox40 antibody pf-04518600,1
37726,allogeneic (allo) hematopoietic stem cell transplantation,1
37727,mesothelin-directed car-t cells,1
37728,allogeneic bone marrow transplant (bmt),1
37729,conventionally fractionated concurrent chemo-radiotherapy,1
37730,paclitaxel (x),1
37731,expression analysis,1
37732,total mesorectal excision / long course radiochemotherapy,1
37733,radiation + cisplatin,1
37734,questionnaire t1 to fill,1
37735,cohort 1 ctap101 capsules - 90µg,1
37736,12 mg/kg ?-tea,1
37737,assessment of the pelvic venous pressure,1
37738,acquisition of images,1
37739,flexible bronchoscopy in moderate sedation,1
37740,selected vegetable and herb mix,1
37741,colo-ad1,1
37742,colon capsule,1
37743,complete mesocolic excision with central vascular ligation,1
37744,"ultrasonography (pelvis and breast), bone mineral density",1
37745,video-based informed consent,1
37746,etoposide plus carboplatin,1
37747,"standard docetaxel, doxorubucin and cyclophosphamide",1
37748,pf-3512676 + paclitaxel + carboplatin,1
37749,radiation and chemoradiation,1
37750,"capecitabine (xeloda, roche), oxaliplatin (sanofi-aventis), docetaxel (sanofi-aventis)",1
37751,needle with sideport (na-230h-8020),1
37752,quality of life instrument,1
37753,bgb324+pembrolizumab,1
37754,standard procedures,1
37755,management algorithm for malignant bowel obstruction,1
37756,mc1r genotyping,1
37757,comparator: octavalent hpv vaccine - dose formulation 2,1
37758,pepcid,1
37759,89zr-trastuzumab injection,1
37760,"cyclophosphamide, vincristine, topotecan ,allogeneic nk cells & 3f8",1
37761,sc-006,1
37762,igimrt using a single dose of 24 gy,1
37763,"2 cycles of bortezomib, lenalidomide, dexamethasone (vrd)",1
37764,apple juice,1
37765,conventional suture and tie,1
37766,light touch therapy,1
37767,fluid optimisation,1
37768,transrectal prostate biopsy (trb):,1
37769,im19,1
37770,cc-92480,1
37771,ketamine or placebo,1
37772,transarterial chemotherapy,1
37773,oral antibiotic,1
37774,gadoxetic acid,1
37775,"pertuzumab (p, 840 mg",1
37776,letrozole (aromatase inhibitor),1
37777,carbon dioxide insufflation,1
37778,primary care physician activation,1
37779,dexmedetomidine 2,1
37780,phase 1b,1
37781,mri-guided focused ultrasound ablation,1
37782,natural killer (nk) lymphocytes,1
37783,apheresis using the oncosorb column,1
37784,dinutuximab beta,1
37785,enhancing cancer pain management,1
37786,trisenox (arsenic trioxide),1
37787,gefitinib plus olaparib,1
37788,outdoor exercise,1
37789,consultation by a trained physician,1
37790,standard endhole microcatheter,1
37791,latg,1
37792,sws supp,1
37793,carboplatin plus paclitaxel,1
37794,fluorodeoxyglucose f-18,1
37795,usual care delivery,1
37796,bi1206,1
37797,palliative care with decision aids,1
37798,y-90 microspheres,1
37799,resistance training and nutrition counseling,1
37800,anti-gd2 in combination with nk cells,1
37801,intranodal injection of ad-isf35,1
37802,tetrahydrouridine (iv),1
37803,cesm with a reduced dose of contrast agent,1
37804,pcle-tb,1
37805,accs,1
37806,mvt-1075,1
37807,family history: number + pictograph,1
37808,identification of sentinel nodes + full pelvic lymph-node dissection,1
37809,integrated palliative care program,1
37810,cisplatin (tp),1
37811,cgc-11047 and gemcitabine,1
37812,cv8102,1
37813,i.v. palonosetron,1
37814,yttrium microsphere injection,1
37815,cardiologic assessment,1
37816,intratumoral ipilimumab and interleukin-2,1
37817,cervical conization,1
37818,docetaxel + gsk1120212,1
37819,intravenous ezn-2968 (anti-hif-1? lna as-odn),1
37820,endoscopic bipolar radiofrequency probe used to remove tumors in bile duct to manage pancreatic cancer,1
37821,dcx,1
37822,cohort,1
37823,the foundation treatment including against hepatitis b virus treatment using nucleoside analogue drug and protect liver treatment,1
37824,whole-body electromyostimulation wb-ems,1
37825,information booklet receipt,1
37826,late ccrt,1
37827,"fat-free mri images utilizing standard magnetization, questionnaire before the mri exam",1
37828,total brain radiotherapy,1
37829,alvac-mart-1 vaccine,1
37830,interventional palliative care,1
37831,gadovist (gadobutrol),1
37832,stereotactic radiotherapy (srt) or highly conformal (crt),1
37833,flo regimen or flot regimen,1
37834,eoc202,1
37835,folfirinox bevacizumab,1
37836,compression anastomotic ring-locking procedure (carp),1
37837,atn-224 + bortezomib,1
37838,patient coaching,1
37839,surefire,1
37840,0.25g/kgof 20% mannitol,1
37841,multi-epitope folate receptor alpha-loaded dendritic cell vaccine,1
37842,health messaging via sms,1
37843,blood and ffpe sample collection,1
37844,ambisome,1
37845,dapagliflozin plus glucophage (met er),1
37846,adjuvant fl,1
37847,pomalyst® (pomalidomide),1
37848,allogenic immunotherapy based on natural killer cells adoptive transfer,1
37849,lumiliximab,1
37850,vemurafenib and cobimetinib (combination treatment),1
37851,help with decision making on prostate cancer treatment,1
37852,radiotherapy to the bilateral neck lymphatics and tumor bed (radiotherapy to both sides of the neck),1
37853,22 gauge procore needle aspiration,1
37854,hydroxychloroquine sulfate,1
37855,alt02,1
37856,brain tissue imprint - medical device (protool),1
37857,promis physical function items,1
37858,ng-nitro-l-arginine,1
37859,"capecitabine, tarceva",1
37860,fludarabine-melphalan & rabbit antithymocyte globulin (r-atg),1
37861,forced,1
37862,lenalidomide-dexamethasone,1
37863,perox quench placebo,1
37864,standard oral hygiene + sham acupuncture,1
37865,oncorine,1
37866,digital breast tomosynthesis exam,1
37867,nutritional support program,1
37868,lbh589 and carboplatin with etoposide,1
37869,dovitinib placebo,1
37870,lap. tme,1
37871,questionnaire t3 to fill,1
37872,wearable technology - polar loop 2,1
37873,surefire® infusion system,1
37874,vaginal packing,1
37875,cannabidiol (cbd),1
37876,glucagon,1
37877,radical operation,1
37878,agen1884 + agen2034,1
37879,infusion of stem cells,1
37880,bibf + paclitaxel,1
37881,corneal epithelial autograft,1
37882,panitumumab + docetaxel + cisplatino,1
37883,"radiofrequency ablation, microwave, radiation therapy",1
37884,telatinib mesylate,1
37885,anlotinib?erlotinib?ibi308?pemetrexed?gemcitabine?carboplatin,1
37886,"globo-h-gm2-stn-tf-tn-klh conjugate, plus the immunological adjuvant qs-21",1
37887,gallium ga 68 dota-neobomb1,1
37888,biological,1
37889,accelerated radiotherapy with 'low' dose cisplatin,1
37890,cc-90010,1
37891,trastuzumab emtansine [kadcyla] 3.0 mg/kg,1
37892,68ga-rm2,1
37893,psa measurement,1
37894,correlation of flow cytometric & rt pcr for tnm stage,1
37895,external beam radiation and cyberknife radiosurgery boost and capecitabine,1
37896,hazardous materials online education and study feedback,1
37897,tacrolimus 60,1
37898,single dose radiotherapy (sdrt),1
37899,olaparib (for dose level 2),1
37900,dsp-0337,1
37901,endometrial biopsy catheter,1
37902,mage-a4 tcr gene-modified t cells,1
37903,outpatient management,1
37904,crc prevention and screening education,1
37905,electromagnetic navigation guided transthoracic needle aspiration,1
37906,1 sample oc-micron,1
37907,nrt sampling,1
37908,oligosecretary,1
37909,gp100:280-288 (288v),1
37910,pemetrexed and erlotinib,1
37911,neurosurgical resection,1
37912,owise,1
37913,ham + vitamin e,1
37914,low-dose ct-scan and induced sputum sample and blood test,1
37915,arm 4,1
37916,pc-based tailored intervention,1
37917,camptosar,1
37918,molecularly tailored second line therapy,1
37919,mindfulness based stress reduction program,1
37920,educational intervention and behavioral skills training,1
37921,hyperglycemic clamp procedure,1
37922,melanoma gvax,1
37923,daily oral dose of hepcortespenlisimut-l,1
37924,pca,1
37925,"vp16, carboplatin",1
37926,a multiparametric prostate mri,1
37927,palbociclib pd-0332991,1
37928,genetic profiling,1
37929,laparoscopic radical prostatectomy (with a simulator),1
37930,"amn107, sti571",1
37931,sampling of tumor tissue,1
37932,alk qpcr assay,1
37933,gem333,1
37934,everolimus + bibf 1120,1
37935,supervised physical activity,1
37936,"association of gemcitabine, oxaliplatin and radiotherapy",1
37937,stereotactic frameless brain tumour biopsy,1
37938,osimertininb tablet dosing,1
37939,oncoral therapeutic education,1
37940,bh group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr,1
37941,gamma-secretase inhibitor ly3039478,1
37942,megestrol acetate placebo 20 mg/day,1
37943,standard of care intravenous chemotherapy,1
37944,"tki: sutent, nexavar or votrient",1
37945,mesna (oral),1
37946,prophylactic white cell transfusion,1
37947,scqolit questionnaire,1
37948,extracellular contrast media (eccm) mri,1
37949,tetwtcea dna (wt cea with tetanus toxoid th epitope),1
37950,beneo synergy 1,1
37951,sexual history inventory for men,1
37952,combination of sorafenib and everolimus,1
37953,archived tissue collection,1
37954,pass oct® spinal system,1
37955,enhanced monitoring and education (eme),1
37956,lapatinib in combination with an anti-cancer agent as specified by parent protocol,1
37957,chest physiotherapy education intervention,1
37958,radiation therapy following surgery,1
37959,arm b: paclitaxel,1
37960,clinical findings,1
37961,globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine,1
37962,detection of adverse events,1
37963,gsk biologicals' hpv-16/18 vaccine (cervarix™),1
37964,low-dose radiotherapy,1
37965,stereotactic body radiation therapy for oligometastases,1
37966,post-treatment swallowing exercises.,1
37967,beacopp escalated,1
37968,temporary skin markings,1
37969,leuplin or zoladex,1
37970,idiotype-pulsed allogeneic dendritic cells,1
37971,pf-03814735,1
37972,apatinib+oral etoposide,1
37973,rituximab fludarabine cyclophosphamide,1
37974,lletz with colposcopy,1
37975,urate oxidase,1
37976,"carboplatin, docetaxel",1
37977,re-patterning sitting time group,1
37978,sorafenib-sunitinib,1
37979,cancer antigen 125 level,1
37980,interferon-alfa-2a (roferon-a),1
37981,matristem psm,1
37982,bmtp-11,1
37983,epratuzumab and 90y-epratuzumab,1
37984,immunostaining,1
37985,aquatic exercise arm,1
37986,olaparib pill 200 mg,1
37987,standard of care (soc) chemotherapy,1
37988,symptom assessment,1
37989,bmi group (successive patients),1
37990,ischemic heart disease diagnostic,1
37991,ivf (in vitro fertilization) antagonist protocol,1
37992,doxorubicin and cisplatin (intrapleural) + cisplatin and pemetrexed (systemic),1
37993,tension-anxiety subscale,1
37994,cd80 breast cancer vaccine,1
37995,"tamoxifen,",1
37996,domatinostat,1
37997,e. coli l-asparaginase,1
37998,resistance training - fixed schedule,1
37999,nasal high flow therapy,1
38000,ingenol mebutate 0.05% gel,1
38001,45 gy external radiations,1
38002,cardiac index,1
38003,oral lactose placebo,1
38004,immunohistochemistry assay,1
38005,ct7001,1
38006,administration of common sage,1
38007,plerixafor dose escalation,1
38008,gimatecan® (st 1481),1
38009,f-18 fdg breast pet scan,1
38010,i:e ratio,1
38011,ogx-427 600 mg,1
38012,1200 total body irradiation (tbi),1
38013,nutritional supplement (protein + mix),1
38014,xeloda [capecitabine],1
38015,cdca1,1
38016,magnet assissted capsule endoscopy,1
38017,"salvage reinduction chemotherapy including gemtuzumab ozogamicin, idarubicin and cytarabine and vorinostat",1
38018,18f fpm,1
38019,ml-predicare,1
38020,avelumab and radical radiotherapy,1
38021,additional pvb (ropivacaine),1
38022,acetylsalicylic acid + loperamide,1
38023,single-incision laparoscopic surgery,1
38024,sems alone,1
38025,standard-of-care therapy,1
38026,comparison of automated whole breast ultrasound screening with blinded screening mammography,1
38027,specific block of medial and lateral plantar nerves,1
38028,gs-9901,1
38029,r-huepo,1
38030,ensartinib capsules (reference product),1
38031,ledipasvir,1
38032,dexamethasone in consolidation-2,1
38033,scoring of late toxicity,1
38034,"fludarabine, cytarabine, liposomal daunorubicin (daunoxome)",1
38035,laparoscopic right colectomy with extracorporeal ileocolic anastomosis (eia),1
38036,omo-1,1
38037,training program intervention,1
38038,fungalai platform technology,1
38039,imatinib mesylate (gleevec®; sti571; nsc #716051),1
38040,diurnal cortisol,1
38041,bkt140,1
38042,4d-ct scan,1
38043,infrared laser therapy,1
38044,ys-0n-001,1
38045,anti-cd137,1
38046,zw49,1
38047,radiofrequency assisted liver partition with portal vein ligation (ralpp),1
38048,human gp100 plasmid dna vaccine,1
38049,the early palliative care programme,1
38050,routine imaging ct with a vr model,1
38051,light activated wst11,1
38052,voice evaluation and fmri,1
38053,lv305,1
38054,music therapy (books on tape),1
38055,mailed outreach,1
38056,circulating tumor cells counting at baseline,1
38057,ciprofloxacin and amoxicillin,1
38058,complementary medicine use,1
38059,mixed car-t transfer,1
38060,concurrent radiation therapy,1
38061,video fluoroscopy,1
38062,osi-461,1
38063,geriatric assessment summary,1
38064,next generation sequencing exome,1
38065,adjuvant proton radiotherapy,1
38066,dacarbazine 1000mg/m2 q3w,1
38067,opioids titration,1
38068,ecosac 400 eco-t,1
38069,care plan only,1
38070,acid zoledronic,1
38071,prospective registry,1
38072,fec-docgemzar adjuvant chemotherapy,1
38073,[18f]-fdg pet/ct imaging,1
38074,hormone study and imaging study,1
38075,reishi mushroom extract,1
38076,melfalan in conditioning before transplantation,1
38077,domiciliary exercises for the upper limbs,1
38078,substance use disorders,1
38079,radiation during chemoradio-immunotherapy,1
38080,inhalational anesthesia,1
38081,dabrafenib and trametinib (combination),1
38082,focal prostate brachytherapy with cesium-131,1
38083,mp-470 + topotecan,1
38084,open approach,1
38085,oat bran,1
38086,five facet mindfulness questionnaire (ffmq),1
38087,cholangioscopy (frimberger),1
38088,wide-field radiation therapy,1
38089,"gefitinib, cisplatin and radiotherapy",1
38090,intensive surveillance,1
38091,zolendric acid,1
38092,salpingo-oophorectomy with hysterectomy by laparoscopy,1
38093,steroid eye drop,1
38094,tumor lysate-pulsed autologous dendritic cell vaccine,1
38095,bsi-201 + topotecan,1
38096,sinus pilonidal excision+ prgf,1
38097,placebo pec/spb block + multilevel intercostal nerve block with active anesthetic followed by latissimus dorsi flap breast reconstruction,1
38098,insertion of double drains,1
38099,screening test,1
38100,ultratrace iobenguane (mibg) i 131,1
38101,aguix,1
38102,"cytoreductive surgery (crs) plus postoperative intraperitoneal chemotherapy (5-fluorouracil, isovorin)",1
38103,patient derived cd171 specific car t cells expressing egfrt (2nd generation t cells),1
38104,any approved or standard-of-care therapy,1
38105,nc-4016,1
38106,bisthianostat,1
38107,hula,1
38108,pimonidazole hydrochloride,1
38109,nutritional supplements and advice,1
38110,toluidine blue,1
38111,ethyl icosapentate,1
38112,usual and customary waiting room process,1
38113,"rituximab, bendamustine",1
38114,excision of tumor,1
38115,abx-1431 hcl,1
38116,colorectal cancer resection via minilaparotomy,1
38117,physical activity plus positive affect,1
38118,continuous screening,1
38119,beam chemotherapy and autologous stem-cell transplantation,1
38120,left colic artery preservation,1
38121,tethered capsule endoscope,1
38122,central nervous system (cns) prophylaxis,1
38123,injection of ebv specific ctls,1
38124,prometrium® 300 mg,1
38125,tocilizumab and interferon alpha 2-b,1
38126,gp100:280-288(288v),1
38127,experimental photoacoustic imaging,1
38128,peer support dyad intervention,1
38129,upd guidance,1
38130,robotic assisted bronchoscopy,1
38131,x-ray based radiation therapy,1
38132,therabite® jaw motion rehabilitation system™,1
38133,nktr-214 (cohort a),1
38134,gemcitabine and split-dose cisplatin plus escalating doses of continuous everolimus (rad001),1
38135,relaxation and talking group,1
38136,brain health program,1
38137,dynamic contrast agent (dce) mri,1
38138,docetaxel 75 milligrams per square meters (mg/m^2) iv infusion,1
38139,alfacalcidol and calcitriol,1
38140,glucose monitor,1
38141,general supporting,1
38142,bevacizumab + endocrine treatment consisting of either letrozole or fulvestrant.,1
38143,oral opioids,1
38144,cart20,1
38145,clinical evaluations,1
38146,steep trendelenburg,1
38147,3h-afl-pdt,1
38148,standard preparation instructions,1
38149,"docetaxol, cisplatin, capecitabine",1
38150,tipifarnib (r115777),1
38151,12 week exercise program,1
38152,cart-19 t cells,1
38153,mtor inhibitor with nab-paclitaxel,1
38154,peppermint and lavender essential oils,1
38155,wound closure with vicryl and monocryl,1
38156,cs1-car t therapy,1
38157,craniotomy and tumor resection,1
38158,patients with chemotherapy induced anemia,1
38159,"doxorubicin, methotrexate",1
38160,lidocaine hydrochloride ophthalmic gel 3.5%,1
38161,doxil and estramustine,1
38162,motexafin gadolinium and pemetrexed,1
38163,pecs ii and parasternal block,1
38164,parathyroid hormone-related protein (1-36),1
38165,bax69 single-route arm,1
38166,ta-hpv,1
38167,caz-avi,1
38168,blood red cell transfusion,1
38169,tobi + dbt,1
38170,anti-smoking drug,1
38171,physical activity measurement,1
38172,"erlotinib, bevacizumab",1
38173,computerised tomography,1
38174,177lu-dotatate prrt,1
38175,deep inspiration breath hold (dibh),1
38176,excision of the lesion,1
38177,eortc qlq-c30 and eortc qlq-fa12 surveys,1
38178,"clofarabine, arac, mitoxantrone (clam)",1
38179,"br-ups 5 mg tablet, inisia 5 mg tablet",1
38180,roux-en-y pouch reconstruction (ryp),1
38181,plx9486,1
38182,pertuzumab-placebo,1
38183,qmrt with the cytotron®,1
38184,"clofar, cyclophos,alemtuzumab(ph ii)",1
38185,clinical monitoring (palpation and node ultrasound),1
38186,on-site pathologist,1
38187,mk-5890,1
38188,clonidine 150 µg/ml in sacrococcygeal block,1
38189,tciv,1
38190,"dce-mri, dw-mri, mt-mri, and cest-mri",1
38191,tpf,1
38192,administration of water before upper endoscopy,1
38193,400mg/day of imatinib,1
38194,fec 100,1
38195,hepatic arteriography,1
38196,1 mg/kg gr-md-02,1
38197,shenqifuzheng injection,1
38198,"oxaliplatin, 5-fluorouracil,leucovorin,panitumumab",1
38199,sensory testing and biopsy,1
38200,egfr(v)-edv-dox,1
38201,ls 11(taporfin sodium),1
38202,"treatment with endostar, cbp and 5-fu",1
38203,low-residue diet,1
38204,total mesorectal excision after 56 days (8-12 weeks),1
38205,neuromuscular block,1
38206,immunological analyses,1
38207,pegylated interferon-alfa 2a,1
38208,lexatumumab alone,1
38209,cc>0 - cisplatin (ip/iv)- epirubicin (iv),1
38210,maple,1
38211,folfox-4+cetuximab,1
38212,self massage,1
38213,doxil®,1
38214,[14c]-tak-659,1
38215,straw,1
38216,placebo vaccine for male participants only,1
38217,baclofen,1
38218,biopsy and blood samples,1
38219,cofactor and 5fu,1
38220,recombinant human chorionic gonadotropin (r-hcg),1
38221,[68ga]-dotanoc pet/ct,1
38222,pha-848125ac,1
38223,tas-114 + s-1,1
38224,standard of care foley urinary catheter insertion,1
38225,checkpoint inhibitor therapy,1
38226,polypectomy and biopsy,1
38227,emepepimut-s,1
38228,cdx1127,1
38229,2nd reminder letter for pap testing,1
38230,portal vein blood sample,1
38231,technology intervention,1
38232,tti-621 + pd-1/pd-l1 inhibitor,1
38233,azd 2281,1
38234,hlx20,1
38235,"taxotere, carboplatin, herceptin + pertuzumab",1
38236,abituzumab,1
38237,bd onclarity™ hpv assay on bd viper™ lt,1
38238,patient-derived cd22-specific car t-cells also expressing an egfrt,1
38239,sentinel node detection in cervical cancer,1
38240,doxorubicin+cisplatin+ifosfamide+methotrexate,1
38241,polymorphisms of hsp70 and tnf promoter,1
38242,nine-valent hpv vaccine,1
38243,robotic assisted total gastrectomy,1
38244,chemotherapy (fluorouracil and cisplatin),1
38245,ino-1401,1
38246,intervention a: irinotecan; oxaliplatin; neulasta,1
38247,etoposide + carboplatin,1
38248,rfusin2-aml1,1
38249,21capecitabine + bevacizumab + oxaliplatin,1
38250,7-day self-monitoring period,1
38251,objective grading of skin findings,1
38252,debio1347 (ch5183284),1
38253,cardiopulmonary resuscitation (cpr) narrative script and questionnaires,1
38254,ara-c (cytosine arabinoside),1
38255,complete axillary lymph node dissection,1
38256,portable spectroscopy system,1
38257,oros hydromorphone hci sr (slow release),1
38258,glembatumumab vedotin and pd-1 targeted checkpoint inhibitor (nivolumab or pembrolizumab),1
38259,"sp+ms, day before-only dosing",1
38260,cdx-301 (cohort b),1
38261,amn107- nilotinib,1
38262,nivolumab 10 mg/ml intravenous solution [opdivo],1
38263,post treatment as usual,1
38264,ridaforolimus 40 mg,1
38265,defibrotide,1
38266,superdimension™ navigation system version 7.2,1
38267,folfirinox regimen,1
38268,carboplatin and pemetrexed with bevacizumab 7.5 mg/kg,1
38269,irinotecan/cisplatin,1
38270,subclinical cardiac lesions and biomarkers,1
38271,eprime symptom monitoring tool,1
38272,pegcsf first level prophylactic use,1
38273,oral sorafenib,1
38274,volasertib iv infusion,1
38275,research registry,1
38276,decitabine 15 mg/m2 i.v.,1
38277,eating disorders,1
38278,psma-radioguided surgery,1
38279,anti-egfr agent (cetuximab +/- irinotecan or panitumumab),1
38280,f-miso pet imaging,1
38281,breast cancer population,1
38282,antimelanoma injection of gsl alpha-gal,1
38283,blue dyes,1
38284,dietician advise,1
38285,total body irradiation with fludarabine in ucb transplants,1
38286,ngs-mrd,1
38287,etoposid,1
38288,"dental scaling, ultrasonic",1
38289,epo906 (epothilone b),1
38290,lung metastasis from soft-tissue sarcoma,1
38291,metformin and chloroquine combination,1
38292,epro,1
38293,protective ileostomy group,1
38294,sonobiopsy catheter,1
38295,"regimen 1 course 2, it mafosfamide",1
38296,serratus plane bloc : placebo,1
38297,standard proctologic examination,1
38298,combination of varlilumab and sunitinib,1
38299,"gemcitabine, irinotecan, allopurinol.",1
38300,ator-1015,1
38301,recombinant human egf-rp64k/montanide isa 51 vaccine,1
38302,immunotherapy responders/non-responders,1
38303,blood punction,1
38304,endoscopic papillectomy,1
38305,xeloxa,1
38306,pki-179,1
38307,patient survey,1
38308,atezolizumab 1200 mg,1
38309,part 1: sym004 6/12 mg/kg + carboplatin/paclitaxel,1
38310,phenix usb 8.,1
38311,tesetaxel and capecitabine,1
38312,hyperacute-pancreas immunotherapy,1
38313,dexa,1
38314,induction of ovulation using letrozole-pioglitazone-metformin,1
38315,symptom experience report,1
38316,tlc diet,1
38317,the multi-faceted (mf) strategy,1
38318,cetuximab (erbitux ®),1
38319,bomp,1
38320,mri-scan,1
38321,nvisionvle with real time targeting,1
38322,5fu chemoradiation,1
38323,computer aided analysis of breast lesions,1
38324,neoadjuvant concurrent chemoradiotherapy,1
38325,sleep information,1
38326,thermal ablation procedure,1
38327,floxuridine (ip),1
38328,u3-1784,1
38329,boronophenylalanine and ihni-based bnct,1
38330,online yoga,1
38331,brain lesioning,1
38332,ezn-2968,1
38333,gem-5fu,1
38334,exablate enhanced sonication,1
38335,surgery or wait-and-see,1
38336,cervico-vaginal secretion (cvs) samples,1
38337,propofol + remifentanil,1
38338,vad,1
38339,tetanus pre-conditioning,1
38340,ctc isolocation and analysis,1
38341,omeprazole tablet dosing,1
38342,preoperative docetaxel-cisplatin combination chemotherapy,1
38343,general health education control,1
38344,"mri screening form, mri. demographic / medical data",1
38345,ipilimumab plus nivolumab,1
38346,exablate mr guided focused ultrasound,1
38347,sgi-110 administration,1
38348,moderate volume,1
38349,statin,1
38350,general education dvd,1
38351,palbociclib + taselisib / pictilisib,1
38352,response monitoring (no intervention),1
38353,placebo with enzalutamide,1
38354,safingol,1
38355,abraxane (maintenance),1
38356,behavioral messages,1
38357,psa testing,1
38358,group standard: rocuronium 0.6 mg/kg followed by bolus rocuronium according to standard treatment combined with saline infusion (placebo).,1
38359,tetrathiomolybdate (tm),1
38360,education regarding telomere length,1
38361,interim/maintenance dexamethasone,1
38362,electrocorticography (ecog) with cortec grids,1
38363,"tailored assessments provided to physicians and nurses (choice, the computer-assisted interactive tailored patient assessment tool (itpa))",1
38364,somatostatin-analog,1
38365,symptom checklist,1
38366,radiation in prone position,1
38367,examination under anaesthetic (eua),1
38368,pre-test administration,1
38369,colon capsule endoscopy adherence,1
38370,injection of steroid into foot,1
38371,radiation therapy to brain,1
38372,common fundamental management,1
38373,the conventional hand-sewn anastomosis,1
38374,nac group,1
38375,stem cell transfusion,1
38376,implantable pump with programmable flow.,1
38377,glutamic acid,1
38378,surgery alone or surgery plus preoperative gemcitabine-cisplatin,1
38379,whole-body fdg pet-ct,1
38380,cancer treatment and follow-up according to current regional and national guidelines,1
38381,3 days sie plus 3 weeks pre,1
38382,nimotuzumab and docetaxel,1
38383,distribution of educational materials,1
38384,s-1 combined with leucovorin,1
38385,mab 17-1a,1
38386,"gemcitabine, vinorelbine, ifosfamide, filgastrim",1
38387,quadrantectomy + sentinel node biopsy,1
38388,oocyte/embryo freezing,1
38389,ivac_w_bre1_uid,1
38390,radiotherapy with imrt and cyberknife boost,1
38391,intratumoral (it) poly iclc 1.0 mg,1
38392,high sulforaphane extract (broccoli sprout extract),1
38393,post-operative visit,1
38394,vivosorb,1
38395,delivery of a take-home brochure,1
38396,have levulan kerastick (aminolevulinic acid) solution,1
38397,hypofractionated ablative proton therapy,1
38398,essential hypertension video,1
38399,rmp-7 and carboplatin,1
38400,sterile dressing,1
38401,bio-chemical feedback and expert system intervention ets,1
38402,cls006,1
38403,velafermin,1
38404,lactobacillus rhamnosus gg,1
38405,ponatinib - phase 2,1
38406,k-001,1
38407,search of factors predicting tumor recurrence,1
38408,low intensity exercise training 2,1
38409,mln8237 and erlotinib,1
38410,administration of oral methylprednisolone,1
38411,mel-cfz-td-pace,1
38412,proactive engagement,1
38413,autologous peripheral blood stem cells (auto-pbsc) transplantation,1
38414,xmab2513,1
38415,motivating pacifika against cigarettes and tobacco,1
38416,cosmetics,1
38417,oral perixicam,1
38418,optune (novottf-100a),1
38419,rosuvastatin10 mg tablet,1
38420,succinylcholine,1
38421,"mri screening form, mri, demographic / medical data form",1
38422,insufflation of carbon dioxide (co2),1
38423,heat killed whole cell m.obuense (imm-101) 1.0 mg,1
38424,geriatrician intervention,1
38425,v/q spect,1
38426,palliative decompression,1
38427,"flag (fludarabine, cytarabine and g-csf)",1
38428,periocular carboplatin,1
38429,petrolatum-mineral oil-lanolin-ceresin ointment,1
38430,cavity boost radiation,1
38431,inhaled lipid cisplatin (ilc),1
38432,fluoroscopic-guided teb,1
38433,timing to initiate the adjuvant chemotherapy,1
38434,no aspirin,1
38435,morab-004 (monoclonal antibody),1
38436,hot axios stent and electrocautery- enhanced delivery system,1
38437,observation-post rp,1
38438,acceptance and commitment therapy (act) group,1
38439,gemcitabine/cisplatin /s-1,1
38440,amxt1501,1
38441,icg dye and firefly fluorescence imaging,1
38442,radiotherapy to ipsilateral neck lymphatics and tumor bed (radiotherapy to one side of the neck),1
38443,3d ultrasound elastography by means of shear wave propagation into breast tissue,1
38444,personal hygiene care,1
38445,pipac with abraxane,1
38446,definitive external beam radiation in the ipsilateral neck,1
38447,care pathways for colorectal cancer,1
38448,tsd-001,1
38449,vcd,1
38450,azd1480 daily,1
38451,sh u04722,1
38452,slc1a5 expression,1
38453,bortezomib + igev,1
38454,rna gene expression analysis,1
38455,eus guided stent insertion,1
38456,temozolomide chemotherapy,1
38457,picato,1
38458,scc,1
38459,nivolumab cohort 2,1
38460,endovascular stents implantation,1
38461,transmid™,1
38462,alpha fetoprotein plasmid dna vaccine,1
38463,gp100: 209-217(210m) peptide,1
38464,indium in 111 folic acid,1
38465,prone radiotherapy,1
38466,vaginal hysterectomy,1
38467,"20 hz, 10 s, 10 trains with inter-train interval 30 s 2000 pulses , intensity 80% over hand area daily for 10 consecutive days (5 days/week).",1
38468,upfront cytoreductive surgery,1
38469,"anatomical segmentectomy, lobectomy or bilobectomy",1
38470,non invasive venous ultrasound,1
38471,kpt-9274 & niacin er,1
38472,tomotherapy treatment,1
38473,[131i]icf01012 (therapeutic dose level 3),1
38474,hemoporfin pdt,1
38475,sl-801,1
38476,fruquintinib +paclitaxel,1
38477,radiology,1
38478,philips mr guided hifu system,1
38479,brachytherapy remedial,1
38480,spray cryotherapy,1
38481,cabazitaxel plus prednisone,1
38482,az6244,1
38483,farlutal tab. 500mg/ pfizer,1
38484,polar wand carbon dioxide cryotherapy,1
38485,bevacizumab 25 mg in 1 ml subcutaneously daily,1
38486,bortezomid (velcade®),1
38487,av0113 dc-cit,1
38488,aromatherapy scented wand,1
38489,"cd40 agonist monoclonal antibody cp-870,893",1
38490,immunotherapy with cyclophosphamide plus chemotherapy,1
38491,jnj-527,1
38492,breast tomosynthesis,1
38493,axitinib oral tablet,1
38494,hematopoietic stem cell,1
38495,surgical resection of colonic adenocarcinoma stage iii or ii high risk,1
38496,biological: muc1 peptide specific immunotherapy,1
38497,dynamic contrast enhanced molecular resonance imaging (dce-mri),1
38498,changes in postoperative care,1
38499,individual therapy,1
38500,lde225b,1
38501,observational chemotherapy,1
38502,stereotactic body radiation therapy boost,1
38503,90yttrium-ibritumomab tiuxetan (zevalin®)+rituximab,1
38504,intraoperative radiofrequency ablation,1
38505,cyramza (ramucirumab),1
38506,echotip procore? hd ultrasound biopsy needle,1
38507,aracytine,1
38508,leuprolide or goserelin,1
38509,melatonin (n-acetyl-5-methoxytryptamine),1
38510,onc-201,1
38511,pohim-ccrt,1
38512,dyspnea intervention,1
38513,tissue bank,1
38514,panitumumab and cpt-11,1
38515,ct angiography,1
38516,neuroregen scaffold/bmmcs transplantation,1
38517,afatinib - 1b,1
38518,ly3214996,1
38519,beery test of visual motor integration 6th edition,1
38520,h3b-6527,1
38521,cisplatin (cisplatyl),1
38522,cognitive dysfunction coping strategy teaching sheet,1
38523,endoscopic ultrasound - radiofrequency ablation (eus-rfa),1
38524,da vinci surgical robot platform,1
38525,flow cytometry analyses,1
38526,hpv-16/18 vlp/as04 vaccine (cervarix tm),1
38527,radiation and chemotherapy,1
38528,attention,1
38529,hmg,1
38530,gsk2857916 anti-bcma-adc,1
38531,health enhancement program,1
38532,talotrexin,1
38533,cytokine-induced killer cell (cik) treatment,1
38534,thermographic breast examination performed by braster device,1
38535,bion-1301,1
38536,"endomicroscopy, targeted biopsy and 16s rrna gene sequencing",1
38537,pre-surgical docetaxel and cisplatin and adjuvant bevacizumab,1
38538,pet/ct or conventional diagnostics including ct,1
38539,cnto888 + docetaxel,1
38540,bevacizumab plus docetaxel,1
38541,tumour volume delineation and comparison,1
38542,mesothelin expression,1
38543,hematopoietic progenitor cell transplantation (hpct),1
38544,fff with cad/cam customized cutting guide,1
38545,"assessment of percentage of treg, th17, nkt and serum level of he4, ca125 and roma.",1
38546,oral administration of s-1,1
38547,uae,1
38548,acalabrutinib and pembrolizumab combination,1
38549,usual best practices,1
38550,real-time view,1
38551,fecal samples,1
38552,5 fluorouracyl,1
38553,cyp3a (midazolam),1
38554,s1 plus docetaxel,1
38555,(99m tc) ecdg (ethylenedicysteine-deoxyglucose),1
38556,immediate release (ir) formulation,1
38557,tak-448,1
38558,"gefitinib, irinotecan, cycophosphamide, doxorubicin, etoposide, cisplatin, topotecan, carboplatin, melphalan, 13-cis retinoic acid",1
38559,holerbt,1
38560,c11 methionine pet scan,1
38561,computer-aided diagnosis,1
38562,3d-ultrasound and fusion of ul and pet/ct,1
38563,radio opaque markers (echo tip ultra fiducial needle - etuf),1
38564,intrathecal (it) triple chemotherapy prophylaxis,1
38565,standard palliative chemotherapy,1
38566,hmg-hp,1
38567,hyaluronic acid (ha),1
38568,stereotactic body radiotherapy sbrt,1
38569,daylight mediated photodynamic therapy,1
38570,"tests (fagerström, q-mat, h.a.d.s, scl 90-r)",1
38571,cognitive behavioural therapy (cbt),1
38572,cpx-351 (cytarabine:daunorubicin) liposome injection,1
38573,imilt,1
38574,keyhole limpet hemocyanin (klh),1
38575,high dose melphalan and autologous bone marrow transplantation,1
38576,"s-1, gemcitabine",1
38577,pegylated alfa interferon,1
38578,mflofox6 + pembrolizumab,1
38579,thermochemotherapy (with 5-fluorouracil/interferon-a/liposomal doxorubicin),1
38580,trans sodium crocetinate plus soc,1
38581,gh replacement (nutropinaq®),1
38582,25 gauge needle,1
38583,combination of trastuzumab and ps-341,1
38584,ivc diameters evaluation by intraoperative ultrasound,1
38585,breast cancer,1
38586,"genexol-pm 220mg/?, carboplatin 5auc",1
38587,chemo buddy,1
38588,evicel,1
38589,health chat excluding indoor tanning,1
38590,invagination,1
38591,nasojejunal tube insertion,1
38592,ethanol injection,1
38593,early mri and pet/ct - 2 weeks after commencing chemo/rt,1
38594,neural stem cells loaded with an oncolytic adenovirus,1
38595,hand-foot massage,1
38596,placebo oral gel,1
38597,split cisplatin,1
38598,ptv56,1
38599,"hla-a*2402restricted urlc10, cdca1, and kif20a peptides with adjuvant",1
38600,no other preventive treatment,1
38601,"cyclophosphamide, fludarabine, t-cells, interleukin-2",1
38602,minimally-invasive procedure,1
38603,"placebo (0,9% nacl)",1
38604,latinos cares toolkit,1
38605,proton boost,1
38606,90y-dotatoc,1
38607,etbx-011; adenoviral cea vaccine,1
38608,gsk3326595,1
38609,anti-mesothelin car-t cells,1
38610,patients accessing to radiotherapy unit,1
38611,telephonic interview,1
38612,weekly abraxane and daily vandetanib,1
38613,different temperature-controlled breast prostheses,1
38614,split dose low-volume peg solution,1
38615,engerix-b,1
38616,historical control,1
38617,6000 cgy/20 fractions in 4 weeks,1
38618,control protein diet,1
38619,pbf-1129,1
38620,stabilisation of (impending) pathological fracture,1
38621,chemotherapy for colorectal carcinoma,1
38622,bladder wall thermotherapy with mitomycin-c,1
38623,tylenol #3 oral tablet,1
38624,"flaimy - fluda, ida, ara-c, mylotarg",1
38625,moc31-pe,1
38626,newsletters,1
38627,immunochemistry and molecular biology on sentinel lymph node specimen,1
38628,bibw 2992 plus tmz,1
38629,minimalist/low-risk follow up (ia g1; ia g2),1
38630,cavity spinewand,1
38631,infusion of modified car19 t-cells (4g7-card t-cells),1
38632,haled,1
38633,ect-001 (um171) expanded cord blood,1
38634,monoclonal antibody e2.3,1
38635,2-hydroxyflutamide depot,1
38636,ltme,1
38637,oxaliplatin and capecitabine,1
38638,"gemcitabine, etoposide",1
38639,cogmed®,1
38640,endoluminal bile duct brachytherapy,1
38641,eprex,1
38642,trivalent ganglioside vaccine,1
38643,non-ncrt,1
38644,placebo + gemcitabine,1
38645,virtual biopsy (vb) monitoring protocol,1
38646,placebo qhs and sildenafil and questionnaires,1
38647,lutetium lu 177-dotatate,1
38648,no limited movement after surgery,1
38649,surgical planning,1
38650,abvd q4 weeks,1
38651,olympus nbi colonoscope 180 hdtv narrow band imaging (diagnostic test),1
38652,dc/tumor fusion vaccine,1
38653,autologous dendritic cell cancer vaccine,1
38654,collection of tumor and blood specimen,1
38655,"adma (asymmetric dimethylarginine) , ntprobnp (n-terminal pro b-type natriuretic peptide), il-6 (interleukin 6), adiponectina, leptine, syndecan, resistin",1
38656,ima101 product,1
38657,limited fasciectomy,1
38658,ssg & interferon,1
38659,oxaliplatin;irinotecan;leucovorin;5-fluorouracil;capecitabine;s-1,1
38660,posaconazole prophylaxis 120 mg/m² tid,1
38661,information + narratives + support group,1
38662,hits,1
38663,doxycycline or placebo,1
38664,pazopanib gw786034,1
38665,prophylactic nipple-areolar complex rt,1
38666,stereotactic radiosurgery plus her-2 directed therapy in her2-positive breast cancer with brain metastasis,1
38667,0.5% marcaine 20ml,1
38668,reduced intensity allogeneic hct,1
38669,"irinotecan&temsirolimus:arm1, level 1",1
38670,autologous genetically modified t cells,1
38671,anti-tnf therapy,1
38672,cto and bevacizumab,1
38673,implementation of anl,1
38674,walking (control),1
38675,cyberknife stereotactic ablative body radiation therapy,1
38676,exposed,1
38677,vpa fec100,1
38678,in-person genetic counseling,1
38679,"ipilimumab, melphalan and dactinomycin",1
38680,irhythm zio xt patch,1
38681,varenicline 0.5 mg,1
38682,g-bm transplant,1
38683,"trastuzumab, docetaxel",1
38684,alvac-cea-b7.1 vaccine,1
38685,ar antagonist (bms-641988),1
38686,testimonials from breast cancer survivors,1
38687,ub-921,1
38688,peace of mind program,1
38689,fatigue education program,1
38690,high-flow nasal cannula oxygenation,1
38691,hdr 1 fraction,1
38692,horse chestnut seed extract,1
38693,primary tumor resection,1
38694,arginine,1
38695,physical activity and dietary change,1
38696,sentinel lymph node technique,1
38697,hippocampal avoidance pci,1
38698,standard supportive therapy,1
38699,tno155,1
38700,albumin-bounded paclitaxel,1
38701,internal stent,1
38702,transanally curable surgical resection,1
38703,retroviral vector-transduced autologous t cells to express cd22-specific cars,1
38704,radiation: 50gy in 5 fr (max) to 25 gy in 5 fr (min). dose adapted to deliver the highest dose level while respecting normal tissue tolerance,1
38705,perioperative folfox-bevacizumab,1
38706,inc424/incb018424,1
38707,promis-qol,1
38708,modified folfox-6,1
38709,polymer based fiducial placement,1
38710,low calorie diet,1
38711,rf ablation (rita medical systems model 1500x),1
38712,spi-1005 low dose,1
38713,icotinib with concurrent radiotherapy,1
38714,mds,1
38715,sham tdcs,1
38716,gemcitabine 1250 mg/m^2 plus carboplatin auc 4-6 mg/ml per minute iv infusion,1
38717,"docetaxel, liposomal doxorubicine and cyclophosphamide",1
38718,u3-1287 (amg888),1
38719,bibw 2992 ma2 20mg/day,1
38720,jamar hand dynamometer,1
38721,radiation: proton therapy+pd-1 ab,1
38722,emprint microwave ablation system,1
38723,learning session 2,1
38724,ak001 low dose,1
38725,fmwand surgical system,1
38726,post mastectomy radiation therapy,1
38727,131-i-tm-601 (chlorotoxin),1
38728,lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic stem/progenitor cells,1
38729,gadd45? methylation and expression analysis,1
38730,nucleus profile abi541 auditory brainstem implant,1
38731,"licartin (generic name,[131i]metuximab injection)",1
38732,reexamine,1
38733,optional relative supports,1
38734,iris (intelligent real-time image segmentation),1
38735,peg- bct-100,1
38736,dc-pmat treatment,1
38737,"ugtia1 genotyping (6,7)",1
38738,autologous or allogeneic stem cell transplantation,1
38739,uterine lavage catheter,1
38740,dsm-tace,1
38741,brassica vegetable,1
38742,record general information,1
38743,height rt,1
38744,multi-antigen cmv-modified vaccinia ankara vaccine,1
38745,blood sample(10cc) collection,1
38746,laboratory blood test,1
38747,three-dimensional ultrasound-guided biopsy,1
38748,bortezomib and temozolomide phase ib,1
38749,"capecitabine, oxaliplatine",1
38750,11c-jnj-63779586,1
38751,vats for confirmed non-small cell lung cancer (nsclc),1
38752,without resorbable barrier (seprafilm),1
38753,gastrectomy plus d2 lymphadenectomy,1
38754,fludarabine/ melphalan,1
38755,exercise program moderate intensity,1
38756,no prehab; erp alone,1
38757,imaging: diffusion-weighted mri,1
38758,veru-111,1
38759,bms-275183 (oral taxane),1
38760,mindful awareness practices (maps),1
38761,anti-myeloma treatment at physician discretion,1
38762,153sm-dotmp,1
38763,mr colonography and mr of the liver,1
38764,epistatus alone,1
38765,permanent seed implantation,1
38766,no intervention in this restrospective study,1
38767,"capecitabine, oxaliplatin, docetaxel",1
38768,hyperbaric oxygen treatment,1
38769,cpi-100,1
38770,leuprorelin (gf),1
38771,activated cik and cd3-muc1 bispecific antibody in treating pancreatic cancer,1
38772,arm b calcineurin inhibitor and methotrexate,1
38773,pep-3-klh,1
38774,soccer training,1
38775,questionnaire 1,1
38776,decaffeinated black tea,1
38777,placebo (p),1
38778,tr?freeze® system spray cryotherapy,1
38779,gsk2110183 ir tablet,1
38780,"6-mercaptopurine, methotrexate, vincristine, dexamethasone",1
38781,[18f]-cp18,1
38782,vacuum constriction device,1
38783,oncotype dx breast cancer test,1
38784,zoledronic acid + calcium/vitamin d,1
38785,adl intervention,1
38786,topical myristyl nicotinate cream,1
38787,paclitaxel micelles for injection,1
38788,gleevec + temozolomide,1
38789,systems analysis and improvement approach,1
38790,cti/siemens biography 40 pet/ct,1
38791,dose adaptation,1
38792,[c14] selumetinib (oral),1
38793,pet at 18f-fdopa,1
38794,68gallium dotatate,1
38795,fludarabine 30 mg/m2/d for 3 days,1
38796,tas3681,1
38797,transition program,1
38798,placebo normal saline,1
38799,bevacizumab plus chemotherapy,1
38800,computed tomography scan (ct),1
38801,vinorelbine/cisplatin,1
38802,denosumab inj 60 mg/ml,1
38803,collection of blood specimen,1
38804,placebo beetroot juice,1
38805,bay94-9392,1
38806,conventional ct,1
38807,health related quality of life collected via ches,1
38808,exercise + diet counseling,1
38809,peripheral blood donor,1
38810,mrghifu,1
38811,curative gastrectomy,1
38812,nottingham health profile (nhp),1
38813,"5-azacytidine, erlotinib",1
38814,pd-1 and dc-cik cells,1
38815,"docetaxel, cisplatin, capecitabine",1
38816,oxaliplatin and fluorouracil,1
38817,benfin,1
38818,head and neck garments for pneumatic compression device.,1
38819,no lymphadenectomy (lne),1
38820,cyberknife boost 21 gy,1
38821,behavior activation treatment (bat),1
38822,anthracycline-based,1
38823,ibritumomab tiuxetan (zevalin) + rituximab,1
38824,liposomal ara-c,1
38825,observation or mitotane,1
38826,usual cancer care,1
38827,hdmp,1
38828,cisplatin (dose level 3),1
38829,autologous tumor infiltrating lymphocytes (tils),1
38830,mibefradil,1
38831,na134i,1
38832,gsk 1437173a,1
38833,pt2977 in combination with cabozantinib tablets,1
38834,spectrum analysis,1
38835,nutritional therapy,1
38836,cerebral prophylactic radiation,1
38837,traditional neck dissection,1
38838,etanercept 50 mg/ml,1
38839,tailored web-based care program (health navigation®),1
38840,ala (5-aminolevulinic acid),1
38841,interval dosing,1
38842,iniparib (sar240550/bsi-201),1
38843,hypofractionned radiotherapy,1
38844,standard myeloma treatment,1
38845,irinotecan (3-week schedule),1
38846,pep-3-klh conjugate vaccine,1
38847,combination therapy using decitabine and midostaurin,1
38848,bilateral neck dissection,1
38849,no adjuvant therapy,1
38850,gps communication skills and crc screening,1
38851,larotaxel,1
38852,c13 n15 valine,1
38853,forticare®.,1
38854,recruitment maneuver,1
38855,trans-rectal biopsy,1
38856,tremelimumab (regimen 1),1
38857,sparc1028,1
38858,pol-103a,1
38859,tvs-ctl vaccine,1
38860,radiation method a,1
38861,light glasses (experimental),1
38862,pertuzumab and trastuzumab fdc sc,1
38863,abdominal wall reconstruction with xenmatrix,1
38864,structured exercise,1
38865,plastic and metalic stent inserion,1
38866,photo(chemo)therapy,1
38867,10 cc of 0.375% ropivacaine pectoral nerve block,1
38868,ultrasound-guided insertion of picc,1
38869,active,1
38870,lecture plus cd-rom,1
38871,me-nbi observation and me-nbi targeted biopsy,1
38872,whey powder protein,1
38873,"amr101 (vascepa, icosapent ethyl)",1
38874,partial remission (pr) group,1
38875,ovarian cancer screening and diagnosis,1
38876,multi planar mri,1
38877,antigen-specific cytotoxic t lymphocytes induced by dendritic cells infected by recombinant adeno-associated virus with cea gene,1
38878,"5-flourouracil, interferon-a, il-2 and thalidomide",1
38879,"cobimetinib, dexamethasone, ixazomib, pomalidomide",1
38880,conventional roux-en-y reconstruction (ryc),1
38881,agen1884,1
38882,interstitial multicatheter brachytherapy,1
38883,cisplatine,1
38884,structural image guidance,1
38885,hypofractionated whole breast irradiation,1
38886,arac (intrathecal),1
38887,nanopac® 400 mg/m2,1
38888,dual fdg-pet/ct,1
38889,ultrasound by an expert ultrasonographist,1
38890,video recording of flexible cystoscopic examination,1
38891,k27m peptide,1
38892,patient preference in treatment decision making,1
38893,"lcadls, facit-pal, facit-ts questionnaires",1
38894,mk-4166,1
38895,lactated ringers,1
38896,furocyst,1
38897,telephone based counseling,1
38898,fast mri and mammography screening,1
38899,mdi - self-rating inventory,1
38900,esomeprazole treatment,1
38901,triptorelin (gnrha) + chemotherapy,1
38902,neoadjuvant chemoradiation followed by surgery,1
38903,"temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid",1
38904,epirubicin + cisplatin + 5-fluorouracil or epirubicin + cisplatin + capecitabine or epirubicin + oxaliplatin + capecitabine or 5-fluorouracil + leucovorin + oxaliplatin + docetaxel,1
38905,gm-csf and g-csf,1
38906,"alemtuzumab (mabcampath, bay86-5045) and fludarabine phosphate (fludara, bay86-4864)",1
38907,sorafenib plus capecitabine (sorcape),1
38908,youth tobacco and nicotine product questionnaire,1
38909,btsc mrna-loaded dcs,1
38910,molli localization,1
38911,mailed training intervention,1
38912,castor oil,1
38913,poor responder group adjuvant chemotherapy,1
38914,gluten free diet,1
38915,ni group,1
38916,anti-rankl monoclonal antibody,1
38917,use of ivr system to improve adherene to gi appointments and prep procedures,1
38918,hs-wbrt pci,1
38919,opti-aged,1
38920,hyperimmune caprine serum against hiv lysate,1
38921,personalized coaching,1
38922,sham comparator: control,1
38923,liver transection during laparoscopic liver resection,1
38924,tarenflurbil,1
38925,detection of the expression of dmtb1 by immunohistochemistry,1
38926,"7 day h.pylori eradication omeprazole or rabeprazole, clarithromycin, amoxicillin",1
38927,"e. coli asparaginase, peg-l-asparaginase",1
38928,quality of life questionaries,1
38929,dexpanthenol 5% cream,1
38930,second session,1
38931,injection of tvec into target lesions 2wks after 2nd injection,1
38932,herba scutellaria barbatae (hsb),1
38933,3d laparoscope,1
38934,cetuximab 500 mg/m^2,1
38935,"nivolumab,low dose cyclophosphamide",1
38936,oral belinostat,1
38937,fentanyl ethypharm,1
38938,proton radiation standard fractionation,1
38939,collection of leukemia cells,1
38940,complete surgical removal,1
38941,stereotactic hypofractionated rt 5x5gy,1
38942,jet ventilation group,1
38943,tape measurement of arm,1
38944,chr-3996,1
38945,sorafenib (sor),1
38946,cigb300,1
38947,problem-solving intervention,1
38948,chemical exchange saturation transfer mri,1
38949,nilotinib+mvpd,1
38950,telomerase peptide vaccine gv1001,1
38951,reminder call,1
38952,robotic-assisted partial nephrectomy,1
38953,endotag-1 + paclitaxel,1
38954,ombitasvir/paritaprevir/ritonavir,1
38955,vegf?tki,1
38956,early leukostim,1
38957,modulated radiotherapy (imrt) using rapidarc® or helical tomotherapy® at a dose of 70 gy in 33 fractions to the ptv (gtv) and 59.4 gy in 33 fractions,1
38958,lanreotide (autogel formulation) and temozolomide,1
38959,nivolumab in combination with urelumab,1
38960,uterus transplantation,1
38961,polatuzumab vedotin (liquid),1
38962,cis platinum,1
38963,hekt cell,1
38964,ultrasound guided prostate exam using soc ultrasound system,1
38965,"paclitaxel, cisplatin plus 5-fu (tcf)",1
38966,accelerated fraction,1
38967,conventional lymph node dissection,1
38968,resection of infiltrated veins,1
38969,lebs - low coherence enhanced backscattering,1
38970,resection of metastases,1
38971,ct + ocoxin-viusid,1
38972,paclitaxel/gemcitabine/trastuzumab,1
38973,deca,1
38974,hematopoietic stem cells from bone marrow or peripheral blood,1
38975,"timing of surgery after 3 cycles of standard nact, ids",1
38976,twi 15 fractions,1
38977,tai chi chuan,1
38978,pembrolizumab 100 mg i.v single dose,1
38979,lv5fu2 or capectitabine,1
38980,phase i dose-finding study of sorafenib study,1
38981,non-cathartic ctc,1
38982,focused ultrasound (mrgfus),1
38983,glycosylated recombinant human g-csf avi-014,1
38984,idc-g305,1
38985,simulated ql block,1
38986,ly2875358 at part a highest dose,1
38987,infliximab; gemcitabine,1
38988,high risk with partial remission after 1 abvd and 1 eshap courses. six more chemotherapy courses are delivered alternating eshap and abvd.,1
38989,bladder tumor recurrence,1
38990,placebo sugar pill,1
38991,thrivors+bh,1
38992,"capecitabine, interferon-alpha",1
38993,hand function and balance tests,1
38994,ptk787 (vatalanib),1
38995,lbh589 (panobinostat),1
38996,epidermal growth factor (egf) ointment,1
38997,"8 cycles of mfolfox-6 + cetuximab, followed by cetuximab alone until disease progression or early withdrawal.",1
38998,swallowing questionnaire,1
38999,microwave ablation combined with tace,1
39000,lbh589 and rad001,1
39001,prohibitin-tp01,1
39002,tace+external beam rt,1
39003,induction chemotherapy arm a,1
39004,nutritional questionnaire and nutritional counseling,1
39005,no ai presentation,1
39006,"cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate (cdefm)",1
39007,radiotherapy 60 gy,1
39008,gpert,1
39009,atg (thymoglobulin),1
39010,modified cdt program,1
39011,"bnp, saag, ascites total protein, echocardiography",1
39012,emotions thermometer,1
39013,anti-thymocyte globulin iv,1
39014,daratumumab (16 mg/kg),1
39015,collection of additional data with questionnaires,1
39016,educational advises group,1
39017,peg-asp in consolidation-3,1
39018,mrna coding for melanoma associated antigens,1
39019,maintenance:bevacizumab+capecitabine+cyclophosphamide,1
39020,novottf-l00a,1
39021,apbi (dose escalation),1
39022,sgn-30 (anti-cd30 mab),1
39023,fluid bolus,1
39024,nivolumab 10 mg/ml intravenous solution,1
39025,intraoperative pathological examination,1
39026,amoxycillin/clavulanic acid,1
39027,naloxone hydrochloride,1
39028,sst0001 (roneparstat),1
39029,truthful information on chemotherapy risks,1
39030,lmp1 specific cytotoxic t-lymphocytes,1
39031,"lucentis, chemotherapy",1
39032,paclitaxel (pac),1
39033,audio recordings of clinical consultations,1
39034,paclitaxel + pazopanib,1
39035,robot-assisted resection,1
39036,intravenous patient controlled analgesia,1
39037,kanglaite injection/capsules,1
39038,rituximab-cvp,1
39039,fixed respiratory rehabilitation,1
39040,50% oxygen/50% nitrogen premix,1
39041,tasonermine (tnfa),1
39042,stepped care,1
39043,serial 124i pet/ct,1
39044,email coaching,1
39045,folfox + bevacizumab,1
39046,belinostat and erlotinib,1
39047,osimertinib 80mg/40mg,1
39048,90y-zevalin,1
39049,radiation: chemoradiotherapy with gemcitabine,1
39050,9.6 mg/kg ?-tea,1
39051,leftover surgical tissue homogenization,1
39052,transanal decompression tube,1
39053,antiperistaltic side-to-side ileocecal anastomosis,1
39054,"exjade® (deferasirox, icl670)",1
39055,gemcitabine after surgery,1
39056,colonoscopy with biopsies or lesion removal when required,1
39057,a multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus),1
39058,peripheral blood transplant,1
39059,pet 18fdopa,1
39060,isolated limb perfusion (ilp),1
39061,pre-gastrectomy peritoneal washing cytology,1
39062,focus group session,1
39063,near infrared fluorescence imaging during laparoscopic or robotic gastrectomy,1
39064,2cda,1
39065,"panitumumab, tas-102",1
39066,treatment i,1
39067,comparator: biomarker evaluation,1
39068,clemizole hydrochloride,1
39069,flox (5-fluorouracil/folinic acid/oxaliplatin),1
39070,single injection paravertebral block,1
39071,150mg vandetanib,1
39072,abt-888 40 mg x 5 days,1
39073,c11-choline,1
39074,"rad001, letrozole 2.5mg",1
39075,masct:multiple antigens specific cellular therapy,1
39076,bibw2 component a,1
39077,"air insufflation with standard endoscopy unit, co2 insufflation for colonoscopy (special co2 insufflation unit)",1
39078,"5-fu, capecitabine, oxaliplatin, leucovorin.",1
39079,lenalidomide induction,1
39080,"letrozole, leuprorelin, fluorouracil, epirubicin, cyclophosphamide, docetaxel",1
39081,stereotactic radiosurgery boost,1
39082,mobio powersoil dna isolation kit,1
39083,sequence chemoradiotherapy,1
39084,alln-177,1
39085,oc - drospirenone plus ethynylestradiol,1
39086,doxil and vinorelbine,1
39087,endoscopic posterior mesorectal resection,1
39088,lap protector,1
39089,zd9393 (zoladex) 3.6 mg,1
39090,acetazolamide in combination with platinum and etoposide-based radiochemotherapy,1
39091,breast cancer cohort,1
39092,pro-active eat + exercise,1
39093,clinical pain assessments,1
39094,surgical resection of cancer,1
39095,ch5132799,1
39096,colonoscopy + mailed fit outreach and follow-up,1
39097,bio-seal track plug,1
39098,low carbohydrate diet + exercise,1
39099,arm 3 probes,1
39100,linear aerobic training,1
39101,monoclonal antibody huj591,1
39102,combined physiotherapy,1
39103,transarterial chemoembolisation using cisplatin-lipiodol mixture,1
39104,dcb-bo1202+placebo,1
39105,ly317615,1
39106,adjuvant tmz 200mg,1
39107,non-neutropenic diet,1
39108,caelyx®,1
39109,ct abdomen and pelvis scan + whole body pet-ct scan,1
39110,online gym,1
39111,reduced-intensity maintenance chemotherapy,1
39112,lower-limb drainage isotopic intraoperative detection,1
39113,4dimensional phase contrast magnetic resonance angiography,1
39114,"valrubicin, 800 mg",1
39115,ic-green,1
39116,"irinotecan, capecitabine, oxaliplatin (ixo) and bevacizumab",1
39117,nanosomal docetaxel lipid suspension (75 mg/m2),1
39118,extra imaging,1
39119,gabapentin + tramadol,1
39120,bni-brief negotiated interview,1
39121,t gamma delta lymphocytes,1
39122,"ges (gemcitabine, erlotinib, s-1)",1
39123,placebo plus chemoradiotherapy,1
39124,immther,1
39125,cogmedrm,1
39126,methotrexate (intrathecal),1
39127,neck dissection followed by radiotherapy(50gy) according to risk factors,1
39128,blood and urine,1
39129,radiotherapy 54 gy,1
39130,pet tracer (bay94-9392),1
39131,tailoring the flap according to icg angiography assessment,1
39132,bellows-based breath hold device,1
39133,clomiphene citrate-ufsh arm,1
39134,naltrexone/bupropion,1
39135,palbociclib/placebo,1
39136,atope-b,1
39137,technologist-controlled (tc) compression,1
39138,observational (no sbrt),1
39139,"rituximab, cyclophosphamide, vincristine, and prednisolone",1
39140,health education series,1
39141,"belinostat, carboplatin, paclitaxel and bevacizumab",1
39142,ofatumumab (arm a),1
39143,ercp with 11.5 french biliary plastic stent,1
39144,pf-06647020 combined with avelumab,1
39145,"clofarabine, etoposide, mitoxantrone",1
39146,vaccinia-gm-csf vaccine,1
39147,specificity cd38 car-t cells,1
39148,rfa for ptmc,1
39149,famos: psychosocial family intervention,1
39150,durvalumab + danvatirsen,1
39151,ots167po,1
39152,physical activity counseling via computer,1
39153,fit(eiken oc-sensor) two-day sampling,1
39154,mbp-426,1
39155,haploidentical il-15 stimulated nk cells,1
39156,activella,1
39157,proactive telephone toxicity management,1
39158,secretin-enhanced endoscopic ultrasound,1
39159,high chlorophyll diet - intervention 1st,1
39160,profertil female,1
39161,genomically directed monotherapy,1
39162,e7389 28 day cycle,1
39163,mri pelvic,1
39164,brca 1,1
39165,electromagnetic fields of low energy (eefle),1
39166,oxaliplatin capecitabine,1
39167,4.8 mg/kg ?-tea,1
39168,net intervention,1
39169,mrna-4157,1
39170,paramedical care,1
39171,magnetic resonance lymphangiography sentinel node mapping,1
39172,tredaptive (nicotinic acid/ laropiprant),1
39173,oc:e-e-desogestrel/vaginal ring:e-e -ethonogestrel,1
39174,corticosteroid with normal saline,1
39175,mycophenolic acid (mpa),1
39176,cdx-1401 in combination with resiquimod and/or poly-iclc,1
39177,tace alone,1
39178,pulsed dye laser 577 nm,1
39179,"cp-751,871 + carboplatin + paclitaxel",1
39180,tamoxifen alone,1
39181,tivozanib + paclitaxel,1
39182,usual care of ehr-only intervention,1
39183,magnetic resonance angiography (mra) of the breast,1
39184,psychosocial telephone counseling (ptc),1
39185,topical gemcitabine hydrochloride,1
39186,25 gauge procore needle biopsy,1
39187,12-month icotinib,1
39188,cyclophosphamide; fludarabine; cyclosporin; campath-1h (alemtuzumab); gm-csf,1
39189,tak-931 tablet,1
39190,research questionnaires,1
39191,orange aromatherapy,1
39192,enoxaparin 40mg/0.4ml prefilled syringe,1
39193,circulating tumor dna methylation test,1
39194,preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine,1
39195,cd#2,1
39196,brain radiotherapy or stereotactic radiosurgery,1
39197,cp-4055 (elacyt),1
39198,making a decision about crc screening,1
39199,therasphere® in association with gemcitabine and cisplatin,1
39200,"autologous peripheral blood mononuclear cells ex vivo depleted for reactive t cells, using th9402 based photodynamic therapy, in a final formulation of 10% dmso, 30% autologous plasma in plasmalyte.",1
39201,"bevacizumab, paclitaxel",1
39202,iniparib + irinotecan,1
39203,cyclophosphamide.,1
39204,peripheral blood mononuclear cells (pbmc) for mrna analysis,1
39205,chest ultrasound,1
39206,utility cost evaluation,1
39207,"prostate biopsy, prostatectomy or prostate resection",1
39208,respiratory endoscopy,1
39209,long course radiotherapy,1
39210,k5-rgd pet,1
39211,irofulven + oxaliplatin,1
39212,oral nutrition,1
39213,dexamethasone and dose-dense immunochemoterapy,1
39214,accl. rt,1
39215,full dose antithrombotics,1
39216,neutropenic diet,1
39217,lcar-b4822m car-t cell immunotherapy,1
39218,"blood, stool, pancreatic juice and cyst fluid collection",1
39219,4-l-[131i]iodo-phenylalanine (131i-ipa),1
39220,prephase pdn + cy,1
39221,ac4-cddp4,1
39222,peritoneal washing cytology,1
39223,tazarotene cream 0.1%,1
39224,tocovid suprabio plus pentoxifylline,1
39225,"epirubicin, cyclophosphamide and docetaxel",1
39226,pre-endoscopic screening risk assessment,1
39227,ccr2/ccr5 dual antagonist,1
39228,pf-06952229,1
39229,compound realgar natural indigo tablet,1
39230,e7777 9 mcg/kg,1
39231,subutinib maleate capsules,1
39232,gem/nab-pac,1
39233,surgery for breast cancer,1
39234,irinotecan (administered with & without cetuximab),1
39235,portal embolization or ligation,1
39236,placebo to bibf 1120 es,1
39237,cgm097,1
39238,atir,1
39239,primary antifungal prophylaxis,1
39240,chlorhexidine gluconate disk,1
39241,removal of tumor and tissue,1
39242,trimodal prehabilitation,1
39243,"ict of oxapliplatin, irinotecan, leucovorin, and fluorouracil and ccrt",1
39244,frailty markers,1
39245,nature sounds,1
39246,hai oxaliplatin,1
39247,fenretinide/lxs + ketoconazole,1
39248,haplo-identical transplantation,1
39249,co2-laser treatment,1
39250,letrozolo+sorafenib+cyclophosphamide,1
39251,strong together serious game,1
39252,ms201408-0005a,1
39253,green tea extract of camellia sinensis,1
39254,"cipro, metronidazole, neomycin combo",1
39255,selective neck dissection excluding level iib,1
39256,mdcf + avelumab,1
39257,golytely,1
39258,alemtuzumab i.v.,1
39259,single cycle intensive chemotherapy,1
39260,"veliparib, tablet",1
39261,endorings™,1
39262,sulindac and placebo,1
39263,rhenium-188-hedp,1
39264,sorafenib combined with hydroxychloroquine,1
39265,autologous immune cell therapy,1
39266,incb086550,1
39267,nccn problem list,1
39268,folic acid with riboflavin,1
39269,tru-015,1
39270,lar lanreotide,1
39271,sodium chloride solution 0.9%,1
39272,self-monitoring (fitbit),1
39273,mobile health app tool - twistle,1
39274,arm a : gemcitabine + pemetrexed,1
39275,"oxaliplatin/irinotecan + capecitabine, 5-fui ± bevacizumab",1
39276,mgn1703 treatment,1
39277,interventional arm: early best palliative care,1
39278,pegol-sihematide injection,1
39279,yttrium 90 glass microspheres,1
39280,etv?tdf?adv,1
39281,expanded natural killer (enk) cells,1
39282,cold instant coffee,1
39283,screening invitation (with education),1
39284,islet cell transplant,1
39285,white-light surgery,1
39286,cares intervention educational materials,1
39287,immediate implant breast reconstruction,1
39288,t2* mri of the pancreas,1
39289,lapatinib plus esomeprazole,1
39290,sb as-2 adjuvant,1
39291,eryfotona ak-nmsc® cream,1
39292,impact advanced recovery®,1
39293,prevena,1
39294,vaccinia-cea vaccine,1
39295,polyps resection with laser diode,1
39296,rna-loaded dendritic cell vaccine,1
39297,water exchange sigmoidoscopy,1
39298,single incision laparoscopic hysterectomy,1
39299,paclitaxel and fluorouracil,1
39300,ciprofloxacine,1
39301,optimized internal radiation therapy,1
39302,ofc infusion,1
39303,dcc-3014,1
39304,flag+ida,1
39305,acyclovir 400 mg,1
39306,amlctl,1
39307,etidronate,1
39308,androgen deprivation therapy - bilateral orchidectomy,1
39309,"lsa4, cyclophosphamide, methotrexate, daunomycin, l-asparaginase, bcnu",1
39310,"crenolanib besylate (cp-868,596-26)",1
39311,csc,1
39312,nasal brushing,1
39313,ing-1(hemab),1
39314,pazopanib + gemcitabine,1
39315,ultrasound guided transversus abdominis plane (tap) bock,1
39316,preoperative data,1
39317,educational and counseling in group,1
39318,"fdg-pet, [18f]flutemetamol",1
39319,ag regimen,1
39320,gpbsc,1
39321,low-dose cytarabine (ldac),1
39322,pharmacist's behavioral intervention,1
39323,sr-t100 gel with 1.0 % sm,1
39324,docetaxel 20mg/m2/week + carboplatin auc 2/weekly - concomitant chemoradiation 2gy/day,1
39325,"seprafilm (sanofi, usa)",1
39326,peg interferon alpha 2b (peg intron),1
39327,integra®,1
39328,ipbs,1
39329,melphalan-prednisone-thalidomide,1
39330,occlusive heat patch,1
39331,"topical clindamycin 2%, triamcinolone acetonide 0.1% soln",1
39332,cerebral spinal (cs) radiation,1
39333,ct scan with continuous positive airway pressure (cpap) device,1
39334,177lu-eb-psma-617,1
39335,medi6469 plus rituximab,1
39336,jnj-26483327,1
39337,drainage and sclerotherapy.,1
39338,palifermin before and after,1
39339,cushing's qol (quality of life questionnaire),1
39340,stapled colorectal anastomoses,1
39341,rv-psa,1
39342,ulipristal acetate 5 mg,1
39343,microbiology,1
39344,cabazitaxel 12.5mg/m2,1
39345,mb-002,1
39346,mepitel film,1
39347,gastric atrophy and intestinal metaplasia,1
39348,recombinant tyrosinase-related protein-2,1
39349,internet-based exercise program,1
39350,uncovered biliary stents,1
39351,oral capecitabine with irinotecan,1
39352,liver transplantation combined with neoadjuvant therapy,1
39353,trans-anal total mesorectal excision(tatme),1
39354,targeted chemotherapy prior to surgery,1
39355,mage-12 peptide vaccine,1
39356,advance sling,1
39357,home based balance training,1
39358,carbon c 11 glutamine,1
39359,sonablate 500 (high intensity focused ultrasound (hifu)),1
39360,concurrent boost radiotherapy,1
39361,dce-mri and 18f-fmiso pet,1
39362,withdrawal of immunosuppression and donor lymphocyte infusion,1
39363,spermidine content of natural diet,1
39364,evozac calming skin spray,1
39365,rivogenlecleucel & rimiducid,1
39366,diclofenac sodium gel,1
39367,identification of circulating tumor cells,1
39368,telerehabilitation group,1
39369,gene expression microarray analysis,1
39370,baseline measures,1
39371,rhumab 2c4 (pertuzumab),1
39372,digit span subtest,1
39373,nucleoside analog reverse transcriptase inhibitor,1
39374,usage oral angiogenesis inhibitor,1
39375,"angiodynamics (previously rita med,inc) radiofrequency delivery system (consisting of a generator and starburst xl probe)",1
39376,fentanyl 500mcg + acupan 160mg + nasea 0.6mg,1
39377,glizigen®,1
39378,phil® device,1
39379,5-fu?intravenous infusion?+epirubicin+cyclophosphamide,1
39380,docetaxel 60mg/m2 every 21 days for 6 cycles,1
39381,educational enhancement intervention,1
39382,capecitabine rtd,1
39383,mgso4,1
39384,ruxolitinib 25 mg,1
39385,zirconium-89 girentuximab pet/ct,1
39386,deoxycoformycin (dcf),1
39387,gsk2110183 in combination with carboplatin and paclitaxel,1
39388,klh (keyhole limpet hemocyanin),1
39389,colonoscopy - position change,1
39390,yoga condition,1
39391,lexatumumab in combination,1
39392,tibetan meditation program,1
39393,mindfulness-based relationship enhancement (mbre),1
39394,different range of thyroid surgery,1
39395,diffusion -and perfusion weighted mri including iv contrast agent injection,1
39396,ley car t cells,1
39397,standard hbpc,1
39398,braf v600e positivity,1
39399,"colposcopy, spectroscopy, and biopsy",1
39400,cd19cat-41bbz car t-cells,1
39401,fit test and colonoscopy,1
39402,bcma cart + hucart19,1
39403,erlotinib + celecoxib,1
39404,postoperative treatment of chemotherapy and radiation,1
39405,laparoscopic spleen-preserving no.10 lymph node dissections,1
39406,pegaspargase 1250 iu/m2 x 2,1
39407,mpdl3280a dose level 2,1
39408,s1 capsule,1
39409,decision aid and navigation,1
39410,tem,1
39411,patient controlled opioid analgesia (pca),1
39412,nonmyeloablative allogeneic hsct,1
39413,whole brain radio therapy (wbrt) with sequential depocyte,1
39414,conventional laparoscopic hysterectomy (lh),1
39415,lbh589 (panobinostat®),1
39416,radiation: sbrt,1
39417,fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (facbc),1
39418,rituximab / observation,1
39419,metformin 850 mg twice daily for 3 months,1
39420,raf265,1
39421,niti car,1
39422,calcium salts,1
39423,recombinant adenovirus- ad/l523s,1
39424,exercise guidebook,1
39425,124i-mibg (carrier added),1
39426,internet-based cognitive behavioral therapy.,1
39427,infusion of donor derived ex-vivo selected nk cells to patients after transplant,1
39428,somatostatin (octreotide),1
39429,mpc-6827 + carboplatin,1
39430,nab-paclitaxel 125 mg,1
39431,micro hand s robotic surgery,1
39432,clinimacs tcr alpha-beta-biotin system,1
39433,18f-naf-pet/mr,1
39434,peripheral quantitative computed tomography (pqct),1
39435,"cediranib, azd2171, recentin",1
39436,non-pegylated liposomal doxorubicon (myocet™),1
39437,self-management energy conservation,1
39438,lymphadenectomy in conjugation with nephroureterectomy,1
39439,newly obtained biopsy and blood samples collection,1
39440,recombinant human apolipoprotein(a) kringle v,1
39441,bevacizumab + pemetrexed + carboplatin,1
39442,"lapatinib, caelyx",1
39443,cavity shave margins (csm),1
39444,rph-001,1
39445,small renal mass biopsy,1
39446,"questionnaires, laboratory tests, abdominal mri",1
39447,visudyne,1
39448,"10,000 steps",1
39449,electronic tailored messaging,1
39450,"nivolumab 1mg/kg, ipilimumab 3mg/kg",1
39451,"androgen suppression, radiotherapy",1
39452,urinary mirna,1
39453,"prednisolone, prednisone or equivalent",1
39454,specialized palliative care,1
39455,msctrail,1
39456,pf-04217903,1
39457,auto mailing plus money,1
39458,prednisone 2,1
39459,structured education dvd + verbal teaching,1
39460,wei nasal jet,1
39461,ca4p,1
39462,"bortezomib, cyclophosphamide, thalidomide, dexamethasone",1
39463,verubulin,1
39464,systematic surgery,1
39465,calcitriol + gemcitabine + erlotinib,1
39466,lmp2a-loaded conventional dc vaccine,1
39467,targetprint,1
39468,identification and characterization of molecular markers in musculoskeletal tumors,1
39469,transcutaneous mechanical nerve stimulation (tmns) (ferti care),1
39470,candida albicans skin test reagent,1
39471,quality of life (questionnaires),1
39472,nonclosure of the pelvic peritoneum,1
39473,"paclitaxel ,carboplatin , megesterol acetate",1
39474,radiologic imaging,1
39475,modified sano's classification,1
39476,pep-223/covaccine ht,1
39477,transplant 2 carmustine,1
39478,suspension of erythrocytes encapsulating l-asparaginase,1
39479,dose escalation intensity modulated radiotherapy treatment,1
39480,bpx-201 vaccine plus ap1903,1
39481,holmium-166 radioembolization,1
39482,nativis voyager rfe therapy,1
39483,18f-faza pet scan,1
39484,metformin and chemotherapy,1
39485,control exercises,1
39486,"ugt1a1 genotyping (6,6)",1
39487,needleways™ system,1
39488,cytid,1
39489,active ppp005,1
39490,leuprorelin sr,1
39491,placebo and prednisone,1
39492,immunomodulatory supplement,1
39493,anti-pd-l1 monoclonal antibody mpdl3280a,1
39494,demineralized bone matrix(dbm),1
39495,cx-072,1
39496,palonosetron - triple dose,1
39497,structural image,1
39498,niti-s biliary comvi stent,1
39499,dacarbazine plus placebo (control group),1
39500,amg 162 / denosumab,1
39501,promotora interaction,1
39502,epidural injection of etanercept,1
39503,dexamethosone,1
39504,her2 directed therapy,1
39505,folfox or,1
39506,intrathecal morphine + ketamine,1
39507,imc-20d7s (cohort 1b),1
39508,sodium thiosulfate (sts),1
39509,tpf2,1
39510,partially covered wallstent,1
39511,"rituximab,fludarabine, cyclophosphamide",1
39512,ipilimumab+ placebo,1
39513,sho-saiko-to,1
39514,nutriall,1
39515,hyperacute®-lung immunotherapy,1
39516,prognosis information and provider scripts,1
39517,needle guiding robot,1
39518,dbm for creation of bone marrow microenvironment,1
39519,robotic thyroidectomy,1
39520,stage 4: abiraterone acetate,1
39521,thoracic endosonography,1
39522,"quadrivalent human papillomavirus (hpv, types 6, 11, 16, 18) recombinant vaccine (gardasil®)",1
39523,nordihydroguaiaretic acid (ndga),1
39524,cyh33 for tablet,1
39525,zoloft 50 mg,1
39526,longitudinal uterine incision,1
39527,niraparib 200 mg,1
39528,gs-tblb-x-ray,1
39529,high intensity (group 1),1
39530,physical fitness test,1
39531,yoga skills training (yst),1
39532,morphine gel,1
39533,uro-c (use of new cystoscope),1
39534,conventional abvd,1
39535,trimix injection with doppler ultrasound,1
39536,enhanced care (intervention group and comparison group),1
39537,assessment feedback incentives and exchange,1
39538,acupuncture - group 2,1
39539,automated telephone reminder,1
39540,novocure-ttf-200a,1
39541,robotic nsm,1
39542,igrt associated with imrt,1
39543,kidney therapy,1
39544,secondary fasting,1
39545,body measurements and weight,1
39546,regn2810 (monotherapy),1
39547,microcrystalline cellulose nf (placebo),1
39548,imc-eb10,1
39549,temozolomide capsules,1
39550,"hsp70-peptide tkd/il-2 activated, autologous nk cells",1
39551,72.5 gy/cge,1
39552,post mastectomy ultrasound,1
39553,fluoropyrimidine (capecitabine or 5-fluorouracil),1
39554,aquaphor gel,1
39555,tp38,1
39556,sarcoma-specific car-t cells,1
39557,cyclophosphamide and sirolimus,1
39558,radiopharmaceutical (flotegatide (18f) or rgd (68ga),1
39559,"dexamethasona, idarubicine, ara-c, methotrexate",1
39560,validation group,1
39561,brain sequential rt,1
39562,clinical order check,1
39563,nitroglycerin 0.25 mg (single dose),1
39564,dcvac/ovca with standard of care,1
39565,personalized health information navigator (phin),1
39566,xpert bcr-abl ultra,1
39567,docetaxel (75 mg/m2) and doxorubicin (50 mg/m2),1
39568,ns-9 [poly i: poly c],1
39569,deferasirox + azacitidine,1
39570,dcdp,1
39571,complete remission (cr) group,1
39572,placebo-nalbuphine,1
39573,motivational session,1
39574,intramuscular (im) poly iclc,1
39575,stapling closure of the pancreatic stump,1
39576,self sample from vagina,1
39577,ultratracetm iobenguane i 131 imaging,1
39578,surgical tumor resection,1
39579,suggested exercise program,1
39580,cognitive-affective barriers counseling via brochure,1
39581,bone marrow or peripheral blood stem cells,1
39582,chemotherapy?carboplatin?,1
39583,sentinel,1
39584,air insufflation sigmoidoscopy,1
39585,ultracision harmonic scalpel,1
39586,dc vaccination for postremission therapy in aml,1
39587,correlation of mri results with clinical characteristics of the adnexal mass,1
39588,philips sonalleve mr-hifu breast tumor therapy system,1
39589,surgimend prs,1
39590,conventional mastectomy,1
39591,"r1: ixazomib, lenalidomide, dexamethasone (ird) induction therapy - adaptive arm",1
39592,dos2w,1
39593,filgastrim,1
39594,self-questionnaires of living conditions and quality of life,1
39595,cyt387,1
39596,rituxan™,1
39597,mid-position radiation strategy,1
39598,recombinant human lactoferrin,1
39599,flibanserin pill,1
39600,stage 1 group 1: abiraterone acetate,1
39601,visual acuity,1
39602,spi,1
39603,structured responsive interval exercise training programme,1
39604,qt ultrasound scan,1
39605,tai-gpc3-cart cells,1
39606,leq506,1
39607,control gel,1
39608,metformin 1500mgs per day,1
39609,p16_37-63,1
39610,"ixabepilone, 25 mg, with famotidine",1
39611,myeloma vaccine,1
39612,chemotherapy (cisplatin or cyclophosphamide and doxorubicin),1
39613,chemo,1
39614,modified medical research council,1
39615,ny-eso-1?²??t cell,1
39616,atorvastatin 20mg,1
39617,cardiac mri with dwi,1
39618,trifluridine,1
39619,gonal-f®,1
39620,plasma dosage,1
39621,education intervention: training in narrow band imaging,1
39622,sanger sequencing method,1
39623,"uft, calcium folinate, psk",1
39624,cilengitide dose escalation,1
39625,stat inhibitor opb-111077,1
39626,goalkeeper,1
39627,colonoscopy with blue indigo carmin®,1
39628,photobiological testing,1
39629,diode laser fiber type selective stimulator (dlss),1
39630,web+txt,1
39631,genome-wide association study,1
39632,family history questionnaire (when applicable),1
39633,autologous pbsct,1
39634,"""underwater"" mucosectomy with submucosal injection of viscous solution -sic 8000 (eleviewtm)",1
39635,routine comprehensive treatment,1
39636,fractionated total body irradiation,1
39637,oxaliplatin;capecitabine,1
39638,multiple needle,1
39639,"thalidomide, cyclophosphamide, dexamethasone",1
39640,voc analysis,1
39641,good pain management (gpm) procedure,1
39642,fludeoxyglucose,1
39643,fractionated stem cell infusions,1
39644,calcitriol + docetaxel,1
39645,photodynamic therapy with methyl aminolevulinate,1
39646,ebus/eus,1
39647,ast-008,1
39648,cap7.1,1
39649,candida albicans skin test antigen,1
39650,traditional chinese medicine formula lc09,1
39651,len (lenalidomide),1
39652,microsurgery resection,1
39653,vaginal brachytherapy 1,1
39654,docetaxel + high dose vitamin d2,1
39655,fu-cddp,1
39656,placebo acetylsalicylic acid,1
39657,"facilitated,outpatient specialty palliative care",1
39658,omn54,1
39659,5-fluorouracil and interferon,1
39660,ablative allogeneic hematopoietic cell transplant,1
39661,pf regimen (cisplatin and 5-fu),1
39662,dynamic area telethermometry (dat),1
39663,sipuleucel-t with booster,1
39664,biopsy of target tumor,1
39665,travel voucher,1
39666,pds (primary debulkdung surgery),1
39667,gemcitabine plus oxaliplatin,1
39668,pemetrexed and donor-derived nk cell infusion,1
39669,topotecan (>8cc),1
39670,"arry-438162 (mek162), mek inhibitor; oral",1
39671,computed tomography urography (ctu),1
39672,oral ixazomib,1
39673,high dose rate endorectal brachytherapy (hdr-erbt),1
39674,adaptive autologous cell immunotherapy,1
39675,barratt's impulsivity scale (bis),1
39676,adhexil,1
39677,ganetespib (sta-9090) and crizotinib,1
39678,oculus rift headset,1
39679,lumen-apposing metal stent,1
39680,solar protection formula spf® 60,1
39681,cytoxan and testosterone,1
39682,corticosteroid: prednisolone,1
39683,6 mm nitinol zilver stent,1
39684,amonafide + cytarabine,1
39685,cyclosporine ophthalmic emulsion,1
39686,gallium maltolate,1
39687,modified buflu conditioning,1
39688,sm88 (cohort 2),1
39689,"capecitabine, oxaliplatin and cetuximab",1
39690,etoposide 100 mg/m^2,1
39691,"vitamin d repletion with cholecalciferol (vitamin d3 50,000 international units)",1
39692,palifermin 6 x 60 ?g/kg/day,1
39693,enzalutamide 160 mg,1
39694,sham device,1
39695,brief alcohol intervention,1
39696,lupus treatment- standard of care,1
39697,cetuximab/irinotecan/simvastatin,1
39698,lycopene capsules,1
39699,pegylated irinotecan nktr 102,1
39700,placebo 100 (for aspirin 100),1
39701,ofatumumab + fresh frozen plasma,1
39702,"generic haart triomune : d4t, 3tc, nvp and chemotherapy abv",1
39703,"doxorubicin, vincristine, and etoposide with mitotane",1
39704,"optune system (novottf-200a system, tumor treating fields, ttfields)",1
39705,temsirolimus (torisel) plus liposomal doxorubicin (doxil),1
39706,traditional colorectal cancer screening education document,1
39707,active sphenopalatine ganglion acupuncture,1
39708,lenalidomide 5mg oral capsule,1
39709,standard chemotherapy medicine combined with chinese herbs,1
39710,fludarabine (bayer),1
39711,pulmonary artery energy seal,1
39712,radical surgery for stage ii and iiia small cell lung cancer (sclc),1
39713,reduced intensity conditioning with allogeneic transplant,1
39714,"""i wear sunscreen everyday"" song-based video",1
39715,next-day discharge,1
39716,tacrolimus (arm with methotrexate),1
39717,gammaknifeperfexion®,1
39718,physician notification,1
39719,optimum e-health tool,1
39720,probiotic yogurt a: kaiser micronutrients,1
39721,ecf,1
39722,aldhbr umbilical cord blood cells,1
39723,whole brain radiotherapy with reduced dose to the hippocampi,1
39724,individualized symptom education,1
39725,music imagery,1
39726,doublebare stent,1
39727,nandrolone decanoate,1
39728,mc,1
39729,pelvic floor muscle exercise before stoma closure,1
39730,"nab-paclitaxel 125 mg/m2 weeks 1,2,3/4",1
39731,ct volumetric measurement after y90 radioembolization,1
39732,hma+dli,1
39733,bevacizumab & stereotactic radiotherapy,1
39734,medication event monitoring system (mems),1
39735,oral arsenic trioxide,1
39736,gsk2126458,1
39737,chemotherapeutic agent,1
39738,f-fdg pet/ct,1
39739,bevacizumab and the polyvalent vaccine-klh conjugate + opt-821,1
39740,pd- 0332991,1
39741,exercise prehabilitation during chemotherapy before surgery,1
39742,arimidex (anastrazole),1
39743,revised invitation signed by the coordinating doctor,1
39744,function assessment of cancer therapy (fact) surveys,1
39745,rt+cddp/5-fu,1
39746,dietary,1
39747,rhumab,1
39748,usual oncology care,1
39749,gemcitabine plus rapamycin,1
39750,"gleevec, rad001, and hydroxyurea",1
39751,outlook intervention,1
39752,valomaciclovir,1
39753,antibiotic de-escalation,1
39754,breast scan - electrical impedance mammography,1
39755,proellex 6 mg,1
39756,cognitive behaviour therapy,1
39757,ons from the time of grade 2 radiation esophagitis,1
39758,spectrophotometry,1
39759,adelmidrol vaginal gel,1
39760,ebrfa and sems,1
39761,unmanipulated bone marrow graft with tacrolimus/methotrexate,1
39762,fluorouracil 0.5%,1
39763,radiotherapy after achievement of psa marginal value,1
39764,catheter management,1
39765,folate depletion and supplementation,1
39766,lung sound recording,1
39767,brand carac,1
39768,palliative rehabilitation,1
39769,portable optical spectrometer,1
39770,gs+toripalimab,1
39771,pectasol-c modified citrus pectin (mcp),1
39772,taxol®,1
39773,computer-based decision aid,1
39774,minipdx group,1
39775,erlotinib 100mg qd,1
39776,bay1834942,1
39777,mva.hpv16/18,1
39778,avelumab phase 2,1
39779,autolitt system,1
39780,oxaliplatin lbm,1
39781,post-study measures,1
39782,visicoil smallest size,1
39783,lucanix,1
39784,perioperative fluid management,1
39785,imported expedium screws and opal cage,1
39786,malignant tumor surgery,1
39787,oral vancomycin,1
39788,sham auricular acupressure,1
39789,casodex 150mg,1
39790,investigator's choice of treatment,1
39791,"cisplatin, mitomycin-c, doxifluridine",1
39792,"ongoing fasted state, intake of caffeine containing beverages or 5-item english breakfast",1
39793,optional asa as comedication,1
39794,bay806946,1
39795,training of junior doctors,1
39796,pharmacological ascorbate,1
39797,hpsa (firstep helicobacter pylori antigen rapid test),1
39798,concurrent chemoradiation (crt),1
39799,tace (transcatheter arterial chemoembolization ),1
39800,"gemcitabine,carboplatin",1
39801,patients receiving best supportive care,1
39802,infusion of allogeneic cik cells,1
39803,ny-eso-1 combined with mpla,1
39804,irinotecan plus 5-fu plus leucovorin,1
39805,novottf-100a plus chemotherapy,1
39806,low glycemic diet,1
39807,cisplatin and fluorouracil,1
39808,letrozole in combination with bevacizumab,1
39809,salivary cortisol,1
39810,imatinib 400 mg + peg-interferon,1
39811,leo 43204 formulation 1 dose x,1
39812,radiation combined with immunotherapy,1
39813,care plan during a visit,1
39814,functional imaging analysis,1
39815,car-nk cells targeting nkg2d ligands,1
39816,sentinel ln in breast cancer recurrence,1
39817,"rd-100i, osna",1
39818,nev801,1
39819,her2 bats with pembrolizumab,1
39820,apatinib and folfox regimen,1
39821,br-dhap,1
39822,jackknife posture,1
39823,"folfirinox, ipi-926",1
39824,lhrh agonist/antagonist,1
39825,grape extract,1
39826,pemetrexed followed by cisplatin,1
39827,rapamycin (tablets),1
39828,civasheet 60 gy,1
39829,neoadjuvant letrozole (postmenopausal women),1
39830,nexavar (bay 43-9006) (sorafenib),1
39831,"glucocorticoids (permitted,not necessary)",1
39832,nutritional therapy education and evaluation,1
39833,mouthrinse with hct20,1
39834,peritoneal wash,1
39835,autologous her2-specific t cells,1
39836,us-licensed herceptin,1
39837,haelan,1
39838,bos172738,1
39839,osteomalacia,1
39840,ar-v7 assays,1
39841,brevera breast biopsy system,1
39842,vaginal lubricant,1
39843,endobronchial valve,1
39844,3hr-mal-pdt,1
39845,pr1:169-177 peptide,1
39846,"biograph mmr, siemens",1
39847,pla,1
39848,dcvac and immune enhancers add on to soc,1
39849,trufill,1
39850,mamma board,1
39851,sns-595 injection,1
39852,pre-operative irradiation,1
39853,limberg-flap,1
39854,siltuximab 8.3 mg/kg or 11 mg/kg,1
39855,sir-spheres® (selective internal radiation therapy),1
39856,gene transfer,1
39857,breast irradiation using intensity-modulated radiation therapy,1
39858,center for epidemiological studies depression scale,1
39859,"cisplatin, etoposide",1
39860,excision of adnexal mass through laprotomy,1
39861,questionnaire t4 to fill,1
39862,passive bending function,1
39863,standard high resolution microendoscope and/or line-scanning confocal high resolution microendoscope,1
39864,increased physical activity,1
39865,morphine sr,1
39866,"panobinostat (lbh589), sorafenib",1
39867,2d grey scale vaginal ultrasound,1
39868,dxa scanning,1
39869,ramucirumab (imc-1121b ),1
39870,shc014748m,1
39871,magnetic resonance imaging (fmri,1
39872,lyso-thermosensitive liposomal doxorubicin(thermodox),1
39873,experimental: led group,1
39874,lymphadenectomy excluding no. 14v,1
39875,without thalidomide,1
39876,profile of mood states (poms-b),1
39877,fec75,1
39878,ahrq staying healthy booklet,1
39879,problem solving training,1
39880,plasmid interleukin-12,1
39881,leucostim 5µg/kg/day,1
39882,5-fu/calcium levofolinate,1
39883,bupivacaine 0.25-0.5%,1
39884,individual mbsr,1
39885,nc-503 (anti-amyloidotic (aa) agent),1
39886,chemotherapy at the investigator's discretion,1
39887,"exercising together, supervised",1
39888,intensity-modulated proton beam therapy (impt),1
39889,"ultrasound, ct and wb-dwi/mri",1
39890,bleomycin (active name: bleomycin sulfate),1
39891,pbf-509_80 mg,1
39892,measurements by dxa,1
39893,"bortezomib, docetaxel and cisplatin",1
39894,photofrin photodynamic therapy.,1
39895,stem cell transplantation (sct),1
39896,blood and tissue studies,1
39897,gemcitabine - 28 day cycle,1
39898,activity tracker,1
39899,genetic study,1
39900,anti-hcd70 car transduced pbl,1
39901,champion,1
39902,595/1064 multiplex laser,1
39903,tqb3616,1
39904,"bendamustine, lenalidomide, rituximab",1
39905,occlusive adhesive dressing,1
39906,alpps surgery,1
39907,tarceva plus at-101,1
39908,conventional robot-assisted gastrectomy,1
39909,stereotactic fractionation,1
39910,thymic irradiation,1
39911,etoposide/cis-platin (ep) w concurrent radiotherapy,1
39912,group 3: centrally located tumors,1
39913,boost radiation to hypoperfused volumes,1
39914,low dose chemotherapy,1
39915,d1 gastrectomy,1
39916,imetelstat (9.4 mg/kg),1
39917,partial or radical cytoreductive nephrectomy,1
39918,ecf-endostar,1
39919,venous access port or picc,1
39920,pcr for chlamydia dna in primary tubal cancer,1
39921,"native 1,5 tesla breast mri",1
39922,simotinib hydrochloride,1
39923,ifn-alpha,1
39924,vascular access device placement,1
39925,triptorelin 11.25 mg,1
39926,oral mrx-1024,1
39927,combined ct-fluroscopy,1
39928,cabozantinib 40 mg,1
39929,s-1 plus abraxane,1
39930,calorie and protein restriction diet,1
39931,desvenlafaxine,1
39932,assess overall complications at 1 year postoperatively,1
39933,ultrasonic coagulation device (harmonic ace® scalpel),1
39934,salvage stereotactic radiosurgery arm,1
39935,trimix-dc,1
39936,screening-based nurse navigation,1
39937,pleural fluid tapping,1
39938,estrace (estrogen),1
39939,dna-guided choice of therapy,1
39940,placebo auriculotherapy,1
39941,odanacatib matching placebo,1
39942,adjuvant chemotherapy for experimental group,1
39943,oral management,1
39944,"""sirolimus"" and ""hydroxychloroquine"" 200 mg",1
39945,cabazitaxel-xrp6258 (3-week cycle),1
39946,pd-l1 imaging,1
39947,lams plus double pigtail stent,1
39948,standard of care fdg-pet imaging,1
39949,olaparib continuous (28-day cycle) 300 mg bd.,1
39950,mri spectroscopy,1
39951,rectal balloon with air filling,1
39952,prednisone/prednisolone/methylprednisolone,1
39953,fdg-pet imaging,1
39954,cycle b,1
39955,"nutritional supplements containing arginine, n-3 and nucleotides",1
39956,blood sampling (facultative),1
39957,blood collection (pre and postoperative): plasma coagulation parameters,1
39958,recombinant wt1 antigen-specific cancer immunotherapeutic (asci),1
39959,"immediate gardasil 9, delayed menveo vaccine",1
39960,immediate ibbr+tiloop®bra,1
39961,contrast enhanced mammography (cedm),1
39962,"""ultra"" e.r.a.s.",1
39963,fistulectomy,1
39964,dexamethasone (pre- and post-medication for docetaxel),1
39965,fsf without customized cutting guide,1
39966,flumatinib mesylate tablet 600 mg qd,1
39967,tbl12,1
39968,mbc-11,1
39969,total thyroidectomy (tt),1
39970,nivolumab 360 mg+ docetaxel* 75 mg/m2 +trastuzumab 8 mg/kg +pertuzumab 840 mg,1
39971,anti-nausea therapy,1
39972,descriptive,1
39973,vitamin e ointment application,1
39974,bms-599626,1
39975,surgery for pilonidal sinus disease,1
39976,tace with hyperthermia treatment,1
39977,baking soda,1
39978,lifestyle-based intervention,1
39979,chinese herb huanglian (coptis chinesis),1
39980,pemetrexed-related hematological toxicity,1
39981,cetuximab (scchn),1
39982,fluorescein + ala,1
39983,lobar or segmental bland embolization with microspheres (50-500 microns) to 2-5 heartbeat stasis,1
39984,low-dose computed tomography baseline scan only,1
39985,dual-energy x-ray absorptiometry (dexa scan),1
39986,imatinib mesylate by mouth,1
39987,early dvc ligation,1
39988,(18)fluciclatide,1
39989,hopkins verbal learning test-revised (hvlt-r),1
39990,colonoscopy with biopsies,1
39991,ebv-tcr-t (yt-e001) cells,1
39992,pembrolizumab dose d,1
39993,radiochemotherapy with 70 gy,1
39994,firefly™,1
39995,li-eswt group,1
39996,chemotherapy followed by zevalin,1
39997,99mtc mdp injection:neutron-bombardment,1
39998,sprayshield adhesion barrier system,1
39999,fencing,1
40000,combo pbf-509 (640 mg) + pdr001,1
40001,control position by 3dobi before the fraction,1
40002,actigraphy,1
40003,"comparator: mk0752, notch inhibitor",1
40004,allogenic t cell-depleted hematopoietic stem cell transplantation,1
40005,quality of life measures,1
40006,fat-saturation and diffusion-weighted imaging,1
40007,breast mammogram,1
40008,bf4,1
40009,safety and efficacy assessments,1
40010,group therapy,1
40011,regorafenib (bay73-4506) - continuous / cisplatin / pemetrexed,1
40012,low fat high n3 diet,1
40013,questionnaire or interview,1
40014,hypofractionated whole breast radiation therapy,1
40015,prospective longitudinal data,1
40016,st. john's wort 600 mg,1
40017,histological evaluation of the surgery material,1
40018,collection of stem cells,1
40019,bowel preparation plus antibiotics,1
40020,pd-l1/ido peptide vaccine,1
40021,peptides derived from antiapoptotic proteins,1
40022,reduced dose bevacizumab,1
40023,fluzone standard dose vaccine,1
40024,"nexavar (sorafenib, bay43-9006) with addition of gemcitabine or interferon",1
40025,laparoendoscopic resection,1
40026,combined oral contraceptive pills,1
40027,esophageal variceal ligation,1
40028,hpv 16 e7:12-20,1
40029,aminolevulinic acid nano emulsion,1
40030,indoor tanning intervention,1
40031,famcare program,1
40032,radical prostatectomy with implantation of allograft,1
40033,clinical chemo-drugs,1
40034,psychosocial intervention for couples,1
40035,saline (placebo),1
40036,gain-framed messaging plus nrt,1
40037,adi-peg 20 plus pem cis,1
40038,bvz+xelox or bvz+xeliri or bvz+fuiri or bvz+fuox,1
40039,endocrine treatment consisting of either letrozole or fulvestrant.,1
40040,right axilar vein access.,1
40041,low dose radiation focal brachytherapy,1
40042,tocosol(r) paclitaxel,1
40043,"exercising separately, supervised",1
40044,pmmtb (precision medicine molecular tumor board),1
40045,neoadjuvant gemcitabine/carboplatin therapy,1
40046,administration of stable isotope labeled levothyroxine,1
40047,measurement of fetuin-a level in serum,1
40048,no-touch rfa arm,1
40049,3d-dess mri (3 dimensional double echo steady state mri),1
40050,red light photodynamic therapy,1
40051,abdominal hysterectomy,1
40052,ashwagandha extract,1
40053,inspection during insertion,1
40054,diet diary,1
40055,cadvec,1
40056,fes-pet,1
40057,11c-choline injection,1
40058,mbi scan: the lumagem®,1
40059,"implantation of intralaryngeal prosthesis with a new double valve system, allowing tracheotomy closing",1
40060,treatment of physicians choice,1
40061,quality of life and pain measurement .,1
40062,nccn distress thermometer,1
40063,nida standard research e-cigarette (srec),1
40064,elagolix dose 2 plus estradiol,1
40065,timely pcp communication,1
40066,lhrh,1
40067,ad-reic/dkk-3,1
40068,hla-a*0201restricted urlc10 peptides with adjuvant,1
40069,dc vaccine & placebo,1
40070,eox + panitumumab,1
40071,air insufflation (ai) method.,1
40072,infusion of anticancer agent,1
40073,accelerated rt,1
40074,wl cystoscopy,1
40075,2 mg oral pom + 40 mg oral dex,1
40076,trastuzumab monotherapy,1
40077,blood work,1
40078,guardant360 diagnostic test,1
40079,sotatercept 30 mg,1
40080,"bi 836845, low dose, every week (qw)",1
40081,y-90 radioembolization,1
40082,part 4c tpst-1120 + cetuximab,1
40083,dcf regimen,1
40084,telephone care + educational (av materials),1
40085,imrt or vmat,1
40086,local infiltration of bupivacaine,1
40087,nrx 195183 (retinoid analogue),1
40088,certolizumab,1
40089,male spouse transition toolkit,1
40090,light-ct,1
40091,inofolic®,1
40092,epainq questionnaire,1
40093,immunoglobulin,1
40094,mind body medicine day care clinic,1
40095,reconstruction with implant,1
40096,tpf (docetaxel plus cisplatin and 5-fluorouracil) group,1
40097,ablathermy,1
40098,non-everted suture technique,1
40099,dietary intake -food frequency questionnaire,1
40100,collection of tumor and blood samples,1
40101,interview with a doctor for evaluating suicide risk,1
40102,at home screening procedure on demand,1
40103,high dose rate endorectal brachytherapy,1
40104,azacitidine associated with idarubicine,1
40105,rebamipide,1
40106,drug: ly573636-sodium,1
40107,gsk2816126,1
40108,insole,1
40109,"myocet® plus cyclophosphamide and trastuzumab, 4 cycles, followed by docetaxel plus trastuzumab, 4 cycles",1
40110,eu avastin®,1
40111,cc-292 + lenalidomide,1
40112,vismodegib (150 mg po daily),1
40113,trametinib 2mg daily,1
40114,"vegfr1-1084, vegfr2-169, and gemcitabine",1
40115,ischemia,1
40116,tki258 (dovitinib):,1
40117,pillow,1
40118,"wet suction, standard suction, slow-pull",1
40119,"sampling at baseline, during radiotherapy and after",1
40120,neo-masct,1
40121,cisplatin or carboplatin-based,1
40122,cetuximab iv,1
40123,repetitive per-treatment [18f]fdg-pet for treatment adaptation,1
40124,pelvic irradiation,1
40125,mi2 intervention arm,1
40126,no patient concerns inventory,1
40127,placebo wristbands,1
40128,robotic one-stage colorectal and liver resection,1
40129,daunorubicin (liposomal),1
40130,maldi-tof mass spectrometry,1
40131,bay1161116,1
40132,local therapies,1
40133,tarp dendritic cell vaccine,1
40134,"busulfan, etoposide, cytarabine, melphalan",1
40135,lupin's pegfilgrastim,1
40136,registration of complications,1
40137,[ga-68]psma pet/mr,1
40138,methylene blue subcutaneous injection,1
40139,fff without customized cutting guide,1
40140,one-llung ventilation,1
40141,hyperthermia; thermotron rf-8,1
40142,smartphone confocal microscopy,1
40143,ain457,1
40144,4l polyethylene glycol,1
40145,transoral robotic surgery + neck dissection,1
40146,naive t cell depleted donor lymphocyte infusion,1
40147,bay 94-9343,1
40148,pelvic organ prolapse repair,1
40149,nivolumab 40 mg in 4 ml injection,1
40150,rg1530,1
40151,bioactive glass,1
40152,"celecoxib, vinblastine, cyclophosphamide , methotrexate ,",1
40153,blood samples prior to a new line of ar-targeted therapy,1
40154,tomudex,1
40155,current standard of care,1
40156,smart phone based symptom evaluation application,1
40157,standard chemotherapy for colorectal cancer,1
40158,1rg-cart/m^2 (dose level 2),1
40159,flaxseed powder,1
40160,ra-223 therapy,1
40161,arm1 (hypofractionated radiotherapy),1
40162,axillary sentinel lymph node biopsy,1
40163,postoperative data,1
40164,von hippel-lindau peptide vaccine,1
40165,bupivacaine with epinephrine,1
40166,autologous cik cell infusion,1
40167,l19tnfa,1
40168,self-care toolkit,1
40169,mechlorethamine gel 0.016%,1
40170,intrathecal (it) cytarabine,1
40171,weight maintenance,1
40172,day-time compression sleeve,1
40173,left internal jugular access.,1
40174,"kb004, monoclonal antibody",1
40175,recombinant human endostatin injection (endostar),1
40176,"pemetrexed, docetaxel or gemcitabine",1
40177,high-voltage pulsed radiofrequency,1
40178,adjuvant concurrent chemoradiation,1
40179,train the leaders course,1
40180,video-audio media,1
40181,"nab-paclitaxel, gemcitabine, capecitabine",1
40182,thalidomide/dexamethasone,1
40183,immunonutrition without arginine,1
40184,valanced salt crystalloid group,1
40185,therapeutic entecavir,1
40186,breath sampling for volatile marker detection,1
40187,rg547,1
40188,hysteroscopic morcellation,1
40189,letsgo app,1
40190,two-time implementation intention,1
40191,"cladribine s.c. injection, hcl treatment",1
40192,preemptive high-dose fluconazole,1
40193,tld-1,1
40194,clamp robotic partial nephrectomy,1
40195,abdominal wall reconstruction with strattice,1
40196,90y-dota tyr3-octreotide,1
40197,prehabilitation education,1
40198,human mab 216,1
40199,radiotherapy of the partial brain.,1
40200,b-mode us,1
40201,cm-bc2 irinotecan drug-eluting bead,1
40202,endo-hdr (if randomized to this arm),1
40203,"cetuximab, gemcitabine, oxaliplatin",1
40204,licartin,1
40205,chemotherapy with platine,1
40206,epigallocatechin gallate (egcg),1
40207,standard ebna,1
40208,non-steroidal aromatase inhibitor therapy,1
40209,131i-l19sip radioimmunotherapy (rit) in combination with external beam radiotherapy (ebrt) and concurrent chemotherapy,1
40210,androgen ablation (aa),1
40211,leicester cough monitor (lcm),1
40212,transplant 2 cytarabine,1
40213,rituximab - bendamustine,1
40214,blu-554,1
40215,immunochemical fecal occult blood test and colonoscopy if test is positive,1
40216,dual x-ray absorptiometry (dxa),1
40217,mri and advanced mri sequences,1
40218,used of the pressure adjustable foot-control method,1
40219,ci-1033,1
40220,gemcitabine monotherapy,1
40221,conventional computed tomography (ct),1
40222,comparative analysis of the characteristics,1
40223,isocaloric control,1
40224,"vela xl thulium laser, laser fiber and accessories.",1
40225,icg dye,1
40226,avastin® (bevacizumab),1
40227,systemic chemotherapy (xelox or sox regimens),1
40228,diagnostic work up,1
40229,r-da-epoch + auto-hsct,1
40230,water (exchange) plus dye method,1
40231,percutaneous removal and margin ablation,1
40232,imiquimod and interferon alpha,1
40233,adriamycin®,1
40234,anti-b7h1 monoclonal antibody medi4736,1
40235,mk-1775 and carboplatin,1
40236,compliance supporting measures,1
40237,expressive writing condition,1
40238,measurement of tumor mrna concentration in urine,1
40239,"thalidomide, etoposide, celecoxib",1
40240,18 fdg (fludeoxyglucose 18f),1
40241,scri-hucar19v1,1
40242,"thalidomide, pharmion",1
40243,ethosuximide,1
40244,bortezomib 1.3 mg/m2,1
40245,9-ing-41,1
40246,hti-1066 dose level 4,1
40247,high-intensity interval training,1
40248,ultra-rapid acquisition of bile ducts images,1
40249,individualised rehabilitation,1
40250,standard of care (soc) control,1
40251,ultra-low dose bevacizumab,1
40252,remotely supervised exercise (rem),1
40253,placebo and calcitriol,1
40254,pulmonary,1
40255,(r)-chop regimen,1
40256,midazolam clearance test,1
40257,vp-16 + avastin,1
40258,"cp-675,206 (tremelimumab)",1
40259,usual care with attention control,1
40260,single asct with thalidomide maintenance,1
40261,standard pomegranate extract formulation,1
40262,triciribine phosphate monohydrate,1
40263,circulating tumor cell chip,1
40264,6-month icotinib,1
40265,sf-36 questionnaire,1
40266,cellsearch® ctc kit,1
40267,evaluation of biological predictive factors of clinical response to ustekinumab,1
40268,budesonide/formoterol fumarate dihydrate inhalation aerosol,1
40269,tlk286 in combination with carboplatin,1
40270,chemotherapy followed by talazoparib maintenance,1
40271,estrogen receptor blocker,1
40272,68ga-hbed-cc-psma pet / ct,1
40273,50% oxygen/50% nitrous oxide premix (kalinox 170 bar),1
40274,intraperitoneal chemoperfusion,1
40275,131i-l19sip radioimmunotherapy (rit),1
40276,carmustine(bcnu),1
40277,brochure regarding sedentary behavior,1
40278,adherence-encouraging interventions - monthly phone calls,1
40279,ltld,1
40280,motivational sms,1
40281,"m-vax- autologous, hapten-modified melanoma vaccine",1
40282,standard chemotherapy (pemetrexed and cisplatin),1
40283,allogeneic transplantation,1
40284,polidocanol,1
40285,intra operative radiotherapy,1
40286,custom work endurance,1
40287,ga-68-psma-11,1
40288,"cpg-mcl vaccine, primed t-cells",1
40289,paclitaxel followed by doxorubicin,1
40290,immunomodulating nutrients enriched diet,1
40291,sophrology sessions,1
40292,deslorelin,1
40293,decision aid plus counselling,1
40294,fixed-dose combination,1
40295,il-4pe,1
40296,fermented wheat germ extract,1
40297,prostvac -v,1
40298,third through sixth sessions,1
40299,pil-12,1
40300,clofarabine vp 16 ciclophospahamide,1
40301,combined treatment schema,1
40302,"whole-brain radiation therapy, stereotactic radiosurgery",1
40303,forward view,1
40304,68ga-dotatoc pet,1
40305,nivolumab 3mg/kg,1
40306,high arginine nutritional supplement (nestle's impact ar),1
40307,durvalumab (regimen 1),1
40308,standard surgery (neuronavigation-guided),1
40309,electroacupuncture group,1
40310,taxol plus everolimus,1
40311,cd-rom,1
40312,mesh reinforced staple line (seamguard),1
40313,reciprocating procedure device (rpd) - avanca re no. 1091001,1
40314,liger medical thermocoagulator (us fda 510k clearance received),1
40315,arm 1: dc vaccine + rt,1
40316,68ga-dotatoc pet/ct scan,1
40317,pemetrexed (pemetrexed alvogen),1
40318,"ontak (denileukin difitox, dab389il-2)",1
40319,cattell-warren anastomosis,1
40320,dual energy x-ray absorptiometry (dexa),1
40321,pelvic floor muscles training,1
40322,18f-ef5 pet/ct scan,1
40323,folfox-7,1
40324,serum chemistry,1
40325,"ec0225, for injection (folic acid desacetylvinblastine hydrazide conjugate)",1
40326,foreseal,1
40327,resective surgery,1
40328,ithermonitor,1
40329,ixabepilone (oral formulation),1
40330,anti-p53 t-cell receptor-transduced peripheral blood lymphocytes,1
40331,68gallium citrate,1
40332,mammography decision aid,1
40333,itraconazole 300mg,1
40334,"grape juice (resveratrol, quercetin)",1
40335,docetaxel (doc),1
40336,arm a: vitamin d3 group,1
40337,bkm-120 bevacizumab,1
40338,comprehensive care program,1
40339,f-18 fdg pet,1
40340,whole breast ultrasound,1
40341,mvstr,1
40342,severe anxiety/depression: high intensity stepped care,1
40343,radiotherapy and chemotherapy,1
40344,firmagon® (degarelix),1
40345,lapatinib (gw572016) 1000 mg,1
40346,autologous tumor-infiltrating lymphocytes,1
40347,"sagopilone 16 mg/m^2 i.v., acetyl-l-carnitine (alc) 1000 mg tid, hrpc only: prednisone or prednisolone 5 mg bid",1
40348,intravitreal bevacizumab,1
40349,platinum doublet chemotherapy,1
40350,stereotactic body radiotherapy to the prostate gland,1
40351,ezalutamide,1
40352,"""3-hole"" subxiphorid and subcostal approach",1
40353,therapeutic standard lymphadenectomy,1
40354,bulletin board and teleophone depth interview,1
40355,plx4032,1
40356,transient elastography (fibroscan),1
40357,"bortezomib, dexamethasone, and thalidomide",1
40358,amg 479 (ganitumab) plus metformin,1
40359,standard premedication,1
40360,esterified estrogens,1
40361,levodopa,1
40362,standard chemotherapy chop + ritiximab,1
40363,integrated palliative oncology care,1
40364,rituximab window,1
40365,"geriatric consultation, evaluation questionnaire",1
40366,helical tomotherapy,1
40367,clinical and pathological data ebv-related gzl and dlbcl,1
40368,quercetin (dietary supplement),1
40369,temsirolimus (cci-779) for 34 months,1
40370,oral squamous cell carcinoma,1
40371,111-in-imp-288,1
40372,hs-1000,1
40373,medi4736 + tremelimumab combination therapy,1
40374,capecitabine/paditaxel(xg),1
40375,5-aza-deoxycytidine,1
40376,surgery or debulking surgery,1
40377,allox2 two-port tissue expander placement,1
40378,betamarc,1
40379,doxy.me genetic education +/- color genomics genetic education,1
40380,curette,1
40381,"vitamin d3, 3200iu",1
40382,proteolytic enzymes,1
40383,velcade 1.3 mg/m^2,1
40384,dacarbazine + thymosin-alpha-1 3.2 mg,1
40385,capecitabine and aflibercept,1
40386,adrenaline,1
40387,t-dm1 and pertuzumab,1
40388,lci (linked color imaging),1
40389,lay health advisor education intervention,1
40390,ds-6051b,1
40391,pomegranate juice (ellagic acid),1
40392,low-dose fcr,1
40393,personalized program pvs,1
40394,azd9496 variant b,1
40395,modotuximab,1
40396,tapentadol pr,1
40397,gardisil,1
40398,moderate exercise intervention,1
40399,no axillary surgery versus slnb,1
40400,radiotherapy with cisplatin,1
40401,peripheral venous blood samples,1
40402,mouse prostate-specific membrane antigen plasmid dna vaccine,1
40403,molecular analysis,1
40404,doublet (rad001 and lbh589),1
40405,ft500,1
40406,7 tesla mri,1
40407,empathic conversation,1
40408,clic-1901,1
40409,x-ray and ultrasound imaging scanning,1
40410,ox-tax,1
40411,compression by chest bandage urgo k2®,1
40412,cetuximab/gefitinib combination and/or monotherapy,1
40413,drug testing on pdx per investigator's choice (upto 4),1
40414,atorvastatin 10mg,1
40415,trail making test (tmt),1
40416,ccs1477,1
40417,oxandrolone 20 mg,1
40418,reference1613,1
40419,advanced mr imaging,1
40420,doxorubicin-gnrh agonist conjugate aezs-108,1
40421,gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc,1
40422,topotecan and pazopanib,1
40423,m8891,1
40424,recovery time after bronchoscopy,1
40425,epic questionnaire,1
40426,half cyclophosphamide,1
40427,"bevacizumab, standard chemotherapy and radiation",1
40428,che (cancer health education),1
40429,pd-l1 pet imaging,1
40430,oncologically radical margin-free (r0) resection,1
40431,approved pharmacologic therapy,1
40432,recombinant human endostatin (endostat),1
40433,immunotherapy with dendritic cells,1
40434,informed consent visit,1
40435,177lu-dota-eb-tate 1,1
40436,ck stereotactic accelerated partial breast irradiation,1
40437,recurrence rate of hcc after surgery,1
40438,tnf-alpha inhibitors,1
40439,subcutaneous (sc) azacitidine,1
40440,egfr-tkis,1
40441,women with breast cancer,1
40442,brachytherapy?iodine i 125?,1
40443,placebo of hydroxyzine,1
40444,pts. w/ neutropenic fever associated w/ hematologic malignancy,1
40445,preoperative nutritional drink up to 4 h prior to surgery,1
40446,visual inspection with lugol's iodine,1
40447,caregiver accompaniment time (cat) + preoperative hypnosis session,1
40448,tc,1
40449,placebo c-pdt,1
40450,dcbci0901,1
40451,uft+leucovorin,1
40452,gtx-006 (acapodene),1
40453,contact x-ray brachytherapy 50 kv,1
40454,"proton, gemcitabine, erlotinib, capecitabine",1
40455,rk-0202,1
40456,tace regimen,1
40457,ye-neo-001,1
40458,"docetaxel, cisplatin, cetuximab and bevacizumab (tpe-a) followed by concurrent radiation, cisplatin, cetuximab and bevacizumab (xpe-a), surgery",1
40459,"amg 386 10 mg/kg, capecitabine and lapatinib",1
40460,super-d enb guided-pdt,1
40461,mesenchymal stromal cell infusion,1
40462,double umbilical cord blood unit transplant,1
40463,tandem™,1
40464,perioperative chemotherapy plus bevacizumab,1
40465,cndo-109-aank cells,1
40466,ensure plus,1
40467,no tranexamic acid,1
40468,18f-fdg-pet radiotherapy,1
40469,bodystat quadscan 4000,1
40470,babaodan oral capsule,1
40471,irinotecan hydrochloride (hci) treatment,1
40472,uterine neoplasms,1
40473,fit-soc,1
40474,ha20-humanized anti-cd20 antibody,1
40475,cytarabine (baml-16-001-s1),1
40476,5-aminolevulinic acid (levulan kerasticktm),1
40477,rituximab-bendamustine,1
40478,vinblastine sulphate injection,1
40479,highly active antiretroviral therapy,1
40480,oral palifosfamide tris,1
40481,mammography direct mail coupled with a financial incentive,1
40482,the pac-ifico programme,1
40483,remove tumor only,1
40484,x-ray diffraction of human hair,1
40485,bronchoscopic implantation,1
40486,surgery with ipch,1
40487,1650-g vaccine,1
40488,external beam radiotherapy for head and neck cancer,1
40489,til + il2,1
40490,low fat diet plus exercise,1
40491,intensity- modulated radiation therapy,1
40492,ds-5573a,1
40493,oral swab,1
40494,"timed intercourses, intrauterine insemination",1
40495,educational cd-rom,1
40496,pearl,1
40497,self-acupressure,1
40498,"uft (uracil, tegafur) and tamoxifen",1
40499,"using 20g fnb, the first pass is sp",1
40500,use of an artificial antigen presenting cell (aapc) to generate ctl,1
40501,accelerated fractionation radiation therapy,1
40502,pdt with metvix 160 mg/g cream and placebo cream,1
40503,collection of plasma cell rate,1
40504,doxazosin 4 mg every day (qd),1
40505,pepcan,1
40506,robot assisted hysterectomy,1
40507,epirubicin(eadm),1
40508,"taxotere, cisplatin, 5-fluorouracil (5-fu)",1
40509,medi0680,1
40510,"cervarix®, glaxosmithkline",1
40511,gemcitabine/carboplatin plus iniparib,1
40512,no intervention required,1
40513,ceftobiprole medocaril,1
40514,fixed dose rasburicase,1
40515,circuit training & nutrition,1
40516,lde225; fluorouracil; leucovorin; oxaliplatin; irinotecan,1
40517,il-12 &amp; anti-ny eso1 tcr pbl,1
40518,thioridazine,1
40519,preoperative brain irradiation (single fraction),1
40520,conventional diarthermy knife,1
40521,no intercention,1
40522,placebo for dexamethasone,1
40523,vehicle (inactive control),1
40524,pws testing,1
40525,transplant 1 etoposide,1
40526,simple monitoring without active therapy,1
40527,noscapine hcl,1
40528,fatifue assessment and management,1
40529,prophylactic bilateral salpingectomy,1
40530,lenalidomide/low dose dex,1
40531,intraventricular rituximab plus mtx,1
40532,prostatic acid phosphatase-sargramostim fusion protein,1
40533,umbilical cord blood transfusion,1
40534,somatostatin analogue therapy,1
40535,5fu and capecitabine (xeloda®) dosing based on dpyd genotype,1
40536,autohypnosis learning,1
40537,docetaxel and pemetrexed,1
40538,ablative external beam radiation dose,1
40539,fiau-pet-ct-4,1
40540,sbrt - ablative radiation therapy,1
40541,co2 insufflation,1
40542,intranasal ketamine,1
40543,chop21,1
40544,night-time compression bandages,1
40545,hdepa,1
40546,otsa101-dtpa-90y level 3,1
40547,30gy if-rt (involved-field radiotherapy),1
40548,axitinib plus lomustine,1
40549,focal radiotherapy (srs),1
40550,weekly 45 minute sessions,1
40551,sait101,1
40552,thalidomide+melphalan +bortezomib+stem cell transplant,1
40553,lavage of the uterus,1
40554,whole abdominal radiation [war] therapy,1
40555,pelvic mr examination,1
40556,axumin pet/ct,1
40557,"omp-54f28, nab-paclitaxel and gemcitabine",1
40558,radiofrequency ablation associated with tace,1
40559,paclitaxel(intravenous) + carboplatin(intravenous),1
40560,pavlovian conditioning,1
40561,prescription,1
40562,subfascial flap,1
40563,cold cap,1
40564,blr-cll,1
40565,usg pecs2 with drug p (placebo),1
40566,temozolomide oral capsule,1
40567,moderate sedation for ebus/tbna,1
40568,chemotherapy?pemetrexed/gemcitabine?,1
40569,mri-tobi,1
40570,oral simethicone,1
40571,intratumoral injection of autologous cd1c (bdca-1)+ mydc,1
40572,trastuzumab emtansin,1
40573,proton beam radiation therapy (pbt),1
40574,etoposide plus cisplatin,1
40575,collection of treatment-stratefying prognostic factors,1
40576,pathogen-specific ctls,1
40577,extraction of total rna from healthy and tumour tissues,1
40578,npi-2358,1
40579,unpulsed pbmc and saline,1
40580,rituximab -chop plus velcade,1
40581,superior hypogastric plexus block,1
40582,treatment based on molecular profiling,1
40583,tricom-cea(6d),1
40584,"serum, plasma and dna samples",1
40585,perclot,1
40586,mr-pet scanner,1
40587,continuous low-irradiance photodynamic therapy (clipt),1
40588,cyclophosphamide (conditioning for auto transplant),1
40589,surgery for colorectal cancer,1
40590,bicalutamide (casodex),1
40591,sorafenib and irinotecan combination,1
40592,adjuvant (gm-csf) alone,1
40593,epirubicin injectable product,1
40594,gdc-0425,1
40595,"bortezomib, dexamethasone, ifosfamide",1
40596,tendon repair,1
40597,liposomal doxorubicin and gemcitabine,1
40598,mage-a3 and ny-eso-1 immunotherapy,1
40599,fentanyl plus midazolam,1
40600,"temozolamide, irinotecan",1
40601,personalized vaccine,1
40602,csrt led telephone follow up,1
40603,placebo tab,1
40604,preoperative localization of sln detected by ctlg by either methods,1
40605,phase 2: trabectedin,1
40606,rad001 and sorafenib,1
40607,nutrition program,1
40608,pasireotide sub-cutaneous formulation,1
40609,ralimetinib (ly2228820 dimesylate),1
40610,modulated imaging (mi),1
40611,anx-514,1
40612,azd 4547,1
40613,co-rebreathing technique at diagnosis of polycythemia,1
40614,experimental: v503,1
40615,ordinary diet,1
40616,s-1+leucovorin,1
40617,nab-paclitaxel 150 mg/m^2,1
40618,"22-gauge procore needle (procore, cook medical inc., winston-salem, nc)",1
40619,bwt with mitomycin-c prior turbt,1
40620,4d pet-ct scan,1
40621,gdc-0980 matching placebo,1
40622,lactobacillus acidophilus probiotic,1
40623,total abdominal radical hysterectomy,1
40624,nutrenopimum,1
40625,isometric resistance training,1
40626,carbohydrates,1
40627,dissemination of public health knowledge,1
40628,33a,1
40629,0.9% natrium chloratum with a 2nd generation cephalosporin,1
40630,bolster,1
40631,aminoglutethimide,1
40632,velscope,1
40633,immune cells population assesment,1
40634,cardiac biomarker blood draws,1
40635,sonifilan,1
40636,cd3/her2 bispecific monoclonal antibody,1
40637,oncological home hospitalization,1
40638,ner1008 enema,1
40639,selumetinib 75 mg,1
40640,biological and ultrasound test,1
40641,hepatic resection or ablation with pancreaticoduodenectomy,1
40642,1000csk silicon oil tamponade,1
40643,oxaliplatin 130 mg/m^2,1
40644,autologous 3rd generation cd19-targeting car t cells,1
40645,sleep education,1
40646,cat-8015,1
40647,"cancer vaccine plus immune adjuvant, plus activated white blood cells",1
40648,free-breathing mri,1
40649,icar30 t cells,1
40650,fluorescence diagnosis imaging,1
40651,cholecystojejunostomy,1
40652,transanal surgery,1
40653,motor mapping,1
40654,text for diet (text4diet) group (arm b),1
40655,long intervention protocol,1
40656,27-35 (27l): melanoma antigen recognized by t-cells (mart)-1,1
40657,comparator: repevax™ (non-concomitant),1
40658,"5-fu 2600 mg/m², 24-hour-infusion, day 1",1
40659,hyoscine butyl bromide 20mg/2 ml i.v.,1
40660,mycoach smart text,1
40661,myocet (non-pegylated liposomal doxorubicin (npld)),1
40662,repevax™ (concomitant),1
40663,macroscopic on-site evaluation,1
40664,delayed airbrush,1
40665,newsletter,1
40666,half-strength tryptophan depletion (control),1
40667,bibf 1120 placebo + pemetrexed,1
40668,robust radiotherapy planning,1
40669,conventional whole brain rt,1
40670,high-dose vitamin c 30gm,1
40671,shr 1210+apatinib,1
40672,"cytarabine, leucovorin, methotrexate, procarbazine, rituximab, vincristine",1
40673,sphenopalatine ganglion acupuncture,1
40674,jcar017 (lisocabtagene maraleucel),1
40675,ultrasound guided greater occipital nerve block,1
40676,fluorescence bronchoscopy,1
40677,"chemotherapy, intrathecal chemotherapy",1
40678,azd7451,1
40679,clinic- and patient-focused,1
40680,standard palliative care group,1
40681,biological: mkc1106-mt,1
40682,periprostatic nerve blockade,1
40683,pillcam® colon 2 capsule,1
40684,l-377202,1
40685,pm02734 and erlotinib,1
40686,operative gamma camera,1
40687,lapatinib plus trastuzumab,1
40688,oxidative and antioxidant biomarkers,1
40689,biomed 101,1
40690,"asa404, dmxaa or dxaa",1
40691,"left hemicolectomy, laparoscopic technique",1
40692,meditation-based stress reduction program,1
40693,18f-fes-pet,1
40694,peri-operative chemotherapy of xp,1
40695,cetuximab + afatinib,1
40696,optune novottf-200a system,1
40697,arm 2: exercise + calcium-rich diet,1
40698,cetuximab + gefitinib,1
40699,"xrt, 54-59.4 gy",1
40700,labetalol,1
40701,liposomal amphotericine b,1
40702,fluoropyrimidine-based chemotherapy,1
40703,4-demethyl-4-cholestryloxycarbonylpenclomedine,1
40704,cutaneous ultrasound,1
40705,zarnestra (tipifarnib),1
40706,standard reversal of temporary ileostomy,1
40707,paclitaxel+nedaplatin+endostar,1
40708,ldn,1
40709,bone densitometry.,1
40710,paclitaxel; cisplatin; 5-fluorouracil; capecitabine,1
40711,individual patient tcr-transduced pbl,1
40712,apatinib single agent arm,1
40713,fast mri,1
40714,a6,1
40715,high-dose etoposide,1
40716,none as this is an observational study,1
40717,fried camellia oil,1
40718,consolidation carboplatin,1
40719,phase i (quinacrine),1
40720,amino-acid solution,1
40721,asp4132,1
40722,the risk assessment questionnaire,1
40723,20-gauge procore fnb needle,1
40724,fe 203799,1
40725,evolution® duodenal stent,1
40726,imrt planning,1
40727,aneustat (omn54),1
40728,havrix™,1
40729,tmz and bev induction before chemoradiotherapy,1
40730,dw-mri scans,1
40731,actamax™adhesion barrier,1
40732,lidocaine submucosal injection,1
40733,magnetic resonance elastogram,1
40734,"daunorubicin, cytarabine",1
40735,trendelenburg position - 30 degree,1
40736,alvimopan 0.5 mg/day,1
40737,atezolizumab (1200mg via iv infusion),1
40738,dexamethasone oral,1
40739,12 mg xanthohumol per day,1
40740,sotatercept 15 mg,1
40741,temozolomide+metformin,1
40742,treg cells,1
40743,risk-stratified therapy,1
40744,computer reminders on clinical practice,1
40745,hand therapy mcpj affected,1
40746,tsa-ctl,1
40747,pbf-999,1
40748,slnb and complete level i-ii axillary lymphadenectomy,1
40749,irinotecan injection [camptosar],1
40750,chinese herbal medicine granules or chinese herbal medicine granules placebo,1
40751,metronimic chemotherapy plus chinese traditional medicine,1
40752,vdc2008,1
40753,sf-ssrs,1
40754,lcar-b38m car-t cell,1
40755,proteomic profiling analysis,1
40756,coping skills training,1
40757,clinical/laboratory evaluations,1
40758,part a: azd8186 monotherapy,1
40759,stereotactic body radiosurgery (sbrt),1
40760,zytiga,1
40761,do not leave a chest tube in the pleural cavity.,1
40762,ad-cea vaccine,1
40763,structured exercise program plus hypocaloric diet,1
40764,a sampling of blood,1
40765,meditation classes,1
40766,leucovorin l,1
40767,rgb-286638,1
40768,r306465,1
40769,tamoxifen or aromatase inhibitor or aromatase inhibitor + goserelin,1
40770,oral dfp-11207,1
40771,placebo sessions,1
40772,mckeown mie,1
40773,mibefradil with radiation,1
40774,ro 24-7429,1
40775,real-time kv/mv prostate imaging,1
40776,subjects are mailed informational/educational materials,1
40777,autologous melan-a/mart-1 specific ctl clones,1
40778,bispectral index will be targeted at 35,1
40779,capecitabine-irinotecan,1
40780,cross sectional,1
40781,symptom severity,1
40782,bevacizumab - cohort 3,1
40783,conventional radiotherapy (crt) prostate boost,1
40784,"plerixafor, mozobil",1
40785,not applicable (measuring subject's effect site concentration of propofol during the induction of general anesthesia),1
40786,"regorafenib(stivarga, bay73-4506)",1
40787,normal dose nk cells ×4 times,1
40788,autologous cd19 car+ egftt + t cells,1
40789,nestle impact advanced recovery nutritional supplement,1
40790,medi4276,1
40791,3-d optical surface scan,1
40792,skin care,1
40793,combined exercise group,1
40794,patient decision aid (print-based),1
40795,mgcd265+erlotinib,1
40796,gefitinib + sunitinib,1
40797,salicylate,1
40798,group 1 remove self sample kit at gp consulting room or perform pap smear,1
40799,daily undulating periodization resistance training,1
40800,ccrt followed by vidl chemotherapy,1
40801,resection of the nerve plexus on the right half of celiac and sma associated with extended pancreatoduodenectomy,1
40802,neoadjuvant chemoimmunotherapy,1
40803,peg-alpha interferon (peg-intron),1
40804,prolon,1
40805,gum+peg,1
40806,ebus-tbna needle,1
40807,mi-walk intervention,1
40808,subtotal gastrectomy with gastroduodenostomy,1
40809,(supplement) calcium and magnesium,1
40810,modified cea peptide (10mcg),1
40811,external beam radiotherapy plus 90-y ibritumomab tiuxetan,1
40812,tocotrinol,1
40813,vt-ebv-n,1
40814,cmf chemotherapy,1
40815,contact every 2 weeks,1
40816,"m200 (volociximab), carboplatin, paclitaxel, bevacizumab",1
40817,imdendrim,1
40818,post surgical her2 testing,1
40819,palliative and oncology care,1
40820,3 day low residue diet prior to the colonoscopy,1
40821,serum collection,1
40822,cisplatin + ckm + celecoxib + dc vaccine,1
40823,avl-292,1
40824,long course chemoradiation,1
40825,18f-fmau,1
40826,pembrolizumab alone,1
40827,caregiver-guided pain management training (cg-pmt),1
40828,14 weeks exercise training,1
40829,g-chop,1
40830,jamar hydraulic hand dynamometer,1
40831,non-occlusion technique,1
40832,fdg-pet guided radiation dose escalation,1
40833,behavioral assessments,1
40834,"antineoplaston a10, antineoplaston as2-1 (anp)",1
40835,one on one education,1
40836,"endoscopic biliary stenting, percutaneous biliary stenting",1
40837,pazopanib followed by everolimus,1
40838,perioperative folfox4+cetuximab chemotherapy,1
40839,chemoradiotherapy paclitaxel,1
40840,pretreatment blood urea and serum creatinine,1
40841,16s rrna gene sequencing,1
40842,5-fluorouracil/oxaliplatin,1
40843,unilateral nerve-sparing cryoablation of the prostate,1
40844,hemostat,1
40845,regorafenib/placebo,1
40846,granulocyte macrophage colony stimulating factor,1
40847,abvd + fdg-pet/ct scan treatment adaptation,1
40848,v934-ep,1
40849,danusertib,1
40850,lorvotuzumab mertansine,1
40851,ixazomib 4 mg capsule a,1
40852,"5-fluorouracil, hydroxyurea-[fhx]",1
40853,short-course hypofractionated once-weekly radiation therapy,1
40854,gd2-targeted car-t cells,1
40855,68ga-hbed-cc-psma (dkfz-11) pet/ct,1
40856,cf-crt alone,1
40857,her2bi-armed t cells,1
40858,50 mg pyc and then placebo,1
40859,amg 757,1
40860,buparlisib placebo,1
40861,simultaneous boost along with chemo,1
40862,laboratory processing for results,1
40863,krn7000,1
40864,laryngectomy + adjuvant radiotherapy/chemoradiotherapy,1
40865,cetuximab/gemcitabine,1
40866,breath actuated nebulizer,1
40867,goal-directed fluid optimization,1
40868,pet scan and ultrasound,1
40869,crizotinib plus bevacizumab,1
40870,opsite post-op visible standard sterile dressing,1
40871,excision of sentinel node(s),1
40872,ibi310,1
40873,bos172722,1
40874,total hemihepatic vascular exclusion,1
40875,pembrolizumab 400 mg,1
40876,apheresis procedure,1
40877,focal leep,1
40878,best available care,1
40879,"lapatinib (gw572016, tykerb)",1
40880,tumor sample collection,1
40881,biliary stent (self expandable metallic stent),1
40882,photoacoustic imaging system,1
40883,trifluridin/tipiracil,1
40884,capecitabine-radiotherapy -liver transplantation,1
40885,eras procedure,1
40886,experimental: 1. experimental,1
40887,bcma-cart,1
40888,vsv-hifnbeta-nis,1
40889,imaging agent,1
40890,nab-paclitaxel 150 mg/m2 days 1 and 15,1
40891,water (exchange) method,1
40892,multispectral digital colposcope (mdc),1
40893,hia debiri + systemic folfox,1
40894,gemcitabine + gsk1120212,1
40895,plant-based diet,1
40896,"using 22g fnb, the first pass is sp",1
40897,apatinib+shr-1210,1
40898,interim therapy scintigraphy study gallium scan or pet/ct,1
40899,eus-guided pancreatic pseudocyst drainage,1
40900,academic detailing+telephone education,1
40901,reverse transcriptase-polymerase chain reaction of lymph node specimens,1
40902,nab-paclitaxel group,1
40903,post-operative radiation therapy,1
40904,im19 car-t,1
40905,beta erythropoietin,1
40906,ap611074,1
40907,chemoimmunotherapy,1
40908,opt-822/opt-821,1
40909,fried palm oil,1
40910,prehab exercise,1
40911,the consultation and relational empathy (care) questionnaire,1
40912,"topotecan, cyclophosphamide, cisplatin, doxorubicin, etoposide, ifosfamide, carboplatin",1
40913,bay94-9343 (2.2 mg/kg),1
40914,web-based psycho-educational support for family caregivers,1
40915,stereotactic body radiation therapy with integrated boost,1
40916,leo 43204 gel 0.1%,1
40917,elisa for mor-1 expression,1
40918,b (pembrolizumab),1
40919,psycho-educational intervention,1
40920,evaluation of autobiographical memory,1
40921,pomella™ (pomegranate extract),1
40922,desloratadine,1
40923,bay 1238097,1
40924,watch and wait,1
40925,autologous fecal microbiota transplantation,1
40926,hp802-247,1
40927,virtual bronchoscopy,1
40928,oral steroid administration?prednisone?,1
40929,physician's choice of salvage therapy - temozolomide,1
40930,over- the- scope full- thickness resection device (ftrd),1
40931,temozolomide 150 mg/m^2,1
40932,folinate calcium,1
40933,"rad001, capecitabine, oxaliplatin",1
40934,focus-web,1
40935,arm 2 balloon kyphoplasty,1
40936,in-person or telephone interview,1
40937,hx4 scan,1
40938,pnb of sln,1
40939,"imrt, cetuximab, docetaxel",1
40940,paclitaxel + carboplatin every 3 weeks,1
40941,lanreotide autogel (somatostatin analogue),1
40942,dacarbazine + interferon alpha + thymosin-alpha-1 3.2 mg,1
40943,low protein diet,1
40944,"dexamethasone,vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, methotrexate",1
40945,chemoradiotherapy with gemcitabine,1
40946,nephroureterectomy without lymphadenectomy,1
40947,"nab-paclitaxel 125 mg/m2 + gemcitabine 1000 weeks 1,2,3/4",1
40948,plat,1
40949,anti-cd19 car-nk cells,1
40950,multi-energy digital radiography detector system,1
40951,ts-1 and cisplatin,1
40952,therapeutic 4scar19 cells,1
40953,individualized yoga intervention group,1
40954,scinexa score,1
40955,standardized diet,1
40956,aspiration biopsy,1
40957,r848 gel,1
40958,temozolomide 60 mg x 21 days,1
40959,patient-reported outcomes,1
40960,"questionnaires, anticholinergic treatment, urodynamic study",1
40961,regorafenib (bay 73-4506),1
40962,radial artery catheterization,1
40963,muc1 dendritic cell vaccine (cvac),1
40964,procedure,1
40965,"s-1, oral leucovorin, oxaliplatin",1
40966,ebrt + hdr brachytherapy boost,1
40967,information sunsmart video,1
40968,visual examination,1
40969,r331333 (referred to as jns024 er or cg5503),1
40970,ctdna methylation in and it's correlation wth development and prediction of hcc,1
40971,computerized tomography (ct),1
40972,"low dose aspirin , vitamin d",1
40973,"cetuximab,paclitaxel,cisplatin",1
40974,sl proctectomy,1
40975,ct-guided brachytherapy,1
40976,tumor lysate-pulsed dendritic cell (dc) vaccine,1
40977,spatially modulated quantitative,1
40978,tremelimumab monotherapy,1
40979,lenalidomide and low-dose dexamethasone,1
40980,radial ebus-guided biopsy,1
40981,biodiffusion chamber,1
40982,short-acting triptorelin,1
40983,im-tmi (12gy),1
40984,d961h sachet 10 mg,1
40985,multiple myeloma (mm),1
40986,lu-177 psma-617,1
40987,placebo + avastin + platinum-based chemotherapy,1
40988,sodium phosphate solution (nap),1
40989,phentermine /topiramate (phen/ trp) er,1
40990,foodforcare at home,1
40991,l19-il2 at rd - ph ii,1
40992,continuous hyperthermic peritoneal perfusion (hipec/chpp),1
40993,transanal minimally invasive locoregional resection,1
40994,bms-59926,1
40995,exablate 2000 strappable system,1
40996,short-term counselling for families,1
40997,bp1001 (varying dose),1
40998,zoledronic acid plus ep/tp,1
40999,bupivacaine + triamcinolone acetonide,1
41000,lonafarnib (sch66336),1
41001,usual care: questionnaires,1
41002,pemetrexed phase 2,1
41003,cr diet,1
41004,radiotherapy 76 gy,1
41005,mineralocorticoid receptor antagonist,1
41006,radiofrequency ablation (halo ablation systems),1
41007,plerixafor (amd3100),1
41008,"plant- based, olive oil diet",1
41009,vorinostat (suberoylanilide hydroxamic acid),1
41010,intra-prostatic concentration of sexual steroids,1
41011,fludarabine (conditioning for allo transplant),1
41012,quality of life: functional assessment in cancer therapy - (fact),1
41013,pre-medication: zofran,1
41014,ap or ac,1
41015,zydelig,1
41016,activity monitoring and transplant,1
41017,"gefitinib, 5-fluorouracil, leucovorin and radiotherapy",1
41018,biomarkers assays,1
41019,pomalidomide 4 mg,1
41020,pain/symptom questionnaire,1
41021,"neuropsychological, psycho-pathological and quality of life assessments",1
41022,cervicovaginal lavage fluid collection,1
41023,calaa-01,1
41024,magic app,1
41025,biomarker sampling,1
41026,egfrt/19-28z/4-1bbl car t cells,1
41027,external beam radiotherapy for prostate cancer,1
41028,diet workbook,1
41029,blood and tumor sample,1
41030,vegfr2-169 and gemcitabine,1
41031,ima901,1
41032,ptdna,1
41033,abi-008 (nab-docetaxel),1
41034,"ct, mri and pet scan",1
41035,rupatadin,1
41036,gsk biologicals' hpv vaccine gsk580299,1
41037,electronic portal imaging,1
41038,cetuximab-irdye800cw,1
41039,[¹?c]ly2606368,1
41040,paclitaxel and carboplatin regimen,1
41041,2-mpp (pbcar3-phosphopeptide + pirs2-phosphopeptide),1
41042,pegylated interferon alfa 2a,1
41043,office-based disposable transnasal endoscopy endosheath,1
41044,whole body 18f-fdg pet/ct,1
41045,avmacol®,1
41046,online decision-aid tool,1
41047,imaging by ct and densitometry,1
41048,"oxaliplatin, 5fu/lv, bevacizumab",1
41049,dc rcc-rna,1
41050,pet acetate scan,1
41051,fitbit + facebook + coaching group,1
41052,car-t cells recognizing epcam,1
41053,high flow nasal oxygen,1
41054,standard robot-assisted partial nephrectomy,1
41055,polypectomy or biopsy,1
41056,"paclitaxel,gemcitabine,sunitinib",1
41057,3dcrt or imrt,1
41058,3-dcrt or imrt radiation,1
41059,90y ibritumomab tiuxetan (zevalin),1
41060,tq-b3203,1
41061,autologous followed by non-myeloablative allogeneic transplantation,1
41062,cox-2 inhibitor,1
41063,routine hospice care,1
41064,high-resolution ultrasound guided prostate biopsy,1
41065,fact-b,1
41066,p53 slp,1
41067,everolimus escalating dose,1
41068,fine needle biopsy (fnb),1
41069,"continuous 3,4-dap",1
41070,iodometomidate imaging,1
41071,bipolar diathermy,1
41072,approach method,1
41073,adxs11-001 (lm-llo-e7),1
41074,biological: mkcc1106-mt,1
41075,calcifediol,1
41076,neurosafe procedure,1
41077,hrt iii with non-contact cornea rostock module,1
41078,mirna tool,1
41079,fit-sigmoidoscopy,1
41080,trc093 recombinant humanized igg1k monoclonal antibody,1
41081,plasma exchange (plex),1
41082,"capecitabine, oral, 500 mg",1
41083,"mdct, ecg, echocardiography",1
41084,hybrid operating techniques,1
41085,total androgen suppression (tas) with bicalutamide,1
41086,clodronate,1
41087,"intraoperative neuronavigation ultrasound, intraoperative tractography, intraoperative fluorescence, advanced neuronavigation and intraoperative neurophysiology",1
41088,sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant,1
41089,rebombniant human endostatin,1
41090,ad5-ycd/muttksr39rep-adp adenovirus,1
41091,omission of radiation therapy,1
41092,laryngeal mask airway,1
41093,24-h esophageal ph-impedance test with manometry-control of ph-transducer,1
41094,bortezomib; pegylated liposomal doxorubicin; dexamethasone (vdd),1
41095,apbi: 30 gy,1
41096,mgd019,1
41097,standard supportive group psychotherapy,1
41098,night-time compression system garment,1
41099,scoring model,1
41100,human interferon-?,1
41101,wristband,1
41102,prednisone 1,1
41103,image guided mri based rt (imrt+brachytherapy),1
41104,portable colposcopy (cerviscope),1
41105,bcg strain of mycobacterium bovis,1
41106,prednisone 100 mg/m^2,1
41107,vsl3,1
41108,fixed gantry radiosurgery,1
41109,mmammogram,1
41110,pro-pn,1
41111,placebo excipient,1
41112,bay1251152,1
41113,adaptive radiation,1
41114,simultaneous integrated boost-sib on macroscopic metastases,1
41115,pomegranate pill,1
41116,bosutinib (ski-606),1
41117,vaccine placebo,1
41118,vorinostat and etoposide,1
41119,3 sample g-sensa,1
41120,leuprolide 7.5 mg / degarelix 160 mg,1
41121,argx-111,1
41122,blood will be withdrawn at baseline and in intervals of 3 months for a total period of 2 years,1
41123,safety and efficacy of escalating doses.,1
41124,exergaming program,1
41125,diphenhydramine or equivalent,1
41126,maraviroc 300 mg,1
41127,stapling device during radical cystectomy,1
41128,topical imiquimod,1
41129,cytarabine arabinoside,1
41130,two-stage with acellular dermal matrix (cellis® breast),1
41131,tefinostat,1
41132,cytapheresis,1
41133,moving touch therapy,1
41134,web-based decision support,1
41135,brn01,1
41136,"vinorelbine, gemcitabine and carboplatin",1
41137,her2-peptid-vakzine,1
41138,carlumab,1
41139,individual sleep promotion plan,1
41140,tachosil fibrin patch,1
41141,partial hepatectomy,1
41142,local saline infusion,1
41143,intervention session,1
41144,ibi308\oxaliplatin\capecitabine,1
41145,family-supported,1
41146,tr1801-adc,1
41147,furosemide (phase 1 only),1
41148,oral s-1,1
41149,pei,1
41150,brca genetic data,1
41151,human immune globulin intravenous (igiv),1
41152,cort125134 with nab-paclitaxel,1
41153,balugrastim,1
41154,endocuff group,1
41155,brief pain inventory-short form (bpi-sf),1
41156,oral gw679769,1
41157,"bevacizumab, everolimus and lbh589",1
41158,rapamycin (arm b),1
41159,flutamide (eulexin),1
41160,mm-111 + herceptin,1
41161,"bendamustine 90 mg/m2 iv on days 1-2, cycles 1-6",1
41162,cardiophrenic lymph nodes resection,1
41163,"oral contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)",1
41164,gen 1,1
41165,external beam proton radiation therapy.,1
41166,anti-cd19 car nk cells,1
41167,routine hilar lymphadenectomy,1
41168,standard procedure,1
41169,jcar017 (lisocabtagene maraleucel) 2-dose schedule,1
41170,occupational therapy informed yoga,1
41171,leuprolide acetate (lhrh analogue),1
41172,cart33 cells,1
41173,3 drugs arm,1
41174,standard drainage instructions,1
41175,tumor-infiltrating lymphocyte therapy,1
41176,trimix-dc and ipilimumab,1
41177,total gastrectomy with rou-en-y esophagojejunostomy,1
41178,"busulfex, fludarabine, alemtuzumab",1
41179,dendritic cell activated lymphocyte,1
41180,s-1 plus cddp,1
41181,sm88 (cohort 1),1
41182,yttrium-90 microspheres,1
41183,energy-based therapy,1
41184,direct-to-implant breast reconstruction,1
41185,0.25 ?g/day alfacalcidol,1
41186,multiple beams utilizing either intensity-modulated or 3d-conformal techniques,1
41187,radiosurgical hypophysectomy,1
41188,"denileukin diftitox, ifosfamide, cyclophosphamide, etoposide",1
41189,clomiphene citrate and prednisolone,1
41190,moluodan,1
41191,18f-2-fluoro-2-deoxy-d-glucose - positron emission tomography (fdg-pet),1
41192,percutaneous optical biopsy (oct and drs),1
41193,dn1406131,1
41194,1.0% lugol's solution,1
41195,cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant,1
41196,rcm imaging,1
41197,cervical swab,1
41198,tdap vaccine,1
41199,breastcare,1
41200,"rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone",1
41201,ryodoraku,1
41202,docetaxel 75mg/m2,1
41203,fgfr inhibitor,1
41204,"rfa, mwa, cryo and ire",1
41205,sbrt prostate,1
41206,staple ligation,1
41207,contrast-enhanced kbct,1
41208,photon sbrt,1
41209,olokizumab 60 mg,1
41210,corticosteroid: meprednisone,1
41211,non-invasive image & bioimpedance based techniques,1
41212,everolimus and bevacizumab,1
41213,ipilimumab iv,1
41214,mature dendritic cell vaccine,1
41215,prostate cancer radiotherapy using real-time tracking,1
41216,cmv pp65 peptide,1
41217,pelvic external beam radiation therapy,1
41218,igrt/vmat focal therapy boost to dil,1
41219,telephone counseling.,1
41220,retroviral vector-transduced autologous t cells to express anti-gpc3 cars,1
41221,"bevacizumab, gemcitabine, docetaxel and valproic acid",1
41222,pet positive nodal disease measuring less than 15 mm,1
41223,mri/mrs,1
41224,cg7870,1
41225,tf2/imp288,1
41226,serial text messages and mailed fit kit,1
41227,haip,1
41228,near infrared spectroscopy,1
41229,glidescope guided intubation,1
41230,3'-deoxy-3'-18f-fluorothymidine,1
41231,ga-68 labeled hbed-cc psma pet imaging,1
41232,bms-986115,1
41233,mdx-010 (ctla-4),1
41234,analyzing biopsy samples,1
41235,lancet blood sampling,1
41236,ifetroban sodium,1
41237,abus,1
41238,brain training program,1
41239,blood sample and life quality questionnaires,1
41240,reiki & relaxation response therapy with cognitive restructuring,1
41241,product 4808,1
41242,dose dense with neulasta,1
41243,'my care plan',1
41244,diane-35,1
41245,ercp only,1
41246,pertuzumab + trastuzumab + docetaxel,1
41247,"icotinib,pemetrexed,carboplatin",1
41248,lmb-7 immunotoxin,1
41249,psma -pet/ct scanning,1
41250,surgery without hipec,1
41251,low risk: inpatient management,1
41252,collection of adverse drug events,1
41253,sevoflurane+lidocaine,1
41254,lapatinib plus oral vinorelbine,1
41255,twice daily apbi,1
41256,jump math,1
41257,5fu/lv mayo clinic or lv5fu2,1
41258,th-302 + sunitinib,1
41259,moderate neuromuscular blockade (nmb),1
41260,actiq (oral transmucosal fentanyl citrate),1
41261,cisplatin for injection,1
41262,weight lifting exercises,1
41263,placebo dlbs1425,1
41264,ecil-4 guidelines group,1
41265,cik cell therapy,1
41266,avandamet,1
41267,self administered coping intervention,1
41268,free nonvascularized fibula autograft,1
41269,web-based educational intervention,1
41270,standard supportive care (packed rbc transfusion),1
41271,behavioral dietary and exercise intervention,1
41272,cow's milk,1
41273,cx bladder monitor test,1
41274,ato + ascorbic acid,1
41275,exposure to having a long-term condition.,1
41276,ss1 (dsfv) pe38,1
41277,immediate surgery (resection of primary colorectal tumor),1
41278,mri and targeted biopsies,1
41279,"hyaluronic acid (macrolane vrf 30®, q-med)",1
41280,long-chain triglyceride,1
41281,peg-ifn-a2b,1
41282,peg hydrogel (spaceoar),1
41283,cyclophosphamide & zyc300 (zyc300 with cyclophosphamide pre-dosing),1
41284,navigo bx™,1
41285,mr-guided focal laser ablation,1
41286,calcium chloride,1
41287,eus-fna of pancreatic masses,1
41288,cyad-101,1
41289,"post-test counseling, and post-test assessment",1
41290,vehicle-control topical solution,1
41291,endoractor®,1
41292,gas chromatography / tandem mass spectometry,1
41293,pi-88 and dacarbazine,1
41294,rf-go 100p209,1
41295,experimental ofdi imaging,1
41296,sentinel lymph node mapping and biopsy,1
41297,upper gastrointestinal endoscopy and doppler ultrasound,1
41298,yttrium y 90 monoclonal antibody hmfg1,1
41299,megestrol?yining?,1
41300,tme resection,1
41301,alvac mart-1 vaccine,1
41302,stem cells autotransplantation,1
41303,biobehavioral intervention,1
41304,red blood cells transfusion,1
41305,metformin +doxycycline,1
41306,neurodynamic techniques,1
41307,intimacy enhancing intervention,1
41308,bf+phone,1
41309,ac*4-t*4,1
41310,propolis,1
41311,platinum and gemcitabine,1
41312,lhrha or surgical castration,1
41313,prostate cancer imaging,1
41314,pharmacy intervention,1
41315,crystallized phenol,1
41316,music listening program,1
41317,rgd k5 pet scan,1
41318,measuring hemodynamic parameters heart beat to heart beat during single-frequency exposure,1
41319,np-g2-044,1
41320,computed tomography colonography,1
41321,fat-free milkshake,1
41322,l-glutamine placebo,1
41323,waitlist control group,1
41324,structured exercise training,1
41325,colonoscopic examination,1
41326,external local radiation therapy,1
41327,cobas hpv-dna test,1
41328,only oral intestinal cleaner 12 h pre-operation,1
41329,early enteral nutrition,1
41330,local anaesthetic infiltration of laparoscopic port sites,1
41331,pharmacokinetic sampling - simvastatin,1
41332,"capecitabine, doxcetaxol",1
41333,methoxyflurane,1
41334,"small media, group education (multicomponent)",1
41335,sirolimus 0.1% ointment,1
41336,twisted syringe,1
41337,open label phase with conventional 10mg everolimus dosing week 4-24,1
41338,c2 cryoballoon 180° ablation system,1
41339,probio-fix inum,1
41340,systemic chemotherapy and antibodies,1
41341,serum and dna samples,1
41342,eus-fnb with 20 gauge procore needle,1
41343,sequential bcg and emda mitomycin c,1
41344,torisel 75 mg and r-dha,1
41345,tremelimumab 75 mg,1
41346,faecal test,1
41347,androgen suppression therapy and radiation therapy,1
41348,collection of healthy skin tissue,1
41349,csf analysis,1
41350,decitabine (dtc arm),1
41351,stereotactic radiosurgery (12 gy),1
41352,cdca1?urlc10?kif20a?depdc1 and mphosph1,1
41353,suppressor of the pi3k/akt pathways,1
41354,sbrt 55.0 gy,1
41355,transplant (hct),1
41356,vectibix® (panitumumab),1
41357,text message,1
41358,mobilized cd34-selected peripheral blood stem cell graft,1
41359,thyrotropin releasing hormone (trh),1
41360,autologous hemopoietic stem cell transplant 2,1
41361,kang su,1
41362,acupuncture using seirin® needles,1
41363,lidocaine infusion plus ketamine injection,1
41364,vargatef®,1
41365,"quadrivalent human papillomavirus (types 6,11,16,18) recombinant vaccine",1
41366,"trofosfamide, etoposide",1
41367,ropivacaine with epinephrine injection,1
41368,peg-ifná-2a,1
41369,local-distal points association,1
41370,"ifosphamide, etoposide, methotrexate, vindelsine, prednisone",1
41371,survivor survey (3): 3 month post-visit,1
41372,braf detection on fine needle aspiration biopsy (fnab),1
41373,64-cu-plerixafor,1
41374,vivascope system,1
41375,evaluation of pd-1/pdl-1 expression.,1
41376,bpm31510 nanosuspension injection,1
41377,la tnbc: dc vaccine+preop chemo,1
41378,"combination of metyrosine-derivative with low-dose sirolimus, phenytoin and methoxsalen",1
41379,epirubicin+cisplatin+capecitabine,1
41380,different timing of influenza vaccination,1
41381,hpv self-colleciton,1
41382,imatinib and pegylated interferon,1
41383,kw-2246,1
41384,anti-igf-1r recombinant monoclonal antibody mk-0646,1
41385,intraoperative electron radiation therapy,1
41386,4-d ct scan,1
41387,fluoro-d-glucose-positron emission tomography,1
41388,tilmanocept (technetium tc 99m tilmanocept injection),1
41389,self-regulation plus activity monitoring,1
41390,procedure: spectroscopy and digital imaging,1
41391,bilateral side-by-side insertion,1
41392,radiotherapy (boost versus no boost),1
41393,"carboplatin, etoposide, ifosfamide",1
41394,rating questionnaire,1
41395,administration of azd6738 in combination with carboplatin,1
41396,placebo + cytarabine,1
41397,chemoradiotherapy with integrated boost dose,1
41398,transplant 1 cisplatin,1
41399,wrist-worn accelerometer,1
41400,multimodal,1
41401,stress and symptom management program 2,1
41402,bms-275291,1
41403,anti-cd19/bcma car-t cells,1
41404,dna index,1
41405,low-frequency electro-acupuncture (ea),1
41406,dofequidar fumarate,1
41407,prophylaxis,1
41408,no fulfillment of a preventive programme,1
41409,radiotherapy fractionation,1
41410,treatment with cbp and 5-fu,1
41411,ca-18c3,1
41412,placebo of desloratadine,1
41413,autologous tcm cellular immunotherapy,1
41414,gumdrops,1
41415,psycho-education,1
41416,conformal radiation therapy (rt),1
41417,determination of esr1 mutations,1
41418,0.75% ropivacaine,1
41419,philips sonalleve mr-hifu hyperthermia,1
41420,ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine,1
41421,routine imaging mri with a 3d printed model,1
41422,sbrt plus chemotherapy,1
41423,standardized home exercise,1
41424,lurbinectedin,1
41425,bi-plane chest radiography,1
41426,allogeneic cell therapy w/ tumor-derived lypho,1
41427,5fluorouracil continu,1
41428,reflexology treatment,1
41429,cluster of 3000 women,1
41430,surgery plus 2 adjuvant doses of bcg,1
41431,mrna transfected dendritic cell,1
41432,monosialoganglioside,1
41433,erlotinib plus docetaxel or pemetrexed,1
41434,xiaflex surgery,1
41435,liquid-based cytology,1
41436,ucn-01 (7-hydroxystaurosporine),1
41437,nurse coach intervention,1
41438,clinoleic,1
41439,ultratracetm iobenguane i 131 therapy,1
41440,tookad soluble 4 mg/kg,1
41441,abl cells,1
41442,mepivacaíne,1
41443,without hyperthermic intraperitoneal chemotherapy,1
41444,cold polypectomy,1
41445,bay 43-9006 (sorafenib),1
41446,toronto alexithymia scale (tas),1
41447,pemetrexed + pf-3512676,1
41448,online enhanced education tool,1
41449,white wine,1
41450,placebo abivertinib maleate capsules,1
41451,axillary drainage,1
41452,cd45ra-depleted dli,1
41453,acyclovir 800 mg,1
41454,electromyography,1
41455,specimen ultra-high field mri,1
41456,psa/il-2/gm-csf,1
41457,cat-8015 10 mcg/kg,1
41458,v3-p,1
41459,weight loss counseling- phone,1
41460,low contact,1
41461,li,1
41462,roux-en-y or billroth ii,1
41463,concerta®,1
41464,removal of a central venous access device,1
41465,hou gu mi xi,1
41466,"cyclophosphamide, doxorubicin, vincristine and prednisone",1
41467,core,1
41468,intraperitoneal chemotherapy,1
41469,standard first line treatment with cetuximab + folfiri,1
41470,gnrh analogue and aromatase inhibitor,1
41471,part c1: abiraterone acetate combination with azd8186,1
41472,psma pet,1
41473,fiberoptic naso-tracheal intubation,1
41474,parotid-sparing head & neck radiation guided by mri sialography,1
41475,pre-hct mesna on days -6 and -5,1
41476,magnevist® (intravenous (iv) administration of mri contrast agent),1
41477,0.9% saline group,1
41478,2d-ffdm,1
41479,androgen receptor antagonist arn-509,1
41480,activated cik and cd3-muc1 bispecific antibody in treating colorectal cancer,1
41481,av-299 + gefitinib,1
41482,flt imaging,1
41483,proton beam radiation therapy.,1
41484,fatigue evaluations,1
41485,do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (pro-ctcae) questionaire,1
41486,pet positive nodal disease measuring 15 mm or greater,1
41487,pioglitazone vs. placebo 30 mg,1
41488,upper endoscopy with biopsy,1
41489,digital manometer,1
41490,wiersma head stabilizer,1
41491,mapisal,1
41492,"xofigo (radium 223 dichloride,bay88-8223)",1
41493,cetuximab 250 mg/m^2,1
41494,gdc 695,1
41495,dysphagia inventory questionnaire,1
41496,radiation therapy-3 fractions,1
41497,grn-1201,1
41498,grt (guided relaxation training),1
41499,mixed bacterial vaccine,1
41500,rgt100-pei,1
41501,fast-track perioperative program,1
41502,administration of azd6738 in combination with olaparib,1
41503,"azacitidine with rituximab, vincristine, and cyclophosphamide",1
41504,icp-192,1
41505,pemetrexed/platinum,1
41506,cisplatin?fluorouracil,1
41507,sugammadex sodium,1
41508,lymph nodes cyto-punction,1
41509,pancreatic duct occlusion with neoprene,1
41510,topotecan and pasireotide,1
41511,opb-31121 phase2,1
41512,fluciclovine (18f),1
41513,lutetium lu 177 monoclonal antibody cc49,1
41514,pomegranate extract formulation-2,1
41515,ptsd coach,1
41516,emd 72000,1
41517,200mg kentons@ (tocopherol nicotinate).,1
41518,whole exome sequencing,1
41519,chemoradiotherapy temozolomide,1
41520,follow-up telephone genetic counselling,1
41521,autologous pbmc reconstitution,1
41522,bms-936564,1
41523,revlimid®,1
41524,radiotherapy to oesophageal tumour,1
41525,afxl-assisted ingenol mebutate delivery,1
41526,immunoscore test,1
41527,lc bead loaded with irinotecan,1
41528,"anti-thymoglobulin, rabbit (atg, rabbit atg)",1
41529,bi-1206 single agent dose escalation phase,1
41530,adara 5% cream us,1
41531,99mtc-mibi spect-ct,1
41532,capillary suction technique for eus fna,1
41533,retrovirus vector ln,1
41534,alkylating agents,1
41535,high dose intensity modulated proton radiation,1
41536,integrated traditional chinese and western medicine,1
41537,nutritarian diet-style,1
41538,360 mg anti-pd-1 mab js001 q3w,1
41539,breath-hold pet/ct image set,1
41540,proton chemoradiotherapy followed by surgery,1
41541,49-channel optical spectrometer,1
41542,anti-pd-l1 csr t cells,1
41543,amils,1
41544,bevacizumab 15 and tac,1
41545,non-myeloablative allogeneic transplant,1
41546,medi-551 4 mg/kg,1
41547,psycho-behavioural intervention arm (pbi),1
41548,control ct,1
41549,image fingerprint,1
41550,biological analyses,1
41551,opdivo injectable product or keytruda injectable product,1
41552,mindfulness based resilience training,1
41553,early urinary catheter removal,1
41554,tcd-717,1
41555,okn 007,1
41556,capecitabine plus gemcitabine,1
41557,single fraction radiation,1
41558,incident cancer,1
41559,"npi-0052 on days 1, 4, 8, 11 every 21 days",1
41560,sorafenib combined with tace,1
41561,"larotrectinib (vitravki, bay2757556)",1
41562,pembrolizumab nsclc medium dose,1
41563,cryoballoon focal ablation system,1
41564,distal pancreatectomy with partial splenectomy,1
41565,other flap techniques,1
41566,synchromed ii infusion pumps,1
41567,doxorubicin hydrochloride (a),1
41568,ocdc,1
41569,fac x 3 followed by docetaxel x 3,1
41570,prrt every 5 weeks,1
41571,placebo (wheat flour),1
41572,imcgp100 injection,1
41573,abve-pc,1
41574,biopsy of testicular tumor,1
41575,"coenzyme q10u, l-carnitine",1
41576,email,1
41577,tailored education and coaching,1
41578,special diet therapy (low-fat),1
41579,biopsies of the prostatic fossa in gronau,1
41580,"biological fluids (serum, bronchoalveolar lavage and pulmonary aspiration) and bronchial biopsies collection",1
41581,il28b polymorphism,1
41582,"functionally adapted, dose escalated vmat radiotherapy",1
41583,whey protein,1
41584,combined metformin-cc,1
41585,mrd analysis,1
41586,3d printing + images,1
41587,cabozantinib (xl184) 60 mg,1
41588,epstein-barr virus-specific adoptive t-cells immunotherapy,1
41589,metabolic image guidance,1
41590,treadmill walking dose-finding / escalation,1
41591,pegylated lyposomal doxorubicin,1
41592,3 mg drsp/20 ?g ee,1
41593,cdx-110 with gm-csf,1
41594,wlscc,1
41595,the suture marks the location of the parathyroid gland,1
41596,th/bso,1
41597,iressa day 1 given with arimidex and faslodex,1
41598,glesatinib,1
41599,luteinizing hormone releasing hormone (lhrh) agonist,1
41600,rituximab + dhap,1
41601,standard care chemoradiation,1
41602,60 gy in 40 fractions,1
41603,umbilical cord blood after myeloablative conditioning,1
41604,cohort 2b: carfilzomib 20 mg/m2,1
41605,integrated fdg pet/ct,1
41606,eicosapentaenoic acid enriched nutritional supplement,1
41607,manual acupuncture implemented by junior acupuncturists,1
41608,digital image analysis,1
41609,diagnostic imaging ( 6?-[18f]fluoro-17?-estradiol (fes)),1
41610,tumor-infiltrating lymphocytes (til),1
41611,ca 15-3 assay,1
41612,in 30gy rt in case of pr at the end of chemotherapy,1
41613,"bortezomib, tradename velcade",1
41614,chest radiograph imaging,1
41615,"paclitaxel,",1
41616,radio-ablation,1
41617,early discharge,1
41618,bodyfix,1
41619,isotonic fluid (e153),1
41620,patient-assisted compression (pac),1
41621,paclitaxel/gemcitabine,1
41622,stereotactic body rt with mr-guided boost,1
41623,at1 blocker candesartan,1
41624,narrative visualization,1
41625,civacir® 10%,1
41626,"cop, copd m3, cym",1
41627,sodium ascorbate,1
41628,ct scan before chest physician,1
41629,regn2810/ipi,1
41630,self questionnaires of quality of life and living conditions,1
41631,lde225 0.25%,1
41632,"structured social skills training program, ssip",1
41633,carbon-11 sodium acetate,1
41634,cbti-cs via telehealth,1
41635,navigation system,1
41636,procore needle,1
41637,"cetuximab, cisplatin,5-fluorouracil,leucovorin",1
41638,vincristine/vindesine,1
41639,"bortezomib, chop, rituximab",1
41640,prostate-specific antigen measurement,1
41641,exams and questionnaires,1
41642,cohort 2 matching sugar capsule,1
41643,lenalidomida and rituximab,1
41644,masct,1
41645,ultrasonographic measurement of corrected flow time in carotid artery,1
41646,"bortezomib, dexamethasone",1
41647,varenicline (chantix),1
41648,oncology nurse care management,1
41649,open surgery with limited aponeurectomy,1
41650,"gsk580299 (cervarix™ , hpv -16/18 l1 vlp as04 vaccine)",1
41651,cefazolin/clindamycin,1
41652,cbe,1
41653,exablate 2100; insightec,1
41654,nbi withdrawal method,1
41655,lobectomy + mediastinal lymph node dissection or systematic lymph node sampling,1
41656,eo9(apaziquone),1
41657,veritas®,1
41658,prednisone\prednisolone,1
41659,standard anti-emetic treatment (5-ht3 receptor antagonists and/or dexamethasone),1
41660,pem flex solo ii pet scanner,1
41661,blood stem cell versus bone marrow transplant,1
41662,sildenafil 25 mg oral tablet,1
41663,"rivaroxaban (xarelto, bay59-7939)",1
41664,hypofractionated intensity modulated radiotherapy,1
41665,resistance exercise training (ret),1
41666,grass sd9 stimulator,1
41667,calcium / vitamin d,1
41668,ifosfamide and mesna,1
41669,placebo risedronate oral tablet,1
41670,dasatinib and paclitaxel,1
41671,five-times-sit-to-stand test,1
41672,fluorescent in situ hybridization (fish) panels,1
41673,standard oral hygiene + true acupuncture,1
41674,whey protein (immunocal®),1
41675,massage of maxillofacial and oral cavity,1
41676,consolidation bumel,1
41677,p1101,1
41678,hla-a*2402 or a*0201 restricted peptides,1
41679,study sentinal node dye,1
41680,total resection,1
41681,oxaliplatine / gemcitabine / vinorelbine,1
41682,laser confocal microscopy,1
41683,fotemustine and ipilimumab,1
41684,apollo™ onyx™ delivery micro catheter,1
41685,fib one,1
41686,"biopsies, blood",1
41687,"paclitaxel, carboplatin and irinotecan",1
41688,pain buddy,1
41689,"paclitaxel, 200 mg/m^2",1
41690,bles system and conventional lumpectomy,1
41691,face-flu/bu/cy,1
41692,single fraction ioert,1
41693,breast reconstruction decisional aid (brda),1
41694,pd-l1 positive vs pd-l1 negative nsclc patients,1
41695,measurement of protein expression in tissue and /or blood samples.,1
41696,placebo 15 and tac,1
41697,s-equol,1
41698,single incision needle knife biopsy,1
41699,multi-carotenoids,1
41700,hepatic rfa,1
41701,"urlc10, koc1, vegfr1 and vegfr2",1
41702,telephone assessments,1
41703,capecitabine 1650 mg/m^2/day,1
41704,unmanipulated umbilical cord blood (ucb),1
41705,naviaid™ g-eye procedure,1
41706,bisoprolol,1
41707,sirolimus (rapamune),1
41708,health history,1
41709,"epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)",1
41710,pegylated interferon alfa-2a,1
41711,total endoscopic,1
41712,pet scanning in cancer,1
41713,surgical resection/debulking,1
41714,pbf-509_160 mg,1
41715,usual maintenance,1
41716,intraoperative monitoring during resection of brain tumor,1
41717,continuous glucose monitoring,1
41718,anti-erbb2 therapy as part of a treatment regimen for either brain metastases or primary breast cancer,1
41719,single-port,1
41720,6 fec 100,1
41721,ck,1
41722,"therapeutic education of type ""caratif",1
41723,pet-mr,1
41724,endoscopic mucosal resection protocol,1
41725,limax,1
41726,breast cancer patient,1
41727,pinnacle3 treatment planning system,1
41728,zactima (zd6474),1
41729,stresson,1
41730,bpf-ccrt (randomized),1
41731,overstitch endoscopic suturing system,1
41732,physical exercise and probiotic group,1
41733,nivolumab 480mg,1
41734,lower does topotecan,1
41735,systematic sampling of the lymph-node,1
41736,eaa+leu vs total aa,1
41737,single fraction radiation therapy,1
41738,urinary hcg (u-hcg),1
41739,intermediate risk with complete early response after two cycles of abvd chemotherapy schedule. three more abvd courses are delivered.,1
41740,short-stretch compression bandage,1
41741,nhanes food questionnaire,1
41742,reconstruction with adm.,1
41743,reference standard dermatoscope device images,1
41744,augmented fluoroscopy,1
41745,vital blue dye (optional),1
41746,bevacizumab plus ipilimumab cohort 4,1
41747,hep-v vax,1
41748,hla haploidentical mononuclear cells infusion,1
41749,icbt for insomnia,1
41750,direct laringoscopy,1
41751,iscar,1
41752,carboplatin plus celecoxib,1
41753,gemcitabine + docetaxel,1
41754,symphion® bipolar hysteroscopic tissue resection system,1
41755,room temperature air insufflation,1
41756,trastuzumab (herceptin),1
41757,radium-223 chloride,1
41758,modified measles virus lumbar puncture,1
41759,"oxaliplatin, 5-fu",1
41760,carbon ions boost followed by pelvic photon radiotherapy,1
41761,intensify physiotherapist intervention,1
41762,absorbable chromic gut sutures,1
41763,allogenic tumor cell vaccine (k562),1
41764,observational study: use of patient questionnaires,1
41765,inulin (probiotic),1
41766,"prednison, vincristine, cytarabine, methotrexate, etoposide, cyclophosphamide, doxorubicin",1
41767,dce and dwi mri,1
41768,alcohol block,1
41769,adramycin,1
41770,standard of care (paclitaxel or topotecan or doxorubicin),1
41771,leucapheresis,1
41772,rosettesep,1
41773,single pilot interview,1
41774,as1409,1
41775,bms-986299,1
41776,lm716,1
41777,"trastuzumab (h, 8mg/kg",1
41778,idoxuridine,1
41779,mid-high dose lx1606 - day 29 (start),1
41780,"lanreotide, non steroidal anti androgens and lhrh-a",1
41781,hipec with neoadjuvant chemotherapy,1
41782,carboplatin and pegylated liposomal doxorubicin hydrochloride (pld),1
41783,chemotherapy (taxotere and prednisone),1
41784,patient position during radiotherapy,1
41785,tq-b3101,1
41786,three dimensional laparoscopic resection for pcca,1
41787,carboplatin auc-10,1
41788,aeroform tissue expansion,1
41789,panvac™-vf,1
41790,meat-based diet supplemented with alpha-tocopherol (mbd-t),1
41791,percutaneous zygapophyseal cyst rupture,1
41792,docetaxel and erlotinib,1
41793,giotrif 40mg,1
41794,blood/urine sampling,1
41795,any drug not known as a major teratogen or major fetotoxicant,1
41796,arq 761,1
41797,alpha fetoprotein adenoviral vector vaccine,1
41798,external beam radiotherapy.,1
41799,talabostat mesylate (pt-100) tablets,1
41800,perforator flap breast reconstruction,1
41801,3l peg+dyclonine hydrochloride mucilage,1
41802,"pemetrexed or gemcitabine plus carboplatin,",1
41803,body composition,1
41804,azacitidine (aza) days 1 - 3,1
41805,vp-102 applicator,1
41806,busulfan - fludarabine - tbi,1
41807,two post-remission strategies,1
41808,mdx-1411,1
41809,arginine recovery supplement,1
41810,whole-mount sectioning of the prostate,1
41811,device: tumor localization,1
41812,oral drug and vaginal placebo,1
41813,standard sun protection measures,1
41814,epirubicin plus shr1210,1
41815,rad001 + docetaxel + cisplatin,1
41816,no intervention: observational only,1
41817,anti-pd-l1/tgfbetarii fusion protein m7824,1
41818,n-acetylcysteine 500 mg,1
41819,full information,1
41820,multi-ph-impedance manometry catheter,1
41821,pcmri,1
41822,"pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin?cis-platinum or nedaplatin",1
41823,rapamycin 3mg,1
41824,placebo for pazopanib,1
41825,none remote ischemia precondition,1
41826,regn1400,1
41827,vistide,1
41828,realization of 3 blood samples during study during treatment with lenalidomide,1
41829,sanchi powder simulation,1
41830,"letrozole ,goserelin",1
41831,association of bevacizumab (bvc)+ pazopanib (pzp),1
41832,trx518 with nivolumab,1
41833,collection of blood sample if tumor sample is not available,1
41834,laparoscopic rectal surgery,1
41835,doxorubin,1
41836,group a: carfilzomib & non-imid regimen,1
41837,akt/erk inhibitor onc201,1
41838,incentive,1
41839,crispbread,1
41840,incb081776,1
41841,hpb surgery,1
41842,hemodynamic evaluation,1
41843,convection enhanced delivery (ced) of nanoliposomal irinotecan (nal-iri),1
41844,cable tie,1
41845,arterial catheter infusion chemotherapy,1
41846,radiodine ablation without rhtsh,1
41847,oligofructose-enriched inulin,1
41848,young tumor infiltrating lymphocytes,1
41849,fiberscope-guided nasogastric tube insertion,1
41850,aa4500 collagenase clostridium histolyticum,1
41851,albumin-bound paclitaxel plus s-1,1
41852,(yeast cea vaccine)(gi-6207[recombinant sarrcharomyces cerevusua-cea (610d)]),1
41853,th1/tc1 rapa cell therapy,1
41854,rejuvenair,1
41855,culturally-tailored video,1
41856,laxabon®,1
41857,dose-dense doxorubicin/cyclophosphamide + sunitinib,1
41858,hpv-cytology co-testing,1
41859,blinded accelerometer,1
41860,cellectra™-5p,1
41861,clevidipine,1
41862,conventional vertebroplasty,1
41863,prehabilitation plus,1
41864,bay87-2243,1
41865,screening without fee,1
41866,mgcd0103 & docetaxel,1
41867,cognitive therapy of depression,1
41868,f-18 naf,1
41869,izn-6n4,1
41870,remote ischaemic conditioning,1
41871,taxane plus carboplatin,1
41872,ace 011,1
41873,matching placebo for ser-401,1
41874,"nci-4650, a mrna-based, personalized cancer vaccine",1
41875,axillary clearance,1
41876,mmr vaccine,1
41877,amil,1
41878,api 31510 1.5% topical cream,1
41879,trametinib (2mg)/digoxin (.25mg),1
41880,car-gpc3 t cell,1
41881,blue and isotopic detection of sentinel lymph nodes,1
41882,placebo device,1
41883,paclitaxel for injection (albumin-bound),1
41884,drug: 99mtc-mip-1404,1
41885,team monitoring,1
41886,hodgkin's antigens-gm-csf-expressing cell vaccine,1
41887,uncaria tomentosa (cat´s claw),1
41888,standard-vaginal misoprostol,1
41889,liver-first surgery,1
41890,eia chemotherapy,1
41891,ag2037,1
41892,glidescope®,1
41893,opt-822/opt-821(30 ?g/100 ?g),1
41894,preoperative mri,1
41895,pediasure,1
41896,vigorous exercise intervention - standard,1
41897,air insufflation colonoscopy,1
41898,ensartinib capsules (test product),1
41899,mediastinoscopy/thoracoscopy,1
41900,transplantation with stem cells from umbilical cord,1
41901,"ct, radiation therapy",1
41902,transurethral resection of the bladder tumor & cystoscopy,1
41903,induction trichemotherapy - folfirinox regimen,1
41904,needlescopic adrenalectomy and laparoscopic adrenalectomy,1
41905,fast-track rehabilitation,1
41906,paclitaxel only,1
41907,trph-222,1
41908,connected urinary catheter,1
41909,folfox plus pac(ip),1
41910,diet modification,1
41911,the patient-directed (pd) strategy,1
41912,acupuncture and moxibustion,1
41913,cyclobenzaprine,1
41914,activated nometex device,1
41915,dydrogesterone 10 mg,1
41916,postsurgical adjuvant therapy,1
41917,international physical activity questionnaire short form,1
41918,"oxaliplatin, capecitabine, bevacizumab, imatinib",1
41919,post-treatment phase group,1
41920,adt therapy,1
41921,34 gy in a single fraction,1
41922,study part 2: krp203 lower dose,1
41923,temozolomide(tmz),1
41924,on-q painbuster silver soaker,1
41925,bis vista monitor (bis),1
41926,sb8,1
41927,evaluate the correlation of overall different objective response.,1
41928,nasal fentanyl,1
41929,plasma next generation sequencing (ngs),1
41930,marinated cooked sirloin steak,1
41931,mifepristone and eribulin in combination,1
41932,molecular analysis of cancer,1
41933,narrow band imaging withdrawal,1
41934,ct coronary angiography,1
41935,neoadjuvant docetaxel,1
41936,moderate-intensity aerobic exercise intervention,1
41937,strengthening,1
41938,hr-trus,1
41939,improvisational comedy classes,1
41940,injection of filgrastim,1
41941,augmented ventilation,1
41942,actonel (risedronate),1
41943,ha-irinotecan solution for infusion,1
41944,apn01,1
41945,paclitaxel-hdfl,1
41946,electro-acupunture treatment,1
41947,jnj-64407564,1
41948,high dose dexamethsone,1
41949,provenge,1
41950,her2 dc1 vaccine,1
41951,fecal sample collection for analysis,1
41952,late fdg,1
41953,nivolumab cohort 1,1
41954,pancreaticoduodenectomy with extended lymphadenectomy,1
41955,pd 0332991 (pre-surgery),1
41956,cd8 depleted donor lymphocyte,1
41957,comparator: erlotinib monotherapy,1
41958,pembrolizumab at 35 days post,1
41959,cbt124,1
41960,"blood samples, transvaginal ultrasound",1
41961,l02 (sex hormones used in treatment of neoplastic diseases) and g03 (sex hormones),1
41962,free flap surgery,1
41963,"imrt/igrt, tumor resection, brachytherapy",1
41964,afuresertib hpmc capsule - fasted state,1
41965,intraoperative placement of device in glioma,1
41966,high-dose influenza vaccine,1
41967,psma pet/ct-scan,1
41968,hospital-based home care,1
41969,pva,1
41970,hdac,1
41971,allogeneic blood or marrow transplant,1
41972,hpv vaccine electronic reminders,1
41973,eus-fnb (echotip procore),1
41974,"busulfan, cyclosphosphamide, rabbit atg,",1
41975,cook medical emr gel,1
41976,carboplatin mtd,1
41977,hcc child-pugh a expansion cohort: regorafenib 100 mg,1
41978,hai-90y radioembolization (sir-spheres injection),1
41979,188re-bmeda-liposome,1
41980,posology dose modification,1
41981,adjusted analgesia pump administration,1
41982,intra-articular injection,1
41983,leica sm2000 r,1
41984,late-course accelerated hyperfractionated imrt,1
41985,lenograstim (granogyte 34),1
41986,garlic extract (allicin),1
41987,3'-deoxy-3'-[f-18] fluorothymidine: [f-18]flt,1
41988,paracetamol and ketamine,1
41989,focal laser ablation,1
41990,"double-contrast barium enema, colonoscopy",1
41991,equip,1
41992,leuprorelin 3.75 mg,1
41993,glioma resection,1
41994,transition coach,1
41995,leo 43204 formulation 2,1
41996,independent tailored intervention,1
41997,docetaxel * sunitinib,1
41998,p10s-padre vaccine,1
41999,advanced control,1
42000,autologous natural killer / natural killer t cell immunotherapy,1
42001,ro5137382,1
42002,bcma nanobody car-t cells,1
42003,nicotine replacement patch,1
42004,blu-667,1
42005,3 imaging techniques are done,1
42006,dnp sensititzation,1
42007,peg solution (fortrans®),1
42008,pembrolizumab dose a,1
42009,bibf 1120 m + pemetrexed,1
42010,as needed rasburicase,1
42011,b-mad chemotherapy,1
42012,dynasplint trismus system,1
42013,amv564,1
42014,web-based multimedia intervention,1
42015,piperine extract (standardized),1
42016,puri-nethol,1
42017,pyruvic acid,1
42018,lumpectomy or mastectomy with sentinel node or axillary node dissection,1
42019,pedss - symptom management,1
42020,henatinib,1
42021,nimotuzumab humanized monoclonal antibody,1
42022,r-tatme,1
42023,standard arm - fulvestrant,1
42024,"sonazoid- ceus, cemri, cect",1
42025,passy muir swallowing self trainer,1
42026,rhg-csf 5ug/kg/day,1
42027,500 mg iron isomaltoside 1000,1
42028,sequential and maintenance icotinib,1
42029,individualized therapy,1
42030,robot-assisted laparoscopic myomectomy,1
42031,flurbiprofen,1
42032,cend-1,1
42033,pectoralis type 2 block and catheter insertion with lidocaine dissection,1
42034,individual dietary counselling,1
42035,radiation therapy and high-dose il-2,1
42036,afinitor,1
42037,succinate of solifenacin,1
42038,platinum-based chemotherapy plus nivolumab,1
42039,extended follow up,1
42040,video illness narrative,1
42041,ape with intersphincteric dissection,1
42042,aerobic training presential,1
42043,no systemic anticoagulant prophylaxis,1
42044,involved node rt,1
42045,psoralens with ultraviolet light a,1
42046,favid (id-klh) active immunotherapy,1
42047,patients considered resectable,1
42048,medical oxygen,1
42049,routine monitoring,1
42050,biologic mesh,1
42051,capeox?capecitabine+oxaliplatin?,1
42052,nilotinib 300 mg.,1
42053,mmp1 genotypes polymorphism,1
42054,vitamin b-6+coenzyme q10,1
42055,airseal system,1
42056,ct-guided localization,1
42057,alpha-blockers,1
42058,flumatinib,1
42059,oncological surgery,1
42060,bortezomib-rituximab-bendamustine,1
42061,diagnostic peritoneal lavage,1
42062,medication education for children,1
42063,modified folfox6 + bevacizumab,1
42064,sgt-94,1
42065,moderate intensity exercise training,1
42066,conventional locoregional lymphadenectomy,1
42067,liposomal lurtotecan,1
42068,mx-dng1 retroviral vector,1
42069,observation of ivf outcomes in relation to chemo history and amh,1
42070,balixafortide,1
42071,[68ga]rm2,1
42072,hpv detection in anal canal samples,1
42073,written dietary recommendations,1
42074,targeted therapy based on molecular profiling : imatinib,1
42075,bupivacaine continuous infusion,1
42076,open ramps,1
42077,magnetic resonance imaging of breast,1
42078,postoperative risk stratification,1
42079,nutrition & physical exercise,1
42080,progressive stretching group,1
42081,sib dose-escalation radiotherapy,1
42082,photodynamic therapy with light dose of 70 j/cm2 using a broad-band red light source,1
42083,rapamycin 6mg,1
42084,percutaneous ethanol alcohol injection,1
42085,self affirmation,1
42086,vibrogent smartphone application,1
42087,radiation as adjuvant therapy for breast cancer,1
42088,whole lung imrt,1
42089,regn5458,1
42090,"cognitive-behavioral therapy for worry, uncertainty & insomnia",1
42091,encapsuled fish oil,1
42092,mr perfusion imaging,1
42093,penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site,1
42094,cisplatin and 5-fu combined with nimotuzumab,1
42095,"eortc qlq - br23, eq-5d-5l, eortc qlq-c30",1
42096,olaparib (300 mg bid),1
42097,cessation of hormone replacement therapy,1
42098,cytarabine liposome injection,1
42099,low-flow oxygen,1
42100,hormonal treatment (lh-rh agonist),1
42101,levoketoconazole,1
42102,bdb001,1
42103,expansion phase tk216,1
42104,elective neck dissection in early oral cancer,1
42105,peer support volunteer,1
42106,lumen-apposing metal stent (lams),1
42107,standard temodal® chemotherapy,1
42108,part 4b tpst-1120 + docetaxel,1
42109,cervical thinprep sampling,1
42110,tn-tc11g,1
42111,sphenopalatine ganglion block,1
42112,68ga-dotatate will be given in tracer doses and injected intravenously to image tumors by positron emission tomography.,1
42113,im-slnb and imln dissection,1
42114,"vegf-antisense oligonucleotide , pemetrexed, cisplatin",1
42115,personalized polyepitope dna vaccine,1
42116,"quadrivalent human papillomavirus (types 6, 11, 16,18) recombinant vaccine",1
42117,urine and plasma biomarkes.,1
42118,lean body mass,1
42119,"neo-adjuvant treatment with bevacizumab, capecitabine and oxaliplatin",1
42120,standardized transvaginal ultrasound examination,1
42121,flu/bu4 conditioning regimen,1
42122,intravenous mk-3475/ intravesical bcg,1
42123,"fludarabine, melphalan, atg (reduced intensity)",1
42124,test results only,1
42125,gaitrite,1
42126,drinks diary,1
42127,standard arm: trabectedin in monotherapy,1
42128,low intensity counseling + bupropion,1
42129,ease,1
42130,telatinib,1
42131,gdpt regimen,1
42132,dual energy ct scan with subtraction imaging,1
42133,study on samples of tumor and peri-tumor tissues from patients with hepatocellular carcinoma,1
42134,kisspeptin 112-121,1
42135,conventional cervix biopsy,1
42136,standard planning radiotherapy,1
42137,30 minute walk,1
42138,metastasis-directed treatment,1
42139,meal response,1
42140,hyperfractionated total body irradiation,1
42141,cycle 4 consolidation,1
42142,robot assisted neck dissection via retroauricular approach,1
42143,androgen-deprivation therapy (adt),1
42144,esophagojejunostomy after total gastrectomy,1
42145,arm egf ointment 1ppm,1
42146,tlc monthly,1
42147,s-1 for 6 months,1
42148,interactive internet-based website,1
42149,fecal volatile organic compounds under chemotherapy,1
42150,gemcitabine plus capecitabine,1
42151,care management pathways,1
42152,oncaspar & gemzar; advanced and/or solid tumors and lymphoma,1
42153,adjuvant sbrt,1
42154,68ga-psma pet/ct,1
42155,recombinant human growth hormone,1
42156,alpha beta t cell depletion,1
42157,"s-1, capecitabine",1
42158,orthogonal radiographs,1
42159,oxce,1
42160,mln4924 + paclitaxel + carboplatin (arm 2),1
42161,ad26.hpv18,1
42162,avatrombopag,1
42163,arm a (fortecortin®-etopophos®-ifo-cell®-carbo-cell®),1
42164,colorectal cancer self-management,1
42165,no intervention. only observational study,1
42166,treatment dpcp ointment,1
42167,virtual experience,1
42168,usual diet,1
42169,mini methotrexate,1
42170,pad,1
42171,hot compress plus tobramycin/dexamethasone drops and ointment,1
42172,colonoscopy with olympus technically improved colonoscope,1
42173,endobronchial forceps biopsy,1
42174,rp followed by mpr,1
42175,na.cl 0.9% (placebo),1
42176,tbd2,1
42177,paullinia cupana,1
42178,second questionnaire application,1
42179,fourier transform ion cyclotron resonance mass spectrometry,1
42180,engerix b,1
42181,ivygene dx liver cancer test,1
42182,probiotic natural health product - rephresh pro-b,1
42183,hdr brachytherapy + ebrt + stad,1
42184,parametric imaging,1
42185,quality of life surveys completed at specified timepoints,1
42186,exercise education,1
42187,mg4101(allogeneic natural killer cell),1
42188,radiotherapy:,1
42189,irm with a 5-minute- additional sequence to measure frm,1
42190,testosterone propionate,1
42191,s1 80-120 mg/d,1
42192,inc280 single agent,1
42193,caprelsa,1
42194,mesenchymal stromal cell (msc) injections,1
42195,wli assisted turbt,1
42196,anti-mesothelin car nk cells,1
42197,"br-i (bendamustine, rituximab, ibrutinib)",1
42198,white light was used for colonoscopy withdrawal,1
42199,curcumin c3 complex,1
42200,waitlist (no study treatment),1
42201,non_interventional,1
42202,leuprorelin 1.88 mg,1
42203,traditional reloads,1
42204,thrombopoietin,1
42205,th-302 dose escalation and dexamethasone in combination with pomalidomide,1
42206,holmium-166 microspheres hepatic radioembolization.,1
42207,dose 3,1
42208,dart,1
42209,intra-operative sn mapping with indocyanin green,1
42210,ls301,1
42211,ss1(dsfv)pe38 - lot fil129j01,1
42212,lc beads loaded with doxorubicin,1
42213,vitamin supplement;,1
42214,questionnaire vsp-a,1
42215,sham rtms (same parameters but with coil elevated and angled away from the head)every day for ten consecutive days (5 days/week).,1
42216,68ga-labeled peptides of dimer rgd (alfatide ii) and 18f-fdg,1
42217,fludarabine/busulfan,1
42218,tumor imaging,1
42219,morphine solution for injection,1
42220,tripegfilgrastim,1
42221,ad-ccl21-dc 1 x 07,1
42222,computer-based prostate cancer screening decision aid,1
42223,hal 0.2% with illumination,1
42224,depot lupron followed by estrogen plus placebo,1
42225,lidamycin phosphate and benzoyl peroxide 1.2%/3.75% combination,1
42226,"radiotherapy, capecitabine, oxaliplatin",1
42227,inert capsule,1
42228,bowel prep before endoscopy,1
42229,iodine-123,1
42230,carboplatin + paclitaxel (cp),1
42231,frozen section control,1
42232,self-expandable 125i radioactive seeds-loaded-stent,1
42233,pembrolizumab 200 mg iv twice interval 21 days,1
42234,testosterone injection,1
42235,standard medical photographs including dermoscopy images,1
42236,olfm4,1
42237,dli will be administered to all patients at month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood cd3 chimerism (including if they have full donor chimerism),1
42238,atra+arsenic,1
42239,lr-eshap (lenalidomide 20 mg),1
42240,"innovative colonoscopy (olympus cf-hq190l, nbi + dual focus)",1
42241,fluorestradiol (fes),1
42242,ngs brca 1 and brca 2 full sequencing,1
42243,nivolumab (bms-936558),1
42244,ccrt+gp,1
42245,radiotherapy without carboplatin,1
42246,proton arm 2: hypofractionated proton therapy,1
42247,"busulfan, fludarabine, alemtuzumab",1
42248,individual treatment as usual,1
42249,restrictive intraoperative fluid substitution,1
42250,fluid sample,1
42251,"gemcitabine, gemcitabine-capecitabine, gemcitabine-erlotinib, folfoxiri, folfox, folfiri",1
42252,panzem ncd,1
42253,temsirolimus + weekly paclitaxel + carboplatin,1
42254,laparoscopic assisted transanal surgery (tamis),1
42255,collection for non-craniotomy,1
42256,omega 3 fatty acid,1
42257,examination for presence or absence of lanugo hairs,1
42258,alvac-cea vaccine,1
42259,observation/standard therapy,1
42260,fec100,1
42261,amplitude-modulated electromagnetic fields,1
42262,data record and questionnaires passation,1
42263,phone coaching program,1
42264,lapatinib (gw572016) 1500 mg,1
42265,whole breast irradiation + boost or hypofractionated irradiation,1
42266,endoscopic submucosal dissection (esd) and endoscopic mucosal band ligation (embl) for early cancer,1
42267,compliance,1
42268,stapled or hand-sewn anastomosis,1
42269,jnj-809,1
42270,ct-2103 (xyotax),1
42271,vorinostat and tamoxifen,1
42272,radiotherapy - arm b,1
42273,very low carbohydrate diet (approximately 20 grams per day),1
42274,standardized freeze-dried table grape powder,1
42275,injection of pegfilgrastim,1
42276,sunitinib 4/2,1
42277,ccrt with weekly docetaxel & cisplatin,1
42278,dosage of chimiokines,1
42279,sgn-cd352a,1
42280,self-anal exam arm,1
42281,tattoo,1
42282,propranolol treatment,1
42283,pneumovax vaccine,1
42284,rectal biopsy at 1 year,1
42285,transvaginal digital colposcope (tvdc),1
42286,intraoperative mri-guided tumor resection,1
42287,transanal anastomotic reinforcement,1
42288,culturally appropriate intervention,1
42289,radiotherapy with photons,1
42290,jtx-4014,1
42291,sr-t100 with 2.3% of sm,1
42292,subcutaneous granulocyte macrophage colony stimulating factor (gm-csf),1
42293,curette v/s endocervical brush,1
42294,postoperative nausea and vomiting (ponv) control;,1
42295,transanal tme,1
42296,ex vivo-activated autologous lymph node lymphocytes,1
42297,anti-egfr-containing regimen,1
42298,bay2402234,1
42299,individually tailored nurse navigation,1
42300,cc-95251,1
42301,modified strength training,1
42302,ponatinib - phase 1,1
42303,"mri, digital mammography, ultrasound and positron emission tomography (pet)",1
42304,trus-robot,1
42305,pegfilgrastim 6 mg,1
42306,2-stage screen,1
42307,docetaxel and carboplatin auc 6,1
42308,physical activity group,1
42309,parp inhibitor 2x-121,1
42310,electrosurgical bipolar sealing devices,1
42311,patient monitoring,1
42312,pharmacogenetic,1
42313,2cda +/- rituximab,1
42314,standard exercise program,1
42315,"flot (5-fluorouracil, oxaliplatin, docetaxel)",1
42316,astarabine (bst-236),1
42317,patients with liposarcoma,1
42318,part a - azd9291 in combination with continuous selumetinib (non-asian subjects),1
42319,langerhans-type dendritic cells (a.k.a. langerhans cells or lcs),1
42320,online course,1
42321,magnesium citrate,1
42322,mega-press sequence magnetic resonance spectroscopy,1
42323,toremifene or tamoxifen,1
42324,sensitivity to reinforcement of addictive and other primary rewards (strap-r) food variant,1
42325,initial fecal microbiome,1
42326,standardized endoscopic treatment of local residual neoplasia,1
42327,cyclosporine + methotrexate,1
42328,(pg13-a(f/k-f-sgsg-t2a-b (opt) (2g-1 tcr) retroviral vector-transduced lymphocyte,1
42329,"quisinostat, 12 mg",1
42330,"bevacizumab, abraxane",1
42331,oat biscuits,1
42332,androgel (testosterone gel),1
42333,ethaselen,1
42334,completion of patient diary card,1
42335,microwave ablation device,1
42336,vicky,1
42337,separable clustered electrode,1
42338,linear array hpv genotyping assay,1
42339,"cisplatin, dexamethasone,vitamin b12, folic acid",1
42340,spinal manipulation,1
42341,doppler,1
42342,arm 2 800 cgy x 3 fractions,1
42343,vortex port and celsite port,1
42344,cisplatin (or alternative) - standard,1
42345,weifuchun,1
42346,br as maintenance,1
42347,low dose radiation therapy (ldrt),1
42348,qs-21 (stimulation-qs-21) drug,1
42349,conventional radiotherapy (crt),1
42350,100 mg/m2 lenalidomide (revlimid®) and 180 mg/m2 vorinostat (zolinza®),1
42351,intrauterine ultrasound guided radio-frequency ablation,1
42352,icesense3 system,1
42353,reassurance condition,1
42354,genetic analyses,1
42355,low-dose dexamethasone,1
42356,radiofrequency ablation using endohpb probe,1
42357,isolated hepatic portal and arterial perfusion,1
42358,colonoscopy with endorings™,1
42359,2 vaccine injections in different limbs,1
42360,endoscopy and ph study,1
42361,"questionnaire, interview",1
42362,aspirin low dose,1
42363,supportive psychotherapy (sp),1
42364,placebo of afatinib,1
42365,imc-20d7s (cohort 4a ),1
42366,"combined chemotherapy with streptozotocin, 5-fluorouracil, and doxorubicin",1
42367,etap,1
42368,non-medicated petroleum cream,1
42369,intensity-modulated radiotherapy of the pelvic lymph nodes using sib,1
42370,"melphalan, atg, fludarabine",1
42371,3 tesla mri,1
42372,laparoscopic uterine myomectomy without preventive uterine arteries occlusion,1
42373,digital breast tomosynthesis+synthetic mammography,1
42374,pet/ct and ebv dna,1
42375,triamcinolone acetonide (route of administration),1
42376,vitamin d3 pills,1
42377,involved field irradiation(ifi),1
42378,combination treatment - cohort 2,1
42379,cva21/pembrolizumab,1
42380,[18-f] fluorodeoxyglucose (fdg),1
42381,colonoscopy with chromoscopy,1
42382,tnf inhibitors,1
42383,group m,1
42384,fmd,1
42385,cheek cell samples or blood sample (4ml),1
42386,mg 98,1
42387,smoking cessation treatment plus moderate intensity exercise,1
42388,afatinib 20mg,1
42389,iowa oral performance instrument,1
42390,water-based exercise group,1
42391,sentinel lymph node biopsy?slnb?,1
42392,surgical position,1
42393,patient reported outcomes,1
42394,bladderlight®,1
42395,ilixadencel,1
42396,infusion of ebv specific cytotoxic t-lymphocytes,1
42397,cis (cancer information service) information sheet,1
42398,completion of patient-reported outcome (pro) questionnaires,1
42399,yang yin fu zheng therapy,1
42400,ibrutinib (induction),1
42401,survivor-only progressive walking and resistance exercise,1
42402,imr lag,1
42403,the cognitive rehabilitation program remind,1
42404,su011248 & irinotecan,1
42405,3 mg drospirenone and 20 µg ethinyl-estradiol,1
42406,arm e cpx-351 (200 v 300),1
42407,psa test,1
42408,vitamin d3 ( colecalciferol),1
42409,clove essential oil,1
42410,routine imaging ct with a 3d printed model,1
42411,it-101 (15mg/m2/dose),1
42412,gi-6207 [recombinant saccharomyces cerevisiae-cea (610d)],1
42413,electronic brachytherapy (axxent system),1
42414,dacarbazine(r),1
42415,"rituximab, vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-c",1
42416,11c-metformin,1
42417,frd,1
42418,systematic lymphadenectomy (lne),1
42419,imiquimod topical cream,1
42420,go! to sleep,1
42421,auto plus assisted plus navigation,1
42422,anf-rho™,1
42423,electronic skin surface brachytherapy,1
42424,routine data collection,1
42425,empegfilrastim 6 mg,1
42426,prostate alone imrt,1
42427,"a combination of docetaxel, cisplatin and 5-fluorouracil",1
42428,artery first procedure,1
42429,observation data collection study.,1
42430,imri-guided surgery,1
42431,apn intervention,1
42432,uncut roux-en-y anastomosis,1
42433,tk1258,1
42434,vx15/2503 + avelumab,1
42435,pre-treatment with octreotide,1
42436,111in-cp04 with co-administration of gelofusine/gelaspan,1
42437,ovitrelle,1
42438,bone void filler,1
42439,somatostatin infusion,1
42440,irinotecan liposome injection,1
42441,drug: 5-fu,1
42442,kinetics of microparticles under chemotherapy,1
42443,removal of ovarian vessels,1
42444,docetaxel - cisplatin - 5-fluorouracil,1
42445,gemcitabine prolonged continuous infusion,1
42446,customized automatic phone call invitation (step 1b),1
42447,39.0°c temperature limit defining fever,1
42448,active01 cream,1
42449,2-hydroxyflutamide,1
42450,2-days discharge,1
42451,physical activity and diet group,1
42452,ophthalmic steroid ointment,1
42453,abx combined with cisplatin,1
42454,treatment carboplatin,1
42455,national colorectal cancer roundtable toolbox,1
42456,personal interview,1
42457,post-study questionnaire,1
42458,chromoendoscopy using acetic acid 2.5%,1
42459,pharyngo laryngeal mri,1
42460,surgery followed by adjuvant second-line therapy,1
42461,"surgery, chemotherapy and/or radiotherapy",1
42462,"lobaplatin , 5-fu ,leucovorin",1
42463,adapted german pro-self© plus pain control program,1
42464,chemo only,1
42465,stress reduction,1
42466,leuprolide acetate for injectable suspension 22.5 mg,1
42467,som230 alone or in combination with rad001.,1
42468,paclitaxel for injection?albumin bound?,1
42469,ipilimumab and nivolumab,1
42470,extent of pulmonary resection,1
42471,best standard of care (bsc),1
42472,alginate dressings,1
42473,imagio scan,1
42474,warm water immersion colonoscopy,1
42475,multispectral fluorescence reflectance imaging,1
42476,tips for making exercise enjoyable and personally-valued,1
42477,laparoscopic radical hysterectomy + pelvic lymphadenectomy,1
42478,nst group,1
42479,standard-dose trt,1
42480,transthoracic echocardiogram (ultrasound),1
42481,nox-h94,1
42482,intra-operative radiotherapy (iort),1
42483,tice,1
42484,cancer treatment options,1
42485,sham graf (saline injection),1
42486,fosfomycin,1
42487,colonic or colorectal resection,1
42488,los,1
42489,"cyclo, vcr, pred, dacarb,etop and doxo",1
42490,w0101 - expansion phase,1
42491,placebo + valacyclovir,1
42492,"fludarabine, mitoxantrone, cyclophosphamide and alemtuzumab",1
42493,fec-t+pertuzumab,1
42494,hands-free goggle system,1
42495,endo gia reinforced reload with tri-staple technology,1
42496,magnification endoscopy with narrow band imaging,1
42497,blood sample withdrawn,1
42498,adjuvant group,1
42499,expectant management,1
42500,electrocautery/diatermy,1
42501,fluorodopamine,1
42502,temsirolimus (pre surgery),1
42503,only photodynamic therapy,1
42504,fast track recovery surgery with whey protein infused carbohydrate loading and early oral feeding,1
42505,dc vaccine & cyclophosphamide,1
42506,[18f]fluoroestradiol (fes),1
42507,yogic and routine exercises,1
42508,bexarotene with carboplatin and paclitaxel,1
42509,surgery to remove tumor,1
42510,"group a-standard colonoscopy, then naviaid™ g-eye procedure",1
42511,cmv-specific t cells,1
42512,sass questionnaire,1
42513,decision control preference scale,1
42514,wearable technology - garmin vivosmart,1
42515,zolinza/vorinostat,1
42516,breast mri and/or ct,1
42517,"cisplatin, fluorouracil",1
42518,arm a: f16il2 in combination with paclitaxel,1
42519,jiu-wei-zhen-xiao granule,1
42520,da vinci® robotic surgical system,1
42521,placebo pills of radium bromatum,1
42522,pet/ct scanning,1
42523,avn-944 capsules for oral administration,1
42524,medical analgesics,1
42525,intravenous patient-controlled analgesia (ivpca),1
42526,"cyclophosphamide 50mg/kg/day iv on days -5,-4",1
42527,gm-csf-in-adjuvant,1
42528,hormone suppressors,1
42529,chlorinated polyethylene elastomer,1
42530,multivitamin (mv),1
42531,falls risk questionnaire,1
42532,methylaminolevulinate pdt in 2 sessions,1
42533,"ezn-2208, cetuximab and irinotecan",1
42534,msb2311 injection,1
42535,sbrt to whole prostate,1
42536,subxiphoid approach extended thymectomy by vats,1
42537,usual management,1
42538,ultra-sound guided radio-frequency ablation,1
42539,laparoscopic left-sided hepatectomy,1
42540,total or subtotal colectomy,1
42541,liposome entrapped paclitaxel easy to use (lep-etu),1
42542,docetaxel + lh-rh analogues,1
42543,"sampling at baseline, one week after baseline, two weeks after baseline",1
42544,preoperative dose intense chemotherapy (flac/g-csf),1
42545,lenalidomide 50 mg,1
42546,psychoeducational intervention for cancer-related fatigue,1
42547,mindfulness meditation program,1
42548,percutaneous ethanol ablation,1
42549,walk training and transplant,1
42550,mri assisted focal boost with hdr monotherapy,1
42551,reminders for professionals,1
42552,intratumoral (it) poly iclc 0.5 mg,1
42553,needs assesment tool integrated in nursing consultation.,1
42554,quality of procedure.,1
42555,panitumumab (within maintenance phase),1
42556,photon intensity modulated radiation therapy (imrt),1
42557,sunscreen fps 60,1
42558,methodological trolley tokens,1
42559,printed educational materials,1
42560,birth control,1
42561,filgrastim (eurofarma),1
42562,standard dose imrt,1
42563,brain metastatic patients,1
42564,power drill,1
42565,bms-986178,1
42566,everolimus 2.5 mg,1
42567,flt pet and bold mri scan,1
42568,vein interruption before any other surgical manipulation,1
42569,ns-018,1
42570,carfilzomib and dexamethasone,1
42571,direct visualization and needle based confocal laser-induced endomicroscopy miniprobe,1
42572,standard of care screening,1
42573,intensive and sustained smoking cessation program,1
42574,suprapubic tube ex 5 day,1
42575,semi whole-body mri,1
42576,unilateral neck dissection,1
42577,lumpectomy or mastectomy,1
42578,regular intercourses,1
42579,hepatic artery infusion,1
42580,acceptance and commitment therapy (act),1
42581,robot-assisted laparoscopic radical prostatectomy,1
42582,[68ga]p15-041,1
42583,gorbly compression device,1
42584,liver transplant,1
42585,proactive telephone counseling from va quitline,1
42586,tep au mibi,1
42587,interferon-alfa-2b and ribavirin,1
42588,novel stent,1
42589,usual administration of exogenous recombinant fsh,1
42590,amg 319 hydrate,1
42591,warfarin potassium,1
42592,surgery of percutaneous catheter system,1
42593,continuous propofol sedation,1
42594,ultrasonographic assessment of postmastectomy lymphedema,1
42595,abiraterone acetate + prednisone or prednisolone,1
42596,capillaroscopy,1
42597,bone mineral density,1
42598,yescarta,1
42599,immunological agent,1
42600,american heart association step 2 diet + 10 g/day flax seed,1
42601,capecitabine plus docetaxel,1
42602,ec d-3263 hcl,1
42603,abiraterone acetate 250 mg oral tablet [zytiga],1
42604,peg-interferon,1
42605,gag:267-274 peptide vaccine,1
42606,ebus tbnf,1
42607,6 x 6 gy,1
42608,epirubicin+ctx+5-fu,1
42609,central lymphadenectomy and vascular ligation,1
42610,medical skin screening,1
42611,combination of varlilumab and ipilimumab,1
42612,denosumab 120 mg,1
42613,fibrin glue in breast surgery,1
42614,painucope,1
42615,memory training,1
42616,iodine i 124,1
42617,a stapled anastomosis,1
42618,acetylsalicylic acid (aspirin),1
42619,esmolol administration,1
42620,progressive strength training,1
42621,89zr?j591,1
42622,gsk1120212b (standard dmso content),1
42623,retroview™ colonoscope,1
42624,transfusion of leuko-reduced red blood cell concentrate,1
42625,mrd-directed therapy,1
42626,radiotherapy only,1
42627,"dasatinib, 100 mg + lenalidomide, 20 mg + dexamethasone, 40 mg",1
42628,everolimus and pasireotide,1
42629,crizotinib & sunitinib 37.5 mg cohort 3,1
42630,dynamic contrast enhanced ultrasound (d-ceus) with sonovue® administration,1
42631,impact (r) enteral nutrition,1
42632,control: standard of care,1
42633,[18f]fluorothymidine (flt) pet/ct imaging,1
42634,supportan + glutamine plus,1
42635,usual care plus lef-scp plus follow-up,1
42636,canscript,1
42637,bilateral subcapsular orchidectomy,1
42638,interferon-a-2a,1
42639,radiolabeled humanized pam4 igg,1
42640,vvax001 therapeutic cancer vaccine,1
42641,estramustine phosphate,1
42642,lifestyle management,1
42643,"capecitabine, celecoxib and methotrexate",1
42644,accelerated hypofractionated concurrent chemo-radiotherapy,1
42645,"autologous, dnp-modified vaccine (m-vax)",1
42646,semi-annual systematic pet-tdm,1
42647,entospletinib (baml-16-001-s6),1
42648,eus-fna needle (beacon),1
42649,treatment protocol,1
42650,conventional vascular access,1
42651,"trastuzumab qw, trastuzumab q3w",1
42652,carotid ultrasound,1
42653,"dexamethasone, procarbazine",1
42654,"paclitaxel, gemcitabine, lapatinib",1
42655,facebook-based messages/website,1
42656,silastic stent,1
42657,the mixture including indocyanine green,1
42658,illinois bone marrow aspiration neddle,1
42659,simmiparib,1
42660,dermal chelation,1
42661,temperature measurement of breast,1
42662,local irradiation therapy,1
42663,robot esophagectomy (re),1
42664,group sessions,1
42665,bifico,1
42666,contrast enhanced ultrasound (ceus),1
42667,dx,1
42668,implementation tools,1
42669,optimal medical treatment,1
42670,letrozole-metformin-pioglitazone,1
42671,vats (video assisted thoracic surgery),1
42672,[14c] selumetinib iv solution,1
42673,surgical collection of histology specimen,1
42674,exercise +,1
42675,cpt-11 based regimens,1
42676,placebo 100mg,1
42677,cvx-045,1
42678,live donor liver transplantation,1
42679,tumor and marrow markers,1
42680,synchronous resection surgery,1
42681,oxaliplatin iv,1
42682,sc10914,1
42683,doxorubicin hcl liposome; bevacizumab; carboplatin,1
42684,bmn 673 (talazoparib),1
42685,lung cancer,1
42686,rectus sheath block,1
42687,quality of life survey/ dental statement,1
42688,hardware wound healing,1
42689,computational biology simulations software,1
42690,stellate ganglion block wit ropivacaine 0.2% 2 ml,1
42691,neo-recormon and venofer,1
42692,ga + sham block,1
42693,peg3350,1
42694,gadovist,1
42695,controlled diet with brassica vegetables,1
42696,ropivacaine instillation,1
42697,deep excision,1
42698,alk inhibitor,1
42699,fluorouracil +/- folinic acid,1
42700,infusion of 0.9% saline without ald518,1
42701,early integrated pc,1
42702,pg-11047,1
42703,vegf trap-eye 2.0mg,1
42704,edit management,1
42705,fad,1
42706,pursuit of chemotherapy,1
42707,liposomal paclitaxel and capecitabine,1
42708,standard of care + experimental individualized therapy,1
42709,high-dose intensity-modulated radiation therapy,1
42710,initially dissection of inferior mesenteric vein,1
42711,endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection,1
42712,ebvst cells,1
42713,saline injection (placebo),1
42714,survivin peptide vaccine,1
42715,early interim fdg pet/ct after 1 cycle of r-chop,1
42716,btct4465a (mosunetuzumab) iv,1
42717,active electrostimulator device,1
42718,reminder-recall,1
42719,y-90 selective internal radiation therapy (sirt),1
42720,ergocalciferol,1
42721,autologous transplantation using rituxan/beam,1
42722,histopathological review,1
42723,essential oils massages,1
42724,2 alternating cycles of vamp/cop chemotherapy,1
42725,interferon alfa and cci-779,1
42726,concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy),1
42727,travasol (amino acid injection),1
42728,amino terminal propepetide of type 1 collagen,1
42729,pegaspargase 2500 iu/m2 x 1,1
42730,nilotinib 300mg bid,1
42731,trabectedin and pegylated liposomal doxorubicin,1
42732,folfox/ folfiri with panitumumab,1
42733,rcomp-14 + rituximab,1
42734,methotrexate (low dose),1
42735,montanide + melan-a analogue peptide,1
42736,18f-tetrafluoroborate (18f-tfb),1
42737,transthoracic echocardiography,1
42738,final cellular product,1
42739,boanmycin,1
42740,facility-based exercise,1
42741,gdc-0152,1
42742,nbi-afi imaging,1
42743,fu-based chemoradiotherapy,1
42744,part b: expansion cohort of cantrixil,1
42745,peripheral blood isolation,1
42746,frio oral rinse,1
42747,multivisceral en bloc resection surgery,1
42748,"multi-modality; iort, surgery, radiation, chemotherapy",1
42749,epi procolon testing,1
42750,jnj-64041809 (cohort 1a and 1b),1
42751,intraoperative direct cortical electrical stimulation,1
42752,oraquick swab,1
42753,cisplatinum or carboplatin and e.g.etoposide.,1
42754,"2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)",1
42755,f-18 fluciclovine-pet/ct scan,1
42756,coffee,1
42757,the pops study is collecting pk data on children prescribed the following drugs of interest per standard of care:,1
42758,"immediate cervarix, delayed menveo vaccine",1
42759,hexaminolevulinate hydrochloride,1
42760,imri-guided brain tumour biopsy,1
42761,restrictive red blood cell transfusion,1
42762,mikei red reishi essence ex,1
42763,arm b vosaroxin and decitabine,1
42764,adcetris-levact,1
42765,gemcitabine/docetaxel,1
42766,lymphocyte injection of prophylactic donor (pdli),1
42767,"tumor infiltrating lymphocytes, il-2",1
42768,her-2-targeting car t cells infusion,1
42769,"erlotinib, sunitinib",1
42770,curative resection with pringle manoeuvre,1
42771,brief motivational interviewing,1
42772,aspirin 100mg,1
42773,ova bip peptide,1
42774,131i-tm-601,1
42775,atacicept: with loading dose,1
42776,genexol®,1
42777,hcc child-pugh b expansion cohort: regorafenib 100 mg,1
42778,f-18 fdg pet scan,1
42779,tension free vaginal tape,1
42780,mdx 1411,1
42781,bendamustin/ribomustin,1
42782,natural killer t cell,1
42783,diflomotecan (bn80915),1
42784,acp-196 and nab-paclitaxel and gemcitabine,1
42785,"erlotinib, temozolomide",1
42786,"everolimus, cetuximab, irinotecan",1
42787,tamoxifen + palbociclib,1
42788,placebo-containing mna,1
42789,"gw786034, oral",1
42790,ultrasound guided liver resection,1
42791,imaging assessments,1
42792,placebo olaparib,1
42793,yoga group,1
42794,medi--522,1
42795,plx73086,1
42796,uvadex and uvar xts photopheresis system,1
42797,gimatecan® (st-1481),1
42798,thinprep® lbc,1
42799,getting ahead in a just-gettin'-by world,1
42800,fasn inhibitor tvb-2640,1
42801,"cetuximab and chemotherapy (docetaxel, cisplatin, 5-fluorouracil)",1
42802,step-up intervention,1
42803,questionnaires of quality of life,1
42804,calypso beacon implant,1
42805,ribociclib plus letrozole,1
42806,agen1181,1
42807,accs100,1
42808,bvac-c,1
42809,sphincter preservation surgery,1
42810,ropivicaine,1
42811,transrectal prostate biopsy with ultrasonography.,1
42812,passive cycling,1
42813,grip strength measurement,1
42814,imc-20d7s (cohort 2b ),1
42815,rhuflt3l/cdx-301,1
42816,light physical activity 1,1
42817,ezatiostat hydrochlorine,1
42818,arm precaution,1
42819,stereotactic body radiosurgery,1
42820,placebo insole,1
42821,conventional arm,1
42822,"concomitant cisplatin, 5-fu and radiotherapy",1
42823,cf-crt combined with bt or sbrt boost.,1
42824,sham electroacupuncture group,1
42825,vosaroxin and cytarabine,1
42826,destress for health program,1
42827,motivational intervention group,1
42828,tesetaxel plus capecitabine,1
42829,one injection into the celiac ganglion,1
42830,ppx +tmz+xrt,1
42831,fluid therapy optimization,1
42832,tumor-infiltrating lymphocytes,1
42833,"paclitaxel,cisplatin, bevacizumab",1
42834,reconvan,1
42835,zavedos,1
42836,ciclopirox olamine,1
42837,"zolinza (vorinostat), vinorelbine",1
42838,assessment interview and blood draw,1
42839,comparator red light treatment,1
42840,amg 951 (rhapo2l/trail),1
42841,cytisine,1
42842,68ga-pentixafor,1
42843,tethered capsule sponge,1
42844,bp1001 (fixed dose),1
42845,clinical data,1
42846,gynecare gynocclude™,1
42847,bortezomib 1.0mg/m^2,1
42848,washings for experimental marker testing,1
42849,temodal/radiotherapy,1
42850,cryoablation for the treatment of uterine fibroids,1
42851,delayed acupuncture group,1
42852,nasal saline spray,1
42853,metformin + clomiphene,1
42854,moxonidine,1
42855,sln arm,1
42856,proximal retroflexion,1
42857,basc-3 survey,1
42858,ultracision,1
42859,blood draws to assess gonadal function,1
42860,ire device,1
42861,brain mimicking fluid,1
42862,autologous hematopoietic stem cell transplant,1
42863,classic approach for pancreatoduodenectomy,1
42864,lma®,1
42865,biological/vaccine: bc-819,1
42866,px-866 (crc),1
42867,blood sample analysis,1
42868,2 ogtts with and without glp-1,1
42869,carfilzomib (infusion),1
42870,salbutamol 400 µg (single dose),1
42871,home-based aerobic exercise and nutritional counseling,1
42872,sham acupressure,1
42873,dcam levels in blood,1
42874,t cell donor lymphocyte infusion (dli) with unmanipulated donor t cells,1
42875,"s-1, nedaplatin",1
42876,hct,1
42877,"abx, cisplatin",1
42878,irinotecan high doses,1
42879,docetaxel and ketoconazole,1
42880,neo-adjuvant chemoradiotherapy followed by surgery,1
42881,nab-paclitaxel 100 mg/m^2,1
42882,1. metformin tablets; 2. promets probiotics powder,1
42883,providing a list of patients not compliant with crc sreening,1
42884,actiq®,1
42885,flare type stent,1
42886,ultrasound of the breast,1
42887,alendronate/cholecalciferol,1
42888,risk based screening,1
42889,annona muricata extract,1
42890,stage 1 active methylenedioxymethamphetamine,1
42891,18-naf pet,1
42892,movement to rhythm,1
42893,part a - azd9291 in combination with intermittent selumetinib,1
42894,placebo 1 capsule x 3 daily until progression,1
42895,notch signaling pathway inhibitor mk0752,1
42896,psychological stress assessment,1
42897,precise hepatectomy,1
42898,us-atg-f,1
42899,temodar and o6-benzylguanine (bg),1
42900,rrm1,1
42901,gemfibrozil,1
42902,end of life planning videos,1
42903,dietary counseling via computer,1
42904,ofatumumab + ice,1
42905,part 1 tpst-1120,1
42906,co level testing,1
42907,standard of care treatment options,1
42908,bone marrow or peripheral blood graft (bmt),1
42909,"cto, temodar®, radiation therapy",1
42910,vidscrip educational video,1
42911,mercaptopurine 20mg/ml oral suspension,1
42912,accelerated hypofractionation with tomotherapy,1
42913,lymphoseek plus vital blue dye,1
42914,best systemic therapy (bst),1
42915,(non-radioactive) oral deuterated 3-methylhistidine (d-3mh),1
42916,lozenge intake,1
42917,ags-16m8f,1
42918,[11c] kinase inhibitor pet [15o]water pet and tumor biopsies.,1
42919,egd,1
42920,blood sample (mremvi negative patient),1
42921,booklet-question list,1
42922,gemcitabine combined with cisplatin chemotherapy,1
42923,normal (0.9%) saline,1
42924,hipec (hyperthermic intraperitoneal chemoperfusion) with oxaliplatin,1
42925,activity program,1
42926,ae assessment,1
42927,"epo906, celecoxib",1
42928,prehabilitation group,1
42929,trastuzumab after subq gm-csf,1
42930,high-definition white-light endoscopy,1
42931,intraperitoneal cisplatin with nanocis,1
42932,mldg,1
42933,decitabine and ara-c,1
42934,her2-specific chimeric antigen receptor (car) t cell,1
42935,uplat,1
42936,peg-asp in consolidation-1,1
42937,autologous anti-cd 123 car tcr/4-1bb-expressing t-lymphocytes,1
42938,"post-hct cyclophosphamide 50mg/kg iv on day+3, +4",1
42939,vectibix,1
42940,pemetrexed or gemcitabine or paclitaxel or docetaxel,1
42941,haploidentical natural killer cell infusion,1
42942,th-4000 (tarloxotinib),1
42943,[18f]dabrafenib molecular imaging,1
42944,inotuzumab ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone,1
42945,sham acupuncture and medicine,1
42946,etoposide cisplatin,1
42947,pf3512676,1
42948,bp1001 in combination with decitabine,1
42949,mri and pet scanning procedures,1
42950,azd6094 200 mg,1
42951,ka2237,1
42952,topical imiquimod therapy,1
42953,apocell,1
42954,confocal laser microlaryngoscopy,1
42955,capecitabine with oxaliplatin,1
42956,stiffness measurement using arfi,1
42957,et group,1
42958,endorectal magnetic resonance imaging (1.5tesla) (emri),1
42959,right hemicolectomy with or without primary anastomosis,1
42960,folinic acid (dl racemic),1
42961,tailored printout,1
42962,mp-470,1
42963,strattice™ reconstructive tissue matrix,1
42964,branch i,1
42965,preoperative sentinel lymph node identification and marking,1
42966,none- observational study,1
42967,standard slne,1
42968,"letrozole tablets (femara; novartis pharma, switzerland)",1
42969,co2 standard therapy,1
42970,pct dosage,1
42971,temferon,1
42972,comparator: paclitaxel,1
42973,"cora- device:smartphones""",1
42974,continuous glucose monitoring (cgm),1
42975,gx301,1
42976,intraoperative injection (in vivo),1
42977,bubble packaging for monthly prescription,1
42978,"pet/ct, pet/mri, mpmri",1
42979,vitamin d3 2000 iu,1
42980,fact h&n,1
42981,anal cancer,1
42982,gadolinium contrast,1
42983,eus-guided microbiopsy,1
42984,"sie artery unclamped, vein clamped",1
42985,pylorus preservation,1
42986,autologous followed by nonmyeloablative allogeneic transplant,1
42987,clinical and medical parameters,1
42988,routine dezocine injection,1
42989,"radiation therapy, surgery, peripheral stem cell transplant",1
42990,"leuprolide acetate, bicalutamide, sorafenib",1
42991,transurethral resection of the bladder tumour,1
42992,mastectomy with photonblade,1
42993,surgery and adjuvant chemotherapy,1
42994,cgtg-102,1
42995,reduced follow-up schedule,1
42996,apg115 mono-therapy,1
42997,detection of ctcs,1
42998,tinzaparin sodium 100 ui/kg/od for 12 weeks,1
42999,saxagliptin-metformin xr,1
43000,tidal volume,1
43001,t-cell deplete,1
43002,validation of different dysphagia scores,1
43003,gp100,1
43004,integrative medicine intervention,1
43005,platelet level determination,1
43006,famitinib malate capsule,1
43007,prevena peel & place dressing,1
43008,cc-220,1
43009,"cisplatin,5-fu,leucovorin",1
43010,antidepressant,1
43011,cancer detection cartridge,1
43012,sildenafil citrate and questionaires,1
43013,mdm2 inhibitor ds-3032b,1
43014,stereotactic ablative body radiation therapy,1
43015,align rt,1
43016,endoscopic resection under blue light (hexvix®),1
43017,cyclosporin (neoral) or tacrolimus (prograf),1
43018,ala test group,1
43019,anvirzel,1
43020,"gemcitabine, placebo",1
43021,functional living index - emesis,1
43022,intrauterine insemination (iui),1
43023,bupivacaine/epinephrine/dexamethasone,1
43024,"ixabepilone, 5 mg/d",1
43025,colonoscopy for colorectal cancer screening,1
43026,oh2 injection,1
43027,positive result from pathological test,1
43028,magnetic anastomosis for pancreaticojejunostomy,1
43029,apa program,1
43030,injection mecobalamin,1
43031,interstim implantation,1
43032,cd123car-41bb-cd3zeta-egfrt-expressing t cells,1
43033,qol questionnaires,1
43034,project heal,1
43035,intralesional il-2,1
43036,skin cancer foundation website,1
43037,functional image,1
43038,supplemental oxygen,1
43039,anastrozole 1 mg,1
43040,resilience model-based total care plan,1
43041,titrated pain management,1
43042,secoisolariciresinol,1
43043,ganoderma spores powder capsules,1
43044,atkins diet,1
43045,moderate neuromuscular blockade,1
43046,radio frequency ablation (rfa),1
43047,bl-8040 1.25mg/kg + g-csf,1
43048,trans-rectal ultra-sound guided prostate biopsy,1
43049,standard support,1
43050,calcium-dtpa,1
43051,return to work and living healthy after head and neck cancer,1
43052,support/attention control,1
43053,sc sea-cd40 monotherapy regimen,1
43054,mifamurtide arm,1
43055,metformin + myocet + cyclophosphamide,1
43056,"collect blood, ga and other survey tools",1
43057,computer-aided nodule detection,1
43058,cddo,1
43059,cma 70 catheter directly positioned in bone tissue,1
43060,gross motor function,1
43061,anastozole (arimidex) placebo,1
43062,autologous anti-bcma-car-expressing cd4+/cd8+ t-lymphocytes fcarh143,1
43063,chpp of cisplatin,1
43064,combination of treatments,1
43065,f901318,1
43066,fondaparinux sodium,1
43067,standard multiphase ct,1
43068,testosterone cream,1
43069,ercp drainage,1
43070,coloverin,1
43071,srt-tem,1
43072,transconjunctival orbitotomy approach,1
43073,biological imaging guided antalgic radiotherapy,1
43074,multi-gene next generation sequencing panel,1
43075,cd56-enriched donor lymphocyte infusion,1
43076,2-hydroxyflutamide (2-hof),1
43077,ialuset®,1
43078,hepatitis b virus (hbv) and hepatitis c virus (hcv) serologies and a screening questionnaire to detect risk factors of hepatitis b virus (hbv) and hepatitis c virus (hcv),1
43079,sunphenon,1
43080,tp-0184,1
43081,ati-1123 (active drug = docetaxel),1
43082,clinical biomarker (thermal sensory testing),1
43083,"antiplatelet agent, such as aspirin, or other low-dose antiplatelet agent",1
43084,transdisciplinary intervention,1
43085,salivary samples,1
43086,[89zr]zr-bi 754111,1
43087,bevacizumab biosimilar (bevz92),1
43088,oncoral® test,1
43089,pd-1 knockout,1
43090,sgn-cd48a,1
43091,somatic genetic,1
43092,online education materials,1
43093,human placental derived stem cell,1
43094,percutaneous biopsy,1
43095,sunitinib or pazopanib,1
43096,dt01,1
43097,p16_37-63 peptide without montanide® isa-51 vg,1
43098,hyperacute®-renal (har) immunotherapy,1
43099,green tea catechin extract,1
43100,cc followed by ec,1
43101,men's workshops,1
43102,low dose computed tomography imaging,1
43103,mepitel,1
43104,preoprative tace,1
43105,erlotinib + bevacizumab,1
43106,treatment patterns among aml patients,1
43107,enhanced information about endocrine therapy,1
43108,sccc,1
43109,hormonal contraception,1
43110,acquire fnb device,1
43111,18f fluciclovine,1
43112,dose escalation followed by treatment with mtd,1
43113,tactile imaging sensor or system made in our laboratory,1
43114,screen detected tumor,1
43115,rhenium liposome treatment,1
43116,arm d small molecule or not,1
43117,real-time contrast-enhanced ultrasound imaging (ceus),1
43118,second generation 4-1bb? egfr806-egfrt,1
43119,"questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided",1
43120,higher-volume resistance training (hv),1
43121,ipop (post-operative),1
43122,controls,1
43123,remote ischemic conditioning (ric),1
43124,clyclophosphamide,1
43125,ign002,1
43126,metformin plus yasmin,1
43127,softscan optical breast imaging system,1
43128,eicosapentaenoic acid free fatty acid,1
43129,ultrasound image review with cade,1
43130,loop,1
43131,"sorafenib, cisplatin, fluorouracil",1
43132,mri scan of the liver enhanced with eovist,1
43133,pp65-fllamp dc with gm-csf,1
43134,comparing 2 drugs on their effect on the bowel preparation for colonoscopy,1
43135,menotropin,1
43136,maintenance durvalumab,1
43137,mri sequence,1
43138,chemo plus far,1
43139,dbpr112,1
43140,mailed-fit,1
43141,"fludarabine, mitoxantrone and rituximab",1
43142,nivolumab in combination with ipilimumab,1
43143,blood specimen for non-dna and dna parts,1
43144,vt-464: given orally once daily in 28-day cycles,1
43145,neoadjuvant folfox,1
43146,preoperative endoscopy,1
43147,ep/tp,1
43148,placebo surveillance and written exercise guidelines,1
43149,serum uc-oc,1
43150,pbf-509_320 mg,1
43151,lateral radial incision,1
43152,etoposide capsule + methotrexate tablet + everolimus tablet,1
43153,full field optical coherence tomography (ffoct) procedure,1
43154,sequential chemotherapy,1
43155,positron emission tomography with radiolabeled targeting agent,1
43156,t-cell depleted hpc transplant,1
43157,ave8062,1
43158,trolamine (biafine),1
43159,txa127 1000 mcg/kg/day,1
43160,irrigation with gentamicin solution,1
43161,induction ctx(tpf)+(rt+cddp/5-fu),1
43162,attachment retained obturator,1
43163,navigator support,1
43164,chr-2797 (tosedostat): aminopeptidase inhibitor,1
43165,e39 peptide (1000mg)/gm-csf vaccine,1
43166,video and booklet,1
43167,tas-108,1
43168,barium,1
43169,pembrolizumab mel,1
43170,liposomial cytarabine,1
43171,current exercise behavior questions: international physical activity questionnaire short form (ipaq sf),1
43172,ad/pnp and fludarabine monophosphate,1
43173,rectal excision in bad responders,1
43174,hi-maize 260,1
43175,ablative chemoembolization (ace),1
43176,"thalidomide(thado), tegafur/uracil(ufur)",1
43177,ex vivo expanded and activated haploidentical donor nk cells,1
43178,"s-1,leucovorin,oxaliplatin,gemcitabine",1
43179,nss,1
43180,carboplatin // gemcitabine // docetaxel //cisplatin,1
43181,"cvp (cyclophosphamide, vincristine, prednisone)",1
43182,cdd plus bortezomib,1
43183,low-dose cisplatin,1
43184,injection of tvec into target lesions 3wks after 1st injection,1
43185,resistivity measurement,1
43186,"clarithromycin, lenalidomide, dexamethasone",1
43187,baseline fitness test,1
43188,bevacizumab and folfiri,1
43189,bupivacaine 0.25% preservative-free injectable solution,1
43190,"paclitaxel (phyxol) , cisplatin",1
43191,passive care team alert,1
43192,"cisplatin, taxotere",1
43193,e7 tcr cells,1
43194,50.4gy in 28#,1
43195,palm oil,1
43196,pdx drug sensitivity testing,1
43197,enoxaparin 4000 iu,1
43198,patients with a ucb donor,1
43199,fact-b and brief pain inventory,1
43200,dc bead with doxorubicin,1
43201,"bevacizumab, docetaxel and doxorubicin followed by surgery",1
43202,"rad001, cetuximab, irinotecan",1
43203,pharmacotherapy discussion,1
43204,macimorelin,1
43205,map set at 70-75 mmhg for 5 min,1
43206,in-rt 30 gy (+ boost 6 gy residual),1
43207,biotene (mouth care),1
43208,iv-administation of emi-137,1
43209,awake anesthesia protocol,1
43210,abnormal ovarian ultrasound,1
43211,extreme hypo-fractionation,1
43212,fulvestrant + placebo,1
43213,off therapy,1
43214,mk-7684,1
43215,gefitinib 250mg,1
43216,limonene,1
43217,traditional vitamin d therapy,1
43218,t512,1
43219,gsk biologicals' recombinant mage-a3 antigen-specific cancer immunotherapeutic (asci) gsk1203486a,1
43220,imuran,1
43221,generic website,1
43222,prophylactic selective lateral neck dissection,1
43223,adma3,1
43224,vitamin b-12,1
43225,cc-90009,1
43226,self management of exercise,1
43227,"mfolfox6(the combination therapy of 5-fu, l-lv and oxaliplatin)",1
43228,pet-mr 18f-facbc,1
43229,low risk with partial remission at early response assessment after two cycles of abvd chemotherpay schedule. two abvd courses are delivered.,1
43230,sarcoma and gist,1
43231,donor-derived ebv-specific cytotoxic t-cells (ebv-ctl) transduced with the retroviral vector sfgalpha-cd19-cd3zeta,1
43232,nadaplatin+pemetrexed,1
43233,pa101,1
43234,vec,1
43235,early recovery program after surgery,1
43236,high-intensity focused ultrasound (hifu),1
43237,hand-held poc creatinine analyzer-blood test,1
43238,tumoral irradiation,1
43239,8 cycles beacoppesc plus goserelin,1
43240,connected wellness healthcoach software,1
43241,meglumine gadoterate,1
43242,10 mm stainless steel wallstent,1
43243,enhanced usual care control,1
43244,onlife,1
43245,restaging,1
43246,cv787 (cg7870),1
43247,tai of folfox,1
43248,tissue elastography imaging,1
43249,treatment based on genetic mutation,1
43250,conditioning regimen & gvhd prophylaxis,1
43251,assessment of the follow-up of oncological and geriatric recommendations 4 months after the rcp,1
43252,iniparib (sar240550 - bsi-201),1
43253,rapid testing,1
43254,physical therapy protocol,1
43255,stereotactic radiosurgery (15 gy),1
43256,gemcitabine + s-1,1
43257,ofdi capsule imaging,1
43258,hla-mismatched donor peripheral stem cell infusion,1
43259,"cyclophosphamide, fludarabine, t-cell infusion, and interleukin-2",1
43260,adjustment of mechanical ventilator inspiratory to expiratory time ratio (1:1 to 1:2),1
43261,nutri-jelly with peitc,1
43262,thromboprophylaxis,1
43263,artificial saliva,1
43264,"levonorgestrel, ethinyl estradiol 0.1-0.02mg oral tablet",1
43265,chemotherapy (5-fluorouracil),1
43266,risk assessment,1
43267,vs3 - 3dhd camera,1
43268,3d surface imaging using a non portable and portable camera,1
43269,eortc qlq- fa13,1
43270,serum concentration /serum inflammatory,1
43271,active comparator: vinblastine and methotrexate,1
43272,60gy in 30#,1
43273,advanced cancer symptom management,1
43274,pedicled nerve flap,1
43275,azd9291 80 mg/40 mg,1
43276,bilateral vocal cord paralysis,1
43277,"epirubicin , pirarubicin , hydroxycamptothecin and fluorouracil",1
43278,tg101348,1
43279,tranexamic acid (txa).,1
43280,administration of rrp450 into the hepatic artery,1
43281,countering cognitive impairment,1
43282,arm f da v idac,1
43283,autologous expanded mesenchymal stem cells oti-010,1
43284,dexamethasone and cyclophosphamide,1
43285,"omp-54f28, paclitaxel and carboplatin",1
43286,grooved pegboard,1
43287,"wet suction, slow-pull, standard suction",1
43288,orcellex® rovers brush,1
43289,epoch ii,1
43290,multidimensional rehabilitation after radiotherapy,1
43291,immuno-therapeutic agent,1
43292,sar440234,1
43293,single photon emission tomography,1
43294,betametason 4 mg,1
43295,alphamedix,1
43296,decitabine iv,1
43297,baseline healthcare provider assessment,1
43298,bn-brachyury plus radiation,1
43299,open group,1
43300,bi-6727,1
43301,intrathecal cytarabine (also known as ara-c),1
43302,arimidex placebo,1
43303,"theragene®,ad5-ycd/muttksr39rep-adp",1
43304,canola oil placebo,1
43305,stroke volume variation,1
43306,xpert bladder test,1
43307,part a: debio 1143,1
43308,second forward view (sfv) examination of the right colon,1
43309,simvastatin in addition to radiation therapy,1
43310,radiation therapy groups,1
43311,aracytine (ara c),1
43312,mri guided transurethral hifu ablation of prostatic tissue,1
43313,"cetuximab, irinotecan, capecitabine",1
43314,placebo and docetaxel,1
43315,the center for epidemiological study-depression,1
43316,high dose-rate brachytherapy,1
43317,unsuspected retinoblastoma,1
43318,oncotype dx breast recurrence score,1
43319,cyclophosphamide pill,1
43320,tace containing as2o3,1
43321,nepa,1
43322,pemprolizumab,1
43323,percutaneous local abalation,1
43324,tace + rg3,1
43325,pneumovax,1
43326,uv4me,1
43327,optune(novottf-100a),1
43328,restored kidney transplant between family members,1
43329,laparoscopic colonic resection,1
43330,imexon placebo + gemcitabine,1
43331,exercise and compression garment,1
43332,neck dissection of at least the ipsilateral sub-level 1b,1
43333,afuresertib gc - fed state,1
43334,contrast enhanced spectral mammography,1
43335,self-directed,1
43336,cnto 95 and avastin,1
43337,"mri, fdg-pet/ct scans",1
43338,intensive fitness intervention,1
43339,laparoscopy endoscopy cooperated surgery,1
43340,lifestyle weight loss intervention,1
43341,alt-803 intraperitoneal,1
43342,fractionated radiation therapy followed by chemotherapy,1
43343,lor-253 hcl,1
43344,multiplex ligation-dependent probe amplification (mpla) brca1 brca2,1
43345,follow-up colonoscopy,1
43346,kin keepersm cancer prevention intervention,1
43347,exercise and relaxation intervention,1
43348,skeletal scintigraphy,1
43349,part a - vs-6063,1
43350,exercise and dietary education,1
43351,"tab cefixime,tab azithromycin",1
43352,lpm3480226,1
43353,patient liaison,1
43354,placebo-control meals and snacks,1
43355,autologous dendritic cells electroporated with wt1 mrna,1
43356,gp96-ig vaccine,1
43357,talazoparib plus irinotecan,1
43358,this is a non-intervention study for all groups.,1
43359,circular-stapled esophagogastric anastomosis,1
43360,sham procedure plus anti-secretory medication,1
43361,m.d. anderson symptom inventory (mdasi),1
43362,cabozantinib (xl184) 140 mg,1
43363,single agent,1
43364,su011248; capecitabine,1
43365,aloe barbadensis topical application in a moisturizing cream vehicle.,1
43366,leuprolide acetate - formulation a,1
43367,mitomycin-c/ 5-fluorouracil,1
43368,adrc-enhanced autologous fat transplant,1
43369,rubidium rb-82,1
43370,bgb-a317 and etoposide and cisplatin (or carboplatin),1
43371,177lu-dotatate 25.9 gbq activity,1
43372,early bladder training,1
43373,temozolomide & radiation therapy,1
43374,participant satisfaction survey,1
43375,sensory nerve coaptation,1
43376,trasgex™,1
43377,sorafenib + paclitaxel + carboplatin,1
43378,comparison of surgical margins by coe vs. dvfe,1
43379,cbi plus sbrt,1
43380,radiation (5 days),1
43381,tpc,1
43382,tyrosine kinase inhibitor (tkis),1
43383,bevacizumab and trastuzumab maintenance therapy,1
43384,simmitecan,1
43385,vantictumab combined with paclitaxel,1
43386,patients with antifungal prophylaxis,1
43387,doxorubicin + cyclophosphamide,1
43388,fice (fujinon intelligent chromoendoscopy),1
43389,"ksp-910638g, 0.4 mg",1
43390,bms-901608 (elotuzumab) 10 mg,1
43391,durvalumab + tremelimumab + rt,1
43392,ultrasound of the head and neck,1
43393,physical activity and energy restriction,1
43394,standard fluroscopy,1
43395,kanitinib,1
43396,green tea + vitamin c high dose,1
43397,irinotecan and gemcitabine,1
43398,gene expression study,1
43399,questionnaire about the use of ecg device,1
43400,wst09,1
43401,scprt plus neoadjuvant chemotherapy,1
43402,peak plasmablade,1
43403,biopsy + radioactive seed placement,1
43404,ethinyl estradiol 35 mcg and drospirenone 3 mg,1
43405,jejunostomy,1
43406,bay 1000394 (roniciclib) in combination with docetaxel,1
43407,azacitidine in combination with temozolomide,1
43408,gerdq,1
43409,0.5% ropivacaine local anaesthesia,1
43410,conventional fractionated imrt boost radiotherapy,1
43411,microwave ablaton,1
43412,endoscopic follow-up,1
43413,tsb-9-w1,1
43414,virtual reality intervention,1
43415,an attention-control group,1
43416,ipilimumab at 3 mg/kg dose,1
43417,muscadine grape skin extract,1
43418,"hiltonol, dendritic cells and radiation",1
43419,liposomal doxorubicin and docetaxel,1
43420,mpdl3280a dose level 3,1
43421,accuboost apbi,1
43422,hydralazine and valproic acid: cohort -1,1
43423,symbiotic,1
43424,monomark,1
43425,"calcium carbonate (tums), vitamin d",1
43426,peritonectomy,1
43427,move for surgery preconditioning program using a wearable activity tracker (fitbit) intervention group,1
43428,lavender (lavandula angustifolia),1
43429,cpt- 11,1
43430,discontinuation of imatinib,1
43431,sar566658 (act14884),1
43432,blood analysis by epispot and cellsearch®,1
43433,nano knife,1
43434,gemcitabine plus pm060184,1
43435,optimal booster,1
43436,temozolomide or pcv,1
43437,faza pet scan,1
43438,bn83495 (cohort 3),1
43439,"cycles n8, n5 and n6",1
43440,gp2 peptide + gm-csf vaccine,1
43441,both 2nd and 3rd doses on time,1
43442,blood samples for pharmacokinetics exploration,1
43443,simultaneously,1
43444,pemetrexed and carboplatin,1
43445,sequence chemotherapy and radiotherapy (scrt),1
43446,navi mapping with indocyanine green,1
43447,maxacalcitol placebo,1
43448,zeep group,1
43449,olympus transparent cap,1
43450,accelerated partial breast irradiation - 3d-conformal planning,1
43451,immediate cbt,1
43452,flucam [fludara + campath],1
43453,pancreaticojejunostomy vs pancreaticogastrostomy,1
43454,foscarnet sodium,1
43455,human stem cells,1
43456,cdx-1307 vaccine regimen,1
43457,communication training program and patient prompt sheet,1
43458,citalopram,1
43459,4sc-202,1
43460,lymphodepletion,1
43461,hyperacute®-melanoma (ham) immunotherapy,1
43462,take-n-slide,1
43463,melanoma reactive til,1
43464,humara assay,1
43465,"sra737, gemcitabine",1
43466,ls pet/ct,1
43467,endoscopic eradication therapies (eet),1
43468,text-message reminders,1
43469,omics identity card,1
43470,diagnostic b20- spect imaging.,1
43471,androxal (enclomiphene citrate),1
43472,standard of care smoking cessation smartphone app,1
43473,cd34+ derived dcs,1
43474,mammosite or other single-entry intracavitary device,1
43475,study group,1
43476,gm csf,1
43477,3 x fec 3 x doc,1
43478,project onward website,1
43479,operation;tace plus pei,1
43480,chop regimen alternate with eshap regimen,1
43481,phase i- cytarabine & eltrombopag,1
43482,performance of r-pem,1
43483,recmage-a3 protein + as15 adjuvant,1
43484,hua33 antibody plus chemotherapy,1
43485,written decision aid,1
43486,aviator anterior cervical plating system,1
43487,immediate resection,1
43488,pol arm,1
43489,azd 1775,1
43490,course evaluations,1
43491,decision group - outcome measures,1
43492,2 mediterranean,1
43493,"bortezomib, melphalan, prednisone (vmp)",1
43494,gtx-024 9 or 18 mg,1
43495,da vinci surgical system model is4000,1
43496,idaho,1
43497,hypofractionated stereotactic boost,1
43498,oral cryotherapy,1
43499,[18f]dcfpyl pet/mri scan,1
43500,mobility and activity training,1
43501,single port laparoscopic surgery,1
43502,high-dose conformal radiation therapy,1
43503,surgery(robot versus laparoscopy),1
43504,bmn-673,1
43505,injection of hx-4,1
43506,aflatoxin,1
43507,eucerin,1
43508,untreated control,1
43509,i-131 metaiodobenzylguanidine,1
43510,traditional suture material,1
43511,abdominal/pelvic radiation therapy,1
43512,low-dose involved-field radiotherapy,1
43513,neutrosis,1
43514,cyc116,1
43515,10% maltose,1
43516,standard gvhd prophylaxis,1
43517,blood oxygen level dependent imaging,1
43518,octreotide fluidcrystal® injection depot,1
43519,rxc004,1
43520,cerebral oxygen monitoring,1
43521,lenalidomide 10 mg,1
43522,unmedicated lactose/sucrose globule,1
43523,quirem medical holmium-166 radioembolization microspheres,1
43524,patientslikeme (plm),1
43525,experimental treatment (pcde or pe + bevacizumab),1
43526,"taxane (cytotoxic, bay59-8862)",1
43527,"interstitial high dose-rate brachytherapy, pbi",1
43528,technology,1
43529,trebananib 3 mg/kg,1
43530,"enumeration of endothelial cell progenitor in peripheral blood by flow cytometry, endothelial cell progenitor characterization by primary cell cultures",1
43531,whole-body mri,1
43532,emi-137,1
43533,[11c]osimertinib,1
43534,exposure to colon resection surgery,1
43535,fluoro-l-thymidine-(18f),1
43536,surgery after neoadjuvant therapy,1
43537,insertion of a single drain,1
43538,gene sequencing,1
43539,"ondansetron, dexamethasone, aprepitant",1
43540,tumor-reduction chemotherapy and stem cell mobilization,1
43541,131 i-8h9,1
43542,enhanced supportive care - status checks,1
43543,mage-10.a2,1
43544,peox-based polymer encapsulated paclitaxel fid-007,1
43545,mesna (prior to auto transplant),1
43546,transcatheter hepatic arterial chemoembolization,1
43547,biopsies of the prostatic fossa in magdeburg,1
43548,placebo for bevacizumab 7.5 mg/kg,1
43549,"docetaxel, cisplatin, 5 fluorouracil",1
43550,focus group - parent/caregiver,1
43551,sorafenib plus cisplatin and 5-fluorouracil,1
43552,ro1507,1
43553,czt semiconductor detectors,1
43554,docetaxol,1
43555,onalespib lactate,1
43556,cabazitaxel 17.5mg/m2,1
43557,behavioral counseling sessions,1
43558,mg1ma3,1
43559,perioperative peripheral parenteral nutrition,1
43560,anamorelin,1
43561,"dacarbazine, temozolomide or talimogene laherparepvec",1
43562,no interventional study,1
43563,"self-measured arm circumference, therapist-measured arm-circumference, perometer-measured arm circumference",1
43564,trastuzumab - intravenous solution,1
43565,5 fucmt (chemoradiation),1
43566,ofatumumab combined with sb-485232,1
43567,"fluorescein injection, usp 10%",1
43568,doxil/caelyx (doxorubicin) treatment sequence ab,1
43569,iron sulphate,1
43570,anti cd45 monoclonal antibody,1
43571,stress echocardiogram,1
43572,aesthetic assessment 3d breast scanning,1
43573,gaba 15mg/kg group,1
43574,axitinib [ag-013736],1
43575,hexylaminolaevulinate cream,1
43576,"topotecan, vorinostat",1
43577,calorie restricted diet plus exercise,1
43578,hds vs promece/cytabom,1
43579,radiation therapy brain metastasis in breast cancer,1
43580,prostate artery embolization (pae),1
43581,educational support,1
43582,quitline-delivered proactive telephone counseling,1
43583,111in-idec-159,1
43584,esnap,1
43585,educational intervention-dvd & telephone based navigation,1
43586,arq 621,1
43587,spyglass dvs and spyglass ds,1
43588,enoxaparine,1
43589,metastatic gastroenteropancreatic and lung neuroendocrine tumors,1
43590,gd regimen,1
43591,gemzar and alimta,1
43592,exparel 1.33% (20ml volume),1
43593,ny-eso-1 olp4 + montanide + poly-iclc,1
43594,genasense,1
43595,folfiri+beacizumab,1
43596,5-aminolevulinic acid nanoemulsion,1
43597,17? estradiol hemihydrate,1
43598,nir/us process validation group,1
43599,cerebraca wafer,1
43600,tetanus,1
43601,progel sealant,1
43602,?-ifn,1
43603,home visit,1
43604,itraconazole (sporanox),1
43605,robot assisted laparoscopic hysterectomy,1
43606,liplacis,1
43607,ugt1a1 genotyping (ta7/ta7),1
43608,contrast-enhancement ultrasound with sonovue,1
43609,99mtc-etarfolatide,1
43610,three-incision thoracotomy,1
43611,whole body dynamic 68ga-dotatoc pet/ct,1
43612,cancer symptom questionnaire,1
43613,heliocare with fernblock ple technology,1
43614,modified limberg flap,1
43615,exergaming,1
43616,gonadotropin-releasing hormone (gnrh) agonist therapy,1
43617,embozene® microspheres,1
43618,elective field irradiation,1
43619,endocuff vision device,1
43620,oral voriconazole and iv amphotericin b,1
43621,two-stage with titanium coated polypropylene mesh (tilooop® bra),1
43622,"v501, gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine",1
43623,dendritic killer cell (dkc),1
43624,oral erlotinib and pulsed doses of oral at-101,1
43625,post-sabr biopsy,1
43626,intensified follow-up schedule,1
43627,part a) healthy subjects,1
43628,car-t cells targeting epcam,1
43629,ad100-gp96ig-hla a1,1
43630,the electroporation system,1
43631,fusidic acid,1
43632,multiparametric magnetic resonance imaging (mmri),1
43633,low adherence intervention group,1
43634,sirolimus 0.2%,1
43635,sm-rfa,1
43636,wt-1 analog peptide vaccine,1
43637,epacadostat 300 mg,1
43638,metal stent,1
43639,belloxa,1
43640,peg-paclitaxel,1
43641,radiochemotherapy cap 60,1
43642,"quality of life, status of employment",1
43643,ultrasound chest,1
43644,phase 2 : avelumab,1
43645,ave9633,1
43646,supervision of physical activity,1
43647,cisplatin-gemcitabine,1
43648,control group (closure of anesthetics),1
43649,micro rna,1
43650,transversus abdominis plane catheter,1
43651,proximally extended resection,1
43652,segmental reexamination,1
43653,liver transplantation and liver resection,1
43654,"irinotecan&temsirolimus:arm 1, level 2",1
43655,"diclofenac sodium gel, 3%",1
43656,igev,1
43657,traditional polyethylene stent insertion (cotton huibregtse),1
43658,weekly questionnaires,1
43659,e39 peptide (500mg)/gm-csf vaccine,1
43660,pgv001,1
43661,conventional transarterial chemoembolization (tace),1
43662,350 mg leronlimab,1
43663,pbmc re-infusion,1
43664,epoetin alfa plus iron,1
43665,"crizotinib, bevacizumab",1
43666,cd8+nkg2d+ akt cell,1
43667,siplizumab,1
43668,hyperbaric chemical saddle rhizotomy (6 % pherol in glycerin),1
43669,tivozanib (av-951) plus temsirolimus,1
43670,adaptative treatment plan,1
43671,tramadol hydrochloride; acetaminophen,1
43672,single intratumoral injection of dnx-2401,1
43673,tumorous biopsy,1
43674,hyperfractionated radiation therapy for both arms,1
43675,pbi radiotherapy 8 gy,1
43676,4 gy targeted radiotherapy,1
43677,fobt kit,1
43678,mesa,1
43679,serratus plane block,1
43680,robot-assisted cystectomy,1
43681,clin a. chop-campath (chemo-immunotherapy) + sct,1
43682,body acupuncture,1
43683,radiological arm,1
43684,conventional fraction imrt,1
43685,oral antiandrogen,1
43686,placebo - ascorbic acid,1
43687,peripheral blood sample (optional),1
43688,hpv self-sampling kit on demand,1
43689,peroperative scintillating probe,1
43690,cikatridina,1
43691,spect scan,1
43692,standard default ad forms,1
43693,vitamin e (at),1
43694,d-chiro-inositol,1
43695,pet/nir fluorescent imaging-guided surgery,1
43696,lhrh agonist or antagonist,1
43697,paclitaxel/carboplatin/gefitinib,1
43698,"epidoxorubicine, docetaxel, ciclophosphamide, methotrexate, fluorouracile",1
43699,meat-based diet,1
43700,clinical assessments and blood samples; follow-up for 12 mos,1
43701,sc-003,1
43702,yttrium y 90 anti-cd66 monoclonal antibody bw 250/183,1
43703,part c - azd9291 in combination with azd6094 (japan only),1
43704,copanlisib hydrochloride,1
43705,docetaxel(xrp6976) + modafinil,1
43706,pembrolizumab 25 mg(milligram)/ml,1
43707,"placebo, trastuzumab, docetaxel",1
43708,"fludarabine phosphate, busulfan",1
43709,other chemotherapy in association with trastuzumab,1
43710,temozolomide 150 mg x 5 days,1
43711,certolizumab pegol (cdp870),1
43712,fitness test,1
43713,?lgrastim and pegylated filgrastim,1
43714,whole body vibration resistance training,1
43715,branched-chain amoni acids (bcaa),1
43716,nestle boost high protein drink,1
43717,neoadjuvant chemotherapy (nact),1
43718,self-directed triple p,1
43719,ery001,1
43720,"22-gauge acquire® first, then 20-gauge procore®",1
43721,high-dose and autologous stem cell transplantation,1
43722,second-line therapy alone,1
43723,fitbit charge hr®,1
43724,mirena® intra-uterine device (iud),1
43725,trc105 and bevacizumab,1
43726,shuttle walk test,1
43727,tiweb,1
43728,abt-888 and mfolfox-6,1
43729,sirna-epha2-dopc,1
43730,myo-inositol+l-tyrosine,1
43731,lipiodol demarcation of the bladder tumour,1
43732,multicomponent mhealth intervention,1
43733,change platelet transfusion threshold,1
43734,beating the blues,1
43735,lc bead lumi™ (radiopaque (ro) bead) loaded with doxorubicin,1
43736,cd3-/cd56+,1
43737,high intensity interval training exercise programme,1
43738,open-label ridaforolimus (mk8669),1
43739,"oxaliplatin, irinotecan, s-1",1
43740,bat1706,1
43741,ovarian ultrasound scan,1
43742,thyrogen + radioiodine (131i),1
43743,peg-intron sc injection,1
43744,cd3-depleted/cd56+ selected natural killer cells collected from apheresis products,1
43745,"cisplatin, capecitabine, telatinib",1
43746,stent placement,1
43747,heavy ion radiotherapy (c12),1
43748,subcuticular reabsorbable suture (caprosyn),1
43749,experimental combination beyond focal progression,1
43750,standard dressings,1
43751,mri-guided laser heat ablation (mla),1
43752,test-and-treat ehr-chw intervention,1
43753,apixaban alone,1
43754,pazopanib use,1
43755,custirsen (ogx-011)/mitoxantrone,1
43756,endodrill biopsy,1
43757,oral satraplatin,1
43758,high voltage electrical stimulation - ( healthy women ),1
43759,urinary test,1
43760,infusion #2,1
43761,bipolar electrical resectoscope (versapoint),1
43762,triple therapy for h. pylori infection,1
43763,anastrazole (arimidex),1
43764,osimertinib mesylate tablets,1
43765,fludarabine plus darbopoetin,1
43766,cervical surgery,1
43767,"1 capsule, 3 times per day",1
43768,radiation therapy positioning system (rtps),1
43769,monoclonal antibody a27.15,1
43770,educational training program,1
43771,without intervention type,1
43772,pleural aspiration,1
43773,nivolumab/lirilumab,1
43774,f18fdg-pet,1
43775,nasogastric tube placement,1
43776,caris molecular intelligence profile,1
43777,pgl4001 5 mg,1
43778,dv281 (rp2d),1
43779,tumor infiltrating lymphocyte therapy,1
43780,"folfox regimen=oxaliplatin, fluorouracil, & folinic acid",1
43781,high fat diet,1
43782,"pgl4001, placebo, drug free period",1
43783,tissue sample from tumor,1
43784,6mp,1
43785,"standard topical treatment of the institution, e.g. lotio",1
43786,audio recorded information,1
43787,atrium express dry seal chest drain,1
43788,iv ibuprofen,1
43789,cisplatin + celecoxib + dc vaccine,1
43790,7t mri,1
43791,doxorubicin in combination with placebo,1
43792,dynamic contrast enhanced ultrasound,1
43793,fact-g questionnaire,1
43794,neoadjuvant radiochemotherapy in metabolic non responders,1
43795,separated resection of the splenic vein,1
43796,vst-1001,1
43797,single-port access surgery,1
43798,concomitant coaching,1
43799,ultrasonographic measurement of onsd,1
43800,genexol® 175mg/m2 plus carboplatin 5 auc,1
43801,indium-111-dota-girentuximab-irdye800cw,1
43802,"daratumumab, ixazomib, dexamethasone",1
43803,drug-packaging microparticles,1
43804,synthetic mesh,1
43805,hpv specific t cells,1
43806,whole body stir mri,1
43807,ovarian tissue cryopreservation,1
43808,etoricoxib,1
43809,cytoreductive nephrectomy,1
43810,fentanyl placebo,1
43811,celebrex plus metformin,1
43812,mineralocorticoid receptor antagonists,1
43813,stanford v chemotherapy,1
43814,deoxycytidine,1
43815,covered metal stent,1
43816,generic messages,1
43817,health related quality of life (hrqol) measures,1
43818,hydroxytyrosol,1
43819,revm10 gene,1
43820,"flag-ida (granulocyte-colony stimulating factor (g-csf), fludarabine, cytarabine, idarubicin)",1
43821,haploidentical allogeneic pbsc transp,1
43822,spirometry & flow volume loop assessment,1
43823,family based assessment,1
43824,once daily radiotherapy,1
43825,pembrolizumab dose b,1
43826,nibb: accuboost,1
43827,ramucirumab (imc-1211b) dp,1
43828,white light tur-bt,1
43829,abraxane and cisplatin combination,1
43830,gemcitabine + sunitinib,1
43831,"alignrt system (visionrt ltd., london, uk)",1
43832,shorter wb fractionation + boost,1
43833,"5-fu, oxaliplatin, leukovorin (flo)",1
43834,repaglinide,1
43835,oxygen measurement - eppendorf machine,1
43836,daily fatigue and sleep log,1
43837,laparoscopic d2 radical total gastrectomy without bursectomy,1
43838,lethally irradiated lymphoma cells with gm-csf k562 cells,1
43839,bevacizumab and pemetrexed/cisplatin,1
43840,docetaxel/paclitaxel,1
43841,cryothermal ablation,1
43842,tomuzotuximab,1
43843,a007,1
43844,interleukin-4,1
43845,gnrh (leuprolide),1
43846,classical letter,1
43847,standard physical therapy program,1
43848,aspiration alone,1
43849,olaparib and durvalumab,1
43850,topical calcipotriene ointment,1
43851,"rituximab, ifosfamide, etoposide, carboplatin",1
43852,panitumumab + folfox (dp),1
43853,nhs-il12 (mtd),1
43854,"atezolizumab (mpdl3280a), an engineered anti-programmed death-ligand 1 [pd-l1] antibody",1
43855,morab-066,1
43856,il-3,1
43857,imnovid,1
43858,lifestyle- supportive care,1
43859,endoscope+cellvizio(r) 100 microscope,1
43860,placebo beverage,1
43861,civasheet 75 gy,1
43862,lymphaticovenous anastomosis (lva),1
43863,cd19-tricar-t/silk,1
43864,gm-k562 vaccination,1
43865,samarium 153,1
43866,positron emission tomography (pet) scan imaging,1
43867,radical resection of colon cancer,1
43868,preoperative vestibular rehabilitation,1
43869,mc5-a scrambler device,1
43870,two stage breast reconstruction,1
43871,baseline 18f-thymidine (flt) pet/ct,1
43872,qigong exercise,1
43873,ta or tac,1
43874,hopkins verbal learning test-revised,1
43875,biopsy eus guided,1
43876,uterine manipulator (v care),1
43877,pazopanib 3 week,1
43878,standard of care control,1
43879,autologous car-t cells,1
43880,infrahepatic inferior vena cava clamping,1
43881,position change,1
43882,antigen-escalation stage,1
43883,goal-directed resuscitation therapy (gdt),1
43884,waitlist control ii,1
43885,expressive helping,1
43886,questionnaire application,1
43887,whole-body diffusion- weighted mri,1
43888,mila blooms,1
43889,smoking cessation program tfc-free and activity tracker,1
43890,needle localized breast biopsy with specimen x-ray,1
43891,trans-catheter embolization,1
43892,biopsies using apollo and urostation®,1
43893,leuprolide acetate for depot suspension,1
43894,3f8 and 13-cis-retinoic acid,1
43895,poor metabolism status follow up therapy considerations,1
43896,islet cell transplant plus,1
43897,pemetrexed/ cisplatin,1
43898,patient activation measure questionnaire,1
43899,ct53518,1
43900,ceop chemotherapy regimen for 6 cycles,1
43901,intracytoplasmic sperm injection (icsi),1
43902,moderate whole body hyperthermia using water-filtered ir-a-radiation,1
43903,no maintenance,1
43904,physicians' choice,1
43905,detection and measurement of carotid plaques,1
43906,"conformal 3d radiotherapy with "" eni ""-type prophylactic irradiation of the lymph node",1
43907,clomiphene citrate and folic acid,1
43908,oxychip,1
43909,intrauterine insemination or timed intercourse,1
43910,medication reconciliation: patient medication review,1
43911,intravenous busulphan,1
43912,"taper 3,4-dap to placebo",1
43913,neuropathic pain scale (nps) questionnaire,1
43914,mek 162 therapy or molecularly targeted therapy,1
43915,"blood sample, biopsy",1
43916,parietex parastomal,1
43917,usual care only,1
43918,trastuzumab and pertuzumab,1
43919,y-90 humanized anti-tac,1
43920,capri,1
43921,s65487,1
43922,vb10.neo,1
43923,cycle 2 induction / early consolidation,1
43924,novottf,1
43925,standard trans-arterial embolization (tae),1
43926,"chemoembolization ,radiofrequency ablation",1
43927,chemotherapies recommended in france,1
43928,monoclonal antibody 105ad7 anti-idiotype vaccine,1
43929,fast raman,1
43930,tmmr,1
43931,audio recorded interviews,1
43932,aldara (imiquimod),1
43933,preoperative oral carbohydrate drink,1
43934,alkotinib,1
43935,a arm (da-90),1
43936,heplisav-b,1
43937,"blood sampling, dxa-scan, bone scintigraphy",1
43938,"skindex-16, dlqi, skin health calculator",1
43939,cbti-cs,1
43940,indium in 111-labeled autologous polymorphonuclear leukocytes,1
43941,obtain tissue specimens,1
43942,muscadine plus,1
43943,mammography (cesm) and mri,1
43944,high frequency percussive ventilation,1
43945,directional brachytherapy source implant,1
43946,folfox6/cetuximab,1
43947,dexamethasone physician choice,1
43948,pelvic floor muscle exercise after stoma closure,1
43949,ramosetron 0.3mg,1
43950,4sc-201(resminostat),1
43951,gemcitabine+carboplatin,1
43952,spranc control group,1
43953,morab028,1
43954,strawberry gummy,1
43955,survivin vaccine,1
43956,thyroid surgical methods,1
43957,video game program,1
43958,induction pegfilgrastim,1
43959,highly purified urinary fsh,1
43960,conventional group,1
43961,donor bone marrow stem cell transplantation,1
43962,clinic proforma completion,1
43963,routine gene testing,1
43964,support services,1
43965,print da,1
43966,ono-7475 + ono-4538,1
43967,hpv (human papillomavirus) vaccine,1
43968,pevonedistat (baml-16-001-s9),1
43969,dopamine,1
43970,ductal lavage fluid collection,1
43971,end-of-study participant assessment,1
43972,decipher® testing,1
43973,dc/lncap,1
43974,"bi 6727, iv infusion",1
43975,v3-mommo,1
43976,[18f]vm4-037,1
43977,laparoscopic radical trachelectomy,1
43978,masoprocol,1
43979,classic physical activities,1
43980,gefitinib retreatment,1
43981,mce,1
43982,"comparator: mk0752, notch inhibitor - 3 days on, 4 off 350 mg",1
43983,bpi-7711 capsule,1
43984,standard of care complete decongestive therapy,1
43985,meaning-centered grief therapy (mcgt),1
43986,"new algorithm called veotm (general electric healthcare, milwaukee, mi, usa)",1
43987,unmanipulated ucb unit,1
43988,tricar-t-cd19,1
43989,ga-68 p16-093 pet/ct scan,1
43990,state trait anxiety inventory,1
43991,endocrine therapy interruption,1
43992,vicryl* plus suture,1
43993,exposure to different risk factors and molecular assessment,1
43994,cyclophosphamide (post-operative),1
43995,bilateral radiation,1
43996,iv bisphosphonates,1
43997,botulinum toxin type a 25 iu,1
43998,endonasal transsphenoidal pituitary tumor removal,1
43999,fat graft,1
44000,"ifosfamide, carboplatin, doxorubicin",1
44001,ly3127804,1
44002,0.9% sodium-chloride,1
44003,both inreach and outreach strategies,1
44004,thoracolumbosacral orthosis or cervicothoracolumbar orthosis,1
44005,abivertinib maleate capsules,1
44006,qlb,1
44007,vaccin genhevac b pasteur,1
44008,nanosomal docetaxel lipid suspension (100 mg/m2),1
44009,indium-111 pentetreotide,1
44010,single immediate chemotherapy instillation,1
44011,pegylated liposomal doxorubicin (doxil),1
44012,ovarian stimulation in vitro fertilization cryopreservation,1
44013,msk bfi questionnaires,1
44014,30 gy over 3 weeks,1
44015,idn-6556,1
44016,control group without pcos,1
44017,long gnrh agonist,1
44018,placebo vaginal gel,1
44019,"panitumumab, gemcitabine, oxaliplatin, capecitabine",1
44020,vocal-cord radiotherapy,1
44021,monoclonal antibody a33,1
44022,local hyperthermia,1
44023,selumetinib (azd6244 hyd sulfate) 25mg/m2,1
44024,radical surgery with hipec,1
44025,sertraline hydrochloride,1
44026,nexavar (sorafenib) and irinotecan (campto),1
44027,98% dehydrated alcohol,1
44028,testosterone implant,1
44029,0.06% resiquimod gel - a,1
44030,caresteps,1
44031,recombinant full human anti-egfr monoclonal antibody,1
44032,high position space group,1
44033,16.8 mg/kg ?-tea,1
44034,peripheral blood hematopoietic cell transplantation (hct),1
44035,mri + trus-guided biopsy,1
44036,gi-6301 (yeast brachyury vaccine),1
44037,plasma coagulation,1
44038,auy922 + trastuzumab,1
44039,"somatuline autogel® 60, 90 or 120 mg",1
44040,calcipotriol assisted mal-pdt,1
44041,vidaza (azacitidine),1
44042,magic mouth rinse,1
44043,communication analysis,1
44044,carbon-ion radiotherapy alone,1
44045,conventional digital mammography.,1
44046,js001 240mg+gp,1
44047,"gemcitabine, nab-paclitaxel, gdc-0449",1
44048,supersaturated calcium phosphate rinse,1
44049,prophylactic plnd - pelvic lymph node dissection,1
44050,azd5438,1
44051,retrieve blood samples,1
44052,prolong release brb confection,1
44053,interruption of the treatment by imatinib,1
44054,undergo voice evaluation and fmri prior,1
44055,bnz132-1-40,1
44056,"5-fu, epirubicin, cyclophosphamide, docetaxel, zoledronic acid",1
44057,one autologous transplant,1
44058,hyperfractionated radiotherapy with concomitant cetuximab,1
44059,combined paravertebral infusion and single shot of tap block,1
44060,youth perceptions of tobacco - text messages,1
44061,penguin cold caps,1
44062,mage-3 peptide,1
44063,drug: holiday,1
44064,dose 2,1
44065,bortezomib (ps-341),1
44066,ipilimumab it,1
44067,understanding value in metastatic breast cancer,1
44068,iort with kyphoplasty,1
44069,"brain radiotherapy (wbrt alone, srt/srs alone or wbrt plus srt/srs)",1
44070,management of therapy complications fitbit zip (portable pedometer device),1
44071,vinorelbine iv 25 or 20mg/m2,1
44072,colon cancer screening,1
44073,fish oil lipid emulsion,1
44074,concurrent chemoradiotherapy(ccrt),1
44075,4-valent hpv vaccine,1
44076,tnf inhibitor,1
44077,doxorubicin 50 mg/m^2,1
44078,rfa loosely wound thermal coil,1
44079,retroflexion with the adult colonoscope.,1
44080,psychosocial,1
44081,"expect™19flex needle (boston scientific corp.,natick,ma,usa)",1
44082,ultrasound guided serratus anterior block with ropivacaine,1
44083,dc/aat,1
44084,balanced fluid,1
44085,tislelizumab (bgb-a317) combined with oxaliplatin and capecitabine or tislelizumab (bgb-a317) combined with cisplatin and 5-fu,1
44086,screening advice based on a comprehensive risk assessment,1
44087,t-cell depletion,1
44088,phentolamine mesylate,1
44089,vehicle of test product,1
44090,expanded prostate cancer index composite sf12 questionnaire,1
44091,methylprednisolone 1 mg•kg-1,1
44092,symptom alert and coaching,1
44093,mage-3,1
44094,"radiotherapy, rituximab and dc",1
44095,drain removal at d4,1
44096,communication training and coaching,1
44097,mpc-3100 (an hsp90 inhibitor),1
44098,implant port,1
44099,fluorine-19-fluoroded xyglucose,1
44100,behavioral counseling,1
44101,histopathology analysis,1
44102,iv fluorine-18 labeled methylcholine before pet/ct,1
44103,multifocal lung adenocarcinoma,1
44104,conjugated linoleic acid (cla),1
44105,skin self- examination structured training,1
44106,anagrelide cr,1
44107,quantitative high resolution ct scan,1
44108,cytogenetic analysis of bone marrow specimen,1
44109,roferon-a,1
44110,"part 1, dose level 1 and dose level 2b: rucaparib",1
44111,maintenance treatment with capecitabine plus cetuximab,1
44112,genetically modified ctls in combo with cd45 antibodies,1
44113,exposure: adjuvant chemotherapy treatment,1
44114,immunotherapy treatment for melanoma,1
44115,pain coping skills,1
44116,university of michigan xerostomia index,1
44117,imrt with tomotherapy,1
44118,part 2: jnj-42756493,1
44119,3 weeks conventional everolimus dosing,1
44120,time restricted feeding,1
44121,fertility-sparing surgery,1
44122,?-hydroxy-?-methylbutyrate (hmb),1
44123,gb241,1
44124,hyperboloid,1
44125,myhealth,1
44126,leucovorin calcium injection,1
44127,patients with driver genes,1
44128,hypnoanalgesia group,1
44129,apatinib?250mg/d? combined with egfr-tki,1
44130,"bortezomib, rituximab, dexamethasone",1
44131,voraxaze,1
44132,lung cancer-specific t cells,1
44133,[18f]-labeled substance p antagonist receptor quantifier,1
44134,anti pd-1 with nab-paclitaxel,1
44135,shr9146+shr-1210+apatinib,1
44136,sun safe workplaces - technology,1
44137,pegcsf second level prophylactic use,1
44138,ablative co2 laser therapy,1
44139,ct contrast,1
44140,mk-4830,1
44141,regular physical therapy,1
44142,"online, non-adaptive mr-guided sbrt",1
44143,coagulation and fibrinolysis system,1
44144,nourish-t,1
44145,corn starch (250 mg approx.),1
44146,placebo (a list of resources),1
44147,methylprednisolone (mp),1
44148,artwork,1
44149,mri/ultrasound fusion-guided prostate biopsy,1
44150,health counseling and exercise,1
44151,wheatgerm juice,1
44152,therapeutic resection of the lesion,1
44153,volatile anesthetics,1
44154,autologous platelet-rich plasma,1
44155,"prostate cancer, phytochemical and pufa",1
44156,"vaccine mage-3.a1 peptide, or the na17.a2 peptide + il-2, ifn-? and gmcsf, imiquimod.",1
44157,early palliative care intervention,1
44158,"mage-a1, her-2/neu, fbp peptides ovarian cancer vaccine",1
44159,raf kinase inhibitor lgx818,1
44160,selexipag,1
44161,oc: ethinylestradiol (ee) 30 mcg and levonorgestrel (ln) 150 mcg,1
44162,68ga-nodaga-zigf-1r:4?40,1
44163,scleroplus,1
44164,genz-644282 (21-day dosing schedule),1
44165,sbrt 52.5 gy,1
44166,procervix,1
44167,whole-body magnetic resonance imaging,1
44168,pa-1-stk ovarian carcinoma vaccine,1
44169,utd1 injection plus capecitabine,1
44170,xr9576 (tariquidar),1
44171,"epirubicin, cyclophosphamide",1
44172,delis-kaplan executive function system (d-kefs) verbal fluency test,1
44173,maximum tolerated dose (mtd) of leronlimab,1
44174,pimasertib placebo,1
44175,bevacizumab plus alternating xelox/xeliri,1
44176,local surgery,1
44177,uniportal vats,1
44178,cinobufacini tablet,1
44179,240mg degarelix s.c. injection,1
44180,capsaicin supplement (cayenne by nature's way),1
44181,endoscopic submucosal dissection (esd),1
44182,targin,1
44183,pfc-mrsi,1
44184,nfhc-o2,1
44185,adoptive transfer of re-directed t cells,1
44186,standard materials,1
44187,mini-balance evaluation systems test,1
44188,prophylactic loperamide,1
44189,monitoring by sentinel application,1
44190,consolidation chemotherapy with docetaxel plus cisplatin,1
44191,sunitinib 2/1,1
44192,amc303,1
44193,pre-medication: decadron,1
44194,duodenal-pancreatectomy,1
44195,tac,1
44196,endoscopic approach thyroidectomy,1
44197,early palliative care referral,1
44198,two-piece nasogastric tube,1
44199,mfolfox6 or capox,1
44200,brentuximabvedotin (bv),1
44201,olaparib pill 150 mg,1
44202,"glucarpidase, high-dose methotrexate, leucovorin",1
44203,conventional biopsy forceps,1
44204,daily intake for 10 weeks (+/- 2 weeks),1
44205,conventional dosimetry,1
44206,treatment prevention for secondary cv,1
44207,initial gamma knife radiosurgery,1
44208,lorazepam (active control),1
44209,r-dhap/r-ice,1
44210,gsk2118436 75 mg,1
44211,photon radiation therapy,1
44212,endo-clot(tm),1
44213,low-frequency rotating magnetic therapy system,1
44214,low tie of ima,1
44215,intraperitoneal tgdcc-e1a,1
44216,neoadjuvant radiotherapy program:,1
44217,imatinib mesylate (im),1
44218,laparoscopic distal gastrectomy with d2 lymphadenectomy,1
44219,sndx-6352,1
44220,education information,1
44221,wireless activity tracker: fitbit,1
44222,hipec with mitomycin-c,1
44223,radiofrequency ablation (starmed),1
44224,conventional radiotherapy 74 gy delivered in 37 fractions,1
44225,clinical follow-up 1,1
44226,two step intervention including patient interview followed by an extended information routine to the patients' gp about the patients' rehabilitation needs,1
44227,mdc and pdc vaccination,1
44228,ruti®,1
44229,2-fluoro-2-deoxyglucose,1
44230,fes-pet scan,1
44231,lymphocyte,1
44232,ds-3032,1
44233,ly3143921 hydrate,1
